,os,dfi,dss,pfi,pfs,sex,case,race,type,batch,pfi_1,pfi_2,case_x,clinic,dfi_cr,dss_cr,gender,pfi_cr,ploidy,purity,hrd_loh,hrd_lst,hrd_tai,hrdcall,is_ffpe,os_time,subtype,dfi_time,dss_time,hrdscore,pfi_1_cr,pfi_2_cr,pfi_time,pfs_time,study_id,diagnosis,hrd_score,loh_genes,loh_n_seg,psa_preop,sample_id,sig3_muts,slide_map,metastasis,patient_id,pfi_time_1,pfi_time_2,cancer_type,days_to_mri,days_to_psa,dfi_time_cr,dss_time_cr,lab_prepped,mri_results,pfi_time_cr,sample_type,sig3_status,tumor_level,vial_number,delmut_genes,homdel_genes,oct_embedded,tumor_status,vital_status,birth_days_to,death_days_to,diagnosis_age,gleason_score,num_mutations,oncotree_code,pfi_time_1_cr,pfi_time_2_cr,race_category,sig3_relative,cause_of_death,clinical_stage,mutation_count,residual_tumor,sample_type_id,somatic_status,subclonal_frac,collection_site,collection_type,gleason_primary,other_sample_id,aneuploidy_score,bone_scan_result,genome_doublings,loh_frac_altered,menopause_status,other_patient_id,gleason_secondary,histological_type,longest_dimension,tumor_tissue_site,absolute_hrd_score,ethnicity_category,histologic_subtype,histological_grade,shortest_dimension,tissue_source_site,tmb_nonsynonymous_,bcr_patient_barcode,disease_free_status,gleason_grade_group,ascat2_gdc_hrd_score,cancer_type_detailed,disease_free_months_,form_completion_date,last_contact_days_to,new_tumor_event_site,new_tumor_event_type,patient_death_reason,cause_of_death_source,diagonstic_mri_result,icd_10_classification,pathology_report_uuid,sample_initial_weight,aneuploidy_score_prime,person_neoplasm_status,fraction_genome_altered,overall_survival_status,psa_most_recent_results,gleason_pattern_tertiary,overall_survival_months_,primary_tumor_laterality,ascat2_gdc_2015_hrd_score,ct_scan_ab_pelvis_results,days_to_ct_scan_ab_pelvis,informed_consent_verified,days_to_sample_collection_,initial_pathologic_dx_year,new_tumor_event_dx_days_to,new_tumor_event_site_other,pathology_report_file_name,patient_primary_tumor_site,ajcc_pathologic_tumor_stage,ct_scan_ab_pelvis_indicator,days_to_bone_scan_performed,tumor_cellularity_pathology,lymph_node_s_examined_number,neoplasm_histologic_type_name,number_of_samples_per_patient,year_cancer_initial_diagnosis,treatment_outcome_first_course,tumor_other_histologic_subtype,biochemical_recurrence_indicator,prior_cancer_diagnosis_occurence,surgical_margin_resection_status,specimen_second_longest_dimension,age_at_initial_pathologic_diagnosis,initial_pathologic_diagnosis_method,days_to_biochemical_recurrence_first,primary_therapy_outcome_success_type,tissue_prospective_collection_indicator,tissue_retrospective_collection_indicator,primary_lymph_node_presentation_assessment_ind_3,new_neoplasm_event_post_initial_therapy_indicator,american_joint_committee_on_cancer_tumor_stage_code,did_patient_start_adjuvant_postoperative_radiotherapy?,radical_prostatectomy_gleason_score_for_prostate_cancer,neoadjuvant_therapy_type_administered_prior_to_resection_text,adjuvant_postoperative_targeted_therapy_administered_indicator,last_alive_less_initial_pathologic_diagnosis_date_calculated_day_value,neoplasm_disease_lymph_node_stage_american_joint_committee_on_cancer_code,neoplasm_american_joint_committee_on_cancer_clinical_primary_tumor_t_stage,positive_finding_lymph_node_hematoxylin_and_eosin_staining_microscopy_count,neoplasm_american_joint_committee_on_cancer_clinical_distant_metastasis_m_stage,international_classification_of_diseases_for_oncology_third_edition_icd_o_3_site_code,international_classification_of_diseases_for_oncology_third_edition_icd_o_3_histology_code,slideId,tnbc,tigit,bbd_adh,bbd_alh,bbd_fea,bbd_udh,tacstd2,bbd_none,redaction,tnm_stage,tumor_type,macrophages,tumor_grade,angiogenesis,bbd_adenosis,bbd_mastitis,bbd_papilloma,disease_stage,margin_status,pd1_pdl1_score,site_of_sample,evaluation_date,bbd_duct_ectasia,bbd_fibroadenoma,bbd_gynecomastia,normaltissue_skin,normaltissue_brain,normaltissue_colon,normaltissue_liver,normaltissue_other,normaltissue_ovary,bbd_columnar_lesion,evaluation_feedback,normaltissue_nipple,normaltissue_pleura,tgfb_score_21050467,normaltissue_adipose,normaltissue_stomach,evaluation_stain_type,normaltissue_appendix,normaltissue_pancreas,nsclc_collection_type,bbd_fibrocystic_change,evaluation_pathologist,histologic_subtype_bbd,normaltissue_cartilage,bbd_apocrine_metaplasia,bbd_sclerosing_adenosis,evaluation_scan_quality,normaltissue_lymph_node,normaltissue_peritoneum,evaluation_specimen_type,evaluation_stain_quality,bbd_intraductal_papilloma,evaluation_collection_site,evaluation_section_quality,normaltissue_smooth_muscle,bbd_microglandular_adenosis,normaltissue_fallopian_tube,normaltissue_skeletal_muscle,normaltissue_small_intestine,evaluation_tissue_preparation,histologic_subtype_insitu_dcis,histologic_subtype_insitu_lcis,histologic_subtype_insitu_none,normaltissue_breast_epithelium,evaluation_biopsy_site_evidence,histologic_subtype_invasive_none,evaluation_normal_tissues_present,evaluation_in_situ_carcinoma_detail,histologic_subtype_insitu_carcinoma,metadata_primary_lymph_node_or_mets,evaluation_in_situ_carcinoma_present,histologic_subtype_insitu_dcis_solid,evaluation_invasive_carcinoma_present,histologic_subtype_invasive_carcinoma,bbd_apocrine_adenosis+apocrine_adenoma,evaluation_benign_breast_disease_present,histologic_subtype_insitu_dcis_papillary,bbd_radial_scar+complex_sclerosing_lesion,histologic_subtype_insitu_dcis_cribriform,normaltissue_lung_parenchyma_alveolar_space,histologic_subtype_insitu_dcis_micropapillary,histologic_subtype_insitu_detail_na_no_insitu,evaluation_mitotic_score_of_invasive_carcinoma,evaluation_nuclear_grade_of_invasive_carcinoma,histologic_subtype_insitu_dcis_solid_low_grade,histologic_subtype_insitu_uncertain_if_present,histologic_subtype_insitu_dcis_solid_high_grade,histologic_subtype_insitu_detail_comedonecrosis,normaltissue_bone_marrow_cellular+hematopoietic,histologic_subtype_invasive_uncertain_if_present,normaltissue_bone_marrow_sclerotic+reactive_bone,histologic_subtype_insitu_dcis_clinging_high_grade,histologic_subtype_insitu_dcis_papillary_low_grade,histologic_subtype_insitu_detail_no_detail_present,histologic_subtype_insitu_dcis_cribriform_low_grade,histologic_subtype_insitu_dcis_papillary_high_grade,histologic_subtype_insitu_dcis_cribriform_high_grade,histologic_subtype_insitu_detail_microcalcifications,histologic_subtype_insitu_detail_stromal_alterations,histologic_subtype_insitu_pagets_disease_of_the_nipple,histologic_subtype_invasive_invasive_lobular_carcinoma,histologic_subtype_insitu_dcis_micropapillary_low_grade,histologic_subtype_insitu_dcis_solid_intermediate_grade,histologic_subtype_insitu_dcis_micropapillary_high_grade,histologic_subtype_invasive_invasive_papillary_carcinoma,evaluation_tubule_formation_in_definite_invasive_carcinoma,histologic_subtype_insitu_dcis_clinging_intermediate_grade,histologic_subtype_invasive_invasive_carcinoma_metaplastic,histologic_subtype_insitu_dcis_papillary_intermediate_grade,histologic_subtype_invasive_invasive_ductal_carcinoma_other,histologic_subtype_insitu_dcis_cribriform_intermediate_grade,histologic_subtype_invasive_encapsulated_papillary_carcinoma,histologic_subtype_invasive_dcis_with_microinvasive_carcinoma,histologic_subtype_invasive_invasive_ductal_carcinoma_tubular,histologic_subtype_invasive_invasive_ductal_carcinoma_apocrine,histologic_subtype_invasive_invasive_ductal_carcinoma_mucinous,histologic_subtype_invasive_invasive_ductal_carcinoma_medullary,histologic_subtype_insitu_dcis_micropapillary_intermediate_grade,histologic_subtype_invasive_invasive_ductal_carcinoma_cribriform,histologic_subtype_invasive_invasive_ductal_carcinoma_micropapillary,histologic_subtype_invasive_invasive_ductal_carcinoma_no_special_type,histologic_subtype_invasive_invasive_carcinoma_mixed_ductal_lobular_features,histologic_subtype_invasive_invasive_lobular_carcinoma_classical+pleomorphic,histologic_subtype_insitu_uncommon_dcis_subtype_apocrine+neuroendocrine+signet_ring_cell+clear_cell,histologic_subtype_invasive_uncommon_tumors_benign+malignant_neuroendocrine+salivary_gland+epithelial+myoepithelial+mesenchymal+soft_tissue,age,egfr,kras,keap1,altered,egfr_mut,kras_mut,keap1_mut,m1_sign_mean,m2_sign_mean,ifng_sign_mean,tcell_gep_score,slide_group_name,nsclc_subtype_e2e,cd4_tcell_sig_mean,cd8_tcell_sig_mean,diagnosis_original,fapalpha_expression,suppr_cell_sig_mean,cd8a_expression_z_score,histologic_subtype_adenocarcinoma,histologic_subtype_squamous_cell_carcinoma,case_name,disease_name,partner_short_name,diagnosis_hist_sub_original
0,0,,0,0,0,Male,TCGA-2A-A8VL,,PRAD,389,0,0,,2A,,0,MALE,0,1.97,0.5,2,3,2,HRD,NO,621,1-ERG,,621,,0,0,621,621,prad_tcga,Malignant,7,,38,,TCGA-2A-A8VL-01,0,0,0,TCGA-2A-A8VL,621,621,Prostate Cancer,,585,,621,TCGA,,621,Primary,0,Middle|Base,A,,BRCA1;RAD54L,True,TUMOR FREE,Alive,-18658,,51,6,37,PRAD,621,621,,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,F9F392D3-E3C0-4CF2-AC7D-F21A497F716A,0,Normal (no evidence of prostate cancer) [cM0],0,0.033257,[Not Available],49197847-CC83-4CE1-8397-D09CEA4C4928,3,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,2A,0.766666666667,TCGA-2A-A8VL,0:DiseaseFree,1,8,Prostate Adenocarcinoma,20.4,3/29/14,621,,,,,NO,C61,FC65B44D-EDAD-4A48-A564-8721C5CD3AA8,140,0,TUMOR FREE,0.03,0:LIVING,0.05,4,20.4,Left,8,,,YES,1273,2010,,,TCGA-2A-A8VL.FC65B44D-EDAD-4A48-A564-8721C5CD3AA8.pdf,Peripheral Zone,[Not Applicable],NO,21,31-40%,15,Prostate Adenocarcinoma Acinar Type,1,2010,[Not Available],,NO,No,R0,,51,Core needle biopsy,,,NO,YES,YES,NO,T2b,NO,6,No,NO,0,N0,[Unknown],0,M0,C61.9,8140/3,5225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-2A-A8VV,,PRAD,389,0,0,,2A,,0,MALE,0,1.99,0.84,0,0,0,HRP,NO,671,1-ERG,,671,,0,0,671,671,prad_tcga,Malignant,0,,22,,TCGA-2A-A8VV-01,6,0,0,TCGA-2A-A8VV,671,671,Prostate Cancer,204,560,,671,TCGA,No Evidence of Extraprostatic Extension,671,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-19065,,52,6,32,PRAD,671,671,,0.186713199,[Not Available],[Not Applicable],26,R0,1,Matched,0.04,Prostate,Resection,3,CCADED36-56B9-471B-8348-094B33634EEB,0,Equivocal,0,0.011447,[Not Available],75A7AFB5-66D5-47E3-8A8A-3E3A1E749A96,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,2A,0.866666666667,TCGA-2A-A8VV,0:DiseaseFree,1,3,Prostate Adenocarcinoma,22.04,3/29/14,671,,,,,YES,C61,E42BC148-77A7-4FEB-9ACE-8BC2FFD33BF7,140,0,TUMOR FREE,0.0092,0:LIVING,0.05,4,22.04,Right,12,No Evidence of Extraprostatic Extension,29,YES,1155,2010,,,TCGA-2A-A8VV.E42BC148-77A7-4FEB-9ACE-8BC2FFD33BF7.pdf,Peripheral Zone,[Not Applicable],YES,167,31-40%,16,Prostate Adenocarcinoma Acinar Type,1,2010,[Not Available],,NO,No,R0,,52,Core needle biopsy,,,NO,YES,YES,NO,T2b,NO,6,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5228,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-2A-A8VX,,PRAD,,0,0,,2A,,0,MALE,0,1.99,0.9,1,4,1,HRP,NO,1378,,,1378,,0,0,1378,1378,prad_tcga,Malignant,6,,146,,TCGA-2A-A8VX-01,8,0,0,TCGA-2A-A8VX,1378,1378,Prostate Cancer,89,1033,,1378,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),1378,Primary,0,Middle,A,,,True,TUMOR FREE,Alive,-25904,,70,8,40,PRAD,1378,1378,,0.230409475,[Not Available],[Not Applicable],35,,1,Matched,0.05,Prostate,Resection,4,62C7D77A-C5C0-4D93-B200-EDD85D6E4E6C,2,Normal (no evidence of prostate cancer) [cM0],0,0.045553,[Not Available],942F1788-D977-4AC0-A177-659F9D4CD077,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,2A,1.16666666667,TCGA-2A-A8VX,0:DiseaseFree,4,8,Prostate Adenocarcinoma,45.27,3/29/14,1378,,,,,YES,C61,418E80EE-4886-43F5-9FB9-2619BC89351E,160,1,TUMOR FREE,0.0756,0:LIVING,0.05,,45.27,Bilateral,10,Extraprostatic Extension  Localized (e.g. seminal vesicles),32,YES,922,2011,,,TCGA-2A-A8VX.418E80EE-4886-43F5-9FB9-2619BC89351E.pdf,Peripheral Zone,[Not Applicable],YES,32,,16,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Available],,NO,No,R0,,70,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5229,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-2A-A8W1,,PRAD,389,0,0,,2A,,0,MALE,0,1.96,0.94,3,6,1,HRD,NO,112,2-ETV1,,112,,0,0,112,112,prad_tcga,Malignant,10,,129,,TCGA-2A-A8W1-01,6,0,0,TCGA-2A-A8W1,112,112,Prostate Cancer,,-122,,112,TCGA,,112,Primary,0,Middle|Base,A,,BRCA1,True,,Alive,-19964,,54,7,31,PRAD,112,112,,0.196518876,[Not Available],[Not Applicable],31,R1,1,Matched,0.01,Prostate,Resection,4,5E644B3A-432A-4E3E-93B6-F5B931029CB1,2,Normal (no evidence of prostate cancer) [cM0],0,0.077356,[Not Available],F5319FD5-BEAE-4CA8-8F42-45FCA5E6A2D2,3,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,2A,1.03333333333,TCGA-2A-A8W1,0:DiseaseFree,3,10,Prostate Adenocarcinoma,3.68,3/29/14,112,,,,,NO,C61,3A4CC21B-D751-49EA-BCFB-785B683423A0,140,2,,0.1079,0:LIVING,0.05,,3.68,Left,14,,,YES,888,2011,,,TCGA-2A-A8W1.3A4CC21B-D751-49EA-BCFB-785B683423A0.pdf,Peripheral Zone,[Not Applicable],NO,27,91-100%,12,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Available],,NO,No,R1,,54,Core needle biopsy,,,NO,YES,YES,NO,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,5230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-2A-A8W3,,PRAD,389,1,1,,2A,,0,MALE,1,1.97,0.44,3,3,5,HRP,NO,863,2-ETV1,,863,,1,1,198,198,prad_tcga,Malignant,11,,52,,TCGA-2A-A8W3-01,0,0,0,TCGA-2A-A8W3,198,198,Prostate Cancer,-14,771,,863,TCGA,No Evidence of Extraprostatic Extension,198,Primary,0,Apex|Middle|Base,A,,,True,[Discrepancy],Alive,-25557,,69,9,54,PRAD,198,198,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.01,Prostate,Resection,4,13958347-B417-4EFC-9450-FF58ABE9D7B0,1,Normal (no evidence of prostate cancer) [cM0],0,0.054694,[Not Available],5A790086-4887-4D2B-9C28-0FDD5DD1F1FB,5,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,2A,1.23333333333,TCGA-2A-A8W3,1:Recurred/Progressed,5,11,Prostate Adenocarcinoma,6.5,3/29/14,863,,Biochemical evidence of disease,,,YES,C61,EC74AC3A-610D-46E0-A4DA-1904E42E1EF8,150,2,,0.0776,0:LIVING,0.36,,28.35,Left,12,No Evidence of Extraprostatic Extension,13,YES,882,2011,198,,TCGA-2A-A8W3.EC74AC3A-610D-46E0-A4DA-1904E42E1EF8.pdf,Peripheral Zone,[Not Applicable],YES,13,86-95%,3,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Available],,YES,No,R0,,69,Core needle biopsy,198,,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5231,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-2A-AAYO,,PRAD,,0,0,,2A,0,0,MALE,0,1.98,0.73,3,2,1,,NO,1272,,1272,1272,,0,0,1272,1272,prad_tcga,Malignant,6,BRCA2,16,,TCGA-2A-AAYO-01,0,0,0,TCGA-2A-AAYO,1272,1272,Prostate Cancer,180,922,1272,1272,TCGA,No Evidence of Extraprostatic Extension,1272,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-21183,,57,6,28,PRAD,1272,1272,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.0,Prostate,Resection,3,A9272DFA-C8A7-460A-82D9-1C129DD9389E,1,,0,0.023113,[Not Available],8C0D361F-EAAB-4768-90F2-B7A610E2BBB1,3,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,2A,0.8,TCGA-2A-AAYO,0:DiseaseFree,1,,Prostate Adenocarcinoma,41.79,7/7/14,1272,,,,,YES,C61,3889AA76-F350-4DA4-987B-79E8D2349262,80,1,TUMOR FREE,0.0208,0:LIVING,0.05,,41.79,Bilateral,,,,YES,854,2011,,,TCGA-2A-AAYO.3889AA76-F350-4DA4-987B-79E8D2349262.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,57,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,5233,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-2A-AAYU,,PRAD,,0,0,,2A,,0,MALE,0,1.96,0.82,2,3,2,HRP,NO,615,,,615,,0,0,615,615,prad_tcga,Malignant,7,,65,,TCGA-2A-AAYU-01,0,0,0,TCGA-2A-AAYU,615,615,Prostate Cancer,52,269,,615,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),615,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20582,,56,6,32,PRAD,615,615,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.01,Prostate,Resection,3,64DDF375-8C9D-42D3-96CE-42BA38FE5B24,1,,0,0.041096,[Not Available],AA1A3A43-2F9C-456C-BA74-81C29B9801CB,3,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,2A,0.933333333333,TCGA-2A-AAYU,0:DiseaseFree,1,12,Prostate Adenocarcinoma,20.2,7/7/14,615,,,,,YES,C61,6CD9378F-F5A6-4214-8685-3D56ED6ADB0B,140,1,TUMOR FREE,0.04,0:LIVING,0.05,4,20.2,Left,14,,,YES,693,2012,,,TCGA-2A-AAYU.6CD9378F-F5A6-4214-8685-3D56ED6ADB0B.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,28,Prostate Adenocarcinoma Acinar Type,1,2012,[Discrepancy],,NO,No,R1,,56,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5234,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-4L-AA1F,,PRAD,,0,0,,4L,0,0,MALE,0,3.51,0.26,5,18,14,ambiguous,NO,350,,350,350,,0,0,350,350,prad_tcga,Malignant,37,BRCA1;BRCA2,63,,TCGA-4L-AA1F-01,0,0,0,TCGA-4L-AA1F,350,350,Prostate Cancer,5,350,350,350,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),350,Primary,0,Middle,A,,,False,TUMOR FREE,Alive,-23665,,64,8,37,PRAD,350,350,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.31,Prostate,Resection,4,E52B541A-EE14-4339-B1DB-DB00DD32CFAF,11,Abnormal (not related to prostate cancer),1,0.10152,[Not Available],47ABCD03-C6FF-4777-AC26-F880474092FF,4,Prostate Adenocarcinoma Acinar Type,,Prostate,35,,Acinar Adenocarcinoma,[Not Available],,4L,1.16666666667,TCGA-4L-AA1F,0:DiseaseFree,4,45,Prostate Adenocarcinoma,11.5,11/14/14,350,,,,,YES,C61,A9DCC04F-A189-408C-9EE0-9F36F388068D,380,21,TUMOR FREE,0.1387,0:LIVING,3.5,,11.5,Bilateral,43,Extraprostatic Extension  Localized (e.g. seminal vesicles),4,YES,64,2013,,,TCGA-4L-AA1F.A9DCC04F-A189-408C-9EE0-9F36F388068D.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,0,,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R1,,64,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3b,NO,8,No,YES,0,N0,T2c,0,M1a,C61.9,8140/3,5235,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-CH-5741,White,PRAD,91,0,0,,CH,0,0,MALE,0,1.94,0.82,4,7,1,HRP,NO,395,1-ERG,395,395,,0,0,395,395,prad_tcga,Malignant,12,,39,28.0,TCGA-CH-5741-01,0,0,0,TCGA-CH-5741,395,395,Prostate Cancer,,339,395,395,TCGA,,395,Primary,0,,A,,,,TUMOR FREE,Alive,-20759,,56,9,28,PRAD,395,395,WHITE,0.0,[Not Available],[Not Applicable],50,R1,1,Matched,0.0,Prostate,Resection,4,b22cbb75-e6e5-443d-ab4e-1cfd0079c69a,0,Normal (no evidence of prostate cancer) [cM0],0,0.060292,[Not Available],b3bf57d4-e31a-4740-b438-fa826fb79550,5,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,1.66666666667,TCGA-CH-5741,0:DiseaseFree,5,11,Prostate Adenocarcinoma,12.98,3/16/12,395,,,,,NO,C61,87c977cc-2a28-49c9-adaf-f67c0bc208c2,,1,TUMOR FREE,0.0576,0:LIVING,0.02,,12.98,Bilateral,12,No Evidence of Extraprostatic Extension,30,YES,,2008,,,TCGA-CH-5741.87c977cc-2a28-49c9-adaf-f67c0bc208c2.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,30,91-100%,5,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,0.4,56,Core needle biopsy,,,YES,NO,YES,,T3b,,9,No,,0,N1,,1,M0,C61.9,8550/3,5240,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-CH-5743,White,PRAD,91,0,0,,CH,0,0,MALE,1,,,,,,,NO,425,1-ERG,425,425,,0,0,425,425,prad_tcga,Malignant,,,,2.2,TCGA-CH-5743-01,,0,0,TCGA-CH-5743,425,425,Prostate Cancer,,394,425,425,TCGA,,425,Primary,,,A,,,,TUMOR FREE,Alive,-24321,,66,7,1,PRAD,425,425,WHITE,,[Not Available],[Not Applicable],3,R0,1,Matched,,Prostate,Resection,3,6bd8573d-535f-4f6d-8eaf-60918b5da578,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],2dee4bd8-b00e-4f8a-bfea-5d8d1a068202,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,0.1,TCGA-CH-5743,1:Recurred/Progressed,2,,Prostate Adenocarcinoma,13.96,3/16/12,425,,New Primary Tumor,,,NO,C61,e4f18f30-a6f0-4262-8f34-ce32db5cbe4a,,,TUMOR FREE,0.0,0:LIVING,0.1,,13.96,Bilateral,,No Evidence of Extraprostatic Extension,29,YES,,2008,425,,TCGA-CH-5743.e4f18f30-a6f0-4262-8f34-ce32db5cbe4a.pdf,Peripheral Zone,[Not Applicable],YES,29,51-60%,1,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.5,66,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,5241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5748,White,PRAD,91,0,0,,CH,,0,MALE,0,1.98,0.24,1,6,0,HRD,NO,31,2-ETV1,,31,,0,0,31,31,prad_tcga,Malignant,7,,23,1.6,TCGA-CH-5748-01,0,0,0,TCGA-CH-5748,31,31,Prostate Cancer,,,,31,TCGA,,31,Primary,0,,A,,BRCA2,,WITH TUMOR,Alive,-23649,,64,7,44,PRAD,31,31,WHITE,0.0,[Not Available],[Not Applicable],38,R1,1,Matched,0.06,Prostate,Resection,4,a499bf51-b137-4da9-87a3-d1b1a0f04695,0,,0,0.022403,[Not Available],0af98331-9305-41e9-af55-30390016d65e,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,1.26666666667,TCGA-CH-5748,0:DiseaseFree,3,15,Prostate Adenocarcinoma,1.02,3/21/12,31,,,,,NO,C61,7d2d5d7d-481b-445d-8505-42564e11fce4,,0,WITH TUMOR,0.0125,0:LIVING,,,1.02,Bilateral,19,,,YES,,2009,,,TCGA-CH-5748.7d2d5d7d-481b-445d-8505-42564e11fce4.pdf,,[Not Applicable],NO,,61-70%,2,Prostate Adenocarcinoma Acinar Type,1,2009,[Not Available],,,No,R1,0.4,64,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,,C61.9,8550/3,5245,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5761,White,PRAD,91,0,0,,CH,,0,MALE,0,1.96,0.7,12,11,9,ambiguous,NO,28,8-other,,28,,0,0,28,28,prad_tcga,Malignant,32,ATM;CHEK2,86,8.5,TCGA-CH-5761-01,14,0,0,TCGA-CH-5761,28,28,Prostate Cancer,28,39,,28,TCGA,Equivocal,28,Primary,1,,A,,,,TUMOR FREE,Alive,-22433,,61,9,65,PRAD,28,28,WHITE,0.218141296,[Not Available],[Not Applicable],63,R0,1,Matched,0.04,Prostate,Resection,5,332a54b1-2df4-4baa-84ac-2d95abef4064,7,Normal (no evidence of prostate cancer) [cM0],0,0.21699,[Not Available],854a481b-71a2-4f23-80aa-e91e9f4069b1,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,31,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,CH,2.1,TCGA-CH-5761,0:DiseaseFree,5,39,Prostate Adenocarcinoma,0.92,3/16/12,28,,,,,YES,C61,205f9f59-486c-4211-aa60-0a5b4f746a74,,9,TUMOR FREE,0.3199,0:LIVING,8.49,3,0.92,Left,44,Equivocal,28,YES,,2007,,,TCGA-CH-5761.205f9f59-486c-4211-aa60-0a5b4f746a74.pdf,Peripheral Zone,[Not Applicable],YES,28,81-90%,5,Prostate Adenocarcinoma Acinar Type,1,2007,[Not Available],,NO,No,R0,0.5,61,Core needle biopsy,,,YES,NO,YES,,T3b,,9,No,,0,N0,,0,M0,C61.9,8550/3,5251,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-CH-5767,White,PRAD,108,0,0,,CH,0,0,MALE,0,1.98,0.83,3,3,2,HRP,NO,458,8-other,458,458,,0,0,458,458,prad_tcga,Malignant,8,,47,11.6,TCGA-CH-5767-01,9,0,0,TCGA-CH-5767,458,458,Prostate Cancer,,377,458,458,TCGA,,458,Primary,0,,A,,,,TUMOR FREE,Alive,-24287,,66,7,46,PRAD,458,458,WHITE,0.187221263,[Not Available],[Not Applicable],44,R0,1,Matched,0.01,Prostate,Resection,4,a87e6352-c469-484d-87fc-fabdba237d01,1,,0,0.053292,[Not Available],8dc53431-44ab-485e-b4e6-c3d06509506d,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,CH,1.46666666667,TCGA-CH-5767,0:DiseaseFree,3,9,Prostate Adenocarcinoma,15.05,3/16/12,458,,,,,NO,C61,237374e0-5b18-407c-ae42-898a95c14fa2,,1,TUMOR FREE,0.0836,0:LIVING,0.04,,15.05,Bilateral,11,,,YES,,2007,,,TCGA-CH-5767.237374e0-5b18-407c-ae42-898a95c14fa2.pdf,Peripheral Zone,[Not Applicable],NO,,46-55%,19,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,0.4,66,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,5257,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5494,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.0,0.74,0,0,0,HRP,NO,1477,6-FOXA1,1477,1477,,0,0,1477,1477,prad_tcga,Malignant,0,,5,3.8,TCGA-EJ-5494-01,0,0,0,TCGA-EJ-5494,1477,1477,Prostate Cancer,,184,1477,1477,TCGA,,1477,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-18596,,50,7,38,PRAD,1477,1477,WHITE,0.0,[Not Available],[Not Applicable],42,R0,1,Matched,0.06,Prostate,Resection,4,37103479-02bd-45e8-95b3-7a4a78523999,0,,0,0.0013291,[Not Available],e27c50e2-2a41-4f8c-9ef8-2bc51fb0c23e,3,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.36666666667,TCGA-EJ-5494,0:DiseaseFree,3,0,Prostate Adenocarcinoma,48.52,3/29/12,1477,,,,,,C61,e52eefbc-e27d-4a5d-a261-d06a2dcf5d53,,0,TUMOR FREE,0.0008,0:LIVING,,4,48.52,Bilateral,2,,,YES,,2009,,,TCGA-EJ-5494.e52eefbc-e27d-4a5d-a261-d06a2dcf5d53.pdf,,[Not Applicable],,,76-85%,17,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,50,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5260,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5495,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.02,0.42,3,6,8,HRD,NO,1760,1-ERG,1760,1760,,0,0,1760,1760,prad_tcga,Malignant,17,BRCA2,13,10.8,TCGA-EJ-5495-01,46,0,0,TCGA-EJ-5495,1760,1760,Prostate Cancer,,606,1760,1760,TCGA,,1760,Primary,1,Middle|Base,A,BRCA2:723-724:-/X:frameshift_variant,,,TUMOR FREE,Alive,-24904,,68,8,99,PRAD,1760,1760,WHITE,0.486370408,[Not Available],[Not Applicable],75,R0,1,Matched,0.16,Prostate,Resection,5,8e53414f-455e-4665-ae0e-9e7405262a96,3,Normal (no evidence of prostate cancer) [cM0],0,0.065834,[Not Available],962dd3d5-8501-4658-8cb9-2424b476124c,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,2.5,TCGA-EJ-5495,0:DiseaseFree,4,30,Prostate Adenocarcinoma,57.82,3/29/12,1760,,,,,NO,C61,5c549c39-b223-49eb-aa93-0298cdf33370,,3,TUMOR FREE,0.0709,0:LIVING,0.13,4,57.82,Bilateral,31,,,YES,,2009,,,TCGA-EJ-5495.5c549c39-b223-49eb-aa93-0298cdf33370.pdf,,[Not Applicable],NO,26,66-75%,18,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.5,68,Core needle biopsy,,,YES,NO,YES,,T3b,,8,No,,0,N1,T1c,1,M0,C61.9,8550/3,5261,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5496,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.98,0.49,3,7,3,HRP,NO,595,1-ERG,595,595,,0,0,595,595,prad_tcga,Malignant,13,,12,6.5,TCGA-EJ-5496-01,0,0,0,TCGA-EJ-5496,595,595,Prostate Cancer,,595,595,595,TCGA,,595,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21897,,59,7,43,PRAD,595,595,WHITE,0.0,[Not Available],[Not Applicable],48,R0,1,Matched,0.01,Prostate,Resection,3,d0873929-eac8-42e2-af6f-df3cb9ce698c,1,Normal (no evidence of prostate cancer) [cM0],0,0.046786,[Not Available],6755c231-355f-4cc3-85f1-6306c7f5d44b,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.56666666667,TCGA-EJ-5496,0:DiseaseFree,2,11,Prostate Adenocarcinoma,19.55,3/30/12,595,,,,,NO,C61,80e82784-0bca-4657-9c9f-e9b860dc09bc,,2,TUMOR FREE,0.0687,0:LIVING,0.1,4,19.55,Bilateral,11,No Evidence of Extraprostatic Extension,15,YES,,2009,,,TCGA-EJ-5496.80e82784-0bca-4657-9c9f-e9b860dc09bc.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,15,31-40%,26,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,59,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5497,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.01,0.45,0,7,2,HRP,NO,405,1-ERG,405,405,,0,0,405,405,prad_tcga,Malignant,9,,8,7.2,TCGA-EJ-5497-01,5,0,0,TCGA-EJ-5497,405,405,Prostate Cancer,,204,405,405,TCGA,,405,Primary,0,Middle,A,,,,TUMOR FREE,Alive,-17523,,47,7,26,PRAD,405,405,WHITE,0.200493891,[Not Available],[Not Applicable],30,R0,1,Matched,0.01,Prostate,Resection,3,317be3b2-b7c1-4772-9e33-d55eb4b9faa9,0,,0,0.013986,[Not Available],dee02265-d8dd-4379-ae08-72d72b03a570,4,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,1.03333333333,TCGA-EJ-5497,0:DiseaseFree,2,10,Prostate Adenocarcinoma,13.3,3/30/12,405,,,,,NO,C61,4c6ab617-53f7-4556-a1a0-b44df4f67b6b,,0,TUMOR FREE,0.0283,0:LIVING,0.1,3,13.3,Bilateral,12,,,YES,,2009,,,TCGA-EJ-5497.4c6ab617-53f7-4556-a1a0-b44df4f67b6b.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,36-45%,10,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.6,47,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5498,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.3,0,0,0,HRP,NO,1720,1-ERG,1720,1720,,0,0,1720,1720,prad_tcga,Malignant,0,PALB2,6,5.0,TCGA-EJ-5498-01,0,0,0,TCGA-EJ-5498,1720,1720,Prostate Cancer,,537,1720,1720,TCGA,,1720,Primary,0,Middle,A,,,,TUMOR FREE,Alive,-20472,,56,7,46,PRAD,1720,1720,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.02,Prostate,Resection,4,aaf0af43-dae0-4aa7-9d4c-6caf1f039857,2,Normal (no evidence of prostate cancer) [cM0],0,0.033409,[Not Available],79ec7468-9aaf-4bb0-94c7-72be4f497868,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,1.3,TCGA-EJ-5498,0:DiseaseFree,3,7,Prostate Adenocarcinoma,56.5,3/30/12,1720,,,,,NO,C61,53d058fd-5faa-43ab-8a5e-b6f95134970b,,1,TUMOR FREE,0.0012,0:LIVING,0.1,3,56.5,Bilateral,8,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-EJ-5498.53d058fd-5faa-43ab-8a5e-b6f95134970b.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,12,31-40%,26,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.7,56,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,,C61.9,8550/3,5264,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5499,Asian,PRAD,91,0,0,,EJ,0,0,MALE,0,1.95,0.47,2,4,2,HRP,NO,1415,1-ERG,1415,1415,,0,0,1415,1415,prad_tcga,Malignant,8,,34,5.2,TCGA-EJ-5499-01,0,0,0,TCGA-EJ-5499,1415,1415,Prostate Cancer,,533,1415,1415,TCGA,,1415,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-22286,,61,7,45,PRAD,1415,1415,ASIAN,0.0,[Not Available],[Not Applicable],42,R0,1,Matched,0.0,Prostate,Resection,4,22c4f5c2-1b1e-4212-8110-09dbd5ce10a9,1,,0,0.045521,[Not Available],fd1aa612-df86-4d48-892d-2acebd76ea96,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.36666666667,TCGA-EJ-5499,0:DiseaseFree,3,7,Prostate Adenocarcinoma,46.48,3/30/12,1415,,,,,,C61,f69e29da-24d1-45f2-9b4f-a32f9e5479a4,,1,TUMOR FREE,0.0438,0:LIVING,0.1,3,46.48,Bilateral,10,,,YES,,2010,,,TCGA-EJ-5499.f69e29da-24d1-45f2-9b4f-a32f9e5479a4.pdf,Overlapping / Multiple Zones,[Not Applicable],,,26-35%,19,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.9,61,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5265,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5501,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.93,0.37,4,6,2,ambiguous,NO,1365,2-ETV1,1365,1365,,0,0,1365,1365,prad_tcga,Malignant,12,,34,2.7,TCGA-EJ-5501-01,0,0,0,TCGA-EJ-5501,1365,1365,Prostate Cancer,,729,1365,1365,TCGA,,1365,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-20409,,55,7,38,PRAD,1365,1365,WHITE,0.0,[Not Available],[Not Applicable],22,R0,1,Matched,0.0,Prostate,Resection,4,a1e37a0a-67f5-4a19-a540-a45cb89c4203,2,Normal (no evidence of prostate cancer) [cM0],0,0.073675,[Not Available],8df0c1e8-966c-4f46-ad15-fae9e745a32e,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.733333333333,TCGA-EJ-5501,0:DiseaseFree,3,14,Prostate Adenocarcinoma,44.84,3/30/12,1365,,,,,NO,C61,630dee46-15db-4a16-84ee-a9d25fcccb80,,3,TUMOR FREE,0.0709,0:LIVING,0.1,5,44.84,Bilateral,17,No Evidence of Extraprostatic Extension,9,YES,,2010,,,TCGA-EJ-5501.630dee46-15db-4a16-84ee-a9d25fcccb80.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,9,71-80%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.0,55,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5266,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5502,,PRAD,91,0,0,,EJ,0,0,MALE,0,2.0,0.94,0,0,0,ambiguous,NO,1171,1-ERG,1171,1171,,0,0,1171,1171,prad_tcga,Malignant,0,,0,5.3,TCGA-EJ-5502-01,0,0,0,TCGA-EJ-5502,1171,1171,Prostate Cancer,,603,1171,1171,TCGA,,1171,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-18447,,50,7,12,PRAD,1171,1171,,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,0.0,Prostate,Resection,4,d36a0b54-6e09-4ee2-923b-c1516d78bb03,0,Normal (no evidence of prostate cancer) [cM0],0,0.0,[Not Available],48e83a4c-c602-494a-80cd-e2f4b4dd701e,3,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.766666666667,TCGA-EJ-5502,0:DiseaseFree,3,10,Prostate Adenocarcinoma,38.47,3/30/12,1171,,,,,NO,C61,173e45e9-e2ab-4a1d-8bcc-15374f1ae511,,0,TUMOR FREE,0.0,0:LIVING,0.1,3,38.47,Bilateral,20,No Evidence of Extraprostatic Extension,7,YES,,2010,,,TCGA-EJ-5502.173e45e9-e2ab-4a1d-8bcc-15374f1ae511.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,7,41-50%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.0,50,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5267,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5503,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.0,0.9,0,0,0,HRP,NO,1391,1-ERG,1391,1391,,0,0,1391,1391,prad_tcga,Malignant,0,,0,18.4,TCGA-EJ-5503-01,0,0,0,TCGA-EJ-5503,1391,1391,Prostate Cancer,,530,1391,1391,TCGA,,1391,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-18395,,50,8,5,PRAD,1391,1391,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,5,627b9ff8-2557-4470-824a-b76a8bcd1e9f,0,Normal (no evidence of prostate cancer) [cM0],0,0.0,[Not Available],aa252f78-ebf3-42f9-86af-bb6e57345706,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,0.8,TCGA-EJ-5503,0:DiseaseFree,4,0,Prostate Adenocarcinoma,45.7,3/30/12,1391,,,,,NO,C61,81ca6538-6023-4e21-bd59-0b248e5642ac,,0,TUMOR FREE,0.0002,0:LIVING,0.1,4,45.7,Bilateral,1,No Evidence of Extraprostatic Extension,31,YES,,2010,,,TCGA-EJ-5503.81ca6538-6023-4e21-bd59-0b248e5642ac.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,31,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.0,50,Core needle biopsy,,,YES,NO,YES,,T3a,,8,No,,0,N0,T2b,0,M0,C61.9,8550/3,5268,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5506,White,PRAD,91,0,0,,EJ,0,0,MALE,0,,,,,,,NO,1381,1-ERG,1381,1381,,0,0,1381,1381,prad_tcga,Malignant,,,,7.2,TCGA-EJ-5506-01,0,0,0,TCGA-EJ-5506,1381,1381,Prostate Cancer,,356,1381,1381,TCGA,,1381,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-24617,,67,8,8,PRAD,1381,1381,WHITE,0.0,[Not Available],[Not Applicable],15,RX,1,Matched,,Prostate,Resection,5,9ebda113-b0fc-4233-87ac-dad0e7d033de,,,,,[Not Available],e5e4d3b6-8e58-4dcf-8f67-a00e656a8e27,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,0.5,TCGA-EJ-5506,0:DiseaseFree,4,,Prostate Adenocarcinoma,45.37,4/2/12,1381,,,,,NO,C61,4b6b88e5-b9f5-4bed-8320-b227a30bd1a9,,,TUMOR FREE,0.0,0:LIVING,0.1,4,45.37,Bilateral,,,,YES,,2010,,,TCGA-EJ-5506.4b6b88e5-b9f5-4bed-8320-b227a30bd1a9.pdf,,[Not Applicable],NO,,61-70%,7,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,RX,1.0,67,Core needle biopsy,,,YES,NO,YES,,T3b,,8,No,,0,N1,T3b,1,M0,C61.9,8550/3,5271,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5507,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.83,0.68,9,3,4,ambiguous,NO,1457,1-ERG,1457,1457,,0,0,1457,1457,prad_tcga,Malignant,16,BRCA2;RAD51C,37,8.9,TCGA-EJ-5507-01,0,0,0,TCGA-EJ-5507,1457,1457,Prostate Cancer,,182,1457,1457,TCGA,,1457,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-19759,,54,9,44,PRAD,1457,1457,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.15,Prostate,Resection,4,f93327f7-0290-4915-97bb-e31bae2697dd,3,,0,0.17546,[Not Available],607200f5-df80-4f5d-90fb-fdc455a7415b,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,16,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.3,TCGA-EJ-5507,0:DiseaseFree,5,23,Prostate Adenocarcinoma,47.86,4/2/12,1457,,,,,NO,C61,153de441-fbe9-4c8b-9a84-9cdf9c5edcf2,,8,TUMOR FREE,0.1945,0:LIVING,0.1,4,47.86,Bilateral,27,,,YES,,2010,,,TCGA-EJ-5507.153de441-fbe9-4c8b-9a84-9cdf9c5edcf2.pdf,,[Not Applicable],NO,,81-90%,21,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.6,54,Core needle biopsy,,,YES,NO,YES,,T3b,,9,No,,0,N1,T2c,2,M0,C61.9,8550/3,5272,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5508,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.99,0.34,1,1,2,HRP,NO,1965,1-ERG,1965,1965,,0,0,1965,1965,prad_tcga,Malignant,4,,6,7.4,TCGA-EJ-5508-01,0,0,0,TCGA-EJ-5508,1965,1965,Prostate Cancer,,907,1965,1965,TCGA,,1965,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-23758,,65,7,30,PRAD,1965,1965,WHITE,0.0,[Not Available],[Not Applicable],54,R0,1,Matched,0.0,Prostate,Resection,3,e3969bf5-b0cc-49e3-b8cb-3d9e98f1676d,0,,0,0.012553,[Not Available],bd18dd01-d894-4bdd-9ce2-e25705a52a57,4,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.83333333333,TCGA-EJ-5508,0:DiseaseFree,2,4,Prostate Adenocarcinoma,64.55,4/2/12,1965,,,,,NO,C61,d2590559-0eb6-479e-ba3a-b59c3429ca6d,,0,TUMOR FREE,0.0136,0:LIVING,0.1,4,64.55,Bilateral,6,,,YES,,2008,,,TCGA-EJ-5508.d2590559-0eb6-479e-ba3a-b59c3429ca6d.pdf,,[Not Applicable],NO,,61-70%,17,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.6,65,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5273,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5509,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.51,4,11,0,HRD,NO,1464,5-SPOP,1464,1464,,0,0,1464,1464,prad_tcga,Malignant,15,,78,4.1,TCGA-EJ-5509-01,5,0,0,TCGA-EJ-5509,1464,1464,Prostate Cancer,,1102,1464,1464,TCGA,,1464,Primary,0,Apex|Middle|Base,A,,ATM,,TUMOR FREE,Alive,-23368,,63,7,26,PRAD,1464,1464,WHITE,0.160683284,[Not Available],[Not Applicable],37,R0,1,Matched,0.11,Prostate,Resection,3,99a7115e-046b-488e-95d2-48c35bd29867,2,,0,0.087678,[Not Available],13ce70a8-785c-4b59-b073-41922cb201f9,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,1.23333333333,TCGA-EJ-5509,0:DiseaseFree,2,17,Prostate Adenocarcinoma,48.09,4/2/12,1464,,,,,NO,C61,672ff51d-12ba-402a-b6d6-87cc9c91e7ad,,1,TUMOR FREE,0.1386,0:LIVING,0.1,3,48.09,Bilateral,20,,,YES,,2009,,,TCGA-EJ-5509.672ff51d-12ba-402a-b6d6-87cc9c91e7ad.pdf,,[Not Applicable],NO,,71-80%,10,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.6,63,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5510,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.0,0.38,5,5,5,HRD,NO,1887,2-ETV1,1887,1887,,0,0,1887,1887,prad_tcga,Malignant,15,,19,15.3,TCGA-EJ-5510-01,0,0,0,TCGA-EJ-5510,1887,1887,Prostate Cancer,,738,1887,1887,TCGA,,1887,Primary,0,,A,CHEK2:527-529:PWL/HGX:frameshift_variant,,,TUMOR FREE,Alive,-17895,,48,7,30,PRAD,1887,1887,WHITE,0.0,[Not Available],[Not Applicable],28,R0,1,Matched,0.02,Prostate,Resection,4,3eae6b68-d333-4b36-9e70-d2bed19c1dfa,2,Normal (no evidence of prostate cancer) [cM0],0,0.065139,[Not Available],4a3d9efe-f24e-4135-8a70-e202651e7a81,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,0.933333333333,TCGA-EJ-5510,0:DiseaseFree,3,14,Prostate Adenocarcinoma,61.99,4/2/12,1887,,,,,NO,C61,9f549743-cbb3-46bb-9356-40f80e961b4d,,3,TUMOR FREE,0.1085,0:LIVING,0.1,3,61.99,Bilateral,15,No Evidence of Extraprostatic Extension,14,YES,,2009,,,TCGA-EJ-5510.9f549743-cbb3-46bb-9356-40f80e961b4d.pdf,,[Not Applicable],YES,14,61-70%,17,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.6,48,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5275,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5511,Black or African American,PRAD,91,0,0,,EJ,0,0,MALE,0,1.98,0.8,4,3,4,ambiguous,NO,1476,3-ETV4,1476,1476,,0,0,1476,1476,prad_tcga,Malignant,11,BRCA2;CHEK2,9,9.7,TCGA-EJ-5511-01,0,0,0,TCGA-EJ-5511,1476,1476,Prostate Cancer,,788,1476,1476,TCGA,,1476,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-20409,,55,7,54,PRAD,1476,1476,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.06,Prostate,Resection,3,1da89009-5dbe-4d62-9406-36330f47b738,3,Normal (no evidence of prostate cancer) [cM0],0,0.077833,[Not Available],f8a42feb-fbc9-4a13-bad5-1dcefca2a9bf,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,11,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.3,TCGA-EJ-5511,0:DiseaseFree,2,16,Prostate Adenocarcinoma,48.49,4/3/12,1476,,,,,NO,C61,4e4d79fc-ecc3-4533-ac69-9bdec44a080c,,3,TUMOR FREE,0.1235,0:LIVING,0.04,4,48.49,Bilateral,22,,,YES,,2009,,,TCGA-EJ-5511.4e4d79fc-ecc3-4533-ac69-9bdec44a080c.pdf,,[Not Applicable],NO,18,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.2,55,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5276,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5512,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.36,2,5,0,HRD,NO,1733,1-ERG,1733,1733,,0,0,1733,1733,prad_tcga,Malignant,7,,22,6.1,TCGA-EJ-5512-01,0,0,0,TCGA-EJ-5512,1733,1733,Prostate Cancer,,782,1733,1733,TCGA,,1733,Primary,0,Apex|Middle|Base,A,,BARD1,,TUMOR FREE,Alive,-17127,,46,7,23,PRAD,1733,1733,WHITE,0.0,[Not Available],[Not Applicable],28,R0,1,Matched,0.0,Prostate,Resection,3,d0b41403-8458-45e1-946e-21054fba65b8,0,,0,0.032474,[Not Available],c28f931f-5ab2-4899-9fe9-54024f082d92,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,0.966666666667,TCGA-EJ-5512,0:DiseaseFree,2,11,Prostate Adenocarcinoma,56.93,4/3/12,1733,,,,,,C61,8b273389-2655-4ac1-bcf0-b64505fe7b3d,,0,TUMOR FREE,0.0309,0:LIVING,0.0,3,56.93,Bilateral,13,,,YES,,2009,,,TCGA-EJ-5512.8b273389-2655-4ac1-bcf0-b64505fe7b3d.pdf,,[Not Applicable],,,51-60%,13,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,46,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5277,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5514,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.94,0.6,5,10,4,ambiguous,NO,1829,8-other,1829,1829,,0,0,1829,1829,prad_tcga,Malignant,19,BRCA2,27,7.4,TCGA-EJ-5514-01,0,0,0,TCGA-EJ-5514,1829,1829,Prostate Cancer,,724,1829,1829,TCGA,,1829,Primary,0,,A,,,,TUMOR FREE,Alive,-24165,,66,9,43,PRAD,1829,1829,WHITE,0.0,[Not Available],[Not Applicable],41,R0,1,Matched,0.22,Prostate,Resection,4,29ad80a4-b429-495c-885e-a92cfe2e4501,4,Normal (no evidence of prostate cancer) [cM0],0,0.099771,[Not Available],f82d53b1-3df8-4249-a615-464c9f4e0a32,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,22,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.33333333333,TCGA-EJ-5514,0:DiseaseFree,5,44,Prostate Adenocarcinoma,60.09,4/3/12,1829,,,,,NO,C61,5b64ad18-513e-422d-a847-d1862dd0e453,,5,TUMOR FREE,0.1629,0:LIVING,0.1,4,60.09,Bilateral,45,,,YES,,2009,,,TCGA-EJ-5514.5b64ad18-513e-422d-a847-d1862dd0e453.pdf,,[Not Applicable],NO,7,56-65%,12,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,66,Core needle biopsy,,,YES,NO,YES,,T2c,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,5278,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5515,White,PRAD,91,0,0,,EJ,0,0,MALE,0,,,,,,,NO,1832,8-other,1832,1832,,0,0,1832,1832,prad_tcga,Malignant,,,,4.8,TCGA-EJ-5515-01,0,0,0,TCGA-EJ-5515,1832,1832,Prostate Cancer,,1061,1832,1832,TCGA,,1832,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-22097,,60,7,13,PRAD,1832,1832,WHITE,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,,Prostate,Resection,3,5fba6e4a-3d7d-478e-afa6-e66c816e7852,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],19cf56b2-a85b-43e7-971f-5680b9b1a67a,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.0,TCGA-EJ-5515,0:DiseaseFree,2,,Prostate Adenocarcinoma,60.18,4/3/12,1832,,,,,NO,C61,1029ba11-efb4-42b7-871c-c97192a40e12,,,TUMOR FREE,0.0,0:LIVING,0.1,4,60.18,Right,,No Evidence of Extraprostatic Extension,30,YES,,2009,,,TCGA-EJ-5515.1029ba11-efb4-42b7-871c-c97192a40e12.pdf,,[Not Applicable],YES,30,71-80%,20,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.4,60,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5279,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5517,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.71,2,3,2,HRP,NO,1889,8-other,1889,1889,,0,0,1889,1889,prad_tcga,Malignant,7,,8,9.6,TCGA-EJ-5517-01,0,0,0,TCGA-EJ-5517,1889,1889,Prostate Cancer,,187,1889,1889,TCGA,,1889,Primary,0,,A,,,,TUMOR FREE,Alive,-20422,,55,6,33,PRAD,1889,1889,WHITE,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,0.04,Prostate,Resection,3,b5fe6254-d1c6-4ba2-bd75-5caf4fb2e2b7,0,,0,0.033171,[Not Available],4b9aa301-d2e3-47f3-b724-a34f420b2b6b,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,1.03333333333,TCGA-EJ-5517,0:DiseaseFree,1,7,Prostate Adenocarcinoma,62.06,4/3/12,1889,,,,,NO,C61,67b66178-bd1b-44a8-9a30-762b0fc7c1ba,,1,TUMOR FREE,0.0327,0:LIVING,0.1,2,62.06,Bilateral,8,,,YES,,2008,,,TCGA-EJ-5517.67b66178-bd1b-44a8-9a30-762b0fc7c1ba.pdf,,[Not Applicable],NO,,81-90%,4,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,55,Core needle biopsy,,,YES,NO,YES,,T2c,,6,No,,0,N0,T1c,0,M0,C61.9,8550/3,5281,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5519,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.91,0.67,10,11,5,ambiguous,NO,1962,2-ETV1,1962,1962,,0,0,1962,1962,prad_tcga,Malignant,26,,45,15.0,TCGA-EJ-5519-01,48,0,0,TCGA-EJ-5519,1962,1962,Prostate Cancer,,1153,1962,1962,TCGA,,1962,Primary,1,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-23669,,64,8,104,PRAD,1962,1962,WHITE,0.480706254,[Not Available],[Not Applicable],92,R0,1,Matched,0.01,Prostate,Resection,4,eee1828e-d25f-462b-9735-89ca2eccc7e1,3,Normal (no evidence of prostate cancer) [cM0],0,0.11072,[Not Available],5313a055-c2d7-4cbd-a8c1-57ac85912d89,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,26,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,3.03333333333,TCGA-EJ-5519,0:DiseaseFree,4,24,Prostate Adenocarcinoma,64.45,4/3/12,1962,,,,,NO,C61,57861c52-0d80-484a-a800-65c3481327db,,4,TUMOR FREE,0.1289,0:LIVING,0.2,3,64.45,Bilateral,25,,,YES,,2008,,,TCGA-EJ-5519.57861c52-0d80-484a-a800-65c3481327db.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,13,61-70%,12,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,YES,No,R0,1.2,64,Core needle biopsy,84,,YES,NO,YES,,T3b,,8,No,,0,N1,T2c,3,M0,C61.9,8550/3,5283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5521,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.94,0.43,3,5,4,ambiguous,NO,2279,1-ERG,2279,2279,,0,0,2279,2279,prad_tcga,Malignant,12,BRCA2;RAD51C;RAD51D,28,7.3,TCGA-EJ-5521-01,0,0,0,TCGA-EJ-5521,2279,2279,Prostate Cancer,,240,2279,2279,TCGA,,2279,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-23304,,63,7,61,PRAD,2279,2279,WHITE,0.0,[Not Available],[Not Applicable],51,R0,1,Matched,0.17,Prostate,Resection,3,9eebd2ec-af9d-493c-a006-a436c28d4cd3,0,,0,0.058663,[Not Available],d44d4bcb-beb1-4464-acd2-9972751f5018,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.7,TCGA-EJ-5521,0:DiseaseFree,2,24,Prostate Adenocarcinoma,74.87,4/4/12,2279,,,,,NO,C61,0c816088-3fe4-4646-abaa-94095efd0b26,,3,TUMOR FREE,0.0736,0:LIVING,0.1,3,74.87,Right,26,,,YES,,2008,,,TCGA-EJ-5521.0c816088-3fe4-4646-abaa-94095efd0b26.pdf,,[Not Applicable],NO,,41-50%,2,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,63,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5284,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5522,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.49,1,0,1,HRP,NO,2079,1-ERG,2079,2079,,0,0,2079,2079,prad_tcga,Malignant,2,,33,5.6,TCGA-EJ-5522-01,0,0,0,TCGA-EJ-5522,2079,2079,Prostate Cancer,,1403,2079,2079,TCGA,,2079,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-18802,,51,7,29,PRAD,2079,2079,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,8ac1e1e7-8266-48e0-8d4c-d78873111341,0,,0,0.025505,[Not Available],214884ef-a932-4fc3-b6ff-16ce5164da3e,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.766666666667,TCGA-EJ-5522,0:DiseaseFree,2,2,Prostate Adenocarcinoma,68.3,4/3/12,2079,,,,,NO,C61,756659d2-5e97-40d4-aa4e-c6d777153d0c,,1,TUMOR FREE,0.0245,0:LIVING,0.1,3,68.3,Bilateral,2,,,YES,,2008,,,TCGA-EJ-5522.756659d2-5e97-40d4-aa4e-c6d777153d0c.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,61-70%,22,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.9,51,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5285,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-EJ-5524,White,PRAD,91,1,1,,EJ,,0,MALE,1,1.91,0.61,5,6,7,HRD,NO,1882,1-ERG,,1882,,1,1,265,265,prad_tcga,Malignant,18,BRCA1;CDK12;RAD51D,45,3.8,TCGA-EJ-5524-01,0,0,0,TCGA-EJ-5524,265,265,Prostate Cancer,,811,,1882,TCGA,,265,Primary,0,Base,A,,CHEK2;PALB2,,WITH TUMOR,Alive,-20854,,57,9,48,PRAD,265,265,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.08,Prostate,Resection,4,c197a81d-2aa5-4285-88e3-761798e2c190,0,,0,0.093838,[Not Available],4048c139-1329-4e6a-8d2f-c0aa104a68ee,5,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,19,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,1.3,TCGA-EJ-5524,1:Recurred/Progressed,5,19,Prostate Adenocarcinoma,8.71,4/4/12,1882,,Locoregional Recurrence,,,NO,C61,1f767c93-41f5-45d1-917f-3f1fc5330fb9,,3,WITH TUMOR,0.0951,0:LIVING,0.1,3,61.83,Bilateral,22,,,YES,,2009,265,,TCGA-EJ-5524.1f767c93-41f5-45d1-917f-3f1fc5330fb9.pdf,,[Not Applicable],NO,,66-75%,17,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,NO,No,R0,1.0,57,Core needle biopsy,,,YES,NO,YES,,T3a,,9,No,,0,N0,T2b,0,M0,C61.9,8550/3,5286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-EJ-5525,White,PRAD,91,1,1,,EJ,,0,MALE,1,2.09,0.87,6,10,7,ambiguous,NO,1115,1-ERG,,1115,,1,1,546,546,prad_tcga,Malignant,23,BRCA2,24,4.0,TCGA-EJ-5525-01,30,0,0,TCGA-EJ-5525,546,546,Prostate Cancer,,521,,1115,TCGA,,546,Primary,1,Apex|Base,A,,,,WITH TUMOR,Alive,-24535,,67,9,83,PRAD,546,546,WHITE,0.375931861,[Not Available],[Not Applicable],69,R0,1,Matched,0.0,Prostate,Resection,4,351af15c-b213-4621-8bcb-3f4ddcf72553,4,Normal (no evidence of prostate cancer) [cM0],0,0.1323,[Not Available],554a7381-46fd-4301-b91b-5af7f173c350,5,Prostate Adenocarcinoma Acinar Type,1.6,Prostate,24,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,2.23333333333,TCGA-EJ-5525,1:Recurred/Progressed,5,23,Prostate Adenocarcinoma,17.94,4/4/12,1115,Bone,Distant Metastasis,,,NO,C61,ab82e8b9-a3ba-48ef-ac3e-fd35c67a13e4,,7,WITH TUMOR,0.2169,0:LIVING,3.0,3,36.63,Bilateral,27,No Evidence of Extraprostatic Extension,-6,YES,,2009,546,,TCGA-EJ-5525.ab82e8b9-a3ba-48ef-ac3e-fd35c67a13e4.pdf,,[Not Applicable],YES,-6,71-80%,8,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,YES,No,R0,1.0,67,Core needle biopsy,338,,YES,NO,YES,,T2c,,9,No,,0,N0,T3a,0,M0,C61.9,8550/3,5287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-EJ-5526,White,PRAD,91,1,1,,EJ,,0,MALE,1,2.02,0.54,3,4,3,ambiguous,NO,1909,1-ERG,,1909,,1,1,537,537,prad_tcga,Malignant,10,CHEK2,33,28.6,TCGA-EJ-5526-01,7,0,0,TCGA-EJ-5526,537,537,Prostate Cancer,,175,,1909,TCGA,,537,Primary,0,Middle|Base,A,,,,WITH TUMOR,Alive,-20558,,56,8,39,PRAD,537,537,WHITE,0.188295423,[Not Available],[Not Applicable],30,R0,1,Matched,0.07,Prostate,Resection,4,4dbe4fa2-308f-4d5b-bf33-4c051f7dc537,4,Normal (no evidence of prostate cancer) [cM0],0,0.048625,[Not Available],eec48399-5660-4b25-8d34-191b54315c72,4,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,11,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.966666666667,TCGA-EJ-5526,1:Recurred/Progressed,4,16,Prostate Adenocarcinoma,62.71,4/4/12,1909,,Locoregional Recurrence,,,NO,C61,5afeeeba-2a19-4042-acdc-8dad10ca31f9,,3,WITH TUMOR,0.1147,0:LIVING,0.1,3,62.71,Bilateral,18,No Evidence of Extraprostatic Extension,19,YES,,2009,537,,TCGA-EJ-5526.5afeeeba-2a19-4042-acdc-8dad10ca31f9.pdf,,[Not Applicable],YES,19,71-80%,27,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,NO,No,R0,0.8,56,Core needle biopsy,,,YES,NO,YES,,T3a,,8,No,,0,N1,T1c,1,M0,C61.9,8550/3,5288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5527,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.99,0.49,4,7,4,HRD,NO,1778,1-ERG,1778,1778,,0,0,1778,1778,prad_tcga,Malignant,15,ATM;CHEK1,18,7.7,TCGA-EJ-5527-01,9,0,0,TCGA-EJ-5527,1778,1778,Prostate Cancer,,217,1778,1778,TCGA,,1778,Primary,0,Apex|Middle,A,,BRCA2,,TUMOR FREE,Alive,-25234,,69,7,39,PRAD,1778,1778,WHITE,0.19880582,[Not Available],[Not Applicable],54,R0,1,Matched,0.11,Prostate,Resection,4,15a638fe-4dfd-4280-ad40-5e0d5fde3812,2,,0,0.065049,[Not Available],ba0c9096-5f35-4f0a-ae98-ee1a695b55f0,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.8,TCGA-EJ-5527,0:DiseaseFree,3,20,Prostate Adenocarcinoma,58.41,4/4/12,1778,,,,,NO,C61,b4c74b9e-b639-4488-aef1-8bf008324f73,,3,TUMOR FREE,0.0694,0:LIVING,0.1,3,58.41,Bilateral,22,,,YES,,2009,,,TCGA-EJ-5527.b4c74b9e-b639-4488-aef1-8bf008324f73.pdf,,[Not Applicable],NO,,61-70%,9,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.7,69,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5530,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.98,0.51,1,0,1,HRP,NO,1832,1-ERG,1832,1832,,0,0,1832,1832,prad_tcga,Malignant,2,,2,9.2,TCGA-EJ-5530-01,0,0,0,TCGA-EJ-5530,1832,1832,Prostate Cancer,,586,1832,1832,TCGA,,1832,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-22316,,61,7,60,PRAD,1832,1832,WHITE,0.0,[Not Available],[Not Applicable],68,R0,1,Matched,0.03,Prostate,Resection,3,27d61473-39d6-478a-a576-427d1aeda01f,1,,0,0.015819,[Not Available],e4a755e3-4938-4321-b5a9-27a445036791,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.2,TCGA-EJ-5530,0:DiseaseFree,2,9,Prostate Adenocarcinoma,60.18,4/4/12,1832,,,,,NO,C61,03cb0863-99db-411a-a347-a8675a65cb5a,,1,TUMOR FREE,0.015,0:LIVING,0.1,3,60.18,Bilateral,10,,,YES,,2008,,,TCGA-EJ-5530.03cb0863-99db-411a-a347-a8675a65cb5a.pdf,,[Not Applicable],NO,,76-85%,6,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.8,61,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5532,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.03,0.68,2,0,2,HRP,NO,1828,8-other,1828,1828,,0,0,1828,1828,prad_tcga,Malignant,4,,8,11.4,TCGA-EJ-5532-01,5,0,0,TCGA-EJ-5532,1828,1828,Prostate Cancer,,926,1828,1828,TCGA,,1828,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-21110,,57,7,35,PRAD,1828,1828,WHITE,0.16102725,[Not Available],[Not Applicable],31,R0,1,Matched,0.02,Prostate,Resection,3,f32f7738-bad4-40c9-b49f-084bb098a05a,3,,0,0.025074,[Not Available],ae3a0c92-148d-4f1c-8563-06ac1050f53e,4,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.03333333333,TCGA-EJ-5532,0:DiseaseFree,2,4,Prostate Adenocarcinoma,60.05,4/4/12,1828,,,,,NO,C61,11afaa3c-a99c-4e43-b4cb-eb139c9b1dab,,2,TUMOR FREE,0.0722,0:LIVING,0.1,3,60.05,Bilateral,4,,,YES,,2009,,,TCGA-EJ-5532.11afaa3c-a99c-4e43-b4cb-eb139c9b1dab.pdf,,[Not Applicable],NO,,71-80%,8,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,57,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5542,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.03,0.58,1,1,2,HRP,NO,1513,1-ERG,1513,1513,,0,0,1513,1513,prad_tcga,Malignant,4,,33,19.3,TCGA-EJ-5542-01,0,0,0,TCGA-EJ-5542,1513,1513,Prostate Cancer,-21,519,1513,1513,TCGA,No Evidence of Extraprostatic Extension,1513,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21942,,60,7,37,PRAD,1513,1513,WHITE,0.0,[Not Available],[Not Applicable],41,R0,1,Matched,0.07,Prostate,Resection,3,dffc7994-e957-4451-a9db-56d4560d6547,2,Normal (no evidence of prostate cancer) [cM0],0,0.027786,[Not Available],5a92ec4c-36ee-4588-aca2-e3303f29c7ad,4,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.36666666667,TCGA-EJ-5542,0:DiseaseFree,2,9,Prostate Adenocarcinoma,49.7,4/4/12,1513,,,,,YES,C61,d6fe7cc6-45e5-4b6c-b1f4-1dd7fd3c27be,,1,TUMOR FREE,0.0794,0:LIVING,0.1,3,49.7,Bilateral,13,No Evidence of Extraprostatic Extension,9,YES,,2010,,,TCGA-EJ-5542.d6fe7cc6-45e5-4b6c-b1f4-1dd7fd3c27be.pdf,,[Not Applicable],YES,8,61-70%,17,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,Yes,R0,0.9,60,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5293,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7115,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.59,4,5,1,HRP,NO,2687,5-SPOP,2687,2687,,0,0,2687,2687,prad_tcga,Malignant,10,BRCA2,53,3.6,TCGA-EJ-7115-01,11,0,0,TCGA-EJ-7115,2687,2687,Prostate Cancer,,204,2687,2687,TCGA,,2687,Primary,1,,A,,,,TUMOR FREE,Alive,-23986,,65,7,56,PRAD,2687,2687,WHITE,0.148840543,[Not Available],[Not Applicable],44,R0,1,Matched,0.01,Prostate,Resection,4,2202513c-380f-453c-824c-881296ab638c,1,Normal (no evidence of prostate cancer) [cM0],0,0.066724,[Not Available],c606918f-e8c0-4019-ad6f-47d5cd7615c4,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,10,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,2.13333333333,TCGA-EJ-7115,0:DiseaseFree,3,10,Prostate Adenocarcinoma,88.27,4/5/12,2687,,,,,NO,C61,1638ac15-f8d6-4c88-b91e-e21033ae09db,,1,TUMOR FREE,0.0616,0:LIVING,0.1,2,88.27,Bilateral,12,No Evidence of Extraprostatic Extension,10,YES,,2006,,,TCGA-EJ-7115.1638ac15-f8d6-4c88-b91e-e21033ae09db.pdf,,[Not Applicable],YES,10,11-20%,21,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.9,65,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5294,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7115,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.59,4,5,1,HRP,NO,2687,5-SPOP,2687,2687,,0,0,2687,2687,prad_tcga,Malignant,10,BRCA2,53,3.6,TCGA-EJ-7115-01,11,5294,0,TCGA-EJ-7115,2687,2687,Prostate Cancer,,204,2687,2687,TCGA,,2687,Primary,1,,A,,,,TUMOR FREE,Alive,-23986,,65,7,56,PRAD,2687,2687,WHITE,0.148840543,[Not Available],[Not Applicable],44,R0,1,Matched,0.01,Prostate,Resection,4,2202513c-380f-453c-824c-881296ab638c,1,Normal (no evidence of prostate cancer) [cM0],0,0.066724,[Not Available],c606918f-e8c0-4019-ad6f-47d5cd7615c4,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,10,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,2.13333333333,TCGA-EJ-7115,0:DiseaseFree,3,10,Prostate Adenocarcinoma,88.27,4/5/12,2687,,,,,NO,C61,1638ac15-f8d6-4c88-b91e-e21033ae09db,,1,TUMOR FREE,0.0616,0:LIVING,0.1,2,88.27,Bilateral,12,No Evidence of Extraprostatic Extension,10,YES,,2006,,,TCGA-EJ-7115.1638ac15-f8d6-4c88-b91e-e21033ae09db.pdf,,[Not Applicable],YES,10,11-20%,21,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.9,65,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5295,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7123,White,PRAD,161,0,0,,EJ,0,0,MALE,0,1.96,0.34,4,9,3,ambiguous,NO,2572,5-SPOP,2572,2572,,0,0,2572,2572,prad_tcga,Malignant,16,BRCA2;PALB2,17,5.6,TCGA-EJ-7123-01,0,0,0,TCGA-EJ-7123,2572,2572,Prostate Cancer,,1491,2572,2572,TCGA,,2572,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21741,,59,7,52,PRAD,2572,2572,WHITE,0.0,[Not Available],[Not Applicable],50,R0,1,Matched,0.1,Prostate,Resection,3,a7383a8a-32c0-453b-b26d-d98d6c098a90,4,,0,0.099617,[Not Available],9519be01-d78d-462c-8a95-34149538afeb,4,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,EJ,3.0,TCGA-EJ-7123,0:DiseaseFree,2,19,Prostate Adenocarcinoma,84.49,4/5/12,2572,,,,,NO,C61,1ba8d08d-0be5-46a6-9540-8f6d028e0dea,,3,TUMOR FREE,0.076,0:LIVING,0.1,3,84.49,Bilateral,24,,,YES,,2007,,,TCGA-EJ-7123.1ba8d08d-0be5-46a6-9540-8f6d028e0dea.pdf,,[Not Applicable],NO,,81-90%,22,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,Yes,R0,0.4,59,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5296,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7314,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.6,2,0,3,HRD,NO,1150,1-ERG,1150,1150,,0,0,1150,1150,prad_tcga,Malignant,5,,19,6.1,TCGA-EJ-7314-01,0,0,0,TCGA-EJ-7314,1150,1150,Prostate Cancer,,295,1150,1150,TCGA,,1150,Primary,0,Apex|Middle|Base,A,CHEK2:319:I/NX:frameshift_variant,,,TUMOR FREE,Alive,-22766,,62,7,45,PRAD,1150,1150,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.07,Prostate,Resection,4,89fb9220-8f32-4030-91ee-b02264995f6d,1,,0,0.028267,[Not Available],88c87cce-4361-499c-9e3a-e9d9040af2db,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.1,TCGA-EJ-7314,0:DiseaseFree,3,5,Prostate Adenocarcinoma,37.78,4/5/12,1150,,,,,NO,C61,bbd6fa31-f4d4-4c06-aa64-1e263ccd8844,,2,TUMOR FREE,0.0268,0:LIVING,0.1,5,37.78,Bilateral,5,No Evidence of Extraprostatic Extension,14,YES,,2011,,,TCGA-EJ-7314.bbd6fa31-f4d4-4c06-aa64-1e263ccd8844.pdf,,[Not Applicable],YES,,41-50%,14,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,62,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7314,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.6,2,0,3,HRD,NO,1150,1-ERG,1150,1150,,0,0,1150,1150,prad_tcga,Malignant,5,,19,6.1,TCGA-EJ-7314-01,0,5297,0,TCGA-EJ-7314,1150,1150,Prostate Cancer,,295,1150,1150,TCGA,,1150,Primary,0,Apex|Middle|Base,A,CHEK2:319:I/NX:frameshift_variant,,,TUMOR FREE,Alive,-22766,,62,7,45,PRAD,1150,1150,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.07,Prostate,Resection,4,89fb9220-8f32-4030-91ee-b02264995f6d,1,,0,0.028267,[Not Available],88c87cce-4361-499c-9e3a-e9d9040af2db,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.1,TCGA-EJ-7314,0:DiseaseFree,3,5,Prostate Adenocarcinoma,37.78,4/5/12,1150,,,,,NO,C61,bbd6fa31-f4d4-4c06-aa64-1e263ccd8844,,2,TUMOR FREE,0.0268,0:LIVING,0.1,5,37.78,Bilateral,5,No Evidence of Extraprostatic Extension,14,YES,,2011,,,TCGA-EJ-7314.bbd6fa31-f4d4-4c06-aa64-1e263ccd8844.pdf,,[Not Applicable],YES,,41-50%,14,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,62,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7315,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.63,5,8,3,ambiguous,NO,1008,1-ERG,1008,1008,,0,0,1008,1008,prad_tcga,Malignant,16,,50,5.8,TCGA-EJ-7315-01,0,0,0,TCGA-EJ-7315,1008,1008,Prostate Cancer,,289,1008,1008,TCGA,,1008,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-25154,,68,7,29,PRAD,1008,1008,WHITE,0.0,[Not Available],[Not Applicable],36,R0,1,Matched,0.01,Prostate,Resection,4,f4871dc1-a456-4d69-a5bc-30a5eb8033e9,1,,0,0.083829,[Not Available],2c7ec330-261e-49c7-9424-6d83641dba6d,3,Prostate Adenocarcinoma Acinar Type,2.5,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,2.2,TCGA-EJ-7315,0:DiseaseFree,3,18,Prostate Adenocarcinoma,33.11,4/5/12,1008,,,,,NO,C61,6afa83ac-9060-4b49-90a3-dc19824822e3,,3,TUMOR FREE,0.091,0:LIVING,0.1,5,33.11,Bilateral,21,,,YES,,2011,,,TCGA-EJ-7315.6afa83ac-9060-4b49-90a3-dc19824822e3.pdf,,[Not Applicable],NO,,71-80%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.5,68,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5299,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7315,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.63,5,8,3,ambiguous,NO,1008,1-ERG,1008,1008,,0,0,1008,1008,prad_tcga,Malignant,16,,50,5.8,TCGA-EJ-7315-01,0,5299,0,TCGA-EJ-7315,1008,1008,Prostate Cancer,,289,1008,1008,TCGA,,1008,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-25154,,68,7,29,PRAD,1008,1008,WHITE,0.0,[Not Available],[Not Applicable],36,R0,1,Matched,0.01,Prostate,Resection,4,f4871dc1-a456-4d69-a5bc-30a5eb8033e9,1,,0,0.083829,[Not Available],2c7ec330-261e-49c7-9424-6d83641dba6d,3,Prostate Adenocarcinoma Acinar Type,2.5,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,2.2,TCGA-EJ-7315,0:DiseaseFree,3,18,Prostate Adenocarcinoma,33.11,4/5/12,1008,,,,,NO,C61,6afa83ac-9060-4b49-90a3-dc19824822e3,,3,TUMOR FREE,0.091,0:LIVING,0.1,5,33.11,Bilateral,21,,,YES,,2011,,,TCGA-EJ-7315.6afa83ac-9060-4b49-90a3-dc19824822e3.pdf,,[Not Applicable],NO,,71-80%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.5,68,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7317,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.98,0.67,1,1,0,HRP,NO,771,8-other,771,771,,0,0,771,771,prad_tcga,Malignant,2,BRCA2,4,14.0,TCGA-EJ-7317-01,8,0,0,TCGA-EJ-7317,771,771,Prostate Cancer,,285,771,771,TCGA,,771,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-26064,,71,7,43,PRAD,771,771,WHITE,0.092967375,[Not Available],[Not Applicable],44,R0,1,Matched,0.04,Prostate,Resection,3,aeea2f28-0766-42d7-9e6a-c14beb03e692,0,,0,0.018949,[Not Available],68fc3693-0910-4ee8-8997-99c6333b65f4,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.63333333333,TCGA-EJ-7317,0:DiseaseFree,2,4,Prostate Adenocarcinoma,25.33,4/5/12,771,,,,,,C61,f1531404-e42a-47a0-bbd7-6b0bd5ebf56b,,0,TUMOR FREE,0.0281,0:LIVING,0.1,3,25.33,Bilateral,6,,,YES,,2011,,,TCGA-EJ-7317.f1531404-e42a-47a0-bbd7-6b0bd5ebf56b.pdf,,[Not Applicable],,,51-60%,40,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.8,71,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7321,Black or African American,PRAD,221,0,0,,EJ,0,0,MALE,0,3.95,0.41,0,5,2,ambiguous,NO,824,1-ERG,824,824,,0,0,824,824,prad_tcga,Malignant,7,FANCL,2,2.2,TCGA-EJ-7321-01,4,0,0,TCGA-EJ-7321,824,824,Prostate Cancer,,128,824,824,TCGA,,824,Primary,0,,A,,,,TUMOR FREE,Alive,-21108,,57,6,38,PRAD,824,824,BLACK OR AFRICAN AMERICAN,0.104720176,[Not Available],[Not Applicable],48,R0,1,Matched,0.02,Prostate,Resection,3,3569f2bd-ab7a-4b9d-9fac-09e9e75050f3,0,Normal (no evidence of prostate cancer) [cM0],1,0.0013968,[Not Available],804ee985-18dd-4f2d-a562-61b454601cdd,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.63333333333,TCGA-EJ-7321,0:DiseaseFree,1,17,Prostate Adenocarcinoma,27.07,4/5/12,824,,,,,NO,C61,9d0d3184-b73a-4f24-919d-0ba7d5d32ff2,,2,TUMOR FREE,0.0318,0:LIVING,0.1,4,27.07,Bilateral,17,,,YES,,2011,,,TCGA-EJ-7321.9d0d3184-b73a-4f24-919d-0ba7d5d32ff2.pdf,,[Not Applicable],NO,10,81-90%,25,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,57,Core needle biopsy,,,YES,NO,YES,,T3a,,6,No,,0,N0,T1c,0,M0,C61.9,8550/3,5303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7327,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.98,0.48,1,2,0,HRD,NO,923,1-ERG,923,923,,0,0,923,923,prad_tcga,Malignant,3,,32,12.2,TCGA-EJ-7327-01,0,0,0,TCGA-EJ-7327,923,923,Prostate Cancer,,175,923,923,TCGA,,923,Primary,0,Apex|Middle|Base,A,,CHEK2,,TUMOR FREE,Alive,-22475,,61,7,32,PRAD,923,923,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.01,Prostate,Resection,3,992415ef-53de-4c52-a538-07931e68182b,0,,0,0.019473,[Not Available],e90ab72a-4bbb-4c37-b48a-8a1a85d79d04,4,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,1.53333333333,TCGA-EJ-7327,0:DiseaseFree,2,8,Prostate Adenocarcinoma,30.32,4/5/12,923,,,,,NO,C61,d2a2c78b-e7dd-4bdf-a6a0-4b87383a55bd,,0,TUMOR FREE,0.0189,0:LIVING,0.1,5,30.32,Bilateral,9,,,YES,,2011,,,TCGA-EJ-7327.d2a2c78b-e7dd-4bdf-a6a0-4b87383a55bd.pdf,,[Not Applicable],NO,,61-70%,17,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.6,61,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5304,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7328,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.42,3,5,3,HRD,NO,842,1-ERG,842,842,,0,0,842,842,prad_tcga,Malignant,11,,13,6.5,TCGA-EJ-7328-01,0,0,0,TCGA-EJ-7328,842,842,Prostate Cancer,,,842,842,TCGA,,842,Primary,0,Middle|Base,A,BRCA2:3363:I/IX:frameshift_variant,RAD51B,,TUMOR FREE,Alive,-25756,,70,7,39,PRAD,842,842,WHITE,0.0,[Not Available],[Not Applicable],40,R0,1,Matched,0.03,Prostate,Resection,4,4539a7c3-cca2-4ed0-9310-92cd843aa1cd,0,,0,0.036616,[Not Available],42b7d14f-09e5-4d91-bb98-5fe35907a6a9,3,Prostate Adenocarcinoma Acinar Type,1.8,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,2.4,TCGA-EJ-7328,0:DiseaseFree,3,13,Prostate Adenocarcinoma,27.66,4/5/12,842,,,,,NO,C61,30c9c833-ae7e-46de-951c-a488df1d723a,,1,TUMOR FREE,0.036,0:LIVING,,5,27.66,Bilateral,14,,,YES,,2011,,,TCGA-EJ-7328.30c9c833-ae7e-46de-951c-a488df1d723a.pdf,,[Not Applicable],NO,,71-80%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.8,70,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7328,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.42,3,5,3,HRD,NO,842,1-ERG,842,842,,0,0,842,842,prad_tcga,Malignant,11,,13,6.5,TCGA-EJ-7328-01,0,5306,0,TCGA-EJ-7328,842,842,Prostate Cancer,,,842,842,TCGA,,842,Primary,0,Middle|Base,A,BRCA2:3363:I/IX:frameshift_variant,RAD51B,,TUMOR FREE,Alive,-25756,,70,7,39,PRAD,842,842,WHITE,0.0,[Not Available],[Not Applicable],40,R0,1,Matched,0.03,Prostate,Resection,4,4539a7c3-cca2-4ed0-9310-92cd843aa1cd,0,,0,0.036616,[Not Available],42b7d14f-09e5-4d91-bb98-5fe35907a6a9,3,Prostate Adenocarcinoma Acinar Type,1.8,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,2.4,TCGA-EJ-7328,0:DiseaseFree,3,13,Prostate Adenocarcinoma,27.66,4/5/12,842,,,,,NO,C61,30c9c833-ae7e-46de-951c-a488df1d723a,,1,TUMOR FREE,0.036,0:LIVING,,5,27.66,Bilateral,14,,,YES,,2011,,,TCGA-EJ-7328.30c9c833-ae7e-46de-951c-a488df1d723a.pdf,,[Not Applicable],NO,,71-80%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.8,70,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5307,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-EJ-7330,White,PRAD,184,0,0,,EJ,,0,MALE,0,1.98,0.33,10,18,1,ambiguous,NO,191,5-SPOP,,191,,0,0,191,191,prad_tcga,Malignant,29,ATM,111,6.2,TCGA-EJ-7330-01,0,0,0,TCGA-EJ-7330,191,191,Prostate Cancer,,191,,191,TCGA,,191,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-25050,,68,7,52,PRAD,191,191,WHITE,0.0,[Not Available],[Not Applicable],65,R0,1,Matched,0.09,Prostate,Resection,4,11551cf5-d8e8-4d4b-bf05-aa197f25dabe,4,,0,0.15478,[Not Available],7bc369b7-007b-4b10-bd92-5d326dabf675,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,32,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,3.8,TCGA-EJ-7330,0:DiseaseFree,3,51,Prostate Adenocarcinoma,6.27,4/5/12,191,,,,,NO,C61,d910cd86-89be-4fc9-8f9d-497692a6face,,4,TUMOR FREE,0.1741,0:LIVING,0.1,5,6.27,Bilateral,53,,,YES,,2011,,,TCGA-EJ-7330.d910cd86-89be-4fc9-8f9d-497692a6face.pdf,,[Not Applicable],NO,,66-75%,18,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Available],,NO,No,R0,1.3,68,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5308,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-EJ-7330,White,PRAD,184,0,0,,EJ,,0,MALE,0,1.98,0.33,10,18,1,ambiguous,NO,191,5-SPOP,,191,,0,0,191,191,prad_tcga,Malignant,29,ATM,111,6.2,TCGA-EJ-7330-01,0,5308,0,TCGA-EJ-7330,191,191,Prostate Cancer,,191,,191,TCGA,,191,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-25050,,68,7,52,PRAD,191,191,WHITE,0.0,[Not Available],[Not Applicable],65,R0,1,Matched,0.09,Prostate,Resection,4,11551cf5-d8e8-4d4b-bf05-aa197f25dabe,4,,0,0.15478,[Not Available],7bc369b7-007b-4b10-bd92-5d326dabf675,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,32,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,3.8,TCGA-EJ-7330,0:DiseaseFree,3,51,Prostate Adenocarcinoma,6.27,4/5/12,191,,,,,NO,C61,d910cd86-89be-4fc9-8f9d-497692a6face,,4,TUMOR FREE,0.1741,0:LIVING,0.1,5,6.27,Bilateral,53,,,YES,,2011,,,TCGA-EJ-7330.d910cd86-89be-4fc9-8f9d-497692a6face.pdf,,[Not Applicable],NO,,66-75%,18,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Available],,NO,No,R0,1.3,68,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7331,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.48,2,7,0,HRP,NO,742,8-other,742,742,,0,0,742,742,prad_tcga,Malignant,9,,19,7.0,TCGA-EJ-7331-01,0,5310,0,TCGA-EJ-7331,742,742,Prostate Cancer,,189,742,742,TCGA,,742,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-23458,,64,7,31,PRAD,742,742,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.01,Prostate,Resection,3,5aa2e382-c8df-44e3-8802-994188b11d55,0,,0,0.033828,[Not Available],b424b73a-2dfa-473f-ab56-ab382cd1cdef,4,Prostate Adenocarcinoma Acinar Type,1.9,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.16666666667,TCGA-EJ-7331,0:DiseaseFree,2,10,Prostate Adenocarcinoma,24.38,4/5/12,742,,,,,NO,C61,84790d75-bbef-49b0-9486-94e049c13ddd,,0,TUMOR FREE,0.0322,0:LIVING,0.8,3,24.38,Bilateral,11,,,YES,,2011,,,TCGA-EJ-7331.84790d75-bbef-49b0-9486-94e049c13ddd.pdf,,[Not Applicable],NO,,16-25%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,1.4,64,Core needle biopsy,189,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5311,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7782,Black or African American,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.75,6,13,1,HRD,NO,1167,5-SPOP,1167,1167,,0,0,1167,1167,prad_tcga,Malignant,20,FANCL,169,,TCGA-EJ-7782-01,0,0,0,TCGA-EJ-7782,1167,1167,Prostate Cancer,,350,1167,1167,TCGA,,1167,Primary,0,,A,CDK12:1459:W/X:frameshift_variant,,,TUMOR FREE,Alive,-25965,,71,8,541,PRAD,1167,1167,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],379,R0,1,Matched,0.0,Prostate,Resection,4,951c894e-9354-45ad-834a-ffc04441a3a9,1,Normal (no evidence of prostate cancer) [cM0],0,0.10124,[Not Available],1426b4bf-f4a5-477c-bbbb-e0e656549764,4,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,20,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,21.6,TCGA-EJ-7782,0:DiseaseFree,4,20,Prostate Adenocarcinoma,38.34,4/6/12,1167,,,,,NO,C61,d8500e84-1aa4-4a3b-874c-563d520dec03,,3,TUMOR FREE,0.1234,0:LIVING,0.1,4,38.34,Bilateral,26,,,YES,,2010,,,TCGA-EJ-7782.d8500e84-1aa4-4a3b-874c-563d520dec03.pdf,,[Not Applicable],NO,49,51-60%,17,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.2,71,Core needle biopsy,,,YES,NO,YES,,T2c,,8,No,,0,N0,T2c,0,M0,C61.9,8550/3,5312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7782,Black or African American,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.75,6,13,1,HRD,NO,1167,5-SPOP,1167,1167,,0,0,1167,1167,prad_tcga,Malignant,20,FANCL,169,,TCGA-EJ-7782-01,0,5312,0,TCGA-EJ-7782,1167,1167,Prostate Cancer,,350,1167,1167,TCGA,,1167,Primary,0,,A,CDK12:1459:W/X:frameshift_variant,,,TUMOR FREE,Alive,-25965,,71,8,541,PRAD,1167,1167,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],379,R0,1,Matched,0.0,Prostate,Resection,4,951c894e-9354-45ad-834a-ffc04441a3a9,1,Normal (no evidence of prostate cancer) [cM0],0,0.10124,[Not Available],1426b4bf-f4a5-477c-bbbb-e0e656549764,4,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,20,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,21.6,TCGA-EJ-7782,0:DiseaseFree,4,20,Prostate Adenocarcinoma,38.34,4/6/12,1167,,,,,NO,C61,d8500e84-1aa4-4a3b-874c-563d520dec03,,3,TUMOR FREE,0.1234,0:LIVING,0.1,4,38.34,Bilateral,26,,,YES,,2010,,,TCGA-EJ-7782.d8500e84-1aa4-4a3b-874c-563d520dec03.pdf,,[Not Applicable],NO,49,51-60%,17,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.2,71,Core needle biopsy,,,YES,NO,YES,,T2c,,8,No,,0,N0,T2c,0,M0,C61.9,8550/3,5313,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7783,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.38,2,1,2,HRD,NO,787,1-ERG,787,787,,0,0,787,787,prad_tcga,Malignant,5,ATM;BRCA2;CHEK2;RAD51B,6,12.8,TCGA-EJ-7783-01,0,0,0,TCGA-EJ-7783,787,787,Prostate Cancer,,172,787,787,TCGA,,787,Primary,0,,A,ATM:484:W/X:frameshift_variant,,,TUMOR FREE,Alive,-25600,,70,7,41,PRAD,787,787,WHITE,0.0,[Not Available],[Not Applicable],43,R0,1,Matched,0.2,Prostate,Resection,4,d634f5b6-e808-497e-a594-63559645d2a7,2,,0,0.031065,[Not Available],181c6d37-9d8d-4ffa-827b-e3785450ff88,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.66666666667,TCGA-EJ-7783,0:DiseaseFree,3,10,Prostate Adenocarcinoma,25.85,4/6/12,787,,,,,NO,C61,8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052,,2,TUMOR FREE,0.0357,0:LIVING,0.7,4,25.85,Bilateral,13,,,YES,,2011,,,TCGA-EJ-7783.8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052.pdf,,[Not Applicable],NO,,26-35%,17,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,1.3,70,Core needle biopsy,81,,YES,NO,YES,,T3a,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7783,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.38,2,1,2,HRD,NO,787,1-ERG,787,787,,0,0,787,787,prad_tcga,Malignant,5,ATM;BRCA2;CHEK2;RAD51B,6,12.8,TCGA-EJ-7783-01,0,5314,0,TCGA-EJ-7783,787,787,Prostate Cancer,,172,787,787,TCGA,,787,Primary,0,,A,ATM:484:W/X:frameshift_variant,,,TUMOR FREE,Alive,-25600,,70,7,41,PRAD,787,787,WHITE,0.0,[Not Available],[Not Applicable],43,R0,1,Matched,0.2,Prostate,Resection,4,d634f5b6-e808-497e-a594-63559645d2a7,2,,0,0.031065,[Not Available],181c6d37-9d8d-4ffa-827b-e3785450ff88,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.66666666667,TCGA-EJ-7783,0:DiseaseFree,3,10,Prostate Adenocarcinoma,25.85,4/6/12,787,,,,,NO,C61,8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052,,2,TUMOR FREE,0.0357,0:LIVING,0.7,4,25.85,Bilateral,13,,,YES,,2011,,,TCGA-EJ-7783.8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052.pdf,,[Not Applicable],NO,,26-35%,17,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,1.3,70,Core needle biopsy,81,,YES,NO,YES,,T3a,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7784,White,PRAD,184,0,0,,EJ,0,0,MALE,0,4.26,0.69,2,8,8,ambiguous,NO,781,1-ERG,781,781,,0,0,781,781,prad_tcga,Malignant,18,PALB2;RAD51B;RAD54L,12,4.1,TCGA-EJ-7784-01,0,5316,0,TCGA-EJ-7784,781,781,Prostate Cancer,,167,781,781,TCGA,,781,Primary,0,,A,,,,TUMOR FREE,Alive,-23183,,63,7,45,PRAD,781,781,WHITE,0.0,[Not Available],[Not Applicable],67,R0,1,Matched,0.47,Prostate,Resection,4,0d3ec78c-3da8-443f-baa6-93caed5b065c,6,Normal (no evidence of prostate cancer) [cM0],1,0.039903,[Not Available],4bc71292-60bb-4b63-86c1-0fe021083804,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,4.03333333333,TCGA-EJ-7784,0:DiseaseFree,3,24,Prostate Adenocarcinoma,25.66,4/6/12,781,,,,,NO,C61,d140c74d-8e74-43da-a181-63a7bbe718af,,10,TUMOR FREE,0.2403,0:LIVING,0.1,4,25.66,Bilateral,26,No Evidence of Extraprostatic Extension,0,YES,,2011,,,TCGA-EJ-7784.d140c74d-8e74-43da-a181-63a7bbe718af.pdf,,[Not Applicable],YES,0,81-90%,13,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,63,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7785,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.98,0.41,1,1,2,HRP,NO,1177,1-ERG,1177,1177,,0,0,1177,1177,prad_tcga,Malignant,4,,26,4.3,TCGA-EJ-7785-01,6,0,0,TCGA-EJ-7785,1177,1177,Prostate Cancer,,259,1177,1177,TCGA,,1177,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-19939,,54,7,25,PRAD,1177,1177,WHITE,0.127686922,[Not Available],[Not Applicable],27,R0,1,Matched,0.0,Prostate,Resection,3,63ebd9b1-f118-4315-8722-708f47a07063,0,,0,0.021315,[Not Available],2def2a53-d2e8-46f0-8b07-f32dbf1833a4,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.63333333333,TCGA-EJ-7785,0:DiseaseFree,2,6,Prostate Adenocarcinoma,38.67,4/6/12,1177,,,,,NO,C61,01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b,,0,TUMOR FREE,0.0206,0:LIVING,0.1,3,38.67,Bilateral,8,,,YES,,2011,,,TCGA-EJ-7785.01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b.pdf,,[Not Applicable],NO,,31-40%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,54,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7785,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.98,0.41,1,1,2,HRP,NO,1177,1-ERG,1177,1177,,0,0,1177,1177,prad_tcga,Malignant,4,,26,4.3,TCGA-EJ-7785-01,6,5318,0,TCGA-EJ-7785,1177,1177,Prostate Cancer,,259,1177,1177,TCGA,,1177,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-19939,,54,7,25,PRAD,1177,1177,WHITE,0.127686922,[Not Available],[Not Applicable],27,R0,1,Matched,0.0,Prostate,Resection,3,63ebd9b1-f118-4315-8722-708f47a07063,0,,0,0.021315,[Not Available],2def2a53-d2e8-46f0-8b07-f32dbf1833a4,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.63333333333,TCGA-EJ-7785,0:DiseaseFree,2,6,Prostate Adenocarcinoma,38.67,4/6/12,1177,,,,,NO,C61,01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b,,0,TUMOR FREE,0.0206,0:LIVING,0.1,3,38.67,Bilateral,8,,,YES,,2011,,,TCGA-EJ-7785.01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b.pdf,,[Not Applicable],NO,,31-40%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,54,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5319,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7786,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.96,0.55,2,4,2,HRP,NO,1096,8-other,1096,1096,,0,0,1096,1096,prad_tcga,Malignant,8,BRCA2,5,4.5,TCGA-EJ-7786-01,24,0,0,TCGA-EJ-7786,1096,1096,Prostate Cancer,,79,1096,1096,TCGA,,1096,Primary,1,,A,,,,TUMOR FREE,Alive,-22793,,62,7,31,PRAD,1096,1096,WHITE,0.302699624,[Not Available],[Not Applicable],50,R0,1,Matched,0.03,Prostate,Resection,3,e52217cc-26f9-48ed-a3ce-ca5b963c66ce,0,,0,0.062037,[Not Available],9d499039-37ca-4300-ae95-04bbe007c0d2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.6,EJ,3.1,TCGA-EJ-7786,0:DiseaseFree,2,9,Prostate Adenocarcinoma,36.01,4/6/12,1096,,,,,NO,C61,3b3ac042-2bb6-445b-a82b-eea969f0bd33,,2,TUMOR FREE,0.0839,0:LIVING,0.1,3,36.01,Bilateral,11,,,YES,,2011,,,TCGA-EJ-7786.3b3ac042-2bb6-445b-a82b-eea969f0bd33.pdf,,[Not Applicable],NO,,61-70%,5,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.7,62,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5320,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7786,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.96,0.55,2,4,2,HRP,NO,1096,8-other,1096,1096,,0,0,1096,1096,prad_tcga,Malignant,8,BRCA2,5,4.5,TCGA-EJ-7786-01,24,5320,0,TCGA-EJ-7786,1096,1096,Prostate Cancer,,79,1096,1096,TCGA,,1096,Primary,1,,A,,,,TUMOR FREE,Alive,-22793,,62,7,31,PRAD,1096,1096,WHITE,0.302699624,[Not Available],[Not Applicable],50,R0,1,Matched,0.03,Prostate,Resection,3,e52217cc-26f9-48ed-a3ce-ca5b963c66ce,0,,0,0.062037,[Not Available],9d499039-37ca-4300-ae95-04bbe007c0d2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.6,EJ,3.1,TCGA-EJ-7786,0:DiseaseFree,2,9,Prostate Adenocarcinoma,36.01,4/6/12,1096,,,,,NO,C61,3b3ac042-2bb6-445b-a82b-eea969f0bd33,,2,TUMOR FREE,0.0839,0:LIVING,0.1,3,36.01,Bilateral,11,,,YES,,2011,,,TCGA-EJ-7786.3b3ac042-2bb6-445b-a82b-eea969f0bd33.pdf,,[Not Applicable],NO,,61-70%,5,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.7,62,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5321,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7788,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.71,2,2,0,HRP,NO,859,2-ETV1,859,859,,0,0,859,859,prad_tcga,Malignant,4,BRCA1;RAD51B;RAD54L,23,26.6,TCGA-EJ-7788-01,0,0,0,TCGA-EJ-7788,859,859,Prostate Cancer,,52,859,859,TCGA,,859,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-19623,,53,7,49,PRAD,859,859,WHITE,0.0,[Not Available],[Not Applicable],35,R0,1,Matched,0.04,Prostate,Resection,3,566e79d3-defe-48c8-977e-adfbf3a6069b,0,,0,0.032492,[Not Available],e35336e1-e358-493f-9beb-276b5fc6685a,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.16666666667,TCGA-EJ-7788,0:DiseaseFree,2,6,Prostate Adenocarcinoma,28.22,4/6/12,859,,,,,NO,C61,b66a0868-e91c-4ebf-be9c-ba55e94552fd,,1,TUMOR FREE,0.0647,0:LIVING,0.2,5,28.22,Bilateral,6,,,YES,,2011,,,TCGA-EJ-7788.b66a0868-e91c-4ebf-be9c-ba55e94552fd.pdf,,[Not Applicable],NO,,71-80%,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.2,53,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T3b,0,M0,C61.9,8550/3,5322,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7788,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.71,2,2,0,HRP,NO,859,2-ETV1,859,859,,0,0,859,859,prad_tcga,Malignant,4,BRCA1;RAD51B;RAD54L,23,26.6,TCGA-EJ-7788-01,0,5322,0,TCGA-EJ-7788,859,859,Prostate Cancer,,52,859,859,TCGA,,859,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-19623,,53,7,49,PRAD,859,859,WHITE,0.0,[Not Available],[Not Applicable],35,R0,1,Matched,0.04,Prostate,Resection,3,566e79d3-defe-48c8-977e-adfbf3a6069b,0,,0,0.032492,[Not Available],e35336e1-e358-493f-9beb-276b5fc6685a,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.16666666667,TCGA-EJ-7788,0:DiseaseFree,2,6,Prostate Adenocarcinoma,28.22,4/6/12,859,,,,,NO,C61,b66a0868-e91c-4ebf-be9c-ba55e94552fd,,1,TUMOR FREE,0.0647,0:LIVING,0.2,5,28.22,Bilateral,6,,,YES,,2011,,,TCGA-EJ-7788.b66a0868-e91c-4ebf-be9c-ba55e94552fd.pdf,,[Not Applicable],NO,,71-80%,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.2,53,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T3b,0,M0,C61.9,8550/3,5323,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7791,White,PRAD,184,0,0,,EJ,0,0,MALE,0,,,,,,,NO,1118,8-other,1118,1118,,0,0,1118,1118,prad_tcga,Malignant,,,,4.5,TCGA-EJ-7791-01,0,0,0,TCGA-EJ-7791,1118,1118,Prostate Cancer,,217,1118,1118,TCGA,,1118,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-24621,,67,7,16,PRAD,1118,1118,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,,Prostate,Resection,3,57ed8a64-46f9-4e1f-8550-cef121a6bbc6,,,,,[Not Available],4fe004e5-49f9-4336-a690-6ebad512c813,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.8,TCGA-EJ-7791,0:DiseaseFree,2,,Prostate Adenocarcinoma,36.73,4/9/12,1118,,,,,NO,C61,001c43cb-3e9b-43db-b6d0-61e67d058c9f,,,TUMOR FREE,0.0001,0:LIVING,0.1,4,36.73,Bilateral,,,,YES,,2011,,,TCGA-EJ-7791.001c43cb-3e9b-43db-b6d0-61e67d058c9f.pdf,,[Not Applicable],NO,,81-90%,18,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.5,67,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5326,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7791,White,PRAD,184,0,0,,EJ,0,0,MALE,0,,,,,,,NO,1118,8-other,1118,1118,,0,0,1118,1118,prad_tcga,Malignant,,,,4.5,TCGA-EJ-7791-01,0,5326,0,TCGA-EJ-7791,1118,1118,Prostate Cancer,,217,1118,1118,TCGA,,1118,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-24621,,67,7,16,PRAD,1118,1118,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,,Prostate,Resection,3,57ed8a64-46f9-4e1f-8550-cef121a6bbc6,,,,,[Not Available],4fe004e5-49f9-4336-a690-6ebad512c813,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.8,TCGA-EJ-7791,0:DiseaseFree,2,,Prostate Adenocarcinoma,36.73,4/9/12,1118,,,,,NO,C61,001c43cb-3e9b-43db-b6d0-61e67d058c9f,,,TUMOR FREE,0.0001,0:LIVING,0.1,4,36.73,Bilateral,,,,YES,,2011,,,TCGA-EJ-7791.001c43cb-3e9b-43db-b6d0-61e67d058c9f.pdf,,[Not Applicable],NO,,81-90%,18,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.5,67,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5327,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7792,White,PRAD,184,0,0,,EJ,0,0,MALE,0,2.03,0.4,1,2,2,HRP,NO,1396,8-other,1396,1396,,0,0,1396,1396,prad_tcga,Malignant,5,,6,4.6,TCGA-EJ-7792-01,0,0,0,TCGA-EJ-7792,1396,1396,Prostate Cancer,,526,1396,1396,TCGA,,1396,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-19454,,53,7,22,PRAD,1396,1396,WHITE,0.0,[Not Available],[Not Applicable],19,R0,1,Matched,0.01,Prostate,Resection,3,c6843072-01b3-445f-a093-43b97c967dd9,0,,0,0.010025,[Not Available],28689d40-03e5-4e17-aba1-f2d571535eed,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.2,TCGA-EJ-7792,0:DiseaseFree,2,7,Prostate Adenocarcinoma,45.86,4/9/12,1396,,,,,NO,C61,607fd612-7ab9-475b-8c22-fd7cdbaccb37,,0,TUMOR FREE,0.0252,0:LIVING,0.13,4,45.86,Bilateral,9,,,YES,,2010,,,TCGA-EJ-7792.607fd612-7ab9-475b-8c22-fd7cdbaccb37.pdf,,[Not Applicable],NO,,31-40%,35,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.3,53,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5328,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7792,White,PRAD,184,0,0,,EJ,0,0,MALE,0,2.03,0.4,1,2,2,HRP,NO,1396,8-other,1396,1396,,0,0,1396,1396,prad_tcga,Malignant,5,,6,4.6,TCGA-EJ-7792-01,0,5328,0,TCGA-EJ-7792,1396,1396,Prostate Cancer,,526,1396,1396,TCGA,,1396,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-19454,,53,7,22,PRAD,1396,1396,WHITE,0.0,[Not Available],[Not Applicable],19,R0,1,Matched,0.01,Prostate,Resection,3,c6843072-01b3-445f-a093-43b97c967dd9,0,,0,0.010025,[Not Available],28689d40-03e5-4e17-aba1-f2d571535eed,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.2,TCGA-EJ-7792,0:DiseaseFree,2,7,Prostate Adenocarcinoma,45.86,4/9/12,1396,,,,,NO,C61,607fd612-7ab9-475b-8c22-fd7cdbaccb37,,0,TUMOR FREE,0.0252,0:LIVING,0.13,4,45.86,Bilateral,9,,,YES,,2010,,,TCGA-EJ-7792.607fd612-7ab9-475b-8c22-fd7cdbaccb37.pdf,,[Not Applicable],NO,,31-40%,35,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.3,53,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5329,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7793,White,PRAD,221,0,0,,EJ,0,0,MALE,0,2.0,0.3,0,0,0,HRP,NO,114,1-ERG,114,114,,0,0,114,114,prad_tcga,Malignant,0,,5,3.0,TCGA-EJ-7793-01,0,0,0,TCGA-EJ-7793,114,114,Prostate Cancer,,114,114,114,TCGA,,114,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-17982,,49,7,10,PRAD,114,114,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,11ce16b7-6cf6-416d-ac47-089c813cc34c,0,,0,0.0031313,[Not Available],da07da37-bde6-480a-a302-98683ae3931a,4,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.8,TCGA-EJ-7793,0:DiseaseFree,2,0,Prostate Adenocarcinoma,3.75,4/9/12,114,,,,,NO,C61,c9d3d69c-f362-454f-a8ff-cbda4d713c41,,0,TUMOR FREE,0.0031,0:LIVING,0.1,4,3.75,Bilateral,2,,,YES,,2011,,,TCGA-EJ-7793.c9d3d69c-f362-454f-a8ff-cbda4d713c41.pdf,,[Not Applicable],NO,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.3,49,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,T2c,,M0,C61.9,8550/3,5330,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7794,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.96,0.34,2,7,0,HRD,NO,1306,8-other,1306,1306,,0,0,1306,1306,prad_tcga,Malignant,9,,16,5.2,TCGA-EJ-7794-01,0,0,0,TCGA-EJ-7794,1306,1306,Prostate Cancer,,285,1306,1306,TCGA,,1306,Primary,0,,A,,BRCA2,,TUMOR FREE,Alive,-24478,,67,7,17,PRAD,1306,1306,WHITE,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,0.04,Prostate,Resection,3,6a0e1748-c2cd-43e5-8624-10d8297496fb,0,Normal (no evidence of prostate cancer) [cM0],0,0.039203,[Not Available],aeec3005-25d7-45fc-a9ff-014d57960216,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.73333333333,TCGA-EJ-7794,0:DiseaseFree,2,21,Prostate Adenocarcinoma,42.9,4/9/12,1306,,,,,NO,C61,73164d62-bc3a-4dd3-8201-86c5f35ef168,,1,TUMOR FREE,0.0372,0:LIVING,0.1,3,42.9,Bilateral,24,No Evidence of Extraprostatic Extension,35,YES,,2010,,,TCGA-EJ-7794.73164d62-bc3a-4dd3-8201-86c5f35ef168.pdf,,[Not Applicable],YES,35,6-15%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.5,67,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5331,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7794,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.96,0.34,2,7,0,HRD,NO,1306,8-other,1306,1306,,0,0,1306,1306,prad_tcga,Malignant,9,,16,5.2,TCGA-EJ-7794-01,0,5331,0,TCGA-EJ-7794,1306,1306,Prostate Cancer,,285,1306,1306,TCGA,,1306,Primary,0,,A,,BRCA2,,TUMOR FREE,Alive,-24478,,67,7,17,PRAD,1306,1306,WHITE,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,0.04,Prostate,Resection,3,6a0e1748-c2cd-43e5-8624-10d8297496fb,0,Normal (no evidence of prostate cancer) [cM0],0,0.039203,[Not Available],aeec3005-25d7-45fc-a9ff-014d57960216,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.73333333333,TCGA-EJ-7794,0:DiseaseFree,2,21,Prostate Adenocarcinoma,42.9,4/9/12,1306,,,,,NO,C61,73164d62-bc3a-4dd3-8201-86c5f35ef168,,1,TUMOR FREE,0.0372,0:LIVING,0.1,3,42.9,Bilateral,24,No Evidence of Extraprostatic Extension,35,YES,,2010,,,TCGA-EJ-7794.73164d62-bc3a-4dd3-8201-86c5f35ef168.pdf,,[Not Applicable],YES,35,6-15%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.5,67,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7797,White,PRAD,221,0,0,,EJ,0,0,MALE,0,1.98,0.37,2,1,1,HRP,NO,983,1-ERG,983,983,,0,0,983,983,prad_tcga,Malignant,4,,10,5.4,TCGA-EJ-7797-01,0,0,0,TCGA-EJ-7797,983,983,Prostate Cancer,,187,983,983,TCGA,,983,Primary,0,,A,,,,TUMOR FREE,Alive,-19616,,53,7,28,PRAD,983,983,WHITE,0.0,[Not Available],[Not Applicable],44,R0,1,Matched,0.0,Prostate,Resection,3,0ff50861-6b1a-441d-82f1-bf5d3ca8ac86,1,,0,0.015757,[Not Available],f98366df-9616-41c0-a6b8-ec92dca7177a,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.43333333333,TCGA-EJ-7797,0:DiseaseFree,2,7,Prostate Adenocarcinoma,32.29,4/9/12,983,,,,,NO,C61,d9d6f871-c436-469e-9d7f-9684c379a320,,1,TUMOR FREE,0.015,0:LIVING,0.1,4,32.29,Bilateral,8,,,YES,,2011,,,TCGA-EJ-7797.d9d6f871-c436-469e-9d7f-9684c379a320.pdf,,[Not Applicable],NO,,41-50%,14,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.6,53,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46B,,PRAD,,0,0,,EJ,0,0,MALE,0,2.0,0.27,0,0,0,HRP,NO,657,,657,657,,0,0,657,657,prad_tcga,Malignant,0,,4,,TCGA-EJ-A46B-01,0,0,0,TCGA-EJ-A46B,657,657,Prostate Cancer,,157,657,657,TCGA,,657,Primary,0,,A,,,True,TUMOR FREE,Alive,-24305,,66,8,3,PRAD,657,657,,0.0,[Not Available],[Not Applicable],5,,1,Matched,0.0,Prostate,Resection,4,6F63E03B-4C63-4E29-BFD9-DD5095289F23,0,Normal (no evidence of prostate cancer) [cM0],0,0.0011334,[Not Available],1170F449-DFB5-417A-A89B-B2229A2785DB,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,EJ,0.2,TCGA-EJ-A46B,0:DiseaseFree,4,0,Prostate Adenocarcinoma,21.58,1/22/13,657,,,,,,C61,4B418B68-7866-45C1-8728-9D61BF5A9273,420,0,TUMOR FREE,0.0,0:LIVING,0.1,3,21.58,Bilateral,1,No Evidence of Extraprostatic Extension,10,YES,114,2012,,,TCGA-EJ-A46B.4B418B68-7866-45C1-8728-9D61BF5A9273.pdf,,[Not Applicable],YES,10,,10,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,"Yes, History of Prior Malignancy",R0,,66,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5334,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46D,,PRAD,268,0,0,,EJ,0,0,MALE,0,1.96,0.16,3,4,3,HRP,NO,626,1-ERG,626,626,,0,0,626,626,prad_tcga,Malignant,10,BRCA2,22,,TCGA-EJ-A46D-01,0,0,0,TCGA-EJ-A46D,626,626,Prostate Cancer,,122,626,626,TCGA,,626,Primary,0,,A,,,True,TUMOR FREE,Alive,-19466,,53,8,15,PRAD,626,626,,0.0,[Not Available],[Not Applicable],15,,1,Matched,0.02,Prostate,Resection,3,5FAF8EC8-F94C-4B0C-9D91-70942F15F3C8,0,Normal (no evidence of prostate cancer) [cM0],0,0.038409,[Not Available],93D10D8B-5F98-4D2C-8AF3-11471385D4D4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,EJ,0.566666666667,TCGA-EJ-A46D,0:DiseaseFree,4,0,Prostate Adenocarcinoma,20.57,1/22/13,626,,,,,,C61,A0EF60EA-85C2-40AA-9162-E8C96748F94D,940,2,TUMOR FREE,0.0004,0:LIVING,0.03,4,20.57,Bilateral,3,,,YES,181,2012,,,TCGA-EJ-A46D.A0EF60EA-85C2-40AA-9162-E8C96748F94D.pdf,,[Not Applicable],,42,51-60%,6,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,,,53,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5335,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46E,,PRAD,,0,0,,EJ,0,0,MALE,0,,,,,,,NO,524,,524,524,,0,0,524,524,prad_tcga,Malignant,,,,,TCGA-EJ-A46E-01,0,0,0,TCGA-EJ-A46E,524,524,Prostate Cancer,,503,524,524,TCGA,,524,Primary,0,,A,,,True,TUMOR FREE,Alive,-21054,,57,8,5,PRAD,524,524,,0.0,[Not Available],[Not Applicable],10,,1,Matched,,Prostate,Resection,4,ECD3D671-E830-44AF-8518-9D06ED15D04B,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],A608BF0E-A932-4541-8439-2FFB9F6294B0,4,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,EJ,0.333333333333,TCGA-EJ-A46E,0:DiseaseFree,4,,Prostate Adenocarcinoma,17.21,1/23/13,524,,,,,,C61,F2A59B31-7CFE-4DA8-A7B7-229021357746,760,,TUMOR FREE,0.0,0:LIVING,0.1,,17.21,Bilateral,,No Evidence of Extraprostatic Extension,,YES,489,2011,,,TCGA-EJ-A46E.F2A59B31-7CFE-4DA8-A7B7-229021357746.pdf,,[Not Applicable],YES,,,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,57,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-EJ-A46F,,PRAD,,1,1,,EJ,,0,MALE,1,2.07,0.84,3,6,4,ambiguous,NO,783,,,783,,1,1,215,215,prad_tcga,Malignant,13,BRCA1,48,,TCGA-EJ-A46F-01,0,0,0,TCGA-EJ-A46F,215,215,Prostate Cancer,,215,,783,TCGA,,215,Primary,0,,A,,,True,TUMOR FREE,Alive,-21160,,57,8,51,PRAD,215,215,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.04,Prostate,Resection,4,324FAFE4-0109-4273-87EA-F0E212B2BE84,4,Normal (no evidence of prostate cancer) [cM0],0,0.041826,[Not Available],08F11BDD-D665-45AB-B1A2-5485D91922C2,4,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,EJ,1.16666666667,TCGA-EJ-A46F,1:Recurred/Progressed,4,18,Prostate Adenocarcinoma,7.06,1/24/13,783,,Biochemical evidence of disease,,,,C61,E424A7C8-4DDD-4ECC-A0B4-DF22A9996D01,580,5,TUMOR FREE,0.1446,0:LIVING,19.8,3,25.72,Bilateral,26,,166,YES,286,2011,215,,TCGA-EJ-A46F.E424A7C8-4DDD-4ECC-A0B4-DF22A9996D01.pdf,,[Not Applicable],YES,166,,23,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,YES,No,R0,,57,Core needle biopsy,215,Partial Remission/Response,YES,NO,YES,YES,T3b,NO,8,No,NO,0,N1,T2c,1,M0,C61.9,8140/3,5337,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46G,,PRAD,285,0,0,,EJ,0,0,MALE,0,2.25,0.8,1,5,9,HRD,NO,668,8-other,668,668,,0,0,668,668,prad_tcga,Malignant,15,,71,5.1,TCGA-EJ-A46G-01,0,0,0,TCGA-EJ-A46G,668,668,Prostate Cancer,,93,668,668,TCGA,,668,Primary,0,,A,CDK12:342:L/LX:frameshift_variant,,True,TUMOR FREE,Alive,-26219,,71,8,75,PRAD,668,668,,0.0,[Not Available],[Not Applicable],53,R0,1,Matched,0.07,Prostate,Resection,4,6706E0C7-9ED7-4F65-8F5E-EE9342213499,2,Normal (no evidence of prostate cancer) [cM0],0,0.019288,[Not Available],969399CD-47B6-4C0F-8939-3860BE3014F9,4,"Prostate Adenocarcinoma, Other Subtype",,Prostate,16,,Adenocarcinoma,[Not Available],,EJ,1.8,TCGA-EJ-A46G,0:DiseaseFree,4,12,Prostate Adenocarcinoma,21.94,1/24/13,668,,,,,,C61,ACBA1CE1-E248-47D3-B03D-BE0C1B4A6F21,430,2,TUMOR FREE,0.2006,0:LIVING,0.1,5,21.94,Bilateral,18,,,YES,219,2012,,,TCGA-EJ-A46G.ACBA1CE1-E248-47D3-B03D-BE0C1B4A6F21.pdf,,[Not Applicable],,28,41-50%,17,"Prostate Adenocarcinoma, Other Subtype",1,2012,Complete Remission/Response,Adenocarcinoma prostate with prominent ductal differentiation identified,NO,"Yes, History of Prior Malignancy",R0,,71,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,8,No,NO,0,N0,T3a,0,M0,C61.9,8500/3,5338,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46H,,PRAD,,0,0,,EJ,0,0,MALE,0,2.0,0.29,0,0,0,HRP,NO,724,,724,724,,0,0,724,724,prad_tcga,Malignant,0,,5,,TCGA-EJ-A46H-01,0,0,0,TCGA-EJ-A46H,724,724,Prostate Cancer,,131,724,724,TCGA,,724,Primary,0,,A,,,True,TUMOR FREE,Alive,-22059,,60,7,3,PRAD,724,724,,0.0,[Not Available],[Not Applicable],2,,1,Matched,0.0,Prostate,Resection,3,13A361C3-CE9D-447C-BDDD-A7AA9A1ABCFE,0,Normal (no evidence of prostate cancer) [cM0],0,0.000198,[Not Available],CEC1D2FF-36E6-497E-892C-B329724B4722,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,EJ,0.0666666666667,TCGA-EJ-A46H,0:DiseaseFree,2,0,Prostate Adenocarcinoma,23.78,1/24/13,724,,,,,,C61,CF251041-E282-4840-9652-67665E7B10BB,1800,0,TUMOR FREE,0.0,0:LIVING,0.1,,23.78,Bilateral,2,,,YES,188,2012,,,TCGA-EJ-A46H.CF251041-E282-4840-9652-67665E7B10BB.pdf,,[Not Applicable],,-6,,6,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,60,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,,M0,C61.9,8140/3,5339,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46I,,PRAD,285,0,0,,EJ,0,0,MALE,0,,,,,,,NO,668,8-other,668,668,,0,0,668,668,prad_tcga,Malignant,,,,8.5,TCGA-EJ-A46I-01,0,0,0,TCGA-EJ-A46I,668,668,Prostate Cancer,,484,668,668,TCGA,,668,Primary,0,,A,,,True,TUMOR FREE,Alive,-21046,,57,7,10,PRAD,668,668,,0.0,[Not Available],[Not Applicable],10,R0,1,Matched,,Prostate,Resection,3,2EB58022-5F91-4F18-A35C-17DFC457599B,,,,,[Not Available],9B59ED95-E97F-4356-B976-E3FA0E9EEE02,4,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,EJ,0.4,TCGA-EJ-A46I,0:DiseaseFree,2,,Prostate Adenocarcinoma,21.94,1/24/13,668,,,,,,C61,741CC282-0593-45E4-BEEB-343339F891AA,150,,TUMOR FREE,0.0,0:LIVING,0.1,,21.94,Bilateral,,,,YES,520,2011,,,TCGA-EJ-A46I.741CC282-0593-45E4-BEEB-343339F891AA.pdf,,[Not Applicable],,,41-50%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,57,,,Complete Remission/Response,YES,NO,,NO,T3a,NO,7,No,NO,0,N0,T1c,,M0,C61.9,8140/3,5340,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FC-7961,White,PRAD,308,0,0,,FC,0,0,MALE,0,3.59,0.34,11,16,8,ambiguous,NO,469,5-SPOP,469,469,,0,0,469,469,prad_tcga,Malignant,35,BRCA2;FANCL;RAD54L,66,24.7,TCGA-FC-7961-01,28,0,0,TCGA-FC-7961,469,469,Prostate Cancer,,,469,469,TCGA,,469,Primary,1,Apex,A,,,,TUMOR FREE,Alive,-22888,,62,9,66,PRAD,469,469,WHITE,0.458905916,[Not Available],[Not Applicable],55,,1,Matched,0.12,Prostate,Resection,4,cd0a9875-737e-49d2-a66f-a4b127f22a37,10,,1,0.13765,[Not Available],a8d81122-3f2a-43f4-bdc1-479cab37a19d,5,Prostate Adenocarcinoma Acinar Type,1.9,Prostate,32,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,FC,1.86666666667,TCGA-FC-7961,0:DiseaseFree,5,46,Prostate Adenocarcinoma,15.41,3/16/12,469,,,,,,C61,38213CCD-4ED4-43B8-BFA0-38300DD35095,,14,TUMOR FREE,0.2165,0:LIVING,,,15.41,Bilateral,49,No Evidence of Extraprostatic Extension,65,YES,,2011,,,TCGA-FC-7961.38213CCD-4ED4-43B8-BFA0-38300DD35095.pdf,Peripheral Zone,[Not Applicable],YES,,81-90%,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,,0.8,62,Core needle biopsy,,,YES,NO,YES,,T3a,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,5342,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FC-A4JI,,PRAD,268,0,0,,FC,0,0,MALE,0,3.4,0.65,11,17,17,ambiguous,NO,877,8-other,877,877,,0,0,877,877,prad_tcga,Malignant,45,ATM;BARD1;CHEK1;RAD54L,162,51.7,TCGA-FC-A4JI-01,0,0,0,TCGA-FC-A4JI,877,877,Prostate Cancer,,,877,877,TCGA,,877,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25931,,70,8,46,PRAD,877,877,,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.09,Prostate,Resection,5,0CEA748C-D2E9-418E-84B0-41A07BDDC9DA,14,Normal (no evidence of prostate cancer) [cM0],1,0.19749,[Not Available],30F623A3-DAE7-41DA-AB10-8786D094209E,3,Prostate Adenocarcinoma Acinar Type,,Prostate,52,,Acinar Adenocarcinoma,[Not Available],,FC,1.0,TCGA-FC-A4JI,0:DiseaseFree,4,47,Prostate Adenocarcinoma,28.81,2/11/13,877,,,,,NO,C61,BEFDDE59-6838-433A-BAFC-82B4D3802349,630,30,TUMOR FREE,0.4645,0:LIVING,,,28.81,Bilateral,47,Extraprostatic Extension  Localized (e.g. seminal vesicles),16,YES,101,2012,,,TCGA-FC-A4JI.BEFDDE59-6838-433A-BAFC-82B4D3802349.pdf,Central Zone,[Not Applicable],YES,12,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,,No,R0,,70,Core needle biopsy,,,YES,NO,NO,NO,T3a,YES,8,No,YES,0,,T4,,M0,C61.9,8140/3,5343,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-FC-A5OB,,PRAD,308,0,0,,FC,,0,MALE,0,1.97,0.86,3,7,1,HRP,NO,680,8-other,,680,,0,0,680,680,prad_tcga,Malignant,11,,42,26.9,TCGA-FC-A5OB-01,0,0,0,TCGA-FC-A5OB,680,680,Prostate Cancer,,110,,680,TCGA,,680,Primary,0,Middle|Base,A,,,True,WITH TUMOR,Alive,-19413,,53,9,33,PRAD,680,680,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.0,Prostate,Resection,4,1E8F6337-5129-4F23-ABE7-F158028E434A,0,Abnormal (not related to prostate cancer),0,0.03628,[Not Available],F7238E82-A394-4A7C-8514-6241D0AA17E3,5,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,FC,1.13333333333,TCGA-FC-A5OB,0:DiseaseFree,5,11,Prostate Adenocarcinoma,22.34,7/12/13,680,,,,,NO,C61,E54208A5-C6DA-450A-AA5D-9A8FE5F6ECD6,210,1,WITH TUMOR,0.0326,0:LIVING,5.22,,22.34,Bilateral,13,No Evidence of Extraprostatic Extension,9,YES,162,2012,,,TCGA-FC-A5OB.E54208A5-C6DA-450A-AA5D-9A8FE5F6ECD6.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,9,81-90%,9,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,NO,No,R1,,53,Core needle biopsy,,,YES,NO,YES,NO,T3b,,9,No,,0,N0,T3a,0,M0,C61.9,8140/3,5344,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FC-A6HD,,PRAD,,0,0,,FC,0,0,MALE,0,1.99,0.79,1,1,1,HRP,NO,789,,789,789,,0,0,789,789,prad_tcga,Malignant,3,,15,,TCGA-FC-A6HD-01,0,0,0,TCGA-FC-A6HD,789,789,Prostate Cancer,,,789,789,TCGA,,789,Primary,0,Middle,A,,,True,TUMOR FREE,Alive,-28197,,77,7,40,PRAD,789,789,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.02,Prostate,Resection,4,8255D1A9-9AB7-4D23-B3DE-38A2347E2158,0,Normal (no evidence of prostate cancer) [cM0],0,0.012824,[Not Available],F97FED28-FDF3-4C82-8B6D-1015848B80DC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,FC,1.0,TCGA-FC-A6HD,0:DiseaseFree,3,3,Prostate Adenocarcinoma,25.92,10/17/13,789,,,,,NO,C61,7452FEB1-FFB9-4DD2-8CD7-5BEB2B108208,210,0,,0.0101,0:LIVING,,,25.92,Bilateral,7,No Evidence of Extraprostatic Extension,33,YES,140,2013,,,TCGA-FC-A6HD.7452FEB1-FFB9-4DD2-8CD7-5BEB2B108208.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,33,,10,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,,No,R0,,77,Core needle biopsy,,,YES,NO,YES,NO,T3a,,7,No,,0,N0,T3a,0,M0,C61.9,8140/3,5346,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6329,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.95,0.28,2,0,2,ambiguous,NO,1266,1-ERG,1266,1266,,0,0,1266,1266,prad_tcga,Malignant,4,BRCA2;PALB2,5,6.5,TCGA-G9-6329-01,0,0,0,TCGA-G9-6329,1266,1266,Prostate Cancer,,923,1266,1266,TCGA,,1266,Primary,0,,A,,,,TUMOR FREE,Alive,-24797,,67,7,34,PRAD,1266,1266,WHITE,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,0.05,Prostate,Resection,3,e004f38d-c874-4e03-830b-4e554ef3e274,2,Normal (no evidence of prostate cancer) [cM0],0,0.064051,[Not Available],a08fd0a6-a89a-4adb-b641-d4c1238abb71,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,0.766666666667,TCGA-G9-6329,0:DiseaseFree,2,17,Prostate Adenocarcinoma,41.59,3/20/12,1266,,,,,NO,C61,fd7b8f28-b1ee-428e-859c-c888c459a3b0,,3,TUMOR FREE,0.0115,0:LIVING,0.03,,41.59,Bilateral,19,No Evidence of Extraprostatic Extension,10,YES,,2009,,,TCGA-G9-6329.fd7b8f28-b1ee-428e-859c-c888c459a3b0.pdf,,[Not Applicable],YES,10,46-55%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.7,67,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,5348,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-G9-6332,White,PRAD,,1,1,,G9,1,0,MALE,1,1.96,0.81,3,3,2,ambiguous,NO,2657,,1180,2657,,1,1,1180,1180,prad_tcga,Malignant,8,,33,,TCGA-G9-6332-01,0,0,0,TCGA-G9-6332,1180,1180,Prostate Cancer,,2090,1180,2657,TCGA,,1180,Primary,0,Apex|Base,A,,,,WITH TUMOR,Alive,-20166,,55,7,35,PRAD,1180,1180,WHITE,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.02,Prostate,Resection,4,30558aeb-76b7-4d27-99c0-e3ee21a00bd1,0,Normal (no evidence of prostate cancer) [cM0],0,0.044391,[Not Available],c46022f8-b122-4367-836b-ec1ae641a87d,3,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,G9,1.86666666667,TCGA-G9-6332,1:Recurred/Progressed,3,15,Prostate Adenocarcinoma,42.21,3/20/12,2657,,Biochemical evidence of disease,,,NO,C61,18b9fda1-2d69-4c5e-94ba-bfbbcd742bdd,,1,TUMOR FREE,0.0657,0:LIVING,0.73,,87.29,Bilateral,18,No Evidence of Extraprostatic Extension,11,YES,,2005,1180,,TCGA-G9-6332.18b9fda1-2d69-4c5e-94ba-bfbbcd742bdd.pdf,,[Not Applicable],YES,11,,7,Prostate Adenocarcinoma Acinar Type,1,2005,Complete Remission/Response,,,No,R0,0.2,55,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5349,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6333,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.95,0.44,2,4,0,HRP,NO,2465,5-SPOP,2465,2465,,0,0,2465,2465,prad_tcga,Malignant,6,BARD1,33,10.8,TCGA-G9-6333-01,11,0,0,TCGA-G9-6333,2465,2465,Prostate Cancer,,1920,2465,2465,TCGA,,2465,Primary,1,Apex|Base,A,,,,TUMOR FREE,Alive,-24249,,66,7,37,PRAD,2465,2465,WHITE,0.118823523,[Not Available],[Not Applicable],30,R0,1,Matched,0.0,Prostate,Resection,4,98013499-4fac-4378-9d7e-b3686003a4fc,1,Normal (no evidence of prostate cancer) [cM0],0,0.047419,[Not Available],64bf32c9-9466-404a-a147-e7a0b9e91e34,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,6,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.96666666667,TCGA-G9-6333,0:DiseaseFree,3,7,Prostate Adenocarcinoma,80.98,3/19/12,2465,,,,,NO,C61,df50612f-a299-468b-b6bf-226366f4cf42,,1,TUMOR FREE,0.0463,0:LIVING,0.03,,80.98,Bilateral,9,No Evidence of Extraprostatic Extension,1102,YES,,2006,,,TCGA-G9-6333.df50612f-a299-468b-b6bf-226366f4cf42.pdf,,[Not Applicable],YES,1102,71-80%,13,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.6,66,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5350,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6336,White,PRAD,108,0,0,,G9,0,0,MALE,0,,,,,,,NO,2068,1-ERG,2068,2068,,0,0,2068,2068,prad_tcga,Malignant,,,,10.6,TCGA-G9-6336-01,0,0,0,TCGA-G9-6336,2068,2068,Prostate Cancer,,1669,2068,2068,TCGA,,2068,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-20851,,57,7,24,PRAD,2068,2068,WHITE,0.0,[Not Available],[Not Applicable],21,R1,1,Matched,,Prostate,Resection,3,34c8b195-ecab-492b-aed2-43acfedef708,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],59207bcd-f127-481f-b576-8716da7d7d97,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,0.666666666667,TCGA-G9-6336,0:DiseaseFree,2,,Prostate Adenocarcinoma,67.94,3/19/12,2068,,,,,NO,C61,ceda2ffb-b844-4f89-baba-82a66e6f3f0e,,,TUMOR FREE,0.0001,0:LIVING,0.1,,67.94,Bilateral,,No Evidence of Extraprostatic Extension,104,YES,,2007,,,TCGA-G9-6336.ceda2ffb-b844-4f89-baba-82a66e6f3f0e.pdf,,[Not Applicable],YES,98,71-80%,5,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R1,0.3,57,Core needle biopsy,,,NO,YES,YES,,,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5351,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6338,White,PRAD,,0,0,,G9,0,0,MALE,0,1.94,0.77,5,8,1,HRD,NO,2028,,2028,2028,,0,0,2028,2028,prad_tcga,Malignant,14,,60,,TCGA-G9-6338-01,10,0,0,TCGA-G9-6338,2028,2028,Prostate Cancer,,1634,2028,2028,TCGA,,2028,Primary,0,Apex,A,,BRCA2,,TUMOR FREE,Alive,-22360,,61,7,40,PRAD,2028,2028,WHITE,0.196274312,[Not Available],[Not Applicable],30,,1,Matched,0.09,Prostate,Resection,4,21fc7f0f-fcb3-422f-aa73-0e09fd06da35,0,Normal (no evidence of prostate cancer) [cM0],0,0.087289,[Not Available],2c48b1bf-4e49-4869-874b-f08787fa04b5,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.0,TCGA-G9-6338,0:DiseaseFree,3,15,Prostate Adenocarcinoma,66.62,3/16/12,2028,,,,,NO,C61,d3962697-f160-4a76-bfbe-81c06c89d5c3,,3,WITH TUMOR,0.1109,0:LIVING,0.05,,66.62,Bilateral,24,No Evidence of Extraprostatic Extension,82,YES,,2007,,,TCGA-G9-6338.d3962697-f160-4a76-bfbe-81c06c89d5c3.pdf,,[Not Applicable],YES,13,,2,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,,No,R1,1.0,61,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5352,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-G9-6339,,PRAD,,1,1,,G9,1,0,MALE,1,1.96,0.47,2,0,2,HRP,NO,2551,,1634,2551,,1,1,1634,1634,prad_tcga,Malignant,4,BRCA1,41,,TCGA-G9-6339-01,0,0,0,TCGA-G9-6339,1634,1634,Prostate Cancer,,2110,1634,2551,TCGA,,1634,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21305,,58,7,54,PRAD,1634,1634,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.0,Prostate,Resection,3,912d618a-8003-41d6-a0ac-7051b6ccc31c,2,Normal (no evidence of prostate cancer) [cM0],0,0.036667,[Not Available],d39d1a49-fcc0-4f2c-9338-df904e7f6a09,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.43333333333,TCGA-G9-6339,1:Recurred/Progressed,2,5,Prostate Adenocarcinoma,53.68,10/29/13,2551,,Biochemical evidence of disease,,,NO,C61,10FA561E-76C7-4F83-BC1C-B858DF9CCC46,,2,TUMOR FREE,0.0368,0:LIVING,0.03,,83.8,Bilateral,8,,,YES,,2007,1634,,TCGA-G9-6339.10FA561E-76C7-4F83-BC1C-B858DF9CCC46.pdf,,[Not Applicable],NO,4,,6,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,0.8,58,Core needle biopsy,1634,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,7,No,NO,0,N0,T3b,0,M0,C61.9,8550/3,5353,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6342,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.94,0.48,5,6,3,ambiguous,NO,1696,1-ERG,1696,1696,,0,0,1696,1696,prad_tcga,Malignant,14,,17,3.3,TCGA-G9-6342-01,0,0,0,TCGA-G9-6342,1696,1696,Prostate Cancer,,1338,1696,1696,TCGA,,1696,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22472,,61,6,28,PRAD,1696,1696,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,2c85548b-d1fd-4fc8-9908-60205a42e080,1,Normal (no evidence of prostate cancer) [cM0],0,0.059008,[Not Available],00e41e6a-9fe7-44f9-978b-7b05b179506a,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.5,TCGA-G9-6342,0:DiseaseFree,1,14,Prostate Adenocarcinoma,55.72,3/16/12,1696,,,,,NO,C61,80379cb8-9fb7-4e01-9e4a-2bf7813dc839,,1,TUMOR FREE,0.0524,0:LIVING,0.05,4,55.72,Bilateral,17,No Evidence of Extraprostatic Extension,36,YES,,2008,,,TCGA-G9-6342.80379cb8-9fb7-4e01-9e4a-2bf7813dc839.pdf,,[Not Applicable],YES,32,56-65%,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.4,61,Core needle biopsy,,,NO,YES,NO,,T3a,,6,No,,0,,T2c,,M0,C61.9,8550/3,5354,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6343,White,PRAD,,0,0,,G9,0,0,MALE,0,1.96,0.19,1,1,0,ambiguous,NO,2450,,2450,2450,,0,0,2450,2450,prad_tcga,Malignant,2,,2,,TCGA-G9-6343-01,0,0,0,TCGA-G9-6343,2450,2450,Prostate Cancer,,554,2450,2450,TCGA,,2450,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22843,,62,7,35,PRAD,2450,2450,WHITE,0.0,[Not Available],[Not Applicable],26,,1,Matched,0.0,Prostate,Resection,4,084c6d1f-047e-4b0e-9034-3b0fc18d510d,1,,0,0.029447,[Not Available],36b87d12-9f96-460f-a3b5-a4c08cbf5b07,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,0.833333333333,TCGA-G9-6343,0:DiseaseFree,3,15,Prostate Adenocarcinoma,80.49,3/16/12,2450,,,,,NO,C61,3d7d837b-a09e-4281-93af-a789123a9356,,3,TUMOR FREE,0.0142,0:LIVING,0.03,,80.49,Bilateral,19,,,YES,,2008,,,TCGA-G9-6343.3d7d837b-a09e-4281-93af-a789123a9356.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.6,62,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T2a,,M0,C61.9,8550/3,5355,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6347,,PRAD,,0,0,,G9,0,0,MALE,0,2.0,1.0,0,0,0,HRP,NO,2089,,2089,2089,,0,0,2089,2089,prad_tcga,Malignant,0,,8,,TCGA-G9-6347-01,0,0,0,TCGA-G9-6347,2089,2089,Prostate Cancer,,1718,2089,2089,TCGA,,2089,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-21721,,59,6,29,PRAD,2089,2089,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.0,Prostate,Resection,3,d7709ea1-0f66-430a-8270-22bd5b613a18,0,,0,0.000532,[Not Available],b5268f49-2710-4d17-a78b-4a05412e8375,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.1,G9,0.966666666667,TCGA-G9-6347,0:DiseaseFree,1,0,Prostate Adenocarcinoma,68.63,10/29/13,2089,,,,,NO,C61,2ED4FCE8-5DCF-4529-95E5-C454529D7971,,0,TUMOR FREE,0.0001,0:LIVING,0.03,,68.63,Bilateral,0,,,YES,,2008,,,TCGA-G9-6347.2ED4FCE8-5DCF-4529-95E5-C454529D7971.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.4,59,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,5356,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6348,White,PRAD,108,0,0,,G9,0,0,MALE,0,1.91,0.36,4,5,2,HRP,NO,1515,2-ETV1,1515,1515,,0,0,1515,1515,prad_tcga,Malignant,11,BRCA1,13,4.6,TCGA-G9-6348-01,0,0,0,TCGA-G9-6348,1515,1515,Prostate Cancer,,1136,1515,1515,TCGA,,1515,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-24936,,68,7,46,PRAD,1515,1515,WHITE,0.0,[Not Available],[Not Applicable],45,R0,1,Matched,0.0,Prostate,Resection,3,a692e125-ccfc-4376-9cea-2410511882bf,1,Abnormal (not related to prostate cancer),0,0.086384,[Not Available],8ad78c4f-c84c-4f9e-88c9-42a05eb65498,4,Prostate Adenocarcinoma Acinar Type,1.9,Prostate,10,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,G9,2.86666666667,TCGA-G9-6348,0:DiseaseFree,2,14,Prostate Adenocarcinoma,49.77,3/15/12,1515,,,,,NO,C61,2ee3eb4c-3673-41a1-b005-fec737174aca,,4,TUMOR FREE,0.082,0:LIVING,0.02,,49.77,Bilateral,15,No Evidence of Extraprostatic Extension,31,YES,,2008,,,TCGA-G9-6348.2ee3eb4c-3673-41a1-b005-fec737174aca.pdf,,[Not Applicable],YES,31,71-80%,15,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.8,68,Core needle biopsy,,,NO,YES,,,T2c,,7,No,,0,N0,T3a,0,M0,C61.9,8550/3,5357,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6353,White,PRAD,161,0,0,,G9,0,0,MALE,0,2.0,1.0,0,0,0,HRP,NO,1542,1-ERG,1542,1542,,0,0,1542,1542,prad_tcga,Malignant,0,,0,4.6,TCGA-G9-6353-01,0,0,0,TCGA-G9-6353,1542,1542,Prostate Cancer,,590,1542,1542,TCGA,,1542,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-21221,,58,7,5,PRAD,1542,1542,WHITE,0.0,[Not Available],[Not Applicable],20,R1,1,Matched,0.0,Prostate,Resection,3,4cba0ba5-58c3-455c-9cd5-7d9428d27f8c,0,,0,0.0,[Not Available],bcc94953-ce79-428e-99c1-632e42c1b9bc,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,G9,1.0,TCGA-G9-6353,0:DiseaseFree,2,1,Prostate Adenocarcinoma,50.66,3/14/12,1542,,,,,NO,C61,72b2694f-8b37-402a-a75a-2a50372a789e,,0,TUMOR FREE,0.0,0:LIVING,0.1,,50.66,Bilateral,2,,,YES,,2009,,,TCGA-G9-6353.72b2694f-8b37-402a-a75a-2a50372a789e.pdf,Peripheral Zone,[Not Applicable],NO,,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.6,58,Core needle biopsy,,,NO,YES,NO,,T3a,,7,No,,0,,T1c,,M0,C61.9,8550/3,5359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6354,,PRAD,,0,0,,G9,0,0,MALE,0,1.94,0.61,2,2,2,HRP,NO,2066,,2066,2066,,0,0,2066,2066,prad_tcga,Malignant,6,,46,,TCGA-G9-6354-01,0,0,0,TCGA-G9-6354,2066,2066,Prostate Cancer,,525,2066,2066,TCGA,,2066,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-20403,,55,7,39,PRAD,2066,2066,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.02,Prostate,Resection,3,cb123fb8-700c-4bc9-bc5a-e1816f19f64d,3,,0,0.060809,[Not Available],6bbbe263-3632-4567-912c-95bc9940a1dd,4,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.1,G9,0.966666666667,TCGA-G9-6354,0:DiseaseFree,2,8,Prostate Adenocarcinoma,67.87,10/29/13,2066,,,,,NO,C61,CFFC4C63-D738-41CD-8EE3-25C190A9638C,,3,TUMOR FREE,0.0579,0:LIVING,0.03,,67.87,Right,10,,,YES,,2009,,,TCGA-G9-6354.CFFC4C63-D738-41CD-8EE3-25C190A9638C.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.1,55,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2b,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,5360,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6356,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.01,0.21,1,1,1,ambiguous,NO,1434,1-ERG,1434,1434,,0,0,1434,1434,prad_tcga,Malignant,3,CHEK2,3,8.7,TCGA-G9-6356-01,0,0,0,TCGA-G9-6356,1434,1434,Prostate Cancer,,986,1434,1434,TCGA,,1434,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22010,,60,9,30,PRAD,1434,1434,WHITE,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.1,Prostate,Resection,4,c6e0f83f-aba3-4705-abac-c81c885b53ba,1,Normal (no evidence of prostate cancer) [cM0],0,0.012384,[Not Available],1d7ffbe7-6139-412b-8739-8082a63a2b33,5,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.6,G9,2.1,TCGA-G9-6356,0:DiseaseFree,5,18,Prostate Adenocarcinoma,47.11,3/14/12,1434,,,,,NO,C61,818a2716-ca81-4534-ba13-a0fe3a18b2e9,,2,TUMOR FREE,0.0021,0:LIVING,0.13,3,47.11,Bilateral,20,No Evidence of Extraprostatic Extension,21,YES,,2009,,,TCGA-G9-6356.818a2716-ca81-4534-ba13-a0fe3a18b2e9.pdf,,[Not Applicable],YES,24,36-45%,5,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.6,60,Core needle biopsy,,,NO,YES,YES,,T3b,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,5361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6361,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.95,0.73,3,4,0,ambiguous,NO,1415,1-ERG,1415,1415,,0,0,1415,1415,prad_tcga,Malignant,7,RAD51B;RAD54L,56,5.5,TCGA-G9-6361-01,0,0,0,TCGA-G9-6361,1415,1415,Prostate Cancer,,1002,1415,1415,TCGA,,1415,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22565,,61,7,42,PRAD,1415,1415,WHITE,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.11,Prostate,Resection,3,a369c190-964e-471c-878a-d8fade7cf992,1,Normal (no evidence of prostate cancer) [cM0],0,0.048237,[Not Available],71d14304-ccb0-4a4c-b935-8c014ca75fd0,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.2,TCGA-G9-6361,0:DiseaseFree,2,27,Prostate Adenocarcinoma,46.48,3/13/12,1415,,,,,NO,C61,49fe865a-79e8-4ff3-a52e-9888c4514cf2,,1,TUMOR FREE,0.0515,0:LIVING,0.1,,46.48,Bilateral,34,No Evidence of Extraprostatic Extension,31,YES,,2009,,,TCGA-G9-6361.49fe865a-79e8-4ff3-a52e-9888c4514cf2.pdf,,[Not Applicable],YES,38,31-40%,12,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.7,61,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,5362,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-G9-6362,White,PRAD,,0,0,,G9,,0,MALE,0,2.0,0.87,2,2,3,ambiguous,NO,1443,,,1443,,0,0,1443,1443,prad_tcga,Malignant,7,CHEK2,12,,TCGA-G9-6362-01,0,0,0,TCGA-G9-6362,1443,1443,Prostate Cancer,,815,,1443,TCGA,,1443,Primary,0,Apex|Base,A,,,,WITH TUMOR,Alive,-21149,,57,7,51,PRAD,1443,1443,WHITE,0.0,[Not Available],[Not Applicable],41,,1,Matched,0.01,Prostate,Resection,4,1a626c6c-3dd9-4d87-bb93-cb2feb82fbe8,2,Normal (no evidence of prostate cancer) [cM0],0,0.036882,[Not Available],f228ef91-ecfb-4d1e-8e6a-b43d2185270e,3,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,2.1,TCGA-G9-6362,0:DiseaseFree,3,13,Prostate Adenocarcinoma,47.4,3/13/12,1443,,,,,NO,C61,fc8bac85-e3c5-47c1-b4c1-9b8834e01780,,2,TUMOR FREE,0.0786,0:LIVING,0.07,5,47.4,Bilateral,18,,,YES,,2009,,,TCGA-G9-6362.fc8bac85-e3c5-47c1-b4c1-9b8834e01780.pdf,,[Not Applicable],NO,8,,2,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,NO,No,R1,0.8,57,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5363,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6363,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.02,0.47,3,8,3,ambiguous,NO,1378,1-ERG,1378,1378,,0,0,1378,1378,prad_tcga,Malignant,14,,31,4.6,TCGA-G9-6363-01,0,0,0,TCGA-G9-6363,1378,1378,Prostate Cancer,,993,1378,1378,TCGA,,1378,Primary,0,Base,A,,,,TUMOR FREE,Alive,-23480,,64,7,46,PRAD,1378,1378,WHITE,0.0,[Not Available],[Not Applicable],53,R0,1,Matched,0.03,Prostate,Resection,4,65d588ff-58e3-4932-a7f4-25ef23c433d5,1,Normal (no evidence of prostate cancer) [cM0],0,0.053631,[Not Available],b5b3871c-078c-46a7-ac50-ef916d4a6781,3,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,2.13333333333,TCGA-G9-6363,0:DiseaseFree,3,17,Prostate Adenocarcinoma,45.27,3/9/12,1378,,,,,NO,C61,bd52ccc2-462d-41df-a5a4-dc45bd78aea4,,3,TUMOR FREE,0.0845,0:LIVING,0.03,,45.27,Bilateral,17,No Evidence of Extraprostatic Extension,23,YES,,2009,,,TCGA-G9-6363.bd52ccc2-462d-41df-a5a4-dc45bd78aea4.pdf,,[Not Applicable],YES,58,31-40%,6,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.9,64,Core needle biopsy,,,NO,YES,YES,,T4,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5364,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-G9-6367,White,PRAD,108,0,0,,G9,,0,MALE,0,2.0,0.27,0,0,0,HRP,NO,1222,8-other,,1222,,0,0,1222,1222,prad_tcga,Malignant,0,,0,8.5,TCGA-G9-6367-01,0,0,0,TCGA-G9-6367,1222,1222,Prostate Cancer,,836,,1222,TCGA,,1222,Primary,0,Apex|Base,A,,,,WITH TUMOR,Alive,-22176,,60,9,2,PRAD,1222,1222,WHITE,0.0,[Not Available],[Not Applicable],9,R1,1,Matched,0.0,Prostate,Resection,4,5bc98578-e4c7-4be8-89df-f26aa5d545a9,0,Normal (no evidence of prostate cancer) [cM0],0,0.0,[Not Available],9f751c9d-ad41-4f02-b7f8-12423857d418,5,Prostate Adenocarcinoma Acinar Type,1.6,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.366666666667,TCGA-G9-6367,0:DiseaseFree,5,3,Prostate Adenocarcinoma,40.14,3/8/12,1222,,,,,NO,C61,1306f52c-6633-4ca8-8998-c5306e0c34be,,0,WITH TUMOR,0.0,0:LIVING,0.42,3,40.14,Bilateral,3,No Evidence of Extraprostatic Extension,30,YES,,2009,,,TCGA-G9-6367.1306f52c-6633-4ca8-8998-c5306e0c34be.pdf,,[Not Applicable],YES,30,31-40%,5,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,,No,R1,0.5,60,Core needle biopsy,,,NO,YES,YES,,T3a,,9,No,,0,N0,T2b,0,M0,C61.9,8550/3,5368,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6369,White,PRAD,,0,0,,G9,0,0,MALE,0,1.94,0.87,4,10,2,ambiguous,NO,1215,,1215,1215,,0,0,1215,1215,prad_tcga,Malignant,16,BRCA2,62,,TCGA-G9-6369-01,0,0,0,TCGA-G9-6369,1215,1215,Prostate Cancer,,851,1215,1215,TCGA,,1215,Primary,0,Base,A,,,,TUMOR FREE,Alive,-20238,,55,7,40,PRAD,1215,1215,WHITE,0.0,[Not Available],[Not Applicable],37,,1,Matched,0.02,Prostate,Resection,4,23078e16-3d54-4fca-a09f-e9a4838a2a89,1,Normal (no evidence of prostate cancer) [cM0],0,0.076314,[Not Available],e0ff90e5-e6c3-4fb5-9512-6f09a891378b,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.23333333333,TCGA-G9-6369,0:DiseaseFree,3,17,Prostate Adenocarcinoma,39.91,3/7/12,1215,,,,,NO,C61,8da381e8-6bab-4b75-9ae3-d7b76f90f044,,0,TUMOR FREE,0.0878,0:LIVING,0.03,,39.91,Bilateral,20,No Evidence of Extraprostatic Extension,23,YES,,2009,,,TCGA-G9-6369.8da381e8-6bab-4b75-9ae3-d7b76f90f044.pdf,,[Not Applicable],YES,35,,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.5,55,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5369,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6370,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.0,0.38,0,0,0,HRD,NO,1156,8-other,1156,1156,,0,0,1156,1156,prad_tcga,Malignant,0,,0,6.4,TCGA-G9-6370-01,0,0,0,TCGA-G9-6370,1156,1156,Prostate Cancer,,806,1156,1156,TCGA,,1156,Primary,0,Apex|Base,A,BARD1:507:V/X:frameshift_variant,,,TUMOR FREE,Alive,-19149,,52,7,2,PRAD,1156,1156,WHITE,0.0,[Not Available],[Not Applicable],7,R0,1,Matched,0.0,Prostate,Resection,3,644e1e7d-dfd1-4f83-82dc-ae0c7e010f6f,0,,0,0.0,[Not Available],f947b0bc-bdac-44e8-b5b9-ffae4147740a,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.233333333333,TCGA-G9-6370,0:DiseaseFree,2,0,Prostate Adenocarcinoma,37.98,3/7/12,1156,,,,,NO,C61,fa0332e6-d535-45c0-8ed9-9b36816f1350,,0,TUMOR FREE,0.0,0:LIVING,0.03,,37.98,Bilateral,2,,,YES,,2009,,,TCGA-G9-6370.fa0332e6-d535-45c0-8ed9-9b36816f1350.pdf,,[Not Applicable],NO,,16-25%,1,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.6,52,Core needle biopsy,,,NO,YES,YES,,T3b,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5370,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6371,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.04,0.28,1,0,1,HRP,NO,1226,3-ETV4,1226,1226,,0,0,1226,1226,prad_tcga,Malignant,2,,19,6.3,TCGA-G9-6371-01,0,0,0,TCGA-G9-6371,1226,1226,Prostate Cancer,,846,1226,1226,TCGA,,1226,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-21365,,58,6,32,PRAD,1226,1226,WHITE,0.0,[Not Available],[Not Applicable],35,R1,1,Matched,0.03,Prostate,Resection,3,2f91086c-adcd-4a79-96aa-58819ab28a57,3,,0,0.014285,[Not Available],d5c43a14-21ab-4178-ae33-2d8b7baa256f,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.13333333333,TCGA-G9-6371,0:DiseaseFree,1,4,Prostate Adenocarcinoma,40.28,3/6/12,1226,,,,,NO,C61,26034718-f43a-491d-99fb-934d99ba4a6a,,2,TUMOR FREE,0.0138,0:LIVING,0.03,,40.28,Bilateral,5,,,YES,,2009,,,TCGA-G9-6371.26034718-f43a-491d-99fb-934d99ba4a6a.pdf,,[Not Applicable],NO,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.6,58,Core needle biopsy,,,NO,YES,NO,,T2c,,6,No,,0,,T1c,,M0,C61.9,8550/3,5371,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6373,White,PRAD,,0,0,,G9,0,0,MALE,0,2.02,0.72,3,0,4,HRP,NO,811,,811,811,,0,0,811,811,prad_tcga,Malignant,7,,24,,TCGA-G9-6373-01,6,0,0,TCGA-G9-6373,811,811,Prostate Cancer,,,811,811,TCGA,,811,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-24887,,68,7,36,PRAD,811,811,WHITE,0.094772502,[Not Available],[Not Applicable],42,,1,Matched,0.03,Prostate,Resection,4,18365c1f-9bc0-4865-b40d-def3ee73331c,7,Normal (no evidence of prostate cancer) [cM0],0,0.068527,[Not Available],c3a509c6-35a6-4d17-a9fd-0aa8884b33a0,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,G9,2.26666666667,TCGA-G9-6373,0:DiseaseFree,3,8,Prostate Adenocarcinoma,26.64,3/6/12,811,,,,,NO,C61,ed631fb0-95e4-4b30-963f-1ff4cb4f0ece,,5,TUMOR FREE,0.1457,0:LIVING,,,26.64,Bilateral,12,,,YES,,2009,,,TCGA-G9-6373.ed631fb0-95e4-4b30-963f-1ff4cb4f0ece.pdf,,[Not Applicable],NO,29,,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,,No,R0,0.9,68,Core needle biopsy,,,NO,YES,NO,,T3a,,7,No,,0,,T2b,,M0,C61.9,8550/3,5372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6377,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.93,0.66,3,4,5,ambiguous,NO,958,1-ERG,958,958,,0,0,958,958,prad_tcga,Malignant,12,BRCA1;CDK12;RAD51D,20,3.6,TCGA-G9-6377-01,0,0,0,TCGA-G9-6377,958,958,Prostate Cancer,,518,958,958,TCGA,,958,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22419,,61,7,35,PRAD,958,958,WHITE,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.21,Prostate,Resection,3,8f105d0d-0630-46fc-8168-dcba11a5197f,3,Abnormal (not related to prostate cancer),0,0.067335,[Not Available],007f9081-5093-4323-b4f8-cd510bf20705,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.0,TCGA-G9-6377,0:DiseaseFree,2,21,Prostate Adenocarcinoma,31.47,3/5/12,958,,,,,NO,C61,520abbf9-817a-45db-aecc-22c4fc80ddae,,2,TUMOR FREE,0.1123,0:LIVING,0.03,,31.47,Bilateral,22,No Evidence of Extraprostatic Extension,11,YES,,2009,,,TCGA-G9-6377.520abbf9-817a-45db-aecc-22c4fc80ddae.pdf,,[Not Applicable],YES,36,66-75%,6,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.5,61,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5373,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6378,Black or African American,PRAD,108,0,0,,G9,0,0,MALE,0,1.95,0.26,2,1,2,HRP,NO,1155,8-other,1155,1155,,0,0,1155,1155,prad_tcga,Malignant,5,,9,4.2,TCGA-G9-6378-01,0,0,0,TCGA-G9-6378,1155,1155,Prostate Cancer,,223,1155,1155,TCGA,,1155,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-19879,,54,7,37,PRAD,1155,1155,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],31,R1,1,Matched,0.0,Prostate,Resection,3,940bbb5c-7280-41ed-9332-47c2072ae072,1,Normal (no evidence of prostate cancer) [cM0],0,0.047512,[Not Available],12f225d0-cbff-44eb-9183-bacc7f33b090,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.0,TCGA-G9-6378,0:DiseaseFree,2,10,Prostate Adenocarcinoma,37.94,3/5/12,1155,,,,,NO,C61,425008c5-919c-45b3-beb7-2392d6866ffb,,2,TUMOR FREE,0.0009,0:LIVING,0.03,,37.94,Bilateral,11,No Evidence of Extraprostatic Extension,100,YES,,2009,,,TCGA-G9-6378.425008c5-919c-45b3-beb7-2392d6866ffb.pdf,,[Not Applicable],YES,-176,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.9,54,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,5374,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6379,,PRAD,,0,0,,G9,0,0,MALE,0,3.81,0.21,5,11,6,ambiguous,NO,1778,,1778,1778,,0,0,1778,1778,prad_tcga,Malignant,22,,48,,TCGA-G9-6379-01,0,0,0,TCGA-G9-6379,1778,1778,Prostate Cancer,,1393,1778,1778,TCGA,,1778,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-25126,,68,7,41,PRAD,1778,1778,,0.0,[Not Available],[Not Applicable],23,,1,Matched,0.02,Prostate,Resection,4,a9360ccf-07bc-4c71-80f3-e638b3b88cf0,2,,1,0.075351,[Not Available],d33074f0-5f88-4995-9439-76068a9f4836,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,19,,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.766666666667,TCGA-G9-6379,0:DiseaseFree,3,24,Prostate Adenocarcinoma,58.41,10/29/13,1778,,,,,NO,C61,A097CB29-5440-45F9-B261-025603C37CEF,,3,TUMOR FREE,0.0722,0:LIVING,0.03,5,58.41,Bilateral,23,,,YES,,2009,,,TCGA-G9-6379.A097CB29-5440-45F9-B261-025603C37CEF.pdf,,[Not Applicable],NO,,,6,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,1.0,68,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,7,No,NO,0,N0,T1b,0,M0,C61.9,8550/3,5375,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6384,White,PRAD,108,0,0,,G9,0,0,MALE,0,1.94,0.45,5,5,4,ambiguous,NO,765,1-ERG,765,765,,0,0,765,765,prad_tcga,Malignant,14,,13,7.4,TCGA-G9-6384-01,0,0,0,TCGA-G9-6384,765,765,Prostate Cancer,,390,765,765,TCGA,,765,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-19620,,53,7,25,PRAD,765,765,WHITE,0.0,[Not Available],[Not Applicable],27,R0,1,Matched,0.0,Prostate,Resection,3,1abcbe00-5a6f-4e0f-a61c-d158545c2293,1,,0,0.056924,[Not Available],a279d5aa-51f7-4e75-9e14-b206b97ec4bd,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,13,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.6,G9,1.7,TCGA-G9-6384,0:DiseaseFree,2,15,Prostate Adenocarcinoma,25.13,3/2/12,765,,,,,NO,C61,6987c1c1-6e23-44f0-bba8-6bba4a288025,,2,TUMOR FREE,0.0537,0:LIVING,0.03,,25.13,Bilateral,17,,,YES,,2010,,,TCGA-G9-6384.6987c1c1-6e23-44f0-bba8-6bba4a288025.pdf,,[Not Applicable],NO,,71-80%,14,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.7,53,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6385,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.0,0.2,0,0,0,HRP,NO,830,1-ERG,830,830,,0,0,830,830,prad_tcga,Malignant,0,,0,7.4,TCGA-G9-6385-01,0,0,0,TCGA-G9-6385,830,830,Prostate Cancer,,336,830,830,TCGA,,830,Primary,0,Base,A,,,,TUMOR FREE,Alive,-24399,,66,7,11,PRAD,830,830,WHITE,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,0.0,Prostate,Resection,3,cfe4b1fa-b658-49d3-87ad-6df7d75a58df,0,Normal (no evidence of prostate cancer) [cM0],0,0.0,[Not Available],e82a04cf-e81e-43c6-9cd9-0e29fa0f00ae,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.43333333333,TCGA-G9-6385,0:DiseaseFree,2,1,Prostate Adenocarcinoma,27.27,3/2/12,830,,,,,NO,C61,3027c5cd-f972-469c-a9f2-9a72b83a86c8,,0,TUMOR FREE,0.0,0:LIVING,0.064,,27.27,Bilateral,4,,,YES,,2010,,,TCGA-G9-6385.3027c5cd-f972-469c-a9f2-9a72b83a86c8.pdf,,[Not Applicable],NO,12,41-50%,,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.7,66,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,5377,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-G9-6494,White,PRAD,108,0,0,,G9,,0,MALE,0,1.98,0.57,5,4,5,HRD,NO,1771,2-ETV1,,1771,,0,0,1771,1771,prad_tcga,Malignant,14,ATM;BRCA1;CDK12;RAD51D,26,87.0,TCGA-G9-6494-01,0,0,0,TCGA-G9-6494,1771,1771,Prostate Cancer,,1423,,1771,TCGA,,1771,Primary,0,Base,A,,CHEK1,,WITH TUMOR,Alive,-24381,,66,7,40,PRAD,1771,1771,WHITE,0.0,[Not Available],[Not Applicable],42,R1,1,Matched,0.01,Prostate,Resection,4,45db5303-bbab-4f8c-a2a2-9a9a9bfa2fd1,5,Normal (no evidence of prostate cancer) [cM0],0,0.068649,[Not Available],0c459149-0dfe-4206-b50b-db79180ebb57,3,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,G9,2.66666666667,TCGA-G9-6494,0:DiseaseFree,3,12,Prostate Adenocarcinoma,58.18,4/6/12,1771,,,,,NO,C61,9aad0222-0731-498b-a9c2-400ce0ccfa0d,,3,WITH TUMOR,0.1102,0:LIVING,1.13,,58.18,Bilateral,19,No Evidence of Extraprostatic Extension,-13,YES,,2008,,,TCGA-G9-6494.9aad0222-0731-498b-a9c2-400ce0ccfa0d.pdf,,[Not Applicable],YES,-13,41-50%,2,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,,No,R1,1.0,66,Core needle biopsy,,,NO,YES,YES,,T4,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5378,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6496,White,PRAD,,0,0,,G9,0,0,MALE,0,2.02,0.83,3,6,5,HRP,NO,1726,,1726,1726,,0,0,1726,1726,prad_tcga,Malignant,14,,46,,TCGA-G9-6496-01,22,0,0,TCGA-G9-6496,1726,1726,Prostate Cancer,,703,1726,1726,TCGA,,1726,Primary,1,Apex|Base,A,,,,TUMOR FREE,Alive,-22602,,61,7,47,PRAD,1726,1726,WHITE,0.224968086,[Not Available],[Not Applicable],38,,1,Matched,0.01,Prostate,Resection,4,ece85143-957d-4ad1-bfcc-b71307efb911,1,Normal (no evidence of prostate cancer) [cM0],0,0.062181,[Not Available],ce2b7e17-424e-4954-8a68-19d7f98d2e7e,3,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,G9,2.33333333333,TCGA-G9-6496,0:DiseaseFree,3,9,Prostate Adenocarcinoma,56.7,3/21/12,1726,,,,,NO,C61,193cca51-2d1f-49aa-afdb-63a55d689c86,,2,TUMOR FREE,0.0874,0:LIVING,0.03,,56.7,Bilateral,10,No Evidence of Extraprostatic Extension,20,YES,,2008,,,TCGA-G9-6496.193cca51-2d1f-49aa-afdb-63a55d689c86.pdf,,[Not Applicable],YES,19,,15,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,61,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-G9-6498,,PRAD,,1,1,,G9,1,0,MALE,1,1.99,0.62,1,2,0,HRP,NO,1952,,1342,1952,,1,1,1342,1342,prad_tcga,Malignant,3,,15,,TCGA-G9-6498-01,0,0,0,TCGA-G9-6498,1342,1342,Prostate Cancer,,1608,1342,1952,TCGA,,1342,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-19568,,53,7,34,PRAD,1342,1342,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.02,Prostate,Resection,3,6620b1a5-1ccc-4e6a-9b38-0f41baeba170,0,Normal (no evidence of prostate cancer) [cM0],0,0.0126,[Not Available],b8fbfe87-e92c-4d54-a620-17b2dcde6d53,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.4,G9,1.0,TCGA-G9-6498,1:Recurred/Progressed,2,3,Prostate Adenocarcinoma,44.09,10/29/13,1952,,Biochemical evidence of disease,,,NO,C61,0F610D96-54E9-4E40-B3D4-19554C782057,,0,TUMOR FREE,0.0109,0:LIVING,0.03,,64.13,Bilateral,3,,,YES,,2008,1342,,TCGA-G9-6498.0F610D96-54E9-4E40-B3D4-19554C782057.pdf,,[Not Applicable],NO,47,,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,0.5,53,Core needle biopsy,1342,Complete Remission/Response,NO,YES,NO,YES,T3a,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,5380,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6499,White,PRAD,161,0,0,,G9,0,0,MALE,0,3.62,0.3,5,15,10,ambiguous,NO,1543,8-other,1543,1543,,0,0,1543,1543,prad_tcga,Malignant,30,BRCA1;BRIP1;CDK12;RAD51B;RAD51C;RAD51D;RAD54L,17,8.2,TCGA-G9-6499-01,35,0,0,TCGA-G9-6499,1543,1543,Prostate Cancer,,1109,1543,1543,TCGA,,1543,Primary,1,Apex|Base,A,,,,TUMOR FREE,Alive,-24388,,66,9,51,PRAD,1543,1543,WHITE,0.354658503,[Not Available],[Not Applicable],36,R0,1,Matched,0.3,Prostate,Resection,4,424fb9d8-f70e-4a36-b895-a766176eee7c,17,Equivocal,1,0.10454,[Not Available],acd5ceef-c5cf-4e95-9394-c50fdbc70c8d,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,30,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,2.13333333333,TCGA-G9-6499,0:DiseaseFree,5,53,Prostate Adenocarcinoma,50.69,3/20/12,1543,,,,,NO,C61,8e1d4212-b252-4019-b188-3cdd60be733d,,20,TUMOR FREE,0.2884,0:LIVING,0.11,,50.69,Bilateral,56,No Evidence of Extraprostatic Extension,421,YES,,2008,,,TCGA-G9-6499.8e1d4212-b252-4019-b188-3cdd60be733d.pdf,,[Not Applicable],YES,56,36-45%,13,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,66,Core needle biopsy,,,NO,YES,YES,,T3a,,9,No,,0,N0,T3a,0,M0,C61.9,8550/3,5381,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7509,,PRAD,,0,0,,G9,0,0,MALE,0,1.99,0.57,0,2,1,HRP,NO,1610,,1610,1610,,0,0,1610,1610,prad_tcga,Malignant,3,BRCA1,16,,TCGA-G9-7509-01,0,0,0,TCGA-G9-7509,1610,1610,Prostate Cancer,,352,1610,1610,TCGA,,1610,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-17538,,48,6,28,PRAD,1610,1610,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.07,Prostate,Resection,3,a70549d1-2bc4-4a1e-977a-f24b1c70d4c0,0,,0,0.012005,[Not Available],7d0c6960-710f-42c7-889e-c3a7d4a30b3c,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.4,G9,1.06666666667,TCGA-G9-7509,0:DiseaseFree,1,4,Prostate Adenocarcinoma,52.89,5/14/14,1610,,,,,NO,C61,CF612B37-B575-4D5B-A715-43EBEBEF7300,,0,TUMOR FREE,0.0096,0:LIVING,0.03,4,52.89,Bilateral,6,,,YES,,2009,,,TCGA-G9-7509.CF612B37-B575-4D5B-A715-43EBEBEF7300.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,48,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,6,No,NO,0,,T1c,,M0,C61.9,8550/3,5382,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7510,,PRAD,221,0,0,,G9,0,0,MALE,0,1.93,0.25,3,5,3,ambiguous,NO,1185,5-SPOP,1185,1185,,0,0,1185,1185,prad_tcga,Malignant,11,BRCA2,24,9.7,TCGA-G9-7510-01,0,0,0,TCGA-G9-7510,1185,1185,Prostate Cancer,,674,1185,1185,TCGA,,1185,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-24187,,66,8,40,PRAD,1185,1185,,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.16,Prostate,Resection,4,635f5b8d-7d96-4e28-ad86-e78ceb2c467c,3,Normal (no evidence of prostate cancer) [cM0],0,0.09131,[Not Available],f211f7a9-cf3b-432c-9ea0-1172cce14e9d,4,Prostate Adenocarcinoma Acinar Type,1.6,Prostate,10,,Acinar Adenocarcinoma,[Not Available],0.5,G9,1.2,TCGA-G9-7510,0:DiseaseFree,4,34,Prostate Adenocarcinoma,38.93,5/31/12,1185,,,,,NO,C61,11c8711a-57c0-41fe-82fa-2e9592fef570,,4,TUMOR FREE,0.0311,0:LIVING,0.03,5,38.93,Bilateral,36,Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1],22,YES,,2010,,,TCGA-G9-7510.11c8711a-57c0-41fe-82fa-2e9592fef570.pdf,,[Not Applicable],YES,22,61-70%,10,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R1,0.9,66,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,5383,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7510,,PRAD,221,0,0,,G9,0,0,MALE,0,1.93,0.25,3,5,3,ambiguous,NO,1185,5-SPOP,1185,1185,,0,0,1185,1185,prad_tcga,Malignant,11,BRCA2,24,9.7,TCGA-G9-7510-01,0,5383,0,TCGA-G9-7510,1185,1185,Prostate Cancer,,674,1185,1185,TCGA,,1185,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-24187,,66,8,40,PRAD,1185,1185,,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.16,Prostate,Resection,4,635f5b8d-7d96-4e28-ad86-e78ceb2c467c,3,Normal (no evidence of prostate cancer) [cM0],0,0.09131,[Not Available],f211f7a9-cf3b-432c-9ea0-1172cce14e9d,4,Prostate Adenocarcinoma Acinar Type,1.6,Prostate,10,,Acinar Adenocarcinoma,[Not Available],0.5,G9,1.2,TCGA-G9-7510,0:DiseaseFree,4,34,Prostate Adenocarcinoma,38.93,5/31/12,1185,,,,,NO,C61,11c8711a-57c0-41fe-82fa-2e9592fef570,,4,TUMOR FREE,0.0311,0:LIVING,0.03,5,38.93,Bilateral,36,Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1],22,YES,,2010,,,TCGA-G9-7510.11c8711a-57c0-41fe-82fa-2e9592fef570.pdf,,[Not Applicable],YES,22,61-70%,10,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R1,0.9,66,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,5384,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7519,,PRAD,221,0,0,,G9,0,0,MALE,0,1.97,0.18,0,0,0,HRD,NO,849,8-other,849,849,,0,0,849,849,prad_tcga,Malignant,0,BRCA2,3,5.1,TCGA-G9-7519-01,0,0,0,TCGA-G9-7519,849,849,Prostate Cancer,,457,849,849,TCGA,,849,Primary,0,Apex|Base,A,CDK12:92-102:DRRENDERRGS/DX:frameshift_variant,,,TUMOR FREE,Alive,-21276,,58,7,33,PRAD,849,849,,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.01,Prostate,Resection,3,a0fd8790-8db2-4a4f-8fd6-657b263e1579,0,Abnormal (not related to prostate cancer),0,0.034792,[Not Available],0f01ec33-00a8-4188-a8f0-e90d46ad9bc7,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.7,G9,1.3,TCGA-G9-7519,0:DiseaseFree,2,3,Prostate Adenocarcinoma,27.89,5/31/12,849,,,,,NO,C61,07227b7d-9285-4d1b-9484-ccdb20841905,,1,TUMOR FREE,0.0001,0:LIVING,0.03,,27.89,Bilateral,9,No Evidence of Extraprostatic Extension,7,YES,,2010,,,TCGA-G9-7519.07227b7d-9285-4d1b-9484-ccdb20841905.pdf,,[Not Applicable],YES,7,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.8,58,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,5385,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7519,,PRAD,221,0,0,,G9,0,0,MALE,0,1.97,0.18,0,0,0,HRD,NO,849,8-other,849,849,,0,0,849,849,prad_tcga,Malignant,0,BRCA2,3,5.1,TCGA-G9-7519-01,0,5385,0,TCGA-G9-7519,849,849,Prostate Cancer,,457,849,849,TCGA,,849,Primary,0,Apex|Base,A,CDK12:92-102:DRRENDERRGS/DX:frameshift_variant,,,TUMOR FREE,Alive,-21276,,58,7,33,PRAD,849,849,,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.01,Prostate,Resection,3,a0fd8790-8db2-4a4f-8fd6-657b263e1579,0,Abnormal (not related to prostate cancer),0,0.034792,[Not Available],0f01ec33-00a8-4188-a8f0-e90d46ad9bc7,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.7,G9,1.3,TCGA-G9-7519,0:DiseaseFree,2,3,Prostate Adenocarcinoma,27.89,5/31/12,849,,,,,NO,C61,07227b7d-9285-4d1b-9484-ccdb20841905,,1,TUMOR FREE,0.0001,0:LIVING,0.03,,27.89,Bilateral,9,No Evidence of Extraprostatic Extension,7,YES,,2010,,,TCGA-G9-7519.07227b7d-9285-4d1b-9484-ccdb20841905.pdf,,[Not Applicable],YES,7,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.8,58,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,5386,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-G9-7521,,PRAD,221,0,0,,G9,,0,MALE,0,3.9,0.42,5,9,9,ambiguous,NO,942,8-other,,942,,0,0,942,942,prad_tcga,Malignant,23,BRCA2;RAD51B,13,26.3,TCGA-G9-7521-01,10,0,0,TCGA-G9-7521,942,942,Prostate Cancer,45,487,,942,TCGA,No Evidence of Extraprostatic Extension,942,Primary,0,Apex|Base,A,,,,[Discrepancy],Alive,-19216,,52,8,37,PRAD,942,942,,0.293770367,[Not Available],[Not Applicable],35,R0,1,Matched,0.16,Prostate,Resection,4,74a8d844-92db-4829-b687-a54a41c32f36,10,Normal (no evidence of prostate cancer) [cM0],1,0.090501,[Not Available],cf70909e-5143-47ae-b8ca-c3ae6ace7be2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,24,,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.13333333333,TCGA-G9-7521,0:DiseaseFree,4,23,Prostate Adenocarcinoma,30.95,5/31/12,942,,,,,YES,C61,b0a188e3-c084-4e2d-93dd-31de3a3f47e6,,16,TUMOR FREE,0.189,0:LIVING,0.06,5,30.95,Bilateral,30,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-G9-7521.b0a188e3-c084-4e2d-93dd-31de3a3f47e6.pdf,,[Not Applicable],YES,13,41-50%,9,Prostate Adenocarcinoma Acinar Type,1,2010,[Discrepancy],,NO,No,R0,0.8,52,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,8,No,YES,0,N1,T3a,1,M0,C61.9,8550/3,5387,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-G9-7521,,PRAD,221,0,0,,G9,,0,MALE,0,3.9,0.42,5,9,9,ambiguous,NO,942,8-other,,942,,0,0,942,942,prad_tcga,Malignant,23,BRCA2;RAD51B,13,26.3,TCGA-G9-7521-01,10,5387,0,TCGA-G9-7521,942,942,Prostate Cancer,45,487,,942,TCGA,No Evidence of Extraprostatic Extension,942,Primary,0,Apex|Base,A,,,,[Discrepancy],Alive,-19216,,52,8,37,PRAD,942,942,,0.293770367,[Not Available],[Not Applicable],35,R0,1,Matched,0.16,Prostate,Resection,4,74a8d844-92db-4829-b687-a54a41c32f36,10,Normal (no evidence of prostate cancer) [cM0],1,0.090501,[Not Available],cf70909e-5143-47ae-b8ca-c3ae6ace7be2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,24,,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.13333333333,TCGA-G9-7521,0:DiseaseFree,4,23,Prostate Adenocarcinoma,30.95,5/31/12,942,,,,,YES,C61,b0a188e3-c084-4e2d-93dd-31de3a3f47e6,,16,TUMOR FREE,0.189,0:LIVING,0.06,5,30.95,Bilateral,30,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-G9-7521.b0a188e3-c084-4e2d-93dd-31de3a3f47e6.pdf,,[Not Applicable],YES,13,41-50%,9,Prostate Adenocarcinoma Acinar Type,1,2010,[Discrepancy],,NO,No,R0,0.8,52,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,8,No,YES,0,N1,T3a,1,M0,C61.9,8550/3,5388,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7522,,PRAD,221,0,0,,G9,0,0,MALE,0,1.99,0.21,0,0,0,HRP,NO,1078,1-ERG,1078,1078,,0,0,1078,1078,prad_tcga,Malignant,0,,10,6.8,TCGA-G9-7522-01,0,0,0,TCGA-G9-7522,1078,1078,Prostate Cancer,,452,1078,1078,TCGA,,1078,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-18033,,49,7,12,PRAD,1078,1078,,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.01,Prostate,Resection,3,10bfe256-c4a2-4d88-b907-56f86ef63de9,0,,0,0.0053995,[Not Available],87959988-bb25-47ee-afc1-9af92592bbe7,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.8,TCGA-G9-7522,0:DiseaseFree,2,3,Prostate Adenocarcinoma,35.41,5/31/12,1078,,,,,NO,C61,8d3c4720-f528-4a73-b2f0-95b2aac093f2,,0,TUMOR FREE,0.0051,0:LIVING,0.1,,35.41,Bilateral,3,,,YES,,2011,,,TCGA-G9-7522.8d3c4720-f528-4a73-b2f0-95b2aac093f2.pdf,,[Not Applicable],NO,,51-60%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.9,49,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,5389,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7522,,PRAD,221,0,0,,G9,0,0,MALE,0,1.99,0.21,0,0,0,HRP,NO,1078,1-ERG,1078,1078,,0,0,1078,1078,prad_tcga,Malignant,0,,10,6.8,TCGA-G9-7522-01,0,5389,0,TCGA-G9-7522,1078,1078,Prostate Cancer,,452,1078,1078,TCGA,,1078,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-18033,,49,7,12,PRAD,1078,1078,,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.01,Prostate,Resection,3,10bfe256-c4a2-4d88-b907-56f86ef63de9,0,,0,0.0053995,[Not Available],87959988-bb25-47ee-afc1-9af92592bbe7,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.8,TCGA-G9-7522,0:DiseaseFree,2,3,Prostate Adenocarcinoma,35.41,5/31/12,1078,,,,,NO,C61,8d3c4720-f528-4a73-b2f0-95b2aac093f2,,0,TUMOR FREE,0.0051,0:LIVING,0.1,,35.41,Bilateral,3,,,YES,,2011,,,TCGA-G9-7522.8d3c4720-f528-4a73-b2f0-95b2aac093f2.pdf,,[Not Applicable],NO,,51-60%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.9,49,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,5390,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7523,,PRAD,221,0,0,,G9,0,0,MALE,0,1.84,0.21,0,0,0,HRP,NO,857,7-IDH1,857,857,,0,0,857,857,prad_tcga,Malignant,0,PALB2;RAD51B,10,11.3,TCGA-G9-7523-01,5,0,0,TCGA-G9-7523,857,857,Prostate Cancer,,324,857,857,TCGA,,857,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-16269,,44,10,17,PRAD,857,857,,0.259445228,[Not Available],[Not Applicable],50,R1,1,Matched,0.16,Prostate,Resection,5,01dee5bc-b28d-4251-8875-b0acb02a1000,6,Abnormal (not related to prostate cancer),0,0.16225,[Not Available],93e78f4c-e74b-4675-8d2c-d641fa25d8f2,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.63333333333,TCGA-G9-7523,0:DiseaseFree,5,0,Prostate Adenocarcinoma,28.15,5/31/12,857,,,,,NO,C61,8a16d779-bcf3-4371-87ec-3cd68330b1d6,,4,TUMOR FREE,0.0001,0:LIVING,0.03,,28.15,Bilateral,3,No Evidence of Extraprostatic Extension,20,YES,,2011,,,TCGA-G9-7523.8a16d779-bcf3-4371-87ec-3cd68330b1d6.pdf,,[Not Applicable],YES,20,21-30%,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.8,44,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,10,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,5391,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7523,,PRAD,221,0,0,,G9,0,0,MALE,0,1.84,0.21,0,0,0,HRP,NO,857,7-IDH1,857,857,,0,0,857,857,prad_tcga,Malignant,0,PALB2;RAD51B,10,11.3,TCGA-G9-7523-01,5,5391,0,TCGA-G9-7523,857,857,Prostate Cancer,,324,857,857,TCGA,,857,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-16269,,44,10,17,PRAD,857,857,,0.259445228,[Not Available],[Not Applicable],50,R1,1,Matched,0.16,Prostate,Resection,5,01dee5bc-b28d-4251-8875-b0acb02a1000,6,Abnormal (not related to prostate cancer),0,0.16225,[Not Available],93e78f4c-e74b-4675-8d2c-d641fa25d8f2,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.63333333333,TCGA-G9-7523,0:DiseaseFree,5,0,Prostate Adenocarcinoma,28.15,5/31/12,857,,,,,NO,C61,8a16d779-bcf3-4371-87ec-3cd68330b1d6,,4,TUMOR FREE,0.0001,0:LIVING,0.03,,28.15,Bilateral,3,No Evidence of Extraprostatic Extension,20,YES,,2011,,,TCGA-G9-7523.8a16d779-bcf3-4371-87ec-3cd68330b1d6.pdf,,[Not Applicable],YES,20,21-30%,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.8,44,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,10,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,5392,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7525,,PRAD,,0,0,,G9,0,0,MALE,0,3.98,0.62,1,2,2,HRP,NO,994,,994,994,,0,0,994,994,prad_tcga,Malignant,5,,74,,TCGA-G9-7525-01,0,0,0,TCGA-G9-7525,994,994,Prostate Cancer,,512,994,994,TCGA,,994,Primary,0,Base,A,,,,TUMOR FREE,Alive,-23481,,64,7,43,PRAD,994,994,,0.0,[Not Available],[Not Applicable],48,,1,Matched,0.0,Prostate,Resection,4,bd13998c-d615-4af6-9eab-b59fad85f31f,0,Normal (no evidence of prostate cancer) [cM0],1,0.031145,[Not Available],f4e17ba1-f14f-480e-8fe3-415909fc320a,3,Prostate Adenocarcinoma Acinar Type,1.8,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.4,G9,1.6,TCGA-G9-7525,0:DiseaseFree,3,8,Prostate Adenocarcinoma,32.65,5/31/12,994,,,,,NO,C61,837a5284-61ec-4a13-9743-010fc6a8df6a,,2,TUMOR FREE,0.0583,0:LIVING,0.03,,32.65,Bilateral,11,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-G9-7525.837a5284-61ec-4a13-9743-010fc6a8df6a.pdf,,[Not Applicable],YES,12,,6,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.9,64,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,5393,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7525,,PRAD,,0,0,,G9,0,0,MALE,0,3.98,0.62,1,2,2,HRP,NO,994,,994,994,,0,0,994,994,prad_tcga,Malignant,5,,74,,TCGA-G9-7525-01,0,5393,0,TCGA-G9-7525,994,994,Prostate Cancer,,512,994,994,TCGA,,994,Primary,0,Base,A,,,,TUMOR FREE,Alive,-23481,,64,7,43,PRAD,994,994,,0.0,[Not Available],[Not Applicable],48,,1,Matched,0.0,Prostate,Resection,4,bd13998c-d615-4af6-9eab-b59fad85f31f,0,Normal (no evidence of prostate cancer) [cM0],1,0.031145,[Not Available],f4e17ba1-f14f-480e-8fe3-415909fc320a,3,Prostate Adenocarcinoma Acinar Type,1.8,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.4,G9,1.6,TCGA-G9-7525,0:DiseaseFree,3,8,Prostate Adenocarcinoma,32.65,5/31/12,994,,,,,NO,C61,837a5284-61ec-4a13-9743-010fc6a8df6a,,2,TUMOR FREE,0.0583,0:LIVING,0.03,,32.65,Bilateral,11,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-G9-7525.837a5284-61ec-4a13-9743-010fc6a8df6a.pdf,,[Not Applicable],YES,12,,6,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.9,64,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,5394,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-G9-A9S0,,PRAD,,1,1,,G9,,1,MALE,1,1.94,0.57,10,7,5,ambiguous,NO,791,,,791,,1,1,423,423,prad_tcga,Malignant,22,CDK12;CHEK2,54,,TCGA-G9-A9S0-01,6,0,0,TCGA-G9-A9S0,423,423,Prostate Cancer,,759,,791,TCGA,,423,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Dead,-19530,791,53,8,33,PRAD,423,423,,0.225359883,Prostate Cancer,[Not Applicable],32,,1,Matched,0.1,Prostate,Resection,4,EA9EE289-5CD5-4E0F-B0B5-B359D19C0DF7,3,Normal (no evidence of prostate cancer) [cM0],0,0.11882,[Not Available],084AC674-F4CF-4A4A-A6A2-687C05C272EA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,G9,1.06666666667,TCGA-G9-A9S0,1:Recurred/Progressed,4,22,Prostate Adenocarcinoma,21.35,6/17/14,,Bone,Distant Metastasis,Prostate Cancer,Medical Record,NO,C61,2E6B54C4-BC0A-46E3-A3F9-B55CEB1B1ECD,130,5,WITH TUMOR,0.1906,1:DECEASED,10.87,5,25.99,Bilateral,22,No Evidence of Extraprostatic Extension,73,YES,840,2011,423,,TCGA-G9-A9S0.2E6B54C4-BC0A-46E3-A3F9-B55CEB1B1ECD.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,73,,13,Prostate Adenocarcinoma Acinar Type,1,2011,Progressive Disease,,YES,No,R1,,53,Transurethral resection (TURBT),429,Progressive Disease,NO,YES,YES,YES,T3b,YES,8,No,YES,0,N1,T2a,5,M0,C61.9,8140/3,5395,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-H9-7775,White,PRAD,184,0,0,,H9,0,0,MALE,0,1.97,0.79,2,3,2,HRP,NO,185,4-FLI1,185,185,,0,0,185,185,prad_tcga,Malignant,7,,20,7.2,TCGA-H9-7775-01,0,0,0,TCGA-H9-7775,185,185,Prostate Cancer,,73,185,185,TCGA,,185,Primary,0,,A,,,,TUMOR FREE,Alive,-24898,,68,7,41,PRAD,185,185,WHITE,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,3,09bb6311-41ad-46a1-8195-6d1fdacd7cb0,1,,0,0.032713,[Not Available],ecade538-f882-4f29-a363-7acb89fd0576,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,H9,1.06666666667,TCGA-H9-7775,0:DiseaseFree,2,6,Prostate Adenocarcinoma,6.08,2/8/12,185,,,,,,C61,2a752788-15f1-4879-96a7-eaf5dfa6921d,,1,,0.0311,0:LIVING,0.04,0,6.08,Right,8,,,YES,,2011,,,TCGA-H9-7775.2a752788-15f1-4879-96a7-eaf5dfa6921d.pdf,,[Not Applicable],,,91-100%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.6,68,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,,,,C61.9,8550/3,5398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-H9-A6BX,,PRAD,,0,0,,H9,0,0,MALE,0,2.0,1.0,0,0,0,HRP,NO,941,,941,941,,0,0,941,941,prad_tcga,Malignant,0,,7,,TCGA-H9-A6BX-01,0,0,0,TCGA-H9-A6BX,941,941,Prostate Cancer,,570,941,941,TCGA,,941,Primary,0,,A,,,False,TUMOR FREE,Alive,-22039,,60,6,7,PRAD,941,941,,0.0,[Not Available],[Not Applicable],8,,1,Matched,0.0,Prostate,Resection,3,A077C6A8-F9C7-4E72-842C-78300A89B007,0,,0,0.000499,[Not Available],3BA3D23D-67E2-4F38-9951-F5CFA1131F9F,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,H9,0.333333333333,TCGA-H9-A6BX,0:DiseaseFree,1,0,Prostate Adenocarcinoma,30.91,11/26/13,941,,,,,NO,C61,5AEA61BF-A79E-4A8A-B3F1-45982DAF288E,190,0,TUMOR FREE,0.0,0:LIVING,0.04,,30.91,Bilateral,3,,,YES,479,2012,,,TCGA-H9-A6BX.5AEA61BF-A79E-4A8A-B3F1-45982DAF288E.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,60,,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,6,No,NO,0,,,,,C61.9,8140/3,5399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-H9-A6BY,,PRAD,,0,0,,H9,,0,MALE,0,1.98,0.76,1,2,0,HRP,NO,112,,,112,,0,0,112,112,prad_tcga,Malignant,3,,11,,TCGA-H9-A6BY-01,0,0,0,TCGA-H9-A6BY,112,112,Prostate Cancer,,,,112,TCGA,,112,Primary,0,,A,,,False,,Alive,-23297,,63,7,37,PRAD,112,112,,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.02,Prostate,Resection,3,98735D47-6497-4B8F-8F1B-D6AE01A34748,0,,0,0.019835,[Not Available],701991DA-6DEB-41DF-B9CC-E5049A886B5B,4,Prostate Adenocarcinoma Acinar Type,,Prostate,2,,Acinar Adenocarcinoma,[Not Available],,H9,1.13333333333,TCGA-H9-A6BY,0:DiseaseFree,2,2,Prostate Adenocarcinoma,3.68,12/2/13,112,,,,,,C61,87EDA3C6-8BAC-49FD-8592-1D38812660E6,120,0,,0.019,0:LIVING,,,3.68,Bilateral,6,,,YES,303,2012,,,TCGA-H9-A6BY.87EDA3C6-8BAC-49FD-8592-1D38812660E6.pdf,Overlapping / Multiple Zones,[Not Applicable],,,,19,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,RX,,63,Core needle biopsy,,,YES,NO,YES,NO,T3a,,7,No,,0,N0,T1c,0,,C61.9,8140/3,5400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7075,White,PRAD,161,0,0,,HC,0,0,MALE,0,1.99,0.78,0,0,0,HRP,NO,601,8-other,601,601,,0,0,601,601,prad_tcga,Malignant,0,,19,5.1,TCGA-HC-7075-01,0,0,0,TCGA-HC-7075,601,601,Prostate Cancer,,96,601,601,TCGA,,601,Primary,0,,A,,,,TUMOR FREE,Alive,,,63,6,33,PRAD,601,601,WHITE,0.0,[Not Available],[Not Applicable],34,R0,1,Matched,0.0,Prostate,Resection,3,1fa3e5c2-e415-42fa-aea3-f6c84959522a,0,,0,0.0060158,[Not Available],5dd69c3e-9a3d-450c-9f10-10b4d6daeeba,3,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,1,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.13333333333,TCGA-HC-7075,0:DiseaseFree,1,1,Prostate Adenocarcinoma,19.74,3/29/12,601,,,,,,C61,72e3166c-bbd4-4bc1-931c-5fda225b3cf9,,0,TUMOR FREE,0.0058,0:LIVING,0.01,,19.74,Right,5,,,YES,,2010,,,TCGA-HC-7075.72e3166c-bbd4-4bc1-931c-5fda225b3cf9.pdf,,[Not Applicable],,,81-90%,,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,No,R0,0.4,63,Core needle biopsy,,,NO,YES,NO,,T2a,,6,No,,0,,T1c,,M0,C61.9,8550/3,5401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7077,Black or African American,PRAD,161,0,0,,HC,0,0,MALE,0,1.94,0.65,3,4,1,ambiguous,NO,2115,1-ERG,2115,2115,,0,0,2115,2115,prad_tcga,Malignant,8,BRCA2,28,7.6,TCGA-HC-7077-01,0,0,0,TCGA-HC-7077,2115,2115,Prostate Cancer,,1749,2115,2115,TCGA,,2115,Primary,0,,A,,,,TUMOR FREE,Alive,-23636,,64,6,68,PRAD,2115,2115,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],53,R0,1,Matched,0.24,Prostate,Resection,3,f3e4cc00-d6fe-4291-bb07-8e501e772ce1,2,Normal (no evidence of prostate cancer) [cM0],0,0.065077,[Not Available],92252560-5984-41f6-a4b5-a3aa8654c0c8,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.73333333333,TCGA-HC-7077,0:DiseaseFree,1,19,Prostate Adenocarcinoma,69.48,4/9/12,2115,,,,,NO,C61,67940700-dcd0-4e3c-9cca-4f6daeacf34c,,2,TUMOR FREE,0.0626,0:LIVING,0.83,,69.48,Bilateral,21,,,YES,,2006,,,TCGA-HC-7077.67940700-dcd0-4e3c-9cca-4f6daeacf34c.pdf,,[Not Applicable],NO,-14,56-65%,,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,,No,R0,0.5,64,Transurethral resection (TURBT),,,NO,YES,NO,,T3a,,6,No,,0,,T1c,,M0,C61.9,8550/3,5402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7078,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.73,7,7,9,ambiguous,NO,1985,8-other,1985,1985,,0,0,1985,1985,prad_tcga,Malignant,23,RAD54L,34,25.0,TCGA-HC-7078-01,0,0,0,TCGA-HC-7078,1985,1985,Prostate Cancer,,1409,1985,1985,TCGA,,1985,Primary,0,,A,,,,TUMOR FREE,Alive,-25402,,69,7,42,PRAD,1985,1985,WHITE,0.0,[Not Available],[Not Applicable],47,R0,1,Matched,0.05,Prostate,Resection,3,842cacf7-8288-42c6-b2ae-1099dddeb60f,6,Normal (no evidence of prostate cancer) [cM0],0,0.16213,[Not Available],9f802576-1e98-496c-bda4-4b1dd2e411c8,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,21,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.53333333333,TCGA-HC-7078,0:DiseaseFree,2,20,Prostate Adenocarcinoma,65.21,4/10/12,1985,,,,,NO,C61,fb3865df-5e90-4a2f-b684-063d41369bfc,,9,TUMOR FREE,0.2282,0:LIVING,0.01,,65.21,Bilateral,22,No Evidence of Extraprostatic Extension,,YES,,2007,,,TCGA-HC-7078.fb3865df-5e90-4a2f-b684-063d41369bfc.pdf,,[Not Applicable],NO,,81-90%,3,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,,No,R0,0.5,69,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,5403,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-HC-7079,White,PRAD,161,1,1,,HC,,0,MALE,1,2.0,0.91,0,0,0,HRP,NO,1184,4-FLI1,,1184,,1,1,380,380,prad_tcga,Malignant,0,,19,5.5,TCGA-HC-7079-01,0,0,0,TCGA-HC-7079,380,380,Prostate Cancer,,126,,1184,TCGA,,380,Primary,0,Apex|Middle|Base,A,,,,WITH TUMOR,Alive,-18734,,51,7,0,PRAD,380,380,WHITE,0.0,[Not Available],[Not Applicable],6,R0,1,Matched,0.0,Prostate,Resection,3,190ef71a-5b5d-4009-b707-68f10147cb65,0,,0,1.42e-05,[Not Available],10fbe481-f111-4f88-ae45-4d67cb265567,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,0.2,TCGA-HC-7079,1:Recurred/Progressed,2,1,Prostate Adenocarcinoma,12.48,4/10/12,1184,,Biochemical evidence of disease,,,NO,C61,8e42fce1-33e7-45e1-b8e9-2faf5a02766d,,0,WITH TUMOR,0.0,0:LIVING,0.1,,38.9,Bilateral,2,,,YES,,2010,380,,TCGA-HC-7079.8e42fce1-33e7-45e1-b8e9-2faf5a02766d.pdf,,[Not Applicable],NO,,36-45%,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,,No,R0,0.6,51,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T3a,0,M0,C61.9,8550/3,5404,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-HC-7080,White,PRAD,161,0,0,,HC,0,0,MALE,1,1.89,0.9,6,9,1,ambiguous,NO,1106,5-SPOP,1106,1106,,0,0,894,894,prad_tcga,Malignant,16,CHEK2;PALB2,126,4.1,TCGA-HC-7080-01,0,0,0,TCGA-HC-7080,1106,1106,Prostate Cancer,,104,1106,1106,TCGA,,894,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-24243,,66,7,37,PRAD,1106,1106,WHITE,0.0,[Not Available],[Not Applicable],34,R0,1,Matched,0.0,Prostate,Resection,3,e30730b8-81f1-49a8-8446-547b5c3cc730,0,Normal (no evidence of prostate cancer) [cM0],0,0.10554,[Not Available],fd50ff41-ec9d-4db1-a673-36ba0ca1eac8,4,Prostate Adenocarcinoma Acinar Type,0.5,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.16666666667,TCGA-HC-7080,1:Recurred/Progressed,2,16,Prostate Adenocarcinoma,29.37,4/9/12,1106,,New Primary Tumor,,,NO,C61,f2bf590a-9473-47fe-89a9-69c480b6c42b,,1,TUMOR FREE,0.1135,0:LIVING,0.1,,36.33,Right,20,No Evidence of Extraprostatic Extension,19,YES,,2010,894,,TCGA-HC-7080.f2bf590a-9473-47fe-89a9-69c480b6c42b.pdf,,[Not Applicable],YES,19,81-90%,2,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.4,66,Core needle biopsy,,,NO,YES,YES,,T2a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5405,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-7081,White,PRAD,161,0,0,,HC,,0,MALE,0,1.97,0.55,1,2,2,HRP,NO,1136,1-ERG,,1136,,0,0,1136,1136,prad_tcga,Malignant,5,,26,7.7,TCGA-HC-7081-01,0,0,0,TCGA-HC-7081,1136,1136,Prostate Cancer,,,,1136,TCGA,,1136,Primary,0,,A,,,,WITH TUMOR,Alive,,,62,9,32,PRAD,1136,1136,WHITE,0.0,[Not Available],[Not Applicable],32,R2,1,Matched,0.0,Prostate,Resection,4,d4eaa3c5-a0f0-4cd7-8b93-73dfb09b359a,0,,0,0.02788,[Not Available],3da2e90e-6450-4286-8c74-08dbecbfd788,5,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.06666666667,TCGA-HC-7081,0:DiseaseFree,5,6,Prostate Adenocarcinoma,37.32,4/11/12,1136,,,,,,C61,75d1573a-cbf6-4b3c-93c4-2d410586884c,,0,WITH TUMOR,0.0265,0:LIVING,,,37.32,Bilateral,6,,,YES,,2010,,,TCGA-HC-7081.75d1573a-cbf6-4b3c-93c4-2d410586884c.pdf,,[Not Applicable],,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,,No,R2,0.8,62,Core needle biopsy,,,YES,NO,NO,,T3b,,9,No,,0,,,,,C61.9,8550/3,5406,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7209,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.55,2,7,4,HRP,NO,440,1-ERG,440,440,,0,0,440,440,prad_tcga,Malignant,13,,43,7.9,TCGA-HC-7209-01,0,0,0,TCGA-HC-7209,440,440,Prostate Cancer,,108,440,440,TCGA,,440,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-22129,,60,6,26,PRAD,440,440,WHITE,0.0,[Not Available],[Not Applicable],28,R0,1,Matched,0.0,Prostate,Resection,3,aa7850ac-fb78-433b-8d55-a24c05935db5,0,,0,0.044262,[Not Available],582d1177-73b0-4a9c-8505-70d6b402bd01,3,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,13,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,0.866666666667,TCGA-HC-7209,0:DiseaseFree,1,13,Prostate Adenocarcinoma,14.45,4/10/12,440,,,,,,C61,87f8ff1b-d58b-470e-9156-144cbe34b71c,,0,TUMOR FREE,0.0422,0:LIVING,0.05,,14.45,Bilateral,14,,,YES,,2011,,,TCGA-HC-7209.87f8ff1b-d58b-470e-9156-144cbe34b71c.pdf,,[Not Applicable],,,71-80%,2,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.4,60,Core needle biopsy,,,YES,NO,YES,,T2c,,6,No,,0,N0,T2b,0,,C61.9,8550/3,5407,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7210,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.47,5,10,1,HRD,NO,868,6-FOXA1,868,868,,0,0,868,868,prad_tcga,Malignant,16,,33,8.9,TCGA-HC-7210-01,8,0,0,TCGA-HC-7210,868,868,Prostate Cancer,,149,868,868,TCGA,,868,Primary,0,,A,,ATM;BRCA2;CHEK1,,TUMOR FREE,Alive,-27343,,74,7,51,PRAD,868,868,WHITE,0.203529837,[Not Available],[Not Applicable],29,R0,1,Matched,0.0,Prostate,Resection,3,9069fc65-9bae-49f3-9329-b78c8cc6cf1e,0,,0,0.059512,[Not Available],6a5af80e-07ad-4cd3-aaab-5db1090835d9,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,16,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,0.966666666667,TCGA-HC-7210,0:DiseaseFree,2,26,Prostate Adenocarcinoma,28.52,4/10/12,868,,,,,,C61,8398444a-bfad-41d6-94a6-ab85ddf159aa,,0,TUMOR FREE,0.0743,0:LIVING,0.1,,28.52,Right,27,,,YES,,2011,,,TCGA-HC-7210.8398444a-bfad-41d6-94a6-ab85ddf159aa.pdf,,[Not Applicable],,,61-70%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.9,74,Core needle biopsy,,,YES,NO,YES,,T2a,,7,No,,0,N0,,0,,C61.9,8550/3,5408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7212,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.91,0.78,5,6,4,HRD,NO,870,1-ERG,870,870,,0,0,870,870,prad_tcga,Malignant,15,,15,8.0,TCGA-HC-7212-01,0,0,0,TCGA-HC-7212,870,870,Prostate Cancer,,424,870,870,TCGA,,870,Primary,0,,A,,ATM;BRCA2;CHEK1;CHEK2,,TUMOR FREE,Alive,-20576,,56,7,24,PRAD,870,870,WHITE,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,3,92888479-b534-432d-8f70-cae857e0074b,0,,0,0.089141,[Not Available],907b64d6-a26a-4092-a247-ac9af444d1c7,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.43333333333,TCGA-HC-7212,0:DiseaseFree,2,15,Prostate Adenocarcinoma,28.58,4/11/12,870,,,,,,C61,b401d78b-78c2-4e6e-86db-c93997da85a4,,4,,0.0854,0:LIVING,0.28,,28.58,Right,18,,,YES,,2011,,,TCGA-HC-7212.b401d78b-78c2-4e6e-86db-c93997da85a4.pdf,,[Not Applicable],,,51-60%,4,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,,0.8,56,Core needle biopsy,,,YES,NO,YES,,T2a,,7,No,,0,N0,,0,M0,C61.9,8550/3,5410,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-HC-7213,White,PRAD,184,1,1,,HC,,0,MALE,1,3.55,0.72,4,7,8,ambiguous,NO,1219,1-ERG,,1219,,1,1,170,170,prad_tcga,Malignant,19,BARD1;BRCA1;BRCA2;BRIP1;CDK12;FANCL;RAD51B;RAD51C;RAD51D;RAD54L,23,13.5,TCGA-HC-7213-01,0,0,0,TCGA-HC-7213,170,170,Prostate Cancer,34,170,,1219,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),170,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-19699,,53,9,47,PRAD,170,170,WHITE,0.0,[Not Available],[Not Applicable],47,R0,1,Matched,0.28,Prostate,Resection,4,0cb3dffd-1521-4887-b19c-94dcd340d306,11,,1,0.087443,[Not Available],26eefaa1-1666-4ce1-8cf4-f6fabff81fd2,5,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,19,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.6,TCGA-HC-7213,1:Recurred/Progressed,5,22,Prostate Adenocarcinoma,5.58,4/10/12,1219,,Biochemical evidence of disease,,,YES,C61,8b2f0b23-7a12-432a-b209-37e57a2f112b,,12,TUMOR FREE,0.1697,0:LIVING,4.09,,40.05,Bilateral,29,No Evidence of Extraprostatic Extension,22,YES,,2010,170,,TCGA-HC-7213.8b2f0b23-7a12-432a-b209-37e57a2f112b.pdf,,[Not Applicable],YES,,81-90%,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,YES,No,R0,1.0,53,Core needle biopsy,170,,YES,NO,YES,,T3b,,9,No,,0,N0,T3b,0,M0,C61.9,8550/3,5411,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7230,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.94,0.84,4,1,1,HRD,NO,1001,1-ERG,1001,1001,,0,0,1001,1001,prad_tcga,Malignant,6,,14,3.0,TCGA-HC-7230-01,0,0,0,TCGA-HC-7230,1001,1001,Prostate Cancer,,,1001,1001,TCGA,,1001,Primary,0,,A,BRCA2:602:G/X:frameshift_variant,,,TUMOR FREE,Alive,-18577,,50,7,29,PRAD,1001,1001,WHITE,0.0,[Not Available],[Not Applicable],51,R0,1,Matched,0.01,Prostate,Resection,3,b8bac212-127d-4eee-8647-3bddc13c9415,2,,0,0.05539,[Not Available],03c66cf8-bc68-4ee1-a322-689a29b72262,4,Prostate Adenocarcinoma Acinar Type,0.5,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.7,TCGA-HC-7230,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.88,10/6/11,1001,,,,,,C61,0c078733-c8ed-4d5c-9da0-979f4af4fc4f,,2,TUMOR FREE,0.0527,0:LIVING,3.0,,32.88,,15,,,YES,,2011,,,TCGA-HC-7230.0c078733-c8ed-4d5c-9da0-979f4af4fc4f.pdf,,[Not Applicable],,,51-60%,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.4,50,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,,C61.9,8550/3,5412,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7231,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.71,3,7,0,ambiguous,NO,939,1-ERG,939,939,,0,0,939,939,prad_tcga,Malignant,10,,21,3.7,TCGA-HC-7231-01,0,0,0,TCGA-HC-7231,939,939,Prostate Cancer,,,939,939,TCGA,,939,Primary,0,,A,,,,TUMOR FREE,Alive,-24278,,66,7,48,PRAD,939,939,WHITE,0.0,[Not Available],[Not Applicable],46,R0,1,Matched,0.03,Prostate,Resection,3,6ac7857c-5446-4297-95a9-5f2c11c28220,0,,0,0.037083,[Not Available],b182bda9-3d9f-4958-96eb-bd6cc441830c,4,Prostate Adenocarcinoma Acinar Type,0.3,Prostate,10,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.53333333333,TCGA-HC-7231,0:DiseaseFree,2,14,Prostate Adenocarcinoma,30.85,10/6/11,939,,,,,,C61,4a904b18-b8cf-4666-a384-2b3ce33f7891,,0,TUMOR FREE,0.047,0:LIVING,,,30.85,Bilateral,17,,,YES,,2011,,,TCGA-HC-7231.4a904b18-b8cf-4666-a384-2b3ce33f7891.pdf,,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.2,66,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,5413,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-HC-7232,White,PRAD,184,1,1,,HC,1,0,MALE,1,1.95,0.6,6,8,3,ambiguous,NO,1161,1-ERG,766,1161,,1,1,766,766,prad_tcga,Malignant,17,ATM;BRCA2;CHEK1,22,9.6,TCGA-HC-7232-01,0,0,0,TCGA-HC-7232,766,766,Prostate Cancer,,,766,1161,TCGA,,766,Primary,0,,A,,,,WITH TUMOR,Alive,-24324,,66,9,41,PRAD,766,766,WHITE,0.0,[Not Available],[Not Applicable],40,R0,1,Matched,0.07,Prostate,Resection,4,0f4b7d00-1c4c-4634-a45e-10f8949abb43,2,,0,0.088511,[Not Available],ce3585d3-7388-4d05-84c8-64e0883003b3,5,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,1.33333333333,TCGA-HC-7232,1:Recurred/Progressed,5,16,Prostate Adenocarcinoma,25.16,4/11/12,1161,,Biochemical evidence of disease,,,,C61,d5b6e727-43d6-4d27-a7ae-d89c046ef4eb,,3,TUMOR FREE,0.1165,0:LIVING,,,38.14,Bilateral,19,,,YES,,2011,766,,TCGA-HC-7232.d5b6e727-43d6-4d27-a7ae-d89c046ef4eb.pdf,,[Not Applicable],,,16-25%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.6,66,Core needle biopsy,,,YES,NO,NO,,T3b,,9,No,,0,,,,,C61.9,8550/3,5414,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7233,White,PRAD,184,0,0,,HC,0,0,MALE,0,2.0,0.54,0,0,0,HRP,NO,1355,8-other,1355,1355,,0,0,1355,1355,prad_tcga,Malignant,0,,3,7.7,TCGA-HC-7233-01,8,0,0,TCGA-HC-7233,1355,1355,Prostate Cancer,,,1355,1355,TCGA,,1355,Primary,0,Apex,A,,,,TUMOR FREE,Alive,,,73,7,42,PRAD,1355,1355,WHITE,0.19989634,[Not Available],[Not Applicable],43,R1,1,Matched,0.04,Prostate,Resection,4,848c2c7b-918e-4a09-bad9-3b3d59bbc101,0,,0,0.000493,[Not Available],e2b33861-2247-413f-b2e5-9be3b604666c,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.6,HC,1.43333333333,TCGA-HC-7233,0:DiseaseFree,3,0,Prostate Adenocarcinoma,44.51,4/11/12,1355,,,,,,C61,3531e095-4042-4fc8-aa69-522b16e4e1fc,,0,WITH TUMOR,0.0009,0:LIVING,,,44.51,Left,1,,,YES,,2010,,,TCGA-HC-7233.3531e095-4042-4fc8-aa69-522b16e4e1fc.pdf,,[Not Applicable],,,66-75%,2,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,Yes,R1,0.9,73,Core needle biopsy,,,NO,YES,YES,,T2a,,7,No,,0,N0,,0,,C61.9,8550/3,5415,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7736,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.87,0.6,8,12,2,ambiguous,NO,1103,8-other,1103,1103,,0,0,1103,1103,prad_tcga,Malignant,22,ATM;CHEK1,81,5.0,TCGA-HC-7736-01,3,0,0,TCGA-HC-7736,1103,1103,Prostate Cancer,,102,1103,1103,TCGA,,1103,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-21703,,59,7,27,PRAD,1103,1103,WHITE,0.141806303,[Not Available],[Not Applicable],26,,1,Matched,0.01,Prostate,Resection,3,9b4b5bba-a33f-4ba8-9143-33028556e3e6,1,,0,0.13076,[Not Available],922e5166-85f5-4365-9c09-f8bdc1722da6,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,20,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,0.9,TCGA-HC-7736,0:DiseaseFree,2,20,Prostate Adenocarcinoma,36.24,4/11/12,1103,,,,,,C61,d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494,,2,TUMOR FREE,0.1245,0:LIVING,0.02,,36.24,Bilateral,22,No Evidence of Extraprostatic Extension,-21,YES,,2010,,,TCGA-HC-7736.d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494.pdf,,[Not Applicable],YES,,81-90%,13,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,No,R0,1.0,59,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5416,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7737,Black or African American,PRAD,184,0,0,,HC,0,0,MALE,0,1.91,0.29,4,3,2,ambiguous,NO,1090,8-other,1090,1090,,0,0,1090,1090,prad_tcga,Malignant,9,BRCA2,11,18.1,TCGA-HC-7737-01,2,0,0,TCGA-HC-7737,1090,1090,Prostate Cancer,,147,1090,1090,TCGA,,1090,Primary,0,,A,,,,TUMOR FREE,Alive,-20122,,55,7,18,PRAD,1090,1090,BLACK OR AFRICAN AMERICAN,0.107742921,[Not Available],[Not Applicable],38,R0,1,Matched,0.11,Prostate,Resection,3,47b6e89a-ea86-475a-9f1d-02001069c895,1,Normal (no evidence of prostate cancer) [cM0],0,0.088381,[Not Available],73f875cb-bcfc-43ba-ab97-4e94caf836d4,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,9,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.23333333333,TCGA-HC-7737,0:DiseaseFree,2,18,Prostate Adenocarcinoma,35.81,4/11/12,1090,,,,,NO,C61,deaefdb1-471e-43e7-a9b9-a2264cba6a53,,3,TUMOR FREE,0.0001,0:LIVING,0.1,,35.81,Bilateral,19,No Evidence of Extraprostatic Extension,9,YES,,2010,,,TCGA-HC-7737.deaefdb1-471e-43e7-a9b9-a2264cba6a53.pdf,,[Not Applicable],YES,9,71-80%,8,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,No,R0,0.4,55,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N1,T1c,1,M0,C61.9,8550/3,5417,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7740,White,PRAD,184,0,0,,HC,0,0,MALE,0,2.0,0.22,0,0,0,HRP,NO,717,8-other,717,717,,0,0,717,717,prad_tcga,Malignant,0,,19,5.9,TCGA-HC-7740-01,5,0,0,TCGA-HC-7740,717,717,Prostate Cancer,,154,717,717,TCGA,,717,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21883,,59,7,27,PRAD,717,717,WHITE,0.093151492,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,54d1cf0e-5d54-486c-a863-733b5edc5986,0,,0,1.57e-05,[Not Available],91e249a6-b0b0-487e-9fad-0e9f5798dcae,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.5,TCGA-HC-7740,0:DiseaseFree,2,0,Prostate Adenocarcinoma,23.55,4/11/12,717,,,,,,C61,d2b80346-3a50-4fc3-99c2-0e15225cc433,,0,TUMOR FREE,0.0002,0:LIVING,0.0,,23.55,Bilateral,5,,,YES,,2011,,,TCGA-HC-7740.d2b80346-3a50-4fc3-99c2-0e15225cc433.pdf,,[Not Applicable],,,61-70%,4,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.7,59,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-7742,White,PRAD,184,0,0,,HC,,0,MALE,0,2.01,0.56,6,3,7,ambiguous,NO,938,8-other,,938,,0,0,938,938,prad_tcga,Malignant,16,,28,5.6,TCGA-HC-7742-01,0,0,0,TCGA-HC-7742,938,938,Prostate Cancer,,113,,938,TCGA,,938,Primary,0,,A,,,,WITH TUMOR,Alive,-21323,,58,7,38,PRAD,938,938,WHITE,0.0,[Not Available],[Not Applicable],43,R0,1,Matched,0.22,Prostate,Resection,3,5eb42b0e-e7d5-46da-96de-2284c4372228,5,,0,0.10285,[Not Available],0730216b-c201-443c-9092-81e23fd13c6c,4,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,16,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,2.43333333333,TCGA-HC-7742,0:DiseaseFree,2,18,Prostate Adenocarcinoma,30.81,4/11/12,938,,,,,,C61,1fe1a801-da9e-4e62-935e-0d014c0b5631,,5,WITH TUMOR,0.1224,0:LIVING,0.1,,30.81,,20,,,YES,,2011,,,TCGA-HC-7742.1fe1a801-da9e-4e62-935e-0d014c0b5631.pdf,,[Not Applicable],,,71-80%,2,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,NO,No,R0,0.4,58,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,M0,C61.9,8140/3,5421,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7744,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.98,0.81,1,2,0,HRD,NO,531,1-ERG,531,531,,0,0,531,531,prad_tcga,Malignant,3,BARD1;BRCA1;CDK12;RAD51D,43,4.4,TCGA-HC-7744-01,8,0,0,TCGA-HC-7744,531,531,Prostate Cancer,42,282,531,531,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),531,Primary,0,Apex|Middle|Base,A,,RAD51C,,TUMOR FREE,Alive,-17065,,46,7,31,PRAD,531,531,WHITE,0.23562957,[Not Available],[Not Applicable],43,R1,1,Matched,0.06,Prostate,Resection,4,41e0d8f7-e104-43c4-b3bb-fd0b5cb3c7b2,0,Normal (no evidence of prostate cancer) [cM0],0,0.018255,[Not Available],f6381367-142c-45d0-92b3-c1727d1813ce,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.43333333333,TCGA-HC-7744,0:DiseaseFree,3,3,Prostate Adenocarcinoma,17.44,4/11/12,531,,,,,YES,C61,01b8c2af-bdf8-4627-bf6e-c7a41d929b94,,0,WITH TUMOR,0.0174,0:LIVING,0.04,,17.44,Bilateral,5,,40,YES,,2011,,,TCGA-HC-7744.01b8c2af-bdf8-4627-bf6e-c7a41d929b94.pdf,,[Not Applicable],YES,10,81-90%,8,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.6,46,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,,0,M0,C61.9,8550/3,5422,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7745,White,PRAD,,0,0,,HC,0,0,MALE,0,1.98,0.38,8,12,7,ambiguous,NO,721,,721,721,,0,0,721,721,prad_tcga,Malignant,27,ATM;FANCL,32,,TCGA-HC-7745-01,13,0,0,TCGA-HC-7745,721,721,Prostate Cancer,,,721,721,TCGA,,721,Primary,1,Middle,A,,,,TUMOR FREE,Alive,-24078,,65,7,30,PRAD,721,721,WHITE,0.172856379,[Not Available],[Not Applicable],50,,1,Matched,0.05,Prostate,Resection,4,07fb63a4-839c-4e46-98f8-2908125622e2,3,,0,0.10207,[Not Available],6641a298-1dbd-445d-a4ab-95ceb98e1427,3,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,28,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,2.86666666667,TCGA-HC-7745,0:DiseaseFree,3,32,Prostate Adenocarcinoma,23.69,4/11/12,721,,,,,NO,C61,4a65a2d9-6007-4ff2-9711-46351f540367,,4,TUMOR FREE,0.1515,0:LIVING,,,23.69,Bilateral,34,,,YES,,2011,,,TCGA-HC-7745.4a65a2d9-6007-4ff2-9711-46351f540367.pdf,,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.4,65,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,,0,,C61.9,8550/3,5423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7748,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.47,4,2,4,,NO,792,1-ERG,792,792,,0,0,792,792,prad_tcga,Malignant,10,BRCA1,21,7.5,TCGA-HC-7748-01,0,0,0,TCGA-HC-7748,792,792,Prostate Cancer,,99,792,792,TCGA,,792,Primary,0,,A,,,,TUMOR FREE,Alive,-22072,,60,6,29,PRAD,792,792,WHITE,0.0,[Not Available],[Not Applicable],27,R0,1,Matched,0.01,Prostate,Resection,3,8c97a468-f8af-4a81-912f-ac153aa98a08,0,,0,0.043673,[Not Available],f6040682-4999-4d71-abc2-354b473c6980,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,10,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,0.866666666667,TCGA-HC-7748,0:DiseaseFree,1,,Prostate Adenocarcinoma,26.02,4/12/12,792,,,,,,C61,6516e000-dc8c-4715-a561-ee47a114ad23,,2,TUMOR FREE,0.0414,0:LIVING,0.1,,26.02,Right,,,,YES,,2011,,,TCGA-HC-7748.6516e000-dc8c-4715-a561-ee47a114ad23.pdf,,[Not Applicable],,,36-45%,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,Yes,R0,0.7,60,Core needle biopsy,,,YES,NO,YES,,T2a,,6,No,,0,N0,,0,,C61.9,8550/3,5425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7749,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.97,0.69,3,4,0,HRD,NO,724,3-ETV4,724,724,,0,0,724,724,prad_tcga,Malignant,7,BARD1;BRIP1;FANCL;PALB2;RAD51C,18,4.2,TCGA-HC-7749-01,0,0,0,TCGA-HC-7749,724,724,Prostate Cancer,,102,724,724,TCGA,,724,Primary,0,Middle|Base,A,,BRCA2;CHEK2,,TUMOR FREE,Alive,-25688,,70,7,57,PRAD,724,724,WHITE,0.0,[Not Available],[Not Applicable],70,R0,1,Matched,0.34,Prostate,Resection,4,e7914d79-48ad-4ea1-8a8f-735183c16c56,0,,0,0.033319,[Not Available],13a63fd0-6c8c-4707-9135-8052f454d1ac,3,Prostate Adenocarcinoma Acinar Type,0.3,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,2.36666666667,TCGA-HC-7749,0:DiseaseFree,3,,Prostate Adenocarcinoma,23.78,4/20/12,724,,,,,,C61,35e33cb7-77a7-4d02-b4ec-9374423027c0,,1,TUMOR FREE,0.0318,0:LIVING,0.1,5,23.78,Right,,,,YES,,2011,,,TCGA-HC-7749.35e33cb7-77a7-4d02-b4ec-9374423027c0.pdf,,[Not Applicable],,,81-90%,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,70,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,M0,C61.9,8550/3,5426,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7750,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.99,0.34,1,2,0,HRP,NO,522,8-other,522,522,,0,0,522,522,prad_tcga,Malignant,3,,2,3.7,TCGA-HC-7750-01,0,0,0,TCGA-HC-7750,522,522,Prostate Cancer,,83,522,522,TCGA,,522,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-18580,,50,7,17,PRAD,522,522,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.0,Prostate,Resection,3,10016c62-f9fe-473e-a8d6-6d5380715e1a,0,,0,0.0067239,[Not Available],2d350c73-2a0b-4a3c-8d30-c6fcf6c3ffba,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.3,TCGA-HC-7750,0:DiseaseFree,2,15,Prostate Adenocarcinoma,17.15,4/20/12,522,,,,,,C61,f05d95fd-391d-49ab-8a2f-039110a654bd,,0,TUMOR FREE,0.0066,0:LIVING,0.1,,17.15,Left,15,,,YES,,2011,,,TCGA-HC-7750.f05d95fd-391d-49ab-8a2f-039110a654bd.pdf,,[Not Applicable],,,<10%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,50,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,T2b,,M0,C61.9,8550/3,5427,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7752,White,PRAD,,0,0,,HC,0,0,MALE,0,1.98,0.75,2,2,0,HRP,NO,782,,782,782,,0,0,782,782,prad_tcga,Malignant,4,,44,,TCGA-HC-7752-01,0,0,0,TCGA-HC-7752,782,782,Prostate Cancer,,138,782,782,TCGA,,782,Primary,0,Base,A,,,,TUMOR FREE,Alive,-22366,,61,7,36,PRAD,782,782,WHITE,0.0,[Not Available],[Not Applicable],47,,1,Matched,0.05,Prostate,Resection,3,4769eff8-1976-426e-9ac0-85bb370cab1f,0,,0,0.021324,[Not Available],9b84601b-ee05-4c15-afe3-7bfa7ca5ffac,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,2.86666666667,TCGA-HC-7752,0:DiseaseFree,2,3,Prostate Adenocarcinoma,25.69,4/20/12,782,,,,,,C61,d077f87f-0c7a-4641-a3fd-8bcd89fc67e7,,1,TUMOR FREE,0.0251,0:LIVING,0.1,,25.69,Bilateral,5,,,YES,,2011,,,TCGA-HC-7752.d077f87f-0c7a-4641-a3fd-8bcd89fc67e7.pdf,,[Not Applicable],,,,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,61,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,5428,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7817,,PRAD,,0,0,,HC,0,0,MALE,0,,,,,,HRP,NO,928,,928,928,,0,0,928,928,prad_tcga,Malignant,,,,,TCGA-HC-7817-01,0,0,0,TCGA-HC-7817,928,928,Prostate Cancer,,171,928,928,TCGA,No Evidence of Extraprostatic Extension,928,Primary,0,Apex|Middle|Base,B,,,,TUMOR FREE,Alive,-19207,,52,7,25,PRAD,928,928,,0.0,[Not Available],[Not Applicable],27,,1,Matched,,Prostate,Resection,4,ba22b09b-2328-4725-8810-2ee294b319c4,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],f3aa40b9-7b4d-465a-b7c9-591aebdb56c2,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.5,HC,0.9,TCGA-HC-7817,0:DiseaseFree,3,8,Prostate Adenocarcinoma,30.49,6/20/12,928,,,,,YES,C61,A1E3EC71-D7D2-4286-A12F-78ADFD27E53C,,,TUMOR FREE,0.0016,0:LIVING,0.1,,30.49,Bilateral,8,No Evidence of Extraprostatic Extension,,YES,,2011,,,TCGA-HC-7817.A1E3EC71-D7D2-4286-A12F-78ADFD27E53C.pdf,,[Not Applicable],YES,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.8,52,Core needle biopsy,,,YES,NO,NO,NO,T3b,,7,No,,0,,,,M0,C61.9,8140/3,5429,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7818,White,PRAD,184,0,0,,HC,0,0,MALE,0,,,,,,,NO,938,1-ERG,938,938,,0,0,938,938,prad_tcga,Malignant,,,,4.5,TCGA-HC-7818-01,0,0,0,TCGA-HC-7818,938,938,Prostate Cancer,,99,938,938,TCGA,,938,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-24391,,66,7,21,PRAD,938,938,WHITE,0.0,[Not Available],[Not Applicable],38,R0,1,Matched,,Prostate,Resection,3,152bc45f-6d11-48c3-ab68-2119e4534d64,,,,,[Not Available],ebe711e4-45af-4082-bdf6-b0f7ac899b3e,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.26666666667,TCGA-HC-7818,0:DiseaseFree,2,,Prostate Adenocarcinoma,30.81,4/20/12,938,,,,,,C61,e6f3745f-31bf-4475-85f8-956811ce6cb6,,,TUMOR FREE,0.0,0:LIVING,0.01,,30.81,Bilateral,,,,YES,,2011,,,TCGA-HC-7818.e6f3745f-31bf-4475-85f8-956811ce6cb6.pdf,,[Not Applicable],,,31-40%,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.2,66,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5430,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7819,White,PRAD,,0,0,,HC,0,0,MALE,0,1.97,0.82,2,2,4,ambiguous,NO,543,,543,543,,0,0,543,543,prad_tcga,Malignant,8,BRCA2,10,,TCGA-HC-7819-01,13,0,0,TCGA-HC-7819,543,543,Prostate Cancer,-73,172,543,543,TCGA,No Evidence of Extraprostatic Extension,543,Primary,1,,A,,,,TUMOR FREE,Alive,-19663,,53,8,23,PRAD,543,543,WHITE,0.262497307,[Not Available],[Not Applicable],38,,1,Matched,0.02,Prostate,Resection,4,8b1ad92f-3a3c-474b-89a0-bc14ec6046ba,1,,0,0.04283,[Not Available],d1fd7be0-6daa-4f1f-a198-3dca7a797e49,4,Prostate Adenocarcinoma Acinar Type,0.3,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,2.16666666667,TCGA-HC-7819,0:DiseaseFree,4,14,Prostate Adenocarcinoma,17.84,4/20/12,543,,,,,YES,C61,ab62f75e-d1f0-47f7-8a78-4151af81d409,,2,WITH TUMOR,0.0674,0:LIVING,0.01,4,17.84,Bilateral,19,,,YES,,2011,,,TCGA-HC-7819.ab62f75e-d1f0-47f7-8a78-4151af81d409.pdf,Central Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R2,0.3,53,Core needle biopsy,,,YES,NO,YES,,T2c,,8,No,,0,N0,T2c,0,M0,C61.9,8550/3,5431,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7820,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.48,0,3,0,HRD,NO,747,1-ERG,747,747,,0,0,747,747,prad_tcga,Malignant,3,,15,5.2,TCGA-HC-7820-01,0,0,0,TCGA-HC-7820,747,747,Prostate Cancer,,,747,747,TCGA,,747,Primary,0,,A,ATM:.:.:splice_region_variant,,,TUMOR FREE,Alive,-26576,,72,7,40,PRAD,747,747,WHITE,0.0,[Not Available],[Not Applicable],45,R0,1,Matched,0.0,Prostate,Resection,3,78355462-9ff7-4f1b-96cc-4563b6810b37,2,,0,0.040429,[Not Available],a3cd3599-7c18-491d-be09-6fc7e526c9b1,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,2.73333333333,TCGA-HC-7820,0:DiseaseFree,2,4,Prostate Adenocarcinoma,24.54,4/20/12,747,,,,,,C61,750c91eb-1732-4ca3-8c71-f1309a90e4f5,,1,TUMOR FREE,0.0386,0:LIVING,,,24.54,Bilateral,5,,,YES,,2011,,,TCGA-HC-7820.750c91eb-1732-4ca3-8c71-f1309a90e4f5.pdf,,[Not Applicable],,,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,72,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,,,,C61.9,8550/3,5432,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7821,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.93,0.85,5,3,3,ambiguous,NO,956,1-ERG,956,956,,0,0,956,956,prad_tcga,Malignant,11,RAD51B;RAD54L,50,31.0,TCGA-HC-7821-01,0,0,0,TCGA-HC-7821,956,956,Prostate Cancer,,236,956,956,TCGA,,956,Primary,0,Apex|Middle|Base,A,,,,WITH TUMOR,Alive,-19894,,54,8,32,PRAD,956,956,WHITE,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.13,Prostate,Resection,4,bdf77be2-f833-45f2-bd32-dbf53eb11eb4,4,,0,0.10468,[Not Available],929837f9-297a-47c0-ac9a-a142eef620d3,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.03333333333,TCGA-HC-7821,0:DiseaseFree,4,33,Prostate Adenocarcinoma,31.41,4/20/12,956,,,,,,C61,89c7a876-d606-48a6-9672-7cb976058ebf,,4,WITH TUMOR,0.1347,0:LIVING,0.01,,31.41,Bilateral,38,,,YES,,2011,,,TCGA-HC-7821.89c7a876-d606-48a6-9672-7cb976058ebf.pdf,,[Not Applicable],,,61-70%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,Yes,,0.9,54,Core needle biopsy,,,YES,NO,YES,,T3b,,8,No,,0,N1,,2,M0,C61.9,8550/3,5433,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8213,,PRAD,308,0,0,,HC,0,0,MALE,0,1.99,0.87,0,1,0,HRP,NO,589,1-ERG,589,589,,0,0,589,589,prad_tcga,Malignant,1,,32,3.6,TCGA-HC-8213-01,0,0,0,TCGA-HC-8213,589,589,Prostate Cancer,,,589,589,TCGA,,589,Primary,0,,A,,,,TUMOR FREE,Alive,-17673,,48,6,22,PRAD,589,589,,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,0.0,Prostate,Resection,3,dbe76fc8-1006-4d47-b1c0-2b02e9d55d22,0,,0,0.011974,[Not Available],53c43d14-2310-41e9-ac43-3cc298404338,3,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,1,,Acinar Adenocarcinoma,[Not Available],0.3,HC,0.766666666667,TCGA-HC-8213,0:DiseaseFree,1,1,Prostate Adenocarcinoma,19.35,7/8/12,589,,,,,,C61,E6CE4E34-DE42-455C-AD93-CCE42FCFE049,,0,TUMOR FREE,0.0083,0:LIVING,,,19.35,Bilateral,3,,,YES,,2011,,,TCGA-HC-8213.E6CE4E34-DE42-455C-AD93-CCE42FCFE049.pdf,,[Not Applicable],,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.5,48,,,,YES,NO,NO,NO,T2c,,6,No,,0,,,,,C61.9,8550/3,5435,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8216,,PRAD,308,0,0,,HC,0,0,MALE,0,1.84,0.47,8,8,7,ambiguous,NO,682,8-other,682,682,,0,0,682,682,prad_tcga,Malignant,23,BRCA1;CHEK2;RAD51B,69,5.2,TCGA-HC-8216-01,23,0,0,TCGA-HC-8216,682,682,Prostate Cancer,,137,682,682,TCGA,,682,Primary,1,Middle|Base,A,,,,TUMOR FREE,Alive,-21428,,58,7,121,PRAD,682,682,,0.168809158,[Not Available],[Not Applicable],115,R0,1,Matched,0.68,Prostate,Resection,4,bd2f1591-0615-4df9-a34f-428369b25709,4,Normal (no evidence of prostate cancer) [cM0],0,0.1954,[Not Available],89afdebe-456e-4128-8902-1001876a2106,3,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,22,,Acinar Adenocarcinoma,[Not Available],0.3,HC,3.83333333333,TCGA-HC-8216,0:DiseaseFree,3,22,Prostate Adenocarcinoma,22.4,6/17/12,682,,,,,NO,C61,CD881D57-9CCB-4984-8C37-B3DDE9189814,,10,TUMOR FREE,0.0667,0:LIVING,0.19,5,22.4,Right,23,No Evidence of Extraprostatic Extension,10,YES,,2011,,,TCGA-HC-8216.CD881D57-9CCB-4984-8C37-B3DDE9189814.pdf,,[Not Applicable],YES,10,61-70%,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,58,Core needle biopsy,,,YES,NO,YES,NO,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,5436,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8256,,PRAD,221,0,0,,HC,0,0,MALE,0,2.0,0.48,2,3,3,HRP,NO,860,8-other,860,860,,0,0,860,860,prad_tcga,Malignant,8,,20,6.3,TCGA-HC-8256-01,0,0,0,TCGA-HC-8256,860,860,Prostate Cancer,,,860,860,TCGA,,860,Primary,0,,A,,,,TUMOR FREE,Alive,-19598,,53,7,35,PRAD,860,860,,0.0,[Not Available],[Not Applicable],36,R0,1,Matched,0.03,Prostate,Resection,3,7a9b0cbb-b14f-40b7-9fe1-2375bf68ea3f,2,,0,0.033934,[Not Available],89a297be-ebb5-4b9f-8eda-0e548d14ad91,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,7,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.16666666667,TCGA-HC-8256,0:DiseaseFree,2,7,Prostate Adenocarcinoma,28.25,6/13/12,860,,,,,,C61,2ec7732c-f24c-41eb-ba84-39bfc1c0c5b3,,2,TUMOR FREE,0.0635,0:LIVING,,,28.25,Bilateral,8,,,YES,,2011,,,TCGA-HC-8256.2ec7732c-f24c-41eb-ba84-39bfc1c0c5b3.pdf,,[Not Applicable],,,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,53,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,,,M0,C61.9,8550/3,5437,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8257,,PRAD,221,0,0,,HC,0,0,MALE,0,1.93,0.72,2,5,2,HRD,NO,726,1-ERG,726,726,,0,0,726,726,prad_tcga,Malignant,9,,75,8.6,TCGA-HC-8257-01,0,0,0,TCGA-HC-8257,726,726,Prostate Cancer,,726,726,726,TCGA,,726,Primary,0,,A,,CHEK2,,TUMOR FREE,Alive,-25629,,70,7,61,PRAD,726,726,,0.0,[Not Available],[Not Applicable],50,R1,1,Matched,0.01,Prostate,Resection,3,aefd6142-dccb-45f5-a05e-cef002f81057,0,,0,0.073763,[Not Available],270447ca-19ee-45a2-982e-032325dab05f,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,9,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.63333333333,TCGA-HC-8257,0:DiseaseFree,2,18,Prostate Adenocarcinoma,23.85,10/1/12,726,,,,,,C61,ff35baf5-f38f-4458-8c20-c61d61c61c19,,0,WITH TUMOR,0.0697,0:LIVING,0.1,,23.85,Bilateral,22,,,YES,,2011,,,TCGA-HC-8257.ff35baf5-f38f-4458-8c20-c61d61c61c19.pdf,,[Not Applicable],,,81-90%,8,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.3,70,,,Complete Remission/Response,YES,NO,YES,NO,T3b,NO,7,No,YES,0,N1,,1,,C61.9,8550/3,5438,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8258,,PRAD,221,0,0,,HC,0,0,MALE,0,,,,,,HRD,NO,847,5-SPOP,847,847,,0,0,847,847,prad_tcga,Malignant,,,,4.3,TCGA-HC-8258-01,0,0,0,TCGA-HC-8258,847,847,Prostate Cancer,,162,847,847,TCGA,,847,Primary,0,,A,PALB2:89-110:DEETGEKTSITLDVGPESFNPG/X:frameshift_variant,,,TUMOR FREE,Alive,-20703,,56,6,14,PRAD,847,847,,0.0,[Not Available],[Not Applicable],25,,1,Matched,,Prostate,Resection,3,b8881603-9353-4f63-93d7-e14efed64aa6,,,,,[Not Available],da5b0169-e4f4-4674-b348-220af03ff4b5,3,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,,,Acinar Adenocarcinoma,[Not Available],0.2,HC,0.833333333333,TCGA-HC-8258,0:DiseaseFree,1,,Prostate Adenocarcinoma,27.83,6/20/12,847,,,,,,C61,fffd3795-6c0c-43a0-afe4-30e759e5f20a,,,TUMOR FREE,0.0,0:LIVING,0.01,,27.83,Bilateral,,,,YES,,2011,,,TCGA-HC-8258.fffd3795-6c0c-43a0-afe4-30e759e5f20a.pdf,,[Not Applicable],,,61-70%,2,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.5,56,Core needle biopsy,,,YES,NO,YES,NO,T2c,,6,No,,0,N0,,0,,C61.9,8550/3,5439,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8259,,PRAD,,0,0,,HC,0,0,MALE,0,,,,,,HRP,NO,924,,924,924,,0,0,924,924,prad_tcga,Malignant,,,,,TCGA-HC-8259-01,6,0,0,TCGA-HC-8259,924,924,Prostate Cancer,,123,924,924,TCGA,,924,Primary,0,,A,,,,TUMOR FREE,Alive,-18309,,50,6,50,PRAD,924,924,,0.097856679,[Not Available],[Not Applicable],66,,1,Matched,,Prostate,Resection,3,ef2a9b45-0fb8-485a-911f-ff193ae2452d,,,,,[Not Available],07ccb4e9-a2a9-4bfd-97bd-13873b01977a,3,Prostate Adenocarcinoma Acinar Type,0.5,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.2,HC,2.23333333333,TCGA-HC-8259,0:DiseaseFree,1,1,Prostate Adenocarcinoma,30.35,6/20/12,924,,,,,,C61,e53c1322-0854-4ae8-b087-3ddd3712df56,,,TUMOR FREE,0.0034,0:LIVING,0.01,,30.35,Left,1,,,YES,,2011,,,TCGA-HC-8259.e53c1322-0854-4ae8-b087-3ddd3712df56.pdf,,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.4,50,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2a,NO,6,No,NO,0,,T1c,,M0,C61.9,8550/3,5440,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8260,,PRAD,221,0,0,,HC,0,0,MALE,0,2.0,0.33,0,0,0,HRP,NO,686,1-ERG,686,686,,0,0,686,686,prad_tcga,Malignant,0,,19,5.5,TCGA-HC-8260-01,0,0,0,TCGA-HC-8260,686,686,Prostate Cancer,,106,686,686,TCGA,,686,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-15884,,43,7,12,PRAD,686,686,,0.0,[Not Available],[Not Applicable],16,R1,1,Matched,0.08,Prostate,Resection,3,67df36b3-dea8-4623-a23b-6b28a445e969,0,,0,1.39e-06,[Not Available],3971a2f0-7263-4cda-aa01-9a2ebb2c2ff2,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.1,HC,0.533333333333,TCGA-HC-8260,0:DiseaseFree,2,4,Prostate Adenocarcinoma,22.54,6/20/12,686,,,,,,C61,12d41624-f0a9-4ba1-aa55-18fea0b733af,,0,WITH TUMOR,0.0003,0:LIVING,0.01,,22.54,Bilateral,6,,,YES,,2011,,,TCGA-HC-8260.12d41624-f0a9-4ba1-aa55-18fea0b733af.pdf,Peripheral Zone,[Not Applicable],,,41-50%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.7,43,Core needle biopsy,,,YES,NO,YES,NO,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,5441,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8261,,PRAD,221,0,0,,HC,0,0,MALE,0,1.97,0.69,1,4,0,HRP,NO,546,5-SPOP,546,546,,0,0,546,546,prad_tcga,Malignant,5,,29,14.4,TCGA-HC-8261-01,8,0,0,TCGA-HC-8261,546,546,Prostate Cancer,,,546,546,TCGA,,546,Primary,0,,A,,,,TUMOR FREE,Alive,-17874,,48,7,38,PRAD,546,546,,0.225031259,[Not Available],[Not Applicable],32,R0,1,Matched,0.03,Prostate,Resection,3,75360206-d41f-4ee7-8945-beb259f9b32c,0,,0,0.033091,[Not Available],f16ce517-d51d-499a-a4c4-a6844fefa52c,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.03333333333,TCGA-HC-8261,0:DiseaseFree,2,5,Prostate Adenocarcinoma,17.94,6/13/12,546,,,,,,C61,66690c59-06ae-4d5e-b862-3be6a11d67fb,,0,TUMOR FREE,0.0679,0:LIVING,,,17.94,Bilateral,10,,,YES,,2011,,,TCGA-HC-8261.66690c59-06ae-4d5e-b862-3be6a11d67fb.pdf,,[Not Applicable],,,41-50%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,48,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,,,,C61.9,8550/3,5442,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-8264,,PRAD,244,0,0,,HC,,0,MALE,0,1.98,0.67,4,8,3,ambiguous,NO,48,8-other,,48,,0,0,48,48,prad_tcga,Malignant,15,BRCA2,34,13.4,TCGA-HC-8264-01,0,0,0,TCGA-HC-8264,48,48,Prostate Cancer,,,,48,TCGA,,48,Primary,0,,B,,,,WITH TUMOR,Alive,-22177,,60,9,63,PRAD,48,48,,0.0,[Not Available],[Not Applicable],38,R1,1,Matched,0.02,Prostate,Resection,4,6b519959-9c2d-4009-a9c6-bd2d22be5431,1,,0,0.044794,[Not Available],8740555d-8bf0-40ba-b868-99eef27662a4,5,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,14,,Acinar Adenocarcinoma,[Not Available],0.5,HC,1.3,TCGA-HC-8264,0:DiseaseFree,5,17,Prostate Adenocarcinoma,1.58,1/25/13,48,,,,,,C61,147b5116-ae7b-4c43-8e6d-3a0064f28902,,2,WITH TUMOR,0.0698,0:LIVING,,,1.58,Bilateral,17,,,YES,,2011,,,TCGA-HC-8264.147b5116-ae7b-4c43-8e6d-3a0064f28902.pdf,,[Not Applicable],,,21-30%,2,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Applicable],,,No,R1,0.7,60,Core needle biopsy,,,YES,NO,YES,NO,T3b,,9,No,,0,N1,,1,,C61.9,8550/3,5444,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8265,,PRAD,221,0,0,,HC,0,0,MALE,0,2.16,0.5,0,3,5,HRD,NO,483,6-FOXA1,483,483,,0,0,483,483,prad_tcga,Malignant,8,,18,5.2,TCGA-HC-8265-01,0,0,0,TCGA-HC-8265,483,483,Prostate Cancer,,119,483,483,TCGA,,483,Primary,0,,A,CDK12:54-59:GLVTPE/X:frameshift_variant;CDK12:598:Q/*:stop_gained,,,TUMOR FREE,Alive,-24382,,66,8,75,PRAD,483,483,,0.0,[Not Available],[Not Applicable],70,R1,1,Matched,0.15,Prostate,Resection,3,6715e5bf-1653-4bf6-ba96-149574b3b711,1,,0,0.0078663,[Not Available],3e290dc6-aba3-4135-b844-3e8c4cc8a25f,5,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,10,,Acinar Adenocarcinoma,[Not Available],0.1,HC,2.3,TCGA-HC-8265,0:DiseaseFree,4,6,Prostate Adenocarcinoma,15.87,6/20/12,483,,,,,,C61,7c2f8bb7-3fe0-459e-a885-6d7a97d753f1,,0,WITH TUMOR,0.1478,0:LIVING,0.1,,15.87,Bilateral,12,,,YES,,2011,,,TCGA-HC-8265.7c2f8bb7-3fe0-459e-a885-6d7a97d753f1.pdf,,[Not Applicable],,,41-50%,8,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.8,66,Core needle biopsy,,,YES,NO,YES,NO,T3a,,8,No,,0,N0,,0,,C61.9,8550/3,5445,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-8266,,PRAD,221,0,0,,HC,,0,MALE,0,1.99,0.25,7,3,4,ambiguous,NO,473,8-other,,473,,0,0,473,473,prad_tcga,Malignant,14,BARD1;BRCA2,13,5.1,TCGA-HC-8266-01,3,0,0,TCGA-HC-8266,473,473,Prostate Cancer,,,,473,TCGA,,473,Primary,0,,A,,,,WITH TUMOR,Alive,-20280,,55,8,29,PRAD,473,473,,0.084194156,[Not Available],[Not Applicable],29,R1,1,Matched,0.08,Prostate,Resection,4,7e1bda67-08e8-413f-a99a-00747e0dc437,7,,0,0.24819,[Not Available],fb447e0f-7cf0-49bf-8b15-aae932f8094d,4,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,14,,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.0,TCGA-HC-8266,0:DiseaseFree,4,29,Prostate Adenocarcinoma,15.54,10/1/12,473,,,,,,C61,cb8abdbd-c61d-4ad4-bd8b-a7e9dbc20d2d,,13,WITH TUMOR,0.0385,0:LIVING,,,15.54,Bilateral,33,,,YES,,2012,,,TCGA-HC-8266.cb8abdbd-c61d-4ad4-bd8b-a7e9dbc20d2d.pdf,,[Not Applicable],,,41-50%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,R1,0.5,55,,,,YES,NO,YES,NO,T3b,,8,No,,0,N0,,0,M0,C61.9,8550/3,5446,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-A48F,,PRAD,268,0,0,,HC,0,0,MALE,0,1.84,0.91,10,8,5,ambiguous,NO,680,1-ERG,680,680,,0,0,680,680,prad_tcga,Malignant,23,BRCA1;CDK12;RAD51D;RAD54L,91,,TCGA-HC-A48F-01,0,0,0,TCGA-HC-A48F,680,680,Prostate Cancer,,,680,680,TCGA,,680,Primary,0,,A,,,False,TUMOR FREE,Alive,-17434,,47,8,35,PRAD,680,680,,0.0,[Not Available],[Not Applicable],21,R1,1,Matched,0.2,Prostate,Resection,4,D85BA6E9-F1AB-453A-86D7-C58FCF5D3A07,5,Normal (no evidence of prostate cancer) [cM0],0,0.17708,[Not Available],FF49E0F9-4007-4761-845E-B676B0FC9646,4,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,HC,0.7,TCGA-HC-A48F,0:DiseaseFree,4,21,Prostate Adenocarcinoma,22.34,2/21/13,680,,,,,NO,C61,0886739D-01AE-43B1-9898-F1AB30BA940C,80,7,WITH TUMOR,0.3399,0:LIVING,,,22.34,Bilateral,25,No Evidence of Extraprostatic Extension,30,YES,115,2012,,,TCGA-HC-A48F.0886739D-01AE-43B1-9898-F1AB30BA940C.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,29,31-40%,10,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,,No,R1,,47,Core needle biopsy,,,YES,NO,YES,NO,T2c,,8,No,,0,N1,T1c,1,M0,C61.9,8140/3,5447,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A4ZV,,PRAD,285,0,0,,HC,,0,MALE,0,2.04,0.7,11,21,12,HRD,NO,23,8-other,,23,,0,0,23,23,prad_tcga,Malignant,44,PALB2;RAD51B,72,70.0,TCGA-HC-A4ZV-01,80,0,0,TCGA-HC-A4ZV,23,23,Prostate Cancer,,,,23,TCGA,,23,Primary,1,,A,BRIP1:558:W/SX:frameshift_variant,,False,WITH TUMOR,Alive,-20634,,56,9,158,PRAD,23,23,,0.533914194,[Not Available],[Not Applicable],109,R1,1,Matched,0.12,Prostate,Resection,5,54CC56B3-7AE5-4184-8EBD-BF080A8A22C5,4,,0,0.15244,[Not Available],BB8E6886-EDC7-4127-A85B-C4F3769B6681,4,Prostate Adenocarcinoma Acinar Type,,Prostate,44,,Acinar Adenocarcinoma,[Not Available],,HC,3.63333333333,TCGA-HC-A4ZV,0:DiseaseFree,5,45,Prostate Adenocarcinoma,0.76,3/15/13,23,,,,,,C61,424EBA82-F32C-4387-B919-F7C8F1212232,80,11,WITH TUMOR,0.3551,0:LIVING,,,0.76,Bilateral,50,,,YES,79,2012,,,TCGA-HC-A4ZV.424EBA82-F32C-4387-B919-F7C8F1212232.pdf,Overlapping / Multiple Zones,[Not Applicable],,,61-70%,13,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,R1,,56,Core needle biopsy,,,YES,NO,YES,NO,T3b,,9,No,,0,N0,T2c,0,,C61.9,8140/3,5448,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A632,,PRAD,308,0,0,,HC,,0,MALE,0,1.9,0.71,7,11,7,ambiguous,NO,61,1-ERG,,61,,0,0,61,61,prad_tcga,Malignant,25,BRCA2;RAD51B;RAD54L,78,2.2,TCGA-HC-A632-01,0,0,0,TCGA-HC-A632,61,61,Prostate Cancer,,,,61,TCGA,,61,Primary,0,,A,,,False,TUMOR FREE,Alive,-24916,,68,9,43,PRAD,61,61,,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.11,Prostate,Resection,4,95E3E4D5-393D-418C-A3A9-2EC8D0AD14B3,3,,0,0.13185,[Not Available],E457EB5D-120E-41F4-8455-2ED8D534FF02,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,HC,1.26666666667,TCGA-HC-A632,0:DiseaseFree,5,31,Prostate Adenocarcinoma,2.0,10/15/13,61,,,,,,C61,9EF1E09B-C468-4A42-917E-365F88055077,30,2,TUMOR FREE,0.1546,0:LIVING,,,2.0,Bilateral,38,,,YES,85,2013,,,TCGA-HC-A632.9EF1E09B-C468-4A42-917E-365F88055077.pdf,,[Not Applicable],,,81-90%,5,Prostate Adenocarcinoma Acinar Type,1,2013,[Unknown],,NO,No,R0,,68,Core needle biopsy,,,YES,NO,YES,NO,T3a,,9,No,,0,N0,T1c,0,M0,C61.9,8140/3,5450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A6AN,,PRAD,,0,0,,HC,,0,MALE,0,1.91,0.67,4,2,7,ambiguous,NO,49,,,49,,0,0,49,49,prad_tcga,Malignant,13,BRCA2,58,,TCGA-HC-A6AN-01,0,0,0,TCGA-HC-A6AN,49,49,Prostate Cancer,,,,49,TCGA,,49,Primary,0,,A,,,False,WITH TUMOR,Alive,-24697,,67,7,45,PRAD,49,49,,0.0,[Not Available],[Not Applicable],37,,1,Matched,0.01,Prostate,Resection,4,E78A6EC2-9C2A-4A5C-9EE7-A69513592096,2,,0,0.090965,[Not Available],3FAE5B76-9E22-4EAB-A7FC-13139B2B97C4,3,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,HC,1.23333333333,TCGA-HC-A6AN,0:DiseaseFree,3,17,Prostate Adenocarcinoma,1.61,4/22/14,49,,,,,,C61,D5C8CC7E-BADE-457C-AC31-CC138C8C794C,20,3,WITH TUMOR,0.0831,0:LIVING,,,1.61,Bilateral,19,,,YES,209,2012,,,TCGA-HC-A6AN.D5C8CC7E-BADE-457C-AC31-CC138C8C794C.pdf,,[Not Applicable],,,,1,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Applicable],,,No,R1,,67,Core needle biopsy,,,YES,NO,YES,NO,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,5452,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A6AP,,PRAD,,0,0,,HC,,0,MALE,0,1.96,0.38,4,10,0,ambiguous,NO,71,,,71,,0,0,71,71,prad_tcga,Malignant,14,,29,,TCGA-HC-A6AP-01,11,0,0,TCGA-HC-A6AP,71,71,Prostate Cancer,,,,71,TCGA,,71,Primary,1,,A,,,False,,Alive,-22318,,61,7,33,PRAD,71,71,,0.344609728,[Not Available],[Not Applicable],46,,1,Matched,0.09,Prostate,Resection,3,19E1137B-FBBB-4BBD-B5B3-A6892D91BF4E,0,,0,0.056681,[Not Available],EAD15A1B-726A-46AA-9005-A22F4B89D011,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,HC,1.53333333333,TCGA-HC-A6AP,0:DiseaseFree,2,21,Prostate Adenocarcinoma,2.33,9/19/13,71,,,,,NO,C61,7271E139-D1C7-4FB1-B148-54DE4A1DF42B,40,0,,0.0485,0:LIVING,,,2.33,Bilateral,29,No Evidence of Extraprostatic Extension,15,YES,182,2012,,,TCGA-HC-A6AP.7271E139-D1C7-4FB1-B148-54DE4A1DF42B.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,,,,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,RX,,61,Core needle biopsy,,,YES,NO,NO,NO,T2c,,7,No,,0,,T1c,,M0,C61.9,8140/3,5454,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A6AQ,,PRAD,,0,0,,HC,,0,MALE,0,1.99,0.36,1,1,0,HRP,NO,106,,,106,,0,0,106,106,prad_tcga,Malignant,2,,12,,TCGA-HC-A6AQ-01,0,0,0,TCGA-HC-A6AQ,106,106,Prostate Cancer,,,,106,TCGA,,106,Primary,0,,A,,,False,TUMOR FREE,Alive,-22208,,60,7,32,PRAD,106,106,,0.0,[Not Available],[Not Applicable],23,,1,Matched,0.02,Prostate,Resection,3,2E3E6D4D-D87C-4993-8F41-076CD028C485,0,Normal (no evidence of prostate cancer) [cM0],0,0.011128,[Not Available],3FA83688-1724-42CB-A600-472E4C500E89,4,Prostate Adenocarcinoma Acinar Type,,Prostate,2,,Acinar Adenocarcinoma,[Not Available],,HC,0.766666666667,TCGA-HC-A6AQ,0:DiseaseFree,2,5,Prostate Adenocarcinoma,3.48,9/19/13,106,,,,,NO,C61,1B1D93C4-54AB-43CA-B800-6807A81AA89A,70,1,TUMOR FREE,0.0048,0:LIVING,,,3.48,Bilateral,7,,,YES,204,2012,,,TCGA-HC-A6AQ.1B1D93C4-54AB-43CA-B800-6807A81AA89A.pdf,,[Not Applicable],NO,15,,,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,"Yes, History of Prior Malignancy",R0,,60,Core needle biopsy,,,YES,NO,NO,NO,T2c,,7,No,,0,,T1c,,M0,C61.9,8140/3,5455,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A6AS,,PRAD,,0,0,,HC,,0,MALE,0,,,,,,,NO,44,,,44,,0,0,44,44,prad_tcga,Malignant,,BRCA1;BRCA2,,,TCGA-HC-A6AS-01,0,0,0,TCGA-HC-A6AS,44,44,Prostate Cancer,,,,44,TCGA,,44,Primary,0,,A,,,False,TUMOR FREE,Alive,-25661,,70,7,28,PRAD,44,44,,0.0,[Not Available],[Not Applicable],34,,1,Matched,,Prostate,Resection,3,81987828-DFD9-46ED-BAB7-9E1A1A5DFC4D,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],6B3F53AB-00F4-4C45-9BB5-5C8ADBC66084,4,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,HC,1.13333333333,TCGA-HC-A6AS,0:DiseaseFree,2,,Prostate Adenocarcinoma,1.45,9/19/13,44,,,,,NO,C61,89891821-AF8C-4105-8270-D6FCF714697F,30,,TUMOR FREE,0.0021,0:LIVING,,,1.45,Right,,No Evidence of Extraprostatic Extension,27,YES,127,2012,,,TCGA-HC-A6AS.89891821-AF8C-4105-8270-D6FCF714697F.pdf,,[Not Applicable],YES,27,,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,R0,,70,Core needle biopsy,,,YES,NO,YES,NO,T2a,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,5456,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A6HX,,PRAD,,0,0,,HC,,0,MALE,0,2.0,0.21,3,2,3,HRD,NO,38,,,38,,0,0,38,38,prad_tcga,Malignant,8,PALB2,23,,TCGA-HC-A6HX-01,3,0,0,TCGA-HC-A6HX,38,38,Prostate Cancer,,,,38,TCGA,,38,Primary,0,,A,CDK12:217:K/*:stop_gained,,False,TUMOR FREE,Alive,-20263,,55,7,26,PRAD,38,38,,0.124301499,[Not Available],[Not Applicable],29,,1,Matched,0.05,Prostate,Resection,4,2CE7BA34-3755-46FD-9877-04EEC1D0349B,0,,0,0.032327,[Not Available],F3E93819-A8F5-4D15-A416-3EDD42AA52D1,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,HC,1.06666666667,TCGA-HC-A6HX,0:DiseaseFree,3,13,Prostate Adenocarcinoma,1.25,9/19/13,38,,,,,,C61,0E22E3BE-B28B-40CC-83F9-9B59593B7187,30,3,TUMOR FREE,0.004,0:LIVING,,5,1.25,Bilateral,15,,,YES,112,2013,,,TCGA-HC-A6HX.0E22E3BE-B28B-40CC-83F9-9B59593B7187.pdf,,[Not Applicable],,,,4,Prostate Adenocarcinoma Acinar Type,1,2013,[Unknown],,,No,R0,,55,Core needle biopsy,,,YES,NO,YES,NO,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,5457,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A6HY,,PRAD,,0,0,,HC,,0,MALE,0,1.96,0.69,3,4,3,HRP,NO,134,,,134,,0,0,134,134,prad_tcga,Malignant,10,,20,,TCGA-HC-A6HY-01,0,0,0,TCGA-HC-A6HY,134,134,Prostate Cancer,,,,134,TCGA,,134,Primary,0,,A,,,False,TUMOR FREE,Alive,-18779,,51,7,30,PRAD,134,134,,0.0,[Not Available],[Not Applicable],31,,1,Matched,0.0,Prostate,Resection,3,D5BB8A74-67BE-452E-974D-7EBABDD48B7A,1,,0,0.044057,[Not Available],3D6ABC44-D094-4250-8DFC-347AE9C741F2,4,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,HC,1.03333333333,TCGA-HC-A6HY,0:DiseaseFree,2,11,Prostate Adenocarcinoma,4.4,9/19/13,134,,,,,,C61,91DC18E8-EF04-47C0-A77F-632A9DE2BA55,50,2,TUMOR FREE,0.0408,0:LIVING,,,4.4,Bilateral,13,No Evidence of Extraprostatic Extension,92,YES,179,2012,,,TCGA-HC-A6HY.91DC18E8-EF04-47C0-A77F-632A9DE2BA55.pdf,,[Not Applicable],YES,,,,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,R0,,51,Core needle biopsy,,,YES,NO,NO,NO,T2c,,7,No,,0,,T1c,,M0,C61.9,8140/3,5458,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A76W,,PRAD,348,0,0,,HC,,0,MALE,0,1.98,0.61,1,2,1,HRP,NO,213,3-ETV4,,213,,0,0,213,213,prad_tcga,Malignant,4,BARD1;FANCL;PALB2;RAD51B,31,,TCGA-HC-A76W-01,0,0,0,TCGA-HC-A76W,213,213,Prostate Cancer,,213,,213,TCGA,,213,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-26755,,73,7,43,PRAD,213,213,,0.0,[Not Available],[Not Applicable],41,,1,Matched,0.43,Prostate,Resection,3,67C95255-97F0-41EE-99A3-CEC801512829,0,Normal (no evidence of prostate cancer) [cM0],0,0.019694,[Not Available],5F69CA7D-F8E0-4F5B-9987-1E5C234EB759,4,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,HC,1.36666666667,TCGA-HC-A76W,0:DiseaseFree,2,5,Prostate Adenocarcinoma,7.0,3/28/14,213,,,,,NO,C61,C59C0C25-B1FC-45C5-AD7E-0FBA9574656C,50,0,WITH TUMOR,0.0177,0:LIVING,0.01,,7.0,Bilateral,5,,,YES,260,2012,,,TCGA-HC-A76W.C59C0C25-B1FC-45C5-AD7E-0FBA9574656C.pdf,,[Not Applicable],NO,62,61-70%,4,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,NO,"Yes, History of Synchronous/Bilateral Malignancy",R1,,73,Core needle biopsy,,,YES,NO,YES,NO,T3b,,7,No,,0,N0,T2,0,M0,C61.9,8140/3,5459,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A76X,,PRAD,348,0,0,,HC,,0,MALE,0,2.0,0.74,0,0,0,HRD,NO,150,1-ERG,,150,,0,0,150,150,prad_tcga,Malignant,0,,19,,TCGA-HC-A76X-01,0,0,0,TCGA-HC-A76X,150,150,Prostate Cancer,,150,,150,TCGA,,150,Primary,0,Apex|Middle|Base,A,,ATM,True,TUMOR FREE,Alive,-22756,,62,7,36,PRAD,150,150,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.0,Prostate,Resection,3,64A767B5-953F-4A2B-9DF5-10123D3C1981,0,Normal (no evidence of prostate cancer) [cM0],0,0.0039578,[Not Available],105E12BF-4F39-4D7A-870F-FBC329EE210A,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,HC,1.33333333333,TCGA-HC-A76X,0:DiseaseFree,2,3,Prostate Adenocarcinoma,4.93,3/28/14,150,,,,,,C61,DA72A108-04AA-424B-83EE-714036869E87,60,0,TUMOR FREE,0.0041,0:LIVING,0.01,,4.93,Bilateral,5,,,YES,149,2013,,,TCGA-HC-A76X.DA72A108-04AA-424B-83EE-714036869E87.pdf,,[Not Applicable],,10,91-100%,1,Prostate Adenocarcinoma Acinar Type,1,2013,[Unknown],,NO,No,R0,,62,Core needle biopsy,,,YES,NO,YES,NO,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,5460,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A8CY,,PRAD,370,0,0,,HC,,0,MALE,0,2.08,0.82,2,2,5,HRD,NO,290,2-ETV1,,290,,0,0,290,290,prad_tcga,Malignant,9,,37,,TCGA-HC-A8CY-01,0,0,0,TCGA-HC-A8CY,290,290,Prostate Cancer,,290,,290,TCGA,,290,Primary,0,,A,,BRCA1,False,WITH TUMOR,Alive,-23154,,63,9,48,PRAD,290,290,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.05,Prostate,Resection,5,F3919F4C-E401-4EC4-96C5-A85BF0C398F8,4,Abnormal (not related to prostate cancer),0,0.033823,[Not Available],B6F54BDC-9B1B-4465-A6E3-F0524885E10E,4,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,HC,1.06666666667,TCGA-HC-A8CY,0:DiseaseFree,5,8,Prostate Adenocarcinoma,9.53,3/28/14,290,,,,,NO,C61,4CF73411-E5F6-43E1-8207-076C5C0FE921,70,4,WITH TUMOR,0.1393,0:LIVING,0.9,,9.53,Bilateral,16,No Evidence of Extraprostatic Extension,41,YES,153,2013,,,TCGA-HC-A8CY.4CF73411-E5F6-43E1-8207-076C5C0FE921.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,86-95%,3,Prostate Adenocarcinoma Acinar Type,1,2013,[Unknown],,,No,R1,,63,Core needle biopsy,,,YES,NO,YES,,T3a,,9,No,,0,N1,T1c,1,M0,C61.9,8140/3,5461,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-A8D0,,PRAD,370,0,0,,HC,0,0,MALE,0,1.96,0.34,1,3,2,HRP,NO,775,1-ERG,775,775,,0,0,775,775,prad_tcga,Malignant,6,,56,,TCGA-HC-A8D0-01,0,0,0,TCGA-HC-A8D0,775,775,Prostate Cancer,14,110,775,775,TCGA,No Evidence of Extraprostatic Extension,775,Primary,0,Apex|Middle,A,,,False,TUMOR FREE,Alive,-22465,,61,7,39,PRAD,775,775,,0.0,[Not Available],[Not Applicable],31,,1,Matched,0.0,Prostate,Resection,3,A31E3626-9E80-467A-986B-A83DC3684AC6,2,Normal (no evidence of prostate cancer) [cM0],0,0.043138,[Not Available],0AFA0E02-DAAE-47E6-9CCB-9DE8E4FEB73C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,HC,1.03333333333,TCGA-HC-A8D0,0:DiseaseFree,2,10,Prostate Adenocarcinoma,25.46,3/28/14,775,,,,,YES,C61,E29BD9A6-B0F0-42D8-B952-85B71C3D5BC9,60,1,TUMOR FREE,0.0414,0:LIVING,0.01,,25.46,Left,10,No Evidence of Extraprostatic Extension,11,YES,517,2012,,,TCGA-HC-A8D0.E29BD9A6-B0F0-42D8-B952-85B71C3D5BC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,11,6-15%,10,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,61,Core needle biopsy,,,YES,NO,YES,NO,T2a,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,5462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-A8D1,,PRAD,370,0,0,,HC,0,0,MALE,0,1.99,0.33,0,1,0,HRD,NO,573,1-ERG,573,573,,0,0,573,573,prad_tcga,Malignant,1,,21,,TCGA-HC-A8D1-01,0,0,0,TCGA-HC-A8D1,573,573,Prostate Cancer,,168,573,573,TCGA,,573,Primary,0,,A,,BRCA1;CDK12;RAD51D,False,TUMOR FREE,Alive,-25137,,68,7,27,PRAD,573,573,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.0,Prostate,Resection,3,199C6D34-6693-4533-A2AE-C83ACEDFC004,0,Normal (no evidence of prostate cancer) [cM0],0,0.011534,[Not Available],341940FC-DD2A-485C-A359-D5E5EDB22312,4,Prostate Adenocarcinoma Acinar Type,,Prostate,1,,Acinar Adenocarcinoma,[Not Available],,HC,0.833333333333,TCGA-HC-A8D1,0:DiseaseFree,2,7,Prostate Adenocarcinoma,18.82,3/28/14,573,,,,,NO,C61,6C5B3FD6-3C50-4DF3-9101-D131075F4A5B,40,0,TUMOR FREE,0.0108,0:LIVING,0.01,,18.82,Bilateral,8,,,YES,464,2012,,,TCGA-HC-A8D1.6C5B3FD6-3C50-4DF3-9101-D131075F4A5B.pdf,,[Not Applicable],NO,14,66-75%,6,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,68,Core needle biopsy,,,YES,NO,YES,NO,T2c,,7,No,,0,N0,T2,0,M0,C61.9,8140/3,5463,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-HC-A9TH,,PRAD,,1,1,,HC,,0,MALE,1,1.92,0.7,5,5,1,HRP,NO,844,,,844,,1,1,351,351,prad_tcga,Malignant,11,ATM;CHEK2;PALB2,61,,TCGA-HC-A9TH-01,0,0,0,TCGA-HC-A9TH,351,351,Prostate Cancer,,295,,844,TCGA,,351,Primary,0,Apex|Middle|Base,A,,,False,WITH TUMOR,Alive,-21460,,58,9,65,PRAD,351,351,,0.0,[Not Available],[Not Applicable],49,,1,Matched,0.08,Prostate,Resection,5,4F86D3F7-167E-45EC-8EF5-7E26025F2BD4,0,Normal (no evidence of prostate cancer) [cM0],0,0.086114,[Not Available],433D1441-6D5B-4455-A731-65F172BB016D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,HC,1.63333333333,TCGA-HC-A9TH,1:Recurred/Progressed,5,11,Prostate Adenocarcinoma,11.53,6/10/15,844,"Other, specify",Biochemical evidence of disease,,,,C61,C2755FC2-E4BD-4997-B2F9-1F1C3A9C28AE,60,4,WITH TUMOR,0.0868,0:LIVING,0.38,5,27.73,Bilateral,12,,,YES,320,2013,351,Biochemical,TCGA-HC-A9TH.C2755FC2-E4BD-4997-B2F9-1F1C3A9C28AE.pdf,,[Not Applicable],,155,,2,Prostate Adenocarcinoma Acinar Type,1,2013,Partial Remission/Response,,NO,No,R1,,58,Transurethral resection (TURBT),,Partial Remission/Response,YES,NO,YES,NO,T3b,,9,No,NO,0,N0,T1b,0,M0,C61.9,8140/3,5465,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-HI-7168,White,PRAD,184,1,1,,HI,,0,MALE,1,3.46,0.57,4,8,11,ambiguous,NO,3323,3-ETV4,,3323,,1,1,2505,2505,prad_tcga,Malignant,23,BRCA1;BRCA2;CHEK2;RAD51D;RAD54L,40,5.5,TCGA-HI-7168-01,0,0,0,TCGA-HI-7168,2505,2505,Prostate Cancer,19,2289,,3323,TCGA,No Evidence of Extraprostatic Extension,2505,Primary,0,,A,,,,WITH TUMOR,Alive,-22881,,62,9,61,PRAD,2505,2505,WHITE,0.0,[Not Available],[Not Applicable],42,R0,1,Matched,0.48,Prostate,Resection,4,dd410832-95aa-4fa6-a2b9-3feca6f70e1d,22,Normal (no evidence of prostate cancer) [cM0],1,0.10057,[Not Available],25d70934-01a5-45a2-9960-68d3058b6965,5,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,22,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HI,1.36666666667,TCGA-HI-7168,1:Recurred/Progressed,5,30,Prostate Adenocarcinoma,82.29,2/20/12,3323,Bone,Biochemical evidence of disease,,,YES,C61,d29af7d7-996d-44a9-a571-878ea0f95403,,15,,0.3786,0:LIVING,0.3,,109.17,Bilateral,39,,,YES,,2005,2505,,TCGA-HI-7168.d29af7d7-996d-44a9-a571-878ea0f95403.pdf,,[Not Applicable],NO,19,16-25%,9,Prostate Adenocarcinoma Acinar Type,1,2005,Stable Disease,,YES,No,R0,1.0,62,Core needle biopsy,308,,NO,YES,YES,,T3b,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,5466,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HI-7169,White,PRAD,,0,0,,HI,0,0,MALE,0,2.0,0.45,0,0,0,HRP,NO,2684,,2684,2684,,0,0,2684,2684,prad_tcga,Malignant,0,,4,,TCGA-HI-7169-01,0,0,0,TCGA-HI-7169,2684,2684,Prostate Cancer,,1941,2684,2684,TCGA,,2684,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-20133,,55,7,40,PRAD,2684,2684,WHITE,0.0,[Not Available],[Not Applicable],45,,1,Matched,,Prostate,Resection,3,aeef0836-305c-465c-a9ca-6c1825353ae7,0,Normal (no evidence of prostate cancer) [cM0],0,0.000913,[Not Available],11fb5853-8eeb-4ad8-825d-3eaaf3fa08d6,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HI,1.5,TCGA-HI-7169,0:DiseaseFree,2,0,Prostate Adenocarcinoma,88.17,2/21/12,2684,,,,,NO,C61,ed386bc1-82a8-489e-81e0-53a93325a48e,,0,TUMOR FREE,0.0009,0:LIVING,0.1,,88.17,Bilateral,3,,,YES,,2006,,,TCGA-HI-7169.ed386bc1-82a8-489e-81e0-53a93325a48e.pdf,,[Not Applicable],NO,33,,4,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R1,0.5,55,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,5467,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HI-7170,White,PRAD,184,0,0,,HI,0,0,MALE,0,1.96,0.47,1,0,1,HRP,NO,2522,8-other,2522,2522,,0,0,2522,2522,prad_tcga,Malignant,2,,2,7.4,TCGA-HI-7170-01,0,0,0,TCGA-HI-7170,2522,2522,Prostate Cancer,-78,1746,2522,2522,TCGA,No Evidence of Extraprostatic Extension,2522,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-21199,,58,6,32,PRAD,2522,2522,WHITE,0.0,[Not Available],[Not Applicable],32,R0,1,Matched,0.01,Prostate,Resection,3,70bf0c3e-0c06-4168-996c-46783752fa37,3,Normal (no evidence of prostate cancer) [cM0],0,0.043361,[Not Available],6394e00a-1f6f-4ea2-b885-373bbb59def9,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HI,1.03333333333,TCGA-HI-7170,0:DiseaseFree,1,6,Prostate Adenocarcinoma,82.85,2/21/12,2522,,,,,YES,C61,96f2ece8-246a-43fe-8963-217613c84f0b,,2,TUMOR FREE,0.0428,0:LIVING,0.1,,82.85,Bilateral,9,No Evidence of Extraprostatic Extension,-92,YES,,2006,,,TCGA-HI-7170.96f2ece8-246a-43fe-8963-217613c84f0b.pdf,,[Not Applicable],YES,-96,36-45%,6,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.8,58,Transurethral resection (TURBT),,,NO,YES,YES,,T2c,,6,No,,0,N0,T1c,0,M0,C61.9,8550/3,5468,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-HI-7171,White,PRAD,184,1,1,,HI,,1,MALE,1,1.89,0.88,8,9,2,ambiguous,NO,1329,1-ERG,,1329,,1,1,1329,1329,prad_tcga,Malignant,19,BRCA1;BRCA2;CHEK2;RAD51B,55,5.6,TCGA-HI-7171-01,0,0,0,TCGA-HI-7171,1329,1329,Prostate Cancer,,631,,1329,TCGA,No Evidence of Extraprostatic Extension,1329,Primary,0,Apex|Middle|Base,A,,,,WITH TUMOR,Dead,-20776,1329,56,9,44,PRAD,1329,1329,WHITE,0.0,[Unknown],[Not Applicable],37,R1,1,Matched,0.17,Prostate,Resection,5,b9d6c505-4d71-4189-925f-36914241b831,2,Normal (no evidence of prostate cancer) [cM0],0,0.11482,[Not Available],931feb14-3f69-41c1-8435-5fd4fb775bdf,4,Prostate Adenocarcinoma Acinar Type,1.6,Prostate,18,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HI,1.2,TCGA-HI-7171,,5,24,Prostate Adenocarcinoma,,2/22/12,,,,,,YES,C61,0bdd67bb-5cf4-4972-9ab6-9878c351857f,,3,WITH TUMOR,0.1673,1:DECEASED,0.7,,43.66,Bilateral,30,,,YES,,2008,,,TCGA-HI-7171.0bdd67bb-5cf4-4972-9ab6-9878c351857f.pdf,,[Not Applicable],NO,,41-50%,7,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,YES,No,R1,1.0,56,Core needle biopsy,218,,NO,YES,YES,,T3b,,9,No,,0,N0,T3a,0,M0,C61.9,8550/3,5469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-8198,,PRAD,221,0,0,,J4,0,0,MALE,0,2.04,0.66,1,2,0,HRP,NO,614,1-ERG,614,614,,0,0,614,614,prad_tcga,Malignant,3,,18,17.9,TCGA-J4-8198-01,0,0,0,TCGA-J4-8198,614,614,Prostate Cancer,,76,614,614,TCGA,,614,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-17935,,49,7,35,PRAD,614,614,,0.0,[Not Available],[Not Applicable],38,,1,Matched,0.0,Prostate,Resection,4,6dc2c1b2-ec10-47c9-bde1-72ecb64e258e,2,,0,0.022083,[Not Available],a1e64294-1264-498d-b18b-c9b4c729c2f2,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.4,J4,1.26666666667,TCGA-J4-8198,0:DiseaseFree,3,3,Prostate Adenocarcinoma,20.17,6/6/12,614,,,,,,C61,c61b1da1-f0d2-48c9-ac71-5967799def29,,1,,0.0753,0:LIVING,0.1,5,20.17,Bilateral,4,,,YES,,2011,,,TCGA-J4-8198.c61b1da1-f0d2-48c9-ac71-5967799def29.pdf,,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.7,49,Core needle biopsy,,,YES,NO,NO,NO,T3b,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,5470,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-8200,,PRAD,308,0,0,,J4,0,0,MALE,0,2.02,0.52,1,4,2,HRP,NO,1218,8-other,1218,1218,,0,0,1218,1218,prad_tcga,Malignant,7,,12,8.6,TCGA-J4-8200-01,0,0,0,TCGA-J4-8200,1218,1218,Prostate Cancer,,196,1218,1218,TCGA,,1218,Primary,0,,A,,,,TUMOR FREE,Alive,-17167,,47,7,21,PRAD,1218,1218,,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.01,Prostate,Resection,3,4aacab9c-a663-4aa3-9a90-47563e3e6331,0,Normal (no evidence of prostate cancer) [cM0],0,0.011943,[Not Available],897a2af4-55af-4245-8629-1a71b622c17e,4,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,7,,Acinar Adenocarcinoma,[Not Available],0.4,J4,0.8,TCGA-J4-8200,0:DiseaseFree,2,5,Prostate Adenocarcinoma,40.01,6/6/12,1218,,,,,NO,C61,5E18C318-D20B-4837-850D-34FD96C87EEC,,1,TUMOR FREE,0.034,0:LIVING,0.1,,40.01,Bilateral,6,No Evidence of Extraprostatic Extension,41,YES,,2011,,,TCGA-J4-8200.5E18C318-D20B-4837-850D-34FD96C87EEC.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,61-70%,4,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.5,47,Core needle biopsy,,,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T2,0,M0,C61.9,8550/3,5471,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67K,,PRAD,,0,0,,J4,0,0,MALE,0,1.99,0.55,0,0,0,HRD,NO,1004,,1004,1004,,0,0,1004,1004,prad_tcga,Malignant,0,,15,,TCGA-J4-A67K-01,0,0,0,TCGA-J4-A67K,1004,1004,Prostate Cancer,,557,1004,1004,TCGA,,1004,Primary,0,,A,,BRCA1,True,TUMOR FREE,Alive,-24908,,68,7,35,PRAD,1004,1004,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.01,Prostate,Resection,4,B305B74B-8977-4074-8B80-FFC75D7B8531,0,,0,0.0080311,[Not Available],C4C1B5BE-A0E7-4968-92DE-7F34C71207FB,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,1.16666666667,TCGA-J4-A67K,0:DiseaseFree,3,7,Prostate Adenocarcinoma,32.98,8/16/13,1004,,,,,,C61,F8FF8077-8922-4CC8-95DD-4AF68CCC7EEC,190,0,TUMOR FREE,0.0084,0:LIVING,0.1,,32.98,Bilateral,8,,,YES,580,2011,,,TCGA-J4-A67K.F8FF8077-8922-4CC8-95DD-4AF68CCC7EEC.pdf,Peripheral Zone,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,68,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,T2b,,M0,C61.9,8140/3,5472,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67L,,PRAD,,0,0,,J4,0,0,MALE,0,1.98,0.36,2,4,4,ambiguous,NO,770,,770,770,,0,0,770,770,prad_tcga,Malignant,10,BRCA1;BRCA2;CDK12,34,,TCGA-J4-A67L-01,0,0,0,TCGA-J4-A67L,770,770,Prostate Cancer,,518,770,770,TCGA,,770,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20034,,54,7,34,PRAD,770,770,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.02,Prostate,Resection,3,1E2B64DE-E05F-4FCD-9E41-E47F0E538CA0,1,,0,0.04185,[Not Available],29BD2C05-254B-4BB2-AE32-5B328F772441,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,J4,1.03333333333,TCGA-J4-A67L,0:DiseaseFree,2,14,Prostate Adenocarcinoma,25.3,8/16/13,770,,,,,,C61,91F854F5-D488-4B25-B59A-6CB59C6357BB,70,2,TUMOR FREE,0.0606,0:LIVING,0.01,,25.3,Left,18,,,YES,485,2011,,,TCGA-J4-A67L.91F854F5-D488-4B25-B59A-6CB59C6357BB.pdf,Peripheral Zone,[Not Applicable],,,,1,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,54,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5473,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67M,,PRAD,,0,0,,J4,0,0,MALE,0,1.97,0.37,3,9,1,ambiguous,NO,941,,941,941,,0,0,941,941,prad_tcga,Malignant,13,BRCA2,33,,TCGA-J4-A67M-01,0,0,0,TCGA-J4-A67M,941,941,Prostate Cancer,,482,941,941,TCGA,,941,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20211,,55,7,44,PRAD,941,941,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.07,Prostate,Resection,4,142005B5-FA96-4137-B347-B807E346CB5F,1,,0,0.065571,[Not Available],67CD72E2-A4CF-48E4-943E-406C252F056A,3,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,J4,1.16666666667,TCGA-J4-A67M,0:DiseaseFree,3,19,Prostate Adenocarcinoma,30.91,8/16/13,941,,,,,,C61,590FEE5C-E5FF-4DB2-8A7E-6502E5B9A56B,320,3,TUMOR FREE,0.106,0:LIVING,0.1,,30.91,Bilateral,21,,,YES,482,2011,,,TCGA-J4-A67M.590FEE5C-E5FF-4DB2-8A7E-6502E5B9A56B.pdf,Peripheral Zone,[Not Applicable],,,,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,55,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5474,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-J4-A67N,,PRAD,,1,1,,J4,,0,MALE,1,1.9,0.74,4,8,4,ambiguous,NO,937,,,937,,1,1,442,442,prad_tcga,Malignant,16,BRCA2,98,,TCGA-J4-A67N-01,0,0,0,TCGA-J4-A67N,442,442,Prostate Cancer,,503,,937,TCGA,,442,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-22420,,61,7,33,PRAD,442,442,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,3,A48CC32C-2CA7-47D8-A051-D8206DB59381,2,,0,0.10486,[Not Available],00F7F9D3-7A34-4A5B-9D19-38810DCABBBA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,J4,1.06666666667,TCGA-J4-A67N,1:Recurred/Progressed,2,19,Prostate Adenocarcinoma,14.52,8/16/13,937,,Biochemical evidence of disease,,,,C61,70E5E77E-6B59-40A7-8E87-456EF28AED98,420,2,WITH TUMOR,0.0976,0:LIVING,0.7,,30.78,Bilateral,25,,,YES,504,2011,442,,TCGA-J4-A67N.70E5E77E-6B59-40A7-8E87-456EF28AED98.pdf,Peripheral Zone,[Not Applicable],,,,8,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,YES,No,R0,,61,Core needle biopsy,442,Partial Remission/Response,YES,NO,YES,YES,T3a,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5475,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67Q,,PRAD,,0,0,,J4,0,0,MALE,0,1.96,0.29,1,1,1,HRP,NO,975,,975,975,,0,0,975,975,prad_tcga,Malignant,3,,13,,TCGA-J4-A67Q-01,5,0,0,TCGA-J4-A67Q,975,975,Prostate Cancer,,616,975,975,TCGA,,975,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-28447,,77,6,23,PRAD,975,975,,0.197650139,[Not Available],[Not Applicable],25,,1,Matched,0.02,Prostate,Resection,3,DF184572-7ECF-4911-B4BB-4B7FDA3780D6,0,,0,0.03971,[Not Available],1CBAA137-C3B0-46A2-9B23-208682C2A438,3,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,J4,0.833333333333,TCGA-J4-A67Q,0:DiseaseFree,1,0,Prostate Adenocarcinoma,32.03,8/16/13,975,,,,,,C61,E7702E20-7616-4A88-862B-E860045E9C81,140,1,TUMOR FREE,0.0002,0:LIVING,0.1,,32.03,Bilateral,1,,,YES,584,2011,,,TCGA-J4-A67Q.E7702E20-7616-4A88-862B-E860045E9C81.pdf,Peripheral Zone,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,,77,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,6,No,NO,0,,T2b,,M0,C61.9,8140/3,5477,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67R,,PRAD,,0,0,,J4,0,0,MALE,0,2.0,0.2,0,0,0,HRP,NO,910,,910,910,,0,0,910,910,prad_tcga,Malignant,0,,5,,TCGA-J4-A67R-01,0,0,0,TCGA-J4-A67R,910,910,Prostate Cancer,,454,910,910,TCGA,,910,Primary,0,Middle|Base,A,,,True,TUMOR FREE,Alive,-23807,,65,7,21,PRAD,910,910,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.0,Prostate,Resection,4,42268A74-CFD1-4724-A8C6-4E9B977F1FBE,0,,0,0.000241,[Not Available],DB2779F6-8FE2-48C3-988B-81DB1815A678,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,1.0,TCGA-J4-A67R,0:DiseaseFree,3,0,Prostate Adenocarcinoma,29.89,8/16/13,910,,,,,,C61,EAFE4CB1-BB7F-4D26-851D-49ECE5A73750,80,0,TUMOR FREE,0.0,0:LIVING,0.1,,29.89,Bilateral,1,,,YES,440,2012,,,TCGA-J4-A67R.EAFE4CB1-BB7F-4D26-851D-49ECE5A73750.pdf,Peripheral Zone,[Not Applicable],,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5478,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-J4-A67S,,PRAD,,1,1,,J4,1,0,MALE,1,1.92,0.44,5,7,2,ambiguous,NO,833,,708,833,,1,1,708,708,prad_tcga,Malignant,14,FANCL,53,,TCGA-J4-A67S-01,0,0,0,TCGA-J4-A67S,708,708,Prostate Cancer,,522,708,833,TCGA,,708,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-23332,,63,7,19,PRAD,708,708,,0.0,[Not Available],[Not Applicable],22,,1,Matched,0.0,Prostate,Resection,3,F5D26FFE-21B5-4D4A-BE82-8C858BEF1586,1,,0,0.077842,[Not Available],9FE9CBAE-37B9-4030-A204-4502760F5DAB,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,J4,0.733333333333,TCGA-J4-A67S,1:Recurred/Progressed,2,17,Prostate Adenocarcinoma,23.26,8/16/13,833,,Biochemical evidence of disease,,,,C61,D5BC3AA7-D957-4291-8A6B-D148AA7CA909,50,1,WITH TUMOR,0.0754,0:LIVING,0.1,,27.37,Bilateral,17,,,YES,427,2012,708,,TCGA-J4-A67S.D5BC3AA7-D957-4291-8A6B-D148AA7CA909.pdf,Peripheral Zone,[Not Applicable],,,,3,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,63,Core needle biopsy,,,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5479,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67T,,PRAD,315,0,0,,J4,0,0,MALE,0,1.99,0.44,0,0,0,HRD,NO,183,1-ERG,183,183,,0,0,183,183,prad_tcga,Malignant,0,,22,5.5,TCGA-J4-A67T-01,0,0,0,TCGA-J4-A67T,183,183,Prostate Cancer,,154,183,183,TCGA,,183,Primary,0,Apex|Middle,A,,RAD51D,True,TUMOR FREE,Alive,-23211,,63,7,22,PRAD,183,183,,0.0,[Not Available],[Not Applicable],16,R0,1,Matched,0.01,Prostate,Resection,3,FC2033B2-79B6-4FEB-9084-07082EA73B8B,0,,0,0.0059048,[Not Available],432F15BA-7401-4827-83A5-3EAAFAAA4BEA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,0.5,TCGA-J4-A67T,0:DiseaseFree,2,2,Prostate Adenocarcinoma,6.01,8/16/13,183,,,,,,C61,8E3BAF97-3B7F-4B3A-BC88-BACB5A716DFD,490,0,TUMOR FREE,0.0056,0:LIVING,0.1,,6.01,Bilateral,4,,,YES,409,2012,,,TCGA-J4-A67T.8E3BAF97-3B7F-4B3A-BC88-BACB5A716DFD.pdf,Peripheral Zone,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8140/3,5480,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A6G1,,PRAD,315,0,0,,J4,0,0,MALE,0,2.0,0.58,0,0,0,HRP,NO,769,1-ERG,769,769,,0,0,769,769,prad_tcga,Malignant,0,,10,8.2,TCGA-J4-A6G1-01,0,0,0,TCGA-J4-A6G1,769,769,Prostate Cancer,34,178,769,769,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),769,Primary,0,,A,,,True,TUMOR FREE,Alive,-24945,,68,8,14,PRAD,769,769,,0.0,[Not Available],[Not Applicable],18,R0,1,Matched,0.03,Prostate,Resection,4,BDC630D2-A384-44E2-890D-046BC2C6D0A2,0,,0,0.000605,[Not Available],F9F136A5-3CCB-42B3-BA60-C667FBB0846D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,0.566666666667,TCGA-J4-A6G1,0:DiseaseFree,4,0,Prostate Adenocarcinoma,25.26,9/12/13,769,,,,,YES,C61,6758B6C3-61B6-4D4F-9018-CDC2E932ACC7,80,0,,0.0006,0:LIVING,0.1,3,25.26,Bilateral,1,,,YES,408,2012,,,TCGA-J4-A6G1.6758B6C3-61B6-4D4F-9018-CDC2E932ACC7.pdf,Peripheral Zone,[Not Applicable],,,51-60%,2,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,68,Core needle biopsy,,,YES,NO,YES,NO,T3a,YES,8,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5481,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-J4-A6G3,,PRAD,315,1,1,,J4,,0,MALE,1,,,,,,,NO,849,5-SPOP,,849,,1,1,618,618,prad_tcga,Malignant,,,,7.5,TCGA-J4-A6G3-01,0,0,0,TCGA-J4-A6G3,618,618,Prostate Cancer,15,528,,849,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1],618,Primary,0,,A,,,True,WITH TUMOR,Alive,-20836,,57,8,25,PRAD,618,618,,0.0,[Not Available],[Not Applicable],26,R1,1,Matched,,Prostate,Resection,4,30F54DD8-FD85-407E-816C-C9DB4C1D79EE,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],9B015929-99EB-4E74-8FBF-6B2E6D7F08E4,4,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,J4,0.866666666667,TCGA-J4-A6G3,1:Recurred/Progressed,4,,Prostate Adenocarcinoma,20.3,9/12/13,849,,Biochemical evidence of disease,,,YES,C61,63F0D5A2-CCAB-48C7-9BD9-F75A699DE1AD,80,,TUMOR FREE,0.0001,0:LIVING,0.4,,27.89,Bilateral,,,,YES,479,2012,618,,TCGA-J4-A6G3.63F0D5A2-CCAB-48C7-9BD9-F75A699DE1AD.pdf,Peripheral Zone,[Not Applicable],NO,17,41-50%,5,Prostate Adenocarcinoma Acinar Type,1,2012,Partial Remission/Response,,NO,No,R1,,57,Core needle biopsy,,,YES,NO,YES,NO,T3b,YES,8,No,NO,0,N0,T2,0,M0,C61.9,8140/3,5482,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A83I,,PRAD,370,0,0,,J4,0,0,MALE,0,1.91,0.79,7,10,4,ambiguous,NO,685,1-ERG,685,685,,0,0,685,685,prad_tcga,Malignant,21,PALB2;RAD51B,56,,TCGA-J4-A83I-01,7,0,0,TCGA-J4-A83I,685,685,Prostate Cancer,,257,685,685,TCGA,,685,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23240,,63,7,40,PRAD,685,685,,0.193780289,[Not Available],[Not Applicable],28,R0,1,Matched,0.04,Prostate,Resection,4,8A59B137-8E5E-4484-A9A9-65A596A47EF8,0,,0,0.086973,[Not Available],5DC7E186-7E01-4A54-8AE8-350DACE2297B,3,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,J4,0.933333333333,TCGA-J4-A83I,0:DiseaseFree,3,21,Prostate Adenocarcinoma,22.5,1/20/14,685,,,,,,C61,E3AFE230-AE22-4120-BC42-7FE78FCB06A2,100,2,TUMOR FREE,0.0827,0:LIVING,0.1,,22.5,Bilateral,22,,,YES,183,2013,,,TCGA-J4-A83I.E3AFE230-AE22-4120-BC42-7FE78FCB06A2.pdf,Peripheral Zone,[Not Applicable],,,86-95%,2,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5484,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A83J,,PRAD,,0,0,,J4,0,0,MALE,0,,,,,,ambiguous,NO,696,,696,696,,0,0,696,696,prad_tcga,Malignant,,BRCA2,,,TCGA-J4-A83J-01,0,0,0,TCGA-J4-A83J,696,696,Prostate Cancer,,235,696,696,TCGA,,696,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-24960,,68,7,65,PRAD,696,696,,0.0,[Not Available],[Not Applicable],47,,1,Matched,,Prostate,Resection,3,2426F010-6122-410C-95FD-9EE4A185F4ED,,,,,[Not Available],98240F19-BCA7-4001-8AA2-4D790C7C4C53,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,J4,1.56666666667,TCGA-J4-A83J,0:DiseaseFree,2,24,Prostate Adenocarcinoma,22.86,1/20/14,696,,,,,,C61,D3FF2CCF-E6D0-4C8A-9159-F78176E7EE59,210,,,0.1083,0:LIVING,0.04,,22.86,Bilateral,26,,,YES,272,2013,,,TCGA-J4-A83J.D3FF2CCF-E6D0-4C8A-9159-F78176E7EE59.pdf,Peripheral Zone,[Not Applicable],,,,1,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R1,,68,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5485,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A83K,,PRAD,357,0,0,,J4,0,0,MALE,0,2.0,0.44,0,0,0,HRP,NO,328,1-ERG,328,328,,0,0,328,328,prad_tcga,Malignant,0,,8,,TCGA-J4-A83K-01,0,0,0,TCGA-J4-A83K,328,328,Prostate Cancer,,205,328,328,TCGA,,328,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-19299,,52,6,30,PRAD,328,328,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.02,Prostate,Resection,3,8EF6A082-C440-481B-ACBD-CD4C0D15A90B,0,,0,0.0011274,[Not Available],256F5BCF-10A9-47BE-B265-CFA707D24097,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,0.966666666667,TCGA-J4-A83K,0:DiseaseFree,1,2,Prostate Adenocarcinoma,10.78,1/20/14,328,,,,,,C61,B03E6C45-550E-4657-9292-75D7BB058D2A,30,0,TUMOR FREE,0.0005,0:LIVING,0.1,,10.78,Bilateral,2,,,YES,254,2013,,,TCGA-J4-A83K.B03E6C45-550E-4657-9292-75D7BB058D2A.pdf,Peripheral Zone,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,52,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,5486,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A83L,,PRAD,,0,0,,J4,0,0,MALE,0,1.99,0.32,1,1,2,HRP,NO,720,,720,720,,0,0,720,720,prad_tcga,Malignant,4,,16,,TCGA-J4-A83L-01,0,0,0,TCGA-J4-A83L,720,720,Prostate Cancer,,316,720,720,TCGA,,720,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-22338,,61,7,26,PRAD,720,720,,0.0,[Not Available],[Not Applicable],23,,1,Matched,0.0,Prostate,Resection,3,B3E9AA2D-B3BA-45E7-B3D3-70837FDE3600,0,,0,0.01063,[Not Available],8CC7679D-B963-4B45-B3F8-DCF80EA6CC71,4,Prostate Adenocarcinoma Acinar Type,,Prostate,4,,Acinar Adenocarcinoma,[Not Available],,J4,0.766666666667,TCGA-J4-A83L,0:DiseaseFree,2,4,Prostate Adenocarcinoma,23.65,1/20/14,720,,,,,,C61,837A4811-0DAF-46F6-9C84-D2BBFFC56AF0,50,0,TUMOR FREE,0.0099,0:LIVING,0.1,,23.65,Bilateral,6,,,YES,218,2013,,,TCGA-J4-A83L.837A4811-0DAF-46F6-9C84-D2BBFFC56AF0.pdf,Central Zone,[Not Applicable],,,,5,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,61,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5487,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-J4-A83M,,PRAD,357,1,1,,J4,1,0,MALE,1,1.99,0.6,0,0,0,HRP,NO,543,2-ETV1,521,543,,1,1,521,521,prad_tcga,Malignant,0,,32,,TCGA-J4-A83M-01,0,0,0,TCGA-J4-A83M,521,521,Prostate Cancer,,437,521,543,TCGA,,521,Primary,0,Apex|Middle,A,,,True,,Alive,-23624,,64,7,38,PRAD,521,521,,0.0,[Not Available],[Not Applicable],40,R1,1,Matched,0.02,Prostate,Resection,4,004BDE0B-224A-48CE-AA33-242BA7385ECC,0,,0,0.013056,[Not Available],D6974DB6-2BD3-4082-B48E-9C60F7FE3A1F,3,Prostate Adenocarcinoma Acinar Type,,Prostate,1,,Acinar Adenocarcinoma,[Not Available],,J4,1.33333333333,TCGA-J4-A83M,1:Recurred/Progressed,3,3,Prostate Adenocarcinoma,17.12,1/20/14,543,,Biochemical evidence of disease,,,,C61,8AA3EBE4-49E8-4D0A-A3A4-B51E41B3AA4F,40,0,,0.0102,0:LIVING,0.2,,17.84,Bilateral,5,,,YES,412,2012,521,,TCGA-J4-A83M.8AA3EBE4-49E8-4D0A-A3A4-B51E41B3AA4F.pdf,Peripheral Zone,[Not Applicable],,,41-50%,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,64,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5488,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-J4-A83N,,PRAD,357,0,0,,J4,0,0,MALE,1,1.97,0.53,3,4,3,HRP,NO,992,1-ERG,992,992,,0,0,433,433,prad_tcga,Malignant,10,,32,,TCGA-J4-A83N-01,0,0,0,TCGA-J4-A83N,992,992,Prostate Cancer,,530,992,992,TCGA,,433,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20841,,57,7,26,PRAD,992,992,,0.0,[Not Available],[Not Applicable],22,R0,1,Matched,0.04,Prostate,Resection,3,F3B220B7-F3DA-4EF3-96C3-C4D4091635CD,1,,0,0.072095,[Not Available],C024C4B6-0143-4071-9175-7435F1EAAC58,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,J4,0.733333333333,TCGA-J4-A83N,1:Recurred/Progressed,2,8,Prostate Adenocarcinoma,14.22,1/20/14,992,,New Primary Tumor,,,,C61,C40A9D7F-BFEC-4C07-A1C3-A34706E39713,240,4,TUMOR FREE,0.0351,0:LIVING,0.1,,32.59,Bilateral,15,,,YES,519,2012,433,,TCGA-J4-A83N.C40A9D7F-BFEC-4C07-A1C3-A34706E39713.pdf,Overlapping / Multiple Zones,[Not Applicable],,,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,57,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,YES,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8140/3,5489,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-J4-AATV,,PRAD,,0,0,,J4,,0,MALE,0,2.0,0.98,0,0,0,HRP,NO,553,,,553,,0,0,553,553,prad_tcga,Malignant,0,,5,,TCGA-J4-AATV-01,0,0,0,TCGA-J4-AATV,553,553,Prostate Cancer,,358,,553,TCGA,,553,Primary,0,,A,,,True,WITH TUMOR,Alive,-25943,,71,6,2,PRAD,553,553,,0.0,[Not Available],[Not Applicable],10,,1,Matched,0.0,Prostate,Resection,3,A863236E-3FD1-42B5-A3EB-49F91BB072E7,0,,0,0.000483,[Not Available],FADD80E3-8087-4494-A8F0-1CAA92ACBB67,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,0.266666666667,TCGA-J4-AATV,0:DiseaseFree,1,0,Prostate Adenocarcinoma,18.17,8/13/14,553,,,,,,C61,860F2174-869F-47E4-ABC1-14E4F608669A,50,0,,0.0002,0:LIVING,0.0,,18.17,Bilateral,3,,,YES,151,2013,,,TCGA-J4-AATV.860F2174-869F-47E4-ABC1-14E4F608669A.pdf,,[Not Applicable],,,,4,Prostate Adenocarcinoma Acinar Type,1,2013,[Discrepancy],,NO,No,R1,,71,Core needle biopsy,,,YES,NO,YES,NO,T2c,NO,6,No,NO,0,N0,,,M0,C61.9,8140/3,5490,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-J4-AATZ,,PRAD,,1,1,,J4,1,0,MALE,1,2.03,0.73,2,7,2,HRD,NO,412,,79,412,,1,1,79,79,prad_tcga,Malignant,11,CHEK2,55,,TCGA-J4-AATZ-01,30,0,0,TCGA-J4-AATZ,79,79,Prostate Cancer,23,386,79,412,TCGA,No Evidence of Extraprostatic Extension,79,Primary,1,Apex,A,,RAD51B,True,WITH TUMOR,Alive,-24226,,66,9,48,PRAD,79,79,,0.656422655,[Not Available],[Not Applicable],41,,1,Matched,0.17,Prostate,Resection,4,DF64C493-D290-41C7-ABD3-AB65CDA57B02,1,Normal (no evidence of prostate cancer) [cM0],0,0.04313,[Not Available],73B7D4BC-6B56-4AE8-BE7F-074745563BEE,5,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,J4,1.46666666667,TCGA-J4-AATZ,1:Recurred/Progressed,5,14,Prostate Adenocarcinoma,2.6,8/14/14,412,,Biochemical evidence of disease,,,YES,C61,369F71EC-186A-41DA-91F7-B0FD209BEC8F,80,2,WITH TUMOR,0.1118,0:LIVING,0.0,,13.53,Bilateral,14,No Evidence of Extraprostatic Extension,23,YES,170,2013,79,,TCGA-J4-AATZ.369F71EC-186A-41DA-91F7-B0FD209BEC8F.pdf,Peripheral Zone,[Not Applicable],,33,,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R1,,66,Core needle biopsy,79,Complete Remission/Response,YES,NO,YES,YES,T3a,YES,9,No,YES,0,N0,,0,M0,C61.9,8140/3,5491,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A59V,,PRAD,,0,0,,KK,0,0,MALE,0,1.97,0.58,2,3,1,HRD,NO,3440,,3440,3440,,0,0,3440,3440,prad_tcga,Malignant,6,,44,,TCGA-KK-A59V-01,0,0,0,TCGA-KK-A59V,3440,3440,Prostate Cancer,,2500,3440,3440,TCGA,,3440,Primary,0,Apex|Middle|Base,A,,RAD51C,True,TUMOR FREE,Alive,-23483,,64,9,1193,PRAD,3440,3440,,0.0,[Not Available],[Not Applicable],863,,1,Matched,0.21,Prostate,Resection,4,661E975A-2420-4ADF-869B-9D66F4F03399,1,,0,0.028787,[Not Available],9E48644F-D498-42B0-871B-D11F676241E2,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,KK,28.6666666667,TCGA-KK-A59V,0:DiseaseFree,5,4,Prostate Adenocarcinoma,113.01,3/27/14,3440,,,,,NO,C61,0A977EFF-C276-46CB-9187-92F504C7B535,190,1,TUMOR FREE,0.0273,0:LIVING,0.1,,113.01,Bilateral,4,,,YES,2742,2005,,,TCGA-KK-A59V.0A977EFF-C276-46CB-9187-92F504C7B535.pdf,Peripheral Zone,[Not Applicable],NO,,,9,Prostate Adenocarcinoma Acinar Type,1,2005,Complete Remission/Response,,NO,No,R0,,64,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,NO,0,N0,T3a,0,M0,C61.9,8140/3,5493,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A59X,,PRAD,308,1,1,,KK,,0,MALE,1,1.84,0.86,10,13,0,ambiguous,NO,2535,5-SPOP,,2535,,1,1,2233,2233,prad_tcga,Malignant,23,ATM;FANCL,251,26.3,TCGA-KK-A59X-01,0,0,0,TCGA-KK-A59X,2233,2233,Prostate Cancer,,,,2535,TCGA,,2233,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-20416,,55,9,60,PRAD,2233,2233,,0.0,[Not Available],[Not Applicable],56,R1,1,Matched,0.01,Prostate,Resection,5,009A8866-9CBD-4EF5-BA0A-D9591CB2A1A4,1,Normal (no evidence of prostate cancer) [cM0],0,0.16665,[Not Available],629855EA-551E-456C-B421-83B9A4EB3269,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,KK,1.9,TCGA-KK-A59X,1:Recurred/Progressed,5,23,Prostate Adenocarcinoma,73.36,5/28/13,2535,"Other, specify",Locoregional Recurrence,,,NO,C61,64BB13A6-1071-4C2A-937C-17ACC07ADF75,170,4,TUMOR FREE,0.1551,0:LIVING,,,83.28,Bilateral,27,No Evidence of Extraprostatic Extension,12,YES,1731,2008,2233,Bladder,TCGA-KK-A59X.64BB13A6-1071-4C2A-937C-17ACC07ADF75.pdf,Peripheral Zone,[Not Applicable],YES,12,71-80%,14,Prostate Adenocarcinoma Acinar Type,1,2008,[Unknown],,,No,R1,,55,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,NO,0,N1,T3a,2,M0,C61.9,8140/3,5494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A59Y,,PRAD,285,0,0,,KK,0,0,MALE,0,2.0,0.77,4,6,1,HRP,NO,1968,1-ERG,1968,1968,,0,0,1968,1968,prad_tcga,Malignant,11,RAD51B;RAD51C,53,14.7,TCGA-KK-A59Y-01,0,0,0,TCGA-KK-A59Y,1968,1968,Prostate Cancer,,1359,1968,1968,TCGA,,1968,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20768,,56,9,30,PRAD,1968,1968,,0.0,[Not Available],[Not Applicable],22,RX,1,Matched,0.01,Prostate,Resection,4,F1CA4735-9AA5-4598-8B8A-D2DF857273C8,2,Normal (no evidence of prostate cancer) [cM0],0,0.057964,[Not Available],4C197D76-DAF6-474D-B561-DED42905F52A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,0.733333333333,TCGA-KK-A59Y,0:DiseaseFree,5,13,Prostate Adenocarcinoma,64.65,5/28/13,1968,,,,,NO,C61,324E4C8E-1F95-4DA6-9D1F-97E6087BA2C7,110,2,TUMOR FREE,0.1105,0:LIVING,0.1,,64.65,Bilateral,15,No Evidence of Extraprostatic Extension,13,YES,1158,2009,,,TCGA-KK-A59Y.324E4C8E-1F95-4DA6-9D1F-97E6087BA2C7.pdf,Peripheral Zone,[Not Applicable],YES,13,81-90%,4,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,RX,,56,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,T3a,2,M0,C61.9,8140/3,5495,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A59Z,,PRAD,285,0,0,,KK,,0,MALE,0,4.17,0.8,4,10,5,ambiguous,NO,2628,5-SPOP,,2628,,0,0,2628,2628,prad_tcga,Malignant,19,PALB2;RAD54L,54,3.5,TCGA-KK-A59Z-01,0,0,0,TCGA-KK-A59Z,2628,2628,Prostate Cancer,,849,,2628,TCGA,,2628,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-24306,,66,7,65,PRAD,2628,2628,,0.0,[Not Available],[Not Applicable],52,R0,1,Matched,0.34,Prostate,Resection,4,CE99D7F7-F2BC-4246-8849-4752353475B3,12,Normal (no evidence of prostate cancer) [cM0],1,0.071254,[Not Available],DF7BBD9C-0B35-4855-ACDE-46F4956F4DF1,3,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,KK,1.76666666667,TCGA-KK-A59Z,0:DiseaseFree,3,26,Prostate Adenocarcinoma,86.33,5/28/13,2628,,,,,NO,C61,DDF6F24F-4406-49EE-9EE0-7129D8544677,260,17,TUMOR FREE,0.3999,0:LIVING,0.1,,86.33,Bilateral,35,No Evidence of Extraprostatic Extension,20,YES,1985,2007,,,TCGA-KK-A59Z.DDF6F24F-4406-49EE-9EE0-7129D8544677.pdf,Peripheral Zone,[Not Applicable],YES,24,41-50%,2,Prostate Adenocarcinoma Acinar Type,1,2007,[Not Applicable],,NO,No,R0,,66,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Male,TCGA-KK-A5A1,,PRAD,,1,1,,KK,,,MALE,1,,,,,,HRD,NO,2469,,,2469,,1,1,203,203,prad_tcga,Malignant,,,,,TCGA-KK-A5A1-01,0,0,0,TCGA-KK-A5A1,203,203,Prostate Cancer,,420,,2469,TCGA,,203,Primary,0,Apex|Middle|Base,A,CDK12:.:.:splice_donor_variant;CDK12:588-592:THSKT/X:frameshift_variant,,True,,Dead,-26415,2469,72,9,129,PRAD,203,203,,0.0,[Not Available],[Not Applicable],101,,1,Matched,,Prostate,Resection,4,531D3514-F2E4-49FA-A31B-DF25B26CB99F,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],436B242C-AD5F-432E-A684-27BBA4C1C8A2,5,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,KK,3.46666666667,TCGA-KK-A5A1,1:Recurred/Progressed,5,,Prostate Adenocarcinoma,6.67,5/28/13,,,Locoregional Recurrence,,,NO,C61,DF56D103-963E-4C23-9DB8-1333AFF418CE,90,,,,1:DECEASED,0.1,,81.11,Bilateral,,,14,YES,3586,2003,203,,TCGA-KK-A5A1.DF56D103-963E-4C23-9DB8-1333AFF418CE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,57,,3,Prostate Adenocarcinoma Acinar Type,1,2003,Partial Remission/Response,,NO,No,R1,,72,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,T3a,0,M0,C61.9,8140/3,5497,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A6DY,,PRAD,315,0,0,,KK,,0,MALE,0,1.93,0.44,7,4,6,ambiguous,NO,4295,1-ERG,,4295,,0,0,4295,4295,prad_tcga,Malignant,17,BRCA2,28,4.9,TCGA-KK-A6DY-01,0,0,0,TCGA-KK-A6DY,4295,4295,Prostate Cancer,,903,,4295,TCGA,,4295,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-18420,,50,7,36,PRAD,4295,4295,,0.0,[Not Available],[Not Applicable],35,R1,1,Matched,0.08,Prostate,Resection,3,FE3A9D45-8B34-407F-B915-BF80B49629D1,5,,0,0.10845,[Not Available],B1BDAF2D-7D84-4409-9427-5390150BB96D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,KK,1.16666666667,TCGA-KK-A6DY,0:DiseaseFree,2,15,Prostate Adenocarcinoma,141.1,3/27/14,4295,,,,,NO,C61,3C4C5AAE-6F27-4ECE-8F72-91DC9EF477C0,80,7,WITH TUMOR,0.0995,0:LIVING,0.1,,141.1,Bilateral,16,,,YES,4010,2002,,,TCGA-KK-A6DY.3C4C5AAE-6F27-4ECE-8F72-91DC9EF477C0.pdf,Peripheral Zone,[Not Applicable],NO,,31-40%,12,Prostate Adenocarcinoma Acinar Type,1,2002,[Not Applicable],,NO,No,R1,,50,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5498,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-KK-A6E0,,PRAD,315,1,1,,KK,1,0,MALE,1,1.84,0.64,8,15,2,ambiguous,NO,1483,5-SPOP,941,1483,,1,1,941,941,prad_tcga,Malignant,25,RAD54L,309,13.9,TCGA-KK-A6E0-01,6,0,0,TCGA-KK-A6E0,941,941,Prostate Cancer,,941,941,1483,TCGA,,941,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-21700,,59,9,39,PRAD,941,941,,0.196596935,[Not Available],[Not Applicable],26,R0,1,Matched,0.04,Prostate,Resection,4,504A9351-668C-43D9-ACA9-71177835D29D,1,Normal (no evidence of prostate cancer) [cM0],0,0.15965,[Not Available],D112136D-34FA-426E-B432-4D1E4286ADF8,5,Prostate Adenocarcinoma Acinar Type,,Prostate,25,,Acinar Adenocarcinoma,[Not Available],,KK,0.866666666667,TCGA-KK-A6E0,1:Recurred/Progressed,5,28,Prostate Adenocarcinoma,30.91,3/27/14,1483,,Biochemical evidence of disease,,,NO,C61,41BD5E57-29AE-41C8-96D7-2832C726E83B,140,1,WITH TUMOR,0.1489,0:LIVING,0.3,,48.72,Right,30,,,YES,859,2011,941,,TCGA-KK-A6E0.41BD5E57-29AE-41C8-96D7-2832C726E83B.pdf,Peripheral Zone,[Not Applicable],NO,11,71-80%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,,59,Core needle biopsy,941,,NO,YES,YES,YES,T3a,YES,9,No,YES,0,N0,T2b,0,M0,C61.9,8140/3,5499,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A6E1,,PRAD,315,0,0,,KK,0,0,MALE,0,3.55,0.66,9,14,7,ambiguous,NO,2198,1-ERG,2198,2198,,0,0,2198,2198,prad_tcga,Malignant,30,BRCA2;RAD51B,76,25.6,TCGA-KK-A6E1-01,0,0,0,TCGA-KK-A6E1,2198,2198,Prostate Cancer,,356,2198,2198,TCGA,,2198,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-21063,,57,9,31,PRAD,2198,2198,,0.0,[Not Available],[Not Applicable],28,RX,1,Matched,0.16,Prostate,Resection,4,96790C2C-2E6E-487F-A575-B9F1252CE972,6,Normal (no evidence of prostate cancer) [cM0],1,0.1725,[Not Available],DEB57BD8-545F-477A-9A86-6BC6DB257270,5,Prostate Adenocarcinoma Acinar Type,,Prostate,29,,Acinar Adenocarcinoma,[Not Available],,KK,0.933333333333,TCGA-KK-A6E1,0:DiseaseFree,5,34,Prostate Adenocarcinoma,72.21,3/28/14,2198,,,,,NO,C61,E8264E2D-E4BB-40BB-9305-18DDD777D664,250,10,TUMOR FREE,0.2188,0:LIVING,0.1,,72.21,Bilateral,41,No Evidence of Extraprostatic Extension,-24,YES,1598,2008,,,TCGA-KK-A6E1.E8264E2D-E4BB-40BB-9305-18DDD777D664.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,-24,61-70%,24,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,RX,,57,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,T2c,5,M0,C61.9,8140/3,5500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A6E2,,PRAD,315,0,0,,KK,0,0,MALE,0,1.99,0.86,2,3,1,HRP,NO,5024,1-ERG,5024,5024,,0,0,5024,5024,prad_tcga,Malignant,6,,28,6.7,TCGA-KK-A6E2-01,0,0,0,TCGA-KK-A6E2,5024,5024,Prostate Cancer,,438,5024,5024,TCGA,,5024,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-19974,,54,7,51,PRAD,5024,5024,,0.0,[Not Available],[Not Applicable],44,R0,1,Matched,0.04,Prostate,Resection,3,D92AF9ED-9E94-4E87-B19C-439F5A5AE616,0,,0,0.015779,[Not Available],56C88739-C076-42CC-A2CB-FD613AB567B5,4,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,KK,1.46666666667,TCGA-KK-A6E2,0:DiseaseFree,2,5,Prostate Adenocarcinoma,165.05,3/27/14,5024,,,,,NO,C61,84DBE486-DFA5-4FBC-BA8F-E10CC0247645,290,0,TUMOR FREE,0.0154,0:LIVING,0.1,,165.05,Bilateral,6,,,YES,4724,2000,,,TCGA-KK-A6E2.84DBE486-DFA5-4FBC-BA8F-E10CC0247645.pdf,Transition Zone,[Not Applicable],NO,,81-90%,5,Prostate Adenocarcinoma Acinar Type,1,2000,Complete Remission/Response,,NO,No,R0,,54,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5501,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A6E3,,PRAD,,0,0,,KK,,0,MALE,0,2.0,0.75,0,0,0,HRP,NO,2056,,,2056,,0,0,2056,2056,prad_tcga,Malignant,0,,5,,TCGA-KK-A6E3-01,0,0,0,TCGA-KK-A6E3,2056,2056,Prostate Cancer,,1065,,2056,TCGA,,2056,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20547,,56,7,39,PRAD,2056,2056,,0.0,[Not Available],[Not Applicable],44,,1,Matched,0.0,Prostate,Resection,3,F05CC604-E546-4231-8C07-E8E5D0746753,0,Normal (no evidence of prostate cancer) [cM0],0,0.000238,[Not Available],38A2B705-D8A4-45CA-8BCD-96DBF93D8E4D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,KK,1.46666666667,TCGA-KK-A6E3,0:DiseaseFree,2,0,Prostate Adenocarcinoma,67.54,3/27/14,2056,,,,,NO,C61,4796F9C1-49BD-411E-9D9B-D95001D76F53,140,0,TUMOR FREE,0.0003,0:LIVING,0.1,,67.54,Bilateral,0,,,YES,3355,2004,,,TCGA-KK-A6E3.4796F9C1-49BD-411E-9D9B-D95001D76F53.pdf,Transition Zone,[Not Applicable],NO,10,,3,Prostate Adenocarcinoma Acinar Type,1,2004,[Not Available],,NO,No,R0,,56,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5502,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-KK-A6E4,,PRAD,,0,0,,KK,2,2,MALE,2,1.92,0.82,5,6,1,HRD,NO,3502,,3502,3502,,2,2,3502,3502,prad_tcga,Malignant,12,BARD1;BRCA1;BRIP1;CDK12;FANCL;RAD51C;RAD51D;RAD54L,36,,TCGA-KK-A6E4-01,0,0,0,TCGA-KK-A6E4,3502,3502,Prostate Cancer,,890,3502,3502,TCGA,,3502,Primary,0,Apex|Middle|Base,A,,BRCA2,True,TUMOR FREE,Dead,-25338,3502,69,7,48,PRAD,3502,3502,,0.0,[Not Available],[Not Applicable],39,,1,Matched,0.06,Prostate,Resection,3,A1468DDD-3273-407F-AC8E-8ABF4B952FC1,0,,0,0.070622,[Not Available],DCF383D5-B25A-4EA9-A3F4-4D7EA5DDD9EF,4,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,1.33333333333,TCGA-KK-A6E4,,2,16,Prostate Adenocarcinoma,,3/27/14,,,,,,NO,C61,D4A30E0D-4829-4B4E-863A-DF2ACED85BE8,190,0,TUMOR FREE,0.1139,1:DECEASED,0.1,,115.05,Right,18,,,YES,3094,2004,,,TCGA-KK-A6E4.D4A30E0D-4829-4B4E-863A-DF2ACED85BE8.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2004,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,,NO,YES,YES,NO,T2b,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5503,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A6E5,,PRAD,315,0,0,,KK,0,0,MALE,0,1.9,0.61,7,11,4,ambiguous,NO,2073,8-other,2073,2073,,0,0,2073,2073,prad_tcga,Malignant,22,,97,9.4,TCGA-KK-A6E5-01,8,0,0,TCGA-KK-A6E5,2073,2073,Prostate Cancer,,1496,2073,2073,TCGA,,2073,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23144,,63,7,23,PRAD,2073,2073,,0.363771701,[Not Available],[Not Applicable],21,R0,1,Matched,0.09,Prostate,Resection,4,A0A82F7B-1761-4002-B494-3B0887292651,1,Normal (no evidence of prostate cancer) [cM0],0,0.096906,[Not Available],0FB599CE-5E10-4571-8160-4F5160791A3F,3,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,KK,0.7,TCGA-KK-A6E5,0:DiseaseFree,3,30,Prostate Adenocarcinoma,68.1,3/27/14,2073,,,,,NO,C61,CB009865-4D04-4135-B3F1-5FB473029B12,60,3,TUMOR FREE,0.0884,0:LIVING,0.1,,68.1,Bilateral,34,No Evidence of Extraprostatic Extension,-19,YES,1456,2009,,,TCGA-KK-A6E5.CB009865-4D04-4135-B3F1-5FB473029B12.pdf,Peripheral Zone,[Not Applicable],YES,-19,41-50%,27,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5504,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A6E6,,PRAD,315,0,0,,KK,,0,MALE,0,3.63,0.44,1,9,10,ambiguous,NO,3447,1-ERG,,3447,,0,0,3447,3447,prad_tcga,Malignant,20,CDK12;FANCL;RAD51D;RAD54L,21,10.3,TCGA-KK-A6E6-01,0,0,0,TCGA-KK-A6E6,3447,3447,Prostate Cancer,,3447,,3447,TCGA,,3447,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25320,,69,9,58,PRAD,3447,3447,,0.0,[Not Available],[Not Applicable],40,R0,1,Matched,0.24,Prostate,Resection,4,F3AE5486-0F79-48AA-B10E-352D36BD2AFD,9,,1,0.030562,[Not Available],E377F873-C0D1-4810-9F3D-E551723858E1,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,KK,1.36666666667,TCGA-KK-A6E6,0:DiseaseFree,5,23,Prostate Adenocarcinoma,113.24,3/27/14,3447,,,,,NO,C61,C67B882A-02B1-4511-B55C-87A33FC3E73E,50,11,TUMOR FREE,0.0436,0:LIVING,0.1,,113.24,Bilateral,29,,,YES,3813,2002,,,TCGA-KK-A6E6.C67B882A-02B1-4511-B55C-87A33FC3E73E.pdf,Peripheral Zone,[Not Applicable],NO,,61-70%,5,Prostate Adenocarcinoma Acinar Type,1,2002,[Not Available],,NO,No,R0,,69,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5505,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A6E7,,PRAD,,1,1,,KK,,0,MALE,1,3.8,0.57,3,3,3,ambiguous,NO,2760,,,2760,,1,1,925,925,prad_tcga,Malignant,9,BRCA2;PALB2,30,,TCGA-KK-A6E7-01,0,0,0,TCGA-KK-A6E7,925,925,Prostate Cancer,8,1847,,2760,TCGA,No Evidence of Extraprostatic Extension|Equivocal,925,Primary,0,Apex|Middle,A,,,True,WITH TUMOR,Alive,-17074,,46,9,37,PRAD,925,925,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.13,Prostate,Resection,5,B8852BA4-D41A-434D-9EC8-DC44961B6E77,5,Normal (no evidence of prostate cancer) [cM0],1,0.060156,[Not Available],25C669B3-4D4A-4142-A403-677BE8522875,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,KK,1.1,TCGA-KK-A6E7,1:Recurred/Progressed,5,10,Prostate Adenocarcinoma,30.39,3/27/14,2760,,Biochemical evidence of disease,,,YES,C61,8173D1A9-5564-4824-AFD6-2097B90F4008,40,6,WITH TUMOR,0.0965,0:LIVING,0.1,,90.67,Bilateral,16,No Evidence of Extraprostatic Extension,-45,YES,2151,2007,925,,TCGA-KK-A6E7.8173D1A9-5564-4824-AFD6-2097B90F4008.pdf,Transition Zone,[Not Applicable],YES,-46,,11,Prostate Adenocarcinoma Acinar Type,1,2007,Partial Remission/Response,,NO,No,R1,,46,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,T1c,1,M0,C61.9,8140/3,5506,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A6E8,,PRAD,,0,0,,KK,,0,MALE,0,2.14,0.84,5,14,4,HRD,NO,1770,,,1770,,0,0,1770,1770,prad_tcga,Malignant,23,BRCA2;CHEK1,108,,TCGA-KK-A6E8-01,11,0,0,TCGA-KK-A6E8,1770,1770,Prostate Cancer,104,1769,,1770,TCGA,No Evidence of Extraprostatic Extension,1770,Primary,1,Apex|Middle|Base,A,RAD54L:.:.:splice_region_variant,,True,TUMOR FREE,Alive,-25026,,68,9,49,PRAD,1770,1770,,0.23863741,[Not Available],[Not Applicable],49,,1,Matched,0.12,Prostate,Resection,4,EAA8850B-9A03-40C4-AB17-FE8B405B4FED,6,Normal (no evidence of prostate cancer) [cM0],0,0.094685,[Not Available],8990CE28-C671-4487-8DDA-864F0675BBB3,5,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,KK,1.6,TCGA-KK-A6E8,0:DiseaseFree,5,24,Prostate Adenocarcinoma,58.15,3/27/14,1770,,,,,YES,C61,3716A52E-E0B7-4FE0-AC2B-07F2F3A0D6AD,120,7,TUMOR FREE,0.2482,0:LIVING,0.1,,58.15,Bilateral,30,,,YES,2128,2007,,,TCGA-KK-A6E8.3716A52E-E0B7-4FE0-AC2B-07F2F3A0D6AD.pdf,Transition Zone,[Not Applicable],NO,97,,14,Prostate Adenocarcinoma Acinar Type,1,2007,[Not Available],,NO,No,RX,,68,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,9,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5507,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A7AP,,PRAD,348,0,0,,KK,,0,MALE,0,1.99,0.89,7,12,8,HRD,NO,196,2-ETV1,,196,,0,0,196,196,prad_tcga,Malignant,27,ATM;BARD1;BRCA1;BRCA2;CDK12;CHEK1;RAD51D,48,,TCGA-KK-A7AP-01,0,0,0,TCGA-KK-A7AP,196,196,Prostate Cancer,,,,196,TCGA,,196,Primary,0,Apex|Middle|Base,A,ATM:.:.:splice_region_variant,,True,,Alive,-20403,,55,9,48,PRAD,196,196,,0.0,[Not Available],[Not Applicable],42,,1,Matched,0.1,Prostate,Resection,4,9FB7AC6A-C6C6-48EC-93B8-E7B84AA58476,4,Normal (no evidence of prostate cancer) [cM0],0,0.1003,[Not Available],F4E9A9F9-263C-4CED-A8FB-6CB0FB088983,5,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,KK,1.4,TCGA-KK-A7AP,0:DiseaseFree,5,26,Prostate Adenocarcinoma,6.44,6/6/14,196,,,,,NO,C61,5B2E970F-CF58-4A8E-90FD-A1AA16C95142,160,4,,0.1799,0:LIVING,,,6.44,Right,28,,,YES,1130,2010,,,TCGA-KK-A7AP.5B2E970F-CF58-4A8E-90FD-A1AA16C95142.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,175,51-60%,15,Prostate Adenocarcinoma Acinar Type,1,2010,[Unknown],,,"Yes, History of Prior Malignancy",R1,,55,Core needle biopsy,,,NO,YES,YES,,T3b,,9,No,,0,N1,T2b,2,M0,C61.9,8140/3,5508,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-KK-A7AQ,,PRAD,,1,1,,KK,1,0,MALE,1,1.89,0.76,4,6,2,ambiguous,NO,1610,,1217,1610,,1,1,1217,1217,prad_tcga,Malignant,12,BARD1,212,,TCGA-KK-A7AQ-01,0,0,0,TCGA-KK-A7AQ,1217,1217,Prostate Cancer,38,1385,1217,1610,TCGA,No Evidence of Extraprostatic Extension,1217,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-22731,,62,7,36,PRAD,1217,1217,,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.03,Prostate,Resection,4,A3081D9D-25EB-41FD-8B77-A7FE9910865A,1,,0,0.11433,[Not Available],CECF4EE9-7610-4F47-A825-7FDE8233B75D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,KK,1.16666666667,TCGA-KK-A7AQ,1:Recurred/Progressed,3,13,Prostate Adenocarcinoma,39.98,8/19/14,1610,,Biochemical evidence of disease,,,YES,C61,D507BEE9-3883-4008-B07C-7F257C40AFF6,30,2,TUMOR FREE,0.1193,0:LIVING,0.1,5,52.89,Bilateral,18,,,YES,1066,2010,1217,,TCGA-KK-A7AQ.D507BEE9-3883-4008-B07C-7F257C40AFF6.pdf,Peripheral Zone,[Not Applicable],,,,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,62,Core needle biopsy,1217,Complete Remission/Response,NO,YES,YES,YES,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5509,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A7AU,,PRAD,331,1,1,,KK,,0,MALE,1,2.01,0.88,3,6,4,ambiguous,NO,1775,1-ERG,,1775,,1,1,207,207,prad_tcga,Malignant,13,,55,,TCGA-KK-A7AU-01,0,0,0,TCGA-KK-A7AU,207,207,Prostate Cancer,123,1621,,1775,TCGA,No Evidence of Extraprostatic Extension,207,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23118,,63,9,32,PRAD,207,207,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.02,Prostate,Resection,4,6BB295A8-D8F7-454E-8D7A-B4F12C32ED0C,2,,0,0.057082,[Not Available],39303E7C-5BAF-479D-A112-D8F03A18C621,5,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,KK,0.9,TCGA-KK-A7AU,1:Recurred/Progressed,5,13,Prostate Adenocarcinoma,6.8,8/28/14,1775,,Biochemical evidence of disease,,,YES,C61,4BA7AC63-6B00-44E3-9545-6A4836912B1E,120,5,TUMOR FREE,0.1196,0:LIVING,0.0,,58.31,Bilateral,16,,,YES,1266,2010,207,,TCGA-KK-A7AU.4BA7AC63-6B00-44E3-9545-6A4836912B1E.pdf,Peripheral Zone,[Not Applicable],NO,,51-60%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,R1,,63,Core needle biopsy,207,Progressive Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N1,T2b,3,M0,C61.9,8140/3,5510,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A7AV,,PRAD,331,0,0,,KK,0,0,MALE,0,2.03,0.35,4,6,3,ambiguous,NO,822,8-other,822,822,,0,0,822,822,prad_tcga,Malignant,13,,29,,TCGA-KK-A7AV-01,7,0,0,TCGA-KK-A7AV,822,822,Prostate Cancer,48,822,822,822,TCGA,No Evidence of Extraprostatic Extension,822,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-21192,,58,7,18,PRAD,822,822,,0.287876882,[Not Available],[Not Applicable],17,,1,Matched,0.07,Prostate,Resection,3,53EBD660-7F5D-433A-ACB7-4153F36484D0,2,,0,0.050405,[Not Available],BF462E14-F9E8-4531-905D-1FB59D9088CB,4,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,0.533333333333,TCGA-KK-A7AV,0:DiseaseFree,2,18,Prostate Adenocarcinoma,27.0,8/28/14,822,,,,,YES,C61,7C653DC8-83CE-42D9-A3D5-FA06CAFFF8EE,60,3,TUMOR FREE,0.0418,0:LIVING,0.1,,27.0,Bilateral,20,,,YES,587,2012,,,TCGA-KK-A7AV.7C653DC8-83CE-42D9-A3D5-FA06CAFFF8EE.pdf,Peripheral Zone,[Not Applicable],NO,,51-60%,23,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,RX,,58,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5511,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A7AW,,PRAD,,0,0,,KK,,0,MALE,0,2.0,0.75,1,4,2,HRP,NO,1054,,,1054,,0,0,1054,1054,prad_tcga,Malignant,7,BRCA2,22,,TCGA-KK-A7AW-01,0,0,0,TCGA-KK-A7AW,1054,1054,Prostate Cancer,,204,,1054,TCGA,,1054,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20869,,57,7,42,PRAD,1054,1054,,0.0,[Not Available],[Not Applicable],39,,1,Matched,0.04,Prostate,Resection,4,1854D2D5-95DA-4764-84C9-64E866B1B890,1,,0,0.020865,[Not Available],2F231B79-84BC-4256-BF26-7CE64083D438,3,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,KK,1.3,TCGA-KK-A7AW,0:DiseaseFree,3,9,Prostate Adenocarcinoma,34.63,8/19/14,1054,,,,,NO,C61,B5E8DF63-7C54-4D45-93ED-5C80075C63A5,60,1,TUMOR FREE,0.0705,0:LIVING,0.8,,34.63,Right,15,,11,YES,983,2010,,,TCGA-KK-A7AW.B5E8DF63-7C54-4D45-93ED-5C80075C63A5.pdf,Peripheral Zone,[Not Applicable],YES,,,9,Prostate Adenocarcinoma Acinar Type,1,2010,[Unknown],,YES,No,R0,,57,Core needle biopsy,204,,NO,YES,YES,,T3a,,7,No,,0,N1,T2a,1,M0,C61.9,8140/3,5512,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-KK-A7AY,,PRAD,,1,1,,KK,1,0,MALE,1,2.0,0.78,2,6,4,HRP,NO,1754,,1124,1754,,1,1,1124,1124,prad_tcga,Malignant,12,,51,,TCGA-KK-A7AY-01,0,0,0,TCGA-KK-A7AY,1124,1124,Prostate Cancer,,1572,1124,1754,TCGA,,1124,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-22220,,60,7,54,PRAD,1124,1124,,0.0,[Not Available],[Not Applicable],51,,1,Matched,0.01,Prostate,Resection,4,1A8A6D7F-863C-4EE0-8DBA-02EF52DC074A,0,,0,0.035296,[Not Available],F4AEBD64-A356-4C05-B847-6DD28CF26339,3,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,KK,1.7,TCGA-KK-A7AY,1:Recurred/Progressed,3,10,Prostate Adenocarcinoma,36.93,8/28/14,1754,,Biochemical evidence of disease,,,NO,C61,BA64AA42-00AD-4DAD-ABE7-BDDC253B9B45,110,1,TUMOR FREE,0.0642,0:LIVING,0.2,,57.62,Bilateral,13,,,YES,1246,2010,1124,,TCGA-KK-A7AY.BA64AA42-00AD-4DAD-ABE7-BDDC253B9B45.pdf,Peripheral Zone,[Not Applicable],NO,,,8,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,60,Core needle biopsy,1124,Complete Remission/Response,NO,YES,YES,YES,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A7AZ,,PRAD,,0,0,,KK,,0,MALE,0,2.02,0.87,2,5,3,ambiguous,NO,1519,,,1519,,0,0,1519,1519,prad_tcga,Malignant,10,,60,,TCGA-KK-A7AZ-01,6,0,0,TCGA-KK-A7AZ,1519,1519,Prostate Cancer,141,,,1519,TCGA,Equivocal,1519,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-20507,,56,7,41,PRAD,1519,1519,,0.161044334,[Not Available],[Not Applicable],39,,1,Matched,0.01,Prostate,Resection,4,CB9B0A6A-D09B-4EE9-B30E-E4DA3B6AC0AF,4,,0,0.051353,[Not Available],7D931C19-1FCE-4409-8A9C-9C65631CCBAC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,KK,1.3,TCGA-KK-A7AZ,0:DiseaseFree,3,9,Prostate Adenocarcinoma,49.9,8/19/14,1519,,,,,YES,C61,5DEA3530-6618-4A73-94C7-F23DA06DA52C,200,2,,0.1127,0:LIVING,,,49.9,Right,16,,,YES,1045,2010,,,TCGA-KK-A7AZ.5DEA3530-6618-4A73-94C7-F23DA06DA52C.pdf,Peripheral Zone,[Not Applicable],NO,,,14,Prostate Adenocarcinoma Acinar Type,1,2010,[Unknown],,,No,R0,,56,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T2b,0,,C61.9,8140/3,5514,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A7B0,,PRAD,,1,1,,KK,,0,MALE,1,1.96,0.31,6,8,0,ambiguous,NO,1329,,,1329,,1,1,606,606,prad_tcga,Malignant,14,,58,,TCGA-KK-A7B0-01,0,0,0,TCGA-KK-A7B0,606,606,Prostate Cancer,,999,,1329,TCGA,,606,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-24756,,67,9,46,PRAD,606,606,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,4,E93CC6CC-CE3B-45EB-8928-D5B13D7194AF,2,,0,0.093535,[Not Available],73D4E806-2C15-4C9E-A978-106FB9494E82,5,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,KK,1.06666666667,TCGA-KK-A7B0,1:Recurred/Progressed,5,15,Prostate Adenocarcinoma,19.91,8/28/14,1329,,Biochemical evidence of disease,,,NO,C61,A6F717F0-66D2-4AEB-88F6-1A95D26489BC,150,3,,0.1451,0:LIVING,0.1,,43.66,Bilateral,17,,,YES,783,2011,606,,TCGA-KK-A7B0.A6F717F0-66D2-4AEB-88F6-1A95D26489BC.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,17,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,R0,,67,Core needle biopsy,606,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5515,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A7B1,,PRAD,331,0,0,,KK,0,0,MALE,0,1.97,0.54,0,3,0,HRD,NO,1063,1-ERG,1063,1063,,0,0,1063,1063,prad_tcga,Malignant,3,,47,,TCGA-KK-A7B1-01,0,0,0,TCGA-KK-A7B1,1063,1063,Prostate Cancer,52,179,1063,1063,TCGA,No Evidence of Extraprostatic Extension,1063,Primary,0,Apex|Middle|Base,A,CHEK1:.:.:splice_region_variant,,True,,Alive,-23803,,65,7,22,PRAD,1063,1063,,0.0,[Not Available],[Not Applicable],27,R0,1,Matched,0.01,Prostate,Resection,4,F769B0D1-5736-4A74-A418-9D66A6BE5B75,0,,0,0.027501,[Not Available],7315BB0A-96A1-45AB-A704-B084D237CF5C,3,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,KK,0.9,TCGA-KK-A7B1,0:DiseaseFree,3,3,Prostate Adenocarcinoma,34.92,6/6/14,1063,,,,,YES,C61,F7802347-53BA-44B9-ACFE-7A10A014822B,110,0,,0.0261,0:LIVING,0.1,,34.92,Bilateral,6,,,YES,839,2011,,,TCGA-KK-A7B1.F7802347-53BA-44B9-ACFE-7A10A014822B.pdf,Peripheral Zone,[Not Applicable],NO,,51-60%,21,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5516,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A7B2,,PRAD,,1,1,,KK,,0,MALE,1,2.0,0.97,0,0,0,HRP,NO,1099,,,1099,,1,1,692,692,prad_tcga,Malignant,0,,8,,TCGA-KK-A7B2-01,0,0,0,TCGA-KK-A7B2,692,692,Prostate Cancer,,845,,1099,TCGA,,692,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-24845,,68,9,21,PRAD,692,692,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.06,Prostate,Resection,4,BCCB7F9D-8DDE-45B7-A50D-6C7233239CEB,0,Normal (no evidence of prostate cancer) [cM0],0,0.00015,[Not Available],000D566C-96C7-4F1C-B36E-FA2222467983,5,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,KK,0.866666666667,TCGA-KK-A7B2,1:Recurred/Progressed,5,1,Prostate Adenocarcinoma,22.73,6/6/14,1099,,Biochemical evidence of disease,,,NO,C61,9A37DFF6-CDD7-40DD-A6A6-3966BC4E275A,130,0,WITH TUMOR,0.0,0:LIVING,0.3,,36.1,Left,2,No Evidence of Extraprostatic Extension,58,YES,554,2012,692,,TCGA-KK-A7B2.9A37DFF6-CDD7-40DD-A6A6-3966BC4E275A.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,58,,13,Prostate Adenocarcinoma Acinar Type,1,2012,Stable Disease,,NO,No,R0,,68,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,T1c,1,M0,C61.9,8140/3,5517,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-KK-A7B3,,PRAD,348,1,1,,KK,1,0,MALE,1,3.92,0.5,3,8,1,HRD,NO,899,2-ETV1,294,899,,1,1,294,294,prad_tcga,Malignant,12,,38,,TCGA-KK-A7B3-01,0,0,0,TCGA-KK-A7B3,294,294,Prostate Cancer,112,637,294,899,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),294,Primary,0,Apex|Middle|Base,A,,CHEK2,True,TUMOR FREE,Alive,-22830,,62,9,48,PRAD,294,294,,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.0,Prostate,Resection,4,C9F3E6AE-A78D-4455-B3F3-FE9AC92596E0,1,,1,0.047741,[Not Available],AAEB1D59-D6CE-4422-9639-F1E83C002D84,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,1.16666666667,TCGA-KK-A7B3,1:Recurred/Progressed,5,13,Prostate Adenocarcinoma,9.66,8/28/14,899,,Biochemical evidence of disease,,,YES,C61,45C687C3-52B9-4035-B916-777128B9AAE0,220,4,TUMOR FREE,0.0843,0:LIVING,0.1,,29.53,Bilateral,16,,,YES,486,2012,294,,TCGA-KK-A7B3.45C687C3-52B9-4035-B916-777128B9AAE0.pdf,Peripheral Zone,[Not Applicable],NO,,91-100%,17,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,"Yes, History of Prior Malignancy",R0,,62,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,9,No,NO,0,N0,T3a,0,M0,C61.9,8140/3,5518,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A7B4,,PRAD,331,1,1,,KK,,0,MALE,1,1.9,0.72,6,8,3,ambiguous,NO,987,1-ERG,,987,,1,1,637,637,prad_tcga,Malignant,17,BRCA2;FANCL,71,,TCGA-KK-A7B4-01,0,0,0,TCGA-KK-A7B4,637,637,Prostate Cancer,29,637,,987,TCGA,Equivocal,637,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-23644,,64,9,46,PRAD,637,637,,0.0,[Not Available],[Not Applicable],26,,1,Matched,0.39,Prostate,Resection,4,F6E93A76-4E34-438A-9092-7B3E173E116C,3,Equivocal,0,0.14049,[Not Available],5447A0E0-80CA-40FB-8233-504FDE51F22C,5,Prostate Adenocarcinoma Acinar Type,,Prostate,17,,Acinar Adenocarcinoma,[Not Available],,KK,0.866666666667,TCGA-KK-A7B4,1:Recurred/Progressed,5,30,Prostate Adenocarcinoma,31.64,8/28/14,987,,Biochemical evidence of disease,,,YES,C61,19CE314A-B253-4F6F-9D77-37B33CFC6F2E,160,5,WITH TUMOR,0.204,0:LIVING,0.6,,32.42,Bilateral,32,,,YES,434,2012,637,,TCGA-KK-A7B4.19CE314A-B253-4F6F-9D77-37B33CFC6F2E.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,29,31-40%,20,Prostate Adenocarcinoma Acinar Type,1,2012,Stable Disease,,YES,"Yes, History of Prior Malignancy",R1,,64,Core needle biopsy,637,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,YES,0,N1,T3b,8,M0,C61.9,8140/3,5519,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A8I4,,PRAD,370,1,1,,KK,,0,MALE,1,2.35,0.4,7,9,12,ambiguous,NO,2259,1-ERG,,2259,,1,1,1162,1162,prad_tcga,Malignant,28,RAD51B,102,,TCGA-KK-A8I4-01,0,0,0,TCGA-KK-A8I4,1162,1162,Prostate Cancer,70,1964,,2259,TCGA,No Evidence of Extraprostatic Extension,1162,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-23706,,64,7,28,PRAD,1162,1162,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.25,Prostate,Resection,4,CF98AC7D-6791-4B38-9902-000464888F25,11,Normal (no evidence of prostate cancer) [cM0],0,0.17368,[Not Available],9A8CAEF5-6543-4391-8A55-4999035693C5,3,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,KK,0.8,TCGA-KK-A8I4,1:Recurred/Progressed,3,31,Prostate Adenocarcinoma,71.02,8/28/14,2259,Bone,Distant Metastasis,,,YES,C61,633E280A-24F4-49FF-95B8-DDA5F447480E,120,19,WITH TUMOR,0.1893,0:LIVING,0.2,5,74.21,Left,37,,,YES,1798,2008,1162,,TCGA-KK-A8I4.633E280A-24F4-49FF-95B8-DDA5F447480E.pdf,Peripheral Zone,[Not Applicable],NO,70,86-95%,15,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,NO,No,R0,,64,Core needle biopsy,1155,Progressive Disease,NO,YES,YES,YES,T3b,NO,7,No,NO,0,N1,T2c,1,M0,C61.9,8140/3,5520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8I5,,PRAD,370,0,0,,KK,0,0,MALE,0,1.91,0.85,2,9,2,HRD,NO,3096,1-ERG,3096,3096,,0,0,3096,3096,prad_tcga,Malignant,13,RAD54L,87,,TCGA-KK-A8I5-01,0,0,0,TCGA-KK-A8I5,3096,3096,Prostate Cancer,,1979,3096,3096,TCGA,,3096,Primary,0,Apex|Middle|Base,A,,RAD51B,True,TUMOR FREE,Alive,-20337,,55,7,49,PRAD,3096,3096,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.05,Prostate,Resection,3,2F653293-DC10-43BA-B4F0-A4BB54ADE176,0,,0,0.08479,[Not Available],7CE45134-5B1F-4EA7-ACE9-7E463B034A43,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,KK,1.1,TCGA-KK-A8I5,0:DiseaseFree,2,24,Prostate Adenocarcinoma,101.71,8/18/14,3096,,,,,NO,C61,CF19D931-B8BE-4978-8C08-081744230305,130,2,TUMOR FREE,0.1006,0:LIVING,0.1,,101.71,Right,24,,,YES,2717,2006,,,TCGA-KK-A8I5.CF19D931-B8BE-4978-8C08-081744230305.pdf,Peripheral Zone,[Not Applicable],NO,,66-75%,6,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,,55,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2b,NO,7,No,NO,0,N0,T2a,,M0,C61.9,8140/3,5521,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8I6,,PRAD,370,0,0,,KK,0,0,MALE,0,1.97,0.66,2,6,1,ambiguous,NO,668,1-ERG,668,668,,0,0,668,668,prad_tcga,Malignant,9,BRCA1;CDK12;RAD51D,28,,TCGA-KK-A8I6-01,0,0,0,TCGA-KK-A8I6,668,668,Prostate Cancer,17,668,668,668,TCGA,No Evidence of Extraprostatic Extension,668,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-21499,,58,7,39,PRAD,668,668,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.07,Prostate,Resection,4,57E0582E-44EF-4992-83EA-FF4CB63AF578,0,Normal (no evidence of prostate cancer) [cM0],0,0.043537,[Not Available],6E3154D4-2EF6-403D-9DE1-7B6233C4D505,3,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,KK,1.16666666667,TCGA-KK-A8I6,0:DiseaseFree,3,17,Prostate Adenocarcinoma,21.94,8/18/14,668,,,,,YES,C61,11107580-AAF3-4CE8-AC75-8636CE8C515E,170,2,TUMOR FREE,0.061,0:LIVING,0.2,,21.94,Bilateral,22,No Evidence of Extraprostatic Extension,-13,YES,808,2011,,,TCGA-KK-A8I6.11107580-AAF3-4CE8-AC75-8636CE8C515E.pdf,Peripheral Zone,[Not Applicable],YES,-14,86-95%,23,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,58,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5522,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A8I7,,PRAD,,1,1,,KK,,0,MALE,1,,,,,,ambiguous,NO,2002,,,2002,,1,1,1088,1088,prad_tcga,Malignant,,,,,TCGA-KK-A8I7-01,0,0,0,TCGA-KK-A8I7,1088,1088,Prostate Cancer,,1877,,2002,TCGA,,1088,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20256,,55,9,23,PRAD,1088,1088,,0.0,[Not Available],[Not Applicable],19,,1,Matched,,Prostate,Resection,4,2EF0DB46-EC9C-4886-90D2-B16389362529,,,,,[Not Available],108DEE1E-B27D-4056-A167-261725F548C1,5,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,KK,0.633333333333,TCGA-KK-A8I7,1:Recurred/Progressed,5,20,Prostate Adenocarcinoma,57.69,8/18/14,2002,,Biochemical evidence of disease,,,NO,C61,70BA9BA3-05E5-4B40-9D6A-BBECCAAADD81,150,,TUMOR FREE,0.0233,0:LIVING,0.1,,65.77,Bilateral,21,No Evidence of Extraprostatic Extension,24,YES,1634,2009,1088,,TCGA-KK-A8I7.70BA9BA3-05E5-4B40-9D6A-BBECCAAADD81.pdf,Peripheral Zone,[Not Applicable],YES,,,9,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,NO,No,R1,,55,Core needle biopsy,1088,Progressive Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5523,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8I8,,PRAD,370,0,0,,KK,0,0,MALE,0,2.02,0.73,5,2,5,HRP,NO,967,1-ERG,967,967,,0,0,967,967,prad_tcga,Malignant,12,ATM;CHEK1,49,,TCGA-KK-A8I8-01,0,0,0,TCGA-KK-A8I8,967,967,Prostate Cancer,31,757,967,967,TCGA,No Evidence of Extraprostatic Extension,967,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25546,,69,9,29,PRAD,967,967,,0.0,[Not Available],[Not Applicable],19,,1,Matched,0.0,Prostate,Resection,4,0C50F404-D92A-4D72-B085-A4D258B941B0,2,,0,0.064424,[Not Available],30FA311B-05A2-43E4-9EDC-02B327898132,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,0.633333333333,TCGA-KK-A8I8,0:DiseaseFree,5,13,Prostate Adenocarcinoma,31.77,8/18/14,967,,,,,YES,C61,EA62695C-65BD-4E4A-BB9D-0D1CC5B90636,110,4,TUMOR FREE,0.1017,0:LIVING,0.1,,31.77,Bilateral,13,,,YES,535,2012,,,TCGA-KK-A8I8.EA62695C-65BD-4E4A-BB9D-0D1CC5B90636.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,27,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,YES,9,No,NO,0,N0,T2a,,M0,C61.9,8140/3,5524,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-KK-A8I9,,PRAD,370,1,1,,KK,1,0,MALE,1,1.92,0.53,4,9,0,ambiguous,NO,1001,5-SPOP,940,1001,,1,1,940,940,prad_tcga,Malignant,13,BRCA2,44,,TCGA-KK-A8I9-01,15,0,0,TCGA-KK-A8I9,940,940,Prostate Cancer,0,721,940,1001,TCGA,No Evidence of Extraprostatic Extension,940,Primary,1,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-22295,,61,8,44,PRAD,940,940,,0.298928626,[Not Available],[Not Applicable],43,,1,Matched,0.11,Prostate,Resection,4,52FCF737-CDCC-43EA-B33C-4018039B42DD,0,Normal (no evidence of prostate cancer) [cM0],0,0.069919,[Not Available],261C3D74-706E-4751-BD15-8F3C1A402FF0,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,KK,1.46666666667,TCGA-KK-A8I9,1:Recurred/Progressed,4,25,Prostate Adenocarcinoma,30.88,8/18/14,1001,,Biochemical evidence of disease,,,YES,C61,D086A0A1-E06A-4B7E-B158-A5D04BCE06E1,50,1,TUMOR FREE,0.0643,0:LIVING,0.1,,32.88,Bilateral,27,No Evidence of Extraprostatic Extension,-3,YES,528,2012,940,,TCGA-KK-A8I9.D086A0A1-E06A-4B7E-B158-A5D04BCE06E1.pdf,Peripheral Zone,[Not Applicable],YES,0,66-75%,14,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,RX,,61,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,YES,8,No,YES,0,N0,T2b,,M0,C61.9,8140/3,5525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A8IA,,PRAD,370,0,0,,KK,,0,MALE,0,1.93,0.88,5,5,4,ambiguous,NO,1931,1-ERG,,1931,,0,0,1931,1931,prad_tcga,Malignant,14,BRCA1;BRIP1;CDK12;RAD51B;RAD51C;RAD51D;RAD54L,59,,TCGA-KK-A8IA-01,0,0,0,TCGA-KK-A8IA,1931,1931,Prostate Cancer,,1383,,1931,TCGA,,1931,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-25284,,69,9,45,PRAD,1931,1931,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.37,Prostate,Resection,4,7C6FE384-485C-423A-8F84-B8BC6C3100AD,1,Normal (no evidence of prostate cancer) [cM0],0,0.11039,[Not Available],17916C4E-FEBE-48C6-B475-AD29397425E8,5,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,KK,1.1,TCGA-KK-A8IA,0:DiseaseFree,5,15,Prostate Adenocarcinoma,63.44,8/18/14,1931,,,,,NO,C61,641BD2CD-8B57-49BB-A2E1-9EB78097B4D6,230,3,,0.2758,0:LIVING,0.1,,63.44,Bilateral,18,No Evidence of Extraprostatic Extension,26,YES,1665,2009,,,TCGA-KK-A8IA.641BD2CD-8B57-49BB-A2E1-9EB78097B4D6.pdf,Peripheral Zone,[Not Applicable],YES,26,86-95%,19,Prostate Adenocarcinoma Acinar Type,1,2009,[Unknown],,NO,No,RX,,69,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,YES,0,N1,T3b,3,M0,C61.9,8140/3,5526,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A8IB,,PRAD,370,0,0,,KK,,0,MALE,0,4.04,0.59,0,15,3,HRD,NO,83,6-FOXA1,,83,,0,0,83,83,prad_tcga,Malignant,18,CHEK1,11,,TCGA-KK-A8IB-01,11,0,0,TCGA-KK-A8IB,83,83,Prostate Cancer,,,,83,TCGA,,83,Primary,1,Apex|Middle|Base,A,,BRCA2,True,,Alive,-24041,,65,9,57,PRAD,83,83,,0.204947119,[Not Available],[Not Applicable],45,R0,1,Matched,0.1,Prostate,Resection,4,2CC1817C-7EE6-4A0D-ABD4-DC8712F88CF1,7,,1,0.000543,[Not Available],88705B03-AA27-45C5-BEF0-BB697799F9DF,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,KK,1.46666666667,TCGA-KK-A8IB,0:DiseaseFree,5,26,Prostate Adenocarcinoma,2.73,8/19/14,83,,,,,NO,C61,B9FBCA1B-CAEB-48A1-87B8-C873AC07FD8B,360,7,,0.2666,0:LIVING,,,2.73,Bilateral,31,,,YES,338,2012,,,TCGA-KK-A8IB.B9FBCA1B-CAEB-48A1-87B8-C873AC07FD8B.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,21,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,"Yes, History of Prior Malignancy",R0,,65,Core needle biopsy,,,NO,YES,YES,,T3a,,9,No,,0,N0,T2a,,M0,C61.9,8140/3,5527,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A8IC,,PRAD,370,1,1,,KK,,0,MALE,1,1.88,0.35,11,8,7,ambiguous,NO,2051,1-ERG,,2051,,1,1,1060,1060,prad_tcga,Malignant,26,CDK12;RAD51B;RAD51D,81,,TCGA-KK-A8IC-01,0,0,0,TCGA-KK-A8IC,1060,1060,Prostate Cancer,,2047,,2051,TCGA,,1060,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-19902,,54,9,24,PRAD,1060,1060,,0.0,[Not Available],[Not Applicable],19,,1,Matched,0.08,Prostate,Resection,4,E9774C52-8772-4F54-82A9-137E2CCD4650,5,Normal (no evidence of prostate cancer) [cM0],0,0.15986,[Not Available],70C6C3A0-B422-4541-A60F-355356A9A340,5,Prostate Adenocarcinoma Acinar Type,,Prostate,24,,Acinar Adenocarcinoma,[Not Available],,KK,0.7,TCGA-KK-A8IC,1:Recurred/Progressed,5,26,Prostate Adenocarcinoma,34.82,8/28/14,2051,,Biochemical evidence of disease,,,NO,C61,D11CB264-3D9E-49ED-85AA-57E4A26A5ED1,140,5,WITH TUMOR,0.1252,0:LIVING,0.9,,67.38,Bilateral,29,No Evidence of Extraprostatic Extension,6,YES,1784,2008,1060,,TCGA-KK-A8IC.D11CB264-3D9E-49ED-85AA-57E4A26A5ED1.pdf,Peripheral Zone,[Not Applicable],YES,7,86-95%,38,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,YES,No,R0,,54,Core needle biopsy,1060,Progressive Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,5528,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8ID,,PRAD,370,0,0,,KK,0,0,MALE,0,2.27,0.66,1,6,7,HRD,NO,2107,8-other,2107,2107,,0,0,2107,2107,prad_tcga,Malignant,14,,33,,TCGA-KK-A8ID-01,0,0,0,TCGA-KK-A8ID,2107,2107,Prostate Cancer,,1924,2107,2107,TCGA,,2107,Primary,0,Apex|Middle|Base,A,CDK12:1003:L/X:frameshift_variant,,True,TUMOR FREE,Alive,-25851,,70,9,78,PRAD,2107,2107,,0.0,[Not Available],[Not Applicable],56,,1,Matched,0.08,Prostate,Resection,5,ECB5E501-1682-4DAB-988D-70B8F01C470F,2,Normal (no evidence of prostate cancer) [cM0],0,0.01336,[Not Available],717C0FD3-527B-4D5E-A9AB-0F141FCC84E8,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,KK,1.83333333333,TCGA-KK-A8ID,0:DiseaseFree,5,15,Prostate Adenocarcinoma,69.22,8/18/14,2107,,,,,NO,C61,51303D5A-8963-4A4E-8A30-8EB0CA6D9437,160,1,TUMOR FREE,0.2165,0:LIVING,0.1,,69.22,Bilateral,19,No Evidence of Extraprostatic Extension,-5,YES,1717,2009,,,TCGA-KK-A8ID.51303D5A-8963-4A4E-8A30-8EB0CA6D9437.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,43,86-95%,19,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,,70,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,9,No,YES,0,N1,T2b,2,M0,C61.9,8140/3,5529,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A8IF,,PRAD,370,1,1,,KK,,0,MALE,1,2.14,0.97,7,14,3,ambiguous,NO,804,5-SPOP,,804,,1,1,648,648,prad_tcga,Malignant,24,ATM;BRCA2,198,,TCGA-KK-A8IF-01,0,0,0,TCGA-KK-A8IF,648,648,Prostate Cancer,522,788,,804,TCGA,No Evidence of Extraprostatic Extension,648,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-20888,,57,7,43,PRAD,648,648,,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.14,Prostate,Resection,4,41E46BCF-B8FD-46CA-960E-F80E8F75EA42,9,,0,0.10226,[Not Available],3F5270A2-3284-4523-BD81-54FC98C2B933,3,Prostate Adenocarcinoma Acinar Type,,Prostate,26,,Acinar Adenocarcinoma,[Not Available],,KK,1.0,TCGA-KK-A8IF,1:Recurred/Progressed,3,32,Prostate Adenocarcinoma,21.29,8/18/14,804,,Biochemical evidence of disease,,,YES,C61,BF56F683-5D52-4154-B9D4-1B6D2608C5AA,160,7,WITH TUMOR,0.2874,0:LIVING,0.7,,26.41,Bilateral,36,,,YES,2351,2007,648,,TCGA-KK-A8IF.BF56F683-5D52-4154-B9D4-1B6D2608C5AA.pdf,Transition Zone,[Not Applicable],NO,,91-100%,33,Prostate Adenocarcinoma Acinar Type,1,2007,[Unknown],,YES,No,R0,,57,Core needle biopsy,648,,NO,YES,YES,YES,T3a,,7,No,,0,N0,T2a,,M0,C61.9,8140/3,5530,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8IG,,PRAD,370,0,0,,KK,0,0,MALE,0,1.92,0.69,7,5,5,HRD,NO,2505,6-FOXA1,2505,2505,,0,0,2505,2505,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;CHEK2;PALB2;RAD51C;RAD51D;RAD54L,72,,TCGA-KK-A8IG-01,0,0,0,TCGA-KK-A8IG,2505,2505,Prostate Cancer,,2211,2505,2505,TCGA,,2505,Primary,0,Apex|Middle,A,ATM:698:S/X:frameshift_variant,,True,TUMOR FREE,Alive,-20266,,55,7,41,PRAD,2505,2505,,0.0,[Not Available],[Not Applicable],36,,1,Matched,0.24,Prostate,Resection,4,C62DECAC-3413-4414-89DF-43085C3DDF65,5,Normal (no evidence of prostate cancer) [cM0],0,0.13738,[Not Available],1E3C1D8F-B3C9-47BE-89E4-22E6B16ED2AE,3,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,KK,1.2,TCGA-KK-A8IG,0:DiseaseFree,3,21,Prostate Adenocarcinoma,82.29,8/19/14,2505,,,,,NO,C61,D1F786EC-03F5-458B-99AC-3B89EFFF2297,60,5,TUMOR FREE,0.2051,0:LIVING,0.1,,82.29,Bilateral,22,No Evidence of Extraprostatic Extension,63,YES,2057,2008,,,TCGA-KK-A8IG.D1F786EC-03F5-458B-99AC-3B89EFFF2297.pdf,Transition Zone,[Not Applicable],YES,63,76-85%,19,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,,55,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T2a,,M0,C61.9,8140/3,5531,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A8IJ,,PRAD,357,0,0,,KK,,0,MALE,1,1.96,0.57,2,2,2,HRP,NO,1559,8-other,,1559,,0,0,307,307,prad_tcga,Malignant,6,,49,,TCGA-KK-A8IJ-01,0,0,0,TCGA-KK-A8IJ,1559,1559,Prostate Cancer,,167,,1559,TCGA,,307,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-21793,,59,7,36,PRAD,1559,1559,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.02,Prostate,Resection,4,F7C861D9-0AA5-4337-BABA-DCCBF6A5FA6C,1,Normal (no evidence of prostate cancer) [cM0],0,0.037395,[Not Available],98A9CE0E-4F02-4819-BC0C-C1A8D34E3DB6,3,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,KK,1.0,TCGA-KK-A8IJ,1:Recurred/Progressed,3,11,Prostate Adenocarcinoma,10.09,8/19/14,1559,"Other, specify",New Primary Tumor,,,NO,C61,F224443D-410F-4F1E-9CA0-04A652985616,240,2,,0.036,0:LIVING,0.1,5,51.22,Bilateral,13,No Evidence of Extraprostatic Extension,42,YES,1749,2009,307,Melanoma in situ of the right midback,TCGA-KK-A8IJ.F224443D-410F-4F1E-9CA0-04A652985616.pdf,Peripheral Zone,[Not Applicable],YES,42,76-85%,34,Prostate Adenocarcinoma Acinar Type,1,2009,[Unknown],,NO,No,R0,,59,Core needle biopsy,,,NO,YES,YES,YES,T3b,,7,No,,0,N1,T3a,1,M0,C61.9,8140/3,5534,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8IK,,PRAD,370,0,0,,KK,0,0,MALE,0,4.06,0.96,8,12,11,ambiguous,NO,2052,5-SPOP,2052,2052,,0,0,2052,2052,prad_tcga,Malignant,31,ATM;BARD1;CHEK1;RAD54L,47,,TCGA-KK-A8IK-01,0,0,0,TCGA-KK-A8IK,2052,2052,Prostate Cancer,,,2052,2052,TCGA,,2052,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20594,,56,9,47,PRAD,2052,2052,,0.0,[Not Available],[Not Applicable],31,,1,Matched,0.17,Prostate,Resection,4,A3A4C83F-C775-4C69-9179-A726379E0FB2,14,Abnormal (not related to prostate cancer),1,0.11161,[Not Available],D4F4DDC1-CFD7-4C57-ADE6-4F32CB7FFD85,5,Prostate Adenocarcinoma Acinar Type,,Prostate,35,,Acinar Adenocarcinoma,[Not Available],,KK,1.03333333333,TCGA-KK-A8IK,0:DiseaseFree,5,39,Prostate Adenocarcinoma,67.41,8/28/14,2052,,,,,NO,C61,CBFE7CBE-890E-4749-9566-0CE41A93D69D,80,17,TUMOR FREE,0.4633,0:LIVING,0.0,,67.41,Bilateral,46,No Evidence of Extraprostatic Extension,-69,YES,1759,2008,,,TCGA-KK-A8IK.CBFE7CBE-890E-4749-9566-0CE41A93D69D.pdf,Peripheral Zone,[Not Applicable],YES,-69,86-95%,6,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,,56,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,5535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-KK-A8IL,,PRAD,370,0,0,,KK,,,MALE,2,1.99,0.66,1,1,0,HRP,NO,628,8-other,,628,,2,2,628,628,prad_tcga,Malignant,2,,8,,TCGA-KK-A8IL-01,0,0,0,TCGA-KK-A8IL,628,628,Prostate Cancer,87,144,,628,TCGA,No Evidence of Extraprostatic Extension,628,Primary,0,Apex|Middle|Base,A,,,True,,Dead,-23849,628,65,9,44,PRAD,628,628,,0.0,[Unknown],[Not Applicable],28,R1,1,Matched,0.0,Prostate,Resection,4,734195FB-0C2A-44A9-8698-ADD1A5CAA9A0,0,,0,0.010273,[Not Available],2A51E1C2-8A8F-4DF3-BCC6-7DF94A47D94D,5,Prostate Adenocarcinoma Acinar Type,,Prostate,2,,Acinar Adenocarcinoma,[Not Available],,KK,0.933333333333,TCGA-KK-A8IL,,5,5,Prostate Adenocarcinoma,,8/19/14,,,,,Medical Record,YES,C61,9F54DC02-35C0-4D0E-A1D8-63F820CF72C4,60,0,,0.0166,1:DECEASED,0.1,,20.63,Bilateral,7,No Evidence of Extraprostatic Extension,7,YES,1420,2009,,,TCGA-KK-A8IL.9F54DC02-35C0-4D0E-A1D8-63F820CF72C4.pdf,Peripheral Zone,[Not Applicable],YES,,86-95%,8,Prostate Adenocarcinoma Acinar Type,1,2009,[Unknown],,NO,No,R1,,65,Core needle biopsy,,,NO,YES,YES,,T3b,,9,No,,0,N1,T1c,1,M0,C61.9,8140/3,5536,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8IM,,PRAD,,0,0,,KK,0,0,MALE,0,,,,,,HRP,NO,1915,,1915,1915,,0,0,1915,1915,prad_tcga,Malignant,,,,,TCGA-KK-A8IM-01,0,0,0,TCGA-KK-A8IM,1915,1915,Prostate Cancer,,1438,1915,1915,TCGA,,1915,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20425,,55,7,33,PRAD,1915,1915,,0.0,[Not Available],[Not Applicable],30,,1,Matched,,Prostate,Resection,4,CBC53357-B90E-459C-AD5D-B9457084E2E7,,,,,[Not Available],4434864A-8A0D-488E-B9A7-6749719663E5,3,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,KK,1.03333333333,TCGA-KK-A8IM,0:DiseaseFree,3,12,Prostate Adenocarcinoma,62.91,8/18/14,1915,,,,,NO,C61,C0D3148F-A371-4983-9E62-DA5446385173,60,,TUMOR FREE,0.0571,0:LIVING,0.1,,62.91,Bilateral,14,,,YES,1466,2009,,,TCGA-KK-A8IM.C0D3148F-A371-4983-9E62-DA5446385173.pdf,Peripheral Zone,[Not Applicable],NO,,,5,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,55,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T2a,,M0,C61.9,8140/3,5537,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-M7-A71Y,,PRAD,331,0,0,,M7,0,0,MALE,0,1.95,0.19,3,2,2,HRP,NO,493,2-ETV1,493,493,,0,0,493,493,prad_tcga,Malignant,7,CHEK2,23,,TCGA-M7-A71Y-01,0,0,0,TCGA-M7-A71Y,493,493,Prostate Cancer,,158,493,493,TCGA,,493,Primary,0,Apex|Middle|Base,A,,,False,TUMOR FREE,Alive,-20357,,55,7,23,PRAD,493,493,,0.0,[Not Available],[Not Applicable],22,R0,1,Matched,0.03,Prostate,Resection,3,6C728891-8924-4A51-B3ED-F4B83D6C8DE4,2,,0,0.064241,[Not Available],1583AEA0-5D69-4165-9BEF-D5BFDDDF3A65,4,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,M7,0.7,TCGA-M7-A71Y,0:DiseaseFree,2,0,Prostate Adenocarcinoma,16.2,12/10/13,493,,,,,NO,C61,569825C5-98D3-4A52-AD1D-2859F8F54A34,140,4,TUMOR FREE,0.0,0:LIVING,,,16.2,Bilateral,1,,,YES,183,2013,,,TCGA-M7-A71Y.569825C5-98D3-4A52-AD1D-2859F8F54A34.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,41-50%,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,55,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,T1c,,,C61.9,8140/3,5538,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-M7-A71Z,,PRAD,,0,0,,M7,0,0,MALE,0,1.95,0.9,2,1,3,HRP,NO,643,,643,643,,0,0,643,643,prad_tcga,Malignant,6,CHEK2,62,,TCGA-M7-A71Z-01,0,0,0,TCGA-M7-A71Z,643,643,Prostate Cancer,,209,643,643,TCGA,,643,Primary,0,Apex|Base,A,,,False,TUMOR FREE,Alive,-22785,,62,7,33,PRAD,643,643,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.02,Prostate,Resection,4,37E9C5A5-4C5D-41F9-B14D-12337432CACA,1,,0,0.051821,[Not Available],4D5D61C4-2E64-422E-ABA6-EC098F40EEEC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,4,,Acinar Adenocarcinoma,[Not Available],,M7,1.1,TCGA-M7-A71Z,0:DiseaseFree,3,5,Prostate Adenocarcinoma,21.12,12/10/13,643,,,,,NO,C61,5F9BC119-B8E9-4C05-8A34-AA8E79C490B6,160,2,TUMOR FREE,0.0483,0:LIVING,,,21.12,Right,8,,,YES,136,2013,,,TCGA-M7-A71Z.5F9BC119-B8E9-4C05-8A34-AA8E79C490B6.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,9,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,62,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T2a,0,,C61.9,8140/3,5539,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-M7-A720,,PRAD,331,0,0,,M7,0,0,MALE,0,2.0,0.94,0,0,0,HRP,NO,384,1-ERG,384,384,,0,0,384,384,prad_tcga,Malignant,0,,12,,TCGA-M7-A720-01,0,0,0,TCGA-M7-A720,384,384,Prostate Cancer,,302,384,384,TCGA,,384,Primary,0,Middle|Base,A,,,False,TUMOR FREE,Alive,-19642,,53,6,12,PRAD,384,384,,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,0.0,Prostate,Resection,3,E325C4BE-1952-49C8-88F1-B53C8DFCFB8E,0,,0,0.0040347,[Not Available],444E78F7-1221-4882-ADE2-7E45D828EA2A,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,M7,1.03333333333,TCGA-M7-A720,0:DiseaseFree,1,0,Prostate Adenocarcinoma,12.61,12/10/13,384,,,,,NO,C61,65D5D425-D41A-4E98-AA86-119F3BE1D3CE,130,0,TUMOR FREE,0.0,0:LIVING,,,12.61,Bilateral,2,,,YES,190,2013,,,TCGA-M7-A720.65D5D425-D41A-4E98-AA86-119F3BE1D3CE.pdf,Peripheral Zone,[Not Applicable],NO,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,53,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,6,No,NO,0,,T1c,,,C61.9,8140/3,5540,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-M7-A721,,PRAD,331,0,0,,M7,0,0,MALE,0,1.87,0.24,4,10,0,ambiguous,NO,400,8-other,400,400,,0,0,400,400,prad_tcga,Malignant,14,,42,,TCGA-M7-A721-01,15,0,0,TCGA-M7-A721,400,400,Prostate Cancer,-8,162,400,400,TCGA,No Evidence of Extraprostatic Extension,400,Primary,1,Apex|Middle|Base,A,,,False,TUMOR FREE,Alive,-25585,,70,7,37,PRAD,400,400,,0.350601438,[Not Available],[Not Applicable],36,R1,1,Matched,0.12,Prostate,Resection,3,16410934-A686-4DBD-9086-BC060135F0B4,0,Normal (no evidence of prostate cancer) [cM0],0,0.097102,[Not Available],6433F001-DB5C-476B-83C7-23F4C5397AE9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,M7,1.2,TCGA-M7-A721,0:DiseaseFree,2,20,Prostate Adenocarcinoma,13.14,12/10/13,400,,,,,YES,C61,357FE07A-B561-44BF-B59B-811F77C1F634,120,2,TUMOR FREE,0.0558,0:LIVING,,,13.14,Bilateral,21,,,YES,276,2012,,,TCGA-M7-A721.357FE07A-B561-44BF-B59B-811F77C1F634.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,-8,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8140/3,5541,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-M7-A722,,PRAD,,1,1,,M7,,0,MALE,1,1.95,0.88,3,6,0,HRP,NO,1060,,,1060,,1,1,559,559,prad_tcga,Malignant,9,,38,,TCGA-M7-A722-01,5,0,0,TCGA-M7-A722,559,559,Prostate Cancer,,559,,1060,TCGA,,559,Primary,0,,A,,,False,TUMOR FREE,Alive,-23880,,65,8,39,PRAD,559,559,,0.157045962,[Not Available],[Not Applicable],36,,1,Matched,0.0,Prostate,Resection,4,AB7BF9EF-55F2-41FA-BDB1-F7B7C79B9A48,0,Normal (no evidence of prostate cancer) [cM0],0,0.055324,[Not Available],3FA3CFFE-40F1-4853-9CBB-54A99FFD6108,4,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,M7,1.2,TCGA-M7-A722,1:Recurred/Progressed,4,10,Prostate Adenocarcinoma,18.36,3/27/14,1060,,Biochemical evidence of disease,,,NO,C61,4D0EE4BC-69EC-45D2-8739-24E1FE1A526A,190,2,WITH TUMOR,0.0523,0:LIVING,,3,34.82,Bilateral,13,No Evidence of Extraprostatic Extension,3,YES,577,2011,559,,TCGA-M7-A722.4D0EE4BC-69EC-45D2-8739-24E1FE1A526A.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,3,,4,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,YES,No,R1,,65,Core needle biopsy,559,Partial Remission/Response,YES,NO,YES,YES,T3a,NO,8,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5542,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-M7-A723,,PRAD,,0,0,,M7,0,0,MALE,0,,,,,,,NO,763,,763,763,,0,0,763,763,prad_tcga,Malignant,,,,,TCGA-M7-A723-01,0,0,0,TCGA-M7-A723,763,763,Prostate Cancer,,62,763,763,TCGA,,763,Primary,0,Apex|Middle|Base,A,,,False,TUMOR FREE,Alive,-20064,,54,7,7,PRAD,763,763,,0.0,[Not Available],[Not Applicable],5,,1,Matched,,Prostate,Resection,4,680C945D-7BFF-47A6-A520-9AAA677FA7ED,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],E27BC39B-54F1-47B5-AC8F-3245DCE690F4,3,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,M7,0.166666666667,TCGA-M7-A723,0:DiseaseFree,3,,Prostate Adenocarcinoma,25.07,12/10/13,763,,,,,NO,C61,8F42420C-A513-4A6A-A89F-B5C9303FBF59,150,,TUMOR FREE,0.0001,0:LIVING,0.1,5,25.07,Bilateral,,No Evidence of Extraprostatic Extension,11,YES,442,2012,,,TCGA-M7-A723.8F42420C-A513-4A6A-A89F-B5C9303FBF59.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,8,,17,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,54,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3b,YES,7,No,YES,0,N1,T1c,1,M0,C61.9,8140/3,5543,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-M7-A724,,PRAD,,0,0,,M7,,0,MALE,0,2.01,0.97,3,9,3,HRP,NO,889,,,889,,0,0,889,889,prad_tcga,Malignant,15,,269,,TCGA-M7-A724-01,0,0,0,TCGA-M7-A724,889,889,Prostate Cancer,,483,,889,TCGA,,889,Primary,0,Apex|Base,A,,,False,WITH TUMOR,Alive,-23595,,64,8,37,PRAD,889,889,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.0,Prostate,Resection,4,8910606C-191E-4973-8C8B-F34E90198DCA,2,Abnormal (not related to prostate cancer),0,0.0911,[Not Available],F8B98552-AE2A-4609-9929-7864485B3C51,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,M7,1.16666666667,TCGA-M7-A724,0:DiseaseFree,4,11,Prostate Adenocarcinoma,29.2,12/10/13,889,,,,,NO,C61,AF3AE21A-2D5F-4769-B438-C42415A47330,160,3,WITH TUMOR,0.1325,0:LIVING,,,29.2,Right,14,No Evidence of Extraprostatic Extension,35,YES,351,2012,,,TCGA-M7-A724.AF3AE21A-2D5F-4769-B438-C42415A47330.pdf,Peripheral Zone,[Not Applicable],YES,11,,7,Prostate Adenocarcinoma Acinar Type,1,2012,Progressive Disease,,NO,No,R1,,64,Core needle biopsy,,Progressive Disease,YES,NO,YES,NO,T3a,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5544,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MG-AAMC,,PRAD,,0,0,,MG,0,0,MALE,0,1.94,0.79,5,1,4,HRP,NO,173,,173,173,,0,0,173,173,prad_tcga,Malignant,10,BRCA1;CDK12,62,,TCGA-MG-AAMC-01,0,0,0,TCGA-MG-AAMC,173,173,Prostate Cancer,,54,173,173,TCGA,,173,Primary,0,,A,,,True,TUMOR FREE,Alive,-21846,,59,9,28,PRAD,173,173,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.03,Prostate,Resection,4,ACA72F05-77B0-4BF3-AA43-ED10C3898C9F,3,,0,0.066859,[Not Available],9C8447AC-5B26-4558-8BFD-F0E7046C1FB9,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,MG,0.933333333333,TCGA-MG-AAMC,0:DiseaseFree,5,11,Prostate Adenocarcinoma,5.68,7/28/14,173,,,,,,C61,CBC765C1-9191-4A40-979F-CF2434B10CAB,40,3,TUMOR FREE,0.0697,0:LIVING,0.01,3,5.68,,15,,,YES,278,2013,,,TCGA-MG-AAMC.CBC765C1-9191-4A40-979F-CF2434B10CAB.pdf,,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,,NO,T3a,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,5546,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MG-AAMC,,PRAD,,0,0,,MG,0,0,MALE,0,1.94,0.79,5,1,4,HRP,NO,173,,173,173,,0,0,173,173,prad_tcga,Malignant,10,BRCA1;CDK12,62,,TCGA-MG-AAMC-01,0,5546,0,TCGA-MG-AAMC,173,173,Prostate Cancer,,54,173,173,TCGA,,173,Primary,0,,A,,,True,TUMOR FREE,Alive,-21846,,59,9,28,PRAD,173,173,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.03,Prostate,Resection,4,ACA72F05-77B0-4BF3-AA43-ED10C3898C9F,3,,0,0.066859,[Not Available],9C8447AC-5B26-4558-8BFD-F0E7046C1FB9,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,MG,0.933333333333,TCGA-MG-AAMC,0:DiseaseFree,5,11,Prostate Adenocarcinoma,5.68,7/28/14,173,,,,,,C61,CBC765C1-9191-4A40-979F-CF2434B10CAB,40,3,TUMOR FREE,0.0697,0:LIVING,0.01,3,5.68,,15,,,YES,278,2013,,,TCGA-MG-AAMC.CBC765C1-9191-4A40-979F-CF2434B10CAB.pdf,,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,,NO,T3a,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,5547,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-QU-A6IL,,PRAD,,0,0,,QU,0,0,MALE,0,1.98,0.84,3,6,2,HRD,NO,97,,97,97,,0,0,97,97,prad_tcga,Malignant,11,,170,,TCGA-QU-A6IL-01,5,0,0,TCGA-QU-A6IL,97,97,Prostate Cancer,,91,97,97,TCGA,,97,Primary,0,Apex|Middle|Base,A,,RAD54L,True,TUMOR FREE,Alive,-23710,,64,7,40,PRAD,97,97,,0.138780517,[Not Available],[Not Applicable],26,,1,Matched,0.02,Prostate,Resection,3,94767B66-4586-4595-BE8F-50B5FD6337DA,2,,0,0.083854,[Not Available],DFFC3917-BF06-4C3D-B03A-CA54FE5C2E79,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,QU,0.833333333333,TCGA-QU-A6IL,0:DiseaseFree,2,11,Prostate Adenocarcinoma,3.19,8/21/13,97,,,,,,C61,EF13AC98-FA7C-442C-A6A4-A5E7ECB2596D,,3,TUMOR FREE,0.1072,0:LIVING,0.2,,3.19,Bilateral,14,,,YES,4048,2002,,,TCGA-QU-A6IL.EF13AC98-FA7C-442C-A6A4-A5E7ECB2596D.pdf,,[Not Applicable],,,,4,Prostate Adenocarcinoma Acinar Type,1,2002,Complete Remission/Response,,NO,No,R0,,64,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5548,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-QU-A6IM,,PRAD,,0,0,,QU,0,0,MALE,0,2.01,0.58,5,7,2,ambiguous,NO,1247,,1247,1247,,0,0,1247,1247,prad_tcga,Malignant,14,,83,,TCGA-QU-A6IM-01,0,0,0,TCGA-QU-A6IM,1247,1247,Prostate Cancer,35,896,1247,1247,TCGA,No Evidence of Extraprostatic Extension,1247,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-21792,,59,7,83,PRAD,1247,1247,,0.0,[Not Available],[Not Applicable],70,,1,Matched,0.01,Prostate,Resection,3,9FEA5DA6-9E5C-4DB2-ADFC-62D22469C80C,1,Equivocal,0,0.061435,[Not Available],D1B31524-8034-4FCE-B14E-1CEF33C26CA5,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,QU,2.36666666667,TCGA-QU-A6IM,0:DiseaseFree,2,13,Prostate Adenocarcinoma,40.97,8/21/13,1247,,,,,YES,C61,6999B5F3-AC5C-4447-9590-548F103039C3,40,3,,0.0852,0:LIVING,0.1,,40.97,Left,16,Equivocal,50,YES,3796,2003,,,TCGA-QU-A6IM.6999B5F3-AC5C-4447-9590-548F103039C3.pdf,,[Not Applicable],YES,35,,2,Prostate Adenocarcinoma Acinar Type,1,2003,Complete Remission/Response,,NO,"Yes, History of Prior Malignancy",R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2a,NO,7,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-QU-A6IN,,PRAD,,0,0,,QU,0,0,MALE,0,1.96,0.81,3,6,2,HRD,NO,4264,,4264,4264,,0,0,4264,4264,prad_tcga,Malignant,11,,34,,TCGA-QU-A6IN-01,0,0,0,TCGA-QU-A6IN,4264,4264,Prostate Cancer,43,3428,4264,4264,TCGA,,4264,Primary,0,Apex|Middle|Base,A,,BRCA2;RAD54L,True,TUMOR FREE,Alive,-22286,,61,7,37,PRAD,4264,4264,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.0,Prostate,Resection,3,BC8954D4-1D39-4F99-BD91-A3F4E3B6B1E2,0,Normal (no evidence of prostate cancer) [cM0],0,0.037656,[Not Available],D07D20F4-DD65-4FFC-ADD4-01F350CA7B65,4,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,QU,0.8,TCGA-QU-A6IN,0:DiseaseFree,2,10,Prostate Adenocarcinoma,140.08,8/21/13,4264,,,,,YES,C61,11063611-DCFF-427E-89A9-25961C79DF07,110,0,TUMOR FREE,0.0354,0:LIVING,0.1,5,140.08,Bilateral,11,,,YES,3789,2003,,,TCGA-QU-A6IN.11063611-DCFF-427E-89A9-25961C79DF07.pdf,,[Not Applicable],NO,21,,15,Prostate Adenocarcinoma Acinar Type,1,2003,Complete Remission/Response,,NO,No,R0,,61,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-QU-A6IP,,PRAD,320,0,0,,QU,0,0,MALE,0,2.0,0.51,0,0,0,HRP,NO,2620,1-ERG,2620,2620,,0,0,2620,2620,prad_tcga,Malignant,0,,8,4.5,TCGA-QU-A6IP-01,0,0,0,TCGA-QU-A6IP,2620,2620,Prostate Cancer,,2620,2620,2620,TCGA,,2620,Primary,0,Middle|Base,A,,,True,TUMOR FREE,Alive,-24212,,66,6,25,PRAD,2620,2620,,0.0,[Not Available],[Not Applicable],22,R0,1,Matched,0.0,Prostate,Resection,3,B6B501CA-F660-41CD-B459-0CC82A704771,0,,0,0.0021394,[Not Available],9A8E27C9-614B-491F-913D-429DFC4E2C4D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,QU,0.766666666667,TCGA-QU-A6IP,0:DiseaseFree,1,0,Prostate Adenocarcinoma,86.07,8/21/13,2620,,,,,NO,C61,D1E73097-6F07-4B1E-8914-074FA037CB85,140,0,,0.0021,0:LIVING,0.0,,86.07,Right,0,,,YES,3118,2004,,,TCGA-QU-A6IP.D1E73097-6F07-4B1E-8914-074FA037CB85.pdf,,[Not Applicable],NO,,61-70%,2,Prostate Adenocarcinoma Acinar Type,1,2004,Complete Remission/Response,,NO,No,R0,,66,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2a,NO,6,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5552,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-SU-A7E7,,PRAD,348,0,0,,SU,0,0,MALE,0,1.95,0.3,4,4,5,HRP,NO,551,2-ETV1,551,551,,0,0,551,551,prad_tcga,Malignant,13,ATM;CHEK1,38,,TCGA-SU-A7E7-01,5,0,0,TCGA-SU-A7E7,551,551,Prostate Cancer,,426,551,551,TCGA,,551,Primary,0,Base,A,,,True,TUMOR FREE,Alive,-22185,,60,8,29,PRAD,551,551,,0.189177369,[Not Available],[Not Applicable],28,,1,Matched,0.02,Prostate,Resection,5,3908AD4B-E278-422C-8EDE-E4C942F9B451,0,Normal (no evidence of prostate cancer) [cM0],0,0.052074,[Not Available],2648C3C9-9884-4A0C-96AA-61130CD289EA,3,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,SU,0.933333333333,TCGA-SU-A7E7,0:DiseaseFree,4,13,Prostate Adenocarcinoma,18.1,1/24/14,551,,,,,NO,C61,120AA6E7-735D-442E-99AA-4EFE93C365F6,300,3,TUMOR FREE,0.0287,0:LIVING,0.01,,18.1,Right,15,No Evidence of Extraprostatic Extension,-10,YES,165,2013,,,TCGA-SU-A7E7.120AA6E7-735D-442E-99AA-4EFE93C365F6.pdf,Peripheral Zone,[Not Applicable],YES,6,36-45%,9,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,60,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2b,NO,8,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5553,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-TP-A8TT,,PRAD,,0,0,,TP,,0,MALE,0,1.95,0.58,3,7,4,HRP,NO,526,,,526,,0,0,526,526,prad_tcga,Malignant,14,,90,,TCGA-TP-A8TT-01,0,0,0,TCGA-TP-A8TT,526,526,Prostate Cancer,,237,,526,TCGA,,526,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-23476,,64,7,41,PRAD,526,526,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.0,Prostate,Resection,4,722ABE82-A272-4E42-BE72-41FF140C9AD8,0,Normal (no evidence of prostate cancer) [cM0],0,0.065913,[Not Available],A13A7252-DE84-4950-9307-80FC8A6A668D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,TP,1.1,TCGA-TP-A8TT,0:DiseaseFree,3,17,Prostate Adenocarcinoma,17.28,3/28/14,526,,,,,NO,C61,35E5E09D-8872-4BCC-99DC-876A3CCF9761,440,2,,0.0741,0:LIVING,0.024,,17.28,Left,15,No Evidence of Extraprostatic Extension,15,YES,265,2013,,,TCGA-TP-A8TT.35E5E09D-8872-4BCC-99DC-876A3CCF9761.pdf,Peripheral Zone,[Not Applicable],YES,23,,11,Prostate Adenocarcinoma Acinar Type,1,2013,Partial Remission/Response,,NO,No,R0,,64,Core needle biopsy,,Partial Remission/Response,YES,NO,YES,NO,T3a,YES,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5555,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8MF,,PRAD,370,0,0,,V1,0,0,MALE,0,2.05,0.64,3,4,4,HRP,NO,1449,8-other,1449,1449,,0,0,1449,1449,prad_tcga,Malignant,11,BRCA2,41,,TCGA-V1-A8MF-01,0,0,0,TCGA-V1-A8MF,1449,1449,Prostate Cancer,,1218,1449,1449,TCGA,,1449,Primary,0,Apex,A,,,True,,Alive,-24090,,65,6,40,PRAD,1449,1449,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,3,AA0E444B-C913-4A70-A76D-BE70CCF80691,2,,0,0.037853,[Not Available],56DF9DE6-613D-44CE-8827-9213CC6C8B56,3,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,V1,1.1,TCGA-V1-A8MF,0:DiseaseFree,1,13,Prostate Adenocarcinoma,47.6,7/23/14,1449,,,,,NO,C61,C2A32E46-BB93-43E6-BF3A-995745161434,130,3,,0.0886,0:LIVING,0.14,,47.6,Bilateral,14,,,YES,,,,,TCGA-V1-A8MF.C2A32E46-BB93-43E6-BF3A-995745161434.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,8,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,,N0,T2c,0,M0,C61.9,8140/3,5557,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8MG,,PRAD,370,0,0,,V1,0,0,MALE,0,2.09,0.29,8,9,5,HRD,NO,857,8-other,857,857,,0,0,857,857,prad_tcga,Malignant,22,ATM;CHEK1,77,,TCGA-V1-A8MG-01,0,0,0,TCGA-V1-A8MG,857,857,Prostate Cancer,,583,857,857,TCGA,,857,Primary,0,Apex,A,,BRCA2,True,,Alive,-19710,,53,7,28,PRAD,857,857,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.19,Prostate,Resection,3,C5B627DA-4A3C-4DD9-8556-DA2CB78388F0,5,,0,0.11011,[Not Available],301C4C32-BC66-4328-8DCF-FE3DD66FBDE2,4,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,V1,0.933333333333,TCGA-V1-A8MG,0:DiseaseFree,2,37,Prostate Adenocarcinoma,28.15,7/23/14,857,,,,,NO,C61,6E6ED2C5-9591-41BD-A910-F5E1A8637159,70,6,,0.1514,0:LIVING,0.03,,28.15,Bilateral,38,,,YES,,,,,TCGA-V1-A8MG.6E6ED2C5-9591-41BD-A910-F5E1A8637159.pdf,Peripheral Zone,[Not Applicable],NO,,36-45%,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,53,Core needle biopsy,,,NO,YES,NO,NO,T3b,NO,7,No,NO,,,T2c,,M0,C61.9,8140/3,5558,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-V1-A8MJ,,PRAD,370,0,0,,V1,,0,MALE,0,1.97,0.22,5,6,4,ambiguous,NO,1791,2-ETV1,,1791,,0,0,1791,1791,prad_tcga,Malignant,15,CHEK2,44,,TCGA-V1-A8MJ-01,0,0,0,TCGA-V1-A8MJ,1791,1791,Prostate Cancer,,1230,,1791,TCGA,,1791,Primary,0,Apex,A,,,True,,Alive,-21535,,58,7,17,PRAD,1791,1791,,0.0,[Not Available],[Not Applicable],21,,1,Matched,0.01,Prostate,Resection,3,0874A870-9784-4F90-8B32-F28F575E9210,2,,0,0.082358,[Not Available],F4F81316-C99A-4A88-AA6C-E66FC5D60C53,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,V1,0.7,TCGA-V1-A8MJ,0:DiseaseFree,2,17,Prostate Adenocarcinoma,58.84,7/15/14,1791,,,,,NO,C61,5BF9CF4D-B724-4FFD-A336-ECE60FC80E0D,70,4,,0.0001,0:LIVING,0.015,,58.84,Bilateral,22,,,YES,,,,,TCGA-V1-A8MJ.5BF9CF4D-B724-4FFD-A336-ECE60FC80E0D.pdf,Peripheral Zone,[Not Applicable],NO,,41-50%,16,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,NO,No,R0,,58,Core needle biopsy,,,NO,YES,YES,YES,T3a,NO,7,No,NO,,N1,T2a,1,M0,C61.9,8140/3,5559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8MK,,PRAD,,0,0,,V1,0,0,MALE,0,,,,,,,NO,508,,508,508,,0,0,508,508,prad_tcga,Malignant,,,,,TCGA-V1-A8MK-01,0,0,0,TCGA-V1-A8MK,508,508,Prostate Cancer,,-1,508,508,TCGA,,508,Primary,0,Apex,A,,,True,,Alive,-15330,,41,6,7,PRAD,508,508,,0.0,[Not Available],[Not Applicable],15,,1,Matched,,Prostate,Resection,3,7CC7E1EB-2F2A-4721-9F05-A0BD9F3055A7,,,,,[Not Available],9938C4AD-748C-4086-9081-FAC0AEFAD440,3,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,V1,0.466666666667,TCGA-V1-A8MK,0:DiseaseFree,1,,Prostate Adenocarcinoma,16.69,7/15/14,508,,,,,NO,C61,B8FB60DC-69C5-421A-90B0-875AE69E27D5,30,,,0.0,0:LIVING,0.83,,16.69,Bilateral,,,,YES,,,,,TCGA-V1-A8MK.B8FB60DC-69C5-421A-90B0-875AE69E27D5.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R0,,41,Core needle biopsy,,,NO,YES,NO,NO,T2c,NO,6,No,NO,,N0,T2a,,M0,C61.9,8140/3,5560,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8ML,,PRAD,389,0,0,,V1,0,0,MALE,0,1.98,0.35,1,2,1,HRP,NO,448,8-other,448,448,,0,0,448,448,prad_tcga,Malignant,4,RAD51D,20,,TCGA-V1-A8ML-01,0,0,0,TCGA-V1-A8ML,448,448,Prostate Cancer,,448,448,448,TCGA,,448,Primary,0,Apex,A,,,True,,Alive,-23360,,63,7,17,PRAD,448,448,,0.0,[Not Available],[Not Applicable],16,,1,Matched,0.01,Prostate,Resection,3,7E64E9CD-64A6-4AD0-B851-CEA249D4A27A,1,,0,0.016485,[Not Available],69174712-AF41-422D-952A-D8D0D16D7182,4,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,V1,0.566666666667,TCGA-V1-A8ML,0:DiseaseFree,2,3,Prostate Adenocarcinoma,14.72,7/15/14,448,,,,,NO,C61,4C4405A3-FC07-4155-8C5A-2693E34F347B,10,1,,0.0045,0:LIVING,0.01,,14.72,Bilateral,8,,,YES,,,,,TCGA-V1-A8ML.4C4405A3-FC07-4155-8C5A-2693E34F347B.pdf,Peripheral Zone,[Not Applicable],NO,,66-75%,12,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,,N0,T2b,0,M0,C61.9,8140/3,5561,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-V1-A8MM,,PRAD,,1,1,,V1,1,0,MALE,1,1.97,0.78,6,12,2,HRD,NO,1195,,990,1195,,1,1,990,990,prad_tcga,Malignant,20,,84,,TCGA-V1-A8MM-01,0,0,0,TCGA-V1-A8MM,990,990,Prostate Cancer,,990,990,1195,TCGA,,990,Primary,0,Apex,A,,BRCA2,True,,Alive,-22265,,60,7,31,PRAD,990,990,,0.0,[Not Available],[Not Applicable],18,,1,Matched,0.03,Prostate,Resection,4,ED22176A-F208-477C-8941-0DAB957A64CE,1,,0,0.09147,[Not Available],94D6675E-27AE-4F34-9D53-6E19238EB01D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,19,,Acinar Adenocarcinoma,[Not Available],,V1,0.6,TCGA-V1-A8MM,1:Recurred/Progressed,3,17,Prostate Adenocarcinoma,32.52,7/15/14,1195,,Biochemical evidence of disease,,,NO,C61,2FBA596B-858D-4043-BDCF-CCE582A74D67,90,1,,0.1216,0:LIVING,0.37,,39.26,Bilateral,18,,,YES,,,990,,TCGA-V1-A8MM.2FBA596B-858D-4043-BDCF-CCE582A74D67.pdf,Peripheral Zone,[Not Applicable],NO,,,10,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,990,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,7,No,NO,,N0,T2b,0,M0,C61.9,8140/3,5562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-V1-A8MU,,PRAD,389,0,0,,V1,,0,MALE,0,1.95,0.47,4,5,2,HRP,NO,1876,8-other,,1876,,0,0,1876,1876,prad_tcga,Malignant,11,,45,,TCGA-V1-A8MU-01,0,0,0,TCGA-V1-A8MU,1876,1876,Prostate Cancer,,1384,,1876,TCGA,,1876,Primary,0,Apex,A,,,True,,Alive,-20805,,56,7,39,PRAD,1876,1876,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.0,Prostate,Resection,3,D27C7A15-D603-4F85-9DED-6FCD72C78D21,0,,0,0.055404,[Not Available],A76BCD1F-E47F-4DC5-A97A-4C4F00032191,4,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,V1,0.8,TCGA-V1-A8MU,0:DiseaseFree,2,11,Prostate Adenocarcinoma,61.63,7/15/14,1876,,,,,NO,C61,8E072738-2D8E-4254-B1DE-A8008C614B7F,160,1,,0.0528,0:LIVING,0.015,,61.63,Bilateral,13,No Evidence of Extraprostatic Extension,87,YES,,,,,TCGA-V1-A8MU.8E072738-2D8E-4254-B1DE-A8008C614B7F.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,15,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,NO,No,R1,,56,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,7,No,YES,,N1,T2b,1,M0,C61.9,8140/3,5563,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8WL,,PRAD,389,0,0,,V1,0,0,MALE,0,1.96,0.69,2,2,3,HRP,NO,1948,8-other,1948,1948,,0,0,1948,1948,prad_tcga,Malignant,7,,34,,TCGA-V1-A8WL-01,0,0,0,TCGA-V1-A8WL,1948,1948,Prostate Cancer,,1175,1948,1948,TCGA,,1948,Primary,0,Apex,A,,,True,,Alive,-23725,,64,7,39,PRAD,1948,1948,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.04,Prostate,Resection,3,2913B17A-D36B-43D4-9ADA-9AAA6B3249EC,1,,0,0.039,[Not Available],F7FC3F2E-C70E-460D-B34D-BB2EA423A0AE,4,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,V1,0.933333333333,TCGA-V1-A8WL,0:DiseaseFree,2,6,Prostate Adenocarcinoma,63.99,7/23/14,1948,,,,,NO,C61,6E301400-1200-40F7-8249-AD310C44A212,90,1,,0.0359,0:LIVING,0.015,,63.99,Bilateral,7,,,YES,,,,,TCGA-V1-A8WL.6E301400-1200-40F7-8249-AD310C44A212.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,64,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,7,No,NO,,N0,T1c,0,M0,C61.9,8140/3,5564,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8WN,,PRAD,389,0,0,,V1,0,0,MALE,0,2.0,0.38,0,0,0,HRD,NO,924,4-FLI1,924,924,,0,0,924,924,prad_tcga,Malignant,0,,10,,TCGA-V1-A8WN-01,0,0,0,TCGA-V1-A8WN,924,924,Prostate Cancer,,463,924,924,TCGA,,924,Primary,0,Apex,A,RAD51B:.:.:splice_region_variant,CHEK2,True,,Alive,-17520,,47,6,21,PRAD,924,924,,0.0,[Not Available],[Not Applicable],22,,1,Matched,0.0,Prostate,Resection,3,F993AC1F-1F37-4CF1-BA77-85F95D77A62C,0,,0,0.0039368,[Not Available],DC16F348-A49F-4958-A3FF-BC40E18DF2BD,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,V1,0.733333333333,TCGA-V1-A8WN,0:DiseaseFree,1,3,Prostate Adenocarcinoma,30.35,7/15/14,924,,,,,NO,C61,F25C1C00-CDFE-4ABD-A920-857AFEA691A5,30,0,,0.0118,0:LIVING,0.02,,30.35,Bilateral,5,,,YES,,,,,TCGA-V1-A8WN.F25C1C00-CDFE-4ABD-A920-857AFEA691A5.pdf,Peripheral Zone,[Not Applicable],NO,,76-85%,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,47,Core needle biopsy,,,NO,YES,NO,NO,T2c,NO,6,No,NO,,,T2a,,M0,C61.9,8140/3,5565,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-V1-A8WS,,PRAD,389,0,0,,V1,,0,MALE,0,1.96,0.77,2,3,0,HRD,NO,474,1-ERG,,474,,0,0,474,474,prad_tcga,Malignant,5,FANCL,48,,TCGA-V1-A8WS-01,0,0,0,TCGA-V1-A8WS,474,474,Prostate Cancer,,474,,474,TCGA,,474,Primary,0,Apex,A,,CHEK2,True,,Alive,-20805,,56,6,32,PRAD,474,474,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.08,Prostate,Resection,3,EDCF4F2E-0575-42C5-B92A-B37B428F0553,0,,0,0.038102,[Not Available],BEA84D33-3286-44E2-9595-893C34A01F58,3,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,V1,0.966666666667,TCGA-V1-A8WS,0:DiseaseFree,1,10,Prostate Adenocarcinoma,15.57,7/23/14,474,,,,,NO,C61,0BD9565E-DBBB-428D-BF6D-2B31F0E5DDC5,30,1,,0.0417,0:LIVING,0.09,,15.57,Bilateral,12,,,YES,,,,,TCGA-V1-A8WS.0BD9565E-DBBB-428D-BF6D-2B31F0E5DDC5.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,NO,No,R0,,56,Core needle biopsy,,,NO,YES,NO,YES,T3b,NO,6,No,NO,,,T1c,,M0,C61.9,8140/3,5566,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8WV,,PRAD,389,0,0,,V1,0,0,MALE,0,3.13,0.48,8,16,13,ambiguous,NO,686,3-ETV4,686,686,,0,0,686,686,prad_tcga,Malignant,37,BRCA2;RAD51B;RAD54L,70,,TCGA-V1-A8WV-01,8,0,0,TCGA-V1-A8WV,686,686,Prostate Cancer,,686,686,686,TCGA,,686,Primary,0,Middle,A,,,True,,Alive,-19345,,52,9,53,PRAD,686,686,,0.163698777,[Not Available],[Not Applicable],41,,1,Matched,0.23,Prostate,Resection,4,0D44C6BB-2FF0-4ED6-8C38-F58B5CFA2530,19,,1,0.17,[Not Available],8E5B1D47-7D92-4D28-8186-4176ADA96672,5,Prostate Adenocarcinoma Acinar Type,,Prostate,40,,Acinar Adenocarcinoma,[Not Available],,V1,1.36666666667,TCGA-V1-A8WV,0:DiseaseFree,5,41,Prostate Adenocarcinoma,22.54,7/15/14,686,,,,,NO,C61,AD602A56-B2CB-49A0-A994-7927600C952B,70,23,,0.5379,0:LIVING,0.01,,22.54,Bilateral,51,No Evidence of Extraprostatic Extension,95,YES,,,,,TCGA-V1-A8WV.AD602A56-B2CB-49A0-A994-7927600C952B.pdf,Peripheral Zone,[Not Applicable],YES,,86-95%,10,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,52,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,YES,,N1,T2a,1,M0,C61.9,8140/3,5567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8WW,,PRAD,389,0,0,,V1,0,0,MALE,0,1.98,0.84,2,6,4,HRP,NO,1078,1-ERG,1078,1078,,0,0,1078,1078,prad_tcga,Malignant,12,BRCA1;BRCA2;CHEK2;RAD54L,50,,TCGA-V1-A8WW-01,0,0,0,TCGA-V1-A8WW,1078,1078,Prostate Cancer,709,695,1078,1078,TCGA,No Evidence of Extraprostatic Extension,1078,Primary,0,Apex,A,,,True,,Alive,-21900,,59,9,49,PRAD,1078,1078,,0.0,[Not Available],[Not Applicable],36,,1,Matched,0.45,Prostate,Resection,4,75733489-D3CD-4CBA-8B79-DB316298BB15,2,,0,0.065214,[Not Available],D843996C-0F17-4482-8466-9F6144981B8A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,V1,1.16666666667,TCGA-V1-A8WW,0:DiseaseFree,5,11,Prostate Adenocarcinoma,35.41,7/15/14,1078,,,,,YES,C61,36FBC30B-6566-4C5F-BE51-D267B4F856B3,50,2,,0.2146,0:LIVING,0.015,,35.41,Bilateral,14,,,YES,,,,,TCGA-V1-A8WW.36FBC30B-6566-4C5F-BE51-D267B4F856B3.pdf,Peripheral Zone,[Not Applicable],NO,,91-100%,20,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,105,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,YES,,N1,T2b,1,M0,C61.9,8140/3,5568,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8X3,,PRAD,389,0,0,,V1,0,0,MALE,0,1.94,0.65,4,3,3,HRP,NO,202,3-ETV4,202,202,,0,0,202,202,prad_tcga,Malignant,10,CHEK2;PALB2,22,,TCGA-V1-A8X3-01,0,0,0,TCGA-V1-A8X3,202,202,Prostate Cancer,,202,202,202,TCGA,,202,Primary,0,Apex,A,,,True,,Alive,-18980,,51,7,36,PRAD,202,202,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.07,Prostate,Resection,3,7A6297FE-B95F-44ED-A658-F2CA33D17435,1,,0,0.056423,[Not Available],86B82965-B19B-4285-B1A5-51A5D5267103,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,V1,0.933333333333,TCGA-V1-A8X3,0:DiseaseFree,2,10,Prostate Adenocarcinoma,6.64,7/23/14,202,,,,,NO,C61,267C0EAB-ECC4-44BC-89C9-8C54F3B22A6E,170,2,,0.0612,0:LIVING,0.03,,6.64,Bilateral,14,,,YES,,,,,TCGA-V1-A8X3.267C0EAB-ECC4-44BC-89C9-8C54F3B22A6E.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,18,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,51,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,,N0,T1c,0,M0,C61.9,8140/3,5569,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-V1-A9O5,,PRAD,,1,1,,V1,1,0,MALE,1,2.15,0.58,8,10,9,ambiguous,NO,1932,,124,1932,,1,1,124,124,prad_tcga,Malignant,27,ATM;BRCA2;CHEK1,66,,TCGA-V1-A9O5-01,0,0,0,TCGA-V1-A9O5,124,124,Prostate Cancer,,1776,124,1932,TCGA,,124,Primary,0,Apex,A,,,True,,Alive,-23725,,64,9,44,PRAD,124,124,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.28,Prostate,Resection,5,9F03470E-516E-4D9C-8424-0D7A05780504,4,,0,0.14626,[Not Available],E0DFC37A-4A2E-4353-9673-241B100B3467,4,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,V1,1.3,TCGA-V1-A9O5,1:Recurred/Progressed,5,28,Prostate Adenocarcinoma,4.07,7/23/14,1932,,Biochemical evidence of disease,,,NO,C61,4C94E826-144A-4879-99A3-E3B1655D4066,230,11,,0.259,0:LIVING,3.26,,63.47,Bilateral,133,No Evidence of Extraprostatic Extension,25,YES,,,124,,TCGA-V1-A9O5.4C94E826-144A-4879-99A3-E3B1655D4066.pdf,Peripheral Zone,[Not Applicable],YES,,,20,Prostate Adenocarcinoma Acinar Type,2,,Complete Remission/Response,,YES,No,R1,,64,Core needle biopsy,124,Complete Remission/Response,NO,YES,YES,YES,T4,YES,9,No,YES,,N1,T2b,6,M0,C61.9,8140/3,5570,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-V1-A9O7,,PRAD,,1,1,,V1,,0,MALE,1,2.07,0.32,7,8,9,HRD,NO,2499,,,2499,,1,1,819,819,prad_tcga,Malignant,24,BRCA2;CHEK2;RAD54L,46,,TCGA-V1-A9O7-01,0,0,0,TCGA-V1-A9O7,819,819,Prostate Cancer,45,2425,,2499,TCGA,,819,Primary,0,Apex,A,ATM:1396-1397:CH/X:frameshift_variant,,True,,Alive,-22265,,60,9,37,PRAD,819,819,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.35,Prostate,Resection,5,CB4A8A9D-BF54-4A1D-970C-7AA6710C1FB9,5,,0,0.096232,[Not Available],40EBEB10-7390-44FC-9EF2-80D40D251018,4,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,V1,1.1,TCGA-V1-A9O7,1:Recurred/Progressed,5,7,Prostate Adenocarcinoma,26.91,7/23/14,2499,,Biochemical evidence of disease,,,YES,C61,0D2327CA-DE0A-4B74-BD53-6370ED222B96,710,8,,0.1288,0:LIVING,9.69,,82.1,Bilateral,12,,,YES,,,819,,TCGA-V1-A9O7.0D2327CA-DE0A-4B74-BD53-6370ED222B96.pdf,Peripheral Zone,[Not Applicable],NO,,,15,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,YES,No,R1,,60,Core needle biopsy,921,Progressive Disease,NO,YES,YES,YES,T3a,YES,9,No,NO,,N0,T2b,0,M0,C61.9,8140/3,5571,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9O9,,PRAD,,0,0,,V1,0,0,MALE,0,1.93,0.55,3,8,4,ambiguous,NO,2870,,2870,2870,,0,0,2870,2870,prad_tcga,Malignant,15,BRCA2;FANCL,50,,TCGA-V1-A9O9-01,0,0,0,TCGA-V1-A9O9,2870,2870,Prostate Cancer,,-53,2870,2870,TCGA,,2870,Primary,0,Apex,A,,,True,,Alive,-20805,,56,8,34,PRAD,2870,2870,,0.0,[Not Available],[Not Applicable],36,,1,Matched,0.16,Prostate,Resection,3,4C3D7972-4A67-4858-911F-57E20643AEBB,0,,0,0.074708,[Not Available],F6935F67-5C62-4774-8346-711F36F3B547,5,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,V1,1.16666666667,TCGA-V1-A9O9,0:DiseaseFree,4,18,Prostate Adenocarcinoma,94.28,7/23/14,2870,,,,,NO,C61,6AEA4F7C-2680-4BCE-BB38-AF8DF5ED7DE8,80,1,,0.0731,0:LIVING,5.04,,94.28,Bilateral,22,,,YES,,,,,TCGA-V1-A9O9.6AEA4F7C-2680-4BCE-BB38-AF8DF5ED7DE8.pdf,Peripheral Zone,[Not Applicable],NO,,,12,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R0,,56,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,8,No,NO,,N0,,0,M0,C61.9,8140/3,5572,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OA,,PRAD,,0,0,,V1,0,0,MALE,0,1.98,0.61,7,11,8,ambiguous,NO,636,,636,636,,0,0,636,636,prad_tcga,Malignant,26,,50,,TCGA-V1-A9OA-01,0,0,0,TCGA-V1-A9OA,636,636,Prostate Cancer,27,510,636,636,TCGA,,636,Primary,0,Apex,A,,,True,,Alive,-22630,,61,9,25,PRAD,636,636,,0.0,[Not Available],[Not Applicable],20,,1,Matched,0.05,Prostate,Resection,4,A4704150-38CD-4F08-B05E-548A526E0C79,2,,0,0.10118,[Not Available],A8396F6D-53E2-4664-A3E2-DF061D022108,5,Prostate Adenocarcinoma Acinar Type,,Prostate,25,,Acinar Adenocarcinoma,[Not Available],,V1,0.733333333333,TCGA-V1-A9OA,0:DiseaseFree,5,25,Prostate Adenocarcinoma,20.89,7/23/14,636,,,,,YES,C61,F8BC91E0-7D98-40B2-B99E-570564C3ECD2,10,4,,0.1664,0:LIVING,0.01,,20.89,Bilateral,27,,,YES,,,,,TCGA-V1-A9OA.F8BC91E0-7D98-40B2-B99E-570564C3ECD2.pdf,Peripheral Zone,[Not Applicable],NO,,,8,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,61,Core needle biopsy,,,NO,YES,YES,NO,T3b,YES,9,No,NO,,N1,T2c,1,M0,C61.9,8140/3,5573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OF,,PRAD,,0,0,,V1,0,0,MALE,0,1.98,0.81,1,2,0,HRD,NO,1184,,1184,1184,,0,0,1184,1184,prad_tcga,Malignant,3,,28,,TCGA-V1-A9OF-01,0,0,0,TCGA-V1-A9OF,1184,1184,Prostate Cancer,,1184,1184,1184,TCGA,,1184,Primary,0,Apex,A,CDK12:349-355:SRKSMKS/SX:frameshift_variant,,True,,Alive,-18250,,49,6,15,PRAD,1184,1184,,0.0,[Not Available],[Not Applicable],21,,1,Matched,0.0,Prostate,Resection,3,2C17D9BE-A1E8-4C37-879C-C8BAB565B3FB,0,,0,0.024024,[Not Available],D4DC7C5C-45B3-4741-B0C1-FEE477DA2EF4,3,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,V1,0.7,TCGA-V1-A9OF,0:DiseaseFree,1,3,Prostate Adenocarcinoma,38.9,7/23/14,1184,,,,,NO,C61,1C729709-EE1B-421E-A55A-7A048806FA6A,20,0,,0.0223,0:LIVING,0.01,,38.9,Bilateral,4,,,YES,,,,,TCGA-V1-A9OF.1C729709-EE1B-421E-A55A-7A048806FA6A.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,49,Core needle biopsy,,,NO,YES,NO,NO,T2c,NO,6,No,NO,,,T1c,,M0,C61.9,8140/3,5574,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OH,,PRAD,,0,0,,V1,0,0,MALE,0,2.02,0.49,4,6,4,HRD,NO,2403,,2403,2403,,0,0,2403,2403,prad_tcga,Malignant,14,BRCA2,24,,TCGA-V1-A9OH-01,21,0,0,TCGA-V1-A9OH,2403,2403,Prostate Cancer,,1253,2403,2403,TCGA,,2403,Primary,1,Apex,A,BRCA2:212:R/X:frameshift_variant,,True,,Alive,-23360,,63,8,66,PRAD,2403,2403,,0.350149623,[Not Available],[Not Applicable],58,,1,Matched,0.05,Prostate,Resection,4,E67E581C-FBB7-431A-B796-C3089843D96E,0,,0,0.055392,[Not Available],6EF0FC2D-F274-4253-BEC5-6DBD55953D76,4,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,V1,1.93333333333,TCGA-V1-A9OH,0:DiseaseFree,4,21,Prostate Adenocarcinoma,78.94,7/23/14,2403,,,,,NO,C61,8B30DB97-6EB7-42EF-8A12-C9B1F1B5251B,70,2,,0.0905,0:LIVING,0.01,,78.94,Right,22,,,YES,,,,,TCGA-V1-A9OH.8B30DB97-6EB7-42EF-8A12-C9B1F1B5251B.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,,NO,YES,NO,NO,T2b,NO,8,No,NO,,,T1c,,M0,C61.9,8140/3,5575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-V1-A9OL,,PRAD,,1,1,,V1,1,0,MALE,1,1.95,0.9,11,17,7,ambiguous,NO,1913,,105,1913,,1,1,105,105,prad_tcga,Malignant,35,BRCA1;BRCA2;BRIP1;CDK12;CHEK2;FANCL;RAD51C;RAD51D,104,,TCGA-V1-A9OL-01,0,0,0,TCGA-V1-A9OL,105,105,Prostate Cancer,,559,105,1913,TCGA,,105,Primary,0,Apex,A,,,True,,Alive,-24090,,65,9,45,PRAD,105,105,,0.0,[Not Available],[Not Applicable],37,,1,Matched,0.2,Prostate,Resection,5,4E9D56B5-6B3E-4CAE-BDC5-2B29890F9D26,2,,0,0.14235,[Not Available],FCBD7B29-12DA-44C8-B241-1388D1B15684,4,Prostate Adenocarcinoma Acinar Type,,Prostate,34,,Acinar Adenocarcinoma,[Not Available],,V1,1.23333333333,TCGA-V1-A9OL,1:Recurred/Progressed,5,38,Prostate Adenocarcinoma,3.45,7/11/14,1913,,Biochemical evidence of disease,,,NO,C61,E63E681C-8E25-4C1E-8C37-9EAA2697088B,190,6,,0.2705,0:LIVING,0.01,,62.84,Bilateral,44,No Evidence of Extraprostatic Extension,19,YES,,,105,,TCGA-V1-A9OL.E63E681C-8E25-4C1E-8C37-9EAA2697088B.pdf,Peripheral Zone,[Not Applicable],YES,,,9,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,131,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,,N0,T2,0,M0,C61.9,8140/3,5576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OQ,,PRAD,,0,0,,V1,0,0,MALE,0,1.95,0.77,4,5,0,HRD,NO,371,,371,371,,0,0,371,371,prad_tcga,Malignant,9,,58,,TCGA-V1-A9OQ-01,11,0,0,TCGA-V1-A9OQ,371,371,Prostate Cancer,,371,371,371,TCGA,,371,Primary,1,Apex,A,,BRCA2,True,,Alive,-24820,,67,6,60,PRAD,371,371,,0.199604945,[Not Available],[Not Applicable],48,,1,Matched,0.02,Prostate,Resection,3,819C66A0-7074-495E-9993-80A858F46B82,0,,0,0.051128,[Not Available],10271D9C-9B9C-4B5F-A845-A0F1BD03AF51,3,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,V1,1.6,TCGA-V1-A9OQ,0:DiseaseFree,1,9,Prostate Adenocarcinoma,12.19,7/11/14,371,,,,,NO,C61,8EA3FE2C-7C76-41F8-AEC4-A89C5DD2FF7B,60,1,,0.0474,0:LIVING,0.01,,12.19,Bilateral,13,,,YES,,,,,TCGA-V1-A9OQ.8EA3FE2C-7C76-41F8-AEC4-A89C5DD2FF7B.pdf,Peripheral Zone,[Not Applicable],NO,,,0,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,67,Core needle biopsy,,,NO,YES,NO,NO,T3a,NO,6,No,NO,,,T1c,,M0,C61.9,8140/3,5577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-V1-A9OT,,PRAD,,1,1,,V1,,0,MALE,1,1.95,0.79,3,6,0,HRP,NO,476,,,476,,1,1,292,292,prad_tcga,Malignant,9,,40,,TCGA-V1-A9OT-01,0,0,0,TCGA-V1-A9OT,292,292,Prostate Cancer,,349,,476,TCGA,,292,Primary,0,Middle,A,,,True,,Alive,-22630,,61,6,44,PRAD,292,292,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.0,Prostate,Resection,3,3E3BAEF3-4686-41D5-BA55-4456DF023975,0,,0,0.051566,[Not Available],18B8AD7F-0F39-4853-AE13-5B13AA5E6F7D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,V1,0.9,TCGA-V1-A9OT,1:Recurred/Progressed,1,9,Prostate Adenocarcinoma,9.59,7/23/14,476,,Biochemical evidence of disease,,,NO,C61,40B928AE-1977-4077-9F44-282E85273EF2,220,1,,0.05,0:LIVING,0.01,,15.64,Bilateral,14,,,YES,,,292,,TCGA-V1-A9OT.40B928AE-1977-4077-9F44-282E85273EF2.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,YES,No,R1,,61,Core needle biopsy,,,NO,YES,NO,YES,T2c,NO,6,No,NO,,,T1c,,M0,C61.9,8140/3,5578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-V1-A9OX,,PRAD,,0,0,,V1,,0,MALE,0,1.97,0.44,6,8,0,HRD,NO,1134,,,1134,,0,0,1134,1134,prad_tcga,Malignant,14,,123,,TCGA-V1-A9OX-01,9,0,0,TCGA-V1-A9OX,1134,1134,Prostate Cancer,,256,,1134,TCGA,,1134,Primary,0,Apex,A,,BRCA2,True,,Alive,-20805,,56,8,30,PRAD,1134,1134,,0.307500452,[Not Available],[Not Applicable],27,,1,Matched,0.09,Prostate,Resection,3,CD8ACE8B-2A7D-4DE9-82AD-BBAE2D028DF9,2,,0,0.086589,[Not Available],14C2819B-9AFC-4C89-849F-530E289D55BF,5,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,V1,0.9,TCGA-V1-A9OX,0:DiseaseFree,4,14,Prostate Adenocarcinoma,37.25,7/23/14,1134,,,,,NO,C61,4D42611A-3A08-4A1A-A033-13E810FCCA3E,150,2,,0.1368,0:LIVING,0.04,,37.25,Bilateral,17,,,YES,,,,,TCGA-V1-A9OX.4D42611A-3A08-4A1A-A033-13E810FCCA3E.pdf,Peripheral Zone,[Not Applicable],NO,,,8,Prostate Adenocarcinoma Acinar Type,1,,Partial Remission/Response,,NO,No,R0,,56,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,8,No,NO,,N0,,0,M0,C61.9,8140/3,5579,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OY,,PRAD,,0,0,,V1,0,0,MALE,0,1.98,0.53,2,4,0,HRD,NO,1067,,1067,1067,,0,0,1067,1067,prad_tcga,Malignant,6,,23,,TCGA-V1-A9OY-01,0,0,0,TCGA-V1-A9OY,1067,1067,Prostate Cancer,,170,1067,1067,TCGA,,1067,Primary,0,Apex,A,,ATM;BRCA2,True,,Alive,-21170,,57,7,24,PRAD,1067,1067,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.01,Prostate,Resection,4,001824EB-43F0-42EF-B18C-61BEF23235F7,0,,0,0.024214,[Not Available],69FC0351-6496-46B5-BE22-25B80C1DC4CC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,V1,0.9,TCGA-V1-A9OY,0:DiseaseFree,3,8,Prostate Adenocarcinoma,35.05,7/23/14,1067,,,,,NO,C61,93F584C1-F62C-4DA6-B2C8-755DBED9CE18,70,0,,0.0229,0:LIVING,0.099,,35.05,Bilateral,8,,,YES,,,,,TCGA-V1-A9OY.93F584C1-F62C-4DA6-B2C8-755DBED9CE18.pdf,Peripheral Zone,[Not Applicable],NO,,,13,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,57,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,7,No,NO,,N1,T2,1,M0,C61.9,8140/3,5580,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9Z7,,PRAD,,0,0,,V1,0,0,MALE,0,1.99,0.59,3,5,5,ambiguous,NO,874,,874,874,,0,0,874,874,prad_tcga,Malignant,13,,122,,TCGA-V1-A9Z7-01,0,0,0,TCGA-V1-A9Z7,874,874,Prostate Cancer,,-75,874,874,TCGA,,874,Primary,0,Apex,A,,,True,,Alive,-20075,,54,9,40,PRAD,874,874,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.19,Prostate,Resection,5,726C35C5-ABBA-46E9-ADBF-818E15308957,3,,0,0.082085,[Not Available],4DB62B98-ABD4-4A7C-9FCE-8BBDA2AEC8A3,4,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,V1,0.966666666667,TCGA-V1-A9Z7,0:DiseaseFree,5,22,Prostate Adenocarcinoma,28.71,7/23/14,874,,,,,NO,C61,E50B8F61-E948-417F-A5B6-2C087A8D2B01,310,4,,0.1225,0:LIVING,28.1,,28.71,Bilateral,24,No Evidence of Extraprostatic Extension,50,YES,,,,,TCGA-V1-A9Z7.E50B8F61-E948-417F-A5B6-2C087A8D2B01.pdf,Peripheral Zone,[Not Applicable],YES,,,10,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R0,,54,Core needle biopsy,,,NO,YES,YES,YES,T3b,NO,9,No,NO,,N0,T2,0,M0,C61.9,8140/3,5581,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9Z8,,PRAD,,0,0,,V1,0,0,MALE,0,2.04,0.45,2,6,1,HRP,NO,827,,827,827,,0,0,827,827,prad_tcga,Malignant,9,,48,,TCGA-V1-A9Z8-01,9,0,0,TCGA-V1-A9Z8,827,827,Prostate Cancer,,181,827,827,TCGA,,827,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-21900,,59,9,34,PRAD,827,827,,0.284475523,[Not Available],[Not Applicable],34,,1,Matched,0.04,Prostate,Resection,5,F328DE54-F9C2-4280-8D37-35629B1148B1,1,,0,0.036314,[Not Available],9BF4E7BB-6AA9-4BE8-A7C3-E630ECFF4DCE,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,V1,1.13333333333,TCGA-V1-A9Z8,0:DiseaseFree,5,13,Prostate Adenocarcinoma,27.17,7/23/14,827,,,,,NO,C61,3C543195-4F88-4FA4-A397-EDF375FCE61A,120,2,,0.0943,0:LIVING,0.01,,27.17,Bilateral,14,,,YES,,,,,TCGA-V1-A9Z8.3C543195-4F88-4FA4-A397-EDF375FCE61A.pdf,Peripheral Zone,[Not Applicable],NO,,,18,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,59,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,NO,,N0,,0,M0,C61.9,8140/3,5582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9Z9,,PRAD,,0,0,,V1,0,0,MALE,0,1.93,0.65,4,12,0,HRD,NO,540,,540,540,,0,0,540,540,prad_tcga,Malignant,16,,69,,TCGA-V1-A9Z9-01,5,0,0,TCGA-V1-A9Z9,540,540,Prostate Cancer,9,291,540,540,TCGA,,540,Primary,0,Apex,A,,BRCA2,True,TUMOR FREE,Alive,-23360,,63,9,40,PRAD,540,540,,0.161737697,[Not Available],[Not Applicable],34,,1,Matched,0.0,Prostate,Resection,4,296CC7A9-AD1E-45FC-A702-F100F0400817,0,,0,0.066038,[Not Available],0885EB03-DE9F-46BA-9C53-FB69C67AB9F0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,V1,1.13333333333,TCGA-V1-A9Z9,0:DiseaseFree,5,19,Prostate Adenocarcinoma,17.74,7/23/14,540,,,,,YES,C61,9D297084-0545-4D51-8D14-15754BAAB18B,140,0,,0.0623,0:LIVING,0.015,,17.74,Bilateral,20,,,YES,,,,,TCGA-V1-A9Z9.9D297084-0545-4D51-8D14-15754BAAB18B.pdf,Peripheral Zone,[Not Applicable],NO,,,29,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,9,No,NO,,N0,T1c,0,M0,C61.9,8140/3,5583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9ZG,,PRAD,,0,0,,V1,0,0,MALE,0,1.97,0.4,1,1,0,HRP,NO,1517,,1517,1517,,0,0,1517,1517,prad_tcga,Malignant,2,,70,,TCGA-V1-A9ZG-01,0,0,0,TCGA-V1-A9ZG,1517,1517,Prostate Cancer,,893,1517,1517,TCGA,,1517,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23725,,64,9,42,PRAD,1517,1517,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.0,Prostate,Resection,4,7C388E94-D897-4084-B657-437440012FEE,1,,0,0.028585,[Not Available],DEC99F86-622B-477F-A26A-98C954FB1F17,5,Prostate Adenocarcinoma Acinar Type,,Prostate,2,,Acinar Adenocarcinoma,[Not Available],,V1,0.833333333333,TCGA-V1-A9ZG,0:DiseaseFree,5,5,Prostate Adenocarcinoma,49.84,7/23/14,1517,,,,,NO,C61,D7B1ABAE-1A72-496C-B11F-469F65B37347,330,1,,0.0269,0:LIVING,0.015,,49.84,Bilateral,6,,,YES,,,,,TCGA-V1-A9ZG.D7B1ABAE-1A72-496C-B11F-469F65B37347.pdf,Peripheral Zone,[Not Applicable],NO,,,5,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,64,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,9,No,NO,,N0,T1c,0,M0,C61.9,8140/3,5584,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-V1-A9ZI,,PRAD,,0,0,,V1,,0,MALE,0,2.12,0.8,5,4,4,HRP,NO,1640,,,1640,,0,0,1640,1640,prad_tcga,Malignant,13,,54,,TCGA-V1-A9ZI-01,0,0,0,TCGA-V1-A9ZI,1640,1640,Prostate Cancer,,86,,1640,TCGA,,1640,Primary,0,Middle,A,,,True,,Alive,-25185,,68,9,44,PRAD,1640,1640,,0.0,[Not Available],[Not Applicable],39,,1,Matched,0.03,Prostate,Resection,4,9D50549B-DD2E-499B-8768-CE02E3A894C7,7,,0,0.10599,[Not Available],3D92B872-A76A-49CD-9FD5-7993E78D2FB0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,V1,1.3,TCGA-V1-A9ZI,0:DiseaseFree,5,12,Prostate Adenocarcinoma,53.88,7/23/14,1640,,,,,NO,C61,7C3EC6A6-C005-4877-A6C8-C3174709A3FF,120,7,,0.204,0:LIVING,3.11,,53.88,Bilateral,11,No Evidence of Extraprostatic Extension,40,YES,,,,,TCGA-V1-A9ZI.7C3EC6A6-C005-4877-A6C8-C3174709A3FF.pdf,Peripheral Zone,[Not Applicable],YES,,,10,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,YES,No,R0,,68,Core needle biopsy,86,Progressive Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,,N0,,0,M0,C61.9,8140/3,5585,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9ZK,,PRAD,,0,0,,V1,0,0,MALE,0,1.87,0.36,10,15,5,ambiguous,NO,1383,,1383,1383,,0,0,1383,1383,prad_tcga,Malignant,30,BRCA2;CHEK1,49,,TCGA-V1-A9ZK-01,0,0,0,TCGA-V1-A9ZK,1383,1383,Prostate Cancer,,1049,1383,1383,TCGA,,1383,Primary,0,Middle,A,,,True,TUMOR FREE,Alive,-25185,,68,8,27,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.15,Prostate,Resection,4,B860310F-6079-4C82-809E-44624E936F5F,1,,0,0.14521,[Not Available],7DC62C0F-B82D-417F-89A7-4CB984A9D304,4,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,V1,0.9,TCGA-V1-A9ZK,0:DiseaseFree,4,30,Prostate Adenocarcinoma,45.43,10/23/14,1383,,,,,NO,C61,9AD0F7C3-9DEB-427C-B8A3-007B874AB12A,50,4,,0.0276,0:LIVING,0.01,,45.43,Left,32,,,YES,,,,,TCGA-V1-A9ZK.9AD0F7C3-9DEB-427C-B8A3-007B874AB12A.pdf,Peripheral Zone,[Not Applicable],NO,,,6,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,68,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,8,No,NO,,N0,T2a,0,M0,C61.9,8490/3,5586,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9ZR,,PRAD,,0,0,,V1,0,0,MALE,0,1.93,0.54,4,10,2,ambiguous,NO,1361,,1361,1361,,0,0,1361,1361,prad_tcga,Malignant,16,,84,,TCGA-V1-A9ZR-01,0,0,0,TCGA-V1-A9ZR,1361,1361,Prostate Cancer,,54,1361,1361,TCGA,,1361,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25185,,68,8,54,PRAD,1361,1361,,0.0,[Not Available],[Not Applicable],38,,1,Matched,0.0,Prostate,Resection,4,59466347-C5CF-4297-83F0-349A98B6EF97,0,,0,0.075338,[Not Available],338FE754-FC4A-4294-BA15-42D4C7C9AC10,4,Prostate Adenocarcinoma Acinar Type,,Prostate,17,,Acinar Adenocarcinoma,[Not Available],,V1,1.26666666667,TCGA-V1-A9ZR,0:DiseaseFree,4,17,Prostate Adenocarcinoma,44.71,7/23/14,1361,,,,,NO,C61,DB23EC5B-D86A-4B32-8C52-E91CAD4B7695,430,1,,0.0727,0:LIVING,1.44,,44.71,Bilateral,18,No Evidence of Extraprostatic Extension,78,YES,,,,,TCGA-V1-A9ZR.DB23EC5B-D86A-4B32-8C52-E91CAD4B7695.pdf,Peripheral Zone,[Not Applicable],YES,,,7,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R1,,68,Core needle biopsy,,,NO,YES,YES,YES,T4,NO,8,No,NO,,N0,T2c,,M0,C61.9,8140/3,5587,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VP-A872,,PRAD,357,0,0,,VP,0,0,MALE,0,1.91,0.6,5,6,4,ambiguous,NO,3631,1-ERG,3631,3631,,0,0,3631,3631,prad_tcga,Malignant,15,CHEK2,51,,TCGA-VP-A872-01,0,0,0,TCGA-VP-A872,3631,3631,Prostate Cancer,,3253,3631,3631,TCGA,,3631,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-22098,,60,8,34,PRAD,3631,3631,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.36,Prostate,Resection,5,8D739C95-CEB7-4411-ACD5-E9CBFC238023,4,Normal (no evidence of prostate cancer) [cM0],0,0.11486,[Not Available],7FC65E49-0401-4A36-8800-FD87B7927FC1,3,"Prostate Adenocarcinoma, Other Subtype",,Prostate,14,,Adenocarcinoma,[Not Available],,VP,0.966666666667,TCGA-VP-A872,0:DiseaseFree,4,17,Prostate Adenocarcinoma,119.28,3/26/14,3631,,,,,NO,C61,3B27B1E2-C41E-4D31-83F5-78882BDBB284,50,4,TUMOR FREE,0.1414,0:LIVING,0.01,4,119.28,Bilateral,19,No Evidence of Extraprostatic Extension,,YES,3164,2005,,,TCGA-VP-A872.3B27B1E2-C41E-4D31-83F5-78882BDBB284.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,8,66-75%,12,"Prostate Adenocarcinoma, Other Subtype",1,2005,Complete Remission/Response,mixed ductal and acinar,NO,No,R0,,60,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,8,No,NO,0,N0,T2,0,M0,C61.9,8500/3,5588,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VP-A876,,PRAD,357,0,0,,VP,0,0,MALE,0,1.96,0.89,3,4,5,ambiguous,NO,3333,1-ERG,3333,3333,,0,0,3333,3333,prad_tcga,Malignant,12,BRCA2;RAD54L,38,,TCGA-VP-A876-01,0,0,0,TCGA-VP-A876,3333,3333,Prostate Cancer,,2576,3333,3333,TCGA,,3333,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-16934,,46,8,28,PRAD,3333,3333,,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.18,Prostate,Resection,3,798DB560-58B8-47EB-A8CA-05F7748891C5,2,Normal (no evidence of prostate cancer) [cM0],0,0.054161,[Not Available],75D22D59-DEC8-4F59-86C8-36B5E9F4FB0D,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,VP,1.03333333333,TCGA-VP-A876,0:DiseaseFree,4,16,Prostate Adenocarcinoma,109.49,3/26/14,3333,,,,,NO,C61,A10667AF-8A71-492D-B71C-95160DE9EEE6,20,2,TUMOR FREE,0.0688,0:LIVING,0.1,,109.49,Bilateral,19,No Evidence of Extraprostatic Extension,13,YES,3054,2005,,,TCGA-VP-A876.A10667AF-8A71-492D-B71C-95160DE9EEE6.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,13,91-100%,12,Prostate Adenocarcinoma Acinar Type,1,2005,Complete Remission/Response,,NO,No,R0,,46,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,8,No,NO,0,N0,T1c,0,,C61.9,8140/3,5590,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-VP-A879,,PRAD,357,0,0,,VP,2,2,MALE,2,1.99,0.5,1,1,1,HRP,NO,728,1-ERG,728,728,,2,2,728,728,prad_tcga,Malignant,3,,13,,TCGA-VP-A879-01,8,0,0,TCGA-VP-A879,728,728,Prostate Cancer,,688,728,728,TCGA,,728,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Dead,-25799,728,70,9,53,PRAD,728,728,,0.156537996,[Unknown],[Not Applicable],52,R0,1,Matched,0.0,Prostate,Resection,4,5937419C-28B9-401A-916A-A86D2E74B9C8,0,Normal (no evidence of prostate cancer) [cM0],0,0.011183,[Not Available],11882DAC-3BA3-40FA-8AF4-174CBA77881A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,4,,Acinar Adenocarcinoma,[Not Available],,VP,1.73333333333,TCGA-VP-A879,,5,5,Prostate Adenocarcinoma,,4/7/14,,,,,,NO,C61,526F7E5C-B681-46B7-B118-10AB3F2DD30E,110,0,,0.0079,1:DECEASED,0.01,,23.92,Right,7,No Evidence of Extraprostatic Extension,8,YES,2578,2006,,,TCGA-VP-A879.526F7E5C-B681-46B7-B118-10AB3F2DD30E.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,8,56-65%,2,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,,NO,YES,YES,NO,T2b,NO,9,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5592,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-VP-A87B,,PRAD,357,0,0,,VP,0,0,MALE,1,1.98,0.91,4,9,0,HRD,NO,2722,5-SPOP,2722,2722,,0,0,2473,2473,prad_tcga,Malignant,13,,120,,TCGA-VP-A87B-01,6,0,0,TCGA-VP-A87B,2722,2722,Prostate Cancer,,2309,2722,2722,TCGA,,2473,Primary,0,Apex|Base,A,,RAD51B,True,WITH TUMOR,Alive,-23271,,63,8,41,PRAD,2722,2722,,0.14777804,[Not Available],[Not Applicable],44,R0,1,Matched,0.0,Prostate,Resection,4,D3B21774-56E8-4B4E-BCAA-D368AD2EDEF8,2,Normal (no evidence of prostate cancer) [cM0],0,0.073979,[Not Available],17C0CE0F-8227-4119-9B39-EA8DB18F5F4B,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,VP,1.46666666667,TCGA-VP-A87B,1:Recurred/Progressed,4,15,Prostate Adenocarcinoma,81.24,3/28/14,2722,Lung,New Primary Tumor,,,NO,C61,C92C198A-660D-4007-AFC2-EA9FE193C3A4,70,2,TUMOR FREE,0.1284,0:LIVING,3.37,3,89.42,Right,20,No Evidence of Extraprostatic Extension,,YES,2297,2007,2473,,TCGA-VP-A87B.C92C198A-660D-4007-AFC2-EA9FE193C3A4.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,,91-100%,2,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2b,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5593,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VP-A87C,,PRAD,357,0,0,,VP,0,0,MALE,0,1.93,0.4,3,0,4,HRP,NO,1690,1-ERG,1690,1690,,0,0,1690,1690,prad_tcga,Malignant,7,BRCA1,63,,TCGA-VP-A87C-01,0,0,0,TCGA-VP-A87C,1690,1690,Prostate Cancer,,1690,1690,1690,TCGA,,1690,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-24608,,67,7,28,PRAD,1690,1690,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.0,Prostate,Resection,4,5B2C8981-0771-40CD-AE7C-E5B9AC662239,3,Normal (no evidence of prostate cancer) [cM0],0,0.067808,[Not Available],7C398299-D789-4185-ADFA-194817877947,3,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,VP,0.966666666667,TCGA-VP-A87C,0:DiseaseFree,3,7,Prostate Adenocarcinoma,55.52,3/28/14,1690,,,,,NO,C61,2E0994EC-7C5F-4721-972D-5D590674D6AC,30,3,TUMOR FREE,0.0648,0:LIVING,0.5,,55.52,Bilateral,8,No Evidence of Extraprostatic Extension,14,YES,2229,2007,,,TCGA-VP-A87C.2E0994EC-7C5F-4721-972D-5D590674D6AC.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,14,76-85%,12,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,,67,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5594,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-VP-A87D,,PRAD,357,1,1,,VP,1,0,MALE,1,1.96,0.76,5,7,2,ambiguous,NO,1853,1-ERG,1194,1853,,1,1,1194,1194,prad_tcga,Malignant,14,BRCA2;RAD51B,60,,TCGA-VP-A87D-01,0,0,0,TCGA-VP-A87D,1194,1194,Prostate Cancer,12,1853,1194,1853,TCGA,No Evidence of Extraprostatic Extension,1194,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-19818,,54,9,68,PRAD,1194,1194,,0.0,[Not Available],[Not Applicable],57,R0,1,Matched,0.09,Prostate,Resection,4,58F191CF-3C24-4D57-8A50-F7B7EC8F175D,2,Normal (no evidence of prostate cancer) [cM0],0,0.074597,[Not Available],AA405B5F-F75D-486A-96F3-1DF7ADD18193,5,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,VP,1.86666666667,TCGA-VP-A87D,1:Recurred/Progressed,5,26,Prostate Adenocarcinoma,39.22,3/28/14,1853,,Biochemical evidence of disease,,,YES,C61,48B36158-9679-4C74-BBDA-88431481A885,80,3,TUMOR FREE,0.0953,0:LIVING,0.2,,60.87,Bilateral,30,,,YES,2127,2007,1194,,TCGA-VP-A87D.48B36158-9679-4C74-BBDA-88431481A885.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,14,91-100%,12,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,YES,No,R0,,54,Core needle biopsy,1194,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,YES,0,N1,T1c,3,M0,C61.9,8140/3,5595,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VP-A87E,,PRAD,357,0,0,,VP,0,0,MALE,0,2.0,0.66,0,0,0,HRP,NO,2037,8-other,2037,2037,,0,0,2037,2037,prad_tcga,Malignant,0,,5,,TCGA-VP-A87E-01,10,0,0,TCGA-VP-A87E,2037,2037,Prostate Cancer,,2037,2037,2037,TCGA,,2037,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-21811,,59,6,25,PRAD,2037,2037,,0.343278017,[Not Available],[Not Applicable],27,R0,1,Matched,0.0,Prostate,Resection,3,E8BCC7F5-B514-4FC7-B07B-FD4AA8821463,0,Normal (no evidence of prostate cancer) [cM0],0,0.000556,[Not Available],DC20ECF0-2807-4675-A7FD-8EAD1CEE7EA0,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,VP,0.866666666667,TCGA-VP-A87E,0:DiseaseFree,1,1,Prostate Adenocarcinoma,66.92,3/28/14,2037,,,,,NO,C61,6B46F895-B5CD-40B8-8962-AA8DF2505446,220,0,TUMOR FREE,0.0,0:LIVING,0.11,,66.92,Bilateral,2,No Evidence of Extraprostatic Extension,15,YES,2059,2008,,,TCGA-VP-A87E.6B46F895-B5CD-40B8-8962-AA8DF2505446.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,15,46-55%,12,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,6,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5596,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VP-A87H,,PRAD,357,0,0,,VP,0,0,MALE,0,2.32,0.58,3,4,2,HRP,NO,663,5-SPOP,663,663,,0,0,663,663,prad_tcga,Malignant,9,,40,,TCGA-VP-A87H-01,0,0,0,TCGA-VP-A87H,663,663,Prostate Cancer,,663,663,663,TCGA,,663,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-28060,,76,9,32,PRAD,663,663,,0.0,[Not Available],[Not Applicable],36,R2,1,Matched,0.08,Prostate,Resection,4,9B3B019C-B8D4-498C-905C-27DBD44AFE20,10,,0,0.076846,[Not Available],661DC657-D2B3-44FA-B859-2C4EE42B0046,5,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,VP,1.2,TCGA-VP-A87H,0:DiseaseFree,5,8,Prostate Adenocarcinoma,21.78,3/28/14,663,,,,,NO,C61,B2B58670-AE26-43A0-8D3C-AAF354958727,50,12,WITH TUMOR,0.3105,0:LIVING,0.01,,21.78,Bilateral,13,No Evidence of Extraprostatic Extension,24,YES,1714,2009,,,TCGA-VP-A87H.B2B58670-AE26-43A0-8D3C-AAF354958727.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,,56-65%,16,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R2,,76,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,9,No,NO,0,N0,T2,0,M0,C61.9,8140/3,5597,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-VP-A87K,,PRAD,357,1,1,,VP,1,0,MALE,1,1.92,0.89,6,5,4,ambiguous,NO,1306,1-ERG,533,1306,,1,1,533,533,prad_tcga,Malignant,15,CHEK2;RAD51B,48,,TCGA-VP-A87K-01,0,0,0,TCGA-VP-A87K,533,533,Prostate Cancer,,655,533,1306,TCGA,,533,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-23030,,63,8,36,PRAD,533,533,,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.18,Prostate,Resection,4,0D98F39E-CF75-4D68-8B25-1DF098BD4930,3,Normal (no evidence of prostate cancer) [cM0],0,0.076971,[Not Available],24D7D4D8-F5C1-4D71-80E0-72A429FC9DBD,4,"Prostate Adenocarcinoma, Other Subtype",,Prostate,14,,Adenocarcinoma,[Not Available],,VP,1.2,TCGA-VP-A87K,1:Recurred/Progressed,4,17,Prostate Adenocarcinoma,22.9,3/31/14,1306,,Biochemical evidence of disease,,,NO,C61,6B2C5B8F-61B5-4D8B-A091-B28066A1629A,130,4,WITH TUMOR,0.1171,0:LIVING,0.3,,42.9,Bilateral,23,No Evidence of Extraprostatic Extension,13,YES,1112,2010,533,,TCGA-VP-A87K.6B2C5B8F-61B5-4D8B-A091-B28066A1629A.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,13,76-85%,12,"Prostate Adenocarcinoma, Other Subtype",1,2010,Complete Remission/Response,mixed ductal and acinar type,YES,No,R1,,63,Core needle biopsy,473,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8500/3,5599,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VP-AA1N,,PRAD,,0,0,,VP,0,0,MALE,0,3.62,0.54,9,18,8,HRD,NO,1365,,1365,1365,,0,0,1365,1365,prad_tcga,Malignant,35,BRCA1;BRIP1;CDK12;PALB2;RAD51C;RAD51D;RAD54L,139,,TCGA-VP-AA1N-01,6,0,0,TCGA-VP-AA1N,1365,1365,Prostate Cancer,,542,1365,1365,TCGA,,1365,Primary,0,Apex|Base,A,,ATM;CHEK1,True,TUMOR FREE,Alive,-25781,,70,9,49,PRAD,1365,1365,,0.149567758,[Not Available],[Not Applicable],38,,1,Matched,0.18,Prostate,Resection,5,D80E5EAB-10B0-470E-802E-8BA6C006F067,16,Normal (no evidence of prostate cancer) [cM0],1,0.10036,[Not Available],EA953CE5-7082-41FF-8E38-760FE4100414,4,Prostate Adenocarcinoma Acinar Type,,Prostate,37,,Acinar Adenocarcinoma,[Not Available],,VP,1.26666666667,TCGA-VP-AA1N,0:DiseaseFree,5,39,Prostate Adenocarcinoma,44.84,3/31/14,1365,,,,,NO,C61,B76B30C1-F87D-494B-A95A-3F9E511ED3B1,250,12,TUMOR FREE,0.1897,0:LIVING,0.01,,44.84,Bilateral,48,No Evidence of Extraprostatic Extension,17,YES,2112,2008,,,TCGA-VP-AA1N.B76B30C1-F87D-494B-A95A-3F9E511ED3B1.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,17,,5,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,,70,Core needle biopsy,,,NO,YES,YES,NO,T3a,YES,9,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,0,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5601,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5602,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5603,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5604,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5606,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5607,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,5608,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,0,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,5609,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,5610,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,5612,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,5613,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,5614,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,5615,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,5616,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,5617,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KS,,PRAD,,0,0,,X4,,0,MALE,0,2.04,0.24,2,4,0,ambiguous,NO,979,,,979,,0,0,979,979,prad_tcga,Malignant,6,,13,,TCGA-X4-A8KS-01,0,0,0,TCGA-X4-A8KS,979,979,Prostate Cancer,,797,,979,TCGA,,979,Primary,0,,A,,,True,TUMOR FREE,Alive,-22571,,61,7,31,PRAD,979,979,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.0,Prostate,Resection,3,874964AB-D09A-422C-9B51-7239338E78D4,2,,0,0.024833,[Not Available],56829C8D-7BB7-4AAC-999F-B1353DB4915D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,X4,1.0,TCGA-X4-A8KS,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.16,3/7/14,979,,,,,NO,C61,30844429-3F9C-4AD0-8A23-64012532347C,160,1,TUMOR FREE,0.0004,0:LIVING,0.01,,32.16,Bilateral,18,,,YES,735,2011,,,TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,RX,,61,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T2c,,M0,C61.9,8140/3,5618,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KS,,PRAD,,0,0,,X4,,0,MALE,0,2.04,0.24,2,4,0,ambiguous,NO,979,,,979,,0,0,979,979,prad_tcga,Malignant,6,,13,,TCGA-X4-A8KS-01,0,5618,0,TCGA-X4-A8KS,979,979,Prostate Cancer,,797,,979,TCGA,,979,Primary,0,,A,,,True,TUMOR FREE,Alive,-22571,,61,7,31,PRAD,979,979,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.0,Prostate,Resection,3,874964AB-D09A-422C-9B51-7239338E78D4,2,,0,0.024833,[Not Available],56829C8D-7BB7-4AAC-999F-B1353DB4915D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,X4,1.0,TCGA-X4-A8KS,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.16,3/7/14,979,,,,,NO,C61,30844429-3F9C-4AD0-8A23-64012532347C,160,1,TUMOR FREE,0.0004,0:LIVING,0.01,,32.16,Bilateral,18,,,YES,735,2011,,,TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,RX,,61,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T2c,,M0,C61.9,8140/3,5619,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KS,,PRAD,,0,0,,X4,,0,MALE,0,2.04,0.24,2,4,0,ambiguous,NO,979,,,979,,0,0,979,979,prad_tcga,Malignant,6,,13,,TCGA-X4-A8KS-01,0,5618,0,TCGA-X4-A8KS,979,979,Prostate Cancer,,797,,979,TCGA,,979,Primary,0,,A,,,True,TUMOR FREE,Alive,-22571,,61,7,31,PRAD,979,979,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.0,Prostate,Resection,3,874964AB-D09A-422C-9B51-7239338E78D4,2,,0,0.024833,[Not Available],56829C8D-7BB7-4AAC-999F-B1353DB4915D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,X4,1.0,TCGA-X4-A8KS,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.16,3/7/14,979,,,,,NO,C61,30844429-3F9C-4AD0-8A23-64012532347C,160,1,TUMOR FREE,0.0004,0:LIVING,0.01,,32.16,Bilateral,18,,,YES,735,2011,,,TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,RX,,61,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T2c,,M0,C61.9,8140/3,5620,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KS,,PRAD,,0,0,,X4,,0,MALE,0,2.04,0.24,2,4,0,ambiguous,NO,979,,,979,,0,0,979,979,prad_tcga,Malignant,6,,13,,TCGA-X4-A8KS-01,0,5618,0,TCGA-X4-A8KS,979,979,Prostate Cancer,,797,,979,TCGA,,979,Primary,0,,A,,,True,TUMOR FREE,Alive,-22571,,61,7,31,PRAD,979,979,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.0,Prostate,Resection,3,874964AB-D09A-422C-9B51-7239338E78D4,2,,0,0.024833,[Not Available],56829C8D-7BB7-4AAC-999F-B1353DB4915D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,X4,1.0,TCGA-X4-A8KS,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.16,3/7/14,979,,,,,NO,C61,30844429-3F9C-4AD0-8A23-64012532347C,160,1,TUMOR FREE,0.0004,0:LIVING,0.01,,32.16,Bilateral,18,,,YES,735,2011,,,TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,RX,,61,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T2c,,M0,C61.9,8140/3,5621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XJ-A83F,,PRAD,,0,0,,XJ,0,0,MALE,0,1.91,0.81,6,5,4,ambiguous,NO,1127,,1127,1127,,0,0,1127,1127,prad_tcga,Malignant,15,CHEK2;FANCL,71,,TCGA-XJ-A83F-01,0,0,0,TCGA-XJ-A83F,1127,1127,Prostate Cancer,,762,1127,1127,TCGA,,1127,Primary,0,Middle|Base,A,,,False,TUMOR FREE,Alive,,,67,7,38,PRAD,1127,1127,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.0,Prostate,Resection,3,4DA83354-4512-4DCA-AF59-DC8217363511,3,,0,0.088997,[Not Available],BDD4FEFA-512A-4720-9F9E-11EB3892FE3C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,XJ,1.1,TCGA-XJ-A83F,0:DiseaseFree,2,25,Prostate Adenocarcinoma,37.02,3/6/14,1127,,,,,NO,C61,FAFE6F58-BE44-442F-B0E6-F3D7BD60EFBD,20,4,TUMOR FREE,0.0835,0:LIVING,0.01,,37.02,Right,30,,,YES,872,2011,,,TCGA-XJ-A83F.FAFE6F58-BE44-442F-B0E6-F3D7BD60EFBD.pdf,Peripheral Zone,[Not Applicable],NO,,,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,RX,,67,Transurethral resection (TURBT),,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,,C61.9,8140/3,5623,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XJ-A83G,,PRAD,357,0,0,,XJ,0,0,MALE,0,1.88,0.5,9,11,1,ambiguous,NO,1461,5-SPOP,1461,1461,,0,0,1461,1461,prad_tcga,Malignant,21,,91,,TCGA-XJ-A83G-01,0,0,0,TCGA-XJ-A83G,1461,1461,Prostate Cancer,,1126,1461,1461,TCGA,,1461,Primary,0,Apex|Middle,A,,,False,TUMOR FREE,Alive,,,51,7,40,PRAD,1461,1461,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.17,Prostate,Resection,4,853395AD-9986-4800-8C7F-070F5552A5F8,0,,0,0.11786,[Not Available],BF428D43-2DA6-43FC-BD62-7CBFF84E95EC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,XJ,0.9,TCGA-XJ-A83G,0:DiseaseFree,3,23,Prostate Adenocarcinoma,48.0,3/6/14,1461,,,,,,C61,F5DB0EA7-336E-4A5E-9BFD-3291A5DB4D3D,40,3,TUMOR FREE,0.092,0:LIVING,0.01,5,48.0,Bilateral,26,,,YES,1114,2010,,,TCGA-XJ-A83G.F5DB0EA7-336E-4A5E-9BFD-3291A5DB4D3D.pdf,Peripheral Zone,[Not Applicable],NO,,91-100%,4,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,,,51,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,7,No,NO,0,N0,T1c,0,,C61.9,8140/3,5624,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XJ-A9DI,,PRAD,389,0,0,,XJ,0,0,MALE,0,2.0,0.48,0,0,0,HRP,NO,1461,1-ERG,1461,1461,,0,0,1461,1461,prad_tcga,Malignant,0,BRCA2,4,,TCGA-XJ-A9DI-01,0,0,0,TCGA-XJ-A9DI,1461,1461,Prostate Cancer,,1461,1461,1461,TCGA,,1461,Primary,0,Base,A,,,False,TUMOR FREE,Alive,,,62,9,20,PRAD,1461,1461,,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.17,Prostate,Resection,5,11A6BA1A-25F7-4F1F-A9DE-723FABFAA018,0,Normal (no evidence of prostate cancer) [cM0],0,0.000996,[Not Available],39A5AEBE-ACAD-4141-AA5A-66228C4049F8,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XJ,1.03333333333,TCGA-XJ-A9DI,0:DiseaseFree,5,0,Prostate Adenocarcinoma,48.0,5/21/14,1461,,,,,NO,C61,8D5547ED-4864-4CE1-87D0-2FE7621B9B7C,20,0,TUMOR FREE,0.0003,0:LIVING,0.1,,48.0,,1,,,YES,1443,2009,,,TCGA-XJ-A9DI.8D5547ED-4864-4CE1-87D0-2FE7621B9B7C.pdf,Peripheral Zone,[Not Applicable],NO,-61,86-95%,5,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,62,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T2b,0,M0,C61.9,8140/3,5626,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XJ-A9DK,,PRAD,389,0,0,,XJ,0,0,MALE,0,2.0,0.98,0,0,0,HRP,NO,275,1-ERG,275,275,,0,0,275,275,prad_tcga,Malignant,0,,6,,TCGA-XJ-A9DK-01,0,0,0,TCGA-XJ-A9DK,275,275,Prostate Cancer,,275,275,275,TCGA,,275,Primary,0,Apex,A,,,False,TUMOR FREE,Alive,,,63,8,5,PRAD,275,275,,0.0,[Not Available],[Not Applicable],16,R0,1,Matched,0.0,Prostate,Resection,4,36DA3689-5B86-480D-8763-FEFB7A73AD42,0,,0,0.00029,[Not Available],5A4D8694-947D-45E9-9A21-6DE0F63837F0,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XJ,0.466666666667,TCGA-XJ-A9DK,0:DiseaseFree,4,0,Prostate Adenocarcinoma,9.03,5/21/14,275,,,,,NO,C61,67B87CD1-3C76-47DD-93B9-BB9ADCF64404,70,0,,0.0,0:LIVING,0.1,,9.03,Right,5,,,YES,2327,2007,,,TCGA-XJ-A9DK.67B87CD1-3C76-47DD-93B9-BB9ADCF64404.pdf,Peripheral Zone,[Not Applicable],NO,,76-85%,,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,8,No,NO,0,,T1c,,M0,C61.9,8140/3,5627,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XJ-A9DQ,,PRAD,,0,0,,XJ,,0,MALE,0,2.0,0.65,0,0,0,HRP,NO,91,,,91,,0,0,91,91,prad_tcga,Malignant,0,,4,,TCGA-XJ-A9DQ-01,0,0,0,TCGA-XJ-A9DQ,91,91,Prostate Cancer,,,,91,TCGA,,91,Primary,0,Apex|Base,A,,,False,,Alive,,,48,6,8,PRAD,91,91,,0.0,[Not Available],[Not Applicable],11,,1,Matched,0.01,Prostate,Resection,3,60D16CC3-08EF-41A1-8DE0-AEA3A7994F70,0,,0,0.000196,[Not Available],5D8C9B90-8D40-4CDD-900D-03681BC2D2A6,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XJ,0.4,TCGA-XJ-A9DQ,0:DiseaseFree,1,0,Prostate Adenocarcinoma,2.99,5/21/14,91,,,,,NO,C61,CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7,20,0,,0.0007,0:LIVING,,,2.99,Right,3,,,YES,2265,2007,,,TCGA-XJ-A9DQ.CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2007,[Unknown],,NO,No,R0,,48,Core needle biopsy,,,NO,YES,NO,NO,T2a,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,5628,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XJ-A9DX,,PRAD,,0,0,,XJ,,0,MALE,0,2.36,0.74,3,16,18,ambiguous,NO,973,,,973,,0,0,973,973,prad_tcga,Malignant,37,ATM;CDK12;CHEK2,72,,TCGA-XJ-A9DX-01,10,0,0,TCGA-XJ-A9DX,973,973,Prostate Cancer,,790,,973,TCGA,,973,Primary,0,Base,A,,,False,TUMOR FREE,Alive,,,51,9,84,PRAD,973,973,,0.131586321,[Not Available],[Not Applicable],66,,1,Matched,0.11,Prostate,Resection,5,44E15D3B-8CA2-44EE-82A2-1984E6C468F6,5,,0,0.044194,[Not Available],84A5D5FC-7350-4846-A1BC-8BFADBCFF8DC,4,Prostate Adenocarcinoma Acinar Type,,Prostate,33,,Acinar Adenocarcinoma,[Not Available],,XJ,2.2,TCGA-XJ-A9DX,0:DiseaseFree,5,23,Prostate Adenocarcinoma,31.96,5/21/14,973,,,,,NO,C61,FB120749-2C3B-4760-82F2-73C630BF0346,40,2,TUMOR FREE,0.3074,0:LIVING,0.05,,31.96,Bilateral,24,,,YES,651,2012,,,TCGA-XJ-A9DX.FB120749-2C3B-4760-82F2-73C630BF0346.pdf,Peripheral Zone,[Not Applicable],NO,,,22,Prostate Adenocarcinoma Acinar Type,1,2012,Partial Remission/Response,,NO,No,R1,,51,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3b,,9,No,,0,N1,T1c,2,M1c,C61.9,8140/3,5629,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAIR,,PRAD,,0,0,,XK,0,0,MALE,0,1.93,0.32,5,4,3,ambiguous,NO,972,,972,972,,0,0,972,972,prad_tcga,Malignant,12,,104,,TCGA-XK-AAIR-01,0,0,0,TCGA-XK-AAIR,972,972,Prostate Cancer,,953,972,972,TCGA,,972,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-27703,,75,8,31,PRAD,972,972,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.0,Prostate,Resection,4,75C3C1C1-0348-49C5-90A8-0F9C5AABE49F,2,,0,0.074651,[Not Available],12D2B93E-A033-4B36-AE81-C15879EB40BD,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,XK,0.966666666667,TCGA-XK-AAIR,0:DiseaseFree,4,15,Prostate Adenocarcinoma,31.93,5/8/14,972,,,,,NO,C61,72784D06-D1DA-4E0C-B378-771030D57046,10,2,TUMOR FREE,0.0691,0:LIVING,0.09,,31.93,Bilateral,18,,,YES,897,2011,,,TCGA-XK-AAIR.72784D06-D1DA-4E0C-B378-771030D57046.pdf,,[Not Applicable],NO,,,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,75,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5630,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAJP,,PRAD,,0,0,,XK,0,0,MALE,0,1.88,0.81,7,10,2,ambiguous,NO,1259,,1259,1259,,0,0,1259,1259,prad_tcga,Malignant,19,,138,,TCGA-XK-AAJP-01,11,0,0,TCGA-XK-AAJP,1259,1259,Prostate Cancer,18,889,1259,1259,TCGA,No Evidence of Extraprostatic Extension,1259,Primary,1,Middle|Base,A,,,True,TUMOR FREE,Alive,-24320,,66,7,50,PRAD,1259,1259,,0.232056563,[Not Available],[Not Applicable],38,,1,Matched,0.01,Prostate,Resection,4,EC6A094B-D876-4B92-BE62-8833CA961229,1,Normal (no evidence of prostate cancer) [cM0],0,0.115,[Not Available],720D77BC-58E3-42EE-AAE7-5DE586C2AC41,3,Prostate Adenocarcinoma Acinar Type,,Prostate,19,,Acinar Adenocarcinoma,[Not Available],,XK,1.3,TCGA-XK-AAJP,0:DiseaseFree,3,19,Prostate Adenocarcinoma,41.36,5/13/14,1259,,,,,YES,C61,53A095AB-0819-49D5-BC41-7D4F761BFAE0,10,3,TUMOR FREE,0.1054,0:LIVING,0.09,,41.36,Left,23,,,YES,1008,2011,,,TCGA-XK-AAJP.53A095AB-0819-49D5-BC41-7D4F761BFAE0.pdf,Peripheral Zone,[Not Applicable],NO,18,,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,66,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5635,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XK-AAJT,,PRAD,,0,0,,XK,,0,MALE,0,1.95,0.66,10,14,4,HRD,NO,1434,,,1434,,0,0,1434,1434,prad_tcga,Malignant,28,BARD1,257,,TCGA-XK-AAJT-01,0,0,0,TCGA-XK-AAJT,1434,1434,Prostate Cancer,,566,,1434,TCGA,,1434,Primary,0,Base,A,,ATM;CHEK1;FANCL,True,TUMOR FREE,Alive,-27428,,75,7,35,PRAD,1434,1434,,0.0,[Not Available],[Not Applicable],42,,1,Matched,0.23,Prostate,Resection,4,4791634B-BCD4-4FDA-ABDB-DEC79BA05086,4,Normal (no evidence of prostate cancer) [cM0],0,0.15927,[Not Available],5D66AC77-1543-488B-A68F-665811BEC67A,3,Prostate Adenocarcinoma Acinar Type,,Prostate,31,,Acinar Adenocarcinoma,[Not Available],,XK,1.43333333333,TCGA-XK-AAJT,0:DiseaseFree,3,34,Prostate Adenocarcinoma,47.11,5/13/14,1434,,,,,NO,C61,7596C336-6BF6-4188-9C8B-90C0EC840911,10,5,WITH TUMOR,0.2114,0:LIVING,0.09,5,47.11,Bilateral,35,No Evidence of Extraprostatic Extension,14,YES,1135,2010,,,TCGA-XK-AAJT.7596C336-6BF6-4188-9C8B-90C0EC840911.pdf,Peripheral Zone,[Not Applicable],YES,19,,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,NO,No,R1,,75,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5637,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAJU,,PRAD,,0,0,,XK,0,0,MALE,0,2.0,0.5,0,0,0,HRP,NO,1576,,1576,1576,,0,0,1576,1576,prad_tcga,Malignant,0,,8,,TCGA-XK-AAJU-01,0,0,0,TCGA-XK-AAJU,1576,1576,Prostate Cancer,,1206,1576,1576,TCGA,,1576,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23958,,65,7,3,PRAD,1576,1576,,0.0,[Not Available],[Not Applicable],6,,1,Matched,0.0,Prostate,Resection,4,84FA7597-CEAA-4851-B44C-6ED9E4A34E75,0,Normal (no evidence of prostate cancer) [cM0],0,0.0025477,[Not Available],ED7084F8-060C-4780-8B35-A03A5EAB9684,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XK,0.2,TCGA-XK-AAJU,0:DiseaseFree,3,3,Prostate Adenocarcinoma,51.77,5/13/14,1576,,,,,NO,C61,08C5834B-E57D-4182-86DE-4B83314D6799,130,0,TUMOR FREE,0.0,0:LIVING,0.09,,51.77,Bilateral,8,,,YES,1276,2010,,,TCGA-XK-AAJU.08C5834B-E57D-4182-86DE-4B83314D6799.pdf,,[Not Applicable],NO,9,,5,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,5638,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-XQ-A8TA,,PRAD,370,1,1,,XQ,,1,MALE,1,1.94,0.97,12,28,18,HRD,NO,146,3-ETV4,,146,,1,1,146,146,prad_tcga,Malignant,58,CDK12;CHEK2;RAD51C;RAD51D,194,,TCGA-XQ-A8TA-01,85,0,0,TCGA-XQ-A8TA,146,146,Prostate Cancer,-10,62,,146,TCGA,Distant Metastasis [e.g. cM1],146,Primary,1,,A,,BRCA2,True,WITH TUMOR,Dead,-21889,146,59,10,151,PRAD,146,146,,0.607801737,Prostate Cancer,[Not Applicable],112,,1,Matched,0.11,Prostate,Resection,5,24EA6487-8770-452C-AB55-5BACA00E1243,4,Prostate Cancer Metastases Present [cM1b],0,0.25648,[Not Available],B47791BA-85FD-41D0-AC1F-B6FA06F18E96,5,Prostate Adenocarcinoma Acinar Type,,Prostate,59,,Acinar Adenocarcinoma,[Not Available],,XQ,3.73333333333,TCGA-XQ-A8TA,,5,60,Prostate Adenocarcinoma,,1/26/15,,,,Prostate Cancer,Medical Record,YES,C61,8AF39C5E-73E3-40EA-B328-98892AE85971,80,10,WITH TUMOR,0.3508,1:DECEASED,323.0,,4.8,Bilateral,67,Distant Metastasis [e.g. cM1],,YES,601,2012,,,TCGA-XQ-A8TA.8AF39C5E-73E3-40EA-B328-98892AE85971.pdf,Peripheral Zone,[Not Applicable],YES,,86-95%,,Prostate Adenocarcinoma Acinar Type,1,2012,Progressive Disease,,YES,No,,,59,Transurethral resection (TURBT),,Progressive Disease,,,,NO,,NO,10,"Yes, Pharmaceutical Treatment Prior to Resection",YES,0,,T3a,,M1b,C61.9,8140/3,5640,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-XQ-A8TA,,PRAD,370,1,1,,XQ,,1,MALE,1,1.94,0.97,12,28,18,HRD,NO,146,3-ETV4,,146,,1,1,146,146,prad_tcga,Malignant,58,CDK12;CHEK2;RAD51C;RAD51D,194,,TCGA-XQ-A8TA-01,85,5640,0,TCGA-XQ-A8TA,146,146,Prostate Cancer,-10,62,,146,TCGA,Distant Metastasis [e.g. cM1],146,Primary,1,,A,,BRCA2,True,WITH TUMOR,Dead,-21889,146,59,10,151,PRAD,146,146,,0.607801737,Prostate Cancer,[Not Applicable],112,,1,Matched,0.11,Prostate,Resection,5,24EA6487-8770-452C-AB55-5BACA00E1243,4,Prostate Cancer Metastases Present [cM1b],0,0.25648,[Not Available],B47791BA-85FD-41D0-AC1F-B6FA06F18E96,5,Prostate Adenocarcinoma Acinar Type,,Prostate,59,,Acinar Adenocarcinoma,[Not Available],,XQ,3.73333333333,TCGA-XQ-A8TA,,5,60,Prostate Adenocarcinoma,,1/26/15,,,,Prostate Cancer,Medical Record,YES,C61,8AF39C5E-73E3-40EA-B328-98892AE85971,80,10,WITH TUMOR,0.3508,1:DECEASED,323.0,,4.8,Bilateral,67,Distant Metastasis [e.g. cM1],,YES,601,2012,,,TCGA-XQ-A8TA.8AF39C5E-73E3-40EA-B328-98892AE85971.pdf,Peripheral Zone,[Not Applicable],YES,,86-95%,,Prostate Adenocarcinoma Acinar Type,1,2012,Progressive Disease,,YES,No,,,59,Transurethral resection (TURBT),,Progressive Disease,,,,NO,,NO,10,"Yes, Pharmaceutical Treatment Prior to Resection",YES,0,,T3a,,M1b,C61.9,8140/3,5641,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XQ-A8TB,,PRAD,370,0,0,,XQ,0,0,MALE,0,1.93,0.99,5,9,2,ambiguous,NO,770,1-ERG,770,770,,0,0,770,770,prad_tcga,Malignant,16,,82,,TCGA-XQ-A8TB-01,0,0,0,TCGA-XQ-A8TB,770,770,Prostate Cancer,,674,770,770,TCGA,,770,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-24623,,67,9,39,PRAD,770,770,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.03,Prostate,Resection,4,49E270B1-8A45-4AF9-B071-3A54845FF6FE,1,Abnormal (not related to prostate cancer),0,0.085105,[Not Available],5277F041-F9FB-47C2-83F3-65AD230DD40A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,XQ,1.0,TCGA-XQ-A8TB,0:DiseaseFree,5,22,Prostate Adenocarcinoma,25.3,1/26/15,770,,,,,NO,C61,EDF35290-BD43-4527-A8BF-ED6F3CC1F0AB,90,1,TUMOR FREE,0.0652,0:LIVING,0.0,,25.3,Bilateral,25,,,YES,420,2012,,,TCGA-XQ-A8TB.EDF35290-BD43-4527-A8BF-ED6F3CC1F0AB.pdf,Peripheral Zone,[Not Applicable],NO,-24,31-40%,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,67,Core needle biopsy,,Complete Remission/Response,,,YES,NO,T3b,YES,9,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,5642,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-Y6-A8TL,,PRAD,389,0,0,,Y6,,0,MALE,0,1.96,0.59,2,6,0,HRP,NO,992,5-SPOP,,992,,0,0,992,992,prad_tcga,Malignant,8,,79,,TCGA-Y6-A8TL-01,10,0,0,TCGA-Y6-A8TL,992,992,Prostate Cancer,,775,,992,TCGA,,992,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23776,,65,6,33,PRAD,992,992,,0.323169738,[Not Available],[Not Applicable],32,R0,1,Matched,0.0,Prostate,Resection,3,E8FA37B1-2E31-44B6-BA77-3E46DA7E4FEE,0,,0,0.047748,[Not Available],A7045324-CB44-4B37-BBAF-641642C1D903,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,Y6,1.06666666667,TCGA-Y6-A8TL,0:DiseaseFree,1,11,Prostate Adenocarcinoma,32.59,4/17/14,992,,,,,NO,C61,8DE4AB1E-913E-4763-81EE-272430E5CC4A,370,0,TUMOR FREE,0.0468,0:LIVING,0.0,,32.59,Right,12,No Evidence of Extraprostatic Extension,328,YES,677,2012,,,TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Available],,NO,No,R0,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T2a,0,,C61.9,8140/3,5643,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-Y6-A8TL,,PRAD,389,0,0,,Y6,,0,MALE,0,1.96,0.59,2,6,0,HRP,NO,992,5-SPOP,,992,,0,0,992,992,prad_tcga,Malignant,8,,79,,TCGA-Y6-A8TL-01,10,5643,0,TCGA-Y6-A8TL,992,992,Prostate Cancer,,775,,992,TCGA,,992,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23776,,65,6,33,PRAD,992,992,,0.323169738,[Not Available],[Not Applicable],32,R0,1,Matched,0.0,Prostate,Resection,3,E8FA37B1-2E31-44B6-BA77-3E46DA7E4FEE,0,,0,0.047748,[Not Available],A7045324-CB44-4B37-BBAF-641642C1D903,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,Y6,1.06666666667,TCGA-Y6-A8TL,0:DiseaseFree,1,11,Prostate Adenocarcinoma,32.59,4/17/14,992,,,,,NO,C61,8DE4AB1E-913E-4763-81EE-272430E5CC4A,370,0,TUMOR FREE,0.0468,0:LIVING,0.0,,32.59,Right,12,No Evidence of Extraprostatic Extension,328,YES,677,2012,,,TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Available],,NO,No,R0,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T2a,0,,C61.9,8140/3,5644,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-Y6-A8TL,,PRAD,389,0,0,,Y6,,0,MALE,0,1.96,0.59,2,6,0,HRP,NO,992,5-SPOP,,992,,0,0,992,992,prad_tcga,Malignant,8,,79,,TCGA-Y6-A8TL-01,10,5643,0,TCGA-Y6-A8TL,992,992,Prostate Cancer,,775,,992,TCGA,,992,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23776,,65,6,33,PRAD,992,992,,0.323169738,[Not Available],[Not Applicable],32,R0,1,Matched,0.0,Prostate,Resection,3,E8FA37B1-2E31-44B6-BA77-3E46DA7E4FEE,0,,0,0.047748,[Not Available],A7045324-CB44-4B37-BBAF-641642C1D903,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,Y6,1.06666666667,TCGA-Y6-A8TL,0:DiseaseFree,1,11,Prostate Adenocarcinoma,32.59,4/17/14,992,,,,,NO,C61,8DE4AB1E-913E-4763-81EE-272430E5CC4A,370,0,TUMOR FREE,0.0468,0:LIVING,0.0,,32.59,Right,12,No Evidence of Extraprostatic Extension,328,YES,677,2012,,,TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Available],,NO,No,R0,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T2a,0,,C61.9,8140/3,5645,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-Y6-A8TL,,PRAD,389,0,0,,Y6,,0,MALE,0,1.96,0.59,2,6,0,HRP,NO,992,5-SPOP,,992,,0,0,992,992,prad_tcga,Malignant,8,,79,,TCGA-Y6-A8TL-01,10,5643,0,TCGA-Y6-A8TL,992,992,Prostate Cancer,,775,,992,TCGA,,992,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23776,,65,6,33,PRAD,992,992,,0.323169738,[Not Available],[Not Applicable],32,R0,1,Matched,0.0,Prostate,Resection,3,E8FA37B1-2E31-44B6-BA77-3E46DA7E4FEE,0,,0,0.047748,[Not Available],A7045324-CB44-4B37-BBAF-641642C1D903,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,Y6,1.06666666667,TCGA-Y6-A8TL,0:DiseaseFree,1,11,Prostate Adenocarcinoma,32.59,4/17/14,992,,,,,NO,C61,8DE4AB1E-913E-4763-81EE-272430E5CC4A,370,0,TUMOR FREE,0.0468,0:LIVING,0.0,,32.59,Right,12,No Evidence of Extraprostatic Extension,328,YES,677,2012,,,TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Available],,NO,No,R0,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T2a,0,,C61.9,8140/3,5646,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,0,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,5648,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,5649,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,5650,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,5651,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,5652,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,5653,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-YL-A8HJ,,PRAD,370,0,0,,YL,0,0,MALE,0,1.99,0.3,0,1,0,HRD,NO,1611,1-ERG,1611,1611,,0,0,1611,1611,prad_tcga,Malignant,1,,17,,TCGA-YL-A8HJ-01,0,0,0,TCGA-YL-A8HJ,1611,1611,Prostate Cancer,,1589,1611,1611,TCGA,,1611,Primary,0,Apex|Middle|Base,A,,BRCA1;CDK12;RAD51D,True,TUMOR FREE,Alive,-21416,,58,9,44,PRAD,1611,1611,,0.0,[Not Available],[Not Applicable],32,R0,1,Matched,0.01,Prostate,Resection,4,DC782FD9-4012-41C2-B9B8-0B8A65423DF0,0,Normal (no evidence of prostate cancer) [cM0],0,0.010665,[Not Available],666D8B0C-593F-4EC3-B16A-2DADBEAD8C32,5,"Prostate Adenocarcinoma, Other Subtype",,Prostate,1,,Adenocarcinoma,[Not Available],,YL,1.06666666667,TCGA-YL-A8HJ,0:DiseaseFree,5,4,Prostate Adenocarcinoma,52.92,3/13/14,1611,,,,,NO,C61,A4B8AFC5-774E-4FB2-8191-735949EC3E42,370,0,TUMOR FREE,0.0091,0:LIVING,0.03,3,52.92,Bilateral,5,No Evidence of Extraprostatic Extension,-34,YES,1653,2009,,,TCGA-YL-A8HJ.A4B8AFC5-774E-4FB2-8191-735949EC3E42.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,54,31-40%,,"Prostate Adenocarcinoma, Other Subtype",1,2009,Complete Remission/Response,25-30% ductal component,NO,No,R0,,58,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T3b,YES,9,No,YES,0,,,,M0,C61.9,8140/3,5654,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8HK,,PRAD,370,1,1,,YL,1,0,MALE,1,1.86,0.39,10,11,8,ambiguous,NO,1491,1-ERG,1376,1491,,1,1,1376,1376,prad_tcga,Malignant,29,,71,,TCGA-YL-A8HK-01,0,0,0,TCGA-YL-A8HK,1376,1376,Prostate Cancer,,1491,1376,1491,TCGA,,1376,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-21850,,59,9,25,PRAD,1376,1376,,0.0,[Not Available],[Not Applicable],18,R1,1,Matched,0.04,Prostate,Resection,4,38336DB5-6CA9-48D5-BF4F-1F92C8070CA2,3,Normal (no evidence of prostate cancer) [cM0],0,0.14372,[Not Available],351239DB-52D3-4AB5-BD4F-8FEAA6701BA1,5,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,YL,0.6,TCGA-YL-A8HK,1:Recurred/Progressed,5,27,Prostate Adenocarcinoma,45.2,3/13/14,1491,,Biochemical evidence of disease,,,NO,C61,AB7217AC-ABF7-4704-9413-9298DDE688EE,140,4,WITH TUMOR,0.1384,0:LIVING,1.0,,48.98,Bilateral,31,No Evidence of Extraprostatic Extension,195,YES,1477,2009,1376,,TCGA-YL-A8HK.AB7217AC-ABF7-4704-9413-9298DDE688EE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,27,26-35%,1,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,YES,No,R1,,59,Core needle biopsy,1376,Complete Remission/Response,NO,YES,YES,YES,T3b,YES,9,No,YES,0,N0,,0,M0,C61.9,8140/3,5655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8HL,,PRAD,370,0,0,,YL,,0,MALE,0,1.93,0.86,5,5,5,ambiguous,NO,1565,1-ERG,,1565,,0,0,1565,1565,prad_tcga,Malignant,15,,63,,TCGA-YL-A8HL-01,0,0,0,TCGA-YL-A8HL,1565,1565,Prostate Cancer,,1173,,1565,TCGA,,1565,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-21249,,58,9,28,PRAD,1565,1565,,0.0,[Not Available],[Not Applicable],22,R1,1,Matched,0.0,Prostate,Resection,4,4CD7F57C-FD19-4DEF-A5FB-DCA3DBC10320,1,Normal (no evidence of prostate cancer) [cM0],0,0.071852,[Not Available],FF52FA2F-BD12-4DE0-9F5C-CD330FFB5FB3,5,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,YL,0.733333333333,TCGA-YL-A8HL,0:DiseaseFree,5,15,Prostate Adenocarcinoma,51.41,3/13/14,1565,,,,,NO,C61,0C91388C-CCC6-4BBD-B13A-E543A8FC2E5F,170,3,,0.0677,0:LIVING,0.03,,51.41,Bilateral,16,No Evidence of Extraprostatic Extension,27,YES,1387,2010,,,TCGA-YL-A8HL.0C91388C-CCC6-4BBD-B13A-E543A8FC2E5F.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,25,36-45%,8,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,58,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,2,M0,C61.9,8140/3,5656,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8HM,,PRAD,370,1,1,,YL,1,0,MALE,1,2.9,0.79,6,14,9,ambiguous,NO,1482,5-SPOP,1473,1482,,1,1,1473,1473,prad_tcga,Malignant,29,CHEK2,259,,TCGA-YL-A8HM-01,0,0,0,TCGA-YL-A8HM,1473,1473,Prostate Cancer,,1124,1473,1482,TCGA,,1473,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-24121,,66,9,57,PRAD,1473,1473,,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.49,Prostate,Resection,4,05F0B31E-7FEC-4D39-B5BF-BBF9B01173B0,7,Normal (no evidence of prostate cancer) [cM0],1,0.13016,[Not Available],EFF14FED-8A21-41C5-8ED3-75346A06E44E,5,Prostate Adenocarcinoma Acinar Type,,Prostate,34,,Acinar Adenocarcinoma,[Not Available],,YL,1.3,TCGA-YL-A8HM,1:Recurred/Progressed,5,38,Prostate Adenocarcinoma,48.39,3/13/14,1482,,Biochemical evidence of disease,,,NO,C61,4CDB8D1D-D1F1-4A78-A0C0-CA56CBC0689C,160,27,TUMOR FREE,0.2811,0:LIVING,0.03,,48.69,Bilateral,39,,,YES,1323,2010,1473,,TCGA-YL-A8HM.4CDB8D1D-D1F1-4A78-A0C0-CA56CBC0689C.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,26,46-55%,10,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,66,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,,0,M0,C61.9,8140/3,5657,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8HO,,PRAD,370,1,1,,YL,,0,MALE,1,2.05,0.55,12,8,7,HRD,NO,2304,8-other,,2304,,1,1,1068,1068,prad_tcga,Malignant,27,BARD1;BRCA1;BRIP1;CDK12;FANCL;PALB2;RAD51B;RAD51C;RAD51D,166,,TCGA-YL-A8HO-01,0,0,0,TCGA-YL-A8HO,1068,1068,Prostate Cancer,,2168,,2304,TCGA,,1068,Primary,0,Middle|Base,A,,BRCA2,True,WITH TUMOR,Alive,-24509,,67,7,45,PRAD,1068,1068,,0.0,[Not Available],[Not Applicable],35,R1,1,Matched,0.5,Prostate,Resection,4,CC3826CE-285E-4810-B14D-4AF327D0FDA6,8,Abnormal (not related to prostate cancer),0,0.20752,[Not Available],B7C8CA4C-8D9C-4C5B-99EE-2FCEBE4F70E6,3,Prostate Adenocarcinoma Acinar Type,,Prostate,27,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8HO,1:Recurred/Progressed,3,,Prostate Adenocarcinoma,35.09,3/14/14,2304,,Biochemical evidence of disease,,,NO,C61,3C690B20-F9EC-456D-B397-928E39B3FFE2,330,11,,0.2893,0:LIVING,0.01,5,75.69,Bilateral,,No Evidence of Extraprostatic Extension,117,YES,2100,2008,1068,,TCGA-YL-A8HO.3C690B20-F9EC-456D-B397-928E39B3FFE2.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,62,21-30%,18,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,NO,No,R1,,67,Core needle biopsy,1068,Stable Disease,NO,YES,YES,YES,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,5658,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8S8,,PRAD,389,1,1,,YL,,0,MALE,1,2.3,0.61,11,12,7,HRD,NO,1890,5-SPOP,,1890,,1,1,679,679,prad_tcga,Malignant,30,,151,,TCGA-YL-A8S8-01,0,0,0,TCGA-YL-A8S8,679,679,Prostate Cancer,,1890,,1890,TCGA,,679,Primary,0,Apex|Middle|Base,A,,BRCA2,True,WITH TUMOR,Alive,-25119,,68,9,55,PRAD,679,679,,0.0,[Not Available],[Not Applicable],40,R1,1,Matched,0.02,Prostate,Resection,4,FED650B8-8DBA-41EC-9453-076FEAA95795,7,Normal (no evidence of prostate cancer) [cM0],0,0.15576,[Not Available],494A8495-8D10-4A8F-8664-F68AC339C889,5,Prostate Adenocarcinoma Acinar Type,,Prostate,33,,Acinar Adenocarcinoma,[Not Available],,YL,1.33333333333,TCGA-YL-A8S8,1:Recurred/Progressed,5,40,Prostate Adenocarcinoma,22.31,4/25/14,1890,,Biochemical evidence of disease,,,NO,C61,6D4A3078-4C6B-4E94-B859-CCA473B09CF9,130,15,WITH TUMOR,0.3664,0:LIVING,1.36,,62.09,Bilateral,43,No Evidence of Extraprostatic Extension,28,YES,2146,2008,679,,TCGA-YL-A8S8.6D4A3078-4C6B-4E94-B859-CCA473B09CF9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,18,91-100%,10,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,YES,No,R1,,68,Core needle biopsy,679,Stable Disease,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5659,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8S9,,PRAD,389,1,1,,YL,,0,MALE,1,2.06,0.95,4,3,5,HRP,NO,1842,8-other,,1842,,1,1,1006,1006,prad_tcga,Malignant,12,,42,,TCGA-YL-A8S9-01,7,0,0,TCGA-YL-A8S9,1006,1006,Prostate Cancer,,1839,,1842,TCGA,,1006,Primary,0,Apex|Middle,A,,,True,,Alive,-23204,,63,9,48,PRAD,1006,1006,,0.190788927,[Not Available],[Not Applicable],34,R1,1,Matched,0.12,Prostate,Resection,4,6C008A4C-200B-4786-AEE3-135E9D6CD26A,3,Normal (no evidence of prostate cancer) [cM0],0,0.074842,[Not Available],B0669EEC-6A1A-4618-AE23-AE0F9E9C266C,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,YL,1.1,TCGA-YL-A8S9,1:Recurred/Progressed,5,9,Prostate Adenocarcinoma,33.05,4/25/14,1842,,Locoregional Recurrence,,,NO,C61,7E33F018-6494-413F-A68D-AC4013916756,110,5,,0.1121,0:LIVING,0.03,3,60.51,Bilateral,12,,,YES,1891,2008,1006,,TCGA-YL-A8S9.7E33F018-6494-413F-A68D-AC4013916756.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,20,81-90%,5,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,NO,No,R1,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5660,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SA,,PRAD,389,0,0,,YL,,0,MALE,0,1.92,0.81,4,7,3,HRP,NO,512,1-ERG,,512,,0,0,512,512,prad_tcga,Malignant,14,BRCA2,65,,TCGA-YL-A8SA-01,0,0,0,TCGA-YL-A8SA,512,512,Prostate Cancer,,467,,512,TCGA,,512,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-25340,,69,8,43,PRAD,512,512,,0.0,[Not Available],[Not Applicable],29,R1,1,Matched,0.02,Prostate,Resection,4,F2746759-B8E9-4744-8294-04AEF28085D2,1,,0,0.085492,[Not Available],2919AFA2-3FEE-43BD-AE68-E70718E73608,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,YL,0.966666666667,TCGA-YL-A8SA,0:DiseaseFree,4,13,Prostate Adenocarcinoma,16.82,4/25/14,512,,,,,NO,C61,F837EF53-FF44-4F51-8764-27B00168B113,200,1,,0.0816,0:LIVING,0.06,5,16.82,Bilateral,15,,,YES,1465,2009,,,TCGA-YL-A8SA.F837EF53-FF44-4F51-8764-27B00168B113.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,9,Prostate Adenocarcinoma Acinar Type,1,2009,Stable Disease,,NO,No,R1,,69,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,8,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,5661,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8SB,,PRAD,389,1,1,,YL,,0,MALE,1,1.97,0.47,4,2,3,HRP,NO,1719,8-other,,1719,,1,1,1384,1384,prad_tcga,Malignant,9,BRCA1;CHEK2;RAD51B,35,,TCGA-YL-A8SB-01,0,0,0,TCGA-YL-A8SB,1384,1384,Prostate Cancer,,1384,,1719,TCGA,,1384,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-22991,,62,9,34,PRAD,1384,1384,,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.21,Prostate,Resection,4,A3E9018E-97B3-4A9F-B579-D76FCC784168,3,Normal (no evidence of prostate cancer) [cM0],0,0.068595,[Not Available],21A29827-7896-436D-AB52-E7EDFC91E7D0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,YL,1.2,TCGA-YL-A8SB,1:Recurred/Progressed,5,12,Prostate Adenocarcinoma,45.47,4/25/14,1719,,Biochemical evidence of disease,,,NO,C61,5EE4DD0C-075E-458E-8C0C-C118A6E44219,590,3,,0.0844,0:LIVING,0.23,,56.47,Bilateral,15,No Evidence of Extraprostatic Extension,52,YES,1422,2010,1384,,TCGA-YL-A8SB.5EE4DD0C-075E-458E-8C0C-C118A6E44219.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,27,66-75%,3,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,62,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,YES,9,No,YES,0,N0,,0,M0,C61.9,8140/3,5662,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8SC,,PRAD,389,1,1,,YL,,0,MALE,1,1.95,0.66,5,2,3,ambiguous,NO,1261,2-ETV1,,1261,,1,1,152,152,prad_tcga,Malignant,10,BRCA2;FANCL,60,,TCGA-YL-A8SC-01,0,0,0,TCGA-YL-A8SC,152,152,Prostate Cancer,,1261,,1261,TCGA,,152,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-24206,,66,9,54,PRAD,152,152,,0.0,[Not Available],[Not Applicable],44,R1,1,Matched,0.06,Prostate,Resection,4,4BEE9900-172C-43B4-9AE8-83A1B199EE1A,5,Normal (no evidence of prostate cancer) [cM0],0,0.10057,[Not Available],42FA9774-9471-4707-8F6F-8041B34C49E4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,YL,1.46666666667,TCGA-YL-A8SC,1:Recurred/Progressed,5,11,Prostate Adenocarcinoma,4.99,4/27/14,1261,,Biochemical evidence of disease,,,NO,C61,557F4A89-87FC-44FA-9460-F8D1BCA759AE,100,5,WITH TUMOR,0.1463,0:LIVING,0.65,,41.43,Bilateral,16,No Evidence of Extraprostatic Extension,47,YES,1387,2010,152,,TCGA-YL-A8SC.557F4A89-87FC-44FA-9460-F8D1BCA759AE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,40,71-80%,6,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,NO,No,R1,,66,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,NO,9,No,YES,0,N0,,0,M0,C61.9,8140/3,5663,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SF,,PRAD,389,0,0,,YL,,0,MALE,0,1.96,0.69,4,10,3,ambiguous,NO,1373,1-ERG,,1373,,0,0,1373,1373,prad_tcga,Malignant,17,,89,,TCGA-YL-A8SF-01,0,0,0,TCGA-YL-A8SF,1373,1373,Prostate Cancer,,1247,,1373,TCGA,,1373,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-22844,,62,8,23,PRAD,1373,1373,,0.0,[Not Available],[Not Applicable],20,R1,1,Matched,0.01,Prostate,Resection,4,9F016E40-6306-4FE6-B90C-38273E043C30,3,Normal (no evidence of prostate cancer) [cM0],0,0.10206,[Not Available],FE7B283C-9CF4-4BE2-8A3A-251A81A8D78F,4,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,YL,0.666666666667,TCGA-YL-A8SF,0:DiseaseFree,4,19,Prostate Adenocarcinoma,45.11,4/25/14,1373,,,,,NO,C61,9E568211-305B-4F23-8B31-59D80E0EE174,520,4,,0.1365,0:LIVING,0.01,5,45.11,Bilateral,21,No Evidence of Extraprostatic Extension,22,YES,1271,2010,,,TCGA-YL-A8SF.9E568211-305B-4F23-8B31-59D80E0EE174.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,29,76-85%,2,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,62,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,NO,8,No,NO,0,N0,,0,M0,C61.9,8140/3,5664,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-YL-A8SH,,PRAD,389,0,0,,YL,2,2,MALE,2,1.93,0.68,5,9,0,HRD,NO,875,5-SPOP,875,875,,2,2,875,875,prad_tcga,Malignant,14,,97,,TCGA-YL-A8SH-01,0,0,0,TCGA-YL-A8SH,875,875,Prostate Cancer,,617,875,875,TCGA,,875,Primary,0,Apex|Middle|Base,B,ATM:1937:N/X:frameshift_variant,,True,TUMOR FREE,Dead,-25395,875,69,7,42,PRAD,875,875,,0.0,"Other, non-malignant disease",[Not Applicable],35,R0,1,Matched,0.02,Prostate,Resection,4,56A06467-7CB6-4DFF-9F57-88228210619E,0,,0,0.091978,[Not Available],BFB973EB-D42D-4900-A606-A381D2317555,3,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8SH,,3,14,Prostate Adenocarcinoma,,4/25/14,,,,"Other, non-malignant disease",Death Certificate,NO,C61,62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7,510,3,TUMOR FREE,0.0699,1:DECEASED,0.06,,28.75,Bilateral,15,,,YES,1481,2009,,,TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,5665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-YL-A8SH,,PRAD,389,0,0,,YL,2,2,MALE,2,1.93,0.68,5,9,0,HRD,NO,875,5-SPOP,875,875,,2,2,875,875,prad_tcga,Malignant,14,,97,,TCGA-YL-A8SH-01,0,5665,0,TCGA-YL-A8SH,875,875,Prostate Cancer,,617,875,875,TCGA,,875,Primary,0,Apex|Middle|Base,B,ATM:1937:N/X:frameshift_variant,,True,TUMOR FREE,Dead,-25395,875,69,7,42,PRAD,875,875,,0.0,"Other, non-malignant disease",[Not Applicable],35,R0,1,Matched,0.02,Prostate,Resection,4,56A06467-7CB6-4DFF-9F57-88228210619E,0,,0,0.091978,[Not Available],BFB973EB-D42D-4900-A606-A381D2317555,3,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8SH,,3,14,Prostate Adenocarcinoma,,4/25/14,,,,"Other, non-malignant disease",Death Certificate,NO,C61,62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7,510,3,TUMOR FREE,0.0699,1:DECEASED,0.06,,28.75,Bilateral,15,,,YES,1481,2009,,,TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,5666,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-YL-A8SH,,PRAD,389,0,0,,YL,2,2,MALE,2,1.93,0.68,5,9,0,HRD,NO,875,5-SPOP,875,875,,2,2,875,875,prad_tcga,Malignant,14,,97,,TCGA-YL-A8SH-01,0,5665,0,TCGA-YL-A8SH,875,875,Prostate Cancer,,617,875,875,TCGA,,875,Primary,0,Apex|Middle|Base,B,ATM:1937:N/X:frameshift_variant,,True,TUMOR FREE,Dead,-25395,875,69,7,42,PRAD,875,875,,0.0,"Other, non-malignant disease",[Not Applicable],35,R0,1,Matched,0.02,Prostate,Resection,4,56A06467-7CB6-4DFF-9F57-88228210619E,0,,0,0.091978,[Not Available],BFB973EB-D42D-4900-A606-A381D2317555,3,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8SH,,3,14,Prostate Adenocarcinoma,,4/25/14,,,,"Other, non-malignant disease",Death Certificate,NO,C61,62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7,510,3,TUMOR FREE,0.0699,1:DECEASED,0.06,,28.75,Bilateral,15,,,YES,1481,2009,,,TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,5667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-YL-A8SH,,PRAD,389,0,0,,YL,2,2,MALE,2,1.93,0.68,5,9,0,HRD,NO,875,5-SPOP,875,875,,2,2,875,875,prad_tcga,Malignant,14,,97,,TCGA-YL-A8SH-01,0,5665,0,TCGA-YL-A8SH,875,875,Prostate Cancer,,617,875,875,TCGA,,875,Primary,0,Apex|Middle|Base,B,ATM:1937:N/X:frameshift_variant,,True,TUMOR FREE,Dead,-25395,875,69,7,42,PRAD,875,875,,0.0,"Other, non-malignant disease",[Not Applicable],35,R0,1,Matched,0.02,Prostate,Resection,4,56A06467-7CB6-4DFF-9F57-88228210619E,0,,0,0.091978,[Not Available],BFB973EB-D42D-4900-A606-A381D2317555,3,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8SH,,3,14,Prostate Adenocarcinoma,,4/25/14,,,,"Other, non-malignant disease",Death Certificate,NO,C61,62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7,510,3,TUMOR FREE,0.0699,1:DECEASED,0.06,,28.75,Bilateral,15,,,YES,1481,2009,,,TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,5668,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SI,,PRAD,,1,1,,YL,1,0,MALE,1,1.95,0.19,1,4,0,HRP,NO,1614,,1423,1614,,1,1,1423,1423,prad_tcga,Malignant,5,,21,,TCGA-YL-A8SI-01,0,0,0,TCGA-YL-A8SI,1423,1423,Prostate Cancer,,1441,1423,1614,TCGA,,1423,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25292,,69,9,23,PRAD,1423,1423,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.03,Prostate,Resection,4,489EA5D8-AE40-405B-BBF5-E0E091193270,0,Normal (no evidence of prostate cancer) [cM0],0,0.030508,[Not Available],C5F8C89C-EF69-42F4-9B37-5B552FCCDF4B,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,YL,0.833333333333,TCGA-YL-A8SI,1:Recurred/Progressed,5,6,Prostate Adenocarcinoma,46.75,4/25/14,1614,,Biochemical evidence of disease,,,NO,C61,30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE,390,0,WITH TUMOR,0.0146,0:LIVING,0.48,,53.02,Bilateral,8,No Evidence of Extraprostatic Extension,62,YES,1345,2010,1423,,TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,47,,15,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,1423,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5669,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SI,,PRAD,,1,1,,YL,1,0,MALE,1,1.95,0.19,1,4,0,HRP,NO,1614,,1423,1614,,1,1,1423,1423,prad_tcga,Malignant,5,,21,,TCGA-YL-A8SI-01,0,5669,0,TCGA-YL-A8SI,1423,1423,Prostate Cancer,,1441,1423,1614,TCGA,,1423,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25292,,69,9,23,PRAD,1423,1423,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.03,Prostate,Resection,4,489EA5D8-AE40-405B-BBF5-E0E091193270,0,Normal (no evidence of prostate cancer) [cM0],0,0.030508,[Not Available],C5F8C89C-EF69-42F4-9B37-5B552FCCDF4B,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,YL,0.833333333333,TCGA-YL-A8SI,1:Recurred/Progressed,5,6,Prostate Adenocarcinoma,46.75,4/25/14,1614,,Biochemical evidence of disease,,,NO,C61,30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE,390,0,WITH TUMOR,0.0146,0:LIVING,0.48,,53.02,Bilateral,8,No Evidence of Extraprostatic Extension,62,YES,1345,2010,1423,,TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,47,,15,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,1423,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5670,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SI,,PRAD,,1,1,,YL,1,0,MALE,1,1.95,0.19,1,4,0,HRP,NO,1614,,1423,1614,,1,1,1423,1423,prad_tcga,Malignant,5,,21,,TCGA-YL-A8SI-01,0,5669,0,TCGA-YL-A8SI,1423,1423,Prostate Cancer,,1441,1423,1614,TCGA,,1423,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25292,,69,9,23,PRAD,1423,1423,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.03,Prostate,Resection,4,489EA5D8-AE40-405B-BBF5-E0E091193270,0,Normal (no evidence of prostate cancer) [cM0],0,0.030508,[Not Available],C5F8C89C-EF69-42F4-9B37-5B552FCCDF4B,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,YL,0.833333333333,TCGA-YL-A8SI,1:Recurred/Progressed,5,6,Prostate Adenocarcinoma,46.75,4/25/14,1614,,Biochemical evidence of disease,,,NO,C61,30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE,390,0,WITH TUMOR,0.0146,0:LIVING,0.48,,53.02,Bilateral,8,No Evidence of Extraprostatic Extension,62,YES,1345,2010,1423,,TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,47,,15,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,1423,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5671,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SJ,,PRAD,389,1,1,,YL,1,0,MALE,1,1.89,0.63,6,8,5,ambiguous,NO,1395,2-ETV1,752,1395,,1,1,752,752,prad_tcga,Malignant,19,BARD1;BRCA2;FANCL;PALB2;RAD51B;RAD54L,59,,TCGA-YL-A8SJ-01,0,0,0,TCGA-YL-A8SJ,752,752,Prostate Cancer,,1426,752,1395,TCGA,,752,Primary,0,Middle|Base,B,,,True,WITH TUMOR,Alive,-21916,,60,9,36,PRAD,752,752,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.23,Prostate,Resection,4,219FC0A7-7389-40F7-AB99-C2EE6AD501AF,0,,0,0.10711,[Not Available],F3EC5BF3-97AE-4033-91A6-084A1AA152A4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,YL,1.0,TCGA-YL-A8SJ,1:Recurred/Progressed,5,18,Prostate Adenocarcinoma,24.7,4/25/14,1395,,Biochemical evidence of disease,,,NO,C61,86F65B00-7E83-4013-85E8-A4AE42686ACF,460,4,WITH TUMOR,0.0629,0:LIVING,0.24,,45.83,Bilateral,30,,,YES,1306,2010,752,,TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,66-75%,29,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,752,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5672,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SJ,,PRAD,389,1,1,,YL,1,0,MALE,1,1.89,0.63,6,8,5,ambiguous,NO,1395,2-ETV1,752,1395,,1,1,752,752,prad_tcga,Malignant,19,BARD1;BRCA2;FANCL;PALB2;RAD51B;RAD54L,59,,TCGA-YL-A8SJ-01,0,5672,0,TCGA-YL-A8SJ,752,752,Prostate Cancer,,1426,752,1395,TCGA,,752,Primary,0,Middle|Base,B,,,True,WITH TUMOR,Alive,-21916,,60,9,36,PRAD,752,752,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.23,Prostate,Resection,4,219FC0A7-7389-40F7-AB99-C2EE6AD501AF,0,,0,0.10711,[Not Available],F3EC5BF3-97AE-4033-91A6-084A1AA152A4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,YL,1.0,TCGA-YL-A8SJ,1:Recurred/Progressed,5,18,Prostate Adenocarcinoma,24.7,4/25/14,1395,,Biochemical evidence of disease,,,NO,C61,86F65B00-7E83-4013-85E8-A4AE42686ACF,460,4,WITH TUMOR,0.0629,0:LIVING,0.24,,45.83,Bilateral,30,,,YES,1306,2010,752,,TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,66-75%,29,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,752,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5673,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SJ,,PRAD,389,1,1,,YL,1,0,MALE,1,1.89,0.63,6,8,5,ambiguous,NO,1395,2-ETV1,752,1395,,1,1,752,752,prad_tcga,Malignant,19,BARD1;BRCA2;FANCL;PALB2;RAD51B;RAD54L,59,,TCGA-YL-A8SJ-01,0,5672,0,TCGA-YL-A8SJ,752,752,Prostate Cancer,,1426,752,1395,TCGA,,752,Primary,0,Middle|Base,B,,,True,WITH TUMOR,Alive,-21916,,60,9,36,PRAD,752,752,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.23,Prostate,Resection,4,219FC0A7-7389-40F7-AB99-C2EE6AD501AF,0,,0,0.10711,[Not Available],F3EC5BF3-97AE-4033-91A6-084A1AA152A4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,YL,1.0,TCGA-YL-A8SJ,1:Recurred/Progressed,5,18,Prostate Adenocarcinoma,24.7,4/25/14,1395,,Biochemical evidence of disease,,,NO,C61,86F65B00-7E83-4013-85E8-A4AE42686ACF,460,4,WITH TUMOR,0.0629,0:LIVING,0.24,,45.83,Bilateral,30,,,YES,1306,2010,752,,TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,66-75%,29,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,752,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5674,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SJ,,PRAD,389,1,1,,YL,1,0,MALE,1,1.89,0.63,6,8,5,ambiguous,NO,1395,2-ETV1,752,1395,,1,1,752,752,prad_tcga,Malignant,19,BARD1;BRCA2;FANCL;PALB2;RAD51B;RAD54L,59,,TCGA-YL-A8SJ-01,0,5672,0,TCGA-YL-A8SJ,752,752,Prostate Cancer,,1426,752,1395,TCGA,,752,Primary,0,Middle|Base,B,,,True,WITH TUMOR,Alive,-21916,,60,9,36,PRAD,752,752,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.23,Prostate,Resection,4,219FC0A7-7389-40F7-AB99-C2EE6AD501AF,0,,0,0.10711,[Not Available],F3EC5BF3-97AE-4033-91A6-084A1AA152A4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,YL,1.0,TCGA-YL-A8SJ,1:Recurred/Progressed,5,18,Prostate Adenocarcinoma,24.7,4/25/14,1395,,Biochemical evidence of disease,,,NO,C61,86F65B00-7E83-4013-85E8-A4AE42686ACF,460,4,WITH TUMOR,0.0629,0:LIVING,0.24,,45.83,Bilateral,30,,,YES,1306,2010,752,,TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,66-75%,29,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,752,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5675,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SK,,PRAD,389,0,0,,YL,,0,MALE,0,2.03,0.44,6,9,7,HRD,NO,1408,8-other,,1408,,0,0,1408,1408,prad_tcga,Malignant,22,BRCA1;CDK12;CHEK1;RAD51D,61,,TCGA-YL-A8SK-01,0,0,0,TCGA-YL-A8SK,1408,1408,Prostate Cancer,,924,,1408,TCGA,,1408,Primary,0,Apex|Middle|Base,B,ATM:?-416:.:splice_acceptor_variant,ATM,True,,Alive,-24759,,67,9,45,PRAD,1408,1408,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.08,Prostate,Resection,4,F5243BA4-684D-4401-A1A5-7713BCC9106E,2,Normal (no evidence of prostate cancer) [cM0],0,0.10241,[Not Available],159B47B2-DC7D-4856-9A00-454E27301E23,5,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A8SK,0:DiseaseFree,5,23,Prostate Adenocarcinoma,46.25,4/25/14,1408,,,,,NO,C61,F332F5AD-A0BE-455D-9523-13BDF275DB2A,410,5,,0.1851,0:LIVING,0.03,,46.25,Bilateral,26,,,YES,1208,2010,,,TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,38,26-35%,20,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,4,M0,C61.9,8140/3,5676,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SK,,PRAD,389,0,0,,YL,,0,MALE,0,2.03,0.44,6,9,7,HRD,NO,1408,8-other,,1408,,0,0,1408,1408,prad_tcga,Malignant,22,BRCA1;CDK12;CHEK1;RAD51D,61,,TCGA-YL-A8SK-01,0,5676,0,TCGA-YL-A8SK,1408,1408,Prostate Cancer,,924,,1408,TCGA,,1408,Primary,0,Apex|Middle|Base,B,ATM:?-416:.:splice_acceptor_variant,ATM,True,,Alive,-24759,,67,9,45,PRAD,1408,1408,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.08,Prostate,Resection,4,F5243BA4-684D-4401-A1A5-7713BCC9106E,2,Normal (no evidence of prostate cancer) [cM0],0,0.10241,[Not Available],159B47B2-DC7D-4856-9A00-454E27301E23,5,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A8SK,0:DiseaseFree,5,23,Prostate Adenocarcinoma,46.25,4/25/14,1408,,,,,NO,C61,F332F5AD-A0BE-455D-9523-13BDF275DB2A,410,5,,0.1851,0:LIVING,0.03,,46.25,Bilateral,26,,,YES,1208,2010,,,TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,38,26-35%,20,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,4,M0,C61.9,8140/3,5677,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SK,,PRAD,389,0,0,,YL,,0,MALE,0,2.03,0.44,6,9,7,HRD,NO,1408,8-other,,1408,,0,0,1408,1408,prad_tcga,Malignant,22,BRCA1;CDK12;CHEK1;RAD51D,61,,TCGA-YL-A8SK-01,0,5676,0,TCGA-YL-A8SK,1408,1408,Prostate Cancer,,924,,1408,TCGA,,1408,Primary,0,Apex|Middle|Base,B,ATM:?-416:.:splice_acceptor_variant,ATM,True,,Alive,-24759,,67,9,45,PRAD,1408,1408,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.08,Prostate,Resection,4,F5243BA4-684D-4401-A1A5-7713BCC9106E,2,Normal (no evidence of prostate cancer) [cM0],0,0.10241,[Not Available],159B47B2-DC7D-4856-9A00-454E27301E23,5,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A8SK,0:DiseaseFree,5,23,Prostate Adenocarcinoma,46.25,4/25/14,1408,,,,,NO,C61,F332F5AD-A0BE-455D-9523-13BDF275DB2A,410,5,,0.1851,0:LIVING,0.03,,46.25,Bilateral,26,,,YES,1208,2010,,,TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,38,26-35%,20,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,4,M0,C61.9,8140/3,5678,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SK,,PRAD,389,0,0,,YL,,0,MALE,0,2.03,0.44,6,9,7,HRD,NO,1408,8-other,,1408,,0,0,1408,1408,prad_tcga,Malignant,22,BRCA1;CDK12;CHEK1;RAD51D,61,,TCGA-YL-A8SK-01,0,5676,0,TCGA-YL-A8SK,1408,1408,Prostate Cancer,,924,,1408,TCGA,,1408,Primary,0,Apex|Middle|Base,B,ATM:?-416:.:splice_acceptor_variant,ATM,True,,Alive,-24759,,67,9,45,PRAD,1408,1408,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.08,Prostate,Resection,4,F5243BA4-684D-4401-A1A5-7713BCC9106E,2,Normal (no evidence of prostate cancer) [cM0],0,0.10241,[Not Available],159B47B2-DC7D-4856-9A00-454E27301E23,5,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A8SK,0:DiseaseFree,5,23,Prostate Adenocarcinoma,46.25,4/25/14,1408,,,,,NO,C61,F332F5AD-A0BE-455D-9523-13BDF275DB2A,410,5,,0.1851,0:LIVING,0.03,,46.25,Bilateral,26,,,YES,1208,2010,,,TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,38,26-35%,20,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,4,M0,C61.9,8140/3,5679,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-YL-A8SL,,PRAD,389,0,0,,YL,0,0,MALE,0,3.67,0.76,3,15,8,ambiguous,NO,987,1-ERG,987,987,,0,0,987,987,prad_tcga,Malignant,26,BARD1;BRCA2;PALB2;RAD51B;RAD51C;RAD51D,56,,TCGA-YL-A8SL-01,11,0,0,TCGA-YL-A8SL,987,987,Prostate Cancer,,623,987,987,TCGA,,987,Primary,1,Apex|Middle|Base,B,,,True,TUMOR FREE,Alive,-27033,,74,8,54,PRAD,987,987,,0.239765839,[Not Available],[Not Applicable],44,R0,1,Matched,0.08,Prostate,Resection,4,6D07618C-DCF9-46E8-BA3A-F074CD091071,11,Normal (no evidence of prostate cancer) [cM0],1,0.092163,[Not Available],23EBC73D-BE3B-42F8-9390-BF18A21AFC5C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,YL,1.5,TCGA-YL-A8SL,0:DiseaseFree,4,29,Prostate Adenocarcinoma,32.42,4/25/14,987,,,,,NO,C61,561D6EB5-1E61-4134-B6F6-96B1B9A27163,760,14,TUMOR FREE,0.2142,0:LIVING,0.0,3,32.42,Bilateral,37,Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1],43,YES,835,2011,,,TCGA-YL-A8SL.561D6EB5-1E61-4134-B6F6-96B1B9A27163.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,51-60%,19,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,74,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,8,No,YES,0,N1,,3,M0,C61.9,8140/3,5680,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-YL-A8SL,,PRAD,389,0,0,,YL,0,0,MALE,0,3.67,0.76,3,15,8,ambiguous,NO,987,1-ERG,987,987,,0,0,987,987,prad_tcga,Malignant,26,BARD1;BRCA2;PALB2;RAD51B;RAD51C;RAD51D,56,,TCGA-YL-A8SL-01,11,5680,0,TCGA-YL-A8SL,987,987,Prostate Cancer,,623,987,987,TCGA,,987,Primary,1,Apex|Middle|Base,B,,,True,TUMOR FREE,Alive,-27033,,74,8,54,PRAD,987,987,,0.239765839,[Not Available],[Not Applicable],44,R0,1,Matched,0.08,Prostate,Resection,4,6D07618C-DCF9-46E8-BA3A-F074CD091071,11,Normal (no evidence of prostate cancer) [cM0],1,0.092163,[Not Available],23EBC73D-BE3B-42F8-9390-BF18A21AFC5C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,YL,1.5,TCGA-YL-A8SL,0:DiseaseFree,4,29,Prostate Adenocarcinoma,32.42,4/25/14,987,,,,,NO,C61,561D6EB5-1E61-4134-B6F6-96B1B9A27163,760,14,TUMOR FREE,0.2142,0:LIVING,0.0,3,32.42,Bilateral,37,Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1],43,YES,835,2011,,,TCGA-YL-A8SL.561D6EB5-1E61-4134-B6F6-96B1B9A27163.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,51-60%,19,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,74,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,8,No,YES,0,N1,,3,M0,C61.9,8140/3,5681,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-YL-A8SL,,PRAD,389,0,0,,YL,0,0,MALE,0,3.67,0.76,3,15,8,ambiguous,NO,987,1-ERG,987,987,,0,0,987,987,prad_tcga,Malignant,26,BARD1;BRCA2;PALB2;RAD51B;RAD51C;RAD51D,56,,TCGA-YL-A8SL-01,11,5680,0,TCGA-YL-A8SL,987,987,Prostate Cancer,,623,987,987,TCGA,,987,Primary,1,Apex|Middle|Base,B,,,True,TUMOR FREE,Alive,-27033,,74,8,54,PRAD,987,987,,0.239765839,[Not Available],[Not Applicable],44,R0,1,Matched,0.08,Prostate,Resection,4,6D07618C-DCF9-46E8-BA3A-F074CD091071,11,Normal (no evidence of prostate cancer) [cM0],1,0.092163,[Not Available],23EBC73D-BE3B-42F8-9390-BF18A21AFC5C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,YL,1.5,TCGA-YL-A8SL,0:DiseaseFree,4,29,Prostate Adenocarcinoma,32.42,4/25/14,987,,,,,NO,C61,561D6EB5-1E61-4134-B6F6-96B1B9A27163,760,14,TUMOR FREE,0.2142,0:LIVING,0.0,3,32.42,Bilateral,37,Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1],43,YES,835,2011,,,TCGA-YL-A8SL.561D6EB5-1E61-4134-B6F6-96B1B9A27163.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,51-60%,19,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,74,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,8,No,YES,0,N1,,3,M0,C61.9,8140/3,5682,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-YL-A8SL,,PRAD,389,0,0,,YL,0,0,MALE,0,3.67,0.76,3,15,8,ambiguous,NO,987,1-ERG,987,987,,0,0,987,987,prad_tcga,Malignant,26,BARD1;BRCA2;PALB2;RAD51B;RAD51C;RAD51D,56,,TCGA-YL-A8SL-01,11,5680,0,TCGA-YL-A8SL,987,987,Prostate Cancer,,623,987,987,TCGA,,987,Primary,1,Apex|Middle|Base,B,,,True,TUMOR FREE,Alive,-27033,,74,8,54,PRAD,987,987,,0.239765839,[Not Available],[Not Applicable],44,R0,1,Matched,0.08,Prostate,Resection,4,6D07618C-DCF9-46E8-BA3A-F074CD091071,11,Normal (no evidence of prostate cancer) [cM0],1,0.092163,[Not Available],23EBC73D-BE3B-42F8-9390-BF18A21AFC5C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,YL,1.5,TCGA-YL-A8SL,0:DiseaseFree,4,29,Prostate Adenocarcinoma,32.42,4/25/14,987,,,,,NO,C61,561D6EB5-1E61-4134-B6F6-96B1B9A27163,760,14,TUMOR FREE,0.2142,0:LIVING,0.0,3,32.42,Bilateral,37,Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1],43,YES,835,2011,,,TCGA-YL-A8SL.561D6EB5-1E61-4134-B6F6-96B1B9A27163.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,51-60%,19,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,74,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,8,No,YES,0,N1,,3,M0,C61.9,8140/3,5683,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8SP,,PRAD,389,1,1,,YL,,0,MALE,1,1.94,0.87,5,5,5,ambiguous,NO,2366,1-ERG,,2366,,1,1,2036,2036,prad_tcga,Malignant,15,ATM;CHEK1;CHEK2,76,,TCGA-YL-A8SP-01,0,0,0,TCGA-YL-A8SP,2036,2036,Prostate Cancer,,2155,,2366,TCGA,,2036,Primary,0,Apex|Middle|Base,B,,,True,WITH TUMOR,Alive,-21455,,58,9,33,PRAD,2036,2036,,0.0,[Not Available],[Not Applicable],26,R1,1,Matched,0.02,Prostate,Resection,4,E67173E6-2FC8-42AA-A675-9238FBD33FAD,2,,0,0.073363,[Not Available],C506FAE4-7C0A-4705-8E80-5BCC122A8A32,5,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,YL,0.866666666667,TCGA-YL-A8SP,1:Recurred/Progressed,5,17,Prostate Adenocarcinoma,66.89,4/30/14,2366,,Biochemical evidence of disease,,,,C61,C2465F7D-3F73-4DB5-BD34-370978480408,1680,4,WITH TUMOR,0.0768,0:LIVING,0.38,3,77.73,Bilateral,19,,,YES,2125,2008,2036,,TCGA-YL-A8SP.C2465F7D-3F73-4DB5-BD34-370978480408.pdf,Overlapping / Multiple Zones,[Not Applicable],,,76-85%,,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,NO,No,R1,,58,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T3b,NO,9,No,YES,0,,T2a,,M0,C61.9,8140/3,5685,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8SQ,,PRAD,389,1,1,,YL,,0,MALE,1,3.44,0.63,3,11,10,ambiguous,NO,2083,8-other,,2083,,1,1,329,329,prad_tcga,Malignant,24,ATM;BRCA1;BRCA2;BRIP1;CDK12;CHEK2;PALB2;RAD51B;RAD51C;RAD51D;RAD54L,68,,TCGA-YL-A8SQ-01,0,0,0,TCGA-YL-A8SQ,329,329,Prostate Cancer,,1943,,2083,TCGA,,329,Primary,0,Apex|Middle|Base,B,,,True,WITH TUMOR,Alive,-22482,,61,9,47,PRAD,329,329,,0.0,[Not Available],[Not Applicable],40,R1,1,Matched,0.45,Prostate,Resection,4,72BB37E2-A3A1-4DAE-9A12-818ADEBBA4E1,18,Normal (no evidence of prostate cancer) [cM0],1,0.072812,[Not Available],24E5D323-F3D4-4ADD-9A29-79E77CED357C,5,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,YL,1.33333333333,TCGA-YL-A8SQ,1:Recurred/Progressed,5,30,Prostate Adenocarcinoma,10.81,4/30/14,2083,,Biochemical evidence of disease,,,NO,C61,A714B71D-3E37-4C89-908B-1C1F0AA49DEA,2630,19,WITH TUMOR,0.4599,0:LIVING,1.1,3,68.43,Bilateral,35,,,YES,1898,2008,329,,TCGA-YL-A8SQ.A714B71D-3E37-4C89-908B-1C1F0AA49DEA.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,19,61-70%,5,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,YES,No,R1,,61,Core needle biopsy,329,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,5686,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WH,,PRAD,389,0,0,,YL,,0,MALE,0,3.11,0.75,8,12,10,ambiguous,NO,427,2-ETV1,,427,,0,0,427,427,prad_tcga,Malignant,30,BRCA2;CHEK2;RAD51C;RAD54L,63,,TCGA-YL-A9WH-01,0,0,0,TCGA-YL-A9WH,427,427,Prostate Cancer,,349,,427,TCGA,,427,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-24755,,67,9,70,PRAD,427,427,,0.0,[Not Available],[Not Applicable],55,R1,1,Matched,0.49,Prostate,Resection,4,026FCC86-6F9D-4A61-AAFE-97C8F6CC4BA5,19,Normal (no evidence of prostate cancer) [cM0],1,0.12196,[Not Available],1BCB1132-A9FC-4F03-BBED-ABAF80C7A24A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,29,,Acinar Adenocarcinoma,[Not Available],,YL,1.83333333333,TCGA-YL-A9WH,0:DiseaseFree,5,30,Prostate Adenocarcinoma,14.03,4/10/14,427,,,,,NO,C61,D7DFBDEF-50DC-4CE1-9661-110A8EAE8685,90,21,,0.5475,0:LIVING,0.03,,14.03,Bilateral,40,,,YES,853,2011,,,TCGA-YL-A9WH.D7DFBDEF-50DC-4CE1-9661-110A8EAE8685.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,55,51-60%,2,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,1,M0,C61.9,8140/3,5688,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WI,,PRAD,389,0,0,,YL,,0,MALE,0,2.27,0.88,6,12,3,ambiguous,NO,1623,6-FOXA1,,1623,,0,0,1623,1623,prad_tcga,Malignant,21,,166,,TCGA-YL-A9WI-01,19,0,0,TCGA-YL-A9WI,1623,1623,Prostate Cancer,,1259,,1623,TCGA,,1623,Primary,1,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23184,,63,9,51,PRAD,1623,1623,,0.373381833,[Not Available],[Not Applicable],41,R0,1,Matched,0.17,Prostate,Resection,4,563E009C-C93D-46CC-867D-F5C89D9336D9,10,Normal (no evidence of prostate cancer) [cM0],0,0.13134,[Not Available],2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.36666666667,TCGA-YL-A9WI,0:DiseaseFree,5,22,Prostate Adenocarcinoma,53.32,4/10/14,1623,,,,,NO,C61,746DB832-C507-4FD6-8B8A-09E6268BACC9,680,11,,0.376,0:LIVING,0.03,,53.32,Bilateral,31,No Evidence of Extraprostatic Extension,99,YES,1325,2010,,,TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,93,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R0,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,,1,M0,C61.9,8140/3,5689,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WI,,PRAD,389,0,0,,YL,,0,MALE,0,2.27,0.88,6,12,3,ambiguous,NO,1623,6-FOXA1,,1623,,0,0,1623,1623,prad_tcga,Malignant,21,,166,,TCGA-YL-A9WI-01,19,5689,0,TCGA-YL-A9WI,1623,1623,Prostate Cancer,,1259,,1623,TCGA,,1623,Primary,1,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23184,,63,9,51,PRAD,1623,1623,,0.373381833,[Not Available],[Not Applicable],41,R0,1,Matched,0.17,Prostate,Resection,4,563E009C-C93D-46CC-867D-F5C89D9336D9,10,Normal (no evidence of prostate cancer) [cM0],0,0.13134,[Not Available],2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.36666666667,TCGA-YL-A9WI,0:DiseaseFree,5,22,Prostate Adenocarcinoma,53.32,4/10/14,1623,,,,,NO,C61,746DB832-C507-4FD6-8B8A-09E6268BACC9,680,11,,0.376,0:LIVING,0.03,,53.32,Bilateral,31,No Evidence of Extraprostatic Extension,99,YES,1325,2010,,,TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,93,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R0,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,,1,M0,C61.9,8140/3,5690,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WI,,PRAD,389,0,0,,YL,,0,MALE,0,2.27,0.88,6,12,3,ambiguous,NO,1623,6-FOXA1,,1623,,0,0,1623,1623,prad_tcga,Malignant,21,,166,,TCGA-YL-A9WI-01,19,5689,0,TCGA-YL-A9WI,1623,1623,Prostate Cancer,,1259,,1623,TCGA,,1623,Primary,1,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23184,,63,9,51,PRAD,1623,1623,,0.373381833,[Not Available],[Not Applicable],41,R0,1,Matched,0.17,Prostate,Resection,4,563E009C-C93D-46CC-867D-F5C89D9336D9,10,Normal (no evidence of prostate cancer) [cM0],0,0.13134,[Not Available],2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.36666666667,TCGA-YL-A9WI,0:DiseaseFree,5,22,Prostate Adenocarcinoma,53.32,4/10/14,1623,,,,,NO,C61,746DB832-C507-4FD6-8B8A-09E6268BACC9,680,11,,0.376,0:LIVING,0.03,,53.32,Bilateral,31,No Evidence of Extraprostatic Extension,99,YES,1325,2010,,,TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,93,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R0,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,,1,M0,C61.9,8140/3,5691,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WI,,PRAD,389,0,0,,YL,,0,MALE,0,2.27,0.88,6,12,3,ambiguous,NO,1623,6-FOXA1,,1623,,0,0,1623,1623,prad_tcga,Malignant,21,,166,,TCGA-YL-A9WI-01,19,5689,0,TCGA-YL-A9WI,1623,1623,Prostate Cancer,,1259,,1623,TCGA,,1623,Primary,1,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23184,,63,9,51,PRAD,1623,1623,,0.373381833,[Not Available],[Not Applicable],41,R0,1,Matched,0.17,Prostate,Resection,4,563E009C-C93D-46CC-867D-F5C89D9336D9,10,Normal (no evidence of prostate cancer) [cM0],0,0.13134,[Not Available],2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.36666666667,TCGA-YL-A9WI,0:DiseaseFree,5,22,Prostate Adenocarcinoma,53.32,4/10/14,1623,,,,,NO,C61,746DB832-C507-4FD6-8B8A-09E6268BACC9,680,11,,0.376,0:LIVING,0.03,,53.32,Bilateral,31,No Evidence of Extraprostatic Extension,99,YES,1325,2010,,,TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,93,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R0,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,,1,M0,C61.9,8140/3,5692,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-YL-A9WJ,,PRAD,389,1,1,,YL,,1,MALE,1,1.97,0.39,6,5,3,HRD,NO,1855,8-other,,1855,,1,1,1476,1476,prad_tcga,Malignant,14,,45,,TCGA-YL-A9WJ-01,6,0,0,TCGA-YL-A9WJ,1476,1476,Prostate Cancer,51,838,,1855,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),1476,Primary,0,Apex|Middle,A,,BRCA2,True,WITH TUMOR,Dead,-17322,1855,47,8,29,PRAD,1476,1476,,0.249203434,Prostate Cancer,[Not Applicable],33,R1,1,Matched,0.07,Prostate,Resection,4,B6253DE4-A1CA-4C9A-8C82-5C4702009706,2,Normal (no evidence of prostate cancer) [cM0],0,0.060038,[Not Available],0B5ED938-6AB8-4E76-8558-1D86F3A90DFA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.1,TCGA-YL-A9WJ,1:Recurred/Progressed,4,13,Prostate Adenocarcinoma,48.49,4/14/14,,"Other, specify",Distant Metastasis,Prostate Cancer,Medical Record,YES,C61,EC025153-CB9C-4683-82B4-985AAA9E80AC,360,2,WITH TUMOR,0.0872,1:DECEASED,3.1,3,60.94,Bilateral,14,No Evidence of Extraprostatic Extension,21,YES,2017,2008,1476,Neck,TCGA-YL-A9WJ.EC025153-CB9C-4683-82B4-985AAA9E80AC.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,19,41-50%,10,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,YES,No,R1,,47,Core needle biopsy,76,Progressive Disease,NO,YES,YES,YES,T3b,YES,8,No,,0,N1,T4,1,M0,C61.9,8140/3,5693,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A9WK,,PRAD,,1,1,,YL,,0,MALE,1,2.01,0.72,5,3,5,,NO,2136,,,2136,,1,1,1009,1009,prad_tcga,Malignant,13,BARD1;BRCA2;CHEK2;FANCL,84,,TCGA-YL-A9WK-01,4,0,0,TCGA-YL-A9WK,1009,1009,Prostate Cancer,,1871,,2136,TCGA,,1009,Primary,0,Middle,A,,,True,WITH TUMOR,Alive,-23272,,63,9,35,PRAD,1009,1009,,0.110321939,[Not Available],[Not Applicable],34,,1,Matched,0.34,Prostate,Resection,4,225BC907-AFA6-424E-A618-2EB6BBF191EB,7,Normal (no evidence of prostate cancer) [cM0],0,0.14675,[Not Available],B2BCC97F-03A6-409A-8B91-78221CB10D7F,5,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A9WK,1:Recurred/Progressed,5,,Prostate Adenocarcinoma,33.15,4/13/14,2136,,Biochemical evidence of disease,,,NO,C61,B963A02D-0AE8-494C-A522-376AFABA374A,2085,8,WITH TUMOR,0.2269,0:LIVING,15.6,,70.17,Bilateral,,,,YES,1865,2008,1009,,TCGA-YL-A9WK.B963A02D-0AE8-494C-A522-376AFABA374A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,329,,1,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,YES,No,R1,,63,Core needle biopsy,1009,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,YES,0,N0,T2b,0,M0,C61.9,8140/3,5694,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A9WL,,PRAD,,1,1,,YL,1,0,MALE,1,1.87,0.94,8,10,5,ambiguous,NO,740,,740,740,,1,1,740,740,prad_tcga,Malignant,23,BRCA2;CHEK2;RAD54L,88,,TCGA-YL-A9WL-01,0,0,0,TCGA-YL-A9WL,740,740,Prostate Cancer,,740,740,740,TCGA,,740,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-21626,,59,9,35,PRAD,740,740,,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.11,Prostate,Resection,4,0EAB8AB8-59C3-4853-9296-94A9B9D07006,1,Normal (no evidence of prostate cancer) [cM0],0,0.14033,[Not Available],CFCF057A-00FE-4603-A720-586712B75803,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.1,TCGA-YL-A9WL,1:Recurred/Progressed,5,39,Prostate Adenocarcinoma,24.31,4/12/14,740,,Biochemical evidence of disease,,,NO,C61,F309E64F-E31C-478A-9F2B-B33AAD6BE37A,1300,3,WITH TUMOR,0.1404,0:LIVING,6.4,3,24.31,Bilateral,41,No Evidence of Extraprostatic Extension,39,YES,755,2011,740,,TCGA-YL-A9WL.F309E64F-E31C-478A-9F2B-B33AAD6BE37A.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,28,,15,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,,59,Core needle biopsy,740,Complete Remission/Response,NO,YES,YES,YES,T3a,YES,9,No,YES,0,N0,T2a,0,M0,C61.9,8140/3,5695,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A9WY,,PRAD,,1,1,,YL,,0,MALE,1,3.69,0.3,7,13,12,ambiguous,NO,1098,,,1098,,1,1,765,765,prad_tcga,Malignant,32,,56,,TCGA-YL-A9WY-01,0,0,0,TCGA-YL-A9WY,765,765,Prostate Cancer,62,765,,1098,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1],765,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-21164,,57,9,50,PRAD,765,765,,0.0,[Not Available],[Not Applicable],38,,1,Matched,0.19,Prostate,Resection,5,3FB026CB-327C-495C-ADBE-A80F7C5C80B4,10,Normal (no evidence of prostate cancer) [cM0],1,0.11708,[Not Available],D7E22AF5-88AA-4A83-985C-1D346DFF652D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,32,,Acinar Adenocarcinoma,[Not Available],,YL,1.26666666667,TCGA-YL-A9WY,1:Recurred/Progressed,5,33,Prostate Adenocarcinoma,32.03,4/13/14,1098,,Biochemical evidence of disease,,,YES,C61,50396173-9B31-42A1-81BC-9D2B5905E54A,970,12,WITH TUMOR,0.1806,0:LIVING,1.8,,36.07,Bilateral,39,,,YES,785,2011,765,,TCGA-YL-A9WY.50396173-9B31-42A1-81BC-9D2B5905E54A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,50,,19,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,YES,No,R1,,57,Core needle biopsy,765,,NO,YES,YES,YES,T3b,NO,9,No,YES,0,N1,T3a,11,M0,C61.9,8140/3,5697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SI,,PRAD,,1,1,,YL,1,0,MALE,1,1.95,0.19,1,4,0,HRP,NO,1614,,1423,1614,,1,1,1423,1423,prad_tcga,Malignant,5,,21,,TCGA-YL-A8SI-01,0,5669,0,TCGA-YL-A8SI,1423,1423,Prostate Cancer,,1441,1423,1614,TCGA,,1423,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25292,,69,9,23,PRAD,1423,1423,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.03,Prostate,Resection,4,489EA5D8-AE40-405B-BBF5-E0E091193270,0,Normal (no evidence of prostate cancer) [cM0],0,0.030508,[Not Available],C5F8C89C-EF69-42F4-9B37-5B552FCCDF4B,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,YL,0.833333333333,TCGA-YL-A8SI,1:Recurred/Progressed,5,6,Prostate Adenocarcinoma,46.75,4/25/14,1614,,Biochemical evidence of disease,,,NO,C61,30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE,390,0,WITH TUMOR,0.0146,0:LIVING,0.48,,53.02,Bilateral,8,No Evidence of Extraprostatic Extension,62,YES,1345,2010,1423,,TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,47,,15,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,1423,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,16289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6499,White,PRAD,161,0,0,,G9,0,0,MALE,0,3.62,0.3,5,15,10,ambiguous,NO,1543,8-other,1543,1543,,0,0,1543,1543,prad_tcga,Malignant,30,BRCA1;BRIP1;CDK12;RAD51B;RAD51C;RAD51D;RAD54L,17,8.2,TCGA-G9-6499-01,35,5381,0,TCGA-G9-6499,1543,1543,Prostate Cancer,,1109,1543,1543,TCGA,,1543,Primary,1,Apex|Base,A,,,,TUMOR FREE,Alive,-24388,,66,9,51,PRAD,1543,1543,WHITE,0.354658503,[Not Available],[Not Applicable],36,R0,1,Matched,0.3,Prostate,Resection,4,424fb9d8-f70e-4a36-b895-a766176eee7c,17,Equivocal,1,0.10454,[Not Available],acd5ceef-c5cf-4e95-9394-c50fdbc70c8d,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,30,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,2.13333333333,TCGA-G9-6499,0:DiseaseFree,5,53,Prostate Adenocarcinoma,50.69,3/20/12,1543,,,,,NO,C61,8e1d4212-b252-4019-b188-3cdd60be733d,,20,TUMOR FREE,0.2884,0:LIVING,0.11,,50.69,Bilateral,56,No Evidence of Extraprostatic Extension,421,YES,,2008,,,TCGA-G9-6499.8e1d4212-b252-4019-b188-3cdd60be733d.pdf,,[Not Applicable],YES,56,36-45%,13,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,66,Core needle biopsy,,,NO,YES,YES,,T3a,,9,No,,0,N0,T3a,0,M0,C61.9,8550/3,16830,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7788,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.71,2,2,0,HRP,NO,859,2-ETV1,859,859,,0,0,859,859,prad_tcga,Malignant,4,BRCA1;RAD51B;RAD54L,23,26.6,TCGA-EJ-7788-01,0,5322,0,TCGA-EJ-7788,859,859,Prostate Cancer,,52,859,859,TCGA,,859,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-19623,,53,7,49,PRAD,859,859,WHITE,0.0,[Not Available],[Not Applicable],35,R0,1,Matched,0.04,Prostate,Resection,3,566e79d3-defe-48c8-977e-adfbf3a6069b,0,,0,0.032492,[Not Available],e35336e1-e358-493f-9beb-276b5fc6685a,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.16666666667,TCGA-EJ-7788,0:DiseaseFree,2,6,Prostate Adenocarcinoma,28.22,4/6/12,859,,,,,NO,C61,b66a0868-e91c-4ebf-be9c-ba55e94552fd,,1,TUMOR FREE,0.0647,0:LIVING,0.2,5,28.22,Bilateral,6,,,YES,,2011,,,TCGA-EJ-7788.b66a0868-e91c-4ebf-be9c-ba55e94552fd.pdf,,[Not Applicable],NO,,71-80%,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.2,53,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T3b,0,M0,C61.9,8550/3,16915,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-CH-5750,White,PRAD,91,0,0,,CH,0,0,MALE,0,1.99,0.75,1,1,0,HRD,NO,396,2-ETV1,396,396,,0,0,396,396,prad_tcga,Malignant,2,,8,13.2,TCGA-CH-5750-01,0,5246,0,TCGA-CH-5750,396,396,Prostate Cancer,,337,396,396,TCGA,,396,Primary,0,,A,,BRCA1,,TUMOR FREE,Alive,-26389,,72,7,50,PRAD,396,396,WHITE,0.0,[Not Available],[Not Applicable],59,R0,1,Matched,0.0,Prostate,Resection,3,0386d0e9-7bd8-467f-ba97-a379c1d67a83,0,Normal (no evidence of prostate cancer) [cM0],0,0.011542,[Not Available],dc40cf49-b208-4f59-b5f0-cfbdd02970b2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,CH,1.96666666667,TCGA-CH-5750,0:DiseaseFree,2,2,Prostate Adenocarcinoma,13.01,3/16/12,396,,,,,NO,C61,4cbd15a8-2912-4a6d-bdc3-38a4ae4e1381,,0,TUMOR FREE,0.0118,0:LIVING,0.02,,13.01,Bilateral,4,No Evidence of Extraprostatic Extension,31,YES,,2008,,,TCGA-CH-5750.4cbd15a8-2912-4a6d-bdc3-38a4ae4e1381.pdf,Peripheral Zone,[Not Applicable],YES,31,66-75%,7,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.4,72,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,17271,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-2A-AAYF,,PRAD,,0,0,,2A,0,0,MALE,0,1.98,0.84,2,4,0,HRP,NO,1364,,1364,1364,,0,0,1364,1364,prad_tcga,Malignant,6,,25,,TCGA-2A-AAYF-01,0,5232,0,TCGA-2A-AAYF,1364,1364,Prostate Cancer,186,972,1364,1364,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),1364,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20866,,57,7,31,PRAD,1364,1364,,0.0,[Not Available],[Not Applicable],20,,1,Matched,0.0,Prostate,Resection,3,B98E3371-BCB8-4B59-9D23-8156DBF4746B,0,,0,0.023314,[Not Available],490E84ED-3C02-4593-990E-ADE5C109DF44,4,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,2A,0.7,TCGA-2A-AAYF,0:DiseaseFree,2,6,Prostate Adenocarcinoma,44.81,7/7/14,1364,,,,,YES,C61,106166DD-946C-4DD0-85CA-5400104959DB,150,0,TUMOR FREE,0.0222,0:LIVING,0.05,,44.81,Right,9,,,YES,897,2011,,,TCGA-2A-AAYF.106166DD-946C-4DD0-85CA-5400104959DB.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,57,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T3a,NO,7,No,NO,0,,T1c,,M0,C61.9,8140/3,18166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5514,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.94,0.6,5,10,4,ambiguous,NO,1829,8-other,1829,1829,,0,0,1829,1829,prad_tcga,Malignant,19,BRCA2,27,7.4,TCGA-EJ-5514-01,0,5278,0,TCGA-EJ-5514,1829,1829,Prostate Cancer,,724,1829,1829,TCGA,,1829,Primary,0,,A,,,,TUMOR FREE,Alive,-24165,,66,9,43,PRAD,1829,1829,WHITE,0.0,[Not Available],[Not Applicable],41,R0,1,Matched,0.22,Prostate,Resection,4,29ad80a4-b429-495c-885e-a92cfe2e4501,4,Normal (no evidence of prostate cancer) [cM0],0,0.099771,[Not Available],f82d53b1-3df8-4249-a615-464c9f4e0a32,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,22,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.33333333333,TCGA-EJ-5514,0:DiseaseFree,5,44,Prostate Adenocarcinoma,60.09,4/3/12,1829,,,,,NO,C61,5b64ad18-513e-422d-a847-d1862dd0e453,,5,TUMOR FREE,0.1629,0:LIVING,0.1,4,60.09,Bilateral,45,,,YES,,2009,,,TCGA-EJ-5514.5b64ad18-513e-422d-a847-d1862dd0e453.pdf,,[Not Applicable],NO,7,56-65%,12,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,66,Core needle biopsy,,,YES,NO,YES,,T2c,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,18449,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8SC,,PRAD,389,1,1,,YL,,0,MALE,1,1.95,0.66,5,2,3,ambiguous,NO,1261,2-ETV1,,1261,,1,1,152,152,prad_tcga,Malignant,10,BRCA2;FANCL,60,,TCGA-YL-A8SC-01,0,5663,0,TCGA-YL-A8SC,152,152,Prostate Cancer,,1261,,1261,TCGA,,152,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-24206,,66,9,54,PRAD,152,152,,0.0,[Not Available],[Not Applicable],44,R1,1,Matched,0.06,Prostate,Resection,4,4BEE9900-172C-43B4-9AE8-83A1B199EE1A,5,Normal (no evidence of prostate cancer) [cM0],0,0.10057,[Not Available],42FA9774-9471-4707-8F6F-8041B34C49E4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,YL,1.46666666667,TCGA-YL-A8SC,1:Recurred/Progressed,5,11,Prostate Adenocarcinoma,4.99,4/27/14,1261,,Biochemical evidence of disease,,,NO,C61,557F4A89-87FC-44FA-9460-F8D1BCA759AE,100,5,WITH TUMOR,0.1463,0:LIVING,0.65,,41.43,Bilateral,16,No Evidence of Extraprostatic Extension,47,YES,1387,2010,152,,TCGA-YL-A8SC.557F4A89-87FC-44FA-9460-F8D1BCA759AE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,40,71-80%,6,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,NO,No,R1,,66,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,NO,9,No,YES,0,N0,,0,M0,C61.9,8140/3,19274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A83I,,PRAD,370,0,0,,J4,0,0,MALE,0,1.91,0.79,7,10,4,ambiguous,NO,685,1-ERG,685,685,,0,0,685,685,prad_tcga,Malignant,21,PALB2;RAD51B,56,,TCGA-J4-A83I-01,7,5484,0,TCGA-J4-A83I,685,685,Prostate Cancer,,257,685,685,TCGA,,685,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23240,,63,7,40,PRAD,685,685,,0.193780289,[Not Available],[Not Applicable],28,R0,1,Matched,0.04,Prostate,Resection,4,8A59B137-8E5E-4484-A9A9-65A596A47EF8,0,,0,0.086973,[Not Available],5DC7E186-7E01-4A54-8AE8-350DACE2297B,3,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,J4,0.933333333333,TCGA-J4-A83I,0:DiseaseFree,3,21,Prostate Adenocarcinoma,22.5,1/20/14,685,,,,,,C61,E3AFE230-AE22-4120-BC42-7FE78FCB06A2,100,2,TUMOR FREE,0.0827,0:LIVING,0.1,,22.5,Bilateral,22,,,YES,183,2013,,,TCGA-J4-A83I.E3AFE230-AE22-4120-BC42-7FE78FCB06A2.pdf,Peripheral Zone,[Not Applicable],,,86-95%,2,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,19479,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5792,White,PRAD,91,0,0,,CH,,0,MALE,0,1.91,0.38,7,11,1,HRD,NO,91,8-other,,91,,0,0,91,91,prad_tcga,Malignant,19,,94,11.5,TCGA-CH-5792-01,0,0,0,TCGA-CH-5792,91,91,Prostate Cancer,,91,,91,TCGA,,91,Primary,0,,A,,ATM;CHEK1,,WITH TUMOR,Alive,-21002,,57,9,49,PRAD,91,91,WHITE,0.0,[Not Available],[Not Applicable],39,R1,1,Matched,0.0,Prostate,Resection,4,da5f8107-7b69-45b5-8beb-21d17b066cb4,0,Normal (no evidence of prostate cancer) [cM0],0,0.097822,[Not Available],8a5f2d7f-835c-4726-b238-f82d6a7f25bd,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,20,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,1.3,TCGA-CH-5792,0:DiseaseFree,5,25,Prostate Adenocarcinoma,2.99,3/21/12,91,,,,,NO,C61,72de5993-cad1-4ba0-9ea5-c545799a2f6e,,0,WITH TUMOR,0.0871,0:LIVING,11.49,,2.99,Bilateral,25,,,YES,,2009,,,TCGA-CH-5792.72de5993-cad1-4ba0-9ea5-c545799a2f6e.pdf,,[Not Applicable],NO,91,71-80%,6,Prostate Adenocarcinoma Acinar Type,1,2009,[Not Available],,NO,No,R1,0.5,57,Core needle biopsy,,,YES,NO,YES,,T3a,,9,No,,0,N0,,0,M0,C61.9,8550/3,19815,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XJ-A9DQ,,PRAD,,0,0,,XJ,,0,MALE,0,2.0,0.65,0,0,0,HRP,NO,91,,,91,,0,0,91,91,prad_tcga,Malignant,0,,4,,TCGA-XJ-A9DQ-01,0,5628,0,TCGA-XJ-A9DQ,91,91,Prostate Cancer,,,,91,TCGA,,91,Primary,0,Apex|Base,A,,,False,,Alive,,,48,6,8,PRAD,91,91,,0.0,[Not Available],[Not Applicable],11,,1,Matched,0.01,Prostate,Resection,3,60D16CC3-08EF-41A1-8DE0-AEA3A7994F70,0,,0,0.000196,[Not Available],5D8C9B90-8D40-4CDD-900D-03681BC2D2A6,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XJ,0.4,TCGA-XJ-A9DQ,0:DiseaseFree,1,0,Prostate Adenocarcinoma,2.99,5/21/14,91,,,,,NO,C61,CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7,20,0,,0.0007,0:LIVING,,,2.99,Right,3,,,YES,2265,2007,,,TCGA-XJ-A9DQ.CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2007,[Unknown],,NO,No,R0,,48,Core needle biopsy,,,NO,YES,NO,NO,T2a,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,20209,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-YL-A9WJ,,PRAD,389,1,1,,YL,,1,MALE,1,1.97,0.39,6,5,3,HRD,NO,1855,8-other,,1855,,1,1,1476,1476,prad_tcga,Malignant,14,,45,,TCGA-YL-A9WJ-01,6,5693,0,TCGA-YL-A9WJ,1476,1476,Prostate Cancer,51,838,,1855,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),1476,Primary,0,Apex|Middle,A,,BRCA2,True,WITH TUMOR,Dead,-17322,1855,47,8,29,PRAD,1476,1476,,0.249203434,Prostate Cancer,[Not Applicable],33,R1,1,Matched,0.07,Prostate,Resection,4,B6253DE4-A1CA-4C9A-8C82-5C4702009706,2,Normal (no evidence of prostate cancer) [cM0],0,0.060038,[Not Available],0B5ED938-6AB8-4E76-8558-1D86F3A90DFA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.1,TCGA-YL-A9WJ,1:Recurred/Progressed,4,13,Prostate Adenocarcinoma,48.49,4/14/14,,"Other, specify",Distant Metastasis,Prostate Cancer,Medical Record,YES,C61,EC025153-CB9C-4683-82B4-985AAA9E80AC,360,2,WITH TUMOR,0.0872,1:DECEASED,3.1,3,60.94,Bilateral,14,No Evidence of Extraprostatic Extension,21,YES,2017,2008,1476,Neck,TCGA-YL-A9WJ.EC025153-CB9C-4683-82B4-985AAA9E80AC.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,19,41-50%,10,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,YES,No,R1,,47,Core needle biopsy,76,Progressive Disease,NO,YES,YES,YES,T3b,YES,8,No,,0,N1,T4,1,M0,C61.9,8140/3,20408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAIR,,PRAD,,0,0,,XK,0,0,MALE,0,1.93,0.32,5,4,3,ambiguous,NO,972,,972,972,,0,0,972,972,prad_tcga,Malignant,12,,104,,TCGA-XK-AAIR-01,0,5630,0,TCGA-XK-AAIR,972,972,Prostate Cancer,,953,972,972,TCGA,,972,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-27703,,75,8,31,PRAD,972,972,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.0,Prostate,Resection,4,75C3C1C1-0348-49C5-90A8-0F9C5AABE49F,2,,0,0.074651,[Not Available],12D2B93E-A033-4B36-AE81-C15879EB40BD,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,XK,0.966666666667,TCGA-XK-AAIR,0:DiseaseFree,4,15,Prostate Adenocarcinoma,31.93,5/8/14,972,,,,,NO,C61,72784D06-D1DA-4E0C-B378-771030D57046,10,2,TUMOR FREE,0.0691,0:LIVING,0.09,,31.93,Bilateral,18,,,YES,897,2011,,,TCGA-XK-AAIR.72784D06-D1DA-4E0C-B378-771030D57046.pdf,,[Not Applicable],NO,,,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,75,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,21647,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MG-AAMC,,PRAD,,0,0,,MG,0,0,MALE,0,1.94,0.79,5,1,4,HRP,NO,173,,173,173,,0,0,173,173,prad_tcga,Malignant,10,BRCA1;CDK12,62,,TCGA-MG-AAMC-01,0,5546,0,TCGA-MG-AAMC,173,173,Prostate Cancer,,54,173,173,TCGA,,173,Primary,0,,A,,,True,TUMOR FREE,Alive,-21846,,59,9,28,PRAD,173,173,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.03,Prostate,Resection,4,ACA72F05-77B0-4BF3-AA43-ED10C3898C9F,3,,0,0.066859,[Not Available],9C8447AC-5B26-4558-8BFD-F0E7046C1FB9,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,MG,0.933333333333,TCGA-MG-AAMC,0:DiseaseFree,5,11,Prostate Adenocarcinoma,5.68,7/28/14,173,,,,,,C61,CBC765C1-9191-4A40-979F-CF2434B10CAB,40,3,TUMOR FREE,0.0697,0:LIVING,0.01,3,5.68,,15,,,YES,278,2013,,,TCGA-MG-AAMC.CBC765C1-9191-4A40-979F-CF2434B10CAB.pdf,,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,,NO,T3a,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,21923,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7736,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.87,0.6,8,12,2,ambiguous,NO,1103,8-other,1103,1103,,0,0,1103,1103,prad_tcga,Malignant,22,ATM;CHEK1,81,5.0,TCGA-HC-7736-01,3,5416,0,TCGA-HC-7736,1103,1103,Prostate Cancer,,102,1103,1103,TCGA,,1103,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-21703,,59,7,27,PRAD,1103,1103,WHITE,0.141806303,[Not Available],[Not Applicable],26,,1,Matched,0.01,Prostate,Resection,3,9b4b5bba-a33f-4ba8-9143-33028556e3e6,1,,0,0.13076,[Not Available],922e5166-85f5-4365-9c09-f8bdc1722da6,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,20,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,0.9,TCGA-HC-7736,0:DiseaseFree,2,20,Prostate Adenocarcinoma,36.24,4/11/12,1103,,,,,,C61,d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494,,2,TUMOR FREE,0.1245,0:LIVING,0.02,,36.24,Bilateral,22,No Evidence of Extraprostatic Extension,-21,YES,,2010,,,TCGA-HC-7736.d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494.pdf,,[Not Applicable],YES,,81-90%,13,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,No,R0,1.0,59,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,22197,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-8198,,PRAD,221,0,0,,J4,0,0,MALE,0,2.04,0.66,1,2,0,HRP,NO,614,1-ERG,614,614,,0,0,614,614,prad_tcga,Malignant,3,,18,17.9,TCGA-J4-8198-01,0,5470,0,TCGA-J4-8198,614,614,Prostate Cancer,,76,614,614,TCGA,,614,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-17935,,49,7,35,PRAD,614,614,,0.0,[Not Available],[Not Applicable],38,,1,Matched,0.0,Prostate,Resection,4,6dc2c1b2-ec10-47c9-bde1-72ecb64e258e,2,,0,0.022083,[Not Available],a1e64294-1264-498d-b18b-c9b4c729c2f2,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.4,J4,1.26666666667,TCGA-J4-8198,0:DiseaseFree,3,3,Prostate Adenocarcinoma,20.17,6/6/12,614,,,,,,C61,c61b1da1-f0d2-48c9-ac71-5967799def29,,1,,0.0753,0:LIVING,0.1,5,20.17,Bilateral,4,,,YES,,2011,,,TCGA-J4-8198.c61b1da1-f0d2-48c9-ac71-5967799def29.pdf,,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.7,49,Core needle biopsy,,,YES,NO,NO,NO,T3b,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,22264,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46H,,PRAD,,0,0,,EJ,0,0,MALE,0,2.0,0.29,0,0,0,HRP,NO,724,,724,724,,0,0,724,724,prad_tcga,Malignant,0,,5,,TCGA-EJ-A46H-01,0,5339,0,TCGA-EJ-A46H,724,724,Prostate Cancer,,131,724,724,TCGA,,724,Primary,0,,A,,,True,TUMOR FREE,Alive,-22059,,60,7,3,PRAD,724,724,,0.0,[Not Available],[Not Applicable],2,,1,Matched,0.0,Prostate,Resection,3,13A361C3-CE9D-447C-BDDD-A7AA9A1ABCFE,0,Normal (no evidence of prostate cancer) [cM0],0,0.000198,[Not Available],CEC1D2FF-36E6-497E-892C-B329724B4722,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,EJ,0.0666666666667,TCGA-EJ-A46H,0:DiseaseFree,2,0,Prostate Adenocarcinoma,23.78,1/24/13,724,,,,,,C61,CF251041-E282-4840-9652-67665E7B10BB,1800,0,TUMOR FREE,0.0,0:LIVING,0.1,,23.78,Bilateral,2,,,YES,188,2012,,,TCGA-EJ-A46H.CF251041-E282-4840-9652-67665E7B10BB.pdf,,[Not Applicable],,-6,,6,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,60,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,,M0,C61.9,8140/3,22628,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAJP,,PRAD,,0,0,,XK,0,0,MALE,0,1.88,0.81,7,10,2,ambiguous,NO,1259,,1259,1259,,0,0,1259,1259,prad_tcga,Malignant,19,,138,,TCGA-XK-AAJP-01,11,5635,0,TCGA-XK-AAJP,1259,1259,Prostate Cancer,18,889,1259,1259,TCGA,No Evidence of Extraprostatic Extension,1259,Primary,1,Middle|Base,A,,,True,TUMOR FREE,Alive,-24320,,66,7,50,PRAD,1259,1259,,0.232056563,[Not Available],[Not Applicable],38,,1,Matched,0.01,Prostate,Resection,4,EC6A094B-D876-4B92-BE62-8833CA961229,1,Normal (no evidence of prostate cancer) [cM0],0,0.115,[Not Available],720D77BC-58E3-42EE-AAE7-5DE586C2AC41,3,Prostate Adenocarcinoma Acinar Type,,Prostate,19,,Acinar Adenocarcinoma,[Not Available],,XK,1.3,TCGA-XK-AAJP,0:DiseaseFree,3,19,Prostate Adenocarcinoma,41.36,5/13/14,1259,,,,,YES,C61,53A095AB-0819-49D5-BC41-7D4F761BFAE0,10,3,TUMOR FREE,0.1054,0:LIVING,0.09,,41.36,Left,23,,,YES,1008,2011,,,TCGA-XK-AAJP.53A095AB-0819-49D5-BC41-7D4F761BFAE0.pdf,Peripheral Zone,[Not Applicable],NO,18,,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,66,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,22906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAJP,,PRAD,,0,0,,XK,0,0,MALE,0,1.88,0.81,7,10,2,ambiguous,NO,1259,,1259,1259,,0,0,1259,1259,prad_tcga,Malignant,19,,138,,TCGA-XK-AAJP-01,11,5635,0,TCGA-XK-AAJP,1259,1259,Prostate Cancer,18,889,1259,1259,TCGA,No Evidence of Extraprostatic Extension,1259,Primary,1,Middle|Base,A,,,True,TUMOR FREE,Alive,-24320,,66,7,50,PRAD,1259,1259,,0.232056563,[Not Available],[Not Applicable],38,,1,Matched,0.01,Prostate,Resection,4,EC6A094B-D876-4B92-BE62-8833CA961229,1,Normal (no evidence of prostate cancer) [cM0],0,0.115,[Not Available],720D77BC-58E3-42EE-AAE7-5DE586C2AC41,3,Prostate Adenocarcinoma Acinar Type,,Prostate,19,,Acinar Adenocarcinoma,[Not Available],,XK,1.3,TCGA-XK-AAJP,0:DiseaseFree,3,19,Prostate Adenocarcinoma,41.36,5/13/14,1259,,,,,YES,C61,53A095AB-0819-49D5-BC41-7D4F761BFAE0,10,3,TUMOR FREE,0.1054,0:LIVING,0.09,,41.36,Left,23,,,YES,1008,2011,,,TCGA-XK-AAJP.53A095AB-0819-49D5-BC41-7D4F761BFAE0.pdf,Peripheral Zone,[Not Applicable],NO,18,,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,66,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,23193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5519,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.91,0.67,10,11,5,ambiguous,NO,1962,2-ETV1,1962,1962,,0,0,1962,1962,prad_tcga,Malignant,26,,45,15.0,TCGA-EJ-5519-01,48,5283,0,TCGA-EJ-5519,1962,1962,Prostate Cancer,,1153,1962,1962,TCGA,,1962,Primary,1,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-23669,,64,8,104,PRAD,1962,1962,WHITE,0.480706254,[Not Available],[Not Applicable],92,R0,1,Matched,0.01,Prostate,Resection,4,eee1828e-d25f-462b-9735-89ca2eccc7e1,3,Normal (no evidence of prostate cancer) [cM0],0,0.11072,[Not Available],5313a055-c2d7-4cbd-a8c1-57ac85912d89,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,26,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,3.03333333333,TCGA-EJ-5519,0:DiseaseFree,4,24,Prostate Adenocarcinoma,64.45,4/3/12,1962,,,,,NO,C61,57861c52-0d80-484a-a800-65c3481327db,,4,TUMOR FREE,0.1289,0:LIVING,0.2,3,64.45,Bilateral,25,,,YES,,2008,,,TCGA-EJ-5519.57861c52-0d80-484a-a800-65c3481327db.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,13,61-70%,12,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,YES,No,R0,1.2,64,Core needle biopsy,84,,YES,NO,YES,,T3b,,8,No,,0,N1,T2c,3,M0,C61.9,8550/3,24860,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XK-AAJT,,PRAD,,0,0,,XK,,0,MALE,0,1.95,0.66,10,14,4,HRD,NO,1434,,,1434,,0,0,1434,1434,prad_tcga,Malignant,28,BARD1,257,,TCGA-XK-AAJT-01,0,5637,0,TCGA-XK-AAJT,1434,1434,Prostate Cancer,,566,,1434,TCGA,,1434,Primary,0,Base,A,,ATM;CHEK1;FANCL,True,TUMOR FREE,Alive,-27428,,75,7,35,PRAD,1434,1434,,0.0,[Not Available],[Not Applicable],42,,1,Matched,0.23,Prostate,Resection,4,4791634B-BCD4-4FDA-ABDB-DEC79BA05086,4,Normal (no evidence of prostate cancer) [cM0],0,0.15927,[Not Available],5D66AC77-1543-488B-A68F-665811BEC67A,3,Prostate Adenocarcinoma Acinar Type,,Prostate,31,,Acinar Adenocarcinoma,[Not Available],,XK,1.43333333333,TCGA-XK-AAJT,0:DiseaseFree,3,34,Prostate Adenocarcinoma,47.11,5/13/14,1434,,,,,NO,C61,7596C336-6BF6-4188-9C8B-90C0EC840911,10,5,WITH TUMOR,0.2114,0:LIVING,0.09,5,47.11,Bilateral,35,No Evidence of Extraprostatic Extension,14,YES,1135,2010,,,TCGA-XK-AAJT.7596C336-6BF6-4188-9C8B-90C0EC840911.pdf,Peripheral Zone,[Not Applicable],YES,19,,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,NO,No,R1,,75,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,25423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5744,White,PRAD,91,0,0,,CH,,0,MALE,0,1.95,0.59,4,3,5,HRP,NO,60,1-ERG,,60,,0,0,60,60,prad_tcga,Malignant,12,RAD51B,74,9.6,TCGA-CH-5744-01,5,5242,0,TCGA-CH-5744,60,60,Prostate Cancer,,48,,60,TCGA,,60,Primary,0,,A,,,,TUMOR FREE,Alive,-23621,,64,7,42,PRAD,60,60,WHITE,0.134881187,[Not Available],[Not Applicable],35,R0,1,Matched,0.0,Prostate,Resection,4,dcceaf54-0bce-4650-9980-9843abce0c41,1,Normal (no evidence of prostate cancer) [cM0],0,0.053499,[Not Available],4e76de8e-cb0d-4b83-8ab4-53bc67a7a9d3,3,Prostate Adenocarcinoma Acinar Type,0.5,Prostate,11,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,CH,1.16666666667,TCGA-CH-5744,0:DiseaseFree,3,10,Prostate Adenocarcinoma,1.97,3/16/12,60,,,,,NO,C61,797db4c8-a9d9-4404-a520-9be024ced9d5,,2,TUMOR FREE,0.0505,0:LIVING,9.63,5,1.97,Bilateral,11,No Evidence of Extraprostatic Extension,60,YES,,2008,,,TCGA-CH-5744.797db4c8-a9d9-4404-a520-9be024ced9d5.pdf,Peripheral Zone,[Not Applicable],YES,60,71-80%,3,Prostate Adenocarcinoma Acinar Type,1,2008,[Not Available],,NO,No,R0,0.4,64,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,26178,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,2.0,0.65,0,0,0,,,8,,,8,,0,0,8,8,,None,0,,2,,,,21250,N/A (Non-Malignant),,8,8,,,,,8,,,8,,,,,,,,WITH TUMOR,Alive,-11199,,,,24,,8,8,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,0,,0,1.24e-05,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Institute of Human Virology Nigeria,,TCGA-PL-A8LY,,,,,,,8,,,,,,,,,0,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,30,,,,,,,,,,,,,,,,,,,,26524,,,0,0,0,0,1.1895,1,,N/A (Non-Malignant),,,N/A (Non-Malignant),,0,0,0,N/A (Non-Malignant),[Not Available],,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Poor (so bad that tissue is not evaluable),0,Breast,Poor (so bad that tissue is not evaluable),0,0,0,0,0,Frozen,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAJU,,PRAD,,0,0,,XK,0,0,MALE,0,2.0,0.5,0,0,0,HRP,NO,1576,,1576,1576,,0,0,1576,1576,prad_tcga,Malignant,0,,8,,TCGA-XK-AAJU-01,0,5638,0,TCGA-XK-AAJU,1576,1576,Prostate Cancer,,1206,1576,1576,TCGA,,1576,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23958,,65,7,3,PRAD,1576,1576,,0.0,[Not Available],[Not Applicable],6,,1,Matched,0.0,Prostate,Resection,4,84FA7597-CEAA-4851-B44C-6ED9E4A34E75,0,Normal (no evidence of prostate cancer) [cM0],0,0.0025477,[Not Available],ED7084F8-060C-4780-8B35-A03A5EAB9684,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XK,0.2,TCGA-XK-AAJU,0:DiseaseFree,3,3,Prostate Adenocarcinoma,51.77,5/13/14,1576,,,,,NO,C61,08C5834B-E57D-4182-86DE-4B83314D6799,130,0,TUMOR FREE,0.0,0:LIVING,0.09,,51.77,Bilateral,8,,,YES,1276,2010,,,TCGA-XK-AAJU.08C5834B-E57D-4182-86DE-4B83314D6799.pdf,,[Not Applicable],NO,9,,5,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,27375,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-KK-A6E4,,PRAD,,0,0,,KK,2,2,MALE,2,1.92,0.82,5,6,1,HRD,NO,3502,,3502,3502,,2,2,3502,3502,prad_tcga,Malignant,12,BARD1;BRCA1;BRIP1;CDK12;FANCL;RAD51C;RAD51D;RAD54L,36,,TCGA-KK-A6E4-01,0,5503,0,TCGA-KK-A6E4,3502,3502,Prostate Cancer,,890,3502,3502,TCGA,,3502,Primary,0,Apex|Middle|Base,A,,BRCA2,True,TUMOR FREE,Dead,-25338,3502,69,7,48,PRAD,3502,3502,,0.0,[Not Available],[Not Applicable],39,,1,Matched,0.06,Prostate,Resection,3,A1468DDD-3273-407F-AC8E-8ABF4B952FC1,0,,0,0.070622,[Not Available],DCF383D5-B25A-4EA9-A3F4-4D7EA5DDD9EF,4,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,1.33333333333,TCGA-KK-A6E4,,2,16,Prostate Adenocarcinoma,,3/27/14,,,,,,NO,C61,D4A30E0D-4829-4B4E-863A-DF2ACED85BE8,190,0,TUMOR FREE,0.1139,1:DECEASED,0.1,,115.05,Right,18,,,YES,3094,2004,,,TCGA-KK-A6E4.D4A30E0D-4829-4B4E-863A-DF2ACED85BE8.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2004,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,,NO,YES,YES,NO,T2b,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,27465,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-EJ-A7NN,,PRAD,,1,1,,EJ,1,0,MALE,1,,,,,,,NO,197,,197,197,,1,1,197,197,prad_tcga,Malignant,,,,,TCGA-EJ-A7NN-01,0,0,0,TCGA-EJ-A7NN,197,197,Prostate Cancer,,197,197,197,TCGA,,197,Primary,0,,A,,,True,TUMOR FREE,Alive,-22499,,61,7,48,PRAD,197,197,,0.0,[Not Available],[Not Applicable],37,,1,Matched,,Prostate,Resection,4,FBCFE148-21F4-4A60-9343-2A32D9993CA1,,,,,[Not Available],C8FAB4A7-FD7E-4D5E-A330-18C7E148B9D0,3,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,EJ,1.26666666667,TCGA-EJ-A7NN,1:Recurred/Progressed,3,,Prostate Adenocarcinoma,6.47,3/4/14,197,,Biochemical evidence of disease,,,,C61,4027496E-5E84-4502-BD86-980339AD9896,240,,TUMOR FREE,,0:LIVING,0.3,,6.47,Bilateral,,,,YES,191,2013,197,,TCGA-EJ-A7NN.4027496E-5E84-4502-BD86-980339AD9896.pdf,,[Not Applicable],,,,25,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,YES,No,R1,,61,Core needle biopsy,197,Complete Remission/Response,YES,NO,YES,YES,T3b,NO,7,No,NO,0,N1,T3b,3,M0,C61.9,8140/3,27550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,PRAD,184,0,0,TCGA-EJ-7331,University of Pittsburgh,0,0,MALE,0,1.97,0.48,2,7,0,HRP,,742,8-other,742,742,,0,0,742,742,,Malignant,9,,19,7.0,,0,5310,0,,742,742,,,,742,742,TCGA,,742,,0,,,,,,TUMOR FREE,Alive,-23458,,,,31,,742,742,,0.0,[Not Available],[Not Applicable],,R0,,,0.01,Prostate,Resection,,,0,,0,0.033828,[Not Available],,,Prostate Adenocarcinoma Acinar Type,,,9,,Acinar Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-EJ-7331,,,10,,,,742,,,,,,,,,0,,,,,,,,11,,,,,2011,,,,,[Not Applicable],,,16-25%,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,28102,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6370,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.0,0.38,0,0,0,HRD,NO,1156,8-other,1156,1156,,0,0,1156,1156,prad_tcga,Malignant,0,,0,6.4,TCGA-G9-6370-01,0,5370,0,TCGA-G9-6370,1156,1156,Prostate Cancer,,806,1156,1156,TCGA,,1156,Primary,0,Apex|Base,A,BARD1:507:V/X:frameshift_variant,,,TUMOR FREE,Alive,-19149,,52,7,2,PRAD,1156,1156,WHITE,0.0,[Not Available],[Not Applicable],7,R0,1,Matched,0.0,Prostate,Resection,3,644e1e7d-dfd1-4f83-82dc-ae0c7e010f6f,0,,0,0.0,[Not Available],f947b0bc-bdac-44e8-b5b9-ffae4147740a,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.233333333333,TCGA-G9-6370,0:DiseaseFree,2,0,Prostate Adenocarcinoma,37.98,3/7/12,1156,,,,,NO,C61,fa0332e6-d535-45c0-8ed9-9b36816f1350,,0,TUMOR FREE,0.0,0:LIVING,0.03,,37.98,Bilateral,2,,,YES,,2009,,,TCGA-G9-6370.fa0332e6-d535-45c0-8ed9-9b36816f1350.pdf,,[Not Applicable],NO,,16-25%,1,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.6,52,Core needle biopsy,,,NO,YES,YES,,T3b,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,28407,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-H9-7775,White,PRAD,184,0,0,,H9,0,0,MALE,0,1.97,0.79,2,3,2,HRP,NO,185,4-FLI1,185,185,,0,0,185,185,prad_tcga,Malignant,7,,20,7.2,TCGA-H9-7775-01,0,5398,0,TCGA-H9-7775,185,185,Prostate Cancer,,73,185,185,TCGA,,185,Primary,0,,A,,,,TUMOR FREE,Alive,-24898,,68,7,41,PRAD,185,185,WHITE,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,3,09bb6311-41ad-46a1-8195-6d1fdacd7cb0,1,,0,0.032713,[Not Available],ecade538-f882-4f29-a363-7acb89fd0576,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,H9,1.06666666667,TCGA-H9-7775,0:DiseaseFree,2,6,Prostate Adenocarcinoma,6.08,2/8/12,185,,,,,,C61,2a752788-15f1-4879-96a7-eaf5dfa6921d,,1,,0.0311,0:LIVING,0.04,0,6.08,Right,8,,,YES,,2011,,,TCGA-H9-7775.2a752788-15f1-4879-96a7-eaf5dfa6921d.pdf,,[Not Applicable],,,91-100%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.6,68,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,,,,C61.9,8550/3,28879,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7786,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.96,0.55,2,4,2,HRP,NO,1096,8-other,1096,1096,,0,0,1096,1096,prad_tcga,Malignant,8,BRCA2,5,4.5,TCGA-EJ-7786-01,24,5320,0,TCGA-EJ-7786,1096,1096,Prostate Cancer,,79,1096,1096,TCGA,,1096,Primary,1,,A,,,,TUMOR FREE,Alive,-22793,,62,7,31,PRAD,1096,1096,WHITE,0.302699624,[Not Available],[Not Applicable],50,R0,1,Matched,0.03,Prostate,Resection,3,e52217cc-26f9-48ed-a3ce-ca5b963c66ce,0,,0,0.062037,[Not Available],9d499039-37ca-4300-ae95-04bbe007c0d2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.6,EJ,3.1,TCGA-EJ-7786,0:DiseaseFree,2,9,Prostate Adenocarcinoma,36.01,4/6/12,1096,,,,,NO,C61,3b3ac042-2bb6-445b-a82b-eea969f0bd33,,2,TUMOR FREE,0.0839,0:LIVING,0.1,3,36.01,Bilateral,11,,,YES,,2011,,,TCGA-EJ-7786.3b3ac042-2bb6-445b-a82b-eea969f0bd33.pdf,,[Not Applicable],NO,,61-70%,5,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.7,62,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,29090,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,PRAD,184,0,0,TCGA-EJ-7794,University of Pittsburgh,0,0,MALE,0,1.96,0.34,2,7,0,HRD,,1306,8-other,1306,1306,,0,0,1306,1306,,Malignant,9,,16,5.2,,0,5331,0,,1306,1306,,,,1306,1306,TCGA,,1306,,0,,,,BRCA2,,TUMOR FREE,Alive,-24478,,,,17,,1306,1306,,0.0,[Not Available],[Not Applicable],,R0,,,0.04,Prostate,Resection,,,0,,0,0.039203,[Not Available],,,Prostate Adenocarcinoma Acinar Type,,,9,,Acinar Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-EJ-7794,,,21,,,,1306,,,,,,,,,1,,,,,,,,24,,,,,2010,,,,,[Not Applicable],,,6-15%,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,29569,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,PRAD,108,0,0,TCGA-G9-6385,Roswell Park,0,0,MALE,0,2.0,0.2,0,0,0,HRP,,830,1-ERG,830,830,,0,0,830,830,,Malignant,0,,0,7.4,,0,5377,0,,830,830,,,,830,830,TCGA,,830,,0,,,,,,TUMOR FREE,Alive,-24399,,,,11,,830,830,,0.0,[Not Available],[Not Applicable],,R0,,,0.0,Prostate,Resection,,,0,,0,0.0,[Not Available],,,Prostate Adenocarcinoma Acinar Type,,,0,,Acinar Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-G9-6385,,,1,,,,830,,,,,,,,,0,,,,,,,,4,,,,,2010,,,,,[Not Applicable],,,41-50%,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,29870,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-EJ-A65F,,PRAD,315,1,1,,EJ,,0,MALE,1,2.08,0.67,4,12,11,HRD,NO,560,1-ERG,,560,,1,1,75,75,prad_tcga,Malignant,27,,34,25.0,TCGA-EJ-A65F-01,59,0,0,TCGA-EJ-A65F,75,75,Prostate Cancer,,75,,560,TCGA,,75,Primary,1,,A,,BRCA2,True,[Discrepancy],Alive,-21681,,59,9,102,PRAD,75,75,,0.676303587,[Not Available],[Not Applicable],73,R0,1,Matched,0.02,Prostate,Resection,4,AF0C6ECC-502D-46FF-B5AA-4A34D9928A6E,2,,0,0.040876,[Not Available],8631BB5E-6D08-4C20-A85E-CB84F5DAC290,5,"Prostate Adenocarcinoma, Other Subtype",,Prostate,27,,Adenocarcinoma,[Not Available],,EJ,2.4,TCGA-EJ-A65F,1:Recurred/Progressed,5,26,Prostate Adenocarcinoma,2.46,3/4/14,560,,Biochemical evidence of disease,,,,C61,635A6F68-B3A7-4856-BE21-C2DC0AADAA59,360,5,,0.1558,0:LIVING,0.8,,18.4,Bilateral,30,,,YES,293,2012,75,,TCGA-EJ-A65F.635A6F68-B3A7-4856-BE21-C2DC0AADAA59.pdf,,[Not Applicable],,,31-40%,4,"Prostate Adenocarcinoma, Other Subtype",1,2012,Progressive Disease,acinar and cribriform,YES,No,R0,,59,Core needle biopsy,75,Progressive Disease,YES,NO,YES,YES,T3b,NO,9,No,NO,0,N0,T3b,0,M0,C61.9,8255/3,30022,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8265,,PRAD,221,0,0,,HC,0,0,MALE,0,2.16,0.5,0,3,5,HRD,NO,483,6-FOXA1,483,483,,0,0,483,483,prad_tcga,Malignant,8,,18,5.2,TCGA-HC-8265-01,0,5445,0,TCGA-HC-8265,483,483,Prostate Cancer,,119,483,483,TCGA,,483,Primary,0,,A,CDK12:54-59:GLVTPE/X:frameshift_variant;CDK12:598:Q/*:stop_gained,,,TUMOR FREE,Alive,-24382,,66,8,75,PRAD,483,483,,0.0,[Not Available],[Not Applicable],70,R1,1,Matched,0.15,Prostate,Resection,3,6715e5bf-1653-4bf6-ba96-149574b3b711,1,,0,0.0078663,[Not Available],3e290dc6-aba3-4135-b844-3e8c4cc8a25f,5,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,10,,Acinar Adenocarcinoma,[Not Available],0.1,HC,2.3,TCGA-HC-8265,0:DiseaseFree,4,6,Prostate Adenocarcinoma,15.87,6/20/12,483,,,,,,C61,7c2f8bb7-3fe0-459e-a885-6d7a97d753f1,,0,WITH TUMOR,0.1478,0:LIVING,0.1,,15.87,Bilateral,12,,,YES,,2011,,,TCGA-HC-8265.7c2f8bb7-3fe0-459e-a885-6d7a97d753f1.pdf,,[Not Applicable],,,41-50%,8,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.8,66,Core needle biopsy,,,YES,NO,YES,NO,T3a,,8,No,,0,N0,,0,,C61.9,8550/3,30214,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A65D,,PRAD,,0,0,,EJ,0,0,MALE,0,1.95,0.97,4,6,2,ambiguous,NO,393,,393,393,,0,0,393,393,prad_tcga,Malignant,12,,41,,TCGA-EJ-A65D-01,0,0,0,TCGA-EJ-A65D,393,393,Prostate Cancer,,393,393,393,TCGA,,393,Primary,0,,A,,,True,TUMOR FREE,Alive,-24297,,66,8,52,PRAD,393,393,,0.0,[Not Available],[Not Applicable],39,,1,Matched,0.0,Prostate,Resection,4,243DA837-F54B-449C-A7E7-5737935D53D6,2,,0,0.05037,[Not Available],8E1FF72B-F1DB-4BF9-A8D3-F422E25A65E1,4,"Prostate Adenocarcinoma, Other Subtype",,Prostate,12,,Adenocarcinoma,[Not Available],,EJ,1.23333333333,TCGA-EJ-A65D,0:DiseaseFree,4,12,Prostate Adenocarcinoma,12.91,3/5/14,393,,,,,,C61,AD3DEFE9-4977-4334-A197-159F043C92A6,270,2,TUMOR FREE,0.1029,0:LIVING,0.1,,12.91,Bilateral,16,,,YES,240,2012,,,TCGA-EJ-A65D.AD3DEFE9-4977-4334-A197-159F043C92A6.pdf,,[Not Applicable],,,,34,"Prostate Adenocarcinoma, Other Subtype",1,2012,Complete Remission/Response,ductal,NO,No,R0,,66,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,8,No,NO,0,N0,T3a,0,M0,C61.9,8500/3,31425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XK-AAJT,,PRAD,,0,0,,XK,,0,MALE,0,1.95,0.66,10,14,4,HRD,NO,1434,,,1434,,0,0,1434,1434,prad_tcga,Malignant,28,BARD1,257,,TCGA-XK-AAJT-01,0,5637,0,TCGA-XK-AAJT,1434,1434,Prostate Cancer,,566,,1434,TCGA,,1434,Primary,0,Base,A,,ATM;CHEK1;FANCL,True,TUMOR FREE,Alive,-27428,,75,7,35,PRAD,1434,1434,,0.0,[Not Available],[Not Applicable],42,,1,Matched,0.23,Prostate,Resection,4,4791634B-BCD4-4FDA-ABDB-DEC79BA05086,4,Normal (no evidence of prostate cancer) [cM0],0,0.15927,[Not Available],5D66AC77-1543-488B-A68F-665811BEC67A,3,Prostate Adenocarcinoma Acinar Type,,Prostate,31,,Acinar Adenocarcinoma,[Not Available],,XK,1.43333333333,TCGA-XK-AAJT,0:DiseaseFree,3,34,Prostate Adenocarcinoma,47.11,5/13/14,1434,,,,,NO,C61,7596C336-6BF6-4188-9C8B-90C0EC840911,10,5,WITH TUMOR,0.2114,0:LIVING,0.09,5,47.11,Bilateral,35,No Evidence of Extraprostatic Extension,14,YES,1135,2010,,,TCGA-XK-AAJT.7596C336-6BF6-4188-9C8B-90C0EC840911.pdf,Peripheral Zone,[Not Applicable],YES,19,,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,NO,No,R1,,75,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,31756,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAIR,,PRAD,,0,0,,XK,0,0,MALE,0,1.93,0.32,5,4,3,ambiguous,NO,972,,972,972,,0,0,972,972,prad_tcga,Malignant,12,,104,,TCGA-XK-AAIR-01,0,5630,0,TCGA-XK-AAIR,972,972,Prostate Cancer,,953,972,972,TCGA,,972,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-27703,,75,8,31,PRAD,972,972,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.0,Prostate,Resection,4,75C3C1C1-0348-49C5-90A8-0F9C5AABE49F,2,,0,0.074651,[Not Available],12D2B93E-A033-4B36-AE81-C15879EB40BD,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,XK,0.966666666667,TCGA-XK-AAIR,0:DiseaseFree,4,15,Prostate Adenocarcinoma,31.93,5/8/14,972,,,,,NO,C61,72784D06-D1DA-4E0C-B378-771030D57046,10,2,TUMOR FREE,0.0691,0:LIVING,0.09,,31.93,Bilateral,18,,,YES,897,2011,,,TCGA-XK-AAIR.72784D06-D1DA-4E0C-B378-771030D57046.pdf,,[Not Applicable],NO,,,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,75,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,31757,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,PRAD,,1,1,TCGA-G9-6332,Roswell Park,1,0,MALE,1,1.96,0.81,3,3,2,ambiguous,,2657,,1180,2657,,1,1,1180,1180,,Malignant,8,,33,,,0,5349,0,,1180,1180,,,,1180,2657,TCGA,,1180,,0,,,,,,WITH TUMOR,Alive,-20166,,,,35,,1180,1180,,0.0,[Not Available],[Not Applicable],,,,,0.02,Prostate,Resection,,,0,,0,0.044391,[Not Available],,,Prostate Adenocarcinoma Acinar Type,,,8,,Acinar Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-G9-6332,,,15,,,,2657,,Biochemical evidence of disease,,,,,,,1,,,,,,,,18,,,,,2005,1180,,,,[Not Applicable],,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,32189,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-CH-5741,White,PRAD,91,0,0,,CH,0,0,MALE,0,1.94,0.82,4,7,1,HRP,NO,395,1-ERG,395,395,,0,0,395,395,prad_tcga,Malignant,12,,39,28.0,TCGA-CH-5741-01,0,5240,0,TCGA-CH-5741,395,395,Prostate Cancer,,339,395,395,TCGA,,395,Primary,0,,A,,,,TUMOR FREE,Alive,-20759,,56,9,28,PRAD,395,395,WHITE,0.0,[Not Available],[Not Applicable],50,R1,1,Matched,0.0,Prostate,Resection,4,b22cbb75-e6e5-443d-ab4e-1cfd0079c69a,0,Normal (no evidence of prostate cancer) [cM0],0,0.060292,[Not Available],b3bf57d4-e31a-4740-b438-fa826fb79550,5,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,1.66666666667,TCGA-CH-5741,0:DiseaseFree,5,11,Prostate Adenocarcinoma,12.98,3/16/12,395,,,,,NO,C61,87c977cc-2a28-49c9-adaf-f67c0bc208c2,,1,TUMOR FREE,0.0576,0:LIVING,0.02,,12.98,Bilateral,12,No Evidence of Extraprostatic Extension,30,YES,,2008,,,TCGA-CH-5741.87c977cc-2a28-49c9-adaf-f67c0bc208c2.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,30,91-100%,5,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,0.4,56,Core needle biopsy,,,YES,NO,YES,,T3b,,9,No,,0,N1,,1,M0,C61.9,8550/3,32754,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XK-AAJT,,PRAD,,0,0,,XK,,0,MALE,0,1.95,0.66,10,14,4,HRD,NO,1434,,,1434,,0,0,1434,1434,prad_tcga,Malignant,28,BARD1,257,,TCGA-XK-AAJT-01,0,5637,0,TCGA-XK-AAJT,1434,1434,Prostate Cancer,,566,,1434,TCGA,,1434,Primary,0,Base,A,,ATM;CHEK1;FANCL,True,TUMOR FREE,Alive,-27428,,75,7,35,PRAD,1434,1434,,0.0,[Not Available],[Not Applicable],42,,1,Matched,0.23,Prostate,Resection,4,4791634B-BCD4-4FDA-ABDB-DEC79BA05086,4,Normal (no evidence of prostate cancer) [cM0],0,0.15927,[Not Available],5D66AC77-1543-488B-A68F-665811BEC67A,3,Prostate Adenocarcinoma Acinar Type,,Prostate,31,,Acinar Adenocarcinoma,[Not Available],,XK,1.43333333333,TCGA-XK-AAJT,0:DiseaseFree,3,34,Prostate Adenocarcinoma,47.11,5/13/14,1434,,,,,NO,C61,7596C336-6BF6-4188-9C8B-90C0EC840911,10,5,WITH TUMOR,0.2114,0:LIVING,0.09,5,47.11,Bilateral,35,No Evidence of Extraprostatic Extension,14,YES,1135,2010,,,TCGA-XK-AAJT.7596C336-6BF6-4188-9C8B-90C0EC840911.pdf,Peripheral Zone,[Not Applicable],YES,19,,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,NO,No,R1,,75,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,32998,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,PRAD,161,0,0,TCGA-EJ-7125,University of Pittsburgh,0,0,MALE,0,2.0,0.67,0,1,0,HRP,,2850,7-IDH1,2850,2850,,0,0,2850,2850,,Malignant,1,,2,26.6,,0,26234,0,,2850,2850,,,,2850,2850,TCGA,,2850,,0,,,,,,TUMOR FREE,Alive,-16425,,,,29,,2850,2850,,0.0,[Not Available],[Not Applicable],,R0,,,0.11,Prostate,Resection,,,0,,0,0.0036993,[Not Available],,,Prostate Adenocarcinoma Acinar Type,,,1,,Acinar Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-EJ-7125,,,2,,,,2850,,,,,,,,,0,,,,,,,,4,,,,,2005,,,,,[Not Applicable],,,61-70%,,,,,Complete Remission/Response,,,,,,44,,,,,,,,,,,,,,,,,,,,33072,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6342,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.94,0.48,5,6,3,ambiguous,NO,1696,1-ERG,1696,1696,,0,0,1696,1696,prad_tcga,Malignant,14,,17,3.3,TCGA-G9-6342-01,0,5354,0,TCGA-G9-6342,1696,1696,Prostate Cancer,,1338,1696,1696,TCGA,,1696,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22472,,61,6,28,PRAD,1696,1696,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,2c85548b-d1fd-4fc8-9908-60205a42e080,1,Normal (no evidence of prostate cancer) [cM0],0,0.059008,[Not Available],00e41e6a-9fe7-44f9-978b-7b05b179506a,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.5,TCGA-G9-6342,0:DiseaseFree,1,14,Prostate Adenocarcinoma,55.72,3/16/12,1696,,,,,NO,C61,80379cb8-9fb7-4e01-9e4a-2bf7813dc839,,1,TUMOR FREE,0.0524,0:LIVING,0.05,4,55.72,Bilateral,17,No Evidence of Extraprostatic Extension,36,YES,,2008,,,TCGA-G9-6342.80379cb8-9fb7-4e01-9e4a-2bf7813dc839.pdf,,[Not Applicable],YES,32,56-65%,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.4,61,Core needle biopsy,,,NO,YES,NO,,T3a,,6,No,,0,,T2c,,M0,C61.9,8550/3,34193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-49-AARO,Black or African American,LUAD,,1,1,,Johns Hopkins,1,0,FEMALE,1,3.08,0.28,10,11,16,,,3759,,1144,3759,,1,1,1144,1144,,Malignant,37,,96,,,,22886,,,1144,1144,,,,1144,3759,,,1144,,,,,,,,WITH TUMOR,Alive,-14527,,,,749,,1144,1144,,,[Not Available],[Not Applicable],,,,,0.21,,,,,17,,1,0.18506,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AARO,,,,,,,3759,,Locoregional Recurrence,,,,,,,35,,,,,,,,,,,,,2003,1144,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,39,,,,,,,,,,,,,,,,,,,,75661,,1.286440296,,,,,,,,,,0.266146067,,0.181998134,,,,Stage IA,,1.4285,,,,,,,,,,,,,,,,0.6797,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),G12A (driver),,1,,G12A (driver),,,,,-0.105263895,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.6925,,0.1928,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,2.02,0.89,4,2,4,,,2009,BRCA_LumA,2009,2009,,2,2,2009,2009,,Invasive Carcinoma,10,,16,,,,22030,0,,2009,2009,,,,2009,2009,,,2009,,,,,,,,TUMOR FREE,Dead,-28974,2009,,,36,,2009,2009,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,3,,0,0.074963,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18S,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2003,,,,,Stage I,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,75662,,-0.648185424,0,0,0,0,0.7105,1,,,Mucinous Carcinoma,0.157412371,,0.109094705,0,0,0,,Negative,-1.172,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1529,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.67,0,0,0,,,,BRCA_LumA,,,,0,0,,,,Invasive Carcinoma,0,,13,,,,25741,1,,,,,,,,,,,,,,,,,,,TUMOR FREE,Alive,,,,,32,,,,,,[Not Available],[Not Applicable],,,,,0.01,Not Specific/Unknown,Resection/Excision,,,2,,0,0.0045431,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A66H,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,[Not Available],,,,,,,,,,,,,,,,,,,,,,,,,,75663,,0.310436365,0,0,0,0,-0.3448,1,,,Mucinous Carcinoma,0.152210948,,0.183692283,0,0,0,,Negative,-0.3405,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0109,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-YL-A8HJ,,PRAD,370,0,0,,YL,0,0,MALE,0,1.99,0.3,0,1,0,HRD,NO,1611,1-ERG,1611,1611,,0,0,1611,1611,prad_tcga,Malignant,1,,17,,TCGA-YL-A8HJ-01,0,5654,0,TCGA-YL-A8HJ,1611,1611,Prostate Cancer,,1589,1611,1611,TCGA,,1611,Primary,0,Apex|Middle|Base,A,,BRCA1;CDK12;RAD51D,True,TUMOR FREE,Alive,-21416,,58,9,44,PRAD,1611,1611,,0.0,[Not Available],[Not Applicable],32,R0,1,Matched,0.01,Prostate,Resection,4,DC782FD9-4012-41C2-B9B8-0B8A65423DF0,0,Normal (no evidence of prostate cancer) [cM0],0,0.010665,[Not Available],666D8B0C-593F-4EC3-B16A-2DADBEAD8C32,5,"Prostate Adenocarcinoma, Other Subtype",,Prostate,1,,Adenocarcinoma,[Not Available],,YL,1.06666666667,TCGA-YL-A8HJ,0:DiseaseFree,5,4,Prostate Adenocarcinoma,52.92,3/13/14,1611,,,,,NO,C61,A4B8AFC5-774E-4FB2-8191-735949EC3E42,370,0,TUMOR FREE,0.0091,0:LIVING,0.03,3,52.92,Bilateral,5,No Evidence of Extraprostatic Extension,-34,YES,1653,2009,,,TCGA-YL-A8HJ.A4B8AFC5-774E-4FB2-8191-735949EC3E42.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,54,31-40%,,"Prostate Adenocarcinoma, Other Subtype",1,2009,Complete Remission/Response,25-30% ductal component,NO,No,R0,,58,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T3b,YES,9,No,YES,0,,,,M0,C61.9,8140/3,75664,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-BR-8362,White,STAD,,1,1,,,1,1,,1,,,,,,,,398,,356,398,,1,1,356,356,,Malignant,,,,,,,21080,,,356,356,,,,356,398,,,356,,,,,,,,WITH TUMOR,Dead,-23797,398,,,0,,356,356,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8362,,,,,,,,Non-regional / Distant Lymph Nodes,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2012,356,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,75666,,0.700440852,,,,,,,,,,0.142498052,Grade 3,0.129357102,,,,Stage IIIC,,0.563,,,,,,,,,,,,,,,,0.3659,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8362,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-BR-A4J6,White,STAD,,0,0,,,0,0,,0,1.87,0.62,10,6,5,,,20,,20,20,,0,0,20,20,,Malignant,21,,90,,,,17613,,,20,20,,,,20,20,,,20,,,,,,,,TUMOR FREE,Alive,-25279,,,,50,,20,20,,,[Not Available],[Not Applicable],,,,,0.01,Stomach,Unknown,,,3,,0,0.19243,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-A4J6,,,,,,,20,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,75667,,-0.746039722,,,,,,,,,,0.03574577,Grade 2,0.045981018,,,,Stage IIA,,-1.1025,,,,,,,,,,,,,,,,0.0336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4J6,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,Male,TCGA-CD-A4MI,Asian,STAD,,1,1,,,1,1,,1,2.03,0.26,1,1,1,,,358,,271,358,,1,1,271,271,,Malignant,3,,12,,,,17954,,,271,271,,,,271,358,,,271,,,,,,,,WITH TUMOR,Dead,-22721,358,,,1409,,271,271,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,2,,0,0.010819,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G1,,ILSBio,,TCGA-CD-A4MI,,,,,,,,,Locoregional Recurrence,,,,,,,1,,,,,,,,,,,,,2011,271,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,75669,,1.269602122,,,,,,,,,,0.156024735,Grade 1,0.133490388,,,,Stage IIIA,,1.0345,,,,,,,,,,,,,,,,0.4562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A4MI,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-HC-8261,,PRAD,221,0,0,,HC,0,0,MALE,0,1.97,0.69,1,4,0,HRP,NO,546,5-SPOP,546,546,,0,0,546,546,prad_tcga,Malignant,5,,29,14.4,TCGA-HC-8261-01,8,5442,0,TCGA-HC-8261,546,546,Prostate Cancer,,,546,546,TCGA,,546,Primary,0,,A,,,,TUMOR FREE,Alive,-17874,,48,7,38,PRAD,546,546,,0.225031259,[Not Available],[Not Applicable],32,R0,1,Matched,0.03,Prostate,Resection,3,75360206-d41f-4ee7-8945-beb259f9b32c,0,,0,0.033091,[Not Available],f16ce517-d51d-499a-a4c4-a6844fefa52c,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.03333333333,TCGA-HC-8261,0:DiseaseFree,2,5,Prostate Adenocarcinoma,17.94,6/13/12,546,,,,,,C61,66690c59-06ae-4d5e-b862-3be6a11d67fb,,0,TUMOR FREE,0.0679,0:LIVING,,,17.94,Bilateral,10,,,YES,,2011,,,TCGA-HC-8261.66690c59-06ae-4d5e-b862-3be6a11d67fb.pdf,,[Not Applicable],,,41-50%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,48,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,,,,C61.9,8550/3,75671,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-8682,Asian,STAD,,0,0,,,0,0,,0,2.23,0.45,4,4,5,,,991,,991,991,,0,0,991,991,,Malignant,13,,63,,,,21281,,,991,991,,,,991,991,,,991,,,,,,,,TUMOR FREE,Alive,-19165,,,,101,,991,991,,,[Not Available],[Not Applicable],,,,,0.04,Stomach,Unknown,,,8,,0,0.21161,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,Asterand,,TCGA-BR-8682,,,,,,,991,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,75673,,0.380392197,,,,,,,,,,0.141595763,Grade 3,0.157648596,,,,Stage IIB,,-0.299,,,,,,,,,,,,,,,,0.2545,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8682,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,446,,446,446,,0,0,446,446,,Invasive Carcinoma,,,,,,,17706,0,,446,446,,,,446,446,,,446,,,,,,,,TUMOR FREE,Alive,-23008,,,,50,,446,446,,,[Not Available],[Not Applicable],,,,,,Breast,Core Biopsy,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A4SC,,,,,,,446,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,80086,,0.176169931,0,0,0,0,0.1394,1,,,Infiltrating Lobular Carcinoma,0.151912564,,0.238176267,0,0,0,,Negative,0.111,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4913,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-BR-8686,Asian,STAD,,0,0,,,2,2,,2,4.02,0.28,7,8,16,,,635,,635,635,,2,2,635,635,,Malignant,31,,42,,,,23410,,,635,635,,,,635,635,,,635,,,,,,,,TUMOR FREE,Dead,-25372,635,,,142,,635,635,,,[Not Available],[Not Applicable],,,,,0.35,Stomach,Unknown,,,10,,2,0.14682,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8686,,,,,,,,,,,,,,,,53,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,80090,,0.919207402,,,,,,,,,,0.097427255,Grade 3,0.198435798,,,,Stage IIIB,,0.67,,,,,,,,,,,,,,,,0.2215,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8686,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.23,0.43,5,2,5,,,433,BRCA_LumB,433,433,,0,0,433,433,,Invasive Carcinoma,12,,14,,,,34072,0,,433,433,,,,433,433,,,433,,,,,,,,TUMOR FREE,Alive,-26021,,,,26,,433,433,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,10,,0,0.12546,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1Y2,,,,,,,433,,,,,,,,,11,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,80092,,1.032764744,0,0,0,0,-0.1694,1,,,Infiltrating Ductal Carcinoma,0.287971451,,0.163323305,0,0,0,,Negative,0.5555,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6044,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-6522,White,STAD,,0,0,,,0,0,,0,2.0,0.08,0,0,0,,,566,,566,566,,0,0,566,566,,Malignant,0,,4,,,,16228,,,566,566,,,,566,566,,,566,,,,,,,,TUMOR FREE,Alive,-21465,,,,50,,566,566,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,0,,0,0.15922,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6522,,,,,,,566,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,80093,,1.504895229,,,,,,,,,,0.179387829,Grade 3,0.212643984,,,,Stage IB,,1.6595,,,,,,,,,,,,,,,,0.6421,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6522,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,,0,0,0,,,Asian,BRCA,,0,0,,,,0,FEMALE,0,,,,,,,,385,BRCA_Basal,,385,,0,0,385,385,,Invasive Carcinoma,,,,,,,22540,0,,385,385,,,,,385,,,385,,,,,,,,TUMOR FREE,Alive,-20346,,,,57,,385,385,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12V,,,,,,,385,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,80099,TRUE,2.053065315,0,0,0,0,-0.1567,1,,,Infiltrating Ductal Carcinoma,0.206737274,,0.15695091,0,0,0,,[Not Available],2.281,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1765,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-63-5131,,LUSC,,0,0,,Ontario Institute for Cancer Research,2,2,MALE,2,3.1,0.54,17,20,25,,,,,,,,2,2,,,,Malignant,62,,85,,,,18415,,,,,,,,,,,,,,,,,,,,TUMOR FREE,Dead,,,,,407,,,,,,[Not Available],[Not Applicable],,,,,0.42,,,,,14,,1,0.35972,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-5131,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,80101,,0.731153911,,,,,,,,,,0.188872066,,0.065174189,,,,Stage IIB,,-0.4385,,,,,,,,,,,,,,,,0.2646,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.51862283,16.08363605,13.59334811,-0.640983903529132,LUSC,Squamous Cell Carcinoma,17.70284143,15.38654672,Squamous Cell Carcinoma,-1.041,14.11743605,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.74,0.36,13,17,18,,,2155,BRCA_Basal,2155,2155,,0,0,2155,2155,,Invasive Carcinoma,48,,82,,,,33384,0,,2155,2155,,,,2155,2155,,,2155,,,,,,,,TUMOR FREE,Alive,-19614,,,,59,,2155,2155,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,10,,0,0.4828,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DF,,,,,,,2155,,,,,,,,,20,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,80105,TRUE,0.849375312,0,0,0,0,0.5072,1,,,Infiltrating Ductal Carcinoma,0.174581934,,0.168560747,0,0,0,,Negative,0.4355,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4024,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,80108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-97-8171,Asian,LUAD,,1,1,,Washington University - NYU,,0,MALE,1,2.21,0.82,1,7,4,,,568,,,568,,1,1,441,441,,Malignant,12,,100,,,,19898,,,441,441,,,,,568,,,441,,,,,,,,WITH TUMOR,Alive,-29627,,,,71,,441,441,,,[Not Available],[Not Applicable],,,,,0.06,,,,,6,,0,0.052476,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-8171,,,,,,,568,,Distant Metastasis,,,,,,,10,,,,,,,,,,,,,2011,441,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,81,,,,,,,,,,,,,,,,,,,,80114,,-0.962893008,,,,,,,,,,0.149825971,,0.073259138,,,,Stage IV,,-1.6175,,,,,,,,,,,,,,,,-0.5093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,13.92817141,15.77267576,9.740133454,-0.990859211,LUAD,Adenocarcinoma,17.57722244,13.02547159,Adenocarcinoma,-1.6722,12.66411467,-2.8767,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-AAN7,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.08,0.87,2,11,10,,,565,,,565,,1.0,1,321.0,321.0,,Malignant,23,,76,,,,23676.0,,,321.0,321,,,,,565,,,321.0,,,,,,,,WITH TUMOR,Dead,-21951,565,,,193.0,,321.0,321,,,[Not Available],[Not Applicable],,,,,0.23,,,,,14,,1,0.10693,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAN7,,,,,,,,Bladder,Locoregional (Urothelial tumor event),,,,,,,32,,,,,,,,,,,,,2008,321,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,80116,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.93,0.92,8,5,7,,,785,BRCA_LumB,785,785,,0,0,785,785,,Invasive Carcinoma,20,,106,,,,16364,1,,785,785,,,,785,785,,,785,,,,,,,,TUMOR FREE,Alive,-15050,,,,55,,785,785,,,[Not Available],[Not Applicable],,,,,0.0,Not Specific/Unknown,Resection/Excision,,,6,,0,0.17133,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mucinous Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A5UO,,,,,,,785,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,80120,,-2.197944062,0,0,0,0,0.1077,1,,,Mucinous Carcinoma,-0.004940933,,0.134304625,0,0,0,,Negative,-1.4865,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.5573,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.01,0.91,6,8,7,,,677,BRCA_LumA,677,677,,0,0,677,677,,Invasive Carcinoma,21,,61,,,,27281,0,,677,677,,,,677,677,,,677,,,,,,,,TUMOR FREE,Alive,-32873,,,,95,,677,677,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,14,,1,0.22149,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A6FP,,,,,,,677,,,,,,,,,34,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,80122,,-1.745215014,0,0,0,0,0.7814,1,,,Infiltrating Lobular Carcinoma,0.061164409,,0.053477751,0,0,0,,Negative,-2.2165,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.6756,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-FP-7735,Black or African American,STAD,,0,0,,,2,2,,2,,,20,6,20,,,106,,106,106,,2,2,106,106,,Malignant,46,,,,,,23719,,,106,106,,,,106,106,,,106,,,,,,,,TUMOR FREE,Dead,-28232,106,,,63,,106,106,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,International Genomics Consortium,,TCGA-FP-7735,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,80124,,0.850986494,,,,,,,,,,0.084390809,Grade 2,0.155649748,,,,Stage IB,,0.378,,,,,,,,,,,,,,,,0.2039,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-7735,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A43X,White,BLCA,,0.0,0,,,0,0,MALE,0.0,4.19,0.94,3,3,7,,,110,,110,110,,0.0,0,110.0,110.0,,Malignant,13,,31,,,,25157.0,,,110.0,110,,,,110,110,,,110.0,,,,,,,,TUMOR FREE,Alive,-30764,,,,442.0,,110.0,110,,,[Not Available],[Not Applicable],,,,,0.25,,,,,8,,1,0.054629,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A43X,,,,,,,110,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,84.0,,,,,,,,,,,,,,,,,,,,80128,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-D7-8575,White,STAD,,1,1,,,1,1,,1,1.87,0.66,11,9,12,,,554,,427,554,,1,1,427,427,,Malignant,32,,116,,,,17450,,,427,427,,,,427,554,,,427,,,,,,,,WITH TUMOR,Dead,-27712,554,,,67,,427,427,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,8,,0,0.35601,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8575,,,,,,,,Peritoneal Surfaces,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2012,427,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,80129,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8575,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.2,0.75,2,1,2,,,562,BRCA_LumA,,562,,0,0,562,562,,Invasive Carcinoma,5,,8,,,,34002,0,,562,562,,,,,562,,,562,,,,,,,,TUMOR FREE,Alive,-23485,,,,39,,562,562,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,4,,0,0.041415,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1P6,,,,,,,562,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,80130,,-0.472120294,1,0,0,0,-0.2242,0,,,Infiltrating Ductal Carcinoma,0.117568646,,0.09704934,0,0,0,,Close,-0.9895,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2397,1,0,H & E,0,0,,0,Jeffrey Eisenstein,ADH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Solid, Low Grade), Microcalcifications",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,ADH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.26,0.19,5,1,6,,,3072,BRCA_Basal,3072,3072,,0,0,3072,3072,,Invasive Carcinoma,12,,18,,,,29629,0,,3072,3072,,,,3072,3072,,,3072,,,,,,,,TUMOR FREE,Alive,-30489,,,,59,,3072,3072,,,[Not Available],[Not Applicable],,,,,0.51,Breast,Resection/Excision,,,28,,1,0.27859,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AJ,,,,,,,3072,,,,,,,,,26,,,,,,,,,,,,,2005,,,,,Stage I,,,,,,,,[Not Available],,,,,,83,,,,,,,,,,,,,,,,,,,,80131,,,0,0,0,0,-0.2348,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.93,0.73,14,21,27,,,428,BRCA_LumB,428,428,,0,0,428,428,,In Situ Carcinoma,62,,51,,,,19327,0,,428,428,,,,428,428,,,428,,,,,,,,TUMOR FREE,Alive,-12671,,,,82,,428,428,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,10,,1,0.16685,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15S,,,,,,,428,,,,,,,,,22,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,80136,,-1.271690628,0,1,0,0,-1.2275,0,,,Infiltrating Ductal Carcinoma,0.075758957,,0.134925291,0,0,0,,Negative,-1.5875,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3327,1,0,H & E,0,0,,0,Jeffrey Eisenstein,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,1,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,None,None,0,ALH,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-34-5240,White,LUSC,,0,0,,University of Pittsburgh,0,0,FEMALE,0,2.88,0.64,7,6,14,,,1541,,1541,1541,,0,0,1541,1541,,Malignant,27,,36,,,,30943,,,1541,1541,,,,1541,1541,,,1541,,,,,,,,TUMOR FREE,Alive,-26735,,,,231,,1541,1541,,,[Not Available],[Not Applicable],,,,,0.14,,,,,23,,1,0.5669,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-5240,,,,,,,1541,,,,,,,,,27,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,80137,,0.028293523,,,,,,,,,,0.23766863,,0.06014475,,,,Stage IIB,,0.6275,,,,,,,,,,,,,,,,-0.0052,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.18062528,16.3803308,14.11782542,-0.438362692606487,LUSC,,17.59483766,15.0666619,Squamous Cell Carcinoma,0.4143,13.93321716,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-HU-A4GU,Asian,STAD,,0,0,,,0,0,,0,2.68,0.76,14,19,16,,,200,,200,200,,0,0,200,200,,Malignant,49,,169,,,,24604,,,200,200,,,,200,200,,,200,,,,,,,,TUMOR FREE,Alive,-27024,,,,2093,,200,200,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,14,,1,0.36764,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4GU,,,,,,,200,,,,,,,,,37,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,80140,,-0.165295456,,,,,,,,,,0.064548379,Grade 3,-0.032019264,,,,Stage IIB,,-0.3525,,,,,,,,,,,,,,,,-0.1822,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GU,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.57,0.79,3,8,13,,,417,BRCA_Basal,417,417,,0,0,417,417,,Invasive Carcinoma,24,,81,,,,21409,0,,417,417,,,,417,417,,,417,,,,,,,,TUMOR FREE,Alive,-26627,,,,100,,417,417,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,25,,2,0.26389,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A62X,,,,,,,417,,,,,,,,,74,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,80145,,-0.099962351,0,0,0,0,1.6289,1,,,Infiltrating Ductal Carcinoma,0.06273233,,0.093514301,0,0,0,,Negative,0.025,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.1327,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-77-6843,White,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,1.93,0.74,8,5,7,,,2224,,,2224,,2,2,2224,2224,,Malignant,20,,45,,,,25664,,,2224,2224,,,,,2224,,,2224,,,,,,,,,Dead,-27291,2224,,,227,,2224,2224,,,[Not Available],[Not Applicable],,,,,0.19,,,,,7,,0,0.25276,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-6843,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2002,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,80147,,-0.176890056,,,,,,,,,,0.110253696,,0.067266167,,,,Stage IIA,,0.6575,,,,,,,,,,,,,,,,-0.1135,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.00849148,14.70243909,13.96513752,-0.767903538735883,LUSC,Squamous Cell Carcinoma,17.45656785,14.2642193,Squamous Cell Carcinoma,-3.4067,12.76667222,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-BR-8384,White,STAD,,0,0,,,0,0,,0,2.01,0.15,4,5,2,,,113,,113,113,,0,0,113,113,,Malignant,11,,17,,,,26820,,,113,113,,,,113,113,,,113,,,,,,,,TUMOR FREE,Alive,-25281,,,,54,,113,113,,,[Not Available],[Not Applicable],,,,,0.39,Stomach,Unknown,,,0,,0,0.052717,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8384,,,,,,,113,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,80148,,1.177075383,,,,,,,,,,0.110584831,Grade 3,0.227815463,,,,Stage IIIC,,0.606,,,,,,,,,,,,,,,,0.5131,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8384,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-VP-A87E,,PRAD,357,0,0,,VP,0,0,MALE,0,2.0,0.66,0,0,0,HRP,NO,2037,8-other,2037,2037,,0,0,2037,2037,prad_tcga,Malignant,0,,5,,TCGA-VP-A87E-01,10,5596,0,TCGA-VP-A87E,2037,2037,Prostate Cancer,,2037,2037,2037,TCGA,,2037,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-21811,,59,6,25,PRAD,2037,2037,,0.343278017,[Not Available],[Not Applicable],27,R0,1,Matched,0.0,Prostate,Resection,3,E8BCC7F5-B514-4FC7-B07B-FD4AA8821463,0,Normal (no evidence of prostate cancer) [cM0],0,0.000556,[Not Available],DC20ECF0-2807-4675-A7FD-8EAD1CEE7EA0,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,VP,0.866666666667,TCGA-VP-A87E,0:DiseaseFree,1,1,Prostate Adenocarcinoma,66.92,3/28/14,2037,,,,,NO,C61,6B46F895-B5CD-40B8-8962-AA8DF2505446,220,0,TUMOR FREE,0.0,0:LIVING,0.11,,66.92,Bilateral,2,No Evidence of Extraprostatic Extension,15,YES,2059,2008,,,TCGA-VP-A87E.6B46F895-B5CD-40B8-8962-AA8DF2505446.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,15,46-55%,12,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,6,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,80149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.22,0.57,10,8,19,,,565,BRCA_LumB,565,565,,0,0,565,565,,Invasive Carcinoma,37,,71,,,,16683,1,,565,565,,,,565,565,,,565,,,,,,,,TUMOR FREE,Alive,-29734,,,,74,,565,565,,,[Not Available],[Not Applicable],,,,,0.06,Not Specific/Unknown,Resection/Excision,,,17,,1,0.33332,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1X5,,,,,,,565,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,81,,,,,,,,,,,,,,,,,,,,80153,,,0,0,0,0,0.0032,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.71,0.59,28,29,19,,,266,BRCA_Basal,266,266,,0,0,266,266,,Invasive Carcinoma,76,,211,,,,25020,1,,266,266,,,,266,266,,,266,,,,,,,,TUMOR FREE,Alive,-17640,,,,172,,266,266,,,[Not Available],[Not Applicable],,,,,0.1,Not Specific/Unknown,Core Biopsy,,,4,,0,0.4451,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A6VY,,,,,,,266,,,,,,,,,12,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,80156,TRUE,1.043116545,0,0,0,0,0.8326,1,,,Infiltrating Ductal Carcinoma,0.217145859,,0.045807077,0,0,0,,Negative,1.0685,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.5879,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-L5-A4OH,White,ESCA,,0,0,,,0,0,,0,3.1,0.63,8,12,16,,,992,,992,992,,0,0,992,992,,Malignant,36,,163,,,,19102,,,992,992,,,,992,992,,,992,,,,,,,,TUMOR FREE,Alive,-26180,,,,227,,992,992,,,[Not Available],[Not Available],,,,,0.22,Esophagus,Unknown,,,16,,1,0.37902,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A4OH,,,,,,,992,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,80159,,,,,,,,,,,,,Unknown,,,,,Stage I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.77,0.81,7,9,11,,,242,BRCA_Basal,,242,,0,0,242,242,,Invasive Carcinoma,27,,156,,,,27474,0,,242,242,,,,,242,,,242,,,,,,,,TUMOR FREE,Alive,-21910,,,,151,,242,242,,,[Not Available],[Not Applicable],,,,,0.2,Breast,Resection/Excision,,,11,,0,0.40908,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FJ,,,,,,,242,,,,,,,,,16,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,80160,,0.165608911,0,0,0,0,-0.1146,1,,,Infiltrating Ductal Carcinoma,0.129701706,,0.170314962,0,0,0,,Negative,-0.8965,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.1015,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.42,0.56,10,18,25,,,370,BRCA_LumB,370,370,,0,0,370,370,,Invasive Carcinoma,53,,112,,,,28034,0,,370,370,,,,370,370,,,370,,,,,,,,TUMOR FREE,Alive,-19117,,,,59,,370,370,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,17,,1,0.24714,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A130,,,,,,,370,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,80161,,0.407901831,0,0,0,0,-0.8302,1,,,Infiltrating Ductal Carcinoma,0.117104924,,0.219480315,0,0,0,,Negative,-0.785,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2589,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-44-4112,White,LUAD,,1,,,Christiana Healthcare,1,1,FEMALE,1,2.13,0.57,9,9,2,,,808,,619,808,,1,,619,619,,Malignant,20,,37,,,,16636,,,619,,,,,619,808,,,619,,,,,,,,WITH TUMOR,Dead,-22106,808,,,581,,619,,,,[Not Available],[Not Applicable],,,,,0.21,,,,,5,,0,0.13935,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-4112,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2010,619,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,80164,,0.190525099,,,,,,,,,,0.234900185,,0.148240269,,,,Stage IB,,0.4085,,,,,,,,,,,,,,,,0.423,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.245998047,LUAD,,,,Adenocarcinoma,1.3811,,0.076,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-FD-A5C1,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.8,0.49,10,10,10,,,1792,,1792,1792,,0.0,0,1792.0,1792.0,,Malignant,30,,88,,,,32322.0,,,1792.0,1792,,,,1792,1792,,,1792.0,,,,,,,,TUMOR FREE,Alive,-22505,,,,193.0,,1792.0,1792,,,[Not Available],[Not Applicable],,,,,0.74,,,,,14,,0,0.40076,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5C1,,,,,,,1792,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,80169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.87,0.76,9,9,8,,,1156,BRCA_LumA,1156,1156,,0,0,1156,1156,,Invasive Carcinoma,26,,17,,,,22116,0,,1156,1156,,,,1156,1156,,,1156,,,,,,,,TUMOR FREE,Alive,-23366,,,,64,,1156,1156,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,7,,0,0.18808,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DH,,,,,,,1156,,,,,,,,,7,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,80175,,-0.065855722,0,0,0,0,0.929,1,,,Infiltrating Ductal Carcinoma,0.13704508,,0.134703934,0,0,0,,Negative,-0.093,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1015,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-2F-A9KQ,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.91,0.96,3,2,4,,,2886,,2886,2886,,0.0,0,2886.0,2886.0,,Malignant,9,,33,,,,18920.0,,,2886.0,2886,,,,2886,2886,,,2886.0,,,,,,,,TUMOR FREE,Alive,-25259,,,,93.0,,2886.0,2886,,,[Not Available],[Not Applicable],,,,,0.01,,,,,5,,0,0.14901,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KQ,,,,,,,2886,,,,,,,,,7,,,,,,,,,,,,,2007,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,80177,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46B,,PRAD,,0,0,,EJ,0,0,MALE,0,2.0,0.27,0,0,0,HRP,NO,657,,657,657,,0,0,657,657,prad_tcga,Malignant,0,,4,,TCGA-EJ-A46B-01,0,5334,0,TCGA-EJ-A46B,657,657,Prostate Cancer,,157,657,657,TCGA,,657,Primary,0,,A,,,True,TUMOR FREE,Alive,-24305,,66,8,3,PRAD,657,657,,0.0,[Not Available],[Not Applicable],5,,1,Matched,0.0,Prostate,Resection,4,6F63E03B-4C63-4E29-BFD9-DD5095289F23,0,Normal (no evidence of prostate cancer) [cM0],0,0.0011334,[Not Available],1170F449-DFB5-417A-A89B-B2229A2785DB,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,EJ,0.2,TCGA-EJ-A46B,0:DiseaseFree,4,0,Prostate Adenocarcinoma,21.58,1/22/13,657,,,,,,C61,4B418B68-7866-45C1-8728-9D61BF5A9273,420,0,TUMOR FREE,0.0,0:LIVING,0.1,3,21.58,Bilateral,1,No Evidence of Extraprostatic Extension,10,YES,114,2012,,,TCGA-EJ-A46B.4B418B68-7866-45C1-8728-9D61BF5A9273.pdf,,[Not Applicable],YES,10,,10,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,"Yes, History of Prior Malignancy",R0,,66,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,80185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-95-8039,White,LUAD,,1,1,,Washington University - Emory,1,0,MALE,1,1.93,0.47,6,6,7,,,830,,228,830,,1,1,228,228,,Malignant,19,,15,,,,34117,,,228,228,,,,228,830,,,228,,,,,,,,TUMOR FREE,Alive,-26317,,,,125,,228,228,,,[Not Available],[Not Applicable],,,,,0.38,,,,,8,,0,0.28335,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-8039,,,,,,,830,,Locoregional Recurrence,,,,,,,12,,,,,,,,,,,,,2012,228,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,80189,,1.305387485,,,,,,,,,,0.261276857,,0.148408172,,,,Stage IA,,0.976,,,,,,,,,,,,,,,,0.2999,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.232959356,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.4608,,-0.4113,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A8O8,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,,,,,,,,13,,13,13,,0.0,0,13.0,13.0,,Malignant,,,,,,,21845.0,,,13.0,13,,,,13,13,,,13.0,,,,,,,,TUMOR FREE,Alive,-21629,,,,168.0,,13.0,13,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A8O8,,,,,,,13,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,80199,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,,,,,,,,1032,,682,1032,,1,1,682,682,,Invasive Carcinoma,,,,,,,26818,0,,682,682,,,,682,1032,,,682,,,,,,,,WITH TUMOR,Dead,-23000,1032,,,0,,682,682,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3XS,,,,,,,,Lung,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2003,682,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,80200,,0.518122893,0,0,0,0,1.0749,1,,,Infiltrating Ductal Carcinoma,0.112251405,,0.159202813,0,0,0,,Negative,-0.0565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2444,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A3IE,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.94,0.69,11,16,14,,,612,,,612,,1.0,1,612.0,612.0,,Malignant,41,,36,,,,24722.0,,,612.0,612,,,,,612,,,612.0,,,,,,,,WITH TUMOR,Dead,-18983,612,,,506.0,,612.0,612,,,[Not Available],[Not Applicable],,,,,0.38,,,,,4,,0,0.19016,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A3IE,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,51.0,,,,,,,,,,,,,,,,,,,,80203,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6385,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.0,0.2,0,0,0,HRP,NO,830,1-ERG,830,830,,0,0,830,830,prad_tcga,Malignant,0,,0,7.4,TCGA-G9-6385-01,0,5377,0,TCGA-G9-6385,830,830,Prostate Cancer,,336,830,830,TCGA,,830,Primary,0,Base,A,,,,TUMOR FREE,Alive,-24399,,66,7,11,PRAD,830,830,WHITE,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,0.0,Prostate,Resection,3,cfe4b1fa-b658-49d3-87ad-6df7d75a58df,0,Normal (no evidence of prostate cancer) [cM0],0,0.0,[Not Available],e82a04cf-e81e-43c6-9cd9-0e29fa0f00ae,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.43333333333,TCGA-G9-6385,0:DiseaseFree,2,1,Prostate Adenocarcinoma,27.27,3/2/12,830,,,,,NO,C61,3027c5cd-f972-469c-a9f2-9a72b83a86c8,,0,TUMOR FREE,0.0,0:LIVING,0.064,,27.27,Bilateral,4,,,YES,,2010,,,TCGA-G9-6385.3027c5cd-f972-469c-a9f2-9a72b83a86c8.pdf,,[Not Applicable],NO,12,41-50%,,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.7,66,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,80204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-34-8454,White,LUSC,,0,0,,University of Pittsburgh,0,0,FEMALE,0,1.91,0.45,9,9,17,,,1180,,1180,1180,,0,0,1180,1180,,Malignant,35,,103,,,,17563,,,1180,1180,,,,1180,1180,,,1180,,,,,,,,TUMOR FREE,Alive,-22913,,,,747,,1180,1180,,,[Not Available],[Not Applicable],,,,,0.03,,,,,7,,0,0.36834,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-8454,,,,,,,1180,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,80205,,1.771519695,,,,,,,,,,0.167391843,,0.146415433,,,,Stage IIIA,,1.226,,,,,,,,,,,,,,,,0.6092,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.79259867,15.87906042,16.53009642,0.0209917731306103,LUSC,,17.90714485,16.30634741,Squamous Cell Carcinoma,0.2712,14.32345573,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-D7-A4Z0,White,STAD,,0,0,,,0,0,,0,2.2,0.31,1,3,1,,,449,,449,449,,0,0,449,449,,Malignant,5,,22,,,,28527,,,449,449,,,,449,449,,,449,,,,,,,,TUMOR FREE,Alive,-22129,,,,377,,449,449,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,2,,0,0.056947,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,Greater Poland Cancer Center,,TCGA-D7-A4Z0,,,,,,,449,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,80206,,0.626740822,,,,,,,,,,0.114550759,Grade 3,0.212506202,,,,Stage IIB,,0.655,,,,,,,,,,,,,,,,0.4044,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A4Z0,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0.0,1,0,1.0,1.0,Male,TCGA-ZF-A9RL,White,BLCA,,1.0,1,,,1,0,MALE,1.0,3.74,0.85,2,5,9,,,2703,,1064,2703,,1.0,1,1064.0,1064.0,,Malignant,16,,25,,,,19480.0,,,1064.0,1064,,,,1064,2703,,,1064.0,,,,,,,,TUMOR FREE,Alive,-22480,,,,439.0,,1064.0,1064,,,[Not Available],[Not Applicable],,,,,0.12,,,,,16,,1,0.075874,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9RL,,,,,,,2703,Bladder,Locoregional (Urothelial tumor event),,,,,,,18,,,,,,,,,,,,,2007,1064,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,80211,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.77,4,4,5,,,118,BRCA_LumA,118,118,,0,0,118,118,,Invasive Carcinoma,13,,14,,,,23185,0,,118,118,,,,118,118,,,118,,,,,,,,TUMOR FREE,Alive,-28495,,,,45,,118,118,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.083738,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IL,,,,,,,118,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,80212,,-0.285684204,0,0,0,0,0.8907,1,,,Infiltrating Lobular Carcinoma,0.147108716,,0.179302599,0,0,0,,Negative,-1.0525,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3962,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,1.78,0.54,10,9,7,,,524,BRCA_Basal,268,524,,1,1,268,268,,Invasive Carcinoma,26,,79,,,,28393,0,,268,268,,,,268,524,,,268,,,,,,,,WITH TUMOR,Dead,-18482,524,,,73,,268,268,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,13,,0,0.36538,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AR,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,16,,,,,,,,,,,,,2007,268,Breast,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,80227,TRUE,1.143264636,0,0,0,0,-0.0211,1,,,Infiltrating Ductal Carcinoma,0.240205737,,0.196472597,0,0,0,,Negative,0.191,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2858,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-RD-A8N6,White,STAD,,1,1,,,1,1,,1,3.5,0.6,11,24,25,,,272,,163,272,,1,1,163,163,,Malignant,60,,148,,,,26133,,,163,163,,,,163,272,,,163,,,,,,,,WITH TUMOR,Dead,-28834,272,,,222,,163,163,,,Stomach Cancer,[Not Applicable],,,,,0.53,Stomach,Unknown,,,18,,2,0.29818,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8N6,,,,,,,,Liver,Distant Metastasis,,,,,,,71,,,,,,,,,,,,,2006,163,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,80239,,-0.411015489,,,,,,,,,,0.020714633,Grade 3,0.037841142,,,,Stage IIIA,,-0.645,,,,,,,,,,,,,,,,0.155,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8N6,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-EJ-7788,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.71,2,2,0,HRP,NO,859,2-ETV1,859,859,,0,0,859,859,prad_tcga,Malignant,4,BRCA1;RAD51B;RAD54L,23,26.6,TCGA-EJ-7788-01,0,5322,0,TCGA-EJ-7788,859,859,Prostate Cancer,,52,859,859,TCGA,,859,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-19623,,53,7,49,PRAD,859,859,WHITE,0.0,[Not Available],[Not Applicable],35,R0,1,Matched,0.04,Prostate,Resection,3,566e79d3-defe-48c8-977e-adfbf3a6069b,0,,0,0.032492,[Not Available],e35336e1-e358-493f-9beb-276b5fc6685a,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.16666666667,TCGA-EJ-7788,0:DiseaseFree,2,6,Prostate Adenocarcinoma,28.22,4/6/12,859,,,,,NO,C61,b66a0868-e91c-4ebf-be9c-ba55e94552fd,,1,TUMOR FREE,0.0647,0:LIVING,0.2,5,28.22,Bilateral,6,,,YES,,2011,,,TCGA-EJ-7788.b66a0868-e91c-4ebf-be9c-ba55e94552fd.pdf,,[Not Applicable],NO,,71-80%,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.2,53,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T3b,0,M0,C61.9,8550/3,80240,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.3,0.78,5,13,13,,,252,BRCA_LumB,252,252,,0,0,252,252,,Invasive Carcinoma,31,,31,,,,26231,0,,252,252,,,,252,252,,,252,,,,,,,,TUMOR FREE,Alive,-25282,,,,74,,252,252,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,15,,1,0.098709,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A56Z,,,,,,,252,,,,,,,,,25,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,80246,,-0.007855122,0,0,0,0,-0.8538,1,,,Infiltrating Ductal Carcinoma,0.110693674,,0.121709135,0,0,0,,Negative,-1.0595,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1144,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Papillary, Intermediate Grade), Comedonecrosis",,"DCIS (Papillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-A94U,White,STAD,,0,0,,,0,0,,0,2.71,0.64,11,7,10,,,819,,819,819,,0,0,819,819,,Malignant,28,,136,,,,20334,,,819,819,,,,819,819,,,819,,,,,,,,TUMOR FREE,Alive,-25925,,,,208,,819,819,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Unknown,,,18,,1,0.315,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A94U,,,,,,,819,,,,,,,,,31,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,80249,,-1.390704956,,,,,,,,,,0.042401612,Grade 3,0.196765788,,,,Stage IIB,,-0.955,,,,,,,,,,,,,,,,0.2935,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A94U,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.05,0.32,17,29,28,,,3247,BRCA_Basal,3247,3247,,0,0,3247,3247,,Invasive Carcinoma,74,,57,,,,25381,0,,3247,3247,,,,3247,3247,,,3247,,,,,,,,TUMOR FREE,Alive,-21628,,,,249,,3247,3247,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,18,,1,0.43616,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LH,,,,,,,3247,,,,,,,,,38,,,,,,,,,,,,,2002,,,,,Stage I,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,80257,TRUE,1.700610109,0,0,0,0,1.3715,1,,,Infiltrating Ductal Carcinoma,0.193063395,,0.16257266,0,0,0,,Negative,1.142,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2365,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2737,,LUSC,,0,0,,Indivumed,,0,MALE,0,,,,,,,,61,,,61,,0,0,61,61,,Malignant,,,,,,,20358,,,61,61,,,,,61,,,61,,,,,,,,TUMOR FREE,Alive,-26390,,,,0,,61,61,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2737,,,,,,,61,,,,,,,,,,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,80263,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,0.7915,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,not profiled,not profiled,not profiled,16.64498412,16.79076271,16.1090891,-0.167939783683524,LUSC,Squamous Cell Carcinoma,17.95604988,16.01237174,Squamous Cell Carcinoma,1.4246,13.76380556,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-43-2578,White,LUSC,,0,0,,Christiana Healthcare,2,2,FEMALE,2,1.75,0.59,14,18,21,,,684,,684,684,,2,2,684,684,,Malignant,53,,74,,,,27462,,,684,684,,,,684,684,,,684,,,,,,,,TUMOR FREE,Dead,-21747,684,,,451,,684,684,,,[Not Available],[Not Applicable],,,,,0.38,,,,,7,,0,0.58486,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-2578,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,80269,,0.444277045,,,,,,,,,,0.168661215,,0.104246192,,,,Stage IA,,0.6965,,,,,,,,,,,,,,,,0.1827,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V167F,1,,,V167F,,,,-0.457863188379335,LUSC,,,,Squamous Cell Carcinoma,-0.3869,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,80276,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.38,0.61,1,0,3,,,1007,BRCA_LumA,,1007,,0,0,1007,1007,,Invasive Carcinoma,4,,2,,,,17610,0,,1007,1007,,,,,1007,,,1007,,,,,,,,TUMOR FREE,Alive,-20570,,,,68,,1007,1007,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Core Biopsy,,,15,,0,0.027613,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0DB,,,,,,,1007,,,,,,,,,11,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,80284,,,0,0,0,0,0.7204,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Close,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-7670,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,4.89,0.5,14,15,24,,,882,,882,882,,0,0,882,882,,Malignant,53,,142,,,,20645,,,882,882,,,,882,882,,,882,,,,,,,,TUMOR FREE,Alive,-17392,,,,1426,,882,882,,,[Not Available],[Not Applicable],,,,,0.23,,,,,23,,2,0.32848,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-7670,,,,,,,882,,,,,,,,,55,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,47,,,,,,,,,,,,,,,,,,,,80288,,0.416703165,,,,,,,,,,0.156465421,,0.109299083,,,,Stage IIA,,0.9255,,,,,,,,,,,,,,,,0.2316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.52372441,15.54214677,14.99315135,-0.517147469,LUAD,Adenocarcinoma,17.91511021,16.00413011,Adenocarcinoma,-1.0038,12.880658,-0.2946,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-85-8582,White,LUSC,,0,0,,Asterand,0,0,MALE,0,2.59,0.21,11,11,16,,,1160,,1160,1160,,0,0,1160,1160,,Malignant,38,,93,,,,33629,,,1160,1160,,,,1160,1160,,,1160,,,,,,,,TUMOR FREE,Alive,-18168,,,,434,,1160,1160,,,[Not Available],[Not Applicable],,,,,0.34,,,,,23,,1,0.33146,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8582,,,,,,,1160,,,,,,,,,40,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,49,,,,,,,,,,,,,,,,,,,,80292,,0.713550375,,,,,,,,,,0.220590331,,0.134142928,,,,Stage IA,,0.7765,,,,,,,,,,,,,,,,1.1475,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.355338055999839,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.8026,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-56-A49D,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,1.61,0.56,22,11,19,,,637,,637,637,,0,0,637,637,,Malignant,52,,228,,,,0,,,637,637,,,,637,637,,,637,,,,,,,,TUMOR FREE,Alive,-24745,,,,385,,637,637,,,[Not Available],[Not Applicable],,,,,0.13,,,,,15,,0,0.62172,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-A49D,,,,,,,637,,,,,,,,,22,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,80294,,1.262111204,,,,,,,,,,0.197795209,,0.106205329,,,,Stage IIIA,,1.3945,,,,,,,,,,,,,,,,0.1424,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.93834121,17.15456464,16.48397207,-0.203419370716866,LUSC,Squamous Cell Carcinoma,18.15824767,16.45482807,Squamous Cell Carcinoma,-0.8341,13.73947458,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-HC-A6AN,,PRAD,,0,0,,HC,,0,MALE,0,1.91,0.67,4,2,7,ambiguous,NO,49,,,49,,0,0,49,49,prad_tcga,Malignant,13,BRCA2,58,,TCGA-HC-A6AN-01,0,5452,0,TCGA-HC-A6AN,49,49,Prostate Cancer,,,,49,TCGA,,49,Primary,0,,A,,,False,WITH TUMOR,Alive,-24697,,67,7,45,PRAD,49,49,,0.0,[Not Available],[Not Applicable],37,,1,Matched,0.01,Prostate,Resection,4,E78A6EC2-9C2A-4A5C-9EE7-A69513592096,2,,0,0.090965,[Not Available],3FAE5B76-9E22-4EAB-A7FC-13139B2B97C4,3,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,HC,1.23333333333,TCGA-HC-A6AN,0:DiseaseFree,3,17,Prostate Adenocarcinoma,1.61,4/22/14,49,,,,,,C61,D5C8CC7E-BADE-457C-AC31-CC138C8C794C,20,3,WITH TUMOR,0.0831,0:LIVING,,,1.61,Bilateral,19,,,YES,209,2012,,,TCGA-HC-A6AN.D5C8CC7E-BADE-457C-AC31-CC138C8C794C.pdf,,[Not Applicable],,,,1,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Applicable],,,No,R1,,67,Core needle biopsy,,,YES,NO,YES,NO,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,80298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-75-7025,,LUAD,,1,1,,Ontario Institute for Cancer Research (OICR),1,0,MALE,1,3.59,0.34,1,3,3,,,3305,,1481,3305,,1,1,1481,1481,,Malignant,7,,9,,,,20124,,,1481,1481,,,,1481,3305,,,1481,,,,,,,,TUMOR FREE,Alive,,,,,41,,1481,1481,,,[Not Available],[Not Applicable],,,,,0.34,,,,,18,,1,0.12159,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-7025,,,,,,,3305,,Locoregional Recurrence|Distant Metastasis,,,,,,,14,,,,,,,,,,,,,,1481,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,80301,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.3898,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,,,,-0.233274245,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.0934,,0.4076,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,,1.0,1.0,Female,TCGA-DK-A1AB,White,BLCA,,1.0,1,,,,,FEMALE,1.0,1.79,0.56,4,1,4,,,508,,,508,,1.0,1,364.0,364.0,,Malignant,9,,13,,,,19696.0,,,364.0,364,,,,,508,,,364.0,,,,,,,,,Dead,-27126,508,,,276.0,,364.0,364,,,[Not Available],[Not Applicable],,,,,0.0,,,,,11,,0,0.24409,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1AB,,,,,,,,Lung,Metastatic,,,,,,,9,,,,,,,,,,,,,2010,364,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,74.0,,,,,,,,,,,,,,,,,,,,80302,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.63,5,5,7,,,952,BRCA_LumA,952,952,,0,0,952,952,,Invasive Carcinoma,17,,49,,,,33280,0,,952,952,,,,952,952,,,952,,,,,,,,TUMOR FREE,Alive,-21918,,,,47,,952,952,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.090249,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A6SC,,,,,,,952,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,80308,,0.007377343,0,0,0,0,0.3119,1,,,Infiltrating Lobular Carcinoma,0.161305498,,0.180374421,0,0,0,,Negative,-0.09,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.615,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Micropapillary, Intermediate Grade), No Detail Present",,"DCIS (Micropapillary, Intermediate Grade)",0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A9FM,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,,,,,,,,398,,398,398,,0.0,0,398.0,398.0,,,,,,,,,18098.0,,,398.0,398,,,,398,398,,,398.0,,,,,,,,TUMOR FREE,Alive,-18445,,,,35.0,,398.0,398,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,[Not Available],,,,,Unknown,High Grade,,ILSBio,,TCGA-CF-A9FM,,,,,,,398,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,50.0,,,,,,,,,,,,,,,,,,,,80311,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-5644,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,3.11,0.75,20,28,25,,,863,,863,863,,0,0,863,863,,Malignant,73,,117,,,,18086,,,863,863,,,,863,863,,,863,,,,,,,,TUMOR FREE,Alive,-18644,,,,1264,,863,863,,,[Not Available],[Not Applicable],,,,,0.12,,,,,14,,1,0.38287,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-5644,,,,,,,863,,,,,,,,,33,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,80314,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.825725761,LUAD,,,,Adenocarcinoma,-0.59,,-0.7792,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.9,0.69,10,28,24,,,2048,BRCA_Basal,2048,2048,,0,0,2048,2048,,Invasive Carcinoma,62,,167,,,,18309,0,,2048,2048,,,,2048,2048,,,2048,,,,,,,,TUMOR FREE,Alive,-22115,,,,119,,2048,2048,,,[Not Available],[Not Applicable],,,,,0.28,Breast,Resection/Excision,,,15,,1,0.48792,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0D0,,,,,,,2048,,,,,,,,,29,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,80317,TRUE,0.856226809,0,0,0,0,0.683,1,,,Infiltrating Ductal Carcinoma,0.123208726,,-0.003026894,0,0,0,,Negative,0.66,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1124,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A5BR,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.83,0.44,7,11,9,,,813,,813,813,,0.0,0,813.0,813.0,,Malignant,27,,33,,,,20278.0,,,813.0,813,,,,813,813,,,813.0,,,,,,,,TUMOR FREE,Alive,-20964,,,,123.0,,813.0,813,,,[Not Available],[Not Applicable],,,,,0.59,,,,,8,,1,0.12956,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5BR,,,,,,,813,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,57.0,,,,,,,,,,,,,,,,,,,,80322,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A8DV,White,STAD,,1,1,,,,1,,1,4.09,0.58,17,26,24,,,403,,,403,,1,1,288,288,,Malignant,67,,199,,,,29251,,,288,288,,,,,403,,,288,,,,,,,,WITH TUMOR,Dead,-17630,403,,,94,,288,288,,,Stomach Cancer,[Not Applicable],,,,,0.28,Stomach,Unknown,,,17,,2,0.42956,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8DV,,,,,,,,Liver,Distant Metastasis,,,,,,,54,,,,,,,,,,,,,2010,288,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,48,,,,,,,,,,,,,,,,,,,,80326,,-2.279000585,,,,,,,,,,0.016683572,Grade 2,0.061423969,,,,Stage IB,,-1.484,,,,,,,,,,,,,,,,-0.3241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8DV,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.2,0.76,6,3,13,,,470,BRCA_LumA,470,470,,0,0,470,470,,Invasive Carcinoma,22,,52,,,,21235,0,,470,470,,,,470,470,,,470,,,,,,,,TUMOR FREE,Alive,,,,,67,,470,470,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,19,,1,0.16975,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A26Z,,,,,,,470,,,,,,,,,26,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,80327,,-0.998285284,0,0,0,0,0.0399,1,,,Infiltrating Ductal Carcinoma,0.092857168,,0.123456746,0,0,0,,Negative,-1.369,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1693,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-39-5031,,LUSC,,0,0,,MSKCC,2,2,FEMALE,2,3.23,0.4,13,15,17,,,1841,,1841,1841,,2,2,1841,1841,,Malignant,45,,36,,,,16887,,,1841,1841,,,,1841,1841,,,1841,,,,,,,,TUMOR FREE,Dead,-28106,1841,,,853,,1841,1841,,,[Not Available],[Not Applicable],,,,,0.37,,,,,16,,1,0.40417,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5031,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,80330,,0.956189043,,,,,,,,,,0.21759963,,0.076616309,,,,Stage IA,,0.777,,,,,,,,,,,,,,,,0.5959,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.29606790961969,LUSC,,,,Squamous Cell Carcinoma,0.4641,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,1.88,0.78,15,29,18,,,1836,BRCA_LumB,1619,1836,,1,1,1619,1619,,Invasive Carcinoma,62,,81,,,,16441,0,,1619,1619,,,,1619,1836,,,1619,,,,,,,,TUMOR FREE,Alive,-14854,,,,85,,1619,1619,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,6,,0,0.31907,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1L7,,,,,,,1836,"Other, specify",New Primary Tumor,,,,,,,14,,,,,,,,,,,,,2009,1619,left breast,,,Stage IIIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,80339,TRUE,1.394166148,0,0,0,0,-0.2561,1,,,Infiltrating Ductal Carcinoma,0.173229194,,0.09802978,0,0,0,,Negative,1.1395,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1404,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-33-4582,White,LUSC,,1,1,,Johns Hopkins,1,1,MALE,1,2.74,0.54,18,29,25,,,3149,,2923,3149,,1,1,2923,2923,,Malignant,72,,48,,,,24242,,,2923,2923,,,,2923,3149,,,2923,,,,,,,,WITH TUMOR,Dead,-20402,3149,,,259,,2923,2923,,,[Not Available],[Not Applicable],,,,,0.22,,,,,14,,1,0.37677,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4582,,,,,,,,,Locoregional Recurrence,,,,,,,40,,,,,,,,,,,,,2000,2923,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,80349,,0.283862736,,,,,,,,,,0.133166863,,-0.05685051,,,,Stage IA,,-1.159,,,,,,,,,,,,,,,,-0.2626,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.615130883260954,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.1799,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-CF-A8HX,Asian,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.97,0.95,6,7,5,,,345,,345,345,,0.0,0,345.0,345.0,,Malignant,18,,63,,,,22379.0,,,345.0,345,,,,345,345,,,345.0,,,,,,,,TUMOR FREE,Alive,-20259,,,,94.0,,345.0,345,,,[Not Available],[Not Applicable],,,,,0.07,,,,,5,,0,0.099094,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ILSBio,,TCGA-CF-A8HX,,,,,,,345,,,,,,,,,5,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,55.0,,,,,,,,,,,,,,,,,,,,80352,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,4.13,0.7,13,26,25,,,2192,BRCA_LumB,,2192,,1,1,2192,2192,,Invasive Carcinoma,64,,58,,,,18013,0,,2192,2192,,,,,2192,,,2192,,,,,,,,WITH TUMOR,Dead,-12525,2192,,,169,,2192,2192,,,[Not Available],[Not Applicable],,,,,0.4,Breast,Resection/Excision,,,12,,1,0.18765,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FN,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,1997,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,80353,,-0.191605691,0,0,0,0,0.0975,1,,,Infiltrating Ductal Carcinoma,0.189708906,,0.098470622,0,0,0,,[Not Available],-0.421,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4975,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,1.92,0.39,5,4,5,,,2709,BRCA_LumB,2674,2709,,1,1,2674,2674,,Invasive Carcinoma,14,,10,,,,22307,0,,2674,2674,,,,2674,2709,,,2674,,,,,,,,WITH TUMOR,Alive,-17221,,,,23,,2674,2674,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,10,,0,0.24496,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mixed Histology (please specify),,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0C3,,,,,,,2709,Bone,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2006,2674,,,,Stage I,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,80356,,0.704097031,0,0,0,0,-1.2259,0,,,Mixed Histology (NOS),0.173088692,,0.30780185,0,0,0,,Negative,0.1065,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.4637,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Columnar Lesion,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-85-8664,White,LUSC,,1,1,,Asterand,1,1,MALE,1,3.28,0.65,8,9,14,,,550,,434,550,,1,1,434,434,,Malignant,31,,80,,,,25339,,,434,434,,,,434,550,,,434,,,,,,,,WITH TUMOR,Dead,-26954,550,,,320,,434,434,,,[Not Available],[Not Applicable],,,,,0.28,,,,,21,,1,0.38751,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8664,,,,,,,,,Distant Metastasis,,,,,,,33,,,,,,,,,,,,,2011,434,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,80366,,-0.375384983,,,,,,,,,,0.090650294,,-0.082411047,,,,Stage IIB,,-0.731,,,,,,,,,,,,,,,,0.3362,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.58647621,13.23922382,13.6420446,-0.827404046479735,LUSC,Squamous Cell Carcinoma,18.19171846,14.9153851,Squamous Cell Carcinoma,-2.5035,10.41212211,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,3.42,0.48,9,3,9,,,2798,BRCA_LumA,,2798,,2,2,2798,2798,,Invasive Carcinoma,21,,21,,,,19567,0,,2798,2798,,,,,2798,,,2798,,,,,,,,TUMOR FREE,Dead,-25136,2798,,,51,,2798,2798,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,21,,1,0.16445,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1EO,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,1999,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,80373,,0.812295763,0,0,0,0,-0.3496,1,,,Mixed Histology (NOS),0.224397665,,0.236470927,0,0,0,,[Not Available],-0.3975,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6998,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-HQ-A5ND,Unknown,BLCA,,1.0,1,,,,1,MALE,1.0,3.22,0.63,5,7,10,,,274,,,274,,1.0,1,84.0,84.0,,Malignant,22,,53,,,,19926.0,,,84.0,84,,,,,274,,,84.0,,,,,,,,WITH TUMOR,Dead,-28555,274,,,129.0,,84.0,84,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,1,0.13295,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Ontario Institute for Cancer Research (OICR),,TCGA-HQ-A5ND,,,,,,,,Lymph Node Only,Distant Metastasis,,,,,,,33,,,,,,,,,,,,,,84,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,78.0,,,,,,,,,,,,,,,,,,,,80375,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A8PP,Unknown,STAD,,1,1,,,,1,,1,2.14,0.58,2,1,2,,,712,,,712,,1,1,502,502,,Malignant,5,,38,,,,34351,,,502,502,,,,,712,,,502,,,,,,,,WITH TUMOR,Dead,-27774,712,,,2079,,502,502,,,Stomach Cancer,[Not Applicable],,,,,0.05,Stomach,Unknown,,,4,,0,0.038653,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8PP,,,,,,,,,Locoregional Recurrence,,,,,,,7,,,,,,,,,,,,,2008,502,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,76,,,,,,,,,,,,,,,,,,,,80377,,0.98552958,,,,,,,,,,0.080663284,Grade 2,0.022906294,,,,Stage IV,,0.8575,,,,,,,,,,,,,,,,0.5626,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PP,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.72,1,2,0,,,3226,BRCA_LumA,3226,3226,,0,0,3226,3226,,Invasive Carcinoma,3,,19,,,,26117,0,,3226,3226,,,,3226,3226,,,3226,,,,,,,,TUMOR FREE,Alive,-21160,,,,33,,3226,3226,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,0,,0,0.0057785,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DM,,,,,,,3226,,,,,,,,,0,,,,,,,,,,,,,2004,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,80381,,-0.612585882,0,0,0,0,-0.1784,1,,,Infiltrating Ductal Carcinoma,0.14706461,,0.090691263,0,0,0,,Negative,-0.9375,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0457,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Encapsulated Papillary Carcinoma,Encapsulated Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A7B2,,PRAD,,1,1,,KK,,0,MALE,1,2.0,0.97,0,0,0,HRP,NO,1099,,,1099,,1,1,692,692,prad_tcga,Malignant,0,,8,,TCGA-KK-A7B2-01,0,5517,0,TCGA-KK-A7B2,692,692,Prostate Cancer,,845,,1099,TCGA,,692,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-24845,,68,9,21,PRAD,692,692,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.06,Prostate,Resection,4,BCCB7F9D-8DDE-45B7-A50D-6C7233239CEB,0,Normal (no evidence of prostate cancer) [cM0],0,0.00015,[Not Available],000D566C-96C7-4F1C-B36E-FA2222467983,5,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,KK,0.866666666667,TCGA-KK-A7B2,1:Recurred/Progressed,5,1,Prostate Adenocarcinoma,22.73,6/6/14,1099,,Biochemical evidence of disease,,,NO,C61,9A37DFF6-CDD7-40DD-A6A6-3966BC4E275A,130,0,WITH TUMOR,0.0,0:LIVING,0.3,,36.1,Left,2,No Evidence of Extraprostatic Extension,58,YES,554,2012,692,,TCGA-KK-A7B2.9A37DFF6-CDD7-40DD-A6A6-3966BC4E275A.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,58,,13,Prostate Adenocarcinoma Acinar Type,1,2012,Stable Disease,,NO,No,R0,,68,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,T1c,1,M0,C61.9,8140/3,80382,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A631,,PRAD,308,0,0,,HC,,0,MALE,0,1.93,0.92,1,6,4,HRP,NO,54,2-ETV1,,54,,0,0,54,54,prad_tcga,Malignant,11,CHEK2,52,3.3,TCGA-HC-A631-01,0,5449,0,TCGA-HC-A631,54,54,Prostate Cancer,,,,54,TCGA,,54,Primary,0,,A,,,False,WITH TUMOR,Alive,-24749,,67,9,55,PRAD,54,54,,0.0,[Not Available],[Not Applicable],41,R1,1,Matched,0.18,Prostate,Resection,4,66D9FEA0-D11C-4027-AEF4-06110BB27EED,3,Normal (no evidence of prostate cancer) [cM0],0,0.074034,[Not Available],DB4793DC-CD45-4B81-93CE-8322031C2AA3,5,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,HC,1.33333333333,TCGA-HC-A631,0:DiseaseFree,5,12,Prostate Adenocarcinoma,1.77,4/22/14,54,,,,,,C61,70585F33-CB9E-4365-9CA2-E384BED102DD,40,2,WITH TUMOR,0.1911,0:LIVING,,3,1.77,Bilateral,14,No Evidence of Extraprostatic Extension,21,YES,101,2012,,,TCGA-HC-A631.70585F33-CB9E-4365-9CA2-E384BED102DD.pdf,,[Not Applicable],YES,25,71-80%,2,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Applicable],,,No,R1,,67,Core needle biopsy,,,YES,NO,YES,NO,T2c,,9,No,,0,N0,T2,0,M0,C61.9,8140/3,80384,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.13,0.78,6,7,10,,,455,BRCA_LumA,455,455,,0,0,455,455,,Invasive Carcinoma,23,,141,,,,23037,0,,455,455,,,,455,455,,,455,,,,,,,,TUMOR FREE,Alive,-27191,,,,127,,455,455,,,[Not Available],[Not Applicable],,,,,0.6,Breast,Resection/Excision,,,4,,0,0.13357,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A5XU,,,,,,,455,,,,,,,,,9,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,80387,,-0.116441643,0,0,0,0,-2.8892,1,,,Infiltrating Ductal Carcinoma,0.092424443,,0.191259358,0,0,0,,Negative,-0.6125,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.347,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-QU-A6IP,,PRAD,320,0,0,,QU,0,0,MALE,0,2.0,0.51,0,0,0,HRP,NO,2620,1-ERG,2620,2620,,0,0,2620,2620,prad_tcga,Malignant,0,,8,4.5,TCGA-QU-A6IP-01,0,5552,0,TCGA-QU-A6IP,2620,2620,Prostate Cancer,,2620,2620,2620,TCGA,,2620,Primary,0,Middle|Base,A,,,True,TUMOR FREE,Alive,-24212,,66,6,25,PRAD,2620,2620,,0.0,[Not Available],[Not Applicable],22,R0,1,Matched,0.0,Prostate,Resection,3,B6B501CA-F660-41CD-B459-0CC82A704771,0,,0,0.0021394,[Not Available],9A8E27C9-614B-491F-913D-429DFC4E2C4D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,QU,0.766666666667,TCGA-QU-A6IP,0:DiseaseFree,1,0,Prostate Adenocarcinoma,86.07,8/21/13,2620,,,,,NO,C61,D1E73097-6F07-4B1E-8914-074FA037CB85,140,0,,0.0021,0:LIVING,0.0,,86.07,Right,0,,,YES,3118,2004,,,TCGA-QU-A6IP.D1E73097-6F07-4B1E-8914-074FA037CB85.pdf,,[Not Applicable],NO,,61-70%,2,Prostate Adenocarcinoma Acinar Type,1,2004,Complete Remission/Response,,NO,No,R0,,66,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2a,NO,6,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,80392,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.99,0.58,4,10,7,,,1642,BRCA_LumB,1642,1642,,0,0,1642,1642,,Invasive Carcinoma,21,,29,,,,18303,0,,1642,1642,,,,1642,1642,,,1642,,,,,,,,TUMOR FREE,Alive,-24230,,,,113,,1642,1642,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,15,,1,0.12398,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A076,,,,,,,1642,,,,,,,,,22,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,80394,,0.201273268,0,0,0,0,-0.0601,1,,,Infiltrating Ductal Carcinoma,0.201045945,,0.122820027,0,0,0,,Negative,-0.4265,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4296,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2ES,White,BLCA,,0.0,0,,,,1,MALE,1.0,2.01,0.55,4,2,10,,,1004,,,1004,,2.0,2,897.0,897.0,,Malignant,16,,44,,,,23501.0,,,1004.0,1004,,,,,1004,,,897.0,,,,,,,,WITH TUMOR,Dead,-31293,1004,,,659.0,,1004.0,1004,,,[Not Available],[Not Applicable],,,,,0.03,,,,,4,,0,0.28582,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2ES,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2009,897,,,,Stage II,,,,,,,,Progressive Disease,,,,,,85.0,,,,,,,,,,,,,,,,,,,,80410,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-94-A5I6,White,LUSC,,1,1,,Washington University - Emory,,0,MALE,1,2.88,0.38,11,11,15,,,538,,,538,,1,1,481,481,,Malignant,37,,82,,,,31077,,,481,481,,,,,538,,,481,,,,,,,,WITH TUMOR,Alive,-22949,,,,225,,481,481,,,[Not Available],[Not Applicable],,,,,0.36,,,,,22,,1,0.32475,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Emory,,TCGA-94-A5I6,,,,,,,538,,Distant Metastasis,,,,,,,35,,,,,,,,,,,,,2012,481,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,62,,,,,,,,,,,,,,,,,,,,80411,,0.003823164,,,,,,,,,,0.162140781,,-0.016668417,,,,Stage IIB,,0.5625,,,,,,,,,,,,,,,,0.4611,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.75280409,15.5542354,14.65518665,-0.813278976049068,LUSC,Squamous Cell Carcinoma,17.67258919,14.86225278,Squamous Cell Carcinoma,0.154,13.63593318,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.11,0.42,2,9,8,,,2041,BRCA_LumA,2041,2041,,0,0,2041,2041,,Invasive Carcinoma,19,,37,,,,18914,0,,2041,2041,,,,2041,2041,,,2041,,,,,,,,TUMOR FREE,Alive,-11204,,,,56,,2041,2041,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,2,,0,0.079885,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DG,,,,,,,2041,,,,,,,,,5,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,30,,,,,,,,,,,,,,,,,,,,80413,,0.687778996,0,0,0,0,-0.7181,1,,,Infiltrating Ductal Carcinoma,0.191497549,,0.228806533,0,0,0,,Negative,-0.412,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7022,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Cribriform, Intermediate Grade), Microcalcifications",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.69,3,2,4,,,1232,BRCA_LumB,1232,1232,,0,0,1232,1232,,Invasive Carcinoma,9,,9,,,,29085,0,,1232,1232,,,,1232,1232,,,1232,,,,,,,,TUMOR FREE,Alive,-15504,,,,36,,1232,1232,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,3,,0,0.10887,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A22H,,,,,,,1232,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,80418,,0.354341501,0,0,0,0,-0.37,1,,,Infiltrating Ductal Carcinoma,0.113107577,,0.151523942,0,0,0,,Negative,0.1095,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1372,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-BT-A2LD,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.21,0.59,9,12,12,,,623,,,623,,1.0,1,555.0,555.0,,Malignant,33,,61,,,,29376.0,,,555.0,555,,,,,623,,,555.0,,,,,,,,WITH TUMOR,Dead,-28673,623,,,140.0,,555.0,555,,,[Not Available],[Not Applicable],,,,,0.75,,,,,5,,0,0.28761,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A2LD,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,18,,,,,,,,,,,,,2011,555,brain and spinal cord,,,Stage IV,,,,,,,,Progressive Disease,,,,,,78.0,,,,,,,,,,,,,,,,,,,,80425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-77-7465,White,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,1.61,0.68,17,14,19,,,990,,990,990,,0,0,990,990,,Malignant,50,,74,,,,24216,,,990,990,,,,990,990,,,990,,,,,,,,,Alive,-21548,,,,516,,990,990,,,[Not Available],[Not Applicable],,,,,0.08,,,,,15,,0,0.52717,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7465,,,,,,,990,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,80426,,1.519942695,,,,,,,,,,0.208318453,,0.047677584,,,,Stage IIA,,1.386,,,,,,,,,,,,,,,,0.1421,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.28366114,15.84559209,17.68000404,0.106475048293837,LUSC,Squamous Cell Carcinoma,17.91598128,16.81343587,Squamous Cell Carcinoma,-0.0703,13.24156341,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Female,TCGA-97-7546,White,LUAD,,0,0,,Washington University - NYU,,0,FEMALE,1,1.85,0.67,4,2,5,,,1285,,,1285,,0,0,1255,1255,,Malignant,11,,9,,,,31157,,,1285,1285,,,,,1285,,,1255,,,,,,,,WITH TUMOR,Alive,-27913,,,,361,,1285,1285,,,[Not Available],[Not Applicable],,,,,0.61,,,,,6,,0,0.19263,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-7546,,,,,,,1285,,New Primary Tumor,,,,,,,6,,,,,,,,,,,,,2008,1255,,,,Stage IA,,,,,,,,Progressive Disease,,,,,,76,,,,,,,,,,,,,,,,,,,,80438,,0.719308155,,,,,,,,,,0.250589348,,0.205656119,,,,Stage IA,,1.338,,,,,,,,,,,,,,,,0.1303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.141628305,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.1541,,0.5601,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-69-7761,White,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,3.68,0.23,2,1,8,,,186,,,186,,0,0,186,186,,Malignant,11,,21,,,,24327,,,186,186,,,,,186,,,186,,,,,,,,TUMOR FREE,Alive,-31041,,,,40,,186,186,,,[Not Available],[Not Applicable],,,,,0.24,,,,,11,,1,0.068986,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7761,,,,,,,186,,,,,,,,,15,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,80441,,1.64193779,,,,,,,,,,0.254341445,,0.096426499,,,,Stage IB,,1.504,,,,,,,,,,,,,,,,0.4251,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.235189041,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2433,,1.3519,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-NJ-A55R,White,LUAD,,0,0,,Washington University - Rush University,,0,MALE,0,3.5,0.23,3,7,8,,,603,,,603,,0,0,603,603,,Malignant,18,,29,,,,24775,,,603,603,,,,,603,,,603,,,,,,,,TUMOR FREE,Alive,-24738,,,,365,,603,603,,,[Not Available],[Not Applicable],,,,,0.32,,,,,17,,1,0.14562,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A55R,,,,,,,603,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Stable Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,80446,,0.579693036,,,,,,,,,,0.175636078,,0.153655949,,,,Stage IA,,0.3325,,,,,,,,,,,,,,,,0.1776,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),G571D,1,,G12A (driver),G571D,,,,-0.675591672,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.009,,-1.317,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,694,,694,694,,0,0,694,694,,Invasive Carcinoma,,,,,,,32635,0,,694,694,,,,694,694,,,694,,,,,,,,TUMOR FREE,Alive,-21465,,,,0,,694,694,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1OW,,,,,,,694,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,80457,TRUE,0.614437644,0,0,0,0,0.4181,1,,,Infiltrating Ductal Carcinoma,0.166112225,,0.161344499,0,0,0,,Negative,0.329,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5753,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HU-A4H5,Asian,STAD,,0,0,,,0,0,,0,3.26,0.64,28,41,28,,,724,,724,724,,0,0,724,724,,Malignant,97,,215,,,,25390,,,724,724,,,,724,724,,,724,,,,,,,,TUMOR FREE,Alive,-26232,,,,359,,724,724,,,[Not Available],[Not Applicable],,,,,0.12,Stomach,Unknown,,,8,,1,0.38546,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Papillary Type",,,,,Intestinal Gastric Carcinoma,GX,,National Cancer Center Korea,,TCGA-HU-A4H5,,,,,,,724,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,80459,,0.089380393,,,,,,,,,,0.038067432,Unknown,0.0611101,,,,Stage IB,,-0.0555,,,,,,,,,,,,,,,,-0.2396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4H5,Gastric Carcinoma,TCGA,"Adenocarcinoma, Papillary Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.59,0.44,6,5,10,,,373,BRCA_LumB,373,373,,0,0,373,373,,Invasive Carcinoma,21,,28,,,,31549,0,,373,373,,,,373,373,,,373,,,,,,,,TUMOR FREE,Alive,-20173,,,,53,,373,373,,,[Not Available],[Not Applicable],,,,,0.52,Breast,Resection/Excision,,,29,,2,0.14575,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27W,,,,,,,373,,,,,,,,,52,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,80467,,0.390039738,0,0,0,0,-0.6802,1,,,Mucinous Carcinoma,0.162383616,,0.142566346,0,0,0,,Negative,-0.1835,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1237,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-G2-A2EJ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.09,0.61,9,4,7,,,1460,,910,1460,,1.0,1,910.0,910.0,,Malignant,20,,60,,,,25884.0,,,910.0,910,,,,910,1460,,,910.0,,,,,,,,TUMOR FREE,Alive,-20649,,,,428.0,,910.0,910,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.13654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EJ,,,,,,,1460,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2009,910,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,80470,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A3B8,White,BLCA,,0.0,0,,,0,0,MALE,0.0,,,,,,,,384,,384,384,,0.0,0,384.0,384.0,,Malignant,,,,,,,29662.0,,,384.0,384,,,,384,384,,,384.0,,,,,,,,TUMOR FREE,Alive,-20555,,,,35.0,,384.0,384,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3B8,,,,,,,384,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,80474,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.6,0.71,8,3,8,,,641,BRCA_LumA,641,641,,0,0,641,641,,Invasive Carcinoma,19,,78,,,,28339,0,,641,641,,,,641,641,,,641,,,,,,,,TUMOR FREE,Alive,-10832,,,,69,,641,641,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,19,,1,0.18247,[Unknown],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-A6ZH,,,,,,,641,,,,,,,,,22,,,,,,,,,,,,,2013,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,29,,,,,,,,,,,,,,,,,,,,80477,,0.039084448,0,0,0,0,0.3108,1,,,Infiltrating Ductal Carcinoma,0.098701409,,0.098693966,0,0,0,,Negative,-0.562,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1243,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-VP-A87D,,PRAD,357,1,1,,VP,1,0,MALE,1,1.96,0.76,5,7,2,ambiguous,NO,1853,1-ERG,1194,1853,,1,1,1194,1194,prad_tcga,Malignant,14,BRCA2;RAD51B,60,,TCGA-VP-A87D-01,0,5595,0,TCGA-VP-A87D,1194,1194,Prostate Cancer,12,1853,1194,1853,TCGA,No Evidence of Extraprostatic Extension,1194,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-19818,,54,9,68,PRAD,1194,1194,,0.0,[Not Available],[Not Applicable],57,R0,1,Matched,0.09,Prostate,Resection,4,58F191CF-3C24-4D57-8A50-F7B7EC8F175D,2,Normal (no evidence of prostate cancer) [cM0],0,0.074597,[Not Available],AA405B5F-F75D-486A-96F3-1DF7ADD18193,5,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,VP,1.86666666667,TCGA-VP-A87D,1:Recurred/Progressed,5,26,Prostate Adenocarcinoma,39.22,3/28/14,1853,,Biochemical evidence of disease,,,YES,C61,48B36158-9679-4C74-BBDA-88431481A885,80,3,TUMOR FREE,0.0953,0:LIVING,0.2,,60.87,Bilateral,30,,,YES,2127,2007,1194,,TCGA-VP-A87D.48B36158-9679-4C74-BBDA-88431481A885.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,14,91-100%,12,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,YES,No,R0,,54,Core needle biopsy,1194,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,YES,0,N1,T1c,3,M0,C61.9,8140/3,80479,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KS,,PRAD,,0,0,,X4,,0,MALE,0,2.04,0.24,2,4,0,ambiguous,NO,979,,,979,,0,0,979,979,prad_tcga,Malignant,6,,13,,TCGA-X4-A8KS-01,0,5618,0,TCGA-X4-A8KS,979,979,Prostate Cancer,,797,,979,TCGA,,979,Primary,0,,A,,,True,TUMOR FREE,Alive,-22571,,61,7,31,PRAD,979,979,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.0,Prostate,Resection,3,874964AB-D09A-422C-9B51-7239338E78D4,2,,0,0.024833,[Not Available],56829C8D-7BB7-4AAC-999F-B1353DB4915D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,X4,1.0,TCGA-X4-A8KS,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.16,3/7/14,979,,,,,NO,C61,30844429-3F9C-4AD0-8A23-64012532347C,160,1,TUMOR FREE,0.0004,0:LIVING,0.01,,32.16,Bilateral,18,,,YES,735,2011,,,TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,RX,,61,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T2c,,M0,C61.9,8140/3,80482,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-BR-8683,Asian,STAD,,0,0,,,2,2,,2,4.78,0.58,0,13,16,,,300,,300,300,,2,2,300,300,,Malignant,29,,4,,,,24959,,,300,300,,,,300,300,,,300,,,,,,,,TUMOR FREE,Dead,-27549,300,,,204,,300,300,,,[Not Available],[Not Applicable],,,,,0.24,Stomach,Unknown,,,12,,2,0.0019998,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8683,,,,,,,,,,,,,,,,64,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,80484,,0.757142785,,,,,,,,,,0.070405732,Grade 3,0.174898213,,,,Stage IIIB,,0.7465,,,,,,,,,,,,,,,,0.5907,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8683,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-QU-A6IL,,PRAD,,0,0,,QU,0,0,MALE,0,1.98,0.84,3,6,2,HRD,NO,97,,97,97,,0,0,97,97,prad_tcga,Malignant,11,,170,,TCGA-QU-A6IL-01,5,5548,0,TCGA-QU-A6IL,97,97,Prostate Cancer,,91,97,97,TCGA,,97,Primary,0,Apex|Middle|Base,A,,RAD54L,True,TUMOR FREE,Alive,-23710,,64,7,40,PRAD,97,97,,0.138780517,[Not Available],[Not Applicable],26,,1,Matched,0.02,Prostate,Resection,3,94767B66-4586-4595-BE8F-50B5FD6337DA,2,,0,0.083854,[Not Available],DFFC3917-BF06-4C3D-B03A-CA54FE5C2E79,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,QU,0.833333333333,TCGA-QU-A6IL,0:DiseaseFree,2,11,Prostate Adenocarcinoma,3.19,8/21/13,97,,,,,,C61,EF13AC98-FA7C-442C-A6A4-A5E7ECB2596D,,3,TUMOR FREE,0.1072,0:LIVING,0.2,,3.19,Bilateral,14,,,YES,4048,2002,,,TCGA-QU-A6IL.EF13AC98-FA7C-442C-A6A4-A5E7ECB2596D.pdf,,[Not Applicable],,,,4,Prostate Adenocarcinoma Acinar Type,1,2002,Complete Remission/Response,,NO,No,R0,,64,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,80493,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-63-A5M9,Unknown,LUSC,,0,0,,Ontario Institute for Cancer Research,,0,FEMALE,0,3.2,0.6,17,24,28,,,0,,,0,,0,0,0,0,,Malignant,69,,162,,,,17787,,,0,0,,,,,0,,,0,,,,,,,,,Alive,,,,,145,,0,0,,,[Not Available],[Not Applicable],,,,,0.09,,,,,17,,1,0.5935,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5M9,,,,,,,0,,,,,,,,,31,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,[Unknown],,,,,,,,,,,,,,,,,,,,,,,,,,80496,,0.616051603,,,,,,,,,,0.179658282,,0.056762442,,,,Stage IIB,,1.6995,,,,,,,,,,,,,,,,0.3201,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,H274R,1,,,H274R,15.20315538,15.93526838,16.28058988,-0.307344750133081,LUSC,Squamous Cell Carcinoma,17.61860983,16.22054526,Squamous Cell Carcinoma,0.1829,13.28785522,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-D7-A6EZ,White,STAD,,1,1,,,,1,,1,2.05,0.67,8,13,12,,,618,,,618,,1,1,618,618,,Malignant,33,,77,,,,28619,,,618,618,,,,,618,,,618,,,,,,,,WITH TUMOR,Dead,-24425,618,,,375,,618,618,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,3,,0,0.11206,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A6EZ,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,80497,,0.80896104,,,,,,,,,,0.108339275,Grade 3,0.063280746,,,,Stage IIIA,,1.4105,,,,,,,,,,,,,,,,-0.0225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A6EZ,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,0,,0,1,Female,TCGA-39-5030,Asian,LUSC,,0,0,,MSKCC,2,,FEMALE,2,1.87,0.3,6,0,6,,,59,,59,59,,2,2,59,59,,Malignant,12,,10,,,,21564,,,59,59,,,,59,59,,,59,,,,,,,,,Dead,-29893,59,,,274,,59,59,,,[Not Available],[Not Applicable],,,,,0.04,,,,,10,,0,0.23362,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5030,,,,,,,59,,,,,,,,,9,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,80502,,1.882121855,,,,,,,,,,0.251996539,,0.143780523,,,,Stage IIIA,,2.232,,,,,,,,,,,,,,,,0.6739,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.96109203,16.92680213,18.25246453,0.284044992974617,LUSC,Squamous Cell Carcinoma,18.22694965,17.40869256,Squamous Cell Carcinoma,0.7224,14.22881886,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.9,0.86,15,12,22,,,2222,BRCA_Basal,2222,2222,,0,0,2222,2222,,Invasive Carcinoma,49,,98,,,,16273,0,,2222,2222,,,,2222,2222,,,2222,,,,,,,,TUMOR FREE,Alive,-28625,,,,150,,2222,2222,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,10,,1,0.48016,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2BK,,,,,,,2222,,,,,,,,,37,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,80510,TRUE,-0.507651164,0,0,0,0,-3.1286,1,,,Infiltrating Ductal Carcinoma,0.07677208,,0.002634839,0,0,0,,Negative,-0.7195,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2691,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BT-A20T,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.86,0.75,11,11,3,,,453,,,453,,1.0,1,314.0,314.0,,Malignant,25,,58,,,,26568.0,,,314.0,314,,,,,453,,,314.0,,,,,,,,WITH TUMOR,Dead,-23220,453,,,367.0,,314.0,314,,,[Not Available],[Not Applicable],,,,,0.26,,,,,5,,0,0.18661,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20T,,,,,,,,Liver,Distant Metastasis,,,,,,,6,,,,,,,,,,,,,2007,314,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,63.0,,,,,,,,,,,,,,,,,,,,80512,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.11,0.9,6,11,13,,,2082,BRCA_LumA,2082,2082,,0,0,2082,2082,,Invasive Carcinoma,30,,24,,,,17972,0,,2082,2082,,,,2082,2082,,,2082,,,,,,,,TUMOR FREE,Alive,-9840,,,,95,,2082,2082,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,6,,0,0.11969,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RG,,,,,,,2082,,,,,,,,,11,,,,,,,,,,,,,1991,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,26,,,,,,,,,,,,,,,,,,,,80518,,-0.758051624,0,0,0,0,1.1618,1,,,Infiltrating Ductal Carcinoma,0.083299171,,0.127996445,0,0,0,,Negative,-1.301,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3648,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-CD-A4MH,Asian,STAD,,0,0,,,0,0,,0,2.8,0.54,11,5,10,,,371,,371,371,,0,0,371,371,,Malignant,26,,157,,,,20310,,,371,371,,,,371,371,,,371,,,,,,,,TUMOR FREE,Alive,-31683,,,,111,,371,371,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,22,,1,0.36452,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,ILSBio,,TCGA-CD-A4MH,,,,,,,371,,,,,,,,,30,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,86,,,,,,,,,,,,,,,,,,,,80521,,0.228628829,,,,,,,,,,0.045106369,Grade 2,0.012977431,,,,Stage IIA,,-0.1565,,,,,,,,,,,,,,,,-0.1743,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A4MH,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,0,0,0.0,0.0,Male,TCGA-H4-A2HO,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.04,0.63,0,0,0,,,46,,46,46,,0.0,0,46.0,46.0,,Malignant,0,,2,,,,18918.0,,,46.0,46,,,,46,46,,,46.0,,,,,,,,TUMOR FREE,Alive,-19630,,,,131.0,,46.0,46,,,[Not Available],[Not Applicable],,,,,0.01,,,,,0,,0,0.000141,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Medical College of Georgia,,TCGA-H4-A2HO,,,,,,,46,,,,,,,,,0,,,,,,,,,,,,,2010,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,53.0,,,,,,,,,,,,,,,,,,,,80522,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.95,0.88,7,9,8,,,250,BRCA_LumB,250,250,,0,0,250,250,,Invasive Carcinoma,24,,144,,,,17489,0,,250,250,,,,250,250,,,250,,,,,,,,TUMOR FREE,Alive,-18806,,,,59,,250,250,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.18334,[Unknown],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A7VB,,,,,,,250,,,,,,,,,8,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,80524,,-1.534562938,0,0,0,0,0.3707,1,,,Infiltrating Ductal Carcinoma,0.042577106,,0.111451152,0,0,0,,Negative,-0.479,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3181,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,Black or African American,BRCA,,1,1,,,1,0,FEMALE,1,1.8,0.79,11,4,13,,,466,BRCA_LumB,258,466,,1,1,258,258,,Invasive Carcinoma,28,,91,,,,22441,0,,258,258,,,,258,466,,,258,,,,,,,,WITH TUMOR,Alive,-32478,,,,54,,258,258,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,15,,0,0.35185,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A5YM,,,,,,,466,"Other, specify",Locoregional Recurrence,,,,,,,13,,,,,,,,,,,,,2012,258,Skin left chest wall,,,Stage IIIB,,,,,,,,[Not Available],,,,,,88,,,,,,,,,,,,,,,,,,,,80528,,-1.45837543,0,0,0,0,-4.2572,1,,,Infiltrating Ductal Carcinoma,0.102761343,,0.164651884,0,0,0,,Negative,-0.2885,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1459,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Papillary Carcinoma","Invasive Ductal Carcinoma (Mucinous), Invasive Papillary Carcinoma",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A8HY,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,3.27,0.87,8,5,9,,,345,,345,345,,0.0,0,345.0,345.0,,Malignant,22,,79,,,,27768.0,,,345.0,345,,,,345,345,,,345.0,,,,,,,,TUMOR FREE,Alive,-21636,,,,125.0,,345.0,345,,,[Not Available],[Not Applicable],,,,,0.05,,,,,21,,1,0.20955,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ILSBio,,TCGA-CF-A8HY,,,,,,,345,,,,,,,,,16,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,80530,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-6986,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.96,0.4,3,4,2,,,3261,,3261,3261,,0,0,3261,3261,,Malignant,9,,4,,,,16772,,,3261,3261,,,,3261,3261,,,3261,,,,,,,,TUMOR FREE,Alive,,,,,31,,3261,3261,,,[Not Available],[Not Applicable],,,,,0.28,,,,,0,,0,0.04317,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6986,,,,,,,3261,,,,,,,,,1,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,80533,,0.222596863,,,,,,,,,,0.21266293,,0.137810325,,,,Stage IB,,0.434,,,,,,,,,,,,,,,,0.1098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.422815311,LUAD,,,,Adenocarcinoma,-1.013,,-0.4237,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-L5-A4OT,White,ESCA,,1,1,,,,1,,1,3.87,0.47,7,6,12,,,149,,,149,,1,1,149,149,,Malignant,25,,164,,,,26050,,,149,149,,,,,149,,,149,,,,,,,,WITH TUMOR,Dead,-28162,149,,,389,,149,149,,,[Not Available],[Not Available],,,,,0.18,Esophagus,Unknown,,,19,,1,0.29477,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A4OT,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,77,,,,,,,,,,,,,,,,,,,,80540,,,,,,,,,,,,,Unknown,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-66-2765,,LUSC,,0,0,,Indivumed,,0,MALE,0,1.98,0.51,7,5,7,,,61,,,61,,0,0,61,61,,Malignant,19,,17,,,,23298,,,61,61,,,,,61,,,61,,,,,,,,TUMOR FREE,Alive,-23465,,,,123,,61,61,,,[Not Available],[Not Applicable],,,,,0.02,,,,,9,,0,0.21998,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2765,,,,,,,61,,,,,,,,,9,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,80543,,0.785498971,,,,,,,,,,0.169706271,,0.111078461,,,,Stage IB,,0.9575,,,,,,,,,,,,,,,,0.6246,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.131260603130977,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6111,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.13,0.39,2,1,4,,,865,BRCA_LumA,865,865,,0,0,865,865,,Invasive Carcinoma,7,,17,,,,28818,0,,865,865,,,,865,865,,,865,,,,,,,,TUMOR FREE,Alive,-20956,,,,23,,865,865,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,5,,0,0.039712,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IJ,,,,,,,865,,,,,,,,,7,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,80546,,0.9060116,0,0,0,0,0.3083,1,,,Infiltrating Lobular Carcinoma,0.174582401,,0.257764434,0,0,0,,Negative,0.2845,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7175,0,0,H & E,0,0,,0,Theresa Smith,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,Benign Breast Epithelium,N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-BT-A20W,White,BLCA,,0.0,0,,,2,2,MALE,2.0,2.07,0.72,3,6,9,,,254,,254,254,,2.0,2,254.0,254.0,,Malignant,18,,30,,,,23734.0,,,254.0,254,,,,254,254,,,254.0,,,,,,,,TUMOR FREE,Dead,-26078,254,,,121.0,,254.0,254,,,[Not Available],[Not Applicable],,,,,0.74,,,,,3,,0,0.045411,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20W,,,,,,,,,,,,,,,,3,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,71.0,,,,,,,,,,,,,,,,,,,,80550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-RD-A8N0,White,STAD,,0,0,,,0,0,,0,,,,,,,,1236,,1236,1236,,0,0,1236,1236,,Malignant,,,,,,,25916,,,1236,1236,,,,1236,1236,,,1236,,,,,,,,TUMOR FREE,Alive,-19491,,,,4,,1236,1236,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8N0,,,,,,,1236,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,80553,,1.559165055,,,,,,,,,,0.126785993,Grade 3,0.155001193,,,,Stage IIIB,,1.1685,,,,,,,,,,,,,,,,0.119,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8N0,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Male,TCGA-55-6987,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.31,0.16,5,7,5,,,2137,,2137,2137,,0,0,2137,2137,,Malignant,17,,23,,,,32303,,,2137,2137,,,,2137,2137,,,2137,,,,,,,,TUMOR FREE,Alive,-28382,,,,250,,2137,2137,,,[Not Available],[Not Applicable],,,,,0.2,,,,,6,,1,0.57952,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6987,,,,,,,2137,,,,,,,,,32,,,,,,,,,,,,,2006,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,80557,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R116W,1,,,R116W,,,,0.251572854,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2775,,1.9056,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.98,0.75,12,24,19,,,727,BRCA_LumA,,727,,0,0,727,727,,Invasive Carcinoma,55,,57,,,,33516,0,,727,727,,,,,727,,,727,,,,,,,,TUMOR FREE,Alive,-24417,,,,119,,727,727,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,2,,0,0.24116,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1X9,,,,,,,727,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,80561,,0.936487229,0,0,0,0,0.9867,1,,,Infiltrating Ductal Carcinoma,0.189629805,,0.148208873,0,0,0,,[Not Available],0.143,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4077,0,0,H & E,0,0,,0,Christina Luffman,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,Benign Breast Epithelium,Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A8E0,Black or African American,STAD,,1,1,,,,1,,1,2.74,0.46,14,16,15,,,562,,,562,,1,1,531,531,,Malignant,45,,314,,,,18066,,,531,531,,,,,562,,,531,,,,,,,,WITH TUMOR,Dead,-24848,562,,,136,,531,531,,,Stomach Cancer,[Not Applicable],,,,,0.27,Stomach,Unknown,,,19,,1,0.51312,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8E0,,,,,,,,Liver,Distant Metastasis,,,,,,,28,,,,,,,,,,,,,2011,531,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,68,,,,,,,,,,,,,,,,,,,,80567,,-0.3174565,,,,,,,,,,0.065921956,Grade 3,0.096293987,,,,Stage IIIA,,0.0065,,,,,,,,,,,,,,,,-0.0596,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8E0,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-VQ-AA6I,White,STAD,,1,1,,,,1,,1,2.95,0.46,9,7,10,,,491,,,491,,1,1,475,475,,Malignant,26,,109,,,,22445,,,475,475,,,,,491,,,475,,,,,,,,WITH TUMOR,Dead,-25091,491,,,138,,475,475,,,Stomach Cancer,[Not Applicable],,,,,0.04,Stomach,Unknown,,,13,,1,0.20031,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-AA6I,,,,,,,,,Locoregional Recurrence,,,,,,,28,,,,,,,,,,,,,2012,475,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,68,,,,,,,,,,,,,,,,,,,,80572,,-0.063950527,,,,,,,,,,0.052743416,Grade 3,0.032201184,,,,Stage IIIB,,0.3475,,,,,,,,,,,,,,,,0.0376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA6I,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.09,0.79,3,4,10,,,508,BRCA_LumB,508,508,,0,0,508,508,,Invasive Carcinoma,17,,6,,,,31730,0,,508,508,,,,508,508,,,508,,,,,,,,TUMOR FREE,Alive,-23337,,,,282,,508,508,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,14,,1,0.10399,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A274,,,,,,,508,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,80576,,-0.629271103,0,0,0,0,0.6082,1,,,Infiltrating Ductal Carcinoma,0.113364671,,0.06343201,0,0,0,,Negative,-0.9575,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0283,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-MP-A4T6,White,LUAD,,0,0,,Washington University - Mayo Clinic,2,2,FEMALE,2,,,,,,,,1790,,1790,1790,,2,2,1790,1790,,Malignant,,,,,,,27503,,,1790,1790,,,,1790,1790,,,1790,,,,,,,,TUMOR FREE,Dead,-27993,1790,,,131,,1790,1790,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4T6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,80586,,0.880569272,,,,,,,,,,0.189548508,,0.044074656,,,,Stage IIIA,,0.7055,,,,,,,,,,,,,,,,-0.2169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L747_A750delinsP (driver),,,1,L747_A750delinsP (driver),,,15.30526429,15.63586367,16.10837668,-0.237814048,LUAD,Adenocarcinoma,17.97193163,15.82199649,Adenocarcinoma,-1.9742,12.98576677,-0.1434,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,0,,0.0,1.0,Male,TCGA-L5-A4OF,White,ESCA,,0.0,0,,,2,,,2.0,2.1,0.58,6,13,12,,,801,,801,801,,2.0,2,801,801,,Malignant,31,,114,,,,31806.0,0,,801,801,,,,801,801,,,801,,,,,,,,,Dead,-23194,801,,,134.0,,801,801,,,[Not Available],[Not Available],,,,,0.61,Esophagus,Resection,,,6,,0,0.29241,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,University of Michigan,,TCGA-L5-A4OF,,,,,,,,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,80589,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-FP-7916,Asian,STAD,,1,1,,,,1,,1,3.04,0.3,3,2,5,,,428,,,428,,1,1,428,428,,Malignant,10,,20,,,,24517,,,428,428,,,,,428,,,428,,,,,,,,WITH TUMOR,Dead,-28475,428,,,132,,428,428,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,19,,1,0.26296,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,International Genomics Consortium,,TCGA-FP-7916,,,,,,,,,,,,,,,,39,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Progressive Disease,,,,,,77,,,,,,,,,,,,,,,,,,,,80613,,1.168783402,,,,,,,,,,0.110682331,Grade 3,0.140230024,,,,Stage IIIC,,1.243,,,,,,,,,,,,,,,,0.3776,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-7916,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.65,0.67,4,7,9,,,562,BRCA_LumA,562,562,,0,0,562,562,,Invasive Carcinoma,20,,28,,,,22195,0,,562,562,,,,562,562,,,562,,,,,,,,TUMOR FREE,Alive,-26141,,,,76,,562,562,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,14,,1,0.063132,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-A6ZG,,,,,,,562,,,,,,,,,16,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,80617,,0.05070799,0,0,0,0,-0.4897,1,,,Mixed Histology (NOS),0.148560741,,0.083688781,0,0,0,,Negative,-0.239,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0456,0,0,H & E,0,0,,0,Christina Luffman,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-85-7698,White,LUSC,,1,1,,Asterand,1,0,MALE,1,1.81,0.63,13,9,17,,,952,,650,952,,1,1,650,650,,Malignant,39,,39,,,,20955,,,650,650,,,,650,952,,,650,,,,,,,,TUMOR FREE,Alive,-17651,,,,180,,650,650,,,[Not Available],[Not Applicable],,,,,0.4,,,,,6,,0,0.32779,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-7698,,,,,,,952,,Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2011,650,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,48,,,,,,,,,,,,,,,,,,,,80623,,1.117296066,,,,,,,,,,0.206113897,,0.094863096,,,,Stage IA,,2.125,,,,,,,,,,,,,,,,0.6445,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,P612L,1,,,P612L,,,,-0.238317295884968,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.8914,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A3IB,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,1.82,0.91,7,2,7,,,220,,,220,,1.0,1,220.0,220.0,,Malignant,16,,24,,,,28198.0,,,220.0,220,,,,,220,,,220.0,,,,,,,,WITH TUMOR,Dead,-24149,220,,,126.0,,220.0,220,,,[Not Available],[Not Applicable],,,,,0.05,,,,,6,,0,0.20794,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A3IB,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2008,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,80625,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-RD-A8N2,White,STAD,,0,0,,,0,0,,0,,,,,,,,3540,,3540,3540,,0,0,3540,3540,,Malignant,,,,,,,25993,,,3540,3540,,,,3540,3540,,,3540,,,,,,,,TUMOR FREE,Alive,-21749,,,,0,,3540,3540,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8N2,,,,,,,3540,,,,,,,,,,,,,,,,,,,,,,2002,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,80626,,0.303488307,,,,,,,,,,0.081307999,Grade 3,0.173289853,,,,Stage IB,,-0.4055,,,,,,,,,,,,,,,,0.3092,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8N2,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.11,0.68,6,5,7,,,1783,BRCA_LumA,1783,1783,,0,0,1783,1783,,Invasive Carcinoma,18,,53,,,,16193,0,,1783,1783,,,,1783,1783,,,1783,,,,,,,,TUMOR FREE,Alive,-22411,,,,119,,1783,1783,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,6,,0,0.086843,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A5DA,,,,,,,1783,,,,,,,,,7,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,80631,,0.41000871,0,0,0,0,-0.5728,1,,,Infiltrating Lobular Carcinoma,0.088308039,,0.11384624,0,0,0,,Negative,-0.18,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2692,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Female,TCGA-05-4250,,LUAD,,0,0,,Indivumed,,,FEMALE,2,3.19,0.5,4,6,4,,,121,,,121,,2,2,121,121,,Malignant,14,,22,,,,17114,,,121,121,,,,,121,,,121,,,,,,,,,Dead,-29068,121,,,473,,121,121,,,[Not Available],[Not Applicable],,,,,0.1,,,,,16,,1,0.32926,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4250,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,80635,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12C (driver), AMP (driver)",,1,,G12C (driver),,16.26359311,17.94404886,17.46581482,0.105326626,LUAD,,18.0150624,16.60240416,Adenocarcinoma,0.7804,13.49940531,1.3395,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,4.0,0.75,6,3,7,,,160,BRCA_LumA,160,160,,2,2,160,160,,Invasive Carcinoma,16,,16,,,,17602,1,,160,160,,,,160,160,,,160,,,,,,,,,Dead,-25190,160,,,52,,160,160,,,[Not Available],[Not Applicable],,,,,0.05,Skin,Resection/Excision,,,16,,1,0.10114,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TR,,,,,,,,,,,,,,,,20,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,80642,,-0.034553113,0,0,0,0,1.1235,1,,,Infiltrating Ductal Carcinoma,0.058660126,,0.048672073,0,0,0,,Negative,-0.988,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,-0.7225,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.22,0.65,2,5,6,,,339,BRCA_LumA,339,339,,0,0,339,339,,Invasive Carcinoma,13,,35,,,,30967,0,,339,339,,,,339,339,,,339,,,,,,,,TUMOR FREE,Alive,-23347,,,,46,,339,339,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,18,,1,0.23056,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1R6,,,,,,,339,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,80644,,-0.036999479,0,0,0,0,-0.7987,1,,,Infiltrating Ductal Carcinoma,0.11201272,,0.089064004,0,0,0,,Negative,-0.869,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1786,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-60-2698,White,LUSC,,1,,,Roswell Park,,1,MALE,1,5.65,0.26,16,16,27,,,311,,,311,,1,,114,114,,Malignant,59,,64,,,,16546,,,114,,,,,,311,,,114,,,,,,,,WITH TUMOR,Dead,-22800,311,,,1421,,114,,,,[Not Available],[Not Applicable],,,,,0.4,,,,,16,,2,0.33363,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2698,,,,,,,,,,,,,,,,61,,,,,,,,,,,,,1993,114,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,80646,,0.79153901,,,,,,,,,,0.242562548,,0.13140172,,,,Stage IIB,,1.307,,,,,,,,,,,,,,,,0.4051,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"X210_splice, AMP (driver)",AMP (driver),,1,X210_splice,,,16.77346519,17.73098162,15.97219927,-0.139388212537324,LUSC,Squamous Cell Carcinoma,17.92690676,16.71021214,Squamous Cell Carcinoma,-0.0136,14.48929939,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.36,0.61,12,14,11,,,1203,BRCA_Basal,1203,1203,,0,0,1203,1203,,Invasive Carcinoma,37,,97,,,,21507,0,,1203,1203,,,,1203,1203,,,1203,,,,,,,,TUMOR FREE,Alive,-19479,,,,66,,1203,1203,,,[Not Available],[Not Applicable],,,,,0.48,Breast,Resection/Excision,,,7,,0,0.71476,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0B3,,,,,,,1203,,,,,,,,,20,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,80647,TRUE,1.087260352,0,0,0,0,0.592,1,,,Infiltrating Ductal Carcinoma,0.200915724,,0.079982209,0,0,0,,Negative,1.046,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5814,0,0,H & E,0,0,,0,Theresa Smith,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,Benign Breast Epithelium,N/A No in Situ,"DCIS (Solid, Intermediate Grade), N/A No in Situ",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-60-2721,White,LUSC,,0,0,,Roswell Park,0,0,MALE,0,1.95,0.61,7,6,11,,,983,,983,983,,0,0,983,983,,Malignant,24,,38,,,,27164,,,983,983,,,,983,983,,,983,,,,,,,,TUMOR FREE,Alive,-27007,,,,276,,983,983,,,[Not Available],[Not Applicable],,,,,0.15,,,,,10,,0,0.3016,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2721,,,,,,,983,,,,,,,,,13,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,80653,,1.477135258,,,,,,,,,,0.20154489,,0.062272551,,,,Stage IB,,1.301,,,,,,,,,,,,,,,,0.4967,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0112584176837135,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4262,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-2H-A9GF,Unknown,ESCA,,1,1,,,,1,,1,2.84,0.68,12,20,17,,,784,,,784,,1,1,172,172,,Malignant,49,,220,,,,21208,,,172,172,,,,,784,,,172,,,,,,,,WITH TUMOR,Dead,-24487,784,,,467,,172,172,,,[Not Available],[Not Available],,,,,0.03,Esophagus,Unknown,,,15,,1,0.24111,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Erasmus MC,,TCGA-2H-A9GF,,,,,,,,Brain,Distant Metastasis,,,,,,,34,,,,,,,,,,,,,2001,172,,,,Stage III,,,,,,,,,,,,,,67,,,,,,,,,,,,,,,,,,,,80654,,,,,,,,,,,,,Grade 3,,,,,Stage III,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,Female,TCGA-L5-A4OG,White,ESCA,,0,0,,,,0,,0,2.8,0.44,3,6,10,,,143,,,143,,0,0,143,143,,Malignant,19,,109,,,,17441,,,143,143,,,,,143,,,143,,,,,,,,,Alive,-29105,,,,267,,143,143,,,[Not Available],[Not Available],,,,,0.05,Esophagus,Unknown,,,17,,1,0.3265,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G1,,University of Michigan,,TCGA-L5-A4OG,,,,,,,143,,,,,,,,,33,,,,,,,,,,,,,2012,,,,,Stage I,,,,,,,,[Unknown],,,,,,79,,,,,,,,,,,,,,,,,,,,80656,,,,,,,,,,,,,Grade 1,,,,,Stage I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,1.92,0.56,4,1,6,,,501,BRCA_LumA,,501,,0,0,501,501,,Invasive Carcinoma,11,,18,,,,16671,0,,501,501,,,,,501,,,501,,,,,,,,TUMOR FREE,Alive,-23168,,,,48,,501,501,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,7,,0,0.1107,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1BC,,,,,,,501,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,80662,,-0.700124478,0,0,0,0,0.6518,1,,,Infiltrating Ductal Carcinoma,0.144356267,,0.234852788,0,0,0,,Positive,-0.935,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3294,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,1,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Skeletal Muscle",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.07,0.48,12,1,10,,,1132,BRCA_LumA,1132,1132,,0,0,1132,1132,,Invasive Carcinoma,23,,39,,,,21926,0,,1132,1132,,,,1132,1132,,,1132,,,,,,,,TUMOR FREE,Alive,-18839,,,,76,,1132,1132,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,31,,1,0.49709,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mixed Histology (please specify),,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BA,,,,,,,1132,,,,,,,,,15,,,,,,,,,,,,,2006,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,80665,,0.270009912,0,0,0,0,-0.0919,1,,,Mixed Histology (NOS),0.149403352,,0.250904255,0,0,0,,Negative,-0.038,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0734,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6377,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.93,0.66,3,4,5,ambiguous,NO,958,1-ERG,958,958,,0,0,958,958,prad_tcga,Malignant,12,BRCA1;CDK12;RAD51D,20,3.6,TCGA-G9-6377-01,0,5373,0,TCGA-G9-6377,958,958,Prostate Cancer,,518,958,958,TCGA,,958,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22419,,61,7,35,PRAD,958,958,WHITE,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.21,Prostate,Resection,3,8f105d0d-0630-46fc-8168-dcba11a5197f,3,Abnormal (not related to prostate cancer),0,0.067335,[Not Available],007f9081-5093-4323-b4f8-cd510bf20705,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.0,TCGA-G9-6377,0:DiseaseFree,2,21,Prostate Adenocarcinoma,31.47,3/5/12,958,,,,,NO,C61,520abbf9-817a-45db-aecc-22c4fc80ddae,,2,TUMOR FREE,0.1123,0:LIVING,0.03,,31.47,Bilateral,22,No Evidence of Extraprostatic Extension,11,YES,,2009,,,TCGA-G9-6377.520abbf9-817a-45db-aecc-22c4fc80ddae.pdf,,[Not Applicable],YES,36,66-75%,6,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.5,61,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,80669,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.2,0.41,10,19,24,,,612,BRCA_Basal,612,612,,0,0,612,612,,Invasive Carcinoma,53,,72,,,,20944,0,,612,612,,,,612,612,,,612,,,,,,,,TUMOR FREE,Alive,-32872,,,,292,,612,612,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,17,,2,0.26695,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JK,,,,,,,612,,,,,,,,,63,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,80671,,1.072359512,0,0,0,0,-0.1889,1,,,Infiltrating Ductal Carcinoma,0.228295485,,0.16176047,0,0,0,,Negative,1.1945,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6354,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-85-8584,White,LUSC,,0,0,,Asterand,2,2,MALE,2,2.06,0.39,10,8,11,,,383,,383,383,,2,2,383,383,,Malignant,29,,107,,,,20046,,,383,383,,,,383,383,,,383,,,,,,,,TUMOR FREE,Dead,-26081,383,,,352,,383,383,,,[Not Available],[Not Applicable],,,,,0.29,,,,,6,,0,0.17033,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8584,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,80675,,1.468273336,,,,,,,,,,0.15177185,,0.090126905,,,,Stage IIA,,1.7835,,,,,,,,,,,,,,,,0.3246,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,15.25133672,15.45055051,17.60698617,0.0148327351230516,LUSC,Squamous Cell Carcinoma,18.2292098,17.06151361,Squamous Cell Carcinoma,0.4147,13.2353625,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-SW-A7EB,White,STAD,,0,0,,,,0,,0,2.83,0.22,9,18,16,,,176,,,176,,0,0,176,176,,Malignant,43,,140,,,,31839,,,176,176,,,,,176,,,176,,,,,,,,TUMOR FREE,Alive,-16475,,,,181,,176,176,,,[Not Available],[Not Applicable],,,,,0.09,Stomach,Unknown,,,18,,1,0.32336,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G2,,Global Bioclinical-Moldova,,TCGA-SW-A7EB,,,,,,,176,,,,,,,,,33,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,45,,,,,,,,,,,,,,,,,,,,80681,,0.491660238,,,,,,,,,,0.03477071,Grade 2,0.065074629,,,,Stage IIIA,,-0.199,,,,,,,,,,,,,,,,0.0323,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-SW-A7EB,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-ZF-A9R4,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.43,0.91,5,8,9,,,921,,921,921,,0.0,0,921.0,921.0,,Malignant,22,,43,,,,25793.0,,,921.0,921,,,,921,921,,,921.0,,,,,,,,TUMOR FREE,Alive,-30398,,,,339.0,,921.0,921,,,[Not Available],[Not Applicable],,,,,0.4,,,,,18,,1,0.11592,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9R4,,,,,,,921,,,,,,,,,20,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,83.0,,,,,,,,,,,,,,,,,,,,80682,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,0,1,1,Male,TCGA-62-A46P,White,LUAD,,1,1,,Thoraxklinik at University Hospital Heidelberg,1,2,MALE,1,2.05,0.7,6,4,6,,,594,,267,594,,1,1,267,267,,Malignant,16,,57,,,,17448,,,267,267,,,,267,594,,,267,,,,,,,,TUMOR FREE,Dead,-23993,594,,,370,,267,267,,,[Not Available],[Not Applicable],,,,,0.12,,,,,6,,0,0.10874,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A46P,,,,,,,,,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2006,267,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,80684,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,-0.3351,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.579626851,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.804,,-0.939,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-CD-5804,Asian,STAD,,0,0,,,0,0,,0,2.29,0.43,13,14,20,,,368,,368,368,,0,0,368,368,,Malignant,47,,103,,,,19801,,,368,368,,,,368,368,,,368,,,,,,,,TUMOR FREE,Alive,-32872,,,,98,,368,368,,,[Not Available],[Not Applicable],,,,,0.16,Stomach,Unknown,,,11,,1,0.32893,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,ILSBio,,TCGA-CD-5804,,,,,,,368,,,,,,,,,43,,,,,,,,,,,,,2010,,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,90,,,,,,,,,,,,,,,,,,,,80688,,0.037034183,,,,,,,,,,0.100088028,Grade 2,0.154165005,,,,Unknown,,-0.619,,,,,,,,,,,,,,,,0.3551,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-5804,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-HC-7209,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.55,2,7,4,HRP,NO,440,1-ERG,440,440,,0,0,440,440,prad_tcga,Malignant,13,,43,7.9,TCGA-HC-7209-01,0,5407,0,TCGA-HC-7209,440,440,Prostate Cancer,,108,440,440,TCGA,,440,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-22129,,60,6,26,PRAD,440,440,WHITE,0.0,[Not Available],[Not Applicable],28,R0,1,Matched,0.0,Prostate,Resection,3,aa7850ac-fb78-433b-8d55-a24c05935db5,0,,0,0.044262,[Not Available],582d1177-73b0-4a9c-8505-70d6b402bd01,3,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,13,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,0.866666666667,TCGA-HC-7209,0:DiseaseFree,1,13,Prostate Adenocarcinoma,14.45,4/10/12,440,,,,,,C61,87f8ff1b-d58b-470e-9156-144cbe34b71c,,0,TUMOR FREE,0.0422,0:LIVING,0.05,,14.45,Bilateral,14,,,YES,,2011,,,TCGA-HC-7209.87f8ff1b-d58b-470e-9156-144cbe34b71c.pdf,,[Not Applicable],,,71-80%,2,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.4,60,Core needle biopsy,,,YES,NO,YES,,T2c,,6,No,,0,N0,T2b,0,,C61.9,8550/3,80700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-8486,White,STAD,,0,0,,,0,0,,0,1.75,0.65,13,10,11,,,615,,615,615,,0,0,615,615,,Malignant,34,,159,,,,0,,,615,615,,,,615,615,,,615,,,,,,,,TUMOR FREE,Alive,-32872,,,,351,,615,615,,,[Not Available],[Not Applicable],,,,,0.48,Stomach,Unknown,,,5,,0,0.37599,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8486,,,,,,,615,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,90,,,,,,,,,,,,,,,,,,,,80701,,0.224669335,,,,,,,,,,0.077599471,Grade 2,0.188980105,,,,Stage IA,,0.831,,,,,,,,,,,,,,,,0.3113,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8486,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-VQ-AA68,White,STAD,,0,0,,,0,0,,0,6.01,0.33,14,9,24,,,1328,,1328,1328,,0,0,1328,1328,,Malignant,47,,183,,,,17802,,,1328,1328,,,,1328,1328,,,1328,,,,,,,,TUMOR FREE,Alive,-19304,,,,227,,1328,1328,,,[Not Available],[Not Applicable],,,,,0.33,Stomach,Unknown,,,21,,2,0.33485,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-AA68,,,,,,,1328,,,,,,,,,46,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,80713,,0.783220235,,,,,,,,,,0.032999037,Grade 2,-0.00354671,,,,Stage IIIC,,0.4835,,,,,,,,,,,,,,,,0.0485,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA68,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.78,1,0,3,,,1079,BRCA_LumA,1079,1079,,0,0,1079,1079,,Invasive Carcinoma,4,,6,,,,24075,0,,1079,1079,,,,1079,1079,,,1079,,,,,,,,TUMOR FREE,Alive,-29104,,,,0,,1079,1079,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Core Biopsy,,,3,,0,0.017948,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0CH,,,,,,,1079,,,,,,,,,3,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,80732,,-0.576122013,0,0,0,0,0.8277,1,,,Infiltrating Ductal Carcinoma,0.160027882,,0.107407846,0,0,0,,Negative,-1.3165,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3136,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,,0.0,1.0,Male,TCGA-XF-A8HC,Asian,BLCA,,0.0,0,,,,,MALE,2.0,2.99,0.96,6,5,11,,,200,,,200,,2.0,2,200.0,200.0,,Malignant,22,,63,,,,23726.0,,,200.0,200,,,,,200,,,200.0,,,,,,,,,Dead,-28996,200,,,219.0,,200.0,200,,,[Not Available],[Not Applicable],,,,,0.1,,,,,14,,1,0.11124,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A8HC,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2005,,,,,Stage IV,,,,,,,,[Unknown],,,,,,79.0,,,,,,,,,,,,,,,,,,,,80737,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-JY-A93C,Asian,ESCA,,1,1,,,1,0,,1,3.14,0.66,4,6,11,,,705,,652,705,,1,1,652,652,,Malignant,21,,100,,,,26130,,,652,652,,,,652,705,,,652,,,,,,,,WITH TUMOR,Alive,-17228,,,,174,,652,652,,,[Not Available],[Not Available],,,,,0.48,Esophagus,Unknown,,,18,,1,0.2058,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,University Health Network,,TCGA-JY-A93C,,,,,,,705,,Locoregional Recurrence,,,,,,,23,,,,,,,,,,,,,2011,652,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,47,,,,,,,,,,,,,,,,,,,,80739,,,,,,,,,,,,,Grade 3,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,0,0,0,1,Male,TCGA-86-8055,White,LUAD,,0,0,,Asterand,2,2,MALE,2,3.5,0.28,6,6,12,,,124,,124,124,,2,2,124,124,,Malignant,24,,24,,,,19927,,,124,124,,,,124,124,,,124,,,,,,,,TUMOR FREE,Dead,-29124,124,,,58,,124,124,,,[Not Available],[Not Applicable],,,,,0.5,,,,,19,,2,0.32556,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8055,,,,,,,,,,,,,,,,71,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,80742,,0.618170005,,,,,,,,,,0.289593574,,0.16234091,,,,Stage IIA,,0.793,,,,,,,,,,,,,,,,0.9242,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), AMP (driver)",,,1,L858R (driver),,,16.37525181,18.00814506,15.19139042,-0.252589039,LUAD,Adenocarcinoma,17.93021706,15.8057133,Adenocarcinoma,1.5501,14.3112428,-0.6339,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.94,0.61,4,1,4,,,1996,BRCA_LumA,1996,1996,,0,0,1996,1996,,Invasive Carcinoma,9,,28,,,,28554,0,,1996,1996,,,,1996,1996,,,1996,,,,,,,,TUMOR FREE,Alive,-29345,,,,88,,1996,1996,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,3,,0,0.068598,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A66J,,,,,,,1996,,,,,,,,,3,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,80751,,,0,0,0,0,0.4824,1,,,Infiltrating Lobular Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.48,0.54,17,11,17,,,1010,BRCA_Her2,1010,1010,,0,0,1010,1010,,Invasive Carcinoma,45,,143,,,,26249,0,,1010,1010,,,,1010,1010,,,1010,,,,,,,,TUMOR FREE,Alive,-12006,,,,90,,1010,1010,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,23,,1,0.33072,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A6SD,,,,,,,1010,,,,,,,,,21,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,32,,,,,,,,,,,,,,,,,,,,80755,,0.940783513,0,0,0,0,-0.1018,1,,,Infiltrating Ductal Carcinoma,0.161305422,,0.131160521,0,0,0,,Negative,0.9125,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.344,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"DCIS with Microinvasive Carcinoma, Invasive Ductal Carcinoma (No Special Type)","DCIS with Microinvasive Carcinoma, Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.89,0.63,11,10,7,,,396,BRCA_LumA,396,396,,0,0,396,396,,Invasive Carcinoma,28,,39,,,,19562,0,,396,396,,,,396,396,,,396,,,,,,,,TUMOR FREE,Alive,-26693,,,,92,,396,396,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,4,,0,0.2111,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A0A4,,,,,,,396,,,,,,,,,9,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,80759,,-0.598524554,0,0,0,0,0.1709,1,,,Infiltrating Lobular Carcinoma,0.144299677,,0.193160868,0,0,0,,Negative,-0.853,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2906,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.48,3,2,4,,,1648,BRCA_LumA,1648,1648,,0,0,1648,1648,,Invasive Carcinoma,9,,6,,,,20942,0,,1648,1648,,,,1648,1648,,,1648,,,,,,,,TUMOR FREE,Alive,-16403,,,,31,,1648,1648,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.040036,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1L6,,,,,,,1648,,,,,,,,,4,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,80760,,-0.332984203,0,0,0,0,0.4481,1,,,Infiltrating Ductal Carcinoma,0.148669059,,0.183440537,0,0,0,,Negative,-0.4465,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3252,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Papillary, Intermediate Grade), No Detail Present",,"DCIS (Papillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-78-7539,White,LUAD,,1,1,,Prince Charles Hospital,1,0,FEMALE,1,3.49,0.52,6,20,16,,,791,,688,791,,1,1,688,688,,Malignant,42,,51,,,,19706,,,688,688,,,,688,791,,,688,,,,,,,,,Alive,-27445,,,,622,,688,688,,,[Not Available],[Not Applicable],,,,,0.12,,,,,11,,1,0.17328,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7539,,,,,,,791,,Distant Metastasis,,,,,,,30,,,,,,,,,,,,,2011,688,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,80762,,1.257093864,,,,,,,,,,0.257347652,,0.073633484,,,,Stage IIA,,1.3775,,,,,,,,,,,,,,,,-0.2825,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.0687317,16.79334351,16.6680337,0.030542351,LUAD,Adenocarcinoma,18.38495704,16.51676191,Adenocarcinoma,-0.5844,13.47744635,1.0203,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Female,TCGA-D7-6519,White,STAD,,1,1,,,,0,,1,3.28,0.74,15,16,15,,,625,,,625,,1,1,429,429,,Malignant,46,,95,,,,25687,,,429,429,,,,,625,,,429,,,,,,,,WITH TUMOR,Alive,-23413,,,,72,,429,429,,,[Not Available],[Not Applicable],,,,,0.11,Stomach,Unknown,,,23,,1,0.35153,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6519,,,,,,,625,Liver,Distant Metastasis,,,,,,,17,,,,,,,,,,,,,2010,429,cervix,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,64,,,,,,,,,,,,,,,,,,,,80767,,,,,,,,,,,,,Grade 3,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6519,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,,0,0,0,Male,TCGA-HC-A6HX,,PRAD,,0,0,,HC,,0,MALE,0,2.0,0.21,3,2,3,HRD,NO,38,,,38,,0,0,38,38,prad_tcga,Malignant,8,PALB2,23,,TCGA-HC-A6HX-01,3,5457,0,TCGA-HC-A6HX,38,38,Prostate Cancer,,,,38,TCGA,,38,Primary,0,,A,CDK12:217:K/*:stop_gained,,False,TUMOR FREE,Alive,-20263,,55,7,26,PRAD,38,38,,0.124301499,[Not Available],[Not Applicable],29,,1,Matched,0.05,Prostate,Resection,4,2CE7BA34-3755-46FD-9877-04EEC1D0349B,0,,0,0.032327,[Not Available],F3E93819-A8F5-4D15-A416-3EDD42AA52D1,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,HC,1.06666666667,TCGA-HC-A6HX,0:DiseaseFree,3,13,Prostate Adenocarcinoma,1.25,9/19/13,38,,,,,,C61,0E22E3BE-B28B-40CC-83F9-9B59593B7187,30,3,TUMOR FREE,0.004,0:LIVING,,5,1.25,Bilateral,15,,,YES,112,2013,,,TCGA-HC-A6HX.0E22E3BE-B28B-40CC-83F9-9B59593B7187.pdf,,[Not Applicable],,,,4,Prostate Adenocarcinoma Acinar Type,1,2013,[Unknown],,,No,R0,,55,Core needle biopsy,,,YES,NO,YES,NO,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,80773,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.36,0,0,0,,,1051,BRCA_Normal,1051,1051,,0,0,1051,1051,,Invasive Carcinoma,0,,19,,,,25517,0,,1051,1051,,,,1051,1051,,,1051,,,,,,,,TUMOR FREE,Alive,-19464,,,,21,,1051,1051,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,0,,0,1.13e-05,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1PG,,,,,,,1051,,,,,,,,,0,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,80774,,-0.615979727,0,0,0,0,0.7997,1,,,Infiltrating Lobular Carcinoma,0.139847327,,0.210151323,0,0,0,,Negative,0.015,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7216,0,0,H & E,0,0,,0,Theresa Smith,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,Benign Breast Epithelium,N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-55-6975,White,LUAD,,1,1,,International Genomics Consortium,,1,MALE,1,1.69,0.46,10,6,8,,,118,,,118,,1,1,118,118,,Malignant,24,,36,,,,20584,,,118,118,,,,,118,,,118,,,,,,,,WITH TUMOR,Dead,,118,,,105,,118,118,,,[Not Available],[Not Applicable],,,,,0.45,,,,,12,,0,0.32577,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6975,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,80782,,0.308301499,,,,,,,,,,0.191639588,,0.264672628,,,,Stage IIB,,-0.5115,,,,,,,,,,,,,,,,0.6774,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13C (driver),,1,,G13C (driver),,15.03491869,15.74733378,13.51520479,-0.528367525,LUAD,Adenocarcinoma,17.92581104,15.67958429,Adenocarcinoma,1.2978,13.64106608,-0.2356,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-33-A5GW,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,1.73,0.82,10,13,10,,,9,,9,9,,2,2,9,9,,Malignant,33,,123,,,,21830,,,9,9,,,,9,9,,,9,,,,,,,,TUMOR FREE,Dead,-24586,9,,,266,,9,9,,,[Not Available],[Not Applicable],,,,,0.11,,,,,9,,0,0.38235,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-A5GW,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,80783,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.0019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,12.70910454,13.21871213,12.45301135,-1.15552207918939,LUSC,,17.30889349,14.10816003,Squamous Cell Carcinoma,-2.1379,13.22355708,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-85-7844,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.62,0.33,9,9,13,,,911,,911,911,,0,0,911,911,,Malignant,31,,27,,,,25466,,,911,911,,,,911,911,,,911,,,,,,,,TUMOR FREE,Alive,-26141,,,,242,,911,911,,,[Not Available],[Not Applicable],,,,,0.14,,,,,17,,1,0.30394,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-7844,,,,,,,911,,,,,,,,,24,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,80784,,0.381224848,,,,,,,,,,0.191045884,,0.155260789,,,,Stage IB,,1.111,,,,,,,,,,,,,,,,0.8107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.41906094782357,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.0491,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,0,0,0.0,1.0,Female,TCGA-XF-AAN4,White,BLCA,,0.0,0,,,2,2,FEMALE,2.0,2.02,0.46,0,0,1,,,823,,823,823,,2.0,2,823.0,823.0,,Malignant,1,,12,,,,29888.0,,,823.0,823,,,,823,823,,,823.0,,,,,,,,TUMOR FREE,Dead,-28302,823,,,42.0,,823.0,823,,,[Not Available],[Not Applicable],,,,,0.16,,,,,1,,0,0.0052877,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAN4,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,2007,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,80786,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-G9-6494,White,PRAD,108,0,0,,G9,,0,MALE,0,1.98,0.57,5,4,5,HRD,NO,1771,2-ETV1,,1771,,0,0,1771,1771,prad_tcga,Malignant,14,ATM;BRCA1;CDK12;RAD51D,26,87.0,TCGA-G9-6494-01,0,5378,0,TCGA-G9-6494,1771,1771,Prostate Cancer,,1423,,1771,TCGA,,1771,Primary,0,Base,A,,CHEK1,,WITH TUMOR,Alive,-24381,,66,7,40,PRAD,1771,1771,WHITE,0.0,[Not Available],[Not Applicable],42,R1,1,Matched,0.01,Prostate,Resection,4,45db5303-bbab-4f8c-a2a2-9a9a9bfa2fd1,5,Normal (no evidence of prostate cancer) [cM0],0,0.068649,[Not Available],0c459149-0dfe-4206-b50b-db79180ebb57,3,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,G9,2.66666666667,TCGA-G9-6494,0:DiseaseFree,3,12,Prostate Adenocarcinoma,58.18,4/6/12,1771,,,,,NO,C61,9aad0222-0731-498b-a9c2-400ce0ccfa0d,,3,WITH TUMOR,0.1102,0:LIVING,1.13,,58.18,Bilateral,19,No Evidence of Extraprostatic Extension,-13,YES,,2008,,,TCGA-G9-6494.9aad0222-0731-498b-a9c2-400ce0ccfa0d.pdf,,[Not Applicable],YES,-13,41-50%,2,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,,No,R1,1.0,66,Core needle biopsy,,,NO,YES,YES,,T4,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,80787,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-HC-7232,White,PRAD,184,1,1,,HC,1,0,MALE,1,1.95,0.6,6,8,3,ambiguous,NO,1161,1-ERG,766,1161,,1,1,766,766,prad_tcga,Malignant,17,ATM;BRCA2;CHEK1,22,9.6,TCGA-HC-7232-01,0,5414,0,TCGA-HC-7232,766,766,Prostate Cancer,,,766,1161,TCGA,,766,Primary,0,,A,,,,WITH TUMOR,Alive,-24324,,66,9,41,PRAD,766,766,WHITE,0.0,[Not Available],[Not Applicable],40,R0,1,Matched,0.07,Prostate,Resection,4,0f4b7d00-1c4c-4634-a45e-10f8949abb43,2,,0,0.088511,[Not Available],ce3585d3-7388-4d05-84c8-64e0883003b3,5,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,1.33333333333,TCGA-HC-7232,1:Recurred/Progressed,5,16,Prostate Adenocarcinoma,25.16,4/11/12,1161,,Biochemical evidence of disease,,,,C61,d5b6e727-43d6-4d27-a7ae-d89c046ef4eb,,3,TUMOR FREE,0.1165,0:LIVING,,,38.14,Bilateral,19,,,YES,,2011,766,,TCGA-HC-7232.d5b6e727-43d6-4d27-a7ae-d89c046ef4eb.pdf,,[Not Applicable],,,16-25%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.6,66,Core needle biopsy,,,YES,NO,NO,,T3b,,9,No,,0,,,,,C61.9,8550/3,80794,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-DK-A1A3,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.23,0.43,6,7,13,,,665,,,665,,1.0,1,665.0,665.0,,Malignant,26,,27,,,,28118.0,,,665.0,665,,,,,665,,,665.0,,,,,,,,WITH TUMOR,Dead,-22235,665,,,871.0,,665.0,665,,,[Not Available],[Not Applicable],,,,,0.09,,,,,18,,1,0.19297,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1A3,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,[Not Available],,,,,,60.0,,,,,,,,,,,,,,,,,,,,80798,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.56,5,5,8,,,1662,BRCA_LumA,1662,1662,,0,0,1662,1662,,Invasive Carcinoma,18,,18,,,,17445,0,,1662,1662,,,,1662,1662,,,1662,,,,,,,,TUMOR FREE,Alive,-24219,,,,47,,1662,1662,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.10248,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0SU,,,,,,,1662,,,,,,,,,9,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,80804,,0.527843925,0,0,0,0,0.3315,1,,,Infiltrating Ductal Carcinoma,0.131636784,,0.231844537,0,0,0,,Negative,-1.0485,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3275,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.72,2,1,1,,,954,BRCA_LumA,954,954,,0,0,954,954,,Invasive Carcinoma,4,,18,,,,17731,0,,954,954,,,,954,954,,,954,,,,,,,,TUMOR FREE,Alive,-26274,,,,81,,954,954,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Core Biopsy,,,4,,0,0.081716,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A26E,,,,,,,954,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,80805,,-0.669854038,0,0,0,0,0.3605,1,,,Infiltrating Lobular Carcinoma,0.176397269,,0.160367078,0,0,0,,Negative,-1.3475,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3415,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-J4-AATV,,PRAD,,0,0,,J4,,0,MALE,0,2.0,0.98,0,0,0,HRP,NO,553,,,553,,0,0,553,553,prad_tcga,Malignant,0,,5,,TCGA-J4-AATV-01,0,5490,0,TCGA-J4-AATV,553,553,Prostate Cancer,,358,,553,TCGA,,553,Primary,0,,A,,,True,WITH TUMOR,Alive,-25943,,71,6,2,PRAD,553,553,,0.0,[Not Available],[Not Applicable],10,,1,Matched,0.0,Prostate,Resection,3,A863236E-3FD1-42B5-A3EB-49F91BB072E7,0,,0,0.000483,[Not Available],FADD80E3-8087-4494-A8F0-1CAA92ACBB67,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,0.266666666667,TCGA-J4-AATV,0:DiseaseFree,1,0,Prostate Adenocarcinoma,18.17,8/13/14,553,,,,,,C61,860F2174-869F-47E4-ABC1-14E4F608669A,50,0,,0.0002,0:LIVING,0.0,,18.17,Bilateral,3,,,YES,151,2013,,,TCGA-J4-AATV.860F2174-869F-47E4-ABC1-14E4F608669A.pdf,,[Not Applicable],,,,4,Prostate Adenocarcinoma Acinar Type,1,2013,[Discrepancy],,NO,No,R1,,71,Core needle biopsy,,,YES,NO,YES,NO,T2c,NO,6,No,NO,0,N0,,,M0,C61.9,8140/3,80817,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,170,BRCA_Basal,170,170,,0,0,170,170,,Invasive Carcinoma,,,,,,,17581,0,,170,170,,,,170,170,,,170,,,,,,,,TUMOR FREE,Alive,-21857,,,,56,,170,170,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0RX,,,,,,,170,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,80818,TRUE,1.709869931,0,0,0,0,0.2367,1,,,Infiltrating Ductal Carcinoma,0.204745209,,0.257394387,0,0,0,,Negative,1.1055,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4927,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-XF-A8HB,Unknown,BLCA,,0.0,0,,,0,0,FEMALE,0.0,2.09,0.96,6,7,10,,,1370,,1370,1370,,0.0,0,1370.0,1370.0,,Malignant,23,,51,,,,33327.0,,,1370.0,1370,,,,1370,1370,,,1370.0,,,,,,,,TUMOR FREE,Alive,-18544,,,,102.0,,1370.0,1370,,,[Not Available],[Not Applicable],,,,,0.06,,,,,5,,0,0.1072,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A8HB,,,,,,,1370,,,,,,,,,9,,,,,,,,,,,,,2006,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,50.0,,,,,,,,,,,,,,,,,,,,80824,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-60-2695,White,LUSC,,0,0,,Roswell Park,0,0,FEMALE,0,2.52,0.81,4,7,11,,,642,,642,642,,0,0,642,642,,Malignant,22,,30,,,,27037,,,642,642,,,,642,642,,,642,,,,,,,,TUMOR FREE,Alive,-27211,,,,295,,642,642,,,[Not Available],[Not Applicable],,,,,0.2,,,,,20,,1,0.25858,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2695,,,,,,,642,,,,,,,,,36,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,80826,,0.850964323,,,,,,,,,,0.177497004,,0.099876251,,,,Stage IB,,1.0685,,,,,,,,,,,,,,,,0.159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.249134872452571,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1321,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-GU-A42Q,White,BLCA,,0.0,0,,,2,2,MALE,2.0,2.95,0.45,11,10,13,,,344,,344,344,,2.0,2,344.0,344.0,,Malignant,34,,89,,,,22380.0,,,344.0,344,,,,344,344,,,344.0,,,,,,,,TUMOR FREE,Dead,-24534,344,,,253.0,,344.0,344,,,[Not Available],[Not Applicable],,,,,0.09,,,,,7,,1,0.22756,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,,,TCGA-GU-A42Q,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,67.0,,,,,,,,,,,,,,,,,,,,80830,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-AAN0,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.66,0.52,4,0,2,,,1718,,,1718,,1.0,1,603.0,603.0,,Malignant,6,,49,,,,23535.0,,,603.0,603,,,,,1718,,,603.0,,,,,,,,WITH TUMOR,Dead,-24877,1718,,,564.0,,603.0,603,,,[Not Available],[Not Applicable],,,,,0.24,,,,,16,,1,0.17794,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAN0,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,14,,,,,,,,,,,,,2007,603,Scrotum and Perineum,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,68.0,,,,,,,,,,,,,,,,,,,,80831,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.49,9,6,8,,,631,BRCA_LumA,631,631,,0,0,631,631,,Invasive Carcinoma,23,,27,,,,18802,0,,631,631,,,,631,631,,,631,,,,,,,,TUMOR FREE,Alive,-18756,,,,31,,631,631,,,[Not Available],[Not Applicable],,,,,0.33,Breast,Resection/Excision,,,10,,0,0.23009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0T7,,,,,,,631,,,,,,,,,13,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,80838,,-0.025102469,0,0,0,0,0.9397,1,,,Infiltrating Ductal Carcinoma,0.194695927,,0.139981374,0,0,0,,Negative,-0.3065,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.635,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9Z8,,PRAD,,0,0,,V1,0,0,MALE,0,2.04,0.45,2,6,1,HRP,NO,827,,827,827,,0,0,827,827,prad_tcga,Malignant,9,,48,,TCGA-V1-A9Z8-01,9,5582,0,TCGA-V1-A9Z8,827,827,Prostate Cancer,,181,827,827,TCGA,,827,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-21900,,59,9,34,PRAD,827,827,,0.284475523,[Not Available],[Not Applicable],34,,1,Matched,0.04,Prostate,Resection,5,F328DE54-F9C2-4280-8D37-35629B1148B1,1,,0,0.036314,[Not Available],9BF4E7BB-6AA9-4BE8-A7C3-E630ECFF4DCE,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,V1,1.13333333333,TCGA-V1-A9Z8,0:DiseaseFree,5,13,Prostate Adenocarcinoma,27.17,7/23/14,827,,,,,NO,C61,3C543195-4F88-4FA4-A397-EDF375FCE61A,120,2,,0.0943,0:LIVING,0.01,,27.17,Bilateral,14,,,YES,,,,,TCGA-V1-A9Z8.3C543195-4F88-4FA4-A397-EDF375FCE61A.pdf,Peripheral Zone,[Not Applicable],NO,,,18,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,59,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,NO,,N0,,0,M0,C61.9,8140/3,80839,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.5,0.58,5,9,11,,,3022,BRCA_LumB,3022,3022,,0,0,3022,3022,,Invasive Carcinoma,25,,134,,,,21722,0,,3022,3022,,,,3022,3022,,,3022,,,,,,,,TUMOR FREE,Alive,-15212,,,,38,,3022,3022,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,16,,1,0.31136,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2BM,,,,,,,3022,,,,,,,,,19,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,80848,,0.867177845,0,0,0,0,-4.0983,1,,,Infiltrating Ductal Carcinoma,0.112378216,,0.071216317,0,0,0,,Negative,0.073,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0549,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.7,2,4,5,,,275,BRCA_LumB,275,275,,0,0,275,275,,Invasive Carcinoma,11,,23,,,,21470,0,,275,275,,,,275,275,,,275,,,,,,,,TUMOR FREE,Alive,-21514,,,,63,,275,275,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,5,,0,0.069015,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15K,,,,,,,275,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,80849,,1.172025085,0,0,0,0,0.4533,1,,,Infiltrating Ductal Carcinoma,0.144372826,,0.129081888,0,0,0,,Negative,0.197,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.225,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-68-7756,White,LUSC,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,1.85,0.49,3,0,4,,,202,,,202,,0,0,202,202,,Malignant,7,,7,,,,23259,,,202,202,,,,,202,,,202,,,,,,,,,Alive,-30763,,,,146,,202,202,,,[Not Available],[Not Applicable],,,,,0.31,,,,,6,,0,0.23002,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-68-7756,,,,,,,202,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,80865,,0.554119619,,,,,,,,,,0.185815431,,0.099830174,,,,Stage IIIA,,0.574,,,,,,,,,,,,,,,,0.8214,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.16713769,15.71949545,14.90234422,-0.608168155657425,LUSC,Squamous Cell Carcinoma,18.0747551,15.04837595,Squamous Cell Carcinoma,0.6263,13.4344048,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-L5-A4OR,White,ESCA,,0,0,,,2,2,,2,3.85,0.62,8,10,21,,,96,,96,96,,2,2,96,96,,Malignant,39,,115,,,,30859,,,96,96,,,,96,96,,,96,,,,,,,,TUMOR FREE,Dead,-30417,96,,,266,,96,96,,,[Not Available],[Not Available],,,,,0.5,Esophagus,Unknown,,,18,,2,0.20674,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A4OR,,,,,,,,,,,,,,,,61,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,83,,,,,,,,,,,,,,,,,,,,80867,,,,,,,,,,,,,Unknown,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A5BX,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.14,0.57,3,1,4,,,173,,,173,,1.0,1,99.0,99.0,,Malignant,8,,21,,,,29575.0,,,99.0,99,,,,,173,,,99.0,,,,,,,,WITH TUMOR,Dead,-30276,173,,,486.0,,99.0,99,,,[Not Available],[Not Applicable],,,,,0.03,,,,,3,,0,0.083963,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5BX,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,7,,,,,,,,,,,,,2012,99,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,82.0,,,,,,,,,,,,,,,,,,,,80869,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-HU-A4H6,Asian,STAD,,0,0,,,0,0,,0,2.61,0.23,5,13,15,,,644,,644,644,,0,0,644,644,,Malignant,33,,71,,,,29997,,,644,644,,,,644,644,,,644,,,,,,,,WITH TUMOR,Alive,-26445,,,,153,,644,644,,,[Not Available],[Not Applicable],,,,,0.3,Stomach,Unknown,,,20,,1,0.25261,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4H6,,,,,,,644,,,,,,,,,40,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,80870,,0.339238116,,,,,,,,,,0.086311517,Grade 2,0.169137909,,,,Stage IIIA,,0.152,,,,,,,,,,,,,,,,0.0412,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4H6,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-H9-A6BX,,PRAD,,0,0,,H9,0,0,MALE,0,2.0,1.0,0,0,0,HRP,NO,941,,941,941,,0,0,941,941,prad_tcga,Malignant,0,,7,,TCGA-H9-A6BX-01,0,5399,0,TCGA-H9-A6BX,941,941,Prostate Cancer,,570,941,941,TCGA,,941,Primary,0,,A,,,False,TUMOR FREE,Alive,-22039,,60,6,7,PRAD,941,941,,0.0,[Not Available],[Not Applicable],8,,1,Matched,0.0,Prostate,Resection,3,A077C6A8-F9C7-4E72-842C-78300A89B007,0,,0,0.000499,[Not Available],3BA3D23D-67E2-4F38-9951-F5CFA1131F9F,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,H9,0.333333333333,TCGA-H9-A6BX,0:DiseaseFree,1,0,Prostate Adenocarcinoma,30.91,11/26/13,941,,,,,NO,C61,5AEA61BF-A79E-4A8A-B3F1-45982DAF288E,190,0,TUMOR FREE,0.0,0:LIVING,0.04,,30.91,Bilateral,3,,,YES,479,2012,,,TCGA-H9-A6BX.5AEA61BF-A79E-4A8A-B3F1-45982DAF288E.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,60,,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,6,No,NO,0,,,,,C61.9,8140/3,80875,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-18-3415,,LUSC,,0,0,,Princess Margaret Hospital (Canada),2,2,MALE,2,2.82,0.48,10,20,18,,,2803,,2803,2803,,2,2,2803,2803,,Malignant,48,,83,,,,16573,,,2803,2803,,,,2803,2803,,,2803,,,,,,,,TUMOR FREE,Dead,-28430,2803,,,249,,2803,2803,,,[Not Available],[Not Applicable],,,,,0.07,,,,,15,,1,0.44001,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3415,,,,,,,,,,,,,,,,40,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,80876,,0.844421165,,,,,,,,,,0.192960762,,0.071833657,,,,Stage IB,,2.1485,,,,,,,,,,,,,,,,0.4327,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0113482625546484,LUSC,,,,Squamous Cell Carcinoma,0.8193,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-55-A48Y,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,1.95,0.36,6,6,11,,,630,,630,630,,0,0,630,630,,Malignant,23,,41,,,,17142,,,630,630,,,,630,630,,,630,,,,,,,,TUMOR FREE,Alive,-25384,,,,516,,630,630,,,[Not Available],[Not Applicable],,,,,0.08,,,,,6,,0,0.1631,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A48Y,,,,,,,630,,,,,,,,,8,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,80882,,0.796164205,,,,,,,,,,0.215693997,,0.210711921,,,,Stage IIA,,-0.0575,,,,,,,,,,,,,,,,0.4251,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.26373402,15.78816177,15.20795749,-0.239562985,LUAD,Adenocarcinoma,18.11423733,15.40966121,Adenocarcinoma,1.2234,13.7359553,-0.603,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,2.03,0.82,3,4,3,,,1673,BRCA_LumA,,1673,,1,1,1673,1673,,Invasive Carcinoma,10,,14,,,,17850,0,,1673,1673,,,,,1673,,,1673,,,,,,,,WITH TUMOR,Dead,-25558,1673,,,35,,1673,1673,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.047963,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FL,,,,,,,,,,,,,,,,4,,,,,,,,,,,,,1998,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,80883,,0.110864886,0,0,0,0,0.2373,1,,,Infiltrating Ductal Carcinoma,0.114252446,,0.15073862,0,0,0,,[Not Available],-0.4345,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1132,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.26,0.44,7,8,8,,,1463,BRCA_LumA,1463,1463,,0,0,1463,1463,,Invasive Carcinoma,23,,21,,,,25857,0,,1463,1463,,,,1463,1463,,,1463,,,,,,,,TUMOR FREE,Alive,-19731,,,,59,,1463,1463,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,14,,1,0.11038,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SF,,,,,,,1463,,,,,,,,,20,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,80885,,1.025977223,0,0,0,0,0.9904,1,,,Infiltrating Ductal Carcinoma,0.128996428,,0.18397975,0,0,0,,Negative,0.3855,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2248,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-CD-8528,Asian,STAD,,0,0,,,0,0,,0,3.17,0.55,6,8,7,,,375,,375,375,,0,0,375,375,,Malignant,21,,71,,,,24644,,,375,375,,,,375,375,,,375,,,,,,,,TUMOR FREE,Alive,-15986,,,,137,,375,375,,,[Not Available],[Not Applicable],,,,,0.12,Stomach,Unknown,,,19,,1,0.14365,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8528,,,,,,,375,,,,,,,,,26,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,43,,,,,,,,,,,,,,,,,,,,80886,,-0.253840133,,,,,,,,,,0.10868377,Grade 3,0.012822861,,,,Stage IIIA,,-0.2025,,,,,,,,,,,,,,,,0.0474,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8528,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-XQ-A8TA,,PRAD,370,1,1,,XQ,,1,MALE,1,1.94,0.97,12,28,18,HRD,NO,146,3-ETV4,,146,,1,1,146,146,prad_tcga,Malignant,58,CDK12;CHEK2;RAD51C;RAD51D,194,,TCGA-XQ-A8TA-01,85,5640,0,TCGA-XQ-A8TA,146,146,Prostate Cancer,-10,62,,146,TCGA,Distant Metastasis [e.g. cM1],146,Primary,1,,A,,BRCA2,True,WITH TUMOR,Dead,-21889,146,59,10,151,PRAD,146,146,,0.607801737,Prostate Cancer,[Not Applicable],112,,1,Matched,0.11,Prostate,Resection,5,24EA6487-8770-452C-AB55-5BACA00E1243,4,Prostate Cancer Metastases Present [cM1b],0,0.25648,[Not Available],B47791BA-85FD-41D0-AC1F-B6FA06F18E96,5,Prostate Adenocarcinoma Acinar Type,,Prostate,59,,Acinar Adenocarcinoma,[Not Available],,XQ,3.73333333333,TCGA-XQ-A8TA,,5,60,Prostate Adenocarcinoma,,1/26/15,,,,Prostate Cancer,Medical Record,YES,C61,8AF39C5E-73E3-40EA-B328-98892AE85971,80,10,WITH TUMOR,0.3508,1:DECEASED,323.0,,4.8,Bilateral,67,Distant Metastasis [e.g. cM1],,YES,601,2012,,,TCGA-XQ-A8TA.8AF39C5E-73E3-40EA-B328-98892AE85971.pdf,Peripheral Zone,[Not Applicable],YES,,86-95%,,Prostate Adenocarcinoma Acinar Type,1,2012,Progressive Disease,,YES,No,,,59,Transurethral resection (TURBT),,Progressive Disease,,,,NO,,NO,10,"Yes, Pharmaceutical Treatment Prior to Resection",YES,0,,T3a,,M1b,C61.9,8140/3,80887,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,80888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-D7-5577,White,STAD,,1,1,,,,1,,1,2.08,0.64,2,4,4,,,782,,,782,,1,1,376,376,,Malignant,10,,17,,,,25881,,,376,376,,,,,782,,,376,,,,,,,,WITH TUMOR,Dead,-19668,782,,,152,,376,376,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,3,,0,0.11388,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-5577,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,9,,,,,,,,,,,,,2010,376,"liver,  peritoneal surfaces, non-regional/distant lymph nodes",,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,80900,,,,,,,,,,,,,Grade 2,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-5577,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,1,0,1,1,Male,TCGA-NC-A5HT,White,LUSC,,1,1,,Washington University - CHUV,1,0,MALE,1,2.04,0.73,17,11,20,,,804,,203,804,,1,1,203,203,,Malignant,48,,104,,,,24566,,,203,203,,,,203,804,,,203,,,,,,,,WITH TUMOR,Alive,-25466,,,,448,,203,203,,,[Not Available],[Not Applicable],,,,,0.04,,,,,11,,0,0.34768,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HT,,,,,,,804,,Locoregional Recurrence,,,,,,,16,,,,,,,,,,,,,2012,203,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,80906,,-1.28087972,,,,,,,,,,0.044667143,,0.083300026,,,,Stage IIIA,,-1.276,,,,,,,,,,,,,,,,0.2832,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,11.95084817,12.44274531,13.33862543,-1.124076972998,LUSC,Squamous Cell Carcinoma,17.79452995,14.64565633,Squamous Cell Carcinoma,-1.0159,11.60810145,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-G9-6384,White,PRAD,108,0,0,,G9,0,0,MALE,0,1.94,0.45,5,5,4,ambiguous,NO,765,1-ERG,765,765,,0,0,765,765,prad_tcga,Malignant,14,,13,7.4,TCGA-G9-6384-01,0,5376,0,TCGA-G9-6384,765,765,Prostate Cancer,,390,765,765,TCGA,,765,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-19620,,53,7,25,PRAD,765,765,WHITE,0.0,[Not Available],[Not Applicable],27,R0,1,Matched,0.0,Prostate,Resection,3,1abcbe00-5a6f-4e0f-a61c-d158545c2293,1,,0,0.056924,[Not Available],a279d5aa-51f7-4e75-9e14-b206b97ec4bd,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,13,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.6,G9,1.7,TCGA-G9-6384,0:DiseaseFree,2,15,Prostate Adenocarcinoma,25.13,3/2/12,765,,,,,NO,C61,6987c1c1-6e23-44f0-bba8-6bba4a288025,,2,TUMOR FREE,0.0537,0:LIVING,0.03,,25.13,Bilateral,17,,,YES,,2010,,,TCGA-G9-6384.6987c1c1-6e23-44f0-bba8-6bba4a288025.pdf,,[Not Applicable],NO,,71-80%,14,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.7,53,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,80908,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,80910,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-55-6982,White,LUAD,,1,1,,International Genomics Consortium,,1,FEMALE,1,2.61,0.25,9,4,6,,,995,,,995,,1,1,183,183,,Malignant,19,,29,,,,27713,,,183,183,,,,,995,,,183,,,,,,,,WITH TUMOR,Dead,,995,,,287,,183,183,,,[Not Available],[Not Applicable],,,,,0.29,,,,,20,,1,0.20189,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6982,,,,,,,,,Distant Metastasis,,,,,,,34,,,,,,,,,,,,,2004,183,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,79,,,,,,,,,,,,,,,,,,,,80912,,0.840785119,,,,,,,,,,0.297738368,,0.106225528,,,,Stage IIB,,1.1055,,,,,,,,,,,,,,,,0.5963,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.75062043,17.85908802,16.36368309,-0.142569778,LUAD,Adenocarcinoma,17.98956483,15.6370637,Adenocarcinoma,0.9371,14.29214422,-0.3744,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-55-6969,White,LUAD,,0,0,,International Genomics Consortium,,0,MALE,0,2.59,0.25,10,15,13,,,1239,,,1239,,0,0,1239,1239,,Malignant,38,,24,,,,17432,,,1239,1239,,,,,1239,,,1239,,,,,,,,TUMOR FREE,Alive,-19270,,,,530,,1239,1239,,,[Not Available],[Not Applicable],,,,,0.62,,,,,19,,1,0.34831,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6969,,,,,,,1239,,,,,,,,,39,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,80913,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.092676845,LUAD,,,,Adenocarcinoma,1.1233,,0.8041,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46D,,PRAD,268,0,0,,EJ,0,0,MALE,0,1.96,0.16,3,4,3,HRP,NO,626,1-ERG,626,626,,0,0,626,626,prad_tcga,Malignant,10,BRCA2,22,,TCGA-EJ-A46D-01,0,5335,0,TCGA-EJ-A46D,626,626,Prostate Cancer,,122,626,626,TCGA,,626,Primary,0,,A,,,True,TUMOR FREE,Alive,-19466,,53,8,15,PRAD,626,626,,0.0,[Not Available],[Not Applicable],15,,1,Matched,0.02,Prostate,Resection,3,5FAF8EC8-F94C-4B0C-9D91-70942F15F3C8,0,Normal (no evidence of prostate cancer) [cM0],0,0.038409,[Not Available],93D10D8B-5F98-4D2C-8AF3-11471385D4D4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,EJ,0.566666666667,TCGA-EJ-A46D,0:DiseaseFree,4,0,Prostate Adenocarcinoma,20.57,1/22/13,626,,,,,,C61,A0EF60EA-85C2-40AA-9162-E8C96748F94D,940,2,TUMOR FREE,0.0004,0:LIVING,0.03,4,20.57,Bilateral,3,,,YES,181,2012,,,TCGA-EJ-A46D.A0EF60EA-85C2-40AA-9162-E8C96748F94D.pdf,,[Not Applicable],,42,51-60%,6,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,,,53,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,80914,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2ES,White,BLCA,,0.0,0,,,,1,MALE,1.0,2.01,0.55,4,2,10,,,1004,,,1004,,2.0,2,897.0,897.0,,Malignant,16,,44,,,,23501.0,,,1004.0,1004,,,,,1004,,,897.0,,,,,,,,WITH TUMOR,Dead,-31293,1004,,,659.0,,1004.0,1004,,,[Not Available],[Not Applicable],,,,,0.03,,,,,4,,0,0.28582,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2ES,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2009,897,,,,Stage II,,,,,,,,Progressive Disease,,,,,,85.0,,,,,,,,,,,,,,,,,,,,80916,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-XF-AAMJ,Asian,BLCA,,0.0,0,,,2,2,MALE,2.0,3.54,0.24,7,4,10,,,1670,,1670,1670,,2.0,2,1670.0,1670.0,,Malignant,21,,46,,,,32206.0,,,1670.0,1670,,,,1670,1670,,,1670.0,,,,,,,,TUMOR FREE,Dead,-25838,1670,,,51.0,,1670.0,1670,,,[Not Available],[Not Applicable],,,,,0.07,,,,,15,,1,0.17379,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMJ,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2006,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,80923,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,,,White,BRCA,,0,0,,,0,0,FEMALE,1,3.31,0.79,18,33,34,,,1174,BRCA_Basal,1174,1174,,0,0,971,971,,Invasive Carcinoma,85,,130,,,,30057,0,,1174,1174,,,,1174,1174,,,971,,,,,,,,TUMOR FREE,Alive,-22686,,,,184,,1174,1174,,,[Not Available],[Not Applicable],,,,,0.37,Breast,Resection/Excision,,,10,,1,0.39359,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14R,,,,,,,1174,"Other, specify",New Primary Tumor,,,,,,,40,,,,,,,,,,,,,2008,971,Endometrial,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,80924,TRUE,0.998302616,0,0,0,0,1.8605,1,,,Infiltrating Ductal Carcinoma,0.188109407,,0.082401147,0,0,0,,Negative,0.853,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2354,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-IN-8663,White,STAD,,0,0,,,,2,,2,3.22,0.75,11,9,17,,,103,,,103,,2,2,103,103,,Malignant,37,,142,,,,17728,,,103,103,,,,,103,,,103,,,,,,,,TUMOR FREE,Dead,-25172,103,,,235,,103,103,,,"Other, non-malignant disease",[Not Applicable],,,,,0.14,Stomach,Unknown,,,15,,1,0.23238,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,University of Pittsburgh,,TCGA-IN-8663,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,80942,,-0.241760604,,,,,,,,,,-0.011855372,Grade 3,0.009310337,,,,Stage IIB,,0.6005,,,,,,,,,,,,,,,,0.0259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-IN-8663,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,1,1,Male,TCGA-86-7701,White,LUAD,,1,1,,Asterand,,0,MALE,1,2.97,0.42,6,12,8,,,947,,,947,,1,1,424,424,,Malignant,26,,68,,,,24215,,,424,424,,,,,947,,,424,,,,,,,,WITH TUMOR,Alive,-24209,,,,248,,424,424,,,[Not Available],[Not Applicable],,,,,0.25,,,,,16,,1,0.292,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-7701,,,,,,,947,,Distant Metastasis,,,,,,,24,,,,,,,,,,,,,2011,424,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,80945,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.00762357,15.98873526,16.68493419,0.014116959,LUAD,Adenocarcinoma,18.40941966,16.77183785,Adenocarcinoma,0.8876,10.42020411,0.9407,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-DK-A1AD,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.08,0.73,6,17,15,,,3420,,,3420,,0.0,0,3420.0,3420.0,,Malignant,38,,26,,,,34165.0,,,3420.0,3420,,,,,3420,,,3420.0,,,,,,,,TUMOR FREE,Alive,-25317,,,,341.0,,3420.0,3420,,,[Not Available],[Not Applicable],,,,,0.31,,,,,14,,1,0.11251,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1AD,,,,,,,3420,,,,,,,,,42,,,,,,,,,,,,,2002,,,,,Stage IV,,,,,,,,[Not Available],,,,,,69.0,,,,,,,,,,,,,,,,,,,,80950,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2781,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.16,0.4,17,13,22,,,121,,,121,,0,0,121,121,,Malignant,52,,84,,,,17274,,,121,121,,,,,121,,,121,,,,,,,,TUMOR FREE,Alive,-24471,,,,175,,121,121,,,[Not Available],[Not Applicable],,,,,0.27,,,,,19,,1,0.42385,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2781,,,,,,,121,,,,,,,,,29,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,80952,,0.409951418,,,,,,,,,,0.170581422,,0.029405622,,,,Stage IB,,0.037,,,,,,,,,,,,,,,,0.4509,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.469729123344569,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.3479,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1683,,1683,1683,,0,0,1683,1683,,Invasive Carcinoma,,,,,,,21215,0,,1683,1683,,,,1683,1683,,,1683,,,,,,,,TUMOR FREE,Alive,-21895,,,,0,,1683,1683,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JL,,,,,,,1683,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,80964,TRUE,0.137638573,0,0,0,0,1.0244,1,,,Infiltrating Ductal Carcinoma,0.086743577,,0.234741419,0,0,0,,Negative,-0.7005,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1153,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A94T,Unknown,STAD,,1,1,,,,1,,1,3.09,0.75,7,4,14,,,342,,,342,,1,1,296,296,,Malignant,25,,88,,,,25148,,,296,296,,,,,342,,,296,,,,,,,,WITH TUMOR,Dead,-26702,342,,,103,,296,296,,,[Not Available],[Not Applicable],,,,,0.09,Stomach,Unknown,,,20,,1,0.22645,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A94T,,,,,,,,,Locoregional Recurrence,,,,,,,26,,,,,,,,,,,,,2011,296,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,80967,,-0.21251192,,,,,,,,,,0.047598552,Grade 3,0.08037988,,,,Stage IIIB,,-0.2115,,,,,,,,,,,,,,,,0.0176,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A94T,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.62,0.59,4,2,7,,,0,BRCA_LumA,0,0,,0,0,0,0,,Invasive Carcinoma,13,,27,,,,24377,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-27121,,,,59,,0,0,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,14,,1,0.19379,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A090,,,,,,,0,,,,,,,,,17,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,80968,,0.183841671,0,0,0,0,-0.684,1,,,Infiltrating Ductal Carcinoma,0.203318488,,0.138527847,0,0,0,,Negative,-0.005,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.315,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-G2-A2EJ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.09,0.61,9,4,7,,,1460,,910,1460,,1.0,1,910.0,910.0,,Malignant,20,,60,,,,25884.0,,,910.0,910,,,,910,1460,,,910.0,,,,,,,,TUMOR FREE,Alive,-20649,,,,428.0,,910.0,910,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.13654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EJ,,,,,,,1460,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2009,910,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,80975,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,3.57,0.68,5,7,12,,,304,BRCA_LumB,,304,,0,0,304,304,,Invasive Carcinoma,24,,36,,,,29419,0,,304,304,,,,,304,,,304,,,,,,,,WITH TUMOR,Alive,-27942,,,,196,,304,304,,,[Not Available],[Not Applicable],,,,,0.5,Breast,Resection/Excision,,,22,,2,0.17496,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07W,,,,,,,304,,,,,,,,,76,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,80978,,0.406816053,0,0,0,0,-0.5914,1,,,Infiltrating Ductal Carcinoma,0.198129141,,0.099661155,0,0,0,,Positive,-0.2985,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4276,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6333,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.95,0.44,2,4,0,HRP,NO,2465,5-SPOP,2465,2465,,0,0,2465,2465,prad_tcga,Malignant,6,BARD1,33,10.8,TCGA-G9-6333-01,11,5350,0,TCGA-G9-6333,2465,2465,Prostate Cancer,,1920,2465,2465,TCGA,,2465,Primary,1,Apex|Base,A,,,,TUMOR FREE,Alive,-24249,,66,7,37,PRAD,2465,2465,WHITE,0.118823523,[Not Available],[Not Applicable],30,R0,1,Matched,0.0,Prostate,Resection,4,98013499-4fac-4378-9d7e-b3686003a4fc,1,Normal (no evidence of prostate cancer) [cM0],0,0.047419,[Not Available],64bf32c9-9466-404a-a147-e7a0b9e91e34,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,6,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.96666666667,TCGA-G9-6333,0:DiseaseFree,3,7,Prostate Adenocarcinoma,80.98,3/19/12,2465,,,,,NO,C61,df50612f-a299-468b-b6bf-226366f4cf42,,1,TUMOR FREE,0.0463,0:LIVING,0.03,,80.98,Bilateral,9,No Evidence of Extraprostatic Extension,1102,YES,,2006,,,TCGA-G9-6333.df50612f-a299-468b-b6bf-226366f4cf42.pdf,,[Not Applicable],YES,1102,71-80%,13,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.6,66,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,80984,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-J2-8192,White,LUAD,,1,1,,ABS - Lahey Clinic,,0,FEMALE,1,2.76,0.41,5,6,9,,,739,,,739,,1,1,482,482,,Malignant,20,,38,,,,18073,,,482,482,,,,,739,,,482,,,,,,,,TUMOR FREE,Alive,-23892,,,,85,,482,482,,,[Not Available],[Not Applicable],,,,,0.29,,,,,13,,1,0.25868,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ABS - Lahey Clinic,,TCGA-J2-8192,,,,,,,739,,Locoregional Recurrence,,,,,,,35,,,,,,,,,,,,,2011,482,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,80996,,0.981984095,,,,,,,,,,0.310306221,,0.150748443,,,,Stage IIA,,0.8595,,,,,,,,,,,,,,,,0.8887,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,17.24226173,18.42275318,15.52511667,-0.163633883,LUAD,Adenocarcinoma,18.03388563,16.00082269,Adenocarcinoma,1.5924,13.86121604,-0.2649,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.84,0.55,11,6,13,,,1855,BRCA_LumA,1855,1855,,0,0,1855,1855,,Invasive Carcinoma,30,,58,,,,17768,0,,1855,1855,,,,1855,1855,,,1855,,,,,,,,TUMOR FREE,Alive,-13671,,,,20,,1855,1855,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,8,,0,0.29748,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IO,,,,,,,1855,,,,,,,,,14,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,37,,,,,,,,,,,,,,,,,,,,81002,,0.990196417,0,0,0,0,0.2476,1,,,Infiltrating Ductal Carcinoma,0.144920329,,0.206356798,0,0,0,,Negative,0.573,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6975,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7231,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.71,3,7,0,ambiguous,NO,939,1-ERG,939,939,,0,0,939,939,prad_tcga,Malignant,10,,21,3.7,TCGA-HC-7231-01,0,5413,0,TCGA-HC-7231,939,939,Prostate Cancer,,,939,939,TCGA,,939,Primary,0,,A,,,,TUMOR FREE,Alive,-24278,,66,7,48,PRAD,939,939,WHITE,0.0,[Not Available],[Not Applicable],46,R0,1,Matched,0.03,Prostate,Resection,3,6ac7857c-5446-4297-95a9-5f2c11c28220,0,,0,0.037083,[Not Available],b182bda9-3d9f-4958-96eb-bd6cc441830c,4,Prostate Adenocarcinoma Acinar Type,0.3,Prostate,10,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.53333333333,TCGA-HC-7231,0:DiseaseFree,2,14,Prostate Adenocarcinoma,30.85,10/6/11,939,,,,,,C61,4a904b18-b8cf-4666-a384-2b3ce33f7891,,0,TUMOR FREE,0.047,0:LIVING,,,30.85,Bilateral,17,,,YES,,2011,,,TCGA-HC-7231.4a904b18-b8cf-4666-a384-2b3ce33f7891.pdf,,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.2,66,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,81006,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-39-5029,White,LUSC,,1,,,MSKCC,,1,MALE,1,1.78,0.54,13,13,17,,,740,,,740,,1,,491,491,,Malignant,43,,74,,,,21206,,,491,,,,,,740,,,491,,,,,,,,WITH TUMOR,Dead,-24713,740,,,185,,491,,,,[Not Available],[Not Applicable],,,,,0.55,,,,,13,,0,0.46848,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5029,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2006,491,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,81007,,1.111013865,,,,,,,,,,0.199916565,,0.084722328,,,,Stage IIIA,,0.5515,,,,,,,,,,,,,,,,0.5597,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.65226623,16.1494498,16.51740736,-0.140078839626417,LUSC,,18.05150114,15.69356776,Squamous Cell Carcinoma,0.0999,14.04719606,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-FP-7998,White,STAD,,0,0,,,0,0,,0,1.96,0.28,2,3,6,,,678,,678,678,,0,0,678,678,,Malignant,11,,19,,,,25526,,,678,678,,,,678,678,,,678,,,,,,,,TUMOR FREE,Alive,-28302,,,,77,,678,678,,,[Not Available],[Not Applicable],,,,,0.53,Stomach,Unknown,,,5,,0,0.17865,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,International Genomics Consortium,,TCGA-FP-7998,,,,,,,678,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,81011,,1.685220867,,,,,,,,,,0.148203932,Grade 3,0.169395564,,,,Stage IIIC,,3.155,,,,,,,,,,,,,,,,0.3614,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-7998,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,1,1,Male,TCGA-HC-7080,White,PRAD,161,0,0,,HC,0,0,MALE,1,1.89,0.9,6,9,1,ambiguous,NO,1106,5-SPOP,1106,1106,,0,0,894,894,prad_tcga,Malignant,16,CHEK2;PALB2,126,4.1,TCGA-HC-7080-01,0,5405,0,TCGA-HC-7080,1106,1106,Prostate Cancer,,104,1106,1106,TCGA,,894,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-24243,,66,7,37,PRAD,1106,1106,WHITE,0.0,[Not Available],[Not Applicable],34,R0,1,Matched,0.0,Prostate,Resection,3,e30730b8-81f1-49a8-8446-547b5c3cc730,0,Normal (no evidence of prostate cancer) [cM0],0,0.10554,[Not Available],fd50ff41-ec9d-4db1-a673-36ba0ca1eac8,4,Prostate Adenocarcinoma Acinar Type,0.5,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.16666666667,TCGA-HC-7080,1:Recurred/Progressed,2,16,Prostate Adenocarcinoma,29.37,4/9/12,1106,,New Primary Tumor,,,NO,C61,f2bf590a-9473-47fe-89a9-69c480b6c42b,,1,TUMOR FREE,0.1135,0:LIVING,0.1,,36.33,Right,20,No Evidence of Extraprostatic Extension,19,YES,,2010,894,,TCGA-HC-7080.f2bf590a-9473-47fe-89a9-69c480b6c42b.pdf,,[Not Applicable],YES,19,81-90%,2,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.4,66,Core needle biopsy,,,NO,YES,YES,,T2a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,81031,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-XF-A8HE,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.01,0.37,3,0,4,,,3817,,3817,3817,,0.0,0,3817.0,3817.0,,Malignant,7,,33,,,,31440.0,,,3817.0,3817,,,,3817,3817,,,3817.0,,,,,,,,TUMOR FREE,Alive,-17212,,,,552.0,,3817.0,3817,,,[Not Available],[Not Applicable],,,,,0.0,,,,,5,,0,0.14131,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A8HE,,,,,,,3817,,,,,,,,,9,,,,,,,,,,,,,2004,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,47.0,,,,,,,,,,,,,,,,,,,,81033,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7819,White,PRAD,,0,0,,HC,0,0,MALE,0,1.97,0.82,2,2,4,ambiguous,NO,543,,543,543,,0,0,543,543,prad_tcga,Malignant,8,BRCA2,10,,TCGA-HC-7819-01,13,5431,0,TCGA-HC-7819,543,543,Prostate Cancer,-73,172,543,543,TCGA,No Evidence of Extraprostatic Extension,543,Primary,1,,A,,,,TUMOR FREE,Alive,-19663,,53,8,23,PRAD,543,543,WHITE,0.262497307,[Not Available],[Not Applicable],38,,1,Matched,0.02,Prostate,Resection,4,8b1ad92f-3a3c-474b-89a0-bc14ec6046ba,1,,0,0.04283,[Not Available],d1fd7be0-6daa-4f1f-a198-3dca7a797e49,4,Prostate Adenocarcinoma Acinar Type,0.3,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,2.16666666667,TCGA-HC-7819,0:DiseaseFree,4,14,Prostate Adenocarcinoma,17.84,4/20/12,543,,,,,YES,C61,ab62f75e-d1f0-47f7-8a78-4151af81d409,,2,WITH TUMOR,0.0674,0:LIVING,0.01,4,17.84,Bilateral,19,,,YES,,2011,,,TCGA-HC-7819.ab62f75e-d1f0-47f7-8a78-4151af81d409.pdf,Central Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R2,0.3,53,Core needle biopsy,,,YES,NO,YES,,T2c,,8,No,,0,N0,T2c,0,M0,C61.9,8550/3,81034,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.45,3,2,4,,,499,BRCA_LumA,499,499,,0,0,499,499,,Invasive Carcinoma,9,,6,,,,30531,0,,499,499,,,,499,499,,,499,,,,,,,,TUMOR FREE,Alive,-18025,,,,60,,499,499,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,6,,0,0.061439,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27L,,,,,,,499,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,81035,,1.154106342,0,0,0,0,0.3631,1,,,Infiltrating Ductal Carcinoma,0.168245268,,0.171386857,0,0,0,,Negative,0.3135,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6253,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Suboptimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,,,Black or African American,BRCA,,0,0,,,,2,FEMALE,2,4.0,0.5,6,13,21,,,3472,BRCA_Basal,,3472,,2,2,3472,3472,,Invasive Carcinoma,40,,37,,,,16096,0,,3472,3472,,,,,3472,,,3472,,,,,,,,TUMOR FREE,Dead,-28706,3472,,,145,,3472,3472,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,20,,1,0.19996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Medullary Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FC,,,,,,,,,,,,,,,,37,,,,,,,,,,,,,1998,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,81040,TRUE,1.599020157,0,0,0,0,-0.9384,1,,,Medullary Carcinoma,0.169948634,,0.055937103,0,0,0,,[Not Available],1.2745,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2345,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.37,0.68,11,9,11,,,1614,BRCA_LumA,1614,1614,,0,0,1614,1614,,Invasive Carcinoma,31,,35,,,,21577,0,,1614,1614,,,,1614,1614,,,1614,,,,,,,,TUMOR FREE,Alive,-27393,,,,53,,1614,1614,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,23,,1,0.23438,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06T,,,,,,,1614,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,81051,,0.63872738,0,0,0,0,0.0292,1,,,Infiltrating Ductal Carcinoma,0.117592797,,0.10783833,0,0,0,,Negative,0.1425,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.177,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A9FF,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.97,0.73,2,2,5,,,361,,361,361,,0.0,0,361.0,361.0,,Malignant,9,,33,,,,30036.0,,,361.0,361,,,,361,361,,,361.0,,,,,,,,TUMOR FREE,Alive,-19195,,,,186.0,,361.0,361,,,[Not Available],[Not Applicable],,,,,0.12,,,,,5,,0,0.086645,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ILSBio,,TCGA-CF-A9FF,,,,,,,361,,,,,,,,,5,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,52.0,,,,,,,,,,,,,,,,,,,,81055,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-55-A4DF,White,LUAD,,1,1,,International Genomics Consortium,1,1,MALE,1,3.33,0.42,10,14,20,,,614,,515,614,,1,1,515,515,,Malignant,44,,77,,,,32688,,,515,515,,,,515,614,,,515,,,,,,,,WITH TUMOR,Dead,-32432,614,,,1041,,515,515,,,[Not Available],[Not Applicable],,,,,0.42,,,,,10,,1,0.49689,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A4DF,,,,,,,,,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,2012,515,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,88,,,,,,,,,,,,,,,,,,,,81062,,1.104077679,,,,,,,,,,0.246982391,,0.03287131,,,,Stage IA,,1.654,,,,,,,,,,,,,,,,-0.0651,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,X570_splice (driver),1,,,X570_splice (driver),,,,-0.09038928,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3866,,0.6403,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-22-5482,White,LUSC,,0,0,,Mayo Clinic - Rochester,2,2,MALE,2,2.18,0.66,8,8,15,,,357,,357,357,,2,2,357,357,,Malignant,31,,38,,,,20765,,,357,357,,,,357,357,,,357,,,,,,,,TUMOR FREE,Dead,-29657,357,,,221,,357,357,,,[Not Available],[Not Applicable],,,,,0.44,,,,,13,,1,0.44483,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5482,,,,,,,357,,,,,,,,,43,,,,,,,,,,,,,2005,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,81063,,-0.133285333,,,,,,,,,,0.136553976,,0.007685402,,,,Stage IB,,-0.379,,,,,,,,,,,,,,,,0.6626,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.766696151415512,LUSC,,,,Squamous Cell Carcinoma,0.3007,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-RD-A7BW,White,STAD,,0,0,,,2,2,,2,1.88,0.18,9,11,7,,,156,,156,156,,2,2,156,156,,Malignant,27,,36,,,,33083,,,156,156,,,,156,156,,,156,,,,,,,,TUMOR FREE,Dead,-25036,156,,,91,,156,156,,,"Other, non-malignant disease",[Not Applicable],,,,,,Stomach,Unknown,,,2,,0,0.15174,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A7BW,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,81068,,0.88356965,,,,,,,,,,0.130923621,Grade 3,0.205670808,,,,Stage IB,,0.621,,,,,,,,,,,,,,,,0.6494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A7BW,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,1,0,1,1,,,,BRCA,,1,,,,1,0,FEMALE,1,3.47,0.76,4,0,7,,,1004,BRCA_LumA,243,1004,,1,,243,243,,Invasive Carcinoma,11,,13,,,,25280,0,,243,,,,,243,1004,,,243,,,,,,,,TUMOR FREE,Alive,-22554,,,,38,,243,,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Core Biopsy,,,13,,1,0.064844,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A091,,,,,,,1004,,,,,,,,,16,,,,,,,,,,,,,2008,243,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,81073,,-0.294696124,0,0,0,0,-3.4389,1,,,Infiltrating Ductal Carcinoma,0.13247222,,0.189673109,0,0,0,,Negative,-0.751,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1947,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,3.26,0.41,12,12,20,,,563,BRCA_LumA,188,563,,1,1,188,188,,Invasive Carcinoma,44,,93,,,,25722,0,,188,188,,,,188,563,,,188,,,,,,,,WITH TUMOR,Dead,-23682,563,,,105,,188,188,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,20,,1,0.39921,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14Z,,,,,,,,Bone,Distant Metastasis,,,,,,,28,,,,,,,,,,,,,2009,188,,,,Stage I,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,81082,,1.49196378,0,0,0,0,-0.1901,1,,,Infiltrating Ductal Carcinoma,0.15858826,,0.176700954,0,0,0,,Negative,0.9025,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3973,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-A4J2,Asian,STAD,,0,0,,,0,0,,0,2.02,0.63,0,0,1,,,431,,431,431,,0,0,431,431,,Malignant,1,,13,,,,25852,,,431,431,,,,431,431,,,431,,,,,,,,TUMOR FREE,Alive,-25891,,,,62,,431,431,,,[Not Available],[Not Applicable],,,,,0.38,Stomach,Unknown,,,0,,0,0.0017139,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4J2,,,,,,,431,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,81083,,1.014104997,,,,,,,,,,0.128127633,Grade 3,0.217070199,,,,Stage IIB,,1.1965,,,,,,,,,,,,,,,,0.7666,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4J2,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Female,TCGA-55-8097,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.06,0.64,2,0,3,,,476,,476,476,,0,0,476,476,,Malignant,5,,14,,,,31444,,,476,476,,,,476,476,,,476,,,,,,,,TUMOR FREE,Alive,-22260,,,,146,,476,476,,,[Not Available],[Not Applicable],,,,,0.15,,,,,6,,0,0.027998,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8097,,,,,,,476,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,81086,,0.758178896,,,,,,,,,,0.212316155,,0.161094042,,,,Stage IA,,0.382,,,,,,,,,,,,,,,,0.1624,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.385673695,LUAD,,,,Adenocarcinoma,-0.7235,,-0.6818,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-85-8580,White,LUSC,,0,0,,Asterand,0,0,FEMALE,0,1.92,0.33,13,13,17,,,1113,,1113,1113,,0,0,1113,1113,,Malignant,43,,88,,,,0,,,1113,1113,,,,1113,1113,,,1113,,,,,,,,TUMOR FREE,Alive,-19301,,,,360,,1113,1113,,,[Not Available],[Not Applicable],,,,,0.58,,,,,9,,0,0.398,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8580,,,,,,,1113,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,81091,,1.020622122,,,,,,,,,,0.155373348,,0.023176602,,,,Stage IB,,1.035,,,,,,,,,,,,,,,,0.1098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.618420522883245,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.0224,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.85,0.61,9,6,8,,,380,BRCA_LumB,380,380,,0,0,380,380,,Invasive Carcinoma,23,,100,,,,31798,1,,380,380,,,,380,380,,,380,,,,,,,,TUMOR FREE,Alive,-19432,,,,393,,380,380,,,[Not Available],[Not Applicable],,,,,0.02,Skin,Resection/Excision,,,5,,0,0.17171,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A8HQ,,,,,,,380,,,,,,,,,7,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,81092,,1.081067452,0,0,0,0,0.0722,1,,,Mucinous Carcinoma,0.165866469,,0.147019234,0,0,0,,Negative,0.59,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.7222,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6329,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.95,0.28,2,0,2,ambiguous,NO,1266,1-ERG,1266,1266,,0,0,1266,1266,prad_tcga,Malignant,4,BRCA2;PALB2,5,6.5,TCGA-G9-6329-01,0,5348,0,TCGA-G9-6329,1266,1266,Prostate Cancer,,923,1266,1266,TCGA,,1266,Primary,0,,A,,,,TUMOR FREE,Alive,-24797,,67,7,34,PRAD,1266,1266,WHITE,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,0.05,Prostate,Resection,3,e004f38d-c874-4e03-830b-4e554ef3e274,2,Normal (no evidence of prostate cancer) [cM0],0,0.064051,[Not Available],a08fd0a6-a89a-4adb-b641-d4c1238abb71,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,0.766666666667,TCGA-G9-6329,0:DiseaseFree,2,17,Prostate Adenocarcinoma,41.59,3/20/12,1266,,,,,NO,C61,fd7b8f28-b1ee-428e-859c-c888c459a3b0,,3,TUMOR FREE,0.0115,0:LIVING,0.03,,41.59,Bilateral,19,No Evidence of Extraprostatic Extension,10,YES,,2009,,,TCGA-G9-6329.fd7b8f28-b1ee-428e-859c-c888c459a3b0.pdf,,[Not Applicable],YES,10,46-55%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.7,67,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,81098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BT-A20J,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.07,0.4,8,23,20,,,579,,,579,,1.0,1,254.0,254.0,,Malignant,51,,77,,,,19883.0,,,254.0,254,,,,,579,,,254.0,,,,,,,,WITH TUMOR,Dead,-27646,579,,,654.0,,254.0,254,,,[Not Available],[Not Applicable],,,,,0.13,,,,,13,,1,0.30198,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20J,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,34,,,,,,,,,,,,,1999,254,Adrenal,,,Stage II,,,,,,,,Progressive Disease,,,,,,75.0,,,,,,,,,,,,,,,,,,,,81103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-A47G,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,2.29,0.24,2,14,5,,,351,,351,351,,0,0,351,351,,Malignant,21,,12,,,,22098,,,351,351,,,,351,351,,,351,,,,,,,,TUMOR FREE,Alive,-26800,,,,106,,351,351,,,[Not Available],[Not Applicable],,,,,0.58,,,,,3,,0,0.029637,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-A47G,,,,,,,351,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,81104,,1.52881238,,,,,,,,,,0.305108852,,0.136346097,,,,Stage IA,,2.126,,,,,,,,,,,,,,,,0.5737,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.12373684,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.9507,,1.283,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,,0,1,Male,TCGA-77-7463,White,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,4.5,0.41,11,14,18,,,1423,,,1423,,2,2,1423,1423,,Malignant,43,,33,,,,30791,,,1423,1423,,,,,1423,,,1423,,,,,,,,,Dead,-27520,1423,,,510,,1423,1423,,,[Not Available],[Not Applicable],,,,,0.38,,,,,23,,2,0.39751,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7463,,,,,,,,,,,,,,,,61,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,81113,,-0.160246278,,,,,,,,,,0.169168489,,0.009012933,,,,Stage IB,,0.7655,,,,,,,,,,,,,,,,0.141,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.797193125446546,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.7988,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,3202,BRCA_LumA,3202,3202,,0,0,3202,3202,,Invasive Carcinoma,,,,,,,30239,0,,3202,3202,,,,3202,3202,,,3202,,,,,,,,TUMOR FREE,Alive,-17135,,,,31,,3202,3202,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24T,,,,,,,3202,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,81117,,-0.516967549,0,0,0,0,-0.5751,1,,,Infiltrating Lobular Carcinoma,0.183001697,,0.258877042,0,0,0,,Negative,-0.8635,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5908,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-JY-A939,White,ESCA,,0,0,,,,0,,0,,,,,,,,660,,,660,,0,0,660,660,,Malignant,,,,,,,27341,,,660,660,,,,,660,,,660,,,,,,,,WITH TUMOR,Alive,-28181,,,,95,,660,660,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,University Health Network,,TCGA-JY-A939,,,,,,,660,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,77,,,,,,,,,,,,,,,,,,,,81120,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,Not Answered,,,,,,,,,,,,,,,,,,,,,Resection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-62-A46V,White,LUAD,,0,0,,Thoraxklinik at University Hospital Heidelberg,0,0,FEMALE,0,1.92,0.52,10,11,9,,,2199,,2199,2199,,0,0,2199,2199,,Malignant,30,,55,,,,33479,,,2199,2199,,,,2199,2199,,,2199,,,,,,,,TUMOR FREE,Alive,-28495,,,,101,,2199,2199,,,[Not Available],[Not Applicable],,,,,0.05,,,,,5,,0,0.21555,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A46V,,,,,,,2199,,,,,,,,,10,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,81121,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,-0.0052,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.690904392,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.66,,-2.5554,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.45,0.86,3,2,5,,,1165,BRCA_LumA,1165,1165,,0,0,1165,1165,,Invasive Carcinoma,10,,8,,,,19712,0,,1165,1165,,,,1165,1165,,,1165,,,,,,,,TUMOR FREE,Alive,-24242,,,,49,,1165,1165,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,25,,1,0.15259,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0CD,,,,,,,1165,,,,,,,,,17,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,81123,,-0.756967769,0,0,0,0,0.1201,1,,,Infiltrating Ductal Carcinoma,0.119346704,,0.175951569,0,0,0,,Negative,-1.406,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0508,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-66-2790,,LUSC,,1,,,Indivumed,,0,MALE,1,,,,,,,,699,,,699,,1,,699,699,,Malignant,,,,,,,19779,,,699,,,,,,699,,,699,,,,,,,,WITH TUMOR,Alive,-26420,,,,0,,699,,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2790,,,,,,,699,,,,,,,,,,,,,,,,,,,,,,2008,699,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,72,,,,,,,,,,,,,,,,,,,,81124,,1.152909193,,,,,,,,,,0.189981989,,0.066343452,,,,Stage IIB,,1.485,,,,,,,,,,,,,,,,0.6184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.72157677,15.37762585,16.62320867,-0.140442625473154,LUSC,Squamous Cell Carcinoma,18.09557803,16.54721312,Squamous Cell Carcinoma,0.2295,13.40841417,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.41,0.52,13,22,20,,,518,BRCA_LumB,518,518,,0,0,518,518,,Invasive Carcinoma,55,,47,,,,28080,0,,518,518,,,,518,518,,,518,,,,,,,,TUMOR FREE,Alive,-15369,,,,117,,518,518,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,18,,1,0.37353,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A075,,,,,,,518,,,,,,,,,30,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,81125,,0.528193662,0,0,0,0,-1.1114,1,,,Infiltrating Ductal Carcinoma,0.187009774,,0.088034819,0,0,0,,Negative,0.7215,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3532,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-6738,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.88,0.53,10,3,14,,,1927,,1927,1927,,0,0,1927,1927,,Malignant,27,,24,,,,16747,,,1927,1927,,,,1927,1927,,,1927,,,,,,,,TUMOR FREE,Alive,-29368,,,,451,,1927,1927,,,[Not Available],[Not Applicable],,,,,0.4,,,,,17,,0,0.32942,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-6738,,,,,,,1927,,,,,,,,,18,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,81132,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.1559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R362Q,1,,,R362Q,14.01092638,14.28981816,14.00501863,-0.628474808874668,LUSC,,17.94689144,14.92918619,Squamous Cell Carcinoma,,11.92790784,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-43-5670,White,LUSC,,0,0,,Christiana Healthcare,0,0,MALE,0,2.7,0.62,6,9,17,,,849,,849,849,,0,0,849,849,,Malignant,32,,102,,,,16501,,,849,849,,,,849,849,,,849,,,,,,,,TUMOR FREE,Alive,-25652,,,,180,,849,849,,,[Not Available],[Not Applicable],,,,,0.17,,,,,17,,1,0.41776,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-5670,,,,,,,849,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,81133,,-0.491133248,,,,,,,,,,0.108546639,,-0.040798291,,,,Stage IIA,,-0.8035,,,,,,,,,,,,,,,,0.4577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,12.54440096,12.84646575,9.935412392,-1.06055471326516,LUSC,Squamous Cell Carcinoma,17.96435149,13.89360177,Squamous Cell Carcinoma,0.9226,13.59993561,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Male,TCGA-M7-A722,,PRAD,,1,1,,M7,,0,MALE,1,1.95,0.88,3,6,0,HRP,NO,1060,,,1060,,1,1,559,559,prad_tcga,Malignant,9,,38,,TCGA-M7-A722-01,5,5542,0,TCGA-M7-A722,559,559,Prostate Cancer,,559,,1060,TCGA,,559,Primary,0,,A,,,False,TUMOR FREE,Alive,-23880,,65,8,39,PRAD,559,559,,0.157045962,[Not Available],[Not Applicable],36,,1,Matched,0.0,Prostate,Resection,4,AB7BF9EF-55F2-41FA-BDB1-F7B7C79B9A48,0,Normal (no evidence of prostate cancer) [cM0],0,0.055324,[Not Available],3FA3CFFE-40F1-4853-9CBB-54A99FFD6108,4,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,M7,1.2,TCGA-M7-A722,1:Recurred/Progressed,4,10,Prostate Adenocarcinoma,18.36,3/27/14,1060,,Biochemical evidence of disease,,,NO,C61,4D0EE4BC-69EC-45D2-8739-24E1FE1A526A,190,2,WITH TUMOR,0.0523,0:LIVING,,3,34.82,Bilateral,13,No Evidence of Extraprostatic Extension,3,YES,577,2011,559,,TCGA-M7-A722.4D0EE4BC-69EC-45D2-8739-24E1FE1A526A.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,3,,4,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,YES,No,R1,,65,Core needle biopsy,559,Partial Remission/Response,YES,NO,YES,YES,T3a,NO,8,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,81136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.09,0.51,10,9,13,,,2442,BRCA_LumA,2442,2442,,0,0,2442,2442,,Invasive Carcinoma,32,,57,,,,28865,0,,2442,2442,,,,2442,2442,,,2442,,,,,,,,TUMOR FREE,Alive,-12443,,,,51,,2442,2442,,,[Not Available],[Not Applicable],,,,,0.26,Breast,Resection/Excision,,,19,,1,0.25817,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A03L,,,,,,,2442,,,,,,,,,22,,,,,,,,,,,,,2003,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,81141,,0.483393472,0,0,0,1,0.5896,0,,,Infiltrating Ductal Carcinoma,0.129501345,,0.14962201,0,0,0,,Negative,0.0895,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4307,0,0,H & E,0,0,,0,Theresa Smith,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.83,0.68,7,10,15,,,1417,BRCA_LumB,1417,1417,,0,0,1417,1417,,Invasive Carcinoma,32,,64,,,,16207,0,,1417,1417,,,,1417,1417,,,1417,,,,,,,,TUMOR FREE,Alive,-23521,,,,0,,1417,1417,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,13,,1,0.17786,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A109,,,,,,,1417,,,,,,,,,25,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,81142,,0.573141145,0,0,0,0,0.0738,1,,,Infiltrating Ductal Carcinoma,0.135775144,,0.158433104,0,0,0,,Negative,-0.261,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3341,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, High Grade), No Detail Present",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,,1,1,Male,TCGA-33-4586,White,LUSC,,1,1,,Johns Hopkins,1,,MALE,1,3.27,0.42,11,5,17,,,428,,169,428,,1,1,169,169,,Malignant,33,,46,,,,21207,,,169,169,,,,169,428,,,169,,,,,,,,,Dead,-21148,428,,,489,,169,169,,,[Not Available],[Not Applicable],,,,,0.2,,,,,21,,1,0.4552,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4586,,,,,,,,,Locoregional Recurrence,,,,,,,21,,,,,,,,,,,,,2007,169,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,81144,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.4063,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.37155358,14.68105913,14.41155811,-0.627503212363471,LUSC,Squamous Cell Carcinoma,17.45258513,14.61924389,Squamous Cell Carcinoma,,12.60923639,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.14,0.75,5,6,6,,,513,BRCA_LumA,513,513,,0,0,513,513,,Invasive Carcinoma,17,,23,,,,19596,0,,513,513,,,,513,513,,,513,,,,,,,,TUMOR FREE,Alive,,,,,25,,513,513,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,7,,0,0.093606,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A273,,,,,,,513,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,29,,,,,,,,,,,,,,,,,,,,81145,,-0.249178166,0,0,0,0,0.8285,1,,,Infiltrating Ductal Carcinoma,0.117554567,,0.147431638,0,0,0,,Negative,-0.9675,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.395,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.42,1,1,2,,,1980,BRCA_LumA,1980,1980,,0,0,1980,1980,,Invasive Carcinoma,4,,19,,,,19969,0,,1980,1980,,,,1980,1980,,,1980,,,,,,,,TUMOR FREE,Alive,-24923,,,,49,,1980,1980,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,2,,0,0.015657,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JF,,,,,,,1980,,,,,,,,,2,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,81149,,0.46694243,0,0,0,0,0.2541,1,,,Infiltrating Ductal Carcinoma,0.209183281,,0.319243958,0,0,0,,Negative,-0.3545,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5901,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FJ-A3ZF,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.1,0.88,5,15,13,,,524,,524,524,,0.0,0,524.0,524.0,,Malignant,33,,33,,,,24167.0,,,524.0,524,,,,524,524,,,524.0,,,,,,,,TUMOR FREE,Alive,-26825,,,,361.0,,524.0,524,,,[Not Available],[Not Applicable],,,,,0.35,,Resection,,,13,,1,0.1001,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3ZF,,,,,,,524,,,,,,,,,35,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,81157,,,,,,,,,,,,,,,,,,,,,Detrusor muscle,,,,,,,,,,,,,,,,,,,,,Resection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.47,0.42,12,15,10,,,511,BRCA_Her2,511,511,,0,0,511,511,,Invasive Carcinoma,37,,107,,,,32294,0,,511,511,,,,511,511,,,511,,,,,,,,TUMOR FREE,Alive,-27964,,,,230,,511,511,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,21,,1,0.19367,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A5EH,,,,,,,511,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,81161,,0.446755502,0,0,0,0,1.1296,1,,,Infiltrating Ductal Carcinoma,0.195205234,,0.112614335,0,0,0,,Negative,-0.1055,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6513,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.87,9,1,7,,,461,BRCA_LumB,461,461,,0,0,461,461,,Invasive Carcinoma,17,,25,,,,20409,0,,461,461,,,,461,461,,,461,,,,,,,,TUMOR FREE,Alive,-25223,,,,37,,461,461,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,9,,0,0.20766,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0H0,,,,,,,461,,,,,,,,,12,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,81166,,-0.15811782,0,0,0,0,0.6719,1,,,Infiltrating Ductal Carcinoma,0.100745377,,0.13813999,0,0,0,,Negative,-0.8135,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.4945,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.77,9,8,11,,,616,BRCA_LumB,616,616,,0,0,616,616,,Invasive Carcinoma,28,,19,,,,31230,0,,616,616,,,,616,616,,,616,,,,,,,,TUMOR FREE,Alive,-17468,,,,104,,616,616,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,3,,0,0.15597,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A26V,,,,,,,616,,,,,,,,,9,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,81172,,0.387583531,0,0,0,0,-0.2626,1,,,Infiltrating Ductal Carcinoma,0.176575638,,0.077022821,0,0,0,,Negative,0.13,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.2518,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.86,0.8,12,4,7,,,1043,BRCA_LumA,1043,1043,,0,0,1043,1043,,Invasive Carcinoma,23,,77,,,,30074,0,,1043,1043,,,,1043,1043,,,1043,,,,,,,,TUMOR FREE,Alive,-25350,,,,92,,1043,1043,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,8,,0,0.25445,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A576,,,,,,,1043,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,81174,,-0.204861091,0,0,0,0,0.4901,1,,,Infiltrating Lobular Carcinoma,0.078064851,,0.12532565,0,0,0,,Negative,-0.939,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1119,0,0,H & E,0,0,,0,Theresa Smith,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-FJ-A3Z7,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.43,0.54,8,17,23,,,945,,,945,,0.0,0,945.0,945.0,,Malignant,48,,91,,,,28910.0,,,945.0,945,,,,,945,,,945.0,,,,,,,,TUMOR FREE,Alive,-28052,,,,448.0,,945.0,945,,,[Not Available],[Not Applicable],,,,,0.21,,,,,10,,1,0.258,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3Z7,,,,,,,945,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,81178,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.73,0.63,2,2,6,,,579,BRCA_LumA,579,579,,0,0,579,579,,Invasive Carcinoma,10,,15,,,,18141,0,,579,579,,,,579,579,,,579,,,,,,,,TUMOR FREE,Alive,-25110,,,,41,,579,579,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,12,,1,0.050819,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09T,,,,,,,579,,,,,,,,,11,,,,,,,,,,,,,2009,,,,,[Discrepancy],,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,81181,,-0.211761128,0,0,0,0,-0.2303,1,,,Infiltrating Lobular Carcinoma,0.165498447,,0.073722082,0,0,0,,Negative,-0.7505,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.128,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-XF-A8HF,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.7,0.69,9,7,14,,,2954,,2954,2954,,2.0,2,2954.0,2954.0,,Malignant,30,,75,,,,22398.0,,,2954.0,2954,,,,2954,2954,,,2954.0,,,,,,,,TUMOR FREE,Dead,-29288,2954,,,206.0,,2954.0,2954,,,[Not Available],[Not Applicable],,,,,0.31,,,,,23,,2,0.18215,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A8HF,,,,,,,,,,,,,,,,58,,,,,,,,,,,,,2004,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,80.0,,,,,,,,,,,,,,,,,,,,81187,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.7,0.77,29,23,25,,,488,BRCA_Basal,488,488,,0,0,488,488,,Invasive Carcinoma,77,,68,,,,28649,0,,488,488,,,,488,488,,,488,,,,,,,,TUMOR FREE,Alive,-14731,,,,90,,488,488,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,7,,0,0.45939,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27F,,,,,,,488,,,,,,,,,22,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,81188,TRUE,-0.276482146,0,0,0,0,1.1644,1,,,Infiltrating Ductal Carcinoma,0.162599935,,0.125235619,0,0,0,,Negative,-1.025,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4014,0,0,H & E,0,0,,0,Theresa Smith,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,,,,1,0,FEMALE,1,1.9,0.42,2,0,2,,,3607,BRCA_LumA,2561,3607,,1,,2561,2561,,Invasive Carcinoma,4,,7,,,,33298,0,,2561,,,,,2561,3607,,,2561,,,,,,,,WITH TUMOR,Alive,-15977,,,,25,,2561,,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,4,,0,0.10319,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mixed Histology (please specify),,,,,,[Not Available],,Mayo,,TCGA-AR-A24O,,,,,,,3607,,,,,,,,,4,,,,,,,,,,,,,2005,2561,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,81192,,0.656262123,0,0,0,0,0.4655,1,,,Mixed Histology (NOS),0.190964327,,0.299280215,0,0,0,,Negative,-0.208,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.6304,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A1AA,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.94,0.93,0,1,2,,,578,,578,578,,0.0,0,578.0,578.0,,Malignant,3,,11,,,,27210.0,,,578.0,578,,,,578,578,,,578.0,,,,,,,,TUMOR FREE,Alive,-21093,,,,120.0,,578.0,578,,,[Not Available],[Not Applicable],,,,,0.0,,,,,2,,0,0.057851,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1AA,,,,,,,578,,,,,,,,,1,,,,,,,,,,,,,2010,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,57.0,,,,,,,,,,,,,,,,,,,,81193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-66-2758,,LUSC,,0,0,,Indivumed,0,0,MALE,0,2.96,0.5,13,25,29,,,639,,639,639,,0,0,639,639,,Malignant,67,,96,,,,16710,,,639,639,,,,639,639,,,639,,,,,,,,TUMOR FREE,Alive,-26209,,,,467,,639,639,,,[Not Available],[Not Applicable],,,,,0.2,,,,,13,,1,0.51787,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2758,,,,,,,639,,,,,,,,,30,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,81205,,1.277867651,,,,,,,,,,0.209290847,,0.023550536,,,,Stage IB,,2.341,,,,,,,,,,,,,,,,0.0745,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.154164797102892,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.4448,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-18-3408,White,LUSC,,1,1,,Princess Margaret Hospital (Canada),,1,FEMALE,1,1.95,0.76,4,3,4,,,2304,,,2304,,1,1,1793,1793,,Malignant,11,,16,,,,16182,,,1793,1793,,,,,2304,,,1793,,,,,,,,WITH TUMOR,Dead,-28171,2304,,,111,,1793,1793,,,[Not Available],[Not Applicable],,,,,0.22,,,,,4,,0,0.15783,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3408,,,,,,,,,Locoregional Recurrence,,,,,,,5,,,,,,,,,,,,,2004,1793,,,,Stage IB,,,,,,,,[Unknown],,,,,,77,,,,,,,,,,,,,,,,,,,,81214,,0.461653228,,,,,,,,,,0.202625242,,0.090872791,,,,Stage IB,,0.358,,,,,,,,,,,,,,,,-0.1496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,,,,-0.180617052605876,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.1776,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-H9-7775,White,PRAD,184,0,0,,H9,0,0,MALE,0,1.97,0.79,2,3,2,HRP,NO,185,4-FLI1,185,185,,0,0,185,185,prad_tcga,Malignant,7,,20,7.2,TCGA-H9-7775-01,0,5398,0,TCGA-H9-7775,185,185,Prostate Cancer,,73,185,185,TCGA,,185,Primary,0,,A,,,,TUMOR FREE,Alive,-24898,,68,7,41,PRAD,185,185,WHITE,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,3,09bb6311-41ad-46a1-8195-6d1fdacd7cb0,1,,0,0.032713,[Not Available],ecade538-f882-4f29-a363-7acb89fd0576,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,H9,1.06666666667,TCGA-H9-7775,0:DiseaseFree,2,6,Prostate Adenocarcinoma,6.08,2/8/12,185,,,,,,C61,2a752788-15f1-4879-96a7-eaf5dfa6921d,,1,,0.0311,0:LIVING,0.04,0,6.08,Right,8,,,YES,,2011,,,TCGA-H9-7775.2a752788-15f1-4879-96a7-eaf5dfa6921d.pdf,,[Not Applicable],,,91-100%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.6,68,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,,,,C61.9,8550/3,81217,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-95-7947,White,LUAD,,0,0,,Washington University - Emory,0,0,MALE,0,2.07,0.66,14,8,13,,,477,,477,477,,0,0,477,477,,Malignant,35,,27,,,,31928,,,477,477,,,,477,477,,,477,,,,,,,,TUMOR FREE,Alive,-24752,,,,691,,477,477,,,[Not Available],[Not Applicable],,,,,0.03,,,,,11,,0,0.26927,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-7947,,,,,,,477,,,,,,,,,18,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,81220,,0.680833454,,,,,,,,,,0.175458602,,0.115225171,,,,Stage IA,,1.019,,,,,,,,,,,,,,,,-0.2523,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"I91V, R1052I",,S102L,1,"I91V, R1052I",,S102L,,,,-0.257373943,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.0511,,0.072,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-60-2724,White,LUSC,,0,0,,Roswell Park,,0,MALE,0,1.83,0.47,7,3,11,,,717,,,717,,0,0,717,717,,Malignant,21,,35,,,,28876,,,717,717,,,,,717,,,717,,,,,,,,TUMOR FREE,Alive,-17462,,,,459,,717,717,,,[Not Available],[Not Applicable],,,,,0.22,,,,,10,,0,0.3595,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2724,,,,,,,717,,,,,,,,,12,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,81224,,-0.727081826,,,,,,,,,,0.154800451,,0.099118611,,,,Stage IIIA,,-0.6795,,,,,,,,,,,,,,,,0.8567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.10355786,16.82580863,12.523703,-0.8947680339763,LUSC,Squamous Cell Carcinoma,17.55801022,14.77896415,Squamous Cell Carcinoma,1.5889,15.06802631,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-UY-A9PF,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.64,0.37,3,13,11,,,117,,,117,,0.0,0,117.0,117.0,,Malignant,27,,15,,,,17766.0,,,117.0,117,,,,,117,,,117.0,,,,,,,,TUMOR FREE,Alive,-28470,,,,699.0,,117.0,117,,,[Not Available],[Not Applicable],,,,,0.05,,,,,13,,1,0.059208,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A9PF,,,,,,,117,,,,,,,,,22,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,81225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Female,TCGA-BT-A20U,White,BLCA,,0.0,0,,,2,2,FEMALE,2.0,2.0,0.5,3,3,3,,,455,,455,455,,2.0,2,455.0,455.0,,Malignant,9,,8,,,,28968.0,,,455.0,455,,,,455,455,,,455.0,,,,,,,,TUMOR FREE,Dead,-25761,455,,,121.0,,455.0,455,,,[Not Available],[Not Applicable],,,,,0.11,,,,,0,,0,0.056402,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20U,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2008,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,81229,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7077,Black or African American,PRAD,161,0,0,,HC,0,0,MALE,0,1.94,0.65,3,4,1,ambiguous,NO,2115,1-ERG,2115,2115,,0,0,2115,2115,prad_tcga,Malignant,8,BRCA2,28,7.6,TCGA-HC-7077-01,0,5402,0,TCGA-HC-7077,2115,2115,Prostate Cancer,,1749,2115,2115,TCGA,,2115,Primary,0,,A,,,,TUMOR FREE,Alive,-23636,,64,6,68,PRAD,2115,2115,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],53,R0,1,Matched,0.24,Prostate,Resection,3,f3e4cc00-d6fe-4291-bb07-8e501e772ce1,2,Normal (no evidence of prostate cancer) [cM0],0,0.065077,[Not Available],92252560-5984-41f6-a4b5-a3aa8654c0c8,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.73333333333,TCGA-HC-7077,0:DiseaseFree,1,19,Prostate Adenocarcinoma,69.48,4/9/12,2115,,,,,NO,C61,67940700-dcd0-4e3c-9cca-4f6daeacf34c,,2,TUMOR FREE,0.0626,0:LIVING,0.83,,69.48,Bilateral,21,,,YES,,2006,,,TCGA-HC-7077.67940700-dcd0-4e3c-9cca-4f6daeacf34c.pdf,,[Not Applicable],NO,-14,56-65%,,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,,No,R0,0.5,64,Transurethral resection (TURBT),,,NO,YES,NO,,T3a,,6,No,,0,,T1c,,M0,C61.9,8550/3,81230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-95-A4VK,White,LUAD,,1,1,,Washington University - Emory,,0,FEMALE,1,2.02,0.57,3,3,11,,,651,,,651,,1,1,496,496,,Malignant,17,,62,,,,16045,,,496,496,,,,,651,,,496,,,,,,,,WITH TUMOR,Alive,-27040,,,,342,,496,496,,,[Not Available],[Not Applicable],,,,,0.0,,,,,7,,0,0.094338,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-A4VK,,,,,,,651,,Distant Metastasis,,,,,,,8,,,,,,,,,,,,,2012,496,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,81238,,1.135462256,,,,,,,,,,0.149391622,,0.132997786,,,,Stage IIIA,,0.6655,,,,,,,,,,,,,,,,0.1569,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,14.64762246,15.51202058,15.44125454,-0.30300796,LUAD,Adenocarcinoma,18.21848257,16.40754831,Adenocarcinoma,-0.2684,12.8009282,0.3589,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-97-8552,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,0,3.6,0.27,7,10,9,,,626,,626,626,,0,0,626,626,,Malignant,26,,87,,,,18366,,,626,626,,,,626,626,,,626,,,,,,,,TUMOR FREE,Alive,-20331,,,,150,,626,626,,,[Not Available],[Not Applicable],,,,,0.18,,,,,19,,2,0.41313,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-8552,,,,,,,626,,,,,,,,,53,,,,,,,,,,,,,2012,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,81240,,0.667291544,,,,,,,,,,0.251970697,,0.143745894,,,,Stage I,,0.6535,,,,,,,,,,,,,,,,0.0953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,,,,-0.263322738,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.9419,,-0.3133,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-GC-A3RB,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.2,0.85,9,22,25,,,582,,582,582,,0.0,0,582.0,582.0,,Malignant,56,,65,,,,29332.0,,,582.0,582,,,,582,582,,,582.0,,,,,,,,TUMOR FREE,Alive,-20021,,,,235.0,,582.0,582,,,[Not Available],[Not Applicable],,,,,0.11,,,,,8,,1,0.16538,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A3RB,,,,,,,582,,,,,,,,,30,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,54.0,,,,,,,,,,,,,,,,,,,,81244,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-73-7498,White,LUAD,,0,0,,Roswell Park,0,0,FEMALE,0,2.01,0.62,3,3,4,,,1189,,1189,1189,,0,0,1189,1189,,Malignant,10,,22,,,,19307,,,1189,1189,,,,1189,1189,,,1189,,,,,,,,TUMOR FREE,Alive,-21527,,,,152,,1189,1189,,,[Not Available],[Not Applicable],,,,,0.14,,,,,7,,0,0.087705,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-7498,,,,,,,1189,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,81252,,0.625850865,,,,,,,,,,0.199963044,,0.269940569,,,,Stage IA,,0.4505,,,,,,,,,,,,,,,,0.1446,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),E218V,1,,G12C (driver),E218V,,,,-0.503711259,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.5679,,-0.6057,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-FJ-A3Z7,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.43,0.54,8,17,23,,,945,,,945,,0.0,0,945.0,945.0,,Malignant,48,,91,,,,28910.0,,,945.0,945,,,,,945,,,945.0,,,,,,,,TUMOR FREE,Alive,-28052,,,,448.0,,945.0,945,,,[Not Available],[Not Applicable],,,,,0.21,,,,,10,,1,0.258,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3Z7,,,,,,,945,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,81254,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Female,TCGA-55-A48X,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,1,1.78,0.28,7,5,7,,,689,,689,689,,0,0,615,615,,Malignant,19,,47,,,,19646,,,689,689,,,,689,689,,,615,,,,,,,,TUMOR FREE,Alive,-23341,,,,521,,689,689,,,[Not Available],[Not Applicable],,,,,0.12,,,,,12,,0,0.31471,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A48X,,,,,,,689,,New Primary Tumor,,,,,,,13,,,,,,,,,,,,,2012,615,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,81265,,1.250079355,,,,,,,,,,0.191152364,,0.149851126,,,,Stage IIA,,1.419,,,,,,,,,,,,,,,,0.3852,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.96095958,15.98435445,15.9312883,-0.162746404,LUAD,Adenocarcinoma,18.35114581,16.65087416,Adenocarcinoma,-0.3855,13.15083062,0.4382,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.95,0.56,11,11,5,,,519,BRCA_LumA,519,519,,0,0,519,519,,Invasive Carcinoma,27,,38,,,,32072,0,,519,519,,,,519,519,,,519,,,,,,,,,Alive,-23395,,,,107,,519,519,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,5,,0,0.19926,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A5YL,,,,,,,519,,,,,,,,,8,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,81280,,0.099335867,0,0,0,1,0.4064,0,,,Infiltrating Lobular Carcinoma,0.131982915,,0.130826693,0,0,0,,Negative,-0.666,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.225,0,0,H & E,0,0,,0,Theresa Smith,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,Benign Breast Epithelium,No Detail Present,"DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.94,0.52,2,1,4,,,860,BRCA_LumA,,860,,0,0,860,860,,Invasive Carcinoma,7,,11,,,,32500,0,,860,860,,,,,860,,,860,,,,,,,,TUMOR FREE,Alive,-21394,,,,43,,860,860,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,4,,0,0.08037,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1R0,,,,,,,860,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,81283,,0.767985382,0,0,0,0,-0.4812,1,,,Infiltrating Ductal Carcinoma,0.153487929,,0.231461266,0,0,0,,[Not Available],0.0925,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.332,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.1,0.78,3,4,4,,,595,BRCA_LumB,595,595,,0,0,595,595,,Invasive Carcinoma,11,,18,,,,23398,0,,595,595,,,,595,595,,,595,,,,,,,,TUMOR FREE,Alive,-25966,,,,50,,595,595,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.040239,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A1G4,,,,,,,595,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,81293,,0.11882554,0,0,0,0,-0.0209,1,,,Infiltrating Ductal Carcinoma,0.117164825,,0.124377553,0,0,0,,Negative,-0.5405,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1146,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,DCIS with Microinvasive Carcinoma,DCIS with Microinvasive Carcinoma,0,None,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XK-AAJU,,PRAD,,0,0,,XK,0,0,MALE,0,2.0,0.5,0,0,0,HRP,NO,1576,,1576,1576,,0,0,1576,1576,prad_tcga,Malignant,0,,8,,TCGA-XK-AAJU-01,0,5638,0,TCGA-XK-AAJU,1576,1576,Prostate Cancer,,1206,1576,1576,TCGA,,1576,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23958,,65,7,3,PRAD,1576,1576,,0.0,[Not Available],[Not Applicable],6,,1,Matched,0.0,Prostate,Resection,4,84FA7597-CEAA-4851-B44C-6ED9E4A34E75,0,Normal (no evidence of prostate cancer) [cM0],0,0.0025477,[Not Available],ED7084F8-060C-4780-8B35-A03A5EAB9684,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XK,0.2,TCGA-XK-AAJU,0:DiseaseFree,3,3,Prostate Adenocarcinoma,51.77,5/13/14,1576,,,,,NO,C61,08C5834B-E57D-4182-86DE-4B83314D6799,130,0,TUMOR FREE,0.0,0:LIVING,0.09,,51.77,Bilateral,8,,,YES,1276,2010,,,TCGA-XK-AAJU.08C5834B-E57D-4182-86DE-4B83314D6799.pdf,,[Not Applicable],NO,9,,5,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,81297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A47W,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,2.0,0.94,0,0,0,,,368,,368,368,,0.0,0,368.0,368.0,,Malignant,0,,5,,,,27453.0,,,368.0,368,,,,368,368,,,368.0,,,,,,,,TUMOR FREE,Alive,-15497,,,,39.0,,368.0,368,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.000908,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A47W,,,,,,,368,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,42.0,,,,,,,,,,,,,,,,,,,,81306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A6AS,,PRAD,,0,0,,HC,,0,MALE,0,,,,,,,NO,44,,,44,,0,0,44,44,prad_tcga,Malignant,,BRCA1;BRCA2,,,TCGA-HC-A6AS-01,0,5456,0,TCGA-HC-A6AS,44,44,Prostate Cancer,,,,44,TCGA,,44,Primary,0,,A,,,False,TUMOR FREE,Alive,-25661,,70,7,28,PRAD,44,44,,0.0,[Not Available],[Not Applicable],34,,1,Matched,,Prostate,Resection,3,81987828-DFD9-46ED-BAB7-9E1A1A5DFC4D,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],6B3F53AB-00F4-4C45-9BB5-5C8ADBC66084,4,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,HC,1.13333333333,TCGA-HC-A6AS,0:DiseaseFree,2,,Prostate Adenocarcinoma,1.45,9/19/13,44,,,,,NO,C61,89891821-AF8C-4105-8270-D6FCF714697F,30,,TUMOR FREE,0.0021,0:LIVING,,,1.45,Right,,No Evidence of Extraprostatic Extension,27,YES,127,2012,,,TCGA-HC-A6AS.89891821-AF8C-4105-8270-D6FCF714697F.pdf,,[Not Applicable],YES,27,,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,R0,,70,Core needle biopsy,,,YES,NO,YES,NO,T2a,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,81307,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.37,0.43,19,31,29,,,450,BRCA_Basal,450,450,,0,0,450,450,,Invasive Carcinoma,79,,234,,,,18717,1,,450,450,,,,450,450,,,450,,,,,,,,,Alive,-18041,,,,124,,450,450,,,[Not Available],[Not Applicable],,,,,0.3,Skin,Resection/Excision,,,13,,1,0.42785,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A5YP,,,,,,,450,,,,,,,,,30,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,81315,,0.552882998,0,0,0,0,0.8327,1,,,Infiltrating Ductal Carcinoma,0.198810438,,0.182357962,0,0,0,,Negative,0.048,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.7728,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-FJ-A3Z7,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.43,0.54,8,17,23,,,945,,,945,,0.0,0,945.0,945.0,,Malignant,48,,91,,,,28910.0,,,945.0,945,,,,,945,,,945.0,,,,,,,,TUMOR FREE,Alive,-28052,,,,448.0,,945.0,945,,,[Not Available],[Not Applicable],,,,,0.21,,,,,10,,1,0.258,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3Z7,,,,,,,945,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,81316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-55-8096,White,LUAD,,1,1,,International Genomics Consortium,1,1,FEMALE,1,2.73,0.25,7,7,10,,,719,,566,719,,1,1,566,566,,Malignant,24,,22,,,,28636,,,566,566,,,,566,719,,,566,,,,,,,,WITH TUMOR,Dead,-24684,719,,,186,,566,566,,,[Not Available],[Not Applicable],,,,,0.2,,,,,21,,1,0.46314,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8096,,,,,,,,,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,2011,566,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,81317,,0.492649996,,,,,,,,,,0.30346114,,0.16538913,,,,Stage IB,,1.094,,,,,,,,,,,,,,,,0.6388,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), AMP (driver)",,,1,L858R (driver),,,,,,-0.336315076,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.2009,,-0.2713,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-37-4141,White,LUSC,,0,0,,Cureline,,0,FEMALE,0,1.67,0.76,7,6,9,,,12,,,12,,0,0,12,12,,Malignant,22,,24,,,,16738,,,12,12,,,,,12,,,12,,,,,,,,TUMOR FREE,Alive,-24048,,,,448,,12,12,,,[Not Available],[Not Applicable],,,,,0.17,,,,,14,,0,0.41956,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-4141,,,,,,,12,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,81320,,0.768313137,,,,,,,,,,0.129527152,,0.082167147,,,,Stage IA,,1.0125,,,,,,,,,,,,,,,,-0.1387,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.184386885889457,LUSC,,,,Squamous Cell Carcinoma,0.3936,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-78-7145,White,LUAD,,1,,,Prince Charles Hospital,,1,FEMALE,1,3.37,0.63,5,9,12,,,826,,,826,,1,,422,422,,Malignant,26,,43,,,,17797,,,422,,,,,,826,,,422,,,,,,,,WITH TUMOR,Dead,-19080,826,,,253,,422,,,,[Not Available],[Not Applicable],,,,,0.05,,,,,16,,1,0.15964,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7145,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,2000,422,,,,Stage IV,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,81324,,0.253121154,,,,,,,,,,0.247522332,,0.152955813,,,,Stage IV,,0.617,,,,,,,,,,,,,,,,0.2559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12C (driver), G12D (driver)",,1,,"G12C (driver), G12D (driver)",,16.11298267,17.43136329,11.02012487,-0.646810733,LUAD,Adenocarcinoma,17.6694471,14.0767687,Adenocarcinoma,0.1828,13.47486236,-1.9018,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,322,BRCA_Basal,322,322,,0,0,322,322,,Invasive Carcinoma,,,,,,,26057,0,,322,322,,,,322,322,,,322,,,,,,,,TUMOR FREE,Alive,-24319,,,,7,,322,322,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A25F,,,,,,,322,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,81330,,2.28836212,0,0,0,0,-2.6521,1,,,Infiltrating Ductal Carcinoma,0.292331115,,0.253821919,0,0,0,,Negative,1.982,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4113,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-FD-A6TI,White,BLCA,,0.0,0,,,,2,MALE,2.0,4.57,0.5,0,3,4,,,294,,,294,,2.0,2,294.0,294.0,,Malignant,7,,7,,,,17812.0,,,294.0,294,,,,,294,,,294.0,,,,,,,,TUMOR FREE,Dead,-26874,294,,,169.0,,294.0,294,,,[Not Available],[Not Applicable],,,,,0.07,,,,,22,,2,0.051635,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TI,,,,,,,,,,,,,,,,45,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,[Unknown],,,,,,73.0,,,,,,,,,,,,,,,,,,,,81339,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-VP-A87K,,PRAD,357,1,1,,VP,1,0,MALE,1,1.92,0.89,6,5,4,ambiguous,NO,1306,1-ERG,533,1306,,1,1,533,533,prad_tcga,Malignant,15,CHEK2;RAD51B,48,,TCGA-VP-A87K-01,0,5599,0,TCGA-VP-A87K,533,533,Prostate Cancer,,655,533,1306,TCGA,,533,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-23030,,63,8,36,PRAD,533,533,,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.18,Prostate,Resection,4,0D98F39E-CF75-4D68-8B25-1DF098BD4930,3,Normal (no evidence of prostate cancer) [cM0],0,0.076971,[Not Available],24D7D4D8-F5C1-4D71-80E0-72A429FC9DBD,4,"Prostate Adenocarcinoma, Other Subtype",,Prostate,14,,Adenocarcinoma,[Not Available],,VP,1.2,TCGA-VP-A87K,1:Recurred/Progressed,4,17,Prostate Adenocarcinoma,22.9,3/31/14,1306,,Biochemical evidence of disease,,,NO,C61,6B2C5B8F-61B5-4D8B-A091-B28066A1629A,130,4,WITH TUMOR,0.1171,0:LIVING,0.3,,42.9,Bilateral,23,No Evidence of Extraprostatic Extension,13,YES,1112,2010,533,,TCGA-VP-A87K.6B2C5B8F-61B5-4D8B-A091-B28066A1629A.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,13,76-85%,12,"Prostate Adenocarcinoma, Other Subtype",1,2010,Complete Remission/Response,mixed ductal and acinar type,YES,No,R1,,63,Core needle biopsy,473,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8500/3,81345,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.02,0.75,3,4,6,,,7126,BRCA_LumA,1100,7126,,1,1,1100,1100,,Invasive Carcinoma,13,,11,,,,25720,0,,1100,1100,,,,1100,7126,,,1100,,,,,,,,WITH TUMOR,Alive,-16138,,,,41,,1100,1100,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,3,,0,0.037584,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RI,,,,,,,7126,"Other, specify",Locoregional Disease,,,,,,,4,,,,,,,,,,,,,1992,1100,Chest Wall,,,Stage IIIB,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,81356,,-0.95339946,0,0,0,0,0.5139,1,,,Infiltrating Ductal Carcinoma,0.156251195,,0.070998359,0,0,0,,Negative,-0.176,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6483,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GV-A40E,White,BLCA,,1.0,1,,,,1,MALE,1.0,5.52,0.34,13,25,28,,,261,,,261,,1.0,1,219.0,219.0,,Malignant,66,,106,,,,29080.0,,,219.0,219,,,,,261,,,219.0,,,,,,,,WITH TUMOR,Dead,-27569,261,,,225.0,,219.0,219,,,[Not Available],[Not Applicable],,,,,0.38,,,,,21,,2,0.27265,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A40E,,,,,,,,Lung,Distant Metastasis,,,,,,,51,,,,,,,,,,,,,2012,219,,,,Stage II,,,,,,,,Stable Disease,,,,,,75.0,,,,,,,,,,,,,,,,,,,,81361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,439,,439,439,,0,0,439,439,,Invasive Carcinoma,,,,,,,34334,0,,439,439,,,,439,439,,,439,,,,,,,,TUMOR FREE,Alive,-18384,,,,0,,439,439,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1PF,,,,,,,439,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,81362,,0.571004458,0,0,0,0,0.5839,1,,,Infiltrating Ductal Carcinoma,0.153202719,,0.234397905,0,0,0,,Negative,0.043,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6736,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-SY-A9G0,White,BLCA,,0.0,0,,,,2,MALE,2.0,3.0,0.17,5,8,10,,,1008,,,1008,,2.0,2,1008.0,1008.0,,Malignant,23,,25,,,,31693.0,,,1008.0,1008,,,,,1008,,,1008.0,,,,,,,,TUMOR FREE,Dead,-30205,1008,,,67.0,,1008.0,1008,,,[Not Available],[Not Applicable],,,,,0.38,,,,,27,,1,0.098646,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Mayo Clinic Arizona,,TCGA-SY-A9G0,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,82.0,,,,,,,,,,,,,,,,,,,,81366,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.78,17,29,20,,,227,BRCA_Basal,227,227,,0,0,227,227,,Invasive Carcinoma,66,,75,,,,16250,0,,227,227,,,,227,227,,,227,,,,,,,,TUMOR FREE,Alive,-15286,,,,129,,227,227,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,6,,0,0.33925,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0AL,,,,,,,227,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,81371,TRUE,0.862516816,0,0,0,0,1.2419,1,,,Infiltrating Ductal Carcinoma,0.175728243,,0.225075248,0,0,0,,Negative,0.002,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.6675,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-39-5011,White,LUSC,,1,,,MSKCC,1,0,FEMALE,1,1.57,0.43,24,13,18,,,4053,,565,4053,,1,,565,565,,Malignant,55,,62,,,,16475,,,565,,,,,565,4053,,,565,,,,,,,,TUMOR FREE,Alive,-25788,,,,822,,565,,,,[Not Available],[Not Applicable],,,,,0.27,,,,,14,,0,0.56638,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5011,,,,,,,4053,,,,,,,,,19,,,,,,,,,,,,,2002,565,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,81373,,1.092843339,,,,,,,,,,0.272962284,,0.055889187,,,,Stage IA,,1.7585,,,,,,,,,,,,,,,,-0.021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G333C (driver),1,,,G333C (driver),,,,0.0335788664693224,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.4327,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-DK-A1AE,White,BLCA,,1.0,1,,,,0,MALE,1.0,2.06,0.83,0,11,5,,,491,,,491,,1.0,1,211.0,211.0,,Malignant,16,,44,,,,20099.0,,,211.0,211,,,,,491,,,211.0,,,,,,,,WITH TUMOR,Alive,-30707,,,,168.0,,211.0,211,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.022951,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1AE,,,,,,,491,Bone,Metastatic,,,,,,,3,,,,,,,,,,,,,2010,211,,,,Stage III,,,,,,,,Progressive Disease,,,,,,84.0,,,,,,,,,,,,,,,,,,,,81376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.93,0.56,17,24,17,,,748,BRCA_LumA,748,748,,0,0,748,748,,Invasive Carcinoma,58,,32,,,,27771,0,,748,748,,,,748,748,,,748,,,,,,,,TUMOR FREE,Alive,-21773,,,,136,,748,748,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,3,,0,0.24486,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LA,,,,,,,748,,,,,,,,,11,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,81378,,1.339888956,0,0,0,0,0.8124,1,,,Infiltrating Ductal Carcinoma,0.195852278,,0.07896136,0,0,0,,Negative,0.986,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,1,0,0.2695,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Nipple",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-43-A475,White,LUSC,,0,0,,Christiana Healthcare,0,0,FEMALE,0,2.48,0.34,15,14,16,,,296,,296,296,,0,0,296,296,,Malignant,45,,134,,,,27639,,,296,296,,,,296,296,,,296,,,,,,,,TUMOR FREE,Alive,-24680,,,,323,,296,296,,,[Not Available],[Not Applicable],,,,,0.3,,,,,11,,1,0.64518,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-A475,,,,,,,296,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,81380,,1.653121829,,,,,,,,,,0.232196603,,0.040557931,,,,Stage IIB,,2.912,,,,,,,,,,,,,,,,0.0172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98913408,17.53003506,19.33664303,0.316379516515562,LUSC,,18.08887492,17.47748774,Squamous Cell Carcinoma,-0.566,13.3408186,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-G2-A2EO,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.23,0.37,1,3,7,,,1804,,1804,1804,,2.0,2,1804.0,1804.0,,Malignant,11,,27,,,,25306.0,,,1804.0,1804,,,,1804,1804,,,1804.0,,,,,,,,TUMOR FREE,Dead,-25440,1804,,,1247.0,,1804.0,1804,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.10692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EO,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,81381,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,715,,715,715,,0,0,715,715,,Invasive Carcinoma,,,,,,,21677,0,,715,715,,,,715,715,,,715,,,,,,,,TUMOR FREE,Alive,-18850,,,,0,,715,715,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Evaluated],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A424,,,,,,,715,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,81383,,-1.687250301,0,0,0,0,0.2742,0,,,Infiltrating Lobular Carcinoma,0.10351642,,0.149017454,0,0,0,,Negative,-0.955,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3713,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Apocrine Metaplasia,0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Apocrine Metaplasia,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.22,0.55,5,6,6,,,1,BRCA_Her2,1,1,,0,0,1,1,,Invasive Carcinoma,17,,26,,,,22562,0,,1,1,,,,1,1,,,1,,,,,,,,TUMOR FREE,Alive,-20774,,,,155,,1,1,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,5,,0,0.1224,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A275,,,,,,,1,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,81387,,1.305117289,0,0,0,0,-0.3431,1,,,Infiltrating Ductal Carcinoma,0.217315423,,0.129725531,0,0,0,,Negative,1.0865,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1243,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.11,0.55,7,6,10,,,304,BRCA_Basal,304,304,,0,0,304,304,,Invasive Carcinoma,23,,50,,,,16519,0,,304,304,,,,304,304,,,304,,,,,,,,TUMOR FREE,Alive,-18870,,,,76,,304,304,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,9,,0,0.17998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07O,,,,,,,304,,,,,,,,,9,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,81390,TRUE,0.016506546,0,0,0,0,0.2219,1,,,Infiltrating Ductal Carcinoma,0.203104518,,0.09993721,0,0,0,,Negative,-0.516,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.0967,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Male,TCGA-77-8145,Unknown,LUSC,,1,1,,Prince Charles Hospital,,,MALE,1,2.11,0.41,11,5,12,,,212,,,212,,1,1,136,136,,Malignant,28,,36,,,,17893,,,136,136,,,,,212,,,136,,,,,,,,,Dead,-26707,212,,,158,,136,136,,,[Not Available],[Not Applicable],,,,,0.13,,,,,12,,0,0.20984,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8145,,,,,,,,,Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2000,136,,,,Stage IIIB,,,,,,,,[Unknown],,,,,,73,,,,,,,,,,,,,,,,,,,,81392,,0.217585299,,,,,,,,,,0.184683245,,0.074110251,,,,Stage IIIB,,0.3185,,,,,,,,,,,,,,,,1.0449,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.94713596,15.19651493,11.72857175,-0.586553028053977,LUSC,Squamous Cell Carcinoma,18.16740058,15.09555748,Squamous Cell Carcinoma,1.1623,13.38510026,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-K4-A5RI,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.49,0.71,6,4,9,,,356,,,356,,1.0,1,236.0,236.0,,Malignant,19,,101,,,,29339.0,,,236.0,236,,,,,356,,,236.0,,,,,,,,WITH TUMOR,Dead,-24614,356,,,196.0,,236.0,236,,,[Not Available],[Not Applicable],,,,,0.18,,,,,15,,1,0.34206,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A5RI,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,35,,,,,,,,,,,,,2012,236,ileum,,,Stage III,,,,,,,,Progressive Disease,,,,,,67.0,,,,,,,,,,,,,,,,,,,,81397,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A3IT,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.58,0.46,5,5,13,,,648,,648,648,,0.0,0,648.0,648.0,,Malignant,23,,52,,,,30930.0,,,648.0,648,,,,648,648,,,648.0,,,,,,,,TUMOR FREE,Alive,-22786,,,,573.0,,648.0,648,,,[Not Available],[Not Applicable],,,,,0.01,,,,,16,,1,0.1976,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IT,,,,,,,648,,,,,,,,,16,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,62.0,,,,,,,,,,,,,,,,,,,,81402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-M9-A5M8,Unknown,ESCA,,0.0,0,,,0,0,,0.0,1.77,0.63,11,3,8,,,1007,,1007,1007,,0.0,0,1007,1007,,Malignant,22,,131,,,,27926.0,0,,1007,1007,,,,1007,1007,,,1007,,,,,,,,TUMOR FREE,Alive,-21433,,,,135.0,,1007,1007,,,[Not Available],[Not Available],,,,,0.01,Esophagus,Biopsy,,,7,,0,0.32166,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Ontario Institute for Cancer Research (OICR),,TCGA-M9-A5M8,,,,,,,1007,,,,,,,,,14,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,81403,,,,,,,,,,,,,Grade 2,,,,,Stage IIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,Female,TCGA-L5-A43M,Unknown,ESCA,,0,0,,,,0,,0,,,,,,,,272,,,272,,0,0,272,272,,Malignant,,,,,,,24305,,,272,272,,,,,272,,,272,,,,,,,,,Alive,-30783,,,,80,,272,272,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A43M,,,,,,,272,,,,,,,,,,,,,,,,,,,,,,2009,,,,,[Unknown],,,,,,,,[Unknown],,,,,,84,,,,,,,,,,,,,,,,,,,,81411,,,,,,,,,,,,,Unknown,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,1,1,Male,TCGA-YL-A8HO,,PRAD,370,1,1,,YL,,0,MALE,1,2.05,0.55,12,8,7,HRD,NO,2304,8-other,,2304,,1,1,1068,1068,prad_tcga,Malignant,27,BARD1;BRCA1;BRIP1;CDK12;FANCL;PALB2;RAD51B;RAD51C;RAD51D,166,,TCGA-YL-A8HO-01,0,5658,0,TCGA-YL-A8HO,1068,1068,Prostate Cancer,,2168,,2304,TCGA,,1068,Primary,0,Middle|Base,A,,BRCA2,True,WITH TUMOR,Alive,-24509,,67,7,45,PRAD,1068,1068,,0.0,[Not Available],[Not Applicable],35,R1,1,Matched,0.5,Prostate,Resection,4,CC3826CE-285E-4810-B14D-4AF327D0FDA6,8,Abnormal (not related to prostate cancer),0,0.20752,[Not Available],B7C8CA4C-8D9C-4C5B-99EE-2FCEBE4F70E6,3,Prostate Adenocarcinoma Acinar Type,,Prostate,27,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8HO,1:Recurred/Progressed,3,,Prostate Adenocarcinoma,35.09,3/14/14,2304,,Biochemical evidence of disease,,,NO,C61,3C690B20-F9EC-456D-B397-928E39B3FFE2,330,11,,0.2893,0:LIVING,0.01,5,75.69,Bilateral,,No Evidence of Extraprostatic Extension,117,YES,2100,2008,1068,,TCGA-YL-A8HO.3C690B20-F9EC-456D-B397-928E39B3FFE2.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,62,21-30%,18,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,NO,No,R1,,67,Core needle biopsy,1068,Stable Disease,NO,YES,YES,YES,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,81416,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-85-8666,White,LUSC,,0,0,,Asterand,2,2,MALE,2,3.15,0.27,10,14,17,,,687,,687,687,,2,2,687,687,,Malignant,41,,95,,,,18689,,,687,687,,,,687,687,,,687,,,,,,,,TUMOR FREE,Dead,-23906,687,,,323,,687,687,,,[Not Available],[Not Applicable],,,,,0.26,,,,,23,,1,0.33234,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8666,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,81421,,0.758251629,,,,,,,,,,0.245850904,,0.129348009,,,,Stage IB,,0.6305,,,,,,,,,,,,,,,,0.7738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.456828617901139,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6729,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.31,0.71,2,2,5,,,747,BRCA_LumA,747,747,,0,0,747,747,,Invasive Carcinoma,9,,3,,,,19143,0,,747,747,,,,747,747,,,747,,,,,,,,TUMOR FREE,Alive,-30125,,,,36,,747,747,,,[Not Available],[Not Applicable],,,,,0.96,Breast,Resection/Excision,,,3,,0,0.030186,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0H6,,,,,,,747,,,,,,,,,9,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,81422,,-0.687874853,0,0,0,0,0.765,1,,,Infiltrating Ductal Carcinoma,0.120374137,,0.153448453,0,0,0,,Negative,-0.3665,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.512,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A8IA,,PRAD,370,0,0,,KK,,0,MALE,0,1.93,0.88,5,5,4,ambiguous,NO,1931,1-ERG,,1931,,0,0,1931,1931,prad_tcga,Malignant,14,BRCA1;BRIP1;CDK12;RAD51B;RAD51C;RAD51D;RAD54L,59,,TCGA-KK-A8IA-01,0,5526,0,TCGA-KK-A8IA,1931,1931,Prostate Cancer,,1383,,1931,TCGA,,1931,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-25284,,69,9,45,PRAD,1931,1931,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.37,Prostate,Resection,4,7C6FE384-485C-423A-8F84-B8BC6C3100AD,1,Normal (no evidence of prostate cancer) [cM0],0,0.11039,[Not Available],17916C4E-FEBE-48C6-B475-AD29397425E8,5,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,KK,1.1,TCGA-KK-A8IA,0:DiseaseFree,5,15,Prostate Adenocarcinoma,63.44,8/18/14,1931,,,,,NO,C61,641BD2CD-8B57-49BB-A2E1-9EB78097B4D6,230,3,,0.2758,0:LIVING,0.1,,63.44,Bilateral,18,No Evidence of Extraprostatic Extension,26,YES,1665,2009,,,TCGA-KK-A8IA.641BD2CD-8B57-49BB-A2E1-9EB78097B4D6.pdf,Peripheral Zone,[Not Applicable],YES,26,86-95%,19,Prostate Adenocarcinoma Acinar Type,1,2009,[Unknown],,NO,No,RX,,69,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,YES,0,N1,T3b,3,M0,C61.9,8140/3,81430,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-B7-5816,White,STAD,,0,0,,,0,0,,0,4.25,0.31,0,3,1,,,812,,812,812,,0,0,812,812,,Malignant,4,,11,,,,31019,,,812,812,,,,812,812,,,812,,,,,,,,TUMOR FREE,Alive,-18698,,,,1810,,812,812,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,2,,1,0.058877,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,,,TCGA-B7-5816,,,,,,,812,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,81436,,0.864796674,,,,,,,,,,0.181027703,Grade 3,0.097551965,,,,Stage IIB,,2.0485,,,,,,,,,,,,,,,,0.773,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-B7-5816,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Male,TCGA-V1-A9Z9,,PRAD,,0,0,,V1,0,0,MALE,0,1.93,0.65,4,12,0,HRD,NO,540,,540,540,,0,0,540,540,prad_tcga,Malignant,16,,69,,TCGA-V1-A9Z9-01,5,5583,0,TCGA-V1-A9Z9,540,540,Prostate Cancer,9,291,540,540,TCGA,,540,Primary,0,Apex,A,,BRCA2,True,TUMOR FREE,Alive,-23360,,63,9,40,PRAD,540,540,,0.161737697,[Not Available],[Not Applicable],34,,1,Matched,0.0,Prostate,Resection,4,296CC7A9-AD1E-45FC-A702-F100F0400817,0,,0,0.066038,[Not Available],0885EB03-DE9F-46BA-9C53-FB69C67AB9F0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,V1,1.13333333333,TCGA-V1-A9Z9,0:DiseaseFree,5,19,Prostate Adenocarcinoma,17.74,7/23/14,540,,,,,YES,C61,9D297084-0545-4D51-8D14-15754BAAB18B,140,0,,0.0623,0:LIVING,0.015,,17.74,Bilateral,20,,,YES,,,,,TCGA-V1-A9Z9.9D297084-0545-4D51-8D14-15754BAAB18B.pdf,Peripheral Zone,[Not Applicable],NO,,,29,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,9,No,NO,,N0,T1c,0,M0,C61.9,8140/3,81440,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-GU-A42Q,White,BLCA,,0.0,0,,,2,2,MALE,2.0,2.95,0.45,11,10,13,,,344,,344,344,,2.0,2,344.0,344.0,,Malignant,34,,89,,,,22380.0,,,344.0,344,,,,344,344,,,344.0,,,,,,,,TUMOR FREE,Dead,-24534,344,,,253.0,,344.0,344,,,[Not Available],[Not Applicable],,,,,0.09,,,,,7,,1,0.22756,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A42Q,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,67.0,,,,,,,,,,,,,,,,,,,,81441,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-77-7141,White,LUSC,,0,0,,Prince Charles Hospital,,0,MALE,0,3.3,0.61,11,16,20,,,15,,,15,,0,0,15,15,,Malignant,47,,45,,,,22465,,,15,15,,,,,15,,,15,,,,,,,,,Alive,-23584,,,,863,,15,15,,,[Not Available],[Not Applicable],,,,,0.57,,,,,19,,1,0.27937,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7141,,,,,,,15,,,,,,,,,28,,,,,,,,,,,,,2003,,,,,Stage IB,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,81449,,0.466714451,,,,,,,,,,0.156248132,,0.083659693,,,,Stage IB,,0.94,,,,,,,,,,,,,,,,0.0528,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,,,,-0.44914754687843,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.2936,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-XF-A8HG,White,BLCA,,1.0,1,,,1,1,MALE,1.0,3.9,0.84,5,5,8,,,467,,398,467,,1.0,1,398.0,398.0,,Malignant,18,,71,,,,34468.0,,,398.0,398,,,,398,467,,,398.0,,,,,,,,WITH TUMOR,Dead,-25421,467,,,422.0,,398.0,398,,,[Not Available],[Not Applicable],,,,,0.07,,,,,25,,1,0.12142,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A8HG,,,,,,,,Liver,Distant Metastasis,,,,,,,26,,,,,,,,,,,,,2005,398,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,81452,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7736,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.87,0.6,8,12,2,ambiguous,NO,1103,8-other,1103,1103,,0,0,1103,1103,prad_tcga,Malignant,22,ATM;CHEK1,81,5.0,TCGA-HC-7736-01,3,5416,0,TCGA-HC-7736,1103,1103,Prostate Cancer,,102,1103,1103,TCGA,,1103,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-21703,,59,7,27,PRAD,1103,1103,WHITE,0.141806303,[Not Available],[Not Applicable],26,,1,Matched,0.01,Prostate,Resection,3,9b4b5bba-a33f-4ba8-9143-33028556e3e6,1,,0,0.13076,[Not Available],922e5166-85f5-4365-9c09-f8bdc1722da6,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,20,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,0.9,TCGA-HC-7736,0:DiseaseFree,2,20,Prostate Adenocarcinoma,36.24,4/11/12,1103,,,,,,C61,d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494,,2,TUMOR FREE,0.1245,0:LIVING,0.02,,36.24,Bilateral,22,No Evidence of Extraprostatic Extension,-21,YES,,2010,,,TCGA-HC-7736.d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494.pdf,,[Not Applicable],YES,,81-90%,13,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,No,R0,1.0,59,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,81454,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-98-8020,Black or African American,LUSC,,1,1,,Washington University - Alabama,,1,FEMALE,1,3.17,0.46,14,11,17,,,84,,,84,,1,1,11,11,,Malignant,42,,53,,,,21015,,,11,11,,,,,84,,,11,,,,,,,,WITH TUMOR,Dead,-20509,84,,,120,,11,11,,,[Not Available],[Not Applicable],,,,,0.08,,,,,18,,1,0.2633,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-8020,,,,,,,,,Distant Metastasis,,,,,,,29,,,,,,,,,,,,,2011,11,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,56,,,,,,,,,,,,,,,,,,,,81456,,0.933439681,,,,,,,,,,0.208533536,,0.100225857,,,,Stage IIIA,,1.2785,,,,,,,,,,,,,,,,0.8795,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,16.1701988,17.65022227,16.40693303,-0.179461497867696,LUSC,Squamous Cell Carcinoma,17.86721127,15.7045015,Squamous Cell Carcinoma,1.5473,14.1356721,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,2.06,0.88,0,0,3,,,377,BRCA_LumA,,377,,1,1,377,377,,Invasive Carcinoma,3,,19,,,,18915,1,,377,377,,,,,377,,,377,,,,,,,,WITH TUMOR,Dead,-31220,377,,,41,,377,377,,,[Not Available],[Not Applicable],,,,,0.0,Skin,Resection/Excision,,,2,,0,0.0018074,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XC,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2010,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,85,,,,,,,,,,,,,,,,,,,,81457,,,0,0,0,0,-0.2428,1,,,Mucinous Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-CU-A3KJ,White,BLCA,,1.0,1,,,,0,MALE,1.0,3.15,0.75,8,16,20,,,562,,,562,,1.0,1,166.0,166.0,,Malignant,44,,75,,,,22350.0,,,166.0,166,,,,,562,,,166.0,,,,,,,,WITH TUMOR,Alive,-27692,,,,322.0,,166.0,166,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.22446,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,UNC,,TCGA-CU-A3KJ,,,,,,,562,Lung,Distant Metastasis,,,,,,,33,,,,,,,,,,,,,2011,166,,,,Stage III,,,,,,,,Progressive Disease,,,,,,75.0,,,,,,,,,,,,,,,,,,,,81460,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-22-5478,,LUSC,,0,0,,Mayo Clinic - Rochester,2,2,MALE,2,3.75,0.4,3,5,14,,,24,,24,24,,2,2,24,24,,Malignant,22,,22,,,,18834,,,24,24,,,,24,24,,,24,,,,,,,,TUMOR FREE,Dead,-28978,24,,,248,,24,24,,,[Not Available],[Not Applicable],,,,,0.19,,,,,22,,1,0.27897,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5478,,,,,,,24,,,,,,,,,31,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,81461,,0.673629644,,,,,,,,,,0.196460387,,0.093776968,,,,Stage IB,,-0.018,,,,,,,,,,,,,,,,0.8135,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.487001993090173,LUSC,,,,Squamous Cell Carcinoma,0.3769,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,0,1,,,White,BRCA,,0,0,,,,,FEMALE,2,2.18,0.85,4,1,3,,,3736,BRCA_LumA,,3736,,2,2,3736,3736,,Invasive Carcinoma,8,,9,,,,23759,0,,3736,3736,,,,,3736,,,3736,,,,,,,,,Dead,-32295,3736,,,36,,3736,3736,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,5,,0,0.041842,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FG,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,1998,,,,,Stage I,,,,,,,,[Not Available],,,,,,88,,,,,,,,,,,,,,,,,,,,81467,,-0.712351155,0,0,0,0,1.2617,1,,,Infiltrating Ductal Carcinoma,0.117689156,,0.107904457,0,0,0,,[Not Available],-1.2365,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.147,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.09,0.35,2,1,3,,,1138,BRCA_LumA,1138,1138,,0,0,1138,1138,,Invasive Carcinoma,6,,4,,,,19388,0,,1138,1138,,,,1138,1138,,,1138,,,,,,,,TUMOR FREE,Alive,-27341,,,,29,,1138,1138,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.070755,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IF,,,,,,,1138,,,,,,,,,8,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,81470,,-0.218179377,0,0,0,0,0.9331,1,,,Infiltrating Ductal Carcinoma,0.163585904,,0.221394353,0,0,0,,Negative,-1.137,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6014,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-2H-A9GJ,Unknown,ESCA,,1,1,,,,1,,1,,,,,,,,1781,,,1781,,1,1,1261,1261,,Malignant,,,,,,,18005,,,1261,1261,,,,,1781,,,1261,,,,,,,,WITH TUMOR,Dead,-21180,1781,,,201,,1261,1261,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Erasmus MC,,TCGA-2H-A9GJ,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2000,1261,,,,Stage I,,,,,,,,,,,,,,57,,,,,,,,,,,,,,,,,,,,81476,,,,,,,,,,,,,Grade 2,,,,,Stage I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-V1-A9ZK,,PRAD,,0,0,,V1,0,0,MALE,0,1.87,0.36,10,15,5,ambiguous,NO,1383,,1383,1383,,0,0,1383,1383,prad_tcga,Malignant,30,BRCA2;CHEK1,49,,TCGA-V1-A9ZK-01,0,5586,0,TCGA-V1-A9ZK,1383,1383,Prostate Cancer,,1049,1383,1383,TCGA,,1383,Primary,0,Middle,A,,,True,TUMOR FREE,Alive,-25185,,68,8,27,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.15,Prostate,Resection,4,B860310F-6079-4C82-809E-44624E936F5F,1,,0,0.14521,[Not Available],7DC62C0F-B82D-417F-89A7-4CB984A9D304,4,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,V1,0.9,TCGA-V1-A9ZK,0:DiseaseFree,4,30,Prostate Adenocarcinoma,45.43,10/23/14,1383,,,,,NO,C61,9AD0F7C3-9DEB-427C-B8A3-007B874AB12A,50,4,,0.0276,0:LIVING,0.01,,45.43,Left,32,,,YES,,,,,TCGA-V1-A9ZK.9AD0F7C3-9DEB-427C-B8A3-007B874AB12A.pdf,Peripheral Zone,[Not Applicable],NO,,,6,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,68,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,8,No,NO,,N0,T2a,0,M0,C61.9,8490/3,81477,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-39-5016,White,LUSC,,0,0,,MSKCC,0,0,MALE,0,3.01,0.51,7,20,17,,,3850,,3850,3850,,0,0,3850,3850,,Malignant,44,,32,,,,19244,,,3850,3850,,,,3850,3850,,,3850,,,,,,,,TUMOR FREE,Alive,-16306,,,,519,,3850,3850,,,[Not Available],[Not Applicable],,,,,0.19,,,,,20,,1,0.31628,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5016,,,,,,,3850,,,,,,,,,33,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,44,,,,,,,,,,,,,,,,,,,,81483,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.1217,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.01864777,15.73807821,17.80631296,0.047974548180814,LUSC,,17.64405318,16.469332,Squamous Cell Carcinoma,-1.5052,10.5030209,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.66,0.6,9,10,15,,,376,BRCA_LumB,376,376,,0,0,376,376,,Invasive Carcinoma,34,,76,,,,22786,0,,376,376,,,,376,376,,,376,,,,,,,,TUMOR FREE,Alive,-25867,,,,96,,376,376,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,20,,1,0.22373,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A7T0,,,,,,,376,,,,,,,,,32,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,81485,,0.609499201,0,0,0,0,-0.479,0,,,Infiltrating Ductal Carcinoma,0.134956332,,0.084200626,0,0,1,,Negative,0.0095,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1012,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,Papilloma,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-V1-A9O7,,PRAD,,1,1,,V1,,0,MALE,1,2.07,0.32,7,8,9,HRD,NO,2499,,,2499,,1,1,819,819,prad_tcga,Malignant,24,BRCA2;CHEK2;RAD54L,46,,TCGA-V1-A9O7-01,0,5571,0,TCGA-V1-A9O7,819,819,Prostate Cancer,45,2425,,2499,TCGA,,819,Primary,0,Apex,A,ATM:1396-1397:CH/X:frameshift_variant,,True,,Alive,-22265,,60,9,37,PRAD,819,819,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.35,Prostate,Resection,5,CB4A8A9D-BF54-4A1D-970C-7AA6710C1FB9,5,,0,0.096232,[Not Available],40EBEB10-7390-44FC-9EF2-80D40D251018,4,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,V1,1.1,TCGA-V1-A9O7,1:Recurred/Progressed,5,7,Prostate Adenocarcinoma,26.91,7/23/14,2499,,Biochemical evidence of disease,,,YES,C61,0D2327CA-DE0A-4B74-BD53-6370ED222B96,710,8,,0.1288,0:LIVING,9.69,,82.1,Bilateral,12,,,YES,,,819,,TCGA-V1-A9O7.0D2327CA-DE0A-4B74-BD53-6370ED222B96.pdf,Peripheral Zone,[Not Applicable],NO,,,15,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,YES,No,R1,,60,Core needle biopsy,921,Progressive Disease,NO,YES,YES,YES,T3a,YES,9,No,NO,,N0,T2b,0,M0,C61.9,8140/3,81486,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,1.57,0.69,12,8,19,,,239,BRCA_Basal,207,239,,1,1,207,207,,Invasive Carcinoma,39,,52,,,,23901,0,,207,207,,,,207,239,,,207,,,,,,,,WITH TUMOR,Dead,-21501,239,,,59,,207,207,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,14,,0,0.57012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1P8,,,,,,,,Lung,Distant Metastasis,,,,,,,24,,,,,,,,,,,,,2010,207,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,81487,TRUE,0.693481325,0,0,0,0,0.2031,1,,,Infiltrating Ductal Carcinoma,0.184178034,,0.070709516,0,0,0,,Negative,-0.3325,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2655,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-98-A53A,Black or African American,LUSC,,0,0,,Washington University - Alabama,2,,MALE,2,1.86,0.7,16,13,15,,,552,,552,552,,2,2,552,552,,Malignant,44,,160,,,,16236,,,552,552,,,,552,552,,,552,,,,,,,,,Dead,-25662,552,,,451,,552,552,,,[Not Available],[Not Applicable],,,,,0.07,,,,,13,,0,0.36441,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A53A,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,81493,,0.754345094,,,,,,,,,,0.08069707,,0.02759154,,,,Stage IB,,0.4195,,,,,,,,,,,,,,,,0.1797,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.636277306718533,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.8699,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-63-A5MB,Unknown,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,3.15,0.65,22,26,26,,,3123,,3123,3123,,0,0,3123,3123,,Malignant,74,,212,,,,29100,,,3123,3123,,,,3123,3123,,,3123,,,,,,,,TUMOR FREE,Alive,-22930,,,,475,,3123,3123,,,[Not Available],[Not Applicable],,,,,0.29,,,,,16,,1,0.5344,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5MB,,,,,,,3123,,,,,,,,,33,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,81497,,0.790746404,,,,,,,,,,0.134858503,,0.050216201,,,,Stage IB,,0.9405,,,,,,,,,,,,,,,,0.0788,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,-0.463409707720679,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.5805,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-55-6983,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.05,0.27,0,1,1,,,2823,,2823,2823,,0,0,2823,2823,,Malignant,2,,7,,,,32791,,,2823,2823,,,,2823,2823,,,2823,,,,,,,,TUMOR FREE,Alive,,,,,141,,2823,2823,,,[Not Available],[Not Applicable],,,,,0.34,,,,,5,,0,0.10754,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6983,,,,,,,2823,,,,,,,,,7,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,81498,,1.249337191,,,,,,,,,,0.233193171,,0.176878994,,,,Stage IIB,,0.801,,,,,,,,,,,,,,,,0.3081,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,15.54278757,16.22723084,15.10140418,-0.158226328,LUAD,Adenocarcinoma,18.64361742,16.39323107,Adenocarcinoma,0.2518,13.90488572,0.6509,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-55-7914,White,LUAD,,1,1,,International Genomics Consortium,,1,FEMALE,1,1.92,0.56,9,8,9,,,187,,,187,,1,1,187,187,,Malignant,26,,26,,,,18278,,,187,187,,,,,187,,,187,,,,,,,,WITH TUMOR,Dead,-26105,187,,,230,,187,187,,,[Not Available],[Not Applicable],,,,,0.17,,,,,8,,0,0.19557,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7914,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,71,,,,,,,,,,,,,,,,,,,,81501,,0.758665024,,,,,,,,,,0.189931791,,0.129448536,,,,Stage IIA,,0.836,,,,,,,,,,,,,,,,-0.0915,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,15.11932873,15.03146468,16.35862834,-0.062109492,LUAD,Adenocarcinoma,18.34615171,16.18112283,Adenocarcinoma,0.0332,12.60617567,0.591,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Female,TCGA-98-8021,White,LUSC,,1,1,,Washington University - Alabama,1,0,FEMALE,1,3.53,0.41,7,4,9,,,937,,918,937,,1,1,918,918,,Malignant,20,,30,,,,0,,,918,918,,,,918,937,,,918,,,,,,,,TUMOR FREE,Alive,-27738,,,,1267,,918,918,,,[Not Available],[Not Applicable],,,,,0.39,,,,,10,,1,0.33741,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-8021,,,,,,,937,,Locoregional Recurrence,,,,,,,16,,,,,,,,,,,,,2011,918,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,81502,,0.673872261,,,,,,,,,,0.172537515,,0.097504546,,,,Stage IA,,-0.1735,,,,,,,,,,,,,,,,0.8099,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.613749588619414,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1077,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-85-8072,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.83,0.42,7,12,18,,,932,,932,932,,0,0,932,932,,Malignant,37,,20,,,,0,,,932,932,,,,932,932,,,932,,,,,,,,TUMOR FREE,Alive,-22069,,,,220,,932,932,,,[Not Available],[Not Applicable],,,,,0.37,,,,,16,,1,0.1806,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8072,,,,,,,932,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,81503,,0.620581189,,,,,,,,,,0.185122887,,0.055180536,,,,Stage IA,,1.6745,,,,,,,,,,,,,,,,0.0819,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.388420671554255,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.6993,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.69,0.28,12,16,13,,,1688,BRCA_LumA,1688,1688,,0,0,1688,1688,,Invasive Carcinoma,41,,29,,,,31934,0,,1688,1688,,,,1688,1688,,,1688,,,,,,,,TUMOR FREE,Alive,-19822,,,,64,,1688,1688,,,[Not Available],[Not Applicable],,,,,0.38,Breast,Resection/Excision,,,8,,0,0.40264,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JB,,,,,,,1688,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,81506,,1.684383609,0,0,0,0,0.4604,1,,,Infiltrating Ductal Carcinoma,0.164901769,,0.208427825,0,0,0,,Negative,0.9605,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1661,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GU-A42R,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.96,0.78,8,9,9,,,577,,,577,,1.0,1,91.0,91.0,,Malignant,26,,102,,,,26030.0,,,91.0,91,,,,,577,,,91.0,,,,,,,,WITH TUMOR,Dead,-25134,577,,,241.0,,91.0,91,,,[Not Available],[Not Applicable],,,,,0.06,,,,,6,,0,0.24645,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A42R,,,,,,,,Lung,Distant Metastasis,,,,,,,12,,,,,,,,,,,,,2012,91,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,68.0,,,,,,,,,,,,,,,,,,,,81509,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.71,11,7,11,,,382,BRCA_Her2,382,382,,0,0,382,382,,Invasive Carcinoma,29,,41,,,,17566,0,,382,382,,,,382,382,,,382,,,,,,,,TUMOR FREE,Alive,-16508,,,,64,,382,382,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,8,,0,0.18238,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12Z,,,,,,,382,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,81511,,-1.323004364,0,0,0,0,1.1834,1,,,Infiltrating Ductal Carcinoma,0.153275462,,0.091878349,0,0,0,,Negative,-1.472,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2678,1,0,H & E,0,0,,0,Scott  Bourne,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-62-A46R,White,LUAD,,0,0,,Thoraxklinik at University Hospital Heidelberg,2,2,FEMALE,2,2.88,0.42,4,6,10,,,1725,,1725,1725,,2,2,1725,1725,,Malignant,20,,58,,,,31580,,,1725,1725,,,,1725,1725,,,1725,,,,,,,,TUMOR FREE,Dead,-20063,1725,,,220,,1725,1725,,,[Not Available],[Not Applicable],,,,,0.13,,,,,21,,1,0.33433,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A46R,,,,,,,,,,,,,,,,31,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,81516,,1.212452367,,,,,,,,,,0.22981631,,0.085931896,,,,Stage IB,,0.5685,,,,,,,,,,,,,,,,-0.1073,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,,,,-0.178643345,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3345,,0.371,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,,,White,BRCA,,1,,,,1,0,FEMALE,1,1.81,0.57,12,10,14,,,1534,BRCA_Basal,1239,1534,,1,,1239,1239,,Invasive Carcinoma,36,,61,,,,20231,0,,1239,,,,,1239,1534,,,1239,,,,,,,,WITH TUMOR,Alive,-17774,,,,54,,1239,,,,[Not Available],[Not Applicable],,,,,0.34,Breast,Resection/Excision,,,10,,0,0.46214,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0SX,,,,,,,1534,,,,,,,,,20,,,,,,,,,,,,,2007,1239,,,,Stage IA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,81517,TRUE,1.74087503,0,0,0,0,0.831,1,,,Infiltrating Ductal Carcinoma,0.228293636,,0.112131788,0,0,0,,Negative,1.3195,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4784,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-60-2719,White,LUSC,,0,0,,Roswell Park,0,0,FEMALE,0,1.77,0.79,12,5,13,,,1297,,1297,1297,,0,0,1297,1297,,Malignant,30,,48,,,,21719,,,1297,1297,,,,1297,1297,,,1297,,,,,,,,TUMOR FREE,Alive,-30379,,,,300,,1297,1297,,,[Not Available],[Not Applicable],,,,,0.14,,,,,13,,0,0.38748,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2719,,,,,,,1297,,,,,,,,,16,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,83,,,,,,,,,,,,,,,,,,,,81520,,0.701201884,,,,,,,,,,0.171017091,,0.053572953,,,,Stage IB,,0.2495,,,,,,,,,,,,,,,,0.1709,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.480121816449619,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.0037,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,,,Unknown,BRCA,,1,1,,,1,1,FEMALE,1,2.02,0.42,1,3,3,,,1900,BRCA_LumA,1543,1900,,1,1,1543,1543,,Invasive Carcinoma,7,,22,,,,17208,0,,1543,1543,,,,1543,1900,,,1543,,,,,,,,WITH TUMOR,Dead,-16672,1900,,,30,,1543,1543,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,2,,0,0.031519,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-HN-A2OB,,,,,,,,Bone,Distant Metastasis,,,,,,,2,,,,,,,,,,,,,,1543,,,,Stage IIB,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,81528,,-0.358563829,0,0,0,0,0.1254,0,,,Infiltrating Lobular Carcinoma,0.148241539,,0.237456387,0,0,0,,Negative,-0.5135,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.7115,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Columnar Lesion,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-ZF-AA4T,White,BLCA,,1.0,1,,,,1,MALE,1.0,5.59,0.39,14,18,29,,,599,,,599,,1.0,1,511.0,511.0,,Malignant,61,,132,,,,20640.0,,,511.0,511,,,,,599,,,511.0,,,,,,,,WITH TUMOR,Dead,-23974,599,,,134.0,,511.0,511,,,[Not Available],[Not Applicable],,,,,0.23,,,,,18,,2,0.30909,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA4T,,,,,,,,Lung,Distant Metastasis,,,,,,,47,,,,,,,,,,,,,2008,511,,,,Stage IV,,,,,,,,[Unknown],,,,,,65.0,,,,,,,,,,,,,,,,,,,,81530,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-BR-A4QL,White,STAD,,0,0,,,2,2,,2,,,,,,,,491,,491,491,,2,2,491,491,,Malignant,,,,,,,30154,,,491,491,,,,491,491,,,491,,,,,,,,TUMOR FREE,Dead,-27668,491,,,2637,,491,491,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-A4QL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,81534,,,,,,,,,,,,,Grade 2,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4QL,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,0,0,1,Male,TCGA-18-3414,Asian,LUSC,,0,0,,Princess Margaret Hospital (Canada),,2,MALE,2,2.21,0.77,7,6,13,,,716,,,716,,2,2,716,716,,Malignant,26,,43,,,,16829,,,716,716,,,,,716,,,716,,,,,,,,TUMOR FREE,Dead,-26938,716,,,410,,716,716,,,[Not Available],[Not Applicable],,,,,0.31,,,,,10,,0,0.19083,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3414,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2005,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,81540,,0.645013244,,,,,,,,,,0.181816316,,0.059123754,,,,Stage IV,,0.433,,,,,,,,,,,,,,,,0.3546,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.60877159,15.02278949,14.54455947,-0.364842993799945,LUSC,Squamous Cell Carcinoma,17.70675183,16.05320752,Squamous Cell Carcinoma,0.5168,13.63897317,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,0,1,Female,TCGA-51-4079,Black or African American,LUSC,,0,0,,UNC,,,FEMALE,2,1.82,0.62,12,12,12,,,12,,,12,,2,2,12,12,,Malignant,36,,25,,,,22281,,,12,12,,,,,12,,,12,,,,,,,,,Dead,-26899,12,,,562,,12,12,,,[Not Available],[Not Applicable],,,,,0.31,,,,,7,,0,0.28763,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,UNC,,TCGA-51-4079,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,81547,,0.705355045,,,,,,,,,,0.207773807,,0.059589013,,,,Stage IB,,1.4485,,,,,,,,,,,,,,,,0.4848,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.232653190549115,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.2434,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.87,0.69,2,0,4,,,320,BRCA_LumA,320,320,,0,0,320,320,,Invasive Carcinoma,6,,7,,,,34292,0,,320,320,,,,320,320,,,320,,,,,,,,TUMOR FREE,Alive,-20694,,,,46,,320,320,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,6,,0,0.18017,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1PE,,,,,,,320,,,,,,,,,5,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,81548,,0.721893644,0,0,0,0,0.8997,1,,,Infiltrating Ductal Carcinoma,0.207624083,,0.197199067,0,0,0,,Negative,0.859,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5421,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,,1,1,Male,TCGA-HU-A4H8,Asian,STAD,,1,1,,,1,,,1,2.05,0.71,1,0,1,,,428,,354,428,,1,1,354,354,,Malignant,2,,24,,,,19083,,,354,354,,,,354,428,,,354,,,,,,,,WITH TUMOR,[Discrepancy],-28292,,,,1732,,354,354,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,2,,0,0.0094798,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4H8,,,,,,,428,,Distant Metastasis,,,,,,,1,,,,,,,,,,,,,2012,354,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,81549,,0.244013919,,,,,,,,,,0.024085479,Grade 2,0.0309082,,,,Stage IB,,-0.058,,,,,,,,,,,,,,,,-0.4429,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4H8,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.87,0.35,16,33,23,,,424,BRCA_LumB,424,424,,0,0,424,424,,Invasive Carcinoma,72,,73,,,,20233,0,,424,424,,,,424,424,,,424,,,,,,,,TUMOR FREE,Alive,-23642,,,,190,,424,424,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,7,,1,0.20787,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-AA17,,,,,,,424,,,,,,,,,25,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,81552,,1.938609193,0,0,0,0,-0.5438,1,,,Infiltrating Ductal Carcinoma,0.176512102,,0.135589106,0,0,0,,Negative,1.46,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1512,1,0,H & E,0,0,,0,Scott  Bourne,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-A4J7,Asian,STAD,,0,0,,,0,0,,0,3.58,0.41,0,13,15,,,989,,989,989,,0,0,989,989,,Malignant,28,,7,,,,17882,,,989,989,,,,989,989,,,989,,,,,,,,TUMOR FREE,Alive,-17932,,,,69,,989,989,,,[Not Available],[Not Applicable],,,,,0.43,Stomach,Unknown,,,11,,1,0.000262,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,Asterand,,TCGA-BR-A4J7,,,,,,,989,,,,,,,,,22,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,49,,,,,,,,,,,,,,,,,,,,81555,,0.400005453,,,,,,,,,,0.092778959,Grade 3,0.169442199,,,,Stage IIB,,0.653,,,,,,,,,,,,,,,,0.3361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4J7,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,1,,1,1,1,Male,TCGA-2H-A9GM,Unknown,ESCA,,1,1,,,,1,,1,,,,,,,,424,,,424,,1,1,367,367,,Malignant,,,,,,,32459,,,367,367,,,,,424,,,367,,,,,,,,WITH TUMOR,Dead,-19484,424,,,199,,367,367,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Erasmus MC,,TCGA-2H-A9GM,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2000,367,peritoneum,,,Stage IIB,,,,,,,,,,,,,,53,,,,,,,,,,,,,,,,,,,,81556,,,,,,,,,,,,,Grade 2,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,1,1,Female,TCGA-55-7911,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,1,4.05,0.23,2,3,7,,,537,,537,537,,0,0,515,515,,Malignant,12,,8,,,,21718,,,537,537,,,,537,537,,,515,,,,,,,,TUMOR FREE,Alive,-25746,,,,291,,537,537,,,[Not Available],[Not Applicable],,,,,0.04,,,,,11,,1,0.056378,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7911,,,,,,,537,,New Primary Tumor,,,,,,,17,,,,,,,,,,,,,2011,515,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,81559,,1.628698415,,,,,,,,,,0.205111505,,0.119994154,,,,Stage IA,,2.2325,,,,,,,,,,,,,,,,-0.0666,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12V (driver), K88*",,1,,"G12V (driver), K88*",,,,,0.171604772,LUAD,,,,Adenocarcinoma,0.7957,,1.3423,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-2F-A9KO,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.85,0.36,12,13,16,,,734,,,734,,1.0,1,651.0,651.0,,Malignant,41,,96,,,,23015.0,,,651.0,651,,,,,734,,,651.0,,,,,,,,WITH TUMOR,Dead,-23323,734,,,731.0,,651.0,651,,,[Not Available],[Not Applicable],,,,,0.12,,,,,17,,1,0.2661,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KO,,,,,,,,Liver,Distant Metastasis,,,,,,,36,,,,,,,,,,,,,2008,651,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,63.0,,,,,,,,,,,,,,,,,,,,81563,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.25,0.71,6,1,8,,,627,BRCA_LumA,627,627,,0,0,627,627,,Invasive Carcinoma,15,,40,,,,18229,0,,627,627,,,,627,627,,,627,,,,,,,,TUMOR FREE,Alive,-17930,,,,55,,627,627,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,17,,0,0.1442,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A26J,,,,,,,627,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,81566,,-0.018115264,0,0,0,0,0.156,1,,,Infiltrating Ductal Carcinoma,0.151493019,,0.129216111,0,0,0,,Negative,-0.3125,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.3396,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,None of the Above,Comedonecrosis,"DCIS (Clinging, High Grade), Comedonecrosis",,"DCIS (Clinging, High Grade)",0,"Invasive Carcinoma (Mixed Ductal-Lobular Features), Invasive Lobular Carcinoma (Classical/Pleomorphic)","Invasive Carcinoma (Mixed Ductal-Lobular Features), Invasive Lobular Carcinoma (Classical/Pleomorphic)",0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-YC-A89H,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,2.08,0.66,2,2,4,,,573,,573,573,,0.0,0,573.0,573.0,,Malignant,8,,26,,,,23865.0,,,573.0,573,,,,573,573,,,573.0,,,,,,,,TUMOR FREE,Alive,-28741,,,,2404.0,,573.0,573,,,[Not Available],[Not Applicable],,,,,0.02,,,,,4,,0,0.026546,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Spectrum Health,,TCGA-YC-A89H,,,,,,,573,,,,,,,,,4,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,78.0,,,,,,,,,,,,,,,,,,,,81569,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.93,0.38,2,1,3,,,3276,BRCA_Normal,3276,3276,,0,0,3276,3276,,Invasive Carcinoma,6,,5,,,,27710,0,,3276,3276,,,,3276,3276,,,3276,,,,,,,,TUMOR FREE,Alive,-16084,,,,517,,3276,3276,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.095842,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A25A,,,,,,,3276,,,,,,,,,5,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,81570,,0.64850351,0,0,0,0,0.5199,1,,,Infiltrating Lobular Carcinoma,0.164233607,,0.347326056,0,0,0,,Negative,0.183,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5678,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-37-3789,White,LUSC,,0,0,,Cureline,,0,MALE,0,2.02,0.62,13,8,22,,,13,,,13,,0,0,13,13,,Malignant,43,,61,,,,27149,,,13,13,,,,,13,,,13,,,,,,,,TUMOR FREE,Alive,-23782,,,,392,,13,13,,,[Not Available],[Not Applicable],,,,,0.06,,,,,9,,0,0.28264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-3789,,,,,,,13,,,,,,,,,14,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,81574,,0.837901972,,,,,,,,,,0.189035629,,0.037952897,,,,Stage IB,,0.9895,,,,,,,,,,,,,,,,0.394,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,,,,-0.0230241645580575,LUSC,,,,Squamous Cell Carcinoma,0.023,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.77,0.28,14,8,10,,,396,BRCA_Her2,396,396,,0,0,396,396,,Invasive Carcinoma,32,,151,,,,30120,0,,396,396,,,,396,396,,,396,,,,,,,,TUMOR FREE,Alive,-21613,,,,298,,396,396,,,[Not Available],[Not Applicable],,,,,0.44,Breast,Resection/Excision,,,7,,0,0.36711,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Metaplastic Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A8HP,,,,,,,396,,,,,,,,,17,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,81578,,1.320751977,0,0,0,0,0.2146,1,,,Metaplastic Carcinoma,0.165636535,,0.110818226,0,0,0,,Negative,0.8315,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3331,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (No Special Type), Invasive Ductal Carcinoma (Other Type)","Invasive Ductal Carcinoma (No Special Type), Invasive Ductal Carcinoma (Other Type)",0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-VQ-A8DT,Unknown,STAD,,1,1,,,1,0,,1,2.12,0.9,2,7,5,,,1484,,1376,1484,,1,1,1376,1376,,Malignant,14,,59,,,,32026,,,1376,1376,,,,1376,1484,,,1376,,,,,,,,WITH TUMOR,Alive,-15937,,,,231,,1376,1376,,,[Not Available],[Not Applicable],,,,,0.63,Stomach,Unknown,,,3,,0,0.047979,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8DT,,,,,,,1484,Liver,Distant Metastasis,,,,,,,4,,,,,,,,,,,,,2010,1376,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,43,,,,,,,,,,,,,,,,,,,,81580,,-0.464843971,,,,,,,,,,0.036898668,Grade 3,-0.000351423,,,,Stage IIIB,,-0.55,,,,,,,,,,,,,,,,-0.1789,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8DT,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.69,0.75,11,33,21,,,4894,BRCA_LumB,4894,4894,,0,0,4894,4894,,Invasive Carcinoma,65,,57,,,,19357,0,,4894,4894,,,,4894,4894,,,4894,,,,,,,,TUMOR FREE,Alive,-24046,,,,199,,4894,4894,,,[Not Available],[Not Applicable],,,,,0.28,Breast,Resection/Excision,,,12,,1,0.26322,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24H,,,,,,,4894,,,,,,,,,24,,,,,,,,,,,,,2001,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,81584,,0.87699043,0,0,0,0,-0.1076,1,,,Infiltrating Lobular Carcinoma,0.130341467,,0.064409284,0,0,0,,Negative,0.111,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.341,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,1,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Lymph Node",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-18-3421,White,LUSC,,0,0,,Princess Margaret Hospital (Canada),0,0,MALE,0,3.21,0.47,10,32,24,,,2645,,2645,2645,,0,0,2645,2645,,Malignant,66,,71,,,,20884,,,2645,2645,,,,2645,2645,,,2645,,,,,,,,TUMOR FREE,Alive,-23972,,,,422,,2645,2645,,,[Not Available],[Not Applicable],,,,,0.27,,,,,12,,1,0.39938,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3421,,,,,,,2645,,,,,,,,,31,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,81589,,0.47352763,,,,,,,,,,0.209526055,,0.05079018,,,,Stage IB,,1.1295,,,,,,,,,,,,,,,,0.0409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.142606626148558,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.3087,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-HU-A4HD,Asian,STAD,,0,0,,,,0,,0,2.73,0.53,13,15,19,,,1016,,,1016,,0,0,1016,1016,,Malignant,47,,294,,,,26530,,,1016,1016,,,,,1016,,,1016,,,,,,,,TUMOR FREE,Alive,-26699,,,,260,,1016,1016,,,[Not Available],[Not Applicable],,,,,0.17,Stomach,Unknown,,,20,,1,0.39014,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4HD,,,,,,,1016,,,,,,,,,39,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,81596,,0.234380558,,,,,,,,,,0.061425276,Grade 2,0.071720505,,,,Stage IIIA,,-0.4635,,,,,,,,,,,,,,,,0.1815,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4HD,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,1,0,1,1,Male,TCGA-KK-A7B3,,PRAD,348,1,1,,KK,1,0,MALE,1,3.92,0.5,3,8,1,HRD,NO,899,2-ETV1,294,899,,1,1,294,294,prad_tcga,Malignant,12,,38,,TCGA-KK-A7B3-01,0,5518,0,TCGA-KK-A7B3,294,294,Prostate Cancer,112,637,294,899,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),294,Primary,0,Apex|Middle|Base,A,,CHEK2,True,TUMOR FREE,Alive,-22830,,62,9,48,PRAD,294,294,,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.0,Prostate,Resection,4,C9F3E6AE-A78D-4455-B3F3-FE9AC92596E0,1,,1,0.047741,[Not Available],AAEB1D59-D6CE-4422-9639-F1E83C002D84,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,1.16666666667,TCGA-KK-A7B3,1:Recurred/Progressed,5,13,Prostate Adenocarcinoma,9.66,8/28/14,899,,Biochemical evidence of disease,,,YES,C61,45C687C3-52B9-4035-B916-777128B9AAE0,220,4,TUMOR FREE,0.0843,0:LIVING,0.1,,29.53,Bilateral,16,,,YES,486,2012,294,,TCGA-KK-A7B3.45C687C3-52B9-4035-B916-777128B9AAE0.pdf,Peripheral Zone,[Not Applicable],NO,,91-100%,17,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,"Yes, History of Prior Malignancy",R0,,62,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,9,No,NO,0,N0,T3a,0,M0,C61.9,8140/3,81597,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2ES,White,BLCA,,0.0,0,,,,1,MALE,1.0,2.01,0.55,4,2,10,,,1004,,,1004,,2.0,2,897.0,897.0,,Malignant,16,,44,,,,23501.0,,,1004.0,1004,,,,,1004,,,897.0,,,,,,,,WITH TUMOR,Dead,-31293,1004,,,659.0,,1004.0,1004,,,[Not Available],[Not Applicable],,,,,0.03,,,,,4,,0,0.28582,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2ES,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2009,897,,,,Stage II,,,,,,,,Progressive Disease,,,,,,85.0,,,,,,,,,,,,,,,,,,,,81607,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.19,0.42,20,24,23,,,907,BRCA_Basal,907,907,,0,0,907,907,,Invasive Carcinoma,67,,96,,,,27901,0,,907,907,,,,907,907,,,907,,,,,,,,TUMOR FREE,Alive,-15989,,,,96,,907,907,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,15,,1,0.41649,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Medullary Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1P4,,,,,,,907,,,,,,,,,28,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,81610,TRUE,1.395231819,0,0,0,0,0.7697,1,,,Medullary Carcinoma,0.174665071,,0.071132239,0,0,0,,Negative,1.4785,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4736,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,762,,762,762,,0,0,762,762,,Invasive Carcinoma,,,,,,,17066,0,,762,762,,,,762,762,,,762,,,,,,,,TUMOR FREE,Alive,-18535,,,,0,,762,762,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Peri (6-12 months since last menstrual period),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3TM,,,,,,,762,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,81612,,-0.08327249,0,0,0,0,0.2412,1,,,Infiltrating Lobular Carcinoma,0.119329044,,0.09104072,0,0,0,,Negative,-0.0705,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1866,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FP-8099,White,STAD,,0,0,,,0,0,,0,4.31,0.6,7,14,18,,,519,,519,519,,0,0,519,519,,Malignant,39,,50,,,,23541,,,519,519,,,,519,519,,,519,,,,,,,,TUMOR FREE,Alive,-29129,,,,189,,519,519,,,[Not Available],[Not Applicable],,,,,0.39,Stomach,Unknown,,,17,,2,0.16149,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,International Genomics Consortium,,TCGA-FP-8099,,,,,,,519,,,,,,,,,58,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,81625,,-0.173172381,,,,,,,,,,0.075053354,Grade 2,0.005229891,,,,Stage IIA,,-0.287,,,,,,,,,,,,,,,,0.3024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-8099,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-HC-8257,,PRAD,221,0,0,,HC,0,0,MALE,0,1.93,0.72,2,5,2,HRD,NO,726,1-ERG,726,726,,0,0,726,726,prad_tcga,Malignant,9,,75,8.6,TCGA-HC-8257-01,0,5438,0,TCGA-HC-8257,726,726,Prostate Cancer,,726,726,726,TCGA,,726,Primary,0,,A,,CHEK2,,TUMOR FREE,Alive,-25629,,70,7,61,PRAD,726,726,,0.0,[Not Available],[Not Applicable],50,R1,1,Matched,0.01,Prostate,Resection,3,aefd6142-dccb-45f5-a05e-cef002f81057,0,,0,0.073763,[Not Available],270447ca-19ee-45a2-982e-032325dab05f,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,9,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.63333333333,TCGA-HC-8257,0:DiseaseFree,2,18,Prostate Adenocarcinoma,23.85,10/1/12,726,,,,,,C61,ff35baf5-f38f-4458-8c20-c61d61c61c19,,0,WITH TUMOR,0.0697,0:LIVING,0.1,,23.85,Bilateral,22,,,YES,,2011,,,TCGA-HC-8257.ff35baf5-f38f-4458-8c20-c61d61c61c19.pdf,,[Not Applicable],,,81-90%,8,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.3,70,,,Complete Remission/Response,YES,NO,YES,NO,T3b,NO,7,No,YES,0,N1,,1,,C61.9,8550/3,81637,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-60-2713,White,LUSC,,1,,,Roswell Park,1,0,MALE,1,1.79,0.63,19,7,19,,,1731,,1356,1731,,1,,1356,1356,,Malignant,45,,55,,,,19364,,,1356,,,,,1356,1731,,,1356,,,,,,,,,Alive,-23630,,,,330,,1356,,,,[Not Available],[Not Applicable],,,,,0.2,,,,,11,,0,0.43752,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2713,,,,,,,1731,,,,,,,,,16,,,,,,,,,,,,,2006,1356,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,81645,,0.904516206,,,,,,,,,,0.294276772,,0.117472179,,,,Stage IB,,1.4705,,,,,,,,,,,,,,,,0.7227,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0637945185072763,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.0046,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,1.87,0.29,4,4,5,,,322,BRCA_Basal,,322,,1,1,301,301,,Invasive Carcinoma,13,,32,,,,22849,1,,301,301,,,,,322,,,301,,,,,,,,WITH TUMOR,Dead,-24841,322,,,123,,301,301,,,[Not Available],[Not Applicable],,,,,0.25,Skin,Resection/Excision,,,7,,0,0.1466,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Mayo,,TCGA-AR-A5QQ,,,,,,,,Lung,Distant Metastasis,,,,,,,6,,,,,,,,,,,,,2011,301,"Liver, bone, chest wall, adrenal glands",,,Stage IIIA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,81646,TRUE,1.431451327,0,0,0,0,0.1423,1,,,Other,0.213385166,,0.100035394,0,0,0,,[Not Available],2.158,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.6808,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A8I4,,PRAD,370,1,1,,KK,,0,MALE,1,2.35,0.4,7,9,12,ambiguous,NO,2259,1-ERG,,2259,,1,1,1162,1162,prad_tcga,Malignant,28,RAD51B,102,,TCGA-KK-A8I4-01,0,5520,0,TCGA-KK-A8I4,1162,1162,Prostate Cancer,70,1964,,2259,TCGA,No Evidence of Extraprostatic Extension,1162,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-23706,,64,7,28,PRAD,1162,1162,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.25,Prostate,Resection,4,CF98AC7D-6791-4B38-9902-000464888F25,11,Normal (no evidence of prostate cancer) [cM0],0,0.17368,[Not Available],9A8CAEF5-6543-4391-8A55-4999035693C5,3,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,KK,0.8,TCGA-KK-A8I4,1:Recurred/Progressed,3,31,Prostate Adenocarcinoma,71.02,8/28/14,2259,Bone,Distant Metastasis,,,YES,C61,633E280A-24F4-49FF-95B8-DDA5F447480E,120,19,WITH TUMOR,0.1893,0:LIVING,0.2,5,74.21,Left,37,,,YES,1798,2008,1162,,TCGA-KK-A8I4.633E280A-24F4-49FF-95B8-DDA5F447480E.pdf,Peripheral Zone,[Not Applicable],NO,70,86-95%,15,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,NO,No,R0,,64,Core needle biopsy,1155,Progressive Disease,NO,YES,YES,YES,T3b,NO,7,No,NO,0,N1,T2c,1,M0,C61.9,8140/3,81649,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-A5DR,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,,,,,,,,4,,4,4,,0,0,4,4,,Malignant,,,,,,,28658,,,4,4,,,,4,4,,,4,,,,,,,,TUMOR FREE,Alive,-29828,,,,1255,,4,4,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-A5DR,,,,,,,4,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,81650,,0.573556475,,,,,,,,,,0.142406326,,0.001787277,,,,Stage IA,,0.484,,,,,,,,,,,,,,,,0.5146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.560291307619943,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.3268,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Male,TCGA-KK-A8IJ,,PRAD,357,0,0,,KK,,0,MALE,1,1.96,0.57,2,2,2,HRP,NO,1559,8-other,,1559,,0,0,307,307,prad_tcga,Malignant,6,,49,,TCGA-KK-A8IJ-01,0,5534,0,TCGA-KK-A8IJ,1559,1559,Prostate Cancer,,167,,1559,TCGA,,307,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-21793,,59,7,36,PRAD,1559,1559,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.02,Prostate,Resection,4,F7C861D9-0AA5-4337-BABA-DCCBF6A5FA6C,1,Normal (no evidence of prostate cancer) [cM0],0,0.037395,[Not Available],98A9CE0E-4F02-4819-BC0C-C1A8D34E3DB6,3,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,KK,1.0,TCGA-KK-A8IJ,1:Recurred/Progressed,3,11,Prostate Adenocarcinoma,10.09,8/19/14,1559,"Other, specify",New Primary Tumor,,,NO,C61,F224443D-410F-4F1E-9CA0-04A652985616,240,2,,0.036,0:LIVING,0.1,5,51.22,Bilateral,13,No Evidence of Extraprostatic Extension,42,YES,1749,2009,307,Melanoma in situ of the right midback,TCGA-KK-A8IJ.F224443D-410F-4F1E-9CA0-04A652985616.pdf,Peripheral Zone,[Not Applicable],YES,42,76-85%,34,Prostate Adenocarcinoma Acinar Type,1,2009,[Unknown],,NO,No,R0,,59,Core needle biopsy,,,NO,YES,YES,YES,T3b,,7,No,,0,N1,T3a,1,M0,C61.9,8140/3,81651,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.36,0.47,5,7,9,,,375,BRCA_LumA,375,375,,0,0,375,375,,Invasive Carcinoma,21,,18,,,,24642,1,,375,375,,,,375,375,,,375,,,,,,,,TUMOR FREE,Alive,-25957,,,,111,,375,375,,,[Not Available],[Not Applicable],,,,,0.08,Skin,Resection/Excision,,,20,,1,0.2216,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A295,,,,,,,375,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,81653,,0.483561421,0,0,0,0,-0.0736,1,,,Infiltrating Lobular Carcinoma,0.114958494,,0.223979045,0,0,0,,Negative,-0.2275,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.3751,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.78,0,0,0,,,0,BRCA_Normal,0,0,,0,0,0,0,,Invasive Carcinoma,0,,0,,,,18876,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-24137,,,,315,,0,0,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,0,,0,0.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08H,,,,,,,0,,,,,,,,,0,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,81654,,0.512716493,0,0,0,0,-0.9335,1,,,Infiltrating Ductal Carcinoma,0.267236881,,0.345328858,0,0,0,,Negative,0.0295,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.745,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.44,0.37,7,8,13,,,385,BRCA_LumA,385,385,,0,0,385,385,,Invasive Carcinoma,28,,74,,,,29141,0,,385,385,,,,385,385,,,385,,,,,,,,TUMOR FREE,Alive,-18506,,,,48,,385,385,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,23,,1,0.24041,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12O,,,,,,,385,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,81656,,0.622227272,0,0,0,0,-0.6651,1,,,Infiltrating Ductal Carcinoma,0.198064033,,0.145037437,0,0,0,,Negative,-0.3915,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6125,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,0,No,0,Adipose Tissue,Comedonecrosis,"LCIS, Comedonecrosis",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-49-AARQ,Black or African American,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,3.38,0.52,7,13,19,,,6732,,6732,6732,,0,0,6732,6732,,Malignant,39,,89,,,,17979,,,6732,6732,,,,6732,6732,,,6732,,,,,,,,TUMOR FREE,Alive,-15065,,,,931,,6732,6732,,,[Not Available],[Not Applicable],,,,,0.13,,,,,15,,1,0.20846,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AARQ,,,,,,,6732,,,,,,,,,35,,,,,,,,,,,,,1996,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,41,,,,,,,,,,,,,,,,,,,,81660,,0.411885262,,,,,,,,,,0.141214609,,-0.030057726,,,,Stage I,,0.884,,,,,,,,,,,,,,,,-0.3715,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,-0.234158377,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1741,,-0.0539,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Female,TCGA-J2-8194,White,LUAD,,1,1,,ABS - Lahey Clinic,,0,FEMALE,1,3.38,0.44,2,2,3,,,724,,,724,,1,1,470,470,,Malignant,7,,3,,,,23502,,,470,470,,,,,724,,,470,,,,,,,,WITH TUMOR,Alive,-25441,,,,198,,470,470,,,[Not Available],[Not Applicable],,,,,0.05,,,,,14,,1,0.054234,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ABS - Lahey Clinic,,TCGA-J2-8194,,,,,,,724,,Distant Metastasis,,,,,,,28,,,,,,,,,,,,,2011,470,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,81667,,0.058338505,,,,,,,,,,0.209616415,,0.224795501,,,,Stage IIB,,0.378,,,,,,,,,,,,,,,,0.3107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),E540Rfs*32 (driver),1,,G12C (driver),E540Rfs*32 (driver),15.70108402,16.94671906,14.07014441,-0.607493465,LUAD,Adenocarcinoma,17.78046247,14.87820604,Adenocarcinoma,0.2769,12.77632636,-1.2582,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Male,TCGA-18-3410,,LUSC,,0,0,,Princess Margaret Hospital (Canada),,2,MALE,2,3.21,0.65,8,6,6,,,146,,,146,,2,2,146,146,,Malignant,20,,29,,,,24880,,,146,146,,,,,146,,,146,,,,,,,,TUMOR FREE,Dead,-29827,146,,,260,,146,146,,,[Not Available],[Not Applicable],,,,,0.1,,Resection/Excision,,,17,,1,0.23609,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3410,,,,,,,,,,,,,,,,19,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,[Not Applicable],,,,,,81,,,,,,,,,,,,,,,,,,,,81668,,1.300820855,,,,,,,,,,0.214713637,,0.049006564,,,,Stage IIB,,2.837,Not Answered,,,,,,,,,,,,,,,-0.0554,,,,,,Resection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.27390137,15.88572212,17.89439536,0.0534748155744754,LUSC,Squamous Cell Carcinoma,17.87948661,17.16371056,Squamous Cell Carcinoma,-0.4617,13.89788787,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-E7-A6MD,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.02,0.47,9,8,12,,,129,,,129,,0.0,0,129.0,129.0,,Malignant,29,,90,,,,25143.0,,,129.0,129,,,,,129,,,129.0,,,,,,,,,Alive,-24180,,,,628.0,,129.0,129,,,[Not Available],[Not Applicable],,,,,0.16,,,,,17,,1,0.23724,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A6MD,,,,,,,129,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,[Unknown],,,,,,66.0,,,,,,,,,,,,,,,,,,,,81669,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-NC-A5HH,White,LUSC,,0,0,,Washington University - CHUV,0,0,MALE,0,2.41,0.77,21,16,22,,,37,,37,37,,0,0,37,37,,Malignant,59,,186,,,,22762,,,37,37,,,,37,37,,,37,,,,,,,,TUMOR FREE,Alive,-19485,,,,477,,37,37,,,[Not Available],[Not Applicable],,,,,0.07,,,,,7,,1,0.67088,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HH,,,,,,,37,,,,,,,,,33,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,81681,,0.103780794,,,,,,,,,,0.103751335,,-0.038672941,,,,Stage IA,,-0.3995,,,,,,,,,,,,,,,,0.1903,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.724733291825213,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.3471,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.91,0.52,5,6,5,,,423,BRCA_LumA,423,423,,0,0,423,423,,Invasive Carcinoma,16,,30,,,,16893,0,,423,423,,,,423,423,,,423,,,,,,,,TUMOR FREE,Alive,-18237,,,,137,,423,423,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,6,,0,0.16571,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DK,,,,,,,423,,,,,,,,,7,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,81683,,1.642086484,0,0,0,0,0.3319,1,,,Infiltrating Ductal Carcinoma,0.172728965,,0.274613286,0,0,0,,Negative,0.8015,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6667,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-GC-A3YS,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.82,0.48,22,14,23,,,758,,,758,,0.0,0,758.0,758.0,,Malignant,59,,186,,,,27263.0,,,758.0,758,,,,,758,,,758.0,,,,,,,,TUMOR FREE,Alive,-22515,,,,337.0,,758.0,758,,,[Not Available],[Not Applicable],,,,,0.26,,,,,17,,2,0.58424,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A3YS,,,,,,,758,,,,,,,,,61,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,81688,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XJ-A83G,,PRAD,357,0,0,,XJ,0,0,MALE,0,1.88,0.5,9,11,1,ambiguous,NO,1461,5-SPOP,1461,1461,,0,0,1461,1461,prad_tcga,Malignant,21,,91,,TCGA-XJ-A83G-01,0,5624,0,TCGA-XJ-A83G,1461,1461,Prostate Cancer,,1126,1461,1461,TCGA,,1461,Primary,0,Apex|Middle,A,,,False,TUMOR FREE,Alive,,,51,7,40,PRAD,1461,1461,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.17,Prostate,Resection,4,853395AD-9986-4800-8C7F-070F5552A5F8,0,,0,0.11786,[Not Available],BF428D43-2DA6-43FC-BD62-7CBFF84E95EC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,XJ,0.9,TCGA-XJ-A83G,0:DiseaseFree,3,23,Prostate Adenocarcinoma,48.0,3/6/14,1461,,,,,,C61,F5DB0EA7-336E-4A5E-9BFD-3291A5DB4D3D,40,3,TUMOR FREE,0.092,0:LIVING,0.01,5,48.0,Bilateral,26,,,YES,1114,2010,,,TCGA-XJ-A83G.F5DB0EA7-336E-4A5E-9BFD-3291A5DB4D3D.pdf,Peripheral Zone,[Not Applicable],NO,,91-100%,4,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,,,51,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,7,No,NO,0,N0,T1c,0,,C61.9,8140/3,81690,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-50-8457,Black or African American,LUAD,,0,0,,University of Pittsburgh,0,0,FEMALE,0,2.03,0.6,3,2,4,,,1125,,1125,1125,,0,0,1125,1125,,Malignant,9,,13,,,,23582,,,1125,1125,,,,1125,1125,,,1125,,,,,,,,TUMOR FREE,Alive,-23055,,,,76,,1125,1125,,,[Not Available],[Not Applicable],,,,,0.52,,,,,3,,0,0.049373,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-8457,,,,,,,1125,,,,,,,,,5,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,81693,,1.316437458,,,,,,,,,,0.240423391,,0.205180859,,,,Stage IA,,1.0305,,,,,,,,,,,,,,,,0.2828,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.049131052,LUAD,,,,Adenocarcinoma,-0.204,,0.6332,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-BR-A4J8,White,STAD,,0,0,,,0,0,,0,2.6,0.59,2,4,8,,,411,,411,411,,0,0,411,411,,Malignant,14,,151,,,,21563,,,411,411,,,,411,411,,,411,,,,,,,,TUMOR FREE,Alive,-26048,,,,122,,411,411,,,[Not Available],[Not Applicable],,,,,0.55,Stomach,Unknown,,,24,,1,0.49587,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4J8,,,,,,,411,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,81695,,-0.420028953,,,,,,,,,,0.058172333,Grade 3,0.174361868,,,,Stage IIIB,,-0.645,,,,,,,,,,,,,,,,0.2593,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4J8,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.6,0.66,8,6,12,,,1156,BRCA_Her2,1156,1156,,0,0,1156,1156,,Invasive Carcinoma,26,,28,,,,17964,0,,1156,1156,,,,1156,1156,,,1156,,,,,,,,TUMOR FREE,Alive,-19114,,,,84,,1156,1156,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,18,,1,0.2345,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08B,,,,,,,1156,,,,,,,,,16,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,81697,,0.674133566,0,0,0,0,-0.1231,1,,,Infiltrating Ductal Carcinoma,0.121706951,,-0.006733223,0,0,0,,Negative,0.534,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1791,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.64,0.29,13,18,18,,,2558,BRCA_Basal,2558,2558,,0,0,2558,2558,,Invasive Carcinoma,49,,39,,,,23710,0,,2558,2558,,,,2558,2558,,,2558,,,,,,,,TUMOR FREE,Alive,-17141,,,,112,,2558,2558,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,11,,0,0.57022,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TS,,,,,,,2558,,,,,,,,,23,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,81699,TRUE,1.675228689,0,0,0,0,1.0737,0,,,Infiltrating Ductal Carcinoma,0.163852259,,0.174588809,0,0,0,,Negative,0.545,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3221,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Sclerosing Adenosis,0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Sclerosing Adenosis,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,881,,881,881,,0,0,881,881,,Invasive Carcinoma,,,,,,,17493,0,,881,881,,,,881,881,,,881,,,,,,,,TUMOR FREE,Alive,-24017,,,,9,,881,881,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08C,,,,,,,881,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,81703,,-0.4844354,0,0,0,0,-1.9637,1,,,Infiltrating Ductal Carcinoma,0.096833411,,0.097376407,0,0,0,,Negative,-0.973,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1178,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Female,TCGA-XF-AAMX,Black or African American,BLCA,,0.0,0,,,2,2,FEMALE,2.0,2.61,0.86,31,38,32,,,206,,206,206,,2.0,2,206.0,206.0,,Malignant,101,,405,,,,26223.0,,,206.0,206,,,,206,206,,,206.0,,,,,,,,TUMOR FREE,Dead,-31884,206,,,460.0,,206.0,206,,,[Not Available],[Not Applicable],,,,,0.15,,,,,9,,1,0.52426,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMX,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2006,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,87.0,,,,,,,,,,,,,,,,,,,,81708,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-33-4533,Black or African American,LUSC,,0,0,,Johns Hopkins,0,0,FEMALE,0,4.08,0.7,9,11,12,,,4068,,4068,4068,,0,0,4068,4068,,Malignant,32,,218,,,,20460,,,4068,4068,,,,4068,4068,,,4068,,,,,,,,TUMOR FREE,Alive,-28001,,,,402,,4068,4068,,,[Not Available],[Not Applicable],,,,,0.3,,,,,8,,2,0.50033,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4533,,,,,,,4068,,,,,,,,,47,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,81715,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.6873,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.540159886413279,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.33,0.42,2,1,5,,,476,BRCA_LumA,476,476,,0,0,476,476,,Invasive Carcinoma,8,,3,,,,21578,0,,476,476,,,,476,476,,,476,,,,,,,,TUMOR FREE,Alive,-22199,,,,64,,476,476,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,16,,1,0.026389,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DP,,,,,,,476,,,,,,,,,26,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,81717,,0.259455488,0,0,0,0,0.4409,0,,,Infiltrating Lobular Carcinoma,0.1866426,,0.185965786,0,0,0,,Negative,0.15,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.5748,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,"Columnar Lesion, Sclerosing Adenosis",0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"Columnar Lesion, Sclerosing Adenosis",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-DK-A1A6,White,BLCA,,0.0,0,,,,0,MALE,0.0,,,,,,,,2020,,,2020,,0.0,0,2020.0,2020.0,,Malignant,,,,,,,20123.0,,,2020.0,2020,,,,,2020,,,2020.0,,,,,,,,TUMOR FREE,Alive,-19554,,,,371.0,,2020.0,2020,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1A6,,,,,,,2020,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,53.0,,,,,,,,,,,,,,,,,,,,81718,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-22-1000,White,LUSC,,1,,,Mayo Clinic - Rochester,1,1,MALE,1,1.78,0.18,3,2,4,,,454,,263,454,,1,,263,263,,Malignant,9,,13,,,,20009,,,263,,,,,263,454,,,263,,,,,,,,WITH TUMOR,Dead,-27901,454,,,99,,263,,,,[Not Available],[Not Applicable],,,,,0.08,,,,,10,,0,0.31719,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-1000,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2000,263,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,81721,,1.400998196,,,,,,,,,,0.282111255,,0.180635158,,,,Stage IB,,1.38,,,,,,,,,,,,,,,,0.9733,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0288497214638197,LUSC,,,,Squamous Cell Carcinoma,1.8561,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,0,0.0,1.0,Female,TCGA-DK-A3IL,White,BLCA,,0.0,0,,,,2,FEMALE,2.0,3.06,0.74,7,7,8,,,413,,,413,,2.0,2,413.0,413.0,,Malignant,22,,23,,,,26753.0,,,413.0,413,,,,,413,,,413.0,,,,,,,,TUMOR FREE,Dead,-29047,413,,,243.0,,413.0,413,,,[Not Available],[Not Applicable],,,,,0.1,,,,,16,,1,0.14418,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IL,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,79.0,,,,,,,,,,,,,,,,,,,,81723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-33-A4WN,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,2.07,0.39,8,9,13,,,143,,143,143,,2,2,143,143,,Malignant,30,,107,,,,22145,,,143,143,,,,143,143,,,143,,,,,,,,TUMOR FREE,Dead,-22268,143,,,279,,143,143,,,[Not Available],[Not Applicable],,,,,0.12,,,,,4,,0,0.24741,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-A4WN,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,81727,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.1501,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.645979844947283,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-DK-A3IM,White,BLCA,,1.0,1,,,1,1,MALE,1.0,2.8,0.83,17,15,28,,,248,,201,248,,1.0,1,201.0,201.0,,Malignant,60,,107,,,,34387.0,,,201.0,201,,,,201,248,,,201.0,,,,,,,,WITH TUMOR,Dead,-28106,248,,,117.0,,201.0,201,,,[Not Available],[Not Applicable],,,,,0.43,,,,,12,,1,0.46791,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IM,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,30,,,,,,,,,,,,,2011,201,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,81729,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.51,11,15,16,,,1919,BRCA_LumA,1919,1919,,0,0,1919,1919,,Invasive Carcinoma,42,,29,,,,20398,0,,1919,1919,,,,1919,1919,,,1919,,,,,,,,TUMOR FREE,Alive,-17465,,,,93,,1919,1919,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,3,,0,0.22989,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0AZ,,,,,,,1919,,,,,,,,,14,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,81734,,-0.016003944,0,0,0,0,0.2187,0,,,Infiltrating Ductal Carcinoma,0.171865325,,0.281066126,0,0,0,,Negative,-0.481,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.934,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.83,3,4,1,,,448,BRCA_LumA,448,448,,0,0,448,448,,Invasive Carcinoma,8,,9,,,,28221,1,,448,448,,,,448,448,,,448,,,,,,,,TUMOR FREE,Alive,-31748,,,,43,,448,448,,,[Not Available],[Not Applicable],,,,,0.02,Skin,Resection/Excision,,,4,,0,0.12011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XG,,,,,,,448,,,,,,,,,3,,,,,,,,,,,,,2010,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,86,,,,,,,,,,,,,,,,,,,,81735,,-1.520707977,0,0,0,0,0.0013,1,,,Infiltrating Ductal Carcinoma,0.161331014,,0.080597722,0,0,0,,Negative,-0.9615,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.2462,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,"Adipose Tissue, Skin",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.27,0.49,15,8,16,,,345,BRCA_LumB,345,345,,0,0,345,345,,Invasive Carcinoma,39,,75,,,,18520,0,,345,345,,,,345,345,,,345,,,,,,,,TUMOR FREE,Alive,,,,,80,,345,345,,,[Not Available],[Not Applicable],,,,,0.37,Breast,Resection/Excision,,,15,,1,0.25216,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HG,,,,,,,345,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,81739,,1.472208985,0,0,0,0,-2.144,1,,,Infiltrating Ductal Carcinoma,0.159907422,,0.095619422,0,0,0,,Negative,0.394,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1255,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.54,0.69,1,2,4,,,431,BRCA_LumB,431,431,,0,0,431,431,,Invasive Carcinoma,7,,29,,,,26828,0,,431,431,,,,431,431,,,431,,,,,,,,TUMOR FREE,Alive,-28444,,,,1127,,431,431,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,15,,0,0.57943,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1J8,,,,,,,431,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,81742,,,0,0,0,0,-0.263,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,501,BRCA_Normal,501,501,,0,0,501,501,,Invasive Carcinoma,,,,,,,30896,0,,501,501,,,,501,501,,,501,,,,,,,,TUMOR FREE,Alive,-18514,,,,12,,501,501,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A1G6,,,,,,,501,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,81743,TRUE,-0.155077366,0,0,0,1,1.0943,0,,,Infiltrating Ductal Carcinoma,0.155531175,,0.220981836,0,0,0,,Negative,-0.5765,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0663,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,"Radial Scar/Complex Sclerosing Lesion, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Radial Scar/Complex Sclerosing Lesion, UDH",0,1,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.0,0.7,4,0,6,,,1359,BRCA_LumB,1359,1359,,0,0,1359,1359,,Invasive Carcinoma,10,,17,,,,26729,0,,1359,1359,,,,1359,1359,,,1359,,,,,,,,TUMOR FREE,Alive,-27837,,,,42,,1359,1359,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,28,,1,0.4691,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14O,,,,,,,1359,,,,,,,,,21,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,81750,,-0.388747125,0,0,0,0,-0.1063,1,,,Infiltrating Ductal Carcinoma,0.14860237,,0.046558332,0,0,0,,Negative,-1.2305,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1027,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1604,,1604,1604,,0,0,1604,1604,,Invasive Carcinoma,,,,,,,21379,0,,1604,1604,,,,1604,1604,,,1604,,,,,,,,TUMOR FREE,Alive,-16887,,,,108,,1604,1604,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LS,,,,,,,1604,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,81752,TRUE,0.388728247,0,0,0,0,1.7422,1,,,Infiltrating Ductal Carcinoma,0.071767726,,0.148932891,0,0,0,,Negative,-1.7385,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1133,1,0,H & E,0,0,,0,Scott  Bourne,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Female,TCGA-BR-A4IZ,Asian,STAD,,0,0,,,,2,,2,2.0,0.83,0,0,0,,,273,,,273,,2,2,273,273,,Malignant,0,,4,,,,18801,,,273,273,,,,,273,,,273,,,,,,,,TUMOR FREE,Dead,-16695,273,,,18,,273,273,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,0,,0,0.000146,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4IZ,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,45,,,,,,,,,,,,,,,,,,,,81758,,0.151300409,,,,,,,,,,0.171787772,Grade 3,0.248809828,,,,Stage IIIB,,0.192,,,,,,,,,,,,,,,,0.9386,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4IZ,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.66,0.84,5,1,6,,,839,BRCA_LumA,839,839,,0,0,839,839,,Invasive Carcinoma,12,,23,,,,31605,0,,839,839,,,,839,839,,,839,,,,,,,,TUMOR FREE,Alive,-23387,,,,35,,839,839,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,14,,0,0.41405,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XA,,,,,,,839,,,,,,,,,13,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,81759,,0.088014881,0,0,0,0,-0.1202,1,,,Infiltrating Ductal Carcinoma,0.153186647,,0.046069975,0,0,0,,Negative,-0.573,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2142,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,4.42,0.27,2,5,8,,,411,BRCA_Basal,411,411,,0,0,411,411,,Invasive Carcinoma,15,,8,,,,18630,0,,411,411,,,,411,411,,,411,,,,,,,,TUMOR FREE,Alive,-29966,,,,81,,411,411,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,19,,2,0.17115,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A131,,,,,,,411,,,,,,,,,58,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,81760,TRUE,0.072805297,0,0,0,0,1.0748,1,,,Infiltrating Ductal Carcinoma,0.18747941,,0.162036371,0,0,0,,Negative,-0.6,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7103,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-92-7341,White,LUSC,,0,0,,Washington University - St. Louis,,0,MALE,0,2.88,0.51,13,15,19,,,106,,,106,,0,0,106,106,,Malignant,47,,60,,,,19697,,,106,106,,,,,106,,,106,,,,,,,,WITH TUMOR,Alive,-26134,,,,228,,106,106,,,[Not Available],[Not Applicable],,,,,0.51,,,,,19,,1,0.42433,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - St. Louis,,TCGA-92-7341,,,,,,,106,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Partial Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,81772,,0.44823594,,,,,,,,,,0.215303225,,0.053742401,,,,Stage IB,,0.3465,,,,,,,,,,,,,,,,0.6395,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.539816712628361,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6388,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,81775,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-IN-7808,White,STAD,,1.0,1,,,,1,,1.0,2.81,0.3,8,9,11,,,105,,,105,,1.0,1,105,105,,Malignant,28,,29,,,,27103.0,0,,105,105,,,,,105,,,105,,,,,,,,WITH TUMOR,Dead,-21569,105,,,133.0,,105,105,,,[Not Available],[Not Applicable],,,,,0.31,Stomach,Resection,,,28,,1,0.30144,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,University of Pittsburgh,,TCGA-IN-7808,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,2011,,,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,81776,,1.84652538,,,,,,,,,,0.046904182,Grade 3,0.106136684,,,,Unknown,,1.291,,,,,,,,,,,,,,,,-0.4253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-IN-7808,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,,0,0,0,Male,TCGA-D7-A4YU,White,STAD,,0,0,,,,0,,0,3.44,0.33,5,4,9,,,500,,,500,,0,0,500,500,,Malignant,18,,78,,,,16490,,,500,500,,,,,500,,,500,,,,,,,,WITH TUMOR,Alive,-26781,,,,290,,500,500,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,26,,1,0.21378,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A4YU,,,,,,,500,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Stable Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,81791,,1.569030411,,,,,,,,,,0.101997957,Grade 3,0.121342183,,,,Stage IIIB,,1.6595,,,,,,,,,,,,,,,,-0.0633,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A4YU,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Male,TCGA-KK-A6DY,,PRAD,315,0,0,,KK,,0,MALE,0,1.93,0.44,7,4,6,ambiguous,NO,4295,1-ERG,,4295,,0,0,4295,4295,prad_tcga,Malignant,17,BRCA2,28,4.9,TCGA-KK-A6DY-01,0,5498,0,TCGA-KK-A6DY,4295,4295,Prostate Cancer,,903,,4295,TCGA,,4295,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-18420,,50,7,36,PRAD,4295,4295,,0.0,[Not Available],[Not Applicable],35,R1,1,Matched,0.08,Prostate,Resection,3,FE3A9D45-8B34-407F-B915-BF80B49629D1,5,,0,0.10845,[Not Available],B1BDAF2D-7D84-4409-9427-5390150BB96D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,KK,1.16666666667,TCGA-KK-A6DY,0:DiseaseFree,2,15,Prostate Adenocarcinoma,141.1,3/27/14,4295,,,,,NO,C61,3C4C5AAE-6F27-4ECE-8F72-91DC9EF477C0,80,7,WITH TUMOR,0.0995,0:LIVING,0.1,,141.1,Bilateral,16,,,YES,4010,2002,,,TCGA-KK-A6DY.3C4C5AAE-6F27-4ECE-8F72-91DC9EF477C0.pdf,Peripheral Zone,[Not Applicable],NO,,31-40%,12,Prostate Adenocarcinoma Acinar Type,1,2002,[Not Applicable],,NO,No,R1,,50,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,81792,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.7,0.58,17,15,7,,,0,BRCA_Her2,0,0,,0,0,0,0,,Invasive Carcinoma,39,,85,,,,20109,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-27729,,,,269,,0,0,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,10,,0,0.41073,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A094,,,,,,,0,,,,,,,,,14,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,81795,,1.069025789,0,0,0,0,0.0318,1,,,Infiltrating Ductal Carcinoma,0.235156203,,0.116846875,0,0,0,,Negative,1.391,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2231,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.54,0.77,13,16,26,,,368,BRCA_Basal,368,368,,0,0,368,368,,Invasive Carcinoma,55,,325,,,,29659,1,,368,368,,,,368,368,,,368,,,,,,,,TUMOR FREE,Alive,-22966,,,,0,,368,368,,,[Not Available],[Not Applicable],,,,,0.11,Not Specific/Unknown,Core Biopsy,,,14,,1,0.5015,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Carcinoma NOS,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A5ZV,,,,,,,368,,,,,,,,,39,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,81796,,-0.5563135,0,0,0,0,-0.1923,1,,,Infiltrating Carcinoma (NOS),0.168453986,,0.039550591,0,0,0,,Negative,-0.897,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.2759,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9O9,,PRAD,,0,0,,V1,0,0,MALE,0,1.93,0.55,3,8,4,ambiguous,NO,2870,,2870,2870,,0,0,2870,2870,prad_tcga,Malignant,15,BRCA2;FANCL,50,,TCGA-V1-A9O9-01,0,5572,0,TCGA-V1-A9O9,2870,2870,Prostate Cancer,,-53,2870,2870,TCGA,,2870,Primary,0,Apex,A,,,True,,Alive,-20805,,56,8,34,PRAD,2870,2870,,0.0,[Not Available],[Not Applicable],36,,1,Matched,0.16,Prostate,Resection,3,4C3D7972-4A67-4858-911F-57E20643AEBB,0,,0,0.074708,[Not Available],F6935F67-5C62-4774-8346-711F36F3B547,5,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,V1,1.16666666667,TCGA-V1-A9O9,0:DiseaseFree,4,18,Prostate Adenocarcinoma,94.28,7/23/14,2870,,,,,NO,C61,6AEA4F7C-2680-4BCE-BB38-AF8DF5ED7DE8,80,1,,0.0731,0:LIVING,5.04,,94.28,Bilateral,22,,,YES,,,,,TCGA-V1-A9O9.6AEA4F7C-2680-4BCE-BB38-AF8DF5ED7DE8.pdf,Peripheral Zone,[Not Applicable],NO,,,12,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R0,,56,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,8,No,NO,,N0,,0,M0,C61.9,8140/3,81803,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2ES,White,BLCA,,0.0,0,,,,1,MALE,1.0,2.01,0.55,4,2,10,,,1004,,,1004,,2.0,2,897.0,897.0,,Malignant,16,,44,,,,23501.0,,,1004.0,1004,,,,,1004,,,897.0,,,,,,,,WITH TUMOR,Dead,-31293,1004,,,659.0,,1004.0,1004,,,[Not Available],[Not Applicable],,,,,0.03,,,,,4,,0,0.28582,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2ES,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2009,897,,,,Stage II,,,,,,,,Progressive Disease,,,,,,85.0,,,,,,,,,,,,,,,,,,,,81809,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-HU-A4GN,Asian,STAD,,1,,,,1,0,,1,2.0,0.36,0,0,0,,,912,,168,912,,1,,168,168,,Malignant,0,,10,,,,21635,,,168,,,,,168,912,,,168,,,,,,,,TUMOR FREE,Alive,-22288,,,,1630,,168,,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Unknown,,,0,,0,0.000404,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4GN,,,,,,,912,"Other, specify",,,,,,,,0,,,,,,,,,,,,,2011,168,thyroid,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,81811,,0.58980198,,,,,,,,,,0.046692934,Grade 2,0.030391415,,,,Stage IIA,,0.335,,,,,,,,,,,,,,,,0.0052,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GN,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1.0,1,1,1.0,1.0,Female,TCGA-5N-A9KM,White,BLCA,,1.0,,,,1,1,FEMALE,1.0,1.98,0.72,12,9,13,,,530,,276,530,,1.0,,276.0,276.0,,Malignant,34,,93,,,,28131.0,,,276.0,,,,,276,530,,,276.0,,,,,,,,WITH TUMOR,Dead,-26906,530,,,293.0,,276.0,,,,[Not Available],[Not Applicable],,,,,0.11,,,,,6,,0,0.16707,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University Hospital Erlangen,,TCGA-5N-A9KM,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2012,276,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,81819,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-8676,White,STAD,,0,0,,,0,0,,0,,,,,,,,229,,229,229,,0,0,229,229,,Malignant,,,,,,,27655,,,229,229,,,,229,229,,,229,,,,,,,,TUMOR FREE,Alive,-21619,,,,121,,229,229,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8676,,,,,,,229,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,81820,,,,,,,,,,,,,Grade 3,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8676,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-HC-8264,,PRAD,244,0,0,,HC,,0,MALE,0,1.98,0.67,4,8,3,ambiguous,NO,48,8-other,,48,,0,0,48,48,prad_tcga,Malignant,15,BRCA2,34,13.4,TCGA-HC-8264-01,0,5444,0,TCGA-HC-8264,48,48,Prostate Cancer,,,,48,TCGA,,48,Primary,0,,B,,,,WITH TUMOR,Alive,-22177,,60,9,63,PRAD,48,48,,0.0,[Not Available],[Not Applicable],38,R1,1,Matched,0.02,Prostate,Resection,4,6b519959-9c2d-4009-a9c6-bd2d22be5431,1,,0,0.044794,[Not Available],8740555d-8bf0-40ba-b868-99eef27662a4,5,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,14,,Acinar Adenocarcinoma,[Not Available],0.5,HC,1.3,TCGA-HC-8264,0:DiseaseFree,5,17,Prostate Adenocarcinoma,1.58,1/25/13,48,,,,,,C61,147b5116-ae7b-4c43-8e6d-3a0064f28902,,2,WITH TUMOR,0.0698,0:LIVING,,,1.58,Bilateral,17,,,YES,,2011,,,TCGA-HC-8264.147b5116-ae7b-4c43-8e6d-3a0064f28902.pdf,,[Not Applicable],,,21-30%,2,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Applicable],,,No,R1,0.7,60,Core needle biopsy,,,YES,NO,YES,NO,T3b,,9,No,,0,N1,,1,,C61.9,8550/3,81821,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-75-7031,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),,0,FEMALE,0,3.86,0.49,11,13,20,,,,,,,,0,0,,,,Malignant,44,,53,,,,34466,,,,,,,,,,,,,,,,,,,,TUMOR FREE,Alive,,,,,278,,,,,,[Not Available],[Not Applicable],,,,,0.18,,,,,15,,1,0.14001,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-7031,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,[Not Available],,,,,,,,,,,,,,,,,,,,,,,,,,81825,,1.10314842,,,,,,,,,,0.216923471,,0.065411975,,,,Stage IB,,1.045,,,,,,,,,,,,,,,,-0.312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.210507693,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.9942,,0.9344,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.09,0.5,8,6,10,,,1042,BRCA_Her2,1042,1042,,0,0,1042,1042,,Invasive Carcinoma,24,,48,,,,34489,0,,1042,1042,,,,1042,1042,,,1042,,,,,,,,TUMOR FREE,Alive,-19643,,,,139,,1042,1042,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,16,,1,0.18085,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14V,,,,,,,1042,,,,,,,,,28,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,81826,,-0.235838281,0,0,0,0,-0.0126,1,,,Infiltrating Ductal Carcinoma,0.107403671,,0.068267098,0,0,0,,Negative,-1.104,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2852,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Female,TCGA-FD-A6TF,White,BLCA,,0.0,0,,,,2,FEMALE,2.0,3.13,0.31,8,14,19,,,69,,,69,,2.0,2,69.0,69.0,,Malignant,41,,99,,,,28195.0,,,69.0,69,,,,,69,,,69.0,,,,,,,,TUMOR FREE,Dead,-29317,69,,,201.0,,69.0,69,,,[Not Available],[Not Applicable],,,,,0.1,,,,,18,,1,0.33075,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TF,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,80.0,,,,,,,,,,,,,,,,,,,,81831,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Male,TCGA-77-6842,White,LUSC,,1,,,Prince Charles Hospital,,,MALE,1,3.14,0.48,8,8,12,,,899,,,899,,1,,201,201,,Malignant,28,,34,,,,16406,,,201,,,,,,899,,,201,,,,,,,,,Dead,-28861,899,,,480,,201,,,,[Not Available],[Not Applicable],,,,,0.26,,,,,18,,1,0.26955,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-6842,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2000,201,,,,Stage IIB,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,81834,,1.332679357,,,,,,,,,,0.199709595,,0.139791982,,,,Stage IIB,,2.855,,,,,,,,,,,,,,,,0.2927,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.26567041,16.44509192,17.62105899,-0.0125629274908705,LUSC,Squamous Cell Carcinoma,17.96923512,16.68035753,Squamous Cell Carcinoma,-0.5956,13.80189757,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-55-8089,White,LUAD,,0,0,,International Genomics Consortium,2,2,MALE,2,1.8,0.33,7,7,10,,,702,,702,702,,2,2,702,702,,Malignant,24,,30,,,,23918,,,702,702,,,,702,702,,,702,,,,,,,,TUMOR FREE,Dead,-20576,702,,,1592,,702,702,,,[Not Available],[Not Applicable],,,,,0.25,,,,,10,,0,0.35801,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8089,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,81836,,1.631292111,,,,,,,,,,0.287656104,,0.141042559,,,,Stage IA,,2.2205,,,,,,,,,,,,,,,,0.3275,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,,,,0.411248607,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.7015,,1.7864,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HF-7132,,STAD,,0,0,,,0,0,,0,2.11,0.39,2,0,3,,,2351,,2351,2351,,0,0,2351,2351,,Malignant,5,,9,,,,23463,,,2351,2351,,,,2351,2351,,,2351,,,,,,,,TUMOR FREE,Alive,,,,,1689,,2351,2351,,,[Not Available],[Not Applicable],,,,,0.26,Stomach,Unknown,,,5,,0,0.072182,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G2,,Ontario Institute for Cancer Research (OICR),,TCGA-HF-7132,,,,,,,2351,,,,,,,,,5,,,,,,,,,,,,,2006,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,81848,,1.089548907,,,,,,,,,,0.104802105,Grade 2,0.082957678,,,,Stage II,,1.106,,,,,,,,,,,,,,,,0.256,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HF-7132,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0,0,0,0,0,Male,TCGA-CH-5767,White,PRAD,108,0,0,,CH,0,0,MALE,0,1.98,0.83,3,3,2,HRP,NO,458,8-other,458,458,,0,0,458,458,prad_tcga,Malignant,8,,47,11.6,TCGA-CH-5767-01,9,5257,0,TCGA-CH-5767,458,458,Prostate Cancer,,377,458,458,TCGA,,458,Primary,0,,A,,,,TUMOR FREE,Alive,-24287,,66,7,46,PRAD,458,458,WHITE,0.187221263,[Not Available],[Not Applicable],44,R0,1,Matched,0.01,Prostate,Resection,4,a87e6352-c469-484d-87fc-fabdba237d01,1,,0,0.053292,[Not Available],8dc53431-44ab-485e-b4e6-c3d06509506d,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,CH,1.46666666667,TCGA-CH-5767,0:DiseaseFree,3,9,Prostate Adenocarcinoma,15.05,3/16/12,458,,,,,NO,C61,237374e0-5b18-407c-ae42-898a95c14fa2,,1,TUMOR FREE,0.0836,0:LIVING,0.04,,15.05,Bilateral,11,,,YES,,2007,,,TCGA-CH-5767.237374e0-5b18-407c-ae42-898a95c14fa2.pdf,Peripheral Zone,[Not Applicable],NO,,46-55%,19,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,0.4,66,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,81852,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.13,0.38,1,2,3,,,792,BRCA_LumA,792,792,,0,0,792,792,,Invasive Carcinoma,6,,23,,,,32670,0,,792,792,,,,792,792,,,792,,,,,,,,TUMOR FREE,Alive,-21608,,,,71,,792,792,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,18,,2,0.074053,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A66N,,,,,,,792,,,,,,,,,59,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,81853,,,0,0,0,0,0.4798,1,,,Infiltrating Lobular Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,Asian,BRCA,,0,0,,,,0,FEMALE,0,1.87,0.23,1,1,0,,,3283,BRCA_LumA,,3283,,0,0,3283,3283,,Invasive Carcinoma,2,,4,,,,21724,0,,3283,3283,,,,,3283,,,3283,,,,,,,,TUMOR FREE,Alive,-20075,,,,224,,3283,3283,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,5,,0,0.12617,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CR,,,,,,,3283,,,,,,,,,4,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,81856,,1.748479793,0,0,0,0,0.6834,0,,,Infiltrating Lobular Carcinoma,0.160101613,,0.240625113,0,0,0,,Close,0.7005,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3089,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Apocrine Metaplasia,0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Apocrine Metaplasia,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-D7-6817,White,STAD,,0,0,,,,0,,0,2.99,0.44,4,14,11,,,389,,,389,,0,0,389,389,,Malignant,29,,31,,,,22392,,,389,389,,,,,389,,,389,,,,,,,,TUMOR FREE,Alive,-23142,,,,103,,389,389,,,[Not Available],[Not Applicable],,,,,0.1,Stomach,Unknown,,,16,,1,0.16071,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6817,,,,,,,389,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,81863,,0.457305313,,,,,,,,,,0.077492211,Grade 3,0.04231481,,,,Stage IIIA,,0.3095,,,,,,,,,,,,,,,,0.1653,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6817,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.83,1,0,3,,,457,BRCA_LumA,457,457,,0,0,457,457,,Invasive Carcinoma,4,,13,,,,21710,0,,457,457,,,,457,457,,,457,,,,,,,,TUMOR FREE,Alive,-18628,,,,48,,457,457,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.026426,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09V,,,,,,,457,,,,,,,,,3,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,81864,,-1.193499825,0,0,0,0,-0.0304,1,,,Infiltrating Lobular Carcinoma,0.113831261,,0.126190419,0,0,0,,Negative,-1.723,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3084,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.41,5,6,11,,,1972,BRCA_Her2,1972,1972,,0,0,1972,1972,,Invasive Carcinoma,22,,40,,,,20668,0,,1972,1972,,,,1972,1972,,,1972,,,,,,,,TUMOR FREE,Alive,-23653,,,,429,,1972,1972,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.1606,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TX,,,,,,,1972,,,,,,,,,14,,,,,,,,,,,,,2005,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,81868,,1.584240858,0,0,0,0,-0.3902,1,,,Infiltrating Ductal Carcinoma,0.214230006,,0.178761888,0,0,0,,Negative,1.3585,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3278,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5494,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.0,0.74,0,0,0,HRP,NO,1477,6-FOXA1,1477,1477,,0,0,1477,1477,prad_tcga,Malignant,0,,5,3.8,TCGA-EJ-5494-01,0,5260,0,TCGA-EJ-5494,1477,1477,Prostate Cancer,,184,1477,1477,TCGA,,1477,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-18596,,50,7,38,PRAD,1477,1477,WHITE,0.0,[Not Available],[Not Applicable],42,R0,1,Matched,0.06,Prostate,Resection,4,37103479-02bd-45e8-95b3-7a4a78523999,0,,0,0.0013291,[Not Available],e27c50e2-2a41-4f8c-9ef8-2bc51fb0c23e,3,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.36666666667,TCGA-EJ-5494,0:DiseaseFree,3,0,Prostate Adenocarcinoma,48.52,3/29/12,1477,,,,,,C61,e52eefbc-e27d-4a5d-a261-d06a2dcf5d53,,0,TUMOR FREE,0.0008,0:LIVING,,4,48.52,Bilateral,2,,,YES,,2009,,,TCGA-EJ-5494.e52eefbc-e27d-4a5d-a261-d06a2dcf5d53.pdf,,[Not Applicable],,,76-85%,17,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,50,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,81869,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.85,0.65,3,5,4,,,1682,BRCA_LumA,1682,1682,,0,0,1682,1682,,Invasive Carcinoma,12,,20,,,,19021,0,,1682,1682,,,,1682,1682,,,1682,,,,,,,,TUMOR FREE,Alive,-20606,,,,33,,1682,1682,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.19864,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XO,,,,,,,1682,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,81870,,0.20729991,0,0,0,0,0.4846,1,,,Infiltrating Lobular Carcinoma,0.17031999,,0.144439592,0,0,0,,Negative,0.133,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.403,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-22-4604,White,LUSC,,1,,,Mayo Clinic - Rochester,,1,MALE,1,5.39,0.84,0,16,18,,,399,,,399,,1,,306,306,,Malignant,34,,0,,,,18456,,,306,,,,,,399,,,306,,,,,,,,WITH TUMOR,Dead,-26952,399,,,328,,306,,,,[Not Available],[Not Applicable],,,,,0.41,,,,,18,,2,0.0,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4604,,,,,,,,,,,,,,,,61,,,,,,,,,,,,,2003,306,,,,Stage IIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,81871,,1.099503453,,,,,,,,,,0.273089425,,0.088292718,,,,Stage IIA,,1.9315,,,,,,,,,,,,,,,,0.6864,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98831431,17.24674473,17.58067991,0.024837391286132,LUSC,,18.07110367,16.24279175,Squamous Cell Carcinoma,0.9571,15.42194855,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.35,0.45,6,8,11,,,968,BRCA_LumA,968,968,,0,0,968,968,,Invasive Carcinoma,25,,15,,,,16659,0,,968,968,,,,968,968,,,968,,,,,,,,TUMOR FREE,Alive,-29285,,,,96,,968,968,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,14,,1,0.173,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EV,,,,,,,968,,,,,,,,,24,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,81874,,0.628034842,0,0,0,0,1.0797,1,,,Infiltrating Ductal Carcinoma,0.205604245,,0.133162334,0,0,0,,Negative,-0.076,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.4839,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.6,1,3,1,,,421,BRCA_LumA,421,421,,0,0,421,421,,Invasive Carcinoma,5,,14,,,,19582,0,,421,421,,,,421,421,,,421,,,,,,,,TUMOR FREE,Alive,-24813,,,,118,,421,421,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,1,,0,0.022672,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-AA11,,,,,,,421,,,,,,,,,1,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,81875,,-0.676984088,0,0,0,0,0.1742,0,,,Infiltrating Ductal Carcinoma,0.094688704,,0.055775299,0,0,1,,Negative,-0.9965,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0828,1,0,H & E,0,0,,0,Di (Andy) Ai,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Papillary, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Papillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Papilloma,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-4547,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.91,0.49,12,11,19,,,2419,,2419,2419,,0,0,2419,2419,,Malignant,42,,169,,,,17065,,,2419,2419,,,,2419,2419,,,2419,,,,,,,,TUMOR FREE,Alive,-25056,,,,256,,2419,2419,,,[Not Available],[Not Applicable],,,,,0.02,,,,,12,,0,0.33781,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4547,,,,,,,2419,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,81877,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.7549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.460033798952849,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.8,0.85,3,18,12,,,528,BRCA_LumB,528,528,,0,0,528,528,,Invasive Carcinoma,33,,44,,,,25478,0,,528,528,,,,528,528,,,528,,,,,,,,TUMOR FREE,Alive,-22779,,,,108,,528,528,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Core Biopsy,,,18,,1,0.1583,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A1FW,,,,,,,528,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,81878,,-0.268169898,0,0,0,0,-0.7562,1,,,Infiltrating Ductal Carcinoma,0.139469325,,0.113636108,0,0,0,,Negative,-0.7405,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1572,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-L9-A8F4,Black or African American,LUAD,,0,0,,Candler,,0,FEMALE,0,3.05,0.32,14,7,16,,,476,,,476,,0,0,476,476,,Malignant,37,,118,,,,33751,,,476,476,,,,,476,,,476,,,,,,,,TUMOR FREE,Alive,-23617,,,,1025,,476,476,,,[Not Available],[Not Applicable],,,,,0.33,,,,,20,,1,0.37399,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Candler,,TCGA-L9-A8F4,,,,,,,476,,,,,,,,,28,,,,,,,,,,,,,2013,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,64,,,,,,,,,,,,,,,,,,,,81879,,1.438548811,,,,,,,,,,0.222663452,,0.069867448,,,,Stage IB,,1.4855,,,,,,,,,,,,,,,,0.3004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.091062739,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2413,,1.0515,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-39-5040,White,LUSC,,1,,,MSKCC,,1,MALE,1,3.04,0.59,7,9,15,,,519,,,519,,1,,442,442,,Malignant,31,,29,,,,17132,,,442,,,,,,519,,,442,,,,,,,,WITH TUMOR,Dead,-21790,519,,,655,,442,,,,[Not Available],[Not Applicable],,,,,0.46,,,,,12,,1,0.35017,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5040,,,,,,,,,,,,,,,,29,,,,,,,,,,,,,2008,442,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,81880,,0.526438364,,,,,,,,,,0.133920808,,0.060078304,,,,Stage IIIA,,1.138,,,,,,,,,,,,,,,,0.0254,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.50892849,15.07999604,15.23327251,-0.43578605369455,LUSC,,17.50886582,15.32010175,Squamous Cell Carcinoma,-0.6834,12.83372799,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Female,TCGA-49-6767,White,LUAD,,0,0,,Johns Hopkins,,0,FEMALE,0,3.24,0.43,10,9,11,,,677,,,677,,0,0,677,677,,Malignant,30,,43,,,,20746,,,677,677,,,,,677,,,677,,,,,,,,TUMOR FREE,Alive,-17108,,,,618,,677,677,,,[Not Available],[Not Applicable],,,,,0.26,,,,,21,,1,0.33704,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6767,,,,,,,677,,,,,,,,,33,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Unknown],,,,,,46,,,,,,,,,,,,,,,,,,,,81881,,1.110048058,,,,,,,,,,0.189484606,,0.01849799,,,,Stage IIB,,1.488,,,,,,,,,,,,,,,,0.2542,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.06413847,16.59908087,17.88511017,0.135891669,LUAD,Adenocarcinoma,18.24381755,16.83669734,Adenocarcinoma,0.248,10.13606579,0.9549,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.03,0.53,7,7,16,,,2707,BRCA_LumB,2707,2707,,0,0,2707,2707,,Invasive Carcinoma,30,,27,,,,21768,0,,2707,2707,,,,2707,2707,,,2707,,,,,,,,TUMOR FREE,Alive,-21309,,,,170,,2707,2707,,,[Not Available],[Not Applicable],,,,,0.62,Breast,Resection/Excision,,,18,,1,0.13023,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A250,,,,,,,2707,,,,,,,,,30,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,81889,,0.996253034,0,0,0,0,0.1287,1,,,Infiltrating Ductal Carcinoma,0.190096362,,0.180638858,0,0,0,,Negative,0.1645,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6145,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,602,,602,602,,0,0,602,602,,Invasive Carcinoma,,,,,,,16438,0,,602,602,,,,602,602,,,602,,,,,,,,TUMOR FREE,Alive,-32872,,,,0,,602,602,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3W6,,,,,,,602,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,81894,,0.757526032,0,0,0,0,0.4389,1,,,Infiltrating Lobular Carcinoma,0.161695962,,0.283375548,0,0,0,,Negative,0.3475,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7113,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,,,,,,,,273,,,273,,0,0,273,273,,Invasive Carcinoma,,,,,,,18077,0,,273,273,,,,,273,,,273,,,,,,,,,Alive,-29251,,,,0,,273,273,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07R,,,,,,,273,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,81895,,-0.833913321,0,0,0,0,-2.1233,1,,,Infiltrating Ductal Carcinoma,0.143640179,,0.016015006,0,0,0,,Positive,0.1975,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1239,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-56-8308,White,LUSC,,0,0,,International Genomics Consortium,,0,MALE,0,3.24,0.44,6,15,17,,,517,,,517,,0,0,517,517,,Malignant,38,,34,,,,17716,,,517,517,,,,,517,,,517,,,,,,,,WITH TUMOR,Alive,-29139,,,,454,,517,517,,,[Not Available],[Not Applicable],,,,,0.16,,,,,14,,1,0.28846,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8308,,,,,,,517,,,,,,,,,27,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,79,,,,,,,,,,,,,,,,,,,,81896,,0.672568955,,,,,,,,,,0.179528516,,0.105722528,,,,Stage IIB,,1.631,,,,,,,,,,,,,,,,0.6909,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.15154661,15.64268547,14.92012976,-0.495432356057893,LUSC,Squamous Cell Carcinoma,17.9165487,15.86001929,Squamous Cell Carcinoma,0.207,14.03882572,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-BT-A42F,White,BLCA,,0.0,0,,,,0,MALE,0.0,2.67,0.22,8,15,19,,,864,,,864,,0.0,0,864.0,864.0,,Malignant,42,,39,,,,24404.0,,,864.0,864,,,,,864,,,864.0,,,,,,,,TUMOR FREE,Alive,-23713,,,,211.0,,864.0,864,,,[Not Available],[Not Applicable],,,,,0.5,,,,,22,,1,0.19125,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A42F,,,,,,,864,,,,,,,,,37,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,64.0,,,,,,,,,,,,,,,,,,,,81898,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-55-8620,White,LUAD,,1,1,,International Genomics Consortium,,1,MALE,1,2.47,0.62,12,10,13,,,375,,,375,,1,1,375,375,,Malignant,35,,150,,,,29184,,,375,375,,,,,375,,,375,,,,,,,,WITH TUMOR,Dead,-22091,375,,,668,,375,375,,,[Not Available],[Not Applicable],,,,,0.4,,,,,15,,1,0.30212,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8620,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,60,,,,,,,,,,,,,,,,,,,,81901,,1.022080699,,,,,,,,,,0.160534833,,0.016136817,,,,Stage IV,,0.9955,,,,,,,,,,,,,,,,-0.3772,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,HOMDEL,,G417W (driver),1,,,G417W (driver),15.34213771,16.26813864,16.64199608,-0.383671295,LUAD,Adenocarcinoma,18.14129413,16.04887476,Adenocarcinoma,-1.1305,12.68669808,0.4808,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-A9SV,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.93,0.63,3,12,10,,,388,,,388,,1.0,1,237.0,237.0,,Malignant,25,,62,,,,32722.0,,,237.0,237,,,,,388,,,237.0,,,,,,,,WITH TUMOR,Dead,-30265,388,,,102.0,,237.0,237,,,[Not Available],[Not Applicable],,,,,0.12,,,,,16,,2,0.20393,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SV,,,,,,,,Lung,Distant Metastasis,,,,,,,55,,,,,,,,,,,,,2006,237,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,82.0,,,,,,,,,,,,,,,,,,,,81902,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-22-4605,,LUSC,,0,0,,Mayo Clinic - Rochester,2,2,FEMALE,2,3.43,0.24,3,4,7,,,974,,974,974,,2,2,974,974,,Malignant,14,,11,,,,22519,,,974,974,,,,974,974,,,974,,,,,,,,TUMOR FREE,Dead,-28623,974,,,104,,974,974,,,[Not Available],[Not Applicable],,,,,0.1,,,,,19,,1,0.20264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4605,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2003,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,81904,,0.523272425,,,,,,,,,,0.280557445,,0.176082057,,,,Stage IB,,0.912,,,,,,,,,,,,,,,,0.7531,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.460946175836122,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.3021,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-BR-8368,White,STAD,,0,0,,,0,0,,0,2.02,0.74,4,6,2,,,131,,131,131,,0,0,131,131,,Malignant,12,,36,,,,24765,,,131,131,,,,131,131,,,131,,,,,,,,TUMOR FREE,Alive,-30874,,,,1511,,131,131,,,[Not Available],[Not Applicable],,,,,0.01,Stomach,Unknown,,,2,,0,0.065336,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8368,,,,,,,131,,,,,,,,,1,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,84,,,,,,,,,,,,,,,,,,,,81910,,0.48292172,,,,,,,,,,0.016240712,Grade 3,0.044843021,,,,Stage IB,,0.6885,,,,,,,,,,,,,,,,-0.1594,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8368,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-66-2792,,LUSC,,0,0,,Indivumed,0,0,MALE,0,2.98,0.66,11,12,19,,,913,,913,913,,0,0,913,913,,Malignant,42,,44,,,,19004,,,913,913,,,,913,913,,,913,,,,,,,,TUMOR FREE,Alive,-21428,,,,185,,913,913,,,[Not Available],[Not Applicable],,,,,0.12,,,,,19,,1,0.49783,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2792,,,,,,,913,,,,,,,,,28,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,81923,,0.270311438,,,,,,,,,,0.18797149,,0.03631634,,,,Stage IIB,,1.195,,,,,,,,,,,,,,,,0.4402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,14.83938961,15.90223248,15.75285454,-0.472833081391515,LUSC,Squamous Cell Carcinoma,17.84799296,15.45972831,Squamous Cell Carcinoma,0.3504,14.14311428,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-K4-A5RJ,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.5,0.33,11,10,13,,,539,,539,539,,0.0,0,539.0,539.0,,Malignant,34,,63,,,,34467.0,,,539.0,539,,,,539,539,,,539.0,,,,,,,,TUMOR FREE,Alive,-27518,,,,502.0,,539.0,539,,,[Not Available],[Not Applicable],,,,,0.16,,,,,13,,1,0.21727,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A5RJ,,,,,,,539,,,,,,,,,18,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,81926,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,2.18,0.59,5,5,11,,,2573,BRCA_LumB,1412,2573,,1,1,1412,1412,,Invasive Carcinoma,21,,58,,,,32877,0,,1412,1412,,,,1412,2573,,,1412,,,,,,,,WITH TUMOR,Dead,-16705,2573,,,74,,1412,1412,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,6,,0,0.087981,Indeterminate (neither Pre or Postmenopausal),,,"Other, specify",,,,,,[Not Available],,Duke,,TCGA-B6-A0IN,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,10,,,,,,,,,,,,,1996,1412,"bone, brain",,,Stage X,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,81931,,0.946595581,0,0,0,0,0.0424,1,,,Other,0.198680501,,0.304932461,0,0,0,,Negative,0.0225,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3354,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Papillary Carcinoma","Invasive Ductal Carcinoma (Mucinous), Invasive Papillary Carcinoma",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.86,0.25,6,10,13,,,297,BRCA_Her2,297,297,,0,0,297,297,,Invasive Carcinoma,29,,10,,,,20739,1,,297,297,,,,297,297,,,297,,,,,,,,TUMOR FREE,Alive,-22598,,,,57,,297,297,,,[Not Available],[Not Applicable],,,,,0.43,Not Specific/Unknown,Resection/Excision,,,13,,1,0.059709,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A278,,,,,,,297,,,,,,,,,23,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,81933,,1.277766315,0,0,0,0,-0.2943,1,,,Infiltrating Ductal Carcinoma,0.245806217,,0.156610098,0,0,0,,Negative,0.898,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2664,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Suboptimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7750,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.99,0.34,1,2,0,HRP,NO,522,8-other,522,522,,0,0,522,522,prad_tcga,Malignant,3,,2,3.7,TCGA-HC-7750-01,0,5427,0,TCGA-HC-7750,522,522,Prostate Cancer,,83,522,522,TCGA,,522,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-18580,,50,7,17,PRAD,522,522,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.0,Prostate,Resection,3,10016c62-f9fe-473e-a8d6-6d5380715e1a,0,,0,0.0067239,[Not Available],2d350c73-2a0b-4a3c-8d30-c6fcf6c3ffba,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.3,TCGA-HC-7750,0:DiseaseFree,2,15,Prostate Adenocarcinoma,17.15,4/20/12,522,,,,,,C61,f05d95fd-391d-49ab-8a2f-039110a654bd,,0,TUMOR FREE,0.0066,0:LIVING,0.1,,17.15,Left,15,,,YES,,2011,,,TCGA-HC-7750.f05d95fd-391d-49ab-8a2f-039110a654bd.pdf,,[Not Applicable],,,<10%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,50,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,T2b,,M0,C61.9,8550/3,81934,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-BT-A42C,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.46,0.66,10,20,23,,,873,,873,873,,0.0,0,873.0,873.0,,Malignant,53,,58,,,,29817.0,,,873.0,873,,,,873,873,,,873.0,,,,,,,,TUMOR FREE,Alive,-23584,,,,527.0,,873.0,873,,,[Not Available],[Not Applicable],,,,,0.51,,,,,16,,1,0.19272,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A42C,,,,,,,873,,,,,,,,,25,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,64.0,,,,,,,,,,,,,,,,,,,,81935,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.38,6,6,10,,,2255,BRCA_LumA,2255,2255,,0,0,2255,2255,,Invasive Carcinoma,22,,19,,,,16703,0,,2255,2255,,,,2255,2255,,,2255,,,,,,,,TUMOR FREE,Alive,-23928,,,,37,,2255,2255,,,[Not Available],[Not Applicable],,,,,0.2,Breast,Resection/Excision,,,2,,0,0.077296,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2FO,,,,,,,2255,,,,,,,,,3,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,81940,,1.15901407,0,0,0,0,0.5514,1,,,Infiltrating Lobular Carcinoma,0.177296766,,0.248284103,0,0,0,,Negative,0.5665,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.343,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5764,White,PRAD,91,0,0,,CH,,0,MALE,0,1.94,0.51,3,4,3,ambiguous,NO,31,1-ERG,,31,,0,0,31,31,prad_tcga,Malignant,10,PALB2,41,14.0,TCGA-CH-5764-01,0,5254,0,TCGA-CH-5764,31,31,Prostate Cancer,,29,,31,TCGA,,31,Primary,0,,A,,,,TUMOR FREE,Alive,-24257,,66,7,45,PRAD,31,31,WHITE,0.0,[Not Available],[Not Applicable],52,R0,1,Matched,0.03,Prostate,Resection,4,48726d56-93a1-4730-a660-fceee0321084,2,Normal (no evidence of prostate cancer) [cM0],0,0.060461,[Not Available],ed73f136-42e8-4100-b432-d10370d07e8b,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,CH,1.66666666667,TCGA-CH-5764,0:DiseaseFree,3,15,Prostate Adenocarcinoma,1.02,3/16/12,31,,,,,NO,C61,e7f4fceb-1960-44f0-8e0b-fde2337011ce,,3,TUMOR FREE,0.0578,0:LIVING,13.95,,1.02,Bilateral,16,No Evidence of Extraprostatic Extension,31,YES,,2008,,,TCGA-CH-5764.e7f4fceb-1960-44f0-8e0b-fde2337011ce.pdf,Peripheral Zone,[Not Applicable],YES,31,51-60%,8,Prostate Adenocarcinoma Acinar Type,1,2008,[Not Available],,NO,Yes,R0,0.3,66,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,,0,M0,C61.9,8550/3,81942,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MN-A4N4,White,LUAD,,0,0,,BLN - Baylor,0,0,MALE,0,4.12,0.34,8,19,24,,,1175,,1175,1175,,0,0,1175,1175,,Malignant,51,,40,,,,32074,,,1175,1175,,,,1175,1175,,,1175,,,,,,,,TUMOR FREE,Alive,-20888,,,,1969,,1175,1175,,,[Not Available],[Not Applicable],,,,,0.56,,,,,17,,2,0.17792,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,BLN - Baylor,,TCGA-MN-A4N4,,,,,,,1175,,,,,,,,,79,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,81943,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,0.6622,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.373600442,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.8766,,-0.1441,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-85-6561,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.82,0.4,14,5,10,,,1224,,1224,1224,,0,0,1224,1224,,Malignant,29,,24,,,,20588,,,1224,1224,,,,1224,1224,,,1224,,,,,,,,TUMOR FREE,Alive,-24234,,,,333,,1224,1224,,,[Not Available],[Not Applicable],,,,,0.28,,,,,10,,0,0.39661,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-6561,,,,,,,1224,,,,,,,,,15,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,81944,,1.439033209,,,,,,,,,,0.238160701,,0.159393949,,,,Stage IB,,2.0815,,,,,,,,,,,,,,,,0.8981,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,H274Q,1,,,H274Q,,,,-0.121047501090192,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.4883,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-86-7714,Black or African American,LUAD,,1,1,,Asterand,,1,FEMALE,1,1.93,0.67,1,0,1,,,625,,,625,,1,1,625,625,,Malignant,2,,4,,,,16688,,,625,625,,,,,625,,,625,,,,,,,,WITH TUMOR,Dead,-22619,625,,,104,,625,625,,,[Not Available],[Not Applicable],,,,,0.0,,,,,3,,0,0.067424,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-7714,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,81945,,-0.872674283,,,,,,,,,,0.244340769,,0.107220447,,,,Stage IIIA,,-0.1315,,,,,,,,,,,,,,,,0.1622,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.07787498,16.74995835,10.99525238,-0.446892881,LUAD,Adenocarcinoma,18.03408937,15.0243223,Adenocarcinoma,0.4157,12.6409687,-1.0362,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-33-4532,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,5.54,0.56,11,14,20,,,3924,,3924,3924,,2,2,3924,3924,,Malignant,45,,150,,,,19419,,,3924,3924,,,,3924,3924,,,3924,,,,,,,,TUMOR FREE,Dead,-25169,3924,,,509,,3924,3924,,,[Not Available],[Not Applicable],,,,,0.28,,,,,22,,2,0.25208,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4532,,,,,,,,,,,,,,,,52,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,81949,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,-0.0077,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,N469Kfs*11 (driver),1,,,N469Kfs*11 (driver),,,,-0.885497586366189,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-78-7147,White,LUAD,,1,,,Prince Charles Hospital,,1,FEMALE,1,3.15,0.62,11,12,17,,,586,,,586,,1,,578,578,,Malignant,40,,73,,,,21184,,,578,,,,,,586,,,578,,,,,,,,WITH TUMOR,Dead,-24809,586,,,445,,578,,,,[Not Available],[Not Applicable],,,,,0.11,,,,,19,,1,0.22188,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7147,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2001,578,,,,Stage IIB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,81950,,0.36944933,,,,,,,,,,0.185822123,,0.026741546,,,,Stage IIB,,0.225,,,,,,,,,,,,,,,,-0.0694,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L861Q (driver), L387M, D1083Efs*11",,,1,"L861Q (driver), L387M, D1083Efs*11",,,14.80423429,15.58520798,15.99538487,-0.180881608,LUAD,Adenocarcinoma,18.15223375,15.8603279,Adenocarcinoma,-1.6629,12.7731904,0.179,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,727,,727,727,,0,0,727,727,,Invasive Carcinoma,,,,,,,20170,0,,727,727,,,,727,727,,,727,,,,,,,,TUMOR FREE,Alive,-31173,,,,0,,727,727,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A54X,,,,,,,727,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,[Not Available],,,,,,85,,,,,,,,,,,,,,,,,,,,81956,,-2.148405352,0,0,0,0,0.3884,1,,,Mucinous Carcinoma,0.017784974,,-0.045314735,0,0,0,,Negative,-2.138,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.7591,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,No Detail Present,"DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-49-4494,White,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,2.05,0.46,6,6,3,,,1081,,,1081,,1,1,1081,1081,,Malignant,15,,19,,,,20702,,,1081,1081,,,,,1081,,,1081,,,,,,,,WITH TUMOR,Dead,-28387,1081,,,257,,1081,1081,,,[Not Available],[Not Applicable],,,,,0.32,,,,,3,,0,0.2271,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4494,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1995,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,81961,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), T790M (driver)",,,1,"L858R (driver), T790M (driver)",,,15.83983572,16.56385538,16.03537556,-0.171017566,LUAD,,17.59504698,15.01237642,Adenocarcinoma,,12.61159328,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-49-6745,White,LUAD,,0,0,,Johns Hopkins,,0,MALE,0,3.83,0.24,4,3,4,,,522,,,522,,0,0,522,522,,Malignant,11,,15,,,,24410,,,522,522,,,,,522,,,522,,,,,,,,TUMOR FREE,Alive,-30133,,,,158,,522,522,,,[Not Available],[Not Applicable],,,,,0.33,,,,,9,,1,0.12048,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6745,,,,,,,522,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,81967,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,16.54620904,17.9432589,17.24792879,0.037185585,LUAD,Adenocarcinoma,18.32630782,16.40113647,Adenocarcinoma,,13.66230496,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,,,Asian,BRCA,,1,1,,,1,1,FEMALE,1,2.05,0.42,1,3,2,,,1034,BRCA_LumA,1034,1034,,1,1,1034,1034,,Invasive Carcinoma,6,,22,,,,21173,0,,1034,1034,,,,1034,1034,,,1034,,,,,,,,WITH TUMOR,Dead,-22096,1034,,,243,,1034,1034,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,8,,0,0.082381,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A3M7,,,,,,,,,Locoregional Recurrence,,,,,,,6,,,,,,,,,,,,,2010,1034,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,81969,TRUE,-0.032842965,0,0,0,0,0.5544,1,,,Infiltrating Lobular Carcinoma,0.130683648,,0.362792649,0,0,0,,Negative,-0.3445,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1791,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BT-A3PH,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.71,0.83,5,5,9,,,142,,,142,,1.0,1,142.0,142.0,,Malignant,19,,19,,,,17650.0,,,142.0,142,,,,,142,,,142.0,,,,,,,,WITH TUMOR,Dead,-28030,142,,,611.0,,142.0,142,,,[Not Available],[Not Applicable],,,,,0.11,,,,,13,,1,0.12242,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A3PH,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,76.0,,,,,,,,,,,,,,,,,,,,81973,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-YC-A9TC,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.03,0.8,1,2,2,,,20,,,20,,1.0,1,20.0,20.0,,Malignant,5,,37,,,,27233.0,,,20.0,20,,,,,20,,,20.0,,,,,,,,WITH TUMOR,Dead,-26283,20,,,159.0,,20.0,20,,,[Not Available],[Not Applicable],,,,,0.0,,,,,1,,0,0.02795,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Spectrum Health,,TCGA-YC-A9TC,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,71.0,,,,,,,,,,,,,,,,,,,,81977,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SK,,PRAD,389,0,0,,YL,,0,MALE,0,2.03,0.44,6,9,7,HRD,NO,1408,8-other,,1408,,0,0,1408,1408,prad_tcga,Malignant,22,BRCA1;CDK12;CHEK1;RAD51D,61,,TCGA-YL-A8SK-01,0,5676,0,TCGA-YL-A8SK,1408,1408,Prostate Cancer,,924,,1408,TCGA,,1408,Primary,0,Apex|Middle|Base,B,ATM:?-416:.:splice_acceptor_variant,ATM,True,,Alive,-24759,,67,9,45,PRAD,1408,1408,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.08,Prostate,Resection,4,F5243BA4-684D-4401-A1A5-7713BCC9106E,2,Normal (no evidence of prostate cancer) [cM0],0,0.10241,[Not Available],159B47B2-DC7D-4856-9A00-454E27301E23,5,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A8SK,0:DiseaseFree,5,23,Prostate Adenocarcinoma,46.25,4/25/14,1408,,,,,NO,C61,F332F5AD-A0BE-455D-9523-13BDF275DB2A,410,5,,0.1851,0:LIVING,0.03,,46.25,Bilateral,26,,,YES,1208,2010,,,TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,38,26-35%,20,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,4,M0,C61.9,8140/3,81981,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-DK-A3X1,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.33,0.47,10,11,19,,,2009,,2009,2009,,0.0,0,2009.0,2009.0,,Malignant,40,,77,,,,16042.0,,,2009.0,2009,,,,2009,2009,,,2009.0,,,,,,,,TUMOR FREE,Alive,-28757,,,,1241.0,,2009.0,2009,,,[Not Available],[Not Applicable],,,,,0.11,,,,,16,,1,0.16659,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3X1,,,,,,,2009,,,,,,,,,27,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,78.0,,,,,,,,,,,,,,,,,,,,81990,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-49-4494,White,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,2.05,0.46,6,6,3,,,1081,,,1081,,1,1,1081,1081,,Malignant,15,,19,,,,20702,,,1081,1081,,,,,1081,,,1081,,,,,,,,WITH TUMOR,Dead,-28387,1081,,,257,,1081,1081,,,[Not Available],[Not Applicable],,,,,0.32,,,,,3,,0,0.2271,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4494,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1995,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,81994,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), T790M (driver)",,,1,"L858R (driver), T790M (driver)",,,15.83983572,16.56385538,16.03537556,-0.171017566,LUAD,,17.59504698,15.01237642,Adenocarcinoma,,12.61159328,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A62P,White,BLCA,,1.0,1,,,,1,MALE,1.0,5.3,0.19,6,20,20,,,191,,,191,,1.0,1,191.0,191.0,,Malignant,46,,36,,,,33218.0,,,191.0,191,,,,,191,,,191.0,,,,,,,,WITH TUMOR,Dead,-27843,191,,,508.0,,191.0,191,,,[Not Available],[Not Applicable],,,,,0.38,,,,,22,,2,0.092449,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A62P,,,,,,,,,,,,,,,,57,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,[Not Applicable],,,,,,76.0,,,,,,,,,,,,,,,,,,,,81995,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5508,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.99,0.34,1,1,2,HRP,NO,1965,1-ERG,1965,1965,,0,0,1965,1965,prad_tcga,Malignant,4,,6,7.4,TCGA-EJ-5508-01,0,5273,0,TCGA-EJ-5508,1965,1965,Prostate Cancer,,907,1965,1965,TCGA,,1965,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-23758,,65,7,30,PRAD,1965,1965,WHITE,0.0,[Not Available],[Not Applicable],54,R0,1,Matched,0.0,Prostate,Resection,3,e3969bf5-b0cc-49e3-b8cb-3d9e98f1676d,0,,0,0.012553,[Not Available],bd18dd01-d894-4bdd-9ce2-e25705a52a57,4,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.83333333333,TCGA-EJ-5508,0:DiseaseFree,2,4,Prostate Adenocarcinoma,64.55,4/2/12,1965,,,,,NO,C61,d2590559-0eb6-479e-ba3a-b59c3429ca6d,,0,TUMOR FREE,0.0136,0:LIVING,0.1,4,64.55,Bilateral,6,,,YES,,2008,,,TCGA-EJ-5508.d2590559-0eb6-479e-ba3a-b59c3429ca6d.pdf,,[Not Applicable],NO,,61-70%,17,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.6,65,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,81997,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,4.49,0.42,17,19,24,,,375,BRCA_LumB,375,375,,0,0,375,375,,Invasive Carcinoma,60,,52,,,,20976,0,,375,375,,,,375,375,,,375,,,,,,,,TUMOR FREE,Alive,-27063,,,,487,,375,375,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,19,,2,0.37939,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HM,,,,,,,375,,,,,,,,,59,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,82000,,1.79289068,0,0,0,0,-0.9085,1,,,Infiltrating Ductal Carcinoma,0.182403446,,0.043644801,0,0,0,,Negative,2.165,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1828,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.63,2,2,2,,,0,BRCA_LumB,0,0,,0,0,0,0,,Invasive Carcinoma,6,,2,,,,28423,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-26723,,,,55,,0,0,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.036605,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A096,,,,,,,0,,,,,,,,,3,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,82002,,0.964300105,0,0,0,0,-0.2494,1,,,Infiltrating Ductal Carcinoma,0.214686537,,0.174439124,0,0,0,,Negative,0.903,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5691,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-69-7974,White,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,FEMALE,0,3.55,0.29,6,9,12,,,184,,,184,,0,0,184,184,,Malignant,27,,29,,,,32345,,,184,184,,,,,184,,,184,,,,,,,,WITH TUMOR,Alive,-20021,,,,658,,184,184,,,[Not Available],[Not Applicable],,,,,0.11,,,,,19,,2,0.34419,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7974,,,,,,,184,,,,,,,,,63,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,54,,,,,,,,,,,,,,,,,,,,82003,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,Q61H (driver),,1,,Q61H (driver),,17.42922833,18.16608397,17.37391039,0.017722847,LUAD,Adenocarcinoma,17.90639748,15.89532067,Adenocarcinoma,-0.0752,13.06831192,0.1065,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,,0.0,1.0,Female,TCGA-BT-A20R,White,BLCA,,0.0,0,,,,,FEMALE,2.0,3.07,0.46,5,8,14,,,154,,,154,,2.0,2,154.0,154.0,,Malignant,27,,21,,,,27547.0,,,154.0,154,,,,,154,,,154.0,,,,,,,,,Dead,-28987,154,,,360.0,,154.0,154,,,[Not Available],[Not Applicable],,,,,0.27,,,,,13,,1,0.17654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20R,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,[Not Available],,,,,,79.0,,,,,,,,,,,,,,,,,,,,82008,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.28,0.7,8,4,9,,,2535,BRCA_LumA,2535,2535,,0,0,2535,2535,,Invasive Carcinoma,21,,27,,,,22324,0,,2535,2535,,,,2535,2535,,,2535,,,,,,,,TUMOR FREE,Alive,-21122,,,,35,,2535,2535,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,15,,0,0.31515,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DC,,,,,,,2535,,,,,,,,,24,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,82012,,-0.295242051,0,0,0,0,-0.2478,1,,,Infiltrating Ductal Carcinoma,0.094329537,,0.16394593,0,0,0,,Negative,-1.1595,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2132,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.96,1.0,15,34,27,,,450,BRCA_Basal,450,450,,0,0,450,450,,Invasive Carcinoma,76,,104,,,,16876,0,,450,450,,,,450,450,,,450,,,,,,,,TUMOR FREE,Alive,-15903,,,,112,,450,450,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,7,,0,0.36281,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A158,,,,,,,450,,,,,,,,,15,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,82017,TRUE,-0.070989406,0,0,0,0,-0.4057,1,,,Infiltrating Ductal Carcinoma,0.045988572,,0.035284735,0,0,0,,Negative,-0.417,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3748,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Tubular),Invasive Ductal Carcinoma (Tubular),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.91,0.74,13,6,14,,,480,BRCA_LumB,480,480,,0,0,480,480,,Invasive Carcinoma,33,,47,,,,19055,0,,480,480,,,,480,480,,,480,,,,,,,,TUMOR FREE,Alive,-21898,,,,132,,480,480,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,13,,0,0.27436,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JC,,,,,,,480,,,,,,,,,12,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,82018,,,0,0,0,0,-0.8095,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.64,0.62,1,1,6,,,591,BRCA_LumA,591,591,,0,0,591,591,,Invasive Carcinoma,8,,3,,,,32894,0,,591,591,,,,591,591,,,591,,,,,,,,TUMOR FREE,Alive,-24999,,,,66,,591,591,,,[Not Available],[Not Applicable],,,,,0.55,Breast,Resection/Excision,,,25,,2,0.015875,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A154,,,,,,,591,,,,,,,,,53,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,82019,,-1.251188431,0,0,0,1,-0.5375,0,,,Infiltrating Ductal Carcinoma,0.140790801,,0.07883107,0,0,0,,Negative,-2.527,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3155,1,0,H & E,0,0,,0,Jeffrey Eisenstein,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,1,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skeletal Muscle",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-JY-A6FB,White,ESCA,,0,0,,,0,0,,0,2.88,0.64,5,8,8,,,1837,,1837,1837,,0,0,1837,1837,,Malignant,21,,89,,,,24169,,,1837,1837,,,,1837,1837,,,1837,,,,,,,,TUMOR FREE,Alive,-28269,,,,184,,1837,1837,,,[Not Available],[Not Available],,,,,0.35,Esophagus,Unknown,,,12,,1,0.21083,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,University Health Network,,TCGA-JY-A6FB,,,,,,,1837,,,,,,,,,30,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,82023,,,,,,,,,,,,,Grade 2,,,,,Stage I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-55-7570,Black or African American,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,1.81,0.57,9,3,12,,,824,,824,824,,0,0,824,824,,Malignant,24,,34,,,,30393,,,824,824,,,,824,824,,,824,,,,,,,,TUMOR FREE,Alive,-22218,,,,493,,824,824,,,[Not Available],[Not Applicable],,,,,0.11,,,,,10,,0,0.3125,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7570,,,,,,,824,,,,,,,,,13,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,82026,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,V300M,,,1,V300M,,,,,,-0.696147123,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1404,,0.1505,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-33-4532,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,5.54,0.56,11,14,20,,,3924,,3924,3924,,2,2,3924,3924,,Malignant,45,,150,,,,19419,,,3924,3924,,,,3924,3924,,,3924,,,,,,,,TUMOR FREE,Dead,-25169,3924,,,509,,3924,3924,,,[Not Available],[Not Applicable],,,,,0.28,,,,,22,,2,0.25208,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4532,,,,,,,,,,,,,,,,52,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,82037,,-0.035228763,,,,,,,,,,0.124471764,,-0.01992794,,,,Stage IB,,0.222,,,,,,,,,,,,,,,,-0.0077,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,N469Kfs*11 (driver),1,,,N469Kfs*11 (driver),,,,-0.885497586366189,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.64,0.41,2,2,4,,,745,BRCA_LumA,745,745,,0,0,745,745,,Invasive Carcinoma,8,,4,,,,32750,0,,745,745,,,,745,745,,,745,,,,,,,,TUMOR FREE,Alive,-25259,,,,72,,745,745,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,18,,1,0.05714,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0EB,,,,,,,745,,,,,,,,,11,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,82041,,0.991582078,0,0,0,0,1.1033,1,,,Infiltrating Ductal Carcinoma,0.188867961,,0.213675518,0,0,0,,Negative,-0.204,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4322,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-38-4625,White,LUAD,,0,0,,UNC,0,0,FEMALE,0,2.98,0.35,9,12,19,,,2973,,2973,2973,,0,0,2973,2973,,Malignant,40,,37,,,,18909,,,2973,2973,,,,2973,2973,,,2973,,,,,,,,,Alive,-24241,,,,788,,2973,2973,,,[Not Available],[Not Applicable],,,,,0.05,,,,,13,,1,0.334,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-4625,,,,,,,2973,,,,,,,,,39,,,,,,,,,,,,,2002,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,82042,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.053812339,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.733,,0.426,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-64-5778,White,LUAD,,1,1,,Fox Chase,1,0,MALE,1,1.76,0.59,11,6,10,,,1305,,962,1305,,1,1,962,962,,Malignant,27,,24,,,,30286,,,962,962,,,,962,1305,,,962,,,,,,,,WITH TUMOR,Alive,-21927,,,,631,,962,962,,,[Not Available],[Not Applicable],,,,,0.15,,,,,9,,0,0.30702,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-5778,,,,,,,1305,,Distant Metastasis,,,,,,,13,,,,,,,,,,,,,2008,962,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,82043,,1.54709104,,,,,,,,,,0.243228291,,0.056006021,,,,Stage IB,,1.945,,,,,,,,,,,,,,,,-0.2758,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,0.354252477,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.4279,,1.9328,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Female,TCGA-E7-A97Q,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,3.65,0.65,12,14,14,,,246,,,246,,1.0,1,246.0,246.0,,Malignant,40,,107,,,,30068.0,,,246.0,246,,,,,246,,,246.0,,,,,,,,WITH TUMOR,Dead,-22249,246,,,92.0,,246.0,246,,,[Not Available],[Not Applicable],,,,,0.06,,,,,22,,1,0.25992,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A97Q,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,60.0,,,,,,,,,,,,,,,,,,,,82044,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-G2-AA3B,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.82,0.84,24,22,19,,,2008,,2008,2008,,0.0,0,2008.0,2008.0,,Malignant,65,,339,,,,16845.0,,,2008.0,2008,,,,2008,2008,,,2008.0,,,,,,,,TUMOR FREE,Alive,-27646,,,,963.0,,2008.0,2008,,,[Not Available],[Not Applicable],,,,,0.71,,,,,7,,0,0.45452,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3B,,,,,,,2008,,,,,,,,,22,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,82047,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-CD-A4MJ,Asian,STAD,,1,1,,,1,0,,1,2.05,0.67,1,1,1,,,384,,69,384,,1,1,69,69,,Malignant,3,,11,,,,16909,,,69,69,,,,69,384,,,69,,,,,,,,WITH TUMOR,Alive,-21932,,,,964,,69,69,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,2,,0,0.012437,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,ILSBio,,TCGA-CD-A4MJ,,,,,,,384,,Locoregional Recurrence,,,,,,,1,,,,,,,,,,,,,2011,69,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,82054,,0.169691435,,,,,,,,,,0.051217153,Grade 2,0.02357831,,,,Stage IB,,0.4235,,,,,,,,,,,,,,,,0.2844,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A4MJ,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-HC-7737,Black or African American,PRAD,184,0,0,,HC,0,0,MALE,0,1.91,0.29,4,3,2,ambiguous,NO,1090,8-other,1090,1090,,0,0,1090,1090,prad_tcga,Malignant,9,BRCA2,11,18.1,TCGA-HC-7737-01,2,5417,0,TCGA-HC-7737,1090,1090,Prostate Cancer,,147,1090,1090,TCGA,,1090,Primary,0,,A,,,,TUMOR FREE,Alive,-20122,,55,7,18,PRAD,1090,1090,BLACK OR AFRICAN AMERICAN,0.107742921,[Not Available],[Not Applicable],38,R0,1,Matched,0.11,Prostate,Resection,3,47b6e89a-ea86-475a-9f1d-02001069c895,1,Normal (no evidence of prostate cancer) [cM0],0,0.088381,[Not Available],73f875cb-bcfc-43ba-ab97-4e94caf836d4,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,9,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.23333333333,TCGA-HC-7737,0:DiseaseFree,2,18,Prostate Adenocarcinoma,35.81,4/11/12,1090,,,,,NO,C61,deaefdb1-471e-43e7-a9b9-a2264cba6a53,,3,TUMOR FREE,0.0001,0:LIVING,0.1,,35.81,Bilateral,19,No Evidence of Extraprostatic Extension,9,YES,,2010,,,TCGA-HC-7737.deaefdb1-471e-43e7-a9b9-a2264cba6a53.pdf,,[Not Applicable],YES,9,71-80%,8,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,No,R0,0.4,55,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N1,T1c,1,M0,C61.9,8550/3,82059,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-7994,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,3.05,0.51,12,14,25,,,603,,603,603,,0,0,603,603,,Malignant,51,,134,,,,19703,,,603,603,,,,603,603,,,603,,,,,,,,TUMOR FREE,Alive,-29858,,,,1990,,603,603,,,[Not Available],[Not Applicable],,,,,0.16,,,,,14,,1,0.40195,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7994,,,,,,,603,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,82061,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.88844863,17.87322709,18.68007667,0.250344506,LUAD,,18.13799855,16.8390055,Adenocarcinoma,-0.754,13.2566904,1.1994,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-BR-8381,White,STAD,,0.0,0,,,0,0,,0.0,2.26,0.34,1,4,3,,,224,,224,224,,0.0,0,224,224,,Malignant,8,,17,,,,21219.0,0,,224,224,,,,224,224,,,224,,,,,,,,TUMOR FREE,Alive,-18843,,,,164.0,,224,224,,,[Not Available],[Not Applicable],,,,,0.16,Stomach,Resection,,,8,,0,0.012052,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8381,,,,,,,224,,,,,,,,,6,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,82067,,1.276343825,,,,,,,,,,0.114296541,Grade 3,0.094793286,,,,Stage IIB,,1.4625,,,,,,,,,,,,,,,,0.3238,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8381,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.69,0.8,2,7,7,,,1224,BRCA_LumA,1224,1224,,0,0,1224,1224,,Invasive Carcinoma,16,,42,,,,18478,0,,1224,1224,,,,1224,1224,,,1224,,,,,,,,TUMOR FREE,Alive,-20795,,,,62,,1224,1224,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,25,,1,0.17554,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Asterand,,TCGA-E9-A1RC,,,,,,,1224,,,,,,,,,33,,,,,,,,,,,,,2007,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,82075,,-1.869296815,0,0,0,0,-0.6065,1,,,Mixed Histology (NOS),0.139715135,,0.050827759,0,0,0,,Negative,-1.689,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2599,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,364,,364,364,,0,0,364,364,,Invasive Carcinoma,,,,,,,23765,0,,364,364,,,,364,364,,,364,,,,,,,,TUMOR FREE,Alive,-18296,,,,0,,364,364,,,[Not Available],[Not Applicable],,,,,,Breast,Core Biopsy,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A426,,,,,,,364,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,82079,,-0.212129906,0,0,0,0,0.5684,1,,,Infiltrating Lobular Carcinoma,0.112574934,,0.261127347,0,0,0,,Negative,0.048,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4315,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-ZF-AA5N,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.09,0.7,1,1,2,,,168,,,168,,1.0,1,168.0,168.0,,Malignant,4,,10,,,,31828.0,,,168.0,168,,,,,168,,,168.0,,,,,,,,WITH TUMOR,Dead,-22741,168,,,72.0,,168.0,168,,,[Not Available],[Not Applicable],,,,,0.0,,,,,3,,0,0.012615,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA5N,,,,,,,,,,,,,,,,3,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,62.0,,,,,,,,,,,,,,,,,,,,82080,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,1.95,0.73,11,5,11,,,558,BRCA_LumB,447,558,,1,1,447,447,,Invasive Carcinoma,27,,28,,,,19425,0,,447,447,,,,447,558,,,447,,,,,,,,WITH TUMOR,Dead,-21479,558,,,57,,447,447,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,9,,0,0.23818,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0WW,,,,,,,,Liver,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,1997,447,,,,Stage X,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,82085,,-0.173417278,0,0,0,0,-0.0759,1,,,Infiltrating Ductal Carcinoma,0.129123235,,0.143303675,0,0,0,,Negative,-0.6165,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1955,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.63,2,2,4,,,552,BRCA_LumA,552,552,,0,0,552,552,,Invasive Carcinoma,8,,10,,,,24426,1,,552,552,,,,552,552,,,552,,,,,,,,TUMOR FREE,Alive,-22976,,,,52,,552,552,,,[Not Available],[Not Applicable],,,,,0.69,Skin,Resection/Excision,,,3,,0,0.050661,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XB,,,,,,,552,,,,,,,,,3,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,82087,,,0,0,0,0,-0.058,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-K4-A5RH,White,BLCA,,1.0,1,,,,0,MALE,1.0,2.29,0.48,10,13,17,,,276,,,276,,1.0,1,196.0,196.0,,Malignant,40,,178,,,,19630.0,,,196.0,196,,,,,276,,,196.0,,,,,,,,WITH TUMOR,Alive,-25305,,,,250.0,,196.0,196,,,[Not Available],[Not Applicable],,,,,0.36,,,,,11,,1,0.39135,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A5RH,,,,,,,276,Lung,Distant Metastasis,,,,,,,42,,,,,,,,,,,,,2012,196,,,,Stage III,,,,,,,,Progressive Disease,,,,,,69.0,,,,,,,,,,,,,,,,,,,,82088,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-96-7544,White,LUSC,,0,0,,Washington University - NYU,2,2,MALE,2,1.86,0.58,17,15,18,,,2160,,2160,2160,,2,2,2160,2160,,Malignant,50,,67,,,,16411,,,2160,2160,,,,2160,2160,,,2160,,,,,,,,TUMOR FREE,Dead,-30548,2160,,,515,,2160,2160,,,[Not Available],[Not Applicable],,,,,0.03,,,,,11,,0,0.39527,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - NYU,,TCGA-96-7544,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,83,,,,,,,,,,,,,,,,,,,,82089,,1.089920248,,,,,,,,,,0.237460733,,0.136830913,,,,Stage IIB,,1.4165,,,,,,,,,,,,,,,,0.6388,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.30403135,17.13814939,16.16399664,-0.0877494993439424,LUSC,Squamous Cell Carcinoma,18.01490501,15.89906549,Squamous Cell Carcinoma,0.9195,14.82620643,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-HC-7748,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.47,4,2,4,,NO,792,1-ERG,792,792,,0,0,792,792,prad_tcga,Malignant,10,BRCA1,21,7.5,TCGA-HC-7748-01,0,5425,0,TCGA-HC-7748,792,792,Prostate Cancer,,99,792,792,TCGA,,792,Primary,0,,A,,,,TUMOR FREE,Alive,-22072,,60,6,29,PRAD,792,792,WHITE,0.0,[Not Available],[Not Applicable],27,R0,1,Matched,0.01,Prostate,Resection,3,8c97a468-f8af-4a81-912f-ac153aa98a08,0,,0,0.043673,[Not Available],f6040682-4999-4d71-abc2-354b473c6980,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,10,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,0.866666666667,TCGA-HC-7748,0:DiseaseFree,1,,Prostate Adenocarcinoma,26.02,4/12/12,792,,,,,,C61,6516e000-dc8c-4715-a561-ee47a114ad23,,2,TUMOR FREE,0.0414,0:LIVING,0.1,,26.02,Right,,,,YES,,2011,,,TCGA-HC-7748.6516e000-dc8c-4715-a561-ee47a114ad23.pdf,,[Not Applicable],,,36-45%,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,Yes,R0,0.7,60,Core needle biopsy,,,YES,NO,YES,,T2a,,6,No,,0,N0,,0,,C61.9,8550/3,82090,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Female,TCGA-50-6597,White,LUAD,,0,0,,University of Pittsburgh,,2,FEMALE,2,3.59,0.48,8,6,8,,,1268,,,1268,,2,2,1268,1268,,Malignant,22,,27,,,,18007,,,1268,1268,,,,,1268,,,1268,,,,,,,,TUMOR FREE,Dead,-29195,1268,,,75,,1268,1268,,,[Not Available],[Not Applicable],,,,,,,,,,11,,1,0.18806,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-6597,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Partial Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,82091,,1.08948694,,,,,,,,,,0.17795492,,0.093232964,,,,Stage IB,,0.7015,,,,,,,,,,,,,,,,-0.309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.058321929,LUAD,,,,Adenocarcinoma,-0.6077,,-0.1074,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-BR-8591,White,STAD,,0,0,,,0,0,,0,2.11,0.27,1,1,0,,,856,,856,856,,0,0,856,856,,Malignant,2,,32,,,,26037,,,856,856,,,,856,856,,,856,,,,,,,,TUMOR FREE,Alive,-29054,,,,2203,,856,856,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,2,,0,0.038821,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8591,,,,,,,856,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,82092,,0.431165687,,,,,,,,,,0.081791666,Grade 3,0.095782162,,,,Stage IIIC,,0.6065,,,,,,,,,,,,,,,,0.1763,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8591,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-05-4420,,LUAD,,0,0,,Indivumed,0,0,MALE,0,3.49,0.59,9,18,19,,,912,,912,912,,0,0,912,912,,Malignant,46,,31,,,,22729,,,912,912,,,,912,912,,,912,,,,,,,,TUMOR FREE,Alive,-15159,,,,388,,912,912,,,[Not Available],[Not Applicable],,,,,0.28,,,,,21,,1,0.16756,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4420,,,,,,,912,,,,,,,,,32,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,41,,,,,,,,,,,,,,,,,,,,82094,,-0.384850815,,,,,,,,,,0.166471381,,0.13981578,,,,Stage IB,,-0.18,,,,,,,,,,,,,,,,0.1043,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.716097882,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2379,,-0.9075,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.15,0.59,2,1,3,,,598,BRCA_LumA,598,598,,0,0,598,598,,Invasive Carcinoma,6,,4,,,,33464,0,,598,598,,,,598,598,,,598,,,,,,,,TUMOR FREE,Alive,-14868,,,,34,,598,598,,,[Not Available],[Not Applicable],,,,,0.39,Breast,Resection/Excision,,,4,,0,0.0362,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1L9,,,,,,,598,,,,,,,,,8,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,82099,,0.261131296,0,0,0,0,-0.8566,1,,,Infiltrating Ductal Carcinoma,0.186646084,,0.196903893,0,0,0,,Negative,-0.424,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.668,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-49-4487,White,LUAD,,1,,,Johns Hopkins,1,1,FEMALE,1,3.17,0.17,3,9,17,,,855,,697,855,,1,,697,697,,Malignant,29,,17,,,,23022,,,697,,,,,697,855,,,697,,,,,,,,WITH TUMOR,Dead,-26583,855,,,450,,697,,,,[Not Available],[Not Applicable],,,,,0.34,,,,,23,,1,0.16476,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4487,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,1992,697,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,82103,,1.65312753,,,,,,,,,,0.220713847,,0.145949226,,,,Stage IA,,1.311,,,,,,,,,,,,,,,,0.3874,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.082860051,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.9158,,1.4298,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,0.0,1.0,1.0,Male,TCGA-VQ-A8PM,White,STAD,,1.0,1,,,,2.0,,1.0,1.79,0.3,14,15,16,,,57.0,,,57.0,,1.0,1,57.0,57.0,,Malignant,45,,152,,,,31117.0,0,,57.0,57,,,,,57.0,,,57.0,,,,,,,,WITH TUMOR,Dead,-20665.0,57,,,66.0,,57.0,57,,,"Other, non-malignant disease",[Not Applicable],,,,,0.37,Stomach,Resection,,,8,,0,0.38392,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8PM,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2009.0,,,,,Stage IV,,,,,,,,[Not Applicable],,,,,,56.0,,,,,,,,,,,,,,,,,,,,82104,,0.890925081,,,,,,,,,,0.108926697,Grade 3,0.164819322,,,,Stage IV,,0.7075,,,,,,,,,,,,,,,,0.3215,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PM,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,1,1,1,1,1,Female,TCGA-51-6867,White,LUSC,,1,,,UNC,1,1,FEMALE,1,,,,,,,,1856,,788,1856,,1,,788,788,,Malignant,,,,,,,21237,,,788,,,,,788,1856,,,788,,,,,,,,WITH TUMOR,Dead,-26523,1856,,,831,,788,,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,UNC,,TCGA-51-6867,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2003,788,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,82108,,1.195982683,,,,,,,,,,0.143895711,,0.103367978,,,,Stage I,,2.075,,,,,,,,,,,,,,,,0.5153,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,-0.0742499302365433,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.97,0.38,1,1,2,,,1369,BRCA_LumA,1369,1369,,0,0,1369,1369,,Invasive Carcinoma,4,,4,,,,30242,0,,1369,1369,,,,1369,1369,,,1369,,,,,,,,TUMOR FREE,Alive,-17699,,,,31,,1369,1369,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,21,,1,0.16474,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1RA,,,,,,,1369,,,,,,,,,24,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,82109,,0.165848658,0,0,0,1,-0.5336,0,,,Infiltrating Ductal Carcinoma,0.128791465,,0.14936607,0,0,0,,Negative,-0.767,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3808,1,0,H & E,0,0,,0,Ola El-Zammar,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,3.33,0.58,6,4,8,,,2128,BRCA_Her2,54,2128,,1,1,54,54,,Invasive Carcinoma,18,,22,,,,31965,0,,54,54,,,,54,2128,,,54,,,,,,,,TUMOR FREE,Alive,-20705,,,,189,,54,54,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,23,,1,0.20184,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A152,,,,,,,2128,Liver,Distant Metastasis,,,,,,,19,,,,,,,,,,,,,2009,54,,,,Stage I,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,82112,,0.05639673,0,0,0,1,0.0209,0,,,Infiltrating Ductal Carcinoma,0.187257647,,0.143447524,0,0,0,,Negative,-0.7075,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6796,1,0,H & E,0,0,,0,Di (Andy) Ai,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HI-7170,White,PRAD,184,0,0,,HI,0,0,MALE,0,1.96,0.47,1,0,1,HRP,NO,2522,8-other,2522,2522,,0,0,2522,2522,prad_tcga,Malignant,2,,2,7.4,TCGA-HI-7170-01,0,5468,0,TCGA-HI-7170,2522,2522,Prostate Cancer,-78,1746,2522,2522,TCGA,No Evidence of Extraprostatic Extension,2522,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-21199,,58,6,32,PRAD,2522,2522,WHITE,0.0,[Not Available],[Not Applicable],32,R0,1,Matched,0.01,Prostate,Resection,3,70bf0c3e-0c06-4168-996c-46783752fa37,3,Normal (no evidence of prostate cancer) [cM0],0,0.043361,[Not Available],6394e00a-1f6f-4ea2-b885-373bbb59def9,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HI,1.03333333333,TCGA-HI-7170,0:DiseaseFree,1,6,Prostate Adenocarcinoma,82.85,2/21/12,2522,,,,,YES,C61,96f2ece8-246a-43fe-8963-217613c84f0b,,2,TUMOR FREE,0.0428,0:LIVING,0.1,,82.85,Bilateral,9,No Evidence of Extraprostatic Extension,-92,YES,,2006,,,TCGA-HI-7170.96f2ece8-246a-43fe-8963-217613c84f0b.pdf,,[Not Applicable],YES,-96,36-45%,6,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.8,58,Transurethral resection (TURBT),,,NO,YES,YES,,T2c,,6,No,,0,N0,T1c,0,M0,C61.9,8550/3,82113,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-F1-A72C,Asian,STAD,,1,1,,,1,0,,1,1.86,0.39,7,3,9,,,346,,343,346,,1,1,343,343,,Malignant,19,,76,,,,30938,,,343,343,,,,343,346,,,343,,,,,,,,WITH TUMOR,Alive,-25104,,,,71,,343,343,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Unknown,,,12,,0,0.25781,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,UNC,,TCGA-F1-A72C,,,,,,,346,Liver,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2013,343,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,82117,,0.495886109,,,,,,,,,,0.089831685,Grade 2,0.096151083,,,,Stage IIA,,0.3115,,,,,,,,,,,,,,,,0.3445,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-F1-A72C,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1.0,1,1,1.0,1.0,Male,TCGA-FP-8209,White,STAD,,1.0,1,,,1,1,,1.0,,,,,,,,1811,,1676,1811,,1.0,1,1676,1676,,Malignant,,,,,,,28840.0,0,,1676,1676,,,,1676,1811,,,1676,,,,,,,,WITH TUMOR,Dead,-18171,1811,,,0.0,,1676,1676,,,Stomach Cancer,[Not Applicable],,,,,,Stomach,Resection,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,International Genomics Consortium,,TCGA-FP-8209,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2005,1676,pancreas,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,49,,,,,,,,,,,,,,,,,,,,82133,,1.467160858,,,,,,,,,,0.108681166,Grade 3,0.233006407,,,,Stage IB,,1.0875,,,,,,,,,,,,,,,,0.4805,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-8209,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,1,1,1,Male,TCGA-22-4591,White,LUSC,,1,,,Mayo Clinic - Rochester,,1,MALE,1,3.38,0.73,16,16,20,,,623,,,623,,1,,443,443,,Malignant,52,,173,,,,20519,,,443,,,,,,623,,,443,,,,,,,,WITH TUMOR,Dead,-29250,623,,,474,,443,,,,[Not Available],[Not Applicable],,,,,0.21,,,,,15,,2,0.3964,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4591,,,,,,,623,,,,,,,,,72,,,,,,,,,,,,,2001,443,,,,Stage IIIA,,,,,,,,Partial Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,82135,,0.039217614,,,,,,,,,,0.172701756,,0.043151679,,,,Stage IIIA,,0.044,,,,,,,,,,,,,,,,0.0779,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.57535258,15.28784958,14.93708633,-0.628046217547358,LUSC,,17.65251627,15.19928979,Squamous Cell Carcinoma,-1.0929,12.80087312,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-49-4512,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,4.56,0.32,4,9,12,,,905,,,905,,1,1,905,905,,Malignant,25,,37,,,,24504,,,905,905,,,,,905,,,905,,,,,,,,WITH TUMOR,Dead,-25502,905,,,58,,905,905,,,[Not Available],[Not Applicable],,,,,0.24,,,,,27,,2,0.36924,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4512,,,,,,,157,,,,,,,,,48,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,82139,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98542375,16.9089662,11.37952049,-0.399506954,LUAD,,18.11303383,14.40690717,Adenocarcinoma,,13.80128998,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.66,0.38,10,13,15,,,2426,BRCA_Her2,2426,2426,,0,0,2426,2426,,Invasive Carcinoma,38,,26,,,,19830,0,,2426,2426,,,,2426,2426,,,2426,,,,,,,,TUMOR FREE,Alive,-23543,,,,334,,2426,2426,,,[Not Available],[Not Applicable],,,,,0.52,Breast,Resection/Excision,,,19,,1,0.3204,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EQ,,,,,,,2426,,,,,,,,,34,,,,,,,,,,,,,2004,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,82141,,1.870380466,0,0,0,0,-0.6687,1,,,Infiltrating Ductal Carcinoma,0.200164552,,0.162200639,0,0,0,,Negative,1.4925,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0536,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-KK-A6E4,,PRAD,,0,0,,KK,2,2,MALE,2,1.92,0.82,5,6,1,HRD,NO,3502,,3502,3502,,2,2,3502,3502,prad_tcga,Malignant,12,BARD1;BRCA1;BRIP1;CDK12;FANCL;RAD51C;RAD51D;RAD54L,36,,TCGA-KK-A6E4-01,0,5503,0,TCGA-KK-A6E4,3502,3502,Prostate Cancer,,890,3502,3502,TCGA,,3502,Primary,0,Apex|Middle|Base,A,,BRCA2,True,TUMOR FREE,Dead,-25338,3502,69,7,48,PRAD,3502,3502,,0.0,[Not Available],[Not Applicable],39,,1,Matched,0.06,Prostate,Resection,3,A1468DDD-3273-407F-AC8E-8ABF4B952FC1,0,,0,0.070622,[Not Available],DCF383D5-B25A-4EA9-A3F4-4D7EA5DDD9EF,4,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,1.33333333333,TCGA-KK-A6E4,,2,16,Prostate Adenocarcinoma,,3/27/14,,,,,,NO,C61,D4A30E0D-4829-4B4E-863A-DF2ACED85BE8,190,0,TUMOR FREE,0.1139,1:DECEASED,0.1,,115.05,Right,18,,,YES,3094,2004,,,TCGA-KK-A6E4.D4A30E0D-4829-4B4E-863A-DF2ACED85BE8.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2004,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,,NO,YES,YES,NO,T2b,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,82143,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Female,TCGA-49-AARN,Black or African American,LUAD,,0,0,,Johns Hopkins,2,,FEMALE,2,1.84,0.43,10,4,6,,,1135,,1135,1135,,2,2,1135,1135,,Malignant,20,,63,,,,19320,,,1135,1135,,,,1135,1135,,,1135,,,,,,,,,Dead,-20605,1135,,,1010,,1135,1135,,,[Not Available],[Not Applicable],,,,,0.28,,,,,6,,0,0.16967,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AARN,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,2000,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,82146,,0.322842686,,,,,,,,,,0.16961983,,0.138177499,,,,Stage IA,,0.7095,,,,,,,,,,,,,,,,0.3465,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.218109774,LUAD,,,,Adenocarcinoma,0.2117,,-0.2012,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.44,0.78,12,3,12,,,463,BRCA_LumB,,463,,0,0,463,463,,Invasive Carcinoma,27,,28,,,,22300,0,,463,463,,,,,463,,,463,,,,,,,,TUMOR FREE,Alive,-16787,,,,66,,463,463,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,23,,1,0.3192,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XF,,,,,,,463,,,,,,,,,25,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,82150,,,0,0,0,0,-0.1926,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,[Not Available],,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5766,White,PRAD,91,0,0,,CH,,0,MALE,0,1.91,0.55,7,8,4,ambiguous,NO,31,1-ERG,,31,,0,0,31,31,prad_tcga,Malignant,19,CHEK2,72,13.9,TCGA-CH-5766-01,0,5256,0,TCGA-CH-5766,31,31,Prostate Cancer,,39,,31,TCGA,,31,Primary,0,,A,,,,TUMOR FREE,Alive,-20392,,55,7,45,PRAD,31,31,WHITE,0.0,[Not Available],[Not Applicable],36,R0,1,Matched,0.11,Prostate,Resection,4,8477da86-95bd-4b6d-a3e8-c16c9d61ea1f,2,Normal (no evidence of prostate cancer) [cM0],0,0.088492,[Not Available],a5c77ab6-6e98-4a3d-81c8-f3d5fabd31d2,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,20,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,1.2,TCGA-CH-5766,0:DiseaseFree,3,27,Prostate Adenocarcinoma,1.02,3/16/12,31,,,,,NO,C61,f6f3fdff-8296-449a-9a1c-d23803cf078a,,3,TUMOR FREE,0.0616,0:LIVING,13.9,,1.02,Bilateral,35,No Evidence of Extraprostatic Extension,31,YES,,2007,,,TCGA-CH-5766.f6f3fdff-8296-449a-9a1c-d23803cf078a.pdf,Peripheral Zone,[Not Applicable],YES,31,61-70%,4,Prostate Adenocarcinoma Acinar Type,1,2007,[Not Available],,NO,No,R0,0.4,55,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N1,,1,M0,C61.9,8550/3,82151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-3396,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,2.13,0.24,3,2,5,,,1130,,1130,1130,,0,0,1130,1130,,Malignant,10,,3,,,,17685,,,1130,1130,,,,1130,1130,,,1130,,,,,,,,TUMOR FREE,Alive,-27073,,,,254,,1130,1130,,,[Not Available],[Not Applicable],,,,,0.16,,,,,6,,0,0.046878,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-3396,,,,,,,1130,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,82152,,1.28258779,,,,,,,,,,0.277890067,,0.174673826,,,,Stage IIIA,,2.08,,,,,,,,,,,,,,,,0.6029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.66876896,17.67149479,16.49312659,0.070925214,LUAD,,17.81819355,16.86079477,Adenocarcinoma,1.3806,14.60137033,1.0145,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-BR-8295,White,STAD,,1,1,,,,1,,1,,,,,,,,67,,,67,,1,1,67,67,,Malignant,,,,,,,19505,,,67,67,,,,,67,,,67,,,,,,,,WITH TUMOR,Dead,-22256,67,,,69,,67,67,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8295,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,60,,,,,,,,,,,,,,,,,,,,82156,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8295,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,Male,TCGA-44-6146,White,LUAD,,1,1,,Christiana Healthcare,1,0,MALE,1,1.87,0.7,5,2,4,,,728,,631,728,,1,1,631,631,,Malignant,11,,28,,,,18921,,,631,631,,,,631,728,,,631,,,,,,,,TUMOR FREE,Alive,-23378,,,,36,,631,631,,,[Not Available],[Not Applicable],,,,,0.0,,,,,4,,0,0.13135,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6146,,,,,,,728,,Locoregional Recurrence,,,,,,,6,,,,,,,,,,,,,2010,631,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,82161,,-0.475445295,,,,,,,,,,0.145246114,,0.166441082,,,,Stage IIB,,-0.6285,,,,,,,,,,,,,,,,0.0007,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,14.15840424,15.60188983,12.57870552,-0.609578227,LUAD,Adenocarcinoma,17.67040271,14.58538217,Adenocarcinoma,-2.4236,12.2367018,-0.8114,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.11,0.7,5,7,8,,,403,BRCA_LumA,403,403,,0,0,403,403,,Invasive Carcinoma,20,,87,,,,30375,0,,403,403,,,,403,403,,,403,,,,,,,,TUMOR FREE,Alive,-22900,,,,150,,403,403,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,5,,0,0.11463,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A140,,,,,,,403,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,82162,,,0,0,0,0,0.4043,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.88,8,5,14,,,1732,BRCA_LumA,1732,1732,,0,0,1732,1732,,Invasive Carcinoma,27,,15,,,,26914,0,,1732,1732,,,,1732,1732,,,1732,,,,,,,,TUMOR FREE,Alive,-23570,,,,54,,1732,1732,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,8,,0,0.18334,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15R,,,,,,,1732,,,,,,,,,13,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,82163,,-1.542105776,0,0,0,0,-2.4542,1,,,Infiltrating Ductal Carcinoma,0.082957969,,0.084264945,0,0,0,,Negative,-1.355,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0811,1,0,H & E,0,0,,0,Scott  Bourne,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.73,0.89,7,5,9,,,1561,BRCA_LumB,1561,1561,,0,0,1561,1561,,In Situ Carcinoma,21,,23,,,,17033,0,,1561,1561,,,,1561,1561,,,1561,,,,,,,,TUMOR FREE,Alive,-22962,,,,54,,1561,1561,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,10,,1,0.10397,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HW,,,,,,,1561,,,,,,,,,9,,,,,,,,,,,,,2006,,,,,Stage IA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,82175,,-1.473758243,0,0,0,0,0.0981,1,,,Infiltrating Ductal Carcinoma,0.043401853,,0.130026944,0,0,0,,Negative,-1.68,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.274,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,1,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade)",0,None,None,0,None,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.9,0.22,3,0,5,,,2590,BRCA_LumA,2590,2590,,0,0,2590,2590,,Invasive Carcinoma,8,,7,,,,18964,0,,2590,2590,,,,2590,2590,,,2590,,,,,,,,TUMOR FREE,Alive,-19030,,,,84,,2590,2590,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,9,,0,0.16928,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DI,,,,,,,2590,,,,,,,,,7,,,,,,,,,,,,,2005,,,,,Stage I,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,82177,,1.931593843,0,0,0,0,0.3295,1,,,Infiltrating Ductal Carcinoma,0.189293292,,0.221340228,0,0,0,,Negative,1.754,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.52,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,,,White,BRCA,,1,1,,,,0,FEMALE,1,3.02,0.18,2,8,12,,,3287,BRCA_LumA,,3287,,1,1,181,181,,Invasive Carcinoma,22,,89,,,,20595,0,,181,181,,,,,3287,,,181,,,,,,,,WITH TUMOR,Alive,-22280,,,,49,,181,181,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,18,,1,0.083956,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,John Wayne Cancer Center,,TCGA-Z7-A8R5,,,,,,,3287,,Locoregional Recurrence,,,,,,,28,,,,,,,,,,,,,2005,181,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,82181,,0.142448965,0,0,0,0,1.2497,1,,,Infiltrating Lobular Carcinoma,0.189660144,,0.209821197,0,0,0,,Positive,-1.073,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2821,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-7580,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,3.44,0.37,8,0,7,,,925,,925,925,,0,0,925,925,,Malignant,15,,24,,,,26992,,,925,925,,,,925,925,,,925,,,,,,,,TUMOR FREE,Alive,-30740,,,,174,,925,925,,,[Not Available],[Not Applicable],,,,,0.07,,,,,27,,1,0.32105,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7580,,,,,,,925,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,84,,,,,,,,,,,,,,,,,,,,82182,,0.318017285,,,,,,,,,,0.147402376,,0.010848302,,,,Stage IB,,-0.4295,,,,,,,,,,,,,,,,0.3346,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.732937260494116,LUSC,,,,Squamous Cell Carcinoma,0.0979,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-69-7763,White,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,2.64,0.35,5,9,9,,,690,,,690,,0,0,690,690,,Malignant,23,,36,,,,22869,,,690,690,,,,,690,,,690,,,,,,,,,Alive,-25316,,,,98,,690,690,,,[Not Available],[Not Applicable],,,,,0.19,,,,,22,,1,0.3584,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7763,,,,,,,690,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,82183,,0.22057791,,,,,,,,,,0.229357222,,0.260907933,,,,Stage IA,,-0.025,,,,,,,,,,,,,,,,0.4629,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,HOMDEL,,,1,,,,,,,-0.355062102,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.5501,,-0.5462,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-CH-5739,White,PRAD,91,0,0,,CH,0,0,MALE,0,2.02,0.68,4,1,3,HRP,NO,671,1-ERG,671,671,,0,0,671,671,prad_tcga,Malignant,8,BRCA2,51,4.8,TCGA-CH-5739-01,0,5238,0,TCGA-CH-5739,671,671,Prostate Cancer,,586,671,671,TCGA,,671,Primary,0,,A,,,,TUMOR FREE,Alive,-23953,,65,7,40,PRAD,671,671,WHITE,0.0,[Not Available],[Not Applicable],35,R0,1,Matched,0.01,Prostate,Resection,3,b3888450-4b79-41ca-bac2-ae1cbd8494ab,4,,0,0.046542,[Not Available],79601d90-b198-4b94-b60f-4cff329c7a10,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,1.16666666667,TCGA-CH-5739,0:DiseaseFree,2,6,Prostate Adenocarcinoma,22.04,3/16/12,671,,,,,NO,C61,6db82b14-85e4-40c4-9827-a588c4a25ce8,,2,TUMOR FREE,0.0882,0:LIVING,0.02,,22.04,Left,10,,,YES,,2006,,,TCGA-CH-5739.6db82b14-85e4-40c4-9827-a588c4a25ce8.pdf,Peripheral Zone,[Not Applicable],NO,,76-85%,8,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.4,65,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,M0,C61.9,8550/3,82184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-86-8280,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,2.56,0.45,3,4,12,,,701,,701,701,,0,0,701,701,,Malignant,19,,39,,,,20720,,,701,701,,,,701,701,,,701,,,,,,,,TUMOR FREE,Alive,-19977,,,,56,,701,701,,,[Not Available],[Not Applicable],,,,,0.54,,,,,22,,1,0.238,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8280,,,,,,,701,,,,,,,,,34,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,82186,,1.251741229,,,,,,,,,,0.271652673,,0.191833507,,,,Stage IIA,,1.48,,,,,,,,,,,,,,,,0.2754,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,16.02363643,17.38905197,16.85168125,-0.020382672,LUAD,Adenocarcinoma,18.40049494,16.34345415,Adenocarcinoma,0.104,13.76627249,0.2261,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-BR-A4CR,White,STAD,,0.0,0,,,0,0,,0.0,3.22,0.77,11,7,12,,,0,,0,0,,0.0,0,0,0,,Malignant,30,,157,,,,22319.0,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-25669,,,,89.0,,0,0,,,[Not Available],[Not Applicable],,,,,0.31,Stomach,Resection,,,18,,1,0.49284,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4CR,,,,,,,0,,,,,,,,,32,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,82189,,-1.145747541,,,,,,,,,,-0.002865366,Grade 3,-0.013842421,,,,Stage IIIC,,-0.977,,,,,,,,,,,,,,,,-0.3507,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4CR,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-86-A4P7,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,2.1,0.19,6,15,11,,,415,,415,415,,0,0,415,415,,Malignant,32,,38,,,,33653,,,415,415,,,,415,415,,,415,,,,,,,,TUMOR FREE,Alive,-23330,,,,81,,415,415,,,[Not Available],[Not Applicable],,,,,0.33,,,,,6,,0,0.23001,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-A4P7,,,,,,,415,,,,,,,,,13,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,82191,,1.003409884,,,,,,,,,,0.24895672,,0.286234915,,,,Stage IB,,1.109,,,,,,,,,,,,,,,,0.1669,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E709_T710delinsD (driver),,,1,E709_T710delinsD (driver),,,,,,-0.116595151,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.7061,,0.7328,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-66-2753,,LUSC,,0,0,,Indivumed,,0,MALE,0,,,,,,,,31,,,31,,0,0,31,31,,Malignant,,,,,,,16618,,,31,31,,,,,31,,,31,,,,,,,,TUMOR FREE,Alive,-25506,,,,0,,31,31,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2753,,,,,,,31,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,82194,,0.198912819,,,,,,,,,,0.18790061,,0.092226947,,,,Stage IB,,0.2585,,,,,,,,,,,,,,,,0.659,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.490160306713807,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.382,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-43-6771,White,LUSC,,1,,,Christiana Healthcare,,1,MALE,1,2.02,0.48,4,3,6,,,166,,,166,,1,,154,154,,Malignant,13,,24,,,,24561,,,154,,,,,,166,,,154,,,,,,,,WITH TUMOR,Dead,-31052,166,,,274,,154,,,,[Not Available],[Not Applicable],,,,,0.37,,,,,6,,0,0.26041,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-6771,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2006,154,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,85,,,,,,,,,,,,,,,,,,,,82195,,0.578949356,,,,,,,,,,0.175835751,,0.080075244,,,,Stage IB,,1.266,,,,,,,,,,,,,,,,0.833,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.320945789843591,LUSC,,,,Squamous Cell Carcinoma,1.0207,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-38-4631,White,LUAD,,1,1,,,,1,FEMALE,1,3.1,0.49,11,17,14,,,354,,,354,,1,1,354,354,,Malignant,42,,38,,,,19056,,,354,354,,,,,354,,,354,,,,,,,,WITH TUMOR,Dead,-26538,354,,,982,,354,354,,,[Not Available],[Not Applicable],,,,,0.65,,,,,16,,1,0.27788,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,,,TCGA-38-4631,,,,,,,,,,,,,,,,37,,,,,,,,,,,,,1997,,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,72,,,,,,,,,,,,,,,,,,,,82216,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,-0.1696,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,F139L,1,,,F139L,,,,-0.528011209,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-97-A4M7,White,LUAD,,0,0,,Washington University - NYU,0,0,MALE,0,2.03,0.37,5,9,6,,,629,,629,629,,0,0,629,629,,Malignant,20,,53,,,,23404,,,629,629,,,,629,629,,,629,,,,,,,,TUMOR FREE,Alive,-27062,,,,424,,629,629,,,[Not Available],[Not Applicable],,,,,0.56,,,,,9,,0,0.15441,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4M7,,,,,,,629,,,,,,,,,9,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,82220,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,0.3807,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.008052726,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,3.12,0.83,6,2,7,,,303,BRCA_LumB,,303,,0,0,303,303,,Invasive Carcinoma,15,,64,,,,34272,0,,303,303,,,,,303,,,303,,,,,,,,,Alive,-19031,,,,94,,303,303,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,13,,1,0.15016,[Unknown],,,"Other, specify",,,,,,[Not Available],,Holy Cross,,TCGA-5T-A9QA,,,,,,,303,,,,,,,,,21,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,82229,,-2.136260327,0,0,0,0,-0.2217,1,,,Other,0.03643378,,0.01525431,0,0,0,,[Unknown],-1.5155,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.709,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-CH-5765,White,PRAD,91,0,0,,CH,0,0,MALE,0,1.95,0.75,3,5,1,HRP,NO,700,1-ERG,700,700,,0,0,700,700,prad_tcga,Malignant,9,,39,37.9,TCGA-CH-5765-01,0,5255,0,TCGA-CH-5765,700,700,Prostate Cancer,,694,700,700,TCGA,,700,Primary,0,,A,,,,TUMOR FREE,Alive,-20364,,55,7,45,PRAD,700,700,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.0,Prostate,Resection,3,e2359111-b056-4676-a8b6-c5cea259b478,1,Normal (no evidence of prostate cancer) [cM0],0,0.05691,[Not Available],716eb429-d7af-4d4f-bd8d-afcff1a323ee,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,1.3,TCGA-CH-5765,0:DiseaseFree,2,8,Prostate Adenocarcinoma,23.0,3/16/12,700,,,,,NO,C61,bf80f60e-d5c8-4a5b-b523-358c51ad7d2c,,2,TUMOR FREE,0.0544,0:LIVING,0.02,,23.0,Bilateral,10,No Evidence of Extraprostatic Extension,31,YES,,2007,,,TCGA-CH-5765.bf80f60e-d5c8-4a5b-b523-358c51ad7d2c.pdf,,[Not Applicable],YES,31,46-55%,7,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,0.4,55,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,M0,C61.9,8550/3,82241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Male,TCGA-KK-A5A1,,PRAD,,1,1,,KK,,,MALE,1,,,,,,HRD,NO,2469,,,2469,,1,1,203,203,prad_tcga,Malignant,,,,,TCGA-KK-A5A1-01,0,5497,0,TCGA-KK-A5A1,203,203,Prostate Cancer,,420,,2469,TCGA,,203,Primary,0,Apex|Middle|Base,A,CDK12:.:.:splice_donor_variant;CDK12:588-592:THSKT/X:frameshift_variant,,True,,Dead,-26415,2469,72,9,129,PRAD,203,203,,0.0,[Not Available],[Not Applicable],101,,1,Matched,,Prostate,Resection,4,531D3514-F2E4-49FA-A31B-DF25B26CB99F,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],436B242C-AD5F-432E-A684-27BBA4C1C8A2,5,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,KK,3.46666666667,TCGA-KK-A5A1,1:Recurred/Progressed,5,,Prostate Adenocarcinoma,6.67,5/28/13,,,Locoregional Recurrence,,,NO,C61,DF56D103-963E-4C23-9DB8-1333AFF418CE,90,,,,1:DECEASED,0.1,,81.11,Bilateral,,,14,YES,3586,2003,203,,TCGA-KK-A5A1.DF56D103-963E-4C23-9DB8-1333AFF418CE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,57,,3,Prostate Adenocarcinoma Acinar Type,1,2003,Partial Remission/Response,,NO,No,R1,,72,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,T3a,0,M0,C61.9,8140/3,82242,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.38,0.38,5,13,17,,,1248,BRCA_LumB,1248,1248,,0,0,1248,1248,,Invasive Carcinoma,35,,41,,,,25451,0,,1248,1248,,,,1248,1248,,,1248,,,,,,,,TUMOR FREE,Alive,-14115,,,,40,,1248,1248,,,[Not Available],[Not Applicable],,,,,0.56,Breast,Resection/Excision,,,13,,1,0.11889,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A22D,,,,,,,1248,,,,,,,,,34,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,82243,,2.008030096,0,0,0,0,-0.7952,1,,,Infiltrating Ductal Carcinoma,0.188792437,,0.101667189,0,0,0,,Negative,2.445,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0366,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.53,0.6,4,11,14,,,666,BRCA_LumB,666,666,,0,0,666,666,,Invasive Carcinoma,29,,14,,,,23883,0,,666,666,,,,666,666,,,666,,,,,,,,TUMOR FREE,Alive,-23058,,,,81,,666,666,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,25,,1,0.088497,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YG,,,,,,,666,,,,,,,,,24,,,,,,,,,,,,,2009,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,82255,,0.015455562,0,0,0,0,0.448,1,,,Infiltrating Ductal Carcinoma,0.122315374,,0.123273743,0,0,0,,Negative,-0.894,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0019,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-AAMZ,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,5.87,0.3,3,15,24,,,1348,,,1348,,1.0,1,1344.0,1344.0,,Malignant,42,,29,,,,21345.0,,,1344.0,1344,,,,,1348,,,1344.0,,,,,,,,WITH TUMOR,Dead,-29667,1348,,,332.0,,1344.0,1344,,,[Not Available],[Not Applicable],,,,,0.42,,,,,20,,2,0.032802,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMZ,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,54,,,,,,,,,,,,,2007,1344,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,81.0,,,,,,,,,,,,,,,,,,,,82257,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-SW-A7EA,White,STAD,,0,0,,,0,0,,0,2.04,0.66,1,4,1,,,579,,579,579,,0,0,579,579,,Malignant,6,,27,,,,17215,,,579,579,,,,579,579,,,579,,,,,,,,TUMOR FREE,Alive,-22294,,,,902,,579,579,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,2,,0,0.026794,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,GX,,Global Bioclinical-Moldova,,TCGA-SW-A7EA,,,,,,,579,,,,,,,,,1,,,,,,,,,,,,,2013,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,82273,,0.130528514,,,,,,,,,,0.067308695,Unknown,-0.040908197,,,,Stage IB,,1.8965,,,,,,,,,,,,,,,,-0.0185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-SW-A7EA,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.7,0.71,18,18,19,,,567,BRCA_Basal,567,567,,0,0,567,567,,Invasive Carcinoma,55,,102,,,,24141,0,,567,567,,,,567,567,,,567,,,,,,,,TUMOR FREE,Alive,-18927,,,,133,,567,567,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,9,,0,0.45186,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A5IZ,,,,,,,567,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,82274,,-0.648740913,0,0,0,0,1.5213,1,,,Infiltrating Ductal Carcinoma,0.16265235,,0.077871164,0,0,0,,Negative,-1.032,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2421,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,5.83,0.62,10,22,25,,,214,BRCA_LumA,214,214,,0,0,214,214,,Invasive Carcinoma,57,,62,,,,17244,0,,214,214,,,,214,214,,,214,,,,,,,,TUMOR FREE,Alive,-23300,,,,150,,214,214,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,16,,2,0.18755,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FT,,,,,,,214,,,,,,,,,44,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,82275,,-0.283198983,0,0,0,0,1.2793,1,,,Infiltrating Ductal Carcinoma,0.146414575,,0.247025726,0,0,0,,Negative,-0.8815,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.3182,0,0,H & E,0,0,,0,Scott  Bourne,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,,1,1,,,White,BRCA,,1,1,,,1,,FEMALE,1,1.76,0.86,10,7,9,,,3262,BRCA_LumA,1313,3262,,1,1,1313,1313,,Invasive Carcinoma,26,,43,,,,20564,0,,1313,1313,,,,1313,3262,,,1313,,,,,,,,,Dead,-15720,3262,,,70,,1313,1313,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,6,,0,0.25848,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TZ,,,,,,,,Bone,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2004,1313,,,,[Discrepancy],,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,82276,,-0.317508899,0,0,0,0,0.0296,1,,,Infiltrating Ductal Carcinoma,0.111496003,,0.087984921,0,0,0,,Negative,-0.9125,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2563,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-78-7153,White,LUAD,,0,0,,Prince Charles Hospital,0,0,FEMALE,0,4.0,0.57,1,1,4,,,3635,,3635,3635,,0,0,3635,3635,,Malignant,6,,11,,,,23172,,,3635,3635,,,,3635,3635,,,3635,,,,,,,,,Alive,-23922,,,,155,,3635,3635,,,[Not Available],[Not Applicable],,,,,0.41,,,,,14,,1,0.021295,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7153,,,,,,,3635,,,,,,,,,16,,,,,,,,,,,,,2003,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,82291,,-0.218847235,,,,,,,,,,0.125044574,,0.105299503,,,,Stage IB,,-0.7515,,,,,,,,,,,,,,,,-0.3136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,E117K,1,,,E117K,,,,-0.467305365,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.8973,,-0.0095,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BT-A0S7,White,BLCA,,1.0,1,,,,1,MALE,1.0,5.67,0.29,2,6,14,,,200,,,200,,1.0,1,200.0,200.0,,Malignant,22,,39,,,,20676.0,,,200.0,200,,,,,200,,,200.0,,,,,,,,WITH TUMOR,Dead,-27533,200,,,58.0,,200.0,200,,,[Not Available],[Not Applicable],,,,,0.27,,,,,19,,2,0.20769,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A0S7,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2007,,,,,Stage III,,,,,,,,Progressive Disease,,,,,,75.0,,,,,,,,,,,,,,,,,,,,82295,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MN-A4N4,White,LUAD,,0,0,,BLN - Baylor,0,0,MALE,0,4.12,0.34,8,19,24,,,1175,,1175,1175,,0,0,1175,1175,,Malignant,51,,40,,,,32074,,,1175,1175,,,,1175,1175,,,1175,,,,,,,,TUMOR FREE,Alive,-20888,,,,1969,,1175,1175,,,[Not Available],[Not Applicable],,,,,0.56,,,,,17,,2,0.17792,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,BLN - Baylor,,TCGA-MN-A4N4,,,,,,,1175,,,,,,,,,79,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,82298,,0.231347447,,,,,,,,,,0.207742502,,0.149865325,,,,Stage IA,,0.217,,,,,,,,,,,,,,,,0.6622,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.373600442,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,5.0,0.51,12,6,21,,,1516,BRCA_LumB,1516,1516,,0,0,1516,1516,,Invasive Carcinoma,39,,52,,,,19266,0,,1516,1516,,,,1516,1516,,,1516,,,,,,,,TUMOR FREE,Alive,-13680,,,,48,,1516,1516,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,27,,2,0.27181,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0T3,,,,,,,1516,,,,,,,,,50,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,[Not Available],,,,,,37,,,,,,,,,,,,,,,,,,,,82306,,-0.444443542,0,0,0,1,-0.1212,0,,,Infiltrating Ductal Carcinoma,0.058997489,,0.156451372,0,0,0,,Negative,-0.855,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1988,1,0,H & E,0,0,,0,Scott  Bourne,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-44-6775,White,LUAD,,1,1,,Christiana Healthcare,1,0,FEMALE,1,3.36,0.27,8,6,13,,,705,,684,705,,1,1,684,684,,Malignant,27,,65,,,,17897,,,684,684,,,,684,705,,,684,,,,,,,,WITH TUMOR,Alive,-26415,,,,83,,684,684,,,[Not Available],[Not Applicable],,,,,0.46,,,,,24,,1,0.25821,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6775,,,,,,,705,,Locoregional Recurrence,,,,,,,35,,,,,,,,,,,,,2011,684,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,82310,,1.176100052,,,,,,,,,,0.322607398,,0.133024011,,,,Stage IB,,0.799,,,,,,,,,,,,,,,,0.7537,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.223750967,LUAD,,,,Adenocarcinoma,1.7105,,-0.5262,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-05-4417,,LUAD,,0,0,,Indivumed,,0,FEMALE,0,2.93,0.4,4,10,8,,,455,,,455,,0,0,455,455,,Malignant,22,,11,,,,20629,,,455,455,,,,,455,,,455,,,,,,,,TUMOR FREE,Alive,-18780,,,,383,,455,455,,,[Not Available],[Not Applicable],,,,,0.36,,,,,15,,1,0.12842,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4417,,,,,,,455,,,,,,,,,34,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,Partial Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,82314,,1.635431654,,,,,,,,,,0.258859925,,0.267569658,,,,Stage IB,,1.35,,,,,,,,,,,,,,,,0.5142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,0.020739038,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.0692,,0.6018,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,323,BRCA_Normal,323,323,,0,0,323,323,,Invasive Carcinoma,,,,,,,17414,0,,323,323,,,,323,323,,,323,,,,,,,,TUMOR FREE,Alive,-26869,,,,45,,323,323,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Hartford Hospital,,TCGA-LD-A9QF,,,,,,,323,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,82316,,1.744639579,0,0,0,1,0.8094,0,,,Infiltrating Ductal Carcinoma,0.274183753,,0.244759216,0,0,0,,Negative,1.5695,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6755,1,0,H & E,0,0,,0,Ola El-Zammar,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, High Grade), No Detail Present",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.31,0.38,3,17,17,,,635,BRCA_Her2,635,635,,0,0,635,635,,Invasive Carcinoma,37,,42,,,,16293,1,,635,635,,,,635,635,,,635,,,,,,,,TUMOR FREE,Alive,-18942,,,,128,,635,635,,,[Not Available],[Not Applicable],,,,,0.32,Not Specific/Unknown,Resection/Excision,,,23,,2,0.40181,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A13Z,,,,,,,635,,,,,,,,,55,,,,,,,,,,,,,2010,,,,,[Not Available],,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,82317,TRUE,0.779620684,0,0,0,0,0.594,1,,,Infiltrating Ductal Carcinoma,0.213550405,,0.145129528,0,0,0,,Negative,0.5705,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5235,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Suboptimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.9,0.56,12,8,16,,,506,BRCA_Her2,506,506,,0,0,506,506,,Invasive Carcinoma,36,,93,,,,31947,1,,506,506,,,,506,506,,,506,,,,,,,,TUMOR FREE,Alive,-22448,,,,49,,506,506,,,[Not Available],[Not Applicable],,,,,0.04,Not Specific/Unknown,Resection/Excision,,,10,,0,0.35727,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XT,,,,,,,506,,,,,,,,,19,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,82323,,0.029950615,0,0,0,0,0.2796,1,,,Infiltrating Ductal Carcinoma,0.194402687,,0.18899319,0,0,0,,Negative,-0.2395,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6232,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.12,0.63,2,1,4,,,1692,BRCA_LumA,1692,1692,,0,0,1692,1692,,None,7,,5,,,,16339,N/A (Non-Malignant),,1692,1692,,,,1692,1692,,,1692,,,,,,,,TUMOR FREE,Alive,-16163,,,,45,,1692,1692,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.085248,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15I,,,,,,,1692,,,,,,,,,10,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,82324,,0.978607201,0,0,0,0,0.9729,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.140929928,N/A (Non-Malignant),0.139472407,0,0,0,N/A (Non-Malignant),Negative,0.158,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1987,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.26,0.75,9,13,16,,,607,BRCA_Basal,607,607,,0,0,607,607,,None,38,,33,,,,18524,N/A (Non-Malignant),,607,607,,,,607,607,,,607,,,,,,,,TUMOR FREE,Alive,-19073,,,,66,,607,607,,,[Not Available],[Not Applicable],,,,,0.33,Breast,Resection/Excision,,,7,,1,0.20175,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1PH,,,,,,,607,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,82327,TRUE,0.438880251,0,0,0,0,0.6636,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.166621835,N/A (Non-Malignant),0.040556398,0,0,0,N/A (Non-Malignant),Negative,0.0045,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1081,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5521,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.94,0.43,3,5,4,ambiguous,NO,2279,1-ERG,2279,2279,,0,0,2279,2279,prad_tcga,Malignant,12,BRCA2;RAD51C;RAD51D,28,7.3,TCGA-EJ-5521-01,0,5284,0,TCGA-EJ-5521,2279,2279,Prostate Cancer,,240,2279,2279,TCGA,,2279,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-23304,,63,7,61,PRAD,2279,2279,WHITE,0.0,[Not Available],[Not Applicable],51,R0,1,Matched,0.17,Prostate,Resection,3,9eebd2ec-af9d-493c-a006-a436c28d4cd3,0,,0,0.058663,[Not Available],d44d4bcb-beb1-4464-acd2-9972751f5018,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.7,TCGA-EJ-5521,0:DiseaseFree,2,24,Prostate Adenocarcinoma,74.87,4/4/12,2279,,,,,NO,C61,0c816088-3fe4-4646-abaa-94095efd0b26,,3,TUMOR FREE,0.0736,0:LIVING,0.1,3,74.87,Right,26,,,YES,,2008,,,TCGA-EJ-5521.0c816088-3fe4-4646-abaa-94095efd0b26.pdf,,[Not Applicable],NO,,41-50%,2,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,63,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,82328,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-44-7671,Black or African American,LUAD,,1,1,,Christiana Healthcare,1,0,MALE,1,3.03,0.58,4,3,5,,,889,,883,889,,1,1,883,883,,Malignant,12,,11,,,,17020,,,883,883,,,,883,889,,,883,,,,,,,,WITH TUMOR,Alive,-23538,,,,311,,883,883,,,[Not Available],[Not Applicable],,,,,0.43,,,,,14,,1,0.11326,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-7671,,,,,,,889,,Locoregional Recurrence,,,,,,,21,,,,,,,,,,,,,2010,883,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,82329,,-0.589905896,,,,,,,,,,0.200056965,,0.203270767,,,,Stage IB,,-0.6055,,,,,,,,,,,,,,,,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),P278S,1,,G12C (driver),P278S,,,,-0.796959342,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1736,,-1.4865,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.75,0.79,11,9,11,,,4080,BRCA_LumA,4080,4080,,0,0,4080,4080,,Invasive Carcinoma,31,,86,,,,21260,0,,4080,4080,,,,4080,4080,,,4080,,,,,,,,TUMOR FREE,Alive,-21755,,,,54,,4080,4080,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,13,,0,0.35172,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0U3,,,,,,,4080,,,,,,,,,13,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,82330,,0.441287189,0,0,0,0,-0.6553,1,,,Infiltrating Ductal Carcinoma,0.131296757,,0.105761995,0,0,0,,Negative,-0.472,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0369,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-A91K,White,STAD,,0,0,,,0,0,,0,1.98,0.72,3,4,4,,,1862,,1862,1862,,0,0,1862,1862,,Malignant,11,,68,,,,19631,,,1862,1862,,,,1862,1862,,,1862,,,,,,,,TUMOR FREE,Alive,-25424,,,,1947,,1862,1862,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,0,,0,0.051584,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A91K,,,,,,,1862,,,,,,,,,2,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,82335,,0.488919364,,,,,,,,,,0.10540695,Grade 2,0.029737274,,,,Stage IIIA,,0.508,,,,,,,,,,,,,,,,0.1927,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91K,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,1,1,Male,TCGA-YL-A8S9,,PRAD,389,1,1,,YL,,0,MALE,1,2.06,0.95,4,3,5,HRP,NO,1842,8-other,,1842,,1,1,1006,1006,prad_tcga,Malignant,12,,42,,TCGA-YL-A8S9-01,7,5660,0,TCGA-YL-A8S9,1006,1006,Prostate Cancer,,1839,,1842,TCGA,,1006,Primary,0,Apex|Middle,A,,,True,,Alive,-23204,,63,9,48,PRAD,1006,1006,,0.190788927,[Not Available],[Not Applicable],34,R1,1,Matched,0.12,Prostate,Resection,4,6C008A4C-200B-4786-AEE3-135E9D6CD26A,3,Normal (no evidence of prostate cancer) [cM0],0,0.074842,[Not Available],B0669EEC-6A1A-4618-AE23-AE0F9E9C266C,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,YL,1.1,TCGA-YL-A8S9,1:Recurred/Progressed,5,9,Prostate Adenocarcinoma,33.05,4/25/14,1842,,Locoregional Recurrence,,,NO,C61,7E33F018-6494-413F-A68D-AC4013916756,110,5,,0.1121,0:LIVING,0.03,3,60.51,Bilateral,12,,,YES,1891,2008,1006,,TCGA-YL-A8S9.7E33F018-6494-413F-A68D-AC4013916756.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,20,81-90%,5,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,NO,No,R1,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,82337,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9ZR,,PRAD,,0,0,,V1,0,0,MALE,0,1.93,0.54,4,10,2,ambiguous,NO,1361,,1361,1361,,0,0,1361,1361,prad_tcga,Malignant,16,,84,,TCGA-V1-A9ZR-01,0,5587,0,TCGA-V1-A9ZR,1361,1361,Prostate Cancer,,54,1361,1361,TCGA,,1361,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25185,,68,8,54,PRAD,1361,1361,,0.0,[Not Available],[Not Applicable],38,,1,Matched,0.0,Prostate,Resection,4,59466347-C5CF-4297-83F0-349A98B6EF97,0,,0,0.075338,[Not Available],338FE754-FC4A-4294-BA15-42D4C7C9AC10,4,Prostate Adenocarcinoma Acinar Type,,Prostate,17,,Acinar Adenocarcinoma,[Not Available],,V1,1.26666666667,TCGA-V1-A9ZR,0:DiseaseFree,4,17,Prostate Adenocarcinoma,44.71,7/23/14,1361,,,,,NO,C61,DB23EC5B-D86A-4B32-8C52-E91CAD4B7695,430,1,,0.0727,0:LIVING,1.44,,44.71,Bilateral,18,No Evidence of Extraprostatic Extension,78,YES,,,,,TCGA-V1-A9ZR.DB23EC5B-D86A-4B32-8C52-E91CAD4B7695.pdf,Peripheral Zone,[Not Applicable],YES,,,7,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R1,,68,Core needle biopsy,,,NO,YES,YES,YES,T4,NO,8,No,NO,,N0,T2c,,M0,C61.9,8140/3,82338,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7785,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.98,0.41,1,1,2,HRP,NO,1177,1-ERG,1177,1177,,0,0,1177,1177,prad_tcga,Malignant,4,,26,4.3,TCGA-EJ-7785-01,6,5318,0,TCGA-EJ-7785,1177,1177,Prostate Cancer,,259,1177,1177,TCGA,,1177,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-19939,,54,7,25,PRAD,1177,1177,WHITE,0.127686922,[Not Available],[Not Applicable],27,R0,1,Matched,0.0,Prostate,Resection,3,63ebd9b1-f118-4315-8722-708f47a07063,0,,0,0.021315,[Not Available],2def2a53-d2e8-46f0-8b07-f32dbf1833a4,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.63333333333,TCGA-EJ-7785,0:DiseaseFree,2,6,Prostate Adenocarcinoma,38.67,4/6/12,1177,,,,,NO,C61,01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b,,0,TUMOR FREE,0.0206,0:LIVING,0.1,3,38.67,Bilateral,8,,,YES,,2011,,,TCGA-EJ-7785.01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b.pdf,,[Not Applicable],NO,,31-40%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,54,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,82341,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-86-8585,White,LUAD,,0,0,,Asterand,0,0,MALE,0,2.82,0.29,15,15,22,,,353,,353,353,,0,0,353,353,,Malignant,52,,88,,,,17410,,,353,353,,,,353,353,,,353,,,,,,,,TUMOR FREE,Alive,-20918,,,,760,,353,353,,,[Not Available],[Not Applicable],,,,,0.23,,,,,17,,1,0.47357,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8585,,,,,,,353,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,82344,,1.277733623,,,,,,,,,,0.216712431,,0.038934201,,,,Stage IB,,1.359,,,,,,,,,,,,,,,,0.106,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.025313838,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.0642,,0.8597,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,3.4,0.36,11,33,26,,,304,BRCA_LumA,,304,,0,0,304,304,,Invasive Carcinoma,70,,44,,,,17895,0,,304,304,,,,,304,,,304,,,,,,,,WITH TUMOR,Alive,-14883,,,,314,,304,304,,,[Not Available],[Not Applicable],,,,,0.55,Breast,Resection/Excision,,,12,,1,0.27317,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09A,,,,,,,304,,,,,,,,,29,,,,,,,,,,,,,2009,,,,,Stage X,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,82352,,0.674080375,0,0,0,0,0.5784,1,,,Infiltrating Ductal Carcinoma,0.16512843,,0.195575414,0,0,0,,Positive,0.1675,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4755,0,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-2F-A9KP,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.96,0.64,6,10,12,,,364,,,364,,1.0,1,343.0,343.0,,Malignant,28,,70,,,,28569.0,,,343.0,343,,,,,364,,,343.0,,,,,,,,WITH TUMOR,Dead,-24428,364,,,185.0,,343.0,343,,,[Not Available],[Not Applicable],,,,,0.12,,,,,9,,1,0.087759,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KP,,,,,,,,Liver,Distant Metastasis,,,,,,,18,,,,,,,,,,,,,2011,343,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,82361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,82367,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-78-7167,White,LUAD,,1,,,Prince Charles Hospital,,1,MALE,1,3.68,0.84,8,14,15,,,2681,,,2681,,1,,726,726,,Malignant,37,,33,,,,18492,,,726,,,,,,2681,,,726,,,,,,,,WITH TUMOR,Dead,-28295,2681,,,280,,726,,,,[Not Available],[Not Applicable],,,,,0.05,,,,,14,,1,0.11114,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7167,,,,,,,,,,,,,,,,22,,,,,,,,,,,,,2002,726,,,,Stage IV,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,82370,,-0.198205788,,,,,,,,,,0.123748224,,0.136969518,,,,Stage IV,,-1.204,,,,,,,,,,,,,,,,-0.0149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12V (driver), G12C (driver)",G480W (driver),1,,"G12V (driver), G12C (driver)",G480W (driver),13.78627243,14.65152146,13.75048103,-0.867442104,LUAD,Adenocarcinoma,18.07558406,14.84538913,Adenocarcinoma,-0.7537,12.57181501,-0.8952,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-73-A9RS,Black or African American,LUAD,,1,1,,Roswell Park,,1,MALE,1,2.78,0.61,11,17,17,,,340,,,340,,1,1,107,107,,Malignant,45,,108,,,,32703,,,107,107,,,,,340,,,107,,,,,,,,WITH TUMOR,Dead,-15162,340,,,1242,,107,107,,,[Not Available],[Not Applicable],,,,,0.08,,,,,17,,1,0.27459,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-A9RS,,,,,,,,,Locoregional Recurrence,,,,,,,36,,,,,,,,,,,,,2013,107,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,41,,,,,,,,,,,,,,,,,,,,82372,,0.330315321,,,,,,,,,,0.105414851,,0.052066744,,,,Stage IIB,,0.9315,,,,,,,,,,,,,,,,-0.5115,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.43032524,16.58018804,15.9607775,-0.481855691,LUAD,Adenocarcinoma,17.7575215,15.62039316,Adenocarcinoma,-1.3877,10.47002598,0.0044,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,82373,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,-0.8043,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.74,0,0,0,,,1234,BRCA_LumA,1234,1234,,0,0,1234,1234,,Invasive Carcinoma,0,,0,,,,23939,0,,1234,1234,,,,1234,1234,,,1234,,,,,,,,TUMOR FREE,Alive,-25515,,,,40,,1234,1234,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,0,,0,0.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,MSKCC,,TCGA-AO-A12H,,,,,,,1234,,,,,,,,,0,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,82375,,-1.419720364,0,0,0,0,-0.2212,1,,,Other,0.106899915,,0.158541543,0,0,0,,Negative,-1.932,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0596,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-50-6590,White,LUAD,,0,0,,University of Pittsburgh,2,2,FEMALE,2,2.93,0.25,7,9,11,,,1288,,1288,1288,,2,2,1288,1288,,Malignant,27,,34,,,,26624,,,1288,1288,,,,1288,1288,,,1288,,,,,,,,TUMOR FREE,Dead,-26444,1288,,,1116,,1288,1288,,,[Not Available],[Not Applicable],,,,,0.49,,,,,14,,1,0.49266,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-6590,,,,,,,,,,,,,,,,33,,,,,,,,,,,,,2005,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,82377,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.076026149,LUAD,,,,Adenocarcinoma,1.6835,,0.8726,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.39,0.45,10,22,20,,,1587,BRCA_Basal,1587,1587,,0,0,1587,1587,,Invasive Carcinoma,52,,42,,,,18777,0,,1587,1587,,,,1587,1587,,,1587,,,,,,,,TUMOR FREE,Alive,-15052,,,,185,,1587,1587,,,[Not Available],[Not Applicable],,,,,0.53,Breast,Resection/Excision,,,16,,1,0.28003,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0J4,,,,,,,1587,,,,,,,,,25,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,82379,TRUE,1.140583263,0,0,0,0,1.4952,1,,,Infiltrating Ductal Carcinoma,0.176709688,,0.124283535,0,0,0,,Negative,0.8965,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.459,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.62,4,3,6,,,1217,BRCA_LumA,1217,1217,,0,0,1217,1217,,Invasive Carcinoma,13,,16,,,,19867,0,,1217,1217,,,,1217,1217,,,1217,,,,,,,,TUMOR FREE,Alive,-28003,,,,56,,1217,1217,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.06787,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08Z,,,,,,,1217,,,,,,,,,6,,,,,,,,,,,,,2004,,,,,[Discrepancy],,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,82381,,-0.065468354,0,0,0,0,-0.8739,1,,,Infiltrating Ductal Carcinoma,0.246836761,,0.174790818,0,0,0,,Negative,0.0925,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6456,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,0,No,0,Adipose Tissue,No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,,1,1,Female,TCGA-22-5481,White,LUSC,,1,,,Mayo Clinic - Rochester,1,,FEMALE,1,3.0,0.7,12,18,22,,,2409,,346,2409,,1,,346,346,,Malignant,52,,42,,,,28171,,,346,,,,,346,2409,,,346,,,,,,,,,Dead,-26419,2409,,,406,,346,,,,[Not Available],[Not Applicable],,,,,0.11,,,,,12,,1,0.25489,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5481,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2002,346,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,82383,,0.922464189,,,,,,,,,,0.107629098,,0.029102818,,,,Stage IIB,,1.94,,,,,,,,,,,,,,,,-0.2271,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.10910498,14.57699871,17.53930397,-0.195177884086088,LUSC,Squamous Cell Carcinoma,18.42636509,16.30618829,Squamous Cell Carcinoma,-0.6443,10.36142804,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-49-6742,White,LUAD,,1,,,Johns Hopkins,,1,MALE,1,3.61,0.49,3,2,4,,,488,,,488,,1,,214,214,,Malignant,9,,13,,,,21488,,,214,,,,,,488,,,214,,,,,,,,WITH TUMOR,Dead,-25839,488,,,364,,214,,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,1,0.068622,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6742,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2010,214,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,82384,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L268P,1,,,L268P,14.47771424,15.94131454,13.47401445,-0.704663899,LUAD,,17.8890364,13.61750443,Adenocarcinoma,,13.10424721,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-FP-A9TM,White,STAD,,0,0,,,0,0,,0,2.45,0.28,13,15,14,,,189,,189,189,,0,0,189,189,,Malignant,42,,155,,,,17625,,,189,189,,,,189,189,,,189,,,,,,,,TUMOR FREE,Alive,-28376,,,,216,,189,189,,,[Not Available],[Not Applicable],,,,,0.59,Stomach,Unknown,,,12,,1,0.43133,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,International Genomics Consortium,,TCGA-FP-A9TM,,,,,,,189,,,,,,,,,31,,,,,,,,,,,,,2013,,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,82387,,1.050952149,,,,,,,,,,0.054453663,Grade 2,0.033557638,,,,Unknown,,0.7755,,,,,,,,,,,,,,,,-0.2688,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-A9TM,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Female,TCGA-55-8616,White,LUAD,,0,0,,International Genomics Consortium,,0,FEMALE,0,3.91,0.39,9,6,16,,,48,,,48,,0,0,48,48,,Malignant,31,,88,,,,18391,,,48,48,,,,,48,,,48,,,,,,,,TUMOR FREE,Alive,-21225,,,,979,,48,48,,,[Not Available],[Not Applicable],,,,,0.23,,,,,20,,1,0.32003,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8616,,,,,,,48,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,58,,,,,,,,,,,,,,,,,,,,82391,,0.372468001,,,,,,,,,,0.167367738,,0.10647173,,,,Stage IB,,0.947,,,,,,,,,,,,,,,,0.1059,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.51243031,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.8357,,-0.2142,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.92,0.25,6,9,11,,,2273,BRCA_LumA,,2273,,1,1,2273,2273,,Invasive Carcinoma,26,,24,,,,20176,0,,2273,2273,,,,,2273,,,2273,,,,,,,,WITH TUMOR,Dead,-11650,2273,,,28,,2273,2273,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,5,,1,0.078846,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FE,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,1998,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,31,,,,,,,,,,,,,,,,,,,,82392,,1.502091182,0,0,0,0,-0.4677,1,,,Infiltrating Ductal Carcinoma,0.158686218,,0.20854845,0,0,0,,[Not Available],0.4955,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5442,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-4Z-AA80,White,BLCA,,0.0,0,,,,2,MALE,2.0,4.8,0.47,10,23,31,,,19,,,19,,2.0,2,19.0,19.0,,Malignant,64,,119,,,,33435.0,,,19.0,19,,,,,19,,,19.0,,,,,,,,TUMOR FREE,Dead,-26873,19,,,549.0,,19.0,19,,,[Not Available],[Not Applicable],,,,,0.41,,,,,20,,2,0.24773,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA80,,,,,,,,,,,,,,,,64,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,[Not Applicable],,,,,,73.0,,,,,,,,,,,,,,,,,,,,82393,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-M7-A71Y,,PRAD,331,0,0,,M7,0,0,MALE,0,1.95,0.19,3,2,2,HRP,NO,493,2-ETV1,493,493,,0,0,493,493,prad_tcga,Malignant,7,CHEK2,23,,TCGA-M7-A71Y-01,0,5538,0,TCGA-M7-A71Y,493,493,Prostate Cancer,,158,493,493,TCGA,,493,Primary,0,Apex|Middle|Base,A,,,False,TUMOR FREE,Alive,-20357,,55,7,23,PRAD,493,493,,0.0,[Not Available],[Not Applicable],22,R0,1,Matched,0.03,Prostate,Resection,3,6C728891-8924-4A51-B3ED-F4B83D6C8DE4,2,,0,0.064241,[Not Available],1583AEA0-5D69-4165-9BEF-D5BFDDDF3A65,4,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,M7,0.7,TCGA-M7-A71Y,0:DiseaseFree,2,0,Prostate Adenocarcinoma,16.2,12/10/13,493,,,,,NO,C61,569825C5-98D3-4A52-AD1D-2859F8F54A34,140,4,TUMOR FREE,0.0,0:LIVING,,,16.2,Bilateral,1,,,YES,183,2013,,,TCGA-M7-A71Y.569825C5-98D3-4A52-AD1D-2859F8F54A34.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,41-50%,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,55,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,T1c,,,C61.9,8140/3,82395,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6373,White,PRAD,,0,0,,G9,0,0,MALE,0,2.02,0.72,3,0,4,HRP,NO,811,,811,811,,0,0,811,811,prad_tcga,Malignant,7,,24,,TCGA-G9-6373-01,6,5372,0,TCGA-G9-6373,811,811,Prostate Cancer,,,811,811,TCGA,,811,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-24887,,68,7,36,PRAD,811,811,WHITE,0.094772502,[Not Available],[Not Applicable],42,,1,Matched,0.03,Prostate,Resection,4,18365c1f-9bc0-4865-b40d-def3ee73331c,7,Normal (no evidence of prostate cancer) [cM0],0,0.068527,[Not Available],c3a509c6-35a6-4d17-a9fd-0aa8884b33a0,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,G9,2.26666666667,TCGA-G9-6373,0:DiseaseFree,3,8,Prostate Adenocarcinoma,26.64,3/6/12,811,,,,,NO,C61,ed631fb0-95e4-4b30-963f-1ff4cb4f0ece,,5,TUMOR FREE,0.1457,0:LIVING,,,26.64,Bilateral,12,,,YES,,2009,,,TCGA-G9-6373.ed631fb0-95e4-4b30-963f-1ff4cb4f0ece.pdf,,[Not Applicable],NO,29,,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,,No,R0,0.9,68,Core needle biopsy,,,NO,YES,NO,,T3a,,7,No,,0,,T2b,,M0,C61.9,8550/3,82396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-86-8279,White,LUAD,,0,0,,Asterand,0,0,MALE,0,5.48,0.5,7,12,21,,,949,,949,949,,0,0,949,949,,Malignant,40,,67,,,,27489,,,949,949,,,,949,949,,,949,,,,,,,,TUMOR FREE,Alive,-17032,,,,679,,949,949,,,[Not Available],[Not Applicable],,,,,0.38,,,,,24,,2,0.50176,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8279,,,,,,,949,,,,,,,,,42,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,46,,,,,,,,,,,,,,,,,,,,82401,,-0.260101174,,,,,,,,,,0.20780655,,0.134247203,,,,Stage IIA,,-0.4305,,,,,,,,,,,,,,,,0.4502,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.60704948,15.92439103,13.63068917,-0.617123182,LUAD,Adenocarcinoma,17.79756836,14.22004438,Adenocarcinoma,0.5338,13.4355365,-1.8532,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-69-8253,Black or African American,LUAD,,0,0,,Washington University - Cleveland Clinic,0,0,FEMALE,0,3.14,0.39,3,3,8,,,426,,426,426,,0,0,426,426,,Malignant,14,,12,,,,19411,,,426,426,,,,426,426,,,426,,,,,,,,TUMOR FREE,Alive,-21771,,,,211,,426,426,,,[Not Available],[Not Applicable],,,,,0.03,,,,,14,,1,0.059542,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-8253,,,,,,,426,,,,,,,,,20,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,82415,,0.236596397,,,,,,,,,,0.18956337,,0.177467947,,,,Stage IIA,,0.0505,,,,,,,,,,,,,,,,0.0287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),E41* (driver),1,,G12D (driver),E41* (driver),14.92179156,16.9858345,13.63477327,-0.539927301,LUAD,Adenocarcinoma,17.93256868,14.98036762,Adenocarcinoma,-0.7723,13.17909958,-1.0383,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.28,0.8,5,4,9,,,3256,BRCA_LumB,3256,3256,,0,0,3256,3256,,Invasive Carcinoma,18,,60,,,,28853,0,,3256,3256,,,,3256,3256,,,3256,,,,,,,,TUMOR FREE,Alive,-16955,,,,124,,3256,3256,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,13,,0,0.10117,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,John Wayne Cancer Center,,TCGA-Z7-A8R6,,,,,,,3256,,,,,,,,,12,,,,,,,,,,,,,2005,,,,,Stage I,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,82425,,-0.303544121,0,0,0,0,-0.0462,1,,,Infiltrating Lobular Carcinoma,0.121458688,,0.085340692,0,0,0,,Negative,-0.511,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1918,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-V1-A8MM,,PRAD,,1,1,,V1,1,0,MALE,1,1.97,0.78,6,12,2,HRD,NO,1195,,990,1195,,1,1,990,990,prad_tcga,Malignant,20,,84,,TCGA-V1-A8MM-01,0,5562,0,TCGA-V1-A8MM,990,990,Prostate Cancer,,990,990,1195,TCGA,,990,Primary,0,Apex,A,,BRCA2,True,,Alive,-22265,,60,7,31,PRAD,990,990,,0.0,[Not Available],[Not Applicable],18,,1,Matched,0.03,Prostate,Resection,4,ED22176A-F208-477C-8941-0DAB957A64CE,1,,0,0.09147,[Not Available],94D6675E-27AE-4F34-9D53-6E19238EB01D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,19,,Acinar Adenocarcinoma,[Not Available],,V1,0.6,TCGA-V1-A8MM,1:Recurred/Progressed,3,17,Prostate Adenocarcinoma,32.52,7/15/14,1195,,Biochemical evidence of disease,,,NO,C61,2FBA596B-858D-4043-BDCF-CCE582A74D67,90,1,,0.1216,0:LIVING,0.37,,39.26,Bilateral,18,,,YES,,,990,,TCGA-V1-A8MM.2FBA596B-858D-4043-BDCF-CCE582A74D67.pdf,Peripheral Zone,[Not Applicable],NO,,,10,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,990,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,7,No,NO,,N0,T2b,0,M0,C61.9,8140/3,82426,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-BR-A4QI,White,STAD,,1,1,,,1,1,,1,3.05,0.53,19,11,29,,,652,,383,652,,1,1,383,383,,Malignant,59,,555,,,,32040,,,383,383,,,,383,652,,,383,,,,,,,,WITH TUMOR,Dead,-25928,652,,,171,,383,383,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,14,,1,0.45585,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4QI,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,36,,,,,,,,,,,,,2012,383,Pancreas,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,82428,,0.367773686,,,,,,,,,,0.09509921,Grade 3,0.009250928,,,,Stage IIA,,0.406,,,,,,,,,,,,,,,,-0.2268,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4QI,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-34-5928,White,LUSC,,0,0,,University of Pittsburgh,0,0,FEMALE,0,3.54,0.4,22,15,24,,,1196,,1196,1196,,0,0,1196,1196,,Malignant,61,,71,,,,22172,,,1196,1196,,,,1196,1196,,,1196,,,,,,,,TUMOR FREE,Alive,-30334,,,,444,,1196,1196,,,[Not Available],[Not Applicable],,,,,0.15,,,,,24,,2,0.52166,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-5928,,,,,,,1196,,,,,,,,,58,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,83,,,,,,,,,,,,,,,,,,,,82431,,0.968335594,,,,,,,,,,0.236786718,,0.134514419,,,,Stage IIB,,0.8535,,,,,,,,,,,,,,,,1.2274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.83507334,16.45417481,15.82845943,-0.242949704856555,LUSC,,18.2440856,15.67472775,Squamous Cell Carcinoma,1.6277,14.69679186,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.87,4,2,5,,,672,BRCA_LumB,672,672,,0,0,672,672,,Invasive Carcinoma,11,,38,,,,22117,0,,672,672,,,,672,672,,,672,,,,,,,,TUMOR FREE,Alive,-19085,,,,31,,672,672,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,5,,0,0.17542,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,University of Miami,,TCGA-EW-A2FW,,,,,,,672,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,82432,,-0.530293573,0,0,0,0,-3.17,1,,,Other,0.079992039,,0.190803458,0,0,0,,Negative,-1.5,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0143,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Low Grade), No Detail Present",,"DCIS (Cribriform, Low Grade)",0,Encapsulated Papillary Carcinoma,Encapsulated Papillary Carcinoma,0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-CU-A0YR,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.3,0.47,15,18,21,,,460,,,460,,1.0,1,219.0,219.0,,Malignant,54,,49,,,,20537.0,,,219.0,219,,,,,460,,,219.0,,,,,,,,WITH TUMOR,Dead,-30674,460,,,217.0,,219.0,219,,,[Not Available],[Not Applicable],,,,,0.09,,,,,11,,1,0.21878,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,UNC,,TCGA-CU-A0YR,,,,,,,,Lymph Node Only,Metastatic,,,,,,,25,,,,,,,,,,,,,2010,219,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,83.0,,,,,,,,,,,,,,,,,,,,82437,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5519,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.91,0.67,10,11,5,ambiguous,NO,1962,2-ETV1,1962,1962,,0,0,1962,1962,prad_tcga,Malignant,26,,45,15.0,TCGA-EJ-5519-01,48,5283,0,TCGA-EJ-5519,1962,1962,Prostate Cancer,,1153,1962,1962,TCGA,,1962,Primary,1,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-23669,,64,8,104,PRAD,1962,1962,WHITE,0.480706254,[Not Available],[Not Applicable],92,R0,1,Matched,0.01,Prostate,Resection,4,eee1828e-d25f-462b-9735-89ca2eccc7e1,3,Normal (no evidence of prostate cancer) [cM0],0,0.11072,[Not Available],5313a055-c2d7-4cbd-a8c1-57ac85912d89,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,26,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,3.03333333333,TCGA-EJ-5519,0:DiseaseFree,4,24,Prostate Adenocarcinoma,64.45,4/3/12,1962,,,,,NO,C61,57861c52-0d80-484a-a800-65c3481327db,,4,TUMOR FREE,0.1289,0:LIVING,0.2,3,64.45,Bilateral,25,,,YES,,2008,,,TCGA-EJ-5519.57861c52-0d80-484a-a800-65c3481327db.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,13,61-70%,12,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,YES,No,R0,1.2,64,Core needle biopsy,84,,YES,NO,YES,,T3b,,8,No,,0,N1,T2c,3,M0,C61.9,8550/3,82438,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.75,0.92,14,24,20,,,1728,BRCA_LumB,1728,1728,,0,0,1728,1728,,Invasive Carcinoma,58,,69,,,,29509,0,,1728,1728,,,,1728,1728,,,1728,,,,,,,,TUMOR FREE,Alive,-19028,,,,95,,1728,1728,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,10,,0,0.41652,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A13Y,,,,,,,1728,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,82441,,-2.427332325,0,0,0,0,-6.2703,1,,,Infiltrating Ductal Carcinoma,0.075259706,,0.033274391,0,0,0,,Negative,-0.3255,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1911,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-D7-8575,White,STAD,,1,1,,,1,1,,1,1.87,0.66,11,9,12,,,554,,427,554,,1,1,427,427,,Malignant,32,,116,,,,17450,,,427,427,,,,427,554,,,427,,,,,,,,WITH TUMOR,Dead,-27712,554,,,67,,427,427,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,8,,0,0.35601,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8575,,,,,,,,Peritoneal Surfaces,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2012,427,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,82443,,0.097699258,,,,,,,,,,0.164146116,Grade 3,0.007005083,,,,Stage IIIA,,0.531,,,,,,,,,,,,,,,,0.0959,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8575,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,82447,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-56-A4BY,White,LUSC,,1,1,,International Genomics Consortium,,1,MALE,1,3.87,0.45,8,13,13,,,543,,,543,,1,1,543,543,,Malignant,34,,69,,,,27359,,,543,543,,,,,543,,,543,,,,,,,,WITH TUMOR,Dead,-24445,543,,,193,,543,543,,,[Not Available],[Not Applicable],,,,,0.2,,,,,13,,1,0.20793,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-A4BY,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,82448,,0.740506527,,,,,,,,,,0.121802567,,0.099841544,,,,Stage IB,,1.429,,,,,,,,,,,,,,,,0.1219,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.397953312184115,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.9835,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-D7-A4YX,White,STAD,,0,0,,,0,0,,0,2.09,0.55,4,2,4,,,1108,,1108,1108,,0,0,1108,1108,,Malignant,10,,101,,,,28144,,,1108,1108,,,,1108,1108,,,1108,,,,,,,,TUMOR FREE,Alive,-23249,,,,108,,1108,1108,,,[Not Available],[Not Applicable],,,,,0.09,Stomach,Unknown,,,7,,0,0.13523,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A4YX,,,,,,,1108,,,,,,,,,9,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,82458,,0.805896776,,,,,,,,,,0.062691191,Grade 3,0.021365133,,,,Stage IIB,,1.3435,,,,,,,,,,,,,,,,-0.1795,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A4YX,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,Male,TCGA-CD-8533,Asian,STAD,,1,1,,,1,0,,1,,,,,,,,468,,226,468,,1,1,226,226,,Malignant,,,,,,,24529,,,226,226,,,,226,468,,,226,,,,,,,,WITH TUMOR,Alive,-17821,,,,163,,226,226,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8533,,,,,,,468,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2011,226,liver and lung,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,48,,,,,,,,,,,,,,,,,,,,82462,,,,,,,,,,,,,Grade 3,,,,,Stage II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8533,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-VQ-A8PC,White,STAD,,1,1,,,,1,,1,1.79,0.34,14,14,13,,,1407,,,1407,,1,1,1287,1287,,Malignant,41,,102,,,,23649,,,1287,1287,,,,,1407,,,1287,,,,,,,,WITH TUMOR,Dead,-23912,1407,,,159,,1287,1287,,,[Unknown],[Not Applicable],,,,,0.31,Stomach,Unknown,,,11,,0,0.34922,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8PC,,,,,,,,,Locoregional Recurrence,,,,,,,12,,,,,,,,,,,,,2009,1287,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,82477,,0.151494368,,,,,,,,,,0.109739346,Grade 3,0.125995584,,,,Stage IIIA,,0.4465,,,,,,,,,,,,,,,,0.282,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PC,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,1,,1,1,1,Female,TCGA-78-7161,White,LUAD,,1,,,Prince Charles Hospital,,1,FEMALE,1,3.36,0.75,8,31,21,,,291,,,291,,1,,162,162,,Malignant,60,,57,,,,20190,,,162,,,,,,291,,,162,,,,,,,,WITH TUMOR,Dead,-25294,291,,,239,,162,,,,[Not Available],[Not Applicable],,,,,0.16,,,,,7,,1,0.14206,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7161,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2011,162,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,82478,,-0.403425994,,,,,,,,,,0.128354345,,0.187501404,,,,Stage IIB,,-0.672,,,,,,,,,,,,,,,,0.2732,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,13.852773,14.32367878,13.62660361,-0.705600178,LUAD,Adenocarcinoma,18.04874337,14.60261053,Adenocarcinoma,0.001,12.81119798,-0.7692,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,,1,1,Female,TCGA-78-8648,Unknown,LUAD,,1,1,,Prince Charles Hospital,,,FEMALE,1,,,,,,,,1209,,,1209,,1,1,720,720,,Malignant,,,,,,,31821,,,720,720,,,,,1209,,,720,,,,,,,,,Dead,-21443,1209,,,13,,720,720,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-8648,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2002,720,,,,Stage IIB,,,,,,,,[Unknown],,,,,,58,,,,,,,,,,,,,,,,,,,,82481,,1.342704273,,,,,,,,,,0.311215608,,0.293059489,,,,Stage IIB,,1.793,,,,,,,,,,,,,,,,0.8778,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.27506165,18.87588191,16.6664836,0.140931258,LUAD,Adenocarcinoma,18.33136838,17.12666973,Adenocarcinoma,1.4375,14.90906633,1.5251,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.4,0.5,5,15,20,,,552,BRCA_LumB,552,552,,0,0,552,552,,Invasive Carcinoma,40,,18,,,,34157,0,,552,552,,,,552,552,,,552,,,,,,,,TUMOR FREE,Alive,-15166,,,,141,,552,552,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,15,,2,0.090756,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JD,,,,,,,552,,,,,,,,,58,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,82484,,0.915617802,0,0,0,0,-0.6647,1,,,Infiltrating Ductal Carcinoma,0.195136398,,0.092211333,0,0,0,,Negative,-0.144,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4502,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-49-6742,White,LUAD,,1,,,Johns Hopkins,,1,MALE,1,3.61,0.49,3,2,4,,,488,,,488,,1,,214,214,,Malignant,9,,13,,,,21488,,,214,,,,,,488,,,214,,,,,,,,WITH TUMOR,Dead,-25839,488,,,364,,214,,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,1,0.068622,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6742,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2010,214,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,82485,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L268P,1,,,L268P,14.47771424,15.94131454,13.47401445,-0.704663899,LUAD,,17.8890364,13.61750443,Adenocarcinoma,-1.5784,13.10424721,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-BR-8485,White,STAD,,0,0,,,0,0,,0,5.0,0.38,9,17,22,,,280,,280,280,,0,0,280,280,,Malignant,48,,195,,,,23566,,,280,280,,,,280,280,,,280,,,,,,,,TUMOR FREE,Alive,-24845,,,,476,,280,280,,,[Not Available],[Not Applicable],,,,,0.47,Stomach,Unknown,,,19,,2,0.35845,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8485,,,,,,,280,,,,,,,,,58,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,82487,,1.099058125,,,,,,,,,,0.076951475,Grade 3,0.119838544,,,,Stage IIIC,,0.7655,,,,,,,,,,,,,,,,0.4166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8485,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,Female,TCGA-MP-A4TA,White,LUAD,,1,1,,Washington University - Mayo Clinic,1,1,FEMALE,1,1.65,0.33,13,10,7,,,950,,725,950,,1,1,725,725,,Malignant,30,,74,,,,22020,,,725,725,,,,725,950,,,725,,,,,,,,WITH TUMOR,Dead,-27513,950,,,486,,725,725,,,[Not Available],[Not Applicable],,,,,0.45,,,,,9,,0,0.40836,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TA,,,,,,,,,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2006,725,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,82489,,1.00348764,,,,,,,,,,0.146045018,,0.055245097,,,,Stage IA,,0.9455,,,,,,,,,,,,,,,,0.1448,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.118901989,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0726,,0.5962,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,,,,1,1,FEMALE,1,4.88,0.38,7,14,19,,,754,BRCA_Basal,382,754,,1,,382,382,,Invasive Carcinoma,40,,48,,,,17694,0,,382,,,,,382,754,,,382,,,,,,,,WITH TUMOR,Dead,-14969,754,,,106,,382,,,,[Not Available],[Not Applicable],,,,,0.45,Breast,Resection/Excision,,,20,,2,0.29099,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CM,,,,,,,,,,,,,,,,50,,,,,,,,,,,,,2003,382,,,,Stage IIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,82492,TRUE,1.448775739,0,0,0,0,0.4301,1,,,Infiltrating Ductal Carcinoma,0.187393442,,0.124087735,0,0,0,,Negative,1.5055,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1997,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WI,,PRAD,389,0,0,,YL,,0,MALE,0,2.27,0.88,6,12,3,ambiguous,NO,1623,6-FOXA1,,1623,,0,0,1623,1623,prad_tcga,Malignant,21,,166,,TCGA-YL-A9WI-01,19,5689,0,TCGA-YL-A9WI,1623,1623,Prostate Cancer,,1259,,1623,TCGA,,1623,Primary,1,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23184,,63,9,51,PRAD,1623,1623,,0.373381833,[Not Available],[Not Applicable],41,R0,1,Matched,0.17,Prostate,Resection,4,563E009C-C93D-46CC-867D-F5C89D9336D9,10,Normal (no evidence of prostate cancer) [cM0],0,0.13134,[Not Available],2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.36666666667,TCGA-YL-A9WI,0:DiseaseFree,5,22,Prostate Adenocarcinoma,53.32,4/10/14,1623,,,,,NO,C61,746DB832-C507-4FD6-8B8A-09E6268BACC9,680,11,,0.376,0:LIVING,0.03,,53.32,Bilateral,31,No Evidence of Extraprostatic Extension,99,YES,1325,2010,,,TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,93,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R0,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,,1,M0,C61.9,8140/3,82494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67T,,PRAD,315,0,0,,J4,0,0,MALE,0,1.99,0.44,0,0,0,HRD,NO,183,1-ERG,183,183,,0,0,183,183,prad_tcga,Malignant,0,,22,5.5,TCGA-J4-A67T-01,0,5480,0,TCGA-J4-A67T,183,183,Prostate Cancer,,154,183,183,TCGA,,183,Primary,0,Apex|Middle,A,,RAD51D,True,TUMOR FREE,Alive,-23211,,63,7,22,PRAD,183,183,,0.0,[Not Available],[Not Applicable],16,R0,1,Matched,0.01,Prostate,Resection,3,FC2033B2-79B6-4FEB-9084-07082EA73B8B,0,,0,0.0059048,[Not Available],432F15BA-7401-4827-83A5-3EAAFAAA4BEA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,0.5,TCGA-J4-A67T,0:DiseaseFree,2,2,Prostate Adenocarcinoma,6.01,8/16/13,183,,,,,,C61,8E3BAF97-3B7F-4B3A-BC88-BACB5A716DFD,490,0,TUMOR FREE,0.0056,0:LIVING,0.1,,6.01,Bilateral,4,,,YES,409,2012,,,TCGA-J4-A67T.8E3BAF97-3B7F-4B3A-BC88-BACB5A716DFD.pdf,Peripheral Zone,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8140/3,82496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.9,0.61,17,22,28,,,439,BRCA_Basal,439,439,,0,0,439,439,,Invasive Carcinoma,67,,75,,,,26912,1,,439,439,,,,439,439,,,439,,,,,,,,TUMOR FREE,Alive,-17763,,,,201,,439,439,,,[Not Available],[Not Applicable],,,,,0.11,Not Specific/Unknown,Resection/Excision,,,13,,1,0.53398,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A27B,,,,,,,439,,,,,,,,,36,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,82499,TRUE,1.151764881,0,0,0,0,1.8469,1,,,Infiltrating Ductal Carcinoma,0.18896193,,0.063916374,0,0,0,,Negative,1.2875,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.186,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-4547,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.91,0.49,12,11,19,,,2419,,2419,2419,,0,0,2419,2419,,Malignant,42,,169,,,,17065,,,2419,2419,,,,2419,2419,,,2419,,,,,,,,TUMOR FREE,Alive,-25056,,,,256,,2419,2419,,,[Not Available],[Not Applicable],,,,,0.02,,,,,12,,0,0.33781,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4547,,,,,,,2419,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,82500,,0.162545246,,,,,,,,,,0.179129892,,0.090753256,,,,Stage IB,,-0.264,,,,,,,,,,,,,,,,0.7549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.460033798952849,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-85-A4JB,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.54,0.33,13,16,22,,,942,,942,942,,0,0,942,942,,Malignant,51,,104,,,,18261,,,942,942,,,,942,942,,,942,,,,,,,,TUMOR FREE,Alive,-27315,,,,612,,942,942,,,[Not Available],[Not Applicable],,,,,0.24,,,,,18,,1,0.30858,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A4JB,,,,,,,942,,,,,,,,,26,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,82503,,0.071909346,,,,,,,,,,0.128853611,,0.011498523,,,,Stage IIB,,0.11,,,,,,,,,,,,,,,,0.6494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.28113283,13.99181849,15.55880197,-0.660087260782968,LUSC,Squamous Cell Carcinoma,17.89891475,15.2202683,Squamous Cell Carcinoma,-0.0036,13.38347874,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,82505,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.32,0.64,1,0,3,,,8556,BRCA_LumA,8556,8556,,0,0,8556,8556,,Invasive Carcinoma,4,,2,,,,22214,0,,8556,8556,,,,8556,8556,,,8556,,,,,,,,TUMOR FREE,Alive,-18038,,,,42,,8556,8556,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,9,,0,0.015883,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0I5,,,,,,,8556,,,,,,,,,9,,,,,,,,,,,,,1988,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,82509,,-0.097550568,0,0,0,0,0.2597,1,,,Infiltrating Ductal Carcinoma,0.100254696,,0.144591028,0,0,0,,Negative,-0.912,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3396,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Cribriform, Intermediate Grade), Microcalcifications",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-G2-A2EO,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.23,0.37,1,3,7,,,1804,,1804,1804,,2.0,2,1804.0,1804.0,,Malignant,11,,27,,,,25306.0,,,1804.0,1804,,,,1804,1804,,,1804.0,,,,,,,,TUMOR FREE,Dead,-25440,1804,,,1247.0,,1804.0,1804,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.10692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EO,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,82510,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,,1,1,Female,TCGA-49-4506,White,LUAD,,1,1,,Johns Hopkins,1,,FEMALE,1,2.67,0.25,4,1,4,,,999,,692,999,,1,1,692,692,,Malignant,9,,15,,,,20949,,,692,692,,,,692,999,,,692,,,,,,,,[Discrepancy],Dead,-25132,999,,,149,,692,692,,,[Not Available],[Not Applicable],,,,,0.02,,,,,16,,1,0.32656,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4506,,,,,,,,,Locoregional Recurrence,,,,,,,27,,,,,,,,,,,,,1997,692,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,82513,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,-0.2181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13D (driver),M503K,1,,G13D (driver),M503K,15.95123481,16.55036123,16.82054215,0.016190116,LUAD,Adenocarcinoma,17.88942384,16.49569218,Adenocarcinoma,,13.24541738,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,1.99,0.66,1,0,2,,,2520,BRCA_LumA,,2520,,2,2,2520,2520,,Invasive Carcinoma,3,,4,,,,16255,0,,2520,2520,,,,,2520,,,2520,,,,,,,,TUMOR FREE,Dead,-20425,2520,,,36,,2520,2520,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.02545,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1ET,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,1999,,,,,Stage I,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,82514,,-0.02013703,0,0,0,0,0.4917,1,,,Infiltrating Ductal Carcinoma,0.149058305,,0.219263558,0,0,0,,[Not Available],-0.6785,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.136,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-86-6851,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,3.26,0.32,11,11,16,,,179,,179,179,,0,0,179,179,,Malignant,38,,42,,,,16530,,,179,179,,,,179,179,,,179,,,,,,,,TUMOR FREE,Alive,-26808,,,,1131,,179,179,,,[Not Available],[Not Applicable],,,,,0.53,,,,,17,,1,0.31184,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-6851,,,,,,,179,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,82523,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.2281,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.8090313,17.47903619,18.40148336,0.239346842,LUAD,Adenocarcinoma,17.89330862,17.37451171,Adenocarcinoma,0.0138,10.79932546,1.3126,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.48,0.76,6,7,9,,,366,BRCA_Her2,366,366,,0,0,366,366,,Invasive Carcinoma,22,,29,,,,27433,0,,366,366,,,,366,366,,,366,,,,,,,,TUMOR FREE,Alive,,,,,78,,366,366,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,24,,1,0.15097,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HK,,,,,,,366,,,,,,,,,22,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,82525,,0.272630889,0,0,0,0,-0.5207,1,,,Infiltrating Ductal Carcinoma,0.123252887,,0.123359683,0,0,0,,Negative,-1.1075,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1715,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, High Grade), No Detail Present",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.66,20,31,22,,,1140,BRCA_Basal,1140,1140,,0,0,1140,1140,,Invasive Carcinoma,73,,100,,,,16156,0,,1140,1140,,,,1140,1140,,,1140,,,,,,,,TUMOR FREE,Alive,-22462,,,,160,,1140,1140,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,2,,0,0.46915,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0J6,,,,,,,1140,,,,,,,,,16,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,82528,TRUE,1.439931167,0,0,0,0,0.7507,1,,,Infiltrating Ductal Carcinoma,0.154051895,,0.002373565,0,0,0,,Negative,1.001,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0185,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,72,,72,72,,0,0,72,72,,Invasive Carcinoma,,,,,,,20180,1,,72,72,,,,72,72,,,72,,,,,,,,TUMOR FREE,Alive,-20804,,,,57,,72,72,,,[Not Available],[Not Applicable],,,,,,Skin,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HL,,,,,,,72,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,82529,,-1.983011999,0,0,0,0,-4.0396,1,Redacted,,Infiltrating Ductal Carcinoma,0.017370219,,0.081020576,0,0,0,,Negative,-0.2465,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,-0.2276,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.03,0.35,4,11,17,,,293,BRCA_Basal,293,293,,0,0,293,293,,Invasive Carcinoma,32,,28,,,,23490,0,,293,293,,,,293,293,,,293,,,,,,,,TUMOR FREE,Alive,-25408,,,,0,,293,293,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,17,,1,0.32484,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0E6,,,,,,,293,,,,,,,,,39,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,82531,,0.80023738,0,0,0,0,1.2784,1,,,Infiltrating Ductal Carcinoma,0.128878264,,0.1676965,0,0,0,,Negative,0.1245,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2834,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-44-6148,White,LUAD,,0,0,,Christiana Healthcare,0,0,MALE,0,2.06,0.3,0,0,0,,,704,,704,704,,0,0,704,704,,Malignant,0,,0,,,,22659,,,704,704,,,,704,704,,,704,,,,,,,,TUMOR FREE,Alive,-22138,,,,8,,704,704,,,[Not Available],[Not Applicable],,,,,,,,,,2,,0,0.0,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6148,,,,,,,704,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,82537,,0.312201824,,,,,,,,,,0.199733709,,0.191718089,,,,Stage IA,,0.2515,,,,,,,,,,,,,,,,0.1702,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.390433577,LUAD,Adenocarcinoma,,,Adenocarcinoma,-3.7298,,-0.5132,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.32,0.44,7,8,13,,,1026,BRCA_LumA,1026,1026,,0,0,1026,1026,,Invasive Carcinoma,28,,41,,,,33590,0,,1026,1026,,,,1026,1026,,,1026,,,,,,,,TUMOR FREE,Alive,-29444,,,,99,,1026,1026,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,20,,1,0.13664,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IH,,,,,,,1026,,,,,,,,,24,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,82540,,1.422426117,0,0,0,0,-1.0632,1,,,Infiltrating Lobular Carcinoma,0.227776148,,0.266476344,0,0,0,,Negative,0.3775,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5539,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,Adipose Tissue,No Detail Present,"DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.52,6,4,6,,,538,BRCA_LumA,538,538,,0,0,538,538,,Invasive Carcinoma,16,,12,,,,25189,0,,538,538,,,,538,538,,,538,,,,,,,,TUMOR FREE,Alive,-21056,,,,72,,538,538,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,4,,0,0.10735,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XM,,,,,,,538,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,82545,,0.940304505,0,0,0,0,-0.0741,1,,,Infiltrating Ductal Carcinoma,0.200090454,,0.162774719,0,0,0,,Negative,0.2105,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5233,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,2.94,0.49,22,13,27,,,2296,BRCA_LumA,2296,2296,,2,2,2296,2296,,Invasive Carcinoma,62,,134,,,,24496,0,,2296,2296,,,,2296,2296,,,2296,,,,,,,,TUMOR FREE,Dead,-27917,2296,,,208,,2296,2296,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,13,,1,0.42228,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BP,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2006,,,,,Stage I,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,82553,,0.135645056,0,0,0,0,0.4922,1,,,Infiltrating Ductal Carcinoma,0.179757179,,0.241204923,0,0,0,,Negative,-0.5415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6687,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Female,TCGA-98-A53H,White,LUSC,,0,0,,Washington University - Alabama,0,0,FEMALE,1,2.0,0.43,0,0,0,,,618,,618,618,,0,0,427,427,,Malignant,0,,9,,,,28775,,,618,618,,,,618,618,,,427,,,,,,,,,Alive,-27928,,,,32,,618,618,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.0012023,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A53H,,,,,,,618,,New Primary Tumor,,,,,,,0,,,,,,,,,,,,,2012,427,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,82555,,1.339180341,,,,,,,,,,0.235434785,,0.275422473,,,,Stage IA,,1.805,,,,,,,,,,,,,,,,0.7093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.126442520448289,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.7871,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,1,1,Male,TCGA-VQ-A8E3,White,STAD,,1,1,,,,,,1,2.26,0.6,8,11,13,,,661,,,661,,1,1,538,538,,Malignant,32,,159,,,,21611,,,538,538,,,,,661,,,538,,,,,,,,,Dead,-28919,661,,,1036,,538,538,,,[Unknown],[Not Applicable],,,,,0.2,Stomach,Unknown,,,12,,1,0.42718,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8E3,,,,,,,,,Locoregional Recurrence,,,,,,,40,,,,,,,,,,,,,2011,538,,,,Stage IIA,,,,,,,,[Unknown],,,,,,79,,,,,,,,,,,,,,,,,,,,82558,,0.842111915,,,,,,,,,,0.018882067,Grade 3,0.068137333,,,,Stage IIA,,2.0035,,,,,,,,,,,,,,,,0.0253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8E3,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-KK-A7AW,,PRAD,,0,0,,KK,,0,MALE,0,2.0,0.75,1,4,2,HRP,NO,1054,,,1054,,0,0,1054,1054,prad_tcga,Malignant,7,BRCA2,22,,TCGA-KK-A7AW-01,0,5512,0,TCGA-KK-A7AW,1054,1054,Prostate Cancer,,204,,1054,TCGA,,1054,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20869,,57,7,42,PRAD,1054,1054,,0.0,[Not Available],[Not Applicable],39,,1,Matched,0.04,Prostate,Resection,4,1854D2D5-95DA-4764-84C9-64E866B1B890,1,,0,0.020865,[Not Available],2F231B79-84BC-4256-BF26-7CE64083D438,3,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,KK,1.3,TCGA-KK-A7AW,0:DiseaseFree,3,9,Prostate Adenocarcinoma,34.63,8/19/14,1054,,,,,NO,C61,B5E8DF63-7C54-4D45-93ED-5C80075C63A5,60,1,TUMOR FREE,0.0705,0:LIVING,0.8,,34.63,Right,15,,11,YES,983,2010,,,TCGA-KK-A7AW.B5E8DF63-7C54-4D45-93ED-5C80075C63A5.pdf,Peripheral Zone,[Not Applicable],YES,,,9,Prostate Adenocarcinoma Acinar Type,1,2010,[Unknown],,YES,No,R0,,57,Core needle biopsy,204,,NO,YES,YES,,T3a,,7,No,,0,N1,T2a,1,M0,C61.9,8140/3,82560,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-56-A4ZK,White,LUSC,,0,0,,International Genomics Consortium,0,0,FEMALE,0,,,,,,,,570,,570,570,,0,0,570,570,,Malignant,,,,,,,32376,,,570,570,,,,570,570,,,570,,,,,,,,TUMOR FREE,Alive,-28039,,,,310,,570,570,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-A4ZK,,,,,,,570,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,82561,,0.801624492,,,,,,,,,,0.233484356,,0.004602588,,,,Stage IB,,1.8035,,,,,,,,,,,,,,,,0.235,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.150003178972674,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.2008,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-55-A492,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,3.8,0.54,1,5,5,,,596,,596,596,,0,0,596,596,,Malignant,11,,16,,,,23945,,,596,596,,,,596,596,,,596,,,,,,,,TUMOR FREE,Alive,-25719,,,,448,,596,596,,,[Not Available],[Not Applicable],,,,,0.14,,,,,12,,1,0.055442,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A492,,,,,,,596,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,82576,,-0.101019106,,,,,,,,,,0.166054495,,0.21366137,,,,Stage IA,,-1.349,,,,,,,,,,,,,,,,-0.5979,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,E441* (driver),1,,,E441* (driver),,,,-0.689164662,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.8202,,-1.1896,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-J4-AATZ,,PRAD,,1,1,,J4,1,0,MALE,1,2.03,0.73,2,7,2,HRD,NO,412,,79,412,,1,1,79,79,prad_tcga,Malignant,11,CHEK2,55,,TCGA-J4-AATZ-01,30,5491,0,TCGA-J4-AATZ,79,79,Prostate Cancer,23,386,79,412,TCGA,No Evidence of Extraprostatic Extension,79,Primary,1,Apex,A,,RAD51B,True,WITH TUMOR,Alive,-24226,,66,9,48,PRAD,79,79,,0.656422655,[Not Available],[Not Applicable],41,,1,Matched,0.17,Prostate,Resection,4,DF64C493-D290-41C7-ABD3-AB65CDA57B02,1,Normal (no evidence of prostate cancer) [cM0],0,0.04313,[Not Available],73B7D4BC-6B56-4AE8-BE7F-074745563BEE,5,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,J4,1.46666666667,TCGA-J4-AATZ,1:Recurred/Progressed,5,14,Prostate Adenocarcinoma,2.6,8/14/14,412,,Biochemical evidence of disease,,,YES,C61,369F71EC-186A-41DA-91F7-B0FD209BEC8F,80,2,WITH TUMOR,0.1118,0:LIVING,0.0,,13.53,Bilateral,14,No Evidence of Extraprostatic Extension,23,YES,170,2013,79,,TCGA-J4-AATZ.369F71EC-186A-41DA-91F7-B0FD209BEC8F.pdf,Peripheral Zone,[Not Applicable],,33,,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R1,,66,Core needle biopsy,79,Complete Remission/Response,YES,NO,YES,YES,T3a,YES,9,No,YES,0,N0,,0,M0,C61.9,8140/3,82578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-38-6178,White,LUAD,,0,0,,,,0,FEMALE,0,3.89,0.32,5,10,15,,,448,,,448,,0,0,448,448,,Malignant,30,,41,,,,16243,,,448,448,,,,,448,,,448,,,,,,,,WITH TUMOR,Alive,-25593,,,,82,,448,448,,,[Not Available],[Not Applicable],,,,,0.48,,,,,18,,2,0.45622,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,,,TCGA-38-6178,,,,,,,448,,,,,,,,,52,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,82582,,0.539006761,,,,,,,,,,0.209513152,,0.167921013,,,,Stage IIIA,,0.555,,,,,,,,,,,,,,,,0.5333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"E746_A750del (driver), AMP (driver)",,,1,E746_A750del (driver),,,15.41980198,16.49531163,11.59115394,-0.395671818,LUAD,Adenocarcinoma,18.15176143,15.11689819,Adenocarcinoma,,12.89314161,-1.137,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.52,4,4,5,,,403,BRCA_LumA,403,403,,0,0,403,403,,Invasive Carcinoma,13,,11,,,,30019,0,,403,403,,,,403,403,,,403,,,,,,,,TUMOR FREE,Alive,-18558,,,,46,,403,403,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,3,,0,0.0987,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1J2,,,,,,,403,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,[Discrepancy],,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,82583,,0.243201242,0,0,0,0,0.2662,1,,,Infiltrating Lobular Carcinoma,0.213290866,,0.215783532,0,0,0,,Negative,0.4385,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6521,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A76X,,PRAD,348,0,0,,HC,,0,MALE,0,2.0,0.74,0,0,0,HRD,NO,150,1-ERG,,150,,0,0,150,150,prad_tcga,Malignant,0,,19,,TCGA-HC-A76X-01,0,5460,0,TCGA-HC-A76X,150,150,Prostate Cancer,,150,,150,TCGA,,150,Primary,0,Apex|Middle|Base,A,,ATM,True,TUMOR FREE,Alive,-22756,,62,7,36,PRAD,150,150,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.0,Prostate,Resection,3,64A767B5-953F-4A2B-9DF5-10123D3C1981,0,Normal (no evidence of prostate cancer) [cM0],0,0.0039578,[Not Available],105E12BF-4F39-4D7A-870F-FBC329EE210A,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,HC,1.33333333333,TCGA-HC-A76X,0:DiseaseFree,2,3,Prostate Adenocarcinoma,4.93,3/28/14,150,,,,,,C61,DA72A108-04AA-424B-83EE-714036869E87,60,0,TUMOR FREE,0.0041,0:LIVING,0.01,,4.93,Bilateral,5,,,YES,149,2013,,,TCGA-HC-A76X.DA72A108-04AA-424B-83EE-714036869E87.pdf,,[Not Applicable],,10,91-100%,1,Prostate Adenocarcinoma Acinar Type,1,2013,[Unknown],,NO,No,R0,,62,Core needle biopsy,,,YES,NO,YES,NO,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,82585,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.11,0.1,5,5,8,,,1308,BRCA_LumA,1308,1308,,0,0,1308,1308,,Invasive Carcinoma,18,,44,,,,17130,0,,1308,1308,,,,1308,1308,,,1308,,,,,,,,TUMOR FREE,Alive,-28855,,,,0,,1308,1308,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,5,,1,0.088086,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A105,,,,,,,1308,,,,,,,,,15,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,82587,,-0.713954401,0,0,0,0,0.213,1,,,Infiltrating Ductal Carcinoma,0.108243064,,0.089044899,0,0,0,,Negative,-1.0215,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0462,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-FD-A62O,White,BLCA,,0.0,0,,,,2,MALE,2.0,3.14,0.85,4,6,10,,,216,,,216,,2.0,2,216.0,216.0,,Malignant,20,,44,,,,33621.0,,,216.0,216,,,,,216,,,216.0,,,,,,,,TUMOR FREE,Dead,-27310,216,,,259.0,,216.0,216,,,[Not Available],[Not Applicable],,,,,0.43,,,,,20,,1,0.13514,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A62O,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,[Unknown],,,,,,74.0,,,,,,,,,,,,,,,,,,,,82591,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,2.0,0.75,2,1,2,,,3926,BRCA_LumA,3926,3926,,2,2,3926,3926,,Invasive Carcinoma,5,,2,,,,31083,0,,3926,3926,,,,3926,3926,,,3926,,,,,,,,TUMOR FREE,Dead,-27047,3926,,,0,,3926,3926,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,2,,0,0.032679,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0IP,,,,,,,,,,,,,,,,3,,,,,,,,,,,,,1997,,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,82595,,0.373724922,0,0,0,0,0.6197,1,,,Infiltrating Lobular Carcinoma,0.118293885,,0.125955509,0,0,0,,Negative,-0.236,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.28,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.84,3,0,1,,,40,BRCA_LumA,40,40,,0,0,40,40,,Invasive Carcinoma,4,,15,,,,23509,1,,40,40,,,,40,40,,,40,,,,,,,,TUMOR FREE,Alive,-27605,,,,72,,40,40,,,[Not Available],[Not Applicable],,,,,0.01,Not Specific/Unknown,Resection/Excision,,,1,,0,0.033835,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A8OR,,,,,,,40,,,,,,,,,1,,,,,,,,,,,,,2013,,,,,Stage IA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,82606,,-1.672684827,0,0,0,0,1.26,1,,,Mucinous Carcinoma,0.116547274,,0.04532099,0,0,0,,Negative,-1.383,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.162,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-63-A5MU,Unknown,LUSC,,1,1,,Ontario Institute for Cancer Research,1,1,MALE,1,3.41,0.81,7,6,8,,,,,420,,,1,1,420,420,,Malignant,21,,84,,,,24222,,,420,420,,,,420,,,,420,,,,,,,,WITH TUMOR,Dead,-17801,,,,288,,420,420,,,[Not Available],[Not Applicable],,,,,0.15,,,,,14,,2,0.21419,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5MU,,,,,,,,,Distant Metastasis,,,,,,,70,,,,,,,,,,,,,,420,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,48,,,,,,,,,,,,,,,,,,,,82609,,-0.074525461,,,,,,,,,,0.042095512,,-0.03127582,,,,Stage IIB,,0.313,,,,,,,,,,,,,,,,-0.0608,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.74968279,13.70565145,14.27533309,-0.871618595932713,LUSC,Squamous Cell Carcinoma,17.59050883,14.04851495,Squamous Cell Carcinoma,-1.8459,12.84445988,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.06,0.66,6,10,12,,,5739,BRCA_LumA,3862,5739,,1,1,3862,3862,,Invasive Carcinoma,28,,18,,,,17301,0,,3862,3862,,,,3862,5739,,,3862,,,,,,,,TUMOR FREE,Alive,-22362,,,,29,,3862,3862,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,3,,0,0.090812,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0WT,,,,,,,5739,"Other, specify",New Primary Tumor,,,,,,,8,,,,,,,,,,,,,1995,3862,right breast cancer contralateral,,,Stage IIB,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,82610,,0.376801977,0,0,0,0,-0.3309,1,,,Infiltrating Ductal Carcinoma,0.125186058,,0.124756541,0,0,0,,Negative,-0.661,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4824,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-44-3918,White,LUAD,,1,,,Christiana Healthcare,1,0,FEMALE,1,1.8,0.45,18,22,18,,,1036,,511,1036,,1,,511,511,,Malignant,58,,156,,,,16685,,,511,,,,,511,1036,,,511,,,,,,,,WITH TUMOR,Alive,-22236,,,,1223,,511,,,,[Not Available],[Not Applicable],,,,,0.61,,,,,11,,0,0.40855,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-3918,,,,,,,1036,,,,,,,,,20,,,,,,,,,,,,,2010,511,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,82614,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.276450051,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.2839,,1.4517,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-55-8514,Black or African American,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,3.13,0.54,10,13,17,,,520,,520,520,,0,0,520,520,,Malignant,40,,136,,,,32728,,,520,520,,,,520,520,,,520,,,,,,,,TUMOR FREE,Alive,-25608,,,,377,,520,520,,,[Not Available],[Not Applicable],,,,,0.15,,,,,24,,1,0.37558,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8514,,,,,,,520,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,82621,,0.279862481,,,,,,,,,,0.217676473,,0.103502321,,,,Stage IB,,0.6205,,,,,,,,,,,,,,,,-0.1373,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),G12A (driver),,1,,G12A (driver),,,,,-0.501440767,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.686,,-1.4581,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,,,,BRCA,,1,,,,1,0,FEMALE,1,1.91,0.92,2,0,2,,,791,BRCA_LumA,791,791,,1,,791,791,,Invasive Carcinoma,4,,16,,,,18789,0,,791,,,,,791,791,,,791,,,,,,,,TUMOR FREE,Alive,-24442,,,,52,,791,,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,10,,0,0.21466,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06Y,,,,,,,791,,,,,,,,,8,,,,,,,,,,,,,2008,791,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,82623,,-1.868586773,0,0,0,0,-0.1512,1,,,Infiltrating Ductal Carcinoma,0.069816618,,0.15365504,0,0,0,,Negative,-2.083,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-KK-A7AQ,,PRAD,,1,1,,KK,1,0,MALE,1,1.89,0.76,4,6,2,ambiguous,NO,1610,,1217,1610,,1,1,1217,1217,prad_tcga,Malignant,12,BARD1,212,,TCGA-KK-A7AQ-01,0,5509,0,TCGA-KK-A7AQ,1217,1217,Prostate Cancer,38,1385,1217,1610,TCGA,No Evidence of Extraprostatic Extension,1217,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-22731,,62,7,36,PRAD,1217,1217,,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.03,Prostate,Resection,4,A3081D9D-25EB-41FD-8B77-A7FE9910865A,1,,0,0.11433,[Not Available],CECF4EE9-7610-4F47-A825-7FDE8233B75D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,KK,1.16666666667,TCGA-KK-A7AQ,1:Recurred/Progressed,3,13,Prostate Adenocarcinoma,39.98,8/19/14,1610,,Biochemical evidence of disease,,,YES,C61,D507BEE9-3883-4008-B07C-7F257C40AFF6,30,2,TUMOR FREE,0.1193,0:LIVING,0.1,5,52.89,Bilateral,18,,,YES,1066,2010,1217,,TCGA-KK-A7AQ.D507BEE9-3883-4008-B07C-7F257C40AFF6.pdf,Peripheral Zone,[Not Applicable],,,,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,62,Core needle biopsy,1217,Complete Remission/Response,NO,YES,YES,YES,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,82625,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-97-7553,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,0,1.44,0.29,5,3,8,,,1870,,1870,1870,,0,0,1870,1870,,Malignant,16,,23,,,,18350,,,1870,1870,,,,1870,1870,,,1870,,,,,,,,TUMOR FREE,Alive,-21518,,,,60,,1870,1870,,,[Not Available],[Not Applicable],,,,,0.15,,,,,14,,0,0.65768,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-7553,,,,,,,1870,,,,,,,,,20,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,82627,,1.169250431,,,,,,,,,,0.316337351,,0.266078886,,,,Stage IA,,1.598,,,,,,,,,,,,,,,,0.3604,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.010384952,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2791,,0.997,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,2.29,0.19,11,15,16,,,785,BRCA_Basal,,785,,1,1,785,785,,Invasive Carcinoma,42,,26,,,,23425,0,,785,785,,,,,785,,,785,,,,,,,,WITH TUMOR,Dead,-29335,785,,,95,,785,785,,,[Not Available],[Not Applicable],,,,,0.58,Breast,Resection/Excision,,,7,,1,0.46696,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1F0,,,,,,,,,,,,,,,,39,,,,,,,,,,,,,2000,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,82629,,,0,0,0,0,0.295,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,[Not Available],,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, High Grade), No Detail Present",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-C4-A0EZ,,BLCA,,1.0,1,,,,1,FEMALE,1.0,3.28,0.93,3,5,9,,,273,,,273,,1.0,1,273.0,273.0,,Malignant,17,,25,,,,30331.0,,,273.0,273,,,,,273,,,273.0,,,,,,,,WITH TUMOR,Dead,-25202,273,,,269.0,,273.0,273,,,[Not Available],[Not Applicable],,,,,0.4,,,,,14,,1,0.081171,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Indivumed,,TCGA-C4-A0EZ,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,82630,,,,,,,,,Redacted,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-IG-A7DP,White,ESCA,,0,0,,,0,0,,0,,,,,,,,452,,452,452,,0,0,452,452,,Malignant,,,,,,,20507,,,452,452,,,,452,452,,,452,,,,,,,,TUMOR FREE,Alive,-18364,,,,12,,452,452,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Asterand,,TCGA-IG-A7DP,,,,,,,452,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,50,,,,,,,,,,,,,,,,,,,,82633,,,,,,,,,,,,,Grade 2,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.59,6,4,5,,,783,BRCA_LumA,783,783,,0,0,783,783,,Invasive Carcinoma,15,,7,,,,17739,0,,783,783,,,,783,783,,,783,,,,,,,,TUMOR FREE,Alive,-22995,,,,67,,783,783,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.080477,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1X8,,,,,,,783,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,82634,,0.143876159,0,0,0,0,0.4587,1,,,Infiltrating Lobular Carcinoma,0.176318101,,0.238654718,0,0,0,,Negative,-0.41,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.198,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.76,0.38,3,4,5,,,972,BRCA_Basal,972,972,,0,0,972,972,,Invasive Carcinoma,12,,14,,,,23361,0,,972,972,,,,972,972,,,972,,,,,,,,TUMOR FREE,Alive,-20105,,,,48,,972,972,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,23,,1,0.10848,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14X,,,,,,,972,,,,,,,,,28,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,82635,TRUE,1.385049452,0,0,0,0,1.467,1,,,Infiltrating Ductal Carcinoma,0.139754525,,0.164083021,0,0,0,,Negative,0.637,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1252,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-GV-A3QF,White,BLCA,,0.0,0,,,,2,MALE,2.0,3.32,0.54,9,6,15,,,617,,,617,,2.0,2,617.0,617.0,,Malignant,30,,93,,,,28837.0,,,617.0,617,,,,,617,,,617.0,,,,,,,,TUMOR FREE,Dead,-28890,617,,,185.0,,617.0,617,,,[Not Available],[Not Applicable],,,,,0.03,,,,,17,,1,0.28854,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3QF,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,79.0,,,,,,,,,,,,,,,,,,,,82638,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.72,6,3,8,,,1847,BRCA_LumB,1847,1847,,0,0,1847,1847,,Invasive Carcinoma,17,,28,,,,19556,0,,1847,1847,,,,1847,1847,,,1847,,,,,,,,TUMOR FREE,Alive,-22344,,,,31,,1847,1847,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,14,,0,0.21733,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A1FX,,,,,,,1847,,,,,,,,,10,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,82639,,0.115506718,0,0,0,0,-1.722,1,,,Infiltrating Ductal Carcinoma,0.151608306,,0.201583807,0,0,0,,Negative,-0.575,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0173,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-93-7348,White,LUAD,,0,0,,Washington University - St. Louis,0,0,FEMALE,0,1.83,0.45,5,4,6,,,531,,531,531,,0,0,531,531,,Malignant,15,,12,,,,21749,,,531,531,,,,531,531,,,531,,,,,,,,TUMOR FREE,Alive,-27456,,,,130,,531,531,,,[Not Available],[Not Applicable],,,,,0.58,,,,,11,,0,0.30929,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - St. Louis,,TCGA-93-7348,,,,,,,531,,,,,,,,,9,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,82641,,0.977094322,,,,,,,,,,0.209726167,,0.172497271,,,,Stage IA,,0.2175,,,,,,,,,,,,,,,,0.5547,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.239548342,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.035,,-0.0893,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.18,2,0,1,,,218,BRCA_LumA,218,218,,0,0,218,218,,Invasive Carcinoma,3,,2,,,,27936,0,,218,218,,,,218,218,,,218,,,,,,,,TUMOR FREE,Alive,-22629,,,,98,,218,218,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,3,,0,0.072327,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FN,,,,,,,218,,,,,,,,,2,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,82643,,1.544456773,0,0,0,0,-0.8145,1,,,Infiltrating Lobular Carcinoma,0.211027981,,0.33962745,0,0,0,,Negative,0.978,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.8583,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Q9-A6FW,White,ESCA,,0,0,,,0,0,,0,2.08,0.56,10,12,16,,,238,,238,238,,0,0,238,238,,Malignant,38,,89,,,,24793,,,238,238,,,,238,238,,,238,,,,,,,,TUMOR FREE,Alive,-22586,,,,321,,238,238,,,[Not Available],[Not Available],,,,,0.35,Esophagus,Unknown,,,4,,0,0.1652,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Emory University,,TCGA-Q9-A6FW,,,,,,,238,,,,,,,,,11,,,,,,,,,,,,,2013,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,82645,,,,,,,,,,,,,Grade 2,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.75,0.47,2,0,5,,,2442,BRCA_LumA,,2442,,0,0,2442,2442,,Invasive Carcinoma,7,,7,,,,28488,0,,2442,2442,,,,,2442,,,2442,,,,,,,,TUMOR FREE,Alive,-19880,,,,62,,2442,2442,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,20,,1,0.087424,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EO,,,,,,,2442,,,,,,,,,17,,,,,,,,,,,,,2003,,,,,Stage IA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,82654,,0.256137445,0,0,0,0,0.4131,1,,,Infiltrating Ductal Carcinoma,0.178876229,,0.222420094,0,0,0,,Close,-0.4875,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7087,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.7,0.75,11,28,15,,,1158,BRCA_LumB,1158,1158,,0,0,1158,1158,,Invasive Carcinoma,54,,33,,,,18906,0,,1158,1158,,,,1158,1158,,,1158,,,,,,,,TUMOR FREE,Alive,-18046,,,,96,,1158,1158,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,8,,1,0.17336,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A3HO,,,,,,,1158,,,,,,,,,23,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,82656,,0.915154173,0,0,0,0,-1.3568,1,,,Infiltrating Lobular Carcinoma,0.073783948,,0.194887605,0,0,0,,Negative,0.174,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1526,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.21,0.68,3,3,2,,,554,BRCA_LumB,554,554,,0,0,554,554,,In Situ Carcinoma,8,,10,,,,17826,0,,554,554,,,,554,554,,,554,,,,,,,,TUMOR FREE,Alive,-17275,,,,44,,554,554,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,5,,0,0.077604,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BD,,,,,,,554,,,,,,,,,8,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,82658,,0.872019268,0,0,0,0,-0.0086,1,,,Infiltrating Ductal Carcinoma,0.165212367,,0.171986799,0,0,0,,Negative,0.3895,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5938,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"DCIS (Solid, Low Grade), N/A No in Situ",,"DCIS (Solid, Low Grade)",0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,82660,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-7728,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.01,0.42,4,4,3,,,704,,704,704,,0,0,704,704,,Malignant,11,,12,,,,17664,,,704,704,,,,704,704,,,704,,,,,,,,TUMOR FREE,Alive,-23505,,,,127,,704,704,,,[Not Available],[Not Applicable],,,,,0.01,,,,,1,,0,0.042806,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7728,,,,,,,704,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,82663,,0.947918581,,,,,,,,,,0.286755902,,0.053470697,,,,Stage IB,,1.2775,,,,,,,,,,,,,,,,0.0838,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,-0.19555686,LUAD,,,,Adenocarcinoma,-1.4176,,0.1707,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.99,0.22,17,29,25,,,34,BRCA_Basal,34,34,,0,0,34,34,,Invasive Carcinoma,71,,284,,,,29335,0,,34,34,,,,34,34,,,34,,,,,,,,TUMOR FREE,Alive,-26535,,,,176,,34,34,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,19,,2,0.4874,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A8OQ,,,,,,,34,,,,,,,,,68,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,82665,,1.258342368,0,0,0,0,0.8126,1,,,Infiltrating Ductal Carcinoma,0.171269662,,0.211859854,0,0,0,,Negative,0.9745,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5381,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.66,0,0,0,,,2618,BRCA_Normal,2618,2618,,0,0,2618,2618,,In Situ Carcinoma,0,,19,,,,22474,0,,2618,2618,,,,2618,2618,,,2618,,,,,,,,TUMOR FREE,Alive,-17332,,,,125,,2618,2618,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Core Biopsy,,,0,,0,5e-05,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AO,,,,,,,2618,,,,,,,,,0,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,82667,,1.522859913,0,0,0,0,-0.1703,1,,,Infiltrating Ductal Carcinoma,0.319893517,,0.263509825,0,0,0,,Negative,1.1905,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6083,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,1,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Clinging, High Grade), No Detail Present",,"DCIS (Clinging, High Grade)",0,None,None,0,None,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,1,1,,,White,BRCA,,0,0,,,,2,FEMALE,1,2.06,0.59,6,5,6,,,1781,BRCA_LumA,,1781,,2,2,1104,1104,,Invasive Carcinoma,17,,10,,,,20892,0,,1781,1781,,,,,1781,,,1104,,,,,,,,TUMOR FREE,Dead,-22723,1781,,,0,,1781,1781,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,5,,0,0.087691,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Duke,,TCGA-B6-A0X7,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,7,,,,,,,,,,,,,1994,1104,colon,,,Stage X,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,82670,,-0.863691399,0,0,0,0,-0.1827,1,,,Mixed Histology (NOS),0.121107348,,0.245779661,0,0,0,,[Not Available],-1.494,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4228,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.15,0.26,6,2,8,,,2632,BRCA_LumB,2632,2632,,0,0,2632,2632,,Invasive Carcinoma,16,,22,,,,33977,0,,2632,2632,,,,2632,2632,,,2632,,,,,,,,TUMOR FREE,Alive,-23855,,,,49,,2632,2632,,,[Not Available],[Not Applicable],,,,,0.43,Breast,Resection/Excision,,,10,,0,0.24958,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AW,,,,,,,2632,,,,,,,,,17,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,82672,,2.30158601,0,0,0,0,-3.0198,1,,,Infiltrating Ductal Carcinoma,0.239884772,,0.128643546,0,0,0,,Negative,2.381,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1697,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Medullary), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Medullary), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,5.22,0.77,10,19,27,,,1842,BRCA_Basal,1842,1842,,0,0,1842,1842,,In Situ Carcinoma,56,,96,,,,19573,0,,1842,1842,,,,1842,1842,,,1842,,,,,,,,TUMOR FREE,Alive,-13409,,,,50,,1842,1842,,,[Not Available],[Not Applicable],,,,,0.25,Breast,Resection/Excision,,,18,,2,0.39385,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A12F,,,,,,,1842,,,,,,,,,59,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,36,,,,,,,,,,,,,,,,,,,,82675,TRUE,-0.540288446,0,0,0,0,1.2781,1,,,Infiltrating Ductal Carcinoma,0.14365198,,0.259689519,0,0,0,,Negative,-1.1605,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4513,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Clinging, Intermediate Grade), DCIS (Cribriform, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Clinging, Intermediate Grade), DCIS (Cribriform, High Grade), DCIS (Solid, High Grade)",0,None,None,0,None,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.23,3,3,2,,,1234,BRCA_LumA,1234,1234,,0,0,1234,1234,,Invasive Carcinoma,8,,14,,,,16677,0,,1234,1234,,,,1234,1234,,,1234,,,,,,,,TUMOR FREE,Alive,-23851,,,,17,,1234,1234,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,4,,0,0.065411,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2FB,,,,,,,1234,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,82681,,1.868404978,0,0,0,0,0.3589,1,,,Infiltrating Lobular Carcinoma,0.164468549,,0.255474047,0,0,0,,Negative,1.251,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.259,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-BL-A13I,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.07,0.33,2,1,2,,,223,,,223,,1.0,1,216.0,216.0,,Malignant,5,,11,,,,19097.0,,,216.0,216,,,,,223,,,216.0,,,,,,,,WITH TUMOR,Dead,-20885,223,,,166.0,,216.0,216,,,[Not Available],[Not Applicable],,,,,0.13,,,,,2,,0,0.13507,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Christiana Healthcare,,TCGA-BL-A13I,,,,,,,,,Metastatic,,,,,,,3,,,,,,,,,,,,,2010,216,,,,Stage III,,,,,,,,Progressive Disease,,,,,,57.0,,,,,,,,,,,,,,,,,,,,82682,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-77-7140,White,LUSC,,1,,,Prince Charles Hospital,,,FEMALE,1,2.79,0.78,26,29,30,,,632,,,632,,1,,250,250,,Malignant,85,,139,,,,30197,,,250,,,,,,632,,,250,,,,,,,,,Dead,-25303,632,,,249,,250,,,,[Not Available],[Not Applicable],,,,,0.15,,,,,14,,1,0.60395,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7140,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,2002,250,,,,Stage IIB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,82683,,0.026957413,,,,,,,,,,0.146038618,,0.039743916,,,,Stage IIB,,0.761,,,,,,,,,,,,,,,,0.4104,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.60697371,14.71576297,15.87515865,-0.597547282858096,LUSC,Squamous Cell Carcinoma,17.86876555,14.7118723,Squamous Cell Carcinoma,0.1325,14.61563722,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.13,0.52,7,5,6,,,4929,BRCA_LumA,4929,4929,,0,0,4929,4929,,None,18,,15,,,,18661,N/A (Non-Malignant),,4929,4929,,,,4929,4929,,,4929,,,,,,,,TUMOR FREE,Alive,-26269,,,,48,,4929,4929,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,16,,1,0.12355,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RO,,,,,,,4929,,,,,,,,,22,,,,,,,,,,,,,1993,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,82686,,-0.973364211,0,0,0,0,1.166,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.096808803,N/A (Non-Malignant),0.109343939,0,0,0,N/A (Non-Malignant),Negative,-1.0775,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1262,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2754,,LUSC,,0,0,,Indivumed,,0,MALE,0,2.71,0.87,8,15,19,,,61,,,61,,0,0,61,61,,Malignant,42,,125,,,,29693,,,61,61,,,,,61,,,61,,,,,,,,TUMOR FREE,Alive,-24471,,,,371,,61,61,,,[Not Available],[Not Applicable],,,,,0.21,,,,,9,,1,0.43311,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2754,,,,,,,61,,,,,,,,,32,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,82693,,-0.137972062,,,,,,,,,,0.107272698,,0.043499545,,,,Stage IIIA,,-0.7895,,,,,,,,,,,,,,,,-0.5553,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,W544C,1,,,W544C,14.56516972,15.45423057,14.01748939,-0.78513514219765,LUSC,Squamous Cell Carcinoma,17.60680676,14.33593268,Squamous Cell Carcinoma,-0.5716,12.85580268,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-FC-A4JI,,PRAD,268,0,0,,FC,0,0,MALE,0,3.4,0.65,11,17,17,ambiguous,NO,877,8-other,877,877,,0,0,877,877,prad_tcga,Malignant,45,ATM;BARD1;CHEK1;RAD54L,162,51.7,TCGA-FC-A4JI-01,0,5343,0,TCGA-FC-A4JI,877,877,Prostate Cancer,,,877,877,TCGA,,877,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25931,,70,8,46,PRAD,877,877,,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.09,Prostate,Resection,5,0CEA748C-D2E9-418E-84B0-41A07BDDC9DA,14,Normal (no evidence of prostate cancer) [cM0],1,0.19749,[Not Available],30F623A3-DAE7-41DA-AB10-8786D094209E,3,Prostate Adenocarcinoma Acinar Type,,Prostate,52,,Acinar Adenocarcinoma,[Not Available],,FC,1.0,TCGA-FC-A4JI,0:DiseaseFree,4,47,Prostate Adenocarcinoma,28.81,2/11/13,877,,,,,NO,C61,BEFDDE59-6838-433A-BAFC-82B4D3802349,630,30,TUMOR FREE,0.4645,0:LIVING,,,28.81,Bilateral,47,Extraprostatic Extension  Localized (e.g. seminal vesicles),16,YES,101,2012,,,TCGA-FC-A4JI.BEFDDE59-6838-433A-BAFC-82B4D3802349.pdf,Central Zone,[Not Applicable],YES,12,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,,No,R0,,70,Core needle biopsy,,,YES,NO,NO,NO,T3a,YES,8,No,YES,0,,T4,,M0,C61.9,8140/3,82694,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BL-A13J,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.59,0.56,9,13,21,,,81,,,81,,1.0,1,81.0,81.0,,Malignant,43,,119,,,,16596.0,,,81.0,81,,,,,81,,,81.0,,,,,,,,WITH TUMOR,Dead,-23927,81,,,154.0,,81.0,81,,,[Not Available],[Not Applicable],,,,,0.21,,,,,17,,2,0.31785,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Christiana Healthcare,,TCGA-BL-A13J,,,,,,,,,,,,,,,,64,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,65.0,,,,,,,,,,,,,,,,,,,,82696,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-7727,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,1.91,0.56,7,9,8,,,119,,119,119,,0,0,119,119,,Malignant,24,,30,,,,18998,,,119,119,,,,119,119,,,119,,,,,,,,TUMOR FREE,Alive,-25929,,,,318,,119,119,,,[Not Available],[Not Applicable],,,,,0.46,,,,,10,,0,0.24345,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7727,,,,,,,119,,,,,,,,,13,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,82697,,1.394489335,,,,,,,,,,0.236230892,,0.090326861,,,,Stage IIIA,,0.14,,,,,,,,,,,,,,,,-0.3723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.10345451,16.84387012,16.30247734,-0.117734353,LUAD,Adenocarcinoma,17.92663476,16.03810527,Adenocarcinoma,-0.1957,13.68157867,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-YL-A8SQ,,PRAD,389,1,1,,YL,,0,MALE,1,3.44,0.63,3,11,10,ambiguous,NO,2083,8-other,,2083,,1,1,329,329,prad_tcga,Malignant,24,ATM;BRCA1;BRCA2;BRIP1;CDK12;CHEK2;PALB2;RAD51B;RAD51C;RAD51D;RAD54L,68,,TCGA-YL-A8SQ-01,0,5686,0,TCGA-YL-A8SQ,329,329,Prostate Cancer,,1943,,2083,TCGA,,329,Primary,0,Apex|Middle|Base,B,,,True,WITH TUMOR,Alive,-22482,,61,9,47,PRAD,329,329,,0.0,[Not Available],[Not Applicable],40,R1,1,Matched,0.45,Prostate,Resection,4,72BB37E2-A3A1-4DAE-9A12-818ADEBBA4E1,18,Normal (no evidence of prostate cancer) [cM0],1,0.072812,[Not Available],24E5D323-F3D4-4ADD-9A29-79E77CED357C,5,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,YL,1.33333333333,TCGA-YL-A8SQ,1:Recurred/Progressed,5,30,Prostate Adenocarcinoma,10.81,4/30/14,2083,,Biochemical evidence of disease,,,NO,C61,A714B71D-3E37-4C89-908B-1C1F0AA49DEA,2630,19,WITH TUMOR,0.4599,0:LIVING,1.1,3,68.43,Bilateral,35,,,YES,1898,2008,329,,TCGA-YL-A8SQ.A714B71D-3E37-4C89-908B-1C1F0AA49DEA.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,19,61-70%,5,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,YES,No,R1,,61,Core needle biopsy,329,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,82709,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-78-7166,White,LUAD,,0,0,,Prince Charles Hospital,,,MALE,2,2.04,0.63,3,4,5,,,258,,,258,,2,2,258,258,,Malignant,12,,6,,,,18443,,,258,258,,,,,258,,,258,,,,,,,,,Dead,-30869,258,,,295,,258,258,,,[Not Available],[Not Applicable],,,,,0.03,,,,,3,,0,0.029536,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7166,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2002,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,82710,,0.45354224,,,,,,,,,,0.123389823,,0.071507563,,,,Stage IIB,,0.259,,,,,,,,,,,,,,,,-0.1594,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),F280Y,1,,G12C (driver),F280Y,13.76007124,14.28861571,15.25547149,-0.601789946,LUAD,Adenocarcinoma,18.19691893,15.40216757,Adenocarcinoma,-0.6202,9.49703683,-0.7301,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.94,0.6,6,4,8,,,1163,BRCA_LumA,1163,1163,,0,0,1163,1163,,In Situ Carcinoma,18,,17,,,,23135,0,,1163,1163,,,,1163,1163,,,1163,,,,,,,,TUMOR FREE,Alive,-18507,,,,49,,1163,1163,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,7,,0,0.13189,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14Q,,,,,,,1163,,,,,,,,,7,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,82711,,0.177481201,0,0,0,0,0.8908,1,,,Infiltrating Ductal Carcinoma,0.101747456,,0.171301945,0,0,0,,Negative,-0.094,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2455,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,1,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,None,None,0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SK,,PRAD,389,0,0,,YL,,0,MALE,0,2.03,0.44,6,9,7,HRD,NO,1408,8-other,,1408,,0,0,1408,1408,prad_tcga,Malignant,22,BRCA1;CDK12;CHEK1;RAD51D,61,,TCGA-YL-A8SK-01,0,5676,0,TCGA-YL-A8SK,1408,1408,Prostate Cancer,,924,,1408,TCGA,,1408,Primary,0,Apex|Middle|Base,B,ATM:?-416:.:splice_acceptor_variant,ATM,True,,Alive,-24759,,67,9,45,PRAD,1408,1408,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.08,Prostate,Resection,4,F5243BA4-684D-4401-A1A5-7713BCC9106E,2,Normal (no evidence of prostate cancer) [cM0],0,0.10241,[Not Available],159B47B2-DC7D-4856-9A00-454E27301E23,5,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A8SK,0:DiseaseFree,5,23,Prostate Adenocarcinoma,46.25,4/25/14,1408,,,,,NO,C61,F332F5AD-A0BE-455D-9523-13BDF275DB2A,410,5,,0.1851,0:LIVING,0.03,,46.25,Bilateral,26,,,YES,1208,2010,,,TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,38,26-35%,20,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,4,M0,C61.9,8140/3,82713,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-49-4501,White,LUAD,,1,,,Johns Hopkins,1,1,FEMALE,1,2.72,0.43,7,9,12,,,1421,,545,1421,,1,,545,545,,Malignant,28,,53,,,,20774,,,545,,,,,545,1421,,,545,,,,,,,,WITH TUMOR,Dead,-24817,1421,,,77,,545,,,,[Not Available],[Not Applicable],,,,,0.46,,,,,15,,1,0.31611,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4501,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,1996,545,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,82717,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.2617,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"E746_A750del (driver), AMP (driver)",,,1,E746_A750del (driver),,,,,,-0.114924814,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.6467,,0.0149,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-D7-6818,White,STAD,,1,1,,,,1,,1,2.37,0.43,6,9,13,,,376,,,376,,1,1,247,247,,Malignant,28,,50,,,,24969,,,247,247,,,,,376,,,247,,,,,,,,WITH TUMOR,Dead,-19391,376,,,211,,247,247,,,[Not Available],[Not Applicable],,,,,0.25,Stomach,Unknown,,,13,,1,0.36674,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6818,,,,,,,,,Locoregional Recurrence,,,,,,,36,,,,,,,,,,,,,2011,247,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,82739,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6818,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1.0,,,0.0,1.0,Male,TCGA-CU-A0YN,White,BLCA,,0.0,0,,,,,MALE,2.0,3.36,0.4,8,9,14,,,393,,,393,,2.0,2,393.0,393.0,,Malignant,31,,24,,,,25540.0,,,393.0,393,,,,,393,,,393.0,,,,,,,,,Dead,-21927,393,,,225.0,,393.0,393,,,[Not Available],[Not Applicable],,,,,0.39,,,,,19,,1,0.26006,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,UNC,,TCGA-CU-A0YN,,,,,,,,,,,,,,,,22,,,,,,,,,,,,,2005,,,,,Stage III,,,,,,,,[Not Available],,,,,,60.0,,,,,,,,,,,,,,,,,,,,82742,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-05-4422,,LUAD,,0,0,,Indivumed,,0,MALE,0,2.06,0.62,6,6,8,,,365,,,365,,0,0,365,365,,Malignant,20,,41,,,,19526,,,365,365,,,,,365,,,365,,,,,,,,,Alive,-24837,,,,59,,365,365,,,[Not Available],[Not Applicable],,,,,0.01,,,,,6,,0,0.1308,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4422,,,,,,,365,,,,,,,,,7,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,82744,,1.320244876,,,,,,,,,,0.188808988,,0.058813706,,,,Stage IB,,1.3625,,,,,,,,,,,,,,,,-0.4185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.025503573,LUAD,,,,Adenocarcinoma,-2.052,,1.4827,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-35-5375,White,LUAD,,0,0,,Cureline,,0,MALE,0,3.7,0.58,9,20,16,,,264,,,264,,0,0,264,264,,Malignant,45,,51,,,,19406,,,264,264,,,,,264,,,264,,,,,,,,TUMOR FREE,Alive,-22628,,,,559,,264,264,,,[Not Available],[Not Applicable],,,,,0.57,,,,,21,,2,0.41529,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Cureline,,TCGA-35-5375,,,,,,,264,,,,,,,,,63,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,82752,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,E593Rfs*2 (driver),1,,,E593Rfs*2 (driver),16.25303674,15.0122198,17.29959393,-0.074831158,LUAD,,18.19594323,15.91801636,Adenocarcinoma,0.639,13.82124882,0.9806,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-05-4430,,LUAD,,0,0,,Indivumed,,0,FEMALE,0,3.49,0.2,5,4,11,,,761,,,761,,0,0,761,761,,Malignant,20,,19,,,,20954,,,761,761,,,,,761,,,761,,,,,,,,TUMOR FREE,Alive,-21884,,,,362,,761,761,,,[Not Available],[Not Applicable],,,,,0.32,,,,,17,,1,0.18639,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4430,,,,,,,761,,,,,,,,,28,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,59,,,,,,,,,,,,,,,,,,,,82754,,0.616470872,,,,,,,,,,0.269453772,,0.235623536,,,,Stage IB,,0.794,,,,,,,,,,,,,,,,0.6665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.077545805,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.1526,,0.2029,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.22,0.69,8,6,8,,,533,BRCA_LumA,533,533,,0,0,533,533,,Invasive Carcinoma,22,,73,,,,26618,0,,533,533,,,,533,533,,,533,,,,,,,,TUMOR FREE,Alive,-27627,,,,104,,533,533,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,24,,1,0.24541,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A423,,,,,,,533,,,,,,,,,16,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,82755,,,0,0,0,0,1.3028,1,,,Infiltrating Lobular Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,1.92,0.71,9,10,13,,,2362,BRCA_LumA,1810,2362,,1,1,1810,1810,,Invasive Carcinoma,32,,41,,,,27677,0,,1810,1810,,,,1810,2362,,,1810,,,,,,,,WITH TUMOR,Alive,-22510,,,,39,,1810,1810,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,5,,0,0.21769,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IE,,,,,,,2362,Liver,Distant Metastasis,,,,,,,10,,,,,,,,,,,,,2008,1810,,,,Stage IIB,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,82756,,-1.012588967,0,0,0,0,-0.366,0,,,Infiltrating Ductal Carcinoma,0.086747015,,0.174671125,0,0,1,,Negative,-1.475,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0161,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,Papilloma,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-62-A470,White,LUAD,,1,1,,Thoraxklinik at University Hospital Heidelberg,1,1,MALE,1,2.99,0.59,11,6,13,,,1194,,539,1194,,1,1,539,539,,Malignant,30,,77,,,,25697,,,539,539,,,,539,1194,,,539,,,,,,,,WITH TUMOR,Dead,-30689,1194,,,161,,539,539,,,[Not Available],[Not Applicable],,,,,0.01,,,,,22,,1,0.2775,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A470,,,,,,,,,Locoregional Recurrence,,,,,,,24,,,,,,,,,,,,,2009,539,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,84,,,,,,,,,,,,,,,,,,,,82757,,-0.518618785,,,,,,,,,,0.243156815,,0.124921051,,,,Stage IB,,-0.6605,,,,,,,,,,,,,,,,-0.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R459Pfs*39 (driver),1,,,R459Pfs*39 (driver),,,,-0.689147813,LUAD,Adenocarcinoma,,,Adenocarcinoma,-2.3444,,-1.311,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-EJ-5509,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.51,4,11,0,HRD,NO,1464,5-SPOP,1464,1464,,0,0,1464,1464,prad_tcga,Malignant,15,,78,4.1,TCGA-EJ-5509-01,5,5274,0,TCGA-EJ-5509,1464,1464,Prostate Cancer,,1102,1464,1464,TCGA,,1464,Primary,0,Apex|Middle|Base,A,,ATM,,TUMOR FREE,Alive,-23368,,63,7,26,PRAD,1464,1464,WHITE,0.160683284,[Not Available],[Not Applicable],37,R0,1,Matched,0.11,Prostate,Resection,3,99a7115e-046b-488e-95d2-48c35bd29867,2,,0,0.087678,[Not Available],13ce70a8-785c-4b59-b073-41922cb201f9,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,1.23333333333,TCGA-EJ-5509,0:DiseaseFree,2,17,Prostate Adenocarcinoma,48.09,4/2/12,1464,,,,,NO,C61,672ff51d-12ba-402a-b6d6-87cc9c91e7ad,,1,TUMOR FREE,0.1386,0:LIVING,0.1,3,48.09,Bilateral,20,,,YES,,2009,,,TCGA-EJ-5509.672ff51d-12ba-402a-b6d6-87cc9c91e7ad.pdf,,[Not Applicable],NO,,71-80%,10,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.6,63,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,82760,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A922,Unknown,STAD,,1,1,,,,1,,1,5.76,0.35,25,28,35,,,275,,,275,,1,1,252,252,,Malignant,88,,489,,,,29636,,,252,252,,,,,275,,,252,,,,,,,,,Dead,-25700,275,,,205,,252,252,,,Stomach Cancer,[Not Applicable],,,,,0.36,Stomach,Unknown,,,14,,2,0.44947,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A922,,,,,,,262,Liver,Distant Metastasis,,,,,,,55,,,,,,,,,,,,,2010,252,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,82761,,0.022170978,,,,,,,,,,0.04968256,Grade 2,0.174225536,,,,Stage IV,,-0.4235,,,,,,,,,,,,,,,,0.6761,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A922,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Female,TCGA-97-A4M1,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,0,2.84,0.36,2,8,10,,,601,,601,601,,0,0,601,601,,Malignant,20,,86,,,,34499,,,601,601,,,,601,601,,,601,,,,,,,,TUMOR FREE,Alive,-19272,,,,59,,601,601,,,[Not Available],[Not Applicable],,,,,0.26,,,,,17,,1,0.15743,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4M1,,,,,,,601,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,82762,,0.20732909,,,,,,,,,,0.231713907,,0.24713007,,,,Stage IA,,0.0515,,,,,,,,,,,,,,,,-0.1329,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.365530581,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.9689,,-0.2915,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HC-7740,White,PRAD,184,0,0,,HC,0,0,MALE,0,2.0,0.22,0,0,0,HRP,NO,717,8-other,717,717,,0,0,717,717,prad_tcga,Malignant,0,,19,5.9,TCGA-HC-7740-01,5,5419,0,TCGA-HC-7740,717,717,Prostate Cancer,,154,717,717,TCGA,,717,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21883,,59,7,27,PRAD,717,717,WHITE,0.093151492,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,54d1cf0e-5d54-486c-a863-733b5edc5986,0,,0,1.57e-05,[Not Available],91e249a6-b0b0-487e-9fad-0e9f5798dcae,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.5,TCGA-HC-7740,0:DiseaseFree,2,0,Prostate Adenocarcinoma,23.55,4/11/12,717,,,,,,C61,d2b80346-3a50-4fc3-99c2-0e15225cc433,,0,TUMOR FREE,0.0002,0:LIVING,0.0,,23.55,Bilateral,5,,,YES,,2011,,,TCGA-HC-7740.d2b80346-3a50-4fc3-99c2-0e15225cc433.pdf,,[Not Applicable],,,61-70%,4,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.7,59,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,82767,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,1,1,1,Female,TCGA-75-6212,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),2,1,FEMALE,1,2.74,0.43,0,0,0,,,1516,,1516,1516,,2,2,1340,1340,,Malignant,0,,19,,,,24786,,,1516,1516,,,,1516,1516,,,1340,,,,,,,,WITH TUMOR,Dead,,1516,,,27,,1516,1516,,,[Not Available],[Not Applicable],,,,,0.14,,,,,14,,1,0.031066,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-6212,,,,,,,,,New Primary Tumor,,,,,,,33,,,,,,,,,,,,,,1340,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,82768,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,0.1697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L747_A750delinsP (driver),,,1,L747_A750delinsP (driver),,,16.76730532,17.63667323,11.73086576,-0.242763327,LUAD,Adenocarcinoma,18.48875746,15.36712645,Adenocarcinoma,1.2228,12.83768551,-1.1675,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,,,,,,,,991,,859,991,,1,1,859,859,,Invasive Carcinoma,,,,,,,27720,0,,859,859,,,,859,991,,,859,,,,,,,,WITH TUMOR,Dead,-18014,991,,,137,,859,859,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0I6,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,1990,859,Skin and bone,,,Stage IIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,82774,,-0.343539897,0,0,0,0,0.4201,1,,,Infiltrating Ductal Carcinoma,0.145827448,,0.099944137,0,0,0,,Negative,-1.3085,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4703,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-49-4505,White,LUAD,,1,1,,Johns Hopkins,1,1,FEMALE,1,3.02,0.45,5,12,13,,,428,,417,428,,1,1,417,417,,Malignant,30,,24,,,,18359,,,417,417,,,,417,428,,,417,,,,,,,,WITH TUMOR,Dead,-22628,428,,,285,,417,417,,,[Not Available],[Not Applicable],,,,,0.51,,,,,20,,1,0.21126,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4505,,,,,,,,,Distant Metastasis|New Primary Tumor,,,,,,,29,,,,,,,,,,,,,1996,417,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,82777,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,0.4168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.88383404,16.93429577,16.71465036,0.043107766,LUAD,,18.35721897,15.87671745,Adenocarcinoma,,14.43486803,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,0,1,1,Female,TCGA-73-7499,White,LUAD,,1,1,,Roswell Park,1,2,FEMALE,1,3.22,0.38,10,9,16,,,1531,,1447,1531,,1,1,1447,1447,,Malignant,35,,73,,,,17145,,,1447,1447,,,,1447,1531,,,1447,,,,,,,,TUMOR FREE,Dead,-29683,1531,,,88,,1447,1447,,,[Not Available],[Not Applicable],,,,,0.35,,,,,20,,1,0.50811,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-7499,,,,,,,,,Distant Metastasis,,,,,,,30,,,,,,,,,,,,,2010,1447,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,82778,,1.306169201,,,,,,,,,,0.229627295,,0.084339832,,,,Stage IB,,1.4685,,,,,,,,,,,,,,,,-0.072,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.178562991,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.4348,,1.701,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.61,6,1,9,,,477,BRCA_LumA,477,477,,0,0,477,477,,Invasive Carcinoma,16,,16,,,,33567,0,,477,477,,,,477,477,,,477,,,,,,,,TUMOR FREE,Alive,-21559,,,,565,,477,477,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,8,,0,0.18391,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1J5,,,,,,,477,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,82781,,1.58937959,0,0,0,0,-0.7318,1,,,Infiltrating Lobular Carcinoma,0.151490089,,0.130984534,0,0,0,,Negative,0.968,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1524,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.9,0.61,6,0,5,,,883,BRCA_LumA,883,883,,0,0,883,883,,Invasive Carcinoma,11,,77,,,,31868,0,,883,883,,,,883,883,,,883,,,,,,,,TUMOR FREE,Alive,,,,,75,,883,883,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,16,,1,0.1687,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Kansas,,TCGA-WT-AB44,,,,,,,883,,,,,,,,,16,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,82783,,-0.896003309,0,0,0,0,0.687,1,,,Infiltrating Lobular Carcinoma,0.156527087,,0.118062585,0,0,0,,Negative,-0.0615,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4465,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-64-5781,White,LUAD,,1,,,Fox Chase,,0,FEMALE,1,1.91,0.38,6,3,6,,,1559,,,1559,,1,,96,96,,Malignant,15,,16,,,,29732,,,96,,,,,,1559,,,96,,,,,,,,TUMOR FREE,Alive,-20219,,,,1448,,96,,,,[Not Available],[Not Applicable],,,,,0.34,,,,,9,,0,0.33614,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-5781,,,,,,,1559,,,,,,,,,18,,,,,,,,,,,,,2007,96,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,55,,,,,,,,,,,,,,,,,,,,82787,,1.394425815,,,,,,,,,,0.173724092,,0.078239914,,,,Stage IB,,1.407,,,,,,,,,,,,,,,,0.3925,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V99L,1,,,V99L,,,,0.104343312,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.11,,1.7355,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Male,TCGA-18-3407,Asian,LUSC,,0,0,,Princess Margaret Hospital (Canada),,2,MALE,2,3.46,0.29,5,4,9,,,136,,,136,,2,2,136,136,,Malignant,18,,20,,,,16026,,,136,136,,,,,136,,,136,,,,,,,,TUMOR FREE,Dead,-26615,136,,,99,,136,136,,,[Not Available],[Not Applicable],,,,,0.2,,,,,24,,1,0.20992,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3407,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2003,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,72,,,,,,,,,,,,,,,,,,,,82790,,0.591915378,,,,,,,,,,0.205306468,,0.133504373,,,,Stage IB,,1.623,,,,,,,,,,,,,,,,0.656,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V155F (driver),1,,,V155F (driver),,,,-0.376299894165685,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.9392,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7782,Black or African American,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.75,6,13,1,HRD,NO,1167,5-SPOP,1167,1167,,0,0,1167,1167,prad_tcga,Malignant,20,FANCL,169,,TCGA-EJ-7782-01,0,5312,0,TCGA-EJ-7782,1167,1167,Prostate Cancer,,350,1167,1167,TCGA,,1167,Primary,0,,A,CDK12:1459:W/X:frameshift_variant,,,TUMOR FREE,Alive,-25965,,71,8,541,PRAD,1167,1167,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],379,R0,1,Matched,0.0,Prostate,Resection,4,951c894e-9354-45ad-834a-ffc04441a3a9,1,Normal (no evidence of prostate cancer) [cM0],0,0.10124,[Not Available],1426b4bf-f4a5-477c-bbbb-e0e656549764,4,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,20,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,21.6,TCGA-EJ-7782,0:DiseaseFree,4,20,Prostate Adenocarcinoma,38.34,4/6/12,1167,,,,,NO,C61,d8500e84-1aa4-4a3b-874c-563d520dec03,,3,TUMOR FREE,0.1234,0:LIVING,0.1,4,38.34,Bilateral,26,,,YES,,2010,,,TCGA-EJ-7782.d8500e84-1aa4-4a3b-874c-563d520dec03.pdf,,[Not Applicable],NO,49,51-60%,17,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.2,71,Core needle biopsy,,,YES,NO,YES,,T2c,,8,No,,0,N0,T2c,0,M0,C61.9,8550/3,82792,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-49-6742,White,LUAD,,1,,,Johns Hopkins,,1,MALE,1,3.61,0.49,3,2,4,,,488,,,488,,1,,214,214,,Malignant,9,,13,,,,21488,,,214,,,,,,488,,,214,,,,,,,,WITH TUMOR,Dead,-25839,488,,,364,,214,,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,1,0.068622,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6742,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2010,214,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,82794,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L268P,1,,,L268P,14.47771424,15.94131454,13.47401445,-0.704663899,LUAD,,17.8890364,13.61750443,Adenocarcinoma,,13.10424721,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,1.0,1.0,Male,TCGA-G2-A2EK,White,BLCA,,1.0,1,,,,0,MALE,1.0,2.06,0.54,7,8,6,,,485,,,485,,1.0,1,485.0,485.0,,Malignant,21,,37,,,,28027.0,,,485.0,485,,,,,485,,,485.0,,,,,,,,WITH TUMOR,Alive,-20995,,,,88.0,,485.0,485,,,[Not Available],[Not Applicable],,,,,0.04,,,,,4,,0,0.1064,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EK,,,,,,,485,Renal Pelvis,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2010,485,,,,Stage II,,,,,,,,Stable Disease,,,,,,57.0,,,,,,,,,,,,,,,,,,,,82798,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,1882,,1882,1882,,0,0,1882,1882,,Invasive Carcinoma,,,,,,,33162,0,,1882,1882,,,,1882,1882,,,1882,,,,,,,,TUMOR FREE,Alive,-30859,,,,0,,1882,1882,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A1KQ,,,,,,,1882,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,82799,,0.959951196,0,0,0,0,-0.2518,0,,,Infiltrating Ductal Carcinoma,0.130993408,,0.089296966,0,0,0,,Negative,0.0245,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.142,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.65,14,8,15,,,1467,BRCA_LumB,1467,1467,,0,0,1467,1467,,Invasive Carcinoma,37,,72,,,,18545,0,,1467,1467,,,,1467,1467,,,1467,,,,,,,,TUMOR FREE,Alive,-23397,,,,66,,1467,1467,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,13,,0,0.29541,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1R7,,,,,,,1467,,,,,,,,,16,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,82800,,-0.566529782,0,0,0,0,0.8458,1,,,Infiltrating Ductal Carcinoma,0.093414706,,0.149458511,0,0,0,,Negative,-1.651,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1842,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.25,0.27,6,6,9,,,1532,BRCA_Her2,1532,1532,,0,0,1532,1532,,Invasive Carcinoma,21,,61,,,,29295,0,,1532,1532,,,,1532,1532,,,1532,,,,,,,,TUMOR FREE,Alive,-16978,,,,67,,1532,1532,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,9,,0,0.088679,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3XZ,,,,,,,1532,,,,,,,,,9,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,82806,,1.476784718,0,0,0,0,-0.1965,1,,,Infiltrating Ductal Carcinoma,0.116476712,,0.105222388,0,0,0,,Negative,1.0185,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2203,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.0,0.6,14,26,23,,,701,BRCA_Basal,701,701,,0,0,701,701,,Invasive Carcinoma,63,,48,,,,21939,0,,701,701,,,,701,701,,,701,,,,,,,,TUMOR FREE,Alive,-30025,,,,138,,701,701,,,[Not Available],[Not Applicable],,,,,0.34,Breast,Resection/Excision,,,11,,1,0.43699,[Not Available],,,[Not Available],,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0WA,,,,,,,701,,,,,,,,,32,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,82808,TRUE,0.442157284,0,0,0,0,-0.1304,1,,,Breast Invasive Carcinoma,0.169301647,,0.120593221,0,0,0,,Negative,-0.002,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4889,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-GU-A42P,White,BLCA,,0.0,0,,,,2,MALE,2.0,5.31,0.8,6,5,18,,,332,,,332,,2.0,2,332.0,332.0,,Malignant,29,,53,,,,33303.0,,,332.0,332,,,,,332,,,332.0,,,,,,,,TUMOR FREE,Dead,-26546,332,,,392.0,,332.0,332,,,[Not Available],[Not Applicable],,,,,0.47,,,,,21,,2,0.21061,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A42P,,,,,,,,,,,,,,,,59,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,72.0,,,,,,,,,,,,,,,,,,,,82812,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,3.17,0.38,14,15,18,,,3296,BRCA_Basal,588,3296,,1,1,588,588,,Invasive Carcinoma,47,,64,,,,0,0,,588,588,,,,588,3296,,,588,,,,,,,,TUMOR FREE,Alive,-17229,,,,98,,588,588,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,19,,1,0.49892,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Medullary Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AI,,,,,,,3296,"Other, specify",New Primary Tumor,,,,,,,40,,,,,,,,,,,,,2005,588,Contralateral Breast,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,82815,,1.709146517,0,0,0,0,1.0135,1,,,Medullary Carcinoma,0.22260027,,0.031518195,0,0,0,,Negative,1.3565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1098,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.53,0.67,11,4,10,,,395,BRCA_LumA,395,395,,0,0,395,395,,Invasive Carcinoma,25,,45,,,,31916,0,,395,395,,,,395,395,,,395,,,,,,,,TUMOR FREE,Alive,-20715,,,,36,,395,395,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,16,,0,0.5063,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XU,,,,,,,395,,,,,,,,,14,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,82820,,0.15380816,0,0,0,0,0.6806,1,,,Infiltrating Ductal Carcinoma,0.16098869,,0.147963044,0,0,0,,Negative,-0.5465,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4276,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,1,0,0,Yes,0,Adipose Tissue,Stromal Alterations,"DCIS (Solid, Intermediate Grade), LCIS, Stromal Alterations",,"DCIS (Solid, Intermediate Grade), LCIS",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2787,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.15,0.36,12,14,18,,,1217,,,1217,,0,0,1217,1217,,Malignant,44,,54,,,,16485,,,1217,1217,,,,,1217,,,1217,,,,,,,,TUMOR FREE,Alive,-21124,,,,624,,1217,1217,,,[Not Available],[Not Applicable],,,,,0.17,,,,,22,,1,0.43495,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2787,,,,,,,1217,,,,,,,,,31,,,,,,,,,,,,,2004,,,,,Stage IA,,,,,,,,[Not Applicable],,,,,,57,,,,,,,,,,,,,,,,,,,,82826,,0.994797975,,,,,,,,,,0.199879504,,0.101849176,,,,Stage IA,,2.49,,,,,,,,,,,,,,,,0.0469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0347370647254948,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.0504,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-49-6745,White,LUAD,,0,0,,Johns Hopkins,,0,MALE,0,3.83,0.24,4,3,4,,,522,,,522,,0,0,522,522,,Malignant,11,,15,,,,24410,,,522,522,,,,,522,,,522,,,,,,,,TUMOR FREE,Alive,-30133,,,,158,,522,522,,,[Not Available],[Not Applicable],,,,,0.33,,,,,9,,1,0.12048,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6745,,,,,,,522,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,82829,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,16.54620904,17.9432589,17.24792879,0.037185585,LUAD,Adenocarcinoma,18.32630782,16.40113647,Adenocarcinoma,0.5304,13.66230496,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,,,,,,,,749,,,749,,1,1,746,746,,Invasive Carcinoma,,,,,,,29426,0,,746,746,,,,,749,,,746,,,,,,,,WITH TUMOR,Dead,-17073,749,,,191,,746,746,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0I8,,,,,,,,"Other, specify",Locoregional Disease,,,,,,,,,,,,,,,,,,,,1992,746,Pectoral muscle,,,Stage X,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,82833,,-1.696259327,0,0,0,0,1.042,1,,,Infiltrating Ductal Carcinoma,0.123695787,,0.170146706,0,0,0,,[Not Available],-1.363,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1839,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-83-5908,White,LUAD,,0,0,,CHI-Penrose Colorado,,0,FEMALE,0,1.66,0.4,6,5,5,,,824,,,824,,0,0,824,824,,Malignant,16,,25,,,,22495,,,824,824,,,,,824,,,824,,,,,,,,TUMOR FREE,Alive,-21760,,,,308,,824,824,,,[Not Available],[Not Applicable],,,,,0.52,,,,,13,,0,0.42807,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,CHI-Penrose Colorado,,TCGA-83-5908,,,,,,,824,,,,,,,,,15,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Stable Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,82834,,1.656732523,,,,,,,,,,0.183968952,,0.115606919,,,,Stage IA,,2.963,,,,,,,,,,,,,,,,0.4827,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,,,,0.305645661,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.662,,1.8759,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-VQ-A8PX,Unknown,STAD,,0,0,,,0,0,,0,3.26,0.41,4,7,5,,,1964,,1964,1964,,0,0,1964,1964,,Malignant,16,,54,,,,16334,,,1964,1964,,,,1964,1964,,,1964,,,,,,,,TUMOR FREE,Alive,-18902,,,,861,,1964,1964,,,[Not Available],[Not Applicable],,,,,0.19,Stomach,Unknown,,,13,,1,0.18913,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8PX,,,,,,,1964,,,,,,,,,25,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,82835,,0.228740434,,,,,,,,,,0.0026598,Grade 2,0.021560161,,,,Stage IA,,-0.298,,,,,,,,,,,,,,,,-0.3466,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PX,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,0,0,1,Male,TCGA-O2-A52N,White,LUSC,,0,0,,Washington University - CALGB,,2,MALE,2,3.46,0.46,15,14,23,,,1006,,,1006,,2,2,1006,1006,,Malignant,52,,190,,,,16478,,,1006,1006,,,,,1006,,,1006,,,,,,,,TUMOR FREE,Dead,-28520,1006,,,654,,1006,1006,,,[Not Available],[Not Applicable],,,,,0.17,,,,,20,,2,0.39274,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CALGB,,TCGA-O2-A52N,,,,,,,,,,,,,,,,78,,,,,,,,,,,,,2005,,,,,Stage I,,,,,,,,[Unknown],,,,,,78,,,,,,,,,,,,,,,,,,,,82843,,0.931549693,,,,,,,,,,0.134434064,,-0.001621299,,,,Stage I,,0.9315,,,,,,,,,,,,,,,,0.5475,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"AMP (driver), EGFR-CHODL",,,1,,,,,,,-0.271376749952313,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6465,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-4Z-AA7S,Black or African American,BLCA,,0.0,0,,,,2,MALE,2.0,3.85,0.87,1,3,6,,,1064,,,1064,,2.0,2,1064.0,1064.0,,Malignant,10,,19,,,,31900.0,,,1064.0,1064,,,,,1064,,,1064.0,,,,,,,,TUMOR FREE,Dead,-24111,1064,,,82.0,,1064.0,1064,,,[Not Available],[Not Applicable],,,,,0.04,,,,,12,,1,0.049294,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA7S,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage III,,,,,,,,[Not Applicable],,,,,,66.0,,,,,,,,,,,,,,,,,,,,82852,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-50-5055,White,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,2.12,0.13,1,0,1,,,1830,,,1830,,1,1,771,771,,Malignant,2,,5,,,,17585,,,771,771,,,,,1830,,,771,,,,,,,,WITH TUMOR,Dead,-28988,1830,,,17,,771,771,,,[Not Available],[Not Applicable],,,,,0.18,,,,,1,,0,0.060969,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5055,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,5,,,,,,,,,,,,,2008,771,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,79,,,,,,,,,,,,,,,,,,,,82853,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.441,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.52224168,16.53041127,16.31442507,0.186107913,LUAD,Adenocarcinoma,18.91449377,17.24361981,Adenocarcinoma,1.1424,14.37681673,1.4681,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,1,1,Female,TCGA-97-A4M3,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,1,2.03,0.69,9,11,11,,,540,,540,540,,0,0,54,54,,Malignant,31,,124,,,,28711,,,540,540,,,,540,540,,,54,,,,,,,,TUMOR FREE,Alive,-25384,,,,272,,540,540,,,[Not Available],[Not Applicable],,,,,0.04,,,,,4,,0,0.16183,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4M3,,,,,,,540,,New Primary Tumor,,,,,,,8,,,,,,,,,,,,,2012,54,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,82854,,0.050224423,,,,,,,,,,0.154553672,,0.209435051,,,,Stage IA,,-0.1765,,,,,,,,,,,,,,,,0.1532,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,E219Q,1,,,E219Q,,,,-0.699474357,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1928,,-1.1133,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-46-6026,White,LUSC,,0,0,,St. Joseph's Medical Center (MD),0,0,MALE,0,3.7,0.9,7,11,13,,,423,,423,423,,0,0,423,423,,Malignant,31,,44,,,,25905,,,423,423,,,,423,423,,,423,,,,,,,,TUMOR FREE,Alive,-29890,,,,294,,423,423,,,[Not Available],[Not Applicable],,,,,0.35,,,,,24,,1,0.20553,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,St. Joseph's Medical Center (MD),,TCGA-46-6026,,,,,,,423,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,82860,,0.533133851,,,,,,,,,,0.102537371,,0.007961593,,,,Stage IIB,,-1.283,,,,,,,,,,,,,,,,0.2359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.21161067,14.87968473,13.03857484,-0.843630271130863,LUSC,,18.24922897,15.84984468,Squamous Cell Carcinoma,-1.5511,15.45886444,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-L9-A5IP,Black or African American,LUAD,,1,1,,Candler,,1,FEMALE,1,2.64,0.53,12,6,14,,,58,,,58,,1,1,49,49,,Malignant,32,,235,,,,30933,,,49,49,,,,,58,,,49,,,,,,,,WITH TUMOR,Dead,-14681,58,,,376,,49,49,,,[Not Available],[Not Applicable],,,,,0.08,,,,,22,,1,0.7015,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Candler,,TCGA-L9-A5IP,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,30,,,,,,,,,,,,,2012,49,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,40,,,,,,,,,,,,,,,,,,,,82861,,0.479139958,,,,,,,,,,0.12420001,,0.139286883,,,,Stage IV,,0.949,,,,,,,,,,,,,,,,0.091,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.98542449,15.44705555,15.53866371,-0.570886359,LUAD,Adenocarcinoma,17.5502544,15.73780839,Adenocarcinoma,0.4356,12.97264492,-0.0069,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.15,0.77,2,2,5,,,3035,BRCA_LumB,3035,3035,,0,0,3035,3035,,Invasive Carcinoma,9,,2,,,,16896,0,,3035,3035,,,,3035,3035,,,3035,,,,,,,,TUMOR FREE,Alive,-19989,,,,49,,3035,3035,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,2,,0,0.043288,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24N,,,,,,,3035,,,,,,,,,9,,,,,,,,,,,,,2005,,,,,Stage I,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,82872,,0.037370583,0,0,0,0,-2.4934,1,,,Infiltrating Ductal Carcinoma,0.122549732,,0.105317677,0,0,0,,Negative,-0.6885,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1973,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-49-4501,White,LUAD,,1,,,Johns Hopkins,1,1,FEMALE,1,2.72,0.43,7,9,12,,,1421,,545,1421,,1,,545,545,,Malignant,28,,53,,,,20774,,,545,,,,,545,1421,,,545,,,,,,,,WITH TUMOR,Dead,-24817,1421,,,77,,545,,,,[Not Available],[Not Applicable],,,,,0.46,,,,,15,,1,0.31611,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4501,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,1996,545,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,82876,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.2617,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"E746_A750del (driver), AMP (driver)",,,1,E746_A750del (driver),,,,,,-0.114924814,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-46-3765,White,LUSC,,0,0,,St. Joseph's Medical Center (MD),0,0,FEMALE,0,3.88,0.36,12,12,20,,,405,,405,405,,0,0,405,405,,Malignant,44,,60,,,,20412,,,405,405,,,,405,405,,,405,,,,,,,,TUMOR FREE,Alive,-21762,,,,309,,405,405,,,[Not Available],[Not Applicable],,,,,0.15,,,,,14,,1,0.32245,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,St. Joseph's Medical Center (MD),,TCGA-46-3765,,,,,,,405,,,,,,,,,27,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,82877,,0.552380455,,,,,,,,,,0.222544266,,0.059175181,,,,Stage IA,,0.75,,,,,,,,,,,,,,,,0.3455,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,G627*,,,1,G627*,,,,,,-0.252109794513442,LUSC,,,,Squamous Cell Carcinoma,0.6321,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-YL-A8SH,,PRAD,389,0,0,,YL,2,2,MALE,2,1.93,0.68,5,9,0,HRD,NO,875,5-SPOP,875,875,,2,2,875,875,prad_tcga,Malignant,14,,97,,TCGA-YL-A8SH-01,0,5665,0,TCGA-YL-A8SH,875,875,Prostate Cancer,,617,875,875,TCGA,,875,Primary,0,Apex|Middle|Base,B,ATM:1937:N/X:frameshift_variant,,True,TUMOR FREE,Dead,-25395,875,69,7,42,PRAD,875,875,,0.0,"Other, non-malignant disease",[Not Applicable],35,R0,1,Matched,0.02,Prostate,Resection,4,56A06467-7CB6-4DFF-9F57-88228210619E,0,,0,0.091978,[Not Available],BFB973EB-D42D-4900-A606-A381D2317555,3,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8SH,,3,14,Prostate Adenocarcinoma,,4/25/14,,,,"Other, non-malignant disease",Death Certificate,NO,C61,62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7,510,3,TUMOR FREE,0.0699,1:DECEASED,0.06,,28.75,Bilateral,15,,,YES,1481,2009,,,TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,82880,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-8204,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.96,0.34,10,3,9,,,515,,515,515,,0,0,515,515,,Malignant,22,,15,,,,16515,,,515,515,,,,515,515,,,515,,,,,,,,TUMOR FREE,Alive,-31818,,,,276,,515,515,,,[Not Available],[Not Applicable],,,,,0.14,,,,,8,,0,0.32389,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8204,,,,,,,515,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,87,,,,,,,,,,,,,,,,,,,,82882,,0.291659943,,,,,,,,,,0.153796917,,0.152128452,,,,Stage IB,,0.804,,,,,,,,,,,,,,,,0.7701,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.240870587,LUAD,,,,Adenocarcinoma,0.5476,,0.0226,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HC-7749,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.97,0.69,3,4,0,HRD,NO,724,3-ETV4,724,724,,0,0,724,724,prad_tcga,Malignant,7,BARD1;BRIP1;FANCL;PALB2;RAD51C,18,4.2,TCGA-HC-7749-01,0,5426,0,TCGA-HC-7749,724,724,Prostate Cancer,,102,724,724,TCGA,,724,Primary,0,Middle|Base,A,,BRCA2;CHEK2,,TUMOR FREE,Alive,-25688,,70,7,57,PRAD,724,724,WHITE,0.0,[Not Available],[Not Applicable],70,R0,1,Matched,0.34,Prostate,Resection,4,e7914d79-48ad-4ea1-8a8f-735183c16c56,0,,0,0.033319,[Not Available],13a63fd0-6c8c-4707-9135-8052f454d1ac,3,Prostate Adenocarcinoma Acinar Type,0.3,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,2.36666666667,TCGA-HC-7749,0:DiseaseFree,3,,Prostate Adenocarcinoma,23.78,4/20/12,724,,,,,,C61,35e33cb7-77a7-4d02-b4ec-9374423027c0,,1,TUMOR FREE,0.0318,0:LIVING,0.1,5,23.78,Right,,,,YES,,2011,,,TCGA-HC-7749.35e33cb7-77a7-4d02-b4ec-9374423027c0.pdf,,[Not Applicable],,,81-90%,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,70,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,M0,C61.9,8550/3,82885,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.58,0.36,15,11,17,,,1062,BRCA_Basal,1062,1062,,0,0,1062,1062,,Invasive Carcinoma,43,,114,,,,32915,0,,1062,1062,,,,1062,1062,,,1062,,,,,,,,TUMOR FREE,Alive,-17689,,,,89,,1062,1062,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,23,,1,0.52176,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A573,,,,,,,1062,,,,,,,,,30,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,82886,,1.378489836,0,0,0,0,0.9913,1,,,Infiltrating Ductal Carcinoma,0.151609061,,0.113253694,0,0,0,,Negative,1.077,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1365,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2742,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.32,0.44,4,5,12,,,641,,,641,,0,0,641,641,,Malignant,21,,27,,,,19335,,,641,641,,,,,641,,,641,,,,,,,,TUMOR FREE,Alive,-25688,,,,317,,641,641,,,[Not Available],[Not Applicable],,,,,0.2,,,,,18,,1,0.37932,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2742,,,,,,,641,,,,,,,,,26,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,[Not Applicable],,,,,,70,,,,,,,,,,,,,,,,,,,,82890,,0.509389735,,,,,,,,,,0.200961291,,0.087489721,,,,Stage IV,,0.237,,,,,,,,,,,,,,,,0.5595,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L861Q (driver),,,1,L861Q (driver),,,15.4799402,16.54258141,14.74649594,-0.367923577799304,LUSC,Squamous Cell Carcinoma,17.81845535,15.30325391,Squamous Cell Carcinoma,0.1269,14.49116651,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.85,0.85,15,10,17,,,590,BRCA_Basal,590,590,,0,0,590,590,,Invasive Carcinoma,42,,78,,,,22774,0,,590,590,,,,590,590,,,590,,,,,,,,TUMOR FREE,Alive,-21602,,,,67,,590,590,,,[Not Available],[Not Applicable],,,,,0.25,Breast,Resection/Excision,,,11,,0,0.38302,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JM,,,,,,,590,,,,,,,,,23,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,82892,,0.624599176,0,0,0,0,1.0429,1,,,Infiltrating Ductal Carcinoma,0.108433706,,0.0353949,0,0,0,,Negative,-0.102,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3154,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,3.25,0.28,11,13,15,,,336,BRCA_LumA,336,336,,2,2,336,336,,Invasive Carcinoma,39,,47,,,,16705,0,,336,336,,,,336,336,,,336,,,,,,,,TUMOR FREE,Dead,-24266,336,,,135,,336,336,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,14,,1,0.34246,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15M,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,82898,,1.516019938,0,0,0,0,-0.1642,0,,,Infiltrating Lobular Carcinoma,0.206478382,,0.296117949,0,0,0,,Negative,0.4145,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.3501,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,"Columnar Lesion, Sclerosing Adenosis",0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"Columnar Lesion, Sclerosing Adenosis",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,82900,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-VQ-A91V,Unknown,STAD,,1,1,,,,0,,1,1.85,0.86,11,6,10,,,1297,,,1297,,1,1,504,504,,Malignant,27,,142,,,,31278,,,504,504,,,,,1297,,,504,,,,,,,,WITH TUMOR,Alive,-21505,,,,315,,504,504,,,[Not Available],[Not Applicable],,,,,0.52,Stomach,Unknown,,,7,,0,0.21346,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A91V,,,,,,,1297,Lung,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2011,504,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,58,,,,,,,,,,,,,,,,,,,,82902,,-0.978628725,,,,,,,,,,0.005537758,Grade 2,0.024860301,,,,Stage IIIA,,-0.876,,,,,,,,,,,,,,,,-0.275,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91V,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,,1,1,1,Male,TCGA-75-5122,,LUAD,,1,1,,Ontario Institute for Cancer Research (OICR),,1,MALE,1,1.87,0.32,6,4,7,,,,,,,,1,1,,,,Malignant,17,,20,,,,16199,,,,,,,,,,,,,,,,,,,,WITH TUMOR,Dead,,,,,171,,,,,,[Not Available],[Not Applicable],,,,,0.52,,,,,8,,0,0.26284,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-5122,,,,,,,,,,,,,,,,13,,,,,,,,,,,,,2005,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,82908,,1.867068572,,,,,,,,,,0.303314713,,0.153192868,,,,Stage IB,,2.9135,,,,,,,,,,,,,,,,0.1389,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"AMP (driver), KRAS-SLC2A14",,1,,,,,,,0.507001426,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.7428,,2.9042,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,1,1,Male,TCGA-VP-A87B,,PRAD,357,0,0,,VP,0,0,MALE,1,1.98,0.91,4,9,0,HRD,NO,2722,5-SPOP,2722,2722,,0,0,2473,2473,prad_tcga,Malignant,13,,120,,TCGA-VP-A87B-01,6,5593,0,TCGA-VP-A87B,2722,2722,Prostate Cancer,,2309,2722,2722,TCGA,,2473,Primary,0,Apex|Base,A,,RAD51B,True,WITH TUMOR,Alive,-23271,,63,8,41,PRAD,2722,2722,,0.14777804,[Not Available],[Not Applicable],44,R0,1,Matched,0.0,Prostate,Resection,4,D3B21774-56E8-4B4E-BCAA-D368AD2EDEF8,2,Normal (no evidence of prostate cancer) [cM0],0,0.073979,[Not Available],17C0CE0F-8227-4119-9B39-EA8DB18F5F4B,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,VP,1.46666666667,TCGA-VP-A87B,1:Recurred/Progressed,4,15,Prostate Adenocarcinoma,81.24,3/28/14,2722,Lung,New Primary Tumor,,,NO,C61,C92C198A-660D-4007-AFC2-EA9FE193C3A4,70,2,TUMOR FREE,0.1284,0:LIVING,3.37,3,89.42,Right,20,No Evidence of Extraprostatic Extension,,YES,2297,2007,2473,,TCGA-VP-A87B.C92C198A-660D-4007-AFC2-EA9FE193C3A4.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,,91-100%,2,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2b,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,82913,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,Asian,BRCA,,1,1,,,1,0,FEMALE,1,1.93,0.74,8,6,5,,,3307,BRCA_LumA,267,3307,,1,1,267,267,,Invasive Carcinoma,19,,37,,,,18652,0,,267,267,,,,267,3307,,,267,,,,,,,,TUMOR FREE,Alive,-14264,,,,0,,267,267,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.12559,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A126,,,,,,,3307,,Locoregional Disease,,,,,,,5,,,,,,,,,,,,,2002,267,,,,Stage IIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,82914,,0.497190311,0,0,0,0,0.7656,1,,,Infiltrating Ductal Carcinoma,0.137728286,,0.237970415,0,0,0,,Negative,-1.15,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4982,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1015,,1015,1015,,0,0,1015,1015,,Invasive Carcinoma,,,,,,,30515,0,,1015,1015,,,,1015,1015,,,1015,,,,,,,,TUMOR FREE,Alive,-19846,,,,0,,1015,1015,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A3Z5,,,,,,,1015,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,82921,,-0.605499611,0,0,0,1,1.0466,0,,,Infiltrating Lobular Carcinoma,0.078294008,,0.217098406,0,0,0,,Negative,-0.4565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1004,1,0,H & E,0,0,,0,Murray Resnick,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,UDH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7786,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.96,0.55,2,4,2,HRP,NO,1096,8-other,1096,1096,,0,0,1096,1096,prad_tcga,Malignant,8,BRCA2,5,4.5,TCGA-EJ-7786-01,24,5320,0,TCGA-EJ-7786,1096,1096,Prostate Cancer,,79,1096,1096,TCGA,,1096,Primary,1,,A,,,,TUMOR FREE,Alive,-22793,,62,7,31,PRAD,1096,1096,WHITE,0.302699624,[Not Available],[Not Applicable],50,R0,1,Matched,0.03,Prostate,Resection,3,e52217cc-26f9-48ed-a3ce-ca5b963c66ce,0,,0,0.062037,[Not Available],9d499039-37ca-4300-ae95-04bbe007c0d2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.6,EJ,3.1,TCGA-EJ-7786,0:DiseaseFree,2,9,Prostate Adenocarcinoma,36.01,4/6/12,1096,,,,,NO,C61,3b3ac042-2bb6-445b-a82b-eea969f0bd33,,2,TUMOR FREE,0.0839,0:LIVING,0.1,3,36.01,Bilateral,11,,,YES,,2011,,,TCGA-EJ-7786.3b3ac042-2bb6-445b-a82b-eea969f0bd33.pdf,,[Not Applicable],NO,,61-70%,5,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.7,62,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,82926,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-2A-A8VX,,PRAD,,0,0,,2A,,0,MALE,0,1.99,0.9,1,4,1,HRP,NO,1378,,,1378,,0,0,1378,1378,prad_tcga,Malignant,6,,146,,TCGA-2A-A8VX-01,8,5229,0,TCGA-2A-A8VX,1378,1378,Prostate Cancer,89,1033,,1378,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),1378,Primary,0,Middle,A,,,True,TUMOR FREE,Alive,-25904,,70,8,40,PRAD,1378,1378,,0.230409475,[Not Available],[Not Applicable],35,,1,Matched,0.05,Prostate,Resection,4,62C7D77A-C5C0-4D93-B200-EDD85D6E4E6C,2,Normal (no evidence of prostate cancer) [cM0],0,0.045553,[Not Available],942F1788-D977-4AC0-A177-659F9D4CD077,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,2A,1.16666666667,TCGA-2A-A8VX,0:DiseaseFree,4,8,Prostate Adenocarcinoma,45.27,3/29/14,1378,,,,,YES,C61,418E80EE-4886-43F5-9FB9-2619BC89351E,160,1,TUMOR FREE,0.0756,0:LIVING,0.05,,45.27,Bilateral,10,Extraprostatic Extension  Localized (e.g. seminal vesicles),32,YES,922,2011,,,TCGA-2A-A8VX.418E80EE-4886-43F5-9FB9-2619BC89351E.pdf,Peripheral Zone,[Not Applicable],YES,32,,16,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Available],,NO,No,R0,,70,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,82927,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-85-8277,White,LUSC,,0,0,,Asterand,2,2,MALE,2,2.77,0.56,15,14,21,,,307,,307,307,,2,2,307,307,,Malignant,50,,72,,,,31309,,,307,307,,,,307,307,,,307,,,,,,,,TUMOR FREE,Dead,-25793,307,,,315,,307,307,,,[Not Available],[Not Applicable],,,,,0.15,,,,,17,,1,0.48894,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8277,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,82928,,0.729299468,,,,,,,,,,0.144647289,,0.011628672,,,,Stage IIIA,,2.082,,,,,,,,,,,,,,,,0.2127,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,14.47446024,15.17504777,16.61369511,-0.325608461160274,LUSC,Squamous Cell Carcinoma,17.87296167,15.68042159,Squamous Cell Carcinoma,-0.5727,12.54785452,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Female,TCGA-HU-A4G9,Asian,STAD,,0.0,0,,,,0,,0.0,2.22,0.87,0,0,0,,,736,,,736,,0.0,0,736,736,,Malignant,0,,83,,,,16443.0,0,,736,736,,,,,736,,,736,,,,,,,,TUMOR FREE,Alive,-24753,,,,1157.0,,736,736,,,[Not Available],[Not Applicable],,,,,0.33,Stomach,Biopsy,,,6,,0,0.2112,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4G9,,,,,,,736,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Stable Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,82936,,-0.99342078,,,,,,,,,,0.003256452,Grade 2,-0.029838702,,,,Stage IA,,-1.4175,,,,,,,,,,,,,,,,-0.8141,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4G9,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-VP-A87H,,PRAD,357,0,0,,VP,0,0,MALE,0,2.32,0.58,3,4,2,HRP,NO,663,5-SPOP,663,663,,0,0,663,663,prad_tcga,Malignant,9,,40,,TCGA-VP-A87H-01,0,5597,0,TCGA-VP-A87H,663,663,Prostate Cancer,,663,663,663,TCGA,,663,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-28060,,76,9,32,PRAD,663,663,,0.0,[Not Available],[Not Applicable],36,R2,1,Matched,0.08,Prostate,Resection,4,9B3B019C-B8D4-498C-905C-27DBD44AFE20,10,,0,0.076846,[Not Available],661DC657-D2B3-44FA-B859-2C4EE42B0046,5,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,VP,1.2,TCGA-VP-A87H,0:DiseaseFree,5,8,Prostate Adenocarcinoma,21.78,3/28/14,663,,,,,NO,C61,B2B58670-AE26-43A0-8D3C-AAF354958727,50,12,WITH TUMOR,0.3105,0:LIVING,0.01,,21.78,Bilateral,13,No Evidence of Extraprostatic Extension,24,YES,1714,2009,,,TCGA-VP-A87H.B2B58670-AE26-43A0-8D3C-AAF354958727.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,,56-65%,16,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R2,,76,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,9,No,NO,0,N0,T2,0,M0,C61.9,8140/3,82939,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-C4-A0F0,,BLCA,,0.0,0,,,,0,MALE,0.0,5.89,0.39,10,6,11,,,59,,,59,,0.0,0,59.0,59.0,,Malignant,27,,22,,,,18564.0,,,59.0,59,,,,,59,,,59.0,,,,,,,,TUMOR FREE,Alive,-22068,,,,146.0,,59.0,59,,,[Not Available],[Not Applicable],,,,,0.35,,,,,22,,2,0.22448,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Indivumed,,TCGA-C4-A0F0,,,,,,,59,,,,,,,,,36,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,[Not Available],,,,,,60.0,,,,,,,,,,,,,,,,,,,,82960,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-L5-A4OU,White,ESCA,,0,0,,,,0,,0,3.14,0.35,4,6,11,,,882,,,882,,0,0,882,882,,Malignant,21,,89,,,,25571,,,882,882,,,,,882,,,882,,,,,,,,TUMOR FREE,Alive,-29674,,,,320,,882,882,,,[Not Available],[Not Available],,,,,0.23,Esophagus,Unknown,,,12,,1,0.23586,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A4OU,,,,,,,882,,,,,,,,,32,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Unknown],,,,,,81,,,,,,,,,,,,,,,,,,,,82962,,,,,,,,,,,,,Unknown,,,,,Stage IIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-YL-A8SA,,PRAD,389,0,0,,YL,,0,MALE,0,1.92,0.81,4,7,3,HRP,NO,512,1-ERG,,512,,0,0,512,512,prad_tcga,Malignant,14,BRCA2,65,,TCGA-YL-A8SA-01,0,5661,0,TCGA-YL-A8SA,512,512,Prostate Cancer,,467,,512,TCGA,,512,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-25340,,69,8,43,PRAD,512,512,,0.0,[Not Available],[Not Applicable],29,R1,1,Matched,0.02,Prostate,Resection,4,F2746759-B8E9-4744-8294-04AEF28085D2,1,,0,0.085492,[Not Available],2919AFA2-3FEE-43BD-AE68-E70718E73608,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,YL,0.966666666667,TCGA-YL-A8SA,0:DiseaseFree,4,13,Prostate Adenocarcinoma,16.82,4/25/14,512,,,,,NO,C61,F837EF53-FF44-4F51-8764-27B00168B113,200,1,,0.0816,0:LIVING,0.06,5,16.82,Bilateral,15,,,YES,1465,2009,,,TCGA-YL-A8SA.F837EF53-FF44-4F51-8764-27B00168B113.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,9,Prostate Adenocarcinoma Acinar Type,1,2009,Stable Disease,,NO,No,R1,,69,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,8,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,82971,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-55-7815,,LUAD,,1,1,,International Genomics Consortium,1,0,MALE,1,3.48,0.29,4,10,9,,,773,,466,773,,1,1,466,466,,Malignant,23,,12,,,,27933,,,466,466,,,,466,773,,,466,,,,,,,,WITH TUMOR,Alive,-28119,,,,187,,466,466,,,[Not Available],[Not Applicable],,,,,0.62,,,,,21,,1,0.10861,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7815,,,,,,,773,,Locoregional Recurrence,,,,,,,22,,,,,,,,,,,,,2011,466,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,82972,,1.026950284,,,,,,,,,,0.280419003,,0.133488337,,,,Stage IB,,0.3765,,,,,,,,,,,,,,,,-0.203,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12V (driver), AMP (driver)",A191T,1,,G12V (driver),A191T,,,,-0.180629001,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.5035,,-0.2504,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.03,0.55,11,11,24,,,965,BRCA_Basal,965,965,,0,0,965,965,,Invasive Carcinoma,46,,223,,,,19129,1,,965,965,,,,965,965,,,965,,,,,,,,TUMOR FREE,Alive,-17070,,,,178,,965,965,,,[Not Available],[Not Applicable],,,,,0.36,Not Specific/Unknown,Resection/Excision,,,25,,1,0.61757,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A13D,,,,,,,965,,,,,,,,,25,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,82979,,,0,0,0,0,0.8664,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,,0,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-75-6206,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),0,0,MALE,0,3.23,0.7,6,1,7,,,2590,,2590,2590,,0,0,2590,2590,,Malignant,14,,9,,,,21584,,,2590,2590,,,,2590,2590,,,2590,,,,,,,,TUMOR FREE,Alive,,,,,114,,2590,2590,,,[Not Available],[Not Applicable],,,,,,,,,,14,,1,0.11902,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-6206,,,,,,,2590,,,,,,,,,25,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,82981,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.0636,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13D (driver),V214L,1,,G13D (driver),V214L,,,,-0.425727937,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.7249,,-0.8993,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-KK-A6E0,,PRAD,315,1,1,,KK,1,0,MALE,1,1.84,0.64,8,15,2,ambiguous,NO,1483,5-SPOP,941,1483,,1,1,941,941,prad_tcga,Malignant,25,RAD54L,309,13.9,TCGA-KK-A6E0-01,6,5499,0,TCGA-KK-A6E0,941,941,Prostate Cancer,,941,941,1483,TCGA,,941,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-21700,,59,9,39,PRAD,941,941,,0.196596935,[Not Available],[Not Applicable],26,R0,1,Matched,0.04,Prostate,Resection,4,504A9351-668C-43D9-ACA9-71177835D29D,1,Normal (no evidence of prostate cancer) [cM0],0,0.15965,[Not Available],D112136D-34FA-426E-B432-4D1E4286ADF8,5,Prostate Adenocarcinoma Acinar Type,,Prostate,25,,Acinar Adenocarcinoma,[Not Available],,KK,0.866666666667,TCGA-KK-A6E0,1:Recurred/Progressed,5,28,Prostate Adenocarcinoma,30.91,3/27/14,1483,,Biochemical evidence of disease,,,NO,C61,41BD5E57-29AE-41C8-96D7-2832C726E83B,140,1,WITH TUMOR,0.1489,0:LIVING,0.3,,48.72,Right,30,,,YES,859,2011,941,,TCGA-KK-A6E0.41BD5E57-29AE-41C8-96D7-2832C726E83B.pdf,Peripheral Zone,[Not Applicable],NO,11,71-80%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,,59,Core needle biopsy,941,,NO,YES,YES,YES,T3a,YES,9,No,YES,0,N0,T2b,0,M0,C61.9,8140/3,82982,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-D7-6527,White,STAD,,1,1,,,,1,,1,5.06,0.46,10,22,19,,,312,,,312,,1,1,75,75,,Malignant,51,,57,,,,18462,,,75,75,,,,,312,,,75,,,,,,,,WITH TUMOR,Dead,-22793,312,,,276,,75,75,,,[Not Available],[Not Applicable],,,,,0.2,Stomach,Unknown,,,22,,2,0.14049,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Papillary Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6527,,,,,,,,Liver,Distant Metastasis,,,,,,,51,,,,,,,,,,,,,2010,75,,,,Stage II,,,,,,,,Progressive Disease,,,,,,62,,,,,,,,,,,,,,,,,,,,82984,,0.200177832,,,,,,,,,,0.056883424,Grade 2,0.124884239,,,,Stage II,,-0.4785,,,,,,,,,,,,,,,,0.2204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6527,Gastric Carcinoma,TCGA,"Adenocarcinoma, Papillary Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.19,0.59,3,2,4,,,989,BRCA_LumA,989,989,,0,0,989,989,,Invasive Carcinoma,9,,3,,,,22796,0,,989,989,,,,989,989,,,989,,,,,,,,TUMOR FREE,Alive,-18177,,,,39,,989,989,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,9,,0,0.032935,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,,,TCGA-AQ-A1H3,,,,,,,989,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,82985,,0.517634659,0,0,0,0,-0.2104,1,,,Infiltrating Ductal Carcinoma,0.14920602,,0.214949978,0,0,0,,Negative,-0.1335,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5068,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6366,White,PRAD,184,0,0,,G9,0,0,MALE,0,2.09,0.63,2,4,4,HRP,NO,1947,8-other,1947,1947,,0,0,1947,1947,prad_tcga,Malignant,10,,14,7.6,TCGA-G9-6366-01,4,5367,0,TCGA-G9-6366,1947,1947,Prostate Cancer,,101,1947,1947,TCGA,,1947,Primary,0,Apex|Base,A,,,,,Alive,-22428,,61,7,37,PRAD,1947,1947,WHITE,0.101148845,[Not Available],[Not Applicable],44,R0,1,Matched,0.01,Prostate,Resection,4,34d7178f-cfc8-463a-9e04-f0bb0e3e5154,1,,0,0.031423,[Not Available],df3abb97-c790-4ff6-a726-6645b3058d72,3,Prostate Adenocarcinoma Acinar Type,1.8,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.46666666667,TCGA-G9-6366,0:DiseaseFree,3,11,Prostate Adenocarcinoma,63.96,3/8/12,1947,,,,,NO,C61,6ef07861-a4db-4aa2-ba73-4cd43e10d72f,,4,,0.1159,0:LIVING,0.1,,63.96,Left,15,,,YES,,2009,,,TCGA-G9-6366.6ef07861-a4db-4aa2-ba73-4cd43e10d72f.pdf,,[Not Applicable],NO,,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.2,61,Core needle biopsy,,,NO,YES,NO,,T3b,,7,No,,0,,T1c,,,C61.9,8550/3,82987,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-86-A4JF,White,LUAD,,1,1,,Asterand,1,1,MALE,1,3.59,0.25,4,4,11,,,737,,436,737,,1,1,436,436,,Malignant,19,,21,,,,27337,,,436,436,,,,436,737,,,436,,,,,,,,WITH TUMOR,Dead,-20491,737,,,1852,,436,436,,,[Not Available],[Not Applicable],,,,,0.07,,,,,14,,1,0.077789,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-A4JF,,,,,,,,,Distant Metastasis,,,,,,,19,,,,,,,,,,,,,2012,436,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,82990,,0.559685834,,,,,,,,,,0.210489032,,0.164005456,,,,Stage IIB,,1.6355,,,,,,,,,,,,,,,,-0.0222,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,16.42552024,17.18539066,16.60388673,-0.015920122,LUAD,Adenocarcinoma,17.69248188,15.79622229,Adenocarcinoma,-0.829,14.09063878,0.1517,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,,0,1,Female,TCGA-ZQ-A9CR,White,STAD,,0,0,,,,,,2,2.79,0.33,14,16,21,,,24,,,24,,2,2,24,24,,Malignant,51,,100,,,,24342,,,24,24,,,,,24,,,24,,,,,,,,,Dead,-29107,24,,,142,,24,24,,,[Unknown],[Not Applicable],,,,,0.31,Stomach,Unknown,,,16,,1,0.34914,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Tayside Tissue Bank,,TCGA-ZQ-A9CR,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2013,,,,,Stage IIIC,,,,,,,,[Unknown],,,,,,79,,,,,,,,,,,,,,,,,,,,82993,,0.011313906,,,,,,,,,,0.123114641,Grade 3,0.209640165,,,,Stage IIIC,,0.6825,,,,,,,,,,,,,,,,0.6707,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-ZQ-A9CR,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,1,0,1,1,Male,TCGA-G9-6339,,PRAD,,1,1,,G9,1,0,MALE,1,1.96,0.47,2,0,2,HRP,NO,2551,,1634,2551,,1,1,1634,1634,prad_tcga,Malignant,4,BRCA1,41,,TCGA-G9-6339-01,0,5353,0,TCGA-G9-6339,1634,1634,Prostate Cancer,,2110,1634,2551,TCGA,,1634,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21305,,58,7,54,PRAD,1634,1634,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.0,Prostate,Resection,3,912d618a-8003-41d6-a0ac-7051b6ccc31c,2,Normal (no evidence of prostate cancer) [cM0],0,0.036667,[Not Available],d39d1a49-fcc0-4f2c-9338-df904e7f6a09,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.43333333333,TCGA-G9-6339,1:Recurred/Progressed,2,5,Prostate Adenocarcinoma,53.68,10/29/13,2551,,Biochemical evidence of disease,,,NO,C61,10FA561E-76C7-4F83-BC1C-B858DF9CCC46,,2,TUMOR FREE,0.0368,0:LIVING,0.03,,83.8,Bilateral,8,,,YES,,2007,1634,,TCGA-G9-6339.10FA561E-76C7-4F83-BC1C-B858DF9CCC46.pdf,,[Not Applicable],NO,4,,6,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,0.8,58,Core needle biopsy,1634,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,7,No,NO,0,N0,T3b,0,M0,C61.9,8550/3,82994,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7820,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.48,0,3,0,HRD,NO,747,1-ERG,747,747,,0,0,747,747,prad_tcga,Malignant,3,,15,5.2,TCGA-HC-7820-01,0,5432,0,TCGA-HC-7820,747,747,Prostate Cancer,,,747,747,TCGA,,747,Primary,0,,A,ATM:.:.:splice_region_variant,,,TUMOR FREE,Alive,-26576,,72,7,40,PRAD,747,747,WHITE,0.0,[Not Available],[Not Applicable],45,R0,1,Matched,0.0,Prostate,Resection,3,78355462-9ff7-4f1b-96cc-4563b6810b37,2,,0,0.040429,[Not Available],a3cd3599-7c18-491d-be09-6fc7e526c9b1,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,2.73333333333,TCGA-HC-7820,0:DiseaseFree,2,4,Prostate Adenocarcinoma,24.54,4/20/12,747,,,,,,C61,750c91eb-1732-4ca3-8c71-f1309a90e4f5,,1,TUMOR FREE,0.0386,0:LIVING,,,24.54,Bilateral,5,,,YES,,2011,,,TCGA-HC-7820.750c91eb-1732-4ca3-8c71-f1309a90e4f5.pdf,,[Not Applicable],,,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,72,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,,,,C61.9,8550/3,82998,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-G2-A2EC,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,,,,,,,,696,,,696,,1.0,1,679.0,679.0,,Malignant,,,,,,,19026.0,,,679.0,679,,,,,696,,,679.0,,,,,,,,WITH TUMOR,Dead,-21215,696,,,244.0,,679.0,679,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,679,small bowel,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,83001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.8,0.76,23,25,24,,,5,BRCA_Basal,5,5,,0,0,5,5,,Invasive Carcinoma,72,,109,,,,18289,0,,5,5,,,,5,5,,,5,,,,,,,,TUMOR FREE,Alive,-19629,,,,159,,5,5,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,8,,0,0.5225,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HJ,,,,,,,5,,,,,,,,,19,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,83004,TRUE,0.339948293,0,0,0,0,0.6982,1,,,Infiltrating Ductal Carcinoma,0.079684985,,0.174989043,0,0,0,,Negative,-0.784,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0407,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-97-A4M7,White,LUAD,,0,0,,Washington University - NYU,0,0,MALE,0,2.03,0.37,5,9,6,,,629,,629,629,,0,0,629,629,,Malignant,20,,53,,,,23404,,,629,629,,,,629,629,,,629,,,,,,,,TUMOR FREE,Alive,-27062,,,,424,,629,629,,,[Not Available],[Not Applicable],,,,,0.56,,,,,9,,0,0.15441,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4M7,,,,,,,629,,,,,,,,,9,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,83005,,1.447385376,,,,,,,,,,0.250869267,,0.191347512,,,,Stage IA,,1.1695,,,,,,,,,,,,,,,,0.3807,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.008052726,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2884,,0.2031,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-YL-A8S8,,PRAD,389,1,1,,YL,,0,MALE,1,2.3,0.61,11,12,7,HRD,NO,1890,5-SPOP,,1890,,1,1,679,679,prad_tcga,Malignant,30,,151,,TCGA-YL-A8S8-01,0,5659,0,TCGA-YL-A8S8,679,679,Prostate Cancer,,1890,,1890,TCGA,,679,Primary,0,Apex|Middle|Base,A,,BRCA2,True,WITH TUMOR,Alive,-25119,,68,9,55,PRAD,679,679,,0.0,[Not Available],[Not Applicable],40,R1,1,Matched,0.02,Prostate,Resection,4,FED650B8-8DBA-41EC-9453-076FEAA95795,7,Normal (no evidence of prostate cancer) [cM0],0,0.15576,[Not Available],494A8495-8D10-4A8F-8664-F68AC339C889,5,Prostate Adenocarcinoma Acinar Type,,Prostate,33,,Acinar Adenocarcinoma,[Not Available],,YL,1.33333333333,TCGA-YL-A8S8,1:Recurred/Progressed,5,40,Prostate Adenocarcinoma,22.31,4/25/14,1890,,Biochemical evidence of disease,,,NO,C61,6D4A3078-4C6B-4E94-B859-CCA473B09CF9,130,15,WITH TUMOR,0.3664,0:LIVING,1.36,,62.09,Bilateral,43,No Evidence of Extraprostatic Extension,28,YES,2146,2008,679,,TCGA-YL-A8S8.6D4A3078-4C6B-4E94-B859-CCA473B09CF9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,18,91-100%,10,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,YES,No,R1,,68,Core needle biopsy,679,Stable Disease,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,83008,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-22-1012,White,LUSC,,0,0,,Mayo Clinic - Rochester,2,2,FEMALE,2,3.44,0.32,9,19,21,,,429,,429,429,,2,2,429,429,,Malignant,49,,32,,,,20763,,,429,429,,,,429,429,,,429,,,,,,,,TUMOR FREE,Dead,-29273,429,,,383,,429,429,,,[Not Available],[Not Applicable],,,,,0.33,,,,,20,,1,0.3256,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-1012,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,83011,,0.501171936,,,,,,,,,,0.193262127,,0.042564336,,,,Stage IB,,0.663,,,,,,,,,,,,,,,,0.3548,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.493962454319959,LUSC,,,,Squamous Cell Carcinoma,0.061,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,3.33,0.64,14,21,26,,,904,BRCA_LumB,524,904,,1,1,524,524,,Invasive Carcinoma,61,,38,,,,16302,0,,524,524,,,,524,904,,,524,,,,,,,,WITH TUMOR,Dead,-26407,904,,,98,,524,524,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,14,,1,0.39122,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A2JS,,,,,,,,Bone,Distant Metastasis,,,,,,,35,,,,,,,,,,,,,2011,524,Liver,,,Stage IIB,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,83013,,0.175936949,0,0,0,0,-0.5071,1,,,Infiltrating Lobular Carcinoma,0.133705179,,0.073153274,0,0,0,,Negative,-0.4495,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2329,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-64-5779,White,LUAD,,1,1,,Fox Chase,,0,MALE,1,2.99,0.44,14,10,20,,,864,,,864,,1,1,795,795,,Malignant,44,,57,,,,23153,,,795,795,,,,,864,,,795,,,,,,,,TUMOR FREE,Alive,-22305,,,,470,,795,795,,,[Not Available],[Not Applicable],,,,,0.39,,,,,17,,1,0.3346,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-5779,,,,,,,864,,Distant Metastasis,,,,,,,33,,,,,,,,,,,,,2009,795,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,83021,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.57323885,14.99317581,15.30549825,-0.229772638,LUAD,Adenocarcinoma,18.16544926,16.3870874,Adenocarcinoma,1.351,13.07103354,0.4803,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A3SP,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.13,0.32,5,7,7,,,783,,783,783,,0.0,0,783.0,783.0,,Malignant,19,,45,,,,33750.0,,,783.0,783,,,,783,783,,,783.0,,,,,,,,TUMOR FREE,Alive,-22005,,,,164.0,,783.0,783,,,[Not Available],[Not Applicable],,,,,0.47,,,,,6,,0,0.23773,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SP,,,,,,,783,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,83031,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-49-6743,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,2.96,0.27,11,10,12,,,1621,,1621,1621,,0,0,1621,1621,,Malignant,33,,35,,,,21545,,,1621,1621,,,,1621,1621,,,1621,,,,,,,,TUMOR FREE,Alive,-29807,,,,991,,1621,1621,,,[Not Available],[Not Applicable],,,,,0.08,,,,,21,,1,0.26935,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6743,,,,,,,1621,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,83032,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,"G527V, G527C",1,,,"G527V, G527C",15.89322553,17.46493985,16.01451465,-0.289411461,LUAD,Adenocarcinoma,17.7192686,15.86975845,Adenocarcinoma,,13.79242264,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-KK-A6E3,,PRAD,,0,0,,KK,,0,MALE,0,2.0,0.75,0,0,0,HRP,NO,2056,,,2056,,0,0,2056,2056,prad_tcga,Malignant,0,,5,,TCGA-KK-A6E3-01,0,5502,0,TCGA-KK-A6E3,2056,2056,Prostate Cancer,,1065,,2056,TCGA,,2056,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20547,,56,7,39,PRAD,2056,2056,,0.0,[Not Available],[Not Applicable],44,,1,Matched,0.0,Prostate,Resection,3,F05CC604-E546-4231-8C07-E8E5D0746753,0,Normal (no evidence of prostate cancer) [cM0],0,0.000238,[Not Available],38A2B705-D8A4-45CA-8BCD-96DBF93D8E4D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,KK,1.46666666667,TCGA-KK-A6E3,0:DiseaseFree,2,0,Prostate Adenocarcinoma,67.54,3/27/14,2056,,,,,NO,C61,4796F9C1-49BD-411E-9D9B-D95001D76F53,140,0,TUMOR FREE,0.0003,0:LIVING,0.1,,67.54,Bilateral,0,,,YES,3355,2004,,,TCGA-KK-A6E3.4796F9C1-49BD-411E-9D9B-D95001D76F53.pdf,Transition Zone,[Not Applicable],NO,10,,3,Prostate Adenocarcinoma Acinar Type,1,2004,[Not Available],,NO,No,R0,,56,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,83034,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-80-5611,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR)/Ottawa,0,0,MALE,0,3.08,0.51,16,19,19,,,2595,,2595,2595,,0,0,2595,2595,,Malignant,54,,62,,,,31635,,,2595,2595,,,,2595,2595,,,2595,,,,,,,,TUMOR FREE,Alive,,,,,260,,2595,2595,,,[Not Available],[Not Applicable],,,,,0.37,,,,,10,,1,0.37148,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR)/Ottawa,,TCGA-80-5611,,,,,,,2595,,,,,,,,,32,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,83035,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.065095167,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.7128,,-0.5958,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1102,,1102,1102,,0,0,1102,1102,,Invasive Carcinoma,,,,,,,17674,0,,1102,1102,,,,1102,1102,,,1102,,,,,,,,TUMOR FREE,Alive,-20401,,,,0,,1102,1102,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3KC,,,,,,,1102,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,83036,,0.101005167,0,0,0,1,-0.3114,0,,,Infiltrating Lobular Carcinoma,0.169954686,,0.282777227,0,0,0,,Negative,0.1365,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6548,1,0,H & E,0,0,,0,Murray Resnick,"Sclerosing Adenosis, UDH",0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,"Sclerosing Adenosis, UDH",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-AA6B,White,STAD,,0,0,,,0,0,,0,3.18,0.74,4,4,7,,,1002,,1002,1002,,0,0,1002,1002,,Malignant,15,,94,,,,18551,,,1002,1002,,,,1002,1002,,,1002,,,,,,,,TUMOR FREE,Alive,-17852,,,,105,,1002,1002,,,[Not Available],[Not Applicable],,,,,0.15,Stomach,Unknown,,,20,,1,0.28585,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-AA6B,,,,,,,1002,,,,,,,,,24,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,48,,,,,,,,,,,,,,,,,,,,83037,,-0.666302637,,,,,,,,,,0.015928627,Grade 2,0.027388952,,,,Stage IIIB,,-0.898,,,,,,,,,,,,,,,,0.0378,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA6B,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1.0,0,0,0.0,1.0,Male,TCGA-G2-A2EO,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.23,0.37,1,3,7,,,1804,,1804,1804,,2.0,2,1804.0,1804.0,,Malignant,11,,27,,,,25306.0,,,1804.0,1804,,,,1804,1804,,,1804.0,,,,,,,,TUMOR FREE,Dead,-25440,1804,,,1247.0,,1804.0,1804,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.10692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EO,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,83039,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,,,White,BRCA,,0,0,,,,,FEMALE,2,3.17,0.44,6,16,10,,,2965,BRCA_Basal,,2965,,2,2,2965,2965,,Invasive Carcinoma,32,,60,,,,18568,1,,2965,2965,,,,,2965,,,2965,,,,,,,,,Dead,-18691,2965,,,63,,2965,2965,,,[Not Available],[Not Applicable],,,,,0.14,Not Specific/Unknown,Resection/Excision,,,19,,1,0.29437,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1F6,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,1996,,,,,[Not Available],,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,83052,TRUE,0.564494031,0,0,0,0,1.1563,1,,,Infiltrating Ductal Carcinoma,0.199194579,,0.09224866,0,0,0,,[Not Available],0.195,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2694,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,83055,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-HU-A4G3,Asian,STAD,,0,0,,,,0,,0,,,0,0,0,,,170,,,170,,0,0,170,170,,Malignant,0,,,,,,20211,,,170,170,,,,,170,,,170,,,,,,,,TUMOR FREE,Alive,-20064,,,,144,,170,170,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4G3,,,,,,,170,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,54,,,,,,,,,,,,,,,,,,,,83060,,-0.52128156,,,,,,,,,,0.04134895,Grade 2,0.102588745,,,,Stage IIB,,-1.11,,,,,,,,,,,,,,,,0.0531,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4G3,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.1,0.21,8,9,15,,,760,BRCA_Basal,760,760,,0,0,760,760,,Invasive Carcinoma,32,,110,,,,28620,0,,760,760,,,,760,760,,,760,,,,,,,,TUMOR FREE,Alive,-22844,,,,99,,760,760,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,20,,1,0.40352,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A6SB,,,,,,,760,,,,,,,,,36,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,83063,TRUE,1.798139176,0,0,0,0,0.6497,1,,,Infiltrating Ductal Carcinoma,0.173698232,,0.037490299,0,0,0,,Negative,1.4285,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.6056,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, High Grade), Stromal Alterations",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-G9-A9S0,,PRAD,,1,1,,G9,,1,MALE,1,1.94,0.57,10,7,5,ambiguous,NO,791,,,791,,1,1,423,423,prad_tcga,Malignant,22,CDK12;CHEK2,54,,TCGA-G9-A9S0-01,6,5395,0,TCGA-G9-A9S0,423,423,Prostate Cancer,,759,,791,TCGA,,423,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Dead,-19530,791,53,8,33,PRAD,423,423,,0.225359883,Prostate Cancer,[Not Applicable],32,,1,Matched,0.1,Prostate,Resection,4,EA9EE289-5CD5-4E0F-B0B5-B359D19C0DF7,3,Normal (no evidence of prostate cancer) [cM0],0,0.11882,[Not Available],084AC674-F4CF-4A4A-A6A2-687C05C272EA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,G9,1.06666666667,TCGA-G9-A9S0,1:Recurred/Progressed,4,22,Prostate Adenocarcinoma,21.35,6/17/14,,Bone,Distant Metastasis,Prostate Cancer,Medical Record,NO,C61,2E6B54C4-BC0A-46E3-A3F9-B55CEB1B1ECD,130,5,WITH TUMOR,0.1906,1:DECEASED,10.87,5,25.99,Bilateral,22,No Evidence of Extraprostatic Extension,73,YES,840,2011,423,,TCGA-G9-A9S0.2E6B54C4-BC0A-46E3-A3F9-B55CEB1B1ECD.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,73,,13,Prostate Adenocarcinoma Acinar Type,1,2011,Progressive Disease,,YES,No,R1,,53,Transurethral resection (TURBT),429,Progressive Disease,NO,YES,YES,YES,T3b,YES,8,No,YES,0,N1,T2a,5,M0,C61.9,8140/3,83064,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-86-8076,White,LUAD,,0,0,,Asterand,0,0,MALE,0,2.09,0.24,0,2,2,,,993,,993,993,,0,0,993,993,,Malignant,4,,2,,,,0,,,993,993,,,,993,993,,,993,,,,,,,,TUMOR FREE,Alive,-15605,,,,81,,993,993,,,[Not Available],[Not Applicable],,,,,0.01,,,,,1,,0,0.000131,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8076,,,,,,,993,,,,,,,,,3,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,42,,,,,,,,,,,,,,,,,,,,83067,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,0.1583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,,,,0.08635294,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.1685,,1.4669,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-YL-A8SF,,PRAD,389,0,0,,YL,,0,MALE,0,1.96,0.69,4,10,3,ambiguous,NO,1373,1-ERG,,1373,,0,0,1373,1373,prad_tcga,Malignant,17,,89,,TCGA-YL-A8SF-01,0,5664,0,TCGA-YL-A8SF,1373,1373,Prostate Cancer,,1247,,1373,TCGA,,1373,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-22844,,62,8,23,PRAD,1373,1373,,0.0,[Not Available],[Not Applicable],20,R1,1,Matched,0.01,Prostate,Resection,4,9F016E40-6306-4FE6-B90C-38273E043C30,3,Normal (no evidence of prostate cancer) [cM0],0,0.10206,[Not Available],FE7B283C-9CF4-4BE2-8A3A-251A81A8D78F,4,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,YL,0.666666666667,TCGA-YL-A8SF,0:DiseaseFree,4,19,Prostate Adenocarcinoma,45.11,4/25/14,1373,,,,,NO,C61,9E568211-305B-4F23-8B31-59D80E0EE174,520,4,,0.1365,0:LIVING,0.01,5,45.11,Bilateral,21,No Evidence of Extraprostatic Extension,22,YES,1271,2010,,,TCGA-YL-A8SF.9E568211-305B-4F23-8B31-59D80E0EE174.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,29,76-85%,2,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,62,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,NO,8,No,NO,0,N0,,0,M0,C61.9,8140/3,83068,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-CF-A1HS,Asian,BLCA,,1.0,1,,,1,0,FEMALE,1.0,3.11,0.54,14,14,17,,,382,,133,382,,1.0,1,133.0,133.0,,Malignant,45,,33,,,,31945.0,,,133.0,133,,,,133,382,,,133.0,,,,,,,,WITH TUMOR,Alive,-27565,,,,338.0,,133.0,133,,,[Not Available],[Not Applicable],,,,,0.5,,,,,14,,1,0.26864,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ILSBio,,TCGA-CF-A1HS,,,,,,,382,"Other, specify",Distant Metastasis,,,,,,,28,,,,,,,,,,,,,2010,133,Pelvis,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,83070,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5496,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.98,0.49,3,7,3,HRP,NO,595,1-ERG,595,595,,0,0,595,595,prad_tcga,Malignant,13,,12,6.5,TCGA-EJ-5496-01,0,5262,0,TCGA-EJ-5496,595,595,Prostate Cancer,,595,595,595,TCGA,,595,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21897,,59,7,43,PRAD,595,595,WHITE,0.0,[Not Available],[Not Applicable],48,R0,1,Matched,0.01,Prostate,Resection,3,d0873929-eac8-42e2-af6f-df3cb9ce698c,1,Normal (no evidence of prostate cancer) [cM0],0,0.046786,[Not Available],6755c231-355f-4cc3-85f1-6306c7f5d44b,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.56666666667,TCGA-EJ-5496,0:DiseaseFree,2,11,Prostate Adenocarcinoma,19.55,3/30/12,595,,,,,NO,C61,80e82784-0bca-4657-9c9f-e9b860dc09bc,,2,TUMOR FREE,0.0687,0:LIVING,0.1,4,19.55,Bilateral,11,No Evidence of Extraprostatic Extension,15,YES,,2009,,,TCGA-EJ-5496.80e82784-0bca-4657-9c9f-e9b860dc09bc.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,15,31-40%,26,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,59,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,83074,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.68,9,9,13,,,1639,BRCA_LumA,1639,1639,,0,0,1639,1639,,Invasive Carcinoma,31,,25,,,,18641,0,,1639,1639,,,,1639,1639,,,1639,,,,,,,,TUMOR FREE,Alive,-27705,,,,0,,1639,1639,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,5,,0,0.15226,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,MSKCC,,TCGA-AO-A12G,,,,,,,1639,,,,,,,,,12,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,83075,,0.276642485,0,0,0,0,-0.0877,1,,,Other,0.143009802,,0.252746844,0,0,0,,Negative,-0.6175,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3692,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-60-2723,White,LUSC,,0,0,,Roswell Park,0,0,FEMALE,0,2.86,0.39,15,11,16,,,1092,,1092,1092,,0,0,1092,1092,,Malignant,42,,58,,,,17679,,,1092,1092,,,,1092,1092,,,1092,,,,,,,,TUMOR FREE,Alive,-27225,,,,380,,1092,1092,,,[Not Available],[Not Applicable],,,,,0.14,,,,,16,,1,0.46139,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2723,,,,,,,1092,,,,,,,,,32,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,83077,,1.034950624,,,,,,,,,,0.236716681,,0.07416935,,,,Stage IB,,2.6665,,,,,,,,,,,,,,,,0.5888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L231V,1,,,L231V,,,,0.0299521323599123,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.7126,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.12,0.43,7,4,10,,,659,BRCA_LumB,659,659,,0,0,659,659,,Invasive Carcinoma,21,,22,,,,20553,0,,659,659,,,,659,659,,,659,,,,,,,,TUMOR FREE,Alive,-19596,,,,121,,659,659,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,16,,1,0.18495,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YH,,,,,,,659,,,,,,,,,32,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,83084,,1.097605884,0,0,0,0,-0.3382,1,,,Infiltrating Ductal Carcinoma,0.245197282,,0.108472453,0,0,0,,Negative,0.899,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2724,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Apocrine),Invasive Ductal Carcinoma (Apocrine),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-22-0944,White,LUSC,,0,0,,Mayo Clinic - Rochester,,2,MALE,2,1.91,0.66,13,8,15,,,223,,,223,,2,2,223,223,,Malignant,36,,38,,,,16536,,,223,223,,,,,223,,,223,,,,,,,,TUMOR FREE,Dead,-22329,223,,,165,,223,223,,,[Not Available],[Not Applicable],,,,,0.34,,,,,9,,0,0.3629,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-0944,,,,,,,223,,,,,,,,,13,,,,,,,,,,,,,2000,,,,,Stage IB,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,83085,,-0.397316068,,,,,,,,,,0.10665172,,0.02145624,,,,Stage IB,,-0.1105,,,,,,,,,,,,,,,,0.3521,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.824590736479308,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.3622,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-NK-A5CR,Unknown,LUSC,,0,0,,Washington University - Rush University,,0,MALE,0,3.66,0.61,10,13,21,,,2542,,,2542,,0,0,2542,2542,,Malignant,44,,92,,,,32905,,,2542,2542,,,,,2542,,,2542,,,,,,,,TUMOR FREE,Alive,-28126,,,,411,,2542,2542,,,[Not Available],[Not Applicable],,,,,0.22,,,,,13,,1,0.30798,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Rush University,,TCGA-NK-A5CR,,,,,,,2542,,,,,,,,,25,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,77,,,,,,,,,,,,,,,,,,,,83086,,-0.768216779,,,,,,,,,,0.110105361,,-0.025303358,,,,Stage IB,,0.064,,,,,,,,,,,,,,,,0.0724,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.937740398363461,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.9066,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5514,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.94,0.6,5,10,4,ambiguous,NO,1829,8-other,1829,1829,,0,0,1829,1829,prad_tcga,Malignant,19,BRCA2,27,7.4,TCGA-EJ-5514-01,0,5278,0,TCGA-EJ-5514,1829,1829,Prostate Cancer,,724,1829,1829,TCGA,,1829,Primary,0,,A,,,,TUMOR FREE,Alive,-24165,,66,9,43,PRAD,1829,1829,WHITE,0.0,[Not Available],[Not Applicable],41,R0,1,Matched,0.22,Prostate,Resection,4,29ad80a4-b429-495c-885e-a92cfe2e4501,4,Normal (no evidence of prostate cancer) [cM0],0,0.099771,[Not Available],f82d53b1-3df8-4249-a615-464c9f4e0a32,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,22,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.33333333333,TCGA-EJ-5514,0:DiseaseFree,5,44,Prostate Adenocarcinoma,60.09,4/3/12,1829,,,,,NO,C61,5b64ad18-513e-422d-a847-d1862dd0e453,,5,TUMOR FREE,0.1629,0:LIVING,0.1,4,60.09,Bilateral,45,,,YES,,2009,,,TCGA-EJ-5514.5b64ad18-513e-422d-a847-d1862dd0e453.pdf,,[Not Applicable],NO,7,56-65%,12,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,66,Core needle biopsy,,,YES,NO,YES,,T2c,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,83088,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-8507,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.72,0.64,10,19,17,,,418,,418,418,,0,0,418,418,,Malignant,46,,119,,,,29821,,,418,418,,,,418,418,,,418,,,,,,,,TUMOR FREE,Alive,-19390,,,,1388,,418,418,,,[Not Available],[Not Applicable],,,,,0.39,,,,,19,,1,0.2595,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8507,,,,,,,418,,,,,,,,,38,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,83091,,-0.021091377,,,,,,,,,,0.206852562,,0.161769348,,,,Stage IA,,0.172,,,,,,,,,,,,,,,,0.1408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,-0.599681766,LUAD,,,,Adenocarcinoma,-0.4835,,-0.6832,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-56-8628,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,1.91,0.41,11,3,10,,,616,,616,616,,0,0,616,616,,Malignant,24,,140,,,,28483,,,616,616,,,,616,616,,,616,,,,,,,,TUMOR FREE,Alive,-28805,,,,548,,616,616,,,[Not Available],[Not Applicable],,,,,0.48,,,,,15,,0,0.28388,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8628,,,,,,,616,,,,,,,,,11,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,83092,,0.944915789,,,,,,,,,,0.255245376,,0.211200886,,,,Stage IA,,0.944,,,,,,,,,,,,,,,,0.8183,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.185487714141167,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.1684,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,,,,,,,,1642,BRCA_LumA,,1642,,1,1,1642,1642,,Invasive Carcinoma,,,,,,,18037,0,,1642,1642,,,,,1642,,,1642,,,,,,,,WITH TUMOR,Dead,-26684,1642,,,19,,1642,1642,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,"Other, specify",,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,83094,,0.047354606,0,0,0,0,0.0769,1,,,Other,0.120121401,,0.18440407,0,0,0,,[Not Available],-0.5295,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0747,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5506,White,PRAD,91,0,0,,EJ,0,0,MALE,0,,,,,,,NO,1381,1-ERG,1381,1381,,0,0,1381,1381,prad_tcga,Malignant,,,,7.2,TCGA-EJ-5506-01,0,5271,0,TCGA-EJ-5506,1381,1381,Prostate Cancer,,356,1381,1381,TCGA,,1381,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-24617,,67,8,8,PRAD,1381,1381,WHITE,0.0,[Not Available],[Not Applicable],15,RX,1,Matched,,Prostate,Resection,5,9ebda113-b0fc-4233-87ac-dad0e7d033de,,,,,[Not Available],e5e4d3b6-8e58-4dcf-8f67-a00e656a8e27,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,0.5,TCGA-EJ-5506,0:DiseaseFree,4,,Prostate Adenocarcinoma,45.37,4/2/12,1381,,,,,NO,C61,4b6b88e5-b9f5-4bed-8320-b227a30bd1a9,,,TUMOR FREE,0.0,0:LIVING,0.1,4,45.37,Bilateral,,,,YES,,2010,,,TCGA-EJ-5506.4b6b88e5-b9f5-4bed-8320-b227a30bd1a9.pdf,,[Not Applicable],NO,,61-70%,7,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,RX,1.0,67,Core needle biopsy,,,YES,NO,YES,,T3b,,8,No,,0,N1,T3b,1,M0,C61.9,8550/3,83099,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-95-7944,White,LUAD,,0,0,,Washington University - Emory,,0,MALE,0,1.64,0.41,6,6,9,,,377,,,377,,0,0,377,377,,Malignant,21,,43,,,,19488,,,377,377,,,,,377,,,377,,,,,,,,TUMOR FREE,Alive,-26003,,,,318,,377,377,,,[Not Available],[Not Applicable],,,,,0.45,,,,,12,,0,0.45651,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-7944,,,,,,,377,,,,,,,,,11,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Stable Disease,,,,,,71,,,,,,,,,,,,,,,,,,,,83106,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.332283556,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.8037,,1.9728,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.89,0.61,4,3,3,,,0,BRCA_Her2,0,0,,0,0,0,0,,Invasive Carcinoma,10,,33,,,,17619,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-29006,,,,378,,0,0,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,8,,0,0.18727,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09G,,,,,,,0,,,,,,,,,7,,,,,,,,,,,,,2008,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,83112,,0.836214571,0,0,0,0,1.6112,1,,,Infiltrating Ductal Carcinoma,0.150935925,,0.147670038,0,0,0,,Negative,0.5945,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0765,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.85,0.48,15,28,29,,,499,BRCA_Basal,499,499,,0,0,499,499,,Invasive Carcinoma,72,,106,,,,24962,0,,499,499,,,,499,499,,,499,,,,,,,,TUMOR FREE,Alive,-25345,,,,1274,,499,499,,,[Not Available],[Not Applicable],,,,,0.34,Breast,Resection/Excision,,,9,,2,0.51974,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XQ,,,,,,,499,,,,,,,,,72,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,83116,TRUE,1.036152239,0,0,0,0,-2.1668,1,,,Infiltrating Ductal Carcinoma,0.223879933,,0.073728092,0,0,0,,Negative,1.0485,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3085,1,0,H & E,0,0,,0,Christina Luffman,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3SM,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.96,0.69,3,0,4,,,547,,,547,,1.0,1,144.0,144.0,,Malignant,7,,29,,,,27415.0,,,144.0,144,,,,,547,,,144.0,,,,,,,,WITH TUMOR,Dead,-25852,547,,,274.0,,144.0,144,,,[Not Available],[Not Applicable],,,,,0.01,,,,,6,,0,0.12806,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SM,,,,,,,,Lymph Node Only,Distant Metastasis,,,,,,,6,,,,,,,,,,,,,2011,144,,,,Stage IV,,,,,,,,[Unknown],,,,,,70.0,,,,,,,,,,,,,,,,,,,,83121,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.76,6,4,7,,,1476,BRCA_LumA,1476,1476,,0,0,1476,1476,,Invasive Carcinoma,17,,23,,,,18668,0,,1476,1476,,,,1476,1476,,,1476,,,,,,,,TUMOR FREE,Alive,,,,,53,,1476,1476,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,6,,0,0.1288,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12Y,,,,,,,1476,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,83127,,-0.147960073,0,0,0,0,0.0434,1,,,Infiltrating Ductal Carcinoma,0.124250976,,0.112438802,0,0,0,,Negative,-0.7415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2529,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-99-8032,White,LUAD,,0,0,,Washington University - Alabama,0,0,MALE,0,3.74,0.31,6,8,8,,,44,,44,44,,0,0,44,44,,Malignant,22,,12,,,,24857,,,44,44,,,,44,44,,,44,,,,,,,,TUMOR FREE,Alive,-22635,,,,509,,44,44,,,[Not Available],[Not Applicable],,,,,0.44,,,,,15,,1,0.1192,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Alabama,,TCGA-99-8032,,,,,,,44,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,83129,,0.86396896,,,,,,,,,,0.212027628,,0.193027409,,,,Stage IA,,0.439,,,,,,,,,,,,,,,,0.4992,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.39641037,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.8232,,-0.5097,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.41,0.54,19,19,24,,,1871,BRCA_Basal,1871,1871,,0,0,1871,1871,,Invasive Carcinoma,62,,37,,,,21442,0,,1871,1871,,,,1871,1871,,,1871,,,,,,,,TUMOR FREE,Alive,-26988,,,,47,,1871,1871,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,17,,1,0.40384,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BG,,,,,,,1871,,,,,,,,,29,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,83130,TRUE,1.465350464,0,0,0,0,-0.2802,1,,,Infiltrating Ductal Carcinoma,0.183963745,,0.086712509,0,0,0,,Negative,1.158,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1816,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-50-6594,Black or African American,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,3.61,0.6,15,12,20,,,370,,,370,,1,1,285,285,,Malignant,47,,76,,,,24294,,,285,285,,,,,370,,,285,,,,,,,,WITH TUMOR,Dead,-28924,370,,,686,,285,285,,,[Not Available],[Not Applicable],,,,,0.05,,,,,15,,1,0.31966,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-6594,,,,,,,,,Distant Metastasis,,,,,,,27,,,,,,,,,,,,,2009,285,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,79,,,,,,,,,,,,,,,,,,,,83137,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.1864372,17.13430261,15.3253322,-0.390388527,LUAD,Adenocarcinoma,17.96093236,14.54875904,Adenocarcinoma,0.498,10.58107482,-1.2176,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-50-5946,White,LUAD,,1,1,,University of Pittsburgh,,0,MALE,1,2.63,0.75,9,8,15,,,1617,,,1617,,1,1,221,221,,Malignant,32,,67,,,,17347,,,221,221,,,,,1617,,,221,,,,,,,,WITH TUMOR,Alive,-22852,,,,856,,221,221,,,[Not Available],[Not Applicable],,,,,0.48,,,,,18,,2,0.95294,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5946,,,,,,,1617,,Distant Metastasis,,,,,,,54,,,,,,,,,,,,,2010,221,,,,Stage IA,,,,,,,,Progressive Disease,,,,,,62,,,,,,,,,,,,,,,,,,,,83140,,0.353863248,,,,,,,,,,0.123195517,,0.079270546,,,,Stage IA,,-0.0675,,,,,,,,,,,,,,,,-0.0503,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.677724718,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.7948,,-0.7553,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-50-5068,White,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,2.91,0.24,5,3,6,,,1499,,,1499,,1,1,686,686,,Malignant,14,,29,,,,20186,,,686,686,,,,,1499,,,686,,,,,,,,WITH TUMOR,Dead,-21728,1499,,,115,,686,686,,,[Not Available],[Not Applicable],,,,,0.36,,,,,27,,1,0.42605,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5068,,,,,,,1499,,Distant Metastasis,,,,,,,21,,,,,,,,,,,,,2003,686,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,83144,,0.789224701,,,,,,,,,,0.252516725,,0.1252369,,,,Stage IIB,,0.826,,,,,,,,,,,,,,,,-0.3086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G423V (driver),1,,,G423V (driver),16.76015299,16.38258776,16.80648123,0.23588023,LUAD,Adenocarcinoma,18.34186037,16.92624511,Adenocarcinoma,,11.03305371,1.206,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1330,,1330,1330,,0,0,1330,1330,,Invasive Carcinoma,,,,,,,23626,0,,1330,1330,,,,1330,1330,,,1330,,,,,,,,TUMOR FREE,Alive,-16948,,,,0,,1330,1330,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A3XG,,,,,,,1330,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,83145,,-0.857001345,0,0,0,0,0.8404,1,,,Infiltrating Lobular Carcinoma,0.092286949,,0.152528321,0,0,0,,Negative,-1.3165,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1073,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Low Grade), Stromal Alterations",,"DCIS (Solid, Low Grade)",0,DCIS with Microinvasive Carcinoma,DCIS with Microinvasive Carcinoma,0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-78-7220,White,LUAD,,1,,,Prince Charles Hospital,,1,FEMALE,1,2.71,0.61,10,10,21,,,807,,,807,,1,,531,531,,Malignant,41,,63,,,,24413,,,531,,,,,,807,,,531,,,,,,,,WITH TUMOR,Dead,-19480,807,,,1111,,531,,,,[Not Available],[Not Applicable],,,,,0.2,,,,,24,,1,0.44262,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7220,,,,,,,,,,,,,,,,33,,,,,,,,,,,,,2000,531,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,83146,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,HOMDEL,,,1,,,,14.32953032,15.84514907,15.31908464,-0.69426557,LUAD,Adenocarcinoma,17.36919878,15.48865581,Adenocarcinoma,-0.7692,12.76482852,0.0676,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-CD-A48A,Asian,STAD,,0,0,,,0,0,,0,4.43,0.64,12,12,26,,,378,,378,378,,0,0,378,378,,Malignant,50,,275,,,,27526,,,378,378,,,,378,378,,,378,,,,,,,,TUMOR FREE,Alive,-20839,,,,305,,378,378,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,14,,2,0.38971,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,ILSBio,,TCGA-CD-A48A,,,,,,,378,,,,,,,,,51,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,83151,,-0.270408621,,,,,,,,,,0.070706188,Grade 2,0.006513472,,,,Stage IIA,,1.12,,,,,,,,,,,,,,,,0.0525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A48A,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,2632,,2632,2632,,0,0,2632,2632,,Invasive Carcinoma,,,,,,,25134,0,,2632,2632,,,,2632,2632,,,2632,,,,,,,,TUMOR FREE,Alive,-14723,,,,0,,2632,2632,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A2LJ,,,,,,,2632,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,83169,,0.501163901,0,0,0,0,-0.002,0,,,Infiltrating Lobular Carcinoma,0.221623571,,0.183041543,0,0,0,,Negative,-0.088,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.5249,1,0,H & E,0,0,,0,Chunhui Yi,"Columnar Lesion, Microglandular Adenosis",0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,1,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Low Grade), Comedonecrosis",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Columnar Lesion, Microglandular Adenosis",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-98-A53C,White,LUSC,,0,0,,Washington University - Alabama,0,0,FEMALE,0,2.0,0.47,0,0,0,,,822,,822,822,,0,0,822,822,,Malignant,0,,7,,,,31732,,,822,822,,,,822,822,,,822,,,,,,,,TUMOR FREE,Alive,-28146,,,,3,,822,822,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.000406,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A53C,,,,,,,822,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,83175,,1.449885512,,,,,,,,,,0.267560595,,0.331067197,,,,Stage IA,,2.167,,,,,,,,,,,,,,,,0.4096,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0722125440847294,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4221,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,3.99,0.83,6,4,16,,,811,BRCA_LumB,811,811,,2,2,811,811,,Invasive Carcinoma,26,,24,,,,17534,0,,811,811,,,,811,811,,,811,,,,,,,,,Dead,-18519,811,,,72,,811,811,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,23,,1,0.19439,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18L,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2003,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,83180,,-0.414484733,0,0,0,0,-0.4211,1,,,Infiltrating Ductal Carcinoma,0.093384579,,0.138734401,0,0,0,,Negative,-0.7735,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.6021,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-46-3769,White,LUSC,,0,0,,St. Joseph's Medical Center (MD),0,0,MALE,0,3.65,0.47,17,30,32,,,135,,135,135,,0,0,135,135,,Malignant,79,,126,,,,29751,,,135,135,,,,135,135,,,135,,,,,,,,TUMOR FREE,Alive,-20941,,,,1251,,135,135,,,[Not Available],[Not Applicable],,,,,0.2,,,,,15,,2,0.5256,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,St. Joseph's Medical Center (MD),,TCGA-46-3769,,,,,,,135,,,,,,,,,70,,,,,,,,,,,,,2009,,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,83183,,0.682050159,,,,,,,,,,0.233356702,,0.079040736,,,,Unknown,,1.622,,,,,,,,,,,,,,,,0.2341,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"P589L (driver), AMP (driver)",,,1,P589L (driver),,,,,,-0.0499393593031877,LUSC,,,,Squamous Cell Carcinoma,1.0943,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-BR-8284,White,STAD,,0,0,,,2,2,,2,2.13,0.5,3,5,4,,,245,,245,245,,2,2,245,245,,Malignant,12,,20,,,,24172,,,245,245,,,,245,245,,,245,,,,,,,,TUMOR FREE,Dead,-26526,245,,,442,,245,245,,,[Not Available],[Not Applicable],,,,,0.11,Stomach,Unknown,,,5,,0,0.05837,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8284,,,,,,,,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,83184,,1.054336334,,,,,,,,,,0.130567505,Grade 3,0.155847216,,,,Stage IIIC,,1.228,,,,,,,,,,,,,,,,0.3961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8284,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,Male,TCGA-85-8276,White,LUSC,,1,1,,Asterand,1,0,MALE,1,3.47,0.26,15,19,22,,,1050,,1048,1050,,1,1,1048,1048,,Malignant,56,,122,,,,27056,,,1048,1048,,,,1048,1050,,,1048,,,,,,,,WITH TUMOR,Alive,-22707,,,,365,,1048,1048,,,[Not Available],[Not Applicable],,,,,0.27,,,,,21,,1,0.28001,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8276,,,,,,,1050,,Distant Metastasis,,,,,,,29,,,,,,,,,,,,,2011,1048,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,83186,,1.350814504,,,,,,,,,,0.249898316,,0.105898871,,,,Stage IIA,,1.1465,,,,,,,,,,,,,,,,0.6453,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.82825184,16.74952577,16.99289606,-0.0714098231755215,LUSC,Squamous Cell Carcinoma,18.11836636,16.69567688,Squamous Cell Carcinoma,0.8044,13.45964689,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,,,Black or African American,BRCA,,1,1,,,,1,FEMALE,1,3.3,0.61,13,14,21,,,116,BRCA_Her2,,116,,1,1,116,116,,None,48,,217,,,,17571,N/A (Non-Malignant),,116,116,,,,,116,,,116,,,,,,,,WITH TUMOR,Dead,-23278,116,,,244,,116,116,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,14,,1,0.2909,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mary Bird Perkins Cancer Center - Our Lady of the Lake,,TCGA-UU-A93S,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,83189,,-0.470322664,0,0,0,0,-4.0351,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.127911684,N/A (Non-Malignant),0.090520861,0,0,0,N/A (Non-Malignant),Positive,-0.047,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.4253,0,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,1,None of the Above,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,454,,454,454,,0,0,454,454,,Invasive Carcinoma,,,,,,,17680,0,,454,454,,,,454,454,,,454,,,,,,,,TUMOR FREE,Alive,-14906,,,,0,,454,454,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A4SA,,,,,,,454,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,83192,,1.299333118,0,0,0,0,-0.484,1,,,Infiltrating Lobular Carcinoma,0.145169644,,0.178253613,0,0,0,,Negative,1.089,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3716,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GU-AATO,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.23,0.52,6,8,11,,,324,,,324,,1.0,1,324.0,324.0,,Malignant,25,,75,,,,29651.0,,,324.0,324,,,,,324,,,324.0,,,,,,,,WITH TUMOR,Dead,-27684,324,,,421.0,,324.0,324,,,[Not Available],[Not Applicable],,,,,0.11,,,,,20,,2,0.16849,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-AATO,,,,,,,,,,,,,,,,70,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,75.0,,,,,,,,,,,,,,,,,,,,83195,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.78,1,0,3,,,767,BRCA_LumA,767,767,,0,0,767,767,,Invasive Carcinoma,4,,25,,,,29658,0,,767,767,,,,767,767,,,767,,,,,,,,TUMOR FREE,Alive,-19607,,,,66,,767,767,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,3,,0,0.059027,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A73X,,,,,,,767,,,,,,,,,5,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,83200,,-0.418252332,0,0,0,0,0.2574,1,,,Other,0.171442893,,0.105942228,0,0,0,,Negative,-0.153,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4549,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Carcinoma (Mixed Ductal-Lobular Features), Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)","Invasive Carcinoma (Mixed Ductal-Lobular Features), Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-44-2668,White,LUAD,,1,,,Christiana Healthcare,1,1,MALE,1,2.13,0.3,10,13,10,,,761,,433,761,,1,,433,433,,Malignant,33,,93,,,,16528,,,433,,,,,433,761,,,433,,,,,,,,WITH TUMOR,Dead,-18856,761,,,394,,433,,,,[Not Available],[Not Applicable],,,,,0.24,,,,,10,,0,0.23532,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-2668,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,433,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,83203,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.027052725,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.1114,,1.1091,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,1.0,1.0,Male,TCGA-S8-A6BV,White,ESCA,,1.0,1,,,,0,,1.0,3.0,0.41,2,11,17,,,609,,,609,,1.0,1,267,267,,Malignant,30,,75,,,,28781.0,0,,267,267,,,,,609,,,267,,,,,,,,WITH TUMOR,Alive,-28111,,,,211.0,,267,267,,,[Not Available],Stage IB,,,,,0.04,Esophagus,Resection,,,16,,1,0.17776,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,ABS - IUPUI,,TCGA-S8-A6BV,,,,,,,609,Liver,Distant Metastasis,,,,,,,35,,,,,,,,,,,,,2012,267,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,76,,,,,,,,,,,,,,,,,,,,83204,,,,,,,,,,,,,Grade 2,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.36,0.83,6,5,9,,,0,BRCA_LumB,0,0,,0,0,0,0,,Invasive Carcinoma,20,,17,,,,20829,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-24288,,,,0,,0,0,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,20,,1,0.16318,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06N,,,,,,,0,,,,,,,,,25,,,,,,,,,,,,,2009,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,83209,,-1.512139041,0,0,0,0,0.3922,1,,,Infiltrating Ductal Carcinoma,0.077107276,,0.042392028,0,0,0,,Negative,-0.821,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.9891,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.48,0.55,9,8,9,,,332,BRCA_Her2,332,332,,0,0,332,332,,Benign Breast Disease,26,,43,,,,24829,N/A (Non-Malignant),,332,332,,,,332,332,,,332,,,,,,,,TUMOR FREE,Alive,,,,,46,,332,332,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,21,,1,0.23056,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HF,,,,,,,332,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,83210,,1.49634916,0,0,0,0,-1.0424,0,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.188317595,N/A (Non-Malignant),0.135436563,0,0,0,N/A (Non-Malignant),Negative,0.8485,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.3913,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,"Columnar Lesion, Sclerosing Adenosis",0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,"Columnar Lesion, Sclerosing Adenosis",0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Female,TCGA-78-7146,White,LUAD,,0,0,,Prince Charles Hospital,,,FEMALE,2,2.79,0.68,11,17,22,,,173,,,173,,2,2,173,173,,Malignant,50,,61,,,,21559,,,173,173,,,,,173,,,173,,,,,,,,,Dead,-26272,173,,,489,,173,173,,,[Not Available],[Not Applicable],,,,,0.12,,,,,14,,1,0.27853,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7146,,,,,,,,,,,,,,,,41,,,,,,,,,,,,,1999,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,83215,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,P492Qfs*8 (driver),1,,,P492Qfs*8 (driver),15.6049312,16.54484941,15.96884031,-0.391293125,LUAD,Adenocarcinoma,17.69013982,15.30123582,Adenocarcinoma,-0.687,12.32879945,-0.0988,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-D7-6520,White,STAD,,1,1,,,,0,,1,3.86,0.52,8,12,12,,,573,,,573,,1,1,46,46,,Malignant,32,,51,,,,28159,,,46,46,,,,,573,,,46,,,,,,,,WITH TUMOR,Alive,-19467,,,,79,,46,46,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,10,,1,0.19233,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6520,,,,,,,573,Liver,Distant Metastasis,,,,,,,17,,,,,,,,,,,,,2010,46,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,83217,,0.399113669,,,,,,,,,,0.058555176,Grade 3,0.052933798,,,,Stage IIIA,,-0.054,,,,,,,,,,,,,,,,0.3522,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6520,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Male,TCGA-G9-A9S7,,PRAD,,0,0,,G9,,0,MALE,0,1.94,0.53,5,2,5,HRP,NO,728,,,728,,0,0,728,728,prad_tcga,Malignant,12,,61,,TCGA-G9-A9S7-01,0,5397,0,TCGA-G9-A9S7,728,728,Prostate Cancer,,643,,728,TCGA,,728,Primary,0,Apex|Middle,A,,,True,WITH TUMOR,Alive,-20213,,55,8,29,PRAD,728,728,,0.0,[Not Available],[Not Applicable],36,,1,Matched,0.07,Prostate,Resection,4,E8DB9EBC-0E20-43B3-9D9C-2B6A26C6B0ED,2,Abnormal (not related to prostate cancer),0,0.066951,[Not Available],27953774-E97B-48E7-B966-1EC1E9C830B4,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,G9,1.2,TCGA-G9-A9S7,0:DiseaseFree,4,11,Prostate Adenocarcinoma,23.92,7/14/14,728,,,,,NO,C61,32AD969B-10BB-4FA2-872B-D789382CD3CC,170,3,WITH TUMOR,0.0549,0:LIVING,0.13,,23.92,Bilateral,14,No Evidence of Extraprostatic Extension,32,YES,452,2012,,,TCGA-G9-A9S7.32AD969B-10BB-4FA2-872B-D789382CD3CC.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,32,,8,Prostate Adenocarcinoma Acinar Type,1,2012,Partial Remission/Response,,NO,No,R0,,55,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,YES,8,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,83218,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-DK-A3WY,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,,,,,,,,4967,,4967,4967,,0.0,0,4967.0,4967.0,,Malignant,,,,,,,33946.0,,,4967.0,4967,,,,4967,4967,,,4967.0,,,,,,,,TUMOR FREE,Alive,-24536,,,,20.0,,4967.0,4967,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3WY,,,,,,,4967,,,,,,,,,,,,,,,,,,,,,,2001,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,67.0,,,,,,,,,,,,,,,,,,,,83219,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-8206,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,3.27,0.46,1,1,2,,,888,,888,888,,0,0,888,888,,Malignant,4,,8,,,,29235,,,888,888,,,,888,888,,,888,,,,,,,,TUMOR FREE,Alive,-20690,,,,38,,888,888,,,[Not Available],[Not Applicable],,,,,0.03,,,,,18,,1,0.133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8206,,,,,,,888,,,,,,,,,18,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,83222,,1.027856303,,,,,,,,,,0.268954976,,0.151821358,,,,Stage IA,,0.453,,,,,,,,,,,,,,,,-0.0136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,,,,-0.378509266,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.7404,,-1.1047,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-L7-A6VZ,White,ESCA,,0,0,,,0,0,,0,,,,,,,,315,,315,315,,0,0,315,315,,Malignant,,,,,,,16219,,,315,315,,,,315,315,,,315,,,,,,,,TUMOR FREE,Alive,-22730,,,,215,,315,315,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Christiana Care,,TCGA-L7-A6VZ,,,,,,,315,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,83223,,,,,,,,,,,,,Grade 2,,,,,Stage IIIC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.9,0.54,7,4,5,,,798,BRCA_LumA,,798,,0,0,798,798,,Invasive Carcinoma,16,,43,,,,23195,0,,798,798,,,,,798,,,798,,,,,,,,TUMOR FREE,Alive,-18021,,,,21,,798,798,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.18339,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JG,,,,,,,798,,,,,,,,,8,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,83232,,1.351340848,0,0,0,0,0.4747,1,,,Other,0.135156649,,0.258649286,0,0,0,,Close,0.565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2221,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-CU-A3YL,White,BLCA,,1.0,1,,,1,0,MALE,1.0,2.1,0.73,6,4,3,,,906,,370,906,,1.0,1,370.0,370.0,,Malignant,13,,36,,,,24161.0,,,370.0,370,,,,370,906,,,370.0,,,,,,,,TUMOR FREE,Alive,-24524,,,,306.0,,370.0,370,,,[Not Available],[Not Applicable],,,,,0.03,,,,,4,,0,0.07553,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,UNC,,TCGA-CU-A3YL,,,,,,,906,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2011,370,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,67.0,,,,,,,,,,,,,,,,,,,,83233,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-05-4418,,LUAD,,0,0,,Indivumed,,,MALE,2,2.0,0.55,1,2,2,,,274,,,274,,2,2,274,274,,Malignant,5,,7,,,,21622,,,274,274,,,,,274,,,274,,,,,,,,,Dead,-25417,274,,,367,,274,274,,,[Not Available],[Not Applicable],,,,,0.59,,,,,5,,0,0.13733,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4418,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,83235,,1.349156407,,,,,,,,,,0.221882613,,0.071964584,,,,Stage IIIA,,1.575,,,,,,,,,,,,,,,,0.1044,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),R460G,1,,G12C (driver),R460G,16.13376395,17.03192716,16.67094006,-0.012177959,LUAD,,17.91283533,16.41226057,Adenocarcinoma,0.1791,13.15975619,0.6722,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HC-7818,White,PRAD,184,0,0,,HC,0,0,MALE,0,,,,,,,NO,938,1-ERG,938,938,,0,0,938,938,prad_tcga,Malignant,,,,4.5,TCGA-HC-7818-01,0,5430,0,TCGA-HC-7818,938,938,Prostate Cancer,,99,938,938,TCGA,,938,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-24391,,66,7,21,PRAD,938,938,WHITE,0.0,[Not Available],[Not Applicable],38,R0,1,Matched,,Prostate,Resection,3,152bc45f-6d11-48c3-ab68-2119e4534d64,,,,,[Not Available],ebe711e4-45af-4082-bdf6-b0f7ac899b3e,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.26666666667,TCGA-HC-7818,0:DiseaseFree,2,,Prostate Adenocarcinoma,30.81,4/20/12,938,,,,,,C61,e6f3745f-31bf-4475-85f8-956811ce6cb6,,,TUMOR FREE,0.0,0:LIVING,0.01,,30.81,Bilateral,,,,YES,,2011,,,TCGA-HC-7818.e6f3745f-31bf-4475-85f8-956811ce6cb6.pdf,,[Not Applicable],,,31-40%,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.2,66,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,83236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Female,TCGA-PQ-A6FN,White,BLCA,,0.0,0,,,,0,FEMALE,0.0,3.5,0.22,11,9,16,,,507,,,507,,0.0,0,507.0,507.0,,Malignant,36,,99,,,,25917.0,,,507.0,507,,,,,507,,,507.0,,,,,,,,,Alive,-28546,,,,112.0,,507.0,507,,,[Not Available],[Not Applicable],,,,,0.15,,,,,18,,1,0.25551,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Colorado Denver,,TCGA-PQ-A6FN,,,,,,,507,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,[Unknown],,,,,,78.0,,,,,,,,,,,,,,,,,,,,83241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-8052,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.27,0.37,5,4,6,,,734,,734,734,,0,0,734,734,,Malignant,15,,11,,,,32525,,,734,734,,,,734,734,,,734,,,,,,,,TUMOR FREE,Alive,-19671,,,,168,,734,734,,,[Not Available],[Not Applicable],,,,,0.3,,,,,19,,1,0.27076,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8052,,,,,,,734,,,,,,,,,25,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,83242,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,0.3309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.94428192,16.88312466,14.54836182,-0.580766893764837,LUSC,Squamous Cell Carcinoma,18.06680748,15.497707,Squamous Cell Carcinoma,-0.2112,14.02234718,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-YL-A8SL,,PRAD,389,0,0,,YL,0,0,MALE,0,3.67,0.76,3,15,8,ambiguous,NO,987,1-ERG,987,987,,0,0,987,987,prad_tcga,Malignant,26,BARD1;BRCA2;PALB2;RAD51B;RAD51C;RAD51D,56,,TCGA-YL-A8SL-01,11,5680,0,TCGA-YL-A8SL,987,987,Prostate Cancer,,623,987,987,TCGA,,987,Primary,1,Apex|Middle|Base,B,,,True,TUMOR FREE,Alive,-27033,,74,8,54,PRAD,987,987,,0.239765839,[Not Available],[Not Applicable],44,R0,1,Matched,0.08,Prostate,Resection,4,6D07618C-DCF9-46E8-BA3A-F074CD091071,11,Normal (no evidence of prostate cancer) [cM0],1,0.092163,[Not Available],23EBC73D-BE3B-42F8-9390-BF18A21AFC5C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,YL,1.5,TCGA-YL-A8SL,0:DiseaseFree,4,29,Prostate Adenocarcinoma,32.42,4/25/14,987,,,,,NO,C61,561D6EB5-1E61-4134-B6F6-96B1B9A27163,760,14,TUMOR FREE,0.2142,0:LIVING,0.0,3,32.42,Bilateral,37,Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1],43,YES,835,2011,,,TCGA-YL-A8SL.561D6EB5-1E61-4134-B6F6-96B1B9A27163.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,51-60%,19,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,74,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,8,No,YES,0,N1,,3,M0,C61.9,8140/3,83244,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5498,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.3,0,0,0,HRP,NO,1720,1-ERG,1720,1720,,0,0,1720,1720,prad_tcga,Malignant,0,PALB2,6,5.0,TCGA-EJ-5498-01,0,5264,0,TCGA-EJ-5498,1720,1720,Prostate Cancer,,537,1720,1720,TCGA,,1720,Primary,0,Middle,A,,,,TUMOR FREE,Alive,-20472,,56,7,46,PRAD,1720,1720,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.02,Prostate,Resection,4,aaf0af43-dae0-4aa7-9d4c-6caf1f039857,2,Normal (no evidence of prostate cancer) [cM0],0,0.033409,[Not Available],79ec7468-9aaf-4bb0-94c7-72be4f497868,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,1.3,TCGA-EJ-5498,0:DiseaseFree,3,7,Prostate Adenocarcinoma,56.5,3/30/12,1720,,,,,NO,C61,53d058fd-5faa-43ab-8a5e-b6f95134970b,,1,TUMOR FREE,0.0012,0:LIVING,0.1,3,56.5,Bilateral,8,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-EJ-5498.53d058fd-5faa-43ab-8a5e-b6f95134970b.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,12,31-40%,26,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.7,56,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,,C61.9,8550/3,83245,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-64-1677,White,LUAD,,1,,,Fox Chase,,,FEMALE,1,2.81,0.32,6,14,10,,,628,,,628,,1,,360,360,,Malignant,30,,17,,,,17622,,,360,,,,,,628,,,360,,,,,,,,,Dead,-28482,628,,,292,,360,,,,[Not Available],[Not Applicable],,,,,0.36,,,,,16,,1,0.24508,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-1677,,,,,,,,,,,,,,,,31,,,,,,,,,,,,,2005,360,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,83246,,1.018095498,,,,,,,,,,0.173595444,,0.058894725,,,,Stage IIIA,,1.2705,,,,,,,,,,,,,,,,-0.1532,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,15.27733398,15.26352752,17.05975636,-0.07863665,LUAD,Adenocarcinoma,18.06366281,16.33846657,Adenocarcinoma,-0.1772,12.61566486,0.3434,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-44-6778,Black or African American,LUAD,,0,0,,Christiana Healthcare,0,0,MALE,0,3.27,0.25,8,10,20,,,1864,,1864,1864,,0,0,1864,1864,,Malignant,38,,54,,,,20752,,,1864,1864,,,,1864,1864,,,1864,,,,,,,,TUMOR FREE,Alive,-21725,,,,515,,1864,1864,,,[Not Available],[Not Applicable],,,,,0.09,,,,,20,,1,0.31813,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6778,,,,,,,1864,,,,,,,,,23,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,83257,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,M110V (driver),1,,,M110V (driver),,,,0.182190943,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.9664,,1.313,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-86-8672,White,LUAD,,0,0,,Asterand,2,2,MALE,2,2.74,0.32,13,8,15,,,19,,19,19,,2,2,19,19,,Malignant,36,,101,,,,29016,,,19,19,,,,19,19,,,19,,,,,,,,TUMOR FREE,Dead,-21682,19,,,410,,19,19,,,[Not Available],[Not Applicable],,,,,0.2,,,,,18,,1,0.41383,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8672,,,,,,,,,,,,,,,,33,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,83258,,1.482284603,,,,,,,,,,0.2240617,,0.099686689,,,,Stage IIB,,1.932,,,,,,,,,,,,,,,,0.2615,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V123Rfs*31 (driver),1,,,V123Rfs*31 (driver),16.58187099,17.04460096,17.58904269,-0.015268315,LUAD,Adenocarcinoma,18.24275531,16.75482557,Adenocarcinoma,1.0789,8.120616983,1.0491,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Male,TCGA-55-8092,White,LUAD,,1,1,,International Genomics Consortium,1,1,MALE,1,3.24,0.38,7,13,18,,,154,,127,154,,1,1,127,127,,Malignant,38,,43,,,,0,,,127,127,,,,127,154,,,127,,,,,,,,WITH TUMOR,Dead,-27597,154,,,744,,127,127,,,[Not Available],[Not Applicable],,,,,0.19,,,,,14,,2,0.31795,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8092,,,,,,,,,Locoregional Recurrence,,,,,,,73,,,,,,,,,,,,,2012,127,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,83264,,1.463490822,,,,,,,,,,0.18322152,,0.082369828,,,,Stage IIB,,1.4295,,,,,,,,,,,,,,,,0.1054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,15.92685559,16.79323444,17.63184028,0.152306208,LUAD,Adenocarcinoma,17.94233814,17.07249129,Adenocarcinoma,0.403,12.87404445,1.4735,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-49-4490,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,5.15,0.26,6,8,14,,,385,,,385,,1,1,385,385,,Malignant,28,,29,,,,23533,,,385,385,,,,,385,,,385,,,,,,,,WITH TUMOR,Dead,-16634,385,,,65,,385,385,,,[Not Available],[Not Applicable],,,,,0.42,,,,,26,,2,0.245,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4490,,,,,,,,,,,,,,,,48,,,,,,,,,,,,,1993,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,83270,,0.678301867,,,,,,,,,,0.176256001,,0.164310291,,,,Stage IIIA,,-0.1345,,,,,,,,,,,,,,,,0.5283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,14.95813934,15.40312664,13.8353783,-0.483626278,LUAD,Adenocarcinoma,18.18408044,15.19834945,Adenocarcinoma,,12.95053452,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-44-6774,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,2.07,0.45,4,6,4,,,658,,658,658,,0,0,658,658,,Malignant,14,,12,,,,27568,,,658,658,,,,658,658,,,658,,,,,,,,TUMOR FREE,Alive,-20462,,,,379,,658,658,,,[Not Available],[Not Applicable],,,,,0.49,,,,,4,,0,0.11827,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6774,,,,,,,658,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,83275,,0.965774479,,,,,,,,,,0.278563338,,0.270421201,,,,Stage IIIA,,0.867,,,,,,,,,,,,,,,,0.9725,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.73609649,17.48629743,14.93093799,-0.240975814,LUAD,,18.26590204,15.68441187,Adenocarcinoma,2.4754,13.59683145,-0.7786,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-22-1005,White,LUSC,,0,0,,Mayo Clinic - Rochester,2,2,MALE,2,1.88,0.12,4,4,3,,,1953,,1953,1953,,2,2,1953,1953,,Malignant,11,,9,,,,19636,,,1953,1953,,,,1953,1953,,,1953,,,,,,,,TUMOR FREE,Dead,-23322,1953,,,355,,1953,1953,,,[Not Available],[Not Applicable],,,,,0.31,,,,,3,,0,0.12138,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-1005,,,,,,,1953,,,,,,,,,7,,,,,,,,,,,,,2001,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,83284,,1.867627696,,,,,,,,,,0.225229719,,0.198636728,,,,Stage IA,,1.8225,,,,,,,,,,,,,,,,0.3497,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.312318493712785,LUSC,,,,Squamous Cell Carcinoma,0.7844,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-37-4133,White,LUSC,,0,0,,Cureline,,0,MALE,0,3.32,0.67,7,8,19,,,238,,,238,,0,0,238,238,,Malignant,34,,34,,,,25969,,,238,238,,,,,238,,,238,,,,,,,,TUMOR FREE,Alive,-23083,,,,376,,238,238,,,[Not Available],[Not Applicable],,,,,0.42,,,,,15,,1,0.23779,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-4133,,,,,,,238,,,,,,,,,36,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,83286,,0.209382424,,,,,,,,,,0.17240839,,0.027141704,,,,Stage IIIA,,1.835,,,,,,,,,,,,,,,,-0.2324,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,S243C (driver),1,,,S243C (driver),16.09226499,15.0182467,16.62167457,-0.0748072584576425,LUSC,Squamous Cell Carcinoma,17.47056408,15.64739896,Squamous Cell Carcinoma,-0.0206,12.76262535,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-LT-A5Z6,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.88,0.86,6,5,9,,,474,,474,474,,0.0,0,474.0,474.0,,Malignant,20,,123,,,,29098.0,,,474.0,474,,,,474,474,,,474.0,,,,,,,,TUMOR FREE,Alive,-20746,,,,723.0,,474.0,474,,,[Not Available],[Not Applicable],,,,,0.29,,,,,8,,0,0.27249,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Gundersen Lutheran Health System,,TCGA-LT-A5Z6,,,,,,,474,,,,,,,,,10,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,83288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FP-8211,White,STAD,,0.0,0,,,0,0,,0.0,1.8,0.73,16,23,19,,,413,,413,413,,0.0,0,413,413,,Malignant,58,,107,,,,29797.0,0,,413,413,,,,413,413,,,413,,,,,,,,TUMOR FREE,Alive,-22957,,,,143.0,,413,413,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Resection,,,5,,0,0.40119,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,International Genomics Consortium,,TCGA-FP-8211,,,,,,,413,,,,,,,,,18,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,83299,,0.204502401,,,,,,,,,,0.022586063,Grade 2,0.016078498,,,,Stage IIB,,0.436,,,,,,,,,,,,,,,,0.0788,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-8211,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,1,0,1.0,1.0,Male,TCGA-GV-A3QI,White,BLCA,,1.0,1,,,1,0,MALE,1.0,3.26,0.95,12,24,21,,,1110,,768,1110,,1.0,1,768.0,768.0,,Malignant,57,,111,,,,19257.0,,,768.0,768,,,,768,1110,,,768.0,,,,,,,,WITH TUMOR,Alive,-17383,,,,627.0,,768.0,768,,,[Not Available],[Not Applicable],,,,,0.13,,,,,13,,1,0.22545,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3QI,,,,,,,1110,"Other, specify",Distant Metastasis,,,,,,,24,,,,,,,,,,,,,2011,768,Abdominal wall,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,47.0,,,,,,,,,,,,,,,,,,,,83301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.04,0.39,2,3,1,,,336,BRCA_LumA,,336,,0,0,336,336,,Invasive Carcinoma,6,,10,,,,18105,0,,336,336,,,,,336,,,336,,,,,,,,TUMOR FREE,Alive,-17683,,,,53,,336,336,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,3,,0,0.03449,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A5ZX,,,,,,,336,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,83302,,-1.359088152,0,0,0,0,0.584,1,,,Infiltrating Lobular Carcinoma,0.133074304,,0.185816646,0,0,0,,[Unknown],-1.028,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4688,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,0,No,0,Adipose Tissue,No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-BR-A4IV,Asian,STAD,,1,1,,,1,1,,1,2.0,0.6,0,0,0,,,869,,737,869,,1,1,737,737,,Malignant,0,,5,,,,22284,,,737,737,,,,737,869,,,737,,,,,,,,WITH TUMOR,Dead,-17515,869,,,30,,737,737,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,0,,0,0.0010765,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4IV,,,,,,,,,Locoregional Recurrence,,,,,,,0,,,,,,,,,,,,,2012,737,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,47,,,,,,,,,,,,,,,,,,,,83304,,-0.019492948,,,,,,,,,,0.114968102,Grade 3,0.225173799,,,,Stage IIIB,,-0.397,,,,,,,,,,,,,,,,0.748,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4IV,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.66,3,2,3,,,996,BRCA_Her2,996,996,,0,0,996,996,,Invasive Carcinoma,8,,26,,,,21243,0,,996,996,,,,996,996,,,996,,,,,,,,TUMOR FREE,Alive,-16971,,,,67,,996,996,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,6,,0,0.059325,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3XV,,,,,,,996,,,,,,,,,3,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,83306,,-0.802886332,0,0,0,0,-0.0923,1,,,Infiltrating Ductal Carcinoma,0.123818025,,0.149639014,0,0,0,,Negative,-1.318,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.4784,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.56,0.65,5,7,11,,,11,BRCA_LumA,11,11,,0,0,11,11,,Invasive Carcinoma,23,,37,,,,27490,0,,11,11,,,,11,11,,,11,,,,,,,,TUMOR FREE,Alive,-24692,,,,160,,11,11,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,18,,1,0.12796,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FW,,,,,,,11,,,,,,,,,25,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,83308,,0.436673311,0,0,0,0,0.5739,1,,,Infiltrating Ductal Carcinoma,0.117581716,,0.194058652,0,0,0,,Negative,-1.033,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1148,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-ZF-A9RM,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.67,0.82,5,13,15,,,1455,,1455,1455,,0.0,0,1455.0,1455.0,,Malignant,33,,69,,,,19584.0,,,1455.0,1455,,,,1455,1455,,,1455.0,,,,,,,,TUMOR FREE,Alive,-25642,,,,114.0,,1455.0,1455,,,[Not Available],[Not Applicable],,,,,0.42,,,,,11,,1,0.075004,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9RM,,,,,,,1455,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,83312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-8621,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.05,0.2,3,1,4,,,515,,515,515,,0,0,515,515,,Malignant,8,,21,,,,26200,,,515,515,,,,515,515,,,515,,,,,,,,TUMOR FREE,Alive,-27485,,,,78,,515,515,,,[Not Available],[Not Applicable],,,,,0.42,,,,,1,,0,0.034227,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8621,,,,,,,515,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,83313,,1.031734523,,,,,,,,,,0.30966301,,0.286100976,,,,Stage IA,,1.799,,,,,,,,,,,,,,,,0.3726,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.056269256,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2312,,0.3823,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,681,,681,681,,0,0,681,681,,Invasive Carcinoma,,,,,,,28088,0,,681,681,,,,681,681,,,681,,,,,,,,TUMOR FREE,Alive,-16213,,,,0,,681,681,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Minnesota,,TCGA-MS-A51U,,,,,,,681,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,83314,,0.489831809,0,0,0,0,0.3224,1,,,Infiltrating Lobular Carcinoma,0.142097377,,0.196223781,0,0,0,,Negative,0.1385,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6123,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,83317,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,-0.029,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-35-3615,White,LUAD,,0,0,,Cureline,,0,MALE,0,2.07,0.69,1,2,4,,,14,,,14,,0,0,14,14,,Malignant,7,,14,,,,24113,,,14,14,,,,,14,,,14,,,,,,,,TUMOR FREE,Alive,-21076,,,,162,,14,14,,,[Not Available],[Not Applicable],,,,,0.09,,,,,5,,0,0.08363,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Cureline,,TCGA-35-3615,,,,,,,14,,,,,,,,,5,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,83325,,0.384252153,,,,,,,,,,0.207936623,,0.129009411,,,,Stage IB,,0.0905,,,,,,,,,,,,,,,,-0.3518,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),E449* (driver),1,,G12C (driver),E449* (driver),,,,-0.42826315,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3755,,-0.3634,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.95,0.88,11,12,13,,,3709,BRCA_LumB,3709,3709,,0,0,3709,3709,,Invasive Carcinoma,36,,22,,,,17570,0,,3709,3709,,,,3709,3709,,,3709,,,,,,,,TUMOR FREE,Alive,-13483,,,,118,,3709,3709,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.20749,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04R,,,,,,,3709,,,,,,,,,13,,,,,,,,,,,,,2004,,,,,Stage IA,,,,,,,,[Not Available],,,,,,36,,,,,,,,,,,,,,,,,,,,83328,,-1.712196094,0,0,0,1,-0.0917,0,,,Infiltrating Ductal Carcinoma,0.110095781,,0.142757614,0,0,0,,Negative,-1.533,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1587,1,0,H & E,0,0,,0,Chunhui Yi,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SJ,,PRAD,389,1,1,,YL,1,0,MALE,1,1.89,0.63,6,8,5,ambiguous,NO,1395,2-ETV1,752,1395,,1,1,752,752,prad_tcga,Malignant,19,BARD1;BRCA2;FANCL;PALB2;RAD51B;RAD54L,59,,TCGA-YL-A8SJ-01,0,5672,0,TCGA-YL-A8SJ,752,752,Prostate Cancer,,1426,752,1395,TCGA,,752,Primary,0,Middle|Base,B,,,True,WITH TUMOR,Alive,-21916,,60,9,36,PRAD,752,752,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.23,Prostate,Resection,4,219FC0A7-7389-40F7-AB99-C2EE6AD501AF,0,,0,0.10711,[Not Available],F3EC5BF3-97AE-4033-91A6-084A1AA152A4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,YL,1.0,TCGA-YL-A8SJ,1:Recurred/Progressed,5,18,Prostate Adenocarcinoma,24.7,4/25/14,1395,,Biochemical evidence of disease,,,NO,C61,86F65B00-7E83-4013-85E8-A4AE42686ACF,460,4,WITH TUMOR,0.0629,0:LIVING,0.24,,45.83,Bilateral,30,,,YES,1306,2010,752,,TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,66-75%,29,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,752,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,83329,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.65,0.42,4,3,10,,,777,BRCA_LumA,777,777,,0,0,777,777,,Invasive Carcinoma,17,,24,,,,18399,1,,777,777,,,,777,777,,,777,,,,,,,,TUMOR FREE,Alive,-22703,,,,113,,777,777,,,[Not Available],[Not Applicable],,,,,0.03,Not Specific/Unknown,Resection/Excision,,,21,,1,0.13752,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0AY,,,,,,,777,,,,,,,,,21,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,83331,,0.517490477,0,0,0,0,0.0626,1,,,Infiltrating Ductal Carcinoma,0.194505158,,0.259423182,0,0,0,,Negative,-0.367,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,0.485,1,0,H & E,0,0,,0,David Jou,None,0,0,0,Optimal,0,0,Resection/Excision,Poor (so bad that tissue is not evaluable),0,Not Specific/Unknown,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-7742,White,PRAD,184,0,0,,HC,,0,MALE,0,2.01,0.56,6,3,7,ambiguous,NO,938,8-other,,938,,0,0,938,938,prad_tcga,Malignant,16,,28,5.6,TCGA-HC-7742-01,0,5421,0,TCGA-HC-7742,938,938,Prostate Cancer,,113,,938,TCGA,,938,Primary,0,,A,,,,WITH TUMOR,Alive,-21323,,58,7,38,PRAD,938,938,WHITE,0.0,[Not Available],[Not Applicable],43,R0,1,Matched,0.22,Prostate,Resection,3,5eb42b0e-e7d5-46da-96de-2284c4372228,5,,0,0.10285,[Not Available],0730216b-c201-443c-9092-81e23fd13c6c,4,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,16,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,2.43333333333,TCGA-HC-7742,0:DiseaseFree,2,18,Prostate Adenocarcinoma,30.81,4/11/12,938,,,,,,C61,1fe1a801-da9e-4e62-935e-0d014c0b5631,,5,WITH TUMOR,0.1224,0:LIVING,0.1,,30.81,,20,,,YES,,2011,,,TCGA-HC-7742.1fe1a801-da9e-4e62-935e-0d014c0b5631.pdf,,[Not Applicable],,,71-80%,2,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,NO,No,R0,0.4,58,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,M0,C61.9,8140/3,83333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-MP-A4T8,Unknown,LUAD,,0,0,,Washington University - Mayo Clinic,,,MALE,2,3.17,0.59,7,9,16,,,161,,,161,,2,2,161,161,,Malignant,32,,60,,,,20657,,,161,161,,,,,161,,,161,,,,,,,,,Dead,-25069,161,,,163,,161,161,,,[Not Available],[Not Applicable],,,,,0.35,,,,,12,,1,0.13437,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4T8,,,,,,,,,,,,,,,,32,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,68,,,,,,,,,,,,,,,,,,,,83334,,-0.372879639,,,,,,,,,,0.160064237,,0.1406664,,,,Stage IIIA,,-0.203,,,,,,,,,,,,,,,,0.3695,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,14.54472029,14.96021473,12.9075804,-0.834276994,LUAD,Adenocarcinoma,18.05025583,14.8894764,Adenocarcinoma,0.5042,13.44798117,-1.7493,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,83336,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.8,0.67,23,27,22,,,2108,BRCA_Basal,2108,2108,,0,0,2108,2108,,Invasive Carcinoma,72,,140,,,,17758,0,,2108,2108,,,,2108,2108,,,2108,,,,,,,,TUMOR FREE,Alive,-18171,,,,185,,2108,2108,,,[Not Available],[Not Applicable],,,,,0.45,Breast,Resection/Excision,,,3,,0,0.34537,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A3XL,,,,,,,2108,,,,,,,,,12,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,83339,,1.048337425,0,0,0,0,-1.8494,0,,,Infiltrating Ductal Carcinoma,0.180296968,,-0.003083607,0,0,0,,Negative,1.182,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3713,1,0,H & E,0,0,,0,Chunhui Yi,Microglandular Adenosis,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,1,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Microglandular Adenosis,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-G9-7521,,PRAD,221,0,0,,G9,,0,MALE,0,3.9,0.42,5,9,9,ambiguous,NO,942,8-other,,942,,0,0,942,942,prad_tcga,Malignant,23,BRCA2;RAD51B,13,26.3,TCGA-G9-7521-01,10,5387,0,TCGA-G9-7521,942,942,Prostate Cancer,45,487,,942,TCGA,No Evidence of Extraprostatic Extension,942,Primary,0,Apex|Base,A,,,,[Discrepancy],Alive,-19216,,52,8,37,PRAD,942,942,,0.293770367,[Not Available],[Not Applicable],35,R0,1,Matched,0.16,Prostate,Resection,4,74a8d844-92db-4829-b687-a54a41c32f36,10,Normal (no evidence of prostate cancer) [cM0],1,0.090501,[Not Available],cf70909e-5143-47ae-b8ca-c3ae6ace7be2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,24,,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.13333333333,TCGA-G9-7521,0:DiseaseFree,4,23,Prostate Adenocarcinoma,30.95,5/31/12,942,,,,,YES,C61,b0a188e3-c084-4e2d-93dd-31de3a3f47e6,,16,TUMOR FREE,0.189,0:LIVING,0.06,5,30.95,Bilateral,30,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-G9-7521.b0a188e3-c084-4e2d-93dd-31de3a3f47e6.pdf,,[Not Applicable],YES,13,41-50%,9,Prostate Adenocarcinoma Acinar Type,1,2010,[Discrepancy],,NO,No,R0,0.8,52,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,8,No,YES,0,N1,T3a,1,M0,C61.9,8550/3,83341,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-49-6743,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,2.96,0.27,11,10,12,,,1621,,1621,1621,,0,0,1621,1621,,Malignant,33,,35,,,,21545,,,1621,1621,,,,1621,1621,,,1621,,,,,,,,TUMOR FREE,Alive,-29807,,,,991,,1621,1621,,,[Not Available],[Not Applicable],,,,,0.08,,,,,21,,1,0.26935,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6743,,,,,,,1621,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,83345,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,"G527V, G527C",1,,,"G527V, G527C",15.89322553,17.46493985,16.01451465,-0.289411461,LUAD,Adenocarcinoma,17.7192686,15.86975845,Adenocarcinoma,,13.79242264,-0.0511,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.59,0.61,22,31,31,,,10,BRCA_Basal,10,10,,0,0,10,10,,Invasive Carcinoma,84,,99,,,,25075,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-20052,,,,175,,10,10,,,[Not Available],[Not Applicable],,,,,0.32,Breast,Resection/Excision,,,9,,2,0.43109,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0XU,,,,,,,10,,,,,,,,,67,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,83346,TRUE,0.888452768,0,0,0,0,0.2083,1,,,Infiltrating Ductal Carcinoma,0.157662685,,0.028348849,0,0,0,,Negative,0.817,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1668,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-66-2793,,LUSC,,0,0,,Indivumed,,2,MALE,2,3.44,0.85,14,20,23,,,306,,,306,,2,2,306,306,,Malignant,57,,224,,,,19947,,,306,306,,,,,306,,,306,,,,,,,,TUMOR FREE,Dead,-25111,306,,,416,,306,306,,,[Not Available],[Not Applicable],,,,,0.23,,,,,24,,1,0.38924,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2793,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2008,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,83349,,0.262469877,,,,,,,,,,0.057143494,,-0.010904604,,,,Stage IIIB,,-1.0345,,,,,,,,,,,,,,,,-0.1778,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.58681802,14.06167024,13.58136327,-0.872524815554548,LUSC,Squamous Cell Carcinoma,17.24960058,14.93868713,Squamous Cell Carcinoma,-1.981,13.66411229,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-BR-6456,White,STAD,,0,0,,,2,2,,2,3.56,0.3,14,16,13,,,526,,526,526,,2,2,526,526,,Malignant,43,,77,,,,16745,,,526,526,,,,526,526,,,526,,,,,,,,TUMOR FREE,Dead,-27288,526,,,54,,526,526,,,[Not Available],[Not Applicable],,,,,0.15,Stomach,Unknown,,,20,,1,0.30704,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-6456,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,83359,,0.371659253,,,,,,,,,,0.131622571,Grade 2,0.150672501,,,,Stage IIB,,0.4205,,,,,,,,,,,,,,,,0.7137,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6456,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,Female,TCGA-MP-A4TK,Unknown,LUAD,,1,1,,Washington University - Mayo Clinic,1,1,FEMALE,1,2.63,0.34,21,17,23,,,582,,397,582,,1,1,397,397,,Malignant,61,,172,,,,16665,,,397,397,,,,397,582,,,397,,,,,,,,WITH TUMOR,Dead,-20581,582,,,466,,397,397,,,[Not Available],[Not Applicable],,,,,0.4,,,,,15,,1,0.40137,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TK,,,,,,,,,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,2002,397,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,83364,,1.191119987,,,,,,,,,,0.308513161,,0.181943864,,,,Stage IIB,,1.0405,,,,,,,,,,,,,,,,0.9614,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12V (driver), AMP (driver)",,1,,G12V (driver),,16.68540578,17.9941578,15.57703734,-0.171133406,LUAD,Adenocarcinoma,18.19557372,16.25956663,Adenocarcinoma,1.3248,13.89907086,-0.0562,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-FC-A5OB,,PRAD,308,0,0,,FC,,0,MALE,0,1.97,0.86,3,7,1,HRP,NO,680,8-other,,680,,0,0,680,680,prad_tcga,Malignant,11,,42,26.9,TCGA-FC-A5OB-01,0,5344,0,TCGA-FC-A5OB,680,680,Prostate Cancer,,110,,680,TCGA,,680,Primary,0,Middle|Base,A,,,True,WITH TUMOR,Alive,-19413,,53,9,33,PRAD,680,680,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.0,Prostate,Resection,4,1E8F6337-5129-4F23-ABE7-F158028E434A,0,Abnormal (not related to prostate cancer),0,0.03628,[Not Available],F7238E82-A394-4A7C-8514-6241D0AA17E3,5,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,FC,1.13333333333,TCGA-FC-A5OB,0:DiseaseFree,5,11,Prostate Adenocarcinoma,22.34,7/12/13,680,,,,,NO,C61,E54208A5-C6DA-450A-AA5D-9A8FE5F6ECD6,210,1,WITH TUMOR,0.0326,0:LIVING,5.22,,22.34,Bilateral,13,No Evidence of Extraprostatic Extension,9,YES,162,2012,,,TCGA-FC-A5OB.E54208A5-C6DA-450A-AA5D-9A8FE5F6ECD6.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,9,81-90%,9,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,NO,No,R1,,53,Core needle biopsy,,,YES,NO,YES,NO,T3b,,9,No,,0,N0,T3a,0,M0,C61.9,8140/3,83368,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-77-8139,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,3.53,0.3,8,5,13,,,3166,,3166,3166,,0,0,3166,3166,,Malignant,26,,21,,,,19662,,,3166,3166,,,,3166,3166,,,3166,,,,,,,,TUMOR FREE,Alive,-26464,,,,264,,3166,3166,,,[Not Available],[Not Applicable],,,,,0.16,,,,,21,,1,0.24748,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8139,,,,,,,3166,,,,,,,,,28,,,,,,,,,,,,,2003,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,83379,,0.345407782,,,,,,,,,,0.151059499,,0.063698801,,,,Stage IIB,,0.4225,,,,,,,,,,,,,,,,0.694,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.52363408,15.45901463,15.21177795,-0.520028236558231,LUSC,Squamous Cell Carcinoma,17.7647133,15.77092078,Squamous Cell Carcinoma,0.4213,12.14735051,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Female,TCGA-44-2659,White,LUAD,,1,1,,Christiana Healthcare,1,0,FEMALE,1,3.57,0.42,7,2,8,,,1367,,1146,1367,,1,1,1146,1146,,Malignant,17,,18,,,,19153,,,1146,1146,,,,1146,1367,,,1146,,,,,,,,TUMOR FREE,Alive,-23808,,,,553,,1146,1146,,,[Not Available],[Not Applicable],,,,,0.31,,,,,22,,1,0.19939,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-2659,,,,,,,1367,,Locoregional Recurrence,,,,,,,34,,,,,,,,,,,,,2009,1146,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,83382,,1.26004491,,,,,,,,,,0.223336207,,0.203332426,,,,Stage IIB,,0.973,,,,,,,,,,,,,,,,0.2122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.80964324,16.57878032,16.05039826,0.00343514,LUAD,,18.23875242,16.54514281,Adenocarcinoma,0.3618,13.28909509,1.0652,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-64-5815,White,LUAD,,0,0,,Fox Chase,0,0,MALE,0,1.99,0.35,10,9,12,,,866,,866,866,,0,0,866,866,,Malignant,31,,20,,,,19389,,,866,866,,,,866,866,,,866,,,,,,,,TUMOR FREE,Alive,-27280,,,,229,,866,866,,,[Not Available],[Not Applicable],,,,,0.14,,,,,8,,0,0.19926,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-5815,,,,,,,866,,,,,,,,,9,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,83384,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,Q61L (driver),,1,,Q61L (driver),,17.08747381,18.46367687,14.73908336,-0.195918596,LUAD,Adenocarcinoma,18.38789031,15.49084422,Adenocarcinoma,2.1892,14.42737605,-0.5481,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Male,TCGA-CD-A489,Asian,STAD,,1,1,,,1,1,,1,1.66,0.47,16,8,11,,,344,,277,344,,1,1,277,277,,Malignant,35,,140,,,,22260,,,277,277,,,,277,344,,,277,,,,,,,,WITH TUMOR,Dead,-21517,344,,,103,,277,277,,,[Not Available],[Not Applicable],,,,,0.23,Stomach,Unknown,,,10,,0,0.40589,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-A489,,,,,,,,,Locoregional Recurrence,,,,,,,12,,,,,,,,,,,,,2011,277,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,83389,,-0.071354446,,,,,,,,,,0.055320071,Grade 3,0.134305684,,,,Stage IIA,,-0.3305,,,,,,,,,,,,,,,,0.4436,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A489,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,,,,,,,,3669,,,3669,,1,1,3669,3669,,Invasive Carcinoma,,,,,,,24862,0,,3669,3669,,,,,3669,,,3669,,,,,,,,WITH TUMOR,Dead,-21933,3669,,,0,,3669,3669,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2000,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,83393,,1.46809707,0,0,0,0,-0.0978,0,,,Infiltrating Ductal Carcinoma,0.198217876,,0.198252937,0,0,0,,[Not Available],0.7895,,10/21/22,0,0,0,0,0,0,0,0,0,1,No,0,0,0.502,1,0,H & E,0,0,,0,David Jou,"Apocrine Metaplasia, Columnar Lesion, Sclerosing Adenosis",0,1,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Micropapillary, Intermediate Grade), DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Micropapillary, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Apocrine Metaplasia, Columnar Lesion, Sclerosing Adenosis",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-A9SX,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,1.98,0.5,6,6,8,,,719,,,719,,1.0,1,475.0,475.0,,Malignant,20,,55,,,,16494.0,,,475.0,475,,,,,719,,,475.0,,,,,,,,WITH TUMOR,Dead,-23349,719,,,145.0,,475.0,475,,,[Not Available],[Not Applicable],,,,,0.24,,,,,4,,0,0.10194,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SX,,,,,,,,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2006,475,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,63.0,,,,,,,,,,,,,,,,,,,,83395,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.71,2,4,1,,,620,BRCA_LumA,620,620,,0,0,620,620,,Invasive Carcinoma,7,,10,,,,28967,0,,620,620,,,,620,620,,,620,,,,,,,,TUMOR FREE,Alive,-28644,,,,37,,620,620,,,[Not Available],[Not Applicable],,,,,0.28,Breast,Resection/Excision,,,2,,0,0.041024,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HI,,,,,,,620,,,,,,,,,2,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,83396,,-0.128585216,0,0,0,0,0.9484,1,,,Infiltrating Ductal Carcinoma,0.175132117,,0.223192531,0,0,0,,Negative,-0.6485,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3984,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-05-4426,,LUAD,,1,,,Indivumed,1,0,MALE,1,1.99,0.7,5,4,5,,,791,,457,791,,1,,457,457,,Malignant,14,,15,,,,24882,,,457,,,,,457,791,,,457,,,,,,,,TUMOR FREE,Alive,-26084,,,,59,,457,,,,[Not Available],[Not Applicable],,,,,0.08,,,,,4,,0,0.10905,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4426,,,,,,,791,,,,,,,,,6,,,,,,,,,,,,,2008,457,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,83404,,0.318047384,,,,,,,,,,0.237501307,,0.074623151,,,,Stage IB,,1.632,,,,,,,,,,,,,,,,0.2166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.463436274,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2277,,-0.8246,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Female,TCGA-67-6217,White,LUAD,,1,,,St Joseph's Medical Center (MD),,0,FEMALE,1,6.17,0.25,6,14,15,,,422,,,422,,1,,296,296,,Malignant,35,,27,,,,18782,,,296,,,,,,422,,,296,,,,,,,,WITH TUMOR,Alive,-26920,,,,242,,296,,,,[Not Available],[Not Applicable],,,,,0.32,,,,,19,,2,0.17885,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-6217,,,,,,,422,,,,,,,,,46,,,,,,,,,,,,,2010,296,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,83405,,1.257989246,,,,,,,,,,0.234570352,,0.123644196,,,,Stage IIA,,1.038,,,,,,,,,,,,,,,,-0.023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,16.03872298,16.83014413,15.84509352,-0.076055649,LUAD,Adenocarcinoma,18.41561681,16.13933566,Adenocarcinoma,-0.3699,12.74137659,0.8025,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-49-6745,White,LUAD,,0,0,,Johns Hopkins,,0,MALE,0,3.83,0.24,4,3,4,,,522,,,522,,0,0,522,522,,Malignant,11,,15,,,,24410,,,522,522,,,,,522,,,522,,,,,,,,TUMOR FREE,Alive,-30133,,,,158,,522,522,,,[Not Available],[Not Applicable],,,,,0.33,,,,,9,,1,0.12048,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6745,,,,,,,522,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,83406,,1.289445859,,,,,,,,,,0.271651431,,0.182043682,,,,Stage IIIA,,2.435,,,,,,,,,,,,,,,,0.5605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,16.54620904,17.9432589,17.24792879,0.037185585,LUAD,Adenocarcinoma,18.32630782,16.40113647,Adenocarcinoma,,13.66230496,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-49-6745,White,LUAD,,0,0,,Johns Hopkins,,0,MALE,0,3.83,0.24,4,3,4,,,522,,,522,,0,0,522,522,,Malignant,11,,15,,,,24410,,,522,522,,,,,522,,,522,,,,,,,,TUMOR FREE,Alive,-30133,,,,158,,522,522,,,[Not Available],[Not Applicable],,,,,0.33,,,,,9,,1,0.12048,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6745,,,,,,,522,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,83407,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,16.54620904,17.9432589,17.24792879,0.037185585,LUAD,Adenocarcinoma,18.32630782,16.40113647,Adenocarcinoma,,13.66230496,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-G2-AA3B,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.82,0.84,24,22,19,,,2008,,2008,2008,,0.0,0,2008.0,2008.0,,Malignant,65,,339,,,,16845.0,,,2008.0,2008,,,,2008,2008,,,2008.0,,,,,,,,TUMOR FREE,Alive,-27646,,,,963.0,,2008.0,2008,,,[Not Available],[Not Applicable],,,,,0.71,,,,,7,,0,0.45452,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3B,,,,,,,2008,,,,,,,,,22,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,83409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3SJ,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.4,0.46,12,23,20,,,739,,,739,,1.0,1,281.0,281.0,,Malignant,55,,101,,,,18240.0,,,281.0,281,,,,,739,,,281.0,,,,,,,,WITH TUMOR,Dead,-21615,739,,,339.0,,281.0,281,,,[Not Available],[Not Applicable],,,,,0.21,,,,,14,,1,0.23357,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SJ,,,,,,,,Lymph Node Only,Distant Metastasis,,,,,,,31,,,,,,,,,,,,,2010,281,,,,Stage IV,,,,,,,,[Not Applicable],,,,,,59.0,,,,,,,,,,,,,,,,,,,,83411,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-G2-A2EC,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,,,,,,,,696,,,696,,1.0,1,679.0,679.0,,Malignant,,,,,,,19026.0,,,679.0,679,,,,,696,,,679.0,,,,,,,,WITH TUMOR,Dead,-21215,696,,,244.0,,679.0,679,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,679,small bowel,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,83417,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-A62T,Black or African American,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,3.8,0.51,4,5,13,,,440,,440,440,,0,0,440,440,,Malignant,22,,152,,,,29647,,,440,440,,,,440,440,,,440,,,,,,,,TUMOR FREE,Alive,-28522,,,,660,,440,440,,,[Not Available],[Not Applicable],,,,,0.09,,,,,20,,2,0.42142,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-A62T,,,,,,,440,,,,,,,,,54,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,83423,,-0.059401391,,,,,,,,,,0.160876948,,0.004668296,,,,Stage IIA,,0.009,,,,,,,,,,,,,,,,0.6946,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,E493V,1,,,E493V,15.79494252,15.65271795,14.31704448,-0.747181860306848,LUSC,Squamous Cell Carcinoma,17.56684125,14.56838337,Squamous Cell Carcinoma,0.5833,14.05614531,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-YL-A9WL,,PRAD,,1,1,,YL,1,0,MALE,1,1.87,0.94,8,10,5,ambiguous,NO,740,,740,740,,1,1,740,740,prad_tcga,Malignant,23,BRCA2;CHEK2;RAD54L,88,,TCGA-YL-A9WL-01,0,5695,0,TCGA-YL-A9WL,740,740,Prostate Cancer,,740,740,740,TCGA,,740,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-21626,,59,9,35,PRAD,740,740,,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.11,Prostate,Resection,4,0EAB8AB8-59C3-4853-9296-94A9B9D07006,1,Normal (no evidence of prostate cancer) [cM0],0,0.14033,[Not Available],CFCF057A-00FE-4603-A720-586712B75803,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.1,TCGA-YL-A9WL,1:Recurred/Progressed,5,39,Prostate Adenocarcinoma,24.31,4/12/14,740,,Biochemical evidence of disease,,,NO,C61,F309E64F-E31C-478A-9F2B-B33AAD6BE37A,1300,3,WITH TUMOR,0.1404,0:LIVING,6.4,3,24.31,Bilateral,41,No Evidence of Extraprostatic Extension,39,YES,755,2011,740,,TCGA-YL-A9WL.F309E64F-E31C-478A-9F2B-B33AAD6BE37A.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,28,,15,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,,59,Core needle biopsy,740,Complete Remission/Response,NO,YES,YES,YES,T3a,YES,9,No,YES,0,N0,T2a,0,M0,C61.9,8140/3,83425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-46-6025,White,LUSC,,0,0,,St. Joseph's Medical Center (MD),0,0,MALE,0,2.83,0.54,17,33,23,,,324,,324,324,,0,0,324,324,,Malignant,73,,98,,,,20562,,,324,324,,,,324,324,,,324,,,,,,,,TUMOR FREE,Alive,-26168,,,,277,,324,324,,,[Not Available],[Not Applicable],,,,,0.31,,,,,18,,1,0.60077,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,St. Joseph's Medical Center (MD),,TCGA-46-6025,,,,,,,324,,,,,,,,,38,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,83429,,-0.166225749,,,,,,,,,,0.146444945,,0.038465585,,,,Stage IIB,,1.208,,,,,,,,,,,,,,,,0.7005,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,Q75* (driver),1,,,Q75* (driver),14.9496512,16.20925524,16.43133369,-0.419003695614898,LUSC,Squamous Cell Carcinoma,17.66408401,14.87138388,Squamous Cell Carcinoma,-0.0473,12.63437035,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,1.97,0.52,4,2,7,,,6593,BRCA_LumA,3014,6593,,1,1,3014,3014,,Invasive Carcinoma,13,,19,,,,22178,0,,3014,3014,,,,3014,6593,,,3014,,,,,,,,WITH TUMOR,Dead,-16854,6593,,,49,,3014,3014,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,4,,0,0.097289,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DA,,,,,,,,Bone,Distant Metastasis,,,,,,,6,,,,,,,,,,,,,1993,3014,,,,Stage IIB,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,83430,,0.935849857,0,0,0,0,0.8262,0,,,Infiltrating Ductal Carcinoma,0.15728557,,0.253427033,0,0,0,,Negative,0.4875,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4498,1,0,H & E,0,0,,0,Chunhui Yi,Microglandular Adenosis,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,1,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Microglandular Adenosis,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.1,0.61,4,1,5,,,752,BRCA_LumA,752,752,,0,0,752,752,,Invasive Carcinoma,10,,17,,,,20431,0,,752,752,,,,752,752,,,752,,,,,,,,TUMOR FREE,Alive,-16858,,,,47,,752,752,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,5,,0,0.041101,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EX,,,,,,,752,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,83431,,0.168491775,0,0,0,0,0.369,1,,,Infiltrating Lobular Carcinoma,0.137139786,,0.208826881,0,0,0,,Negative,-0.949,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4232,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,1.99,0.69,3,0,4,,,4159,BRCA_LumA,1364,4159,,1,1,1364,1364,,Invasive Carcinoma,7,,7,,,,29123,0,,1364,1364,,,,1364,4159,,,1364,,,,,,,,TUMOR FREE,Alive,-22094,,,,38,,1364,1364,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,4,,0,0.053199,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CK,,,,,,,4159,"Other, specify",New Primary Tumor,,,,,,,4,,,,,,,,,,,,,2001,1364,LEFT BREAST,,,Stage IIIA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,83432,,0.135254866,0,0,0,0,0.2416,1,,,Infiltrating Lobular Carcinoma,0.118546703,,0.210064613,0,0,0,,Negative,-0.4415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2419,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.01,0.24,2,4,7,,,2721,BRCA_Basal,,2721,,0,0,2721,2721,,Invasive Carcinoma,13,,6,,,,20381,0,,2721,2721,,,,,2721,,,2721,,,,,,,,TUMOR FREE,Alive,-14374,,,,68,,2721,2721,,,[Not Available],[Not Applicable],,,,,0.41,Breast,Resection/Excision,,,2,,0,0.05586,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RT,,,,,,,2721,,,,,,,,,3,,,,,,,,,,,,,1996,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,83436,,2.433955082,0,0,0,0,-0.4945,1,,,Infiltrating Ductal Carcinoma,0.181542995,,0.176106947,0,0,0,,Close,2.131,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.121,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-51-4080,Black or African American,LUSC,,0,0,,UNC,,2,MALE,2,2.03,0.96,7,7,7,,,12,,,12,,2,2,12,12,,Malignant,21,,21,,,,21367,,,12,12,,,,,12,,,12,,,,,,,,TUMOR FREE,Dead,-24054,12,,,380,,12,12,,,[Not Available],[Not Applicable],,,,,0.14,,,,,10,,0,0.19854,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,UNC,,TCGA-51-4080,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,2009,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,83440,,-0.616348311,,,,,,,,,,0.142149482,,0.033460639,,,,Stage IIIB,,-0.0205,,,,,,,,,,,,,,,,-0.3028,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,15.00000854,14.75181851,14.03739175,-0.619583462408322,LUSC,,18.0064329,14.57021606,Squamous Cell Carcinoma,-0.9627,13.85685671,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-CD-A487,Asian,STAD,,0,0,,,0,0,,0,2.49,0.42,7,17,13,,,374,,374,374,,0,0,374,374,,Malignant,37,,144,,,,28745,,,374,374,,,,374,374,,,374,,,,,,,,TUMOR FREE,Alive,-18694,,,,217,,374,374,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,13,,1,0.26199,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-A487,,,,,,,374,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,83447,,-0.475487878,,,,,,,,,,0.067923674,Grade 3,0.077835235,,,,Stage IIB,,-0.8375,,,,,,,,,,,,,,,,0.2831,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A487,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Male,TCGA-G9-6354,,PRAD,,0,0,,G9,0,0,MALE,0,1.94,0.61,2,2,2,HRP,NO,2066,,2066,2066,,0,0,2066,2066,prad_tcga,Malignant,6,,46,,TCGA-G9-6354-01,0,5360,0,TCGA-G9-6354,2066,2066,Prostate Cancer,,525,2066,2066,TCGA,,2066,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-20403,,55,7,39,PRAD,2066,2066,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.02,Prostate,Resection,3,cb123fb8-700c-4bc9-bc5a-e1816f19f64d,3,,0,0.060809,[Not Available],6bbbe263-3632-4567-912c-95bc9940a1dd,4,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.1,G9,0.966666666667,TCGA-G9-6354,0:DiseaseFree,2,8,Prostate Adenocarcinoma,67.87,10/29/13,2066,,,,,NO,C61,CFFC4C63-D738-41CD-8EE3-25C190A9638C,,3,TUMOR FREE,0.0579,0:LIVING,0.03,,67.87,Right,10,,,YES,,2009,,,TCGA-G9-6354.CFFC4C63-D738-41CD-8EE3-25C190A9638C.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.1,55,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2b,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,83448,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-CD-5798,Asian,STAD,,0,0,,,0,0,,0,2.02,0.19,0,1,3,,,408,,408,408,,0,0,408,408,,Malignant,4,,10,,,,29988,,,408,408,,,,408,408,,,408,,,,,,,,TUMOR FREE,Alive,-30310,,,,121,,408,408,,,[Not Available],[Not Applicable],,,,,0.12,Stomach,Unknown,,,1,,0,0.0063575,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G2,,ILSBio,,TCGA-CD-5798,,,,,,,408,,,,,,,,,2,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,82,,,,,,,,,,,,,,,,,,,,83449,,-0.458803325,,,,,,,,,,0.130667149,Grade 2,0.148520316,,,,Stage II,,-0.383,,,,,,,,,,,,,,,,0.758,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-5798,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,4.49,0.56,3,6,16,,,566,BRCA_Basal,559,566,,1,1,559,559,,Invasive Carcinoma,25,,34,,,,19424,0,,559,559,,,,559,566,,,559,,,,,,,,WITH TUMOR,Alive,-14448,,,,101,,559,559,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,21,,2,0.23663,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YJ,,,,,,,566,"Other, specify",Distant Metastasis,,,,,,,60,,,,,,,,,,,,,2010,559,Left Cervical Lymph Node,,,Stage IIIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,83450,,-0.995842415,0,0,0,0,1.3011,1,,,Infiltrating Ductal Carcinoma,0.150442817,,0.024940858,0,0,0,,Negative,-1.1045,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.0762,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-CD-5813,Asian,STAD,,1,1,,,1,1,,1,,,,,,,,377,,315,377,,1,1,315,315,,Malignant,,,,,,,22091,,,315,315,,,,315,377,,,315,,,,,,,,WITH TUMOR,Dead,-21995,377,,,232,,315,315,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,ILSBio,,TCGA-CD-5813,,,,,,,,Liver,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,315,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,83451,,1.15927765,,,,,,,,,,0.132985408,Grade 3,0.262626818,,,,Stage II,,1.014,,,,,,,,,,,,,,,,0.5749,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-5813,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.04,0.46,18,28,26,,,441,BRCA_Basal,441,441,,0,0,441,441,,Invasive Carcinoma,72,,88,,,,20485,0,,441,441,,,,441,441,,,441,,,,,,,,TUMOR FREE,Alive,-20092,,,,1541,,441,441,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,12,,1,0.47453,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XK,,,,,,,441,,,,,,,,,27,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,83455,TRUE,0.873715467,0,0,0,0,-0.1394,1,,,Infiltrating Ductal Carcinoma,0.211553625,,0.020567976,0,0,0,,Negative,1.0685,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0066,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.46,0.64,4,9,10,,,350,BRCA_LumB,350,350,,0,0,350,350,,Invasive Carcinoma,23,,20,,,,23289,0,,350,350,,,,350,350,,,350,,,,,,,,TUMOR FREE,Alive,-25230,,,,73,,350,350,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,21,,1,0.085244,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A1KS,,,,,,,350,,,,,,,,,20,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,83456,,0.496439366,0,0,0,0,-1.1853,1,,,Infiltrating Lobular Carcinoma,0.143388077,,0.145508702,0,0,0,,Negative,-1.101,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,-0.1516,1,0,H & E,0,0,,0,David Jou,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-8570,White,STAD,,0,0,,,0,0,,0,2.14,0.32,9,15,14,,,752,,752,752,,0,0,752,752,,Malignant,38,,65,,,,22100,,,752,752,,,,752,752,,,752,,,,,,,,WITH TUMOR,Alive,-16150,,,,160,,752,752,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,8,,0,0.15971,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8570,,,,,,,752,,,,,,,,,13,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,44,,,,,,,,,,,,,,,,,,,,83457,,,,,,,,,,,,,Grade 3,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8570,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,1,0,1,1,Male,TCGA-86-8669,White,LUAD,,1,1,,Asterand,1,0,MALE,1,3.66,0.57,6,15,18,,,938,,849,938,,1,1,849,849,,Malignant,39,,54,,,,23803,,,849,849,,,,849,938,,,849,,,,,,,,TUMOR FREE,Alive,-23443,,,,269,,849,849,,,[Not Available],[Not Applicable],,,,,0.52,,,,,18,,1,0.1566,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8669,,,,,,,938,,Distant Metastasis,,,,,,,24,,,,,,,,,,,,,2012,849,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,83460,,0.844555694,,,,,,,,,,0.220572044,,0.138579262,,,,Stage IA,,1.0315,,,,,,,,,,,,,,,,-0.184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.275385158,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.3298,,-0.1357,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.32,0.61,23,24,30,,,2246,BRCA_Basal,2246,2246,,0,0,2246,2246,,Invasive Carcinoma,77,,103,,,,31735,0,,2246,2246,,,,2246,2246,,,2246,,,,,,,,TUMOR FREE,Alive,-22707,,,,140,,2246,2246,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,13,,1,0.54788,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04T,,,,,,,2246,,,,,,,,,36,,,,,,,,,,,,,2004,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,83465,,1.359409162,0,0,0,0,-0.1766,1,,,Infiltrating Ductal Carcinoma,0.171626329,,0.050389425,0,0,0,,Negative,0.9235,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0332,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Medullary), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Medullary), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-39-5035,White,LUSC,,0,0,,MSKCC,0,0,FEMALE,0,3.45,0.44,4,9,13,,,2080,,2080,2080,,0,0,2080,2080,,Malignant,26,,40,,,,17419,,,2080,2080,,,,2080,2080,,,2080,,,,,,,,TUMOR FREE,Alive,-26383,,,,199,,2080,2080,,,[Not Available],[Not Applicable],,,,,0.07,,,,,15,,1,0.25708,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5035,,,,,,,2080,,,,,,,,,26,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,83467,,1.273226981,,,,,,,,,,0.207015738,,0.060756164,,,,Stage IA,,2.677,,,,,,,,,,,,,,,,0.1789,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.244887318474313,LUSC,,,,Squamous Cell Carcinoma,-0.0409,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-L5-A4OW,Unknown,ESCA,,0,0,,,2,2,,2,2.74,0.53,9,12,14,,,217,,217,217,,2,2,217,217,,Malignant,35,,137,,,,16716,,,217,217,,,,217,217,,,217,,,,,,,,TUMOR FREE,Dead,-20796,217,,,390,,217,217,,,[Not Available],[Not Available],,,,,0.56,Esophagus,Unknown,,,14,,1,0.34501,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A4OW,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,83469,,,,,,,,,,,,,Unknown,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-EJ-5522,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.49,1,0,1,HRP,NO,2079,1-ERG,2079,2079,,0,0,2079,2079,prad_tcga,Malignant,2,,33,5.6,TCGA-EJ-5522-01,0,5285,0,TCGA-EJ-5522,2079,2079,Prostate Cancer,,1403,2079,2079,TCGA,,2079,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-18802,,51,7,29,PRAD,2079,2079,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,8ac1e1e7-8266-48e0-8d4c-d78873111341,0,,0,0.025505,[Not Available],214884ef-a932-4fc3-b6ff-16ce5164da3e,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.766666666667,TCGA-EJ-5522,0:DiseaseFree,2,2,Prostate Adenocarcinoma,68.3,4/3/12,2079,,,,,NO,C61,756659d2-5e97-40d4-aa4e-c6d777153d0c,,1,TUMOR FREE,0.0245,0:LIVING,0.1,3,68.3,Bilateral,2,,,YES,,2008,,,TCGA-EJ-5522.756659d2-5e97-40d4-aa4e-c6d777153d0c.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,61-70%,22,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.9,51,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,83470,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-39-5024,White,LUSC,,0,0,,MSKCC,0,0,FEMALE,0,2.13,0.32,7,8,11,,,2510,,2510,2510,,0,0,2510,2510,,Malignant,26,,25,,,,18528,,,2510,2510,,,,2510,2510,,,2510,,,,,,,,TUMOR FREE,Alive,-23975,,,,274,,2510,2510,,,[Not Available],[Not Applicable],,,,,0.3,,,,,4,,0,0.2695,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5024,,,,,,,2510,,,,,,,,,22,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,83471,,0.692998153,,,,,,,,,,0.151971718,,0.062862262,,,,Stage IIIA,,0.379,,,,,,,,,,,,,,,,0.3402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.98401704,14.49055312,15.1342112,-0.35434934266954,LUSC,Squamous Cell Carcinoma,18.06913181,15.63022852,Squamous Cell Carcinoma,-0.6002,12.84562017,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7792,White,PRAD,184,0,0,,EJ,0,0,MALE,0,2.03,0.4,1,2,2,HRP,NO,1396,8-other,1396,1396,,0,0,1396,1396,prad_tcga,Malignant,5,,6,4.6,TCGA-EJ-7792-01,0,5328,0,TCGA-EJ-7792,1396,1396,Prostate Cancer,,526,1396,1396,TCGA,,1396,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-19454,,53,7,22,PRAD,1396,1396,WHITE,0.0,[Not Available],[Not Applicable],19,R0,1,Matched,0.01,Prostate,Resection,3,c6843072-01b3-445f-a093-43b97c967dd9,0,,0,0.010025,[Not Available],28689d40-03e5-4e17-aba1-f2d571535eed,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.2,TCGA-EJ-7792,0:DiseaseFree,2,7,Prostate Adenocarcinoma,45.86,4/9/12,1396,,,,,NO,C61,607fd612-7ab9-475b-8c22-fd7cdbaccb37,,0,TUMOR FREE,0.0252,0:LIVING,0.13,4,45.86,Bilateral,9,,,YES,,2010,,,TCGA-EJ-7792.607fd612-7ab9-475b-8c22-fd7cdbaccb37.pdf,,[Not Applicable],NO,,31-40%,35,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.3,53,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,83473,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,,BRCA,,1,,,,,1,FEMALE,1,2.23,0.78,3,3,6,,,3409,BRCA_LumA,,3409,,1,,2557,2557,,Invasive Carcinoma,12,,14,,,,18842,0,,2557,,,,,,3409,,,2557,,,,,,,,WITH TUMOR,Dead,-23560,3409,,,80,,2557,,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,8,,0,0.084394,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08T,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,2002,2557,,,,Stage IV,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,83474,,0.004638806,0,0,0,0,-0.0566,1,,,Infiltrating Ductal Carcinoma,0.152919204,,0.112730507,0,0,0,,Positive,-0.563,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.2033,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.95,0.5,12,3,9,,,373,BRCA_LumA,373,373,,0,0,373,373,,Invasive Carcinoma,24,,62,,,,26631,0,,373,373,,,,373,373,,,373,,,,,,,,TUMOR FREE,Alive,-17969,,,,86,,373,373,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.14868,Peri (6-12 months since last menstrual period),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A6IX,,,,,,,373,,,,,,,,,9,,,,,,,,,,,,,2013,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,83475,,0.592919756,0,0,0,0,0.5379,1,,,Infiltrating Lobular Carcinoma,0.15479062,,0.25238034,0,0,0,,Negative,-0.1495,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4435,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-49-6745,White,LUAD,,0,0,,Johns Hopkins,,0,MALE,0,3.83,0.24,4,3,4,,,522,,,522,,0,0,522,522,,Malignant,11,,15,,,,24410,,,522,522,,,,,522,,,522,,,,,,,,TUMOR FREE,Alive,-30133,,,,158,,522,522,,,[Not Available],[Not Applicable],,,,,0.33,,,,,9,,1,0.12048,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6745,,,,,,,522,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,83484,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,16.54620904,17.9432589,17.24792879,0.037185585,LUAD,Adenocarcinoma,18.32630782,16.40113647,Adenocarcinoma,,13.66230496,0.9987,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.59,4,8,6,,,1686,BRCA_Her2,1686,1686,,0,0,1686,1686,,Invasive Carcinoma,18,,50,,,,22528,0,,1686,1686,,,,1686,1686,,,1686,,,,,,,,TUMOR FREE,Alive,-12642,,,,61,,1686,1686,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,7,,0,0.1783,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04X,,,,,,,1686,,,,,,,,,7,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,83487,,1.371938768,0,0,0,0,-0.9113,1,,,Infiltrating Ductal Carcinoma,0.16272246,,0.153967511,0,0,0,,Negative,1.0035,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,0.0005,1,0,H & E,0,0,,0,David Jou,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Clinging, Intermediate Grade), DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Clinging, Intermediate Grade), DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),1,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.57,0.46,4,1,8,,,795,BRCA_LumB,,795,,0,0,795,795,,Invasive Carcinoma,13,,16,,,,32099,0,,795,795,,,,,795,,,795,,,,,,,,TUMOR FREE,Alive,-22052,,,,36,,795,795,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,18,,1,0.20249,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A202,,,,,,,795,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,83489,,1.092497321,0,0,0,0,-1.7233,1,,,Infiltrating Ductal Carcinoma,0.200573104,,0.136785551,0,0,0,,[Not Available],0.5865,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.3198,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.41,0.88,4,4,5,,,405,BRCA_LumB,405,405,,0,0,405,405,,Invasive Carcinoma,13,,8,,,,19296,0,,405,405,,,,405,405,,,405,,,,,,,,TUMOR FREE,Alive,-25677,,,,47,,405,405,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,17,,0,0.088689,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JT,,,,,,,405,,,,,,,,,13,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,83492,,-1.147255945,0,0,0,0,-1.5962,0,,,Other,0.134609041,,0.066304342,0,0,1,,Negative,-0.716,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3423,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,Papilloma,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-2A-A8W3,,PRAD,389,1,1,,2A,,0,MALE,1,1.97,0.44,3,3,5,HRP,NO,863,2-ETV1,,863,,1,1,198,198,prad_tcga,Malignant,11,,52,,TCGA-2A-A8W3-01,0,5231,0,TCGA-2A-A8W3,198,198,Prostate Cancer,-14,771,,863,TCGA,No Evidence of Extraprostatic Extension,198,Primary,0,Apex|Middle|Base,A,,,True,[Discrepancy],Alive,-25557,,69,9,54,PRAD,198,198,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.01,Prostate,Resection,4,13958347-B417-4EFC-9450-FF58ABE9D7B0,1,Normal (no evidence of prostate cancer) [cM0],0,0.054694,[Not Available],5A790086-4887-4D2B-9C28-0FDD5DD1F1FB,5,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,2A,1.23333333333,TCGA-2A-A8W3,1:Recurred/Progressed,5,11,Prostate Adenocarcinoma,6.5,3/29/14,863,,Biochemical evidence of disease,,,YES,C61,EC74AC3A-610D-46E0-A4DA-1904E42E1EF8,150,2,,0.0776,0:LIVING,0.36,,28.35,Left,12,No Evidence of Extraprostatic Extension,13,YES,882,2011,198,,TCGA-2A-A8W3.EC74AC3A-610D-46E0-A4DA-1904E42E1EF8.pdf,Peripheral Zone,[Not Applicable],YES,13,86-95%,3,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Available],,YES,No,R0,,69,Core needle biopsy,198,,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,83495,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-33-A5GW,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,1.73,0.82,10,13,10,,,9,,9,9,,2,2,9,9,,Malignant,33,,123,,,,21830,,,9,9,,,,9,9,,,9,,,,,,,,TUMOR FREE,Dead,-24586,9,,,266,,9,9,,,[Not Available],[Not Applicable],,,,,0.11,,,,,9,,0,0.38235,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-A5GW,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,83501,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.0019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,12.70910454,13.21871213,12.45301135,-1.15552207918939,LUSC,,17.30889349,14.10816003,Squamous Cell Carcinoma,,13.22355708,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-85-8288,White,LUSC,,0,0,,Asterand,2,2,MALE,2,1.74,0.61,9,3,8,,,402,,402,402,,2,2,402,402,,Malignant,20,,23,,,,18941,,,402,402,,,,402,402,,,402,,,,,,,,TUMOR FREE,Dead,-25629,402,,,326,,402,402,,,[Not Available],[Not Applicable],,,,,0.08,,,,,10,,0,0.33135,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8288,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,83506,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.7075,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.8184056,14.80474133,15.33556043,-0.308345572236283,LUSC,Squamous Cell Carcinoma,18.01962317,16.40918878,Squamous Cell Carcinoma,0.7871,12.99512371,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-97-A4M6,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,0,1.79,0.43,6,5,7,,,568,,568,568,,0,0,568,568,,Malignant,18,,85,,,,28431,,,568,568,,,,568,568,,,568,,,,,,,,TUMOR FREE,Alive,-16764,,,,45,,568,568,,,[Not Available],[Not Applicable],,,,,0.15,,,,,9,,0,0.27136,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4M6,,,,,,,568,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,45,,,,,,,,,,,,,,,,,,,,83508,,1.178255038,,,,,,,,,,0.253056633,,0.136407976,,,,Stage IA,,1.1965,,,,,,,,,,,,,,,,0.1558,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,,,,-0.018156353,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.1331,,-0.0811,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.2,4,5,7,,,2385,BRCA_Basal,2385,2385,,0,0,2385,2385,,Invasive Carcinoma,16,,16,,,,22633,0,,2385,2385,,,,2385,2385,,,2385,,,,,,,,TUMOR FREE,Alive,-17660,,,,77,,2385,2385,,,[Not Available],[Not Applicable],,,,,0.58,Breast,Resection/Excision,,,10,,0,0.41652,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04Q,,,,,,,2385,,,,,,,,,21,,,,,,,,,,,,,2004,,,,,Stage IA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,83510,,2.087824209,0,0,0,0,-0.2994,1,,,Infiltrating Ductal Carcinoma,0.218465266,,0.138377631,0,0,0,,Negative,2.034,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3514,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (No Special Type), Invasive Papillary Carcinoma","Invasive Ductal Carcinoma (No Special Type), Invasive Papillary Carcinoma",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-73-4676,White,LUAD,,1,1,,Roswell Park,,1,MALE,1,1.31,0.77,7,3,10,,,281,,,281,,1,1,281,281,,Malignant,20,,54,,,,22965,,,281,281,,,,,281,,,281,,,,,,,,WITH TUMOR,Dead,-16746,281,,,124,,281,281,,,[Not Available],[Not Applicable],,,,,0.51,,,,,9,,0,0.7565,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4676,,,,,,,,,,,,,,,,22,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Unknown],,,,,,45,,,,,,,,,,,,,,,,,,,,83512,,-0.25296431,,,,,,,,,,0.250713387,,0.174748136,,,,Stage IIA,,0.924,,,,,,,,,,,,,,,,0.0533,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R415C (driver),1,,,R415C (driver),15.95930437,17.27615333,14.25866653,-0.507356871,LUAD,Adenocarcinoma,17.90236714,14.90919589,Adenocarcinoma,-0.1795,13.67554681,-0.0148,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-55-8207,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,3.01,0.57,5,8,10,,,977,,977,977,,0,0,977,977,,Malignant,23,,20,,,,19767,,,977,977,,,,977,977,,,977,,,,,,,,TUMOR FREE,Alive,-26897,,,,412,,977,977,,,[Not Available],[Not Applicable],,,,,0.04,,,,,12,,1,0.26915,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8207,,,,,,,977,,,,,,,,,25,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,83513,,0.547372429,,,,,,,,,,0.313453343,,0.21779839,,,,Stage IB,,0.554,,,,,,,,,,,,,,,,0.6162,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.391004479,LUAD,,,,Adenocarcinoma,0.8351,,-0.0055,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,,,,,,,,879,,361,879,,1,1,361,361,,Invasive Carcinoma,,,,,,,16733,0,,361,361,,,,361,879,,,361,,,,,,,,WITH TUMOR,Dead,-26239,879,,,0,,361,361,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LE,,,,,,,,Lung,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2008,361,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,83514,,0.849982236,0,0,0,0,-0.1076,1,,,Infiltrating Ductal Carcinoma,0.155507281,,0.277545198,0,0,0,,Negative,0.062,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.6788,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.32,0.45,8,10,11,,,820,BRCA_Basal,820,820,,0,0,820,820,,Invasive Carcinoma,29,,90,,,,30282,0,,820,820,,,,820,820,,,820,,,,,,,,TUMOR FREE,Alive,-24353,,,,116,,820,820,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,24,,1,0.26385,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Metaplastic Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A4S1,,,,,,,820,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,83515,,-0.159196881,0,0,0,0,-4.4816,0,,,Metaplastic Carcinoma,0.250614087,,0.242459587,0,0,0,,Negative,-1.631,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,0.8277,1,0,H & E,0,0,,0,David Jou,Sclerosing Adenosis,0,0,1,Suboptimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,Sclerosing Adenosis,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-BR-A452,Asian,STAD,,0,0,,,2,2,,2,1.8,0.62,9,6,10,,,229,,229,229,,2,2,229,229,,Malignant,25,,186,,,,20058,,,229,229,,,,229,229,,,229,,,,,,,,TUMOR FREE,Dead,-21107,229,,,150,,229,229,,,[Not Available],[Not Applicable],,,,,0.6,Stomach,Unknown,,,9,,0,0.30232,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A452,,,,,,,,,,,,,,,,13,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,83520,,-0.179508082,,,,,,,,,,-0.000500149,Grade 3,-0.02504216,,,,Stage IIIA,,1.4095,,,,,,,,,,,,,,,,0.0491,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A452,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.9,0.57,10,6,4,,,371,BRCA_LumA,371,371,,0,0,371,371,,Invasive Carcinoma,20,,36,,,,22725,0,,371,371,,,,371,371,,,371,,,,,,,,TUMOR FREE,Alive,-29529,,,,131,,371,371,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,5,,0,0.14591,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1IW,,,,,,,371,,,,,,,,,5,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,83522,,0.654619515,0,1,0,0,-1.073,0,,,Infiltrating Lobular Carcinoma,0.162598544,,0.176658058,0,0,0,,Negative,-0.153,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.5042,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,"ALH, Columnar Lesion",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"ALH, Columnar Lesion",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-4547,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.91,0.49,12,11,19,,,2419,,2419,2419,,0,0,2419,2419,,Malignant,42,,169,,,,17065,,,2419,2419,,,,2419,2419,,,2419,,,,,,,,TUMOR FREE,Alive,-25056,,,,256,,2419,2419,,,[Not Available],[Not Applicable],,,,,0.02,,,,,12,,0,0.33781,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4547,,,,,,,2419,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,83524,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.7549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.460033798952849,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GC-A3BM,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.38,0.86,7,4,10,,,651,,,651,,1.0,1,651.0,651.0,,Malignant,21,,49,,,,16309.0,,,651.0,651,,,,,651,,,651.0,,,,,,,,WITH TUMOR,Dead,-25609,651,,,178.0,,651.0,651,,,[Not Available],[Not Applicable],,,,,0.45,,,,,24,,1,0.14645,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A3BM,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,70.0,,,,,,,,,,,,,,,,,,,,83525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-55-7995,White,LUAD,,1,1,,International Genomics Consortium,1,0,FEMALE,1,2.53,0.49,15,16,19,,,889,,468,889,,1,1,468,468,,Malignant,50,,115,,,,27896,,,468,468,,,,468,889,,,468,,,,,,,,TUMOR FREE,Alive,-26837,,,,857,,468,468,,,[Not Available],[Not Applicable],,,,,0.17,,,,,20,,1,0.48201,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7995,,,,,,,889,,Locoregional Recurrence,,,,,,,39,,,,,,,,,,,,,2012,468,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,83526,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,0.02100086,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.215,,1.4137,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-50-5939,White,LUAD,,0,0,,University of Pittsburgh,2,2,MALE,2,1.75,0.38,13,10,12,,,460,,460,460,,2,2,460,460,,Malignant,35,,30,,,,18179,,,460,460,,,,460,460,,,460,,,,,,,,TUMOR FREE,Dead,-31236,460,,,109,,460,460,,,[Not Available],[Not Applicable],,,,,0.17,,,,,7,,0,0.2818,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5939,,,,,,,,,,,,,,,,11,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,85,,,,,,,,,,,,,,,,,,,,83527,,0.956501171,,,,,,,,,,0.251840651,,0.186024596,,,,Stage IB,,1.3535,,,,,,,,,,,,,,,,0.6289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,R261P,1,,,R261P,,,,-0.299592239,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2598,,-1.2849,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.8,1,0,3,,,2695,BRCA_LumA,2695,2695,,0,0,2695,2695,,Invasive Carcinoma,4,,4,,,,18132,0,,2695,2695,,,,2695,2695,,,2695,,,,,,,,TUMOR FREE,Alive,-22810,,,,75,,2695,2695,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.078752,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CQ,,,,,,,2695,,,,,,,,,4,,,,,,,,,,,,,2003,,,,,Stage IA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,83530,,-0.917854714,0,0,0,0,0.4137,0,,,Infiltrating Ductal Carcinoma,0.139038915,,0.110053831,0,0,1,,Negative,-0.6705,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0635,1,0,H & E,0,0,,0,Chunhui Yi,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Papilloma,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-68-8250,Black or African American,LUSC,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,3.04,0.44,8,19,18,,,244,,,244,,0,0,244,244,,Malignant,45,,46,,,,24087,,,244,244,,,,,244,,,244,,,,,,,,TUMOR FREE,Alive,-24118,,,,398,,244,244,,,[Not Available],[Not Applicable],,,,,0.2,,,,,15,,1,0.39681,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-68-8250,,,,,,,244,,,,,,,,,34,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,83531,,0.767096931,,,,,,,,,,0.214154069,,0.126053076,,,,Stage IA,,1.244,,,,,,,,,,,,,,,,0.4848,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.306667782247272,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.785,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-97-7941,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,0,1.97,0.36,1,0,2,,,484,,484,484,,0,0,484,484,,Malignant,3,,8,,,,25178,,,484,484,,,,484,484,,,484,,,,,,,,TUMOR FREE,Alive,-26298,,,,115,,484,484,,,[Not Available],[Not Applicable],,,,,0.06,,,,,2,,0,0.040671,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-7941,,,,,,,484,,,,,,,,,1,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,83535,,0.575376821,,,,,,,,,,0.223478116,,0.215773529,,,,Stage IA,,0.272,,,,,,,,,,,,,,,,0.3034,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,,,,-0.341155301,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3488,,-0.1508,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-O2-A5IB,White,LUSC,,1,1,,Washington University - CALGB,,1,FEMALE,1,1.92,0.93,15,15,14,,,340,,,340,,1,1,253,253,,Malignant,44,,79,,,,24691,,,253,253,,,,,340,,,253,,,,,,,,WITH TUMOR,Dead,-26211,340,,,343,,253,253,,,[Not Available],[Not Applicable],,,,,0.05,,,,,9,,0,0.30017,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CALGB,,TCGA-O2-A5IB,,,,,,,,,Distant Metastasis,,,,,,,12,,,,,,,,,,,,,2005,253,,,,Stage III,,,,,,,,[Unknown],,,,,,71,,,,,,,,,,,,,,,,,,,,83539,,,,,,,,,,,,,,,,,,Stage III,,,,,,,,,,,,,,,,,,-0.2365,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.15621674,13.3195248,13.42490849,-0.970004037931396,LUSC,Squamous Cell Carcinoma,17.39119303,14.73963566,Squamous Cell Carcinoma,-1.014,11.78181554,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Male,TCGA-55-7284,White,LUAD,,1,1,,International Genomics Consortium,1,1,MALE,1,2.26,0.4,2,4,5,,,243,,231,243,,1,1,231,231,,Malignant,11,,4,,,,0,,,231,231,,,,231,243,,,231,,,,,,,,WITH TUMOR,Dead,-27087,243,,,52,,231,231,,,[Not Available],[Not Applicable],,,,,0.04,,,,,9,,0,0.016305,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7284,,,,,,,,,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2011,231,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,83540,,0.295527869,,,,,,,,,,0.281873206,,0.226208414,,,,Stage IIB,,0.553,,,,,,,,,,,,,,,,0.3534,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,15.9024359,17.76506808,14.94784163,-0.223767196,LUAD,Adenocarcinoma,17.99171685,15.63475688,Adenocarcinoma,-0.2168,12.65804428,0.0936,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-49-6745,White,LUAD,,0,0,,Johns Hopkins,,0,MALE,0,3.83,0.24,4,3,4,,,522,,,522,,0,0,522,522,,Malignant,11,,15,,,,24410,,,522,522,,,,,522,,,522,,,,,,,,TUMOR FREE,Alive,-30133,,,,158,,522,522,,,[Not Available],[Not Applicable],,,,,0.33,,,,,9,,1,0.12048,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6745,,,,,,,522,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,83548,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,16.54620904,17.9432589,17.24792879,0.037185585,LUAD,Adenocarcinoma,18.32630782,16.40113647,Adenocarcinoma,,13.66230496,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-MP-A4TC,White,LUAD,,0,0,,Washington University - Mayo Clinic,2,2,MALE,2,1.47,0.45,12,1,10,,,74,,74,74,,2,2,74,74,,Malignant,23,,185,,,,33937,,,74,74,,,,74,74,,,74,,,,,,,,TUMOR FREE,Dead,-28471,74,,,354,,74,74,,,[Not Available],[Not Applicable],,,,,0.33,,,,,12,,0,0.63574,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TC,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,83549,,0.834665715,,,,,,,,,,0.259979744,,0.115862021,,,,Stage IIIA,,2.1145,,,,,,,,,,,,,,,,0.7502,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.52715536,16.71470027,17.84727322,0.021732722,LUAD,Adenocarcinoma,18.06752683,16.13171713,Adenocarcinoma,1.1967,13.29049768,0.093,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Male,TCGA-22-1002,White,LUSC,,0,0,,Mayo Clinic - Rochester,,2,MALE,2,1.83,0.38,7,2,6,,,131,,,131,,2,2,131,131,,Malignant,15,,19,,,,17428,,,131,131,,,,,131,,,131,,,,,,,,TUMOR FREE,Dead,-25359,131,,,298,,131,131,,,[Not Available],[Not Applicable],,,,,0.54,,,,,9,,0,0.242,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-1002,,,,,,,131,,,,,,,,,7,,,,,,,,,,,,,2001,,,,,Stage IA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,83553,,0.892309729,,,,,,,,,,0.223291066,,0.245730639,,,,Stage IA,,0.499,,,,,,,,,,,,,,,,0.5817,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.242546710992363,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.2914,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Female,TCGA-66-2734,,LUSC,,0,0,,Indivumed,,0,FEMALE,0,1.75,0.36,5,1,5,,,1311,,,1311,,0,0,1311,1311,,Malignant,11,,11,,,,16225,,,1311,1311,,,,,1311,,,1311,,,,,,,,TUMOR FREE,Alive,-22919,,,,264,,1311,1311,,,[Not Available],[Not Applicable],,,,,0.15,,,,,11,,0,0.31147,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2734,,,,,,,1311,,,,,,,,,11,,,,,,,,,,,,,2005,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,62,,,,,,,,,,,,,,,,,,,,83560,,-0.276621223,,,,,,,,,,0.235208584,,0.101764575,,,,Stage IB,,0.109,,,,,,,,,,,,,,,,0.7848,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.522981725862504,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.9301,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-NC-A5HF,White,LUSC,,1,1,,Washington University - CHUV,,1,MALE,1,1.86,0.75,10,5,12,,,138,,,138,,1,1,132,132,,Malignant,27,,118,,,,29407,,,132,132,,,,,138,,,132,,,,,,,,WITH TUMOR,Dead,-27038,138,,,341,,132,132,,,[Not Available],[Not Applicable],,,,,0.06,,,,,10,,0,0.35831,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HF,,,,,,,,,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2008,132,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,83561,,-0.469292874,,,,,,,,,,0.087975134,,-0.027678547,,,,Stage IIIB,,-0.5675,,,,,,,,,,,,,,,,0.4221,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,12.85648688,14.2738664,12.47303491,-1.2171871218449,LUSC,Squamous Cell Carcinoma,17.84012698,14.01032417,Squamous Cell Carcinoma,-1.3347,13.33235324,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-05-4432,,LUAD,,0,0,,Indivumed,0,0,MALE,0,3.43,0.36,4,10,15,,,761,,761,761,,0,0,761,761,,Malignant,29,,27,,,,21066,,,761,761,,,,761,761,,,761,,,,,,,,TUMOR FREE,Alive,-24350,,,,771,,761,761,,,[Not Available],[Not Applicable],,,,,0.49,,,,,18,,1,0.13832,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4432,,,,,,,761,,,,,,,,,32,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,83563,,0.933993315,,,,,,,,,,0.228367907,,0.124264447,,,,Stage IIB,,1.0695,,,,,,,,,,,,,,,,0.2037,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.94208079,16.62573526,16.33076395,-0.174875375,LUAD,,18.08685018,16.08871735,Adenocarcinoma,-0.0093,13.6708295,0.3818,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,2.98,0.57,4,9,8,,,158,BRCA_LumA,,158,,2,2,158,158,,Invasive Carcinoma,21,,32,,,,18072,0,,158,158,,,,,158,,,158,,,,,,,,TUMOR FREE,Dead,-26823,158,,,75,,158,158,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,16,,1,0.18096,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CU,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,2005,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,83572,,0.032282488,0,0,0,0,0.4429,1,,,Infiltrating Ductal Carcinoma,0.085685365,,0.185224242,0,0,0,,Close,-0.73,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2914,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-6566,White,STAD,,0,0,,,0,0,,0,2.18,0.47,0,0,1,,,997,,997,997,,0,0,997,997,,Malignant,1,,9,,,,16110,,,997,997,,,,997,997,,,997,,,,,,,,TUMOR FREE,Alive,-23404,,,,1275,,997,997,,,[Not Available],[Not Applicable],,,,,0.14,Stomach,Unknown,,,4,,0,0.094017,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6566,,,,,,,997,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,83574,,0.770949462,,,,,,,,,,0.15318523,Grade 3,0.027338875,,,,Stage IIA,,1.202,,,,,,,,,,,,,,,,0.4414,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6566,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.94,0.65,9,4,9,,,495,BRCA_LumA,495,495,,0,0,495,495,,Invasive Carcinoma,22,,31,,,,20768,0,,495,495,,,,495,495,,,495,,,,,,,,TUMOR FREE,Alive,-15980,,,,425,,495,495,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,4,,0,0.16106,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DZ,,,,,,,495,,,,,,,,,8,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,83578,,0.124729141,0,0,0,0,-0.5178,1,,,Infiltrating Ductal Carcinoma,0.18971677,,0.158711985,0,0,0,,Negative,0.104,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6717,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.22,0.55,7,11,12,,,2311,BRCA_LumA,2311,2311,,0,0,2311,2311,,Invasive Carcinoma,30,,78,,,,22974,0,,2311,2311,,,,2311,2311,,,2311,,,,,,,,TUMOR FREE,Alive,-19237,,,,55,,2311,2311,,,[Not Available],[Not Applicable],,,,,0.2,Breast,Resection/Excision,,,15,,1,0.11679,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14T,,,,,,,2311,,,,,,,,,29,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,83579,,-0.298574545,0,0,0,0,0.1218,1,,,Infiltrating Ductal Carcinoma,0.173960242,,0.105785829,0,0,0,,Negative,-1.3585,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0002,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-77-A5G7,Unknown,LUSC,,0,0,,Prince Charles Hospital,2,,MALE,2,1.87,0.58,13,9,12,,,180,,180,180,,2,2,180,180,,Malignant,34,,76,,,,28067,,,180,180,,,,180,180,,,180,,,,,,,,,Dead,-23090,180,,,132,,180,180,,,[Not Available],[Not Applicable],,,,,0.5,,,,,10,,0,0.32019,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5G7,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,83580,,0.344760907,,,,,,,,,,0.05477423,,0.013807669,,,,Stage IA,,-0.763,,,,,,,,,,,,,,,,-0.133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.806591013261176,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.1041,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.08,0.19,0,1,1,,,1233,BRCA_Normal,1233,1233,,0,0,1233,1233,,Invasive Carcinoma,2,,0,,,,26606,0,,1233,1233,,,,1233,1233,,,1233,,,,,,,,TUMOR FREE,Alive,-21865,,,,21,,1233,1233,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,1,,0,0.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A2LQ,,,,,,,1233,,,,,,,,,1,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,83581,,-0.694735735,0,1,0,0,0.4242,0,,,Infiltrating Lobular Carcinoma,0.226623284,,0.307942631,0,0,0,,Negative,-0.4785,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.8207,1,0,H & E,0,0,,0,Ioana Tolocica,"ALH, Sclerosing Adenosis",0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"LCIS, Stromal Alterations",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"ALH, Sclerosing Adenosis",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.17,0.52,5,3,8,,,273,BRCA_LumB,273,273,,0,0,273,273,,Invasive Carcinoma,16,,11,,,,21664,0,,273,273,,,,273,273,,,273,,,,,,,,TUMOR FREE,Alive,-30196,,,,0,,273,273,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,18,,1,0.24976,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09R,,,,,,,273,,,,,,,,,32,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,83583,,0.679070393,0,0,0,0,-0.4217,1,,,Infiltrating Ductal Carcinoma,0.179904751,,0.119566666,0,0,0,,Negative,0.939,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6174,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,Black or African American,BRCA,,0,0,,,2,2,FEMALE,2,2.09,0.78,6,3,5,,,3873,BRCA_LumA,3873,3873,,2,2,3873,3873,,Invasive Carcinoma,14,,10,,,,28490,0,,3873,3873,,,,3873,3873,,,3873,,,,,,,,TUMOR FREE,Dead,-27557,3873,,,65,,3873,3873,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,8,,0,0.084617,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Duke,,TCGA-B6-A0IM,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,1997,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,83584,,-0.525019953,0,0,0,0,-0.4122,1,,,Other,0.141026837,,0.157090753,0,0,0,,Negative,-1.0835,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,0.4658,1,0,H & E,0,0,,0,David Jou,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Micropapillary, Low Grade), DCIS (Solid, Low Grade), Comedonecrosis",,"DCIS (Micropapillary, Low Grade), DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-55-6978,White,LUAD,,1,,,International Genomics Consortium,,1,MALE,1,2.07,0.26,2,2,5,,,176,,,176,,1,,42,42,,Malignant,9,,14,,,,22150,,,42,,,,,,176,,,42,,,,,,,,WITH TUMOR,Dead,,176,,,37,,42,,,,[Not Available],[Not Applicable],,,,,0.45,,,,,3,,0,0.22,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6978,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2010,42,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,81,,,,,,,,,,,,,,,,,,,,83590,,1.681367301,,,,,,,,,,0.276827928,,0.186557766,,,,Stage IIA,,2.771,,,,,,,,,,,,,,,,0.7277,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.3774027,18.17658687,18.87924298,0.397219963,LUAD,,18.07203942,17.63675949,Adenocarcinoma,1.4825,14.97356586,1.8233,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-86-8671,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,2.0,1.0,0,0,1,,,839,,839,839,,0,0,839,839,,Malignant,1,,4,,,,27761,,,839,839,,,,839,839,,,839,,,,,,,,TUMOR FREE,Alive,-26448,,,,39,,839,839,,,[Not Available],[Not Applicable],,,,,0.16,,,,,0,,0,0.000304,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8671,,,,,,,839,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,83591,,1.927844072,,,,,,,,,,0.289361469,,0.262901306,,,,Stage IIB,,2.1845,,,,,,,,,,,,,,,,0.3673,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.92104322,17.96568735,18.06810646,0.360607585,LUAD,Adenocarcinoma,18.65205603,17.54235032,Adenocarcinoma,0.9534,11.48572038,1.5906,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A6TB,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.92,0.28,10,1,8,,,572,,572,572,,0.0,0,572.0,572.0,,Malignant,19,,47,,,,33603.0,,,572.0,572,,,,572,572,,,572.0,,,,,,,,TUMOR FREE,Alive,-30185,,,,261.0,,572.0,572,,,[Not Available],[Not Applicable],,,,,0.3,,,,,8,,0,0.20779,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TB,,,,,,,572,,,,,,,,,11,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,82.0,,,,,,,,,,,,,,,,,,,,83595,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,16,,16,16,,0,0,16,16,,Invasive Carcinoma,,,,,,,17957,0,,16,16,,,,16,16,,,16,,,,,,,,TUMOR FREE,Alive,-20504,,,,56,,16,16,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0G0,,,,,,,16,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,83596,TRUE,0.038404509,0,0,0,0,-0.5914,1,,,Infiltrating Ductal Carcinoma,0.166154106,,0.089837393,0,0,0,,Negative,-0.193,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4722,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-8077,White,STAD,,0,0,,,0,0,,0,4.8,0.6,14,21,28,,,21,,21,21,,0,0,21,21,,Malignant,63,,143,,,,29631,,,21,21,,,,21,21,,,21,,,,,,,,TUMOR FREE,Alive,-21413,,,,156,,21,21,,,[Not Available],[Not Applicable],,,,,0.33,Stomach,Unknown,,,20,,2,0.33578,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8077,,,,,,,21,,,,,,,,,59,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,83600,,0.637828166,,,,,,,,,,0.082759767,Grade 2,0.147238898,,,,Stage IIIB,,0.654,,,,,,,,,,,,,,,,0.0601,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8077,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,Male,TCGA-BR-6706,White,STAD,,1,1,,,1,1,,1,2.11,0.23,0,0,0,,,549,,402,549,,1,1,402,402,,Malignant,0,,3,,,,18006,,,402,402,,,,402,549,,,402,,,,,,,,WITH TUMOR,Dead,-23053,549,,,236,,402,402,,,[Not Available],[Not Applicable],,,,,0.09,Stomach,Unknown,,,4,,0,0.000207,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6706,,,,,,,,,Locoregional Recurrence,,,,,,,3,,,,,,,,,,,,,2010,402,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,83602,,1.264688926,,,,,,,,,,0.107956276,Grade 3,0.17926716,,,,Stage IIIA,,3.837,,,,,,,,,,,,,,,,0.5136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6706,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,Female,TCGA-55-8511,White,LUAD,,1,,,International Genomics Consortium,1,0,FEMALE,1,3.18,0.19,15,22,27,,,552,,460,552,,1,,460,460,,Malignant,64,,157,,,,16711,,,460,,,,,460,552,,,460,,,,,,,,WITH TUMOR,Alive,-26986,,,,723,,460,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,20,,1,0.33576,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8511,,,,,,,552,,,,,,,,,29,,,,,,,,,,,,,2012,460,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,83612,,1.405508454,,,,,,,,,,0.20261157,,0.124236697,,,,Stage IB,,1.9655,,,,,,,,,,,,,,,,0.4116,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.009868915,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.7963,,0.619,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,3.95,0.59,13,11,20,,,723,BRCA_LumB,723,723,,2,2,723,723,,Invasive Carcinoma,44,,49,,,,21814,0,,723,723,,,,723,723,,,723,,,,,,,,TUMOR FREE,Dead,-20482,723,,,92,,723,723,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,21,,2,0.29459,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YT,,,,,,,,,,,,,,,,65,,,,,,,,,,,,,2008,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,83613,,-0.448861846,0,0,0,0,0.5412,1,,,Infiltrating Ductal Carcinoma,0.10806476,,0.172053423,0,0,0,,Negative,-0.9055,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0244,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-73-4670,White,LUAD,,0,0,,Roswell Park,,0,FEMALE,0,2.91,0.62,9,5,13,,,131,,,131,,0,0,131,131,,Malignant,27,,49,,,,25762,,,131,131,,,,,131,,,131,,,,,,,,WITH TUMOR,Alive,-25526,,,,489,,131,131,,,[Not Available],[Not Applicable],,,,,0.26,,,,,24,,1,0.40726,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4670,,,,,,,131,,,,,,,,,33,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,83614,,-0.16194382,,,,,,,,,,0.206305092,,0.107629483,,,,Stage IV,,0.0035,,,,,,,,,,,,,,,,0.447,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,A146P (driver),V123L,1,,A146P (driver),V123L,15.52045449,16.4136901,14.60189233,-0.664788548,LUAD,Adenocarcinoma,17.79903838,14.75973364,Adenocarcinoma,0.9052,14.09229686,-1.0435,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-86-8668,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,3.93,0.41,4,10,5,,,423,,423,423,,0,0,423,423,,Malignant,19,,44,,,,17799,,,423,423,,,,423,423,,,423,,,,,,,,TUMOR FREE,Alive,-22383,,,,46,,423,423,,,[Not Available],[Not Applicable],,,,,0.34,,,,,9,,1,0.12356,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8668,,,,,,,423,,,,,,,,,13,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,83617,,0.808396249,,,,,,,,,,0.245560495,,0.204503502,,,,Stage IA,,1.064,,,,,,,,,,,,,,,,0.5255,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.210817255,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.3389,,-0.3961,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,3.49,0.55,24,33,28,,,1556,BRCA_Basal,1556,1556,,2,2,1556,1556,,Invasive Carcinoma,85,,155,,,,16616,0,,1556,1556,,,,1556,1556,,,1556,,,,,,,,,Dead,-17682,1556,,,280,,1556,1556,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,13,,1,0.55198,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18V,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2001,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,83626,TRUE,1.032527137,0,0,0,0,0.7987,0,,,Infiltrating Ductal Carcinoma,0.202146458,,0.134270763,0,0,0,,Negative,0.449,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.325,1,0,H & E,0,0,,0,Chunhui Yi,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"Uncertain if In Situ Disease Present, N/A No in Situ",,Uncertain if In Situ Disease Present,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Female,TCGA-22-4594,,LUSC,,0,0,,Mayo Clinic - Rochester,,,FEMALE,2,4.98,0.24,3,24,24,,,1470,,,1470,,2,2,1470,1470,,Malignant,51,,96,,,,19998,,,1470,1470,,,,,1470,,,1470,,,,,,,,,Dead,-22115,1470,,,451,,1470,1470,,,[Not Available],[Not Applicable],,,,,0.43,,,,,20,,2,0.264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4594,,,,,,,1470,,,,,,,,,52,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,83628,,1.17509209,,,,,,,,,,0.21611562,,0.104575291,,,,Stage IIIA,,1.3005,,,,,,,,,,,,,,,,-0.0513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,P318Rfs*10 (driver),1,,,P318Rfs*10 (driver),16.29687911,15.70569256,15.73668102,-0.164072841104879,LUSC,,18.24572585,16.42332906,Squamous Cell Carcinoma,1.0855,13.89313488,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.5,0.58,3,13,20,,,965,BRCA_Basal,965,965,,0,0,965,965,,Invasive Carcinoma,36,,91,,,,28368,0,,965,965,,,,965,965,,,965,,,,,,,,TUMOR FREE,Alive,-24831,,,,119,,965,965,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,23,,2,0.38347,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YM,,,,,,,965,,,,,,,,,76,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,83629,,0.657898438,0,0,0,0,0.7171,1,,,Infiltrating Ductal Carcinoma,0.194184505,,0.049471551,0,0,0,,Negative,0.247,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3267,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A3Y1,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.04,0.82,3,2,4,,,163,,163,163,,0.0,0,163.0,163.0,,Malignant,9,,19,,,,17412.0,,,163.0,163,,,,163,163,,,163.0,,,,,,,,TUMOR FREE,Alive,-20917,,,,222.0,,163.0,163,,,[Not Available],[Not Applicable],,,,,0.07,,,,,1,,0,0.063159,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,Asterand,,TCGA-E7-A3Y1,,,,,,,163,,,,,,,,,2,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,57.0,,,,,,,,,,,,,,,,,,,,83630,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-NJ-A7XG,Black or African American,LUAD,,0,0,,Washington University - Rush University,,0,MALE,0,3.84,0.62,1,10,6,,,617,,,617,,0,0,617,617,,Malignant,17,,29,,,,27392,,,617,617,,,,,617,,,617,,,,,,,,WITH TUMOR,Alive,-18127,,,,46,,617,617,,,[Not Available],[Not Applicable],,,,,0.46,,,,,11,,1,0.034571,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A7XG,,,,,,,617,,,,,,,,,16,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,49,,,,,,,,,,,,,,,,,,,,83635,,-0.565820509,,,,,,,,,,0.095971239,,0.059105393,,,,Stage IIIA,,-0.745,,,,,,,,,,,,,,,,-0.3046,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.68133177,13.70073837,12.6711003,-0.787659485,LUAD,Adenocarcinoma,18.33902274,14.37170685,Adenocarcinoma,-1.7341,11.67003817,-1.8244,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,TCGA-A2-A0CY,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1673,,1673,1673,,0,0,1673,1673,,Invasive Carcinoma,,,,,,,29398,0,,1673,1673,,,,1673,1673,,,1673,,,,,,,,TUMOR FREE,Alive,-23229,,,,0,,1673,1673,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CY,,,,,,,1673,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,83638,,-1.704729466,0,0,0,0,,1,,,,0.091851898,,0.041188761,0,0,0,,Negative,-1.5735,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1166,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-UY-A9PD,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.65,0.63,5,16,18,,,542,,542,542,,0.0,0,542.0,542.0,,Malignant,39,,92,,,,24528.0,,,542.0,542,,,,542,542,,,542.0,,,,,,,,TUMOR FREE,Alive,-29565,,,,401.0,,542.0,542,,,[Not Available],[Not Applicable],,,,,0.02,,,,,15,,1,0.12588,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A9PD,,,,,,,542,,,,,,,,,29,,,,,,,,,,,,,,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,80.0,,,,,,,,,,,,,,,,,,,,83642,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,0,1,1,Male,TCGA-BR-7901,White,STAD,,1,1,,,1,2,,1,4.69,0.31,5,18,20,,,105,,91,105,,1,1,91,91,,Malignant,43,,44,,,,16328,,,91,91,,,,91,105,,,91,,,,,,,,TUMOR FREE,Dead,-27031,105,,,207,,91,91,,,[Not Available],[Not Applicable],,,,,0.56,Stomach,Unknown,,,19,,2,0.15016,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-7901,,,,,,,,,Locoregional Recurrence,,,,,,,61,,,,,,,,,,,,,2011,91,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,83643,,0.212582869,,,,,,,,,,0.122910042,Grade 2,0.161022216,,,,Stage IIB,,0.147,,,,,,,,,,,,,,,,0.6757,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7901,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,0,0,0.0,0.0,Female,TCGA-DK-A2I1,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.17,0.58,5,5,11,,,546,,546,546,,0.0,0,546.0,546.0,,Malignant,21,,85,,,,30745.0,,,546.0,546,,,,546,546,,,546.0,,,,,,,,TUMOR FREE,Alive,-26726,,,,334.0,,546.0,546,,,[Not Available],[Not Applicable],,,,,0.16,,,,,21,,1,0.24954,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A2I1,,,,,,,546,,,,,,,,,28,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,83644,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-D7-6524,White,STAD,,1,1,,,,0,,1,2.13,0.18,0,1,1,,,543,,,543,,1,1,543,543,,Malignant,2,,3,,,,16734,,,543,543,,,,,543,,,543,,,,,,,,WITH TUMOR,Alive,-19532,,,,132,,543,543,,,[Not Available],[Not Applicable],,,,,0.1,Stomach,Unknown,,,2,,0,0.099936,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6524,,,,,,,543,Non-regional / Distant Lymph Nodes,Locoregional Recurrence,,,,,,,7,,,,,,,,,,,,,2010,543,,,,Stage II,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,83646,,,,,,,,,,,,,Grade 3,,,,,Stage II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6524,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,0,0,1,Female,TCGA-34-5929,White,LUSC,,0,0,,University of Pittsburgh,,2,FEMALE,2,1.74,0.75,7,3,8,,,151,,,151,,2,2,151,151,,Malignant,18,,27,,,,20547,,,151,151,,,,,151,,,151,,,,,,,,TUMOR FREE,Dead,-28844,151,,,312,,151,151,,,[Not Available],[Not Applicable],,,,,0.03,,,,,9,,0,0.38368,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-5929,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,78,,,,,,,,,,,,,,,,,,,,83647,,0.699016321,,,,,,,,,,0.156042679,,0.073046795,,,,Stage IB,,0.2345,,,,,,,,,,,,,,,,0.4258,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.54982968073388,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.6128,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,588,,588,588,,0,0,588,588,,Invasive Carcinoma,,,,,,,22367,0,,588,588,,,,588,588,,,588,,,,,,,,TUMOR FREE,Alive,-27865,,,,0,,588,588,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2QI,,,,,,,588,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,83650,,0.476199449,0,0,0,0,1.3268,1,,,Infiltrating Lobular Carcinoma,0.168376964,,0.223685802,0,0,0,,Negative,-0.145,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5187,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,0,Yes,0,Adipose Tissue,No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WI,,PRAD,389,0,0,,YL,,0,MALE,0,2.27,0.88,6,12,3,ambiguous,NO,1623,6-FOXA1,,1623,,0,0,1623,1623,prad_tcga,Malignant,21,,166,,TCGA-YL-A9WI-01,19,5689,0,TCGA-YL-A9WI,1623,1623,Prostate Cancer,,1259,,1623,TCGA,,1623,Primary,1,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23184,,63,9,51,PRAD,1623,1623,,0.373381833,[Not Available],[Not Applicable],41,R0,1,Matched,0.17,Prostate,Resection,4,563E009C-C93D-46CC-867D-F5C89D9336D9,10,Normal (no evidence of prostate cancer) [cM0],0,0.13134,[Not Available],2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.36666666667,TCGA-YL-A9WI,0:DiseaseFree,5,22,Prostate Adenocarcinoma,53.32,4/10/14,1623,,,,,NO,C61,746DB832-C507-4FD6-8B8A-09E6268BACC9,680,11,,0.376,0:LIVING,0.03,,53.32,Bilateral,31,No Evidence of Extraprostatic Extension,99,YES,1325,2010,,,TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,93,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R0,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,,1,M0,C61.9,8140/3,83654,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.66,5,3,6,,,523,BRCA_LumB,523,523,,0,0,523,523,,Invasive Carcinoma,14,,37,,,,18737,0,,523,523,,,,523,523,,,523,,,,,,,,TUMOR FREE,Alive,-18508,,,,49,,523,523,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,8,,0,0.21363,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A25C,,,,,,,523,,,,,,,,,8,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,83660,,0.288012224,0,0,0,0,0.1178,1,,,Infiltrating Ductal Carcinoma,0.115638813,,0.174943413,0,0,0,,Negative,-0.1515,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1827,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-75-6211,,LUAD,,1,1,,Ontario Institute for Cancer Research (OICR),,1,FEMALE,1,3.09,0.39,6,17,16,,,,,,,,1,1,,,,Malignant,39,,71,,,,19333,,,,,,,,,,,,,,,,,,,,WITH TUMOR,Dead,,,,,478,,,,,,[Not Available],[Not Applicable],,,,,0.16,,,,,15,,1,0.33233,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-6211,,,,,,,,,,,,,,,,29,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,83662,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.0628,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,R204P,1,,,R204P,,,,-0.540914724,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.6196,,-0.0298,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.91,0.4,3,0,3,,,588,BRCA_Normal,,588,,0,0,588,588,,Invasive Carcinoma,6,,5,,,,17557,0,,588,588,,,,,588,,,588,,,,,,,,TUMOR FREE,Alive,-22625,,,,494,,588,588,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,6,,0,0.1076,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YK,,,,,,,588,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,83664,,1.611232838,0,0,0,0,0.2903,0,,,Infiltrating Lobular Carcinoma,0.182019658,,0.292588482,0,0,0,,Close,1.2225,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3773,1,0,H & E,0,0,,0,Chunhui Yi,Sclerosing Adenosis,0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Sclerosing Adenosis,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-G2-A2EO,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.23,0.37,1,3,7,,,1804,,1804,1804,,2.0,2,1804.0,1804.0,,Malignant,11,,27,,,,25306.0,,,1804.0,1804,,,,1804,1804,,,1804.0,,,,,,,,TUMOR FREE,Dead,-25440,1804,,,1247.0,,1804.0,1804,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.10692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EO,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,83666,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SJ,,PRAD,389,1,1,,YL,1,0,MALE,1,1.89,0.63,6,8,5,ambiguous,NO,1395,2-ETV1,752,1395,,1,1,752,752,prad_tcga,Malignant,19,BARD1;BRCA2;FANCL;PALB2;RAD51B;RAD54L,59,,TCGA-YL-A8SJ-01,0,5672,0,TCGA-YL-A8SJ,752,752,Prostate Cancer,,1426,752,1395,TCGA,,752,Primary,0,Middle|Base,B,,,True,WITH TUMOR,Alive,-21916,,60,9,36,PRAD,752,752,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.23,Prostate,Resection,4,219FC0A7-7389-40F7-AB99-C2EE6AD501AF,0,,0,0.10711,[Not Available],F3EC5BF3-97AE-4033-91A6-084A1AA152A4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,YL,1.0,TCGA-YL-A8SJ,1:Recurred/Progressed,5,18,Prostate Adenocarcinoma,24.7,4/25/14,1395,,Biochemical evidence of disease,,,NO,C61,86F65B00-7E83-4013-85E8-A4AE42686ACF,460,4,WITH TUMOR,0.0629,0:LIVING,0.24,,45.83,Bilateral,30,,,YES,1306,2010,752,,TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,66-75%,29,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,752,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,83668,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-53-A4EZ,White,LUAD,,0,0,,University of Miami,,0,MALE,0,3.08,0.47,17,9,18,,,1071,,,1071,,0,0,1071,1071,,Malignant,44,,126,,,,29686,,,1071,1071,,,,,1071,,,1071,,,,,,,,TUMOR FREE,Alive,-23201,,,,711,,1071,1071,,,[Not Available],[Not Applicable],,,,,0.12,,,,,19,,1,0.40171,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Miami,,TCGA-53-A4EZ,,,,,,,1071,,,,,,,,,31,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,63,,,,,,,,,,,,,,,,,,,,83678,,0.522334034,,,,,,,,,,0.123187882,,0.02277957,,,,Stage IIA,,0.3855,,,,,,,,,,,,,,,,-0.563,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G417V (driver),1,,,G417V (driver),14.36836313,14.91601133,14.56870486,-0.655006543,LUAD,,17.85120101,15.31576021,Adenocarcinoma,-1.1309,12.26049947,-0.4144,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-HC-7213,White,PRAD,184,1,1,,HC,,0,MALE,1,3.55,0.72,4,7,8,ambiguous,NO,1219,1-ERG,,1219,,1,1,170,170,prad_tcga,Malignant,19,BARD1;BRCA1;BRCA2;BRIP1;CDK12;FANCL;RAD51B;RAD51C;RAD51D;RAD54L,23,13.5,TCGA-HC-7213-01,0,5411,0,TCGA-HC-7213,170,170,Prostate Cancer,34,170,,1219,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),170,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-19699,,53,9,47,PRAD,170,170,WHITE,0.0,[Not Available],[Not Applicable],47,R0,1,Matched,0.28,Prostate,Resection,4,0cb3dffd-1521-4887-b19c-94dcd340d306,11,,1,0.087443,[Not Available],26eefaa1-1666-4ce1-8cf4-f6fabff81fd2,5,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,19,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.6,TCGA-HC-7213,1:Recurred/Progressed,5,22,Prostate Adenocarcinoma,5.58,4/10/12,1219,,Biochemical evidence of disease,,,YES,C61,8b2f0b23-7a12-432a-b209-37e57a2f112b,,12,TUMOR FREE,0.1697,0:LIVING,4.09,,40.05,Bilateral,29,No Evidence of Extraprostatic Extension,22,YES,,2010,170,,TCGA-HC-7213.8b2f0b23-7a12-432a-b209-37e57a2f112b.pdf,,[Not Applicable],YES,,81-90%,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,YES,No,R0,1.0,53,Core needle biopsy,170,,YES,NO,YES,,T3b,,9,No,,0,N0,T3b,0,M0,C61.9,8550/3,83679,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.68,0.27,2,4,9,,,3248,BRCA_Basal,3248,3248,,0,0,3248,3248,,Invasive Carcinoma,15,,25,,,,16783,0,,3248,3248,,,,3248,3248,,,3248,,,,,,,,TUMOR FREE,Alive,-22340,,,,1644,,3248,3248,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,22,,1,0.60289,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A128,,,,,,,3248,,,,,,,,,33,,,,,,,,,,,,,2002,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,83680,TRUE,2.055396117,0,0,0,0,-0.0595,1,,,Infiltrating Ductal Carcinoma,0.241236153,,0.085191341,0,0,0,,Negative,3.227,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0234,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,5.51,0.49,12,18,16,,,761,BRCA_LumB,,761,,0,0,761,761,,Invasive Carcinoma,46,,176,,,,17658,0,,761,761,,,,,761,,,761,,,,,,,,WITH TUMOR,Alive,-30528,,,,215,,761,761,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,20,,2,0.31207,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09Q,,,,,,,761,,,,,,,,,46,,,,,,,,,,,,,2008,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,83,,,,,,,,,,,,,,,,,,,,83691,,1.240472075,0,0,0,0,-0.352,1,,,Infiltrating Ductal Carcinoma,0.223228337,,0.144673196,0,0,0,,Positive,0.691,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2352,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-8305,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,3.52,0.41,9,8,15,,,105,,105,105,,0,0,105,105,,Malignant,32,,46,,,,19693,,,105,105,,,,105,105,,,105,,,,,,,,TUMOR FREE,Alive,-26428,,,,499,,105,105,,,[Not Available],[Not Applicable],,,,,0.24,,,,,15,,1,0.31501,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8305,,,,,,,105,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,83697,,-0.038735286,,,,,,,,,,0.181580295,,0.057421405,,,,Stage IB,,-0.264,,,,,,,,,,,,,,,,0.5743,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.926265644985044,LUSC,,,,Squamous Cell Carcinoma,0.1857,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-G2-A2EO,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.23,0.37,1,3,7,,,1804,,1804,1804,,2.0,2,1804.0,1804.0,,Malignant,11,,27,,,,25306.0,,,1804.0,1804,,,,1804,1804,,,1804.0,,,,,,,,TUMOR FREE,Dead,-25440,1804,,,1247.0,,1804.0,1804,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.10692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EO,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,83698,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.57,3,2,5,,,1935,BRCA_LumA,1935,1935,,0,0,1935,1935,,Invasive Carcinoma,10,,17,,,,32334,0,,1935,1935,,,,1935,1935,,,1935,,,,,,,,TUMOR FREE,Alive,-18053,,,,21,,1935,1935,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,4,,0,0.047206,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A2LM,,,,,,,1935,,,,,,,,,4,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,83708,,0.12426175,0,1,1,0,-0.0992,0,,,Infiltrating Lobular Carcinoma,0.169972818,,0.18250291,0,0,0,,Negative,-0.056,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,0.6388,1,0,H & E,0,0,,0,David Jou,"ALH, FEA",0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"ALH, FEA",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,,,White,BRCA,,0,0,,,0,0,FEMALE,1,2.11,0.53,4,7,8,,,677,BRCA_LumA,677,677,,0,0,654,654,,Invasive Carcinoma,19,,14,,,,32534,0,,677,677,,,,677,677,,,654,,,,,,,,TUMOR FREE,Alive,-31003,,,,147,,677,677,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,3,,0,0.12139,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2B8,,,,,,,677,"Other, specify",New Primary Tumor,,,,,,,9,,,,,,,,,,,,,2011,654,Rectum,,,Stage IIB,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,83718,,0.405067641,0,0,0,1,-0.1329,0,,,Infiltrating Lobular Carcinoma,0.215235704,,0.233470933,0,0,0,,Negative,0.045,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6119,1,0,H & E,0,0,,0,Chunhui Yi,"Apocrine Metaplasia, UDH",0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"Apocrine Metaplasia, UDH",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-05-4433,,LUAD,,0,0,,Indivumed,,0,MALE,0,1.89,0.62,8,2,7,,,730,,,730,,0,0,730,730,,Malignant,17,,19,,,,22996,,,730,730,,,,,730,,,730,,,,,,,,TUMOR FREE,Alive,-30194,,,,46,,730,730,,,[Not Available],[Not Applicable],,,,,0.09,,,,,6,,0,0.14609,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4433,,,,,,,730,,,,,,,,,9,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,82,,,,,,,,,,,,,,,,,,,,83719,,0.83583697,,,,,,,,,,0.29933517,,0.148897557,,,,Stage IB,,0.6485,,,,,,,,,,,,,,,,-0.0091,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12V (driver), AMP (driver)",,1,,G12V (driver),,,,,-0.142888652,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.665,,0.5409,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-HQ-A2OE,Unknown,BLCA,,0.0,0,,,,0,MALE,0.0,3.57,0.8,9,19,19,,,1174,,,1174,,0.0,0,1174.0,1174.0,,Malignant,47,,50,,,,16852.0,,,1174.0,1174,,,,,1174,,,1174.0,,,,,,,,,Alive,,,,,209.0,,1174.0,1174,,,[Not Available],[Not Applicable],,,,,0.23,,,,,22,,1,0.23864,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,[Unknown],,Ontario Institute for Cancer Research (OICR),,TCGA-HQ-A2OE,,,,,,,1174,,,,,,,,,28,,,,,,,,,,,,,2007,,,,,[Not Available],,,,,,,,[Unknown],,,,,,69.0,,,,,,,,,,,,,,,,,,,,83729,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-55-8094,White,LUAD,,0,0,,International Genomics Consortium,,0,MALE,0,2.82,0.79,8,12,17,,,541,,,541,,0,0,541,541,,Malignant,37,,44,,,,26438,,,541,541,,,,,541,,,541,,,,,,,,WITH TUMOR,Alive,-18903,,,,594,,541,541,,,[Not Available],[Not Applicable],,,,,0.04,,,,,14,,1,0.21058,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8094,,,,,,,541,,,,,,,,,41,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,51,,,,,,,,,,,,,,,,,,,,83730,,-1.08487283,,,,,,,,,,0.08500849,,0.054661276,,,,Stage IV,,0.0575,,,,,,,,,,,,,,,,-0.4247,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G13C (driver), AMP (driver)",Y162C,1,,G13C (driver),Y162C,13.17869959,16.67651179,10.38837841,-0.984721627,LUAD,Adenocarcinoma,17.454255,14.33505755,Adenocarcinoma,-3.2388,11.5018971,-1.7739,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Female,TCGA-VQ-A8PU,White,STAD,,0,0,,,2,2,,2,3.84,0.66,16,26,22,,,832,,832,832,,2,2,832,832,,Malignant,64,,147,,,,21150,,,832,832,,,,832,832,,,832,,,,,,,,TUMOR FREE,Dead,-26625,832,,,177,,832,832,,,[Not Available],[Not Applicable],,,,,0.27,Stomach,Unknown,,,12,,2,0.28567,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8PU,,,,,,,,,,,,,,,,67,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,83733,,-1.093161759,,,,,,,,,,0.019871725,Grade 3,0.033937977,,,,Stage IIIA,,-2.2245,,,,,,,,,,,,,,,,-0.1031,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PU,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0.0,,0,1.0,1.0,Male,TCGA-FD-A3SN,White,BLCA,,1.0,1,,,,0,MALE,1.0,1.69,0.73,16,9,12,,,887,,,887,,1.0,1,110.0,110.0,,Malignant,37,,53,,,,28152.0,,,110.0,110,,,,,887,,,110.0,,,,,,,,TUMOR FREE,Alive,-29169,,,,582.0,,110.0,110,,,[Not Available],[Not Applicable],,,,,0.03,,,,,8,,0,0.36261,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SN,,,,,,,887,Lung,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2011,110,,,,Stage III,,,,,,,,Progressive Disease,,,,,,79.0,,,,,,,,,,,,,,,,,,,,83736,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7752,White,PRAD,,0,0,,HC,0,0,MALE,0,1.98,0.75,2,2,0,HRP,NO,782,,782,782,,0,0,782,782,prad_tcga,Malignant,4,,44,,TCGA-HC-7752-01,0,5428,0,TCGA-HC-7752,782,782,Prostate Cancer,,138,782,782,TCGA,,782,Primary,0,Base,A,,,,TUMOR FREE,Alive,-22366,,61,7,36,PRAD,782,782,WHITE,0.0,[Not Available],[Not Applicable],47,,1,Matched,0.05,Prostate,Resection,3,4769eff8-1976-426e-9ac0-85bb370cab1f,0,,0,0.021324,[Not Available],9b84601b-ee05-4c15-afe3-7bfa7ca5ffac,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,2.86666666667,TCGA-HC-7752,0:DiseaseFree,2,3,Prostate Adenocarcinoma,25.69,4/20/12,782,,,,,,C61,d077f87f-0c7a-4641-a3fd-8bcd89fc67e7,,1,TUMOR FREE,0.0251,0:LIVING,0.1,,25.69,Bilateral,5,,,YES,,2011,,,TCGA-HC-7752.d077f87f-0c7a-4641-a3fd-8bcd89fc67e7.pdf,,[Not Applicable],,,,6,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,61,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,83737,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.9,0.64,9,8,9,,,575,BRCA_LumA,575,575,,0,0,575,575,,Invasive Carcinoma,26,,52,,,,30026,0,,575,575,,,,575,575,,,575,,,,,,,,TUMOR FREE,Alive,-21837,,,,61,,575,575,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,7,,0,0.32992,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1PA,,,,,,,575,,,,,,,,,21,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,83738,,0.614545074,0,0,0,0,0.2797,1,,,Infiltrating Ductal Carcinoma,0.12008839,,0.214122739,0,0,0,,Negative,0.0345,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2371,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.32,0.72,11,15,18,,,1186,BRCA_LumA,1186,1186,,0,0,1186,1186,,Invasive Carcinoma,44,,28,,,,23524,0,,1186,1186,,,,1186,1186,,,1186,,,,,,,,TUMOR FREE,Alive,-21562,,,,77,,1186,1186,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,18,,2,0.19988,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A247,,,,,,,1186,,,,,,,,,64,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,83743,,-0.69526763,0,0,0,0,0.0239,1,,,Infiltrating Ductal Carcinoma,0.108209317,,0.090580554,0,0,0,,Negative,-1.167,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0869,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Solid, Intermediate Grade), Microcalcifications",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7745,White,PRAD,,0,0,,HC,0,0,MALE,0,1.98,0.38,8,12,7,ambiguous,NO,721,,721,721,,0,0,721,721,prad_tcga,Malignant,27,ATM;FANCL,32,,TCGA-HC-7745-01,13,5423,0,TCGA-HC-7745,721,721,Prostate Cancer,,,721,721,TCGA,,721,Primary,1,Middle,A,,,,TUMOR FREE,Alive,-24078,,65,7,30,PRAD,721,721,WHITE,0.172856379,[Not Available],[Not Applicable],50,,1,Matched,0.05,Prostate,Resection,4,07fb63a4-839c-4e46-98f8-2908125622e2,3,,0,0.10207,[Not Available],6641a298-1dbd-445d-a4ab-95ceb98e1427,3,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,28,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,2.86666666667,TCGA-HC-7745,0:DiseaseFree,3,32,Prostate Adenocarcinoma,23.69,4/11/12,721,,,,,NO,C61,4a65a2d9-6007-4ff2-9711-46351f540367,,4,TUMOR FREE,0.1515,0:LIVING,,,23.69,Bilateral,34,,,YES,,2011,,,TCGA-HC-7745.4a65a2d9-6007-4ff2-9711-46351f540367.pdf,,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.4,65,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,,0,,C61.9,8550/3,83746,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4512,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,4.56,0.32,4,9,12,,,905,,,905,,1,1,905,905,,Malignant,25,,37,,,,24504,,,905,905,,,,,905,,,905,,,,,,,,WITH TUMOR,Dead,-25502,905,,,58,,905,905,,,[Not Available],[Not Applicable],,,,,0.24,,,,,27,,2,0.36924,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4512,,,,,,,157,,,,,,,,,48,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,83747,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98542375,16.9089662,11.37952049,-0.399506954,LUAD,,18.11303383,14.40690717,Adenocarcinoma,1.0726,13.80128998,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-97-A4M5,White,LUAD,,0,0,,Washington University - NYU,0,0,MALE,0,1.83,0.25,9,7,5,,,634,,634,634,,0,0,634,634,,Malignant,21,,48,,,,27194,,,634,634,,,,634,634,,,634,,,,,,,,TUMOR FREE,Alive,-30665,,,,193,,634,634,,,[Not Available],[Not Applicable],,,,,0.04,,,,,6,,0,0.22455,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4M5,,,,,,,634,,,,,,,,,6,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,83,,,,,,,,,,,,,,,,,,,,83752,,0.557202462,,,,,,,,,,0.244627134,,0.249545897,,,,Stage IA,,0.793,,,,,,,,,,,,,,,,0.3109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.210839986,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3408,,-0.5821,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.1,0.34,1,0,2,,,612,BRCA_LumA,612,612,,0,0,612,612,,Invasive Carcinoma,3,,6,,,,17238,0,,612,612,,,,612,612,,,612,,,,,,,,TUMOR FREE,Alive,-16658,,,,614,,612,612,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,4,,0,0.093602,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A2L8,,,,,,,612,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,83756,,1.654778833,0,0,0,0,-1.2661,1,,,Infiltrating Lobular Carcinoma,0.166742484,,0.120641834,0,0,0,,Negative,0.9285,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3638,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"LCIS, Comedonecrosis",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-55-A48Z,White,LUAD,,1,1,,International Genomics Consortium,,0,FEMALE,1,3.0,0.41,7,9,13,,,651,,,651,,1,1,536,536,,Malignant,29,,71,,,,22815,,,536,536,,,,,651,,,536,,,,,,,,WITH TUMOR,Alive,-22056,,,,73,,536,536,,,[Not Available],[Not Applicable],,,,,0.45,,,,,15,,1,0.25559,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A48Z,,,,,,,651,,Distant Metastasis,,,,,,,31,,,,,,,,,,,,,2012,536,,,,Stage IIIB,,,,,,,,Stable Disease,,,,,,60,,,,,,,,,,,,,,,,,,,,83764,,0.75561102,,,,,,,,,,0.246488762,,0.105852522,,,,Stage IIIB,,1.262,,,,,,,,,,,,,,,,0.5074,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"G719A (driver), AMP (driver)",,,1,G719A (driver),,,16.12764103,16.08756322,16.64233848,-0.040498504,LUAD,Adenocarcinoma,18.19683119,15.99751005,Adenocarcinoma,1.1912,13.55017133,0.1453,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.83,0.22,19,26,24,,,1434,BRCA_Basal,1434,1434,,0,0,1434,1434,,Invasive Carcinoma,69,,57,,,,34379,0,,1434,1434,,,,1434,1434,,,1434,,,,,,,,TUMOR FREE,Alive,-13743,,,,117,,1434,1434,,,[Not Available],[Not Applicable],,,,,0.38,Breast,Resection/Excision,,,16,,1,0.49622,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14N,,,,,,,1434,,,,,,,,,34,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,37,,,,,,,,,,,,,,,,,,,,83770,TRUE,1.082421474,0,0,0,0,0.8702,1,,,Infiltrating Ductal Carcinoma,0.154853988,,0.003816714,0,0,0,,Negative,-0.023,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1449,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-93-A4JQ,White,LUAD,,0,0,,Washington University - St. Louis,0,0,MALE,0,2.87,0.2,9,30,22,,,526,,526,526,,0,0,526,526,,Malignant,61,,47,,,,16128,,,526,526,,,,526,526,,,526,,,,,,,,TUMOR FREE,Alive,-17951,,,,177,,526,526,,,[Not Available],[Not Applicable],,,,,0.64,,,,,17,,1,0.16164,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - St. Louis,,TCGA-93-A4JQ,,,,,,,526,,,,,,,,,42,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,49,,,,,,,,,,,,,,,,,,,,83771,,1.5468274,,,,,,,,,,0.21121714,,0.160469031,,,,Stage IA,,2.0125,,,,,,,,,,,,,,,,0.7337,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.024481089,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.4958,,0.2186,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,1.0,1.0,Male,TCGA-G2-A2EK,White,BLCA,,1.0,1,,,,0,MALE,1.0,2.06,0.54,7,8,6,,,485,,,485,,1.0,1,485.0,485.0,,Malignant,21,,37,,,,28027.0,,,485.0,485,,,,,485,,,485.0,,,,,,,,WITH TUMOR,Alive,-20995,,,,88.0,,485.0,485,,,[Not Available],[Not Applicable],,,,,0.04,,,,,4,,0,0.1064,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EK,,,,,,,485,Renal Pelvis,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2010,485,,,,Stage II,,,,,,,,Stable Disease,,,,,,57.0,,,,,,,,,,,,,,,,,,,,83774,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.34,10,8,11,,,912,BRCA_LumA,912,912,,0,0,912,912,,Invasive Carcinoma,29,,36,,,,19568,0,,912,912,,,,912,912,,,912,,,,,,,,TUMOR FREE,Alive,-23327,,,,67,,912,912,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,8,,0,0.19736,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DI,,,,,,,912,,,,,,,,,10,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,83778,,0.627973805,0,0,0,0,-0.0507,1,,,Infiltrating Ductal Carcinoma,0.224545968,,0.245299795,0,0,0,,Negative,0.2275,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.9293,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-75-5146,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),0,0,MALE,1,1.78,0.58,8,5,5,,,2368,,2368,2368,,0,0,1773,1773,,Malignant,18,,39,,,,24901,,,2368,2368,,,,2368,2368,,,1773,,,,,,,,TUMOR FREE,Alive,,,,,249,,2368,2368,,,[Not Available],[Not Applicable],,,,,0.18,,,,,8,,0,0.28427,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-5146,,,,,,,2368,,New Primary Tumor,,,,,,,9,,,,,,,,,,,,,,1773,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,83783,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,-0.4172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.194572563,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.662,,0.0141,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Female,TCGA-DK-A3WX,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,1.78,0.37,6,2,6,,,321,,,321,,1.0,1,167.0,167.0,,Malignant,14,,34,,,,31284.0,,,167.0,167,,,,,321,,,167.0,,,,,,,,WITH TUMOR,Dead,-24553,321,,,61.0,,167.0,167,,,[Not Available],[Not Applicable],,,,,0.49,,,,,12,,0,0.25937,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3WX,,,,,,,,Bladder,Locoregional (Urothelial tumor event),,,,,,,8,,,,,,,,,,,,,2011,167,,,,Stage III,,,,,,,,Progressive Disease,,,,,,67.0,,,,,,,,,,,,,,,,,,,,83784,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.55,0.66,6,9,11,,,466,BRCA_LumB,466,466,,0,0,466,466,,Invasive Carcinoma,26,,31,,,,27457,0,,466,466,,,,466,466,,,466,,,,,,,,TUMOR FREE,Alive,-29916,,,,108,,466,466,,,[Not Available],[Not Applicable],,,,,0.43,Breast,Resection/Excision,,,16,,1,0.10293,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XZ,,,,,,,466,,,,,,,,,21,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,81,,,,,,,,,,,,,,,,,,,,83788,,0.802001722,0,0,0,0,-0.3885,1,,,Infiltrating Ductal Carcinoma,0.186355211,,0.093201076,0,0,0,,Negative,-0.062,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1286,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Female,TCGA-DK-A1AF,White,BLCA,,1.0,1,,,,0,FEMALE,1.0,1.92,0.13,1,1,1,,,536,,,536,,1.0,1,283.0,283.0,,Malignant,3,,3,,,,18168.0,,,283.0,283,,,,,536,,,283.0,,,,,,,,TUMOR FREE,Alive,-30914,,,,120.0,,283.0,283,,,[Not Available],[Not Applicable],,,,,0.14,,,,,4,,0,0.087018,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1AF,,,,,,,536,Lymph Node Only,Metastatic,,,,,,,2,,,,,,,,,,,,,2010,283,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,84.0,,,,,,,,,,,,,,,,,,,,83790,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,American Indian or Alaska Native,BRCA,,0,0,,,0,0,FEMALE,0,3.49,0.19,8,11,12,,,521,BRCA_Her2,521,521,,0,0,521,521,,Invasive Carcinoma,31,,26,,,,16632,0,,521,521,,,,521,521,,,521,,,,,,,,TUMOR FREE,Alive,-20227,,,,36,,521,521,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,15,,1,0.10017,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0T1,,,,,,,521,,,,,,,,,32,,,,,,,,,,,,,2009,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,83794,,1.410575254,0,0,0,0,-2.7156,1,,,Infiltrating Ductal Carcinoma,0.220033119,,0.239814474,0,0,0,,Negative,1.3205,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7072,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-2A-A8VL,,PRAD,389,0,0,,2A,,0,MALE,0,1.97,0.5,2,3,2,HRD,NO,621,1-ERG,,621,,0,0,621,621,prad_tcga,Malignant,7,,38,,TCGA-2A-A8VL-01,0,5225,0,TCGA-2A-A8VL,621,621,Prostate Cancer,,585,,621,TCGA,,621,Primary,0,Middle|Base,A,,BRCA1;RAD54L,True,TUMOR FREE,Alive,-18658,,51,6,37,PRAD,621,621,,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,F9F392D3-E3C0-4CF2-AC7D-F21A497F716A,0,Normal (no evidence of prostate cancer) [cM0],0,0.033257,[Not Available],49197847-CC83-4CE1-8397-D09CEA4C4928,3,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,2A,0.766666666667,TCGA-2A-A8VL,0:DiseaseFree,1,8,Prostate Adenocarcinoma,20.4,3/29/14,621,,,,,NO,C61,FC65B44D-EDAD-4A48-A564-8721C5CD3AA8,140,0,TUMOR FREE,0.03,0:LIVING,0.05,4,20.4,Left,8,,,YES,1273,2010,,,TCGA-2A-A8VL.FC65B44D-EDAD-4A48-A564-8721C5CD3AA8.pdf,Peripheral Zone,[Not Applicable],NO,21,31-40%,15,Prostate Adenocarcinoma Acinar Type,1,2010,[Not Available],,NO,No,R0,,51,Core needle biopsy,,,NO,YES,YES,NO,T2b,NO,6,No,NO,0,N0,[Unknown],0,M0,C61.9,8140/3,83795,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-67-3774,White,LUAD,,0,0,,St Joseph's Medical Center (MD),,0,FEMALE,0,1.87,0.48,4,2,4,,,385,,,385,,0,0,385,385,,Malignant,10,,23,,,,31949,,,385,385,,,,,385,,,385,,,,,,,,TUMOR FREE,Alive,-26704,,,,154,,385,385,,,[Not Available],[Not Applicable],,,,,0.07,,,,,6,,0,0.20643,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-3774,,,,,,,385,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,83796,,0.669451916,,,,,,,,,,0.258232415,,0.179022255,,,,Stage IB,,0.814,,,,,,,,,,,,,,,,0.1133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12V (driver), G12C (driver), AMP (driver)",,1,,"G12V (driver), G12C (driver)",,,,,-0.155949411,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.5862,,0.0118,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.57,0.45,8,10,7,,,503,BRCA_LumA,,503,,0,0,503,503,,Invasive Carcinoma,25,,30,,,,33528,0,,503,503,,,,,503,,,503,,,,,,,,TUMOR FREE,Alive,-27106,,,,65,,503,503,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,21,,1,0.1885,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XY,,,,,,,503,,,,,,,,,24,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,83798,,,0,0,0,0,-0.4011,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,[Not Available],,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-YL-A8SH,,PRAD,389,0,0,,YL,2,2,MALE,2,1.93,0.68,5,9,0,HRD,NO,875,5-SPOP,875,875,,2,2,875,875,prad_tcga,Malignant,14,,97,,TCGA-YL-A8SH-01,0,5665,0,TCGA-YL-A8SH,875,875,Prostate Cancer,,617,875,875,TCGA,,875,Primary,0,Apex|Middle|Base,B,ATM:1937:N/X:frameshift_variant,,True,TUMOR FREE,Dead,-25395,875,69,7,42,PRAD,875,875,,0.0,"Other, non-malignant disease",[Not Applicable],35,R0,1,Matched,0.02,Prostate,Resection,4,56A06467-7CB6-4DFF-9F57-88228210619E,0,,0,0.091978,[Not Available],BFB973EB-D42D-4900-A606-A381D2317555,3,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8SH,,3,14,Prostate Adenocarcinoma,,4/25/14,,,,"Other, non-malignant disease",Death Certificate,NO,C61,62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7,510,3,TUMOR FREE,0.0699,1:DECEASED,0.06,,28.75,Bilateral,15,,,YES,1481,2009,,,TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,83799,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-71-8520,Asian,LUAD,,1,1,,ILSBio,1,1,FEMALE,1,,,,,,,,210,,179,210,,1,1,179,179,,Malignant,,,,,,,21606,,,179,179,,,,179,210,,,179,,,,,,,,WITH TUMOR,Dead,-21921,210,,,114,,179,179,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ILSBio,,TCGA-71-8520,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2011,179,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,83800,,0.216276689,,,,,,,,,,0.204075253,,0.171327884,,,,Stage IB,,0.2715,,,,,,,,,,,,,,,,0.5624,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), L62R (driver)",,,1,"L858R (driver), L62R (driver)",,,,,,-0.40580887,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.9553,,-1.2952,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-58-A46N,White,LUSC,,1,1,,Thoraxklinik at University Hospital Heidelberg,1,0,MALE,1,1.49,0.89,12,6,12,,,910,,630,910,,1,1,630,630,,Malignant,30,,176,,,,26895,,,630,630,,,,630,910,,,630,,,,,,,,WITH TUMOR,Alive,-19050,,,,290,,630,630,,,[Not Available],[Not Applicable],,,,,0.15,,,,,13,,0,0.58992,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-58-A46N,,,,,,,910,,Locoregional Recurrence,,,,,,,16,,,,,,,,,,,,,2011,630,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,83804,,-0.17072528,,,,,,,,,,0.067919532,,-0.017567853,,,,Stage IB,,1.0635,,,,,,,,,,,,,,,,0.1579,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.71481790845327,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-2.0669,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-D7-6822,White,STAD,,0,0,,,0,0,,0,2.32,0.73,18,14,23,,,375,,375,375,,0,0,375,375,,Malignant,55,,202,,,,17447,,,375,375,,,,375,375,,,375,,,,,,,,TUMOR FREE,Alive,-28214,,,,318,,375,375,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,13,,0,0.39472,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6822,,,,,,,375,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,83812,,,,,,,,,,,,,Grade 2,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6822,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,1,1,Male,TCGA-HI-7168,White,PRAD,184,1,1,,HI,,0,MALE,1,3.46,0.57,4,8,11,ambiguous,NO,3323,3-ETV4,,3323,,1,1,2505,2505,prad_tcga,Malignant,23,BRCA1;BRCA2;CHEK2;RAD51D;RAD54L,40,5.5,TCGA-HI-7168-01,0,5466,0,TCGA-HI-7168,2505,2505,Prostate Cancer,19,2289,,3323,TCGA,No Evidence of Extraprostatic Extension,2505,Primary,0,,A,,,,WITH TUMOR,Alive,-22881,,62,9,61,PRAD,2505,2505,WHITE,0.0,[Not Available],[Not Applicable],42,R0,1,Matched,0.48,Prostate,Resection,4,dd410832-95aa-4fa6-a2b9-3feca6f70e1d,22,Normal (no evidence of prostate cancer) [cM0],1,0.10057,[Not Available],25d70934-01a5-45a2-9960-68d3058b6965,5,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,22,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HI,1.36666666667,TCGA-HI-7168,1:Recurred/Progressed,5,30,Prostate Adenocarcinoma,82.29,2/20/12,3323,Bone,Biochemical evidence of disease,,,YES,C61,d29af7d7-996d-44a9-a571-878ea0f95403,,15,,0.3786,0:LIVING,0.3,,109.17,Bilateral,39,,,YES,,2005,2505,,TCGA-HI-7168.d29af7d7-996d-44a9-a571-878ea0f95403.pdf,,[Not Applicable],NO,19,16-25%,9,Prostate Adenocarcinoma Acinar Type,1,2005,Stable Disease,,YES,No,R0,1.0,62,Core needle biopsy,308,,NO,YES,YES,,T3b,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,83818,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.9,3,6,7,,,2953,BRCA_LumB,2953,2953,,0,0,2953,2953,,Invasive Carcinoma,16,,11,,,,28267,0,,2953,2953,,,,2953,2953,,,2953,,,,,,,,TUMOR FREE,Alive,-28247,,,,25,,2953,2953,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,6,,0,0.093194,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A1KP,,,,,,,2953,,,,,,,,,5,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,83819,,-1.051931232,0,0,0,0,-0.1581,1,,,Infiltrating Ductal Carcinoma,0.046974849,,0.0455087,0,0,0,,Negative,-1.005,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1281,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.74,0.58,12,13,19,,,3283,BRCA_LumB,3283,3283,,0,0,3283,3283,,Invasive Carcinoma,44,,92,,,,22997,0,,3283,3283,,,,3283,3283,,,3283,,,,,,,,TUMOR FREE,Alive,-24541,,,,90,,3283,3283,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,11,,1,0.21124,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CW,,,,,,,3283,,,,,,,,,23,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,83821,,0.387804817,0,0,0,0,0.3699,1,,,Infiltrating Ductal Carcinoma,0.092585507,,0.088681455,0,0,0,,Negative,0.197,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.2099,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,Benign Breast Epithelium,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,,,,,,,,792,,780,792,,1,1,780,780,,Invasive Carcinoma,,,,,,,22650,0,,780,780,,,,780,792,,,780,,,,,,,,WITH TUMOR,Dead,-31805,792,,,0,,780,780,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2FM,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2004,780,Bone Marrow,,,Stage IIB,,,,,,,,[Not Available],,,,,,87,,,,,,,,,,,,,,,,,,,,83823,,-0.788041261,0,0,0,0,-0.3463,1,,,Infiltrating Lobular Carcinoma,0.085489743,,0.200668094,0,0,0,,Negative,-1.4435,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.135,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,,,,,,,,1325,,,1325,,0,0,1325,1325,,Invasive Carcinoma,,,,,,,21171,0,,1325,1325,,,,,1325,,,1325,,,,,,,,TUMOR FREE,Alive,-15969,,,,0,,1325,1325,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A3DX,,,,,,,1325,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,83828,,1.355519714,0,0,0,0,0.3031,1,,,Infiltrating Lobular Carcinoma,0.215462343,,0.264582809,0,0,0,,Positive,0.998,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6551,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4490,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,5.15,0.26,6,8,14,,,385,,,385,,1,1,385,385,,Malignant,28,,29,,,,23533,,,385,385,,,,,385,,,385,,,,,,,,WITH TUMOR,Dead,-16634,385,,,65,,385,385,,,[Not Available],[Not Applicable],,,,,0.42,,,,,26,,2,0.245,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4490,,,,,,,,,,,,,,,,48,,,,,,,,,,,,,1993,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,83830,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,14.95813934,15.40312664,13.8353783,-0.483626278,LUAD,Adenocarcinoma,18.18408044,15.19834945,Adenocarcinoma,0.3378,12.95053452,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-69-7980,White,LUAD,,0,0,,Washington University - Cleveland Clinic,0,0,FEMALE,0,3.76,0.55,12,13,24,,,411,,411,411,,0,0,411,411,,Malignant,49,,111,,,,25009,,,411,411,,,,411,411,,,411,,,,,,,,TUMOR FREE,Alive,-25583,,,,1033,,411,411,,,[Not Available],[Not Applicable],,,,,0.21,,,,,18,,2,0.48996,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7980,,,,,,,411,,,,,,,,,60,,,,,,,,,,,,,2011,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,83831,,1.006876118,,,,,,,,,,0.232376891,,0.113409179,,,,Stage I,,1.56,,,,,,,,,,,,,,,,0.4336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,,,,-0.153937388,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3562,,0.6039,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,,1,1,Female,TCGA-39-5034,White,LUSC,,1,,,MSKCC,1,,FEMALE,1,3.07,0.51,12,6,19,,,1107,,352,1107,,1,,352,352,,Malignant,37,,105,,,,20303,,,352,,,,,352,1107,,,352,,,,,,,,,Dead,-26682,1107,,,824,,352,,,,[Not Available],[Not Applicable],,,,,0.11,,,,,11,,1,0.37521,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5034,,,,,,,1107,,,,,,,,,34,,,,,,,,,,,,,2007,352,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,83835,,0.665278124,,,,,,,,,,0.179423221,,0.119989923,,,,Stage IIB,,0.496,,,,,,,,,,,,,,,,0.1931,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R554Q,1,,,R554Q,15.1890157,16.46132945,15.37288354,-0.246238551310868,LUSC,Squamous Cell Carcinoma,17.8179026,15.62455185,Squamous Cell Carcinoma,0.7659,12.56649803,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-56-A4ZJ,White,LUSC,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.96,0.16,9,7,11,,,640,,640,640,,0,0,640,640,,Malignant,27,,52,,,,30443,,,640,640,,,,640,640,,,640,,,,,,,,TUMOR FREE,Alive,-27516,,,,141,,640,640,,,[Not Available],[Not Applicable],,,,,0.16,,,,,8,,0,0.25429,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-A4ZJ,,,,,,,640,,,,,,,,,13,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,83850,,0.237248254,,,,,,,,,,0.277362796,,0.196544781,,,,Stage IA,,0.6285,,,,,,,,,,,,,,,,0.9636,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.272992180038811,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.3718,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,1001,,1001,1001,,0,0,1001,1001,,Invasive Carcinoma,,,,,,,20747,0,,1001,1001,,,,1001,1001,,,1001,,,,,,,,TUMOR FREE,Alive,-18694,,,,35,,1001,1001,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UNC ,,TCGA-AQ-A54O,,,,,,,1001,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,83851,,-0.204365286,0,0,0,0,-0.213,1,,,Infiltrating Ductal Carcinoma,0.10849514,,0.021390695,0,0,0,,Negative,-0.5555,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1239,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.31,0.47,7,35,29,,,10,BRCA_LumA,10,10,,0,0,10,10,,Invasive Carcinoma,71,,58,,,,21337,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-25029,,,,214,,10,10,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,10,,1,0.19418,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0XN,,,,,,,10,,,,,,,,,39,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,83857,,0.059147558,0,0,0,0,-0.8238,1,,,Infiltrating Ductal Carcinoma,0.245229647,,0.19807099,0,0,0,,Negative,-0.1105,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.8499,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-UY-A9PA,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.91,0.18,7,8,10,,,1072,,1072,1072,,0.0,0,1072.0,1072.0,,Malignant,25,,55,,,,16275.0,,,1072.0,1072,,,,1072,1072,,,1072.0,,,,,,,,TUMOR FREE,Alive,-17520,,,,222.0,,1072.0,1072,,,[Not Available],[Not Applicable],,,,,0.43,,,,,7,,0,0.2747,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A9PA,,,,,,,1072,,,,,,,,,15,,,,,,,,,,,,,,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,48.0,,,,,,,,,,,,,,,,,,,,83860,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.03,0.54,11,26,20,,,4285,BRCA_Basal,4285,4285,,0,0,4285,4285,,Invasive Carcinoma,57,,82,,,,19634,0,,4285,4285,,,,4285,4285,,,4285,,,,,,,,TUMOR FREE,Alive,-14669,,,,0,,4285,4285,,,[Not Available],[Not Applicable],,,,,0.41,Breast,Resection/Excision,,,9,,1,0.31923,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0IQ,,,,,,,4285,,,,,,,,,28,,,,,,,,,,,,,1996,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,83862,,0.822306309,0,0,0,0,-1.817,1,,,Infiltrating Ductal Carcinoma,0.089815494,,0.059634914,0,0,0,,Negative,0.024,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0693,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-Y6-A8TL,,PRAD,389,0,0,,Y6,,0,MALE,0,1.96,0.59,2,6,0,HRP,NO,992,5-SPOP,,992,,0,0,992,992,prad_tcga,Malignant,8,,79,,TCGA-Y6-A8TL-01,10,5643,0,TCGA-Y6-A8TL,992,992,Prostate Cancer,,775,,992,TCGA,,992,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23776,,65,6,33,PRAD,992,992,,0.323169738,[Not Available],[Not Applicable],32,R0,1,Matched,0.0,Prostate,Resection,3,E8FA37B1-2E31-44B6-BA77-3E46DA7E4FEE,0,,0,0.047748,[Not Available],A7045324-CB44-4B37-BBAF-641642C1D903,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,Y6,1.06666666667,TCGA-Y6-A8TL,0:DiseaseFree,1,11,Prostate Adenocarcinoma,32.59,4/17/14,992,,,,,NO,C61,8DE4AB1E-913E-4763-81EE-272430E5CC4A,370,0,TUMOR FREE,0.0468,0:LIVING,0.0,,32.59,Right,12,No Evidence of Extraprostatic Extension,328,YES,677,2012,,,TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Available],,NO,No,R0,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T2a,0,,C61.9,8140/3,83867,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.72,5,2,5,,,1093,BRCA_LumA,1093,1093,,0,0,1093,1093,,Invasive Carcinoma,12,,14,,,,27563,0,,1093,1093,,,,1093,1093,,,1093,,,,,,,,TUMOR FREE,Alive,-19489,,,,43,,1093,1093,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,4,,0,0.091947,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18I,,,,,,,1093,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,83870,,1.169705367,0,0,0,0,0.4155,1,,,Infiltrating Ductal Carcinoma,0.181975562,,0.172014502,0,0,0,,Negative,0.8735,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5917,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Cribriform, Intermediate Grade), Microcalcifications",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WH,,PRAD,389,0,0,,YL,,0,MALE,0,3.11,0.75,8,12,10,ambiguous,NO,427,2-ETV1,,427,,0,0,427,427,prad_tcga,Malignant,30,BRCA2;CHEK2;RAD51C;RAD54L,63,,TCGA-YL-A9WH-01,0,5688,0,TCGA-YL-A9WH,427,427,Prostate Cancer,,349,,427,TCGA,,427,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-24755,,67,9,70,PRAD,427,427,,0.0,[Not Available],[Not Applicable],55,R1,1,Matched,0.49,Prostate,Resection,4,026FCC86-6F9D-4A61-AAFE-97C8F6CC4BA5,19,Normal (no evidence of prostate cancer) [cM0],1,0.12196,[Not Available],1BCB1132-A9FC-4F03-BBED-ABAF80C7A24A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,29,,Acinar Adenocarcinoma,[Not Available],,YL,1.83333333333,TCGA-YL-A9WH,0:DiseaseFree,5,30,Prostate Adenocarcinoma,14.03,4/10/14,427,,,,,NO,C61,D7DFBDEF-50DC-4CE1-9661-110A8EAE8685,90,21,,0.5475,0:LIVING,0.03,,14.03,Bilateral,40,,,YES,853,2011,,,TCGA-YL-A9WH.D7DFBDEF-50DC-4CE1-9661-110A8EAE8685.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,55,51-60%,2,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,1,M0,C61.9,8140/3,83871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Female,TCGA-DK-A2HX,White,BLCA,,0.0,0,,,,2,FEMALE,2.0,3.79,0.49,2,10,12,,,1420,,,1420,,2.0,2,1420.0,1420.0,,Malignant,24,,6,,,,31212.0,,,1420.0,1420,,,,,1420,,,1420.0,,,,,,,,TUMOR FREE,Dead,-29332,1420,,,140.0,,1420.0,1420,,,[Not Available],[Not Applicable],,,,,0.13,,,,,18,,1,0.073261,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A2HX,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,[Not Available],,,,,,80.0,,,,,,,,,,,,,,,,,,,,83875,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8256,,PRAD,221,0,0,,HC,0,0,MALE,0,2.0,0.48,2,3,3,HRP,NO,860,8-other,860,860,,0,0,860,860,prad_tcga,Malignant,8,,20,6.3,TCGA-HC-8256-01,0,5437,0,TCGA-HC-8256,860,860,Prostate Cancer,,,860,860,TCGA,,860,Primary,0,,A,,,,TUMOR FREE,Alive,-19598,,53,7,35,PRAD,860,860,,0.0,[Not Available],[Not Applicable],36,R0,1,Matched,0.03,Prostate,Resection,3,7a9b0cbb-b14f-40b7-9fe1-2375bf68ea3f,2,,0,0.033934,[Not Available],89a297be-ebb5-4b9f-8eda-0e548d14ad91,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,7,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.16666666667,TCGA-HC-8256,0:DiseaseFree,2,7,Prostate Adenocarcinoma,28.25,6/13/12,860,,,,,,C61,2ec7732c-f24c-41eb-ba84-39bfc1c0c5b3,,2,TUMOR FREE,0.0635,0:LIVING,,,28.25,Bilateral,8,,,YES,,2011,,,TCGA-HC-8256.2ec7732c-f24c-41eb-ba84-39bfc1c0c5b3.pdf,,[Not Applicable],,,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,53,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,,,M0,C61.9,8550/3,83880,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-78-8640,Unknown,LUAD,,0,0,,Prince Charles Hospital,0,0,MALE,0,2.72,0.35,7,24,18,,,7062,,7062,7062,,0,0,7062,7062,,Malignant,49,,89,,,,21089,,,7062,7062,,,,7062,7062,,,7062,,,,,,,,TUMOR FREE,Alive,-21832,,,,1003,,7062,7062,,,[Not Available],[Not Applicable],,,,,0.26,,,,,12,,1,0.23385,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-8640,,,,,,,7062,,,,,,,,,42,,,,,,,,,,,,,1994,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,83885,,0.550105595,,,,,,,,,,0.192778861,,0.061698994,,,,Stage IIA,,0.611,,,,,,,,,,,,,,,,-0.1381,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.22705572,16.58631346,16.01600749,-0.404354664,LUAD,Adenocarcinoma,17.6421608,15.46065669,Adenocarcinoma,-0.4304,13.16380017,0.0045,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,1.85,0.43,7,10,9,,,1324,BRCA_LumB,1324,1324,,2,2,1324,1324,,Invasive Carcinoma,26,,42,,,,17239,0,,1324,1324,,,,1324,1324,,,1324,,,,,,,,TUMOR FREE,Dead,-20691,1324,,,42,,1324,1324,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,10,,0,0.29052,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BF,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,83886,,1.8402391,0,0,0,0,-1.3196,1,,,Infiltrating Ductal Carcinoma,0.220252409,,0.195522018,0,0,0,,Negative,1.3565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6631,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.53,11,15,17,,,2124,BRCA_Normal,2124,2124,,0,0,2124,2124,,Invasive Carcinoma,43,,18,,,,28613,0,,2124,2124,,,,2124,2124,,,2124,,,,,,,,TUMOR FREE,Alive,-15540,,,,156,,2124,2124,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,6,,0,0.19939,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A03T,,,,,,,2124,,,,,,,,,11,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,83887,,0.480035212,0,0,0,0,0.3319,1,,,Infiltrating Ductal Carcinoma,0.091076993,,0.166799083,0,0,0,,Negative,-0.459,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0201,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HU-8249,Asian,STAD,,0,0,,,0,0,,0,3.76,0.76,6,16,18,,,881,,881,881,,0,0,881,881,,Malignant,40,,105,,,,33411,,,881,881,,,,881,881,,,881,,,,,,,,TUMOR FREE,Alive,-28012,,,,190,,881,881,,,[Not Available],[Not Applicable],,,,,0.26,Stomach,Unknown,,,15,,1,0.24106,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-8249,,,,,,,881,,,,,,,,,30,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,83888,,0.091273957,,,,,,,,,,0.022982972,Grade 2,0.079639561,,,,Stage IIIA,,1.049,,,,,,,,,,,,,,,,0.1226,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-8249,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Female,TCGA-05-4427,,LUAD,,0,0,,Indivumed,0,0,FEMALE,0,4.77,0.47,5,11,18,,,791,,791,791,,0,0,791,791,,Malignant,34,,7,,,,25633,,,791,791,,,,791,791,,,791,,,,,,,,TUMOR FREE,Alive,-23893,,,,1310,,791,791,,,[Not Available],[Not Applicable],,,,,0.51,,,,,18,,2,0.12284,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4427,,,,,,,791,,,,,,,,,55,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,83889,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,16.30988589,18.06962046,16.23860834,-0.2217678,LUAD,,17.66196132,15.96043165,Adenocarcinoma,0.4901,13.2989426,0.1683,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.83,0.79,11,12,10,,,1026,BRCA_Basal,1026,1026,,0,0,1026,1026,,Invasive Carcinoma,33,,43,,,,29195,0,,1026,1026,,,,1026,1026,,,1026,,,,,,,,TUMOR FREE,Alive,-23927,,,,83,,1026,1026,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,12,,0,0.42488,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AY,,,,,,,1026,,,,,,,,,18,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,83890,TRUE,-0.773260866,0,0,0,0,0.181,1,,,Infiltrating Ductal Carcinoma,0.147855396,,0.072119017,0,0,0,,Negative,-0.9265,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.254,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-7221,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,1.86,0.58,10,5,8,,,608,,608,608,,0,0,608,608,,Malignant,23,,41,,,,26371,,,608,608,,,,608,608,,,608,,,,,,,,TUMOR FREE,Alive,-28873,,,,383,,608,608,,,[Not Available],[Not Applicable],,,,,0.22,,,,,12,,0,0.40309,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7221,,,,,,,608,,,,,,,,,18,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,83891,,-0.171009133,,,,,,,,,,0.131888345,,-0.06188155,,,,Stage IB,,-0.661,,,,,,,,,,,,,,,,-0.0217,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-1.12906957964254,LUSC,,,,Squamous Cell Carcinoma,-1.0084,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,742,,742,742,,0,0,742,742,,Invasive Carcinoma,,,,,,,17265,0,,742,742,,,,742,742,,,742,,,,,,,,TUMOR FREE,Alive,-24779,,,,0,,742,742,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Metaplastic Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A4RX,,,,,,,742,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,83896,,0.941464197,0,0,0,0,0.8668,1,,,Metaplastic Carcinoma,0.161259617,,0.174679044,0,0,0,,Negative,0.235,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.8261,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,83899,,0.655633346,,,,,,,,,,0.193372703,,0.052727865,,,,Stage IA,,1.109,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-50-5045,Black or African American,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,2.22,0.22,2,4,5,,,2174,,,2174,,1,1,1433,1433,,Malignant,11,,14,,,,18678,,,1433,1433,,,,,2174,,,1433,,,,,,,,WITH TUMOR,Dead,-20961,2174,,,364,,1433,1433,,,[Not Available],[Not Applicable],,,,,0.44,,,,,3,,0,0.24146,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5045,,,,,,,,,Locoregional Recurrence,,,,,,,25,,,,,,,,,,,,,2004,1433,,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,57,,,,,,,,,,,,,,,,,,,,83900,,1.71581939,,,,,,,,,,0.299713596,,0.244453817,,,,Unknown,,1.75,,,,,,,,,,,,,,,,0.5228,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.180141759,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.3789,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.37,0.64,7,13,20,,,303,BRCA_LumB,303,303,,0,0,303,303,,Invasive Carcinoma,40,,75,,,,21591,0,,303,303,,,,303,303,,,303,,,,,,,,TUMOR FREE,Alive,-29131,,,,129,,303,303,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,15,,1,0.20585,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0AJ,,,,,,,303,,,,,,,,,40,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,83906,,1.270539891,0,0,0,0,-0.2223,1,,,Infiltrating Ductal Carcinoma,0.216164211,,0.045746219,0,0,0,,Negative,0.8955,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1189,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HU-A4GC,Asian,STAD,,0,0,,,,0,,0,2.37,0.33,12,14,18,,,99,,,99,,0,0,99,99,,Malignant,44,,97,,,,26282,,,99,99,,,,,99,,,99,,,,,,,,TUMOR FREE,Alive,-27267,,,,190,,99,99,,,[Not Available],[Not Applicable],,,,,0.17,Stomach,Unknown,,,13,,1,0.33931,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4GC,,,,,,,99,,,,,,,,,41,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Stable Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,83908,,-0.197592428,,,,,,,,,,0.038709061,Grade 3,0.067867189,,,,Stage IIIB,,-0.944,,,,,,,,,,,,,,,,-0.1228,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GC,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0.0,0,0,0.0,0.0,Female,TCGA-G2-AA3B,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.82,0.84,24,22,19,,,2008,,2008,2008,,0.0,0,2008.0,2008.0,,Malignant,65,,339,,,,16845.0,,,2008.0,2008,,,,2008,2008,,,2008.0,,,,,,,,TUMOR FREE,Alive,-27646,,,,963.0,,2008.0,2008,,,[Not Available],[Not Applicable],,,,,0.71,,,,,7,,0,0.45452,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3B,,,,,,,2008,,,,,,,,,22,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,83914,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4490,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,5.15,0.26,6,8,14,,,385,,,385,,1,1,385,385,,Malignant,28,,29,,,,23533,,,385,385,,,,,385,,,385,,,,,,,,WITH TUMOR,Dead,-16634,385,,,65,,385,385,,,[Not Available],[Not Applicable],,,,,0.42,,,,,26,,2,0.245,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4490,,,,,,,,,,,,,,,,48,,,,,,,,,,,,,1993,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,83916,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,14.95813934,15.40312664,13.8353783,-0.483626278,LUAD,Adenocarcinoma,18.18408044,15.19834945,Adenocarcinoma,,12.95053452,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,906,,906,906,,0,0,906,906,,Benign Breast Disease,,,,,,,82142,N/A (Non-Malignant),,906,906,,,,906,906,,,906,,,,,,,,TUMOR FREE,Alive,-23294,,,,0,,906,906,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0DC,,,,,,,906,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,83918,,,0,0,0,0,-0.5798,0,Redacted,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,,N/A (Non-Malignant),,0,0,1,N/A (Non-Malignant),Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,Benign Breast Epithelium,N/A No in Situ,None,,None,0,None,None,0,Papilloma,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.99,0.39,3,5,3,,,1043,BRCA_LumA,,1043,,0,0,1043,1043,,Invasive Carcinoma,11,,14,,,,16305,0,,1043,1043,,,,,1043,,,1043,,,,,,,,TUMOR FREE,Alive,-28596,,,,87,,1043,1043,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,6,,0,0.11445,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0CG,,,,,,,1043,,,,,,,,,8,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,83923,,,0,0,0,0,0.7198,1,,,Mixed Histology (NOS),,,,0,0,0,,Close,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-77-A5G6,Unknown,LUSC,,1,1,,Prince Charles Hospital,1,1,MALE,1,3.24,0.7,10,15,18,,,678,,392,678,,1,1,392,392,,Malignant,43,,74,,,,18561,,,392,392,,,,392,678,,,392,,,,,,,,WITH TUMOR,Dead,-24215,678,,,657,,392,392,,,[Not Available],[Not Applicable],,,,,0.17,,,,,16,,1,0.27667,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5G6,,,,,,,,,Locoregional Recurrence,,,,,,,28,,,,,,,,,,,,,2009,392,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,83926,,-0.109075486,,,,,,,,,,0.12128174,,0.019423741,,,,Stage IIIA,,-0.586,,,,,,,,,,,,,,,,0.1897,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.04880405,14.88929102,13.86980423,-0.880410321284756,LUSC,Squamous Cell Carcinoma,17.70564934,14.8417942,Squamous Cell Carcinoma,-1.1937,13.15517834,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-G2-A2EC,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,,,,,,,,696,,,696,,1.0,1,679.0,679.0,,Malignant,,,,,,,19026.0,,,679.0,679,,,,,696,,,679.0,,,,,,,,WITH TUMOR,Dead,-21215,696,,,244.0,,679.0,679,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,679,small bowel,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,83928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-D7-6817,White,STAD,,0,0,,,,0,,0,2.99,0.44,4,14,11,,,389,,,389,,0,0,389,389,,Malignant,29,,31,,,,22392,,,389,389,,,,,389,,,389,,,,,,,,TUMOR FREE,Alive,-23142,,,,103,,389,389,,,[Not Available],[Not Applicable],,,,,0.1,Stomach,Unknown,,,16,,1,0.16071,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6817,,,,,,,389,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,83929,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6817,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Female,TCGA-75-5147,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),0,0,FEMALE,0,3.29,0.4,8,7,13,,,1333,,1333,1333,,0,0,1333,1333,,Malignant,28,,24,,,,16628,,,1333,1333,,,,1333,1333,,,1333,,,,,,,,TUMOR FREE,Alive,,,,,50,,1333,1333,,,[Not Available],[Not Applicable],,,,,0.35,,,,,12,,1,0.19559,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-5147,,,,,,,1333,,,,,,,,,24,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,83938,,1.060638421,,,,,,,,,,0.251530349,,0.073153443,,,,Stage IB,,0.902,,,,,,,,,,,,,,,,0.0667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.122965949,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.8831,,-0.0035,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-93-7347,White,LUAD,,0,0,,Washington University - St. Louis,0,0,FEMALE,0,2.01,0.3,4,3,3,,,683,,683,683,,0,0,683,683,,Malignant,10,,11,,,,21659,,,683,683,,,,683,683,,,683,,,,,,,,TUMOR FREE,Alive,-27949,,,,149,,683,683,,,[Not Available],[Not Applicable],,,,,0.18,,,,,5,,0,0.098524,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - St. Louis,,TCGA-93-7347,,,,,,,683,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,83939,,1.74065403,,,,,,,,,,0.288206484,,0.18154776,,,,Stage IA,,1.403,,,,,,,,,,,,,,,,0.4504,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,0.138006259,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.1556,,1.458,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HC-7230,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.94,0.84,4,1,1,HRD,NO,1001,1-ERG,1001,1001,,0,0,1001,1001,prad_tcga,Malignant,6,,14,3.0,TCGA-HC-7230-01,0,5412,0,TCGA-HC-7230,1001,1001,Prostate Cancer,,,1001,1001,TCGA,,1001,Primary,0,,A,BRCA2:602:G/X:frameshift_variant,,,TUMOR FREE,Alive,-18577,,50,7,29,PRAD,1001,1001,WHITE,0.0,[Not Available],[Not Applicable],51,R0,1,Matched,0.01,Prostate,Resection,3,b8bac212-127d-4eee-8647-3bddc13c9415,2,,0,0.05539,[Not Available],03c66cf8-bc68-4ee1-a322-689a29b72262,4,Prostate Adenocarcinoma Acinar Type,0.5,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.7,TCGA-HC-7230,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.88,10/6/11,1001,,,,,,C61,0c078733-c8ed-4d5c-9da0-979f4af4fc4f,,2,TUMOR FREE,0.0527,0:LIVING,3.0,,32.88,,15,,,YES,,2011,,,TCGA-HC-7230.0c078733-c8ed-4d5c-9da0-979f4af4fc4f.pdf,,[Not Applicable],,,51-60%,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.4,50,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,,C61.9,8550/3,83942,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.91,0.74,4,1,2,,,1611,BRCA_LumA,1611,1611,,0,0,1611,1611,,Invasive Carcinoma,7,,12,,,,16461,0,,1611,1611,,,,1611,1611,,,1611,,,,,,,,TUMOR FREE,Alive,-11379,,,,493,,1611,1611,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,3,,0,0.087672,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HA,,,,,,,1611,,,,,,,,,4,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,31,,,,,,,,,,,,,,,,,,,,83945,,1.232159169,0,0,0,1,1.025,0,,,Infiltrating Ductal Carcinoma,0.133853578,,0.25028715,0,0,0,,Negative,0.279,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5542,1,0,H & E,0,0,,0,Theresa Smith,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-77-8143,Unknown,LUSC,,1,1,,Prince Charles Hospital,,1,MALE,1,3.15,0.66,7,3,13,,,803,,,803,,1,1,803,803,,Malignant,23,,28,,,,31253,,,803,803,,,,,803,,,803,,,,,,,,WITH TUMOR,Dead,-27772,803,,,194,,803,803,,,[Not Available],[Not Applicable],,,,,0.11,,,,,16,,1,0.3289,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8143,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2004,,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,76,,,,,,,,,,,,,,,,,,,,83950,,0.305527348,,,,,,,,,,0.135444132,,-0.01606161,,,,Stage IIIA,,0.858,,,,,,,,,,,,,,,,-0.3042,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,14.15344764,15.27403795,15.20701093,-0.563695032711409,LUSC,Squamous Cell Carcinoma,17.594851,14.92697279,Squamous Cell Carcinoma,-1.3345,12.88634509,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-E7-A3X6,White,BLCA,,1.0,1,,,1,1,MALE,1.0,1.81,0.71,9,6,8,,,904,,369,904,,1.0,1,369.0,369.0,,Malignant,23,,76,,,,31118.0,,,369.0,369,,,,369,904,,,369.0,,,,,,,,WITH TUMOR,Dead,-25584,904,,,156.0,,369.0,369,,,[Not Available],[Not Applicable],,,,,0.03,,,,,10,,0,0.25537,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,Asterand,,TCGA-E7-A3X6,,,,,,,,Bone,Distant Metastasis,,,,,,,9,,,,,,,,,,,,,2011,369,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,83954,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-77-7142,White,LUSC,,0,0,,Prince Charles Hospital,,0,FEMALE,0,3.53,0.39,9,13,19,,,2227,,,2227,,0,0,2227,2227,,Malignant,41,,71,,,,19525,,,2227,2227,,,,,2227,,,2227,,,,,,,,TUMOR FREE,Alive,-21796,,,,344,,2227,2227,,,[Not Available],[Not Applicable],,,,,0.22,,,,,17,,1,0.40779,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7142,,,,,,,2227,,,,,,,,,31,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,83959,,1.445368992,,,,,,,,,,0.220593039,,0.136409658,,,,Stage IB,,-0.25,,,,,,,,,,,,,,,,0.2317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.436135739055648,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.0977,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-GC-A3RD,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,2.89,0.71,12,15,17,,,428,,428,428,,0.0,0,428.0,428.0,,Malignant,44,,88,,,,26681.0,,,428.0,428,,,,428,428,,,428.0,,,,,,,,TUMOR FREE,Alive,-30529,,,,122.0,,428.0,428,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.46858,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A3RD,,,,,,,428,,,,,,,,,39,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,83.0,,,,,,,,,,,,,,,,,,,,83966,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-63-6202,,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,2.15,0.42,8,11,16,,,1602,,1602,1602,,0,0,1602,1602,,Malignant,35,,49,,,,25152,,,1602,1602,,,,1602,1602,,,1602,,,,,,,,TUMOR FREE,Alive,,,,,443,,1602,1602,,,[Not Available],[Not Applicable],,,,,0.46,,,,,13,,1,0.53894,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-6202,,,,,,,1602,,,,,,,,,40,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,83970,,1.450726223,,,,,,,,,,0.236086215,,0.198292576,,,,Stage IIA,,2.444,,,,,,,,,,,,,,,,0.4304,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,Q61H (driver),,1,,Q61H (driver),,17.26386502,17.83573156,18.09310692,0.279909032500558,LUSC,Squamous Cell Carcinoma,18.11936449,16.6594295,Squamous Cell Carcinoma,0.3701,13.89344504,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A1AG,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.95,0.92,0,0,0,,,475,,475,475,,0.0,0,475.0,475.0,,Malignant,0,,12,,,,29218.0,,,475.0,475,,,,475,475,,,475.0,,,,,,,,TUMOR FREE,Alive,-24095,,,,299.0,,475.0,475,,,[Not Available],[Not Applicable],,,,,0.01,,,,,2,,0,0.053666,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1AG,,,,,,,475,,,,,,,,,1,,,,,,,,,,,,,2010,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,65.0,,,,,,,,,,,,,,,,,,,,83974,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.7,2,4,5,,,30,BRCA_LumA,30,30,,0,0,30,30,,Invasive Carcinoma,11,,6,,,,30425,0,,30,30,,,,30,30,,,30,,,,,,,,TUMOR FREE,Alive,-32750,,,,0,,30,30,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,3,,0,0.042036,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08A,,,,,,,30,,,,,,,,,4,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,89,,,,,,,,,,,,,,,,,,,,83975,,0.00362735,0,0,0,0,0.1812,1,,,Infiltrating Ductal Carcinoma,0.160099455,,0.103531625,0,0,0,,Negative,-0.551,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3295,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-49-6744,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,1.9,0.37,9,8,9,,,1683,,1683,1683,,0,0,1683,1683,,Malignant,26,,24,,,,19681,,,1683,1683,,,,1683,1683,,,1683,,,,,,,,TUMOR FREE,Alive,-23484,,,,273,,1683,1683,,,[Not Available],[Not Applicable],,,,,0.57,,,,,4,,0,0.16693,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6744,,,,,,,1683,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,83976,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.5446,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.81227495,17.88169462,15.96454625,0.112267588,LUAD,,18.26810023,16.55309108,Adenocarcinoma,,14.17567917,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-YL-A9WK,,PRAD,,1,1,,YL,,0,MALE,1,2.01,0.72,5,3,5,,NO,2136,,,2136,,1,1,1009,1009,prad_tcga,Malignant,13,BARD1;BRCA2;CHEK2;FANCL,84,,TCGA-YL-A9WK-01,4,5694,0,TCGA-YL-A9WK,1009,1009,Prostate Cancer,,1871,,2136,TCGA,,1009,Primary,0,Middle,A,,,True,WITH TUMOR,Alive,-23272,,63,9,35,PRAD,1009,1009,,0.110321939,[Not Available],[Not Applicable],34,,1,Matched,0.34,Prostate,Resection,4,225BC907-AFA6-424E-A618-2EB6BBF191EB,7,Normal (no evidence of prostate cancer) [cM0],0,0.14675,[Not Available],B2BCC97F-03A6-409A-8B91-78221CB10D7F,5,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A9WK,1:Recurred/Progressed,5,,Prostate Adenocarcinoma,33.15,4/13/14,2136,,Biochemical evidence of disease,,,NO,C61,B963A02D-0AE8-494C-A522-376AFABA374A,2085,8,WITH TUMOR,0.2269,0:LIVING,15.6,,70.17,Bilateral,,,,YES,1865,2008,1009,,TCGA-YL-A9WK.B963A02D-0AE8-494C-A522-376AFABA374A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,329,,1,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,YES,No,R1,,63,Core needle biopsy,1009,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,YES,0,N0,T2b,0,M0,C61.9,8140/3,83984,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-GC-A3OO,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.41,0.33,1,3,3,,,481,,481,481,,0.0,0,481.0,481.0,,Malignant,7,,29,,,,19455.0,,,481.0,481,,,,481,481,,,481.0,,,,,,,,TUMOR FREE,Alive,-29065,,,,180.0,,481.0,481,,,[Not Available],[Not Applicable],,,,,0.55,,,,,12,,0,0.16692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A3OO,,,,,,,481,,,,,,,,,17,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,79.0,,,,,,,,,,,,,,,,,,,,83987,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-05-4424,,LUAD,,1,1,,Indivumed,,0,MALE,1,4.42,0.24,4,11,14,,,913,,,913,,1,1,153,153,,Malignant,29,,14,,,,18389,,,153,153,,,,,913,,,153,,,,,,,,WITH TUMOR,Alive,-25689,,,,904,,153,153,,,[Not Available],[Not Applicable],,,,,0.45,,,,,15,,2,0.10282,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4424,,,,,,,913,,Distant Metastasis,,,,,,,62,,,,,,,,,,,,,2008,153,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,83989,,1.029355901,,,,,,,,,,0.282187942,,0.208017768,,,,Stage IIB,,0.507,,,,,,,,,,,,,,,,0.3044,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.56559466,18.50846552,14.97298117,-0.207384413,LUAD,Adenocarcinoma,17.81521452,15.73890178,Adenocarcinoma,0.155,13.58607475,0.251,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,1.0,0,0,0,,,2650,BRCA_Normal,2650,2650,,0,0,2650,2650,,Invasive Carcinoma,0,,0,,,,21661,0,,2650,2650,,,,2650,2650,,,2650,,,,,,,,TUMOR FREE,Alive,-16627,,,,2,,2650,2650,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,0,,0,0.0,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2FK,,,,,,,2650,,,,,,,,,0,,,,,,,,,,,,,2006,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,83991,,0.22035037,0,0,0,0,0.8198,1,,,Infiltrating Lobular Carcinoma,0.160298662,,0.226197338,0,0,0,,Negative,-0.2545,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0731,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-CF-A1HR,Asian,BLCA,,1.0,1,,,1,0,MALE,1.0,3.72,0.4,2,4,8,,,389,,294,389,,1.0,1,294.0,294.0,,Malignant,14,,14,,,,27565.0,,,294.0,294,,,,294,389,,,294.0,,,,,,,,WITH TUMOR,Alive,-22777,,,,364.0,,294.0,294,,,[Not Available],[Not Applicable],,,,,0.27,,,,,16,,1,0.068868,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ILSBio,,TCGA-CF-A1HR,,,,,,,389,Liver,Distant Metastasis,,,,,,,17,,,,,,,,,,,,,2010,294,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,62.0,,,,,,,,,,,,,,,,,,,,83993,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,,,,,,,,1616,,,1616,,0,0,1616,1616,,Invasive Carcinoma,,,,,,,17294,0,,1616,1616,,,,,1616,,,1616,,,,,,,,TUMOR FREE,Alive,-17026,,,,0,,1616,1616,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CZ,,,,,,,1616,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,83996,,0.828241342,0,0,0,0,-0.494,1,,,Infiltrating Ductal Carcinoma,0.174065633,,0.252784122,0,0,0,,Positive,0.201,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.8752,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5769,White,PRAD,91,0,0,,CH,,0,MALE,0,1.97,0.61,2,3,1,HRD,NO,62,1-ERG,,62,,0,0,62,62,prad_tcga,Malignant,6,,66,,TCGA-CH-5769-01,0,5259,0,TCGA-CH-5769,62,62,Prostate Cancer,,60,,62,TCGA,,62,Primary,0,,A,,ATM,,WITH TUMOR,Alive,-17807,,48,9,143,PRAD,62,62,WHITE,0.0,[Not Available],[Not Applicable],151,R1,1,Matched,0.0,Prostate,Resection,5,18606532-21d5-40bf-92cf-a42b027449a1,0,Normal (no evidence of prostate cancer) [cM0],0,0.030546,[Not Available],a7b76662-8380-4f35-9307-99c0acacb904,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,6,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,5.0,TCGA-CH-5769,0:DiseaseFree,5,10,Prostate Adenocarcinoma,2.04,3/16/12,62,,,,,NO,C61,7d49b105-6652-41b9-8e3a-e806a14de604,,0,WITH TUMOR,0.0284,0:LIVING,11.16,,2.04,Bilateral,22,No Evidence of Extraprostatic Extension,62,YES,,2007,,,TCGA-CH-5769.7d49b105-6652-41b9-8e3a-e806a14de604.pdf,,[Not Applicable],YES,62,61-70%,8,Prostate Adenocarcinoma Acinar Type,1,2007,[Not Available],,NO,No,R1,0.4,48,Core needle biopsy,,,YES,NO,YES,,T3b,,9,No,,0,N0,,0,M0,C61.9,8550/3,83998,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.51,0.78,2,0,5,,,546,BRCA_LumA,546,546,,0,0,546,546,,Invasive Carcinoma,7,,12,,,,22347,0,,546,546,,,,546,546,,,546,,,,,,,,TUMOR FREE,Alive,-22373,,,,158,,546,546,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,18,,1,0.078723,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A093,,,,,,,546,,,,,,,,,17,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,83999,,-1.537635235,0,0,0,0,0.4998,1,,,Infiltrating Ductal Carcinoma,0.145717455,,0.144960198,0,0,0,,Negative,-1.1005,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3993,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-98-A538,White,LUSC,,0,0,,Washington University - Alabama,0,0,MALE,0,2.73,0.45,13,6,17,,,826,,826,826,,0,0,826,826,,Malignant,36,,139,,,,32105,,,826,826,,,,826,826,,,826,,,,,,,,TUMOR FREE,Alive,-24698,,,,876,,826,826,,,[Not Available],[Not Applicable],,,,,0.05,,,,,19,,1,0.41293,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A538,,,,,,,826,,,,,,,,,35,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,84000,,0.476433693,,,,,,,,,,0.180276657,,0.033509321,,,,Stage IIB,,0.7555,,,,,,,,,,,,,,,,0.3436,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.069216,16.22786873,16.00666593,-0.398257137796907,LUSC,Squamous Cell Carcinoma,17.50320552,15.36847443,Squamous Cell Carcinoma,-0.1782,12.29280026,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,343,,343,343,,0,0,343,343,,Invasive Carcinoma,,,,,,,20329,0,,343,343,,,,343,343,,,343,,,,,,,,TUMOR FREE,Alive,-23209,,,,0,,343,343,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A3J1,,,,,,,343,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,84005,,1.007166203,0,0,0,0,-0.4009,1,,,Infiltrating Lobular Carcinoma,0.149604372,,0.222090116,0,0,0,,Negative,0.959,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3803,1,0,H & E,0,0,,0,Scott  Bourne,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-97-7937,White,LUAD,,0,0,,Washington University - NYU,,0,MALE,0,2.82,0.59,5,5,11,,,564,,,564,,0,0,564,564,,Malignant,21,,36,,,,32957,,,564,564,,,,,564,,,564,,,,,,,,TUMOR FREE,Alive,-23919,,,,592,,564,564,,,[Not Available],[Not Applicable],,,,,0.52,,,,,22,,1,0.18355,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-7937,,,,,,,564,,,,,,,,,38,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,84009,,-0.532558389,,,,,,,,,,0.193655511,,0.051477937,,,,Stage IB,,-0.6865,,,,,,,,,,,,,,,,0.0713,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.679412298,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2654,,-1.8218,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.48,9,17,12,,,577,BRCA_LumA,577,577,,0,0,577,577,,Invasive Carcinoma,38,,30,,,,18878,0,,577,577,,,,577,577,,,577,,,,,,,,TUMOR FREE,Alive,-23926,,,,107,,577,577,,,[Not Available],[Not Applicable],,,,,0.46,Breast,Resection/Excision,,,5,,0,0.1962,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07G,,,,,,,577,,,,,,,,,13,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,84010,,0.290316777,0,0,0,0,-0.1465,1,,,Infiltrating Ductal Carcinoma,0.175443508,,0.168275243,0,0,0,,Negative,-0.6405,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6852,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,1.65,0.78,12,8,10,,,763,BRCA_LumB,,763,,1,1,763,763,,Invasive Carcinoma,30,,51,,,,18576,0,,763,763,,,,,763,,,763,,,,,,,,WITH TUMOR,Dead,-32871,763,,,207,,763,763,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,14,,0,0.43305,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1F8,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,1999,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,84014,,-0.275787175,0,0,0,0,-0.8438,1,,,Infiltrating Ductal Carcinoma,0.150587889,,0.108844847,0,0,0,,[Not Available],-0.262,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,1,0,0.0245,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Nipple",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-8573,White,STAD,,0,0,,,0,0,,0,3.06,0.62,4,6,7,,,593,,593,593,,0,0,593,593,,Malignant,17,,61,,,,23349,,,593,593,,,,593,593,,,593,,,,,,,,WITH TUMOR,Alive,-20963,,,,110,,593,593,,,[Not Available],[Not Applicable],,,,,0.23,Stomach,Unknown,,,8,,1,0.082629,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8573,,,,,,,593,,,,,,,,,25,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,84017,,-0.060037194,,,,,,,,,,0.02805596,Grade 3,-0.000917218,,,,Stage IIA,,-0.1055,,,,,,,,,,,,,,,,-0.0029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8573,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0.0,0,0.0,0.0,0.0,Male,TCGA-HU-A4GF,Asian,STAD,,0.0,0,,,0,0.0,,0.0,2.52,0.66,15,14,23,,,785.0,,785,785.0,,0.0,0,785.0,785.0,,Malignant,52,,294,,,,32792.0,0,,785.0,785,,,,785,785.0,,,785.0,,,,,,,,TUMOR FREE,Alive,-25223.0,,,,187.0,,785.0,785,,,[Not Available],[Not Applicable],,,,,0.3,Stomach,Biopsy,,,18,,1,0.4354,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4GF,,,,,,,785,,,,,,,,,38,,,,,,,,,,,,,2011.0,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,84022,,0.439443937,,,,,,,,,,0.037882024,Grade 2,0.116310846,,,,Stage IIA,,0.1655,,,,,,,,,,,,,,,,-0.0872,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GF,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.47,2,0,3,,,2813,BRCA_LumA,2813,2813,,0,0,2813,2813,,Invasive Carcinoma,5,,4,,,,20597,0,,2813,2813,,,,2813,2813,,,2813,,,,,,,,TUMOR FREE,Alive,-22133,,,,179,,2813,2813,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.040803,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CP,,,,,,,2813,,,,,,,,,5,,,,,,,,,,,,,2003,,,,,Stage IA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,84023,,-0.550163563,0,0,0,0,-0.0737,1,,,Infiltrating Ductal Carcinoma,0.141871543,,0.234396101,0,0,0,,Negative,-0.682,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6742,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4510,Black or African American,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,3.38,0.64,7,6,8,,,896,,,896,,1,1,502,502,,Malignant,21,,26,,,,18902,,,502,502,,,,,896,,,502,,,,,,,,WITH TUMOR,Dead,-18762,896,,,68,,502,502,,,[Not Available],[Not Applicable],,,,,0.48,,,,,21,,1,0.28249,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4510,,,,,,,,,Distant Metastasis,,,,,,,22,,,,,,,,,,,,,2001,502,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,51,,,,,,,,,,,,,,,,,,,,84024,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,0.0766,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,14.8704777,17.143932,14.3621079,-0.478415728,LUAD,Adenocarcinoma,18.26935628,15.26840283,Adenocarcinoma,,13.25866352,-0.6709,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,1864,,1864,1864,,0,0,1864,1864,,Invasive Carcinoma,,,,,,,28686,1,,1864,1864,,,,1864,1864,,,1864,,,,,,,,TUMOR FREE,Alive,-24875,,,,66,,1864,1864,,,[Not Available],[Not Applicable],,,,,,Skin,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AV,,,,,,,1864,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,84027,,-1.073798644,0,0,0,0,-0.091,1,,,Infiltrating Ductal Carcinoma,0.147559593,,0.154597963,0,0,0,,Negative,-1.707,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.3945,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-77-8144,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,3.6,0.57,10,10,19,,,833,,833,833,,0,0,833,833,,Malignant,39,,42,,,,32052,,,833,833,,,,833,833,,,833,,,,,,,,,Alive,-25796,,,,519,,833,833,,,[Not Available],[Not Applicable],,,,,0.15,,,,,12,,1,0.24317,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8144,,,,,,,833,,,,,,,,,20,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,84029,,0.279812694,,,,,,,,,,0.087015274,,0.032891018,,,,Stage IB,,0.26,,,,,,,,,,,,,,,,0.1291,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.701068557654891,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.9587,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-63-A5MY,Unknown,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,1.93,0.85,19,14,21,,,1052,,1052,1052,,0,0,1052,1052,,Malignant,54,,208,,,,25402,,,1052,1052,,,,1052,1052,,,1052,,,,,,,,TUMOR FREE,Alive,-23276,,,,227,,1052,1052,,,[Not Available],[Not Applicable],,,,,0.09,,,,,9,,0,0.33767,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5MY,,,,,,,1052,,,,,,,,,17,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,84035,,-0.992955385,,,,,,,,,,0.033785294,,-0.040336033,,,,Stage IA,,-0.3555,,,,,,,,,,,,,,,,-0.3699,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-1.20711569610963,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-2.1821,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,322,,322,322,,0,0,322,322,,Invasive Carcinoma,,,,,,,25035,0,,322,322,,,,322,322,,,322,,,,,,,,TUMOR FREE,Alive,-22997,,,,0,,322,322,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A3IZ,,,,,,,322,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,84043,,-1.039717733,0,0,0,0,-4.8501,1,,,Infiltrating Lobular Carcinoma,0.137441016,,0.151326402,0,0,0,,Negative,-1.3885,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0432,0,0,H & E,0,0,,0,Christina Luffman,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-FD-A43U,White,BLCA,,1.0,1,,,,0,MALE,1.0,3.45,0.2,8,13,13,,,636,,,636,,1.0,1,497.0,497.0,,Malignant,34,,44,,,,17268.0,,,497.0,497,,,,,636,,,497.0,,,,,,,,WITH TUMOR,Alive,-25841,,,,114.0,,497.0,497,,,[Not Available],[Not Applicable],,,,,0.35,,,,,23,,1,0.26215,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A43U,,,,,,,636,Bone,Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2012,497,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,84054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.76,0.19,9,8,16,,,760,BRCA_Basal,760,760,,0,0,760,760,,Invasive Carcinoma,33,,39,,,,21357,0,,760,760,,,,760,760,,,760,,,,,,,,TUMOR FREE,Alive,-24411,,,,137,,760,760,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,23,,1,0.47627,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07U,,,,,,,760,,,,,,,,,36,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,84055,,1.816867096,0,0,0,0,-0.2668,1,,,Infiltrating Ductal Carcinoma,0.248180601,,0.180641977,0,0,0,,Negative,1.875,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2943,1,0,H & E,0,0,,0,Theresa Smith,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-22-1017,White,LUSC,,1,1,,Mayo Clinic - Rochester,1,1,MALE,1,,,,,,,,1485,,904,1485,,1,1,904,904,,Malignant,,,,,,,19124,,,904,904,,,,904,1485,,,904,,,,,,,,WITH TUMOR,Dead,-22880,1485,,,0,,904,904,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-1017,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,,,,,,,,,,,,,,1999,904,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,84057,,0.772790533,,,,,,,,,,0.224995139,,0.10711562,,,,Stage IA,,2.284,,,,,,,,,,,,,,,,0.0319,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.133268830477046,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.4396,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.65,1,1,2,,,49,BRCA_LumA,49,49,,0,0,49,49,,Invasive Carcinoma,4,,19,,,,32658,0,,49,49,,,,49,49,,,49,,,,,,,,TUMOR FREE,Alive,-23576,,,,35,,49,49,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.015637,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27P,,,,,,,49,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,84059,,-0.601236962,0,0,0,0,1.0969,1,,,Infiltrating Ductal Carcinoma,0.1377487,,0.124178679,0,0,0,,Negative,-0.885,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.343,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-97-A4LX,White,LUAD,,0,0,,Washington University - NYU,0,0,MALE,0,1.77,0.2,9,12,6,,,614,,614,614,,0,0,614,614,,Malignant,27,,77,,,,24633,,,614,614,,,,614,614,,,614,,,,,,,,TUMOR FREE,Alive,-29915,,,,239,,614,614,,,[Not Available],[Not Applicable],,,,,0.29,,,,,12,,0,0.3097,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4LX,,,,,,,614,,,,,,,,,14,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,84060,,1.757387684,,,,,,,,,,0.285671335,,0.168809708,,,,Stage IB,,2.5035,,,,,,,,,,,,,,,,0.3594,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.27073195,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.8711,,1.1757,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.02,0.27,1,4,9,,,59,BRCA_Her2,59,59,,0,0,59,59,,Invasive Carcinoma,14,,46,,,,17452,0,,59,59,,,,59,59,,,59,,,,,,,,TUMOR FREE,Alive,-18684,,,,34,,59,59,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,12,,1,0.14765,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A248,,,,,,,59,,,,,,,,,39,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,84063,,1.653363129,0,0,0,0,-0.132,0,,,Infiltrating Ductal Carcinoma,0.217450327,,0.064986319,0,0,0,,Negative,1.508,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0753,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Apocrine Metaplasia,0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,Apocrine Metaplasia,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A7AV,,PRAD,331,0,0,,KK,0,0,MALE,0,2.03,0.35,4,6,3,ambiguous,NO,822,8-other,822,822,,0,0,822,822,prad_tcga,Malignant,13,,29,,TCGA-KK-A7AV-01,7,5511,0,TCGA-KK-A7AV,822,822,Prostate Cancer,48,822,822,822,TCGA,No Evidence of Extraprostatic Extension,822,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-21192,,58,7,18,PRAD,822,822,,0.287876882,[Not Available],[Not Applicable],17,,1,Matched,0.07,Prostate,Resection,3,53EBD660-7F5D-433A-ACB7-4153F36484D0,2,,0,0.050405,[Not Available],BF462E14-F9E8-4531-905D-1FB59D9088CB,4,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,0.533333333333,TCGA-KK-A7AV,0:DiseaseFree,2,18,Prostate Adenocarcinoma,27.0,8/28/14,822,,,,,YES,C61,7C653DC8-83CE-42D9-A3D5-FA06CAFFF8EE,60,3,TUMOR FREE,0.0418,0:LIVING,0.1,,27.0,Bilateral,20,,,YES,587,2012,,,TCGA-KK-A7AV.7C653DC8-83CE-42D9-A3D5-FA06CAFFF8EE.pdf,Peripheral Zone,[Not Applicable],NO,,51-60%,23,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,RX,,58,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,84066,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-S5-AA26,Black or African American,BLCA,,0.0,0,,,0,0,MALE,0.0,3.77,0.95,4,6,5,,,503,,503,503,,0.0,0,503.0,503.0,,Malignant,15,,70,,,,28026.0,,,503.0,503,,,,503,503,,,503.0,,,,,,,,TUMOR FREE,Alive,-16972,,,,316.0,,503.0,503,,,[Not Available],[Not Applicable],,,,,0.0,,,,,6,,1,0.20312,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,, University of Oklahoma HSC,,TCGA-S5-AA26,,,,,,,503,,,,,,,,,8,,,,,,,,,,,,,2013,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,46.0,,,,,,,,,,,,,,,,,,,,84070,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5495,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.02,0.42,3,6,8,HRD,NO,1760,1-ERG,1760,1760,,0,0,1760,1760,prad_tcga,Malignant,17,BRCA2,13,10.8,TCGA-EJ-5495-01,46,5261,0,TCGA-EJ-5495,1760,1760,Prostate Cancer,,606,1760,1760,TCGA,,1760,Primary,1,Middle|Base,A,BRCA2:723-724:-/X:frameshift_variant,,,TUMOR FREE,Alive,-24904,,68,8,99,PRAD,1760,1760,WHITE,0.486370408,[Not Available],[Not Applicable],75,R0,1,Matched,0.16,Prostate,Resection,5,8e53414f-455e-4665-ae0e-9e7405262a96,3,Normal (no evidence of prostate cancer) [cM0],0,0.065834,[Not Available],962dd3d5-8501-4658-8cb9-2424b476124c,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,2.5,TCGA-EJ-5495,0:DiseaseFree,4,30,Prostate Adenocarcinoma,57.82,3/29/12,1760,,,,,NO,C61,5c549c39-b223-49eb-aa93-0298cdf33370,,3,TUMOR FREE,0.0709,0:LIVING,0.13,4,57.82,Bilateral,31,,,YES,,2009,,,TCGA-EJ-5495.5c549c39-b223-49eb-aa93-0298cdf33370.pdf,,[Not Applicable],NO,26,66-75%,18,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.5,68,Core needle biopsy,,,YES,NO,YES,,T3b,,8,No,,0,N1,T1c,1,M0,C61.9,8550/3,84082,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.58,0.74,6,6,7,,,575,BRCA_LumA,575,575,,0,0,575,575,,Invasive Carcinoma,19,,27,,,,30032,0,,575,575,,,,575,575,,,575,,,,,,,,TUMOR FREE,Alive,-14122,,,,35,,575,575,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,12,,1,0.09788,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1J1,,,,,,,575,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,84088,,1.014795119,0,0,0,0,0.9227,1,,,Infiltrating Ductal Carcinoma,0.115023932,,0.10491374,0,0,0,,Negative,0.5495,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0187,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4510,Black or African American,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,3.38,0.64,7,6,8,,,896,,,896,,1,1,502,502,,Malignant,21,,26,,,,18902,,,502,502,,,,,896,,,502,,,,,,,,WITH TUMOR,Dead,-18762,896,,,68,,502,502,,,[Not Available],[Not Applicable],,,,,0.48,,,,,21,,1,0.28249,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4510,,,,,,,,,Distant Metastasis,,,,,,,22,,,,,,,,,,,,,2001,502,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,51,,,,,,,,,,,,,,,,,,,,84090,,-0.102805598,,,,,,,,,,0.189775696,,0.201173003,,,,Stage IIB,,0.0815,,,,,,,,,,,,,,,,0.0766,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,14.8704777,17.143932,14.3621079,-0.478415728,LUAD,Adenocarcinoma,18.26935628,15.26840283,Adenocarcinoma,-0.5139,13.25866352,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Male,TCGA-18-3417,,LUSC,,0,0,,Princess Margaret Hospital (Canada),,2,MALE,2,3.69,0.31,12,9,20,,,1097,,,1097,,2,2,1097,1097,,Malignant,41,,62,,,,17517,,,1097,1097,,,,,1097,,,1097,,,,,,,,TUMOR FREE,Dead,-24019,1097,,,381,,1097,1097,,,[Not Available],[Not Applicable],,,,,0.33,,,,,26,,2,0.53292,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3417,,,,,,,,,,,,,,,,66,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,84094,,0.428136206,,,,,,,,,,0.224337578,,0.133758171,,,,Stage IV,,0.211,,,,,,,,,,,,,,,,0.8516,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,X297_splice,,,1,X297_splice,,,16.39535222,16.60938034,14.50506676,-0.358871844519247,LUSC,Squamous Cell Carcinoma,17.99127074,15.48863876,Squamous Cell Carcinoma,1.7411,13.84482982,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-G9-6342,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.94,0.48,5,6,3,ambiguous,NO,1696,1-ERG,1696,1696,,0,0,1696,1696,prad_tcga,Malignant,14,,17,3.3,TCGA-G9-6342-01,0,5354,0,TCGA-G9-6342,1696,1696,Prostate Cancer,,1338,1696,1696,TCGA,,1696,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22472,,61,6,28,PRAD,1696,1696,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,2c85548b-d1fd-4fc8-9908-60205a42e080,1,Normal (no evidence of prostate cancer) [cM0],0,0.059008,[Not Available],00e41e6a-9fe7-44f9-978b-7b05b179506a,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.5,TCGA-G9-6342,0:DiseaseFree,1,14,Prostate Adenocarcinoma,55.72,3/16/12,1696,,,,,NO,C61,80379cb8-9fb7-4e01-9e4a-2bf7813dc839,,1,TUMOR FREE,0.0524,0:LIVING,0.05,4,55.72,Bilateral,17,No Evidence of Extraprostatic Extension,36,YES,,2008,,,TCGA-G9-6342.80379cb8-9fb7-4e01-9e4a-2bf7813dc839.pdf,,[Not Applicable],YES,32,56-65%,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.4,61,Core needle biopsy,,,NO,YES,NO,,T3a,,6,No,,0,,T2c,,M0,C61.9,8550/3,84095,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.74,0.48,3,1,6,,,2136,BRCA_LumA,,2136,,0,0,2136,2136,,Invasive Carcinoma,10,,8,,,,23580,0,,2136,2136,,,,,2136,,,2136,,,,,,,,TUMOR FREE,Alive,-14920,,,,93,,2136,2136,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,18,,1,0.072746,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0B5,,,,,,,2136,,,,,,,,,17,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,84098,,0.532169375,0,0,0,0,0.4856,1,,,Infiltrating Lobular Carcinoma,0.172657216,,0.142682702,0,0,0,,Positive,0.4305,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5062,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-49-6743,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,2.96,0.27,11,10,12,,,1621,,1621,1621,,0,0,1621,1621,,Malignant,33,,35,,,,21545,,,1621,1621,,,,1621,1621,,,1621,,,,,,,,TUMOR FREE,Alive,-29807,,,,991,,1621,1621,,,[Not Available],[Not Applicable],,,,,0.08,,,,,21,,1,0.26935,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6743,,,,,,,1621,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,84110,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,"G527V, G527C",1,,,"G527V, G527C",15.89322553,17.46493985,16.01451465,-0.289411461,LUAD,Adenocarcinoma,17.7192686,15.86975845,Adenocarcinoma,0.6405,13.79242264,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-L9-A743,Black or African American,LUAD,,0,0,,Candler,0,0,MALE,0,6.48,0.09,5,18,28,,,664,,664,664,,0,0,664,664,,Malignant,51,,45,,,,31441,,,664,664,,,,664,664,,,664,,,,,,,,TUMOR FREE,Alive,-20780,,,,163,,664,664,,,[Not Available],[Not Applicable],,,,,0.2,,,,,14,,2,0.071054,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Candler,,TCGA-L9-A743,,,,,,,664,,,,,,,,,60,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,84116,,1.828839756,,,,,,,,,,0.287047255,,0.177584244,,,,Stage IIA,,1.9755,,,,,,,,,,,,,,,,0.5987,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.89592777,17.65461538,17.02185502,0.053039996,LUAD,Adenocarcinoma,18.45693247,16.82709631,Adenocarcinoma,0.4942,14.15733993,0.8626,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-IP-7968,White,STAD,,0,0,,,,0,,0,2.03,0.72,5,5,12,,,77,,,77,,0,0,77,77,,Malignant,22,,129,,,,20644,,,77,77,,,,,77,,,77,,,,,,,,TUMOR FREE,Alive,-27114,,,,146,,77,77,,,[Not Available],[Not Applicable],,,,,0.15,Stomach,Unknown,,,5,,0,0.40248,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,ABS - IUPUI,,TCGA-IP-7968,,,,,,,77,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,84120,,0.945763865,,,,,,,,,,0.056420821,Grade 2,0.14061431,,,,Stage IIIB,,1.096,,,,,,,,,,,,,,,,0.6566,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-IP-7968,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.76,0.83,9,3,10,,,31,BRCA_LumB,31,31,,0,0,31,31,,None,22,,84,,,,16477,N/A (Non-Malignant),,31,31,,,,31,31,,,31,,,,,,,,TUMOR FREE,Alive,-21002,,,,179,,31,31,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,11,,0,0.31243,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09N,,,,,,,31,,,,,,,,,11,,,,,,,,,,,,,2006,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,84121,,0.31883083,0,0,0,0,0.7799,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.127826504,N/A (Non-Malignant),0.110432848,0,0,0,N/A (Non-Malignant),Negative,-0.552,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.1005,0,0,H & E,0,0,,0,Christina Luffman,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,1,None of the Above,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.12,0.85,1,4,4,,,626,BRCA_LumA,626,626,,0,0,626,626,,Invasive Carcinoma,9,,2,,,,27475,0,,626,626,,,,626,626,,,626,,,,,,,,TUMOR FREE,Alive,-23845,,,,44,,626,626,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,3,,0,0.016972,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15L,,,,,,,626,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,84123,,-0.934018646,0,0,0,0,0.0217,1,,,Infiltrating Lobular Carcinoma,0.163918947,,0.127626823,0,0,0,,Negative,-1.4515,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4859,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4512,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,4.56,0.32,4,9,12,,,905,,,905,,1,1,905,905,,Malignant,25,,37,,,,24504,,,905,905,,,,,905,,,905,,,,,,,,WITH TUMOR,Dead,-25502,905,,,58,,905,905,,,[Not Available],[Not Applicable],,,,,0.24,,,,,27,,2,0.36924,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4512,,,,,,,157,,,,,,,,,48,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,84124,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98542375,16.9089662,11.37952049,-0.399506954,LUAD,,18.11303383,14.40690717,Adenocarcinoma,,13.80128998,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-EJ-7783,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.38,2,1,2,HRD,NO,787,1-ERG,787,787,,0,0,787,787,prad_tcga,Malignant,5,ATM;BRCA2;CHEK2;RAD51B,6,12.8,TCGA-EJ-7783-01,0,5314,0,TCGA-EJ-7783,787,787,Prostate Cancer,,172,787,787,TCGA,,787,Primary,0,,A,ATM:484:W/X:frameshift_variant,,,TUMOR FREE,Alive,-25600,,70,7,41,PRAD,787,787,WHITE,0.0,[Not Available],[Not Applicable],43,R0,1,Matched,0.2,Prostate,Resection,4,d634f5b6-e808-497e-a594-63559645d2a7,2,,0,0.031065,[Not Available],181c6d37-9d8d-4ffa-827b-e3785450ff88,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.66666666667,TCGA-EJ-7783,0:DiseaseFree,3,10,Prostate Adenocarcinoma,25.85,4/6/12,787,,,,,NO,C61,8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052,,2,TUMOR FREE,0.0357,0:LIVING,0.7,4,25.85,Bilateral,13,,,YES,,2011,,,TCGA-EJ-7783.8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052.pdf,,[Not Applicable],NO,,26-35%,17,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,1.3,70,Core needle biopsy,81,,YES,NO,YES,,T3a,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,84128,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.98,0.46,9,11,20,,,4361,BRCA_Basal,,4361,,0,0,4361,4361,,Invasive Carcinoma,40,,37,,,,26478,0,,4361,4361,,,,,4361,,,4361,,,,,,,,TUMOR FREE,Alive,-16702,,,,87,,4361,4361,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,20,,1,0.53247,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0I2,,,,,,,4361,,,,,,,,,23,,,,,,,,,,,,,1995,,,,,Stage IA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,84129,,1.389041313,0,0,0,0,0.1293,1,,,Infiltrating Ductal Carcinoma,0.146117223,,0.045038406,0,0,0,,[Not Available],1.353,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3934,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,3.29,0.52,11,12,16,,,959,BRCA_LumB,,959,,2,2,959,959,,Invasive Carcinoma,39,,33,,,,29505,0,,959,959,,,,,959,,,959,,,,,,,,TUMOR FREE,Dead,-19701,959,,,77,,959,959,,,[Not Available],[Not Applicable],,,,,0.26,Breast,Resection/Excision,,,18,,1,0.26657,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1F2,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,1999,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,84133,,-0.935066557,0,0,0,0,0.4471,1,,,Infiltrating Ductal Carcinoma,0.205802955,,0.218100255,0,0,0,,[Not Available],-1.64,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3489,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-NC-A5HM,White,LUSC,,0,0,,Washington University - CHUV,0,0,MALE,0,1.7,0.69,13,9,13,,,1212,,1212,1212,,0,0,1212,1212,,Malignant,35,,94,,,,24509,,,1212,1212,,,,1212,1212,,,1212,,,,,,,,TUMOR FREE,Alive,-27938,,,,382,,1212,1212,,,[Not Available],[Not Applicable],,,,,0.59,,,,,11,,0,0.38955,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HM,,,,,,,1212,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,84135,,0.547931192,,,,,,,,,,0.10015994,,-0.013491853,,,,Stage IB,,0.8895,,,,,,,,,,,,,,,,0.3336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.351250470568381,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.6115,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,0,1,1,,,Black or African American,BRCA,,1,1,,,1,2,FEMALE,1,2.16,0.78,13,18,12,,,2361,BRCA_Basal,1120,2361,,1,1,1120,1120,,Invasive Carcinoma,43,,62,,,,24176,0,,1120,1120,,,,1120,2361,,,1120,,,,,,,,TUMOR FREE,Dead,-26902,2361,,,109,,1120,1120,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,7,,0,0.28476,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0I1,,,,,,,,Lung,Distant Metastasis,,,,,,,17,,,,,,,,,,,,,1998,1120,,,,Stage IIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,84143,,-0.374622455,0,0,0,0,1.4063,1,,,Infiltrating Ductal Carcinoma,0.10776931,,-0.019727732,0,0,0,,Negative,-2.2405,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2988,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A6E1,,PRAD,315,0,0,,KK,0,0,MALE,0,3.55,0.66,9,14,7,ambiguous,NO,2198,1-ERG,2198,2198,,0,0,2198,2198,prad_tcga,Malignant,30,BRCA2;RAD51B,76,25.6,TCGA-KK-A6E1-01,0,5500,0,TCGA-KK-A6E1,2198,2198,Prostate Cancer,,356,2198,2198,TCGA,,2198,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-21063,,57,9,31,PRAD,2198,2198,,0.0,[Not Available],[Not Applicable],28,RX,1,Matched,0.16,Prostate,Resection,4,96790C2C-2E6E-487F-A575-B9F1252CE972,6,Normal (no evidence of prostate cancer) [cM0],1,0.1725,[Not Available],DEB57BD8-545F-477A-9A86-6BC6DB257270,5,Prostate Adenocarcinoma Acinar Type,,Prostate,29,,Acinar Adenocarcinoma,[Not Available],,KK,0.933333333333,TCGA-KK-A6E1,0:DiseaseFree,5,34,Prostate Adenocarcinoma,72.21,3/28/14,2198,,,,,NO,C61,E8264E2D-E4BB-40BB-9305-18DDD777D664,250,10,TUMOR FREE,0.2188,0:LIVING,0.1,,72.21,Bilateral,41,No Evidence of Extraprostatic Extension,-24,YES,1598,2008,,,TCGA-KK-A6E1.E8264E2D-E4BB-40BB-9305-18DDD777D664.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,-24,61-70%,24,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,RX,,57,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,T2c,5,M0,C61.9,8140/3,84146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,1,2.27,0.63,2,1,3,,,6292,BRCA_LumA,6292,6292,,0,0,5117,5117,,Invasive Carcinoma,6,,4,,,,16658,0,,6292,6292,,,,6292,6292,,,5117,,,,,,,,TUMOR FREE,Alive,-18584,,,,99,,6292,6292,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,10,,0,0.023207,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0WZ,,,,,,,6292,Bone,New Primary Tumor,,,,,,,8,,,,,,,,,,,,,1996,5117,,,,Stage II,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,84148,,-1.368504601,0,1,0,0,1.2184,0,,,Infiltrating Ductal Carcinoma,0.092501406,,0.134506621,0,0,0,,Negative,-1.086,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.1722,1,0,H & E,0,0,,0,Ioana Tolocica,"ALH, Columnar Lesion",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,"ALH, Columnar Lesion",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-21-5784,White,LUSC,,0,0,,Fox Chase Cancer Center,0,0,FEMALE,0,2.39,0.18,5,4,5,,,1268,,1268,1268,,0,0,1268,1268,,Malignant,14,,14,,,,20289,,,1268,1268,,,,1268,1268,,,1268,,,,,,,,TUMOR FREE,Alive,-29362,,,,242,,1268,1268,,,[Not Available],[Not Applicable],,,,,0.1,,,,,10,,1,0.44799,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Fox Chase Cancer Center,,TCGA-21-5784,,,,,,,1268,,,,,,,,,34,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,84155,,0.462414191,,,,,,,,,,0.202438198,,0.15314213,,,,Stage IB,,0.217,,,,,,,,,,,,,,,,0.5177,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.200521086760375,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.38,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8WN,,PRAD,389,0,0,,V1,0,0,MALE,0,2.0,0.38,0,0,0,HRD,NO,924,4-FLI1,924,924,,0,0,924,924,prad_tcga,Malignant,0,,10,,TCGA-V1-A8WN-01,0,5565,0,TCGA-V1-A8WN,924,924,Prostate Cancer,,463,924,924,TCGA,,924,Primary,0,Apex,A,RAD51B:.:.:splice_region_variant,CHEK2,True,,Alive,-17520,,47,6,21,PRAD,924,924,,0.0,[Not Available],[Not Applicable],22,,1,Matched,0.0,Prostate,Resection,3,F993AC1F-1F37-4CF1-BA77-85F95D77A62C,0,,0,0.0039368,[Not Available],DC16F348-A49F-4958-A3FF-BC40E18DF2BD,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,V1,0.733333333333,TCGA-V1-A8WN,0:DiseaseFree,1,3,Prostate Adenocarcinoma,30.35,7/15/14,924,,,,,NO,C61,F25C1C00-CDFE-4ABD-A920-857AFEA691A5,30,0,,0.0118,0:LIVING,0.02,,30.35,Bilateral,5,,,YES,,,,,TCGA-V1-A8WN.F25C1C00-CDFE-4ABD-A920-857AFEA691A5.pdf,Peripheral Zone,[Not Applicable],NO,,76-85%,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,47,Core needle biopsy,,,NO,YES,NO,NO,T2c,NO,6,No,NO,,,T2a,,M0,C61.9,8140/3,84157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-8354,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.44,0.75,10,24,23,,,995,,995,995,,0,0,995,995,,Malignant,57,,144,,,,0,,,995,995,,,,995,995,,,995,,,,,,,,TUMOR FREE,Alive,-19692,,,,297,,995,995,,,[Not Available],[Not Applicable],,,,,0.25,,,,,13,,1,0.24802,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8354,,,,,,,995,,,,,,,,,33,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,84160,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,-0.0787,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,E117K,1,,,E117K,,,,-0.777221465752962,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.4969,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-HF-A5NB,,STAD,,0,0,,,0,0,,0,2.08,0.91,1,3,1,,,928,,928,928,,0,0,928,928,,Malignant,5,,62,,,,25524,,,928,928,,,,928,928,,,928,,,,,,,,TUMOR FREE,Alive,-27676,,,,2113,,928,928,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Unknown,,,2,,0,0.093903,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,Ontario Institute for Cancer Research (OICR),,TCGA-HF-A5NB,,,,,,,928,,,,,,,,,4,,,,,,,,,,,,,,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,84165,,0.381963822,,,,,,,,,,0.039435018,Grade 3,-0.023003655,,,,Stage IIIC,,0.7715,,,,,,,,,,,,,,,,-0.3008,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HF-A5NB,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.4,0.7,17,15,21,,,224,BRCA_Basal,,224,,1,1,224,224,,Invasive Carcinoma,53,,151,,,,16456,0,,224,224,,,,,224,,,224,,,,,,,,WITH TUMOR,Dead,-25674,224,,,111,,224,224,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,20,,1,0.46348,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18T,,,,,,,,,,,,,,,,31,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,84177,,0.220116726,0,0,0,0,-0.0911,1,,,Infiltrating Ductal Carcinoma,0.151508719,,0.078697062,0,0,0,,Negative,-0.1675,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0965,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-VQ-A8PB,White,STAD,,0,0,,,2,2,,2,2.11,0.6,0,0,0,,,1043,,1043,1043,,2,2,1043,1043,,Malignant,0,,8,,,,17532,,,1043,1043,,,,1043,1043,,,1043,,,,,,,,TUMOR FREE,Dead,-23927,1043,,,1167,,1043,1043,,,[Not Available],[Not Applicable],,,,,0.04,Stomach,Unknown,,,4,,0,0.000305,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Papillary Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8PB,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,84182,,0.542269359,,,,,,,,,,0.091703427,Grade 2,0.049656189,,,,Stage II,,-0.242,,,,,,,,,,,,,,,,0.1702,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PB,Gastric Carcinoma,TCGA,"Adenocarcinoma, Papillary Type"
0,1,1,1,1,1,Male,TCGA-RD-A8MW,White,STAD,,1,1,,,1,1,,1,2.89,0.27,13,21,21,,,1153,,98,1153,,1,1,98,98,,Malignant,55,,134,,,,21785,,,98,98,,,,98,1153,,,98,,,,,,,,WITH TUMOR,Dead,-26590,1153,,,103,,98,98,,,Stomach Cancer,[Not Applicable],,,,,0.11,Stomach,Unknown,,,10,,1,0.48892,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8MW,,,,,,,1153,Peritoneal Surfaces,Distant Metastasis,,,,,,,34,,,,,,,,,,,,,2004,98,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,84193,,0.502872072,,,,,,,,,,0.171908079,Grade 3,0.102396602,,,,Stage IIIB,,1.126,,,,,,,,,,,,,,,,0.6271,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8MW,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-HU-8610,Asian,STAD,,0,0,,,,0,,0,1.76,0.97,6,4,3,,,23,,,23,,0,0,23,23,,Malignant,13,,52,,,,18814,,,23,23,,,,,23,,,23,,,,,,,,TUMOR FREE,Alive,-27594,,,,74,,23,23,,,[Not Available],[Not Applicable],,,,,0.99,Stomach,Unknown,,,8,,0,0.24002,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-8610,,,,,,,23,,,,,,,,,8,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Stable Disease,,,,,,75,,,,,,,,,,,,,,,,,,,,84197,,0.679513313,,,,,,,,,,0.125091562,Grade 2,0.17624733,,,,Stage IA,,1.2075,,,,,,,,,,,,,,,,0.3949,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-8610,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-2F-A9KT,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.62,0.41,5,9,12,,,3314,,3314,3314,,0.0,0,3314.0,3314.0,,Malignant,26,,70,,,,27942.0,,,3314.0,3314,,,,3314,3314,,,3314.0,,,,,,,,TUMOR FREE,Alive,-30520,,,,470.0,,3314.0,3314,,,[Not Available],[Not Applicable],,,,,0.08,,,,,10,,1,0.1822,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KT,,,,,,,3314,,,,,,,,,15,,,,,,,,,,,,,2006,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,83.0,,,,,,,,,,,,,,,,,,,,84198,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-63-A5MW,Unknown,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,3.27,0.66,5,15,14,,,1639,,1639,1639,,0,0,1639,1639,,Malignant,34,,115,,,,29198,,,1639,1639,,,,1639,1639,,,1639,,,,,,,,TUMOR FREE,Alive,-27892,,,,618,,1639,1639,,,[Not Available],[Not Applicable],,,,,0.3,,,,,17,,1,0.19989,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5MW,,,,,,,1639,,,,,,,,,31,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,84205,,0.715442297,,,,,,,,,,0.158754046,,0.121325089,,,,Stage IB,,-0.1315,,,,,,,,,,,,,,,,0.7347,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.622911865567428,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6709,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,0,0,1,Male,TCGA-93-A4JO,White,LUAD,,0,0,,Washington University - St. Louis,,2,MALE,2,2.18,0.2,4,13,12,,,33,,,33,,2,2,33,33,,Malignant,29,,92,,,,28926,,,33,33,,,,,33,,,33,,,,,,,,TUMOR FREE,Dead,-25898,33,,,76,,33,33,,,[Not Available],[Not Applicable],,,,,0.46,,,,,14,,0,0.4807,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - St. Louis,,TCGA-93-A4JO,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,[Not Applicable],,,,,,70,,,,,,,,,,,,,,,,,,,,84206,,1.296723447,,,,,,,,,,0.22506402,,0.190960598,,,,Stage IA,,1.5585,,,,,,,,,,,,,,,,0.2089,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,,,,-0.020461081,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1003,,0.8699,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-J4-A83K,,PRAD,357,0,0,,J4,0,0,MALE,0,2.0,0.44,0,0,0,HRP,NO,328,1-ERG,328,328,,0,0,328,328,prad_tcga,Malignant,0,,8,,TCGA-J4-A83K-01,0,5486,0,TCGA-J4-A83K,328,328,Prostate Cancer,,205,328,328,TCGA,,328,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-19299,,52,6,30,PRAD,328,328,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.02,Prostate,Resection,3,8EF6A082-C440-481B-ACBD-CD4C0D15A90B,0,,0,0.0011274,[Not Available],256F5BCF-10A9-47BE-B265-CFA707D24097,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,0.966666666667,TCGA-J4-A83K,0:DiseaseFree,1,2,Prostate Adenocarcinoma,10.78,1/20/14,328,,,,,,C61,B03E6C45-550E-4657-9292-75D7BB058D2A,30,0,TUMOR FREE,0.0005,0:LIVING,0.1,,10.78,Bilateral,2,,,YES,254,2013,,,TCGA-J4-A83K.B03E6C45-550E-4657-9292-75D7BB058D2A.pdf,Peripheral Zone,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,52,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,84211,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.0,0.74,0,0,0,,,408,BRCA_LumA,174,408,,1,1,174,174,,Invasive Carcinoma,0,,6,,,,34204,0,,174,174,,,,174,408,,,174,,,,,,,,WITH TUMOR,Alive,-29184,,,,56,,174,174,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Core Biopsy,,,0,,0,0.0023086,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A3RF,,,,,,,408,Bone,Distant Metastasis,,,,,,,0,,,,,,,,,,,,,2012,174,,,,Stage IIA,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,84212,,-1.940684453,0,0,0,0,-0.4269,1,,,Mucinous Carcinoma,0.098405719,,0.138708012,0,0,0,,Negative,-2.0215,,10/21/22,0,0,0,0,0,0,0,1,0,0,No,0,0,-0.0842,0,0,H & E,0,0,,0,David Jou,None,0,0,0,Suboptimal,0,0,Core Biopsy,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-99-8033,White,LUAD,,1,1,,Washington University - Alabama,,1,FEMALE,1,3.04,0.29,8,13,10,,,656,,,656,,1,1,656,656,,Malignant,31,,25,,,,23993,,,656,656,,,,,656,,,656,,,,,,,,WITH TUMOR,Dead,-27342,656,,,227,,656,656,,,[Not Available],[Not Applicable],,,,,0.13,,,,,18,,1,0.34295,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Alabama,,TCGA-99-8033,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,84214,,1.413824316,,,,,,,,,,0.205234007,,0.082266611,,,,Stage IV,,1.9095,,,,,,,,,,,,,,,,0.3118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13C (driver),R554Q,1,,G13C (driver),R554Q,15.48633264,16.18228144,17.56699439,-0.032514361,LUAD,Adenocarcinoma,17.90014401,16.63382136,Adenocarcinoma,0.2468,12.52390558,0.9476,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-68-A59J,White,LUSC,,0,0,,Washington University - Cleveland Clinic,0,0,FEMALE,0,2.95,0.45,20,14,20,,,448,,448,448,,0,0,448,448,,Malignant,54,,131,,,,30984,,,448,448,,,,448,448,,,448,,,,,,,,TUMOR FREE,Alive,-27031,,,,498,,448,448,,,[Not Available],[Not Applicable],,,,,0.14,,,,,17,,1,0.42773,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-68-A59J,,,,,,,448,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,84215,,1.248048429,,,,,,,,,,0.168776208,,0.093268599,,,,Stage IB,,2.841,,,,,,,,,,,,,,,,0.2507,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0980070065828933,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.3911,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-L5-A4OQ,White,ESCA,,1,1,,,,1,,1,,,,,,,,42,,,42,,1,1,29,29,,Malignant,,,,,,,24721,,,29,29,,,,,42,,,29,,,,,,,,WITH TUMOR,Dead,-27565,42,,,111,,29,29,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A4OQ,,,,,,,,Brain,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,29,,,,Stage IIIA,,,,,,,,,,,,,,75,,,,,,,,,,,,,,,,,,,,84224,,,,,,,,,,,,,Unknown,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.3,3,1,5,,,755,BRCA_LumA,755,755,,0,0,755,755,,Invasive Carcinoma,9,,7,,,,17425,0,,755,755,,,,755,755,,,755,,,,,,,,TUMOR FREE,Alive,-22397,,,,28,,755,755,,,[Not Available],[Not Applicable],,,,,0.48,Breast,Resection/Excision,,,11,,0,0.10764,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1QZ,,,,,,,755,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,84230,,1.413230558,0,0,0,0,-0.9956,1,,,Infiltrating Ductal Carcinoma,0.157894673,,0.236809695,0,0,0,,Negative,0.2805,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1635,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Microcalcifications,"DCIS (Cribriform, Low Grade), DCIS (Solid, Low Grade), Microcalcifications",,"DCIS (Cribriform, Low Grade), DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-55-7227,White,LUAD,,1,1,,International Genomics Consortium,1,1,MALE,1,,,,,,,,952,,255,952,,1,1,255,255,,Malignant,,,,,,,0,,,255,255,,,,255,952,,,255,,,,,,,,WITH TUMOR,Dead,-28458,952,,,212,,255,255,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7227,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2011,255,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,84231,,1.330371478,,,,,,,,,,0.285459247,,0.178074687,,,,Stage IIIA,,1.5535,,,,,,,,,,,,,,,,0.4813,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.70909691,17.48125204,16.6339407,-0.015034396,LUAD,Adenocarcinoma,18.57819275,16.21493652,Adenocarcinoma,0.3781,14.31814648,0.0946,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,,0.0,1.0,Female,TCGA-XF-AAN8,White,BLCA,,0.0,0,,,,,FEMALE,2.0,2.0,0.58,0,0,0,,,118,,,118,,2.0,2,118.0,118.0,,Malignant,0,,4,,,,17148.0,,,118.0,118,,,,,118,,,118.0,,,,,,,,,Dead,-27309,118,,,3.0,,118.0,118,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.000153,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAN8,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,2007,,,,,Stage III,,,,,,,,[Unknown],,,,,,74.0,,,,,,,,,,,,,,,,,,,,84233,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A7I0,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.87,0.68,4,4,3,,,368,,368,368,,0.0,0,368.0,368.0,,Malignant,11,,68,,,,23966.0,,,368.0,368,,,,368,368,,,368.0,,,,,,,,TUMOR FREE,Alive,-20059,,,,71.0,,368.0,368,,,[Not Available],[Not Applicable],,,,,0.0,,,,,3,,0,0.15015,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A7I0,,,,,,,368,,,,,,,,,2,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,54.0,,,,,,,,,,,,,,,,,,,,84236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-86-7955,White,LUAD,,1,1,,Asterand,1,0,MALE,1,3.16,0.73,11,8,22,,,1072,,820,1072,,1,1,820,820,,Malignant,41,,144,,,,22023,,,820,820,,,,820,1072,,,820,,,,,,,,TUMOR FREE,Alive,-22772,,,,397,,820,820,,,[Not Available],[Not Applicable],,,,,0.16,,,,,20,,1,0.48237,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-7955,,,,,,,1072,,Locoregional Recurrence,,,,,,,35,,,,,,,,,,,,,2011,820,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,84244,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.810644076,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.6897,,-0.9297,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-75-6205,,LUAD,,1,1,,Ontario Institute for Cancer Research (OICR),,1,FEMALE,1,1.4,0.27,3,3,4,,,,,,,,1,1,,,,Malignant,10,,25,,,,22509,,,,,,,,,,,,,,,,,,,,WITH TUMOR,Dead,,,,,63,,,,,,[Not Available],[Not Applicable],,,,,0.68,,,,,20,,0,0.5194,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-6205,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,84246,,1.359795456,,,,,,,,,,0.277607521,,0.204998533,,,,Stage IB,,1.832,,,,,,,,,,,,,,,,0.5938,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.216806512,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.7695,,1.2577,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-GU-A764,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.66,0.23,10,17,22,,,610,,610,610,,0.0,0,610.0,610.0,,Malignant,49,,57,,,,33930.0,,,610.0,610,,,,610,610,,,610.0,,,,,,,,TUMOR FREE,Alive,-24343,,,,156.0,,610.0,610,,,[Not Available],[Not Applicable],,,,,0.58,,,,,15,,1,0.16423,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A764,,,,,,,610,,,,,,,,,42,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,66.0,,,,,,,,,,,,,,,,,,,,84248,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SI,,PRAD,,1,1,,YL,1,0,MALE,1,1.95,0.19,1,4,0,HRP,NO,1614,,1423,1614,,1,1,1423,1423,prad_tcga,Malignant,5,,21,,TCGA-YL-A8SI-01,0,5669,0,TCGA-YL-A8SI,1423,1423,Prostate Cancer,,1441,1423,1614,TCGA,,1423,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25292,,69,9,23,PRAD,1423,1423,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.03,Prostate,Resection,4,489EA5D8-AE40-405B-BBF5-E0E091193270,0,Normal (no evidence of prostate cancer) [cM0],0,0.030508,[Not Available],C5F8C89C-EF69-42F4-9B37-5B552FCCDF4B,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,YL,0.833333333333,TCGA-YL-A8SI,1:Recurred/Progressed,5,6,Prostate Adenocarcinoma,46.75,4/25/14,1614,,Biochemical evidence of disease,,,NO,C61,30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE,390,0,WITH TUMOR,0.0146,0:LIVING,0.48,,53.02,Bilateral,8,No Evidence of Extraprostatic Extension,62,YES,1345,2010,1423,,TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,47,,15,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,1423,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,84258,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7522,,PRAD,221,0,0,,G9,0,0,MALE,0,1.99,0.21,0,0,0,HRP,NO,1078,1-ERG,1078,1078,,0,0,1078,1078,prad_tcga,Malignant,0,,10,6.8,TCGA-G9-7522-01,0,5389,0,TCGA-G9-7522,1078,1078,Prostate Cancer,,452,1078,1078,TCGA,,1078,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-18033,,49,7,12,PRAD,1078,1078,,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.01,Prostate,Resection,3,10bfe256-c4a2-4d88-b907-56f86ef63de9,0,,0,0.0053995,[Not Available],87959988-bb25-47ee-afc1-9af92592bbe7,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.8,TCGA-G9-7522,0:DiseaseFree,2,3,Prostate Adenocarcinoma,35.41,5/31/12,1078,,,,,NO,C61,8d3c4720-f528-4a73-b2f0-95b2aac093f2,,0,TUMOR FREE,0.0051,0:LIVING,0.1,,35.41,Bilateral,3,,,YES,,2011,,,TCGA-G9-7522.8d3c4720-f528-4a73-b2f0-95b2aac093f2.pdf,,[Not Applicable],NO,,51-60%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.9,49,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,84259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A6E2,,PRAD,315,0,0,,KK,0,0,MALE,0,1.99,0.86,2,3,1,HRP,NO,5024,1-ERG,5024,5024,,0,0,5024,5024,prad_tcga,Malignant,6,,28,6.7,TCGA-KK-A6E2-01,0,5501,0,TCGA-KK-A6E2,5024,5024,Prostate Cancer,,438,5024,5024,TCGA,,5024,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-19974,,54,7,51,PRAD,5024,5024,,0.0,[Not Available],[Not Applicable],44,R0,1,Matched,0.04,Prostate,Resection,3,D92AF9ED-9E94-4E87-B19C-439F5A5AE616,0,,0,0.015779,[Not Available],56C88739-C076-42CC-A2CB-FD613AB567B5,4,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,KK,1.46666666667,TCGA-KK-A6E2,0:DiseaseFree,2,5,Prostate Adenocarcinoma,165.05,3/27/14,5024,,,,,NO,C61,84DBE486-DFA5-4FBC-BA8F-E10CC0247645,290,0,TUMOR FREE,0.0154,0:LIVING,0.1,,165.05,Bilateral,6,,,YES,4724,2000,,,TCGA-KK-A6E2.84DBE486-DFA5-4FBC-BA8F-E10CC0247645.pdf,Transition Zone,[Not Applicable],NO,,81-90%,5,Prostate Adenocarcinoma Acinar Type,1,2000,Complete Remission/Response,,NO,No,R0,,54,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,84262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-A6F2,White,STAD,,0,0,,,0,0,,0,3.44,0.63,12,10,18,,,476,,476,476,,0,0,476,476,,Malignant,40,,98,,,,27587,,,476,476,,,,476,476,,,476,,,,,,,,TUMOR FREE,Alive,-22801,,,,97,,476,476,,,[Not Available],[Not Applicable],,,,,0.24,Stomach,Unknown,,,19,,1,0.21952,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A6F2,,,,,,,476,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,84263,,0.662162258,,,,,,,,,,0.114418894,Grade 3,0.047547238,,,,Stage IB,,0.4425,,,,,,,,,,,,,,,,0.0682,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A6F2,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,1,1,1,1,Male,TCGA-77-A5GF,Unknown,LUSC,,1,1,,Prince Charles Hospital,1,1,MALE,1,2.79,0.56,13,10,14,,,840,,722,840,,1,1,722,722,,Malignant,37,,116,,,,25680,,,722,722,,,,722,840,,,722,,,,,,,,WITH TUMOR,Dead,-25654,840,,,148,,722,722,,,[Not Available],[Not Applicable],,,,,0.48,,,,,23,,1,0.50692,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5GF,,,,,,,,,Locoregional Recurrence,,,,,,,24,,,,,,,,,,,,,2011,722,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,84274,,0.802014726,,,,,,,,,,0.154773535,,0.058233629,,,,Stage IIA,,2.3445,,,,,,,,,,,,,,,,0.3179,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.94492593,15.704054,16.65356835,-0.324461007913567,LUSC,Squamous Cell Carcinoma,17.80005749,15.79055051,Squamous Cell Carcinoma,-0.047,13.24538731,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,84276,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-VQ-A91A,White,STAD,,0,0,,,0,0,,1,2.97,0.39,14,18,17,,,1200,,1200,1200,,0,0,129,129,,Malignant,49,,141,,,,20875,,,1200,1200,,,,1200,1200,,,129,,,,,,,,TUMOR FREE,Alive,-24670,,,,175,,1200,1200,,,[Not Available],[Not Applicable],,,,,0.25,Stomach,Unknown,,,13,,1,0.3412,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G1,,Barretos Cancer Hospital,,TCGA-VQ-A91A,,,,,,,1200,,New Primary Tumor,,,,,,,30,,,,,,,,,,,,,2011,129,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,84279,,-0.624571884,,,,,,,,,,0.141152595,Grade 1,0.179574937,,,,Stage IIIB,,0.1625,,,,,,,,,,,,,,,,0.8069,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91A,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,1,,,0,1,Male,TCGA-VQ-A91U,Asian,STAD,,0,0,,,,,,2,3.53,0.56,7,19,16,,,52,,,52,,2,2,52,52,,Malignant,42,,138,,,,33842,,,52,52,,,,,52,,,52,,,,,,,,,Dead,-28791,52,,,201,,52,52,,,[Unknown],[Not Applicable],,,,,0.07,Stomach,Unknown,,,20,,2,0.27529,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A91U,,,,,,,,,,,,,,,,65,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,78,,,,,,,,,,,,,,,,,,,,84281,,0.955722979,,,,,,,,,,0.063855024,Grade 2,0.090040658,,,,Stage IIIA,,0.475,,,,,,,,,,,,,,,,-0.1316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91U,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1.0,0,0,0.0,1.0,Male,TCGA-G2-A2EO,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.23,0.37,1,3,7,,,1804,,1804,1804,,2.0,2,1804.0,1804.0,,Malignant,11,,27,,,,25306.0,,,1804.0,1804,,,,1804,1804,,,1804.0,,,,,,,,TUMOR FREE,Dead,-25440,1804,,,1247.0,,1804.0,1804,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.10692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EO,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,84286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-A8D0,,PRAD,370,0,0,,HC,0,0,MALE,0,1.96,0.34,1,3,2,HRP,NO,775,1-ERG,775,775,,0,0,775,775,prad_tcga,Malignant,6,,56,,TCGA-HC-A8D0-01,0,5462,0,TCGA-HC-A8D0,775,775,Prostate Cancer,14,110,775,775,TCGA,No Evidence of Extraprostatic Extension,775,Primary,0,Apex|Middle,A,,,False,TUMOR FREE,Alive,-22465,,61,7,39,PRAD,775,775,,0.0,[Not Available],[Not Applicable],31,,1,Matched,0.0,Prostate,Resection,3,A31E3626-9E80-467A-986B-A83DC3684AC6,2,Normal (no evidence of prostate cancer) [cM0],0,0.043138,[Not Available],0AFA0E02-DAAE-47E6-9CCB-9DE8E4FEB73C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,HC,1.03333333333,TCGA-HC-A8D0,0:DiseaseFree,2,10,Prostate Adenocarcinoma,25.46,3/28/14,775,,,,,YES,C61,E29BD9A6-B0F0-42D8-B952-85B71C3D5BC9,60,1,TUMOR FREE,0.0414,0:LIVING,0.01,,25.46,Left,10,No Evidence of Extraprostatic Extension,11,YES,517,2012,,,TCGA-HC-A8D0.E29BD9A6-B0F0-42D8-B952-85B71C3D5BC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,11,6-15%,10,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,61,Core needle biopsy,,,YES,NO,YES,NO,T2a,,7,No,,0,N0,T1c,0,M0,C61.9,8140/3,84288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-G9-6332,White,PRAD,,1,1,,G9,1,0,MALE,1,1.96,0.81,3,3,2,ambiguous,NO,2657,,1180,2657,,1,1,1180,1180,prad_tcga,Malignant,8,,33,,TCGA-G9-6332-01,0,5349,0,TCGA-G9-6332,1180,1180,Prostate Cancer,,2090,1180,2657,TCGA,,1180,Primary,0,Apex|Base,A,,,,WITH TUMOR,Alive,-20166,,55,7,35,PRAD,1180,1180,WHITE,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.02,Prostate,Resection,4,30558aeb-76b7-4d27-99c0-e3ee21a00bd1,0,Normal (no evidence of prostate cancer) [cM0],0,0.044391,[Not Available],c46022f8-b122-4367-836b-ec1ae641a87d,3,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,G9,1.86666666667,TCGA-G9-6332,1:Recurred/Progressed,3,15,Prostate Adenocarcinoma,42.21,3/20/12,2657,,Biochemical evidence of disease,,,NO,C61,18b9fda1-2d69-4c5e-94ba-bfbbcd742bdd,,1,TUMOR FREE,0.0657,0:LIVING,0.73,,87.29,Bilateral,18,No Evidence of Extraprostatic Extension,11,YES,,2005,1180,,TCGA-G9-6332.18b9fda1-2d69-4c5e-94ba-bfbbcd742bdd.pdf,,[Not Applicable],YES,11,,7,Prostate Adenocarcinoma Acinar Type,1,2005,Complete Remission/Response,,,No,R0,0.2,55,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,84292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-77-7138,,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,,,,,,,,340,,,340,,2,2,340,340,,Malignant,,,,,,,33748,,,340,340,,,,,340,,,340,,,,,,,,,Dead,-24594,340,,,39,,340,340,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7138,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999,,,,,Stage IB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,84297,,0.107422403,,,,,,,,,,0.103238475,,-0.005980882,,,,Stage IB,,-0.363,,,,,,,,,,,,,,,,0.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.870786378894219,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.5479,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-UY-A9PE,White,BLCA,,1.0,1,,,,0,MALE,1.0,3.43,0.48,6,18,15,,,189,,,189,,1.0,1,473.0,473.0,,Malignant,39,,57,,,,17854.0,,,473.0,473,,,,,189,,,473.0,,,,,,,,WITH TUMOR,Alive,-31755,,,,301.0,,473.0,473,,,[Not Available],[Not Applicable],,,,,0.11,,,,,14,,1,0.13676,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A9PE,,,,,,,189,Lung,Distant Metastasis,,,,,,,29,,,,,,,,,,,,,,473,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,86.0,,,,,,,,,,,,,,,,,,,,84300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-56-8083,White,LUSC,,0,0,,International Genomics Consortium,,0,MALE,0,1.99,0.91,13,10,13,,,150,,,150,,0,0,150,150,,Malignant,36,,23,,,,0,,,150,150,,,,,150,,,150,,,,,,,,TUMOR FREE,Alive,-20696,,,,217,,150,150,,,[Not Available],[Not Applicable],,,,,0.04,,,,,7,,0,0.22969,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8083,,,,,,,150,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,[Unknown],,,,,,56,,,,,,,,,,,,,,,,,,,,84301,,-1.230220765,,,,,,,,,,0.111773498,,0.060994539,,,,Stage IB,,0.165,,,,,,,,,,,,,,,,0.3469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-1.0392824406895,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1167,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-A9SJ,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.1,0.56,17,15,19,,,98,,,98,,1.0,1,98.0,98.0,,Malignant,51,,95,,,,22983.0,,,98.0,98,,,,,98,,,98.0,,,,,,,,WITH TUMOR,Dead,-30362,98,,,376.0,,98.0,98,,,[Not Available],[Not Applicable],,,,,0.72,,,,,11,,0,0.40768,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SJ,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2004,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,83.0,,,,,,,,,,,,,,,,,,,,84302,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.37,0.53,5,3,6,,,532,BRCA_LumA,532,532,,0,0,532,532,,Invasive Carcinoma,14,,36,,,,26053,0,,532,532,,,,532,532,,,532,,,,,,,,TUMOR FREE,Alive,-25477,,,,86,,532,532,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,13,,1,0.065108,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A9Q3,,,,,,,532,,,,,,,,,13,,,,,,,,,,,,,2013,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,84303,,0.279888756,0,0,0,0,-0.4069,1,,,Infiltrating Lobular Carcinoma,0.136168412,,0.114017111,0,0,0,,Negative,-0.9455,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.2153,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-67-3773,White,LUAD,,0,0,,St Joseph's Medical Center (MD),,0,FEMALE,0,1.96,0.7,4,3,5,,,427,,,427,,0,0,427,427,,Malignant,12,,8,,,,16928,,,427,427,,,,,427,,,427,,,,,,,,TUMOR FREE,Alive,-30706,,,,141,,427,427,,,[Not Available],[Not Applicable],,,,,0.02,,,,,5,,0,0.10228,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-3773,,,,,,,427,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,84306,,0.446889132,,,,,,,,,,0.265412839,,0.17620505,,,,Stage IB,,1.0895,,,,,,,,,,,,,,,,-0.1628,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,0.131678527,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.2465,,0.5136,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,,,,,,,,3492,,,3492,,2,2,3492,3492,,Invasive Carcinoma,,,,,,,21708,0,,3492,3492,,,,,3492,,,3492,,,,,,,,TUMOR FREE,Dead,-31404,3492,,,0,,3492,3492,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2002,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,85,,,,,,,,,,,,,,,,,,,,84311,,1.45166254,0,0,0,0,0.9277,0,,,Infiltrating Lobular Carcinoma,0.175093784,,0.32678752,0,0,0,,Positive,1.1025,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.4972,1,0,H & E,0,0,,0,Chunhui Yi,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Columnar Lesion,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,,BRCA,,0,0,,,2,2,FEMALE,2,3.96,0.67,21,19,27,,,883,BRCA_LumA,883,883,,2,2,883,883,,Invasive Carcinoma,67,,243,,,,30931,1,,883,883,,,,883,883,,,883,,,,,,,,TUMOR FREE,Dead,-29525,883,,,112,,883,883,,,[Not Available],[Not Applicable],,,,,0.2,Lymph Node,Resection/Excision,,,15,,2,0.38664,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06U,,,,,,,,,,,,,,,,57,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,84329,,0.760274012,0,0,0,0,0.0425,1,,,Infiltrating Ductal Carcinoma,0.163989159,,0.08367167,0,0,0,,Negative,-0.148,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.0688,0,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,1,0,Resection/Excision,Optimal,0,Lymph Node,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Lymph Node,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-L3-A4E7,White,LUSC,,0,0,,Gundersen Lutheran Health System,0,0,MALE,0,1.78,0.46,12,7,11,,,392,,392,392,,0,0,392,392,,Malignant,30,,78,,,,34447,,,392,392,,,,392,392,,,392,,,,,,,,TUMOR FREE,Alive,-26232,,,,124,,392,392,,,[Not Available],[Not Applicable],,,,,0.28,,,,,9,,0,0.29895,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Gundersen Lutheran Health System,,TCGA-L3-A4E7,,,,,,,392,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,84331,,0.103755822,,,,,,,,,,0.174377667,,0.096324597,,,,Stage IB,,0.788,,,,,,,,,,,,,,,,0.5524,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.383120911345067,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.3166,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.42,2,1,4,,,4088,BRCA_LumA,4088,4088,,0,0,4088,4088,,Invasive Carcinoma,7,,10,,,,21419,0,,4088,4088,,,,4088,4088,,,4088,,,,,,,,TUMOR FREE,Alive,-25771,,,,45,,4088,4088,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,7,,0,0.13043,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EN,,,,,,,4088,,,,,,,,,7,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,84333,,1.426018677,0,0,0,0,0.4501,1,,,Infiltrating Lobular Carcinoma,0.198461577,,0.273381298,0,0,0,,Negative,0.9405,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6641,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-XF-AAN3,White,BLCA,,0.0,0,,,,0,MALE,0.0,1.93,0.29,5,1,5,,,2625,,,2625,,0.0,0,2625.0,2625.0,,Malignant,11,,78,,,,25004.0,,,2625.0,2625,,,,,2625,,,2625.0,,,,,,,,TUMOR FREE,Alive,-27909,,,,215.0,,2625.0,2625,,,[Not Available],[Not Applicable],,,,,0.11,,,,,16,,0,0.33377,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAN3,,,,,,,2625,,,,,,,,,16,,,,,,,,,,,,,2007,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,84336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-BT-A42E,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.17,0.48,20,14,22,,,1108,,1108,1108,,0.0,0,1108.0,1108.0,,Malignant,56,,108,,,,22999.0,,,1108.0,1108,,,,1108,1108,,,1108.0,,,,,,,,TUMOR FREE,Alive,-27045,,,,238.0,,1108.0,1108,,,[Not Available],[Not Applicable],,,,,0.21,,,,,13,,1,0.4087,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A42E,,,,,,,1108,,,,,,,,,31,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,74.0,,,,,,,,,,,,,,,,,,,,84339,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-62-A471,White,LUAD,,0,0,,Thoraxklinik at University Hospital Heidelberg,0,0,MALE,0,3.11,0.46,13,4,16,,,1246,,1246,1246,,0,0,1246,1246,,Malignant,33,,104,,,,30892,,,1246,1246,,,,1246,1246,,,1246,,,,,,,,TUMOR FREE,Alive,-23689,,,,162,,1246,1246,,,[Not Available],[Not Applicable],,,,,0.22,,,,,21,,1,0.39899,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A471,,,,,,,1246,,,,,,,,,32,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,84342,,0.607064531,,,,,,,,,,0.106483014,,0.035858823,,,,Stage IIB,,0.252,,,,,,,,,,,,,,,,-0.0211,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.47804631,14.50962158,15.1338874,-0.659258512,LUAD,Adenocarcinoma,17.66071855,15.45578222,Adenocarcinoma,-0.9087,12.45146927,-0.0913,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.24,0.45,3,3,6,,,1047,BRCA_LumA,1047,1047,,0,0,1047,1047,,Invasive Carcinoma,12,,14,,,,22487,0,,1047,1047,,,,1047,1047,,,1047,,,,,,,,TUMOR FREE,Alive,-20065,,,,0,,1047,1047,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,20,,2,0.069997,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A107,,,,,,,1047,,,,,,,,,55,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,84344,,-0.528903517,0,0,0,0,1.273,1,,,Infiltrating Lobular Carcinoma,0.096242532,,0.150629296,0,0,0,,Negative,-1.0755,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1068,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-HU-A4GD,Asian,STAD,,1,1,,,,0,,1,1.38,0.82,19,13,16,,,692,,,692,,1,1,399,399,,Malignant,48,,243,,,,18704,,,399,399,,,,,692,,,399,,,,,,,,WITH TUMOR,Alive,-20700,,,,121,,399,399,,,[Not Available],[Not Applicable],,,,,0.38,Stomach,Unknown,,,10,,0,0.74758,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4GD,,,,,,,692,Liver,Distant Metastasis,,,,,,,23,,,,,,,,,,,,,2011,399,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,56,,,,,,,,,,,,,,,,,,,,84349,,-0.152051624,,,,,,,,,,0.008713386,Grade 3,-0.046801642,,,,Stage IIB,,-0.297,,,,,,,,,,,,,,,,-0.2303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GD,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1.0,,1,1.0,1.0,Male,TCGA-UY-A8OC,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.29,0.55,5,10,7,,,92,,,92,,1.0,1,32.0,32.0,,Malignant,22,,92,,,,17995.0,,,32.0,32,,,,,92,,,32.0,,,,,,,,WITH TUMOR,Dead,-32918,92,,,133.0,,32.0,32,,,[Not Available],[Not Applicable],,,,,0.02,,,,,14,,1,0.16817,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A8OC,,,,,,,,Lymph Node Only,Distant Metastasis,,,,,,,24,,,,,,,,,,,,,,32,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,90.0,,,,,,,,,,,,,,,,,,,,84359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.58,2,1,6,,,1301,BRCA_LumA,1301,1301,,0,0,1301,1301,,Invasive Carcinoma,9,,45,,,,30426,1,,1301,1301,,,,1301,1301,,,1301,,,,,,,,TUMOR FREE,Alive,-26186,,,,102,,1301,1301,,,[Not Available],[Not Applicable],,,,,0.0,Skin,Resection/Excision,,,4,,0,0.076416,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A66L,,,,,,,1301,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,84362,,,0,0,0,0,0.3012,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,1,0,0,0,0,0,0,no,0,0,,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Skin,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,1.99,0.26,5,5,4,,,584,BRCA_LumA,584,584,,2,2,584,584,,Invasive Carcinoma,14,,76,,,,28353,0,,584,584,,,,584,584,,,584,,,,,,,,TUMOR FREE,Dead,-20239,584,,,117,,584,584,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,8,,0,0.23024,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,UNC ,,TCGA-AQ-A7U7,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,84363,,1.8215011,0,1,0,0,-0.6496,0,,,Infiltrating Lobular Carcinoma,0.18376512,,0.250889771,0,0,0,,Negative,1.9355,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.584,1,0,H & E,0,0,,0,Ioana Tolocica,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,ALH,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.3,0.6,3,3,10,,,675,BRCA_LumA,675,675,,0,0,675,675,,Invasive Carcinoma,16,,28,,,,24989,0,,675,675,,,,675,675,,,675,,,,,,,,TUMOR FREE,Alive,-22199,,,,266,,675,675,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,17,,1,0.09912,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IN,,,,,,,675,,,,,,,,,24,,,,,,,,,,,,,2010,,,,,Stage I,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,84370,,0.044486439,0,0,0,0,0.214,1,,,Infiltrating Ductal Carcinoma,0.153320418,,0.163769725,0,0,0,,Negative,-1.2285,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6087,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-RD-A8N9,Asian,STAD,,0,0,,,0,0,,0,2.4,0.37,10,16,23,,,1083,,1083,1083,,0,0,1083,1083,,Malignant,49,,164,,,,21945,,,1083,1083,,,,1083,1083,,,1083,,,,,,,,TUMOR FREE,Alive,-23059,,,,165,,1083,1083,,,[Not Available],[Not Applicable],,,,,0.31,Stomach,Unknown,,,17,,1,0.6118,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8N9,,,,,,,1083,,,,,,,,,41,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,84371,,0.977334398,,,,,,,,,,0.121480821,Grade 3,0.227511822,,,,Stage II,,0.7685,,,,,,,,,,,,,,,,0.6678,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8N9,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,84378,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-78-7163,White,LUAD,,0,0,,Prince Charles Hospital,0,0,MALE,0,2.56,0.68,2,4,6,,,7248,,7248,7248,,0,0,7248,7248,,Malignant,12,,16,,,,17807,,,7248,7248,,,,7248,7248,,,7248,,,,,,,,TUMOR FREE,Alive,-22002,,,,31,,7248,7248,,,[Not Available],[Not Applicable],,,,,0.04,,,,,23,,1,0.12201,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7163,,,,,,,7248,,,,,,,,,36,,,,,,,,,,,,,1992,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,84380,,-0.506176595,,,,,,,,,,0.087592704,,-0.015019999,,,,Stage IB,,0.203,,,,,,,,,,,,,,,,-0.5443,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.41297893,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.8072,,-0.2243,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-77-8146,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,,,,,,,,3189,,3189,3189,,0,0,3189,3189,,Malignant,,,,,,,17420,,,3189,3189,,,,3189,3189,,,3189,,,,,,,,,Alive,-26533,,,,203,,3189,3189,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8146,,,,,,,3189,,,,,,,,,,,,,,,,,,,,,,2005,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,84382,,0.333244286,,,,,,,,,,0.201242882,,0.087284896,,,,Stage IA,,0.0205,,,,,,,,,,,,,,,,0.8144,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,-0.539065413172083,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-J4-A67S,,PRAD,,1,1,,J4,1,0,MALE,1,1.92,0.44,5,7,2,ambiguous,NO,833,,708,833,,1,1,708,708,prad_tcga,Malignant,14,FANCL,53,,TCGA-J4-A67S-01,0,5479,0,TCGA-J4-A67S,708,708,Prostate Cancer,,522,708,833,TCGA,,708,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-23332,,63,7,19,PRAD,708,708,,0.0,[Not Available],[Not Applicable],22,,1,Matched,0.0,Prostate,Resection,3,F5D26FFE-21B5-4D4A-BE82-8C858BEF1586,1,,0,0.077842,[Not Available],9FE9CBAE-37B9-4030-A204-4502760F5DAB,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,J4,0.733333333333,TCGA-J4-A67S,1:Recurred/Progressed,2,17,Prostate Adenocarcinoma,23.26,8/16/13,833,,Biochemical evidence of disease,,,,C61,D5BC3AA7-D957-4291-8A6B-D148AA7CA909,50,1,WITH TUMOR,0.0754,0:LIVING,0.1,,27.37,Bilateral,17,,,YES,427,2012,708,,TCGA-J4-A67S.D5BC3AA7-D957-4291-8A6B-D148AA7CA909.pdf,Peripheral Zone,[Not Applicable],,,,3,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,63,Core needle biopsy,,,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,84384,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.35,0.72,4,4,6,,,396,BRCA_LumA,396,396,,0,0,396,396,,Invasive Carcinoma,14,,11,,,,18536,0,,396,396,,,,396,396,,,396,,,,,,,,TUMOR FREE,Alive,-21731,,,,0,,396,396,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,12,,0,0.088973,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A086,,,,,,,396,,,,,,,,,12,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,84386,,-0.469517499,0,0,0,0,-1.4262,1,,,Infiltrating Ductal Carcinoma,0.166287765,,0.121038933,0,0,0,,Negative,-0.923,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.525,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-8087,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.98,0.82,2,2,5,,,462,,462,462,,0,0,462,462,,Malignant,9,,17,,,,0,,,462,462,,,,462,462,,,462,,,,,,,,TUMOR FREE,Alive,-21655,,,,39,,462,462,,,[Not Available],[Not Applicable],,,,,0.01,,,,,5,,0,0.055803,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8087,,,,,,,462,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,84387,,-0.066699567,,,,,,,,,,0.221167909,,0.077804961,,,,Stage IB,,-0.235,,,,,,,,,,,,,,,,-0.0564,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.700067878,LUAD,,,,Adenocarcinoma,-0.3034,,-1.7026,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.19,0.79,4,3,6,,,504,BRCA_LumA,504,504,,0,0,504,504,,Invasive Carcinoma,13,,11,,,,17091,0,,504,504,,,,504,504,,,504,,,,,,,,TUMOR FREE,Alive,-22332,,,,36,,504,504,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,9,,0,0.062714,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1J3,,,,,,,504,,,,,,,,,9,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,84398,,-0.296955628,0,0,0,0,0.4739,1,,,Infiltrating Lobular Carcinoma,0.157045814,,0.125087523,0,0,0,,Negative,-0.4475,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3095,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.87,0.63,6,3,7,,,658,BRCA_LumA,658,658,,0,0,658,658,,Invasive Carcinoma,16,,70,,,,20301,0,,658,658,,,,658,658,,,658,,,,,,,,TUMOR FREE,Alive,-23660,,,,0,,658,658,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,7,,0,0.20047,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15F,,,,,,,658,,,,,,,,,8,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,84410,,0.137312383,0,0,0,0,-0.4888,1,,,Infiltrating Ductal Carcinoma,0.104378892,,0.106221016,0,0,0,,Negative,-0.1625,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.2476,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-39-5037,White,LUSC,,0,0,,MSKCC,0,0,MALE,0,4.22,0.49,3,27,25,,,1690,,1690,1690,,0,0,1690,1690,,Malignant,55,,43,,,,22808,,,1690,1690,,,,1690,1690,,,1690,,,,,,,,TUMOR FREE,Alive,-23868,,,,320,,1690,1690,,,[Not Available],[Not Applicable],,,,,0.58,,,,,18,,2,0.32993,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5037,,,,,,,1690,,,,,,,,,63,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,84414,,-1.647663864,,,,,,,,,,0.078998003,,-0.094942291,,,,Stage IIA,,-1.104,,,,,,,,,,,,,,,,-0.4433,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,11.89865689,12.20104433,10.96861212,-0.927285524942656,LUSC,,18.05940569,14.11355517,Squamous Cell Carcinoma,-3.6204,9.449445733,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-RD-A8N1,White,STAD,,0,0,,,0,0,,0,2.59,0.28,24,25,22,,,3519,,3519,3519,,0,0,3519,3519,,Malignant,71,,168,,,,24468,,,3519,3519,,,,3519,3519,,,3519,,,,,,,,TUMOR FREE,Alive,-25737,,,,136,,3519,3519,,,[Not Available],[Not Applicable],,,,,0.29,Stomach,Unknown,,,14,,1,0.48941,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8N1,,,,,,,3519,,,,,,,,,37,,,,,,,,,,,,,2001,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,84415,,1.686082028,,,,,,,,,,0.105126151,Grade 3,0.104189858,,,,Stage IIIB,,1.546,,,,,,,,,,,,,,,,0.2008,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8N1,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Male,TCGA-56-7582,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,3.4,0.62,9,10,13,,,601,,601,601,,0,0,601,601,,Malignant,32,,26,,,,17467,,,601,601,,,,601,601,,,601,,,,,,,,TUMOR FREE,Alive,-30678,,,,218,,601,601,,,[Not Available],[Not Applicable],,,,,0.17,,,,,20,,1,0.49381,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7582,,,,,,,601,,,,,,,,,25,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,83,,,,,,,,,,,,,,,,,,,,84417,,0.738551597,,,,,,,,,,0.181657536,,0.058335406,,,,Stage IB,,0.352,,,,,,,,,,,,,,,,0.3106,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.327318013039545,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1165,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Female,TCGA-ZF-AA58,White,BLCA,,0.0,0,,,,0,FEMALE,0.0,2.35,0.31,19,19,24,,,1649,,,1649,,0.0,0,1649.0,1649.0,,Malignant,62,,109,,,,32361.0,,,1649.0,1649,,,,,1649,,,1649.0,,,,,,,,TUMOR FREE,Alive,-22549,,,,298.0,,1649.0,1649,,,[Not Available],[Not Applicable],,,,,0.52,,,,,9,,1,0.37422,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA58,,,,,,,1649,,,,,,,,,44,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,84420,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.49,8,2,8,,,2645,BRCA_LumA,2645,2645,,0,0,2645,2645,,Invasive Carcinoma,18,,28,,,,22954,0,,2645,2645,,,,2645,2645,,,2645,,,,,,,,TUMOR FREE,Alive,-21198,,,,38,,2645,2645,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,5,,0,0.11259,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DK,,,,,,,2645,,,,,,,,,13,,,,,,,,,,,,,2005,,,,,Stage I,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,84422,,-0.040394168,0,0,0,0,0.6275,1,,,Infiltrating Ductal Carcinoma,0.190209744,,0.279319429,0,0,0,,Negative,-0.4795,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3943,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Cribriform, Intermediate Grade), Microcalcifications",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-RD-A8MV,White,STAD,,0,0,,,0,0,,0,2.27,0.31,6,14,15,,,3720,,3720,3720,,0,0,3720,3720,,Malignant,35,,66,,,,18959,,,3720,3720,,,,3720,3720,,,3720,,,,,,,,TUMOR FREE,Alive,-20771,,,,92,,3720,3720,,,[Not Available],[Not Applicable],,,,,0.38,Stomach,Unknown,,,4,,0,0.10702,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8MV,,,,,,,3720,,,,,,,,,10,,,,,,,,,,,,,2001,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,84424,,1.14950447,,,,,,,,,,0.116174953,Grade 3,0.114482377,,,,Stage IIIB,,1.3725,,,,,,,,,,,,,,,,0.0139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8MV,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.68,3,2,4,,,1611,BRCA_LumA,1611,1611,,0,0,1611,1611,,Invasive Carcinoma,9,,8,,,,16843,0,,1611,1611,,,,1611,1611,,,1611,,,,,,,,TUMOR FREE,Alive,-17637,,,,36,,1611,1611,,,[Not Available],[Not Applicable],,,,,0.26,Breast,Resection/Excision,,,9,,0,0.092824,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1P3,,,,,,,1611,,,,,,,,,7,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,84427,,-0.061617884,0,0,0,0,0.7351,1,,,Infiltrating Ductal Carcinoma,0.109485187,,0.187710783,0,0,0,,Negative,-0.5665,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3096,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-49-AARR,Black or African American,LUAD,,1,1,,Johns Hopkins,1,0,MALE,1,2.0,0.64,0,0,0,,,4992,,4812,4992,,1,1,1099,1099,,Malignant,0,,10,,,,16723,,,4812,4812,,,,4812,4992,,,1099,,,,,,,,WITH TUMOR,Alive,-24942,,,,3,,4812,4812,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.000367,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AARR,,,,,,,4992,,New Primary Tumor,,,,,,,0,,,,,,,,,,,,,2001,1099,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,84428,,0.890401103,,,,,,,,,,0.236592265,,0.287445529,,,,Stage IA,,1.3835,,,,,,,,,,,,,,,,0.2806,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.20910272,LUAD,,,,Adenocarcinoma,-1.0387,,0.4308,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Female,TCGA-XF-A9T3,White,BLCA,,0.0,0,,,,0,FEMALE,0.0,3.09,0.41,9,12,16,,,68,,,68,,0.0,0,68.0,68.0,,Malignant,37,,66,,,,23118.0,,,68.0,68,,,,,68,,,68.0,,,,,,,,TUMOR FREE,Alive,-25532,,,,564.0,,68.0,68,,,[Not Available],[Not Applicable],,,,,0.14,,,,,12,,1,0.21542,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9T3,,,,,,,68,,,,,,,,,28,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,[Unknown],,,,,,69.0,,,,,,,,,,,,,,,,,,,,84429,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.42,0.27,8,12,11,,,376,BRCA_Her2,376,376,,0,0,376,376,,Invasive Carcinoma,31,,42,,,,24522,0,,376,376,,,,376,376,,,376,,,,,,,,TUMOR FREE,Alive,-21463,,,,90,,376,376,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,22,,1,0.28888,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A26X,,,,,,,376,,,,,,,,,28,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,84430,TRUE,1.406746758,0,0,0,0,-0.546,1,,,Infiltrating Ductal Carcinoma,0.242234178,,0.227766786,0,0,0,,Negative,1.0945,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3678,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-AA69,White,STAD,,0,0,,,0,0,,0,2.0,0.85,1,0,3,,,864,,864,864,,0,0,864,864,,Malignant,4,,24,,,,17757,,,864,864,,,,864,864,,,864,,,,,,,,TUMOR FREE,Alive,-13087,,,,94,,864,864,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,0,,0,0.016611,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-AA69,,,,,,,864,,,,,,,,,0,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,35,,,,,,,,,,,,,,,,,,,,84431,,0.205395788,,,,,,,,,,0.049996206,Grade 2,-0.026833344,,,,Stage IIIA,,1.6735,,,,,,,,,,,,,,,,-0.2949,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA69,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-78-7536,White,LUAD,,1,,,Prince Charles Hospital,,1,MALE,1,3.04,0.78,10,35,21,,,244,,,244,,1,,231,231,,Malignant,66,,124,,,,25443,,,231,,,,,,244,,,231,,,,,,,,WITH TUMOR,Dead,-25558,244,,,792,,231,,,,[Not Available],[Not Applicable],,,,,0.11,,,,,14,,1,0.37597,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7536,,,,,,,,,,,,,,,,41,,,,,,,,,,,,,2001,231,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,84434,,0.305553999,,,,,,,,,,0.160741434,,0.032099568,,,,Stage IIIA,,0.6535,,,,,,,,,,,,,,,,-0.393,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.24405503,16.11910754,16.67787172,-0.358270548,LUAD,Adenocarcinoma,17.54866103,15.53821263,Adenocarcinoma,-0.8182,10.30898527,-0.0428,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,2.2,0.44,3,2,3,,,1596,BRCA_LumA,,1596,,0,0,1596,1596,,Invasive Carcinoma,8,,9,,,,25269,0,,1596,1596,,,,,1596,,,1596,,,,,,,,TUMOR FREE,Alive,-25666,,,,33,,1596,1596,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,4,,0,0.044326,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A259,,,,,,,1596,,,,,,,,,6,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,84437,,0.681004634,0,0,0,0,0.303,1,,,Infiltrating Ductal Carcinoma,0.153591637,,0.221833337,0,0,0,,Close,0.5045,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.282,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-R6-A6DQ,White,ESCA,,1,1,,,,1,,1,,,,,,,,231,,,231,,1,1,231,231,,Malignant,,,,,,,17032,,,231,231,,,,,231,,,231,,,,,,,,WITH TUMOR,Dead,-27098,231,,,146,,231,231,,,[Not Available],Stage IIIA,,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,MD Anderson Cancer Center,,TCGA-R6-A6DQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,,,,,[Not Available],,,,,,,,,,,,,,74,,,,,,,,,,,,,,,,,,,,84442,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,3.04,0.72,11,27,24,,,1692,BRCA_Basal,1692,1692,,2,2,1692,1692,,Invasive Carcinoma,62,,46,,,,18427,0,,1692,1692,,,,1692,1692,,,1692,,,,,,,,,Dead,-20675,1692,,,129,,1692,1692,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,15,,1,0.41028,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18Q,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2001,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,84446,,0.785698716,0,0,0,1,0.1324,0,,,Infiltrating Ductal Carcinoma,0.140384894,,0.132046102,0,0,0,,Negative,0.522,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.0014,1,0,H & E,0,0,,0,Ioana Tolocica,"Columnar Lesion, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, High Grade), Stromal Alterations",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Columnar Lesion, UDH",0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,2486,,2486,2486,,0,0,2486,2486,,Invasive Carcinoma,,,,,,,17528,0,,2486,2486,,,,2486,2486,,,2486,,,,,,,,TUMOR FREE,Alive,-21386,,,,54,,2486,2486,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DD,,,,,,,2486,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,84448,,0.461751052,0,0,0,0,0.1434,1,,,Infiltrating Ductal Carcinoma,0.12977322,,0.056990609,0,0,0,,Negative,0.1155,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.142,1,0,H & E,0,0,,0,Fabio Tavora,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Cribriform, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-37-A5EM,White,LUSC,,0,0,,Cureline,0,0,MALE,0,,,,,,,,867,,867,867,,0,0,867,867,,Malignant,,,,,,,19087,,,867,867,,,,867,867,,,867,,,,,,,,TUMOR FREE,Alive,-18011,,,,457,,867,867,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-A5EM,,,,,,,867,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,49,,,,,,,,,,,,,,,,,,,,84455,,1.244695971,,,,,,,,,,0.220155589,,0.118750064,,,,Stage II,,1.178,,,,,,,,,,,,,,,,0.7383,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,16.16758461,17.47900583,16.30019285,-0.203168094525005,LUSC,,17.67854545,16.4072872,Squamous Cell Carcinoma,,14.77100756,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.49,0.54,4,12,15,,,413,BRCA_Basal,413,413,,0,0,413,413,,Invasive Carcinoma,31,,331,,,,18506,0,,413,413,,,,413,413,,,413,,,,,,,,TUMOR FREE,Alive,-26896,,,,256,,413,413,,,[Not Available],[Not Applicable],,,,,0.39,Breast,Resection/Excision,,,12,,0,0.79941,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A6IW,,,,,,,413,,,,,,,,,26,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,84459,TRUE,1.41821731,0,0,0,0,0.4547,1,,,Infiltrating Ductal Carcinoma,0.177438743,,0.077523581,0,0,0,,Negative,1.3295,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.2785,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-HU-A4GX,Asian,STAD,,0,0,,,0,0,,0,2.12,0.52,2,2,2,,,616,,616,616,,0,0,616,616,,Malignant,6,,29,,,,17435,,,616,616,,,,616,616,,,616,,,,,,,,TUMOR FREE,Alive,-25913,,,,1765,,616,616,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,6,,0,0.031962,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4GX,,,,,,,616,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,84460,,0.998017019,,,,,,,,,,0.055754536,Grade 3,0.005423262,,,,Stage IIIC,,1.1185,,,,,,,,,,,,,,,,-0.229,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GX,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0.0,,0,0.0,0.0,Male,TCGA-FD-A43N,White,BLCA,,0.0,0,,,,0,MALE,0.0,5.9,0.5,3,19,17,,,699,,,699,,0.0,0,699.0,699.0,,Malignant,39,,27,,,,31924.0,,,699.0,699,,,,,699,,,699.0,,,,,,,,TUMOR FREE,Alive,-27833,,,,253.0,,699.0,699,,,[Not Available],[Not Applicable],,,,,0.4,,,,,17,,2,0.053217,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A43N,,,,,,,699,,,,,,,,,51,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,[Not Applicable],,,,,,76.0,,,,,,,,,,,,,,,,,,,,84463,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KS,,PRAD,,0,0,,X4,,0,MALE,0,2.04,0.24,2,4,0,ambiguous,NO,979,,,979,,0,0,979,979,prad_tcga,Malignant,6,,13,,TCGA-X4-A8KS-01,0,5618,0,TCGA-X4-A8KS,979,979,Prostate Cancer,,797,,979,TCGA,,979,Primary,0,,A,,,True,TUMOR FREE,Alive,-22571,,61,7,31,PRAD,979,979,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.0,Prostate,Resection,3,874964AB-D09A-422C-9B51-7239338E78D4,2,,0,0.024833,[Not Available],56829C8D-7BB7-4AAC-999F-B1353DB4915D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,X4,1.0,TCGA-X4-A8KS,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.16,3/7/14,979,,,,,NO,C61,30844429-3F9C-4AD0-8A23-64012532347C,160,1,TUMOR FREE,0.0004,0:LIVING,0.01,,32.16,Bilateral,18,,,YES,735,2011,,,TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,RX,,61,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T2c,,M0,C61.9,8140/3,84465,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-G9-6367,White,PRAD,108,0,0,,G9,,0,MALE,0,2.0,0.27,0,0,0,HRP,NO,1222,8-other,,1222,,0,0,1222,1222,prad_tcga,Malignant,0,,0,8.5,TCGA-G9-6367-01,0,5368,0,TCGA-G9-6367,1222,1222,Prostate Cancer,,836,,1222,TCGA,,1222,Primary,0,Apex|Base,A,,,,WITH TUMOR,Alive,-22176,,60,9,2,PRAD,1222,1222,WHITE,0.0,[Not Available],[Not Applicable],9,R1,1,Matched,0.0,Prostate,Resection,4,5bc98578-e4c7-4be8-89df-f26aa5d545a9,0,Normal (no evidence of prostate cancer) [cM0],0,0.0,[Not Available],9f751c9d-ad41-4f02-b7f8-12423857d418,5,Prostate Adenocarcinoma Acinar Type,1.6,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.366666666667,TCGA-G9-6367,0:DiseaseFree,5,3,Prostate Adenocarcinoma,40.14,3/8/12,1222,,,,,NO,C61,1306f52c-6633-4ca8-8998-c5306e0c34be,,0,WITH TUMOR,0.0,0:LIVING,0.42,3,40.14,Bilateral,3,No Evidence of Extraprostatic Extension,30,YES,,2009,,,TCGA-G9-6367.1306f52c-6633-4ca8-8998-c5306e0c34be.pdf,,[Not Applicable],YES,30,31-40%,5,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,,No,R1,0.5,60,Core needle biopsy,,,NO,YES,YES,,T3a,,9,No,,0,N0,T2b,0,M0,C61.9,8550/3,84467,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,,,,,,,,1034,BRCA_LumA,,1034,,1,1,1034,1034,,Invasive Carcinoma,,,,,,,23586,0,,1034,1034,,,,,1034,,,1034,,,,,,,,WITH TUMOR,Dead,-17172,1034,,,35,,1034,1034,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1998,,,,,Stage IV,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,84470,,-0.306626367,0,0,0,0,-0.5893,0,,,Infiltrating Ductal Carcinoma,0.183494844,,0.292844236,0,0,0,,[Not Available],-0.3815,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.7299,0,0,H & E,0,0,,0,Katherine Huenerberg,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.4,0.66,22,30,31,,,997,BRCA_Her2,997,997,,0,0,997,997,,Invasive Carcinoma,83,,101,,,,22564,0,,997,997,,,,997,997,,,997,,,,,,,,TUMOR FREE,Alive,-15324,,,,114,,997,997,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,9,,1,0.38051,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0J2,,,,,,,997,,,,,,,,,29,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,84473,,0.930265219,0,0,0,0,0.0614,1,,,Infiltrating Ductal Carcinoma,0.118584392,,0.064932816,0,0,0,,Negative,1.174,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.0466,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,4.44,0.75,10,16,18,,,1179,BRCA_Basal,1179,1179,,0,0,1179,1179,,Invasive Carcinoma,44,,128,,,,33595,1,,1179,1179,,,,1179,1179,,,1179,,,,,,,,TUMOR FREE,Alive,-16195,,,,176,,1179,1179,,,[Not Available],[Not Applicable],,,,,0.27,Not Specific/Unknown,Resection/Excision,,,23,,2,0.38771,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A574,,,,,,,1179,,,,,,,,,54,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,84474,,-1.744337813,0,0,0,0,0.7577,1,,,Infiltrating Ductal Carcinoma,0.091005199,,-0.032600705,0,0,0,,Negative,-2.773,,10/21/22,0,0,0,0,0,0,0,0,0,0,This is a serous carcinoma (not a breast cancer),0,0,-0.1829,1,0,H & E,0,0,,0,David Jou,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.24,0.81,8,12,13,,,3001,BRCA_LumB,3001,3001,,0,0,3001,3001,,Invasive Carcinoma,33,,96,,,,29053,0,,3001,3001,,,,3001,3001,,,3001,,,,,,,,TUMOR FREE,Alive,-20900,,,,62,,3001,3001,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,16,,1,0.19284,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24Z,,,,,,,3001,,,,,,,,,23,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,84476,,-0.007084226,0,0,0,0,0.5726,1,,,Infiltrating Ductal Carcinoma,0.155879993,,0.083758709,0,0,0,,Negative,-0.558,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.056,0,0,H & E,0,0,,0,Fabio Tavora,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,84483,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-KB-A93G,White,STAD,,0,0,,,0,0,,0,,,,,,,,613,,613,613,,0,0,613,613,,Malignant,,,,,,,30347,,,613,613,,,,613,613,,,613,,,,,,,,TUMOR FREE,Alive,-24924,,,,117,,613,613,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G1,,"University Health Network, Toronto",,TCGA-KB-A93G,,,,,,,613,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,84485,,0.08717649,,,,,,,,,,0.162811406,Grade 1,0.210561351,,,,Stage IB,,0.7045,,,,,,,,,,,,,,,,1.1763,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-KB-A93G,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0.0,1,0,1.0,1.0,Male,TCGA-XF-AAMY,White,BLCA,,1.0,1,,,1,0,MALE,1.0,3.58,0.61,4,7,11,,,3011,,637,3011,,1.0,1,637.0,637.0,,Malignant,22,,82,,,,32631.0,,,637.0,637,,,,637,3011,,,637.0,,,,,,,,TUMOR FREE,Alive,-28509,,,,158.0,,637.0,637,,,[Not Available],[Not Applicable],,,,,0.09,,,,,21,,1,0.10729,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMY,,,,,,,3011,Lung,Distant Metastasis,,,,,,,34,,,,,,,,,,,,,2006,637,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,78.0,,,,,,,,,,,,,,,,,,,,84488,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7519,,PRAD,221,0,0,,G9,0,0,MALE,0,1.97,0.18,0,0,0,HRD,NO,849,8-other,849,849,,0,0,849,849,prad_tcga,Malignant,0,BRCA2,3,5.1,TCGA-G9-7519-01,0,5385,0,TCGA-G9-7519,849,849,Prostate Cancer,,457,849,849,TCGA,,849,Primary,0,Apex|Base,A,CDK12:92-102:DRRENDERRGS/DX:frameshift_variant,,,TUMOR FREE,Alive,-21276,,58,7,33,PRAD,849,849,,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.01,Prostate,Resection,3,a0fd8790-8db2-4a4f-8fd6-657b263e1579,0,Abnormal (not related to prostate cancer),0,0.034792,[Not Available],0f01ec33-00a8-4188-a8f0-e90d46ad9bc7,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.7,G9,1.3,TCGA-G9-7519,0:DiseaseFree,2,3,Prostate Adenocarcinoma,27.89,5/31/12,849,,,,,NO,C61,07227b7d-9285-4d1b-9484-ccdb20841905,,1,TUMOR FREE,0.0001,0:LIVING,0.03,,27.89,Bilateral,9,No Evidence of Extraprostatic Extension,7,YES,,2010,,,TCGA-G9-7519.07227b7d-9285-4d1b-9484-ccdb20841905.pdf,,[Not Applicable],YES,7,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.8,58,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,84489,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,TCGA-AO-A12C,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,2372,,2372,2372,,0,0,2372,2372,,Invasive Carcinoma,,,,,,,18090,0,,2372,2372,,,,2372,2372,,,2372,,,,,,,,TUMOR FREE,Alive,-15469,,,,0,,2372,2372,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A12C,,,,,,,2372,,,,,,,,,,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,84491,,-1.405813302,0,0,0,0,,1,,,,0.13066688,,0.230729556,0,0,0,,Negative,-1.534,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6792,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A94O,Black or African American,STAD,,1,1,,,,1,,1,3.92,0.63,6,9,14,,,640,,,640,,1,1,185,185,,Malignant,29,,226,,,,27297,,,185,185,,,,,640,,,185,,,,,,,,WITH TUMOR,Dead,-27306,640,,,84,,185,185,,,Stomach Cancer,[Not Applicable],,,,,0.21,Stomach,Unknown,,,19,,2,0.2891,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A94O,,,,,,,,Liver,Distant Metastasis,,,,,,,53,,,,,,,,,,,,,2012,185,,,,Stage IIIC,,,,,,,,Progressive Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,84494,,0.176899208,,,,,,,,,,0.008329021,Grade 2,0.060826727,,,,Stage IIIC,,0.1635,,,,,,,,,,,,,,,,0.1161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A94O,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,,0,0.0,0.0,Male,TCGA-FD-A6TA,White,BLCA,,0.0,0,,,,0,MALE,0.0,1.76,0.6,9,3,9,,,1912,,,1912,,0.0,0,1912.0,1912.0,,Malignant,21,,212,,,,32659.0,,,1912.0,1912,,,,,1912,,,1912.0,,,,,,,,TUMOR FREE,Alive,-21196,,,,357.0,,1912.0,1912,,,[Not Available],[Not Applicable],,,,,0.0,,,,,9,,0,0.28519,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TA,,,,,,,1912,,,,,,,,,9,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,84495,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.76,0.64,20,24,23,,,10,BRCA_Basal,10,10,,0,0,10,10,,Invasive Carcinoma,67,,127,,,,19128,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-22798,,,,161,,10,10,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,7,,0,0.47309,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0AT,,,,,,,10,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,84496,TRUE,0.821099254,0,0,0,0,0.0922,1,,,Infiltrating Ductal Carcinoma,0.163625477,,0.023953975,0,0,0,,Negative,0.389,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.1397,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,,1,1,Female,TCGA-78-8662,Unknown,LUAD,,1,1,,Prince Charles Hospital,1,,FEMALE,1,2.74,0.79,17,24,27,,,3361,,3044,3361,,1,1,3044,3044,,Malignant,68,,229,,,,16851,,,3044,3044,,,,3044,3361,,,3044,,,,,,,,,Dead,-19563,3361,,,1552,,3044,3044,,,[Not Available],[Not Applicable],,,,,0.14,,,,,17,,1,0.54396,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-8662,,,,,,,,,Locoregional Recurrence,,,,,,,31,,,,,,,,,,,,,2000,3044,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,84497,,-0.347939248,,,,,,,,,,0.119964765,,0.10557126,,,,Stage IB,,-0.7745,,,,,,,,,,,,,,,,-0.1976,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.811270424,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.2559,,-0.9274,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-49-4490,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,5.15,0.26,6,8,14,,,385,,,385,,1,1,385,385,,Malignant,28,,29,,,,23533,,,385,385,,,,,385,,,385,,,,,,,,WITH TUMOR,Dead,-16634,385,,,65,,385,385,,,[Not Available],[Not Applicable],,,,,0.42,,,,,26,,2,0.245,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4490,,,,,,,,,,,,,,,,48,,,,,,,,,,,,,1993,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,84501,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,14.95813934,15.40312664,13.8353783,-0.483626278,LUAD,Adenocarcinoma,18.18408044,15.19834945,Adenocarcinoma,,12.95053452,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-KK-A7AU,,PRAD,331,1,1,,KK,,0,MALE,1,2.01,0.88,3,6,4,ambiguous,NO,1775,1-ERG,,1775,,1,1,207,207,prad_tcga,Malignant,13,,55,,TCGA-KK-A7AU-01,0,5510,0,TCGA-KK-A7AU,207,207,Prostate Cancer,123,1621,,1775,TCGA,No Evidence of Extraprostatic Extension,207,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23118,,63,9,32,PRAD,207,207,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.02,Prostate,Resection,4,6BB295A8-D8F7-454E-8D7A-B4F12C32ED0C,2,,0,0.057082,[Not Available],39303E7C-5BAF-479D-A112-D8F03A18C621,5,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,KK,0.9,TCGA-KK-A7AU,1:Recurred/Progressed,5,13,Prostate Adenocarcinoma,6.8,8/28/14,1775,,Biochemical evidence of disease,,,YES,C61,4BA7AC63-6B00-44E3-9545-6A4836912B1E,120,5,TUMOR FREE,0.1196,0:LIVING,0.0,,58.31,Bilateral,16,,,YES,1266,2010,207,,TCGA-KK-A7AU.4BA7AC63-6B00-44E3-9545-6A4836912B1E.pdf,Peripheral Zone,[Not Applicable],NO,,51-60%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,R1,,63,Core needle biopsy,207,Progressive Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N1,T2b,3,M0,C61.9,8140/3,84509,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,,,,BRCA,,0,0,,,,,FEMALE,2,3.44,0.3,4,10,12,,,426,BRCA_Her2,,426,,2,2,426,426,,Invasive Carcinoma,26,,27,,,,18144,0,,426,426,,,,,426,,,426,,,,,,,,,Dead,-22858,426,,,90,,426,426,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,17,,1,0.079163,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09X,,,,,,,,,,,,,,,,20,,,,,,,,,,,,,2009,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,84519,TRUE,1.4138458,0,1,0,0,-0.5027,1,,,Infiltrating Lobular Carcinoma,0.179774767,,0.20122363,0,0,0,,[Not Available],0.6865,,10/21/22,0,0,0,0,0,0,0,1,0,0,no,0,0,0.0935,0,0,H & E,0,0,,0,Ioana Tolocica,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,"Invasive Carcinoma (Mixed Ductal-Lobular Features), Invasive Lobular Carcinoma (Classical/Pleomorphic)","Invasive Carcinoma (Mixed Ductal-Lobular Features), Invasive Lobular Carcinoma (Classical/Pleomorphic)",0,ALH,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-6145,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,1.66,0.31,3,2,3,,,595,,595,595,,0,0,595,595,,Malignant,8,,18,,,,17855,,,595,595,,,,595,595,,,595,,,,,,,,TUMOR FREE,Alive,-22745,,,,390,,595,595,,,[Not Available],[Not Applicable],,,,,0.22,,,,,13,,0,0.46998,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6145,,,,,,,595,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,84532,,1.365955629,,,,,,,,,,0.237693563,,0.165562641,,,,Stage IA,,2.2855,,,,,,,,,,,,,,,,0.4708,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,0.188904028,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.889,,1.6959,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-BR-A4PD,White,STAD,,0,0,,,0,0,,0,4.26,0.43,8,13,22,,,628,,628,628,,0,0,628,628,,Malignant,43,,119,,,,28681,,,628,628,,,,628,628,,,628,,,,,,,,TUMOR FREE,Alive,-26334,,,,203,,628,628,,,[Not Available],[Not Applicable],,,,,0.38,Stomach,Unknown,,,7,,2,0.36917,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4PD,,,,,,,628,,,,,,,,,60,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,84533,,0.475225823,,,,,,,,,,0.045518589,Grade 3,0.087276201,,,,Stage IIB,,0.2855,,,,,,,,,,,,,,,,-0.0031,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4PD,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-XJ-A9DI,,PRAD,389,0,0,,XJ,0,0,MALE,0,2.0,0.48,0,0,0,HRP,NO,1461,1-ERG,1461,1461,,0,0,1461,1461,prad_tcga,Malignant,0,BRCA2,4,,TCGA-XJ-A9DI-01,0,5626,0,TCGA-XJ-A9DI,1461,1461,Prostate Cancer,,1461,1461,1461,TCGA,,1461,Primary,0,Base,A,,,False,TUMOR FREE,Alive,,,62,9,20,PRAD,1461,1461,,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.17,Prostate,Resection,5,11A6BA1A-25F7-4F1F-A9DE-723FABFAA018,0,Normal (no evidence of prostate cancer) [cM0],0,0.000996,[Not Available],39A5AEBE-ACAD-4141-AA5A-66228C4049F8,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XJ,1.03333333333,TCGA-XJ-A9DI,0:DiseaseFree,5,0,Prostate Adenocarcinoma,48.0,5/21/14,1461,,,,,NO,C61,8D5547ED-4864-4CE1-87D0-2FE7621B9B7C,20,0,TUMOR FREE,0.0003,0:LIVING,0.1,,48.0,,1,,,YES,1443,2009,,,TCGA-XJ-A9DI.8D5547ED-4864-4CE1-87D0-2FE7621B9B7C.pdf,Peripheral Zone,[Not Applicable],NO,-61,86-95%,5,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,62,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T2b,0,M0,C61.9,8140/3,84534,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-55-6712,White,LUAD,,1,1,,International Genomics Consortium,,1,MALE,1,3.38,0.29,6,11,10,,,171,,,171,,1,1,171,171,,Malignant,27,,21,,,,21683,,,171,171,,,,,171,,,171,,,,,,,,WITH TUMOR,Dead,,171,,,201,,171,171,,,[Not Available],[Not Applicable],,,,,0.39,,,,,18,,1,0.17434,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6712,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,71,,,,,,,,,,,,,,,,,,,,84545,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.4685,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.48810577,17.77948735,17.24220573,0.257346693,LUAD,,18.51516144,17.18297911,Adenocarcinoma,0.0045,13.64507099,1.5939,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.78,4,1,5,,,178,BRCA_LumA,178,178,,0,0,178,178,,Invasive Carcinoma,10,,12,,,,16482,0,,178,178,,,,178,178,,,178,,,,,,,,TUMOR FREE,Alive,-29751,,,,186,,178,178,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,5,,0,0.056312,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HK,,,,,,,178,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,81,,,,,,,,,,,,,,,,,,,,84551,,-0.193675347,0,0,0,0,0.3895,0,,,Infiltrating Ductal Carcinoma,0.144500045,,0.284561438,0,0,0,,Negative,-0.5605,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.3257,1,0,H & E,0,0,,0,Chunhui Yi,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Columnar Lesion,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1162,,1162,1162,,0,0,1162,1162,,Invasive Carcinoma,,,,,,,27799,0,,1162,1162,,,,1162,1162,,,1162,,,,,,,,TUMOR FREE,Alive,-26642,,,,0,,1162,1162,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A3NY,,,,,,,1162,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,84554,,-0.414862081,0,0,0,0,0.8622,1,,,Infiltrating Lobular Carcinoma,0.086250202,,0.174360204,0,0,0,,Negative,-0.7285,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.0977,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,Benign Breast Epithelium,No Detail Present,"DCIS (Papillary, Low Grade), No Detail Present",,"DCIS (Papillary, Low Grade)",0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.14,0.48,4,3,5,,,646,BRCA_LumA,646,646,,0,0,646,646,,Invasive Carcinoma,12,,26,,,,31810,0,,646,646,,,,646,646,,,646,,,,,,,,TUMOR FREE,Alive,-16101,,,,45,,646,646,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,9,,0,0.12262,[Not Evaluated],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Hartford Hospital,,TCGA-LD-A66U,,,,,,,646,,,,,,,,,13,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,84568,,1.008040555,0,0,0,0,0.2663,1,,,Infiltrating Lobular Carcinoma,0.11370458,,0.151886729,0,0,0,,Negative,0.257,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3823,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-4Z-AA89,White,BLCA,,0.0,0,,,,0,MALE,1.0,1.99,0.87,2,5,3,,,1029,,,1029,,0.0,0,648.0,648.0,,Malignant,10,,25,,,,19285.0,,,1029.0,1029,,,,,1029,,,648.0,,,,,,,,WITH TUMOR,Alive,-22271,,,,176.0,,1029.0,1029,,,[Not Available],[Not Applicable],,,,,0.31,,,,,1,,0,0.034981,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA89,,,,,,,1029,Lung,New Primary Tumor,,,,,,,2,,,,,,,,,,,,,2011,648,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,84575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-64-5774,White,LUAD,,1,,,Fox Chase,1,0,MALE,1,2.86,0.76,10,14,18,,,2676,,246,2676,,1,,246,246,,Malignant,42,,46,,,,19864,,,246,,,,,246,2676,,,246,,,,,,,,TUMOR FREE,Alive,-22059,,,,186,,246,,,,[Not Available],[Not Applicable],,,,,0.09,,,,,15,,1,0.34358,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-5774,,,,,,,2676,,,,,,,,,30,,,,,,,,,,,,,2004,246,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,84579,,0.261621321,,,,,,,,,,0.092187062,,0.107157756,,,,Stage IB,,0.5125,,,,,,,,,,,,,,,,0.0864,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.611201872,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.1532,,-0.7359,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-K4-A54R,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.62,0.46,12,14,13,,,842,,842,842,,0.0,0,842.0,842.0,,Malignant,39,,67,,,,29140.0,,,842.0,842,,,,842,842,,,842.0,,,,,,,,TUMOR FREE,Alive,-21601,,,,1290.0,,842.0,842,,,[Not Available],[Not Applicable],,,,,0.09,,,,,5,,1,0.21672,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A54R,,,,,,,842,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,84582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-AAMH,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.21,0.88,2,0,2,,,344,,,344,,1.0,1,313.0,313.0,,Malignant,4,,25,,,,26340.0,,,313.0,313,,,,,344,,,313.0,,,,,,,,WITH TUMOR,Dead,-29547,344,,,81.0,,313.0,313,,,[Not Available],[Not Applicable],,,,,0.0,,,,,6,,0,0.054643,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMH,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,10,,,,,,,,,,,,,2005,313,lumbar spine and right hemipelvis,,,Stage IV,,,,,,,,Progressive Disease,,,,,,80.0,,,,,,,,,,,,,,,,,,,,84583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-6820,White,STAD,,0,0,,,0,0,,0,1.57,0.69,13,9,11,,,344,,344,344,,0,0,344,344,,Malignant,33,,49,,,,21318,,,344,344,,,,344,344,,,344,,,,,,,,TUMOR FREE,Alive,-23486,,,,120,,344,344,,,[Not Available],[Not Applicable],,,,,0.46,Stomach,Unknown,,,15,,0,0.51913,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6820,,,,,,,344,,,,,,,,,17,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,84586,,,,,,,,,,,,,Grade 2,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6820,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0.0,,0,0.0,0.0,Male,TCGA-G2-A2EF,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.04,0.61,7,15,18,,,1884,,,1884,,0.0,0,1884.0,1884.0,,Malignant,40,,62,,,,26289.0,,,1884.0,1884,,,,,1884,,,1884.0,,,,,,,,TUMOR FREE,Alive,-18467,,,,357.0,,1884.0,1884,,,[Not Available],[Not Applicable],,,,,0.23,,,,,12,,1,0.21003,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EF,,,,,,,1884,,,,,,,,,39,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,50.0,,,,,,,,,,,,,,,,,,,,84590,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A5C0,White,BLCA,,0.0,0,,,,1,MALE,1.0,2.89,0.58,9,7,16,,,550,,,550,,2.0,2,27.0,27.0,,Malignant,32,,78,,,,30639.0,,,550.0,550,,,,,550,,,27.0,,,,,,,,WITH TUMOR,Dead,-22500,550,,,183.0,,550.0,550,,,[Not Available],[Not Applicable],,,,,0.07,,,,,19,,1,0.2736,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5C0,,,,,,,,Lung,New Primary Tumor,,,,,,,39,,,,,,,,,,,,,2012,27,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,84593,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-V5-AASW,White,ESCA,,1,1,,,,0,,1,2.75,0.73,7,4,11,,,282,,,282,,1,1,282,282,,Malignant,22,,129,,,,21772,,,282,282,,,,,282,,,282,,,,,,,,WITH TUMOR,Alive,-26571,,,,238,,282,282,,,[Not Available],Stage IIIA,,,,,0.31,Esophagus,Unknown,,,20,,1,0.27046,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Duke University,,TCGA-V5-AASW,,,,,,,282,Lung,Distant Metastasis,,,,,,,32,,,,,,,,,,,,,,282,,,,[Not Available],,,,,,,,[Unknown],,,,,,72,,,,,,,,,,,,,,,,,,,,84599,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,Not Answered,,,,,,,,,,,,,,,,,,,,,Biopsy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,,,0,1,Male,TCGA-05-4397,,LUAD,,0,0,,Indivumed,,,MALE,2,1.99,0.87,11,15,17,,,731,,,731,,2,2,731,731,,Malignant,43,,56,,,,23845,,,731,731,,,,,731,,,731,,,,,,,,,Dead,-23833,731,,,1070,,731,731,,,[Not Available],[Not Applicable],,,,,0.06,,,,,7,,0,0.17168,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4397,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,84600,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.89970106,17.03151975,14.78471751,-0.32787694,LUAD,Adenocarcinoma,17.06646108,14.96536222,Adenocarcinoma,-0.5646,13.91354025,-0.7028,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-D7-6522,White,STAD,,0,0,,,0,0,,0,2.0,0.08,0,0,0,,,566,,566,566,,0,0,566,566,,Malignant,0,,4,,,,16228,,,566,566,,,,566,566,,,566,,,,,,,,TUMOR FREE,Alive,-21465,,,,50,,566,566,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,0,,0,0.15922,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6522,,,,,,,566,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,84602,,,,,,,,,,,,,Grade 3,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6522,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0.0,,0,0.0,0.0,Male,TCGA-FJ-A3Z7,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.43,0.54,8,17,23,,,945,,,945,,0.0,0,945.0,945.0,,Malignant,48,,91,,,,28910.0,,,945.0,945,,,,,945,,,945.0,,,,,,,,TUMOR FREE,Alive,-28052,,,,448.0,,945.0,945,,,[Not Available],[Not Applicable],,,,,0.21,,,,,10,,1,0.258,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3Z7,,,,,,,945,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,84603,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-77-8131,Unknown,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,1.81,0.23,7,3,6,,,383,,,383,,2,2,383,383,,Malignant,16,,15,,,,34145,,,383,383,,,,,383,,,383,,,,,,,,,Dead,-26611,383,,,83,,383,383,,,[Not Available],[Not Applicable],,,,,0.31,,,,,9,,0,0.33107,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8131,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2000,,,,,Stage IB,,,,,,,,[Unknown],,,,,,72,,,,,,,,,,,,,,,,,,,,84605,,1.225647702,,,,,,,,,,0.291265329,,0.16115683,,,,Stage IB,,1.815,,,,,,,,,,,,,,,,0.5556,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.120403133024356,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.2811,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-ZF-A9RE,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,1.9,0.76,6,2,7,,,106,,,106,,1.0,1,106.0,106.0,,Malignant,15,,84,,,,27006.0,,,106.0,106,,,,,106,,,106.0,,,,,,,,WITH TUMOR,Dead,-28622,106,,,82.0,,106.0,106,,,[Not Available],[Not Applicable],,,,,0.39,,,,,10,,0,0.26788,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9RE,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,78.0,,,,,,,,,,,,,,,,,,,,84609,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-A91W,White,STAD,,0,0,,,0,0,,0,2.13,0.55,0,0,0,,,1851,,1851,1851,,0,0,1851,1851,,Malignant,0,,13,,,,22263,,,1851,1851,,,,1851,1851,,,1851,,,,,,,,,Alive,-10963,,,,59,,1851,1851,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,6,,0,0.000406,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A91W,,,,,,,1851,,,,,,,,,3,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,30,,,,,,,,,,,,,,,,,,,,84611,,0.161483766,,,,,,,,,,0.049119784,Grade 2,0.057735251,,,,Stage IIIA,,0.6215,,,,,,,,,,,,,,,,-0.0456,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91W,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-86-6562,White,LUAD,,1,,,Asterand,,1,MALE,1,3.46,0.46,5,3,8,,,376,,,376,,1,,274,274,,Malignant,16,,18,,,,19251,,,274,,,,,,376,,,274,,,,,,,,WITH TUMOR,Dead,-19301,376,,,72,,274,,,,[Not Available],[Not Applicable],,,,,0.25,,,,,13,,1,0.2339,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-6562,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2011,274,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,52,,,,,,,,,,,,,,,,,,,,84614,,-0.051011651,,,,,,,,,,0.221529201,,0.182997744,,,,Stage IIA,,0.2595,,,,,,,,,,,,,,,,0.5408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.80475603,16.79466145,13.69318039,-0.411548961,LUAD,Adenocarcinoma,17.99955624,14.91515288,Adenocarcinoma,1.0154,14.51656423,-1.2473,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-J2-A4AD,White,LUAD,,1,1,,ABS - Lahey Clinic,,1,FEMALE,1,1.82,0.57,7,8,8,,,550,,,550,,1,1,524,524,,Malignant,23,,76,,,,31207,,,524,524,,,,,550,,,524,,,,,,,,WITH TUMOR,Dead,-22414,550,,,428,,524,524,,,[Not Available],[Not Applicable],,,,,0.4,,,,,7,,0,0.26659,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ABS - Lahey Clinic,,TCGA-J2-A4AD,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,9,,,,,,,,,,,,,2012,524,,,,Stage IA,,,,,,,,[Unknown],,,,,,61,,,,,,,,,,,,,,,,,,,,84615,,-0.441197241,,,,,,,,,,0.153776501,,0.081762495,,,,Stage IA,,-0.287,,,,,,,,,,,,,,,,0.3153,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.802509306,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.0751,,-0.8989,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.18,0.58,9,13,16,,,572,BRCA_LumB,572,572,,0,0,572,572,,Invasive Carcinoma,38,,65,,,,19382,0,,572,572,,,,572,572,,,572,,,,,,,,TUMOR FREE,Alive,-23650,,,,64,,572,572,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,18,,1,0.19763,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-A6ZF,,,,,,,572,,,,,,,,,28,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,84616,,0.660599778,0,0,0,0,-0.0108,1,,,Infiltrating Ductal Carcinoma,0.158062604,,0.117764801,0,0,0,,Negative,0.259,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2618,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Microcalcifications,"DCIS (Cribriform, High Grade), Microcalcifications",,"DCIS (Cribriform, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.3,2,2,2,,,554,BRCA_LumA,554,554,,0,0,554,554,,Invasive Carcinoma,6,,6,,,,29214,0,,554,554,,,,554,554,,,554,,,,,,,,TUMOR FREE,Alive,-19706,,,,583,,554,554,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,1,,0,0.069565,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1IZ,,,,,,,554,,,,,,,,,3,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,84617,,2.066812565,0,0,0,0,0.116,1,,,Infiltrating Ductal Carcinoma,0.150243196,,0.170426085,0,0,0,,Negative,1.6335,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0708,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-05-4415,,LUAD,,1,,,Indivumed,,1,MALE,1,3.59,0.67,7,4,13,,,91,,,91,,1,,60,60,,Malignant,24,,27,,,,24717,,,60,,,,,,91,,,60,,,,,,,,WITH TUMOR,Dead,-20880,91,,,254,,60,,,,[Not Available],[Not Applicable],,,,,0.22,,,,,19,,1,0.13161,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4415,,,,,,,,,,,,,,,,20,,,,,,,,,,,,,2008,60,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,57,,,,,,,,,,,,,,,,,,,,84619,,0.832597238,,,,,,,,,,0.148679329,,0.049015626,,,,Stage IIIB,,0.709,,,,,,,,,,,,,,,,-0.2839,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),G12C (driver),HOMDEL (driver),1,,G12C (driver),,15.36632414,16.097768,16.45280041,-0.368237377,LUAD,,17.69134816,15.77946851,Adenocarcinoma,-0.7197,13.07595773,0.5469,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,,,Black or African American,BRCA,,1,1,,,,0,FEMALE,1,,,,,,,,1291,BRCA_LumB,,1291,,1,1,1290,1290,,Invasive Carcinoma,,,,,,,20906,0,,1290,1290,,,,,1291,,,1290,,,,,,,,WITH TUMOR,Alive,-14454,,,,147,,1290,1290,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A25B,,,,,,,1291,Bone,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,1290,,,,Stage IIB,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,84620,,0.439522847,0,0,0,1,-0.0833,0,,,Infiltrating Ductal Carcinoma,0.175673019,,0.107350038,0,0,0,,Close,-0.017,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2735,1,0,H & E,0,0,,0,Chunhui Yi,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-FD-A6TG,White,BLCA,,0.0,0,,,,2,MALE,2.0,3.29,0.39,2,17,13,,,93,,,93,,2.0,2,93.0,93.0,,Malignant,32,,21,,,,23206.0,,,93.0,93,,,,,93,,,93.0,,,,,,,,TUMOR FREE,Dead,-26893,93,,,513.0,,93.0,93,,,[Not Available],[Not Applicable],,,,,0.57,,,,,20,,1,0.024681,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TG,,,,,,,,,,,,,,,,39,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,[Not Applicable],,,,,,73.0,,,,,,,,,,,,,,,,,,,,84621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-44-5643,Black or African American,LUAD,,0,0,,Christiana Healthcare,,0,MALE,0,1.63,0.56,7,4,13,,,1013,,,1013,,0,0,1013,1013,,Malignant,24,,42,,,,16980,,,1013,1013,,,,,1013,,,1013,,,,,,,,TUMOR FREE,Alive,-19426,,,,169,,1013,1013,,,[Not Available],[Not Applicable],,,,,0.01,,,,,15,,0,0.59246,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-5643,,,,,,,1013,,,,,,,,,24,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,84624,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.92873065,15.24268111,15.89605578,-0.224699082,LUAD,Adenocarcinoma,18.19946973,16.3627036,Adenocarcinoma,-1.5293,9.826010311,0.1794,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-YL-A8HL,,PRAD,370,0,0,,YL,,0,MALE,0,1.93,0.86,5,5,5,ambiguous,NO,1565,1-ERG,,1565,,0,0,1565,1565,prad_tcga,Malignant,15,,63,,TCGA-YL-A8HL-01,0,5656,0,TCGA-YL-A8HL,1565,1565,Prostate Cancer,,1173,,1565,TCGA,,1565,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-21249,,58,9,28,PRAD,1565,1565,,0.0,[Not Available],[Not Applicable],22,R1,1,Matched,0.0,Prostate,Resection,4,4CD7F57C-FD19-4DEF-A5FB-DCA3DBC10320,1,Normal (no evidence of prostate cancer) [cM0],0,0.071852,[Not Available],FF52FA2F-BD12-4DE0-9F5C-CD330FFB5FB3,5,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,YL,0.733333333333,TCGA-YL-A8HL,0:DiseaseFree,5,15,Prostate Adenocarcinoma,51.41,3/13/14,1565,,,,,NO,C61,0C91388C-CCC6-4BBD-B13A-E543A8FC2E5F,170,3,,0.0677,0:LIVING,0.03,,51.41,Bilateral,16,No Evidence of Extraprostatic Extension,27,YES,1387,2010,,,TCGA-YL-A8HL.0C91388C-CCC6-4BBD-B13A-E543A8FC2E5F.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,25,36-45%,8,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,58,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,2,M0,C61.9,8140/3,84625,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-85-8353,White,LUSC,,1,1,,Asterand,,1,MALE,1,1.69,0.41,10,7,14,,,94,,,94,,1,1,94,94,,Malignant,31,,35,,,,30900,,,94,94,,,,,94,,,94,,,,,,,,WITH TUMOR,Dead,-26549,94,,,230,,94,94,,,[Not Available],[Not Applicable],,,,,0.15,,,,,14,,0,0.50498,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8353,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,72,,,,,,,,,,,,,,,,,,,,84626,,1.122634612,,,,,,,,,,0.217742856,,0.146784362,,,,Stage IIIA,,1.1365,,,,,,,,,,,,,,,,1.0183,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.70643418,16.19966617,15.96777553,-0.289723140803437,LUSC,Squamous Cell Carcinoma,17.95064182,16.45131308,Squamous Cell Carcinoma,1.2239,13.5581645,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-R6-A6Y2,White,ESCA,,1,1,,,,1,,1,2.99,0.48,10,7,10,,,283,,,283,,1,1,102,102,,Malignant,27,,123,,,,16088,,,102,102,,,,,283,,,102,,,,,,,,WITH TUMOR,Dead,-25940,283,,,197,,102,102,,,[Not Available],Stage IIB,,,,,0.04,Esophagus,Unknown,,,10,,1,0.41548,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,MD Anderson Cancer Center,,TCGA-R6-A6Y2,,,,,,,,Bone,Distant Metastasis,,,,,,,27,,,,,,,,,,,,,2005,102,,,,[Not Available],,,,,,,,,,,,,,71,,,,,,,,,,,,,,,,,,,,84627,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1.0,,1,1.0,1.0,Female,TCGA-XF-A9SU,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,4.36,0.26,2,16,12,,,182,,,182,,1.0,1,103.0,103.0,,Malignant,30,,63,,,,33643.0,,,103.0,103,,,,,182,,,103.0,,,,,,,,WITH TUMOR,Dead,-27068,182,,,69.0,,103.0,103,,,[Not Available],[Not Applicable],,,,,0.4,,,,,15,,2,0.16192,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SU,,,,,,,,Liver,Distant Metastasis,,,,,,,60,,,,,,,,,,,,,2006,103,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,74.0,,,,,,,,,,,,,,,,,,,,84630,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-96-A4JL,Asian,LUSC,,0,0,,Washington University - NYU,0,0,FEMALE,0,2.05,0.38,8,13,9,,,842,,842,842,,0,0,842,842,,Malignant,30,,33,,,,27686,,,842,842,,,,842,842,,,842,,,,,,,,TUMOR FREE,Alive,-28686,,,,79,,842,842,,,[Not Available],[Not Applicable],,,,,0.15,,,,,6,,0,0.12754,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - NYU,,TCGA-96-A4JL,,,,,,,842,,,,,,,,,8,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,84631,,1.657956445,,,,,,,,,,0.161307928,,0.143494015,,,,Stage IIA,,2.064,,,,,,,,,,,,,,,,0.2215,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.47780125,15.77963826,17.85950522,0.161370236021717,LUSC,Squamous Cell Carcinoma,18.36228925,17.46208648,Squamous Cell Carcinoma,-0.4015,12.7423141,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-38-4632,Black or African American,LUAD,,1,,,UNC,,1,MALE,1,3.86,0.37,6,15,19,,,1357,,,1357,,1,,680,680,,Malignant,40,,19,,,,20045,,,680,,,,,,1357,,,680,,,,,,,,WITH TUMOR,Dead,-15418,1357,,,687,,680,,,,[Not Available],[Not Applicable],,,,,0.55,,,,,20,,1,0.16045,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-4632,,,,,,,,,,,,,,,,32,,,,,,,,,,,,,1998,680,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,42,,,,,,,,,,,,,,,,,,,,84632,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,,,,,,,,,,,0.0138,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.41639239,17.13866259,16.39610449,0.012347292,LUAD,,18.16291342,16.10691901,Adenocarcinoma,,13.95336483,0.439,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.76,3,1,4,,,358,BRCA_LumA,358,358,,0,0,358,358,,Invasive Carcinoma,8,,4,,,,17298,0,,358,358,,,,358,358,,,358,,,,,,,,TUMOR FREE,Alive,-21428,,,,33,,358,358,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,4,,0,0.035888,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12N,,,,,,,358,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,84633,,0.241837971,0,0,0,0,0.2377,1,,,Infiltrating Ductal Carcinoma,0.150762164,,0.13322687,0,0,0,,Negative,-0.5435,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.5747,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-6738,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.88,0.53,10,3,14,,,1927,,1927,1927,,0,0,1927,1927,,Malignant,27,,24,,,,16747,,,1927,1927,,,,1927,1927,,,1927,,,,,,,,TUMOR FREE,Alive,-29368,,,,451,,1927,1927,,,[Not Available],[Not Applicable],,,,,0.4,,,,,17,,0,0.32942,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-6738,,,,,,,1927,,,,,,,,,18,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,84639,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.1559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R362Q,1,,,R362Q,14.01092638,14.28981816,14.00501863,-0.628474808874668,LUSC,,17.94689144,14.92918619,Squamous Cell Carcinoma,,11.92790784,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.08,0.68,19,31,19,,,639,BRCA_LumA,639,639,,0,0,639,639,,Invasive Carcinoma,69,,59,,,,33253,0,,639,639,,,,639,639,,,639,,,,,,,,TUMOR FREE,Alive,-26862,,,,162,,639,639,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,4,,0,0.32994,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JP,,,,,,,639,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,84656,,0.615011265,0,0,0,0,-0.391,1,,,Infiltrating Ductal Carcinoma,0.189820179,,0.174496439,0,0,0,,Negative,-0.2935,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4466,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"DCIS (Solid, Intermediate Grade), LCIS, N/A No in Situ",,"DCIS (Solid, Intermediate Grade), LCIS",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,84666,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,0,1,Male,TCGA-05-4396,,LUAD,,0,0,,Indivumed,,,MALE,2,1.86,0.82,6,2,5,,,303,,,303,,2,2,303,303,,Malignant,13,,31,,,,23605,,,303,303,,,,,303,,,303,,,,,,,,,Dead,-28094,303,,,326,,303,303,,,[Not Available],[Not Applicable],,,,,0.16,,,,,8,,0,0.25022,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4396,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2006,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,84667,,0.272763634,,,,,,,,,,0.13788167,,0.149641653,,,,Stage IIIB,,-0.122,,,,,,,,,,,,,,,,-0.0432,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.1563743,15.29250699,14.62048807,-0.599016305,LUAD,,17.79933727,15.02535161,Adenocarcinoma,-1.1758,11.69802324,-1.2463,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,0,1,1,,,White,BRCA,,1,1,,,1,2,FEMALE,1,1.52,0.74,24,28,26,,,7455,BRCA_Basal,490,7455,,1,1,490,490,,Invasive Carcinoma,78,,219,,,,21060,0,,490,490,,,,490,7455,,,490,,,,,,,,TUMOR FREE,Dead,-17624,7455,,,112,,490,490,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,10,,0,0.70658,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0X1,,,,,,,,Brain,Distant Metastasis,,,,,,,24,,,,,,,,,,,,,1994,490,,,,[Discrepancy],,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,84668,,,0,0,0,0,1.0919,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.94,0.42,24,26,28,,,3261,BRCA_Basal,3261,3261,,0,0,3261,3261,,Invasive Carcinoma,78,,103,,,,30572,0,,3261,3261,,,,3261,3261,,,3261,,,,,,,,TUMOR FREE,Alive,-19729,,,,0,,3261,3261,,,[Not Available],[Not Applicable],,,,,0.25,Breast,Resection/Excision,,,10,,0,0.51054,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0U4,,,,,,,3261,,,,,,,,,25,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,84675,TRUE,0.835037757,0,0,0,0,0.7434,1,,,Infiltrating Ductal Carcinoma,0.260474186,,0.117275737,0,0,0,,Negative,0.767,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1481,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-8614,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,4.05,0.32,10,7,13,,,536,,536,536,,0,0,536,536,,Malignant,30,,56,,,,18064,,,536,536,,,,536,536,,,536,,,,,,,,TUMOR FREE,Alive,-27924,,,,310,,536,536,,,[Not Available],[Not Applicable],,,,,0.19,,,,,19,,1,0.20814,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8614,,,,,,,536,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,84697,,0.823404101,,,,,,,,,,0.1818461,,0.101995736,,,,Stage IB,,0.4,,,,,,,,,,,,,,,,0.841,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.347377266,LUAD,,,,Adenocarcinoma,0.3036,,-0.1496,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.21,0.61,2,0,3,,,931,BRCA_LumA,931,931,,0,0,931,931,,Invasive Carcinoma,5,,7,,,,32960,0,,931,931,,,,931,931,,,931,,,,,,,,TUMOR FREE,Alive,-17456,,,,55,,931,931,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,7,,0,0.015997,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A570,,,,,,,931,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,84700,,-0.443553814,1,0,0,0,-0.1719,0,,,Infiltrating Ductal Carcinoma,0.129949287,,0.156133437,0,0,0,,Negative,-0.65,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.5154,1,0,H & E,0,0,,0,Chunhui Yi,"ADH, Columnar Lesion",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, High Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"ADH, Columnar Lesion",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.51,0.53,1,1,2,,,1121,BRCA_LumA,1121,1121,,0,0,1121,1121,,Invasive Carcinoma,4,,19,,,,18759,0,,1121,1121,,,,1121,1121,,,1121,,,,,,,,TUMOR FREE,Alive,-20719,,,,64,,1121,1121,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,20,,1,0.020943,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HQ,,,,,,,1121,,,,,,,,,21,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,84702,,-0.934682406,0,0,0,0,0.5562,0,,,Infiltrating Ductal Carcinoma,0.151743212,,0.159294979,0,0,0,,Negative,-0.881,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5851,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Apocrine Metaplasia,0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"DCIS (Cribriform, Intermediate Grade), N/A No in Situ",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Apocrine Metaplasia,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-33-4533,Black or African American,LUSC,,0,0,,Johns Hopkins,0,0,FEMALE,0,4.08,0.7,9,11,12,,,4068,,4068,4068,,0,0,4068,4068,,Malignant,32,,218,,,,20460,,,4068,4068,,,,4068,4068,,,4068,,,,,,,,TUMOR FREE,Alive,-28001,,,,402,,4068,4068,,,[Not Available],[Not Applicable],,,,,0.3,,,,,8,,2,0.50033,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4533,,,,,,,4068,,,,,,,,,47,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,84706,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.6873,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.540159886413279,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-G9-6499,White,PRAD,161,0,0,,G9,0,0,MALE,0,3.62,0.3,5,15,10,ambiguous,NO,1543,8-other,1543,1543,,0,0,1543,1543,prad_tcga,Malignant,30,BRCA1;BRIP1;CDK12;RAD51B;RAD51C;RAD51D;RAD54L,17,8.2,TCGA-G9-6499-01,35,5381,0,TCGA-G9-6499,1543,1543,Prostate Cancer,,1109,1543,1543,TCGA,,1543,Primary,1,Apex|Base,A,,,,TUMOR FREE,Alive,-24388,,66,9,51,PRAD,1543,1543,WHITE,0.354658503,[Not Available],[Not Applicable],36,R0,1,Matched,0.3,Prostate,Resection,4,424fb9d8-f70e-4a36-b895-a766176eee7c,17,Equivocal,1,0.10454,[Not Available],acd5ceef-c5cf-4e95-9394-c50fdbc70c8d,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,30,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,2.13333333333,TCGA-G9-6499,0:DiseaseFree,5,53,Prostate Adenocarcinoma,50.69,3/20/12,1543,,,,,NO,C61,8e1d4212-b252-4019-b188-3cdd60be733d,,20,TUMOR FREE,0.2884,0:LIVING,0.11,,50.69,Bilateral,56,No Evidence of Extraprostatic Extension,421,YES,,2008,,,TCGA-G9-6499.8e1d4212-b252-4019-b188-3cdd60be733d.pdf,,[Not Applicable],YES,56,36-45%,13,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,66,Core needle biopsy,,,NO,YES,YES,,T3a,,9,No,,0,N0,T3a,0,M0,C61.9,8550/3,84708,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-44-A47B,White,LUAD,,0,0,,Christiana Healthcare,0,0,MALE,0,3.26,0.5,3,4,7,,,287,,287,287,,0,0,287,287,,Malignant,14,,59,,,,27318,,,287,287,,,,287,287,,,287,,,,,,,,TUMOR FREE,Alive,-28869,,,,74,,287,287,,,[Not Available],[Not Applicable],,,,,0.12,,,,,15,,1,0.087709,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-A47B,,,,,,,287,,,,,,,,,20,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,84712,,0.710672338,,,,,,,,,,0.213714434,,0.105760578,,,,Stage IB,,0.55,,,,,,,,,,,,,,,,0.1727,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.2318555,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0692,,0.7378,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-BR-8483,White,STAD,,0,0,,,,0,,0,3.1,0.75,3,6,9,,,164,,,164,,0,0,164,164,,Malignant,18,,89,,,,0,,,164,164,,,,,164,,,164,,,,,,,,TUMOR FREE,Alive,-21731,,,,171,,164,164,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,19,,1,0.27447,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8483,,,,,,,164,,,,,,,,,38,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,59,,,,,,,,,,,,,,,,,,,,84713,,-0.583234595,,,,,,,,,,0.002694258,Grade 2,-0.013068218,,,,Stage IIIA,,-0.544,,,,,,,,,,,,,,,,-0.1098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8483,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-Y6-A8TL,,PRAD,389,0,0,,Y6,,0,MALE,0,1.96,0.59,2,6,0,HRP,NO,992,5-SPOP,,992,,0,0,992,992,prad_tcga,Malignant,8,,79,,TCGA-Y6-A8TL-01,10,5643,0,TCGA-Y6-A8TL,992,992,Prostate Cancer,,775,,992,TCGA,,992,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23776,,65,6,33,PRAD,992,992,,0.323169738,[Not Available],[Not Applicable],32,R0,1,Matched,0.0,Prostate,Resection,3,E8FA37B1-2E31-44B6-BA77-3E46DA7E4FEE,0,,0,0.047748,[Not Available],A7045324-CB44-4B37-BBAF-641642C1D903,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,Y6,1.06666666667,TCGA-Y6-A8TL,0:DiseaseFree,1,11,Prostate Adenocarcinoma,32.59,4/17/14,992,,,,,NO,C61,8DE4AB1E-913E-4763-81EE-272430E5CC4A,370,0,TUMOR FREE,0.0468,0:LIVING,0.0,,32.59,Right,12,No Evidence of Extraprostatic Extension,328,YES,677,2012,,,TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Available],,NO,No,R0,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T2a,0,,C61.9,8140/3,84716,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.94,6,6,7,,,574,BRCA_LumA,574,574,,0,0,574,574,,Invasive Carcinoma,19,,43,,,,25324,0,,574,574,,,,574,574,,,574,,,,,,,,TUMOR FREE,Alive,-30101,,,,79,,574,574,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,4,,0,0.087484,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-AA12,,,,,,,574,,,,,,,,,7,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,84719,,-0.213646494,0,0,0,0,-0.1822,1,,,Infiltrating Ductal Carcinoma,0.094717589,,0.050392138,0,0,0,,Negative,-0.64,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2626,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.69,0.5,8,6,15,,,477,BRCA_Basal,477,477,,0,0,477,477,,Invasive Carcinoma,29,,167,,,,25468,0,,477,477,,,,477,477,,,477,,,,,,,,TUMOR FREE,Alive,-24647,,,,231,,477,477,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,21,,1,0.69288,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A73Y,,,,,,,477,,,,,,,,,30,,,,,,,,,,,,,2013,,,,,Stage IA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,84721,TRUE,1.046453857,0,0,0,0,-0.301,1,,,Infiltrating Ductal Carcinoma,0.170863699,,0.221798136,0,0,0,,Negative,0.53,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6394,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,1,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Lymph Node",N/A No in Situ,None,,None,0,"DCIS with Microinvasive Carcinoma, Invasive Ductal Carcinoma (Tubular)","DCIS with Microinvasive Carcinoma, Invasive Ductal Carcinoma (Tubular)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.52,0.52,29,18,25,,,608,BRCA_Basal,608,608,,0,0,608,608,,Invasive Carcinoma,72,,99,,,,21454,0,,608,608,,,,608,608,,,608,,,,,,,,TUMOR FREE,Alive,-25770,,,,192,,608,608,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,12,,0,0.65143,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1PB,,,,,,,608,,,,,,,,,21,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,84722,TRUE,1.133113145,0,0,0,0,-2.503,1,,,Infiltrating Ductal Carcinoma,0.227920341,,0.030592536,0,0,0,,Negative,3.1805,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3128,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-7703,White,STAD,,0,0,,,0,0,,0,1.95,0.66,2,6,0,,,1100,,1100,1100,,0,0,1100,1100,,Malignant,8,,131,,,,18945,,,1100,1100,,,,1100,1100,,,1100,,,,,,,,TUMOR FREE,Alive,-29711,,,,935,,1100,1100,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Unknown,,,0,,0,0.049319,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Papillary Type",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-7703,,,,,,,1100,,,,,,,,,0,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,84727,,0.245871087,,,,,,,,,,0.033906893,Grade 2,0.010426218,,,,Stage IA,,-0.042,,,,,,,,,,,,,,,,-0.157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7703,Gastric Carcinoma,TCGA,"Adenocarcinoma, Papillary Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-XF-A8HD,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.35,0.43,6,10,7,,,2964,,2964,2964,,0.0,0,2964.0,2964.0,,Malignant,23,,78,,,,33251.0,,,2964.0,2964,,,,2964,2964,,,2964.0,,,,,,,,TUMOR FREE,Alive,-28305,,,,643.0,,2964.0,2964,,,[Not Available],[Not Applicable],,,,,0.13,,,,,16,,1,0.29352,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A8HD,,,,,,,2964,,,,,,,,,33,,,,,,,,,,,,,2006,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,84728,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.41,0.28,11,19,21,,,714,BRCA_Basal,714,714,,0,0,714,714,,Invasive Carcinoma,51,,178,,,,28690,0,,714,714,,,,714,714,,,714,,,,,,,,TUMOR FREE,Alive,-13458,,,,63,,714,714,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,18,,1,0.30635,[Not Evaluated],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A66I,,,,,,,714,,,,,,,,,30,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,36,,,,,,,,,,,,,,,,,,,,84730,,,0,0,0,0,-1.5883,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,"Per latest WHO Breast 5th Edition,  Medullary carcinoma is not a distinct entity anymore. 
The recommended terminology is carcinoma with medullary features",0,0,,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Female,TCGA-D7-8576,White,STAD,,1.0,1,,,1,1,,1.0,1.65,0.69,10,10,9,,,446,,204,446,,1.0,1,204,204,,Malignant,29,,75,,,,17756.0,0,,204,204,,,,204,446,,,204,,,,,,,,WITH TUMOR,Dead,-20014,446,,,77.0,,204,204,,,[Not Available],[Not Applicable],,,,,0.33,Stomach,Resection,,,12,,0,0.45779,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8576,,,,,,,,Lung,Locoregional Recurrence|Distant Metastasis,,,,,,,18,,,,,,,,,,,,,2012,204,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,84732,,-0.294172288,,,,,,,,,,0.117503742,Grade 3,0.126803491,,,,Stage IIIB,,-0.3645,,,,,,,,,,,,,,,,0.1026,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8576,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A3IS,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.41,0.9,3,7,5,,,1529,,1529,1529,,0.0,0,1529.0,1529.0,,Malignant,15,,37,,,,26253.0,,,1529.0,1529,,,,1529,1529,,,1529.0,,,,,,,,TUMOR FREE,Alive,-25098,,,,480.0,,1529.0,1529,,,[Not Available],[Not Applicable],,,,,0.49,,,,,19,,1,0.087536,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IS,,,,,,,1529,,,,,,,,,14,,,,,,,,,,,,,2008,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,68.0,,,,,,,,,,,,,,,,,,,,84736,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-EJ-5526,White,PRAD,91,1,1,,EJ,,0,MALE,1,2.02,0.54,3,4,3,ambiguous,NO,1909,1-ERG,,1909,,1,1,537,537,prad_tcga,Malignant,10,CHEK2,33,28.6,TCGA-EJ-5526-01,7,5288,0,TCGA-EJ-5526,537,537,Prostate Cancer,,175,,1909,TCGA,,537,Primary,0,Middle|Base,A,,,,WITH TUMOR,Alive,-20558,,56,8,39,PRAD,537,537,WHITE,0.188295423,[Not Available],[Not Applicable],30,R0,1,Matched,0.07,Prostate,Resection,4,4dbe4fa2-308f-4d5b-bf33-4c051f7dc537,4,Normal (no evidence of prostate cancer) [cM0],0,0.048625,[Not Available],eec48399-5660-4b25-8d34-191b54315c72,4,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,11,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.966666666667,TCGA-EJ-5526,1:Recurred/Progressed,4,16,Prostate Adenocarcinoma,62.71,4/4/12,1909,,Locoregional Recurrence,,,NO,C61,5afeeeba-2a19-4042-acdc-8dad10ca31f9,,3,WITH TUMOR,0.1147,0:LIVING,0.1,3,62.71,Bilateral,18,No Evidence of Extraprostatic Extension,19,YES,,2009,537,,TCGA-EJ-5526.5afeeeba-2a19-4042-acdc-8dad10ca31f9.pdf,,[Not Applicable],YES,19,71-80%,27,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,NO,No,R0,0.8,56,Core needle biopsy,,,YES,NO,YES,,T3a,,8,No,,0,N1,T1c,1,M0,C61.9,8550/3,84746,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.59,0.64,12,5,13,,,396,BRCA_LumB,396,396,,0,0,396,396,,Invasive Carcinoma,30,,43,,,,22002,0,,396,396,,,,396,396,,,396,,,,,,,,TUMOR FREE,Alive,-22157,,,,108,,396,396,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,21,,1,0.31011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06O,,,,,,,396,,,,,,,,,19,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,84750,,0.5975268,0,0,0,0,-0.7653,1,,,Infiltrating Ductal Carcinoma,0.152753036,,0.123985823,0,0,0,,Negative,-0.3465,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0088,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-FD-A43S,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,,,,,,,,455,,455,455,,0.0,0,455.0,455.0,,Malignant,,,,,,,34340.0,,,455.0,455,,,,455,455,,,455.0,,,,,,,,TUMOR FREE,Alive,-25993,,,,4.0,,455.0,455,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A43S,,,,,,,455,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,71.0,,,,,,,,,,,,,,,,,,,,84751,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-38-7271,White,LUAD,,1,,,UNC,1,1,FEMALE,1,2.08,0.26,0,1,1,,,800,,304,800,,1,,304,304,,Malignant,2,,19,,,,20173,,,304,,,,,304,800,,,304,,,,,,,,WITH TUMOR,Dead,-26440,800,,,92,,304,,,,[Not Available],[Not Applicable],,,,,0.18,,,,,2,,0,1.9e-05,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-7271,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2006,304,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,84754,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,0.2962,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.263849637,LUAD,,,,Adenocarcinoma,-0.2757,,1.7421,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-55-7816,White,LUAD,,1,1,,International Genomics Consortium,,1,FEMALE,1,,,,,,,,468,,,468,,1,1,468,468,,Malignant,,,,,,,18305,,,468,468,,,,,468,,,468,,,,,,,,WITH TUMOR,Dead,-18170,468,,,4,,468,468,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7816,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,49,,,,,,,,,,,,,,,,,,,,84759,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,,,,,,,,,,,0.4759,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.65157845,18.57198395,17.22750882,0.068561689,LUAD,Adenocarcinoma,18.03277831,15.90195657,Adenocarcinoma,0.1542,13.64900839,0.8343,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-VQ-A928,White,STAD,,1,1,,,,1,,1,2.09,0.56,0,2,7,,,174,,,174,,1,1,148,148,,Malignant,9,,239,,,,33717,,,148,148,,,,,174,,,148,,,,,,,,WITH TUMOR,Dead,-18058,174,,,91,,148,148,,,Stomach Cancer,[Not Applicable],,,,,0.14,Stomach,Unknown,,,5,,0,0.029607,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Papillary Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A928,,,,,,,,Liver,Distant Metastasis,,,,,,,3,,,,,,,,,,,,,2010,148,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,49,,,,,,,,,,,,,,,,,,,,84779,,-0.040885129,,,,,,,,,,0.042894277,Grade 2,0.118815907,,,,Stage IV,,-0.2975,,,,,,,,,,,,,,,,0.633,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A928,Gastric Carcinoma,TCGA,"Adenocarcinoma, Papillary Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.66,2,0,3,,,337,BRCA_LumA,337,337,,0,0,337,337,,Invasive Carcinoma,5,,10,,,,17600,0,,337,337,,,,337,337,,,337,,,,,,,,TUMOR FREE,Alive,-22279,,,,38,,337,337,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,3,,0,0.038746,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IU,,,,,,,337,,,,,,,,,3,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,84780,,-0.02412541,1,0,0,0,0.1908,0,,,Infiltrating Ductal Carcinoma,0.136238673,,0.151604462,0,0,1,,Negative,-0.6195,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.0676,1,0,H & E,0,0,,0,Chunhui Yi,"ADH, Papilloma",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skin",Microcalcifications,"DCIS (Micropapillary, High Grade), DCIS (Papillary, High Grade), Microcalcifications",,"DCIS (Micropapillary, High Grade), DCIS (Papillary, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"ADH, Papilloma",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-7576,Black or African American,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.84,0.47,10,21,22,,,670,,670,670,,0,0,670,670,,Malignant,53,,61,,,,17388,,,670,670,,,,670,670,,,670,,,,,,,,TUMOR FREE,Alive,-19917,,,,532,,670,670,,,[Not Available],[Not Applicable],,,,,0.47,,,,,15,,1,0.34453,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7576,,,,,,,670,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,84781,,1.018157348,,,,,,,,,,0.263018848,,0.143932604,,,,Stage IB,,0.936,,,,,,,,,,,,,,,,0.311,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12S (driver), AMP (driver)",,1,,G12S (driver),,,,,-0.257116552,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.0383,,0.3502,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-56-8082,White,LUSC,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.83,0.81,14,9,11,,,455,,455,455,,0,0,455,455,,Malignant,34,,46,,,,0,,,455,455,,,,455,455,,,455,,,,,,,,TUMOR FREE,Alive,-29440,,,,285,,455,455,,,[Not Available],[Not Applicable],,,,,0.09,,,,,12,,0,0.42825,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8082,,,,,,,455,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,84782,,0.479117147,,,,,,,,,,0.116250049,,0.01769044,,,,Stage IIA,,-0.0685,,,,,,,,,,,,,,,,0.2751,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.23187706,14.48582188,13.34837748,-0.773375872348752,LUSC,,17.69266788,14.62657971,Squamous Cell Carcinoma,-1.0218,12.26828579,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-DK-A6B5,White,BLCA,,0.0,0,,,,0,MALE,0.0,1.68,0.76,22,10,13,,,1542,,,1542,,0.0,0,1542.0,1542.0,,Malignant,45,,218,,,,18035.0,,,1542.0,1542,,,,,1542,,,1542.0,,,,,,,,TUMOR FREE,Alive,-16453,,,,191.0,,1542.0,1542,,,[Not Available],[Not Applicable],,,,,0.05,,,,,12,,0,0.42096,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A6B5,,,,,,,1542,,,,,,,,,14,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,45.0,,,,,,,,,,,,,,,,,,,,84783,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-33-A4WN,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,2.07,0.39,8,9,13,,,143,,143,143,,2,2,143,143,,Malignant,30,,107,,,,22145,,,143,143,,,,143,143,,,143,,,,,,,,TUMOR FREE,Dead,-22268,143,,,279,,143,143,,,[Not Available],[Not Applicable],,,,,0.12,,,,,4,,0,0.24741,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-A4WN,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,84785,,0.525923987,,,,,,,,,,0.146327984,,-0.031796054,,,,Stage IB,,0.801,,,,,,,,,,,,,,,,0.1501,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.645979844947283,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.9432,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-RD-A8NB,White,STAD,,1,1,,,,1,,1,,,,,,,,513,,,513,,1,1,230,230,,Malignant,,,,,,,33835,,,230,230,,,,,513,,,230,,,,,,,,WITH TUMOR,Dead,-29503,513,,,891,,230,230,,,Stomach Cancer,[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8NB,,,,,,,,Non-regional / Distant Lymph Nodes,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2000,230,,,,Stage IIIA,,,,,,,,Partial Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,84793,,0.804037633,,,,,,,,,,0.098839649,Grade 3,0.126298497,,,,Stage IIIA,,1.334,,,,,,,,,,,,,,,,0.2626,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8NB,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Male,TCGA-85-8048,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.89,0.18,9,7,9,,,765,,765,765,,0,0,765,765,,Malignant,25,,19,,,,21230,,,765,765,,,,765,765,,,765,,,,,,,,TUMOR FREE,Alive,-22907,,,,251,,765,765,,,[Not Available],[Not Applicable],,,,,0.25,,,,,6,,0,0.33172,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8048,,,,,,,765,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,84796,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,0.6509,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0497915028390165,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.5466,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Male,TCGA-97-7552,White,LUAD,,1,,,Washington University - NYU,,0,MALE,1,1.95,0.18,1,2,1,,,1932,,,1932,,1,,798,798,,Malignant,4,,7,,,,20065,,,798,,,,,,1932,,,798,,,,,,,,TUMOR FREE,Alive,-25578,,,,45,,798,,,,[Not Available],[Not Applicable],,,,,0.0,,,,,2,,0,0.050543,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-7552,,,,,,,1932,,,,,,,,,2,,,,,,,,,,,,,2007,798,,,,Stage IB,,,,,,,,Stable Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,84797,,1.581691876,,,,,,,,,,0.258779209,,0.205516125,,,,Stage IB,,1.51,,,,,,,,,,,,,,,,0.1431,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.241984915,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.0594,,2.0729,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-66-2759,,LUSC,,0,0,,Indivumed,0,0,MALE,0,3.31,0.5,8,15,21,,,762,,762,762,,0,0,762,762,,Malignant,44,,41,,,,18968,,,762,762,,,,762,762,,,762,,,,,,,,TUMOR FREE,Alive,-24287,,,,568,,762,762,,,[Not Available],[Not Applicable],,,,,0.23,,,,,16,,1,0.17363,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2759,,,,,,,762,,,,,,,,,37,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,84808,,0.825104129,,,,,,,,,,0.218446872,,0.036721073,,,,Stage IIIA,,2.2645,,,,,,,,,,,,,,,,0.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.46622972,16.59836355,17.22845091,-0.126240282125449,LUSC,Squamous Cell Carcinoma,17.73655129,16.0695167,Squamous Cell Carcinoma,0.1881,14.00035326,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-66-2788,,LUSC,,0,0,,Indivumed,,0,MALE,0,1.89,0.41,5,4,10,,,699,,,699,,0,0,699,699,,Malignant,19,,38,,,,21069,,,699,699,,,,,699,,,699,,,,,,,,TUMOR FREE,Alive,-20637,,,,269,,699,699,,,[Not Available],[Not Applicable],,,,,0.35,,,,,9,,0,0.35249,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2788,,,,,,,699,,,,,,,,,15,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,56,,,,,,,,,,,,,,,,,,,,84811,,1.094920076,,,,,,,,,,0.240686543,,0.111497623,,,,Stage IB,,1.342,,,,,,,,,,,,,,,,0.8466,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0676092863635254,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.1719,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,,,,BRCA,,1,,,,,0,FEMALE,1,1.8,0.75,9,6,10,,,943,BRCA_LumA,,943,,1,,762,762,,Invasive Carcinoma,25,,94,,,,23798,0,,762,,,,,,943,,,762,,,,,,,,WITH TUMOR,Alive,-16681,,,,44,,762,,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,5,,0,0.21604,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08O,,,,,,,943,,,,,,,,,10,,,,,,,,,,,,,2008,762,,,,Stage IV,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,84818,,-1.018190229,0,0,0,0,0.3671,1,,,Infiltrating Ductal Carcinoma,0.118914329,,0.130458894,0,0,0,,Positive,-0.7295,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4108,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4512,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,4.56,0.32,4,9,12,,,905,,,905,,1,1,905,905,,Malignant,25,,37,,,,24504,,,905,905,,,,,905,,,905,,,,,,,,WITH TUMOR,Dead,-25502,905,,,58,,905,905,,,[Not Available],[Not Applicable],,,,,0.24,,,,,27,,2,0.36924,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4512,,,,,,,157,,,,,,,,,48,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,84819,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98542375,16.9089662,11.37952049,-0.399506954,LUAD,,18.11303383,14.40690717,Adenocarcinoma,,13.80128998,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.29,0.66,2,0,1,,,1043,BRCA_LumA,1043,1043,,0,0,1043,1043,,Invasive Carcinoma,3,,5,,,,23470,0,,1043,1043,,,,1043,1043,,,1043,,,,,,,,TUMOR FREE,Alive,-29144,,,,62,,1043,1043,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,22,,2,0.066923,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EU,,,,,,,1043,,,,,,,,,57,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,84824,,-0.131187996,0,0,0,0,0.2618,1,,,Infiltrating Ductal Carcinoma,0.107681584,,0.143591681,0,0,0,,Negative,-1.1585,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2129,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-SU-A7E7,,PRAD,348,0,0,,SU,0,0,MALE,0,1.95,0.3,4,4,5,HRP,NO,551,2-ETV1,551,551,,0,0,551,551,prad_tcga,Malignant,13,ATM;CHEK1,38,,TCGA-SU-A7E7-01,5,5553,0,TCGA-SU-A7E7,551,551,Prostate Cancer,,426,551,551,TCGA,,551,Primary,0,Base,A,,,True,TUMOR FREE,Alive,-22185,,60,8,29,PRAD,551,551,,0.189177369,[Not Available],[Not Applicable],28,,1,Matched,0.02,Prostate,Resection,5,3908AD4B-E278-422C-8EDE-E4C942F9B451,0,Normal (no evidence of prostate cancer) [cM0],0,0.052074,[Not Available],2648C3C9-9884-4A0C-96AA-61130CD289EA,3,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,SU,0.933333333333,TCGA-SU-A7E7,0:DiseaseFree,4,13,Prostate Adenocarcinoma,18.1,1/24/14,551,,,,,NO,C61,120AA6E7-735D-442E-99AA-4EFE93C365F6,300,3,TUMOR FREE,0.0287,0:LIVING,0.01,,18.1,Right,15,No Evidence of Extraprostatic Extension,-10,YES,165,2013,,,TCGA-SU-A7E7.120AA6E7-735D-442E-99AA-4EFE93C365F6.pdf,Peripheral Zone,[Not Applicable],YES,6,36-45%,9,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,60,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2b,NO,8,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,84826,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-3398,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,2.12,0.19,0,2,1,,,1163,,1163,1163,,0,0,1163,1163,,Malignant,3,,0,,,,22337,,,1163,1163,,,,1163,1163,,,1163,,,,,,,,TUMOR FREE,Alive,-28392,,,,244,,1163,1163,,,[Not Available],[Not Applicable],,,,,,,,,,2,,0,0.0,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-3398,,,,,,,1163,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,84830,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.017606498,LUAD,Adenocarcinoma,,,Adenocarcinoma,2.3603,,0.132,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Female,TCGA-33-AAS8,Black or African American,LUSC,,0,0,,Johns Hopkins,2,2,FEMALE,2,1.75,0.64,11,8,6,,,1114,,1114,1114,,2,2,1114,1114,,Malignant,25,,133,,,,29436,,,1114,1114,,,,1114,1114,,,1114,,,,,,,,TUMOR FREE,Dead,-21675,1114,,,307,,1114,1114,,,[Not Available],[Not Applicable],,,,,0.18,,,,,7,,0,0.35636,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-AAS8,,,,,,,,,,,,,,,,11,,,,,,,,,,,,,1998,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,84834,,0.166985915,,,,,,,,,,0.080056484,,-0.022788808,,,,Stage IA,,0.7675,,,,,,,,,,,,,,,,-0.0539,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.780414282677364,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-2.1151,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-38-4631,White,LUAD,,1,1,,UNC,,1,FEMALE,1,3.1,0.49,11,17,14,,,354,,,354,,1,1,354,354,,Malignant,42,,38,,,,19056,,,354,354,,,,,354,,,354,,,,,,,,WITH TUMOR,Dead,-26538,354,,,982,,354,354,,,[Not Available],[Not Applicable],,,,,0.65,,,,,16,,1,0.27788,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-4631,,,,,,,,,,,,,,,,37,,,,,,,,,,,,,1997,,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,72,,,,,,,,,,,,,,,,,,,,84837,,0.129124448,,,,,,,,,,0.153389729,,-0.00357916,,,,Stage IB,,-0.214,,,,,,,,,,,,,,,,-0.1696,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,F139L,1,,,F139L,,,,-0.528011209,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.0225,,-0.2591,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-V5-A7RE,White,ESCA,,1,1,,,,0,,1,2.79,0.64,6,6,15,,,500,,,500,,1,1,294,294,,Malignant,27,,210,,,,20871,,,294,294,,,,,500,,,294,,,,,,,,WITH TUMOR,Alive,-16643,,,,261,,294,294,,,[Not Available],Stage IIIA,,,,,0.11,Esophagus,Unknown,,,15,,1,0.22055,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Duke University,,TCGA-V5-A7RE,,,,,,,500,"Other, specify",Distant Metastasis,,,,,,,33,,,,,,,,,,,,,,294,bone,,,Stage IB,,,,,,,,Partial Remission/Response,,,,,,45,,,,,,,,,,,,,,,,,,,,84841,,,,,,,,,,,,,Grade 2,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,1,,1,1,Female,TCGA-49-4506,White,LUAD,,1,1,,Johns Hopkins,1,,FEMALE,1,2.67,0.25,4,1,4,,,999,,692,999,,1,1,692,692,,Malignant,9,,15,,,,20949,,,692,692,,,,692,999,,,692,,,,,,,,[Discrepancy],Dead,-25132,999,,,149,,692,692,,,[Not Available],[Not Applicable],,,,,0.02,,,,,16,,1,0.32656,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4506,,,,,,,,,Locoregional Recurrence,,,,,,,27,,,,,,,,,,,,,1997,692,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,84842,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,-0.2181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13D (driver),M503K,1,,G13D (driver),M503K,15.95123481,16.55036123,16.82054215,0.016190116,LUAD,Adenocarcinoma,17.88942384,16.49569218,Adenocarcinoma,,13.24541738,1.6425,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-GV-A6ZA,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.72,0.7,5,13,14,,,691,,691,691,,0.0,0,691.0,691.0,,Malignant,32,,49,,,,21253.0,,,691.0,691,,,,691,691,,,691.0,,,,,,,,TUMOR FREE,Alive,-19871,,,,416.0,,691.0,691,,,[Not Available],[Not Applicable],,,,,0.29,,,,,12,,1,0.12792,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A6ZA,,,,,,,691,,,,,,,,,22,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,54.0,,,,,,,,,,,,,,,,,,,,84850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-L9-A444,White,LUAD,,0,0,,Candler,0,0,FEMALE,0,2.77,0.37,15,11,20,,,307,,307,307,,0,0,307,307,,Malignant,46,,122,,,,22688,,,307,307,,,,307,307,,,307,,,,,,,,TUMOR FREE,Alive,-22202,,,,753,,307,307,,,[Not Available],[Not Applicable],,,,,0.44,,,,,26,,1,0.43663,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Candler,,TCGA-L9-A444,,,,,,,307,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,84851,,1.882824405,,,,,,,,,,0.238847796,,0.187044104,,,,Stage IA,,2.669,,,,,,,,,,,,,,,,0.2004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,,,,0.396579567,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.1558,,2.0769,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-D7-A6EX,White,STAD,,0,0,,,0,0,,0,2.81,0.77,4,9,8,,,344,,344,344,,0,0,344,344,,Malignant,21,,63,,,,21951,,,344,344,,,,344,344,,,344,,,,,,,,TUMOR FREE,Alive,-26525,,,,157,,344,344,,,[Not Available],[Not Applicable],,,,,0.15,Stomach,Unknown,,,21,,1,0.15572,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A6EX,,,,,,,344,,,,,,,,,36,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,84853,,-0.150684538,,,,,,,,,,-0.013201704,Grade 3,-0.0156137,,,,Stage IIIA,,-0.039,,,,,,,,,,,,,,,,-0.1882,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A6EX,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,471,,471,471,,0,0,471,471,,Invasive Carcinoma,,,,,,,23433,0,,471,471,,,,471,471,,,471,,,,,,,,TUMOR FREE,Alive,-24327,,,,0,,471,471,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3W7,,,,,,,471,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,84860,,-0.065598212,0,0,0,0,1.4179,1,,,Infiltrating Lobular Carcinoma,0.115783264,,0.179731065,0,0,0,,Negative,-0.333,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5497,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-AA6J,Black or African American,STAD,,0,0,,,0,0,,0,1.82,0.35,18,12,14,,,838,,838,838,,0,0,838,838,,Malignant,44,,144,,,,25097,,,838,838,,,,838,838,,,838,,,,,,,,TUMOR FREE,Alive,-27506,,,,171,,838,838,,,[Not Available],[Not Applicable],,,,,0.45,Stomach,Unknown,,,8,,0,0.41564,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-AA6J,,,,,,,838,,,,,,,,,18,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,84863,,0.800569107,,,,,,,,,,0.146898808,Grade 3,0.096342869,,,,Stage IIIB,,1.0445,,,,,,,,,,,,,,,,0.1627,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA6J,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-BR-8081,White,STAD,,0,0,,,0,0,,0,2.0,0.37,0,0,0,,,981,,981,981,,0,0,981,981,,Malignant,0,,11,,,,24796,,,981,981,,,,981,981,,,981,,,,,,,,TUMOR FREE,Alive,-26095,,,,1320,,981,981,,,[Not Available],[Not Applicable],,,,,0.01,Stomach,Unknown,,,0,,0,0.063038,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8081,,,,,,,981,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,84869,,1.362085743,,,,,,,,,,0.162011295,Grade 2,0.110340451,,,,Stage IIB,,2.008,,,,,,,,,,,,,,,,0.3954,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8081,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,0,0,0.0,0.0,Male,TCGA-BR-6453,White,STAD,,0.0,0,,,0,0,,0.0,2.16,0.19,1,1,1,,,485,,485,485,,0.0,0,485,485,,Malignant,3,,4,,,,17302.0,0,,485,485,,,,485,485,,,485,,,,,,,,TUMOR FREE,Alive,-20061,,,,227.0,,485,485,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Resection,,,4,,0,0.078649,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6453,,,,,,,485,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,84871,,1.485793695,,,,,,,,,,0.124261585,Grade 3,0.198191877,,,,Stage IIA,,0.8775,,,,,,,,,,,,,,,,0.1698,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6453,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-X4-A8KS,,PRAD,,0,0,,X4,,0,MALE,0,2.04,0.24,2,4,0,ambiguous,NO,979,,,979,,0,0,979,979,prad_tcga,Malignant,6,,13,,TCGA-X4-A8KS-01,0,5618,0,TCGA-X4-A8KS,979,979,Prostate Cancer,,797,,979,TCGA,,979,Primary,0,,A,,,True,TUMOR FREE,Alive,-22571,,61,7,31,PRAD,979,979,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.0,Prostate,Resection,3,874964AB-D09A-422C-9B51-7239338E78D4,2,,0,0.024833,[Not Available],56829C8D-7BB7-4AAC-999F-B1353DB4915D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,X4,1.0,TCGA-X4-A8KS,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.16,3/7/14,979,,,,,NO,C61,30844429-3F9C-4AD0-8A23-64012532347C,160,1,TUMOR FREE,0.0004,0:LIVING,0.01,,32.16,Bilateral,18,,,YES,735,2011,,,TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,RX,,61,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T2c,,M0,C61.9,8140/3,84876,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A8IB,,PRAD,370,0,0,,KK,,0,MALE,0,4.04,0.59,0,15,3,HRD,NO,83,6-FOXA1,,83,,0,0,83,83,prad_tcga,Malignant,18,CHEK1,11,,TCGA-KK-A8IB-01,11,5527,0,TCGA-KK-A8IB,83,83,Prostate Cancer,,,,83,TCGA,,83,Primary,1,Apex|Middle|Base,A,,BRCA2,True,,Alive,-24041,,65,9,57,PRAD,83,83,,0.204947119,[Not Available],[Not Applicable],45,R0,1,Matched,0.1,Prostate,Resection,4,2CC1817C-7EE6-4A0D-ABD4-DC8712F88CF1,7,,1,0.000543,[Not Available],88705B03-AA27-45C5-BEF0-BB697799F9DF,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,KK,1.46666666667,TCGA-KK-A8IB,0:DiseaseFree,5,26,Prostate Adenocarcinoma,2.73,8/19/14,83,,,,,NO,C61,B9FBCA1B-CAEB-48A1-87B8-C873AC07FD8B,360,7,,0.2666,0:LIVING,,,2.73,Bilateral,31,,,YES,338,2012,,,TCGA-KK-A8IB.B9FBCA1B-CAEB-48A1-87B8-C873AC07FD8B.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,21,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,"Yes, History of Prior Malignancy",R0,,65,Core needle biopsy,,,NO,YES,YES,,T3a,,9,No,,0,N0,T2a,,M0,C61.9,8140/3,84877,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-KK-A8IL,,PRAD,370,0,0,,KK,,,MALE,2,1.99,0.66,1,1,0,HRP,NO,628,8-other,,628,,2,2,628,628,prad_tcga,Malignant,2,,8,,TCGA-KK-A8IL-01,0,5536,0,TCGA-KK-A8IL,628,628,Prostate Cancer,87,144,,628,TCGA,No Evidence of Extraprostatic Extension,628,Primary,0,Apex|Middle|Base,A,,,True,,Dead,-23849,628,65,9,44,PRAD,628,628,,0.0,[Unknown],[Not Applicable],28,R1,1,Matched,0.0,Prostate,Resection,4,734195FB-0C2A-44A9-8698-ADD1A5CAA9A0,0,,0,0.010273,[Not Available],2A51E1C2-8A8F-4DF3-BCC6-7DF94A47D94D,5,Prostate Adenocarcinoma Acinar Type,,Prostate,2,,Acinar Adenocarcinoma,[Not Available],,KK,0.933333333333,TCGA-KK-A8IL,,5,5,Prostate Adenocarcinoma,,8/19/14,,,,,Medical Record,YES,C61,9F54DC02-35C0-4D0E-A1D8-63F820CF72C4,60,0,,0.0166,1:DECEASED,0.1,,20.63,Bilateral,7,No Evidence of Extraprostatic Extension,7,YES,1420,2009,,,TCGA-KK-A8IL.9F54DC02-35C0-4D0E-A1D8-63F820CF72C4.pdf,Peripheral Zone,[Not Applicable],YES,,86-95%,8,Prostate Adenocarcinoma Acinar Type,1,2009,[Unknown],,NO,No,R1,,65,Core needle biopsy,,,NO,YES,YES,,T3b,,9,No,,0,N1,T1c,1,M0,C61.9,8140/3,84879,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.24,0,1,1,,,26,BRCA_LumA,26,26,,0,0,26,26,,Invasive Carcinoma,2,,2,,,,23482,0,,26,26,,,,26,26,,,26,,,,,,,,TUMOR FREE,Alive,-17363,,,,45,,26,26,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,1,,0,0.00072,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A245,,,,,,,26,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,84885,,-0.69140655,0,0,0,0,-0.1249,1,,,Infiltrating Ductal Carcinoma,0.098577647,,0.136265777,0,0,0,,Negative,-0.9655,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1291,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Solid, Intermediate Grade), Microcalcifications",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.02,0.66,4,2,5,,,1119,BRCA_LumA,,1119,,0,0,1119,1119,,Invasive Carcinoma,11,,8,,,,17103,0,,1119,1119,,,,,1119,,,1119,,,,,,,,TUMOR FREE,Alive,-16882,,,,34,,1119,1119,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,6,,0,0.093389,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A28Q,,,,,,,1119,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,84894,,-0.274254532,0,1,0,0,-1.9177,0,,,Infiltrating Lobular Carcinoma,0.119896603,,0.152401474,0,0,0,,[Not Available],-0.721,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4435,1,0,H & E,0,0,,0,Ioana Tolocica,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,ALH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-60-2704,White,LUSC,,1,,,Roswell Park,,1,MALE,1,2.97,0.21,5,2,11,,,1154,,,1154,,1,,532,532,,Malignant,18,,27,,,,19020,,,532,,,,,,1154,,,532,,,,,,,,WITH TUMOR,Dead,-26927,1154,,,255,,532,,,,[Not Available],[Not Applicable],,,,,0.26,,,,,22,,1,0.49337,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2704,,,,,,,,,,,,,,,,33,,,,,,,,,,,,,2003,532,,,,Stage IIB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,84903,,1.465001383,,,,,,,,,,0.305790114,,0.196836622,,,,Stage IIB,,1.3175,,,,,,,,,,,,,,,,0.8708,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.2452248,18.63152334,16.34113366,-0.0506879020558542,LUSC,Squamous Cell Carcinoma,17.93021279,16.71381153,Squamous Cell Carcinoma,1.3859,14.8825854,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-NC-A5HP,White,LUSC,,1,1,,Washington University - CHUV,,1,MALE,1,3.67,0.53,9,10,13,,,770,,,770,,1,1,317,317,,Malignant,32,,66,,,,30627,,,317,317,,,,,770,,,317,,,,,,,,WITH TUMOR,Dead,-25286,770,,,555,,317,317,,,[Not Available],[Not Applicable],,,,,0.22,,,,,15,,1,0.34885,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HP,,,,,,,,,Distant Metastasis,,,,,,,28,,,,,,,,,,,,,2011,317,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,84910,,0.102391692,,,,,,,,,,0.162070934,,0.053705718,,,,Stage IV,,-1.076,,,,,,,,,,,,,,,,0.7148,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.48067156,14.98704865,13.79998312,-0.762903550528132,LUSC,Squamous Cell Carcinoma,17.84309289,14.39457501,Squamous Cell Carcinoma,1.3462,13.66014725,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,1.97,0.64,5,6,7,,,792,BRCA_LumA,,792,,1,1,792,792,,Invasive Carcinoma,18,,20,,,,21177,0,,792,792,,,,,792,,,792,,,,,,,,WITH TUMOR,Dead,-17815,792,,,109,,792,792,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,3,,0,0.14016,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,MSKCC,,TCGA-AO-A0J5,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,84911,,-1.120926094,0,0,0,0,0.1269,1,,,Other,0.163863296,,0.236293326,0,0,0,,Close,-1.06,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7027,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,1,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skeletal Muscle",N/A No in Situ,None,,None,0,"Invasive Carcinoma (Mixed Ductal-Lobular Features), Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)","Invasive Carcinoma (Mixed Ductal-Lobular Features), Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-D7-A74A,White,STAD,,0,0,,,0,0,,0,2.74,0.87,11,13,21,,,607,,607,607,,0,0,607,607,,Malignant,45,,152,,,,22911,,,607,607,,,,607,607,,,607,,,,,,,,TUMOR FREE,Alive,-22435,,,,205,,607,607,,,[Not Available],[Not Applicable],,,,,0.1,Stomach,Unknown,,,20,,1,0.26191,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-A74A,,,,,,,607,,,,,,,,,39,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,84916,,0.089403417,,,,,,,,,,0.004887612,Grade 2,-0.049492769,,,,Stage IIIA,,-0.6165,,,,,,,,,,,,,,,,-0.4139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A74A,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-63-7023,,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,1.92,0.85,16,7,15,,,1682,,1682,1682,,0,0,1682,1682,,Malignant,38,,74,,,,16070,,,1682,1682,,,,1682,1682,,,1682,,,,,,,,TUMOR FREE,Alive,,,,,202,,1682,1682,,,[Not Available],[Not Applicable],,,,,0.08,,,,,10,,0,0.35562,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-7023,,,,,,,1682,,,,,,,,,14,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,84917,,0.86244532,,,,,,,,,,0.12251338,,0.015135273,,,,Stage IIA,,0.302,,,,,,,,,,,,,,,,-0.1039,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.12890006,15.75818725,15.51768749,-0.347690179555286,LUSC,Squamous Cell Carcinoma,17.85614789,15.69720137,Squamous Cell Carcinoma,-1.2058,12.38426855,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.4,9,5,12,,,1189,BRCA_LumB,1189,1189,,0,0,1189,1189,,Invasive Carcinoma,26,,50,,,,16679,0,,1189,1189,,,,1189,1189,,,1189,,,,,,,,TUMOR FREE,Alive,-27288,,,,43,,1189,1189,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,7,,0,0.21577,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A22A,,,,,,,1189,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,84923,,1.181606476,0,0,0,0,-1.2888,1,,,Infiltrating Ductal Carcinoma,0.205857066,,0.205973428,0,0,0,,Negative,0.367,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.686,0,0,H & E,0,0,,0,Andrew Szmit,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7522,,PRAD,221,0,0,,G9,0,0,MALE,0,1.99,0.21,0,0,0,HRP,NO,1078,1-ERG,1078,1078,,0,0,1078,1078,prad_tcga,Malignant,0,,10,6.8,TCGA-G9-7522-01,0,5389,0,TCGA-G9-7522,1078,1078,Prostate Cancer,,452,1078,1078,TCGA,,1078,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-18033,,49,7,12,PRAD,1078,1078,,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.01,Prostate,Resection,3,10bfe256-c4a2-4d88-b907-56f86ef63de9,0,,0,0.0053995,[Not Available],87959988-bb25-47ee-afc1-9af92592bbe7,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.8,TCGA-G9-7522,0:DiseaseFree,2,3,Prostate Adenocarcinoma,35.41,5/31/12,1078,,,,,NO,C61,8d3c4720-f528-4a73-b2f0-95b2aac093f2,,0,TUMOR FREE,0.0051,0:LIVING,0.1,,35.41,Bilateral,3,,,YES,,2011,,,TCGA-G9-7522.8d3c4720-f528-4a73-b2f0-95b2aac093f2.pdf,,[Not Applicable],NO,,51-60%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.9,49,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,84929,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8MG,,PRAD,370,0,0,,V1,0,0,MALE,0,2.09,0.29,8,9,5,HRD,NO,857,8-other,857,857,,0,0,857,857,prad_tcga,Malignant,22,ATM;CHEK1,77,,TCGA-V1-A8MG-01,0,5558,0,TCGA-V1-A8MG,857,857,Prostate Cancer,,583,857,857,TCGA,,857,Primary,0,Apex,A,,BRCA2,True,,Alive,-19710,,53,7,28,PRAD,857,857,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.19,Prostate,Resection,3,C5B627DA-4A3C-4DD9-8556-DA2CB78388F0,5,,0,0.11011,[Not Available],301C4C32-BC66-4328-8DCF-FE3DD66FBDE2,4,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,V1,0.933333333333,TCGA-V1-A8MG,0:DiseaseFree,2,37,Prostate Adenocarcinoma,28.15,7/23/14,857,,,,,NO,C61,6E6ED2C5-9591-41BD-A910-F5E1A8637159,70,6,,0.1514,0:LIVING,0.03,,28.15,Bilateral,38,,,YES,,,,,TCGA-V1-A8MG.6E6ED2C5-9591-41BD-A910-F5E1A8637159.pdf,Peripheral Zone,[Not Applicable],NO,,36-45%,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,53,Core needle biopsy,,,NO,YES,NO,NO,T3b,NO,7,No,NO,,,T2c,,M0,C61.9,8140/3,84931,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-39-5028,White,LUSC,,0,0,,MSKCC,,,MALE,2,3.3,0.19,2,9,10,,,52,,,52,,2,2,52,52,,Malignant,21,,6,,,,16540,,,52,52,,,,,52,,,52,,,,,,,,,Dead,-27707,52,,,221,,52,52,,,[Not Available],[Not Applicable],,,,,0.45,,,,,25,,1,0.15974,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5028,,,,,,,52,,,,,,,,,18,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,84937,,0.668503098,,,,,,,,,,0.193095475,,0.068580564,,,,Stage IIIA,,0.991,,,,,,,,,,,,,,,,0.5843,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.894805,16.1202638,15.55371431,-0.0746045369841851,LUSC,Squamous Cell Carcinoma,18.26091165,15.73645483,Squamous Cell Carcinoma,1.3572,14.67576855,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0.0,0.0,0.0,Male,TCGA-BR-6801,White,STAD,,0.0,0,,,0,0.0,,0.0,1.31,0.68,1,2,6,,,1223.0,,1223,1223.0,,0.0,0,1223.0,1223.0,,Malignant,9,,70,,,,20008.0,0,,1223.0,1223,,,,1223,1223.0,,,1223.0,,,,,,,,TUMOR FREE,Alive,-25637.0,,,,61.0,,1223.0,1223,,,[Not Available],[Not Applicable],,,,,0.55,Stomach,Resection,,,6,,0,0.90652,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-6801,,,,,,,1223,,,,,,,,,29,,,,,,,,,,,,,2011.0,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,84938,,-0.465881576,,,,,,,,,,0.058710222,Grade 2,0.077407056,,,,Stage IIA,,-0.673,,,,,,,,,,,,,,,,0.4925,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6801,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Female,TCGA-69-A59K,Black or African American,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,FEMALE,0,,,,,,,,591,,,591,,0,0,591,591,,Malignant,,,,,,,16310,,,591,591,,,,,591,,,591,,,,,,,,TUMOR FREE,Alive,-22093,,,,653,,591,591,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-A59K,,,,,,,591,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,60,,,,,,,,,,,,,,,,,,,,84940,,1.095983747,,,,,,,,,,0.237987864,,0.11229523,,,,Stage IIB,,2.3215,,,,,,,,,,,,,,,,0.1721,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.0810968,17.83285371,16.6668434,-0.172772401,LUAD,Adenocarcinoma,17.82961981,16.00927819,Adenocarcinoma,-0.4562,12.99918684,0.5696,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,0,0.0,1.0,Male,TCGA-GU-A42P,White,BLCA,,0.0,0,,,,2,MALE,2.0,5.31,0.8,6,5,18,,,332,,,332,,2.0,2,332.0,332.0,,Malignant,29,,53,,,,33303.0,,,332.0,332,,,,,332,,,332.0,,,,,,,,TUMOR FREE,Dead,-26546,332,,,392.0,,332.0,332,,,[Not Available],[Not Applicable],,,,,0.47,,,,,21,,2,0.21061,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A42P,,,,,,,,,,,,,,,,59,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,72.0,,,,,,,,,,,,,,,,,,,,84950,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-ZF-A9R0,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.54,0.51,7,8,15,,,680,,,680,,1.0,1,559.0,559.0,,Malignant,30,,147,,,,25585.0,,,559.0,559,,,,,680,,,559.0,,,,,,,,WITH TUMOR,Dead,-30222,680,,,275.0,,559.0,559,,,[Not Available],[Not Applicable],,,,,0.2,,,,,22,,1,0.34137,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9R0,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,27,,,,,,,,,,,,,2013,559,right hemipelvis,,,Stage III,,,,,,,,Progressive Disease,,,,,,82.0,,,,,,,,,,,,,,,,,,,,84953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-78-7160,White,LUAD,,0,0,,Prince Charles Hospital,,,MALE,2,1.62,0.29,4,2,5,,,697,,,697,,2,2,697,697,,Malignant,11,,14,,,,23996,,,697,697,,,,,697,,,697,,,,,,,,,Dead,-22385,697,,,58,,697,697,,,[Not Available],[Not Applicable],,,,,0.41,,,,,15,,0,0.42173,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7160,,,,,,,,,,,,,,,,11,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,84954,,1.346663266,,,,,,,,,,0.251491938,,0.208880946,,,,Stage IV,,1.2525,,,,,,,,,,,,,,,,0.2503,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,16.72716896,17.61585972,16.92758852,-0.013993949,LUAD,Adenocarcinoma,17.97551804,16.67595802,Adenocarcinoma,0.4258,13.52395921,1.304,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Female,TCGA-86-8278,White,LUAD,,1,,,Asterand,1,0,FEMALE,1,1.82,0.56,7,3,5,,,944,,29,944,,1,,29,29,,Malignant,15,,35,,,,25112,,,29,,,,,29,944,,,29,,,,,,,,WITH TUMOR,Alive,-23117,,,,139,,29,,,,[Not Available],[Not Applicable],,,,,0.22,,,,,8,,0,0.21404,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8278,,,,,,,944,,,,,,,,,10,,,,,,,,,,,,,2011,29,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,84958,,0.195679572,,,,,,,,,,0.221106041,,0.084151791,,,,Stage IIB,,0.749,,,,,,,,,,,,,,,,0.5003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.09082329,16.72429849,15.96746669,-0.291929676,LUAD,Adenocarcinoma,18.31973031,15.77259954,Adenocarcinoma,1.3874,13.53601527,-0.8313,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-99-7458,White,LUAD,,0,0,,Washington University - Alabama,,0,FEMALE,0,1.88,0.36,6,3,3,,,747,,,747,,0,0,747,747,,Malignant,12,,17,,,,29308,,,747,747,,,,,747,,,747,,,,,,,,WITH TUMOR,Alive,-27359,,,,602,,747,747,,,[Not Available],[Not Applicable],,,,,0.38,,,,,10,,0,0.27376,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Alabama,,TCGA-99-7458,,,,,,,747,,,,,,,,,12,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,84962,,1.558322697,,,,,,,,,,0.271399204,,0.233087091,,,,Stage IIIA,,1.832,,,,,,,,,,,,,,,,0.3843,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.07002743,17.72096597,17.09039422,0.128825939,LUAD,Adenocarcinoma,18.2951851,16.67418268,Adenocarcinoma,0.1198,13.497503,1.1086,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,5.56,0.34,2,0,6,,,707,BRCA_LumA,707,707,,0,0,707,707,,None,8,,5,,,,21314,N/A (Non-Malignant),,707,707,,,,707,707,,,707,,,,,,,,TUMOR FREE,Alive,-18875,,,,31,,707,707,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,25,,2,0.03907,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A153,,,,,,,707,,,,,,,,,53,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,84965,,-0.669897691,0,0,0,0,-0.123,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.201452153,N/A (Non-Malignant),0.231899377,0,0,0,N/A (Non-Malignant),Negative,-0.961,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.9104,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5532,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.03,0.68,2,0,2,HRP,NO,1828,8-other,1828,1828,,0,0,1828,1828,prad_tcga,Malignant,4,,8,11.4,TCGA-EJ-5532-01,5,5292,0,TCGA-EJ-5532,1828,1828,Prostate Cancer,,926,1828,1828,TCGA,,1828,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-21110,,57,7,35,PRAD,1828,1828,WHITE,0.16102725,[Not Available],[Not Applicable],31,R0,1,Matched,0.02,Prostate,Resection,3,f32f7738-bad4-40c9-b49f-084bb098a05a,3,,0,0.025074,[Not Available],ae3a0c92-148d-4f1c-8563-06ac1050f53e,4,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.03333333333,TCGA-EJ-5532,0:DiseaseFree,2,4,Prostate Adenocarcinoma,60.05,4/4/12,1828,,,,,NO,C61,11afaa3c-a99c-4e43-b4cb-eb139c9b1dab,,2,TUMOR FREE,0.0722,0:LIVING,0.1,3,60.05,Bilateral,4,,,YES,,2009,,,TCGA-EJ-5532.11afaa3c-a99c-4e43-b4cb-eb139c9b1dab.pdf,,[Not Applicable],NO,,71-80%,8,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,57,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,84967,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A6G1,,PRAD,315,0,0,,J4,0,0,MALE,0,2.0,0.58,0,0,0,HRP,NO,769,1-ERG,769,769,,0,0,769,769,prad_tcga,Malignant,0,,10,8.2,TCGA-J4-A6G1-01,0,5481,0,TCGA-J4-A6G1,769,769,Prostate Cancer,34,178,769,769,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),769,Primary,0,,A,,,True,TUMOR FREE,Alive,-24945,,68,8,14,PRAD,769,769,,0.0,[Not Available],[Not Applicable],18,R0,1,Matched,0.03,Prostate,Resection,4,BDC630D2-A384-44E2-890D-046BC2C6D0A2,0,,0,0.000605,[Not Available],F9F136A5-3CCB-42B3-BA60-C667FBB0846D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,0.566666666667,TCGA-J4-A6G1,0:DiseaseFree,4,0,Prostate Adenocarcinoma,25.26,9/12/13,769,,,,,YES,C61,6758B6C3-61B6-4D4F-9018-CDC2E932ACC7,80,0,,0.0006,0:LIVING,0.1,3,25.26,Bilateral,1,,,YES,408,2012,,,TCGA-J4-A6G1.6758B6C3-61B6-4D4F-9018-CDC2E932ACC7.pdf,Peripheral Zone,[Not Applicable],,,51-60%,2,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,68,Core needle biopsy,,,YES,NO,YES,NO,T3a,YES,8,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,84971,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.93,0.65,9,10,14,,,365,BRCA_LumB,365,365,,0,0,365,365,,Invasive Carcinoma,33,,94,,,,18871,1,,365,365,,,,365,365,,,365,,,,,,,,TUMOR FREE,Alive,-19389,,,,0,,365,365,,,[Not Available],[Not Applicable],,,,,0.3,Not Specific/Unknown,Core Biopsy,,,14,,1,0.35233,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08I,,,,,,,365,,,,,,,,,34,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,84973,,1.56944357,0,0,0,0,-0.3629,1,,,Infiltrating Ductal Carcinoma,0.277405392,,0.011002014,0,0,0,,Negative,2.0375,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.361,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.06,0.68,2,1,2,,,577,BRCA_LumA,577,577,,0,0,577,577,,Invasive Carcinoma,5,,4,,,,18385,0,,577,577,,,,577,577,,,577,,,,,,,,TUMOR FREE,Alive,-23742,,,,50,,577,577,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,18,,1,0.023027,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07F,,,,,,,577,,,,,,,,,28,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,84978,,0.367284522,0,0,0,0,-0.8188,1,,,Infiltrating Ductal Carcinoma,0.152971904,,0.119508736,0,0,0,,Negative,-0.433,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.2683,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A8PJ,Unknown,STAD,,1,1,,,,1,,1,4.54,0.61,7,8,17,,,82,,,82,,1,1,82,82,,Malignant,32,,178,,,,29004,,,82,82,,,,,82,,,82,,,,,,,,WITH TUMOR,Dead,-19390,82,,,205,,82,82,,,Stomach Cancer,[Not Applicable],,,,,0.43,Stomach,Unknown,,,21,,2,0.27698,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,GX,,Barretos Cancer Hospital,,TCGA-VQ-A8PJ,,,,,,,,,,,,,,,,49,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,84979,,-1.026244814,,,,,,,,,,0.01878583,Unknown,0.071771779,,,,Stage IV,,-1.1045,,,,,,,,,,,,,,,,0.0853,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PJ,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A6TK,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.96,0.22,11,15,16,,,330,,330,330,,0.0,0,330.0,330.0,,Malignant,42,,114,,,,27039.0,,,330.0,330,,,,330,330,,,330.0,,,,,,,,TUMOR FREE,Alive,-21942,,,,150.0,,330.0,330,,,[Not Available],[Not Applicable],,,,,0.48,,,,,13,,1,0.39836,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TK,,,,,,,330,,,,,,,,,32,,,,,,,,,,,,,2013,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,84980,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.01,0.56,3,2,5,,,856,BRCA_LumA,,856,,0,0,856,856,,Invasive Carcinoma,10,,15,,,,24436,0,,856,856,,,,,856,,,856,,,,,,,,TUMOR FREE,Alive,-23423,,,,26,,856,856,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,4,,0,0.070615,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A201,,,,,,,856,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,84981,,-0.820053943,0,0,0,0,0.9211,1,,,Infiltrating Ductal Carcinoma,0.181214498,,0.189907338,0,0,0,,[Not Available],-0.106,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6899,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,782.0,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"DCIS (Solid, Low Grade), N/A No in Situ",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-66-2780,,LUSC,,0,0,,Indivumed,,,MALE,2,1.72,0.47,9,9,14,,,366,,,366,,2,2,366,366,,Malignant,32,,43,,,,19834,,,366,366,,,,,366,,,366,,,,,,,,,Dead,-23955,366,,,192,,366,366,,,[Not Available],[Not Applicable],,,,,0.09,,,,,14,,0,0.42423,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2780,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,84990,,0.086264513,,,,,,,,,,0.197824597,,0.073471113,,,,Stage IB,,0.4335,,,,,,,,,,,,,,,,0.8161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.29704982632696,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.3044,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1148,,1148,1148,,0,0,1148,1148,,Invasive Carcinoma,,,,,,,17973,0,,1148,1148,,,,1148,1148,,,1148,,,,,,,,TUMOR FREE,Alive,-24315,,,,129,,1148,1148,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0B1,,,,,,,1148,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,84991,,0.255730876,0,0,0,0,0.4615,1,,,Infiltrating Ductal Carcinoma,0.136549057,,0.221812466,0,0,0,,Negative,-0.7215,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3646,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-BR-8382,White,STAD,,0,0,,,2,2,,2,2.09,0.38,0,0,0,,,762,,762,762,,2,2,762,762,,Malignant,0,,13,,,,19971,,,762,762,,,,762,762,,,762,,,,,,,,TUMOR FREE,Dead,-24737,762,,,1335,,762,762,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,2,,0,0.0028144,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8382,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,84994,,0.696601945,,,,,,,,,,0.104360958,Grade 3,0.077888952,,,,Stage IIIC,,0.926,,,,,,,,,,,,,,,,0.3656,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8382,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-85-8070,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.89,0.95,13,14,18,,,960,,960,960,,0,0,960,960,,Malignant,45,,53,,,,22682,,,960,960,,,,960,960,,,960,,,,,,,,TUMOR FREE,Alive,-26183,,,,295,,960,960,,,[Not Available],[Not Applicable],,,,,0.29,,,,,5,,0,0.34091,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8070,,,,,,,960,,,,,,,,,15,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,84995,,-0.300478745,,,,,,,,,,0.059392347,,-0.056995158,,,,Stage IB,,1.1195,,,,,,,,,,,,,,,,-0.3851,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R135H,1,,,R135H,,,,-0.772493432096832,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.8557,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-55-6543,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.27,0.65,1,1,2,,,435,,435,435,,0,0,435,435,,Malignant,4,,16,,,,22325,,,435,435,,,,435,435,,,435,,,,,,,,TUMOR FREE,Alive,,,,,26,,435,435,,,[Not Available],[Not Applicable],,,,,0.0,,,,,9,,0,0.21542,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6543,,,,,,,435,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,84996,,0.105800545,,,,,,,,,,0.271324191,,0.123593251,,,,Stage IA,,0.57,,,,,,,,,,,,,,,,0.3165,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.30498756,LUAD,,,,Adenocarcinoma,-0.5794,,-0.9014,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-79-5596,,LUSC,,0,0,,Ontario Institute for Cancer Research (OICR)/Ottawa,,0,MALE,0,1.82,0.69,12,7,16,,,,,,,,0,0,,,,Malignant,35,,30,,,,17535,,,,,,,,,,,,,,,,,,,,TUMOR FREE,Alive,,,,,265,,,,,,[Not Available],[Not Applicable],,,,,0.19,,,,,8,,0,0.2654,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR)/Ottawa,,TCGA-79-5596,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,,,,,,,,,,,,,,,,,,,,,85003,,-0.037846044,,,,,,,,,,0.125096301,,0.035065361,,,,Stage IIIA,,0.4615,,,,,,,,,,,,,,,,0.4027,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.05810232,14.43520733,10.53009342,-1.11332042146182,LUSC,Squamous Cell Carcinoma,17.76809927,14.6201689,Squamous Cell Carcinoma,-0.4654,14.06118463,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,345,,345,345,,0,0,345,345,,Invasive Carcinoma,,,,,,,31541,0,,345,345,,,,345,345,,,345,,,,,,,,TUMOR FREE,Alive,-26042,,,,0,,345,345,,,[Not Available],[Not Applicable],,,,,,Breast,Core Biopsy,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A3IY,,,,,,,345,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage I,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,85007,,-0.169069583,0,0,0,0,0.1642,1,,,Mucinous Carcinoma,0.243972625,,0.172632728,0,0,0,,Negative,-0.397,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4138,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-D7-A4YV,White,STAD,,0,0,,,2,2,,2,2.12,0.52,0,0,0,,,180,,180,180,,2,2,180,180,,Malignant,0,,12,,,,32317,,,180,180,,,,180,180,,,180,,,,,,,,TUMOR FREE,Dead,-25421,180,,,1268,,180,180,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,6,,0,0.0017673,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A4YV,,,,,,,,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,85009,,1.310324224,,,,,,,,,,0.089502433,Grade 3,0.103388016,,,,Stage IIB,,1.381,,,,,,,,,,,,,,,,-0.1104,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A4YV,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,85010,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A47V,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,2.07,0.93,1,2,4,,,379,,379,379,,0.0,0,379.0,379.0,,Malignant,7,,23,,,,33971.0,,,379.0,379,,,,379,379,,,379.0,,,,,,,,TUMOR FREE,Alive,-19265,,,,259.0,,379.0,379,,,[Not Available],[Not Applicable],,,,,0.05,,,,,2,,0,0.031313,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ILSBio,,TCGA-CF-A47V,,,,,,,379,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,52.0,,,,,,,,,,,,,,,,,,,,85015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-77-8154,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,1.86,0.68,11,10,15,,,1841,,1841,1841,,0,0,1841,1841,,Malignant,36,,30,,,,34480,,,1841,1841,,,,1841,1841,,,1841,,,,,,,,TUMOR FREE,Alive,-24640,,,,272,,1841,1841,,,[Not Available],[Not Applicable],,,,,0.12,,,,,9,,0,0.31949,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8154,,,,,,,1841,,,,,,,,,14,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,85017,,-0.568765691,,,,,,,,,,0.105220197,,0.082666124,,,,Stage IA,,-0.8075,,,,,,,,,,,,,,,,0.2435,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-1.0627132201435,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.367,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-66-2766,,LUSC,,0,0,,Indivumed,,0,MALE,0,2.95,0.75,19,30,28,,,31,,,31,,0,0,31,31,,Malignant,77,,103,,,,16338,,,31,31,,,,,31,,,31,,,,,,,,TUMOR FREE,Alive,-19814,,,,532,,31,31,,,[Not Available],[Not Applicable],,,,,0.22,,,,,12,,1,0.51576,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2766,,,,,,,31,,,,,,,,,37,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,85018,,0.010215358,,,,,,,,,,0.182550165,,0.03757655,,,,Stage IIIA,,1.606,,,,,,,,,,,,,,,,0.2329,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,HOMDEL,,,1,,,,15.37411576,15.77050691,15.54305094,-0.477476152531239,LUSC,Squamous Cell Carcinoma,17.73196441,15.42428544,Squamous Cell Carcinoma,-0.0332,12.83629215,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-GU-A42P,White,BLCA,,0.0,0,,,,2,MALE,2.0,5.31,0.8,6,5,18,,,332,,,332,,2.0,2,332.0,332.0,,Malignant,29,,53,,,,33303.0,,,332.0,332,,,,,332,,,332.0,,,,,,,,TUMOR FREE,Dead,-26546,332,,,392.0,,332.0,332,,,[Not Available],[Not Applicable],,,,,0.47,,,,,21,,2,0.21061,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,,,TCGA-GU-A42P,,,,,,,,,,,,,,,,59,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,72.0,,,,,,,,,,,,,,,,,,,,85020,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-A8HH,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,3.92,0.43,4,3,6,,,57,,,57,,1.0,1,57.0,57.0,,Malignant,13,,33,,,,18394.0,,,57.0,57,,,,,57,,,57.0,,,,,,,,WITH TUMOR,Dead,-22393,57,,,162.0,,57.0,57,,,[Not Available],[Not Applicable],,,,,0.19,,,,,14,,1,0.082104,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A8HH,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2004,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,85024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9ZG,,PRAD,,0,0,,V1,0,0,MALE,0,1.97,0.4,1,1,0,HRP,NO,1517,,1517,1517,,0,0,1517,1517,prad_tcga,Malignant,2,,70,,TCGA-V1-A9ZG-01,0,5584,0,TCGA-V1-A9ZG,1517,1517,Prostate Cancer,,893,1517,1517,TCGA,,1517,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23725,,64,9,42,PRAD,1517,1517,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.0,Prostate,Resection,4,7C388E94-D897-4084-B657-437440012FEE,1,,0,0.028585,[Not Available],DEC99F86-622B-477F-A26A-98C954FB1F17,5,Prostate Adenocarcinoma Acinar Type,,Prostate,2,,Acinar Adenocarcinoma,[Not Available],,V1,0.833333333333,TCGA-V1-A9ZG,0:DiseaseFree,5,5,Prostate Adenocarcinoma,49.84,7/23/14,1517,,,,,NO,C61,D7B1ABAE-1A72-496C-B11F-469F65B37347,330,1,,0.0269,0:LIVING,0.015,,49.84,Bilateral,6,,,YES,,,,,TCGA-V1-A9ZG.D7B1ABAE-1A72-496C-B11F-469F65B37347.pdf,Peripheral Zone,[Not Applicable],NO,,,5,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,64,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,9,No,NO,,N0,T1c,0,M0,C61.9,8140/3,85025,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.71,9,7,9,,,426,BRCA_Her2,426,426,,0,0,426,426,,Invasive Carcinoma,25,,106,,,,21952,0,,426,426,,,,426,426,,,426,,,,,,,,TUMOR FREE,Alive,-25263,,,,77,,426,426,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,4,,0,0.18637,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07I,,,,,,,426,,,,,,,,,12,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,85028,,0.683289431,0,0,0,0,-3.6642,1,,,Infiltrating Ductal Carcinoma,0.182445645,,0.132954185,0,0,0,,Negative,0.4955,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6052,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-RD-A7BS,White,STAD,,1,1,,,1,1,,1,1.89,0.41,9,3,11,,,336,,244,336,,1,1,244,244,,Malignant,23,,41,,,,30452,,,244,244,,,,244,336,,,244,,,,,,,,WITH TUMOR,Dead,-16847,336,,,78,,244,244,,,Stomach Cancer,[Not Applicable],,,,,0.6,Stomach,Unknown,,,6,,0,0.21057,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A7BS,,,,,,,,Liver,Distant Metastasis,,,,,,,9,,,,,,,,,,,,,2001,244,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,46,,,,,,,,,,,,,,,,,,,,85031,,0.486891048,,,,,,,,,,0.104478308,Grade 3,0.102162917,,,,Stage IIIA,,0.468,,,,,,,,,,,,,,,,0.5325,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A7BS,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.61,0.78,8,10,6,,,1548,BRCA_LumB,1548,1548,,0,0,1548,1548,,Invasive Carcinoma,24,,47,,,,20414,0,,1548,1548,,,,1548,1548,,,1548,,,,,,,,TUMOR FREE,Alive,-16961,,,,39,,1548,1548,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,16,,1,0.25418,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24K,,,,,,,1548,,,,,,,,,22,,,,,,,,,,,,,2004,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,85032,,-0.69828566,0,0,0,0,0.1276,1,,,Infiltrating Ductal Carcinoma,0.086760337,,0.040825746,0,0,0,,Negative,-1.5015,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0166,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.87,5,4,4,,,482,BRCA_LumB,482,482,,0,0,482,482,,None,13,,9,,,,24149,N/A (Non-Malignant),,482,482,,,,482,482,,,482,,,,,,,,TUMOR FREE,Alive,-20488,,,,36,,482,482,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,6,,0,0.13975,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XR,,,,,,,482,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,85034,,-0.988521889,0,0,0,0,0.0855,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.112676175,N/A (Non-Malignant),0.124769741,0,0,0,N/A (Non-Malignant),Negative,-1.3615,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1219,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,2.07,0.73,12,26,18,,,30,BRCA_LumB,,30,,0,0,30,30,,Invasive Carcinoma,56,,28,,,,17343,0,,30,30,,,,,30,,,30,,,,,,,,,Alive,-25659,,,,126,,30,30,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,6,,0,0.23951,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09W,,,,,,,30,,,,,,,,,17,,,,,,,,,,,,,2007,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,85037,,0.023606806,0,0,0,0,0.423,1,,,Infiltrating Lobular Carcinoma,0.174828445,,0.21251691,0,0,0,,[Not Available],-1.6285,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0417,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-60-2714,White,LUSC,,0,0,,Roswell Park,0,0,FEMALE,0,5.13,0.34,14,12,22,,,1531,,1531,1531,,0,0,1531,1531,,Malignant,48,,38,,,,16615,,,1531,1531,,,,1531,1531,,,1531,,,,,,,,TUMOR FREE,Alive,-24169,,,,1145,,1531,1531,,,[Not Available],[Not Applicable],,,,,0.28,,,,,21,,2,0.43601,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2714,,,,,,,1531,,,,,,,,,56,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,85042,,0.716075716,,,,,,,,,,0.202494038,,0.117698522,,,,Stage IIB,,2.797,,,,,,,,,,,,,,,,0.2227,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.28858641,16.53220952,17.40139803,-0.133964548957803,LUSC,Squamous Cell Carcinoma,18.10977396,16.04526464,Squamous Cell Carcinoma,0.1732,13.77342586,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.38,0.57,15,32,22,,,584,BRCA_Basal,584,584,,0,0,584,584,,Invasive Carcinoma,69,,76,,,,16770,0,,584,584,,,,584,584,,,584,,,,,,,,TUMOR FREE,Alive,-16736,,,,223,,584,584,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,10,,1,0.35703,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A147,,,,,,,584,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,[Not Available],,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,85043,TRUE,1.017209947,0,0,0,0,0.6054,1,,,Infiltrating Ductal Carcinoma,0.169468009,,-0.006707563,0,0,0,,Negative,0.9005,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1711,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.23,0.83,10,5,13,,,10,BRCA_LumA,10,10,,0,0,10,10,,Invasive Carcinoma,28,,73,,,,22712,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-16533,,,,104,,10,10,,,[Not Available],[Not Applicable],,,,,0.59,Breast,Resection/Excision,,,15,,0,0.23179,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FZ,,,,,,,10,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,85044,,-1.60875623,0,0,0,0,-0.151,1,,,Infiltrating Ductal Carcinoma,0.084329875,,0.184756088,0,0,0,,Negative,-2.3185,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2275,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,865,,865,865,,0,0,865,865,,Invasive Carcinoma,,,,,,,20288,0,,865,865,,,,865,865,,,865,,,,,,,,TUMOR FREE,Alive,-23684,,,,0,,865,865,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A10E,,,,,,,865,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,85046,,0.250850636,0,0,0,0,-0.0986,1,,,Infiltrating Ductal Carcinoma,0.141987813,,0.123955713,0,0,0,,Negative,-0.195,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.333,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,1.75,0.63,21,17,17,,,1546,BRCA_Basal,,1546,,0,0,1546,1546,,Invasive Carcinoma,55,,187,,,,17337,0,,1546,1546,,,,,1546,,,1546,,,,,,,,TUMOR FREE,Alive,-21024,,,,285,,1546,1546,,,[Not Available],[Not Applicable],,,,,0.48,Breast,Resection/Excision,,,4,,0,0.35919,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3Y0,,,,,,,1546,,,,,,,,,13,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,85049,,1.351490738,0,0,0,0,0.9087,1,,,Infiltrating Ductal Carcinoma,0.137416202,,0.047323092,0,0,0,,Close,1.5185,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0428,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-22-4609,White,LUSC,,0,0,,Mayo Clinic - Rochester,2,2,MALE,2,1.91,0.42,11,2,10,,,291,,291,291,,2,2,291,291,,Malignant,23,,19,,,,16584,,,291,291,,,,291,291,,,291,,,,,,,,TUMOR FREE,Dead,-29844,291,,,265,,291,291,,,[Not Available],[Not Applicable],,,,,0.01,,,,,14,,0,0.34059,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4609,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2003,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,85055,,1.359045908,,,,,,,,,,0.281512423,,0.162621856,,,,Stage IA,,1.7525,,,,,,,,,,,,,,,,0.6991,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,S229C (driver),,,1,S229C (driver),,,,,,-0.0525983311343033,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4196,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-55-8615,White,LUAD,,1,1,,International Genomics Consortium,1,0,MALE,1,5.23,0.57,9,19,28,,,446,,224,446,,1,1,224,224,,Malignant,56,,92,,,,16134,,,224,224,,,,224,446,,,224,,,,,,,,WITH TUMOR,Alive,-24786,,,,181,,224,224,,,[Not Available],[Not Applicable],,,,,0.38,,,,,21,,2,0.27421,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8615,,,,,,,446,,Distant Metastasis,,,,,,,44,,,,,,,,,,,,,2012,224,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,85057,,-0.102091889,,,,,,,,,,0.158332723,,0.117488691,,,,Stage IIIA,,-0.6745,,,,,,,,,,,,,,,,0.0754,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,14.65429589,16.40465735,10.62904048,-0.831371058,LUAD,Adenocarcinoma,18.07634066,14.50508955,Adenocarcinoma,-0.638,13.93949232,-2.3172,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.95,0.54,4,3,6,,,635,BRCA_LumB,635,635,,0,0,635,635,,Invasive Carcinoma,13,,13,,,,20844,0,,635,635,,,,635,635,,,635,,,,,,,,TUMOR FREE,Alive,-19250,,,,274,,635,635,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,12,,0,0.24503,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SI,,,,,,,635,,,,,,,,,14,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,85058,,1.17665267,0,0,0,0,0.7114,1,,,Infiltrating Ductal Carcinoma,0.1789436,,0.158913013,0,0,0,,Negative,0.7905,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7265,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-05-4249,,LUAD,,0,0,,Indivumed,,0,MALE,0,3.78,0.49,3,3,4,,,1523,,,1523,,0,0,1523,1523,,Malignant,10,,15,,,,26965,,,1523,1523,,,,,1523,,,1523,,,,,,,,TUMOR FREE,Alive,-24532,,,,430,,1523,1523,,,[Not Available],[Not Applicable],,,,,0.26,,,,,22,,1,0.14354,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4249,,,,,,,1523,,,,,,,,,23,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,67,,,,,,,,,,,,,,,,,,,,85059,,0.766775441,,,,,,,,,,0.231926316,,0.154580719,,,,Stage IB,,0.892,,,,,,,,,,,,,,,,0.2006,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.32855336,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1145,,-0.7088,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-78-7535,White,LUAD,,1,,,Prince Charles Hospital,,1,MALE,1,2.82,0.6,8,2,11,,,949,,,949,,1,,809,809,,Malignant,21,,37,,,,25447,,,809,,,,,,949,,,809,,,,,,,,WITH TUMOR,Dead,-16571,949,,,228,,809,,,,[Not Available],[Not Applicable],,,,,0.1,,,,,26,,1,0.5288,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7535,,,,,,,,,,,,,,,,22,,,,,,,,,,,,,2000,809,,,,Stage IB,,,,,,,,Stable Disease,,,,,,45,,,,,,,,,,,,,,,,,,,,85060,,-0.749225974,,,,,,,,,,0.196150788,,0.103511293,,,,Stage IB,,-0.114,,,,,,,,,,,,,,,,0.0907,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.650724363,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.5022,,-1.0496,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-XJ-A9DK,,PRAD,389,0,0,,XJ,0,0,MALE,0,2.0,0.98,0,0,0,HRP,NO,275,1-ERG,275,275,,0,0,275,275,prad_tcga,Malignant,0,,6,,TCGA-XJ-A9DK-01,0,5627,0,TCGA-XJ-A9DK,275,275,Prostate Cancer,,275,275,275,TCGA,,275,Primary,0,Apex,A,,,False,TUMOR FREE,Alive,,,63,8,5,PRAD,275,275,,0.0,[Not Available],[Not Applicable],16,R0,1,Matched,0.0,Prostate,Resection,4,36DA3689-5B86-480D-8763-FEFB7A73AD42,0,,0,0.00029,[Not Available],5A4D8694-947D-45E9-9A21-6DE0F63837F0,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XJ,0.466666666667,TCGA-XJ-A9DK,0:DiseaseFree,4,0,Prostate Adenocarcinoma,9.03,5/21/14,275,,,,,NO,C61,67B87CD1-3C76-47DD-93B9-BB9ADCF64404,70,0,,0.0,0:LIVING,0.1,,9.03,Right,5,,,YES,2327,2007,,,TCGA-XJ-A9DK.67B87CD1-3C76-47DD-93B9-BB9ADCF64404.pdf,Peripheral Zone,[Not Applicable],NO,,76-85%,,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,8,No,NO,0,,T1c,,M0,C61.9,8140/3,85064,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Female,TCGA-78-7540,White,LUAD,,0,0,,Prince Charles Hospital,2,,FEMALE,2,2.02,0.59,6,5,6,,,1197,,1197,1197,,2,2,1197,1197,,Malignant,17,,20,,,,20628,,,1197,1197,,,,1197,1197,,,1197,,,,,,,,,Dead,-24440,1197,,,41,,1197,1197,,,[Not Available],[Not Applicable],,,,,0.0,,,,,6,,0,0.18265,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7540,,,,,,,,,,,,,,,,13,,,,,,,,,,,,,1999,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,85069,,-0.313751442,,,,,,,,,,0.221225614,,0.14789006,,,,Stage IB,,-0.4565,,,,,,,,,,,,,,,,-0.0186,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,-0.453339821,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.5598,,-1.0027,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-55-5899,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.83,0.67,16,10,19,,,930,,930,930,,0,0,930,930,,Malignant,45,,76,,,,21526,,,930,930,,,,930,930,,,930,,,,,,,,TUMOR FREE,Alive,,,,,582,,930,930,,,[Not Available],[Not Applicable],,,,,0.12,,,,,15,,1,0.35262,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-5899,,,,,,,930,,,,,,,,,32,,,,,,,,,,,,,2010,,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,85070,,,,,,,,,,,,,,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G509W,1,,,G509W,,,,-0.279720983,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.0847,,0.1708,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-YL-A8SP,,PRAD,389,1,1,,YL,,0,MALE,1,1.94,0.87,5,5,5,ambiguous,NO,2366,1-ERG,,2366,,1,1,2036,2036,prad_tcga,Malignant,15,ATM;CHEK1;CHEK2,76,,TCGA-YL-A8SP-01,0,5685,0,TCGA-YL-A8SP,2036,2036,Prostate Cancer,,2155,,2366,TCGA,,2036,Primary,0,Apex|Middle|Base,B,,,True,WITH TUMOR,Alive,-21455,,58,9,33,PRAD,2036,2036,,0.0,[Not Available],[Not Applicable],26,R1,1,Matched,0.02,Prostate,Resection,4,E67173E6-2FC8-42AA-A675-9238FBD33FAD,2,,0,0.073363,[Not Available],C506FAE4-7C0A-4705-8E80-5BCC122A8A32,5,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,YL,0.866666666667,TCGA-YL-A8SP,1:Recurred/Progressed,5,17,Prostate Adenocarcinoma,66.89,4/30/14,2366,,Biochemical evidence of disease,,,,C61,C2465F7D-3F73-4DB5-BD34-370978480408,1680,4,WITH TUMOR,0.0768,0:LIVING,0.38,3,77.73,Bilateral,19,,,YES,2125,2008,2036,,TCGA-YL-A8SP.C2465F7D-3F73-4DB5-BD34-370978480408.pdf,Overlapping / Multiple Zones,[Not Applicable],,,76-85%,,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,NO,No,R1,,58,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T3b,NO,9,No,YES,0,,T2a,,M0,C61.9,8140/3,85075,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-A9T4,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.02,0.78,3,1,2,,,495,,,495,,1.0,1,182.0,182.0,,Malignant,6,,91,,,,23414.0,,,182.0,182,,,,,495,,,182.0,,,,,,,,WITH TUMOR,Dead,-17728,495,,,54.0,,182.0,182,,,[Not Available],[Not Applicable],,,,,0.01,,,,,2,,0,0.065673,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9T4,,,,,,,,Lung,Distant Metastasis,,,,,,,4,,,,,,,,,,,,,2008,182,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,48.0,,,,,,,,,,,,,,,,,,,,85077,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-HU-8604,Asian,STAD,,0,0,,,0,0,,0,2.87,0.26,4,8,13,,,694,,694,694,,0,0,694,694,,Malignant,25,,63,,,,23568,,,694,694,,,,694,694,,,694,,,,,,,,TUMOR FREE,Alive,-30178,,,,267,,694,694,,,[Not Available],[Not Applicable],,,,,0.1,Stomach,Unknown,,,15,,1,0.19397,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-8604,,,,,,,694,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,82,,,,,,,,,,,,,,,,,,,,85081,,1.119228085,,,,,,,,,,0.149892028,Grade 2,0.102700882,,,,Stage IIA,,2.938,,,,,,,,,,,,,,,,0.3348,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-8604,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.74,12,6,8,,,1285,BRCA_LumB,1285,1285,,0,0,1285,1285,,Invasive Carcinoma,26,,45,,,,23847,0,,1285,1285,,,,1285,1285,,,1285,,,,,,,,TUMOR FREE,Alive,-21294,,,,57,,1285,1285,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,3,,0,0.18215,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A228,,,,,,,1285,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,85089,,-0.947326705,0,0,0,0,-0.8854,1,,,Infiltrating Ductal Carcinoma,0.19857595,,0.163566345,0,0,0,,Negative,-1.066,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.018,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type), Invasive Papillary Carcinoma","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type), Invasive Papillary Carcinoma",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-BR-6564,White,STAD,,0,0,,,2,2,,2,1.88,0.22,10,5,6,,,794,,794,794,,2,2,794,794,,Malignant,21,,21,,,,30855,,,794,794,,,,794,794,,,794,,,,,,,,TUMOR FREE,Dead,-17129,794,,,42,,794,794,,,[Not Available],[Not Applicable],,,,,0.14,Stomach,Unknown,,,8,,0,0.31537,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6564,,,,,,,,,,,,,,,,13,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,46,,,,,,,,,,,,,,,,,,,,85094,,0.310909126,,,,,,,,,,0.081089601,Grade 3,0.210694795,,,,Stage IIIA,,0.5095,,,,,,,,,,,,,,,,0.5685,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6564,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Female,TCGA-86-A4P8,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,2.0,0.46,0,0,0,,,805,,805,805,,0,0,805,805,,Malignant,0,,15,,,,25686,,,805,805,,,,805,805,,,805,,,,,,,,TUMOR FREE,Alive,-21738,,,,1,,805,805,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.0020867,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-A4P8,,,,,,,805,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,85096,,0.928236512,,,,,,,,,,0.295192358,,0.309621026,,,,Stage IIIA,,1.222,,,,,,,,,,,,,,,,-0.0764,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.86272727,18.61955596,16.11241616,0.002894398,LUAD,Adenocarcinoma,18.26405104,17.05051078,Adenocarcinoma,-1.182,11.11636207,1.1261,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.45,0.45,5,5,11,,,1728,BRCA_Her2,1728,1728,,0,0,1728,1728,,Invasive Carcinoma,21,,55,,,,23483,0,,1728,1728,,,,1728,1728,,,1728,,,,,,,,TUMOR FREE,Alive,-19152,,,,409,,1728,1728,,,[Not Available],[Not Applicable],,,,,0.28,Breast,Resection/Excision,,,16,,1,0.14623,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CX,,,,,,,1728,,,,,,,,,28,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,85098,,0.639523027,0,0,0,0,0.961,1,,,Infiltrating Ductal Carcinoma,0.177121469,,0.162265168,0,0,0,,Negative,0.31,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.5243,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Papillary, High Grade), Stromal Alterations",,"DCIS (Papillary, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-37-4130,White,LUSC,,0,0,,Cureline,,0,MALE,0,4.62,0.4,16,22,25,,,247,,,247,,0,0,247,247,,Malignant,63,,61,,,,21680,,,247,247,,,,,247,,,247,,,,,,,,TUMOR FREE,Alive,-20652,,,,1493,,247,247,,,[Not Available],[Not Applicable],,,,,0.29,,,,,19,,2,0.41431,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-4130,,,,,,,247,,,,,,,,,60,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,85107,,1.885482176,,,,,,,,,,0.207315561,,0.057568227,,,,Stage IA,,1.723,,,,,,,,,,,,,,,,-0.5598,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.490406742959296,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.7033,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.57,0.65,3,5,8,,,703,BRCA_LumA,703,703,,0,0,703,703,,Invasive Carcinoma,16,,10,,,,16152,0,,703,703,,,,703,703,,,703,,,,,,,,TUMOR FREE,Alive,-28177,,,,29,,703,703,,,[Not Available],[Not Applicable],,,,,0.44,Breast,Resection/Excision,,,16,,1,0.098938,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1P5,,,,,,,703,,,,,,,,,16,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,85115,,0.488311995,0,0,0,0,-0.0347,1,,,Infiltrating Ductal Carcinoma,0.167168585,,0.063446278,0,0,0,,Negative,0.266,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2666,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-6820,White,STAD,,0,0,,,0,0,,0,1.57,0.69,13,9,11,,,344,,344,344,,0,0,344,344,,Malignant,33,,49,,,,21318,,,344,344,,,,344,344,,,344,,,,,,,,TUMOR FREE,Alive,-23486,,,,120,,344,344,,,[Not Available],[Not Applicable],,,,,0.46,Stomach,Unknown,,,15,,0,0.51913,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6820,,,,,,,344,,,,,,,,,17,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,85117,,-0.912720936,,,,,,,,,,0.056871778,Grade 2,0.10710181,,,,Stage IIB,,0.026,,,,,,,,,,,,,,,,0.0057,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6820,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.48,3,3,4,,,496,BRCA_LumA,496,496,,0,0,496,496,,Invasive Carcinoma,10,,9,,,,17359,0,,496,496,,,,496,496,,,496,,,,,,,,TUMOR FREE,Alive,-32061,,,,38,,496,496,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.055539,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3HN,,,,,,,496,,,,,,,,,5,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,87,,,,,,,,,,,,,,,,,,,,85121,,0.723634769,0,0,0,0,0.6185,1,,,Infiltrating Lobular Carcinoma,0.20186934,,0.272383942,0,0,0,,Negative,0.5105,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6455,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,85123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A925,White,STAD,,1,1,,,,1,,1,4.9,0.52,7,14,23,,,138,,,138,,1,1,138,138,,Malignant,44,,214,,,,23253,,,138,138,,,,,138,,,138,,,,,,,,WITH TUMOR,Dead,-24230,138,,,162,,138,138,,,Stomach Cancer,[Not Applicable],,,,,0.29,Stomach,Unknown,,,18,,2,0.22727,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A925,,,,,,,,,,,,,,,,51,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,66,,,,,,,,,,,,,,,,,,,,85124,,-0.059090843,,,,,,,,,,0.046209346,Grade 2,0.066589245,,,,Stage IIIA,,-0.15,,,,,,,,,,,,,,,,-0.0612,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A925,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-HC-A48F,,PRAD,268,0,0,,HC,0,0,MALE,0,1.84,0.91,10,8,5,ambiguous,NO,680,1-ERG,680,680,,0,0,680,680,prad_tcga,Malignant,23,BRCA1;CDK12;RAD51D;RAD54L,91,,TCGA-HC-A48F-01,0,5447,0,TCGA-HC-A48F,680,680,Prostate Cancer,,,680,680,TCGA,,680,Primary,0,,A,,,False,TUMOR FREE,Alive,-17434,,47,8,35,PRAD,680,680,,0.0,[Not Available],[Not Applicable],21,R1,1,Matched,0.2,Prostate,Resection,4,D85BA6E9-F1AB-453A-86D7-C58FCF5D3A07,5,Normal (no evidence of prostate cancer) [cM0],0,0.17708,[Not Available],FF49E0F9-4007-4761-845E-B676B0FC9646,4,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,HC,0.7,TCGA-HC-A48F,0:DiseaseFree,4,21,Prostate Adenocarcinoma,22.34,2/21/13,680,,,,,NO,C61,0886739D-01AE-43B1-9898-F1AB30BA940C,80,7,WITH TUMOR,0.3399,0:LIVING,,,22.34,Bilateral,25,No Evidence of Extraprostatic Extension,30,YES,115,2012,,,TCGA-HC-A48F.0886739D-01AE-43B1-9898-F1AB30BA940C.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,29,31-40%,10,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,,No,R1,,47,Core needle biopsy,,,YES,NO,YES,NO,T2c,,8,No,,0,N1,T1c,1,M0,C61.9,8140/3,85125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-7715,White,STAD,,0,0,,,0,0,,0,3.3,0.67,5,7,11,,,1023,,1023,1023,,0,0,1023,1023,,Malignant,23,,69,,,,26108,,,1023,1023,,,,1023,1023,,,1023,,,,,,,,TUMOR FREE,Alive,-23861,,,,167,,1023,1023,,,[Not Available],[Not Applicable],,,,,0.51,Stomach,Unknown,,,25,,1,0.13325,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-7715,,,,,,,1023,,,,,,,,,39,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,85130,,-0.642519918,,,,,,,,,,0.053110713,Grade 2,0.117713336,,,,Stage IIA,,-0.1005,,,,,,,,,,,,,,,,0.2905,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7715,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.65,8,8,11,,,806,BRCA_LumA,806,806,,0,0,806,806,,Invasive Carcinoma,27,,85,,,,16609,0,,806,806,,,,806,806,,,806,,,,,,,,TUMOR FREE,Alive,-20448,,,,61,,806,806,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,6,,0,0.18649,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HB,,,,,,,806,,,,,,,,,10,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,85141,,1.018138318,0,0,0,0,0.8215,1,,,Infiltrating Ductal Carcinoma,0.188455332,,0.100564038,0,0,0,,Negative,0.3625,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1735,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-34-2600,White,LUSC,,0,0,,University of Pittsburgh,2,2,FEMALE,2,2.93,0.86,10,11,13,,,1874,,1874,1874,,2,2,1874,1874,,Malignant,34,,36,,,,20735,,,1874,1874,,,,1874,1874,,,1874,,,,,,,,TUMOR FREE,Dead,-28072,1874,,,559,,1874,1874,,,[Not Available],[Not Applicable],,,,,0.33,,,,,18,,1,0.46173,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-2600,,,,,,,1874,,,,,,,,,32,,,,,,,,,,,,,2000,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,85142,,-0.24368044,,,,,,,,,,0.087905578,,0.041351932,,,,Stage IA,,-0.6325,,,,,,,,,,,,,,,,-0.0619,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.813455192426606,LUSC,,,,Squamous Cell Carcinoma,-2.5593,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.23,0.77,12,14,16,,,1419,BRCA_LumB,1419,1419,,0,0,1419,1419,,Invasive Carcinoma,42,,80,,,,28356,0,,1419,1419,,,,1419,1419,,,1419,,,,,,,,TUMOR FREE,Alive,-27392,,,,68,,1419,1419,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,15,,1,0.20717,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1RE,,,,,,,1419,,,,,,,,,32,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,85149,,0.052233538,0,0,0,0,-0.7091,1,,,Infiltrating Ductal Carcinoma,0.095961027,,0.116287306,0,0,0,,Negative,-1.2925,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0955,1,0,H & E,0,0,,0,Chunhui Yi,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-4Z-AA83,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.97,0.84,1,1,1,,,2024,,2024,2024,,0.0,0,2024.0,2024.0,,Malignant,3,,25,,,,16589.0,,,2024.0,2024,,,,2024,2024,,,2024.0,,,,,,,,TUMOR FREE,Alive,-19280,,,,120.0,,2024.0,2024,,,[Not Available],[Not Applicable],,,,,0.01,,,,,5,,0,0.05676,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA83,,,,,,,2024,,,,,,,,,3,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,52.0,,,,,,,,,,,,,,,,,,,,85150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-50-5044,White,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,2.05,0.23,2,2,2,,,624,,,624,,1,1,483,483,,Malignant,6,,4,,,,16850,,,483,483,,,,,624,,,483,,,,,,,,WITH TUMOR,Dead,-26567,624,,,164,,483,483,,,[Not Available],[Not Applicable],,,,,0.03,,,,,1,,0,0.095604,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5044,,,,,,,,,Distant Metastasis,,,,,,,4,,,,,,,,,,,,,2002,483,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,72,,,,,,,,,,,,,,,,,,,,85151,,0.620514419,,,,,,,,,,0.180159685,,0.225790523,,,,Stage IIIB,,1.893,,,,,,,,,,,,,,,,0.6503,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.23639602,17.00525724,16.63912891,-0.036523501,LUAD,Adenocarcinoma,18.298363,15.97061233,Adenocarcinoma,1.8202,13.53636939,0.6934,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Female,TCGA-MP-A4T9,White,LUAD,,1,1,,Washington University - Mayo Clinic,1,1,FEMALE,1,2.11,0.18,11,13,13,,,1265,,341,1265,,1,1,341,341,,Malignant,37,,73,,,,31537,,,341,341,,,,341,1265,,,341,,,,,,,,WITH TUMOR,Dead,-19767,1265,,,48,,341,341,,,[Not Available],[Not Applicable],,,,,0.47,,,,,9,,0,0.31113,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4T9,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,17,,,,,,,,,,,,,2006,341,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,85153,,0.499273122,,,,,,,,,,0.26842047,,0.211062134,,,,Stage IIIA,,1.864,,,,,,,,,,,,,,,,0.5562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), AMP (driver)",,,1,L858R (driver),,,16.12074971,17.98977572,15.17766725,-0.310689235,LUAD,Adenocarcinoma,18.00557671,16.24379361,Adenocarcinoma,0.5276,14.33764153,-0.119,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-4L-AA1F,,PRAD,,0,0,,4L,0,0,MALE,0,3.51,0.26,5,18,14,ambiguous,NO,350,,350,350,,0,0,350,350,prad_tcga,Malignant,37,BRCA1;BRCA2,63,,TCGA-4L-AA1F-01,0,5235,0,TCGA-4L-AA1F,350,350,Prostate Cancer,5,350,350,350,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),350,Primary,0,Middle,A,,,False,TUMOR FREE,Alive,-23665,,64,8,37,PRAD,350,350,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.31,Prostate,Resection,4,E52B541A-EE14-4339-B1DB-DB00DD32CFAF,11,Abnormal (not related to prostate cancer),1,0.10152,[Not Available],47ABCD03-C6FF-4777-AC26-F880474092FF,4,Prostate Adenocarcinoma Acinar Type,,Prostate,35,,Acinar Adenocarcinoma,[Not Available],,4L,1.16666666667,TCGA-4L-AA1F,0:DiseaseFree,4,45,Prostate Adenocarcinoma,11.5,11/14/14,350,,,,,YES,C61,A9DCC04F-A189-408C-9EE0-9F36F388068D,380,21,TUMOR FREE,0.1387,0:LIVING,3.5,,11.5,Bilateral,43,Extraprostatic Extension  Localized (e.g. seminal vesicles),4,YES,64,2013,,,TCGA-4L-AA1F.A9DCC04F-A189-408C-9EE0-9F36F388068D.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,0,,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R1,,64,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3b,NO,8,No,YES,0,N0,T2c,0,M1a,C61.9,8140/3,85154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-A4DG,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,3.7,0.41,11,10,17,,,608,,608,608,,0,0,608,608,,Malignant,38,,95,,,,24420,,,608,608,,,,608,608,,,608,,,,,,,,TUMOR FREE,Alive,-26044,,,,1023,,608,608,,,[Not Available],[Not Applicable],,,,,0.17,,,,,19,,2,0.26563,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A4DG,,,,,,,608,,,,,,,,,70,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,85175,,0.87713044,,,,,,,,,,0.192364562,,0.074090584,,,,Stage IA,,0.4905,,,,,,,,,,,,,,,,-0.0953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.259863539,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.4723,,0.5308,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-PQ-A6FI,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.78,0.75,8,16,15,,,372,,372,372,,0.0,0,372.0,372.0,,Malignant,39,,147,,,,16230.0,,,372.0,372,,,,372,372,,,372.0,,,,,,,,TUMOR FREE,Alive,-25672,,,,212.0,,372.0,372,,,[Not Available],[Not Applicable],,,,,0.11,,,,,15,,1,0.34856,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Colorado Denver,,TCGA-PQ-A6FI,,,,,,,372,,,,,,,,,32,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,85179,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8MF,,PRAD,370,0,0,,V1,0,0,MALE,0,2.05,0.64,3,4,4,HRP,NO,1449,8-other,1449,1449,,0,0,1449,1449,prad_tcga,Malignant,11,BRCA2,41,,TCGA-V1-A8MF-01,0,5557,0,TCGA-V1-A8MF,1449,1449,Prostate Cancer,,1218,1449,1449,TCGA,,1449,Primary,0,Apex,A,,,True,,Alive,-24090,,65,6,40,PRAD,1449,1449,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,3,AA0E444B-C913-4A70-A76D-BE70CCF80691,2,,0,0.037853,[Not Available],56DF9DE6-613D-44CE-8827-9213CC6C8B56,3,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,V1,1.1,TCGA-V1-A8MF,0:DiseaseFree,1,13,Prostate Adenocarcinoma,47.6,7/23/14,1449,,,,,NO,C61,C2A32E46-BB93-43E6-BF3A-995745161434,130,3,,0.0886,0:LIVING,0.14,,47.6,Bilateral,14,,,YES,,,,,TCGA-V1-A8MF.C2A32E46-BB93-43E6-BF3A-995745161434.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,8,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,,N0,T2c,0,M0,C61.9,8140/3,85189,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.74,0.43,3,12,10,,,611,BRCA_LumB,611,611,,0,0,611,611,,Invasive Carcinoma,25,,27,,,,28452,0,,611,611,,,,611,611,,,611,,,,,,,,TUMOR FREE,Alive,-19966,,,,99,,611,611,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,20,,1,0.15493,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JJ,,,,,,,611,,,,,,,,,25,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,85190,,,0,0,0,0,-0.0743,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Ola El-Zammar,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-43-6143,White,LUSC,,0,0,,Christiana Healthcare,0,0,MALE,0,3.42,0.86,11,14,18,,,699,,699,699,,0,0,699,699,,Malignant,43,,91,,,,22859,,,699,699,,,,699,699,,,699,,,,,,,,TUMOR FREE,Alive,-25820,,,,424,,699,699,,,[Not Available],[Not Applicable],,,,,0.55,,,,,16,,1,0.28778,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-6143,,,,,,,699,,,,,,,,,34,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,85191,,0.404206218,,,,,,,,,,0.157162078,,0.06382948,,,,Stage IB,,0.2835,,,,,,,,,,,,,,,,0.1925,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,I506V,1,,,I506V,,,,-0.744051379523772,LUSC,,,,Squamous Cell Carcinoma,-0.2349,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-HC-8260,,PRAD,221,0,0,,HC,0,0,MALE,0,2.0,0.33,0,0,0,HRP,NO,686,1-ERG,686,686,,0,0,686,686,prad_tcga,Malignant,0,,19,5.5,TCGA-HC-8260-01,0,5441,0,TCGA-HC-8260,686,686,Prostate Cancer,,106,686,686,TCGA,,686,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-15884,,43,7,12,PRAD,686,686,,0.0,[Not Available],[Not Applicable],16,R1,1,Matched,0.08,Prostate,Resection,3,67df36b3-dea8-4623-a23b-6b28a445e969,0,,0,1.39e-06,[Not Available],3971a2f0-7263-4cda-aa01-9a2ebb2c2ff2,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.1,HC,0.533333333333,TCGA-HC-8260,0:DiseaseFree,2,4,Prostate Adenocarcinoma,22.54,6/20/12,686,,,,,,C61,12d41624-f0a9-4ba1-aa55-18fea0b733af,,0,WITH TUMOR,0.0003,0:LIVING,0.01,,22.54,Bilateral,6,,,YES,,2011,,,TCGA-HC-8260.12d41624-f0a9-4ba1-aa55-18fea0b733af.pdf,Peripheral Zone,[Not Applicable],,,41-50%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.7,43,Core needle biopsy,,,YES,NO,YES,NO,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,85193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A5UA,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,2.24,0.92,5,5,12,,,365,,365,365,,0.0,0,365.0,365.0,,Malignant,22,,68,,,,17805.0,,,365.0,365,,,,365,365,,,365.0,,,,,,,,TUMOR FREE,Alive,-24625,,,,105.0,,365.0,365,,,[Not Available],[Not Applicable],,,,,0.02,,,,,8,,0,0.073202,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A5UA,,,,,,,365,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,67.0,,,,,,,,,,,,,,,,,,,,85204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-33-4566,White,LUSC,,0,0,,Johns Hopkins,,,MALE,2,2.55,0.53,16,11,18,,,5287,,,5287,,2,2,5287,5287,,Malignant,45,,50,,,,19477,,,5287,5287,,,,,5287,,,5287,,,,,,,,,Dead,-14643,5287,,,1792,,5287,5287,,,[Not Available],[Not Applicable],,,,,0.16,,,,,17,,1,0.45345,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4566,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,1996,,,,,Stage IB,,,,,,,,[Unknown],,,,,,40,,,,,,,,,,,,,,,,,,,,85209,,1.005031237,,,,,,,,,,0.194596609,,0.087896041,,,,Stage IB,,0.7955,,,,,,,,,,,,,,,,-0.0635,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,X1039_splice,AMP (driver),,1,X1039_splice,,,,,,0.0918410049600524,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.1695,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-50-5055,White,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,2.12,0.13,1,0,1,,,1830,,,1830,,1,1,771,771,,Malignant,2,,5,,,,17585,,,771,771,,,,,1830,,,771,,,,,,,,WITH TUMOR,Dead,-28988,1830,,,17,,771,771,,,[Not Available],[Not Applicable],,,,,0.18,,,,,1,,0,0.060969,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5055,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,5,,,,,,,,,,,,,2008,771,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,79,,,,,,,,,,,,,,,,,,,,85224,,1.659142414,,,,,,,,,,0.25347638,,0.265597403,,,,Stage IIA,,1.296,,,,,,,,,,,,,,,,0.441,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.52224168,16.53041127,16.31442507,0.186107913,LUAD,Adenocarcinoma,18.91449377,17.24361981,Adenocarcinoma,,14.37681673,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-BR-8487,White,STAD,,0,0,,,0,0,,0,2.11,0.82,0,0,2,,,34,,34,34,,0,0,34,34,,Malignant,2,,26,,,,20268,,,34,34,,,,34,34,,,34,,,,,,,,TUMOR FREE,Alive,-23400,,,,4287,,34,34,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,4,,0,0.088438,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8487,,,,,,,34,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,85231,,0.11838062,,,,,,,,,,0.085182354,Grade 3,0.021045562,,,,Stage IIA,,0.382,,,,,,,,,,,,,,,,-0.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8487,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.88,0.62,12,12,13,,,1572,BRCA_Basal,1572,1572,,0,0,1572,1572,,Invasive Carcinoma,37,,103,,,,22351,0,,1572,1572,,,,1572,1572,,,1572,,,,,,,,TUMOR FREE,Alive,-16310,,,,60,,1572,1572,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,6,,0,0.31985,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0B9,,,,,,,1572,,,,,,,,,17,,,,,,,,,,,,,2006,,,,,Stage IA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,85233,TRUE,1.365797326,0,0,0,0,0.5781,0,,,Infiltrating Ductal Carcinoma,0.156540783,,-0.002270235,0,0,0,,Negative,0.8405,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,-0.3369,1,0,H & E,0,0,,0,Ioana Tolocica,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, High Grade), Stromal Alterations",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.74,1,0,3,,,680,BRCA_LumA,680,680,,0,0,680,680,,Invasive Carcinoma,4,,4,,,,17837,0,,680,680,,,,680,680,,,680,,,,,,,,TUMOR FREE,Alive,-22284,,,,39,,680,680,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.090388,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0J8,,,,,,,680,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,85234,,0.496112657,0,1,0,0,0.3041,0,,,Infiltrating Lobular Carcinoma,0.195195567,,0.116612751,0,0,0,,Negative,0.069,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4233,1,0,H & E,0,0,,0,Ola El-Zammar,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,ALH,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-4547,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.91,0.49,12,11,19,,,2419,,2419,2419,,0,0,2419,2419,,Malignant,42,,169,,,,17065,,,2419,2419,,,,2419,2419,,,2419,,,,,,,,TUMOR FREE,Alive,-25056,,,,256,,2419,2419,,,[Not Available],[Not Applicable],,,,,0.02,,,,,12,,0,0.33781,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4547,,,,,,,2419,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,85240,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.7549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.460033798952849,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-49-6743,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,2.96,0.27,11,10,12,,,1621,,1621,1621,,0,0,1621,1621,,Malignant,33,,35,,,,21545,,,1621,1621,,,,1621,1621,,,1621,,,,,,,,TUMOR FREE,Alive,-29807,,,,991,,1621,1621,,,[Not Available],[Not Applicable],,,,,0.08,,,,,21,,1,0.26935,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6743,,,,,,,1621,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,85244,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,"G527V, G527C",1,,,"G527V, G527C",15.89322553,17.46493985,16.01451465,-0.289411461,LUAD,Adenocarcinoma,17.7192686,15.86975845,Adenocarcinoma,,13.79242264,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-D7-8572,White,STAD,,0,0,,,0,0,,0,1.99,0.43,1,2,1,,,511,,511,511,,0,0,511,511,,Malignant,4,,34,,,,27903,,,511,511,,,,511,511,,,511,,,,,,,,WITH TUMOR,Alive,-20870,,,,244,,511,511,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,0,,0,0.034455,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-8572,,,,,,,511,,,,,,,,,1,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,85245,,,,,,,,,,,,,Grade 2,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8572,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.92,0.74,4,2,4,,,528,BRCA_LumA,528,528,,0,0,528,528,,Invasive Carcinoma,10,,36,,,,19348,0,,528,528,,,,528,528,,,528,,,,,,,,TUMOR FREE,Alive,-14272,,,,54,,528,528,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Core Biopsy,,,5,,1,0.062395,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A66O,,,,,,,528,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,85246,,,0,1,0,1,0.3101,0,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,,0,0,H & E,0,0,,0,Ioana Tolocica,"ALH, UDH",0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,Benign Breast Epithelium,Microcalcifications,"DCIS (Solid, Low Grade), Microcalcifications",,"DCIS (Solid, Low Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,"ALH, UDH",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-52-7622,White,LUSC,,0,0,,University of Miami,0,0,FEMALE,0,1.85,0.39,9,5,10,,,862,,862,862,,0,0,862,862,,Malignant,24,,31,,,,33749,,,862,862,,,,862,862,,,862,,,,,,,,TUMOR FREE,Alive,-22807,,,,347,,862,862,,,[Not Available],[Not Applicable],,,,,0.4,,,,,12,,0,0.30982,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Miami,,TCGA-52-7622,,,,,,,862,,,,,,,,,16,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,85247,,1.218219796,,,,,,,,,,0.253546872,,0.12788526,,,,Stage IA,,2.4815,,,,,,,,,,,,,,,,0.4713,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0317688422918906,LUSC,,,,Squamous Cell Carcinoma,0.042,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.15,0.8,14,28,26,,,317,BRCA_LumB,317,317,,0,0,317,317,,Invasive Carcinoma,68,,126,,,,28765,0,,317,317,,,,317,317,,,317,,,,,,,,TUMOR FREE,Alive,-25066,,,,253,,317,317,,,[Not Available],[Not Applicable],,,,,0.26,Breast,Resection/Excision,,,17,,1,0.27119,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A6VX,,,,,,,317,,,,,,,,,35,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,85251,,-0.164806888,0,0,0,0,0.1395,1,,,Infiltrating Ductal Carcinoma,0.183624982,,0.118724049,0,0,0,,Negative,0.008,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4617,1,0,H & E,0,0,,0,Ola El-Zammar,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-G2-A2EJ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.09,0.61,9,4,7,,,1460,,910,1460,,1.0,1,910.0,910.0,,Malignant,20,,60,,,,25884.0,,,910.0,910,,,,910,1460,,,910.0,,,,,,,,TUMOR FREE,Alive,-20649,,,,428.0,,910.0,910,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.13654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EJ,,,,,,,1460,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2009,910,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,85252,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.93,0.73,6,9,16,,,274,BRCA_LumB,274,274,,0,0,274,274,,Invasive Carcinoma,31,,40,,,,26197,0,,274,274,,,,274,274,,,274,,,,,,,,TUMOR FREE,Alive,-25294,,,,120,,274,274,,,[Not Available],[Not Applicable],,,,,0.54,Breast,Resection/Excision,,,11,,2,0.1771,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A079,,,,,,,274,,,,,,,,,63,,,,,,,,,,,,,2007,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,85260,,-0.332350727,0,0,0,0,-0.1383,1,,,Infiltrating Ductal Carcinoma,0.144300086,,0.04705427,0,0,0,,Negative,-0.8685,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0719,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-22-5471,White,LUSC,,1,,,Mayo Clinic - Rochester,1,0,MALE,1,3.26,0.44,14,13,21,,,1845,,229,1845,,1,,229,229,,Malignant,48,,33,,,,20977,,,229,,,,,229,1845,,,229,,,,,,,,,Alive,-27749,,,,282,,229,,,,[Not Available],[Not Applicable],,,,,0.4,,,,,16,,1,0.28314,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5471,,,,,,,1845,,,,,,,,,35,,,,,,,,,,,,,2005,229,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,85273,,1.49729004,,,,,,,,,,0.177392631,,0.027984708,,,,Stage IB,,1.809,,,,,,,,,,,,,,,,0.4046,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,0.090481976552016,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.0015,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-73-4658,White,LUAD,,0,0,,Roswell Park,2,2,FEMALE,2,2.14,0.29,4,5,8,,,1600,,1600,1600,,2,2,1600,1600,,Malignant,17,,8,,,,21703,,,1600,1600,,,,1600,1600,,,1600,,,,,,,,TUMOR FREE,Dead,-29508,1600,,,459,,1600,1600,,,[Not Available],[Not Applicable],,,,,0.4,,,,,7,,0,0.12781,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4658,,,,,,,1600,,,,,,,,,13,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,85276,,1.187252023,,,,,,,,,,0.286545022,,0.251889983,,,,Stage IB,,2.18,,,,,,,,,,,,,,,,0.6292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.022206684,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.1481,,0.3476,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-CD-5800,Asian,STAD,,0,0,,,0,0,,0,3.06,0.47,7,18,20,,,400,,400,400,,0,0,400,400,,Malignant,45,,41,,,,18070,,,400,400,,,,400,400,,,400,,,,,,,,TUMOR FREE,Alive,,,,,211,,400,400,,,[Not Available],[Not Applicable],,,,,0.44,Stomach,Unknown,,,14,,1,0.14843,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Papillary Type",,,,,Intestinal Gastric Carcinoma,G1,,ILSBio,,TCGA-CD-5800,,,,,,,400,,,,,,,,,31,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,85279,,-0.154814992,,,,,,,,,,0.055733571,Grade 1,0.027506099,,,,Stage II,,-0.611,,,,,,,,,,,,,,,,0.0465,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-5800,Gastric Carcinoma,TCGA,"Adenocarcinoma, Papillary Type"
0,1,,1,1,1,,,Black or African American,BRCA,,1,1,,,,1,FEMALE,1,2.25,0.23,7,13,12,,,227,BRCA_Normal,,227,,1,1,192,192,,Invasive Carcinoma,32,,81,,,,32249,0,,192,192,,,,,227,,,192,,,,,,,,WITH TUMOR,Dead,-20118,227,,,75,,192,192,,,[Not Available],[Not Applicable],,,,,0.37,Breast,Resection/Excision,,,11,,0,0.20478,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A73Z,,,,,,,,Brain,Distant Metastasis,,,,,,,20,,,,,,,,,,,,,2013,192,,,,Stage IV,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,85284,,0.750627211,0,0,0,0,0.4071,0,,,Infiltrating Ductal Carcinoma,0.163662918,,0.254682891,0,0,1,,Positive,0.2935,,10/21/22,0,0,0,0,0,0,0,0,0,1,nø,0,0,0.4346,1,0,H & E,0,0,,0,Ioana Tolocica,"Columnar Lesion, Papilloma",0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"Columnar Lesion, Papilloma",0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,1.0,1.0,Male,TCGA-L5-A43E,White,ESCA,,0.0,0,,,0,0,,1.0,,,,,,,,920,,920,920,,0.0,0,885,885,,Malignant,,,,,,,28843.0,0,,920,920,,,,920,920,,,885,,,,,,,,TUMOR FREE,Alive,-27143,,,,260.0,,920,920,,,[Not Available],[Not Available],,,,,,Esophagus,Resection,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A43E,,,,,,,920,"Other, specify",New Primary Tumor,,,,,,,,,,,,,,,,,,,,2011,885,Right diaphragm-HG spindle cell sarcoma,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,85286,,,,,,,,,,,,,Unknown,,,,,Stage I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-CH-5737,White,PRAD,91,0,0,,CH,,0,MALE,0,1.94,0.74,4,8,0,HRD,NO,91,6-FOXA1,,91,,0,0,91,91,prad_tcga,Malignant,12,BRCA2,83,14.7,TCGA-CH-5737-01,0,5236,0,TCGA-CH-5737,91,91,Prostate Cancer,91,,,91,TCGA,No Evidence of Extraprostatic Extension,91,Primary,0,,A,CHEK1:477:*/C:stop_lost,,,TUMOR FREE,Alive,-26753,,73,7,71,PRAD,91,91,WHITE,0.0,[Not Available],[Not Applicable],89,R0,1,Matched,0.03,Prostate,Resection,4,144f52d8-5650-475a-9cde-4a1952ee22db,0,Normal (no evidence of prostate cancer) [cM0],0,0.060054,[Not Available],4f9f1fce-d96e-407b-a873-56129985aece,3,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,2.96666666667,TCGA-CH-5737,0:DiseaseFree,3,12,Prostate Adenocarcinoma,2.99,3/16/12,91,,,,,YES,C61,dbf280bb-fb7c-422f-b772-a62381c19afa,,1,TUMOR FREE,0.0572,0:LIVING,14.69,,2.99,Bilateral,15,No Evidence of Extraprostatic Extension,91,YES,,2007,,,TCGA-CH-5737.dbf280bb-fb7c-422f-b772-a62381c19afa.pdf,Peripheral Zone,[Not Applicable],YES,91,91-100%,8,Prostate Adenocarcinoma Acinar Type,1,2007,[Not Available],,NO,No,R0,0.4,73,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,85287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A6B0,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.0,0.9,0,0,1,,,2330,,2330,2330,,0.0,0,2330.0,2330.0,,Malignant,1,,14,,,,24868.0,,,2330.0,2330,,,,2330,2330,,,2330.0,,,,,,,,TUMOR FREE,Alive,-22439,,,,36.0,,2330.0,2330,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.0033128,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A6B0,,,,,,,2330,,,,,,,,,0,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,85289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-V1-A8MU,,PRAD,389,0,0,,V1,,0,MALE,0,1.95,0.47,4,5,2,HRP,NO,1876,8-other,,1876,,0,0,1876,1876,prad_tcga,Malignant,11,,45,,TCGA-V1-A8MU-01,0,5563,0,TCGA-V1-A8MU,1876,1876,Prostate Cancer,,1384,,1876,TCGA,,1876,Primary,0,Apex,A,,,True,,Alive,-20805,,56,7,39,PRAD,1876,1876,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.0,Prostate,Resection,3,D27C7A15-D603-4F85-9DED-6FCD72C78D21,0,,0,0.055404,[Not Available],A76BCD1F-E47F-4DC5-A97A-4C4F00032191,4,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,V1,0.8,TCGA-V1-A8MU,0:DiseaseFree,2,11,Prostate Adenocarcinoma,61.63,7/15/14,1876,,,,,NO,C61,8E072738-2D8E-4254-B1DE-A8008C614B7F,160,1,,0.0528,0:LIVING,0.015,,61.63,Bilateral,13,No Evidence of Extraprostatic Extension,87,YES,,,,,TCGA-V1-A8MU.8E072738-2D8E-4254-B1DE-A8008C614B7F.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,15,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,NO,No,R1,,56,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,7,No,YES,,N1,T2b,1,M0,C61.9,8140/3,85296,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-2F-A9KW,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,3.56,0.58,13,16,19,,,254,,,254,,1.0,1,85.0,85.0,,Malignant,48,,135,,,,20652.0,,,85.0,85,,,,,254,,,85.0,,,,,,,,WITH TUMOR,Dead,-24703,254,,,156.0,,85.0,85,,,[Not Available],[Not Applicable],,,,,0.13,,,,,7,,1,0.20122,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KW,,,,,,,,Bone,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2013,85,,,,Stage III,,,,,,,,Stable Disease,,,,,,67.0,,,,,,,,,,,,,,,,,,,,85299,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A59V,,PRAD,,0,0,,KK,0,0,MALE,0,1.97,0.58,2,3,1,HRD,NO,3440,,3440,3440,,0,0,3440,3440,prad_tcga,Malignant,6,,44,,TCGA-KK-A59V-01,0,5493,0,TCGA-KK-A59V,3440,3440,Prostate Cancer,,2500,3440,3440,TCGA,,3440,Primary,0,Apex|Middle|Base,A,,RAD51C,True,TUMOR FREE,Alive,-23483,,64,9,1193,PRAD,3440,3440,,0.0,[Not Available],[Not Applicable],863,,1,Matched,0.21,Prostate,Resection,4,661E975A-2420-4ADF-869B-9D66F4F03399,1,,0,0.028787,[Not Available],9E48644F-D498-42B0-871B-D11F676241E2,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,KK,28.6666666667,TCGA-KK-A59V,0:DiseaseFree,5,4,Prostate Adenocarcinoma,113.01,3/27/14,3440,,,,,NO,C61,0A977EFF-C276-46CB-9187-92F504C7B535,190,1,TUMOR FREE,0.0273,0:LIVING,0.1,,113.01,Bilateral,4,,,YES,2742,2005,,,TCGA-KK-A59V.0A977EFF-C276-46CB-9187-92F504C7B535.pdf,Peripheral Zone,[Not Applicable],NO,,,9,Prostate Adenocarcinoma Acinar Type,1,2005,Complete Remission/Response,,NO,No,R0,,64,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,NO,0,N0,T3a,0,M0,C61.9,8140/3,85303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-GC-A4ZW,White,BLCA,,0.0,0,,,,0,MALE,0.0,5.25,0.85,11,24,26,,,15,,,15,,0.0,0,15.0,15.0,,Malignant,61,,126,,,,20632.0,,,15.0,15,,,,,15,,,15.0,,,,,,,,TUMOR FREE,Alive,-25964,,,,893.0,,15.0,15,,,[Not Available],[Not Applicable],,,,,0.37,,,,,14,,2,0.20295,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A4ZW,,,,,,,15,,,,,,,,,55,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,[Unknown],,,,,,71.0,,,,,,,,,,,,,,,,,,,,85306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-VQ-A8PQ,White,STAD,,1,1,,,,1,,1,2.07,0.18,2,8,6,,,476,,,476,,1,1,91,91,,Malignant,16,,51,,,,34321,,,91,91,,,,,476,,,91,,,,,,,,WITH TUMOR,Dead,-18318,476,,,17,,91,91,,,Stomach Cancer,[Not Applicable],,,,,0.4,Stomach,Unknown,,,0,,0,0.026813,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8PQ,,,,,,,,,Locoregional Recurrence,,,,,,,4,,,,,,,,,,,,,2008,91,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,50,,,,,,,,,,,,,,,,,,,,85310,,1.59982716,,,,,,,,,,0.120698475,Grade 2,0.17783796,,,,Stage IV,,1.298,,,,,,,,,,,,,,,,0.2454,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PQ,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1.0,0,0,0.0,1.0,Male,TCGA-DK-A3IN,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.57,0.39,7,6,12,,,250,,250,250,,2.0,2,250.0,250.0,,Malignant,25,,14,,,,25789.0,,,250.0,250,,,,250,250,,,250.0,,,,,,,,TUMOR FREE,Dead,-26562,250,,,530.0,,250.0,250,,,[Not Available],[Not Applicable],,,,,0.14,,,,,20,,1,0.15421,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IN,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,72.0,,,,,,,,,,,,,,,,,,,,85312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,Asian,BRCA,,1,1,,,,1,FEMALE,1,2.12,0.51,13,14,14,,,385,BRCA_Her2,,385,,1,1,385,385,,Invasive Carcinoma,41,,96,,,,24320,0,,385,385,,,,,385,,,385,,,,,,,,WITH TUMOR,Dead,-28733,385,,,146,,385,385,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,12,,0,0.28752,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12Q,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,85318,,0.417052583,0,0,0,0,0.1563,1,,,Infiltrating Ductal Carcinoma,0.187044892,,0.193196594,0,0,0,,Negative,-0.007,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4513,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-18-4086,,LUSC,,0,0,,Princess Margaret Hospital (Canada),,2,MALE,2,,,,,,,,85,,,85,,2,2,85,85,,Malignant,,,,,,,17400,,,85,85,,,,,85,,,85,,,,,,,,TUMOR FREE,Dead,-23731,85,,,185,,85,85,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-4086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,85322,,0.553109443,,,,,,,,,,0.19348635,,0.078194918,,,,Stage IB,,1.5315,,,,,,,,,,,,,,,,0.4595,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.266505079959963,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6787,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-4B-A93V,Black or African American,LUAD,,1,1,,Mary Bird Perkins Cancer Center - Our Lady of the Lake,,1,FEMALE,1,2.67,0.62,10,11,15,,,300,,,300,,1,1,251,251,,Malignant,36,,128,,,,33235,,,251,251,,,,,300,,,251,,,,,,,,WITH TUMOR,Dead,-19035,300,,,188,,251,251,,,[Not Available],[Not Applicable],,,,,0.13,,,,,23,,1,0.42834,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Mary Bird Perkins Cancer Center - Our Lady of the Lake,,TCGA-4B-A93V,,,,,,,,,Distant Metastasis,,,,,,,31,,,,,,,,,,,,,2013,251,,,,Stage IA,,,,,,,,Progressive Disease,,,,,,52,,,,,,,,,,,,,,,,,,,,85324,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.223,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),L199F,1,,G12C (driver),L199F,,,,-0.348810255,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.0598,,-0.5532,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.14,0.3,6,8,8,,,3102,BRCA_Her2,3102,3102,,0,0,3102,3102,,Invasive Carcinoma,22,,43,,,,21495,0,,3102,3102,,,,3102,3102,,,3102,,,,,,,,TUMOR FREE,Alive,-18345,,,,198,,3102,3102,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,15,,1,0.21684,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04W,,,,,,,3102,,,,,,,,,27,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,85328,,-0.321079189,0,0,0,0,1.5891,1,,,Other,0.154933191,,0.155200032,0,0,0,,Negative,-0.899,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.667,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A43P,Black or African American,BLCA,,0.0,0,,,0,0,MALE,0.0,3.48,0.42,8,14,17,,,832,,832,832,,0.0,0,832.0,832.0,,Malignant,39,,49,,,,22961.0,,,832.0,832,,,,832,832,,,832.0,,,,,,,,TUMOR FREE,Alive,-27201,,,,561.0,,832.0,832,,,[Not Available],[Not Applicable],,,,,0.18,,,,,13,,1,0.1398,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A43P,,,,,,,832,,,,,,,,,26,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,74.0,,,,,,,,,,,,,,,,,,,,85339,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-67-3772,White,LUAD,,0,0,,St Joseph's Medical Center (MD),,0,FEMALE,0,1.84,0.45,3,2,7,,,573,,,573,,0,0,573,573,,Malignant,12,,30,,,,21955,,,573,573,,,,,573,,,573,,,,,,,,TUMOR FREE,Alive,-29989,,,,112,,573,573,,,[Not Available],[Not Applicable],,,,,0.47,,,,,10,,0,0.2725,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-3772,,,,,,,573,,,,,,,,,10,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,85343,,0.457429365,,,,,,,,,,0.267707791,,0.183119531,,,,Stage IB,,-0.2495,,,,,,,,,,,,,,,,0.2973,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.097407136,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.0401,,-0.4284,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.17,0.33,0,5,5,,,2991,BRCA_LumB,2991,2991,,0,0,2991,2991,,Invasive Carcinoma,10,,12,,,,17683,0,,2991,2991,,,,2991,2991,,,2991,,,,,,,,TUMOR FREE,Alive,-9873,,,,55,,2991,2991,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,11,,1,0.01165,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TQ,,,,,,,2991,,,,,,,,,8,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,27,,,,,,,,,,,,,,,,,,,,85346,,1.216332429,0,0,0,0,-0.6034,1,,,Infiltrating Ductal Carcinoma,0.164818808,,0.162322168,0,0,0,,Negative,0.3925,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1785,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-BR-8365,White,STAD,,1,1,,,,1,,1,1.75,0.28,7,7,9,,,533,,,533,,1,1,533,533,,Malignant,23,,63,,,,31707,,,533,533,,,,,533,,,533,,,,,,,,WITH TUMOR,Dead,-25725,533,,,35,,533,533,,,[Not Available],[Not Applicable],,,,,0.24,Stomach,Unknown,,,6,,0,0.29115,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8365,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,85347,,0.506783774,,,,,,,,,,0.105022777,Grade 3,0.225065675,,,,Stage IIA,,0.443,,,,,,,,,,,,,,,,0.4439,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8365,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,1,1,Male,TCGA-BR-6563,White,STAD,,0,0,,,0,0,,1,2.03,0.23,1,1,1,,,1190,,1190,1190,,0,0,148,148,,Malignant,3,,6,,,,28106,,,1190,1190,,,,1190,1190,,,148,,,,,,,,TUMOR FREE,Alive,-21936,,,,76,,1190,1190,,,[Not Available],[Not Applicable],,,,,0.36,Stomach,Unknown,,,0,,0,0.18558,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6563,,,,,,,1190,,New Primary Tumor,,,,,,,7,,,,,,,,,,,,,2011,148,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,85348,,1.119484179,,,,,,,,,,0.156568153,Grade 3,0.195505146,,,,Stage IIB,,0.893,,,,,,,,,,,,,,,,0.4299,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6563,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-VQ-A8P8,Black or African American,STAD,,0,0,,,0,0,,0,,,2,4,3,,,942,,942,942,,0,0,942,942,,Malignant,9,,,,,,29736,,,942,942,,,,942,942,,,942,,,,,,,,TUMOR FREE,Alive,-26443,,,,131,,942,942,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8P8,,,,,,,942,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,85352,,0.460447298,,,,,,,,,,0.09037538,Grade 2,0.159985885,,,,Stage IIB,,-0.062,,,,,,,,,,,,,,,,0.2383,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8P8,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-EJ-7328,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.42,3,5,3,HRD,NO,842,1-ERG,842,842,,0,0,842,842,prad_tcga,Malignant,11,,13,6.5,TCGA-EJ-7328-01,0,5306,0,TCGA-EJ-7328,842,842,Prostate Cancer,,,842,842,TCGA,,842,Primary,0,Middle|Base,A,BRCA2:3363:I/IX:frameshift_variant,RAD51B,,TUMOR FREE,Alive,-25756,,70,7,39,PRAD,842,842,WHITE,0.0,[Not Available],[Not Applicable],40,R0,1,Matched,0.03,Prostate,Resection,4,4539a7c3-cca2-4ed0-9310-92cd843aa1cd,0,,0,0.036616,[Not Available],42b7d14f-09e5-4d91-bb98-5fe35907a6a9,3,Prostate Adenocarcinoma Acinar Type,1.8,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,2.4,TCGA-EJ-7328,0:DiseaseFree,3,13,Prostate Adenocarcinoma,27.66,4/5/12,842,,,,,NO,C61,30c9c833-ae7e-46de-951c-a488df1d723a,,1,TUMOR FREE,0.036,0:LIVING,,5,27.66,Bilateral,14,,,YES,,2011,,,TCGA-EJ-7328.30c9c833-ae7e-46de-951c-a488df1d723a.pdf,,[Not Applicable],NO,,71-80%,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.8,70,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,85355,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-A53L,Asian,LUSC,,0,0,,Asterand,0,0,MALE,0,1.75,0.43,18,17,18,,,377,,377,377,,0,0,377,377,,Malignant,53,,140,,,,19620,,,377,377,,,,377,377,,,377,,,,,,,,TUMOR FREE,Alive,-23065,,,,259,,377,377,,,[Not Available],[Not Applicable],,,,,0.26,,,,,11,,0,0.48102,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A53L,,,,,,,377,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,85364,,-0.015658335,,,,,,,,,,0.12804363,,-0.01761998,,,,Stage IIA,,-0.1915,,,,,,,,,,,,,,,,0.605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.89777829,14.40594354,13.92728247,-0.605635556028435,LUSC,Squamous Cell Carcinoma,17.87603491,15.52866176,Squamous Cell Carcinoma,0.2464,13.7314398,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-49-6742,White,LUAD,,1,,,Johns Hopkins,,1,MALE,1,3.61,0.49,3,2,4,,,488,,,488,,1,,214,214,,Malignant,9,,13,,,,21488,,,214,,,,,,488,,,214,,,,,,,,WITH TUMOR,Dead,-25839,488,,,364,,214,,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,1,0.068622,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6742,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2010,214,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,85365,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L268P,1,,,L268P,14.47771424,15.94131454,13.47401445,-0.704663899,LUAD,,17.8890364,13.61750443,Adenocarcinoma,,13.10424721,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,3.14,0.25,8,8,13,,,3461,BRCA_LumA,2011,3461,,1,1,2011,2011,,Invasive Carcinoma,29,,36,,,,23497,0,,2011,2011,,,,2011,3461,,,2011,,,,,,,,WITH TUMOR,Dead,-14778,3461,,,43,,2011,2011,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,23,,1,0.31727,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0WY,,,,,,,,Bone,Distant Metastasis,,,,,,,25,,,,,,,,,,,,,1996,2011,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,85366,,0.209187933,0,0,0,0,0.0502,1,,,Infiltrating Ductal Carcinoma,0.127520937,,0.192663163,0,0,0,,Negative,-0.0255,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5223,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,20522.0,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.22,0.88,9,13,12,,,725,BRCA_LumB,725,725,,0,0,725,725,,Invasive Carcinoma,34,,92,,,,33816,0,,725,725,,,,725,725,,,725,,,,,,,,TUMOR FREE,Alive,-23057,,,,74,,725,725,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,8,,0,0.28538,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A54Y,,,,,,,725,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,85367,,-1.150363284,0,0,0,0,1.0208,1,,,Infiltrating Lobular Carcinoma,0.056878838,,0.002242654,0,0,0,,Negative,-1.2305,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.759,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,,,White,BRCA,,0,0,,,,,FEMALE,2,1.96,0.89,8,11,9,,,2534,BRCA_LumB,,2534,,2,2,2534,2534,,Invasive Carcinoma,28,,33,,,,19096,0,,2534,2534,,,,,2534,,,2534,,,,,,,,,Dead,-29529,2534,,,60,,2534,2534,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,7,,0,0.17104,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A204,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1996,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,85375,,-1.711015663,0,0,0,0,-1.3608,1,,,Infiltrating Ductal Carcinoma,0.121446411,,0.180284598,0,0,0,,[Not Available],-1.512,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2571,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.56,16,35,19,,,533,BRCA_Basal,533,533,,0,0,533,533,,None,70,,56,,,,20740,N/A (Non-Malignant),,533,533,,,,533,533,,,533,,,,,,,,TUMOR FREE,Alive,-21575,,,,252,,533,533,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,4,,0,0.27277,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0T0,,,,,,,533,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,85376,TRUE,0.378316197,0,0,0,0,0.4978,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.180729163,N/A (Non-Malignant),0.090434656,0,0,0,N/A (Non-Malignant),Negative,-0.3105,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.2532,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-AA64,White,STAD,,1,1,,,,1,,1,1.87,0.59,20,26,21,,,560,,,560,,1,1,560,560,,Malignant,67,,164,,,,19892,,,560,560,,,,,560,,,560,,,,,,,,WITH TUMOR,Dead,-25109,560,,,358,,560,560,,,Stomach Cancer,[Not Applicable],,,,,0.15,Stomach,Unknown,,,3,,0,0.32032,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-AA64,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,[Unknown],,,,,,68,,,,,,,,,,,,,,,,,,,,85377,,-0.236583555,,,,,,,,,,0.065315702,Grade 2,0.124729023,,,,Stage IIIB,,-0.402,,,,,,,,,,,,,,,,0.6042,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA64,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,,,,,,,,821,,597,821,,1,1,597,597,,Invasive Carcinoma,,,,,,,17899,0,,597,597,,,,597,821,,,597,,,,,,,,WITH TUMOR,Dead,-28621,821,,,0,,597,597,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A2P5,,,,,,,,Bone,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2011,597,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,85378,,0.397184913,0,0,0,0,-0.1132,1,,,Infiltrating Lobular Carcinoma,0.113546852,,0.186503222,0,0,0,,Negative,-0.058,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.2657,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-7081,White,PRAD,161,0,0,,HC,,0,MALE,0,1.97,0.55,1,2,2,HRP,NO,1136,1-ERG,,1136,,0,0,1136,1136,prad_tcga,Malignant,5,,26,7.7,TCGA-HC-7081-01,0,5406,0,TCGA-HC-7081,1136,1136,Prostate Cancer,,,,1136,TCGA,,1136,Primary,0,,A,,,,WITH TUMOR,Alive,,,62,9,32,PRAD,1136,1136,WHITE,0.0,[Not Available],[Not Applicable],32,R2,1,Matched,0.0,Prostate,Resection,4,d4eaa3c5-a0f0-4cd7-8b93-73dfb09b359a,0,,0,0.02788,[Not Available],3da2e90e-6450-4286-8c74-08dbecbfd788,5,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.06666666667,TCGA-HC-7081,0:DiseaseFree,5,6,Prostate Adenocarcinoma,37.32,4/11/12,1136,,,,,,C61,75d1573a-cbf6-4b3c-93c4-2d410586884c,,0,WITH TUMOR,0.0265,0:LIVING,,,37.32,Bilateral,6,,,YES,,2010,,,TCGA-HC-7081.75d1573a-cbf6-4b3c-93c4-2d410586884c.pdf,,[Not Applicable],,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,,No,R2,0.8,62,Core needle biopsy,,,YES,NO,NO,,T3b,,9,No,,0,,,,,C61.9,8550/3,85380,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-93-A4JN,White,LUAD,,0,0,,Washington University - St. Louis,,0,MALE,0,2.59,0.37,11,6,6,,,718,,,718,,0,0,718,718,,Malignant,23,,70,,,,32595,,,718,718,,,,,718,,,718,,,,,,,,WITH TUMOR,Alive,-26273,,,,107,,718,718,,,[Not Available],[Not Applicable],,,,,0.3,,,,,22,,1,0.24677,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - St. Louis,,TCGA-93-A4JN,,,,,,,718,,,,,,,,,28,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,71,,,,,,,,,,,,,,,,,,,,85385,,1.025031056,,,,,,,,,,0.185690991,,0.163474053,,,,Stage IV,,1.2185,,,,,,,,,,,,,,,,0.5378,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.32313854,15.97017937,15.26134495,-0.293504387,LUAD,Adenocarcinoma,18.09096228,15.95689336,Adenocarcinoma,0.488,11.08094829,-0.868,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-G9-6371,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.04,0.28,1,0,1,HRP,NO,1226,3-ETV4,1226,1226,,0,0,1226,1226,prad_tcga,Malignant,2,,19,6.3,TCGA-G9-6371-01,0,5371,0,TCGA-G9-6371,1226,1226,Prostate Cancer,,846,1226,1226,TCGA,,1226,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-21365,,58,6,32,PRAD,1226,1226,WHITE,0.0,[Not Available],[Not Applicable],35,R1,1,Matched,0.03,Prostate,Resection,3,2f91086c-adcd-4a79-96aa-58819ab28a57,3,,0,0.014285,[Not Available],d5c43a14-21ab-4178-ae33-2d8b7baa256f,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.13333333333,TCGA-G9-6371,0:DiseaseFree,1,4,Prostate Adenocarcinoma,40.28,3/6/12,1226,,,,,NO,C61,26034718-f43a-491d-99fb-934d99ba4a6a,,2,TUMOR FREE,0.0138,0:LIVING,0.03,,40.28,Bilateral,5,,,YES,,2009,,,TCGA-G9-6371.26034718-f43a-491d-99fb-934d99ba4a6a.pdf,,[Not Applicable],NO,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.6,58,Core needle biopsy,,,NO,YES,NO,,T2c,,6,No,,0,,T1c,,M0,C61.9,8550/3,85386,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A47Y,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,2.0,0.92,1,0,1,,,373,,373,373,,0.0,0,373.0,373.0,,Malignant,2,,13,,,,33383.0,,,373.0,373,,,,373,373,,,373.0,,,,,,,,TUMOR FREE,Alive,-20432,,,,96.0,,373.0,373,,,[Not Available],[Not Applicable],,,,,0.01,,,,,0,,0,0.016625,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A47Y,,,,,,,373,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,55.0,,,,,,,,,,,,,,,,,,,,85389,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,1124,,1124,1124,,0,0,1124,1124,,Invasive Carcinoma,,,,,,,18788,0,,1124,1124,,,,1124,1124,,,1124,,,,,,,,TUMOR FREE,Alive,-16377,,,,118,,1124,1124,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A085,,,,,,,1124,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,85405,,-2.277492053,0,0,0,0,-0.211,1,,,Infiltrating Ductal Carcinoma,0.114068953,,0.194357558,0,0,0,,Negative,-2.331,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.1403,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-53-7813,White,LUAD,,0,0,,University of Miami,,0,FEMALE,0,3.5,0.36,5,10,9,,,424,,,424,,0,0,424,424,,Malignant,24,,14,,,,26934,,,424,424,,,,,424,,,424,,,,,,,,TUMOR FREE,Alive,-18875,,,,197,,424,424,,,[Not Available],[Not Applicable],,,,,0.28,,,,,16,,1,0.12568,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Miami,,TCGA-53-7813,,,,,,,424,,,,,,,,,24,,,,,,,,,,,,,2008,,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,51,,,,,,,,,,,,,,,,,,,,85407,,1.076578538,,,,,,,,,,0.142804901,,0.043439952,,,,Stage IIIB,,0.0015,,,,,,,,,,,,,,,,-0.3524,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,14.61179471,14.33116796,16.16652209,-0.246643429,LUAD,Adenocarcinoma,17.59975577,16.45929976,Adenocarcinoma,-0.3043,9.816705231,0.8696,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-GV-A40G,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.08,0.73,14,17,18,,,580,,580,580,,0.0,0,580.0,580.0,,Malignant,49,,104,,,,28434.0,,,580.0,580,,,,580,580,,,580.0,,,,,,,,TUMOR FREE,Alive,-28204,,,,214.0,,580.0,580,,,[Not Available],[Not Applicable],,,,,0.41,,,,,17,,1,0.28698,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A40G,,,,,,,580,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,85408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-56-8503,White,LUSC,,0,0,,International Genomics Consortium,,0,FEMALE,0,1.59,0.22,21,15,11,,,41,,,41,,0,0,41,41,,Malignant,47,,474,,,,20966,,,41,41,,,,,41,,,41,,,,,,,,TUMOR FREE,Alive,-28095,,,,219,,41,41,,,[Not Available],[Not Applicable],,,,,0.37,,,,,15,,0,0.48864,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8503,,,,,,,41,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Applicable],,,,,,76,,,,,,,,,,,,,,,,,,,,85413,,1.174447134,,,,,,,,,,0.268317049,,0.172189882,,,,Stage IIB,,1.1525,,,,,,,,,,,,,,,,1.0832,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.58731132,17.57042549,16.39812252,-0.0677185911707825,LUSC,,18.15955766,16.46467092,Squamous Cell Carcinoma,1.5047,14.4972985,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67Q,,PRAD,,0,0,,J4,0,0,MALE,0,1.96,0.29,1,1,1,HRP,NO,975,,975,975,,0,0,975,975,prad_tcga,Malignant,3,,13,,TCGA-J4-A67Q-01,5,5477,0,TCGA-J4-A67Q,975,975,Prostate Cancer,,616,975,975,TCGA,,975,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-28447,,77,6,23,PRAD,975,975,,0.197650139,[Not Available],[Not Applicable],25,,1,Matched,0.02,Prostate,Resection,3,DF184572-7ECF-4911-B4BB-4B7FDA3780D6,0,,0,0.03971,[Not Available],1CBAA137-C3B0-46A2-9B23-208682C2A438,3,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,J4,0.833333333333,TCGA-J4-A67Q,0:DiseaseFree,1,0,Prostate Adenocarcinoma,32.03,8/16/13,975,,,,,,C61,E7702E20-7616-4A88-862B-E860045E9C81,140,1,TUMOR FREE,0.0002,0:LIVING,0.1,,32.03,Bilateral,1,,,YES,584,2011,,,TCGA-J4-A67Q.E7702E20-7616-4A88-862B-E860045E9C81.pdf,Peripheral Zone,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,,77,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,6,No,NO,0,,T2b,,M0,C61.9,8140/3,85416,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-95-7562,Black or African American,LUAD,,0,0,,Washington University - Emory,,2,MALE,2,3.68,0.55,5,9,9,,,87,,,87,,2,2,87,87,,Malignant,23,,30,,,,28185,,,87,87,,,,,87,,,87,,,,,,,,TUMOR FREE,Dead,-26000,87,,,523,,87,87,,,[Not Available],[Not Applicable],,,,,0.34,,,,,23,,2,0.4141,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-7562,,,,,,,,,,,,,,,,57,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Evaluated],,,,,,71,,,,,,,,,,,,,,,,,,,,85422,,0.813991319,,,,,,,,,,0.210830576,,0.08415037,,,,Stage IIA,,0.804,,,,,,,,,,,,,,,,0.1931,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.01372977,16.20863693,16.44470078,-0.244869995,LUAD,Adenocarcinoma,17.5340458,14.97539763,Adenocarcinoma,-0.1868,12.50081773,-0.0172,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-VQ-A8PH,White,STAD,,1.0,1,,,,1,,1.0,3.11,0.52,7,7,17,,,389,,,389,,1.0,1,377,377,,Malignant,31,,253,,,,23150.0,0,,377,377,,,,,389,,,377,,,,,,,,WITH TUMOR,Dead,-22940,389,,,269.0,,377,377,,,[Not Available],[Not Applicable],,,,,0.14,Stomach,Resection,,,19,,1,0.44207,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8PH,,,,,,,,,Locoregional Recurrence,,,,,,,29,,,,,,,,,,,,,2010,377,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,62,,,,,,,,,,,,,,,,,,,,85424,,0.488835354,,,,,,,,,,-0.010941152,Grade 2,-0.003002307,,,,Stage IIIB,,-0.1665,,,,,,,,,,,,,,,,-0.2221,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PH,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,85426,,0.243008737,,,,,,,,,,0.134050697,,0.045478438,,,,Stage IIIA,,1.4845,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-94-A5I4,White,LUSC,,1,1,,Washington University - Emory,1,0,MALE,1,3.26,0.59,19,9,18,,,491,,314,491,,1,1,314,314,,Malignant,46,,168,,,,23317,,,314,314,,,,314,491,,,314,,,,,,,,WITH TUMOR,Alive,-22299,,,,337,,314,314,,,[Not Available],[Not Applicable],,,,,0.29,,,,,21,,1,0.52618,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Emory,,TCGA-94-A5I4,,,,,,,491,,Distant Metastasis,,,,,,,27,,,,,,,,,,,,,2012,314,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,85430,,0.18125187,,,,,,,,,,0.153556493,,-0.001016612,,,,Stage IIA,,-0.3265,,,,,,,,,,,,,,,,0.2688,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.46703891,15.11384816,13.4199326,-0.858131667378208,LUSC,Squamous Cell Carcinoma,18.03667726,14.9183097,Squamous Cell Carcinoma,-0.5796,13.93301965,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-E7-A4XJ,Asian,BLCA,,0.0,0,,,2,2,MALE,2.0,1.98,0.84,1,2,0,,,68,,68,68,,2.0,2,68.0,68.0,,Malignant,3,,13,,,,17323.0,,,68.0,68,,,,68,68,,,68.0,,,,,,,,TUMOR FREE,Dead,-24279,68,,,60.0,,68.0,68,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.029463,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A4XJ,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,66.0,,,,,,,,,,,,,,,,,,,,85434,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.56,0.81,12,15,27,,,931,BRCA_LumB,,931,,0,0,931,931,,Invasive Carcinoma,54,,104,,,,16153,0,,931,931,,,,,931,,,931,,,,,,,,TUMOR FREE,Alive,-21014,,,,113,,931,931,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,18,,1,0.25402,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0CJ,,,,,,,931,,,,,,,,,34,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,85435,,,0,0,0,0,-1.2839,0,,,Infiltrating Ductal Carcinoma,,,,0,0,1,,Positive,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Papilloma,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-D7-6815,White,STAD,,0,0,,,0,0,,0,1.93,0.82,5,8,6,,,486,,486,486,,0,0,486,486,,Malignant,19,,28,,,,22209,,,486,486,,,,486,486,,,486,,,,,,,,TUMOR FREE,Alive,-25811,,,,191,,486,486,,,[Not Available],[Not Applicable],,,,,0.54,Stomach,Unknown,,,4,,0,0.17411,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6815,,,,,,,486,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,85438,,0.051496221,,,,,,,,,,0.093613719,Grade 2,0.017292586,,,,Stage IIB,,0.1725,,,,,,,,,,,,,,,,0.3006,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6815,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,0,0,0,1,Female,TCGA-BR-8080,White,STAD,,0,0,,,2,2,,2,2.99,0.22,7,9,16,,,292,,292,292,,2,2,292,292,,Malignant,32,,28,,,,17108,,,292,292,,,,292,292,,,292,,,,,,,,TUMOR FREE,Dead,-26546,292,,,220,,292,292,,,[Not Available],[Not Applicable],,,,,0.46,Stomach,Unknown,,,17,,1,0.17879,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,Asterand,,TCGA-BR-8080,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,85439,,0.691850622,,,,,,,,,,0.136155766,Grade 3,0.209182122,,,,Stage IIIC,,0.5845,,,,,,,,,,,,,,,,0.5914,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8080,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3SL,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.69,0.42,13,15,16,,,712,,,712,,1.0,1,260.0,260.0,,Malignant,44,,55,,,,19566.0,,,260.0,260,,,,,712,,,260.0,,,,,,,,WITH TUMOR,Dead,-22020,712,,,316.0,,260.0,260,,,[Not Available],[Not Applicable],,,,,0.1,,,,,14,,1,0.25747,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SL,,,,,,,,Lung,Distant Metastasis,,,,,,,26,,,,,,,,,,,,,2011,260,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,60.0,,,,,,,,,,,,,,,,,,,,85443,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-49-AAR9,Black or African American,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,2.06,0.75,16,15,21,,,260,,,260,,1,1,260,260,,Malignant,52,,300,,,,18554,,,260,260,,,,,260,,,260,,,,,,,,WITH TUMOR,Dead,-22510,260,,,872,,260,260,,,[Not Available],[Not Applicable],,,,,0.07,,,,,9,,0,0.51019,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AAR9,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,1999,,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,85444,,0.329795718,,,,,,,,,,0.092660382,,0.050585772,,,,Stage IIB,,-0.1065,,,,,,,,,,,,,,,,0.2901,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),G332C,1,,,G332C,14.14467589,13.66679648,16.01004734,-0.460525609,LUAD,Adenocarcinoma,17.55213203,14.82921384,Adenocarcinoma,-0.1023,10.91695449,-0.4537,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-55-6979,White,LUAD,,1,1,,International Genomics Consortium,,1,FEMALE,1,1.73,0.33,3,4,4,,,237,,,237,,1,1,195,195,,Malignant,11,,20,,,,22765,,,195,195,,,,,237,,,195,,,,,,,,WITH TUMOR,Dead,-21780,237,,,158,,195,195,,,[Not Available],[Not Applicable],,,,,0.5,,,,,12,,0,0.37247,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6979,,,,,,,,,Distant Metastasis,,,,,,,10,,,,,,,,,,,,,2006,195,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,85461,,1.684209214,,,,,,,,,,0.286149976,,0.192724773,,,,Stage IIB,,2.571,,,,,,,,,,,,,,,,0.5298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.34187146,17.97446411,18.55391032,0.313470937,LUAD,Adenocarcinoma,17.99509605,16.90841746,Adenocarcinoma,0.8506,12.9072784,1.2835,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3SR,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.95,0.57,9,17,19,,,602,,,602,,1.0,1,372.0,372.0,,Malignant,45,,76,,,,33540.0,,,372.0,372,,,,,602,,,372.0,,,,,,,,WITH TUMOR,Dead,-24979,602,,,184.0,,372.0,372,,,[Not Available],[Not Applicable],,,,,0.17,,,,,12,,1,0.18475,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SR,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,42,,,,,,,,,,,,,2010,372,pelvis,,,Stage IV,,,,,,,,[Unknown],,,,,,68.0,,,,,,,,,,,,,,,,,,,,85464,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-FJ-A3Z7,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.43,0.54,8,17,23,,,945,,,945,,0.0,0,945.0,945.0,,Malignant,48,,91,,,,28910.0,,,945.0,945,,,,,945,,,945.0,,,,,,,,TUMOR FREE,Alive,-28052,,,,448.0,,945.0,945,,,[Not Available],[Not Applicable],,,,,0.21,,,,,10,,1,0.258,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3Z7,,,,,,,945,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,85468,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.54,0.56,5,4,12,,,10,BRCA_LumA,10,10,,0,0,10,10,,Invasive Carcinoma,21,,39,,,,27090,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-25658,,,,59,,10,10,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,22,,1,0.14512,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0AS,,,,,,,10,,,,,,,,,25,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,85473,,-0.458125459,0,0,0,0,0.338,1,,,Infiltrating Ductal Carcinoma,0.222431534,,0.110618224,0,0,0,,Negative,-1.0645,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6386,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,1,0,FFPE,,0,1,0,No,0,"Adipose Tissue, Skeletal Muscle",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-CD-5801,Asian,STAD,,1,1,,,,1,,1,3.53,0.31,1,3,3,,,401,,,401,,1,1,401,401,,Malignant,7,,3,,,,26443,,,401,401,,,,,401,,,401,,,,,,,,WITH TUMOR,Dead,,401,,,508,,401,401,,,[Not Available],[Not Applicable],,,,,0.09,Stomach,Unknown,,,24,,1,0.060769,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-5801,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,85479,,1.281800647,,,,,,,,,,0.080824126,Grade 3,0.017817786,,,,Stage IIIA,,1.2085,,,,,,,,,,,,,,,,0.0434,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-5801,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,1,1,Male,TCGA-NK-A5CT,White,LUSC,,1,1,,Washington University - Rush University,,0,MALE,1,1.68,0.5,8,2,7,,,1997,,,1997,,1,1,1990,1990,,Malignant,17,,88,,,,33062,,,1990,1990,,,,,1997,,,1990,,,,,,,,WITH TUMOR,Alive,-25726,,,,435,,1990,1990,,,[Not Available],[Not Applicable],,,,,0.04,,,,,14,,0,0.40724,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Rush University,,TCGA-NK-A5CT,,,,,,,1997,,Locoregional Recurrence,,,,,,,14,,,,,,,,,,,,,2008,1990,,,,Stage IA,,,,,,,,Stable Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,85480,,0.336833696,,,,,,,,,,0.104511754,,-0.003361018,,,,Stage IA,,0.7825,,,,,,,,,,,,,,,,0.3214,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.597008614602841,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.511,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Female,TCGA-68-A59I,Black or African American,LUSC,,0,0,,Washington University - Cleveland Clinic,,0,FEMALE,1,,,,,,,,492,,,492,,0,0,159,159,,Malignant,,,,,,,23432,,,492,492,,,,,492,,,159,,,,,,,,WITH TUMOR,Alive,-26839,,,,0,,492,492,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-68-A59I,,,,,,,492,,New Primary Tumor,,,,,,,,,,,,,,,,,,,,2012,159,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,85487,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.7939,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.33519879,15.71219505,15.38252527,-0.343068095109741,LUSC,Squamous Cell Carcinoma,18.22246966,16.40396621,Squamous Cell Carcinoma,0.4302,13.88862481,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-2F-A9KW,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,3.56,0.58,13,16,19,,,254,,,254,,1.0,1,85.0,85.0,,Malignant,48,,135,,,,20652.0,,,85.0,85,,,,,254,,,85.0,,,,,,,,WITH TUMOR,Dead,-24703,254,,,156.0,,85.0,85,,,[Not Available],[Not Applicable],,,,,0.13,,,,,7,,1,0.20122,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KW,,,,,,,,Bone,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2013,85,,,,Stage III,,,,,,,,Stable Disease,,,,,,67.0,,,,,,,,,,,,,,,,,,,,85490,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-FD-A3B6,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.21,0.42,6,16,10,,,1005,,1005,1005,,2.0,2,1005.0,1005.0,,Malignant,32,,32,,,,23769.0,,,1005.0,1005,,,,1005,1005,,,1005.0,,,,,,,,TUMOR FREE,Dead,-27541,1005,,,350.0,,1005.0,1005,,,[Not Available],[Not Applicable],,,,,0.26,,,,,14,,1,0.1449,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3B6,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,85491,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-AAME,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.29,0.14,2,7,7,,,2828,,,2828,,1.0,1,1651.0,1651.0,,Malignant,16,,7,,,,26219.0,,,1651.0,1651,,,,,2828,,,1651.0,,,,,,,,WITH TUMOR,Dead,-23448,2828,,,20.0,,1651.0,1651,,,[Not Available],[Not Applicable],,,,,0.38,,,,,5,,0,0.035307,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAME,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,11,,,,,,,,,,,,,2006,1651,Vagina,,,Stage II,,,,,,,,Progressive Disease,,,,,,64.0,,,,,,,,,,,,,,,,,,,,85492,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-85-8481,White,LUSC,,0,0,,Asterand,,2,MALE,2,1.95,0.29,17,9,15,,,236,,,236,,2,2,236,236,,Malignant,41,,102,,,,31170,,,236,236,,,,,236,,,236,,,,,,,,TUMOR FREE,Dead,-25782,236,,,415,,236,236,,,[Not Available],[Not Applicable],,,,,0.5,,,,,12,,0,0.39577,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8481,,,,,,,,,,,,,,,,22,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Partial Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,85509,,0.300274498,,,,,,,,,,0.22666954,,0.000794883,,,,Stage IIB,,0.5615,,,,,,,,,,,,,,,,1.1645,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.16770924,17.18210514,15.98262624,-0.324429821972919,LUSC,Squamous Cell Carcinoma,17.93106423,15.67713548,Squamous Cell Carcinoma,1.2762,14.22031458,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Male,TCGA-HC-7738,White,PRAD,,1,1,,HC,,0,MALE,1,3.94,0.42,2,4,0,HRD,NO,964,,,964,,1,1,420,420,prad_tcga,Malignant,6,,10,,TCGA-HC-7738-01,0,5418,0,TCGA-HC-7738,420,420,Prostate Cancer,,,,964,TCGA,,420,Primary,0,Apex,A,,BRCA2,,WITH TUMOR,Alive,-21195,,58,7,41,PRAD,420,420,WHITE,0.0,[Not Available],[Not Applicable],57,,1,Matched,0.0,Prostate,Resection,3,f1e56f45-2d59-4975-adff-0bf6998b1958,0,,1,0.028957,[Not Available],698ce9a9-6512-4fb8-a574-a26ee259414c,4,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,6,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,3.26666666667,TCGA-HC-7738,1:Recurred/Progressed,2,32,Prostate Adenocarcinoma,13.8,3/29/12,964,"Other, specify",Biochemical evidence of disease,,,,C61,374827be-3cc2-4da8-a815-40539e441ccd,,2,TUMOR FREE,0.0275,0:LIVING,,,31.67,Bilateral,33,,,YES,,2011,420,biochemical recurrence only,TCGA-HC-7738.374827be-3cc2-4da8-a815-40539e441ccd.pdf,,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,,No,R0,0.3,58,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,,,M0,C61.9,8550/3,85510,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,85513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.53,4,2,4,,,409,BRCA_LumA,409,409,,0,0,409,409,,Invasive Carcinoma,10,,27,,,,30596,0,,409,409,,,,409,409,,,409,,,,,,,,TUMOR FREE,Alive,-27521,,,,1191,,409,409,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.067225,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27G,,,,,,,409,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,85516,,0.94315238,0,0,0,0,-0.684,0,,,Infiltrating Lobular Carcinoma,0.161297129,,0.164680618,0,0,0,,Negative,0.3805,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.5195,1,0,H & E,0,0,,0,Ioana Tolocica,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Columnar Lesion,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-35-4122,White,LUAD,,0,0,,Cureline,,0,MALE,0,3.17,0.21,9,14,12,,,225,,,225,,0,0,225,225,,Malignant,35,,29,,,,19413,,,225,225,,,,,225,,,225,,,,,,,,TUMOR FREE,Alive,-25491,,,,417,,225,225,,,[Not Available],[Not Applicable],,,,,0.37,,,,,19,,1,0.25821,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Cureline,,TCGA-35-4122,,,,,,,225,,,,,,,,,26,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Unknown],,,,,,69,,,,,,,,,,,,,,,,,,,,85532,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.35895541,LUAD,,,,Adenocarcinoma,1.1319,,1.2502,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-DK-A2I6,White,BLCA,,0.0,0,,,,0,MALE,0.0,5.13,0.54,10,22,22,,,2656,,,2656,,0.0,0,2656.0,2656.0,,Malignant,54,,50,,,,27130.0,,,2656.0,2656,,,,,2656,,,2656.0,,,,,,,,TUMOR FREE,Alive,-29789,,,,391.0,,2656.0,2656,,,[Not Available],[Not Applicable],,,,,0.22,,,,,17,,2,0.23183,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A2I6,,,,,,,2656,,,,,,,,,62,,,,,,,,,,,,,2005,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,81.0,,,,,,,,,,,,,,,,,,,,85535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.75,0.56,19,26,23,,,1820,BRCA_Basal,1820,1820,,0,0,1820,1820,,Invasive Carcinoma,68,,59,,,,17043,0,,1820,1820,,,,1820,1820,,,1820,,,,,,,,TUMOR FREE,Alive,-19314,,,,101,,1820,1820,,,[Not Available],[Not Applicable],,,,,0.32,Breast,Resection/Excision,,,12,,0,0.51515,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0AV,,,,,,,1820,,,,,,,,,19,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,85540,,-0.061457063,0,0,0,0,0.0255,1,,,Infiltrating Ductal Carcinoma,0.196208128,,0.178855733,0,0,0,,Negative,-0.605,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.8207,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-CD-8530,Asian,STAD,,0,0,,,0,0,,0,5.33,0.19,10,19,22,,,377,,377,377,,0,0,377,377,,Malignant,51,,127,,,,27062,,,377,377,,,,377,377,,,377,,,,,,,,TUMOR FREE,Alive,-18992,,,,120,,377,377,,,[Not Available],[Not Applicable],,,,,0.25,Stomach,Unknown,,,21,,2,0.44588,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8530,,,,,,,377,,,,,,,,,47,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,85544,,-0.034996272,,,,,,,,,,0.121797919,Grade 3,0.249404381,,,,Stage II,,-0.0995,,,,,,,,,,,,,,,,0.7318,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8530,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1.0,,1,1.0,1.0,Male,TCGA-R6-A8W5,White,ESCA,,1.0,1,,,,1,,1.0,1.83,0.5,9,9,13,,,480,,,480,,1.0,1,336,336,,Malignant,31,,450,,,,0.0,0,,336,336,,,,,480,,,336,,,,,,,,WITH TUMOR,Dead,-21917,480,,,185.0,,336,336,,,[Not Available],[Not Available],,,,,0.76,Esophagus,Biopsy,,,6,,0,0.21997,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,MD Anderson Cancer Center,,TCGA-R6-A8W5,,,,,,,,Liver,Distant Metastasis,,,,,,,5,,,,,,,,,,,,,2004,336,,,,Stage IVA,,,,,,,,,,,,,,60,,,,,,,,,,,,,,,,,,,,85546,,,,,,,,,,,,,Grade 2,,,,,Stage IVA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3B5,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,5.58,0.52,5,22,20,,,272,,,272,,1.0,1,272.0,272.0,,Malignant,47,,40,,,,21642.0,,,272.0,272,,,,,272,,,272.0,,,,,,,,WITH TUMOR,Dead,-31442,272,,,196.0,,272.0,272,,,[Not Available],[Not Applicable],,,,,0.44,,,,,13,,2,0.17514,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3B5,,,,,,,,,,,,,,,,51,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,86.0,,,,,,,,,,,,,,,,,,,,85552,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VP-A872,,PRAD,357,0,0,,VP,0,0,MALE,0,1.91,0.6,5,6,4,ambiguous,NO,3631,1-ERG,3631,3631,,0,0,3631,3631,prad_tcga,Malignant,15,CHEK2,51,,TCGA-VP-A872-01,0,5588,0,TCGA-VP-A872,3631,3631,Prostate Cancer,,3253,3631,3631,TCGA,,3631,Primary,0,Apex|Base,A,,,True,TUMOR FREE,Alive,-22098,,60,8,34,PRAD,3631,3631,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.36,Prostate,Resection,5,8D739C95-CEB7-4411-ACD5-E9CBFC238023,4,Normal (no evidence of prostate cancer) [cM0],0,0.11486,[Not Available],7FC65E49-0401-4A36-8800-FD87B7927FC1,3,"Prostate Adenocarcinoma, Other Subtype",,Prostate,14,,Adenocarcinoma,[Not Available],,VP,0.966666666667,TCGA-VP-A872,0:DiseaseFree,4,17,Prostate Adenocarcinoma,119.28,3/26/14,3631,,,,,NO,C61,3B27B1E2-C41E-4D31-83F5-78882BDBB284,50,4,TUMOR FREE,0.1414,0:LIVING,0.01,4,119.28,Bilateral,19,No Evidence of Extraprostatic Extension,,YES,3164,2005,,,TCGA-VP-A872.3B27B1E2-C41E-4D31-83F5-78882BDBB284.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,8,66-75%,12,"Prostate Adenocarcinoma, Other Subtype",1,2005,Complete Remission/Response,mixed ductal and acinar,NO,No,R0,,60,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,8,No,NO,0,N0,T2,0,M0,C61.9,8500/3,85559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,Black or African American,BRCA,,1,1,,,,1,MALE,1,,,,,,,,348,,,348,,1,1,348,348,,Invasive Carcinoma,,,,,,,21925,0,,348,348,,,,,348,,,348,,,,,,,,WITH TUMOR,Dead,-21389,348,,,125,,348,348,,,[Not Available],[Not Applicable],,,,,,Breast,Core Biopsy,,,,,,,[Not Evaluated],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A62V,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,85561,,-1.238288496,0,0,0,0,-0.1959,1,,,Infiltrating Ductal Carcinoma,0.125756731,,0.118568258,0,0,0,,Negative,-2.1825,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.1582,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-7707,White,STAD,,0,0,,,0,0,,0,2.1,0.57,1,1,1,,,1090,,1090,1090,,0,0,1090,1090,,Malignant,3,,5,,,,17682,,,1090,1090,,,,1090,1090,,,1090,,,,,,,,TUMOR FREE,Alive,-25325,,,,1810,,1090,1090,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,4,,0,0.019661,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-7707,,,,,,,1090,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,85565,,0.479588509,,,,,,,,,,0.053784925,Grade 3,0.041481834,,,,Stage IB,,1.3135,,,,,,,,,,,,,,,,0.1201,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7707,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,,1,1,Male,TCGA-96-7545,White,LUSC,,1,1,,Washington University - NYU,,,MALE,1,1.78,0.4,12,7,16,,,1736,,,1736,,1,1,1693,1693,,Malignant,35,,28,,,,29155,,,1693,1693,,,,,1736,,,1693,,,,,,,,,Dead,-26729,1736,,,162,,1693,1693,,,[Not Available],[Not Applicable],,,,,0.21,,,,,9,,0,0.43425,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - NYU,,TCGA-96-7545,,,,,,,,,Locoregional Recurrence,,,,,,,14,,,,,,,,,,,,,2008,1693,,,,Stage IA,,,,,,,,Progressive Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,85578,,0.921097036,,,,,,,,,,0.255158825,,0.225294698,,,,Stage IA,,0.951,,,,,,,,,,,,,,,,0.4234,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.236265055249941,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1551,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-MF-A522,White,LUSC,,1,1,,University of Minnesota,,1,MALE,1,5.45,0.64,9,9,25,,,360,,,360,,1,1,173,173,,Malignant,43,,99,,,,24021,,,173,173,,,,,360,,,173,,,,,,,,WITH TUMOR,Dead,-20051,360,,,769,,173,173,,,[Not Available],[Not Applicable],,,,,0.18,,,,,26,,2,0.26651,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Minnesota,,TCGA-MF-A522,,,,,,,,,Distant Metastasis,,,,,,,54,,,,,,,,,,,,,2012,173,,,,Stage IB,,,,,,,,Partial Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,85582,,0.394176275,,,,,,,,,,0.107611959,,-0.073891684,,,,Stage IB,,0.492,,,,,,,,,,,,,,,,-0.0668,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),F220L,1,,,F220L,,,,-0.747358421605708,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.4405,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-BR-8680,Asian,STAD,,0.0,0,,,,0,,0.0,2.0,0.68,5,2,7,,,972,,,972,,0.0,0,972,972,,Malignant,14,,32,,,,20554.0,0,,972,972,,,,,972,,,972,,,,,,,,TUMOR FREE,Alive,-16637,,,,8158.0,,972,972,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Resection,,,2,,0,0.064543,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8680,,,,,,,972,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,45,,,,,,,,,,,,,,,,,,,,85583,,-0.733718415,,,,,,,,,,0.000654309,Grade 2,-0.084319591,,,,Stage IV,,-1.2885,,,,,,,,,,,,,,,,-0.119,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8680,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,242,,242,242,,0,0,242,242,,Invasive Carcinoma,,,,,,,27894,0,,242,242,,,,242,242,,,242,,,,,,,,TUMOR FREE,Alive,-28198,,,,73,,242,242,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SM,,,,,,,242,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,85585,,-0.802403733,0,0,0,0,1.1676,1,,,Infiltrating Ductal Carcinoma,0.184905643,,0.158230334,0,0,0,,Negative,-0.665,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6972,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-BR-6458,White,STAD,,1,1,,,1,1,,1,3.03,0.45,11,23,19,,,588,,574,588,,1,1,574,574,,Malignant,53,,55,,,,18547,,,574,574,,,,574,588,,,574,,,,,,,,WITH TUMOR,Dead,-21069,588,,,397,,574,574,,,[Not Available],[Not Applicable],,,,,0.16,Stomach,Unknown,,,10,,1,0.36983,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6458,,,,,,,,Liver,Distant Metastasis,,,,,,,36,,,,,,,,,,,,,2011,574,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,85586,,1.103158427,,,,,,,,,,0.136422298,Grade 3,0.118608755,,,,Stage IIB,,1.1165,,,,,,,,,,,,,,,,0.4094,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6458,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1.0,,1,1.0,1.0,Male,TCGA-2H-A9GL,Unknown,ESCA,,1.0,1,,,,1,,1.0,2.83,0.75,8,14,22,,,180,,,180,,1.0,1,109,109,,Malignant,44,,139,,,,21160.0,0,,109,109,,,,,180,,,109,,,,,,,,WITH TUMOR,Dead,-27115,180,,,363.0,,109,109,,,[Not Available],[Not Available],,,,,0.33,Esophagus,Resection,,,13,,1,0.34828,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Erasmus MC,,TCGA-2H-A9GL,,,,,,,,,Distant Metastasis,,,,,,,39,,,,,,,,,,,,,2000,109,,,,Stage III,,,,,,,,,,,,,,74,,,,,,,,,,,,,,,,,,,,85588,,,,,,,,,,,,,Grade 3,,,,,Stage III,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.59,4,3,6,,,1449,BRCA_LumA,1449,1449,,0,0,1449,1449,,Invasive Carcinoma,13,,11,,,,24579,0,,1449,1449,,,,1449,1449,,,1449,,,,,,,,TUMOR FREE,Alive,-15942,,,,27,,1449,1449,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,6,,0,0.074057,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mixed Histology (please specify),,,,,,[Not Available],,Asterand,,TCGA-E9-A1RI,,,,,,,1449,,,,,,,,,5,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,85595,,0.14524666,0,0,0,0,0.0026,1,,,Mixed Histology (NOS),0.176889028,,0.156690498,0,0,0,,Negative,-0.668,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5104,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.6,3,1,4,,,1876,BRCA_LumA,1876,1876,,0,0,1876,1876,,Invasive Carcinoma,8,,5,,,,19648,0,,1876,1876,,,,1876,1876,,,1876,,,,,,,,TUMOR FREE,Alive,-20049,,,,84,,1876,1876,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,4,,0,0.063337,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BM,,,,,,,1876,,,,,,,,,4,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,85596,,-0.19455875,0,0,0,1,1.7411,0,,,Infiltrating Ductal Carcinoma,0.147196584,,0.225471871,0,0,0,,Negative,-0.6725,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2428,1,0,H & E,0,0,,0,Chunhui Yi,"Microglandular Adenosis, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,1,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"Microglandular Adenosis, UDH",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-HU-A4GP,Asian,STAD,,0,0,,,0,0,,0,1.95,0.78,9,11,8,,,273,,273,273,,0,0,273,273,,Malignant,28,,137,,,,26036,,,273,273,,,,273,273,,,273,,,,,,,,TUMOR FREE,Alive,-22711,,,,272,,273,273,,,[Not Available],[Not Applicable],,,,,0.49,Stomach,Unknown,,,6,,0,0.18534,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4GP,,,,,,,273,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,85600,,-0.349147116,,,,,,,,,,0.061341473,Grade 2,0.13190653,,,,Stage IIA,,-0.792,,,,,,,,,,,,,,,,0.0056,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GP,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,1,1,,,White,BRCA,,0,0,,,0,0,FEMALE,1,,,,,,,,899,,899,899,,0,0,795,795,,Invasive Carcinoma,,,,,,,22311,0,,899,899,,,,899,899,,,795,,,,,,,,TUMOR FREE,Alive,-22643,,,,0,,899,899,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A13H,,,,,,,899,"Other, specify",New Primary Tumor,,,,,,,,,,,,,,,,,,,,2010,795,Skin lesion-Basal Cell Left Lower Lateral Back,,,Stage IIB,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,85603,,,0,0,0,0,0.7906,1,,,Infiltrating Lobular Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,0,No,0,Adipose Tissue,No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,Black or African American,BRCA,,0,0,,,2,2,FEMALE,2,3.05,0.55,3,1,9,,,1439,BRCA_Basal,1439,1439,,2,2,1439,1439,,Invasive Carcinoma,13,,100,,,,19159,0,,1439,1439,,,,1439,1439,,,1439,,,,,,,,TUMOR FREE,Dead,-17981,1439,,,72,,1439,1439,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,19,,1,0.2817,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3XX,,,,,,,,,,,,,,,,37,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,85604,TRUE,0.670978796,0,0,0,0,1.5037,1,,,Infiltrating Ductal Carcinoma,0.127401638,,0.101911514,0,0,0,,Negative,-0.081,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.2898,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,78,,78,78,,0,0,78,78,,Invasive Carcinoma,,,,,,,22900,0,,78,78,,,,78,78,,,78,,,,,,,,TUMOR FREE,Alive,-18741,,,,0,,78,78,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UNC ,,TCGA-AQ-A54N,,,,,,,78,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,85607,,-0.261651146,0,0,0,0,0.0061,1,,,Infiltrating Ductal Carcinoma,0.076250644,,-0.05771028,0,0,0,,Negative,-1.349,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.7422,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-XF-AAN2,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.61,0.6,8,9,10,,,1869,,1869,1869,,2.0,2,1869.0,1869.0,,Malignant,27,,37,,,,26302.0,,,1869.0,1869,,,,1869,1869,,,1869.0,,,,,,,,TUMOR FREE,Dead,-26720,1869,,,647.0,,1869.0,1869,,,[Not Available],[Not Applicable],,,,,0.17,,,,,8,,1,0.1043,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAN2,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,85609,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-YC-A8S6,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.01,0.23,1,2,0,,,293,,293,293,,0.0,0,293.0,293.0,,Malignant,3,,10,,,,17910.0,,,293.0,293,,,,293,293,,,293.0,,,,,,,,TUMOR FREE,Alive,-26130,,,,135.0,,293.0,293,,,[Not Available],[Not Applicable],,,,,0.02,,,,,2,,0,0.010537,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Spectrum Health,,TCGA-YC-A8S6,,,,,,,293,,,,,,,,,1,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,71.0,,,,,,,,,,,,,,,,,,,,85613,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,,1,1,Female,TCGA-49-4506,White,LUAD,,1,1,,Johns Hopkins,1,,FEMALE,1,2.67,0.25,4,1,4,,,999,,692,999,,1,1,692,692,,Malignant,9,,15,,,,20949,,,692,692,,,,692,999,,,692,,,,,,,,[Discrepancy],Dead,-25132,999,,,149,,692,692,,,[Not Available],[Not Applicable],,,,,0.02,,,,,16,,1,0.32656,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4506,,,,,,,,,Locoregional Recurrence,,,,,,,27,,,,,,,,,,,,,1997,692,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,85619,,0.822722918,,,,,,,,,,0.193750493,,0.108967648,,,,Stage IIB,,0.9865,,,,,,,,,,,,,,,,-0.2181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13D (driver),M503K,1,,G13D (driver),M503K,15.95123481,16.55036123,16.82054215,0.016190116,LUAD,Adenocarcinoma,17.88942384,16.49569218,Adenocarcinoma,-0.3096,13.24541738,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-BR-8677,White,STAD,,0,0,,,0,0,,0,1.9,0.26,6,6,7,,,813,,813,813,,0,0,813,813,,Malignant,19,,55,,,,23082,,,813,813,,,,813,813,,,813,,,,,,,,TUMOR FREE,Alive,-27223,,,,234,,813,813,,,[Not Available],[Not Applicable],,,,,0.31,Stomach,Unknown,,,3,,0,0.17493,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8677,,,,,,,813,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,85620,,1.088144772,,,,,,,,,,0.10218823,Grade 3,0.227455116,,,,Stage IIIB,,1.3065,,,,,,,,,,,,,,,,0.3705,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8677,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,0,0,0.0,0.0,Female,TCGA-ZF-A9R7,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.92,0.49,4,5,9,,,665,,665,665,,0.0,0,665.0,665.0,,Malignant,18,,82,,,,16576.0,,,665.0,665,,,,665,665,,,665.0,,,,,,,,TUMOR FREE,Alive,-28063,,,,968.0,,665.0,665,,,[Not Available],[Not Applicable],,,,,0.13,,,,,11,,1,0.17062,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9R7,,,,,,,665,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,85628,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.84,0.55,9,34,31,,,1085,BRCA_Basal,1085,1085,,0,0,1085,1085,,Invasive Carcinoma,74,,85,,,,25618,0,,1085,1085,,,,1085,1085,,,1085,,,,,,,,TUMOR FREE,Alive,-22708,,,,212,,1085,1085,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,15,,1,0.5002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0DA,,,,,,,1085,,,,,,,,,38,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,85633,TRUE,-0.831669083,0,0,0,0,-0.6584,1,,,Infiltrating Ductal Carcinoma,0.154272664,,0.091690528,0,0,0,,Negative,-1.415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5184,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-56-8201,White,LUSC,,1,1,,International Genomics Consortium,,1,MALE,1,3.23,0.22,8,2,12,,,397,,,397,,1,1,397,397,,Malignant,22,,27,,,,17896,,,397,397,,,,,397,,,397,,,,,,,,WITH TUMOR,Dead,-27211,397,,,232,,397,397,,,[Not Available],[Not Applicable],,,,,0.08,,,,,20,,1,0.45861,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8201,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Unknown],,,,,,74,,,,,,,,,,,,,,,,,,,,85635,,1.472399012,,,,,,,,,,0.23140984,,0.142934339,,,,Stage IIB,,2.205,,,,,,,,,,,,,,,,0.7588,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.60030227,18.27883167,17.98241019,0.180068282556759,LUSC,,18.34904759,16.86428147,Squamous Cell Carcinoma,1.2325,14.71669505,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BT-A20N,,BLCA,,1.0,1,,,,1,MALE,1.0,1.61,0.72,22,21,20,,,795,,,795,,1.0,1,795.0,795.0,,Malignant,63,,81,,,,27030.0,,,795.0,795,,,,,795,,,795.0,,,,,,,,WITH TUMOR,Dead,-26456,795,,,374.0,,795.0,795,,,[Not Available],[Not Applicable],,,,,0.64,,,,,12,,0,0.56989,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20N,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2003,,,,,Stage III,,,,,,,,Progressive Disease,,,,,,72.0,,,,,,,,,,,,,,,,,,,,85636,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Female,TCGA-MP-A4T4,White,LUAD,,0,0,,Washington University - Mayo Clinic,2,,FEMALE,2,,,,,,,,2617,,2617,2617,,2,2,2617,2617,,Malignant,,,,,,,20601,,,2617,2617,,,,2617,2617,,,2617,,,,,,,,,Dead,-25052,2617,,,498,,2617,2617,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4T4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,85637,,1.778573239,,,,,,,,,,0.258299412,,0.121863799,,,,Stage IIB,,2.6575,,,,,,,,,,,,,,,,0.4811,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,16.78866658,17.45364419,18.46206379,0.315209063,LUAD,Adenocarcinoma,18.20954077,17.14643731,Adenocarcinoma,0.8357,11.00344226,1.5268,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A9FH,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.98,0.95,2,0,2,,,0,,0,0,,0.0,0,0.0,0.0,,Malignant,4,,39,,,,31166.0,,,0.0,0,,,,0,0,,,0.0,,,,,,,,TUMOR FREE,Alive,-31236,,,,47.0,,0.0,0,,,[Not Available],[Not Applicable],,,,,0.02,,,,,4,,0,0.14445,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A9FH,,,,,,,-64,,,,,,,,,7,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,85.0,,,,,,,,,,,,,,,,,,,,85640,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-63-A5ML,Unknown,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,2.75,0.71,13,12,15,,,1386,,1386,1386,,0,0,1386,1386,,Malignant,40,,103,,,,21934,,,1386,1386,,,,1386,1386,,,1386,,,,,,,,TUMOR FREE,Alive,-24947,,,,330,,1386,1386,,,[Not Available],[Not Applicable],,,,,0.51,,,,,18,,1,0.42837,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5ML,,,,,,,1386,,,,,,,,,33,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,85647,,0.621672262,,,,,,,,,,0.15635938,,0.031802082,,,,Stage IB,,1.8455,,,,,,,,,,,,,,,,0.26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.393717980563304,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.5562,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-39-5019,White,LUSC,,1,,,MSKCC,1,0,MALE,1,1.31,0.55,8,6,9,,,3387,,378,3387,,1,,378,378,,Malignant,23,,62,,,,18795,,,378,,,,,378,3387,,,378,,,,,,,,TUMOR FREE,Alive,-25756,,,,234,,378,,,,[Not Available],[Not Applicable],,,,,0.52,,,,,9,,0,0.83516,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5019,,,,,,,3387,,,,,,,,,22,,,,,,,,,,,,,2004,378,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,85649,,1.050147742,,,,,,,,,,0.225564708,,0.08051911,,,,Stage IB,,1.1965,,,,,,,,,,,,,,,,0.6817,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.265887186984372,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4667,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-22-A5C4,White,LUSC,,0,0,,Mayo Clinic - Rochester,0,0,MALE,0,2.84,0.68,21,16,17,,,671,,671,671,,0,0,671,671,,Malignant,54,,116,,,,27572,,,671,671,,,,671,671,,,671,,,,,,,,TUMOR FREE,Alive,-25629,,,,474,,671,671,,,[Not Available],[Not Applicable],,,,,0.64,,,,,15,,1,0.59551,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-A5C4,,,,,,,671,,,,,,,,,36,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,85653,,0.28246438,,,,,,,,,,0.144252517,,0.044432335,,,,Stage IIA,,-0.0775,,,,,,,,,,,,,,,,0.3048,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.75267475,16.04465055,15.01697351,-0.497973257871885,LUSC,,17.83703756,15.18102642,Squamous Cell Carcinoma,-1.4598,14.19724666,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,0,1,Male,TCGA-78-7154,White,LUAD,,0,0,,Prince Charles Hospital,,,MALE,2,3.82,0.5,13,15,21,,,593,,,593,,2,2,593,593,,Malignant,49,,91,,,,19195,,,593,593,,,,,593,,,593,,,,,,,,,Dead,-26481,593,,,348,,593,593,,,[Not Available],[Not Applicable],,,,,0.14,,,,,19,,2,0.46913,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7154,,,,,,,,,,,,,,,,65,,,,,,,,,,,,,2003,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,85656,,0.46408304,,,,,,,,,,0.175070107,,0.163252976,,,,Stage IIIA,,0.159,,,,,,,,,,,,,,,,0.0914,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,W252C,1,,,W252C,14.99244664,15.53100507,14.72484065,-0.512950698,LUAD,Adenocarcinoma,17.7274969,15.14574896,Adenocarcinoma,-0.2653,11.70899221,-0.4608,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.21,0.47,3,1,5,,,78,BRCA_LumA,78,78,,0,0,78,78,,Invasive Carcinoma,9,,5,,,,17190,0,,78,78,,,,78,78,,,78,,,,,,,,TUMOR FREE,Alive,-25693,,,,32,,78,78,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,20,,1,0.060426,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1R3,,,,,,,78,,,,,,,,,21,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,85659,,-0.152029561,0,0,0,0,0.5794,1,,,Infiltrating Ductal Carcinoma,0.200059308,,0.130588286,0,0,0,,Negative,-0.7665,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6757,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-52-7812,White,LUSC,,1,1,,University of Miami,,1,MALE,1,1.89,0.56,12,11,13,,,835,,,835,,1,1,791,791,,Malignant,36,,41,,,,23345,,,791,791,,,,,835,,,791,,,,,,,,WITH TUMOR,Dead,-24887,835,,,387,,791,791,,,[Not Available],[Not Applicable],,,,,0.06,,,,,5,,0,0.26904,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Miami,,TCGA-52-7812,,,,,,,,,Distant Metastasis,,,,,,,12,,,,,,,,,,,,,2009,791,,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,68,,,,,,,,,,,,,,,,,,,,85661,,1.002052602,,,,,,,,,,0.221774294,,0.055299048,,,,Unknown,,2.241,,,,,,,,,,,,,,,,-0.0088,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,,,,0.0242112409017617,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.0253,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,1.72,0.76,12,20,16,,,285,BRCA_Basal,,285,,0,0,285,285,,Invasive Carcinoma,48,,174,,,,17884,0,,285,285,,,,,285,,,285,,,,,,,,TUMOR FREE,Alive,-17539,,,,111,,285,285,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,10,,0,0.39553,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A6VW,,,,,,,285,,,,,,,,,14,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,85665,TRUE,-0.99496893,0,0,0,0,1.0389,1,,,Infiltrating Ductal Carcinoma,0.195754759,,0.037524626,0,0,0,,Close,-0.474,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2402,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-BR-8592,White,STAD,,0,0,,,2,2,,2,2.0,0.17,2,1,2,,,191,,191,191,,2,2,191,191,,Malignant,5,,24,,,,23854,,,191,191,,,,191,191,,,191,,,,,,,,TUMOR FREE,Dead,-23133,191,,,41,,191,191,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,0,,0,0.040765,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8592,,,,,,,,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,85672,,0.500165349,,,,,,,,,,0.119607316,Grade 3,0.199223237,,,,Stage IIIB,,0.061,,,,,,,,,,,,,,,,0.4562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8592,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,1,1,1,Female,TCGA-BR-6705,White,STAD,,1,1,,,,1,,1,2.14,0.17,2,3,5,,,779,,,779,,1,1,779,779,,Malignant,10,,9,,,,20016,,,779,779,,,,,779,,,779,,,,,,,,WITH TUMOR,Dead,-25073,779,,,117,,779,779,,,[Not Available],[Not Applicable],,,,,0.38,Stomach,Unknown,,,4,,0,0.085525,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6705,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,85673,,0.465714809,,,,,,,,,,0.114159563,Grade 3,0.289612912,,,,Stage IIIB,,0.3485,,,,,,,,,,,,,,,,0.8693,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6705,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-HC-8266,,PRAD,221,0,0,,HC,,0,MALE,0,1.99,0.25,7,3,4,ambiguous,NO,473,8-other,,473,,0,0,473,473,prad_tcga,Malignant,14,BARD1;BRCA2,13,5.1,TCGA-HC-8266-01,3,5446,0,TCGA-HC-8266,473,473,Prostate Cancer,,,,473,TCGA,,473,Primary,0,,A,,,,WITH TUMOR,Alive,-20280,,55,8,29,PRAD,473,473,,0.084194156,[Not Available],[Not Applicable],29,R1,1,Matched,0.08,Prostate,Resection,4,7e1bda67-08e8-413f-a99a-00747e0dc437,7,,0,0.24819,[Not Available],fb447e0f-7cf0-49bf-8b15-aae932f8094d,4,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,14,,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.0,TCGA-HC-8266,0:DiseaseFree,4,29,Prostate Adenocarcinoma,15.54,10/1/12,473,,,,,,C61,cb8abdbd-c61d-4ad4-bd8b-a7e9dbc20d2d,,13,WITH TUMOR,0.0385,0:LIVING,,,15.54,Bilateral,33,,,YES,,2012,,,TCGA-HC-8266.cb8abdbd-c61d-4ad4-bd8b-a7e9dbc20d2d.pdf,,[Not Applicable],,,41-50%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,R1,0.5,55,,,,YES,NO,YES,NO,T3b,,8,No,,0,N0,,0,M0,C61.9,8550/3,85675,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-LT-A8JT,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.96,0.87,2,1,3,,,641,,641,641,,0.0,0,641.0,641.0,,Malignant,6,,27,,,,32597.0,,,641.0,641,,,,641,641,,,641.0,,,,,,,,TUMOR FREE,Alive,-25498,,,,100.0,,641.0,641,,,[Not Available],[Not Applicable],,,,,0.02,,,,,5,,0,0.080305,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Gundersen Lutheran Health System,,TCGA-LT-A8JT,,,,,,,641,,,,,,,,,3,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,85689,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-K4-A4AC,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.9,0.32,11,15,19,,,278,,,278,,1.0,1,170.0,170.0,,Malignant,45,,85,,,,32022.0,,,170.0,170,,,,,278,,,170.0,,,,,,,,WITH TUMOR,Dead,-30655,278,,,203.0,,170.0,170,,,[Not Available],[Not Applicable],,,,,0.31,,,,,17,,1,0.26421,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A4AC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,40,,,,,,,,,,,,,2012,170,psoas,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,83.0,,,,,,,,,,,,,,,,,,,,85693,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-DK-A1A5,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.01,0.59,5,12,20,,,65,,65,65,,2.0,2,65.0,65.0,,Malignant,37,,34,,,,21475.0,,,65.0,65,,,,65,65,,,65.0,,,,,,,,TUMOR FREE,Dead,-29111,65,,,380.0,,65.0,65,,,[Not Available],[Not Applicable],,,,,0.06,,,,,15,,1,0.22613,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1A5,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,79.0,,,,,,,,,,,,,,,,,,,,85695,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.99,0.47,4,6,6,,,348,BRCA_LumA,348,348,,0,0,348,348,,Invasive Carcinoma,16,,39,,,,16647,0,,348,348,,,,348,348,,,348,,,,,,,,TUMOR FREE,Alive,-18371,,,,46,,348,348,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,7,,1,0.060399,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,"Proteogenex, Inc.",,TCGA-4H-AAAK,,,,,,,348,,,,,,,,,9,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,85703,,0.366968788,0,0,0,0,0.3185,1,,,Infiltrating Lobular Carcinoma,0.1697922,,0.122804637,0,0,0,,Negative,-0.351,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7173,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.73,19,27,22,,,1542,BRCA_Normal,1542,1542,,0,0,1542,1542,,Invasive Carcinoma,68,,82,,,,20552,0,,1542,1542,,,,1542,1542,,,1542,,,,,,,,TUMOR FREE,Alive,-18561,,,,192,,1542,1542,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,5,,0,0.38497,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JB,,,,,,,1542,,,,,,,,,21,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,85705,,-0.450294555,0,0,0,0,0.7671,0,,,Infiltrating Ductal Carcinoma,0.134433038,,0.212376619,0,0,0,,Negative,-0.7785,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.2001,1,0,H & E,0,0,,0,Chunhui Yi,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-56-8622,White,LUSC,,0,0,,International Genomics Consortium,,0,MALE,0,2.07,0.47,6,7,9,,,55,,,55,,0,0,55,55,,Malignant,22,,42,,,,24474,,,55,55,,,,,55,,,55,,,,,,,,TUMOR FREE,Alive,-24861,,,,321,,55,55,,,[Not Available],[Not Applicable],,,,,0.24,,,,,7,,0,0.15991,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8622,,,,,,,55,,,,,,,,,10,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,68,,,,,,,,,,,,,,,,,,,,85709,,-0.001834446,,,,,,,,,,0.15800171,,0.113198261,,,,Stage IB,,0.389,,,,,,,,,,,,,,,,0.7003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.681263965450813,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.0855,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.41,0.61,7,3,12,,,416,BRCA_LumA,416,416,,0,0,416,416,,Invasive Carcinoma,22,,76,,,,17871,0,,416,416,,,,416,416,,,416,,,,,,,,TUMOR FREE,Alive,-14383,,,,40,,416,416,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,23,,1,0.17181,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SJ,,,,,,,416,,,,,,,,,23,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,85711,,-0.216669838,0,0,0,0,0.7642,0,,,Infiltrating Ductal Carcinoma,0.138699632,,0.21845521,0,0,1,,Negative,-0.483,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4498,1,0,H & E,0,0,,0,Ioana Tolocica,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Papillary, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Papillary, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Papilloma,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-55-6968,White,LUAD,,1,1,,International Genomics Consortium,,1,MALE,1,1.72,0.65,10,11,13,,,1293,,,1293,,1,1,1293,1293,,Malignant,34,,71,,,,18594,,,1293,1293,,,,,1293,,,1293,,,,,,,,WITH TUMOR,Dead,-22344,1293,,,679,,1293,1293,,,[Not Available],[Not Applicable],,,,,0.2,,,,,10,,0,0.37892,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6968,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2004,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,85712,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E866K,,,1,E866K,,,16.37462965,16.96640586,17.77733365,-0.105302876,LUAD,Adenocarcinoma,17.9972346,16.28923453,Adenocarcinoma,0.0096,13.16486767,0.5626,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-55-6970,White,LUAD,,1,1,,International Genomics Consortium,,1,FEMALE,1,1.36,0.56,5,4,7,,,464,,,464,,1,1,457,457,,Malignant,16,,27,,,,27221,,,457,457,,,,,464,,,457,,,,,,,,WITH TUMOR,Dead,-24773,464,,,221,,457,457,,,[Not Available],[Not Applicable],,,,,0.21,,,,,12,,0,0.69493,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6970,,,,,,,,,Locoregional Recurrence,,,,,,,18,,,,,,,,,,,,,2004,457,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,85714,,1.162946216,,,,,,,,,,0.23262886,,0.167905823,,,,Stage IIIA,,1.308,,,,,,,,,,,,,,,,-0.0581,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),K323* (driver),1,,G12V (driver),K323* (driver),16.28685384,17.46200331,16.48520672,-0.11115306,LUAD,Adenocarcinoma,18.12572141,15.92148735,Adenocarcinoma,-0.5576,13.69792522,0.3916,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.23,0.37,4,6,5,,,1185,BRCA_LumA,,1185,,0,0,1185,1185,,Invasive Carcinoma,15,,15,,,,22944,0,,1185,1185,,,,,1185,,,1185,,,,,,,,TUMOR FREE,Alive,-19805,,,,48,,1185,1185,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,7,,0,0.066885,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A5QP,,,,,,,1185,,,,,,,,,9,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,85717,,-0.256278884,0,0,0,0,0.8773,1,,,Infiltrating Lobular Carcinoma,0.128876716,,0.157902758,0,0,0,,[Not Available],-0.456,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3553,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-BT-A3PJ,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.58,0.51,7,14,22,,,789,,789,789,,0.0,0,789.0,789.0,,Malignant,43,,51,,,,33135.0,,,789.0,789,,,,789,789,,,789.0,,,,,,,,TUMOR FREE,Alive,-27821,,,,704.0,,789.0,789,,,[Not Available],[Not Applicable],,,,,0.06,,,,,20,,1,0.196,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A3PJ,,,,,,,789,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,85719,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-BR-6802,White,STAD,,1,1,,,1,0,,1,2.12,0.33,0,0,0,,,940,,807,940,,1,1,807,807,,Malignant,0,,8,,,,25171,,,807,807,,,,807,940,,,807,,,,,,,,TUMOR FREE,Alive,-23915,,,,633,,807,807,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,4,,0,0.096835,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6802,,,,,,,940,Non-regional / Distant Lymph Nodes,Distant Metastasis,,,,,,,6,,,,,,,,,,,,,2011,807,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,85720,,0.895894989,,,,,,,,,,0.078874451,Grade 3,0.076363212,,,,Stage IIIA,,2.1415,,,,,,,,,,,,,,,,0.3521,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6802,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,0,0,1,Male,TCGA-55-A490,White,LUAD,,0,0,,International Genomics Consortium,,2,MALE,2,3.34,0.58,13,19,22,,,99,,,99,,2,2,99,99,,Malignant,54,,113,,,,29708,,,99,99,,,,,99,,,99,,,,,,,,TUMOR FREE,Dead,-28728,99,,,1773,,99,99,,,[Not Available],[Not Applicable],,,,,0.11,,,,,15,,1,0.27004,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A490,,,,,,,,,,,,,,,,41,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Applicable],,,,,,78,,,,,,,,,,,,,,,,,,,,85723,,0.001763308,,,,,,,,,,0.237584988,,0.142176439,,,,Stage IIA,,0.0805,,,,,,,,,,,,,,,,0.4663,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.26811899,17.04850782,14.61022314,-0.618874463,LUAD,Adenocarcinoma,17.92895378,14.7919487,Adenocarcinoma,-0.0803,13.82595131,-0.604,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.28,0.64,5,6,7,,,381,BRCA_LumA,381,381,,0,0,381,381,,Invasive Carcinoma,18,,41,,,,25927,0,,381,381,,,,381,381,,,381,,,,,,,,TUMOR FREE,Alive,-22958,,,,342,,381,381,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,13,,0,0.087848,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27V,,,,,,,381,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,85727,,,0,0,0,0,0.1959,1,,,Infiltrating Lobular Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Microcalcifications,"DCIS (Solid, Low Grade), Microcalcifications",,"DCIS (Solid, Low Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-K4-A4AB,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.9,0.56,4,5,7,,,84,,,84,,0.0,0,84.0,84.0,,Malignant,16,,39,,,,25191.0,,,84.0,84,,,,,84,,,84.0,,,,,,,,,Alive,-27922,,,,140.0,,84.0,84,,,[Not Available],[Not Applicable],,,,,0.16,,,,,10,,1,0.2426,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A4AB,,,,,,,84,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Partial Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,85728,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-63-A5MS,Unknown,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,3.34,0.2,12,24,20,,,2381,,2381,2381,,0,0,2381,2381,,Malignant,56,,57,,,,21327,,,2381,2381,,,,2381,2381,,,2381,,,,,,,,TUMOR FREE,Alive,-28827,,,,507,,2381,2381,,,[Not Available],[Not Applicable],,,,,0.49,,,,,22,,1,0.44506,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5MS,,,,,,,2381,,,,,,,,,43,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,85729,,1.100209477,,,,,,,,,,0.255751976,,0.107642771,,,,Stage IB,,1.211,,,,,,,,,,,,,,,,0.7184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.16964823608847,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.7658,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,1,1,Male,TCGA-CH-5743,White,PRAD,91,0,0,,CH,0,0,MALE,1,,,,,,,NO,425,1-ERG,425,425,,0,0,425,425,prad_tcga,Malignant,,,,2.2,TCGA-CH-5743-01,,5241,0,TCGA-CH-5743,425,425,Prostate Cancer,,394,425,425,TCGA,,425,Primary,,,A,,,,TUMOR FREE,Alive,-24321,,66,7,1,PRAD,425,425,WHITE,,[Not Available],[Not Applicable],3,R0,1,Matched,,Prostate,Resection,3,6bd8573d-535f-4f6d-8eaf-60918b5da578,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],2dee4bd8-b00e-4f8a-bfea-5d8d1a068202,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,0.1,TCGA-CH-5743,1:Recurred/Progressed,2,,Prostate Adenocarcinoma,13.96,3/16/12,425,,New Primary Tumor,,,NO,C61,e4f18f30-a6f0-4262-8f34-ce32db5cbe4a,,,TUMOR FREE,0.0,0:LIVING,0.1,,13.96,Bilateral,,No Evidence of Extraprostatic Extension,29,YES,,2008,425,,TCGA-CH-5743.e4f18f30-a6f0-4262-8f34-ce32db5cbe4a.pdf,Peripheral Zone,[Not Applicable],YES,29,51-60%,1,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.5,66,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,85732,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Female,TCGA-66-2727,,LUSC,,0,0,,Indivumed,,,FEMALE,2,3.73,0.47,14,19,23,,,516,,,516,,2,2,516,516,,Malignant,56,,105,,,,29279,,,516,516,,,,,516,,,516,,,,,,,,,Dead,-20150,516,,,281,,516,516,,,[Not Available],[Not Applicable],,,,,0.19,,,,,13,,1,0.22968,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2727,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,85733,,0.24217831,,,,,,,,,,0.212275453,,0.021025774,,,,Stage IB,,1.913,,,,,,,,,,,,,,,,0.1637,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.359729956138367,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.001,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.25,0.27,17,28,29,,,1270,BRCA_LumB,1270,1270,,0,0,1270,1270,,Invasive Carcinoma,74,,61,,,,21246,0,,1270,1270,,,,1270,1270,,,1270,,,,,,,,TUMOR FREE,Alive,-23006,,,,126,,1270,1270,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,15,,1,0.39079,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0C0,,,,,,,1270,,,,,,,,,30,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,85734,,1.754060034,0,0,0,0,-0.4004,1,,,Infiltrating Ductal Carcinoma,0.21879579,,0.099873564,0,0,0,,Negative,1.877,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0192,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7794,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.96,0.34,2,7,0,HRD,NO,1306,8-other,1306,1306,,0,0,1306,1306,prad_tcga,Malignant,9,,16,5.2,TCGA-EJ-7794-01,0,5331,0,TCGA-EJ-7794,1306,1306,Prostate Cancer,,285,1306,1306,TCGA,,1306,Primary,0,,A,,BRCA2,,TUMOR FREE,Alive,-24478,,67,7,17,PRAD,1306,1306,WHITE,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,0.04,Prostate,Resection,3,6a0e1748-c2cd-43e5-8624-10d8297496fb,0,Normal (no evidence of prostate cancer) [cM0],0,0.039203,[Not Available],aeec3005-25d7-45fc-a9ff-014d57960216,4,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.73333333333,TCGA-EJ-7794,0:DiseaseFree,2,21,Prostate Adenocarcinoma,42.9,4/9/12,1306,,,,,NO,C61,73164d62-bc3a-4dd3-8201-86c5f35ef168,,1,TUMOR FREE,0.0372,0:LIVING,0.1,3,42.9,Bilateral,24,No Evidence of Extraprostatic Extension,35,YES,,2010,,,TCGA-EJ-7794.73164d62-bc3a-4dd3-8201-86c5f35ef168.pdf,,[Not Applicable],YES,35,6-15%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.5,67,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,85736,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-55-7910,Black or African American,LUAD,,1,,,International Genomics Consortium,1,0,FEMALE,1,3.44,0.58,9,17,16,,,1040,,1018,1040,,1,,1018,1018,,Malignant,42,,75,,,,16561,,,1018,,,,,1018,1040,,,1018,,,,,,,,WITH TUMOR,Alive,-18289,,,,387,,1018,,,,[Not Available],[Not Applicable],,,,,0.13,,,,,18,,1,0.21985,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7910,,,,,,,1040,,,,,,,,,26,,,,,,,,,,,,,2011,1018,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,50,,,,,,,,,,,,,,,,,,,,85749,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G13C (driver), AMP (driver)",,1,,G13C (driver),,14.81009485,15.15676052,14.82737316,-0.555325262,LUAD,Adenocarcinoma,17.78597477,15.30438118,Adenocarcinoma,-0.1888,13.38877102,-1.5705,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-K4-A3WU,White,BLCA,,0.0,0,,,,0,MALE,0.0,2.11,0.58,0,4,3,,,105,,,105,,0.0,0,105.0,105.0,,Malignant,7,,7,,,,32570.0,,,105.0,105,,,,,105,,,105.0,,,,,,,,TUMOR FREE,Alive,-32134,,,,258.0,,105.0,105,,,[Not Available],[Not Applicable],,,,,0.62,,,,,1,,0,0.0050543,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A3WU,,,,,,,105,,,,,,,,,1,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,[Not Applicable],,,,,,87.0,,,,,,,,,,,,,,,,,,,,85760,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,2.01,0.63,8,6,8,,,1048,BRCA_LumB,790,1048,,1,1,790,790,,Invasive Carcinoma,22,,25,,,,25038,0,,790,790,,,,790,1048,,,790,,,,,,,,WITH TUMOR,Dead,-16511,1048,,,82,,790,790,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,5,,0,0.16824,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A226,,,,,,,,Bone,Distant Metastasis,,,,,,,10,,,,,,,,,,,,,2011,790,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,85762,,0.151241488,0,0,0,0,-0.4131,1,,,Infiltrating Ductal Carcinoma,0.151805438,,0.0975037,0,0,0,,Negative,-0.8075,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4113,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-O2-A52W,Black or African American,LUSC,,0,0,,Washington University - CALGB,,2,MALE,2,3.29,0.36,7,3,11,,,261,,,261,,2,2,261,261,,Malignant,21,,56,,,,19777,,,261,261,,,,,261,,,261,,,,,,,,TUMOR FREE,Dead,-23156,261,,,161,,261,261,,,[Not Available],[Not Applicable],,,,,0.09,,,,,25,,1,0.3424,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CALGB,,TCGA-O2-A52W,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2006,,,,,Stage I,,,,,,,,[Not Applicable],,,,,,63,,,,,,,,,,,,,,,,,,,,85767,,0.050727249,,,,,,,,,,0.159702348,,0.033135125,,,,Stage I,,-0.302,,,,,,,,,,,,,,,,-0.0539,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,-0.778662318340053,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-2.2208,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-BR-8484,White,STAD,,0,0,,,2,2,,2,3.06,0.39,8,9,12,,,766,,766,766,,2,2,766,766,,Malignant,29,,76,,,,19687,,,766,766,,,,766,766,,,766,,,,,,,,TUMOR FREE,Dead,-22583,766,,,112,,766,766,,,[Not Available],[Not Applicable],,,,,0.32,Stomach,Unknown,,,16,,1,0.29476,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8484,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,85769,,1.239089403,,,,,,,,,,0.143326554,Grade 2,0.104738216,,,,Stage IIIA,,0.959,,,,,,,,,,,,,,,,0.162,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8484,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-55-7903,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,1.93,0.64,8,5,10,,,567,,567,567,,0,0,567,567,,Malignant,23,,47,,,,16315,,,567,567,,,,567,567,,,567,,,,,,,,TUMOR FREE,Alive,-23509,,,,194,,567,567,,,[Not Available],[Not Applicable],,,,,0.32,,,,,5,,0,0.18219,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7903,,,,,,,567,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,85772,,0.953927114,,,,,,,,,,0.192789081,,0.09674633,,,,Stage IA,,1.557,,,,,,,,,,,,,,,,-0.0893,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.065796864,LUAD,,,,Adenocarcinoma,-0.9364,,0.5513,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-33-4583,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,3.48,0.52,7,3,9,,,4601,,4601,4601,,2,2,4601,4601,,Malignant,19,,31,,,,19840,,,4601,4601,,,,4601,4601,,,4601,,,,,,,,TUMOR FREE,Dead,-26799,4601,,,795,,4601,4601,,,[Not Available],[Not Applicable],,,,,0.21,,,,,23,,1,0.35817,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4583,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,1999,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,85773,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.2166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.36115343149994,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,3.0,0.5,3,5,9,,,172,BRCA_LumA,172,172,,2,2,172,172,,Invasive Carcinoma,17,,53,,,,17154,0,,172,172,,,,172,172,,,172,,,,,,,,TUMOR FREE,Dead,-25793,172,,,74,,172,172,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,19,,1,0.29177,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UNC ,,TCGA-AQ-A0Y5,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,85774,,-0.775526548,0,0,0,0,-1.0838,1,,,Infiltrating Ductal Carcinoma,0.200482417,,0.178680374,0,0,0,,Negative,-1.2965,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5852,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-BR-7717,White,STAD,,0,0,,,,2,,2,2.59,0.55,9,23,17,,,552,,,552,,2,2,552,552,,Malignant,49,,75,,,,18476,,,552,552,,,,,552,,,552,,,,,,,,TUMOR FREE,Dead,-23102,552,,,177,,552,552,,,[Not Available],[Not Applicable],,,,,0.21,Stomach,Unknown,,,19,,1,0.56657,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-7717,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,85776,,-0.545293436,,,,,,,,,,0.07945972,Grade 2,0.105690069,,,,Stage IV,,-0.4475,,,,,,,,,,,,,,,,0.3431,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7717,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,3.6,0.54,1,0,2,,,2348,BRCA_LumA,,2348,,2,2,2348,2348,,Invasive Carcinoma,3,,4,,,,26997,0,,2348,2348,,,,,2348,,,2348,,,,,,,,TUMOR FREE,Dead,-26817,2348,,,63,,2348,2348,,,[Not Available],[Not Applicable],,,,,0.41,Breast,Resection/Excision,,,14,,1,0.13352,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CS,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2004,,,,,Stage IV,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,85778,,0.096396302,0,0,0,0,0.7064,1,,,Infiltrating Ductal Carcinoma,0.161167642,,0.100859023,0,0,0,,Positive,-1.265,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.4442,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,None of the Above,Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.8,0.69,12,11,10,,,0,BRCA_LumB,0,0,,0,0,0,0,,Invasive Carcinoma,33,,69,,,,30230,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-29555,,,,163,,0,0,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,19,,1,0.28789,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A081,,,,,,,0,,,,,,,,,34,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,85779,,1.244730261,0,0,0,0,-1.4175,1,,,Infiltrating Ductal Carcinoma,0.166936527,,0.091616306,0,0,0,,Negative,0.6735,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.2528,0,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.62,2,0,4,,,747,BRCA_LumA,747,747,,0,0,747,747,,Invasive Carcinoma,6,,3,,,,34284,1,,747,747,,,,747,747,,,747,,,,,,,,TUMOR FREE,Alive,-25370,,,,29,,747,747,,,[Not Available],[Not Applicable],,,,,0.0,Not Specific/Unknown,Resection/Excision,,,5,,0,0.062788,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A24A,,,,,,,747,,,,,,,,,5,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,85781,,0.119678477,0,0,0,0,0.179,1,,,Infiltrating Ductal Carcinoma,0.19904345,,0.178140344,0,0,0,,Negative,-0.3295,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3618,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-94-8490,White,LUSC,,0,0,,Washington University - Emory,,0,MALE,0,1.97,0.79,9,6,15,,,153,,,153,,0,0,153,153,,Malignant,30,,66,,,,21922,,,153,153,,,,,153,,,153,,,,,,,,TUMOR FREE,Alive,-25588,,,,1378,,153,153,,,[Not Available],[Not Applicable],,,,,0.04,,,,,8,,0,0.28408,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Emory,,TCGA-94-8490,,,,,,,153,,,,,,,,,11,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,85783,,-0.006895822,,,,,,,,,,0.065535543,,-0.022559306,,,,Stage IIB,,0.2585,,,,,,,,,,,,,,,,-0.0286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L115Q,1,,,L115Q,12.88733584,13.07885218,14.85161646,-0.744398222716667,LUSC,Squamous Cell Carcinoma,17.76342616,14.94753042,Squamous Cell Carcinoma,-1.2786,11.41025431,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,,,,,,,,2636,,766,2636,,1,1,766,766,,Invasive Carcinoma,,,,,,,17222,0,,766,766,,,,766,2636,,,766,,,,,,,,WITH TUMOR,Dead,-22746,2636,,,0,,766,766,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2FE,,,,,,,,Bone,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2005,766,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,85784,,1.145813034,0,0,0,0,-0.9858,1,,,Infiltrating Lobular Carcinoma,0.184755066,,0.214194212,0,0,0,,Negative,0.7565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4986,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MN-A4N1,Black or African American,LUAD,,0,0,,BLN - Baylor,0,0,MALE,0,4.7,0.48,15,21,28,,,827,,827,827,,0,0,827,827,,Malignant,64,,140,,,,29966,,,827,827,,,,827,827,,,827,,,,,,,,TUMOR FREE,Alive,-21939,,,,622,,827,827,,,[Not Available],[Not Applicable],,,,,0.55,,,,,21,,2,0.31952,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,BLN - Baylor,,TCGA-MN-A4N1,,,,,,,827,,,,,,,,,62,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,85790,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.2204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.28281702,14.78119774,12.87663752,-0.842102347,LUAD,Adenocarcinoma,18.15320027,14.92504101,Adenocarcinoma,0.0491,13.00695147,-2.053,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,,0,1,Male,TCGA-66-2791,,LUSC,,0,0,,Indivumed,,,MALE,2,1.65,0.45,16,18,16,,,153,,,153,,2,2,153,153,,Malignant,50,,55,,,,18199,,,153,153,,,,,153,,,153,,,,,,,,,Dead,-24138,153,,,416,,153,153,,,[Not Available],[Not Applicable],,,,,0.25,,,,,12,,0,0.50987,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2791,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2008,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,85793,,1.441576552,,,,,,,,,,0.223783734,,0.069796771,,,,Stage IIIB,,2.5605,,,,,,,,,,,,,,,,0.4102,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.61968547,16.33626902,18.14469793,0.166515269115473,LUSC,Squamous Cell Carcinoma,18.00689757,16.77093299,Squamous Cell Carcinoma,0.8917,13.60864672,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-R5-A7ZF,Black or African American,STAD,,1,1,,,,1,,1,2.7,0.27,5,5,12,,,259,,,259,,1,1,259,259,,Malignant,22,,121,,,,20548,,,259,259,,,,,259,,,259,,,,,,,,WITH TUMOR,Dead,-23908,259,,,81,,259,259,,,Stomach Cancer,[Not Applicable],,,,,0.22,Stomach,Unknown,,,19,,1,0.38559,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,MD Anderson Cancer Center,,TCGA-R5-A7ZF,,,,,,,,,,,,,,,,31,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,85795,,,,,,,,,,,,,Grade 2,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-R5-A7ZF,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.13,0.78,4,7,8,,,2109,BRCA_Basal,2109,2109,,0,0,2109,2109,,Invasive Carcinoma,19,,19,,,,20517,0,,2109,2109,,,,2109,2109,,,2109,,,,,,,,TUMOR FREE,Alive,-13004,,,,56,,2109,2109,,,[Not Available],[Not Applicable],,,,,0.2,Breast,Resection/Excision,,,6,,0,0.064256,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14Y,,,,,,,2109,,,,,,,,,8,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,35,,,,,,,,,,,,,,,,,,,,85796,,-0.266812464,0,0,0,0,0.5339,1,,,Infiltrating Ductal Carcinoma,0.12398397,,0.08779898,0,0,0,,Negative,-1.2055,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0366,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-64-1680,White,LUAD,,0,0,,Fox Chase,,0,MALE,0,3.41,0.61,0,3,6,,,1126,,,1126,,0,0,1126,1126,,Malignant,9,,4,,,,21047,,,1126,1126,,,,,1126,,,1126,,,,,,,,TUMOR FREE,Alive,-23267,,,,78,,1126,1126,,,[Not Available],[Not Applicable],,,,,0.08,,,,,15,,1,0.031484,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-1680,,,,,,,1126,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,85807,,-0.479540213,,,,,,,,,,0.167759627,,0.062671967,,,,Stage IV,,-0.09,,,,,,,,,,,,,,,,-0.3166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.07963037,15.0939239,14.18012398,-0.29063775,LUAD,Adenocarcinoma,18.14599753,15.13329364,Adenocarcinoma,1.8291,12.52325158,-0.8563,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.76,0.76,12,6,12,,,1051,BRCA_Her2,1051,1051,,0,0,1051,1051,,None,30,,64,,,,22164,N/A (Non-Malignant),,1051,1051,,,,1051,1051,,,1051,,,,,,,,TUMOR FREE,Alive,-28084,,,,131,,1051,1051,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,9,,1,0.22273,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,,,TCGA-A2-A0D1,,,,,,,1051,,,,,,,,,14,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,85809,,-0.240006184,0,0,0,0,-0.5897,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.098728354,N/A (Non-Malignant),0.148639433,0,0,0,N/A (Non-Malignant),Negative,-1.2225,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2094,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-MP-A4SW,White,LUAD,,0,0,,Washington University - Mayo Clinic,2,,MALE,2,2.03,0.46,11,14,14,,,1778,,1778,1778,,2,2,1778,1778,,Malignant,39,,80,,,,21695,,,1778,1778,,,,1778,1778,,,1778,,,,,,,,,Dead,-19640,1778,,,90,,1778,1778,,,[Not Available],[Not Applicable],,,,,0.37,,,,,6,,0,0.21521,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4SW,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2002,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,85811,,1.009053615,,,,,,,,,,0.258782944,,0.088301861,,,,Stage IIB,,0.8675,,,,,,,,,,,,,,,,0.1961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), AMP (driver)",,,1,L858R (driver),,,15.84318927,16.99474156,14.91769585,-0.313472737,LUAD,Adenocarcinoma,18.10831225,15.97023333,Adenocarcinoma,0.2545,14.23855623,-0.3784,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-Y6-A8TL,,PRAD,389,0,0,,Y6,,0,MALE,0,1.96,0.59,2,6,0,HRP,NO,992,5-SPOP,,992,,0,0,992,992,prad_tcga,Malignant,8,,79,,TCGA-Y6-A8TL-01,10,5643,0,TCGA-Y6-A8TL,992,992,Prostate Cancer,,775,,992,TCGA,,992,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23776,,65,6,33,PRAD,992,992,,0.323169738,[Not Available],[Not Applicable],32,R0,1,Matched,0.0,Prostate,Resection,3,E8FA37B1-2E31-44B6-BA77-3E46DA7E4FEE,0,,0,0.047748,[Not Available],A7045324-CB44-4B37-BBAF-641642C1D903,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,Y6,1.06666666667,TCGA-Y6-A8TL,0:DiseaseFree,1,11,Prostate Adenocarcinoma,32.59,4/17/14,992,,,,,NO,C61,8DE4AB1E-913E-4763-81EE-272430E5CC4A,370,0,TUMOR FREE,0.0468,0:LIVING,0.0,,32.59,Right,12,No Evidence of Extraprostatic Extension,328,YES,677,2012,,,TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Available],,NO,No,R0,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T2a,0,,C61.9,8140/3,85812,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.43,3,2,5,,,675,BRCA_LumA,675,675,,0,0,675,675,,Invasive Carcinoma,10,,23,,,,26278,0,,675,675,,,,675,675,,,675,,,,,,,,TUMOR FREE,Alive,-29113,,,,47,,675,675,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.038991,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3QP,,,,,,,675,,,,,,,,,5,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,85815,,-0.219566969,0,0,0,0,0.5056,1,,,Infiltrating Lobular Carcinoma,0.161236041,,0.202493279,0,0,0,,Negative,-0.6875,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3745,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Female,TCGA-FT-A3EE,White,BLCA,,0.0,0,,,,2,FEMALE,2.0,2.67,0.61,8,6,9,,,99,,,99,,2.0,2,99.0,99.0,,Malignant,23,,23,,,,30362.0,,,99.0,99,,,,,99,,,99.0,,,,,,,,TUMOR FREE,Dead,-29293,99,,,174.0,,99.0,99,,,[Not Available],[Not Applicable],,,,,0.04,,,,,19,,1,0.41317,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University of Miami,,TCGA-FT-A3EE,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,[Not Available],,,,,,80.0,,,,,,,,,,,,,,,,,,,,85816,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.09,0.77,2,2,4,,,0,BRCA_LumA,0,0,,0,0,0,0,,Invasive Carcinoma,8,,7,,,,32848,1,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-24746,,,,42,,0,0,,,[Not Available],[Not Applicable],,,,,,Not Specific/Unknown,Resection/Excision,,,8,,0,0.053197,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A083,,,,,,,0,,,,,,,,,5,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,85817,,-0.903083297,0,0,0,0,0.2241,1,,,Infiltrating Ductal Carcinoma,0.09154635,,0.107551687,0,0,0,,Negative,-0.908,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.2667,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Encapsulated Papillary Carcinoma,Encapsulated Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-CU-A0YO,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.82,0.33,3,8,1,,,149,,,149,,1.0,1,118.0,118.0,,Malignant,12,,14,,,,22019.0,,,118.0,118,,,,,149,,,118.0,,,,,,,,WITH TUMOR,Dead,-30817,149,,,132.0,,118.0,118,,,[Not Available],[Not Applicable],,,,,0.45,,,,,14,,0,0.38326,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,UNC,,TCGA-CU-A0YO,,,,,,,,"Other, specify",Metastatic,,,,,,,11,,,,,,,,,,,,,2009,118,peritoneum,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,84.0,,,,,,,,,,,,,,,,,,,,85818,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GU-A767,White,BLCA,,1.0,1,,,,1,MALE,1.0,4.03,0.3,8,26,24,,,144,,,144,,1.0,1,144.0,144.0,,Malignant,58,,68,,,,31366.0,,,144.0,144,,,,,144,,,144.0,,,,,,,,WITH TUMOR,Dead,-29739,144,,,510.0,,144.0,144,,,[Not Available],[Not Applicable],,,,,0.48,,,,,12,,2,0.18037,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A767,,,,,,,,,,,,,,,,68,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,81.0,,,,,,,,,,,,,,,,,,,,85823,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-90-A4ED,White,LUSC,,0,0,,ABS - IUPUI,0,0,MALE,0,4.44,0.38,5,10,13,,,615,,615,615,,0,0,615,615,,Malignant,28,,32,,,,24774,,,615,615,,,,615,615,,,615,,,,,,,,TUMOR FREE,Alive,-25453,,,,2866,,615,615,,,[Not Available],[Not Applicable],,,,,0.44,,,,,16,,2,0.084447,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,ABS - IUPUI,,TCGA-90-A4ED,,,,,,,615,,,,,,,,,53,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,85826,,0.147626385,,,,,,,,,,0.157403025,,0.059997473,,,,Stage IB,,0.914,,,,,,,,,,,,,,,,0.3131,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.467886371837321,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.4009,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.59,0.48,3,2,5,,,447,BRCA_LumA,419,447,,1,1,419,419,,None,10,,24,,,,19700,N/A (Non-Malignant),,419,419,,,,419,447,,,419,,,,,,,,WITH TUMOR,Alive,-25678,,,,50,,419,419,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,20,,0,0.067981,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A425,,,,,,,447,"Other, specify",Locoregional Recurrence,,,,,,,18,,,,,,,,,,,,,2012,419,Left Breast,,,Stage IIIC,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,85832,,-1.144888488,0,0,0,0,0.5226,1,,N/A (Non-Malignant),Infiltrating Lobular Carcinoma,0.158767998,N/A (Non-Malignant),0.192959992,0,0,0,N/A (Non-Malignant),Negative,-0.8215,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3403,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.32,0.39,9,15,14,,,3316,BRCA_LumB,3316,3316,,0,0,3316,3316,,Invasive Carcinoma,38,,87,,,,17877,0,,3316,3316,,,,3316,3316,,,3316,,,,,,,,TUMOR FREE,Alive,-19679,,,,89,,3316,3316,,,[Not Available],[Not Applicable],,,,,0.55,Breast,Resection/Excision,,,9,,0,0.29864,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TT,,,,,,,3316,,,,,,,,,23,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,85839,,1.862610125,0,0,0,0,-1.3476,1,,,Infiltrating Ductal Carcinoma,0.227163579,,0.144730069,0,0,0,,Negative,1.622,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2988,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GU-A762,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.55,0.31,16,12,16,,,232,,,232,,1.0,1,232.0,232.0,,Malignant,44,,158,,,,34032.0,,,232.0,232,,,,,232,,,232.0,,,,,,,,WITH TUMOR,Dead,-31812,232,,,137.0,,232.0,232,,,[Not Available],[Not Applicable],,,,,0.13,,,,,16,,1,0.33138,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A762,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,87.0,,,,,,,,,,,,,,,,,,,,85842,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-49-AAR0,Black or African American,LUAD,,0,0,,Johns Hopkins,0,0,MALE,0,1.63,0.51,19,9,10,,,4765,,4765,4765,,0,0,4765,4765,,Malignant,38,,172,,,,18054,,,4765,4765,,,,4765,4765,,,4765,,,,,,,,TUMOR FREE,Alive,-20932,,,,180,,4765,4765,,,[Not Available],[Not Applicable],,,,,0.59,,,,,13,,0,0.43866,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AAR0,,,,,,,4765,,,,,,,,,12,,,,,,,,,,,,,2002,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,85844,,1.056419804,,,,,,,,,,0.218704762,,0.172255924,,,,Stage IA,,1.053,,,,,,,,,,,,,,,,0.1002,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G511C,1,,,G511C,,,,-0.32045286,LUAD,,,,Adenocarcinoma,-0.5823,,0.1025,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-49-4494,White,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,2.05,0.46,6,6,3,,,1081,,,1081,,1,1,1081,1081,,Malignant,15,,19,,,,20702,,,1081,1081,,,,,1081,,,1081,,,,,,,,WITH TUMOR,Dead,-28387,1081,,,257,,1081,1081,,,[Not Available],[Not Applicable],,,,,0.32,,,,,3,,0,0.2271,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4494,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1995,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,85846,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), T790M (driver)",,,1,"L858R (driver), T790M (driver)",,,15.83983572,16.56385538,16.03537556,-0.171017566,LUAD,,17.59504698,15.01237642,Adenocarcinoma,,12.61159328,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.98,0.64,8,12,19,,,7777,BRCA_Basal,7777,7777,,0,0,7777,7777,,Invasive Carcinoma,39,,48,,,,26327,0,,7777,7777,,,,7777,7777,,,7777,,,,,,,,TUMOR FREE,Alive,-22449,,,,229,,7777,7777,,,[Not Available],[Not Applicable],,,,,0.4,Breast,Resection/Excision,,,17,,1,0.38891,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RE,,,,,,,7777,,,,,,,,,32,,,,,,,,,,,,,1989,,,,,Stage X,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,85852,,-0.160763731,0,0,0,0,0.4935,1,,,Infiltrating Ductal Carcinoma,0.152889651,,0.033333985,0,0,0,,Negative,-0.9105,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3611,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8259,,PRAD,,0,0,,HC,0,0,MALE,0,,,,,,HRP,NO,924,,924,924,,0,0,924,924,prad_tcga,Malignant,,,,,TCGA-HC-8259-01,6,5440,0,TCGA-HC-8259,924,924,Prostate Cancer,,123,924,924,TCGA,,924,Primary,0,,A,,,,TUMOR FREE,Alive,-18309,,50,6,50,PRAD,924,924,,0.097856679,[Not Available],[Not Applicable],66,,1,Matched,,Prostate,Resection,3,ef2a9b45-0fb8-485a-911f-ff193ae2452d,,,,,[Not Available],07ccb4e9-a2a9-4bfd-97bd-13873b01977a,3,Prostate Adenocarcinoma Acinar Type,0.5,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.2,HC,2.23333333333,TCGA-HC-8259,0:DiseaseFree,1,1,Prostate Adenocarcinoma,30.35,6/20/12,924,,,,,,C61,e53c1322-0854-4ae8-b087-3ddd3712df56,,,TUMOR FREE,0.0034,0:LIVING,0.01,,30.35,Left,1,,,YES,,2011,,,TCGA-HC-8259.e53c1322-0854-4ae8-b087-3ddd3712df56.pdf,,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.4,50,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2a,NO,6,No,NO,0,,T1c,,M0,C61.9,8550/3,85853,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-33-4583,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,3.48,0.52,7,3,9,,,4601,,4601,4601,,2,2,4601,4601,,Malignant,19,,31,,,,19840,,,4601,4601,,,,4601,4601,,,4601,,,,,,,,TUMOR FREE,Dead,-26799,4601,,,795,,4601,4601,,,[Not Available],[Not Applicable],,,,,0.21,,,,,23,,1,0.35817,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4583,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,1999,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,85856,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.2166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.36115343149994,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-VQ-A8PO,White,STAD,,1,1,,,,1,,1,2.06,0.55,0,5,1,,,282,,,282,,1,1,256,256,,Malignant,6,,63,,,,31547,,,256,256,,,,,282,,,256,,,,,,,,,Dead,-27250,282,,,1249,,256,256,,,Stomach Cancer,[Not Applicable],,,,,0.09,Stomach,Unknown,,,4,,0,0.082099,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8PO,,,,,,,,,Locoregional Recurrence,,,,,,,4,,,,,,,,,,,,,2008,256,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,85858,,1.121814357,,,,,,,,,,0.112723601,Grade 3,0.040791498,,,,Stage IIB,,1.2395,,,,,,,,,,,,,,,,0.0855,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PO,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0.0,0,0,0.0,0.0,Female,TCGA-XF-A9SI,Asian,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.51,0.21,10,7,15,,,2423,,2423,2423,,0.0,0,2423.0,2423.0,,Malignant,32,,175,,,,26397.0,,,2423.0,2423,,,,2423,2423,,,2423.0,,,,,,,,TUMOR FREE,Alive,-26719,,,,443.0,,2423.0,2423,,,[Not Available],[Not Applicable],,,,,0.49,,,,,18,,0,0.52731,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SI,,,,,,,2423,,,,,,,,,19,,,,,,,,,,,,,2006,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,85860,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.39,0.67,4,12,10,,,5042,BRCA_LumA,5042,5042,,0,0,5042,5042,,Invasive Carcinoma,26,,69,,,,18721,0,,5042,5042,,,,5042,5042,,,5042,,,,,,,,TUMOR FREE,Alive,-24322,,,,0,,5042,5042,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,18,,1,0.19072,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0IO,,,,,,,5042,,,,,,,,,18,,,,,,,,,,,,,2001,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,85862,,-0.138825083,0,0,0,0,-0.009,1,,,Infiltrating Ductal Carcinoma,0.093880949,,0.059450592,0,0,0,,Negative,-1.106,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1221,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-B7-5816,White,STAD,,0,0,,,0,0,,0,4.25,0.31,0,3,1,,,812,,812,812,,0,0,812,812,,Malignant,4,,11,,,,31019,,,812,812,,,,812,812,,,812,,,,,,,,TUMOR FREE,Alive,-18698,,,,1810,,812,812,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,2,,1,0.058877,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Cureline,,TCGA-B7-5816,,,,,,,812,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,85865,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-B7-5816,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,1,1,1,Female,TCGA-49-4507,White,LUAD,,1,,,Johns Hopkins,,1,FEMALE,1,2.69,0.35,13,13,16,,,268,,,268,,1,,158,158,,Malignant,42,,47,,,,16920,,,158,,,,,,268,,,158,,,,,,,,WITH TUMOR,Dead,-26851,268,,,259,,158,,,,[Not Available],[Not Applicable],,,,,0.25,,,,,8,,1,0.28066,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4507,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,1997,158,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,85867,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.1309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R470C (driver),1,,,R470C (driver),16.24167246,16.40136642,17.73034256,0.153775689,LUAD,Adenocarcinoma,17.80356211,17.04079249,Adenocarcinoma,,11.81999902,1.8607,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-G9-6496,White,PRAD,,0,0,,G9,0,0,MALE,0,2.02,0.83,3,6,5,HRP,NO,1726,,1726,1726,,0,0,1726,1726,prad_tcga,Malignant,14,,46,,TCGA-G9-6496-01,22,5379,0,TCGA-G9-6496,1726,1726,Prostate Cancer,,703,1726,1726,TCGA,,1726,Primary,1,Apex|Base,A,,,,TUMOR FREE,Alive,-22602,,61,7,47,PRAD,1726,1726,WHITE,0.224968086,[Not Available],[Not Applicable],38,,1,Matched,0.01,Prostate,Resection,4,ece85143-957d-4ad1-bfcc-b71307efb911,1,Normal (no evidence of prostate cancer) [cM0],0,0.062181,[Not Available],ce2b7e17-424e-4954-8a68-19d7f98d2e7e,3,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,G9,2.33333333333,TCGA-G9-6496,0:DiseaseFree,3,9,Prostate Adenocarcinoma,56.7,3/21/12,1726,,,,,NO,C61,193cca51-2d1f-49aa-afdb-63a55d689c86,,2,TUMOR FREE,0.0874,0:LIVING,0.03,,56.7,Bilateral,10,No Evidence of Extraprostatic Extension,20,YES,,2008,,,TCGA-G9-6496.193cca51-2d1f-49aa-afdb-63a55d689c86.pdf,,[Not Applicable],YES,19,,15,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,61,Core needle biopsy,,,NO,YES,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,85871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-DK-A6B2,White,BLCA,,1.0,1,,,,0,MALE,1.0,,,,,,,,477,,,477,,1.0,1,268.0,268.0,,Malignant,,,,,,,24596.0,,,268.0,268,,,,,477,,,268.0,,,,,,,,WITH TUMOR,Alive,-25625,,,,279.0,,268.0,268,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A6B2,,,,,,,477,Liver,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2012,268,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,85874,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-GD-A76B,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,2.0,0.48,7,5,8,,,224,,224,224,,0.0,0,224.0,224.0,,Malignant,20,,45,,,,26054.0,,,224.0,224,,,,224,224,,,224.0,,,,,,,,TUMOR FREE,Alive,-31571,,,,241.0,,224.0,224,,,[Not Available],[Not Applicable],,,,,0.57,,,,,8,,0,0.18935,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - IUPUI,,TCGA-GD-A76B,,,,,,,224,,,,,,,,,10,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,86.0,,,,,,,,,,,,,,,,,,,,85875,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Female,TCGA-C4-A0F6,,BLCA,,0.0,0,,,,0,FEMALE,0.0,3.36,0.68,5,5,7,,,700,,,700,,0.0,0,700.0,700.0,,Malignant,17,,36,,,,16499.0,,,700.0,700,,,,,700,,,700.0,,,,,,,,TUMOR FREE,Alive,-29951,,,,274.0,,700.0,700,,,[Not Available],[Not Applicable],,,,,0.11,,,,,16,,1,0.25231,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Indivumed,,TCGA-C4-A0F6,,,,,,,700,,,,,,,,,28,,,,,,,,,,,,,2008,,,,,Stage III,,,,,,,,[Not Available],,,,,,82.0,,,,,,,,,,,,,,,,,,,,85881,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-2H-A9GR,Unknown,ESCA,,1,1,,,,1,,1,1.9,0.58,15,11,18,,,987,,,987,,1,1,987,987,,Malignant,44,,152,,,,23214,,,987,987,,,,,987,,,987,,,,,,,,WITH TUMOR,Dead,-29451,987,,,508,,987,987,,,[Not Available],[Not Available],,,,,0.66,Esophagus,Unknown,,,5,,0,0.2313,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Erasmus MC,,TCGA-2H-A9GR,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,1999,,,,,Stage IIA,,,,,,,,,,,,,,80,,,,,,,,,,,,,,,,,,,,85892,,,,,,,,,,,,,Grade 2,,,,,Stage IIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-KK-A8I8,,PRAD,370,0,0,,KK,0,0,MALE,0,2.02,0.73,5,2,5,HRP,NO,967,1-ERG,967,967,,0,0,967,967,prad_tcga,Malignant,12,ATM;CHEK1,49,,TCGA-KK-A8I8-01,0,5524,0,TCGA-KK-A8I8,967,967,Prostate Cancer,31,757,967,967,TCGA,No Evidence of Extraprostatic Extension,967,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25546,,69,9,29,PRAD,967,967,,0.0,[Not Available],[Not Applicable],19,,1,Matched,0.0,Prostate,Resection,4,0C50F404-D92A-4D72-B085-A4D258B941B0,2,,0,0.064424,[Not Available],30FA311B-05A2-43E4-9EDC-02B327898132,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,0.633333333333,TCGA-KK-A8I8,0:DiseaseFree,5,13,Prostate Adenocarcinoma,31.77,8/18/14,967,,,,,YES,C61,EA62695C-65BD-4E4A-BB9D-0D1CC5B90636,110,4,TUMOR FREE,0.1017,0:LIVING,0.1,,31.77,Bilateral,13,,,YES,535,2012,,,TCGA-KK-A8I8.EA62695C-65BD-4E4A-BB9D-0D1CC5B90636.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,27,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,YES,9,No,NO,0,N0,T2a,,M0,C61.9,8140/3,85898,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-L9-A7SV,Black or African American,LUAD,,0,0,,Candler,0,0,MALE,0,3.06,0.83,10,17,21,,,565,,565,565,,0,0,565,565,,Malignant,48,,138,,,,17733,,,565,565,,,,565,565,,,565,,,,,,,,TUMOR FREE,Alive,-25298,,,,2107,,565,565,,,[Not Available],[Not Applicable],,,,,0.25,,,,,17,,1,0.24042,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Candler,,TCGA-L9-A7SV,,,,,,,565,,,,,,,,,42,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,85906,,0.247916889,,,,,,,,,,0.115909558,,0.114219841,,,,Stage IIA,,0.115,,,,,,,,,,,,,,,,-0.3238,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.74503588,14.87455695,14.96257405,-0.543869025,LUAD,Adenocarcinoma,18.19836697,14.56190991,Adenocarcinoma,-1.2989,12.19257839,-0.6042,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-KK-A7B4,,PRAD,331,1,1,,KK,,0,MALE,1,1.9,0.72,6,8,3,ambiguous,NO,987,1-ERG,,987,,1,1,637,637,prad_tcga,Malignant,17,BRCA2;FANCL,71,,TCGA-KK-A7B4-01,0,5519,0,TCGA-KK-A7B4,637,637,Prostate Cancer,29,637,,987,TCGA,Equivocal,637,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-23644,,64,9,46,PRAD,637,637,,0.0,[Not Available],[Not Applicable],26,,1,Matched,0.39,Prostate,Resection,4,F6E93A76-4E34-438A-9092-7B3E173E116C,3,Equivocal,0,0.14049,[Not Available],5447A0E0-80CA-40FB-8233-504FDE51F22C,5,Prostate Adenocarcinoma Acinar Type,,Prostate,17,,Acinar Adenocarcinoma,[Not Available],,KK,0.866666666667,TCGA-KK-A7B4,1:Recurred/Progressed,5,30,Prostate Adenocarcinoma,31.64,8/28/14,987,,Biochemical evidence of disease,,,YES,C61,19CE314A-B253-4F6F-9D77-37B33CFC6F2E,160,5,WITH TUMOR,0.204,0:LIVING,0.6,,32.42,Bilateral,32,,,YES,434,2012,637,,TCGA-KK-A7B4.19CE314A-B253-4F6F-9D77-37B33CFC6F2E.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,29,31-40%,20,Prostate Adenocarcinoma Acinar Type,1,2012,Stable Disease,,YES,"Yes, History of Prior Malignancy",R1,,64,Core needle biopsy,637,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,YES,0,N1,T3b,8,M0,C61.9,8140/3,85907,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-J4-A83M,,PRAD,357,1,1,,J4,1,0,MALE,1,1.99,0.6,0,0,0,HRP,NO,543,2-ETV1,521,543,,1,1,521,521,prad_tcga,Malignant,0,,32,,TCGA-J4-A83M-01,0,5488,0,TCGA-J4-A83M,521,521,Prostate Cancer,,437,521,543,TCGA,,521,Primary,0,Apex|Middle,A,,,True,,Alive,-23624,,64,7,38,PRAD,521,521,,0.0,[Not Available],[Not Applicable],40,R1,1,Matched,0.02,Prostate,Resection,4,004BDE0B-224A-48CE-AA33-242BA7385ECC,0,,0,0.013056,[Not Available],D6974DB6-2BD3-4082-B48E-9C60F7FE3A1F,3,Prostate Adenocarcinoma Acinar Type,,Prostate,1,,Acinar Adenocarcinoma,[Not Available],,J4,1.33333333333,TCGA-J4-A83M,1:Recurred/Progressed,3,3,Prostate Adenocarcinoma,17.12,1/20/14,543,,Biochemical evidence of disease,,,,C61,8AA3EBE4-49E8-4D0A-A3A4-B51E41B3AA4F,40,0,,0.0102,0:LIVING,0.2,,17.84,Bilateral,5,,,YES,412,2012,521,,TCGA-J4-A83M.8AA3EBE4-49E8-4D0A-A3A4-B51E41B3AA4F.pdf,Peripheral Zone,[Not Applicable],,,41-50%,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,64,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,85908,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.77,7,7,9,,,334,BRCA_LumA,334,334,,0,0,334,334,,Invasive Carcinoma,23,,22,,,,19575,1,,334,334,,,,334,334,,,334,,,,,,,,TUMOR FREE,Alive,-24929,,,,94,,334,334,,,[Not Available],[Not Applicable],,,,,0.15,Not Specific/Unknown,Resection/Excision,,,4,,0,0.1661,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07P,,,,,,,334,,,,,,,,,10,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,85910,,-0.140265199,0,0,0,0,-0.1977,1,,,Infiltrating Ductal Carcinoma,0.164830601,,0.134857731,0,0,0,,Negative,-0.8925,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1374,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,525,BRCA_Basal,525,525,,0,0,525,525,,Invasive Carcinoma,,,,,,,22344,0,,525,525,,,,525,525,,,525,,,,,,,,TUMOR FREE,Alive,-18659,,,,72,,525,525,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-AA15,,,,,,,525,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,85911,TRUE,,0,0,0,0,-0.8531,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-D7-6528,White,STAD,,0,0,,,0,0,,0,3.56,0.62,8,12,15,,,463,,463,463,,0,0,463,463,,Malignant,35,,37,,,,25394,,,463,463,,,,463,463,,,463,,,,,,,,TUMOR FREE,Alive,-25815,,,,427,,463,463,,,[Not Available],[Not Applicable],,,,,0.28,Stomach,Unknown,,,20,,1,0.2915,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6528,,,,,,,463,,,,,,,,,26,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,85918,,,,,,,,,,,,,Grade 2,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6528,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A3MG,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,3.12,0.8,5,4,7,,,369,,369,369,,0.0,0,369.0,369.0,,Malignant,16,,24,,,,22383.0,,,369.0,369,,,,369,369,,,369.0,,,,,,,,TUMOR FREE,Alive,-17600,,,,189.0,,369.0,369,,,[Not Available],[Not Applicable],,,,,0.38,,,,,18,,1,0.29121,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A3MG,,,,,,,369,,,,,,,,,24,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,48.0,,,,,,,,,,,,,,,,,,,,85925,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,943,BRCA_LumB,943,943,,0,0,943,943,,Invasive Carcinoma,,,,,,,21858,0,,943,943,,,,943,943,,,943,,,,,,,,TUMOR FREE,Alive,-25598,,,,107,,943,943,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08P,,,,,,,943,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,85927,,1.207425843,0,0,0,0,-0.316,1,,,Infiltrating Ductal Carcinoma,0.231855304,,0.148225427,0,0,0,,Negative,0.9495,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3035,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-44-8119,White,LUAD,,0,0,,Christiana Healthcare,0,0,MALE,0,4.63,0.55,9,12,14,,,285,,285,285,,0,0,285,285,,Malignant,35,,51,,,,26056,,,285,285,,,,285,285,,,285,,,,,,,,TUMOR FREE,Alive,-27003,,,,793,,285,285,,,[Not Available],[Not Applicable],,,,,0.15,,,,,22,,2,0.25801,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-8119,,,,,,,285,,,,,,,,,51,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,85928,,0.53442826,,,,,,,,,,0.230308687,,0.184255766,,,,Stage IIB,,0.8795,,,,,,,,,,,,,,,,0.6676,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.68280412,17.28494894,16.6676851,-0.18658252,LUAD,Adenocarcinoma,17.96811799,16.0206825,Adenocarcinoma,1.6128,13.58680081,-0.0178,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-43-3920,White,LUSC,,0,0,,Christiana Healthcare,0,0,MALE,0,3.45,0.52,9,9,17,,,1007,,1007,1007,,0,0,1007,1007,,Malignant,35,,39,,,,23489,,,1007,1007,,,,1007,1007,,,1007,,,,,,,,TUMOR FREE,Alive,-26059,,,,363,,1007,1007,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.33289,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-3920,,,,,,,1007,,,,,,,,,31,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,85938,,0.597331919,,,,,,,,,,0.236484481,,0.050917614,,,,Stage IB,,0.76,,,,,,,,,,,,,,,,0.5031,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0668458788964412,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.3141,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-BR-8371,White,STAD,,1,1,,,,1,,1,2.0,0.95,0,0,0,,,359,,,359,,1,1,357,357,,Malignant,0,,3,,,,24451,,,357,357,,,,,359,,,357,,,,,,,,WITH TUMOR,Dead,-22883,359,,,23,,357,357,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,0,,0,0.000162,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8371,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,0,,,,,,,,,,,,,2011,357,Brain,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,62,,,,,,,,,,,,,,,,,,,,85940,,0.773505527,,,,,,,,,,0.069271609,Grade 3,0.148917653,,,,Stage IIIB,,0.1385,,,,,,,,,,,,,,,,0.1072,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8371,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.92,2,1,3,,,726,BRCA_LumA,726,726,,0,0,726,726,,Invasive Carcinoma,6,,14,,,,21737,0,,726,726,,,,726,726,,,726,,,,,,,,TUMOR FREE,Alive,-22422,,,,35,,726,726,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,2,,0,0.036758,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A156,,,,,,,726,,,,,,,,,2,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,85945,,-2.427332325,0,0,0,0,-0.7747,1,,,Infiltrating Ductal Carcinoma,0.094726229,,0.072585567,0,0,0,,Negative,-1.1145,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2432,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.21,0.78,4,1,10,,,1523,BRCA_Basal,1523,1523,,0,0,1523,1523,,None,15,,31,,,,18627,N/A (Non-Malignant),,1523,1523,,,,1523,1523,,,1523,,,,,,,,TUMOR FREE,Alive,-18492,,,,222,,1523,1523,,,[Not Available],[Not Applicable],,,,,0.07,Skin,Resection/Excision,,,17,,1,0.18142,Peri (6-12 months since last menstrual period),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LG,,,,,,,1523,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,85946,,-0.176317624,0,0,0,0,0.8872,1,,N/A (Non-Malignant),Infiltrating Lobular Carcinoma,0.090798625,N/A (Non-Malignant),-0.001232206,0,0,0,N/A (Non-Malignant),Negative,0.295,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,-0.5969,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,1,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-G2-AA3B,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.82,0.84,24,22,19,,,2008,,2008,2008,,0.0,0,2008.0,2008.0,,Malignant,65,,339,,,,16845.0,,,2008.0,2008,,,,2008,2008,,,2008.0,,,,,,,,TUMOR FREE,Alive,-27646,,,,963.0,,2008.0,2008,,,[Not Available],[Not Applicable],,,,,0.71,,,,,7,,0,0.45452,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3B,,,,,,,2008,,,,,,,,,22,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,85950,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-86-8358,White,LUAD,,0,0,,Asterand,0,0,MALE,0,3.55,0.72,20,27,23,,,653,,653,653,,0,0,653,653,,Malignant,70,,196,,,,18829,,,653,653,,,,653,653,,,653,,,,,,,,TUMOR FREE,Alive,-16409,,,,1503,,653,653,,,[Not Available],[Not Applicable],,,,,0.53,,,,,17,,1,0.29794,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8358,,,,,,,653,,,,,,,,,35,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,44,,,,,,,,,,,,,,,,,,,,85954,,0.69514663,,,,,,,,,,0.113810426,,0.0928844,,,,Stage IB,,0.2885,,,,,,,,,,,,,,,,-0.1365,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G558E,1,,,G558E,,,,-0.44206977,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0025,,-0.0543,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.29,0.69,1,6,6,,,365,BRCA_LumA,365,365,,0,0,365,365,,Invasive Carcinoma,13,,7,,,,20999,0,,365,365,,,,365,365,,,365,,,,,,,,TUMOR FREE,Alive,-21520,,,,65,,365,365,,,[Not Available],[Not Applicable],,,,,0.34,Breast,Resection/Excision,,,25,,1,0.073149,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09B,,,,,,,365,,,,,,,,,23,,,,,,,,,,,,,2009,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,85958,,-0.624527672,0,0,0,0,0.4659,1,,,Infiltrating Ductal Carcinoma,0.130690728,,0.141440362,0,0,0,,Negative,-0.5645,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2942,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A6AP,,PRAD,,0,0,,HC,,0,MALE,0,1.96,0.38,4,10,0,ambiguous,NO,71,,,71,,0,0,71,71,prad_tcga,Malignant,14,,29,,TCGA-HC-A6AP-01,11,5454,0,TCGA-HC-A6AP,71,71,Prostate Cancer,,,,71,TCGA,,71,Primary,1,,A,,,False,,Alive,-22318,,61,7,33,PRAD,71,71,,0.344609728,[Not Available],[Not Applicable],46,,1,Matched,0.09,Prostate,Resection,3,19E1137B-FBBB-4BBD-B5B3-A6892D91BF4E,0,,0,0.056681,[Not Available],EAD15A1B-726A-46AA-9005-A22F4B89D011,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,HC,1.53333333333,TCGA-HC-A6AP,0:DiseaseFree,2,21,Prostate Adenocarcinoma,2.33,9/19/13,71,,,,,NO,C61,7271E139-D1C7-4FB1-B148-54DE4A1DF42B,40,0,,0.0485,0:LIVING,,,2.33,Bilateral,29,No Evidence of Extraprostatic Extension,15,YES,182,2012,,,TCGA-HC-A6AP.7271E139-D1C7-4FB1-B148-54DE4A1DF42B.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,,,,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,RX,,61,Core needle biopsy,,,YES,NO,NO,NO,T2c,,7,No,,0,,T1c,,M0,C61.9,8140/3,85960,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.46,5,5,8,,,5156,BRCA_LumA,5156,5156,,0,0,5156,5156,,Invasive Carcinoma,18,,24,,,,17053,0,,5156,5156,,,,5156,5156,,,5156,,,,,,,,TUMOR FREE,Alive,-15507,,,,70,,5156,5156,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,7,,0,0.1161,Indeterminate (neither Pre or Postmenopausal),,,Mixed Histology (please specify),,,,,,[Not Available],,Duke,,TCGA-B6-A0RV,,,,,,,5156,,,,,,,,,6,,,,,,,,,,,,,1996,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,85963,,0.891818789,0,0,0,0,-0.0025,1,,,Mixed Histology (NOS),0.13063411,,0.194256775,0,0,0,,Negative,-0.028,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1253,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.36,0,0,0,,,2596,BRCA_LumB,2596,2596,,0,0,2596,2596,,Invasive Carcinoma,0,,3,,,,18498,0,,2596,2596,,,,2596,2596,,,2596,,,,,,,,TUMOR FREE,Alive,-19842,,,,238,,2596,2596,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,1,,0,0.000203,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DO,,,,,,,2596,,,,,,,,,1,,,,,,,,,,,,,2006,,,,,Stage I,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,85970,,2.009340722,0,0,0,0,-1.1404,1,,,Infiltrating Lobular Carcinoma,0.140261801,,0.091360176,0,0,0,,Negative,1.6815,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.15,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.26,0.6,3,3,5,,,563,BRCA_LumA,563,563,,0,0,563,563,,Invasive Carcinoma,11,,39,,,,20684,0,,563,563,,,,563,563,,,563,,,,,,,,TUMOR FREE,Alive,-20629,,,,49,,563,563,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,9,,0,0.041415,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A3Z6,,,,,,,563,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,85978,,,0,0,0,0,0.8205,1,,,Infiltrating Lobular Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.96,0.39,1,1,4,,,600,BRCA_LumA,600,600,,0,0,600,600,,Invasive Carcinoma,6,,11,,,,29730,0,,600,600,,,,600,600,,,600,,,,,,,,TUMOR FREE,Alive,-18151,,,,111,,600,600,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,6,,1,0.016204,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A6VQ,,,,,,,600,,,,,,,,,11,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,85983,,0.148939357,0,0,0,0,1.2793,1,,,Infiltrating Lobular Carcinoma,0.137892243,,0.225615329,0,0,0,,Negative,0.159,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6586,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,Asian,BRCA,,1,1,,,1,0,FEMALE,1,1.98,0.75,11,11,12,,,379,BRCA_Her2,136,379,,1,1,136,136,,Invasive Carcinoma,34,,63,,,,18718,0,,136,136,,,,136,379,,,136,,,,,,,,WITH TUMOR,Alive,-12729,,,,69,,136,136,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,4,,0,0.17909,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A137,,,,,,,379,,Locoregional Recurrence,,,,,,,8,,,,,,,,,,,,,2010,136,,,,Stage IIB,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,85987,,-0.64130273,0,0,0,0,-0.5144,1,,,Infiltrating Ductal Carcinoma,0.124728874,,0.11535922,0,0,0,,Negative,-2.0935,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.2803,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.63,0.54,5,4,6,,,393,BRCA_LumA,393,393,,0,0,393,393,,Invasive Carcinoma,15,,41,,,,29780,0,,393,393,,,,393,393,,,393,,,,,,,,TUMOR FREE,Alive,-13985,,,,45,,393,393,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,14,,1,0.13553,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15H,,,,,,,393,,,,,,,,,13,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,85994,,-0.607446347,0,0,0,0,0.6749,1,,,Infiltrating Ductal Carcinoma,0.101765357,,0.102632121,0,0,0,,Negative,-1.0505,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3609,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.34,0.54,16,26,30,,,3172,BRCA_Basal,3172,3172,,0,0,3172,3172,,Invasive Carcinoma,72,,84,,,,25250,0,,3172,3172,,,,3172,3172,,,3172,,,,,,,,TUMOR FREE,Alive,-18084,,,,258,,3172,3172,,,[Not Available],[Not Applicable],,,,,0.25,Breast,Resection/Excision,,,14,,1,0.40274,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24Q,,,,,,,3172,,,,,,,,,32,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,85997,,1.026245304,0,0,0,0,-0.3522,1,,,Infiltrating Ductal Carcinoma,0.203231651,,0.140466129,0,0,0,,Negative,0.1335,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4997,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,,,Black or African American,BRCA,,0,0,,,,2,FEMALE,2,3.62,0.25,7,10,12,,,3959,BRCA_LumB,,3959,,2,2,3959,3959,,Invasive Carcinoma,29,,42,,,,23703,0,,3959,3959,,,,,3959,,,3959,,,,,,,,TUMOR FREE,Dead,-28403,3959,,,150,,3959,3959,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,16,,1,0.22017,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Medullary Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A209,,,,,,,,,,,,,,,,22,,,,,,,,,,,,,1996,,,,,Stage I,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,85999,,,0,0,0,0,-0.9049,1,,,Medullary Carcinoma,,,,0,0,0,,[Not Available],,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,,,,,,,,243,,,243,,0,0,243,243,,Invasive Carcinoma,,,,,,,16196,0,,243,243,,,,,243,,,243,,,,,,,,WITH TUMOR,Alive,-26998,,,,0,,243,243,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Indivumed,,TCGA-A8-A07S,,,,,,,243,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,86000,,-0.855080328,0,0,0,0,-0.2516,1,,,Mixed Histology (NOS),0.169166601,,0.120461597,0,0,0,,Positive,-0.9225,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2323,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,86009,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-R6-A8WG,White,ESCA,,1,1,,,,1,,1,2.88,0.65,8,3,9,,,386,,,386,,1,1,107,107,,Malignant,20,,121,,,,21101,,,107,107,,,,,386,,,107,,,,,,,,WITH TUMOR,Dead,-22093,386,,,183,,107,107,,,[Not Available],Stage IIA,,,,,0.49,Esophagus,Unknown,,,28,,1,0.34139,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,MD Anderson Cancer Center,,TCGA-R6-A8WG,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,25,,,,,,,,,,,,,2013,107,left supraclavicular nodal metastasis,,,[Not Available],,,,,,,,,,,,,,60,,,,,,,,,,,,,,,,,,,,86011,,,,,,,,,,,,,Grade 3,,,,,Stage IIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-2H-A9GQ,Unknown,ESCA,,1,1,,,,1,,1,,,,,,,,128,,,128,,1,1,112,112,,Malignant,,,,,,,17737,,,112,112,,,,,128,,,112,,,,,,,,WITH TUMOR,Dead,-29497,128,,,251,,112,112,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Erasmus MC,,TCGA-2H-A9GQ,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2001,112,,,,Stage III,,,,,,,,,,,,,,80,,,,,,,,,,,,,,,,,,,,86012,,,,,,,,,,,,,Grade 3,,,,,Stage III,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,1,0,1,1,Female,TCGA-55-7281,White,LUAD,,1,1,,International Genomics Consortium,1,0,FEMALE,1,3.07,0.42,5,1,6,,,872,,339,872,,1,1,339,339,,Malignant,12,,22,,,,23767,,,339,339,,,,339,872,,,339,,,,,,,,WITH TUMOR,Alive,-25870,,,,588,,339,339,,,[Not Available],[Not Applicable],,,,,0.08,,,,,15,,1,0.21529,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7281,,,,,,,872,,Distant Metastasis,,,,,,,25,,,,,,,,,,,,,2011,339,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,86014,,0.895446928,,,,,,,,,,0.271810593,,0.145137726,,,,Stage IA,,0.4835,,,,,,,,,,,,,,,,0.5775,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.111152644,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.8794,,0.3085,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,,0,1,Male,TCGA-78-7156,White,LUAD,,0,0,,Prince Charles Hospital,,,MALE,2,1.98,0.8,4,2,6,,,976,,,976,,2,2,976,976,,Malignant,12,,14,,,,25125,,,976,976,,,,,976,,,976,,,,,,,,,Dead,-22720,976,,,432,,976,976,,,[Not Available],[Not Applicable],,,,,0.0,,,,,4,,0,0.066128,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7156,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86015,,-0.366550075,,,,,,,,,,0.09132984,,0.227248464,,,,Stage IV,,-1.161,,,,,,,,,,,,,,,,-0.5646,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G477Afs*23 (driver),1,,,G477Afs*23 (driver),14.1146259,14.69857106,14.4387061,-0.605766866,LUAD,Adenocarcinoma,17.75080665,14.97736095,Adenocarcinoma,-2.4559,9.8323908,-0.9489,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,889,,889,889,,0,0,889,889,,Invasive Carcinoma,,,,,,,26126,0,,889,889,,,,889,889,,,889,,,,,,,,TUMOR FREE,Alive,-20495,,,,0,,889,889,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A442,,,,,,,889,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,86017,,-1.36599293,0,0,0,0,-1.27,1,,,Infiltrating Ductal Carcinoma,0.090062645,,0.198793841,0,0,0,,Negative,-1.014,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3533,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,No Detail Present,"DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.23,0.81,4,5,12,,,3088,BRCA_Basal,3088,3088,,0,0,3088,3088,,Invasive Carcinoma,21,,16,,,,29523,0,,3088,3088,,,,3088,3088,,,3088,,,,,,,,TUMOR FREE,Alive,-24891,,,,84,,3088,3088,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,18,,1,0.17885,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A1KF,,,,,,,3088,,,,,,,,,35,,,,,,,,,,,,,1998,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,86019,,-1.587200596,0,0,0,0,0.6552,1,,,Infiltrating Ductal Carcinoma,0.082607344,,0.155402604,0,0,0,,Negative,-3.024,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0666,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-ZF-AA4V,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.63,0.64,11,11,15,,,1806,,1806,1806,,0.0,0,1806.0,1806.0,,Malignant,37,,91,,,,32641.0,,,1806.0,1806,,,,1806,1806,,,1806.0,,,,,,,,TUMOR FREE,Alive,-24448,,,,968.0,,1806.0,1806,,,[Not Available],[Not Applicable],,,,,0.1,,,,,19,,1,0.21257,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA4V,,,,,,,1806,,,,,,,,,40,,,,,,,,,,,,,2008,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,66.0,,,,,,,,,,,,,,,,,,,,86024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-NC-A5HO,White,LUSC,,0,0,,Washington University - CHUV,0,0,FEMALE,0,1.73,0.63,14,14,15,,,1336,,1336,1336,,0,0,1336,1336,,Malignant,43,,102,,,,27870,,,1336,1336,,,,1336,1336,,,1336,,,,,,,,TUMOR FREE,Alive,-25694,,,,334,,1336,1336,,,[Not Available],[Not Applicable],,,,,0.06,,,,,11,,0,0.42482,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HO,,,,,,,1336,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,86026,,0.564021866,,,,,,,,,,0.096529857,,0.006032086,,,,Stage IIIA,,0.2215,,,,,,,,,,,,,,,,0.0373,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.32566969,14.34734125,15.8172176,-0.65863331366317,LUSC,Squamous Cell Carcinoma,17.49733004,15.74243471,Squamous Cell Carcinoma,-0.9243,13.17168342,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-O1-A52J,White,LUAD,,1,1,,Washington University - CALGB,,1,FEMALE,1,3.44,0.5,9,8,12,,,1798,,,1798,,1,1,898,898,,Malignant,29,,155,,,,33814,,,898,898,,,,,1798,,,898,,,,,,,,WITH TUMOR,Dead,-27223,1798,,,227,,898,898,,,[Not Available],[Not Applicable],,,,,0.17,,,,,25,,1,0.27904,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - CALGB,,TCGA-O1-A52J,,,,,,,,,Locoregional Recurrence,,,,,,,23,,,,,,,,,,,,,2007,898,,,,Stage IA,,,,,,,,[Unknown],,,,,,74,,,,,,,,,,,,,,,,,,,,86027,,0.831513948,,,,,,,,,,0.265311686,,0.051678214,,,,Stage IA,,0.7235,,,,,,,,,,,,,,,,-0.091,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.386190418,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.2198,,-0.9127,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-KK-A8IG,,PRAD,370,0,0,,KK,0,0,MALE,0,1.92,0.69,7,5,5,HRD,NO,2505,6-FOXA1,2505,2505,,0,0,2505,2505,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;CHEK2;PALB2;RAD51C;RAD51D;RAD54L,72,,TCGA-KK-A8IG-01,0,5531,0,TCGA-KK-A8IG,2505,2505,Prostate Cancer,,2211,2505,2505,TCGA,,2505,Primary,0,Apex|Middle,A,ATM:698:S/X:frameshift_variant,,True,TUMOR FREE,Alive,-20266,,55,7,41,PRAD,2505,2505,,0.0,[Not Available],[Not Applicable],36,,1,Matched,0.24,Prostate,Resection,4,C62DECAC-3413-4414-89DF-43085C3DDF65,5,Normal (no evidence of prostate cancer) [cM0],0,0.13738,[Not Available],1E3C1D8F-B3C9-47BE-89E4-22E6B16ED2AE,3,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,KK,1.2,TCGA-KK-A8IG,0:DiseaseFree,3,21,Prostate Adenocarcinoma,82.29,8/19/14,2505,,,,,NO,C61,D1F786EC-03F5-458B-99AC-3B89EFFF2297,60,5,TUMOR FREE,0.2051,0:LIVING,0.1,,82.29,Bilateral,22,No Evidence of Extraprostatic Extension,63,YES,2057,2008,,,TCGA-KK-A8IG.D1F786EC-03F5-458B-99AC-3B89EFFF2297.pdf,Transition Zone,[Not Applicable],YES,63,76-85%,19,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,,55,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T2a,,M0,C61.9,8140/3,86030,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.22,0.75,11,19,19,,,1545,BRCA_LumB,1545,1545,,0,0,1545,1545,,Invasive Carcinoma,49,,65,,,,17796,0,,1545,1545,,,,1545,1545,,,1545,,,,,,,,TUMOR FREE,Alive,-22179,,,,93,,1545,1545,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,15,,1,0.21661,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HY,,,,,,,1545,,,,,,,,,32,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,86031,,-0.772855477,0,0,0,0,-0.397,1,,,Infiltrating Ductal Carcinoma,0.118052553,,0.179835115,0,0,0,,Negative,-1.418,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4031,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"DCIS (Solid, Intermediate Grade), N/A No in Situ",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-73-4659,White,LUAD,,1,,,Roswell Park,,1,MALE,1,3.5,0.33,3,3,10,,,711,,,711,,1,,35,35,,Malignant,16,,18,,,,18682,,,35,,,,,,711,,,35,,,,,,,,WITH TUMOR,Dead,-24253,711,,,286,,35,,,,[Not Available],[Not Applicable],,,,,0.22,,,,,19,,1,0.12288,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4659,,,,,,,711,,,,,,,,,22,,,,,,,,,,,,,2006,35,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,66,,,,,,,,,,,,,,,,,,,,86038,,0.099522541,,,,,,,,,,0.272692652,,0.200126732,,,,Stage IIIA,,0.416,,,,,,,,,,,,,,,,0.316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.39249535,18.6186973,13.42621912,-0.580146993,LUAD,Adenocarcinoma,17.86900327,14.52113049,Adenocarcinoma,0.2325,14.48291701,-1.1443,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Male,TCGA-34-5241,White,LUSC,,0,0,,University of Pittsburgh,,2,MALE,2,3.75,0.88,1,3,10,,,515,,,515,,2,2,515,515,,Malignant,14,,20,,,,17153,,,515,515,,,,,515,,,515,,,,,,,,TUMOR FREE,Dead,-29098,515,,,263,,515,515,,,[Not Available],[Not Applicable],,,,,0.56,,,,,11,,1,0.062957,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-5241,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,79,,,,,,,,,,,,,,,,,,,,86041,,1.013062328,,,,,,,,,,0.254720902,,0.160754137,,,,Stage IB,,0.9405,,,,,,,,,,,,,,,,0.5232,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0579996644335415,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.5181,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,0,1,Female,TCGA-50-6673,White,LUAD,,0,0,,University of Pittsburgh,,,FEMALE,2,3.74,0.35,4,4,8,,,22,,,22,,2,2,22,22,,Malignant,16,,36,,,,16213,,,22,22,,,,,22,,,22,,,,,,,,,Dead,-30689,22,,,77,,22,22,,,[Not Available],[Not Applicable],,,,,0.27,,,,,16,,1,0.126,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-6673,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2004,,,,,Stage I,,,,,,,,[Unknown],,,,,,84,,,,,,,,,,,,,,,,,,,,86042,,,,,,,,,,,,,,,,,,Stage I,,,,,,,,,,,,,,,,,,0.5746,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"H773dup (driver), AMP (driver)",,,1,H773dup (driver),,,,,,-0.487130438,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.329,,-1.3312,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-55-6980,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.18,0.31,2,1,4,,,2109,,2109,2109,,0,0,2109,2109,,Malignant,7,,17,,,,24206,,,2109,2109,,,,2109,2109,,,2109,,,,,,,,TUMOR FREE,Alive,,,,,20,,2109,2109,,,[Not Available],[Not Applicable],,,,,0.35,,,,,13,,0,0.25093,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6980,,,,,,,2109,,,,,,,,,16,,,,,,,,,,,,,2006,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,86044,,1.129242282,,,,,,,,,,0.240660295,,0.165089394,,,,Stage IA,,1.0615,,,,,,,,,,,,,,,,0.7696,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E709_T710delinsD (driver),,,1,E709_T710delinsD (driver),,,,,,-0.089202565,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.6833,,-0.2262,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.12,0.4,10,10,12,,,1988,BRCA_Basal,1988,1988,,0,0,1988,1988,,Invasive Carcinoma,32,,25,,,,21957,0,,1988,1988,,,,1988,1988,,,1988,,,,,,,,TUMOR FREE,Alive,-26993,,,,1125,,1988,1988,,,[Not Available],[Not Applicable],,,,,0.34,Breast,Resection/Excision,,,16,,1,0.28888,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0U0,,,,,,,1988,,,,,,,,,37,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,86046,,1.477333738,0,0,0,0,-2.1857,1,,,Infiltrating Ductal Carcinoma,0.179249368,,0.093733038,0,0,0,,Negative,1.892,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0451,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,,,White,BRCA,,0,0,,,,0,FEMALE,1,2.47,0.38,8,1,4,,,2231,BRCA_LumA,,2231,,0,0,968,968,,Invasive Carcinoma,13,,141,,,,32513,0,,2231,2231,,,,,2231,,,968,,,,,,,,TUMOR FREE,Alive,-22780,,,,42,,2231,2231,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,16,,1,0.57016,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A5QM,,,,,,,2231,"Other, specify",New Primary Tumor,,,,,,,27,,,,,,,,,,,,,2008,968,Malignant melanoma,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86047,,0.011421107,0,0,0,0,1.0459,1,,,Infiltrating Lobular Carcinoma,0.182953843,,0.217831118,0,0,0,,[Not Available],0.088,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5035,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,3.78,0.34,14,5,14,,,639,BRCA_Basal,563,639,,1,1,563,563,,Invasive Carcinoma,33,,47,,,,19886,0,,563,563,,,,563,639,,,563,,,,,,,,WITH TUMOR,Dead,-14784,639,,,49,,563,563,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,12,,1,0.39873,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,Duke,,TCGA-B6-A0WX,,,,,,,,Bone,Distant Metastasis,,,,,,,22,,,,,,,,,,,,,1998,563,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,86049,,0.988937019,0,0,0,0,1.5614,0,,,Other,0.159824784,,0.152468771,0,0,0,,Negative,-0.111,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6082,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Sclerosing Adenosis,0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Sclerosing Adenosis,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8262,,PRAD,221,0,0,,HC,0,0,MALE,0,1.95,0.47,3,2,2,HRP,NO,679,1-ERG,679,679,,0,0,679,679,prad_tcga,Malignant,7,BRCA1,39,4.7,TCGA-HC-8262-01,0,5443,0,TCGA-HC-8262,679,679,Prostate Cancer,,112,679,679,TCGA,,679,Primary,0,,A,,,,TUMOR FREE,Alive,-20946,,57,8,44,PRAD,679,679,,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.02,Prostate,Resection,4,3e598be1-f16d-4efd-9d30-f9bfe7c85cf3,1,,0,0.047043,[Not Available],fb7e9935-32a2-422b-8004-88b827a686c2,4,Prostate Adenocarcinoma Acinar Type,0.3,Prostate,7,,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.3,TCGA-HC-8262,0:DiseaseFree,4,9,Prostate Adenocarcinoma,22.31,6/20/12,679,,,,,,C61,b2b40b37-fcee-4ad0-ae88-0ca54e39cf7c,,2,TUMOR FREE,0.0447,0:LIVING,0.1,,22.31,Bilateral,10,,,YES,,2011,,,TCGA-HC-8262.b2b40b37-fcee-4ad0-ae88-0ca54e39cf7c.pdf,,[Not Applicable],,,51-60%,8,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.2,57,Core needle biopsy,,,YES,NO,YES,NO,T2c,,8,No,,0,N0,,0,,C61.9,8550/3,86054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2756,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.73,0.71,10,22,15,,,30,,,30,,0,0,30,30,,Malignant,47,,50,,,,21027,,,30,30,,,,,30,,,30,,,,,,,,TUMOR FREE,Alive,-24929,,,,668,,30,30,,,[Not Available],[Not Applicable],,,,,0.32,,,,,20,,2,0.23408,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2756,,,,,,,30,,,,,,,,,73,,,,,,,,,,,,,2007,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,86058,,0.180089919,,,,,,,,,,0.123884903,,0.045935466,,,,Stage IIIB,,-0.115,,,,,,,,,,,,,,,,-0.1663,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V369L,1,,,V369L,15.08127566,14.88315299,14.66375791,-0.475253776598329,LUSC,Squamous Cell Carcinoma,17.75063773,15.23436262,Squamous Cell Carcinoma,0.1226,13.2254331,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,0,0,1,Male,TCGA-BR-8289,White,STAD,,0,0,,,,2,,2,3.81,0.5,16,18,21,,,81,,,81,,2,2,81,81,,Malignant,55,,306,,,,26560,,,81,81,,,,,81,,,81,,,,,,,,TUMOR FREE,Dead,-20849,81,,,265,,81,81,,,[Not Available],[Not Applicable],,,,,0.36,Stomach,Unknown,,,18,,2,0.45982,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8289,,,,,,,,,,,,,,,,61,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,86065,,-0.109795439,,,,,,,,,,0.059147027,Grade 3,0.069419792,,,,Stage IV,,-0.232,,,,,,,,,,,,,,,,0.2391,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8289,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-05-4403,,LUAD,,0,0,,Indivumed,,0,MALE,0,2.06,0.46,4,3,3,,,578,,,578,,0,0,578,578,,Malignant,10,,7,,,,16557,,,578,578,,,,,578,,,578,,,,,,,,,Alive,-27881,,,,178,,578,578,,,[Not Available],[Not Applicable],,,,,0.01,,,,,0,,0,0.057736,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4403,,,,,,,578,,,,,,,,,4,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,86067,,0.297440946,,,,,,,,,,0.288564109,,0.156879607,,,,Stage IB,,0.209,,,,,,,,,,,,,,,,0.2989,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.231114843,LUAD,,,,Adenocarcinoma,0.1209,,-0.5683,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HU-8238,Asian,STAD,,0,0,,,0,0,,0,,,,,,,,46,,46,46,,0,0,46,46,,Malignant,,,,,,,20784,,,46,46,,,,46,46,,,46,,,,,,,,TUMOR FREE,Alive,-20708,,,,234,,46,46,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-8238,,,,,,,46,,,,,,,,,,,,,,,,,,,,,,2011,,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,86068,,,,,,,,,,,,,Grade 2,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-8238,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Female,TCGA-BR-8364,White,STAD,,0,0,,,0,0,,0,1.9,0.17,8,10,6,,,675,,675,675,,0,0,675,675,,Malignant,24,,48,,,,18586,,,675,675,,,,675,675,,,675,,,,,,,,TUMOR FREE,Alive,-15389,,,,22,,675,675,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,4,,0,0.25144,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8364,,,,,,,675,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,42,,,,,,,,,,,,,,,,,,,,86069,,0.355972016,,,,,,,,,,0.150293335,Grade 3,0.188579684,,,,Stage IIIC,,0.3235,,,,,,,,,,,,,,,,0.6845,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8364,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0.0,0,0,0.0,0.0,Female,TCGA-FD-A3N6,Black or African American,BLCA,,0.0,0,,,0,0,FEMALE,0.0,2.09,0.83,2,3,4,,,851,,851,851,,0.0,0,851.0,851.0,,Malignant,9,,25,,,,20558.0,,,851.0,851,,,,851,851,,,851.0,,,,,,,,TUMOR FREE,Alive,-15758,,,,156.0,,851.0,851,,,[Not Available],[Not Applicable],,,,,0.0,,,,,1,,0,0.031648,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3N6,,,,,,,851,,,,,,,,,3,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,43.0,,,,,,,,,,,,,,,,,,,,86082,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,,,,1,1,FEMALE,1,1.99,0.84,4,1,5,,,1920,BRCA_LumA,1470,1920,,1,,1470,1470,,Invasive Carcinoma,10,,18,,,,17907,0,,1470,,,,,1470,1920,,,1470,,,,,,,,WITH TUMOR,Dead,-14250,1920,,,57,,1470,,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.07093,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04V,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2005,1470,,,,Stage IIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,86085,,-0.455050455,0,0,0,0,-0.5991,1,,,Infiltrating Ductal Carcinoma,0.14731765,,0.18673968,0,0,0,,Negative,-1.2285,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4897,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.1,0.57,7,7,10,,,1522,BRCA_LumA,1522,1522,,0,0,1522,1522,,In Situ Carcinoma,24,,71,,,,20224,0,,1522,1522,,,,1522,1522,,,1522,,,,,,,,TUMOR FREE,Alive,-17440,,,,83,,1522,1522,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,3,,0,0.15707,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09D,,,,,,,1522,,,,,,,,,8,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,86087,,0.55043865,0,0,0,0,-0.2122,1,,,Infiltrating Ductal Carcinoma,0.227101469,,0.241157846,0,0,0,,Negative,-0.5625,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4724,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,1,Adipose Tissue,Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,None,None,0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-FD-A6TD,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.01,0.37,8,11,10,,,386,,386,386,,2.0,2,386.0,386.0,,Malignant,29,,77,,,,27668.0,,,386.0,386,,,,386,386,,,386.0,,,,,,,,TUMOR FREE,Dead,-28328,386,,,191.0,,386.0,386,,,[Not Available],[Not Applicable],,,,,0.21,,,,,9,,1,0.26037,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TD,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,86089,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.84,0.74,7,9,5,,,1953,BRCA_LumA,1953,1953,,0,0,1953,1953,,Invasive Carcinoma,21,,49,,,,23617,0,,1953,1953,,,,1953,1953,,,1953,,,,,,,,TUMOR FREE,Alive,-23686,,,,101,,1953,1953,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,5,,0,0.20583,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Fox Chase,,TCGA-PE-A5DD,,,,,,,1953,,,,,,,,,7,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,86090,,0.513067049,0,0,0,0,0.4889,1,,,Infiltrating Lobular Carcinoma,0.108454656,,0.271437976,0,0,0,,Negative,-0.061,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4787,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-85-A4CN,White,LUSC,,0,0,,Asterand,0,0,FEMALE,0,1.56,0.54,16,5,12,,,1038,,1038,1038,,0,0,1038,1038,,Malignant,33,,164,,,,34081,,,1038,1038,,,,1038,1038,,,1038,,,,,,,,TUMOR FREE,Alive,-20490,,,,242,,1038,1038,,,[Not Available],[Not Applicable],,,,,0.22,,,,,12,,0,0.56626,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A4CN,,,,,,,1038,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,86091,,0.554318687,,,,,,,,,,0.157828283,,0.091588773,,,,Stage IIB,,1.245,,,,,,,,,,,,,,,,0.7225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.73126986,15.11184274,16.15528107,-0.42449102859389,LUSC,Squamous Cell Carcinoma,18.01771705,16.06646335,Squamous Cell Carcinoma,0.6703,10.71729537,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,,1,1,,,White,BRCA,,1,1,,,1,,FEMALE,1,3.1,0.73,20,19,24,,,2854,BRCA_Basal,1640,2854,,1,1,1640,1640,,Invasive Carcinoma,63,,179,,,,31279,0,,1640,1640,,,,1640,2854,,,1640,,,,,,,,,Dead,-16642,2854,,,285,,1640,1640,,,[Not Available],[Not Applicable],,,,,0.26,Breast,Resection/Excision,,,14,,1,0.45142,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A256,,,,,,,,,Locoregional Disease,,,,,,,29,,,,,,,,,,,,,2001,1640,,,,Stage IIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,86099,TRUE,0.52323935,0,0,0,0,0.4207,1,,,Infiltrating Ductal Carcinoma,0.145785316,,0.062387751,0,0,0,,Negative,-0.6455,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2046,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-50-6593,White,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,2.94,0.31,7,8,13,,,336,,,336,,1,1,266,266,,Malignant,28,,31,,,,22112,,,266,266,,,,,336,,,266,,,,,,,,WITH TUMOR,Dead,-18152,336,,,408,,266,266,,,[Not Available],[Not Applicable],,,,,0.26,,,,,25,,1,0.27017,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-6593,,,,,,,,,Distant Metastasis,,,,,,,36,,,,,,,,,,,,,2008,266,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,49,,,,,,,,,,,,,,,,,,,,86100,,0.455627459,,,,,,,,,,0.289093999,,0.170919919,,,,Stage IIIA,,0.6415,,,,,,,,,,,,,,,,0.64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.35341396,17.76007705,14.29760538,-0.491042202,LUAD,Adenocarcinoma,18.24086497,14.8844591,Adenocarcinoma,0.8827,13.62466724,-1.1023,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-66-2770,,LUSC,,0,0,,Indivumed,,0,MALE,0,1.66,0.64,6,4,6,,,700,,,700,,0,0,700,700,,Malignant,16,,26,,,,21269,,,700,700,,,,,700,,,700,,,,,,,,,Alive,-28945,,,,333,,700,700,,,[Not Available],[Not Applicable],,,,,0.8,,,,,8,,0,0.34482,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2770,,,,,,,700,,,,,,,,,10,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,86103,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.5056,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.153360191815309,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.5445,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-18-4721,White,LUSC,,0,0,,Princess Margaret Hospital (Canada),0,0,MALE,0,1.75,0.39,20,12,19,,,4694,,4694,4694,,0,0,4694,4694,,Malignant,51,,57,,,,17174,,,4694,4694,,,,4694,4694,,,4694,,,,,,,,TUMOR FREE,Alive,-27076,,,,254,,4694,4694,,,[Not Available],[Not Applicable],,,,,0.15,,,,,7,,0,0.50103,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-4721,,,,,,,4694,,,,,,,,,18,,,,,,,,,,,,,2002,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,86109,,1.403486019,,,,,,,,,,0.237919992,,0.103607143,,,,Stage IA,,2.1205,,,,,,,,,,,,,,,,0.358,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.13904897978515,LUSC,,,,Squamous Cell Carcinoma,0.6497,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,510,,510,510,,0,0,510,510,,Invasive Carcinoma,,,,,,,29834,0,,510,510,,,,510,510,,,510,,,,,,,,TUMOR FREE,Alive,-21623,,,,143,,510,510,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A6SA,,,,,,,510,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,86112,,-1.267523178,0,0,0,0,-0.2468,1,,,Infiltrating Ductal Carcinoma,0.021116323,,0.130459863,0,0,0,,Negative,-2.223,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,-0.2773,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-UY-A78M,Asian,BLCA,,1.0,1,,,,1,FEMALE,1.0,1.99,0.69,12,9,13,,,690,,,690,,1.0,1,690.0,690.0,,Malignant,34,,106,,,,17090.0,,,690.0,690,,,,,690,,,690.0,,,,,,,,WITH TUMOR,Dead,-29706,690,,,207.0,,690.0,690,,,[Not Available],[Not Applicable],,,,,0.73,,,,,5,,0,0.33222,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A78M,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,[Unknown],,,,,,81.0,,,,,,,,,,,,,,,,,,,,86114,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-96-8169,White,LUSC,,0,0,,Washington University - NYU,0,0,FEMALE,0,1.87,0.42,9,2,11,,,557,,557,557,,0,0,557,557,,Malignant,22,,31,,,,29003,,,557,557,,,,557,557,,,557,,,,,,,,TUMOR FREE,Alive,-24674,,,,226,,557,557,,,[Not Available],[Not Applicable],,,,,0.24,,,,,13,,0,0.3269,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - NYU,,TCGA-96-8169,,,,,,,557,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,86122,,0.303655237,,,,,,,,,,0.179197651,,0.068954151,,,,Stage IA,,0.503,,,,,,,,,,,,,,,,0.817,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.372506021000813,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.7758,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.27,0.88,4,1,6,,,1371,BRCA_LumA,1371,1371,,0,0,1371,1371,,None,11,,31,,,,23555,N/A (Non-Malignant),,1371,1371,,,,1371,1371,,,1371,,,,,,,,TUMOR FREE,Alive,-31351,,,,42,,1371,1371,,,[Not Available],[Not Applicable],,,,,0.16,Not Specific/Unknown,Resection/Excision,,,10,,0,0.7496,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07Z,,,,,,,1371,,,,,,,,,18,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,85,,,,,,,,,,,,,,,,,,,,86123,,0.104499247,0,0,0,0,-0.0639,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.098589185,N/A (Non-Malignant),0.118031694,0,0,0,N/A (Non-Malignant),Negative,-0.0065,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.0763,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,1,None of the Above,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.94,4,3,3,,,911,BRCA_LumB,911,911,,0,0,911,911,,Invasive Carcinoma,10,,13,,,,33637,0,,911,911,,,,911,911,,,911,,,,,,,,TUMOR FREE,Alive,-15837,,,,46,,911,911,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,1,,0,0.044644,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mucinous Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1OX,,,,,,,911,,,,,,,,,3,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,86126,,-2.001158947,0,0,0,0,-0.393,1,,,Mucinous Carcinoma,0.009384483,,0.09959725,0,0,0,,Negative,-2.313,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.7615,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7210,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.47,5,10,1,HRD,NO,868,6-FOXA1,868,868,,0,0,868,868,prad_tcga,Malignant,16,,33,8.9,TCGA-HC-7210-01,8,5408,0,TCGA-HC-7210,868,868,Prostate Cancer,,149,868,868,TCGA,,868,Primary,0,,A,,ATM;BRCA2;CHEK1,,TUMOR FREE,Alive,-27343,,74,7,51,PRAD,868,868,WHITE,0.203529837,[Not Available],[Not Applicable],29,R0,1,Matched,0.0,Prostate,Resection,3,9069fc65-9bae-49f3-9329-b78c8cc6cf1e,0,,0,0.059512,[Not Available],6a5af80e-07ad-4cd3-aaab-5db1090835d9,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,16,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,HC,0.966666666667,TCGA-HC-7210,0:DiseaseFree,2,26,Prostate Adenocarcinoma,28.52,4/10/12,868,,,,,,C61,8398444a-bfad-41d6-94a6-ab85ddf159aa,,0,TUMOR FREE,0.0743,0:LIVING,0.1,,28.52,Right,27,,,YES,,2011,,,TCGA-HC-7210.8398444a-bfad-41d6-94a6-ab85ddf159aa.pdf,,[Not Applicable],,,61-70%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.9,74,Core needle biopsy,,,YES,NO,YES,,T2a,,7,No,,0,N0,,0,,C61.9,8550/3,86127,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.29,0.41,8,17,15,,,2513,BRCA_Basal,2513,2513,,0,0,2513,2513,,Invasive Carcinoma,40,,44,,,,21747,0,,2513,2513,,,,2513,2513,,,2513,,,,,,,,TUMOR FREE,Alive,-18900,,,,94,,2513,2513,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,11,,1,0.23214,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A1KR,,,,,,,2513,,,,,,,,,28,,,,,,,,,,,,,2005,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,86130,TRUE,0.511196684,0,0,0,0,1.3256,1,,,Infiltrating Ductal Carcinoma,0.039890744,,0.08135412,0,0,0,,Negative,-0.196,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1964,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.53,0,0,0,,,426,BRCA_LumA,426,426,,0,0,426,426,,Invasive Carcinoma,0,,19,,,,23853,0,,426,426,,,,426,426,,,426,,,,,,,,TUMOR FREE,Alive,-20497,,,,35,,426,426,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,0,,0,4.65e-05,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JH,,,,,,,426,,,,,,,,,0,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,86140,,0.745829419,0,0,0,0,0.2278,1,,,Infiltrating Ductal Carcinoma,0.183900421,,0.227225224,0,0,0,,Negative,0.013,,10/21/22,0,0,0,1,0,0,0,0,0,0,no,0,0,0.6111,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Benign Breast Epithelium, Skin",No Detail Present,"DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-6971,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,3.28,0.23,3,8,7,,,1400,,1400,1400,,0,0,1400,1400,,Malignant,18,,15,,,,20155,,,1400,1400,,,,1400,1400,,,1400,,,,,,,,TUMOR FREE,Alive,-21734,,,,114,,1400,1400,,,[Not Available],[Not Applicable],,,,,0.29,,,,,19,,1,0.11287,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6971,,,,,,,1400,,,,,,,,,28,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,86141,,1.997878616,,,,,,,,,,0.283273241,,0.186170286,,,,Stage IB,,2.073,,,,,,,,,,,,,,,,0.4039,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.221632948,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2184,,1.6471,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-77-7139,White,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,3.1,0.72,7,7,13,,,4261,,4261,4261,,0,0,4261,4261,,Malignant,27,,27,,,,23926,,,4261,4261,,,,4261,4261,,,4261,,,,,,,,,Alive,-20632,,,,242,,4261,4261,,,[Not Available],[Not Applicable],,,,,0.23,,,,,16,,1,0.30426,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7139,,,,,,,4261,,,,,,,,,25,,,,,,,,,,,,,2002,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,86143,,0.607958525,,,,,,,,,,0.132117183,,0.087860282,,,,Stage IIB,,1.646,,,,,,,,,,,,,,,,-0.0114,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.02816183,14.60831889,16.26341009,-0.355317842877668,LUSC,Squamous Cell Carcinoma,17.84089914,15.60902362,Squamous Cell Carcinoma,-0.4363,14.25758956,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A5BS,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.0,0.59,0,1,0,,,1639,,1639,1639,,0.0,0,1639.0,1639.0,,Malignant,1,,4,,,,16354.0,,,1639.0,1639,,,,1639,1639,,,1639.0,,,,,,,,TUMOR FREE,Alive,-24963,,,,38.0,,1639.0,1639,,,[Not Available],[Not Applicable],,,,,0.2,,,,,0,,0,4.67e-05,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5BS,,,,,,,1639,,,,,,,,,0,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,68.0,,,,,,,,,,,,,,,,,,,,86145,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,3.86,0.55,1,0,3,,,3126,BRCA_LumA,2787,3126,,1,1,2787,2787,,Invasive Carcinoma,4,,3,,,,19385,0,,2787,2787,,,,2787,3126,,,2787,,,,,,,,WITH TUMOR,Dead,-26941,3126,,,35,,2787,2787,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,16,,1,0.051129,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Duke,,TCGA-B6-A0RP,,,,,,,,Bone,Distant Metastasis,,,,,,,15,,,,,,,,,,,,,1994,2787,,,,[Discrepancy],,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,86148,,-0.01993864,0,0,0,0,0.7714,1,,,Mixed Histology (NOS),0.182575664,,0.158653772,0,0,0,,Negative,-0.3855,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5068,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.5,0.64,6,24,20,,,1309,BRCA_Normal,1309,1309,,0,0,1309,1309,,Invasive Carcinoma,50,,33,,,,34174,0,,1309,1309,,,,1309,1309,,,1309,,,,,,,,TUMOR FREE,Alive,-19478,,,,149,,1309,1309,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,17,,1,0.45365,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XW,,,,,,,1309,,,,,,,,,37,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,86156,,,0,0,0,0,0.9968,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-BR-8297,White,STAD,,0,0,,,,0,,0,4.41,0.22,5,18,18,,,225,,,225,,0,0,225,225,,Malignant,41,,31,,,,24693,,,225,225,,,,,225,,,225,,,,,,,,WITH TUMOR,Alive,-21224,,,,358,,225,225,,,[Not Available],[Not Applicable],,,,,0.41,Stomach,Unknown,,,13,,2,0.16469,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,GX,,Asterand,,TCGA-BR-8297,,,,,,,225,,,,,,,,,67,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Progressive Disease,,,,,,58,,,,,,,,,,,,,,,,,,,,86158,,0.198210558,,,,,,,,,,0.075633498,Unknown,0.153205314,,,,Stage IIIC,,0.0405,,,,,,,,,,,,,,,,0.3114,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8297,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.39,3,1,3,,,402,BRCA_LumA,402,402,,0,0,402,402,,Invasive Carcinoma,7,,24,,,,20270,0,,402,402,,,,402,402,,,402,,,,,,,,WITH TUMOR,Alive,-28981,,,,376,,402,402,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,6,,0,0.13481,[Not Available],,,"Other, specify",,,,,,[Not Available],,Hartford Hospital,,TCGA-LD-A74U,,,,,,,402,,,,,,,,,5,,,,,,,,,,,,,2013,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,86162,,-0.037124101,0,1,0,0,0.5291,0,,,Other,0.209445158,,0.25585711,0,0,0,,Negative,-0.0325,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6365,1,0,H & E,0,0,,0,Jeffrey Eisenstein,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,ALH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-73-4662,White,LUAD,,1,,,Roswell Park,1,0,FEMALE,1,3.0,0.48,10,9,17,,,2515,,21,2515,,1,,21,21,,Malignant,36,,27,,,,21057,,,21,,,,,21,2515,,,21,,,,,,,,TUMOR FREE,Alive,-23762,,,,267,,21,,,,[Not Available],[Not Applicable],,,,,0.26,,,,,10,,1,0.26268,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4662,,,,,,,2515,,,,,,,,,34,,,,,,,,,,,,,2007,21,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,86171,,1.269617614,,,,,,,,,,0.264176841,,0.152165899,,,,Stage IA,,1.5395,,,,,,,,,,,,,,,,0.0869,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.146221869,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2439,,0.4034,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.92,0.81,9,14,17,,,908,BRCA_LumB,908,908,,0,0,908,908,,None,40,,53,,,,31369,N/A (Non-Malignant),,908,908,,,,908,908,,,908,,,,,,,,TUMOR FREE,Alive,-23266,,,,89,,908,908,,,[Not Available],[Not Applicable],,,,,0.34,Breast,Resection/Excision,,,15,,1,0.29868,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1OY,,,,,,,908,,,,,,,,,42,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,86184,,-0.051915753,0,0,0,0,0.8689,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.131591333,N/A (Non-Malignant),0.112725918,0,0,0,N/A (Non-Malignant),Negative,-1.111,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1494,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-GU-A766,White,BLCA,,0.0,0,,,,0,MALE,0.0,1.96,0.39,7,6,11,,,480,,,480,,0.0,0,480.0,480.0,,Malignant,24,,105,,,,28401.0,,,480.0,480,,,,,480,,,480.0,,,,,,,,WITH TUMOR,Alive,-22774,,,,263.0,,480.0,480,,,[Not Available],[Not Applicable],,,,,0.45,,,,,7,,0,0.37511,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A766,,,,,,,480,,,,,,,,,18,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,62.0,,,,,,,,,,,,,,,,,,,,86193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-CU-A5W6,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.62,0.47,9,12,7,,,56,,56,56,,2.0,2,56.0,56.0,,Malignant,28,,62,,,,22410.0,,,56.0,56,,,,56,56,,,56.0,,,,,,,,TUMOR FREE,Dead,-25706,56,,,305.0,,56.0,56,,,[Not Available],[Not Applicable],,,,,0.23,,,,,15,,1,0.15016,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,UNC,,TCGA-CU-A5W6,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,86197,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.34,12,11,11,,,447,BRCA_LumA,447,447,,0,0,447,447,,Invasive Carcinoma,34,,99,,,,33318,0,,447,447,,,,447,447,,,447,,,,,,,,TUMOR FREE,Alive,-16884,,,,66,,447,447,,,[Not Available],[Not Applicable],,,,,0.65,Breast,Resection/Excision,,,4,,0,0.2357,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A5YN,,,,,,,447,,,,,,,,,13,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,86203,,1.721179255,0,0,0,0,0.5288,1,,,Infiltrating Ductal Carcinoma,0.136280489,,0.088866746,0,0,0,,Negative,0.4155,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0419,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.28,0.31,7,12,13,,,2406,BRCA_Her2,2406,2406,,0,0,2406,2406,,Invasive Carcinoma,32,,27,,,,21165,0,,2406,2406,,,,2406,2406,,,2406,,,,,,,,TUMOR FREE,Alive,-22883,,,,164,,2406,2406,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,16,,1,0.15924,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DB,,,,,,,2406,,,,,,,,,29,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86204,TRUE,0.940581306,0,0,0,0,1.1983,1,,,Infiltrating Ductal Carcinoma,0.153832528,,0.090217135,0,0,0,,Negative,0.3045,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0418,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.47,0.37,12,20,17,,,1174,BRCA_Her2,,1174,,1,1,1174,1174,,Invasive Carcinoma,49,,59,,,,17206,0,,1174,1174,,,,,1174,,,1174,,,,,,,,WITH TUMOR,Dead,-28609,1174,,,106,,1174,1174,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,13,,1,0.24734,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A203,,,,,,,,,,,,,,,,37,,,,,,,,,,,,,1996,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,86208,,0.992273869,0,0,0,0,-0.6509,1,,,Infiltrating Ductal Carcinoma,0.17725772,,0.125500249,0,0,0,,[Not Available],-0.2775,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2662,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"DCIS (Solid, Low Grade), N/A No in Situ",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,Black or African American,BRCA,,1,1,,,,1,FEMALE,1,4.07,0.78,4,9,12,,,2911,BRCA_LumB,,2911,,1,1,1922,1922,,Invasive Carcinoma,25,,39,,,,19022,0,,1922,1922,,,,,2911,,,1922,,,,,,,,WITH TUMOR,Dead,-19724,2911,,,89,,1922,1922,,,[Not Available],[Not Applicable],,,,,0.35,Breast,Resection/Excision,,,9,,1,0.099249,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A03P,,,,,,,,Liver,Distant Metastasis,,,,,,,21,,,,,,,,,,,,,2003,1922,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,86210,,-0.042766511,0,0,0,0,-0.1609,1,,,Infiltrating Ductal Carcinoma,0.113330998,,0.156246137,0,0,0,,Close,-1.215,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1357,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,360,,360,360,,0,0,360,360,,Invasive Carcinoma,,,,,,,20159,0,,360,360,,,,360,360,,,360,,,,,,,,,Alive,,,,,0,,360,360,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,ABS - Research Metrics Pakistan,,TCGA-JL-A3YW,,,,,,,360,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,86217,,1.006150374,0,0,0,0,0.8244,1,,,Infiltrating Lobular Carcinoma,0.258475962,,0.167071634,0,0,0,,Negative,1.001,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.8984,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,1.0,1.0,Female,TCGA-BR-8058,White,STAD,,0.0,0,,,0,0,,1.0,1.76,0.3,9,3,5,,,1133,,1133,1133,,0.0,0,89,89,,Malignant,17,,60,,,,0.0,0,,1133,1133,,,,1133,1133,,,89,,,,,,,,TUMOR FREE,Alive,-19658,,,,57.0,,1133,1133,,,[Not Available],[Not Applicable],,,,,0.2,Stomach,Resection,,,7,,0,0.27606,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8058,,,,,,,1133,"Other, specify",New Primary Tumor,,,,,,,9,,,,,,,,,,,,,2011,89,Rectum,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,86219,,1.255964089,,,,,,,,,,0.163563122,Grade 3,0.135692074,,,,Stage IIIB,,1.329,,,,,,,,,,,,,,,,0.4665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8058,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,1.77,0.72,11,5,10,,,4456,BRCA_LumA,,4456,,1,1,4456,4456,,Invasive Carcinoma,26,,60,,,,23440,0,,4456,4456,,,,,4456,,,4456,,,,,,,,WITH TUMOR,Dead,-18433,4456,,,0,,4456,4456,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,10,,0,0.30408,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0IG,,,,,,,,,,,,,,,,11,,,,,,,,,,,,,1994,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,86221,,0.003876746,0,0,0,0,0.1494,1,,,Infiltrating Ductal Carcinoma,0.115278906,,0.117001833,0,0,0,,Negative,-0.956,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2485,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-56-8625,White,LUSC,,1,1,,International Genomics Consortium,,1,FEMALE,1,1.89,0.37,17,17,12,,,315,,,315,,1,1,272,272,,Malignant,46,,107,,,,26377,,,272,272,,,,,315,,,272,,,,,,,,WITH TUMOR,Dead,-24188,315,,,698,,272,272,,,[Not Available],[Not Applicable],,,,,0.2,,,,,6,,0,0.34187,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8625,,,,,,,,,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2012,272,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,66,,,,,,,,,,,,,,,,,,,,86224,,1.604894727,,,,,,,,,,0.29518739,,0.106546113,,,,Stage IIIA,,1.9355,,,,,,,,,,,,,,,,0.7107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.31864095,18.39574287,18.01180435,0.245841409188949,LUSC,Squamous Cell Carcinoma,18.28313203,17.24570773,Squamous Cell Carcinoma,0.7765,14.52917979,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-86-8673,White,LUAD,,1,1,,Asterand,1,0,MALE,1,2.56,0.4,13,20,20,,,862,,636,862,,1,1,636,636,,Malignant,53,,160,,,,25016,,,636,636,,,,636,862,,,636,,,,,,,,TUMOR FREE,Alive,-22571,,,,624,,636,636,,,[Not Available],[Not Applicable],,,,,0.25,,,,,25,,1,0.44604,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8673,,,,,,,862,,Locoregional Recurrence,,,,,,,40,,,,,,,,,,,,,2011,636,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,86229,,0.490763304,,,,,,,,,,0.16285169,,0.117832473,,,,Stage IB,,0.356,,,,,,,,,,,,,,,,0.1553,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.381674044,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2194,,0.3729,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-49-6761,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,3.19,0.29,8,7,9,,,354,,354,354,,0,0,354,354,,Malignant,24,,17,,,,16468,,,354,354,,,,354,354,,,354,,,,,,,,TUMOR FREE,Alive,-24849,,,,241,,354,354,,,[Not Available],[Not Applicable],,,,,0.21,,,,,13,,1,0.28986,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6761,,,,,,,354,,,,,,,,,35,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,86232,,1.593229986,,,,,,,,,,0.197229262,,0.107278439,,,,Stage IIIA,,2.3115,,,,,,,,,,,,,,,,0.3379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.11950115,16.45457624,17.83103591,0.124281935,LUAD,,18.41423595,16.26142641,Adenocarcinoma,0.5508,12.78247644,0.7379,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-4Z-AA7M,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.43,0.6,8,17,21,,,495,,495,495,,0.0,0,495.0,495.0,,Malignant,46,,89,,,,30523.0,,,495.0,495,,,,495,495,,,495.0,,,,,,,,TUMOR FREE,Alive,-23817,,,,714.0,,495.0,495,,,[Not Available],[Not Applicable],,,,,0.2,,,,,16,,1,0.16929,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA7M,,,,,,,495,,,,,,,,,30,,,,,,,,,,,,,2013,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,65.0,,,,,,,,,,,,,,,,,,,,86233,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-CD-5803,Asian,STAD,,1,1,,,,1,,1,1.73,0.27,0,1,1,,,341,,,341,,1,1,300,300,,Malignant,2,,13,,,,19565,,,300,300,,,,,341,,,300,,,,,,,,WITH TUMOR,Dead,-28608,341,,,41,,300,300,,,[Not Available],[Not Applicable],,,,,0.39,Stomach,Unknown,,,9,,0,0.30054,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-5803,,,,,,,,Liver,Distant Metastasis,,,,,,,8,,,,,,,,,,,,,2010,300,,,,Stage II,,,,,,,,Progressive Disease,,,,,,78,,,,,,,,,,,,,,,,,,,,86234,,1.667160219,,,,,,,,,,0.138345377,Grade 3,0.209480832,,,,Stage II,,1.7455,,,,,,,,,,,,,,,,0.7149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-5803,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-VP-AA1N,,PRAD,,0,0,,VP,0,0,MALE,0,3.62,0.54,9,18,8,HRD,NO,1365,,1365,1365,,0,0,1365,1365,prad_tcga,Malignant,35,BRCA1;BRIP1;CDK12;PALB2;RAD51C;RAD51D;RAD54L,139,,TCGA-VP-AA1N-01,6,5600,0,TCGA-VP-AA1N,1365,1365,Prostate Cancer,,542,1365,1365,TCGA,,1365,Primary,0,Apex|Base,A,,ATM;CHEK1,True,TUMOR FREE,Alive,-25781,,70,9,49,PRAD,1365,1365,,0.149567758,[Not Available],[Not Applicable],38,,1,Matched,0.18,Prostate,Resection,5,D80E5EAB-10B0-470E-802E-8BA6C006F067,16,Normal (no evidence of prostate cancer) [cM0],1,0.10036,[Not Available],EA953CE5-7082-41FF-8E38-760FE4100414,4,Prostate Adenocarcinoma Acinar Type,,Prostate,37,,Acinar Adenocarcinoma,[Not Available],,VP,1.26666666667,TCGA-VP-AA1N,0:DiseaseFree,5,39,Prostate Adenocarcinoma,44.84,3/31/14,1365,,,,,NO,C61,B76B30C1-F87D-494B-A95A-3F9E511ED3B1,250,12,TUMOR FREE,0.1897,0:LIVING,0.01,,44.84,Bilateral,48,No Evidence of Extraprostatic Extension,17,YES,2112,2008,,,TCGA-VP-AA1N.B76B30C1-F87D-494B-A95A-3F9E511ED3B1.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,17,,5,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,,70,Core needle biopsy,,,NO,YES,YES,NO,T3a,YES,9,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,86235,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-FD-A62S,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.8,0.36,10,4,9,,,406,,,406,,1.0,1,306.0,306.0,,Malignant,23,,78,,,,28925.0,,,306.0,306,,,,,406,,,306.0,,,,,,,,WITH TUMOR,Dead,-22000,406,,,101.0,,306.0,306,,,[Not Available],[Not Applicable],,,,,0.27,,,,,19,,1,0.29774,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A62S,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,28,,,,,,,,,,,,,2013,306,sigmoid colon,,,Stage III,,,,,,,,Progressive Disease,,,,,,60.0,,,,,,,,,,,,,,,,,,,,86236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Female,TCGA-NJ-A4YI,White,LUAD,,0,0,,Washington University - Rush University,,,FEMALE,2,3.62,0.58,6,5,11,,,4,,,4,,2,2,4,4,,Malignant,22,,40,,,,23808,,,4,4,,,,,4,,,4,,,,,,,,,Dead,-31867,4,,,598,,4,4,,,[Not Available],[Not Applicable],,,,,0.11,,,,,15,,1,0.14184,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A4YI,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,87,,,,,,,,,,,,,,,,,,,,86238,,-0.077061993,,,,,,,,,,0.232783048,,0.086307785,,,,Stage IIIA,,1.311,,,,,,,,,,,,,,,,0.0842,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.42311427,17.37953949,14.0827448,-0.61159758,LUAD,Adenocarcinoma,17.63046616,14.57905643,Adenocarcinoma,2.4379,13.69835871,-1.975,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-49-AAR3,Black or African American,LUAD,,1,1,,Johns Hopkins,1,0,MALE,1,1.71,0.32,10,7,4,,,1893,,1893,1893,,1,1,1893,1893,,Malignant,21,,101,,,,17405,,,1893,1893,,,,1893,1893,,,1893,,,,,,,,[Discrepancy],Alive,-25469,,,,165,,1893,1893,,,[Not Available],[Not Applicable],,,,,0.63,,,,,9,,0,0.39963,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AAR3,,,,,,,1893,,Locoregional Recurrence,,,,,,,13,,,,,,,,,,,,,2008,1893,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,86239,,1.578312437,,,,,,,,,,0.255326928,,0.151168869,,,,Stage IIB,,2.577,,,,,,,,,,,,,,,,0.4373,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,A101G,1,,,A101G,17.15270436,17.89375379,19.05042843,0.244829434,LUAD,Adenocarcinoma,18.0793299,17.63376922,Adenocarcinoma,0.8732,11.15407511,1.7985,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-G2-AA3B,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.82,0.84,24,22,19,,,2008,,2008,2008,,0.0,0,2008.0,2008.0,,Malignant,65,,339,,,,16845.0,,,2008.0,2008,,,,2008,2008,,,2008.0,,,,,,,,TUMOR FREE,Alive,-27646,,,,963.0,,2008.0,2008,,,[Not Available],[Not Applicable],,,,,0.71,,,,,7,,0,0.45452,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3B,,,,,,,2008,,,,,,,,,22,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,86252,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,3.29,0.83,10,8,13,,,614,BRCA_Basal,556,614,,1,1,556,556,,Invasive Carcinoma,31,,29,,,,22396,0,,556,556,,,,556,614,,,556,,,,,,,,WITH TUMOR,Dead,-22690,614,,,59,,556,556,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,18,,1,0.30064,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A13E,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,36,,,,,,,,,,,,,2010,556,"Lung, Bone, Liver, Brain and Skin Nodules",,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86254,,-0.156684283,0,0,0,0,1.2058,1,,,Infiltrating Ductal Carcinoma,0.139736429,,0.05303973,0,0,0,,Negative,-1.2305,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0446,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-22-5479,White,LUSC,,0,0,,Mayo Clinic - Rochester,,,MALE,2,3.4,0.28,4,4,10,,,2625,,,2625,,2,2,2625,2625,,Malignant,18,,8,,,,22290,,,2625,2625,,,,,2625,,,2625,,,,,,,,,Dead,-23563,2625,,,657,,2625,2625,,,[Not Available],[Not Applicable],,,,,0.43,,,,,28,,1,0.11654,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5479,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,[Unknown],,,,,,64,,,,,,,,,,,,,,,,,,,,86263,,0.780110776,,,,,,,,,,0.159694247,,0.073131989,,,,Stage IB,,1.1825,,,,,,,,,,,,,,,,0.392,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.33327213086754,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.1502,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,,0.0,1.0,Male,TCGA-ZF-AA52,White,BLCA,,0.0,0,,,,,MALE,2.0,4.31,0.33,3,4,8,,,1077,,,1077,,2.0,2,1077.0,1077.0,,Malignant,15,,25,,,,17587.0,,,1077.0,1077,,,,,1077,,,1077.0,,,,,,,,,Dead,-25579,1077,,,162.0,,1077.0,1077,,,[Not Available],[Not Applicable],,,,,0.1,,,,,20,,2,0.095963,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA52,,,,,,,,,,,,,,,,60,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Partial Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,86270,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.36,0.51,3,2,5,,,398,BRCA_LumA,398,398,,0,0,398,398,,Invasive Carcinoma,10,,16,,,,20003,0,,398,398,,,,398,398,,,398,,,,,,,,TUMOR FREE,Alive,-19591,,,,35,,398,398,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,27,,1,0.16526,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27T,,,,,,,398,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,86271,,0.773746217,0,0,0,0,0.195,1,,,Infiltrating Lobular Carcinoma,0.216795434,,0.187050957,0,0,0,,Negative,0.38,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5639,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.59,4,3,7,,,974,BRCA_LumA,974,974,,0,0,974,974,,Invasive Carcinoma,14,,22,,,,16643,0,,974,974,,,,974,974,,,974,,,,,,,,TUMOR FREE,Alive,-21949,,,,47,,974,974,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,2,,0,0.13532,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BC,,,,,,,974,,,,,,,,,6,,,,,,,,,,,,,2007,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,86274,,1.13016145,0,0,0,0,0.3196,1,,,Infiltrating Ductal Carcinoma,0.203784123,,0.270872206,0,0,0,,Negative,-0.016,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5025,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7525,,PRAD,,0,0,,G9,0,0,MALE,0,3.98,0.62,1,2,2,HRP,NO,994,,994,994,,0,0,994,994,prad_tcga,Malignant,5,,74,,TCGA-G9-7525-01,0,5393,0,TCGA-G9-7525,994,994,Prostate Cancer,,512,994,994,TCGA,,994,Primary,0,Base,A,,,,TUMOR FREE,Alive,-23481,,64,7,43,PRAD,994,994,,0.0,[Not Available],[Not Applicable],48,,1,Matched,0.0,Prostate,Resection,4,bd13998c-d615-4af6-9eab-b59fad85f31f,0,Normal (no evidence of prostate cancer) [cM0],1,0.031145,[Not Available],f4e17ba1-f14f-480e-8fe3-415909fc320a,3,Prostate Adenocarcinoma Acinar Type,1.8,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.4,G9,1.6,TCGA-G9-7525,0:DiseaseFree,3,8,Prostate Adenocarcinoma,32.65,5/31/12,994,,,,,NO,C61,837a5284-61ec-4a13-9743-010fc6a8df6a,,2,TUMOR FREE,0.0583,0:LIVING,0.03,,32.65,Bilateral,11,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-G9-7525.837a5284-61ec-4a13-9743-010fc6a8df6a.pdf,,[Not Applicable],YES,12,,6,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.9,64,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,86277,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-V1-A8WS,,PRAD,389,0,0,,V1,,0,MALE,0,1.96,0.77,2,3,0,HRD,NO,474,1-ERG,,474,,0,0,474,474,prad_tcga,Malignant,5,FANCL,48,,TCGA-V1-A8WS-01,0,5566,0,TCGA-V1-A8WS,474,474,Prostate Cancer,,474,,474,TCGA,,474,Primary,0,Apex,A,,CHEK2,True,,Alive,-20805,,56,6,32,PRAD,474,474,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.08,Prostate,Resection,3,EDCF4F2E-0575-42C5-B92A-B37B428F0553,0,,0,0.038102,[Not Available],BEA84D33-3286-44E2-9595-893C34A01F58,3,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,V1,0.966666666667,TCGA-V1-A8WS,0:DiseaseFree,1,10,Prostate Adenocarcinoma,15.57,7/23/14,474,,,,,NO,C61,0BD9565E-DBBB-428D-BF6D-2B31F0E5DDC5,30,1,,0.0417,0:LIVING,0.09,,15.57,Bilateral,12,,,YES,,,,,TCGA-V1-A8WS.0BD9565E-DBBB-428D-BF6D-2B31F0E5DDC5.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,NO,No,R0,,56,Core needle biopsy,,,NO,YES,NO,YES,T3b,NO,6,No,NO,,,T1c,,M0,C61.9,8140/3,86278,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-G9-6498,,PRAD,,1,1,,G9,1,0,MALE,1,1.99,0.62,1,2,0,HRP,NO,1952,,1342,1952,,1,1,1342,1342,prad_tcga,Malignant,3,,15,,TCGA-G9-6498-01,0,5380,0,TCGA-G9-6498,1342,1342,Prostate Cancer,,1608,1342,1952,TCGA,,1342,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-19568,,53,7,34,PRAD,1342,1342,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.02,Prostate,Resection,3,6620b1a5-1ccc-4e6a-9b38-0f41baeba170,0,Normal (no evidence of prostate cancer) [cM0],0,0.0126,[Not Available],b8fbfe87-e92c-4d54-a620-17b2dcde6d53,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.4,G9,1.0,TCGA-G9-6498,1:Recurred/Progressed,2,3,Prostate Adenocarcinoma,44.09,10/29/13,1952,,Biochemical evidence of disease,,,NO,C61,0F610D96-54E9-4E40-B3D4-19554C782057,,0,TUMOR FREE,0.0109,0:LIVING,0.03,,64.13,Bilateral,3,,,YES,,2008,1342,,TCGA-G9-6498.0F610D96-54E9-4E40-B3D4-19554C782057.pdf,,[Not Applicable],NO,47,,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,0.5,53,Core needle biopsy,1342,Complete Remission/Response,NO,YES,NO,YES,T3a,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,86283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-M7-A720,,PRAD,331,0,0,,M7,0,0,MALE,0,2.0,0.94,0,0,0,HRP,NO,384,1-ERG,384,384,,0,0,384,384,prad_tcga,Malignant,0,,12,,TCGA-M7-A720-01,0,5540,0,TCGA-M7-A720,384,384,Prostate Cancer,,302,384,384,TCGA,,384,Primary,0,Middle|Base,A,,,False,TUMOR FREE,Alive,-19642,,53,6,12,PRAD,384,384,,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,0.0,Prostate,Resection,3,E325C4BE-1952-49C8-88F1-B53C8DFCFB8E,0,,0,0.0040347,[Not Available],444E78F7-1221-4882-ADE2-7E45D828EA2A,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,M7,1.03333333333,TCGA-M7-A720,0:DiseaseFree,1,0,Prostate Adenocarcinoma,12.61,12/10/13,384,,,,,NO,C61,65D5D425-D41A-4E98-AA86-119F3BE1D3CE,130,0,TUMOR FREE,0.0,0:LIVING,,,12.61,Bilateral,2,,,YES,190,2013,,,TCGA-M7-A720.65D5D425-D41A-4E98-AA86-119F3BE1D3CE.pdf,Peripheral Zone,[Not Applicable],NO,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,53,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,6,No,NO,0,,T1c,,,C61.9,8140/3,86289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Male,TCGA-78-7148,White,LUAD,,1,,,Prince Charles Hospital,,,MALE,1,1.81,0.6,2,1,3,,,626,,,626,,1,,182,182,,Malignant,6,,15,,,,17923,,,182,,,,,,626,,,182,,,,,,,,,Dead,-25990,626,,,288,,182,,,,[Not Available],[Not Applicable],,,,,0.5,,,,,6,,0,0.19639,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7148,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2001,182,,,,Stage IIB,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,86291,,0.912864597,,,,,,,,,,0.169724334,,0.155195256,,,,Stage IIB,,0.34,,,,,,,,,,,,,,,,0.0533,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,14.88775705,15.67628699,15.40429207,-0.380786672,LUAD,Adenocarcinoma,18.05209838,15.93802979,Adenocarcinoma,-0.664,13.10660744,0.6403,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-V1-A9OX,,PRAD,,0,0,,V1,,0,MALE,0,1.97,0.44,6,8,0,HRD,NO,1134,,,1134,,0,0,1134,1134,prad_tcga,Malignant,14,,123,,TCGA-V1-A9OX-01,9,5579,0,TCGA-V1-A9OX,1134,1134,Prostate Cancer,,256,,1134,TCGA,,1134,Primary,0,Apex,A,,BRCA2,True,,Alive,-20805,,56,8,30,PRAD,1134,1134,,0.307500452,[Not Available],[Not Applicable],27,,1,Matched,0.09,Prostate,Resection,3,CD8ACE8B-2A7D-4DE9-82AD-BBAE2D028DF9,2,,0,0.086589,[Not Available],14C2819B-9AFC-4C89-849F-530E289D55BF,5,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,V1,0.9,TCGA-V1-A9OX,0:DiseaseFree,4,14,Prostate Adenocarcinoma,37.25,7/23/14,1134,,,,,NO,C61,4D42611A-3A08-4A1A-A033-13E810FCCA3E,150,2,,0.1368,0:LIVING,0.04,,37.25,Bilateral,17,,,YES,,,,,TCGA-V1-A9OX.4D42611A-3A08-4A1A-A033-13E810FCCA3E.pdf,Peripheral Zone,[Not Applicable],NO,,,8,Prostate Adenocarcinoma Acinar Type,1,,Partial Remission/Response,,NO,No,R0,,56,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,8,No,NO,,N0,,0,M0,C61.9,8140/3,86292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,496,,496,496,,0,0,496,496,,Invasive Carcinoma,,,,,,,23716,0,,496,496,,,,496,496,,,496,,,,,,,,TUMOR FREE,Alive,-17708,,,,33,,496,496,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,"Other, specify",,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XS,,,,,,,496,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,86294,,,0,0,0,0,-0.6429,0,,,Other,,,,0,0,1,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,,0,0,H & E,0,0,,0,Katherine Huenerberg,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,Benign Breast Epithelium,No Detail Present,"DCIS (Micropapillary, Intermediate Grade), DCIS (Papillary, Intermediate Grade), No Detail Present",,"DCIS (Micropapillary, Intermediate Grade), DCIS (Papillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Papilloma,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-56-7823,White,LUSC,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.76,0.92,9,7,14,,,1011,,1011,1011,,0,0,1011,1011,,Malignant,30,,32,,,,34150,,,1011,1011,,,,1011,1011,,,1011,,,,,,,,TUMOR FREE,Alive,-21344,,,,395,,1011,1011,,,[Not Available],[Not Applicable],,,,,0.07,,,,,7,,0,0.37322,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7823,,,,,,,1011,,,,,,,,,16,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,86295,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.0281,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.67869978,14.48354053,15.674669,-0.59816606190996,LUSC,Squamous Cell Carcinoma,17.82802479,15.0156627,Squamous Cell Carcinoma,-1.3175,12.98563313,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5502,,PRAD,91,0,0,,EJ,0,0,MALE,0,2.0,0.94,0,0,0,ambiguous,NO,1171,1-ERG,1171,1171,,0,0,1171,1171,prad_tcga,Malignant,0,,0,5.3,TCGA-EJ-5502-01,0,5267,0,TCGA-EJ-5502,1171,1171,Prostate Cancer,,603,1171,1171,TCGA,,1171,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-18447,,50,7,12,PRAD,1171,1171,,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,0.0,Prostate,Resection,4,d36a0b54-6e09-4ee2-923b-c1516d78bb03,0,Normal (no evidence of prostate cancer) [cM0],0,0.0,[Not Available],48e83a4c-c602-494a-80cd-e2f4b4dd701e,3,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.766666666667,TCGA-EJ-5502,0:DiseaseFree,3,10,Prostate Adenocarcinoma,38.47,3/30/12,1171,,,,,NO,C61,173e45e9-e2ab-4a1d-8bcc-15374f1ae511,,0,TUMOR FREE,0.0,0:LIVING,0.1,3,38.47,Bilateral,20,No Evidence of Extraprostatic Extension,7,YES,,2010,,,TCGA-EJ-5502.173e45e9-e2ab-4a1d-8bcc-15374f1ae511.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,7,41-50%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.0,50,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,86297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-38-4628,White,LUAD,,1,,,UNC,1,1,FEMALE,1,4.98,0.5,10,13,23,,,1492,,1083,1492,,1,,1083,1083,,Malignant,46,,40,,,,20854,,,1083,,,,,1083,1492,,,1083,,,,,,,,WITH TUMOR,Dead,-24057,1492,,,165,,1083,,,,[Not Available],[Not Applicable],,,,,0.32,,,,,20,,2,0.35866,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-4628,,,,,,,,,,,,,,,,53,,,,,,,,,,,,,2002,1083,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,86300,,-0.704453276,,,,,,,,,,0.278907733,,0.118240123,,,,Stage IIB,,-0.521,,,,,,,,,,,,,,,,0.0916,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,16.28711833,17.18526427,10.0227824,-0.711220673,LUAD,,17.67588245,13.84942452,Adenocarcinoma,0.5224,13.2466993,-1.9395,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,0,1,1,Male,TCGA-22-5473,White,LUSC,,1,,,Mayo Clinic - Rochester,1,2,MALE,1,2.93,0.58,13,13,19,,,1933,,1655,1933,,1,,1655,1655,,Malignant,45,,76,,,,24749,,,1655,,,,,1655,1933,,,1655,,,,,,,,TUMOR FREE,Dead,-28826,1933,,,1069,,1655,,,,[Not Available],[Not Applicable],,,,,0.16,,,,,17,,1,0.46452,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5473,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,2005,1655,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,86301,,0.527778209,,,,,,,,,,0.194501239,,0.006073228,,,,Unknown,,1.5375,,,,,,,,,,,,,,,,0.5374,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),AMP (driver),,1,,,,,,,-0.429690580133539,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.254,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Male,TCGA-MP-A4TE,White,LUAD,,1,1,,Washington University - Mayo Clinic,1,1,MALE,1,3.15,0.68,3,5,8,,,896,,226,896,,1,1,226,226,,Malignant,16,,58,,,,20551,,,226,226,,,,226,896,,,226,,,,,,,,WITH TUMOR,Dead,-20627,896,,,189,,226,226,,,[Not Available],[Not Applicable],,,,,0.09,,,,,14,,1,0.15736,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TE,,,,,,,,,Locoregional Recurrence,,,,,,,29,,,,,,,,,,,,,2010,226,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,86305,,-0.297971789,,,,,,,,,,0.101926892,,0.04654923,,,,Stage IIA,,-0.56,,,,,,,,,,,,,,,,-0.2487,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),V604Wfs*68 (driver),1,,G12C (driver),V604Wfs*68 (driver),13.293513,15.24371558,10.39394901,-1.040859371,LUAD,Adenocarcinoma,17.69681519,14.65112334,Adenocarcinoma,-0.5675,12.64776632,-1.446,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Female,TCGA-XC-AA0X,Black or African American,LUSC,,0,0,,Albert Einstein Medical Center,,2,FEMALE,2,2.89,0.21,15,17,23,,,6,,,6,,2,2,6,6,,Malignant,55,,104,,,,18780,,,6,6,,,,,6,,,6,,,,,,,,TUMOR FREE,Dead,-28211,6,,,238,,6,6,,,[Not Available],[Not Applicable],,,,,0.45,,,,,17,,1,0.30177,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Albert Einstein Medical Center,,TCGA-XC-AA0X,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2013,,,,,Stage IA,,,,,,,,[Not Applicable],,,,,,77,,,,,,,,,,,,,,,,,,,,86311,,1.055153696,,,,,,,,,,0.268640263,,0.110306183,,,,Stage IA,,1.4315,,,,,,,,,,,,,,,,0.6118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R135H,1,,,R135H,,,,-0.391893051433255,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.2043,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-46-3767,White,LUSC,,0,0,,St. Joseph's Medical Center (MD),0,0,MALE,0,2.14,0.23,3,10,9,,,396,,396,396,,0,0,396,396,,Malignant,22,,14,,,,17041,,,396,396,,,,396,396,,,396,,,,,,,,TUMOR FREE,Alive,-27912,,,,177,,396,396,,,[Not Available],[Not Applicable],,,,,0.5,,,,,10,,0,0.40616,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,St. Joseph's Medical Center (MD),,TCGA-46-3767,,,,,,,396,,,,,,,,,21,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,86313,,1.151333314,,,,,,,,,,0.270190668,,0.232580714,,,,Stage IA,,0.7575,,,,,,,,,,,,,,,,0.9789,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0864859207558186,LUSC,,,,Squamous Cell Carcinoma,1.6962,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.17,0.56,4,2,4,,,2142,BRCA_LumA,2142,2142,,0,0,2142,2142,,Invasive Carcinoma,10,,16,,,,19005,1,,2142,2142,,,,2142,2142,,,2142,,,,,,,,TUMOR FREE,Alive,-18721,,,,0,,2142,2142,,,[Not Available],[Not Applicable],,,,,0.16,Skin,Resection/Excision,,,16,,0,0.13386,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A12E,,,,,,,2142,,,,,,,,,12,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,86320,,-1.264153096,0,0,0,0,0.1449,1,,,Infiltrating Lobular Carcinoma,0.174373375,,0.201637654,0,0,0,,Negative,-0.208,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.2337,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Skin,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-97-7547,White,LUAD,,1,,,Washington University - NYU,,0,FEMALE,1,3.42,0.55,4,2,8,,,1965,,,1965,,1,,775,775,,Malignant,14,,17,,,,30376,,,775,,,,,,1965,,,775,,,,,,,,WITH TUMOR,Alive,-24737,,,,234,,775,,,,[Not Available],[Not Applicable],,,,,0.1,,,,,14,,1,0.22812,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-7547,,,,,,,1965,,,,,,,,,22,,,,,,,,,,,,,2007,775,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,86323,,0.897947617,,,,,,,,,,0.215180511,,0.131493148,,,,Stage IB,,0.767,,,,,,,,,,,,,,,,0.111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.364524525,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.5496,,-0.7226,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-75-6203,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),0,0,FEMALE,0,2.23,0.26,2,1,2,,,,,,,,0,0,,,,Malignant,5,,3,,,,19807,,,,,,,,,,,,,,,,,,,,TUMOR FREE,Alive,,,,,19,,,,,,[Not Available],[Not Applicable],,,,,0.06,,,,,8,,0,0.03679,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-6203,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,86324,,0.56251796,,,,,,,,,,0.30920373,,0.302266269,,,,Stage IIIA,,0.808,,,,,,,,,,,,,,,,0.0538,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.44377965,19.08608288,15.47996139,-0.04832897,LUAD,Adenocarcinoma,18.15452598,15.93864503,Adenocarcinoma,-0.9227,13.17753779,0.0899,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-D7-6521,White,STAD,,1,1,,,,0,,1,2.87,0.23,3,7,7,,,564,,,564,,1,1,192,192,,Malignant,17,,40,,,,22570,,,192,192,,,,,564,,,192,,,,,,,,WITH TUMOR,Alive,-23776,,,,88,,192,192,,,[Not Available],[Not Applicable],,,,,0.45,Stomach,Unknown,,,27,,1,0.30006,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6521,,,,,,,564,"Other, specify",Locoregional Recurrence,,,,,,,37,,,,,,,,,,,,,2010,192,,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,86329,,,,,,,,,,,,,Grade 3,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6521,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2EL,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.79,0.98,7,6,6,,,819,,,819,,1.0,1,105.0,105.0,,Malignant,19,,45,,,,28836.0,,,105.0,105,,,,,819,,,105.0,,,,,,,,WITH TUMOR,Dead,-28370,819,,,331.0,,105.0,105,,,[Not Available],[Not Applicable],,,,,0.06,,,,,5,,0,0.26109,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EL,,,,,,,,Bone,Distant Metastasis,,,,,,,8,,,,,,,,,,,,,2009,105,,,,Stage II,,,,,,,,Stable Disease,,,,,,77.0,,,,,,,,,,,,,,,,,,,,86334,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-A6AO,,PRAD,,0,0,,HC,0,0,MALE,0,2.0,0.77,5,11,3,ambiguous,NO,530,,530,530,,0,0,530,530,prad_tcga,Malignant,19,,43,,TCGA-HC-A6AO-01,0,5453,0,TCGA-HC-A6AO,530,530,Prostate Cancer,,,530,530,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),530,Primary,0,,A,,,False,TUMOR FREE,Alive,-19298,,52,7,49,PRAD,530,530,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.03,Prostate,Resection,4,C0A067B3-0BD0-4D11-A283-D25799B3090B,2,,0,0.075347,[Not Available],4045F40B-D42A-4598-9EE2-0D371A776D3F,3,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,HC,1.03333333333,TCGA-HC-A6AO,0:DiseaseFree,3,20,Prostate Adenocarcinoma,17.41,9/19/13,530,,,,,YES,C61,37F41695-9D8D-4CA1-9728-6A04AAD76274,30,2,TUMOR FREE,0.1062,0:LIVING,,,17.41,Bilateral,23,,,YES,301,2012,,,TCGA-HC-A6AO.37F41695-9D8D-4CA1-9728-6A04AAD76274.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,,No,R0,,52,Core needle biopsy,,,YES,NO,NO,NO,T2c,,7,No,,0,,T1c,,M0,C61.9,8140/3,86335,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-98-A53I,White,LUSC,,0,0,,Washington University - Alabama,0,0,MALE,0,1.96,0.52,13,7,14,,,565,,565,565,,0,0,565,565,,Malignant,34,,89,,,,30210,,,565,565,,,,565,565,,,565,,,,,,,,TUMOR FREE,Alive,-23502,,,,516,,565,565,,,[Not Available],[Not Applicable],,,,,0.33,,,,,10,,0,0.36814,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A53I,,,,,,,565,,,,,,,,,18,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,86337,,1.42373779,,,,,,,,,,0.155327481,,0.143091569,,,,Stage IIA,,1.4645,,,,,,,,,,,,,,,,0.1283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.55180342,16.12139511,16.87456421,-0.120321148282639,LUSC,Squamous Cell Carcinoma,18.10145397,16.3323857,Squamous Cell Carcinoma,-0.1405,12.91739528,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,0,1,Male,TCGA-21-5783,White,LUSC,,0,0,,Fox Chase Cancer Center,,,MALE,2,3.34,0.57,8,7,19,,,2680,,,2680,,2,2,2680,2680,,Malignant,34,,138,,,,0,,,2680,2680,,,,,2680,,,2680,,,,,,,,,Dead,-27904,2680,,,560,,2680,2680,,,[Not Available],[Not Applicable],,,,,0.08,,,,,16,,1,0.35272,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Fox Chase Cancer Center,,TCGA-21-5783,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,86339,,0.020376737,,,,,,,,,,0.144138707,,0.031639693,,,,Stage IB,,0.029,,,,,,,,,,,,,,,,0.982,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,V14I (driver),,1,,V14I (driver),,,,,-0.780423579401312,LUSC,,,,Squamous Cell Carcinoma,0.9955,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-MV-A51V,White,BLCA,,0.0,0,,,0,0,MALE,0.0,5.35,0.75,3,12,23,,,410,,410,410,,0.0,0,410.0,410.0,,Malignant,38,,20,,,,32804.0,,,410.0,410,,,,410,410,,,410.0,,,,,,,,TUMOR FREE,Alive,-27430,,,,2233.0,,410.0,410,,,[Not Available],[Not Applicable],,,,,0.68,,,,,22,,2,0.064561,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Minnesota,,TCGA-MV-A51V,,,,,,,410,,,,,,,,,62,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,86342,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-S5-A6DX,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.32,0.39,8,7,7,,,56,,,56,,1.0,1,56.0,56.0,,Malignant,22,,151,,,,17594.0,,,56.0,56,,,,,56,,,56.0,,,,,,,,WITH TUMOR,Dead,-30594,56,,,924.0,,56.0,56,,,[Not Available],[Not Applicable],,,,,0.17,,,,,20,,1,0.15859,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,, University of Oklahoma HSC,,TCGA-S5-A6DX,,,,,,,,,,,,,,,,19,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,[Unknown],,,,,,83.0,,,,,,,,,,,,,,,,,,,,86343,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-AA6K,White,STAD,,1,1,,,,1,,1,1.67,0.61,12,8,15,,,378,,,378,,1,1,332,332,,Malignant,35,,150,,,,21568,,,332,332,,,,,378,,,332,,,,,,,,WITH TUMOR,Dead,-21901,378,,,98,,332,332,,,Stomach Cancer,[Not Applicable],,,,,0.29,Stomach,Unknown,,,13,,0,0.45231,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-AA6K,,,,,,,,,Locoregional Recurrence,,,,,,,17,,,,,,,,,,,,,2012,332,,,,Stage IIIC,,,,,,,,Progressive Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,86345,,0.343189949,,,,,,,,,,0.044986939,Grade 3,0.069901691,,,,Stage IIIC,,0.3525,,,,,,,,,,,,,,,,0.3048,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA6K,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0,,0,0,0,Male,TCGA-YL-A8SK,,PRAD,389,0,0,,YL,,0,MALE,0,2.03,0.44,6,9,7,HRD,NO,1408,8-other,,1408,,0,0,1408,1408,prad_tcga,Malignant,22,BRCA1;CDK12;CHEK1;RAD51D,61,,TCGA-YL-A8SK-01,0,5676,0,TCGA-YL-A8SK,1408,1408,Prostate Cancer,,924,,1408,TCGA,,1408,Primary,0,Apex|Middle|Base,B,ATM:?-416:.:splice_acceptor_variant,ATM,True,,Alive,-24759,,67,9,45,PRAD,1408,1408,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.08,Prostate,Resection,4,F5243BA4-684D-4401-A1A5-7713BCC9106E,2,Normal (no evidence of prostate cancer) [cM0],0,0.10241,[Not Available],159B47B2-DC7D-4856-9A00-454E27301E23,5,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A8SK,0:DiseaseFree,5,23,Prostate Adenocarcinoma,46.25,4/25/14,1408,,,,,NO,C61,F332F5AD-A0BE-455D-9523-13BDF275DB2A,410,5,,0.1851,0:LIVING,0.03,,46.25,Bilateral,26,,,YES,1208,2010,,,TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,38,26-35%,20,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,4,M0,C61.9,8140/3,86346,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,Black or African American,BRCA,,1,1,,,,1,FEMALE,1,3.26,0.6,22,33,28,,,548,BRCA_Basal,,548,,1,1,102,102,,Invasive Carcinoma,83,,111,,,,20339,1,,102,102,,,,,548,,,102,,,,,,,,WITH TUMOR,Dead,-13238,548,,,205,,102,102,,,[Not Available],[Not Applicable],,,,,0.32,Not Specific/Unknown,Resection/Excision,,,8,,1,0.41037,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04P,,,,,,,,Bone,Distant Metastasis,,,,,,,30,,,,,,,,,,,,,2003,102,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,36,,,,,,,,,,,,,,,,,,,,86352,,1.161478146,0,0,0,0,1.331,1,,,Infiltrating Ductal Carcinoma,0.11839097,,0.183626901,0,0,0,,Positive,0.4555,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1854,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,1,0,FFPE,,0,0,0,No,0,"Adipose Tissue, Skeletal Muscle",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-8200,,PRAD,308,0,0,,J4,0,0,MALE,0,2.02,0.52,1,4,2,HRP,NO,1218,8-other,1218,1218,,0,0,1218,1218,prad_tcga,Malignant,7,,12,8.6,TCGA-J4-8200-01,0,5471,0,TCGA-J4-8200,1218,1218,Prostate Cancer,,196,1218,1218,TCGA,,1218,Primary,0,,A,,,,TUMOR FREE,Alive,-17167,,47,7,21,PRAD,1218,1218,,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.01,Prostate,Resection,3,4aacab9c-a663-4aa3-9a90-47563e3e6331,0,Normal (no evidence of prostate cancer) [cM0],0,0.011943,[Not Available],897a2af4-55af-4245-8629-1a71b622c17e,4,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,7,,Acinar Adenocarcinoma,[Not Available],0.4,J4,0.8,TCGA-J4-8200,0:DiseaseFree,2,5,Prostate Adenocarcinoma,40.01,6/6/12,1218,,,,,NO,C61,5E18C318-D20B-4837-850D-34FD96C87EEC,,1,TUMOR FREE,0.034,0:LIVING,0.1,,40.01,Bilateral,6,No Evidence of Extraprostatic Extension,41,YES,,2011,,,TCGA-J4-8200.5E18C318-D20B-4837-850D-34FD96C87EEC.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,61-70%,4,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.5,47,Core needle biopsy,,,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T2,0,M0,C61.9,8550/3,86353,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-67-4679,White,LUAD,,0,0,,St Joseph's Medical Center (MD),,0,MALE,0,2.03,0.71,2,8,6,,,448,,,448,,0,0,448,448,,Malignant,16,,5,,,,18357,,,448,448,,,,,448,,,448,,,,,,,,TUMOR FREE,Alive,-25202,,,,375,,448,448,,,[Not Available],[Not Applicable],,,,,0.05,,,,,2,,0,0.045208,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-4679,,,,,,,448,,,,,,,,,3,,,,,,,,,,,,,2009,,,,,[Discrepancy],,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,86359,,,,,,,,,,,,,,,,,,Unknown,,,,,,,,,,,,,,,,,,-0.0079,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,,,,-0.345466865,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.1617,,0.0463,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-05-4382,,LUAD,,1,1,,Indivumed,1,0,MALE,1,2.93,0.21,7,10,16,,,607,,334,607,,1,1,334,334,,Malignant,33,,31,,,,33020,,,334,334,,,,334,607,,,334,,,,,,,,TUMOR FREE,Alive,-24868,,,,2312,,334,334,,,[Not Available],[Not Applicable],,,,,0.5,,,,,18,,1,0.31985,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4382,,,,,,,607,,Distant Metastasis,,,,,,,39,,,,,,,,,,,,,2009,334,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,86362,,0.963013242,,,,,,,,,,0.320745048,,0.152767247,,,,Stage IB,,1.389,,,,,,,,,,,,,,,,0.6156,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"R222L (driver), E545Q",,,1,"R222L (driver), E545Q",,,,,,-0.074090628,LUAD,,,,Adenocarcinoma,1.084,,-0.377,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.24,0.28,1,0,3,,,626,BRCA_LumA,626,626,,0,0,626,626,,Invasive Carcinoma,4,,3,,,,26082,1,,626,626,,,,626,626,,,626,,,,,,,,TUMOR FREE,Alive,-14626,,,,25,,626,626,,,[Not Available],[Not Applicable],,,,,0.02,Not Specific/Unknown,Resection/Excision,,,7,,0,0.096138,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A141,,,,,,,626,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,[Not Available],,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,86365,,1.724485067,0,0,0,0,-0.6456,1,,,Infiltrating Ductal Carcinoma,0.19828325,,0.195359625,0,0,0,,Negative,1.47,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7471,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-86-8073,White,LUAD,,0,0,,Asterand,0,0,MALE,0,1.88,0.43,11,4,7,,,740,,740,740,,0,0,740,740,,Malignant,22,,24,,,,16452,,,740,740,,,,740,740,,,740,,,,,,,,TUMOR FREE,Alive,-21214,,,,1913,,740,740,,,[Not Available],[Not Applicable],,,,,0.25,,,,,9,,0,0.19779,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8073,,,,,,,740,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,86370,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.1581,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.518391472,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0761,,-0.3835,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-G9-6336,White,PRAD,108,0,0,,G9,0,0,MALE,0,,,,,,,NO,2068,1-ERG,2068,2068,,0,0,2068,2068,prad_tcga,Malignant,,,,10.6,TCGA-G9-6336-01,0,5351,0,TCGA-G9-6336,2068,2068,Prostate Cancer,,1669,2068,2068,TCGA,,2068,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-20851,,57,7,24,PRAD,2068,2068,WHITE,0.0,[Not Available],[Not Applicable],21,R1,1,Matched,,Prostate,Resection,3,34c8b195-ecab-492b-aed2-43acfedef708,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],59207bcd-f127-481f-b576-8716da7d7d97,4,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,0.666666666667,TCGA-G9-6336,0:DiseaseFree,2,,Prostate Adenocarcinoma,67.94,3/19/12,2068,,,,,NO,C61,ceda2ffb-b844-4f89-baba-82a66e6f3f0e,,,TUMOR FREE,0.0001,0:LIVING,0.1,,67.94,Bilateral,,No Evidence of Extraprostatic Extension,104,YES,,2007,,,TCGA-G9-6336.ceda2ffb-b844-4f89-baba-82a66e6f3f0e.pdf,,[Not Applicable],YES,98,71-80%,5,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,No,R1,0.3,57,Core needle biopsy,,,NO,YES,YES,,,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,86383,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.78,3,2,4,,,762,BRCA_LumA,762,762,,0,0,762,762,,Invasive Carcinoma,9,,20,,,,23778,0,,762,762,,,,762,762,,,762,,,,,,,,TUMOR FREE,Alive,-30934,,,,59,,762,762,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,4,,0,0.042396,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A50Y,,,,,,,762,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,86384,,-0.295477059,0,0,0,0,0.7972,1,,,Infiltrating Lobular Carcinoma,0.13312553,,0.101899,0,0,0,,Negative,-0.353,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0129,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Female,TCGA-GC-A6I1,White,BLCA,,0.0,0,,,2,2,FEMALE,2.0,2.95,0.31,14,13,17,,,272,,272,272,,2.0,2,272.0,272.0,,Malignant,44,,116,,,,26853.0,,,272.0,272,,,,272,272,,,272.0,,,,,,,,TUMOR FREE,Dead,-32873,272,,,327.0,,272.0,272,,,[Not Available],[Not Applicable],,,,,0.15,,,,,10,,1,0.45001,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A6I1,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,90.0,,,,,,,,,,,,,,,,,,,,86385,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,,,,1,0,FEMALE,1,3.27,0.48,12,25,21,,,3009,BRCA_LumA,739,3009,,1,,739,739,,Invasive Carcinoma,58,,77,,,,18024,0,,739,,,,,739,3009,,,739,,,,,,,,TUMOR FREE,Alive,-18263,,,,73,,739,,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,14,,1,0.20428,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TW,,,,,,,3009,,,,,,,,,28,,,,,,,,,,,,,2005,739,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,86395,,0.867266604,0,0,0,0,-0.0354,1,,,Infiltrating Ductal Carcinoma,0.162995248,,0.077154057,0,0,0,,Negative,0.666,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0495,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.93,0.51,10,5,13,,,1611,BRCA_LumA,1611,1611,,0,0,1611,1611,,Invasive Carcinoma,28,,85,,,,22040,0,,1611,1611,,,,1611,1611,,,1611,,,,,,,,TUMOR FREE,Alive,,,,,75,,1611,1611,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,6,,0,0.24348,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Kansas,,TCGA-WT-AB41,,,,,,,1611,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,86397,,1.339153418,0,0,0,0,-0.2137,1,,,Infiltrating Ductal Carcinoma,0.131609263,,0.10464675,0,0,0,,Negative,0.1505,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.0073,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,Microcalcifications,"None, Microcalcifications",,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-97-8179,White,LUAD,,0,0,,Washington University - NYU,0,0,MALE,0,2.83,0.48,8,2,9,,,435,,435,435,,0,0,435,435,,Malignant,19,,35,,,,19555,,,435,435,,,,435,435,,,435,,,,,,,,TUMOR FREE,Alive,-26305,,,,232,,435,435,,,[Not Available],[Not Applicable],,,,,0.22,,,,,27,,1,0.56025,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-8179,,,,,,,435,,,,,,,,,22,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,86405,,0.065454192,,,,,,,,,,0.189223782,,0.221237074,,,,Stage IA,,0.0625,,,,,,,,,,,,,,,,0.0571,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,L19F (driver),Q201* (driver),1,,L19F (driver),Q201* (driver),,,,-0.67951026,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.7128,,-0.8408,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-44-A4SS,White,LUAD,,0,0,,Christiana Healthcare,0,0,MALE,0,3.29,0.25,8,23,13,,,415,,415,415,,0,0,415,415,,Malignant,44,,39,,,,17743,,,415,415,,,,415,415,,,415,,,,,,,,TUMOR FREE,Alive,-26991,,,,612,,415,415,,,[Not Available],[Not Applicable],,,,,0.5,,,,,15,,1,0.13601,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-A4SS,,,,,,,415,,,,,,,,,25,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,86409,,1.3542447,,,,,,,,,,0.23658656,,0.09893382,,,,Stage IA,,1.5245,,,,,,,,,,,,,,,,0.5156,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,C613Afs*59 (driver),1,,,C613Afs*59 (driver),,,,-0.026581381,LUAD,,,,Adenocarcinoma,0.6338,,0.8714,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-BR-8589,White,STAD,,0,0,,,0,0,,0,2.07,0.53,5,5,7,,,825,,825,825,,0,0,825,825,,Malignant,17,,31,,,,24027,,,825,825,,,,825,825,,,825,,,,,,,,TUMOR FREE,Alive,-20727,,,,1450,,825,825,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,5,,0,0.057026,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8589,,,,,,,825,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,86417,,1.279860923,,,,,,,,,,0.082001459,Grade 3,0.042826943,,,,Stage IIIB,,1.3755,,,,,,,,,,,,,,,,-0.4803,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8589,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.69,0,1,1,,,461,BRCA_LumA,461,461,,0,0,461,461,,Invasive Carcinoma,2,,19,,,,28718,0,,461,461,,,,461,461,,,461,,,,,,,,TUMOR FREE,Alive,-30830,,,,40,,461,461,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,1,,0,0.000358,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XV,,,,,,,461,,,,,,,,,2,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,86423,,-0.815486184,0,0,0,0,-0.3462,1,,,Mucinous Carcinoma,0.126910697,,0.101448133,0,0,0,,Negative,-2.0285,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.4351,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,Black or African American,BRCA,,0,0,,,2,2,FEMALE,2,1.89,0.91,7,4,9,,,2469,BRCA_LumB,2469,2469,,2,2,2469,2469,,Invasive Carcinoma,20,,32,,,,28047,0,,2469,2469,,,,2469,2469,,,2469,,,,,,,,TUMOR FREE,Dead,-22238,2469,,,74,,2469,2469,,,[Not Available],[Not Applicable],,,,,0.35,Breast,Resection/Excision,,,7,,0,0.20082,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RL,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1993,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,86425,,-1.97486908,0,0,0,0,0.1932,1,,,Infiltrating Ductal Carcinoma,0.065672055,,-0.091061391,0,0,0,,Negative,-0.9805,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-1.0072,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FJ-A3ZE,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.91,0.96,9,10,13,,,324,,,324,,1.0,1,152.0,152.0,,Malignant,32,,91,,,,27513.0,,,152.0,152,,,,,324,,,152.0,,,,,,,,WITH TUMOR,Dead,-23866,324,,,582.0,,152.0,152,,,[Not Available],[Not Applicable],,,,,0.39,,,,,10,,0,0.25158,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3ZE,,,,,,,,Bone,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2012,152,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,65.0,,,,,,,,,,,,,,,,,,,,86426,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-LA-A446,White,LUSC,,0,0,,Candler,0,0,MALE,0,3.23,0.41,17,17,18,,,401,,401,401,,0,0,401,401,,Malignant,52,,148,,,,33457,,,401,401,,,,401,401,,,401,,,,,,,,TUMOR FREE,Alive,-25199,,,,438,,401,401,,,[Not Available],[Not Applicable],,,,,0.19,,,,,12,,1,0.3808,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Candler,,TCGA-LA-A446,,,,,,,401,,,,,,,,,31,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,86427,,0.198800882,,,,,,,,,,0.143023192,,0.029706029,,,,Stage IA,,1.2455,,,,,,,,,,,,,,,,-0.011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.740024604605153,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.5218,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.02,0.57,5,4,5,,,3430,BRCA_LumB,3430,3430,,0,0,3430,3430,,Invasive Carcinoma,14,,27,,,,19594,0,,3430,3430,,,,3430,3430,,,3430,,,,,,,,TUMOR FREE,Alive,-16642,,,,39,,3430,3430,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,13,,1,0.13218,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24R,,,,,,,3430,,,,,,,,,18,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,86428,,0.980287658,0,0,0,0,-0.3607,1,,,Infiltrating Ductal Carcinoma,0.121482621,,0.081370766,0,0,0,,Negative,-0.149,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0288,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-8366,White,STAD,,0,0,,,0,0,,0,2.08,0.33,1,0,0,,,29,,29,29,,0,0,29,29,,Malignant,1,,14,,,,25963,,,29,29,,,,29,29,,,29,,,,,,,,TUMOR FREE,Alive,-29394,,,,227,,29,29,,,[Not Available],[Not Applicable],,,,,0.04,Stomach,Unknown,,,6,,0,0.044898,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8366,,,,,,,29,,,,,,,,,3,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,86430,,1.129208382,,,,,,,,,,0.174174158,Grade 3,0.121169108,,,,Stage IIA,,2.105,,,,,,,,,,,,,,,,0.6758,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8366,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A3IB,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,1.82,0.91,7,2,7,,,220,,,220,,1.0,1,220.0,220.0,,Malignant,16,,24,,,,28198.0,,,220.0,220,,,,,220,,,220.0,,,,,,,,WITH TUMOR,Dead,-24149,220,,,126.0,,220.0,220,,,[Not Available],[Not Applicable],,,,,0.05,,,,,6,,0,0.20794,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A3IB,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2008,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,86432,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.39,1,0,3,,,3091,BRCA_LumA,3091,3091,,0,0,3091,3091,,Invasive Carcinoma,4,,2,,,,19718,0,,3091,3091,,,,3091,3091,,,3091,,,,,,,,TUMOR FREE,Alive,-21288,,,,30,,3091,3091,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,3,,0,0.051053,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DN,,,,,,,3091,,,,,,,,,5,,,,,,,,,,,,,2004,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,86433,,1.235916682,0,0,0,0,0.2747,1,,,Infiltrating Ductal Carcinoma,0.198147914,,0.165333231,0,0,0,,Negative,1.1825,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3638,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-A4BW,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,2.05,0.58,13,7,21,,,585,,585,585,,0,0,585,585,,Malignant,41,,148,,,,16856,,,585,585,,,,585,585,,,585,,,,,,,,TUMOR FREE,Alive,-20301,,,,305,,585,585,,,[Not Available],[Not Applicable],,,,,0.14,,,,,14,,0,0.32203,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-A4BW,,,,,,,585,,,,,,,,,20,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,86435,,0.932304153,,,,,,,,,,0.148322621,,0.01840524,,,,Stage IIA,,0.501,,,,,,,,,,,,,,,,0.6637,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.14831301,15.17854009,15.89368487,-0.377988176765582,LUSC,Squamous Cell Carcinoma,17.9734092,15.97028002,Squamous Cell Carcinoma,0.4056,13.29660793,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-50-7109,White,LUAD,,1,1,,University of Pittsburgh,,1,MALE,1,2.86,0.44,3,13,14,,,308,,,308,,1,1,15,15,,Malignant,30,,44,,,,16833,,,15,15,,,,,308,,,15,,,,,,,,WITH TUMOR,Dead,-21979,308,,,314,,15,15,,,[Not Available],[Not Applicable],,,,,0.17,,,,,16,,1,0.19093,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-7109,,,,,,,,,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,2011,15,,,,Stage IA,,,,,,,,Progressive Disease,,,,,,60,,,,,,,,,,,,,,,,,,,,86441,,0.91605355,,,,,,,,,,0.181452233,,0.177703641,,,,Stage IA,,0.6155,,,,,,,,,,,,,,,,0.052,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.106429973,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.3273,,0.6258,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.85,0.7,5,5,7,,,328,BRCA_LumA,328,328,,0,0,328,328,,Invasive Carcinoma,17,,40,,,,21588,0,,328,328,,,,328,328,,,328,,,,,,,,TUMOR FREE,Alive,-22714,,,,52,,328,328,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,4,,0,0.19447,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0GZ,,,,,,,328,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86444,,-0.628520246,0,0,0,0,-0.2934,1,,,Infiltrating Ductal Carcinoma,0.127818706,,0.217309939,0,0,0,,Negative,-0.9285,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4245,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,1.0,1.0,Male,TCGA-GV-A3QH,White,BLCA,,1.0,1,,,,2,MALE,1.0,5.64,0.48,8,11,17,,,258,,,258,,1.0,1,125.0,125.0,,Malignant,36,,70,,,,17677.0,,,125.0,125,,,,,258,,,125.0,,,,,,,,TUMOR FREE,Dead,-24681,258,,,224.0,,125.0,125,,,[Not Available],[Not Applicable],,,,,0.24,,,,,24,,2,0.19322,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3QH,,,,,,,,Bladder,Locoregional (Urothelial tumor event),,,,,,,45,,,,,,,,,,,,,2011,125,,,,Stage II,,,,,,,,Stable Disease,,,,,,67.0,,,,,,,,,,,,,,,,,,,,86449,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-BL-A5ZZ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.31,0.38,4,5,4,,,377,,242,377,,1.0,1,242.0,242.0,,Malignant,13,,19,,,,25445.0,,,242.0,242,,,,242,377,,,242.0,,,,,,,,WITH TUMOR,Alive,-29247,,,,231.0,,242.0,242,,,[Not Available],[Not Applicable],,,,,0.11,,,,,9,,0,0.028636,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Christiana Healthcare,,TCGA-BL-A5ZZ,,,,,,,377,Lung,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2012,242,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,80.0,,,,,,,,,,,,,,,,,,,,86454,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.57,2,0,2,,,326,BRCA_LumA,326,326,,0,0,326,326,,Invasive Carcinoma,4,,9,,,,20087,0,,326,326,,,,326,326,,,326,,,,,,,,TUMOR FREE,Alive,-17529,,,,49,,326,326,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,2,,0,0.015947,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A5ZW,,,,,,,326,,,,,,,,,2,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,86460,,0.145490207,0,0,0,0,0.475,1,,,Infiltrating Ductal Carcinoma,0.185036959,,0.205270677,0,0,0,,Negative,-0.1215,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.5862,0,0,H & E,0,0,,0,Katherine Huenerberg,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Tubular),Invasive Ductal Carcinoma (Tubular),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-34-2596,White,LUSC,,0,0,,University of Pittsburgh,2,2,MALE,2,1.57,0.65,12,7,15,,,80,,80,80,,2,2,80,80,,Malignant,34,,48,,,,22716,,,80,80,,,,80,80,,,80,,,,,,,,TUMOR FREE,Dead,-25574,80,,,354,,80,80,,,[Not Available],[Not Applicable],,,,,0.13,,,,,14,,0,0.57661,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-2596,,,,,,,80,,,,,,,,,18,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,86462,,0.767199503,,,,,,,,,,0.179765176,,0.072924433,,,,Stage IIB,,2.45,,,,,,,,,,,,,,,,0.4684,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.3846048,15.46489321,15.8299987,-0.341829472396961,LUSC,Squamous Cell Carcinoma,18.02411409,15.84491713,Squamous Cell Carcinoma,-0.4902,13.67779232,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-CU-A72E,White,BLCA,,0.0,0,,,,1,MALE,1.0,1.98,0.69,2,0,3,,,413,,,413,,2.0,2,256.0,256.0,,Malignant,5,,61,,,,25861.0,,,413.0,413,,,,,413,,,256.0,,,,,,,,WITH TUMOR,Dead,-27963,413,,,139.0,,413.0,413,,,[Not Available],[Not Applicable],,,,,0.04,,,,,6,,0,0.16717,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,UNC,,TCGA-CU-A72E,,,,,,,,Lymph Node Only,New Primary Tumor,,,,,,,7,,,,,,,,,,,,,2013,256,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,86464,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.08,0.72,2,2,4,,,3094,BRCA_LumA,3094,3094,,0,0,3094,3094,,Invasive Carcinoma,8,,2,,,,17094,0,,3094,3094,,,,3094,3094,,,3094,,,,,,,,TUMOR FREE,Alive,-26845,,,,57,,3094,3094,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.032911,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EM,,,,,,,3094,,,,,,,,,4,,,,,,,,,,,,,2002,,,,,Stage IA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,86468,,-0.794623015,0,0,0,0,0.1365,1,,,Infiltrating Ductal Carcinoma,0.15015635,,0.157172282,0,0,0,,Negative,-0.855,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3743,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,No Detail Present,"DCIS (Cribriform, Low Grade), No Detail Present",,"DCIS (Cribriform, Low Grade)",0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-ZF-AA4W,White,BLCA,,1.0,1,,,1,0,MALE,1.0,1.96,0.35,9,6,13,,,1830,,1679,1830,,1.0,1,1679.0,1679.0,,Malignant,28,,77,,,,22381.0,,,1679.0,1679,,,,1679,1830,,,1679.0,,,,,,,,,Alive,-20611,,,,713.0,,1679.0,1679,,,[Not Available],[Not Applicable],,,,,0.04,,,,,11,,0,0.21942,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA4W,,,,,,,1830,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,11,,,,,,,,,,,,,2009,1679,penile urethra,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,86469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-D7-6519,White,STAD,,1,1,,,,0,,1,3.28,0.74,15,16,15,,,625,,,625,,1,1,429,429,,Malignant,46,,95,,,,25687,,,429,429,,,,,625,,,429,,,,,,,,WITH TUMOR,Alive,-23413,,,,72,,429,429,,,[Not Available],[Not Applicable],,,,,0.11,Stomach,Unknown,,,23,,1,0.35153,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6519,,,,,,,625,Liver,Distant Metastasis,,,,,,,17,,,,,,,,,,,,,2010,429,cervix,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,64,,,,,,,,,,,,,,,,,,,,86473,,-0.078746182,,,,,,,,,,0.04831632,Grade 3,-0.007243746,,,,Unknown,,-0.135,,,,,,,,,,,,,,,,0.3756,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6519,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Male,TCGA-EJ-5530,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.98,0.51,1,0,1,HRP,NO,1832,1-ERG,1832,1832,,0,0,1832,1832,prad_tcga,Malignant,2,,2,9.2,TCGA-EJ-5530-01,0,5290,0,TCGA-EJ-5530,1832,1832,Prostate Cancer,,586,1832,1832,TCGA,,1832,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-22316,,61,7,60,PRAD,1832,1832,WHITE,0.0,[Not Available],[Not Applicable],68,R0,1,Matched,0.03,Prostate,Resection,3,27d61473-39d6-478a-a576-427d1aeda01f,1,,0,0.015819,[Not Available],e4a755e3-4938-4321-b5a9-27a445036791,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.2,TCGA-EJ-5530,0:DiseaseFree,2,9,Prostate Adenocarcinoma,60.18,4/4/12,1832,,,,,NO,C61,03cb0863-99db-411a-a347-a8675a65cb5a,,1,TUMOR FREE,0.015,0:LIVING,0.1,3,60.18,Bilateral,10,,,YES,,2008,,,TCGA-EJ-5530.03cb0863-99db-411a-a347-a8675a65cb5a.pdf,,[Not Applicable],NO,,76-85%,6,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.8,61,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,86474,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-8286,White,STAD,,0,0,,,0,0,,0,3.12,0.54,13,8,16,,,895,,895,895,,0,0,895,895,,Malignant,37,,191,,,,18760,,,895,895,,,,895,895,,,895,,,,,,,,TUMOR FREE,Alive,-17966,,,,192,,895,895,,,[Not Available],[Not Applicable],,,,,0.47,Stomach,Unknown,,,15,,1,0.36965,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8286,,,,,,,895,,,,,,,,,26,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,49,,,,,,,,,,,,,,,,,,,,86483,,0.521547697,,,,,,,,,,0.05203379,Grade 3,0.136884954,,,,Stage II,,0.119,,,,,,,,,,,,,,,,0.2599,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8286,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,0,0,0,1,,,,BRCA,,0,0,,,2,2,FEMALE,2,3.18,0.58,12,21,26,,,943,BRCA_LumB,943,943,,2,2,943,943,,Invasive Carcinoma,59,,103,,,,16951,0,,943,943,,,,943,943,,,943,,,,,,,,TUMOR FREE,Dead,-28338,943,,,344,,943,943,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,10,,1,0.32596,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06X,,,,,,,,,,,,,,,,29,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,86484,,0.807816192,0,0,0,0,-1.7004,1,,,Infiltrating Ductal Carcinoma,0.131856661,,0.118080073,0,0,0,,Negative,0.5285,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1147,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-MP-A5C7,White,LUAD,,0,0,,Washington University - Mayo Clinic,0,0,FEMALE,0,2.01,0.87,5,2,7,,,2248,,2248,2248,,0,0,2248,2248,,Malignant,14,,64,,,,27157,,,2248,2248,,,,2248,2248,,,2248,,,,,,,,TUMOR FREE,Alive,-28015,,,,108,,2248,2248,,,[Not Available],[Not Applicable],,,,,0.07,,,,,6,,0,0.12886,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A5C7,,,,,,,2248,,,,,,,,,6,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,86485,,-0.459557367,,,,,,,,,,0.102918984,,0.125692698,,,,Stage IB,,-1.109,,,,,,,,,,,,,,,,-0.4225,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Y345* (driver),1,,,Y345* (driver),,,,-0.634873141,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.4919,,-2.2738,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.34,0.28,10,18,25,,,594,BRCA_LumA,594,594,,0,0,594,594,,Invasive Carcinoma,53,,171,,,,29460,0,,594,594,,,,594,594,,,594,,,,,,,,TUMOR FREE,Alive,-18161,,,,79,,594,594,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,13,,1,0.36643,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A7SZ,,,,,,,594,,,,,,,,,36,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,86490,,1.147062003,0,0,0,0,-1.5599,1,,,Infiltrating Ductal Carcinoma,0.183366964,,0.093201195,0,0,0,,Negative,0.7295,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0113,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-69-8453,White,LUAD,,1,1,,Washington University - Cleveland Clinic,,0,MALE,1,,,,,,,,813,,,813,,1,1,344,344,,Malignant,,,,,,,34069,,,344,344,,,,,813,,,344,,,,,,,,WITH TUMOR,Alive,-28413,,,,0,,344,344,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-8453,,,,,,,813,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2012,344,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,77,,,,,,,,,,,,,,,,,,,,86493,,1.051259783,,,,,,,,,,0.317198118,,0.183630633,,,,Stage IIB,,1.423,,,,,,,,,,,,,,,,0.3533,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.47374968,19.39973675,16.37143897,0.00302845,LUAD,Adenocarcinoma,18.37020765,16.55857271,Adenocarcinoma,-1.0166,14.8933423,0.4624,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-78-7150,White,LUAD,,1,,,Prince Charles Hospital,,1,MALE,1,2.99,0.46,16,15,24,,,666,,,666,,1,,139,139,,Malignant,55,,62,,,,25340,,,139,,,,,,666,,,139,,,,,,,,WITH TUMOR,Dead,-21891,666,,,533,,139,,,,[Not Available],[Not Applicable],,,,,0.15,,,,,14,,1,0.42949,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7150,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2002,139,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,86496,,0.426181278,,,,,,,,,,0.173169611,,0.060707899,,,,Stage IIB,,-0.002,,,,,,,,,,,,,,,,0.4785,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,HOMDEL (driver),1,,,,14.64109641,15.15394333,14.86336784,-0.631117335,LUAD,Adenocarcinoma,17.6771452,15.09684744,Adenocarcinoma,1.1235,12.71472429,-0.592,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-86-8054,White,LUAD,,0,0,,Asterand,0,0,MALE,0,2.86,0.74,7,10,16,,,1148,,1148,1148,,0,0,1148,1148,,Malignant,33,,44,,,,18847,,,1148,1148,,,,1148,1148,,,1148,,,,,,,,TUMOR FREE,Alive,-22584,,,,287,,1148,1148,,,[Not Available],[Not Applicable],,,,,0.14,,,,,17,,1,0.28265,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8054,,,,,,,1148,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,86499,,0.118614324,,,,,,,,,,0.139440869,,0.117051071,,,,Stage IIB,,-0.1615,,,,,,,,,,,,,,,,-0.0018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,14.7684511,15.67430439,14.00040385,-0.808945462,LUAD,Adenocarcinoma,17.68793823,14.91537333,Adenocarcinoma,0.1587,12.70403393,-1.0772,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Male,TCGA-60-2707,,LUSC,,1,,,Roswell Park,1,1,MALE,1,1.94,0.6,6,3,7,,,667,,579,667,,1,,579,579,,Malignant,16,,15,,,,17621,,,579,,,,,579,667,,,579,,,,,,,,WITH TUMOR,Dead,-25758,667,,,128,,579,,,,[Not Available],[Not Applicable],,,,,0.56,,,,,5,,0,0.14954,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2707,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2003,579,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,86509,,0.133907104,,,,,,,,,,0.213781741,,0.108155356,,,,Stage IB,,0.254,,,,,,,,,,,,,,,,1.0713,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.495602757863331,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.0633,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-33-4533,Black or African American,LUSC,,0,0,,Johns Hopkins,0,0,FEMALE,0,4.08,0.7,9,11,12,,,4068,,4068,4068,,0,0,4068,4068,,Malignant,32,,218,,,,20460,,,4068,4068,,,,4068,4068,,,4068,,,,,,,,TUMOR FREE,Alive,-28001,,,,402,,4068,4068,,,[Not Available],[Not Applicable],,,,,0.3,,,,,8,,2,0.50033,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4533,,,,,,,4068,,,,,,,,,47,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,86510,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.6873,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.540159886413279,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,,,,,,,,545,,,545,,0,0,545,545,,Invasive Carcinoma,,,,,,,33252,0,,545,545,,,,,545,,,545,,,,,,,,TUMOR FREE,Alive,-19985,,,,0,,545,545,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A4SF,,,,,,,545,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,86512,,0.256776877,0,0,0,0,-0.5216,1,,,Infiltrating Ductal Carcinoma,0.142106249,,0.041113714,0,0,0,,Positive,0.2135,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1632,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A3IB,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,1.82,0.91,7,2,7,,,220,,,220,,1.0,1,220.0,220.0,,Malignant,16,,24,,,,28198.0,,,220.0,220,,,,,220,,,220.0,,,,,,,,WITH TUMOR,Dead,-24149,220,,,126.0,,220.0,220,,,[Not Available],[Not Applicable],,,,,0.05,,,,,6,,0,0.20794,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A3IB,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2008,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,86513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,86514,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-UY-A78N,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.35,0.78,4,3,8,,,2641,,,2641,,1.0,1,2472.0,2472.0,,Malignant,15,,71,,,,32696.0,,,2472.0,2472,,,,,2641,,,2472.0,,,,,,,,WITH TUMOR,Dead,-29132,2641,,,327.0,,2472.0,2472,,,[Not Available],[Not Applicable],,,,,0.12,,,,,20,,1,0.11688,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A78N,,,,,,,,Renal Pelvis,Distant Metastasis,,,,,,,17,,,,,,,,,,,,,,2472,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,80.0,,,,,,,,,,,,,,,,,,,,86515,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FJ-A871,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.99,0.81,3,3,2,,,272,,,272,,1.0,1,106.0,106.0,,Malignant,8,,33,,,,24621.0,,,106.0,106,,,,,272,,,106.0,,,,,,,,WITH TUMOR,Dead,-18051,272,,,71.0,,106.0,106,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.029834,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A871,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,0,,,,,,,,,,,,,2013,106,Pelvic,,,Stage III,,,,,,,,Progressive Disease,,,,,,49.0,,,,,,,,,,,,,,,,,,,,86517,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-85-7699,White,LUSC,,1,1,,Asterand,1,1,MALE,1,1.75,0.65,8,8,11,,,1001,,760,1001,,1,1,760,760,,Malignant,27,,18,,,,16825,,,760,760,,,,760,1001,,,760,,,,,,,,WITH TUMOR,Dead,-26965,1001,,,250,,760,760,,,[Not Available],[Not Applicable],,,,,0.26,,,,,14,,0,0.40553,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-7699,,,,,,,,,Distant Metastasis,,,,,,,16,,,,,,,,,,,,,2011,760,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,86520,,1.511736878,,,,,,,,,,0.223991085,,0.080241291,,,,Stage IIIA,,2.0,,,,,,,,,,,,,,,,0.5931,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.45845108,16.83205027,17.84588211,-0.0040196199564759,LUSC,Squamous Cell Carcinoma,17.97384145,16.88264673,Squamous Cell Carcinoma,0.789,13.62690383,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,0,1,Male,TCGA-MX-A5UG,Asian,STAD,,0,0,,,,1,,2,2.01,0.14,2,1,2,,,113,,,113,,2,2,113,113,,Malignant,5,,20,,,,33268,,,113,113,,,,,113,,,113,,,,,,,,TUMOR FREE,Dead,-28714,113,,,48,,113,113,,,Stomach Cancer,[Not Applicable],,,,,0.05,Stomach,Unknown,,,0,,0,0.034932,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,MSKCC,,TCGA-MX-A5UG,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Applicable],,,,,,78,,,,,,,,,,,,,,,,,,,,86521,,1.094587255,,,,,,,,,,0.154738939,Grade 3,0.215080941,,,,Stage IIIA,,1.206,,,,,,,,,,,,,,,,0.7344,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-MX-A5UG,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Male,TCGA-2A-AAYO,,PRAD,,0,0,,2A,0,0,MALE,0,1.98,0.73,3,2,1,,NO,1272,,1272,1272,,0,0,1272,1272,prad_tcga,Malignant,6,BRCA2,16,,TCGA-2A-AAYO-01,0,5233,0,TCGA-2A-AAYO,1272,1272,Prostate Cancer,180,922,1272,1272,TCGA,No Evidence of Extraprostatic Extension,1272,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-21183,,57,6,28,PRAD,1272,1272,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.0,Prostate,Resection,3,A9272DFA-C8A7-460A-82D9-1C129DD9389E,1,,0,0.023113,[Not Available],8C0D361F-EAAB-4768-90F2-B7A610E2BBB1,3,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,2A,0.8,TCGA-2A-AAYO,0:DiseaseFree,1,,Prostate Adenocarcinoma,41.79,7/7/14,1272,,,,,YES,C61,3889AA76-F350-4DA4-987B-79E8D2349262,80,1,TUMOR FREE,0.0208,0:LIVING,0.05,,41.79,Bilateral,,,,YES,854,2011,,,TCGA-2A-AAYO.3889AA76-F350-4DA4-987B-79E8D2349262.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,57,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,86522,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.76,0.89,8,4,5,,,577,BRCA_LumB,577,577,,0,0,577,577,,Invasive Carcinoma,17,,22,,,,28980,0,,577,577,,,,577,577,,,577,,,,,,,,TUMOR FREE,Alive,-20072,,,,50,,577,577,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,8,,0,0.27439,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JI,,,,,,,577,,,,,,,,,9,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,86524,,,0,0,0,0,-0.654,0,,,Infiltrating Ductal Carcinoma,,,,0,0,1,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Papilloma,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-KB-A93H,Asian,STAD,,0,0,,,0,0,,0,,,,,,,,1145,,1145,1145,,0,0,1145,1145,,Malignant,,,,,,,19528,,,1145,1145,,,,1145,1145,,,1145,,,,,,,,TUMOR FREE,Alive,-28966,,,,295,,1145,1145,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G1,,"University Health Network, Toronto",,TCGA-KB-A93H,,,,,,,1145,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,86526,,-1.299348165,,,,,,,,,,0.001230476,Grade 1,-0.015870908,,,,Stage IIB,,-0.8875,,,,,,,,,,,,,,,,-0.6181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-KB-A93H,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.78,4,3,5,,,549,BRCA_LumB,549,549,,0,0,549,549,,Invasive Carcinoma,12,,15,,,,28038,0,,549,549,,,,549,549,,,549,,,,,,,,TUMOR FREE,Alive,-21338,,,,36,,549,549,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Core Biopsy,,,5,,0,0.071809,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A082,,,,,,,549,,,,,,,,,4,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,86543,,-1.580596078,0,0,0,0,0.2722,1,,,Infiltrating Ductal Carcinoma,0.124496384,,0.106167736,0,0,0,,Negative,-1.626,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4325,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5527,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.99,0.49,4,7,4,HRD,NO,1778,1-ERG,1778,1778,,0,0,1778,1778,prad_tcga,Malignant,15,ATM;CHEK1,18,7.7,TCGA-EJ-5527-01,9,5289,0,TCGA-EJ-5527,1778,1778,Prostate Cancer,,217,1778,1778,TCGA,,1778,Primary,0,Apex|Middle,A,,BRCA2,,TUMOR FREE,Alive,-25234,,69,7,39,PRAD,1778,1778,WHITE,0.19880582,[Not Available],[Not Applicable],54,R0,1,Matched,0.11,Prostate,Resection,4,15a638fe-4dfd-4280-ad40-5e0d5fde3812,2,,0,0.065049,[Not Available],ba0c9096-5f35-4f0a-ae98-ee1a695b55f0,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.8,TCGA-EJ-5527,0:DiseaseFree,3,20,Prostate Adenocarcinoma,58.41,4/4/12,1778,,,,,NO,C61,b4c74b9e-b639-4488-aef1-8bf008324f73,,3,TUMOR FREE,0.0694,0:LIVING,0.1,3,58.41,Bilateral,22,,,YES,,2009,,,TCGA-EJ-5527.b4c74b9e-b639-4488-aef1-8bf008324f73.pdf,,[Not Applicable],NO,,61-70%,9,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.7,69,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,86550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7791,White,PRAD,184,0,0,,EJ,0,0,MALE,0,,,,,,,NO,1118,8-other,1118,1118,,0,0,1118,1118,prad_tcga,Malignant,,,,4.5,TCGA-EJ-7791-01,0,5326,0,TCGA-EJ-7791,1118,1118,Prostate Cancer,,217,1118,1118,TCGA,,1118,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-24621,,67,7,16,PRAD,1118,1118,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,,Prostate,Resection,3,57ed8a64-46f9-4e1f-8550-cef121a6bbc6,,,,,[Not Available],4fe004e5-49f9-4336-a690-6ebad512c813,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.8,TCGA-EJ-7791,0:DiseaseFree,2,,Prostate Adenocarcinoma,36.73,4/9/12,1118,,,,,NO,C61,001c43cb-3e9b-43db-b6d0-61e67d058c9f,,,TUMOR FREE,0.0001,0:LIVING,0.1,4,36.73,Bilateral,,,,YES,,2011,,,TCGA-EJ-7791.001c43cb-3e9b-43db-b6d0-61e67d058c9f.pdf,,[Not Applicable],NO,,81-90%,18,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.5,67,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,86552,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-HQ-A2OF,Unknown,BLCA,,1.0,1,,,1,0,FEMALE,1.0,,,,,,,,1947,,907,1947,,1.0,1,907.0,907.0,,Malignant,,,,,,,17209.0,,,907.0,907,,,,907,1947,,,907.0,,,,,,,,TUMOR FREE,Alive,-19016,,,,154.0,,907.0,907,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Ontario Institute for Cancer Research (OICR),,TCGA-HQ-A2OF,,,,,,,1947,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,,,,,,,,,,,,,,,907,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,52.0,,,,,,,,,,,,,,,,,,,,86553,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-49-4494,White,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,2.05,0.46,6,6,3,,,1081,,,1081,,1,1,1081,1081,,Malignant,15,,19,,,,20702,,,1081,1081,,,,,1081,,,1081,,,,,,,,WITH TUMOR,Dead,-28387,1081,,,257,,1081,1081,,,[Not Available],[Not Applicable],,,,,0.32,,,,,3,,0,0.2271,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4494,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1995,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,86560,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), T790M (driver)",,,1,"L858R (driver), T790M (driver)",,,15.83983572,16.56385538,16.03537556,-0.171017566,LUAD,,17.59504698,15.01237642,Adenocarcinoma,-0.4315,12.61159328,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Male,TCGA-V5-A7RB,Unknown,ESCA,,0,0,,,,2,,2,2.1,0.61,10,10,10,,,161,,,161,,2,2,161,161,,Malignant,30,,162,,,,30028,,,161,161,,,,,161,,,161,,,,,,,,TUMOR FREE,Dead,-21654,161,,,397,,161,161,,,[Not Available],Stage IIB,,,,,0.05,Esophagus,Unknown,,,8,,0,0.21482,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,Duke University,,TCGA-V5-A7RB,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,,,,,,[Unknown],,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,86563,,,,,,,,,,,,,Unknown,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-85-8351,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.01,0.49,4,6,10,,,510,,510,510,,0,0,510,510,,Malignant,20,,27,,,,22629,,,510,510,,,,510,510,,,510,,,,,,,,TUMOR FREE,Alive,-26437,,,,189,,510,510,,,[Not Available],[Not Applicable],,,,,0.22,,,,,12,,1,0.33652,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8351,,,,,,,510,,,,,,,,,29,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,86568,,-0.058990537,,,,,,,,,,0.17937924,,0.136834383,,,,Stage IIA,,0.3285,,,,,,,,,,,,,,,,0.4861,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,15.02441135,16.26449275,15.03467325,-0.535377879437322,LUSC,Squamous Cell Carcinoma,17.83933932,15.06220539,Squamous Cell Carcinoma,-0.1483,12.77925069,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Female,TCGA-55-A493,White,LUAD,,0,0,,International Genomics Consortium,,0,FEMALE,0,1.83,0.26,6,9,8,,,28,,,28,,0,0,28,28,,Malignant,23,,77,,,,25985,,,28,28,,,,,28,,,28,,,,,,,,TUMOR FREE,Alive,-20027,,,,472,,28,28,,,[Not Available],[Not Applicable],,,,,0.42,,,,,13,,0,0.41939,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A493,,,,,,,28,,,,,,,,,20,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,[Unknown],,,,,,54,,,,,,,,,,,,,,,,,,,,86571,,1.408053262,,,,,,,,,,0.239594351,,0.051024573,,,,Stage IB,,2.9815,,,,,,,,,,,,,,,,0.5967,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.007191172,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.652,,0.6358,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-18-3406,White,LUSC,,1,1,,Princess Margaret Hospital (Canada),,1,MALE,1,1.78,0.48,14,12,14,,,371,,,371,,1,1,357,357,,Malignant,40,,54,,,,23602,,,357,357,,,,,371,,,357,,,,,,,,WITH TUMOR,Dead,-24477,371,,,285,,357,357,,,[Not Available],[Not Applicable],,,,,0.22,,,,,7,,0,0.35763,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3406,,,,,,,,,Locoregional Recurrence,,,,,,,11,,,,,,,,,,,,,2003,357,,,,Stage IA,,,,,,,,Progressive Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,86581,,1.289195089,,,,,,,,,,0.235034165,,0.120632148,,,,Stage IA,,0.421,,,,,,,,,,,,,,,,0.2209,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.162427664268205,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.8084,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Female,TCGA-95-A4VP,White,LUAD,,1,1,,Washington University - Emory,,0,FEMALE,1,2.73,0.3,6,9,9,,,605,,,605,,1,1,216,216,,Malignant,24,,85,,,,24390,,,216,216,,,,,605,,,216,,,,,,,,WITH TUMOR,Alive,-24130,,,,171,,216,216,,,[Not Available],[Not Applicable],,,,,0.09,,,,,17,,1,0.39967,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-A4VP,,,,,,,605,,Distant Metastasis,,,,,,,37,,,,,,,,,,,,,2012,216,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,66,,,,,,,,,,,,,,,,,,,,86584,,0.937460899,,,,,,,,,,0.182952358,,0.267628855,,,,Stage IIIA,,0.863,,,,,,,,,,,,,,,,0.1867,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,15.69712921,16.05900303,15.88938852,-0.146050849,LUAD,Adenocarcinoma,18.37140115,16.47392485,Adenocarcinoma,-0.4094,10.39156427,0.4626,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.81,0.65,3,4,7,,,579,BRCA_LumA,579,579,,0,0,579,579,,Invasive Carcinoma,14,,11,,,,19836,0,,579,579,,,,579,579,,,579,,,,,,,,TUMOR FREE,Alive,-24380,,,,63,,579,579,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Core Biopsy,,,14,,1,0.038355,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A0A2,,,,,,,579,,,,,,,,,19,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,86586,,0.445194576,0,0,0,0,-0.3392,1,,,Infiltrating Lobular Carcinoma,0.130882297,,0.145680992,0,0,0,,Negative,-0.08,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.2851,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.05,0.64,8,12,12,,,4005,BRCA_Her2,4005,4005,,0,0,4005,4005,,Invasive Carcinoma,32,,89,,,,20598,0,,4005,4005,,,,4005,4005,,,4005,,,,,,,,TUMOR FREE,Alive,-18538,,,,869,,4005,4005,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,20,,1,0.18594,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Columbia University,,TCGA-3C-AALI,,,,,,,4005,,,,,,,,,31,,,,,,,,,,,,,2003,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,86587,,,0,0,0,0,-0.4925,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Solid, Intermediate Grade), Microcalcifications",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-D7-6525,White,STAD,,1,1,,,,1,,1,1.85,0.63,7,7,9,,,406,,,406,,1,1,171,171,,Malignant,23,,52,,,,19628,,,171,171,,,,,406,,,171,,,,,,,,WITH TUMOR,Dead,-21223,406,,,210,,171,171,,,[Not Available],[Not Applicable],,,,,0.19,Stomach,Unknown,,,6,,0,0.22457,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6525,,,,,,,,,Distant Metastasis,,,,,,,13,,,,,,,,,,,,,2010,171,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,58,,,,,,,,,,,,,,,,,,,,86589,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6525,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,1,,1,1,,,White,BRCA,,1,1,,,1,,FEMALE,1,3.03,0.76,3,0,5,,,1649,BRCA_LumB,1304,1649,,1,1,1304,1304,,Invasive Carcinoma,8,,11,,,,31588,0,,1304,1304,,,,1304,1649,,,1304,,,,,,,,,Dead,-22800,1649,,,56,,1304,1304,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,21,,1,0.30531,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A2LK,,,,,,,,Bone,Distant Metastasis,,,,,,,37,,,,,,,,,,,,,2007,1304,,,,Stage III,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86608,,0.202209937,0,0,0,0,-1.7149,1,,,Infiltrating Lobular Carcinoma,0.1891076,,0.101856085,0,0,0,,Negative,-0.727,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2611,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-NC-A5HK,White,LUSC,,0,0,,Washington University - CHUV,0,0,FEMALE,0,3.05,0.48,19,18,21,,,128,,128,128,,0,0,128,128,,Malignant,58,,170,,,,33043,,,128,128,,,,128,128,,,128,,,,,,,,TUMOR FREE,Alive,-21531,,,,362,,128,128,,,[Not Available],[Not Applicable],,,,,0.24,,,,,13,,1,0.52886,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HK,,,,,,,128,,,,,,,,,34,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,86609,,0.427698532,,,,,,,,,,0.086654418,,-0.049207984,,,,Stage IIB,,2.3025,,,,,,,,,,,,,,,,0.2373,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.83861434,15.00349043,15.85410966,-0.51073242792902,LUSC,Squamous Cell Carcinoma,17.83272545,15.3798016,Squamous Cell Carcinoma,-0.3995,12.60048406,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3B7,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,2.17,0.28,11,9,8,,,122,,,122,,1.0,1,110.0,110.0,,Malignant,28,,27,,,,31065.0,,,110.0,110,,,,,122,,,110.0,,,,,,,,WITH TUMOR,Dead,-24245,122,,,84.0,,110.0,110,,,[Not Available],[Not Applicable],,,,,0.39,,,,,9,,0,0.33582,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3B7,,,,,,,,Lymph Node Only,Distant Metastasis,,,,,,,22,,,,,,,,,,,,,2011,110,,,,Stage III,,,,,,,,Progressive Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,86610,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-K4-AAQO,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.08,0.33,8,14,14,,,359,,,359,,0.0,0,359.0,359.0,,Malignant,36,,62,,,,21775.0,,,359.0,359,,,,,359,,,359.0,,,,,,,,,Alive,-20683,,,,341.0,,359.0,359,,,[Not Available],[Not Applicable],,,,,0.07,,,,,13,,1,0.16663,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-AAQO,,,,,,,359,,,,,,,,,36,,,,,,,,,,,,,2013,,,,,Stage III,,,,,,,,[Unknown],,,,,,56.0,,,,,,,,,,,,,,,,,,,,86615,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6370,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.0,0.38,0,0,0,HRD,NO,1156,8-other,1156,1156,,0,0,1156,1156,prad_tcga,Malignant,0,,0,6.4,TCGA-G9-6370-01,0,5370,0,TCGA-G9-6370,1156,1156,Prostate Cancer,,806,1156,1156,TCGA,,1156,Primary,0,Apex|Base,A,BARD1:507:V/X:frameshift_variant,,,TUMOR FREE,Alive,-19149,,52,7,2,PRAD,1156,1156,WHITE,0.0,[Not Available],[Not Applicable],7,R0,1,Matched,0.0,Prostate,Resection,3,644e1e7d-dfd1-4f83-82dc-ae0c7e010f6f,0,,0,0.0,[Not Available],f947b0bc-bdac-44e8-b5b9-ffae4147740a,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.233333333333,TCGA-G9-6370,0:DiseaseFree,2,0,Prostate Adenocarcinoma,37.98,3/7/12,1156,,,,,NO,C61,fa0332e6-d535-45c0-8ed9-9b36816f1350,,0,TUMOR FREE,0.0,0:LIVING,0.03,,37.98,Bilateral,2,,,YES,,2009,,,TCGA-G9-6370.fa0332e6-d535-45c0-8ed9-9b36816f1350.pdf,,[Not Applicable],NO,,16-25%,1,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.6,52,Core needle biopsy,,,NO,YES,YES,,T3b,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,86616,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,Asian,BRCA,,1,1,,,,1,FEMALE,1,3.7,0.95,6,14,13,,,967,BRCA_Basal,,967,,1,1,967,967,,Invasive Carcinoma,33,,34,,,,23561,1,,967,967,,,,,967,,,967,,,,,,,,WITH TUMOR,Dead,-20048,967,,,100,,967,967,,,[Not Available],[Not Applicable],,,,,0.35,Not Specific/Unknown,Resection/Excision,,,14,,1,0.21107,Indeterminate (neither Pre or Postmenopausal),,,"Other, specify",,,,,,[Not Available],,UCSF,,TCGA-A1-A0SK,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,86618,TRUE,,0,0,0,0,-3.5811,1,,,Other,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-22-5480,White,LUSC,,1,,,Mayo Clinic - Rochester,1,1,FEMALE,1,1.95,0.71,3,4,8,,,2170,,1779,2170,,1,,1779,1779,,Malignant,15,,28,,,,24109,,,1779,,,,,1779,2170,,,1779,,,,,,,,WITH TUMOR,Dead,-24245,2170,,,213,,1779,,,,[Not Available],[Not Applicable],,,,,0.35,,,,,7,,0,0.28213,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5480,,,,,,,2170,,,,,,,,,14,,,,,,,,,,,,,2002,1779,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,86619,,1.565391243,,,,,,,,,,0.206461515,,0.069714434,,,,Stage IA,,1.8605,,,,,,,,,,,,,,,,0.3018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0803073105651415,LUSC,,,,Squamous Cell Carcinoma,-0.2528,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7797,White,PRAD,221,0,0,,EJ,0,0,MALE,0,1.98,0.37,2,1,1,HRP,NO,983,1-ERG,983,983,,0,0,983,983,prad_tcga,Malignant,4,,10,5.4,TCGA-EJ-7797-01,0,5333,0,TCGA-EJ-7797,983,983,Prostate Cancer,,187,983,983,TCGA,,983,Primary,0,,A,,,,TUMOR FREE,Alive,-19616,,53,7,28,PRAD,983,983,WHITE,0.0,[Not Available],[Not Applicable],44,R0,1,Matched,0.0,Prostate,Resection,3,0ff50861-6b1a-441d-82f1-bf5d3ca8ac86,1,,0,0.015757,[Not Available],f98366df-9616-41c0-a6b8-ec92dca7177a,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.43333333333,TCGA-EJ-7797,0:DiseaseFree,2,7,Prostate Adenocarcinoma,32.29,4/9/12,983,,,,,NO,C61,d9d6f871-c436-469e-9d7f-9684c379a320,,1,TUMOR FREE,0.015,0:LIVING,0.1,4,32.29,Bilateral,8,,,YES,,2011,,,TCGA-EJ-7797.d9d6f871-c436-469e-9d7f-9684c379a320.pdf,,[Not Applicable],NO,,41-50%,14,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.6,53,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,86620,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A8DZ,Black or African American,STAD,,1,1,,,,1,,1,2.82,0.6,6,14,22,,,396,,,396,,1,1,396,396,,Malignant,42,,123,,,,28694,,,396,396,,,,,396,,,396,,,,,,,,WITH TUMOR,Dead,-25863,396,,,111,,396,396,,,Stomach Cancer,[Not Applicable],,,,,0.71,Stomach,Unknown,,,20,,1,0.17618,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8DZ,,,,,,,,,,,,,,,,41,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,86621,,-0.927741943,,,,,,,,,,0.057987733,Grade 3,0.104776647,,,,Stage IV,,-0.761,,,,,,,,,,,,,,,,0.1284,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8DZ,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0,0,0,0,0,Male,TCGA-85-A4QR,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.05,0.73,19,20,23,,,600,,600,600,,0,0,600,600,,Malignant,62,,125,,,,20704,,,600,600,,,,600,600,,,600,,,,,,,,TUMOR FREE,Alive,-24756,,,,298,,600,600,,,[Not Available],[Not Applicable],,,,,0.35,,,,,21,,1,0.42248,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A4QR,,,,,,,600,,,,,,,,,28,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,86627,,-0.282070299,,,,,,,,,,0.052209849,,-0.078129749,,,,Stage IB,,-0.8955,,,,,,,,,,,,,,,,-0.2999,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-1.16614098658578,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-3.5968,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-YL-A8SK,,PRAD,389,0,0,,YL,,0,MALE,0,2.03,0.44,6,9,7,HRD,NO,1408,8-other,,1408,,0,0,1408,1408,prad_tcga,Malignant,22,BRCA1;CDK12;CHEK1;RAD51D,61,,TCGA-YL-A8SK-01,0,5676,0,TCGA-YL-A8SK,1408,1408,Prostate Cancer,,924,,1408,TCGA,,1408,Primary,0,Apex|Middle|Base,B,ATM:?-416:.:splice_acceptor_variant,ATM,True,,Alive,-24759,,67,9,45,PRAD,1408,1408,,0.0,[Not Available],[Not Applicable],34,R1,1,Matched,0.08,Prostate,Resection,4,F5243BA4-684D-4401-A1A5-7713BCC9106E,2,Normal (no evidence of prostate cancer) [cM0],0,0.10241,[Not Available],159B47B2-DC7D-4856-9A00-454E27301E23,5,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,YL,1.13333333333,TCGA-YL-A8SK,0:DiseaseFree,5,23,Prostate Adenocarcinoma,46.25,4/25/14,1408,,,,,NO,C61,F332F5AD-A0BE-455D-9523-13BDF275DB2A,410,5,,0.1851,0:LIVING,0.03,,46.25,Bilateral,26,,,YES,1208,2010,,,TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,38,26-35%,20,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R1,,67,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N1,,4,M0,C61.9,8140/3,86629,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-67-6216,White,LUAD,,0,0,,St Joseph's Medical Center (MD),0,0,FEMALE,0,1.97,0.56,2,2,2,,,141,,141,141,,0,0,141,141,,Malignant,6,,19,,,,19982,,,141,141,,,,141,141,,,141,,,,,,,,TUMOR FREE,Alive,-20967,,,,42,,141,141,,,[Not Available],[Not Applicable],,,,,0.15,,,,,2,,0,0.032463,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-6216,,,,,,,141,,,,,,,,,2,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,86632,,0.868254022,,,,,,,,,,0.244781783,,0.063210032,,,,Stage IA,,1.174,,,,,,,,,,,,,,,,0.1659,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.180100711,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.4918,,0.1582,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-GD-A3OQ,White,BLCA,,0.0,0,,,,0,MALE,0.0,2.01,0.78,0,4,4,,,95,,,95,,0.0,0,95.0,95.0,,Malignant,8,,8,,,,25950.0,,,95.0,95,,,,,95,,,95.0,,,,,,,,,Alive,-17682,,,,128.0,,95.0,95,,,[Not Available],[Not Applicable],,,,,0.07,,,,,0,,0,0.056896,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - IUPUI,,TCGA-GD-A3OQ,,,,,,,95,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,[Unknown],,,,,,48.0,,,,,,,,,,,,,,,,,,,,86634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A76W,,PRAD,348,0,0,,HC,,0,MALE,0,1.98,0.61,1,2,1,HRP,NO,213,3-ETV4,,213,,0,0,213,213,prad_tcga,Malignant,4,BARD1;FANCL;PALB2;RAD51B,31,,TCGA-HC-A76W-01,0,5459,0,TCGA-HC-A76W,213,213,Prostate Cancer,,213,,213,TCGA,,213,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-26755,,73,7,43,PRAD,213,213,,0.0,[Not Available],[Not Applicable],41,,1,Matched,0.43,Prostate,Resection,3,67C95255-97F0-41EE-99A3-CEC801512829,0,Normal (no evidence of prostate cancer) [cM0],0,0.019694,[Not Available],5F69CA7D-F8E0-4F5B-9987-1E5C234EB759,4,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,HC,1.36666666667,TCGA-HC-A76W,0:DiseaseFree,2,5,Prostate Adenocarcinoma,7.0,3/28/14,213,,,,,NO,C61,C59C0C25-B1FC-45C5-AD7E-0FBA9574656C,50,0,WITH TUMOR,0.0177,0:LIVING,0.01,,7.0,Bilateral,5,,,YES,260,2012,,,TCGA-HC-A76W.C59C0C25-B1FC-45C5-AD7E-0FBA9574656C.pdf,,[Not Applicable],NO,62,61-70%,4,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,NO,"Yes, History of Synchronous/Bilateral Malignancy",R1,,73,Core needle biopsy,,,YES,NO,YES,NO,T3b,,7,No,,0,N0,T2,0,M0,C61.9,8140/3,86638,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.33,8,5,7,,,1198,BRCA_LumA,1198,1198,,0,0,1198,1198,,Invasive Carcinoma,20,,16,,,,17468,0,,1198,1198,,,,1198,1198,,,1198,,,,,,,,TUMOR FREE,Alive,-17080,,,,21,,1198,1198,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,10,,0,0.22967,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A2LO,,,,,,,1198,,,,,,,,,13,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,86643,,1.310348452,0,0,0,0,-0.1232,1,,,Infiltrating Lobular Carcinoma,0.133149652,,0.205215386,0,0,0,,Negative,0.7625,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4052,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-49-4494,White,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,2.05,0.46,6,6,3,,,1081,,,1081,,1,1,1081,1081,,Malignant,15,,19,,,,20702,,,1081,1081,,,,,1081,,,1081,,,,,,,,WITH TUMOR,Dead,-28387,1081,,,257,,1081,1081,,,[Not Available],[Not Applicable],,,,,0.32,,,,,3,,0,0.2271,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4494,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1995,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,86645,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), T790M (driver)",,,1,"L858R (driver), T790M (driver)",,,15.83983572,16.56385538,16.03537556,-0.171017566,LUAD,,17.59504698,15.01237642,Adenocarcinoma,,12.61159328,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-ZF-AA51,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.15,0.5,9,21,21,,,1714,,1714,1714,,0.0,0,1714.0,1714.0,,Malignant,51,,108,,,,34138.0,,,1714.0,1714,,,,1714,1714,,,1714.0,,,,,,,,TUMOR FREE,Alive,-25484,,,,917.0,,1714.0,1714,,,[Not Available],[Not Applicable],,,,,0.34,,,,,20,,1,0.22754,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA51,,,,,,,1714,,,,,,,,,32,,,,,,,,,,,,,2009,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,86651,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.44,0.51,2,2,6,,,616,BRCA_LumA,616,616,,0,0,616,616,,Invasive Carcinoma,10,,14,,,,19003,1,,616,616,,,,616,616,,,616,,,,,,,,TUMOR FREE,Alive,-18002,,,,31,,616,616,,,[Not Available],[Not Applicable],,,,,0.0,Lymph Node,Resection/Excision,,,16,,0,0.030728,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,Walter Reed,,TCGA-A2-A1G0,,,,,,,616,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,86654,,0.538059965,0,0,0,0,0.3594,1,,,Other,0.117176312,,0.220083852,0,0,0,,Negative,0.166,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3154,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Lymph Node,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-J4-A6G3,,PRAD,315,1,1,,J4,,0,MALE,1,,,,,,,NO,849,5-SPOP,,849,,1,1,618,618,prad_tcga,Malignant,,,,7.5,TCGA-J4-A6G3-01,0,5482,0,TCGA-J4-A6G3,618,618,Prostate Cancer,15,528,,849,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1],618,Primary,0,,A,,,True,WITH TUMOR,Alive,-20836,,57,8,25,PRAD,618,618,,0.0,[Not Available],[Not Applicable],26,R1,1,Matched,,Prostate,Resection,4,30F54DD8-FD85-407E-816C-C9DB4C1D79EE,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],9B015929-99EB-4E74-8FBF-6B2E6D7F08E4,4,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,J4,0.866666666667,TCGA-J4-A6G3,1:Recurred/Progressed,4,,Prostate Adenocarcinoma,20.3,9/12/13,849,,Biochemical evidence of disease,,,YES,C61,63F0D5A2-CCAB-48C7-9BD9-F75A699DE1AD,80,,TUMOR FREE,0.0001,0:LIVING,0.4,,27.89,Bilateral,,,,YES,479,2012,618,,TCGA-J4-A6G3.63F0D5A2-CCAB-48C7-9BD9-F75A699DE1AD.pdf,Peripheral Zone,[Not Applicable],NO,17,41-50%,5,Prostate Adenocarcinoma Acinar Type,1,2012,Partial Remission/Response,,NO,No,R1,,57,Core needle biopsy,,,YES,NO,YES,NO,T3b,YES,8,No,NO,0,N0,T2,0,M0,C61.9,8140/3,86661,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-E7-A7PW,Asian,BLCA,,1.0,1,,,1,0,MALE,1.0,3.39,0.84,9,16,13,,,416,,174,416,,1.0,1,174.0,174.0,,Malignant,38,,93,,,,28699.0,,,174.0,174,,,,174,416,,,174.0,,,,,,,,TUMOR FREE,Alive,-23057,,,,120.0,,174.0,174,,,[Not Available],[Not Applicable],,,,,0.5,,,,,14,,1,0.16763,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A7PW,,,,,,,416,Bone,Distant Metastasis,,,,,,,25,,,,,,,,,,,,,2013,174,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,63.0,,,,,,,,,,,,,,,,,,,,86665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A4ZV,,PRAD,285,0,0,,HC,,0,MALE,0,2.04,0.7,11,21,12,HRD,NO,23,8-other,,23,,0,0,23,23,prad_tcga,Malignant,44,PALB2;RAD51B,72,70.0,TCGA-HC-A4ZV-01,80,5448,0,TCGA-HC-A4ZV,23,23,Prostate Cancer,,,,23,TCGA,,23,Primary,1,,A,BRIP1:558:W/SX:frameshift_variant,,False,WITH TUMOR,Alive,-20634,,56,9,158,PRAD,23,23,,0.533914194,[Not Available],[Not Applicable],109,R1,1,Matched,0.12,Prostate,Resection,5,54CC56B3-7AE5-4184-8EBD-BF080A8A22C5,4,,0,0.15244,[Not Available],BB8E6886-EDC7-4127-A85B-C4F3769B6681,4,Prostate Adenocarcinoma Acinar Type,,Prostate,44,,Acinar Adenocarcinoma,[Not Available],,HC,3.63333333333,TCGA-HC-A4ZV,0:DiseaseFree,5,45,Prostate Adenocarcinoma,0.76,3/15/13,23,,,,,,C61,424EBA82-F32C-4387-B919-F7C8F1212232,80,11,WITH TUMOR,0.3551,0:LIVING,,,0.76,Bilateral,50,,,YES,79,2012,,,TCGA-HC-A4ZV.424EBA82-F32C-4387-B919-F7C8F1212232.pdf,Overlapping / Multiple Zones,[Not Applicable],,,61-70%,13,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,R1,,56,Core needle biopsy,,,YES,NO,YES,NO,T3b,,9,No,,0,N0,T2c,0,,C61.9,8140/3,86666,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-R6-A6Y0,White,ESCA,,0,0,,,,0,,0,,,,,,,,1641,,,1641,,0,0,1641,1641,,Malignant,,,,,,,22543,,,1641,1641,,,,,1641,,,1641,,,,,,,,WITH TUMOR,Alive,-20045,,,,286,,1641,1641,,,[Not Available],Stage IVA,,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,MD Anderson Cancer Center,,TCGA-R6-A6Y0,,,,,,,1641,,,,,,,,,,,,,,,,,,,,,,2005,,,,,[Not Available],,,,,,,,Stable Disease,,,,,,54,,,,,,,,,,,,,,,,,,,,86671,,,,,,,,,,,,,Grade 2,,,,,Stage IVA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-RD-A8N4,White,STAD,,0,0,,,0,0,,0,2.01,0.35,0,0,0,,,2171,,2171,2171,,0,0,2171,2171,,Malignant,0,,9,,,,24194,,,2171,2171,,,,2171,2171,,,2171,,,,,,,,TUMOR FREE,Alive,-21324,,,,5,,2171,2171,,,[Not Available],[Not Applicable],,,,,0.12,Stomach,Unknown,,,0,,0,0.0019821,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A8N4,,,,,,,2171,,,,,,,,,0,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,86676,,0.993379524,,,,,,,,,,0.048899908,Grade 3,0.163213301,,,,Stage IIIA,,0.7185,,,,,,,,,,,,,,,,0.1041,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8N4,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-GC-A3RC,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.14,0.69,9,15,17,,,484,,484,484,,0.0,0,484.0,484.0,,Malignant,41,,54,,,,16368.0,,,484.0,484,,,,484,484,,,484.0,,,,,,,,TUMOR FREE,Alive,-21668,,,,536.0,,484.0,484,,,[Not Available],[Not Applicable],,,,,0.09,,,,,17,,1,0.14512,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A3RC,,,,,,,484,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,86690,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Female,TCGA-38-4626,White,LUAD,,0,0,,UNC,0,0,FEMALE,1,2.07,0.28,0,4,4,,,3674,,3674,3674,,0,0,2518,2518,,Malignant,8,,19,,,,16946,,,3674,3674,,,,3674,3674,,,2518,,,,,,,,TUMOR FREE,Alive,-20903,,,,318,,3674,3674,,,[Not Available],[Not Applicable],,,,,0.33,,,,,2,,0,0.0020304,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-4626,,,,,,,3674,,New Primary Tumor,,,,,,,3,,,,,,,,,,,,,2003,2518,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,86692,,0.604222443,,,,,,,,,,0.328229184,,0.281654295,,,,Unknown,,1.0935,,,,,,,,,,,,,,,,0.3491,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.229714724,LUAD,,,,Adenocarcinoma,-0.2322,,-0.0501,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.35,0.5,12,28,19,,,10,BRCA_Basal,10,10,,0,0,10,10,,Invasive Carcinoma,59,,78,,,,20672,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-19309,,,,239,,10,10,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,11,,1,0.48323,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FX,,,,,,,10,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,86693,,-0.176229394,0,0,0,0,0.3457,1,,,Infiltrating Ductal Carcinoma,0.125793756,,0.151308189,0,0,0,,Negative,-0.5505,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5078,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.02,0.69,1,0,3,,,217,BRCA_LumB,217,217,,0,0,217,217,,Invasive Carcinoma,4,,2,,,,32416,0,,217,217,,,,217,217,,,217,,,,,,,,TUMOR FREE,Alive,-16689,,,,33,,217,217,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,20,,1,0.027612,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A249,,,,,,,217,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,86696,,-0.009941685,0,0,0,0,-0.867,1,,,Infiltrating Ductal Carcinoma,0.119203625,,0.066858767,0,0,0,,Negative,-0.174,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0665,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.09,0.48,10,14,19,,,225,BRCA_LumA,225,225,,0,0,225,225,,Invasive Carcinoma,43,,56,,,,19119,1,,225,225,,,,225,225,,,225,,,,,,,,,Alive,-23103,,,,153,,225,225,,,[Not Available],[Not Applicable],,,,,0.14,Not Specific/Unknown,Resection/Excision,,,13,,1,0.22181,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ABS - IUPUI,,TCGA-GI-A2C8,,,,,,,225,,,,,,,,,32,,,,,,,,,,,,,2004,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,86700,,0.524770821,0,0,0,0,-3.2342,1,,,Infiltrating Ductal Carcinoma,0.213048844,,0.235505278,0,0,0,,Negative,-0.1635,,10/21/22,0,0,0,0,0,0,0,0,0,0,METAPLASTIC CARCINOMA,0,0,0.5538,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-33-AASL,Black or African American,LUSC,,1,1,,Johns Hopkins,,1,FEMALE,1,1.74,0.43,20,19,22,,,826,,,826,,1,1,149,149,,Malignant,61,,206,,,,21050,,,149,149,,,,,826,,,149,,,,,,,,WITH TUMOR,Dead,-20940,826,,,401,,149,149,,,[Not Available],[Not Applicable],,,,,0.11,,,,,12,,0,0.44963,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-AASL,,,,,,,,,Locoregional Recurrence,,,,,,,19,,,,,,,,,,,,,2000,149,,,,Stage IA,,,,,,,,Progressive Disease,,,,,,57,,,,,,,,,,,,,,,,,,,,86702,,0.585672547,,,,,,,,,,0.098191457,,-0.060043907,,,,Stage IA,,0.8045,,,,,,,,,,,,,,,,-0.1627,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.317186121291824,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.7646,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,516,,516,516,,0,0,516,516,,Invasive Carcinoma,,,,,,,28587,0,,516,516,,,,516,516,,,516,,,,,,,,TUMOR FREE,Alive,-24731,,,,49,,516,516,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HN,,,,,,,516,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,86704,,-1.67697558,0,0,0,0,-0.276,0,Redacted,,Infiltrating Ductal Carcinoma,0.117888405,,0.046980761,0,0,1,,Negative,-1.9905,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1503,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,Papilloma,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.1,0.5,4,4,5,,,1206,BRCA_LumA,,1206,,0,0,1206,1206,,Invasive Carcinoma,13,,16,,,,22280,0,,1206,1206,,,,,1206,,,1206,,,,,,,,TUMOR FREE,Alive,-17372,,,,26,,1206,1206,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.14078,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mucinous Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3KD,,,,,,,1206,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,86711,,-0.543049477,0,0,0,0,0.1787,1,,,Mucinous Carcinoma,0.13835785,,0.166985478,0,0,0,,Positive,-0.924,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2449,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.15,0.75,19,31,25,,,397,BRCA_Basal,397,397,,0,0,397,397,,Invasive Carcinoma,75,,83,,,,22812,0,,397,397,,,,397,397,,,397,,,,,,,,TUMOR FREE,Alive,-26588,,,,0,,397,397,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,5,,0,0.35971,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27H,,,,,,,397,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,86712,TRUE,-0.240141051,0,0,0,0,1.9538,1,,,Infiltrating Ductal Carcinoma,0.159280949,,0.152092501,0,0,0,,Negative,-1.4475,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7582,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-86-8281,White,LUAD,,0,0,,Asterand,0,0,MALE,0,2.08,0.54,2,2,5,,,0,,0,0,,0,0,0,0,,Malignant,9,,8,,,,26597,,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-27409,,,,351,,0,0,,,[Not Available],[Not Applicable],,,,,0.03,,,,,3,,0,0.04495,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8281,,,,,,,0,,,,,,,,,5,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,86713,,0.535344667,,,,,,,,,,0.179013872,,0.193919467,,,,Stage IA,,-0.412,,,,,,,,,,,,,,,,0.0123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G333S (driver),1,,,G333S (driver),,,,-0.622898727,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.4782,,-0.8542,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-95-7043,White,LUAD,,1,1,,Washington University - Emory,,1,FEMALE,1,3.73,0.76,15,14,25,,,503,,,503,,1,1,503,503,,Malignant,54,,73,,,,16269,,,503,503,,,,,503,,,503,,,,,,,,WITH TUMOR,Dead,-23165,503,,,1407,,503,503,,,[Not Available],[Not Applicable],,,,,0.2,,,,,14,,2,0.53728,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-7043,,,,,,,,,,,,,,,,62,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,86717,,-0.448509085,,,,,,,,,,0.123063733,,0.162649696,,,,Stage IA,,-0.844,,,,,,,,,,,,,,,,-0.2106,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L100P,1,,,L100P,,,,-0.742043781,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3312,,-0.3404,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.77,0,0,0,,,259,BRCA_Normal,259,259,,0,0,259,259,,Invasive Carcinoma,0,,2,,,,30657,0,,259,259,,,,259,259,,,259,,,,,,,,TUMOR FREE,Alive,-25833,,,,0,,259,259,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,0,,0,0.000806,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,UCSF,,TCGA-A1-A0SB,,,,,,,259,,,,,,,,,0,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,86722,,-2.170007124,0,0,0,0,-0.208,1,,,Other,0.118190005,,0.070132856,0,0,0,,Negative,-1.909,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2551,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-AAMW,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,3.68,0.53,4,2,15,,,253,,,253,,1.0,1,253.0,253.0,,Malignant,21,,166,,,,23060.0,,,253.0,253,,,,,253,,,253.0,,,,,,,,WITH TUMOR,Dead,-28903,253,,,49.0,,253.0,253,,,[Not Available],[Not Applicable],,,,,0.02,,,,,15,,1,0.073819,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMW,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,79.0,,,,,,,,,,,,,,,,,,,,86725,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-BR-6709,White,STAD,,1,1,,,,1,,1,,,,,,,,370,,,370,,1,1,370,370,,Malignant,,,,,,,18688,,,370,370,,,,,370,,,370,,,,,,,,WITH TUMOR,Dead,-20935,370,,,55,,370,370,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6709,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Partial Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,86727,,,,,,,,,,,,,Grade 3,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6709,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,3017,BRCA_Basal,3017,3017,,0,0,3017,3017,,Invasive Carcinoma,,,,,,,24639,0,,3017,3017,,,,3017,3017,,,3017,,,,,,,,WITH TUMOR,Alive,-22922,,,,28,,3017,3017,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0ST,,,,,,,3017,,,,,,,,,,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86729,,2.190396117,0,0,0,0,-0.5103,1,,,Infiltrating Ductal Carcinoma,0.233029616,,0.1898029,0,0,0,,Negative,2.1015,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0448,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-JY-A938,White,ESCA,,1,1,,,1,0,,1,1.84,0.42,14,8,16,,,1060,,493,1060,,1,1,493,493,,Malignant,38,,117,,,,19808,,,493,493,,,,493,1060,,,493,,,,,,,,WITH TUMOR,Alive,-27633,,,,229,,493,493,,,[Not Available],[Not Available],,,,,0.07,Esophagus,Unknown,,,10,,0,0.24824,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,University Health Network,,TCGA-JY-A938,,,,,,,1060,"Other, specify",Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2012,493,Adrenal Gland,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,86730,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,Not Answered,,,,,,,,,,,,,,,,,,,,,Resection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1.0,0,0,0.0,1.0,Male,TCGA-L5-A4ON,White,ESCA,,0.0,0,,,2,2,,2.0,,,,,,,,558,,558,558,,2.0,2,558,558,,Malignant,,,,,,,18656.0,0,,558,558,,,,558,558,,,558,,,,,,,,TUMOR FREE,Dead,-23970,558,,,274.0,,558,558,,,[Not Available],[Not Available],,,,,,Esophagus,Resection,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A4ON,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,86732,,,,,,,,,,,,,Unknown,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-85-8479,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.76,0.67,12,11,16,,,468,,468,468,,0,0,468,468,,Malignant,39,,98,,,,16929,,,468,468,,,,468,468,,,468,,,,,,,,TUMOR FREE,Alive,-24350,,,,163,,468,468,,,[Not Available],[Not Applicable],,,,,0.18,,,,,10,,0,0.39186,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8479,,,,,,,468,,,,,,,,,14,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,86733,,-1.049934173,,,,,,,,,,0.048539883,,0.032487403,,,,Stage IA,,-1.5955,,,,,,,,,,,,,,,,0.1478,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-1.06299289543162,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.4291,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-YC-A9TC,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.03,0.8,1,2,2,,,20,,,20,,1.0,1,20.0,20.0,,Malignant,5,,37,,,,27233.0,,,20.0,20,,,,,20,,,20.0,,,,,,,,WITH TUMOR,Dead,-26283,20,,,159.0,,20.0,20,,,[Not Available],[Not Applicable],,,,,0.0,,,,,1,,0,0.02795,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Spectrum Health,,TCGA-YC-A9TC,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,71.0,,,,,,,,,,,,,,,,,,,,86742,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-BL-A0C8,White,BLCA,,1.0,1,,,1,0,MALE,1.0,,,,,,,,1219,,630,1219,,1.0,1,630.0,630.0,,,,,,,,,18022.0,,,630.0,630,,,,630,1219,,,630.0,,,,,,,,,Alive,-26819,,,,211.0,,630.0,630,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,[Not Available],,,,,Unknown,High Grade,,Christiana Healthcare,,TCGA-BL-A0C8,,,,,,,1219,Bladder,Locoregional (Urothelial tumor event),,,,,,,,,,,,,,,,,,,,2009,630,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,86749,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-XQ-A8TB,,PRAD,370,0,0,,XQ,0,0,MALE,0,1.93,0.99,5,9,2,ambiguous,NO,770,1-ERG,770,770,,0,0,770,770,prad_tcga,Malignant,16,,82,,TCGA-XQ-A8TB-01,0,5642,0,TCGA-XQ-A8TB,770,770,Prostate Cancer,,674,770,770,TCGA,,770,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-24623,,67,9,39,PRAD,770,770,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.03,Prostate,Resection,4,49E270B1-8A45-4AF9-B071-3A54845FF6FE,1,Abnormal (not related to prostate cancer),0,0.085105,[Not Available],5277F041-F9FB-47C2-83F3-65AD230DD40A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,XQ,1.0,TCGA-XQ-A8TB,0:DiseaseFree,5,22,Prostate Adenocarcinoma,25.3,1/26/15,770,,,,,NO,C61,EDF35290-BD43-4527-A8BF-ED6F3CC1F0AB,90,1,TUMOR FREE,0.0652,0:LIVING,0.0,,25.3,Bilateral,25,,,YES,420,2012,,,TCGA-XQ-A8TB.EDF35290-BD43-4527-A8BF-ED6F3CC1F0AB.pdf,Peripheral Zone,[Not Applicable],NO,-24,31-40%,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,67,Core needle biopsy,,Complete Remission/Response,,,YES,NO,T3b,YES,9,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,86754,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FJ-A871,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.99,0.81,3,3,2,,,272,,,272,,1.0,1,106.0,106.0,,Malignant,8,,33,,,,24621.0,,,106.0,106,,,,,272,,,106.0,,,,,,,,WITH TUMOR,Dead,-18051,272,,,71.0,,106.0,106,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.029834,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A871,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,0,,,,,,,,,,,,,2013,106,Pelvic,,,Stage III,,,,,,,,Progressive Disease,,,,,,49.0,,,,,,,,,,,,,,,,,,,,86755,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-A4J9,White,STAD,,0,0,,,0,0,,0,2.0,0.99,1,2,0,,,14,,14,14,,0,0,14,14,,Malignant,3,,13,,,,18412,,,14,14,,,,14,14,,,14,,,,,,,,TUMOR FREE,Alive,-20093,,,,56,,14,14,,,[Not Available],[Not Applicable],,,,,0.3,Stomach,Unknown,,,0,,0,0.012253,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4J9,,,,,,,14,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,86762,,0.461382603,,,,,,,,,,0.079826092,Grade 3,0.198787457,,,,Stage IIA,,-0.0005,,,,,,,,,,,,,,,,0.3136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4J9,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-52-7809,White,LUSC,,1,1,,University of Miami,,1,MALE,1,2.73,0.52,12,19,21,,,166,,,166,,1,1,166,166,,Malignant,52,,89,,,,20766,,,166,166,,,,,166,,,166,,,,,,,,WITH TUMOR,Dead,-27233,166,,,321,,166,166,,,[Not Available],[Not Applicable],,,,,0.2,,,,,16,,1,0.54501,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Miami,,TCGA-52-7809,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,86763,,0.495617749,,,,,,,,,,0.136901594,,0.073959792,,,,Stage IB,,0.4475,,,,,,,,,,,,,,,,0.1897,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.697126745015052,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.336,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.0,0.36,0,0,0,,,1210,BRCA_Normal,1014,1210,,1,1,1014,1014,,Invasive Carcinoma,0,,19,,,,33894,0,,1014,1014,,,,1014,1210,,,1014,,,,,,,,TUMOR FREE,Alive,-24923,,,,31,,1014,1014,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,0,,0,1.28e-05,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1P1,,,,,,,1210,Lung,Distant Metastasis,,,,,,,0,,,,,,,,,,,,,2008,1014,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,86765,,1.127660237,0,0,0,0,0.8374,1,,,Infiltrating Ductal Carcinoma,0.226068833,,0.353747491,0,0,0,,Negative,0.4395,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7652,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Clinging, High Grade), Comedonecrosis",,"DCIS (Clinging, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-85-7843,White,LUSC,,0,0,,Asterand,,0,MALE,0,5.38,0.41,16,19,22,,,35,,,35,,0,0,35,35,,Malignant,57,,87,,,,24816,,,35,35,,,,,35,,,35,,,,,,,,,Alive,-18353,,,,299,,35,35,,,[Not Available],[Not Applicable],,,,,0.22,,,,,21,,2,0.32265,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-7843,,,,,,,35,,,,,,,,,48,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,86771,,0.563637478,,,,,,,,,,0.209918944,,0.135804573,,,,Stage IIA,,-0.0495,,,,,,,,,,,,,,,,0.5894,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.47912453,16.15527571,14.32066114,-0.55871765500922,LUSC,Squamous Cell Carcinoma,17.72528369,15.35952681,Squamous Cell Carcinoma,0.5593,14.65425966,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.92,0.57,7,10,10,,,134,BRCA_Basal,134,134,,0,0,134,134,,Invasive Carcinoma,27,,28,,,,16853,0,,134,134,,,,134,134,,,134,,,,,,,,TUMOR FREE,Alive,-14175,,,,59,,134,134,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,19,,1,0.48633,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0E0,,,,,,,134,,,,,,,,,27,,,,,,,,,,,,,2009,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,86773,TRUE,0.781987366,0,0,0,0,0.1551,1,,,Infiltrating Ductal Carcinoma,0.099058373,,0.085716591,0,0,0,,Negative,-0.8225,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2994,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FC-A6HD,,PRAD,,0,0,,FC,0,0,MALE,0,1.99,0.79,1,1,1,HRP,NO,789,,789,789,,0,0,789,789,prad_tcga,Malignant,3,,15,,TCGA-FC-A6HD-01,0,5346,0,TCGA-FC-A6HD,789,789,Prostate Cancer,,,789,789,TCGA,,789,Primary,0,Middle,A,,,True,TUMOR FREE,Alive,-28197,,77,7,40,PRAD,789,789,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.02,Prostate,Resection,4,8255D1A9-9AB7-4D23-B3DE-38A2347E2158,0,Normal (no evidence of prostate cancer) [cM0],0,0.012824,[Not Available],F97FED28-FDF3-4C82-8B6D-1015848B80DC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,FC,1.0,TCGA-FC-A6HD,0:DiseaseFree,3,3,Prostate Adenocarcinoma,25.92,10/17/13,789,,,,,NO,C61,7452FEB1-FFB9-4DD2-8CD7-5BEB2B108208,210,0,,0.0101,0:LIVING,,,25.92,Bilateral,7,No Evidence of Extraprostatic Extension,33,YES,140,2013,,,TCGA-FC-A6HD.7452FEB1-FFB9-4DD2-8CD7-5BEB2B108208.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,33,,10,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,,No,R0,,77,Core needle biopsy,,,YES,NO,YES,NO,T3a,,7,No,,0,N0,T3a,0,M0,C61.9,8140/3,86775,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VP-A875,,PRAD,357,0,0,,VP,0,0,MALE,0,1.98,0.97,0,1,3,HRD,NO,2309,1-ERG,2309,2309,,0,0,2309,2309,prad_tcga,Malignant,4,BARD1;BRCA1;BRCA2;BRIP1;CDK12;FANCL;RAD51C;RAD51D;RAD54L,29,,TCGA-VP-A875-01,0,5589,0,TCGA-VP-A875,2309,2309,Prostate Cancer,,867,2309,2309,TCGA,,2309,Primary,0,Apex|Base,A,,CHEK2;RAD51B,True,TUMOR FREE,Alive,-24742,,67,7,47,PRAD,2309,2309,,0.0,[Not Available],[Not Applicable],35,R0,1,Matched,0.41,Prostate,Resection,3,1CB8EEE3-EBBE-4B8E-8452-C6364B6FDC78,0,Abnormal (not related to prostate cancer),0,0.019539,[Not Available],E833AD67-2CB3-414C-B15E-28F49479E2EF,4,Prostate Adenocarcinoma Acinar Type,,Prostate,4,,Acinar Adenocarcinoma,[Not Available],,VP,1.16666666667,TCGA-VP-A875,0:DiseaseFree,2,27,Prostate Adenocarcinoma,75.85,3/26/14,2309,,,,,NO,C61,2CF80467-58E9-4A65-94D5-08401BE6ACB5,280,0,,0.1832,0:LIVING,0.01,,75.85,Bilateral,31,No Evidence of Extraprostatic Extension,15,YES,3124,2005,,,TCGA-VP-A875.2CF80467-58E9-4A65-94D5-08401BE6ACB5.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,15,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2005,Complete Remission/Response,,NO,No,R0,,67,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,86781,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-A91S,Black or African American,STAD,,0,0,,,0,0,,0,2.44,0.6,9,15,25,,,1000,,1000,1000,,0,0,1000,1000,,Malignant,49,,168,,,,27925,,,1000,1000,,,,1000,1000,,,1000,,,,,,,,TUMOR FREE,Alive,-23187,,,,334,,1000,1000,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,7,,1,0.34998,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,GX,,Barretos Cancer Hospital,,TCGA-VQ-A91S,,,,,,,1000,,,,,,,,,39,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,86782,,0.495129916,,,,,,,,,,0.08205252,Unknown,0.075766239,,,,Stage IIIB,,1.062,,,,,,,,,,,,,,,,-0.0215,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91S,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.98,0.55,2,0,2,,,759,BRCA_LumA,,759,,0,0,759,759,,Invasive Carcinoma,4,,6,,,,26283,0,,759,759,,,,,759,,,759,,,,,,,,TUMOR FREE,Alive,-16911,,,,41,,759,759,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,2,,0,0.053083,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0W4,,,,,,,759,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,86784,,-1.433995015,0,0,0,0,0.5675,0,,,Infiltrating Ductal Carcinoma,0.139844405,,0.166754357,0,0,0,,[Not Available],-0.9845,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.6383,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,"Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)",0,Columnar Lesion,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,,0.0,1.0,Female,TCGA-ZF-A9RD,White,BLCA,,0.0,0,,,,,FEMALE,2.0,3.17,0.38,13,6,16,,,408,,,408,,2.0,2,408.0,408.0,,Malignant,35,,128,,,,22231.0,,,408.0,408,,,,,408,,,408.0,,,,,,,,,Dead,-27496,408,,,246.0,,408.0,408,,,[Not Available],[Not Applicable],,,,,0.14,,,,,16,,1,0.36902,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9RD,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,[Unknown],,,,,,75.0,,,,,,,,,,,,,,,,,,,,86792,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-HU-A4GJ,Asian,STAD,,1,1,,,,0,,1,,,,,,,,650,,,650,,1,1,547,547,,Malignant,,,,,,,18378,,,547,547,,,,,650,,,547,,,,,,,,WITH TUMOR,Alive,-22079,,,,5,,547,547,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4GJ,,,,,,,650,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2011,547,ovary,,,Stage IIIC,,,,,,,,Progressive Disease,,,,,,60,,,,,,,,,,,,,,,,,,,,86798,,,,,,,,,,,,,Grade 3,,,,,Stage IIIC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GJ,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,1,1,1,Male,TCGA-3M-AB47,White,STAD,,1,1,,,,1,,1,2.16,0.39,2,1,1,,,,,,,,1,1,395,395,,Malignant,4,,27,,,,28991,,,395,395,,,,,,,,395,,,,,,,,WITH TUMOR,Dead,,,,,156,,395,395,,,Stomach Cancer,[Not Applicable],,,,,0.0,Stomach,Unknown,,,6,,0,0.035604,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,University of Kansas Medical Center,,TCGA-3M-AB47,,,,,,,,,Locoregional Recurrence,,,,,,,3,,,,,,,,,,,,,2008,395,,,,Stage IIIB,,,,,,,,Stable Disease,,,,,,51,,,,,,,,,,,,,,,,,,,,86807,,0.355601629,,,,,,,,,,0.107742467,Grade 3,0.224977142,,,,Stage IIIB,,-0.4295,,,,,,,,,,,,,,,,0.2937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-3M-AB47,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.05,0.18,3,2,3,,,1550,BRCA_LumA,1550,1550,,0,0,1550,1550,,In Situ Carcinoma,8,,13,,,,25222,0,,1550,1550,,,,1550,1550,,,1550,,,,,,,,TUMOR FREE,Alive,-20123,,,,16,,1550,1550,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,24,,1,0.48993,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24W,,,,,,,1550,,,,,,,,,28,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,86808,,-0.279253516,0,0,0,0,0.779,1,,,Infiltrating Ductal Carcinoma,0.126210446,,0.236404042,0,0,0,,Negative,-0.98,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3874,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,None,None,0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),N/A - No invasive carcinoma (or uncertain),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CD-8529,Asian,STAD,,0,0,,,,0,,0,2.02,0.99,0,3,3,,,374,,,374,,0,0,374,374,,Malignant,6,,9,,,,16295,,,374,374,,,,,374,,,374,,,,,,,,TUMOR FREE,Alive,-23979,,,,574,,374,374,,,[Not Available],[Not Applicable],,,,,0.67,Stomach,Unknown,,,0,,0,0.0012185,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G2,,ILSBio,,TCGA-CD-8529,,,,,,,374,,,,,,,,,0,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,86814,,1.25985572,,,,,,,,,,0.156393034,Grade 2,0.180792845,,,,Stage IV,,1.0945,,,,,,,,,,,,,,,,0.5782,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8529,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.62,0.87,2,0,2,,,618,BRCA_LumB,618,618,,0,0,618,618,,Invasive Carcinoma,4,,12,,,,23985,0,,618,618,,,,618,618,,,618,,,,,,,,TUMOR FREE,Alive,-26281,,,,34,,618,618,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,12,,0,0.42868,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,MSKCC,,TCGA-AO-A0J7,,,,,,,618,,,,,,,,,12,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,86816,,-1.273894834,0,0,0,0,-0.0595,0,,,Other,0.11481893,,0.059485122,0,0,0,,Negative,-1.261,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,-0.0078,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Apocrine Metaplasia,0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Apocrine Metaplasia,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.68,0.4,13,29,24,,,2770,BRCA_Basal,2770,2770,,0,0,2770,2770,,Invasive Carcinoma,66,,88,,,,26096,0,,2770,2770,,,,2770,2770,,,2770,,,,,,,,TUMOR FREE,Alive,-16649,,,,147,,2770,2770,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,12,,1,0.36052,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3XT,,,,,,,2770,,,,,,,,,29,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,86823,TRUE,0.370943339,0,0,0,0,-2.5709,1,,,Infiltrating Ductal Carcinoma,0.200617227,,0.11000592,0,0,0,,Negative,0.1025,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1152,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.77,0.3,12,20,24,,,918,BRCA_Basal,918,918,,0,0,918,918,,Invasive Carcinoma,56,,45,,,,28133,0,,918,918,,,,918,918,,,918,,,,,,,,TUMOR FREE,Alive,-12142,,,,88,,918,918,,,[Not Available],[Not Applicable],,,,,0.25,Breast,Resection/Excision,,,3,,0,0.41668,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Medullary Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A3QA,,,,,,,918,,,,,,,,,16,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,33,,,,,,,,,,,,,,,,,,,,86825,,1.626667771,0,0,0,0,0.0915,1,,,Medullary Carcinoma,0.214410617,,0.08992553,0,0,0,,Negative,1.926,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2446,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-46-3766,White,LUSC,,0,0,,St. Joseph's Medical Center (MD),0,0,FEMALE,0,,,,,,,,370,,370,370,,0,0,370,370,,Malignant,,,,,,,25217,,,370,370,,,,370,370,,,370,,,,,,,,TUMOR FREE,Alive,-22707,,,,0,,370,370,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,St. Joseph's Medical Center (MD),,TCGA-46-3766,,,,,,,370,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,86837,,1.492002159,,,,,,,,,,0.302161463,,0.256986043,,,,Stage IA,,1.165,,,,,,,,,,,,,,,,0.8766,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.181653042179109,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.7399,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Male,TCGA-43-3394,Black or African American,LUSC,,1,,,Christiana Healthcare,1,1,MALE,1,3.4,0.6,8,11,20,,,1190,,552,1190,,1,,552,552,,Malignant,39,,39,,,,23616,,,552,,,,,552,1190,,,552,,,,,,,,WITH TUMOR,Dead,-19310,1190,,,190,,552,,,,[Not Available],[Not Applicable],,,,,0.39,,,,,22,,1,0.44391,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-3394,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2009,552,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,86841,,-0.128205993,,,,,,,,,,0.196561358,,0.043970011,,,,Stage IB,,0.568,,,,,,,,,,,,,,,,0.2404,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.522086452173555,LUSC,,,,Squamous Cell Carcinoma,0.3013,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,,0,1,Female,TCGA-21-5782,White,LUSC,,0,0,,Fox Chase Cancer Center,2,,FEMALE,2,1.96,0.48,15,19,18,,,962,,962,962,,2,2,962,962,,Malignant,52,,47,,,,30857,,,962,962,,,,962,962,,,962,,,,,,,,,Dead,-24969,962,,,512,,962,962,,,[Not Available],[Not Applicable],,,,,0.04,,,,,9,,0,0.32142,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Fox Chase Cancer Center,,TCGA-21-5782,,,,,,,962,,,,,,,,,13,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,86842,,0.993423676,,,,,,,,,,0.16534405,,0.073053772,,,,Stage IB,,0.3735,,,,,,,,,,,,,,,,0.9708,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.467682368136624,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4462,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-J4-8198,,PRAD,221,0,0,,J4,0,0,MALE,0,2.04,0.66,1,2,0,HRP,NO,614,1-ERG,614,614,,0,0,614,614,prad_tcga,Malignant,3,,18,17.9,TCGA-J4-8198-01,0,5470,0,TCGA-J4-8198,614,614,Prostate Cancer,,76,614,614,TCGA,,614,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-17935,,49,7,35,PRAD,614,614,,0.0,[Not Available],[Not Applicable],38,,1,Matched,0.0,Prostate,Resection,4,6dc2c1b2-ec10-47c9-bde1-72ecb64e258e,2,,0,0.022083,[Not Available],a1e64294-1264-498d-b18b-c9b4c729c2f2,3,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.4,J4,1.26666666667,TCGA-J4-8198,0:DiseaseFree,3,3,Prostate Adenocarcinoma,20.17,6/6/12,614,,,,,,C61,c61b1da1-f0d2-48c9-ac71-5967799def29,,1,,0.0753,0:LIVING,0.1,5,20.17,Bilateral,4,,,YES,,2011,,,TCGA-J4-8198.c61b1da1-f0d2-48c9-ac71-5967799def29.pdf,,[Not Applicable],,,61-70%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.7,49,Core needle biopsy,,,YES,NO,NO,NO,T3b,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,86843,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.4,2,0,4,,,447,BRCA_LumA,447,447,,0,0,447,447,,Invasive Carcinoma,6,,5,,,,31205,0,,447,447,,,,447,447,,,447,,,,,,,,TUMOR FREE,Alive,-18733,,,,20,,447,447,,,[Not Available],[Not Applicable],,,,,0.39,Breast,Resection/Excision,,,4,,0,0.1159,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JU,,,,,,,447,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,86844,,-0.140757758,0,0,0,0,-0.3602,0,,,Infiltrating Ductal Carcinoma,0.228461547,,0.285390466,0,0,1,,Negative,-0.063,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5962,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Papilloma,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-GC-A3WC,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,2.04,0.38,6,6,9,,,540,,540,540,,0.0,0,540.0,540.0,,Malignant,21,,41,,,,23014.0,,,540.0,540,,,,540,540,,,540.0,,,,,,,,TUMOR FREE,Alive,-29295,,,,216.0,,540.0,540,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.17883,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A3WC,,,,,,,540,,,,,,,,,9,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,80.0,,,,,,,,,,,,,,,,,,,,86846,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,1,1,Male,TCGA-73-4675,White,LUAD,,1,1,,Roswell Park,,2,MALE,1,3.41,0.57,2,5,6,,,922,,,922,,1,1,361,361,,Malignant,13,,20,,,,17691,,,361,361,,,,,922,,,361,,,,,,,,TUMOR FREE,Dead,-21614,922,,,91,,361,361,,,[Not Available],[Not Applicable],,,,,0.07,,,,,22,,1,0.10835,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4675,,,,,,,,,Locoregional Recurrence,,,,,,,18,,,,,,,,,,,,,2010,361,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,86849,,0.261296097,,,,,,,,,,0.240860986,,0.112656558,,,,Stage IIIA,,-0.483,,,,,,,,,,,,,,,,0.283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.938674,16.92351859,12.15931671,-0.690564038,LUAD,Adenocarcinoma,18.17601433,14.3970247,Adenocarcinoma,0.0676,13.40710315,-1.2469,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Female,TCGA-49-4501,White,LUAD,,1,,,Johns Hopkins,1,1,FEMALE,1,2.72,0.43,7,9,12,,,1421,,545,1421,,1,,545,545,,Malignant,28,,53,,,,20774,,,545,,,,,545,1421,,,545,,,,,,,,WITH TUMOR,Dead,-24817,1421,,,77,,545,,,,[Not Available],[Not Applicable],,,,,0.46,,,,,15,,1,0.31611,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4501,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,1996,545,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,86854,,0.95684435,,,,,,,,,,0.251171673,,0.169478902,,,,Stage IB,,0.809,,,,,,,,,,,,,,,,0.2617,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"E746_A750del (driver), AMP (driver)",,,1,E746_A750del (driver),,,,,,-0.114924814,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.96,0.44,12,13,16,,,2161,BRCA_LumA,2161,2161,,0,0,2161,2161,,Invasive Carcinoma,41,,31,,,,34367,0,,2161,2161,,,,2161,2161,,,2161,,,,,,,,TUMOR FREE,Alive,-22809,,,,96,,2161,2161,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,22,,1,0.30753,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A255,,,,,,,2161,,,,,,,,,31,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86855,,1.030796201,0,0,0,0,-1.11,1,,,Infiltrating Ductal Carcinoma,0.18173827,,0.200674103,0,0,0,,Negative,0.17,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4677,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46G,,PRAD,285,0,0,,EJ,0,0,MALE,0,2.25,0.8,1,5,9,HRD,NO,668,8-other,668,668,,0,0,668,668,prad_tcga,Malignant,15,,71,5.1,TCGA-EJ-A46G-01,0,5338,0,TCGA-EJ-A46G,668,668,Prostate Cancer,,93,668,668,TCGA,,668,Primary,0,,A,CDK12:342:L/LX:frameshift_variant,,True,TUMOR FREE,Alive,-26219,,71,8,75,PRAD,668,668,,0.0,[Not Available],[Not Applicable],53,R0,1,Matched,0.07,Prostate,Resection,4,6706E0C7-9ED7-4F65-8F5E-EE9342213499,2,Normal (no evidence of prostate cancer) [cM0],0,0.019288,[Not Available],969399CD-47B6-4C0F-8939-3860BE3014F9,4,"Prostate Adenocarcinoma, Other Subtype",,Prostate,16,,Adenocarcinoma,[Not Available],,EJ,1.8,TCGA-EJ-A46G,0:DiseaseFree,4,12,Prostate Adenocarcinoma,21.94,1/24/13,668,,,,,,C61,ACBA1CE1-E248-47D3-B03D-BE0C1B4A6F21,430,2,TUMOR FREE,0.2006,0:LIVING,0.1,5,21.94,Bilateral,18,,,YES,219,2012,,,TCGA-EJ-A46G.ACBA1CE1-E248-47D3-B03D-BE0C1B4A6F21.pdf,,[Not Applicable],,28,41-50%,17,"Prostate Adenocarcinoma, Other Subtype",1,2012,Complete Remission/Response,Adenocarcinoma prostate with prominent ductal differentiation identified,NO,"Yes, History of Prior Malignancy",R0,,71,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,8,No,NO,0,N0,T3a,0,M0,C61.9,8500/3,86860,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.85,0.44,8,7,13,,,385,BRCA_LumB,385,385,,0,0,385,385,,Invasive Carcinoma,28,,38,,,,18922,0,,385,385,,,,385,385,,,385,,,,,,,,TUMOR FREE,Alive,-18140,,,,80,,385,385,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,25,,2,0.28851,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12W,,,,,,,385,,,,,,,,,66,,,,,,,,,,,,,2010,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,86861,,0.299817824,0,0,0,0,-0.9589,1,,,Infiltrating Ductal Carcinoma,0.173999941,,0.141873717,0,0,0,,Negative,0.103,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4925,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.1,0.27,2,1,3,,,439,BRCA_LumA,439,439,,0,0,439,439,,Invasive Carcinoma,6,,9,,,,21742,0,,439,439,,,,439,439,,,439,,,,,,,,TUMOR FREE,Alive,-21327,,,,42,,439,439,,,[Not Available],[Not Applicable],,,,,0.26,Breast,Resection/Excision,,,9,,0,0.17034,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27I,,,,,,,439,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,86871,,0.804526463,0,0,0,0,-0.1652,1,,,Infiltrating Lobular Carcinoma,0.205563959,,0.276830812,0,0,0,,Negative,0.2975,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.563,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-43-A474,White,LUSC,,0,0,,Christiana Healthcare,0,0,MALE,0,2.92,0.61,11,11,21,,,353,,353,353,,0,0,353,353,,Malignant,43,,144,,,,33889,,,353,353,,,,353,353,,,353,,,,,,,,TUMOR FREE,Alive,-24286,,,,500,,353,353,,,[Not Available],[Not Applicable],,,,,0.17,,,,,19,,1,0.3598,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-A474,,,,,,,353,,,,,,,,,37,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,86872,,-1.649797191,,,,,,,,,,0.102578717,,-0.001829858,,,,Stage IIA,,-1.179,,,,,,,,,,,,,,,,0.4796,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,12.72731498,13.46754868,10.74080428,-1.28696872594405,LUSC,Squamous Cell Carcinoma,17.73591422,14.11908917,Squamous Cell Carcinoma,0.3688,14.68736864,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Female,TCGA-86-8074,White,LUAD,,0,0,,Asterand,,0,FEMALE,0,3.81,0.51,11,18,17,,,24,,,24,,0,0,24,24,,Malignant,46,,57,,,,19271,,,24,24,,,,,24,,,24,,,,,,,,TUMOR FREE,Alive,-22862,,,,87,,24,24,,,[Not Available],[Not Applicable],,,,,0.44,,,,,15,,2,0.46134,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8074,,,,,,,24,,,,,,,,,66,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,86876,,0.862189067,,,,,,,,,,0.239357066,,0.113489001,,,,Stage IIA,,0.944,,,,,,,,,,,,,,,,0.5943,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"E746_A750del (driver), AMP (driver)",,,1,E746_A750del (driver),,,16.61134792,16.92751616,15.96838962,-0.287729115,LUAD,Adenocarcinoma,17.97121425,15.63160245,Adenocarcinoma,1.1994,13.78436766,-0.416,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HC-A8D1,,PRAD,370,0,0,,HC,0,0,MALE,0,1.99,0.33,0,1,0,HRD,NO,573,1-ERG,573,573,,0,0,573,573,prad_tcga,Malignant,1,,21,,TCGA-HC-A8D1-01,0,5463,0,TCGA-HC-A8D1,573,573,Prostate Cancer,,168,573,573,TCGA,,573,Primary,0,,A,,BRCA1;CDK12;RAD51D,False,TUMOR FREE,Alive,-25137,,68,7,27,PRAD,573,573,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.0,Prostate,Resection,3,199C6D34-6693-4533-A2AE-C83ACEDFC004,0,Normal (no evidence of prostate cancer) [cM0],0,0.011534,[Not Available],341940FC-DD2A-485C-A359-D5E5EDB22312,4,Prostate Adenocarcinoma Acinar Type,,Prostate,1,,Acinar Adenocarcinoma,[Not Available],,HC,0.833333333333,TCGA-HC-A8D1,0:DiseaseFree,2,7,Prostate Adenocarcinoma,18.82,3/28/14,573,,,,,NO,C61,6C5B3FD6-3C50-4DF3-9101-D131075F4A5B,40,0,TUMOR FREE,0.0108,0:LIVING,0.01,,18.82,Bilateral,8,,,YES,464,2012,,,TCGA-HC-A8D1.6C5B3FD6-3C50-4DF3-9101-D131075F4A5B.pdf,,[Not Applicable],NO,14,66-75%,6,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,68,Core needle biopsy,,,YES,NO,YES,NO,T2c,,7,No,,0,N0,T2,0,M0,C61.9,8140/3,86882,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,4.62,0.75,3,2,6,,,822,BRCA_LumA,822,822,,0,0,822,822,,Invasive Carcinoma,11,,11,,,,18540,0,,822,822,,,,822,822,,,822,,,,,,,,TUMOR FREE,Alive,-29370,,,,86,,822,822,,,[Not Available],[Not Applicable],,,,,0.59,Breast,Resection/Excision,,,28,,2,0.055441,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A0A9,,,,,,,822,,,,,,,,,51,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,86883,,0.093159882,0,0,0,0,0.4575,1,,,Infiltrating Ductal Carcinoma,0.176593737,,0.075526218,0,0,0,,Negative,-0.1575,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4001,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Female,TCGA-FD-A3B3,White,BLCA,,0.0,0,,,2,2,FEMALE,2.0,2.33,0.21,1,5,5,,,974,,974,974,,2.0,2,974.0,974.0,,Malignant,11,,9,,,,23048.0,,,974.0,974,,,,974,974,,,974.0,,,,,,,,TUMOR FREE,Dead,-27068,974,,,208.0,,974.0,974,,,[Not Available],[Not Applicable],,,,,0.43,,,,,10,,0,0.10737,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3B3,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,74.0,,,,,,,,,,,,,,,,,,,,86886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-37-3792,White,LUSC,,0,0,,Cureline,,0,MALE,0,2.6,0.4,7,7,12,,,12,,,12,,0,0,12,12,,Malignant,26,,21,,,,24671,,,12,12,,,,,12,,,12,,,,,,,,TUMOR FREE,Alive,-25502,,,,1199,,12,12,,,[Not Available],[Not Applicable],,,,,0.25,,,,,20,,1,0.36731,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-3792,,,,,,,12,,,,,,,,,33,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,86889,,1.131200623,,,,,,,,,,0.251182806,,0.174875282,,,,Stage IB,,2.2915,,,,,,,,,,,,,,,,0.3351,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.299014675258868,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.0562,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-49-4514,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,1.79,0.35,7,13,11,,,1700,,1700,1700,,0,0,1700,1700,,Malignant,31,,47,,,,16363,,,1700,1700,,,,1700,1700,,,1700,,,,,,,,TUMOR FREE,Alive,-28908,,,,422,,1700,1700,,,[Not Available],[Not Applicable],,,,,0.01,,,,,6,,0,0.29223,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4514,,,,,,,1700,,,,,,,,,7,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,86896,,1.007982621,,,,,,,,,,0.161165377,,0.142978933,,,,Stage IA,,0.309,,,,,,,,,,,,,,,,-0.1738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R470S (driver),1,,,R470S (driver),,,,-0.189491862,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.3,0.65,2,2,2,,,1277,BRCA_LumB,1277,1277,,0,0,1277,1277,,Invasive Carcinoma,6,,3,,,,29254,0,,1277,1277,,,,1277,1277,,,1277,,,,,,,,TUMOR FREE,Alive,-16742,,,,237,,1277,1277,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,8,,0,0.03058,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A095,,,,,,,1277,,,,,,,,,10,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,86902,,0.030977845,0,0,0,0,0.0558,1,,,Infiltrating Ductal Carcinoma,0.141257687,,0.165151852,0,0,0,,Negative,-0.645,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2495,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-90-A4EE,White,LUSC,,0,0,,ABS - IUPUI,0,0,MALE,0,1.67,0.42,12,9,12,,,688,,688,688,,0,0,688,688,,Malignant,33,,186,,,,22936,,,688,688,,,,688,688,,,688,,,,,,,,TUMOR FREE,Alive,-19676,,,,482,,688,688,,,[Not Available],[Not Applicable],,,,,0.17,,,,,14,,0,0.51526,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,ABS - IUPUI,,TCGA-90-A4EE,,,,,,,688,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,86903,,1.931761553,,,,,,,,,,0.27224436,,0.092549426,,,,Stage IIA,,2.337,,,,,,,,,,,,,,,,0.258,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.13433746,17.54075023,18.45078246,0.204608900857793,LUSC,Squamous Cell Carcinoma,18.41652402,17.45983749,Squamous Cell Carcinoma,0.3894,13.91873473,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-53-7626,White,LUAD,,1,1,,University of Miami,,1,FEMALE,1,1.79,0.42,8,6,12,,,929,,,929,,1,1,865,865,,Malignant,26,,26,,,,18828,,,865,865,,,,,929,,,865,,,,,,,,WITH TUMOR,Dead,-28024,929,,,471,,865,865,,,[Not Available],[Not Applicable],,,,,0.19,,,,,9,,0,0.30521,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Miami,,TCGA-53-7626,,,,,,,,,Locoregional Recurrence,,,,,,,11,,,,,,,,,,,,,2008,865,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,76,,,,,,,,,,,,,,,,,,,,86907,,1.462537849,,,,,,,,,,0.261458847,,0.249658475,,,,Stage IIA,,1.4085,,,,,,,,,,,,,,,,0.3146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.02311575,17.24098246,16.35678363,0.077011911,LUAD,Adenocarcinoma,18.46028079,16.71002239,Adenocarcinoma,-0.3237,14.38167541,1.1608,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,1,1,Male,TCGA-85-A50Z,White,LUSC,,0,0,,Asterand,0,0,MALE,1,1.84,0.36,18,18,17,,,493,,493,493,,0,0,462,462,,Malignant,53,,116,,,,33824,,,493,493,,,,493,493,,,462,,,,,,,,TUMOR FREE,Alive,-20941,,,,590,,493,493,,,[Not Available],[Not Applicable],,,,,0.02,,,,,6,,0,0.37445,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A50Z,,,,,,,493,,New Primary Tumor,,,,,,,15,,,,,,,,,,,,,2012,462,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,86910,,0.166663502,,,,,,,,,,0.163417015,,0.036606685,,,,Stage IIA,,0.695,,,,,,,,,,,,,,,,0.1807,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.50965608,14.85049698,15.48698864,-0.439781881834048,LUSC,Squamous Cell Carcinoma,17.48991251,15.17026293,Squamous Cell Carcinoma,-0.7162,12.85560409,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.62,5,2,6,,,2091,BRCA_Normal,2091,2091,,0,0,2091,2091,,Invasive Carcinoma,13,,16,,,,25487,0,,2091,2091,,,,2091,2091,,,2091,,,,,,,,TUMOR FREE,Alive,-20930,,,,75,,2091,2091,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,6,,0,0.15134,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A03R,,,,,,,2091,,,,,,,,,10,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,86912,,1.16029757,0,0,0,0,0.1331,1,,,Infiltrating Ductal Carcinoma,0.126068002,,0.20900138,0,0,0,,Negative,0.473,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0219,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-7725,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.0,0.61,4,4,7,,,442,,442,442,,0,0,442,442,,Malignant,15,,10,,,,25126,,,442,442,,,,442,442,,,442,,,,,,,,TUMOR FREE,Alive,-24848,,,,182,,442,442,,,[Not Available],[Not Applicable],,,,,0.01,,,,,6,,0,0.070774,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7725,,,,,,,442,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,86914,,1.082529855,,,,,,,,,,0.250918547,,0.151210696,,,,Stage IA,,0.357,,,,,,,,,,,,,,,,-0.5358,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,0.081643049,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.5321,,0.4878,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.34,0.79,4,1,3,,,80,BRCA_LumA,80,80,,0,0,80,80,,Invasive Carcinoma,8,,72,,,,27322,0,,80,80,,,,80,80,,,80,,,,,,,,,Alive,-28375,,,,86,,80,80,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,19,,1,0.072728,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A6FQ,,,,,,,80,,,,,,,,,15,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,86920,,-1.221846053,0,0,0,0,1.099,1,,,Infiltrating Ductal Carcinoma,0.129873769,,0.105277282,0,0,0,,Negative,-1.0505,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0833,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.53,1,0,3,,,1928,BRCA_LumA,1928,1928,,0,0,1928,1928,,Invasive Carcinoma,4,,2,,,,21725,0,,1928,1928,,,,1928,1928,,,1928,,,,,,,,TUMOR FREE,Alive,-17152,,,,21,,1928,1928,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,3,,0,0.015837,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0H3,,,,,,,1928,,,,,,,,,3,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,86923,,0.343955873,0,0,0,0,-0.1369,1,,,Infiltrating Ductal Carcinoma,0.162500292,,0.259003123,0,0,0,,Negative,-0.3375,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.5063,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-8355,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.84,0.23,8,4,10,,,61,,61,61,,0,0,61,61,,Malignant,22,,27,,,,21218,,,61,61,,,,61,61,,,61,,,,,,,,TUMOR FREE,Alive,-23227,,,,270,,61,61,,,[Not Available],[Not Applicable],,,,,0.43,,,,,8,,0,0.54589,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8355,,,,,,,61,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,86932,,1.862516057,,,,,,,,,,0.261839169,,0.133479964,,,,Stage IA,,2.888,,,,,,,,,,,,,,,,0.3644,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.134713771895274,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.5258,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-97-7938,White,LUAD,,0,0,,Washington University - NYU,2,2,FEMALE,2,2.05,0.61,6,3,7,,,18,,18,18,,2,2,18,18,,Malignant,16,,14,,,,22858,,,18,18,,,,18,18,,,18,,,,,,,,TUMOR FREE,Dead,-27980,18,,,512,,18,18,,,[Not Available],[Not Applicable],,,,,0.14,,,,,7,,0,0.090764,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-7938,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,86936,,0.621418226,,,,,,,,,,0.235353013,,0.164275608,,,,Stage IA,,0.6285,,,,,,,,,,,,,,,,0.0846,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.274487226,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.1529,,0.121,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-AA3C,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.97,0.56,3,3,4,,,211,,,211,,1.0,1,211.0,211.0,,Malignant,10,,69,,,,20804.0,,,211.0,211,,,,,211,,,211.0,,,,,,,,WITH TUMOR,Dead,-24267,211,,,336.0,,211.0,211,,,[Not Available],[Not Applicable],,,,,0.0,,,,,2,,0,0.14536,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3C,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,[Unknown],,,,,,66.0,,,,,,,,,,,,,,,,,,,,86940,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.43,0.34,10,13,21,,,5,BRCA_LumB,5,5,,0,0,5,5,,Invasive Carcinoma,44,,52,,,,21247,0,,5,5,,,,5,5,,,5,,,,,,,,TUMOR FREE,Alive,-20713,,,,139,,5,5,,,[Not Available],[Not Applicable],,,,,0.38,Breast,Resection/Excision,,,20,,1,0.16047,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0AM,,,,,,,5,,,,,,,,,29,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,86941,,0.951642052,0,0,0,0,0.1691,1,,,Infiltrating Ductal Carcinoma,0.181715117,,0.052374476,0,0,0,,Negative,0.8225,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3401,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A59X,,PRAD,308,1,1,,KK,,0,MALE,1,1.84,0.86,10,13,0,ambiguous,NO,2535,5-SPOP,,2535,,1,1,2233,2233,prad_tcga,Malignant,23,ATM;FANCL,251,26.3,TCGA-KK-A59X-01,0,5494,0,TCGA-KK-A59X,2233,2233,Prostate Cancer,,,,2535,TCGA,,2233,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-20416,,55,9,60,PRAD,2233,2233,,0.0,[Not Available],[Not Applicable],56,R1,1,Matched,0.01,Prostate,Resection,5,009A8866-9CBD-4EF5-BA0A-D9591CB2A1A4,1,Normal (no evidence of prostate cancer) [cM0],0,0.16665,[Not Available],629855EA-551E-456C-B421-83B9A4EB3269,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,KK,1.9,TCGA-KK-A59X,1:Recurred/Progressed,5,23,Prostate Adenocarcinoma,73.36,5/28/13,2535,"Other, specify",Locoregional Recurrence,,,NO,C61,64BB13A6-1071-4C2A-937C-17ACC07ADF75,170,4,TUMOR FREE,0.1551,0:LIVING,,,83.28,Bilateral,27,No Evidence of Extraprostatic Extension,12,YES,1731,2008,2233,Bladder,TCGA-KK-A59X.64BB13A6-1071-4C2A-937C-17ACC07ADF75.pdf,Peripheral Zone,[Not Applicable],YES,12,71-80%,14,Prostate Adenocarcinoma Acinar Type,1,2008,[Unknown],,,No,R1,,55,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,NO,0,N1,T3a,2,M0,C61.9,8140/3,86947,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,2.91,0.67,11,11,18,,,2551,BRCA_LumB,1609,2551,,1,1,1609,1609,,Invasive Carcinoma,40,,40,,,,23762,0,,1609,1609,,,,1609,2551,,,1609,,,,,,,,WITH TUMOR,Dead,-17390,2551,,,282,,1609,1609,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,18,,1,0.29061,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0U2,,,,,,,,Bone,Distant Metastasis,,,,,,,40,,,,,,,,,,,,,2004,1609,Liver,,,Stage IIIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,86950,,0.796078955,0,0,0,0,-1.0275,1,,,Infiltrating Ductal Carcinoma,0.124216519,,0.124750372,0,0,0,,Negative,0.0415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2764,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-VQ-A8P5,White,STAD,,0,0,,,,,,2,2.8,0.49,11,18,24,,,235,,,235,,2,2,235,235,,Malignant,53,,156,,,,31224,,,235,235,,,,,235,,,235,,,,,,,,,Dead,-24571,235,,,261,,235,235,,,[Unknown],[Not Applicable],,,,,0.39,Stomach,Unknown,,,17,,1,0.24845,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8P5,,,,,,,,,,,,,,,,44,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,86960,,0.439255515,,,,,,,,,,0.10061859,Grade 3,0.05184913,,,,Stage IIA,,0.3235,,,,,,,,,,,,,,,,0.4535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8P5,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-CD-5799,Asian,STAD,,0,0,,,0,0,,0,3.23,0.63,9,5,11,,,396,,396,396,,0,0,396,396,,Malignant,25,,33,,,,25802,,,396,396,,,,396,396,,,396,,,,,,,,TUMOR FREE,Alive,-16533,,,,52,,396,396,,,[Not Available],[Not Applicable],,,,,0.5,Stomach,Unknown,,,19,,1,0.20319,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-5799,,,,,,,396,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,45,,,,,,,,,,,,,,,,,,,,86963,,-1.436784518,,,,,,,,,,0.078911526,Grade 3,0.058762193,,,,Stage II,,-1.2035,,,,,,,,,,,,,,,,0.3028,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-5799,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,Male,TCGA-21-5786,White,LUSC,,1,1,,Fox Chase Cancer Center,1,0,MALE,1,3.06,0.58,16,9,21,,,1032,,817,1032,,1,1,817,817,,Malignant,46,,47,,,,16178,,,817,817,,,,817,1032,,,817,,,,,,,,TUMOR FREE,Alive,-23649,,,,507,,817,817,,,[Not Available],[Not Applicable],,,,,0.39,,,,,23,,1,0.52427,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Fox Chase Cancer Center,,TCGA-21-5786,,,,,,,1032,,Locoregional Recurrence,,,,,,,33,,,,,,,,,,,,,2009,817,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,86965,,0.317680862,,,,,,,,,,0.17623477,,0.040819619,,,,Stage IB,,0.1905,,,,,,,,,,,,,,,,0.661,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.526033599418872,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.2321,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-E5-A4TZ,White,BLCA,,1.0,1,,,,1,MALE,1.0,5.96,0.67,13,13,22,,,467,,,467,,1.0,1,435.0,435.0,,Malignant,48,,148,,,,19863.0,,,435.0,435,,,,,467,,,435.0,,,,,,,,WITH TUMOR,Dead,-23566,467,,,622.0,,435.0,435,,,[Not Available],[Not Applicable],,,,,0.31,,,,,21,,2,0.28585,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Roswell Park,,TCGA-E5-A4TZ,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,47,,,,,,,,,,,,,2010,435,soft tissue pelvic mass,,,Stage IV,,,,,,,,Progressive Disease,,,,,,64.0,,,,,,,,,,,,,,,,,,,,86967,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-18-5592,,LUSC,,0,0,,Princess Margaret Hospital (Canada),,0,MALE,0,1.85,0.85,8,9,11,,,1519,,,1519,,0,0,1519,1519,,Malignant,28,,29,,,,16218,,,1519,1519,,,,,1519,,,1519,,,,,,,,TUMOR FREE,Alive,-21020,,,,385,,1519,1519,,,[Not Available],[Not Applicable],,,,,0.41,,,,,12,,0,0.42845,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-5592,,,,,,,1519,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Unknown],,,,,,57,,,,,,,,,,,,,,,,,,,,86970,,0.844402818,,,,,,,,,,0.119620294,,0.012636068,,,,Stage IIB,,0.7465,,,,,,,,,,,,,,,,0.3886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,14.5369867,14.69994813,16.17363336,-0.47314752508175,LUSC,Squamous Cell Carcinoma,17.62906181,15.24036082,Squamous Cell Carcinoma,-0.3594,12.30649786,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-55-6972,White,LUAD,,0,0,,International Genomics Consortium,2,2,MALE,2,3.68,0.83,6,7,8,,,1632,,1632,1632,,2,2,1632,1632,,Malignant,21,,14,,,,20935,,,1632,1632,,,,1632,1632,,,1632,,,,,,,,TUMOR FREE,Dead,-26625,1632,,,363,,1632,1632,,,[Not Available],[Not Applicable],,,,,0.71,,,,,16,,1,0.12188,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6972,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2005,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,86972,,-1.001714568,,,,,,,,,,0.062333955,,0.071399372,,,,Stage IB,,-1.5225,,,,,,,,,,,,,,,,-1.2384,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,X570_splice (driver),1,,,X570_splice (driver),,,,-0.943183029,LUAD,,,,Adenocarcinoma,-4.5649,,-1.566,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A6AW,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.98,0.93,2,0,1,,,1621,,1621,1621,,0.0,0,1621.0,1621.0,,Malignant,3,,17,,,,25124.0,,,1621.0,1621,,,,1621,1621,,,1621.0,,,,,,,,TUMOR FREE,Alive,-25644,,,,5281.0,,1621.0,1621,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.02089,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A6AW,,,,,,,1621,,,,,,,,,0,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,70.0,,,,,,,,,,,,,,,,,,,,86973,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,4.08,0.63,12,20,19,,,1229,BRCA_LumB,1229,1229,,0,0,1229,1229,,Invasive Carcinoma,51,,109,,,,28200,0,,1229,1229,,,,1229,1229,,,1229,,,,,,,,TUMOR FREE,Alive,-20664,,,,91,,1229,1229,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,11,,2,0.30753,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1OZ,,,,,,,1229,,,,,,,,,69,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,86981,,0.586236759,0,0,0,0,-1.0235,1,,,Infiltrating Ductal Carcinoma,0.178363401,,0.128994167,0,0,0,,Negative,-0.474,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4461,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-E7-A7XN,Asian,BLCA,,1.0,1,,,,0,MALE,1.0,2.0,0.32,4,2,2,,,428,,,428,,1.0,1,190.0,190.0,,Malignant,8,,29,,,,33345.0,,,190.0,190,,,,,428,,,190.0,,,,,,,,WITH TUMOR,Alive,-24466,,,,1248.0,,190.0,190,,,[Not Available],[Not Applicable],,,,,0.01,,,,,0,,0,0.075127,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A7XN,,,,,,,428,Bladder,Locoregional (Urothelial tumor event),,,,,,,4,,,,,,,,,,,,,2013,190,,,,Stage III,,,,,,,,Progressive Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,86986,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.3,0.43,10,11,18,,,1417,BRCA_Her2,1417,1417,,0,0,1417,1417,,None,39,,68,,,,25225,N/A (Non-Malignant),,1417,1417,,,,1417,1417,,,1417,,,,,,,,TUMOR FREE,Alive,-23224,,,,132,,1417,1417,,,[Not Available],[Not Applicable],,,,,0.57,Breast,Resection/Excision,,,20,,1,0.27145,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1RH,,,,,,,1417,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,86987,,-0.410568716,0,0,0,0,-0.9302,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.187425713,N/A (Non-Malignant),0.027226102,0,0,0,N/A (Non-Malignant),Negative,-0.836,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3921,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-D7-6528,White,STAD,,0,0,,,0,0,,0,3.56,0.62,8,12,15,,,463,,463,463,,0,0,463,463,,Malignant,35,,37,,,,25394,,,463,463,,,,463,463,,,463,,,,,,,,TUMOR FREE,Alive,-25815,,,,427,,463,463,,,[Not Available],[Not Applicable],,,,,0.28,Stomach,Unknown,,,20,,1,0.2915,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6528,,,,,,,463,,,,,,,,,26,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,86995,,-0.822582914,,,,,,,,,,0.022533665,Grade 2,-0.010685432,,,,Stage IB,,0.2595,,,,,,,,,,,,,,,,-0.211,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6528,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-D7-8572,White,STAD,,0,0,,,0,0,,0,1.99,0.43,1,2,1,,,511,,511,511,,0,0,511,511,,Malignant,4,,34,,,,27903,,,511,511,,,,511,511,,,511,,,,,,,,WITH TUMOR,Alive,-20870,,,,244,,511,511,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,0,,0,0.034455,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-8572,,,,,,,511,,,,,,,,,1,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,86997,,0.834787154,,,,,,,,,,0.134462207,Grade 2,0.100704727,,,,Stage IIB,,1.2035,,,,,,,,,,,,,,,,0.6618,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8572,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.82,0.39,2,2,4,,,10,BRCA_LumA,10,10,,0,0,10,10,,Invasive Carcinoma,8,,4,,,,27627,1,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-25158,,,,7948,,10,10,,,[Not Available],[Not Applicable],,,,,0.12,Not Specific/Unknown,Resection/Excision,,,7,,1,0.023199,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A046,,,,,,,10,,,,,,,,,5,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,86999,,1.59149757,0,0,0,0,-0.0402,1,,,Infiltrating Ductal Carcinoma,0.163173414,,0.137404693,0,0,0,,Negative,0.8605,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.4907,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-62-A46U,White,LUAD,,0,0,,Thoraxklinik at University Hospital Heidelberg,0,0,FEMALE,0,3.73,0.25,9,11,14,,,2067,,2067,2067,,0,0,2067,2067,,Malignant,34,,54,,,,27786,,,2067,2067,,,,2067,2067,,,2067,,,,,,,,TUMOR FREE,Alive,-25998,,,,65,,2067,2067,,,[Not Available],[Not Applicable],,,,,0.21,,,,,14,,1,0.16837,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A46U,,,,,,,2067,,,,,,,,,23,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,87001,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,-0.041,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,,,,0.308220749,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2421,,0.7746,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-UY-A8OD,Black or African American,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.76,0.54,13,8,18,,,3432,,3432,3432,,0.0,0,3432.0,3432.0,,Malignant,39,,112,,,,30904.0,,,3432.0,3432,,,,3432,3432,,,3432.0,,,,,,,,TUMOR FREE,Alive,-24588,,,,127.0,,3432.0,3432,,,[Not Available],[Not Applicable],,,,,0.11,,,,,16,,1,0.29949,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A8OD,,,,,,,3432,,,,,,,,,22,,,,,,,,,,,,,,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,68.0,,,,,,,,,,,,,,,,,,,,87006,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-F1-6177,Black or African American,STAD,,0,0,,,0,0,,0,2.08,0.87,1,0,2,,,200,,200,200,,0,0,200,200,,Malignant,3,,7,,,,19937,,,200,200,,,,200,200,,,200,,,,,,,,TUMOR FREE,Alive,-32873,,,,1956,,200,200,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,4,,0,0.08927,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,UNC,,TCGA-F1-6177,,,,,,,200,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,90,,,,,,,,,,,,,,,,,,,,87008,,-0.04672643,,,,,,,,,,0.053563211,Grade 2,-0.013367324,,,,Stage I,,0.109,,,,,,,,,,,,,,,,-0.1869,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-F1-6177,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.32,0.41,5,8,9,,,2255,BRCA_LumB,2255,2255,,0,0,2255,2255,,Invasive Carcinoma,22,,9,,,,16956,0,,2255,2255,,,,2255,2255,,,2255,,,,,,,,TUMOR FREE,Alive,-21856,,,,363,,2255,2255,,,[Not Available],[Not Applicable],,,,,0.5,Breast,Resection/Excision,,,16,,1,0.19081,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BZ,,,,,,,2255,,,,,,,,,25,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,87011,,1.340274352,0,0,0,0,1.0941,1,,,Infiltrating Ductal Carcinoma,0.19692512,,0.190497212,0,0,0,,Negative,1.2555,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5164,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.16,0.6,1,0,2,,,531,BRCA_LumA,531,531,,0,0,531,531,,Invasive Carcinoma,3,,19,,,,18750,0,,531,531,,,,531,531,,,531,,,,,,,,TUMOR FREE,Alive,-14503,,,,26,,531,531,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.021138,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0T5,,,,,,,531,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,87019,,-0.560116474,0,0,0,0,-0.3479,1,,,Infiltrating Ductal Carcinoma,0.116103138,,0.155641961,0,0,0,,Negative,-0.8815,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4874,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-92-8063,White,LUSC,,0,0,,Washington University - St. Louis,0,0,MALE,0,1.81,0.51,14,7,15,,,122,,122,122,,0,0,122,122,,Malignant,36,,54,,,,17735,,,122,122,,,,122,122,,,122,,,,,,,,TUMOR FREE,Alive,-19193,,,,469,,122,122,,,[Not Available],[Not Applicable],,,,,0.1,,,,,12,,0,0.38802,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - St. Louis,,TCGA-92-8063,,,,,,,122,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,87020,,0.289733519,,,,,,,,,,0.173730344,,0.06314362,,,,Stage IIIA,,0.99,,,,,,,,,,,,,,,,0.6066,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,W591L,1,,,W591L,15.30446486,15.95415417,15.57056455,-0.586085786321913,LUSC,Squamous Cell Carcinoma,18.00306224,15.19512507,Squamous Cell Carcinoma,0.6638,14.31874859,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CD-8535,Asian,STAD,,0.0,0,,,0,0,,0.0,2.76,0.91,7,8,12,,,390,,390,390,,0.0,0,390,390,,Malignant,27,,214,,,,21241.0,0,,390,390,,,,390,390,,,390,,,,,,,,TUMOR FREE,Alive,-21559,,,,355.0,,390,390,,,[Not Available],[Not Applicable],,,,,0.2,Stomach,Resection,,,18,,1,0.3256,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8535,,,,,,,390,,,,,,,,,40,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,87021,,-0.998972064,,,,,,,,,,0.017386714,Grade 3,-0.004643761,,,,Stage IIIA,,0.9065,,,,,,,,,,,,,,,,-0.0901,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8535,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-J1-A4AH,White,LUSC,,0,0,,ABS - Lahey Clinic,0,0,MALE,0,3.21,0.33,10,13,19,,,581,,581,581,,0,0,581,581,,Malignant,42,,166,,,,28708,,,581,581,,,,581,581,,,581,,,,,,,,TUMOR FREE,Alive,-25893,,,,247,,581,581,,,[Not Available],[Not Applicable],,,,,0.54,,,,,22,,1,0.33928,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,ABS - Lahey Clinic,,TCGA-J1-A4AH,,,,,,,581,,,,,,,,,36,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,87022,,0.230945339,,,,,,,,,,0.118022234,,-0.040086101,,,,Stage IIA,,1.2025,,,,,,,,,,,,,,,,0.0024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.09213581,14.7725194,15.1332334,-0.689059963202922,LUSC,Squamous Cell Carcinoma,17.85334723,15.35036647,Squamous Cell Carcinoma,-1.1504,12.92107354,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-C4-A0F7,,BLCA,,1.0,1,,,,1,MALE,1.0,,,,,,,,62,,,62,,1.0,1,62.0,62.0,,Malignant,,,,,,,18435.0,,,62.0,62,,,,,62,,,62.0,,,,,,,,WITH TUMOR,Dead,-28428,62,,,119.0,,62.0,62,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Indivumed,,TCGA-C4-A0F7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,[Not Available],,,,,,77.0,,,,,,,,,,,,,,,,,,,,87023,,,,,,,,,Redacted,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-55-7913,Black or African American,LUAD,,1,1,,International Genomics Consortium,1,1,FEMALE,1,2.94,0.35,10,11,11,,,561,,480,561,,1,1,480,480,,Malignant,32,,14,,,,22010,,,480,480,,,,480,561,,,480,,,,,,,,WITH TUMOR,Dead,-22326,561,,,446,,480,480,,,[Not Available],[Not Applicable],,,,,0.21,,,,,18,,1,0.26472,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7913,,,,,,,,,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,2011,480,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87025,,0.226824754,,,,,,,,,,0.140192168,,0.028278428,,,,Stage IA,,-0.242,,,,,,,,,,,,,,,,-0.1321,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.577652815,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.1624,,-0.8244,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-38-4632,Black or African American,LUAD,,1,,,,,1,MALE,1,3.86,0.37,6,15,19,,,1357,,,1357,,1,,680,680,,Malignant,40,,19,,,,20045,,,680,,,,,,1357,,,680,,,,,,,,WITH TUMOR,Dead,-15418,1357,,,687,,680,,,,[Not Available],[Not Applicable],,,,,0.55,,,,,20,,1,0.16045,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,,,TCGA-38-4632,,,,,,,,,,,,,,,,32,,,,,,,,,,,,,1998,680,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,42,,,,,,,,,,,,,,,,,,,,87027,,0.921140827,,,,,,,,,,0.275159992,,0.104968837,,,,Stage IV,,2.088,,,,,,,,,,,,,,,,0.0138,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.41639239,17.13866259,16.39610449,0.012347292,LUAD,,18.16291342,16.10691901,Adenocarcinoma,0.7718,13.95336483,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-60-2716,,LUSC,,0,0,,Roswell Park,0,0,MALE,0,2.0,0.68,0,0,0,,,1475,,1475,1475,,0,0,1475,1475,,Malignant,0,,19,,,,20755,,,1475,1475,,,,1475,1475,,,1475,,,,,,,,TUMOR FREE,Alive,-14345,,,,25,,1475,1475,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,7.95e-06,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2716,,,,,,,1475,,,,,,,,,0,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,39,,,,,,,,,,,,,,,,,,,,87029,,-0.877872846,,,,,,,,,,0.080192007,,0.022687073,,,,Stage IIB,,-0.8345,,,,,,,,,,,,,,,,-0.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.91291955,13.12125092,10.5531525,-0.969481320701006,LUSC,Squamous Cell Carcinoma,17.81109393,13.89845931,Squamous Cell Carcinoma,-1.9187,12.49730793,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-2H-A9GG,Unknown,ESCA,,1,1,,,,1,,1,,,,,,,,610,,,610,,1,1,504,504,,Malignant,,,,,,,24257,,,504,504,,,,,610,,,504,,,,,,,,WITH TUMOR,Dead,-24328,610,,,0,,504,504,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Erasmus MC,,TCGA-2H-A9GG,,,,,,,,Brain,Distant Metastasis,,,,,,,,,,,,,,,,,,,,1999,504,,,,Stage III,,,,,,,,,,,,,,66,,,,,,,,,,,,,,,,,,,,87030,,,,,,,,,,,,,Grade 2,,,,,Stage III,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0.0,,0,0.0,0.0,Female,TCGA-L5-A4OS,White,ESCA,,0.0,0,,,,0,,0.0,1.98,0.37,12,15,18,,,1782,,,1782,,0.0,0,1782,1782,,Malignant,45,,140,,,,24138.0,0,,1782,1782,,,,,1782,,,1782,,,,,,,,TUMOR FREE,Alive,-31601,,,,158.0,,1782,1782,,,[Not Available],[Not Available],,,,,0.31,Esophagus,Resection,,,7,,0,0.23165,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,University of Michigan,,TCGA-L5-A4OS,,,,,,,1782,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Unknown],,,,,,86,,,,,,,,,,,,,,,,,,,,87032,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.23,1,1,1,,,2653,BRCA_LumA,2653,2653,,0,0,2653,2653,,Invasive Carcinoma,3,,9,,,,27812,0,,2653,2653,,,,2653,2653,,,2653,,,,,,,,TUMOR FREE,Alive,-16603,,,,68,,2653,2653,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,1,,0,0.031983,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1B1,,,,,,,2653,,,,,,,,,3,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,87037,,1.292137506,0,0,0,0,0.3797,1,,,Infiltrating Ductal Carcinoma,0.239102984,,0.237349901,0,0,0,,Negative,0.711,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5696,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-37-4129,White,LUSC,,0,0,,Cureline,0,0,FEMALE,0,1.9,0.45,0,0,0,,,242,,242,242,,0,0,242,242,,Malignant,0,,3,,,,19876,,,242,242,,,,242,242,,,242,,,,,,,,TUMOR FREE,Alive,-19154,,,,6,,242,242,,,[Not Available],[Not Applicable],,,,,0.27,,,,,3,,0,0.10388,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-4129,,,,,,,242,,,,,,,,,3,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,87038,,-2.427332325,,,,,,,,,,0.064545449,,0.099947541,,,,Stage IA,,-1.7785,,,,,,,,,,,,,,,,-0.901,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-1.05685629271653,LUSC,,,,Squamous Cell Carcinoma,-4.103,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-HC-A6HY,,PRAD,,0,0,,HC,,0,MALE,0,1.96,0.69,3,4,3,HRP,NO,134,,,134,,0,0,134,134,prad_tcga,Malignant,10,,20,,TCGA-HC-A6HY-01,0,5458,0,TCGA-HC-A6HY,134,134,Prostate Cancer,,,,134,TCGA,,134,Primary,0,,A,,,False,TUMOR FREE,Alive,-18779,,51,7,30,PRAD,134,134,,0.0,[Not Available],[Not Applicable],31,,1,Matched,0.0,Prostate,Resection,3,D5BB8A74-67BE-452E-974D-7EBABDD48B7A,1,,0,0.044057,[Not Available],3D6ABC44-D094-4250-8DFC-347AE9C741F2,4,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,HC,1.03333333333,TCGA-HC-A6HY,0:DiseaseFree,2,11,Prostate Adenocarcinoma,4.4,9/19/13,134,,,,,,C61,91DC18E8-EF04-47C0-A77F-632A9DE2BA55,50,2,TUMOR FREE,0.0408,0:LIVING,,,4.4,Bilateral,13,No Evidence of Extraprostatic Extension,92,YES,179,2012,,,TCGA-HC-A6HY.91DC18E8-EF04-47C0-A77F-632A9DE2BA55.pdf,,[Not Applicable],YES,,,,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,No,R0,,51,Core needle biopsy,,,YES,NO,NO,NO,T2c,,7,No,,0,,T1c,,M0,C61.9,8140/3,87046,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-49-4514,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,1.79,0.35,7,13,11,,,1700,,1700,1700,,0,0,1700,1700,,Malignant,31,,47,,,,16363,,,1700,1700,,,,1700,1700,,,1700,,,,,,,,TUMOR FREE,Alive,-28908,,,,422,,1700,1700,,,[Not Available],[Not Applicable],,,,,0.01,,,,,6,,0,0.29223,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4514,,,,,,,1700,,,,,,,,,7,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,87047,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.1738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R470S (driver),1,,,R470S (driver),,,,-0.189491862,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,0.5642,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.5,0.28,15,6,15,,,383,BRCA_LumA,383,383,,0,0,383,383,,Invasive Carcinoma,36,,53,,,,20126,0,,383,383,,,,383,383,,,383,,,,,,,,TUMOR FREE,Alive,-20471,,,,96,,383,383,,,[Not Available],[Not Applicable],,,,,0.32,Breast,Resection/Excision,,,11,,1,0.211,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A132,,,,,,,383,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,87053,,1.301857213,0,0,0,0,0.3121,1,,,Infiltrating Ductal Carcinoma,0.172321127,,0.189323313,0,0,0,,Negative,0.923,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7398,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BT-A3PK,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.87,0.28,7,11,3,,,303,,,303,,1.0,1,303.0,303.0,,Malignant,21,,20,,,,28205.0,,,303.0,303,,,,,303,,,303.0,,,,,,,,WITH TUMOR,Dead,-29314,303,,,484.0,,303.0,303,,,[Not Available],[Not Applicable],,,,,0.5,,,,,5,,0,0.22632,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A3PK,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Stable Disease,,,,,,80.0,,,,,,,,,,,,,,,,,,,,87058,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BL-A13J,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.59,0.56,9,13,21,,,81,,,81,,1.0,1,81.0,81.0,,Malignant,43,,119,,,,16596.0,,,81.0,81,,,,,81,,,81.0,,,,,,,,WITH TUMOR,Dead,-23927,81,,,154.0,,81.0,81,,,[Not Available],[Not Applicable],,,,,0.21,,,,,17,,2,0.31785,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Christiana Healthcare,,TCGA-BL-A13J,,,,,,,,,,,,,,,,64,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,65.0,,,,,,,,,,,,,,,,,,,,87063,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.89,0.66,10,10,20,,,554,BRCA_Basal,554,554,,0,0,554,554,,Invasive Carcinoma,40,,63,,,,16150,0,,554,554,,,,554,554,,,554,,,,,,,,TUMOR FREE,Alive,-17727,,,,51,,554,554,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,21,,1,0.54271,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YE,,,,,,,554,,,,,,,,,32,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,87064,TRUE,0.043173476,0,0,0,0,0.2033,1,,,Infiltrating Ductal Carcinoma,0.121275685,,0.081278711,0,0,0,,Negative,-0.456,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4629,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-HU-A4HB,Asian,STAD,,1,1,,,1,1,,1,,,,,,,,477,,390,477,,1,1,390,390,,Malignant,,,,,,,18491,,,390,390,,,,390,477,,,390,,,,,,,,WITH TUMOR,Dead,-25131,477,,,14,,390,390,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4HB,,,,,,,,,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2012,390,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,87065,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4HB,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,,0,0,0,Male,TCGA-NK-A7XE,Black or African American,LUSC,,0,0,,Washington University - Rush University,,0,MALE,0,1.47,0.53,12,11,20,,,13,,,13,,0,0,13,13,,Malignant,43,,223,,,,32311,,,13,13,,,,,13,,,13,,,,,,,,TUMOR FREE,Alive,-24319,,,,138,,13,13,,,[Not Available],[Not Applicable],,,,,0.07,,,,,12,,0,0.66665,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Rush University,,TCGA-NK-A7XE,,,,,,,13,,,,,,,,,23,,,,,,,,,,,,,2013,,,,,Stage IIIB,,,,,,,,Stable Disease,,,,,,66,,,,,,,,,,,,,,,,,,,,87071,,,,,,,,,,,,,,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,0.0642,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.1298837,14.35510738,15.44932523,-0.501372333100703,LUSC,Squamous Cell Carcinoma,18.222068,15.17905518,Squamous Cell Carcinoma,-0.6552,12.13463321,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Male,TCGA-85-6798,White,LUSC,,1,1,,Asterand,1,1,MALE,1,3.18,0.47,9,11,18,,,195,,180,195,,1,1,180,180,,Malignant,38,,42,,,,31455,,,180,180,,,,180,195,,,180,,,,,,,,WITH TUMOR,Dead,-20837,195,,,359,,180,180,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,1,0.43206,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-6798,,,,,,,,,Distant Metastasis,,,,,,,34,,,,,,,,,,,,,2011,180,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,87072,,-0.352442622,,,,,,,,,,0.127138037,,0.040740108,,,,Stage IIIA,,0.1395,,,,,,,,,,,,,,,,0.6994,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.2977558,14.83731826,13.53446334,-1.00607054100238,LUSC,Squamous Cell Carcinoma,17.66252726,14.6734509,Squamous Cell Carcinoma,0.4887,14.47989229,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-A2EF,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.04,0.61,7,15,18,,,1884,,,1884,,0.0,0,1884.0,1884.0,,Malignant,40,,62,,,,26289.0,,,1884.0,1884,,,,,1884,,,1884.0,,,,,,,,TUMOR FREE,Alive,-18467,,,,357.0,,1884.0,1884,,,[Not Available],[Not Applicable],,,,,0.23,,,,,12,,1,0.21003,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EF,,,,,,,1884,,,,,,,,,39,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,50.0,,,,,,,,,,,,,,,,,,,,87074,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-64-1679,White,LUAD,,0,0,,Fox Chase,0,0,FEMALE,0,3.34,0.26,5,7,9,,,2488,,2488,2488,,0,0,2488,2488,,Malignant,21,,24,,,,21054,,,2488,2488,,,,2488,2488,,,2488,,,,,,,,TUMOR FREE,Alive,-21310,,,,647,,2488,2488,,,[Not Available],[Not Applicable],,,,,0.37,,,,,23,,1,0.35125,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-1679,,,,,,,2488,,,,,,,,,26,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,87082,,0.133035633,,,,,,,,,,0.281202016,,0.139165851,,,,Stage IIIA,,0.3925,,,,,,,,,,,,,,,,1.0641,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.87959945,16.90966122,12.1825187,-0.438348373,LUAD,Adenocarcinoma,17.74888662,14.45868246,Adenocarcinoma,1.5103,13.5868769,-1.9447,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Female,TCGA-K4-A3WV,White,BLCA,,0.0,0,,,,0,FEMALE,0.0,3.2,0.67,18,22,19,,,646,,,646,,0.0,0,646.0,646.0,,Malignant,59,,261,,,,28245.0,,,646.0,646,,,,,646,,,646.0,,,,,,,,TUMOR FREE,Alive,-28444,,,,87.0,,646.0,646,,,[Not Available],[Not Applicable],,,,,0.07,,,,,14,,1,0.38158,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A3WV,,,,,,,646,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,[Not Applicable],,,,,,77.0,,,,,,,,,,,,,,,,,,,,87084,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.85,0.54,15,21,20,,,2371,BRCA_Basal,2371,2371,,0,0,2371,2371,,Invasive Carcinoma,56,,52,,,,16171,0,,2371,2371,,,,2371,2371,,,2371,,,,,,,,TUMOR FREE,Alive,-25974,,,,131,,2371,2371,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,8,,0,0.4339,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BW,,,,,,,2371,,,,,,,,,18,,,,,,,,,,,,,2006,,,,,Stage I,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,87090,,1.094443021,0,0,0,0,0.5289,1,,,Infiltrating Ductal Carcinoma,0.212131611,,0.092977737,0,0,0,,Negative,1.6975,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1119,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-64-1681,White,LUAD,,1,,,Fox Chase,,,FEMALE,1,5.63,0.31,4,8,14,,,1167,,,1167,,1,,439,439,,Malignant,26,,27,,,,25771,,,439,,,,,,1167,,,439,,,,,,,,,Dead,-22525,1167,,,95,,439,,,,[Not Available],[Not Applicable],,,,,0.48,,,,,23,,2,0.2456,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-1681,,,,,,,,,,,,,,,,40,,,,,,,,,,,,,2008,439,,,,Stage IA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,87091,,0.383379884,,,,,,,,,,0.233312823,,0.193363639,,,,Stage IA,,0.347,,,,,,,,,,,,,,,,0.2541,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.186160282,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0821,,-1.3586,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-86-7711,White,LUAD,,1,1,,Asterand,,1,MALE,1,1.88,0.33,14,16,13,,,1046,,,1046,,1,1,1046,1046,,Malignant,43,,44,,,,29149,,,1046,1046,,,,,1046,,,1046,,,,,,,,WITH TUMOR,Dead,-25719,1046,,,297,,1046,1046,,,[Not Available],[Not Applicable],,,,,0.08,,,,,14,,0,0.45299,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-7711,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,87094,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.57961651,17.31157108,15.7493452,-0.323940713,LUAD,Adenocarcinoma,17.21961814,15.60035906,Adenocarcinoma,0.5947,13.75865072,-0.0391,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,1.93,0.27,5,5,4,,,915,BRCA_Normal,729,915,,1,1,729,729,,Invasive Carcinoma,14,,5,,,,29109,0,,729,729,,,,729,915,,,729,,,,,,,,WITH TUMOR,Alive,-21750,,,,26,,729,729,,,[Not Available],[Not Applicable],,,,,0.52,Breast,Resection/Excision,,,1,,0,0.096877,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1P7,,,,,,,915,"Other, specify",Distant Metastasis,,,,,,,3,,,,,,,,,,,,,2009,729,mediastinal lymph nodes,,,Stage IIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,87095,,1.763912782,0,0,0,0,0.0319,1,,,Infiltrating Ductal Carcinoma,0.194352043,,0.208397376,0,0,0,,Negative,1.3625,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6099,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.85,0.61,4,3,10,,,7,BRCA_LumA,7,7,,0,0,7,7,,None,17,,27,,,,23530,N/A (Non-Malignant),,7,7,,,,7,7,,,7,,,,,,,,TUMOR FREE,Alive,-10812,,,,61,,7,7,,,[Not Available],[Not Applicable],,,,,0.31,Not Specific/Unknown,Resection/Excision,,,13,,1,0.10906,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A041,,,,,,,7,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,29,,,,,,,,,,,,,,,,,,,,87096,,-0.357194243,0,0,0,0,-0.3772,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.109808799,N/A (Non-Malignant),0.220799203,0,0,0,N/A (Non-Malignant),Negative,-1.03,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.4583,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,1,None of the Above,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.86,5,4,5,,,1051,BRCA_LumA,1051,1051,,0,0,1051,1051,,Invasive Carcinoma,14,,26,,,,30850,0,,1051,1051,,,,1051,1051,,,1051,,,,,,,,TUMOR FREE,Alive,-28411,,,,215,,1051,1051,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,6,,0,0.094827,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A2P6,,,,,,,1051,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,87101,,-0.477124131,0,0,0,0,1.1182,1,,,Infiltrating Lobular Carcinoma,0.108375233,,0.174752677,0,0,0,,Negative,-0.774,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0208,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A9WX,,PRAD,,1,1,,YL,,0,MALE,1,1.91,0.2,6,4,3,ambiguous,NO,1518,,,1518,,1,1,1506,1506,prad_tcga,Malignant,13,BRCA2;RAD51B,36,,TCGA-YL-A9WX-01,0,5696,0,TCGA-YL-A9WX,1506,1506,Prostate Cancer,41,1610,,1518,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),1506,Primary,0,Middle,A,,,True,WITH TUMOR,Alive,-25008,,68,9,15,PRAD,1506,1506,,0.0,[Not Available],[Not Applicable],8,,1,Matched,0.08,Prostate,Resection,4,884BE452-353E-4AAF-88BA-3D1169CAE03A,2,Abnormal (not related to prostate cancer),0,0.084675,[Not Available],A468353E-0A96-4A4D-8AEF-5140BF1BF952,5,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,YL,0.266666666667,TCGA-YL-A9WX,1:Recurred/Progressed,5,21,Prostate Adenocarcinoma,49.47,4/12/14,1518,,Biochemical evidence of disease,,,YES,C61,F7A04AAE-D1E0-4842-82AD-64F2813454F2,960,5,WITH TUMOR,0.0056,0:LIVING,0.76,3,49.87,Bilateral,22,No Evidence of Extraprostatic Extension,37,YES,1520,2009,1506,,TCGA-YL-A9WX.F7A04AAE-D1E0-4842-82AD-64F2813454F2.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,34,,11,Prostate Adenocarcinoma Acinar Type,1,2009,Stable Disease,,YES,No,R1,,68,Core needle biopsy,1506,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N1,T3a,1,M0,C61.9,8140/3,87102,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-8085,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.17,0.56,6,8,11,,,904,,904,904,,0,0,904,904,,Malignant,25,,33,,,,23819,,,904,904,,,,904,904,,,904,,,,,,,,TUMOR FREE,Alive,-23596,,,,353,,904,904,,,[Not Available],[Not Applicable],,,,,0.04,,,,,6,,0,0.10226,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8085,,,,,,,904,,,,,,,,,9,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,87103,,1.564694107,,,,,,,,,,0.221316009,,0.109513955,,,,Stage IA,,1.154,,,,,,,,,,,,,,,,-0.0158,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G429V,1,,,G429V,,,,-0.016854575,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.397,,0.9084,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-VR-A8EQ,White,ESCA,,1,1,,,,1,,1,3.07,0.35,6,10,16,,,694,,,694,,1,1,694,694,,Malignant,32,,199,,,,21061,,,694,694,,,,,694,,,694,,,,,,,,WITH TUMOR,Dead,-26912,694,,,286,,694,694,,,[Not Available],Stage III,,,,,0.17,Esophagus,Unknown,,,16,,1,0.5044,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Barretos Cancer Hospital,,TCGA-VR-A8EQ,,,,,,,,,,,,,,,,32,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,,,,,,,73,,,,,,,,,,,,,,,,,,,,87104,,,,,,,,,,,,,Grade 2,,,,,Stage III,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1.0,,1,1.0,1.0,Male,TCGA-ZF-AA4U,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.78,0.88,3,4,7,,,262,,,262,,1.0,1,199.0,199.0,,Malignant,14,,49,,,,25235.0,,,199.0,199,,,,,262,,,199.0,,,,,,,,WITH TUMOR,Dead,-25682,262,,,89.0,,199.0,199,,,[Not Available],[Not Applicable],,,,,0.02,,,,,14,,1,0.057757,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA4U,,,,,,,,Bone,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2008,199,,,,Stage III,,,,,,,,Progressive Disease,,,,,,70.0,,,,,,,,,,,,,,,,,,,,87105,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,2.05,0.48,12,9,13,,,2335,BRCA_Her2,,2335,,0,0,2335,2335,,Invasive Carcinoma,34,,41,,,,19434,0,,2335,2335,,,,,2335,,,2335,,,,,,,,TUMOR FREE,Alive,-19516,,,,64,,2335,2335,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,10,,0,0.23453,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JE,,,,,,,2335,,,,,,,,,17,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,87107,,1.395477298,0,0,0,0,-1.9257,1,,,Infiltrating Ductal Carcinoma,0.191256366,,0.1838075,0,0,0,,Positive,1.1545,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.758,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-EJ-7330,White,PRAD,184,0,0,,EJ,,0,MALE,0,1.98,0.33,10,18,1,ambiguous,NO,191,5-SPOP,,191,,0,0,191,191,prad_tcga,Malignant,29,ATM,111,6.2,TCGA-EJ-7330-01,0,5308,0,TCGA-EJ-7330,191,191,Prostate Cancer,,191,,191,TCGA,,191,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-25050,,68,7,52,PRAD,191,191,WHITE,0.0,[Not Available],[Not Applicable],65,R0,1,Matched,0.09,Prostate,Resection,4,11551cf5-d8e8-4d4b-bf05-aa197f25dabe,4,,0,0.15478,[Not Available],7bc369b7-007b-4b10-bd92-5d326dabf675,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,32,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,3.8,TCGA-EJ-7330,0:DiseaseFree,3,51,Prostate Adenocarcinoma,6.27,4/5/12,191,,,,,NO,C61,d910cd86-89be-4fc9-8f9d-497692a6face,,4,TUMOR FREE,0.1741,0:LIVING,0.1,5,6.27,Bilateral,53,,,YES,,2011,,,TCGA-EJ-7330.d910cd86-89be-4fc9-8f9d-497692a6face.pdf,,[Not Applicable],NO,,66-75%,18,Prostate Adenocarcinoma Acinar Type,1,2011,[Not Available],,NO,No,R0,1.3,68,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,87110,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,622,BRCA_Normal,622,622,,0,0,622,622,,Invasive Carcinoma,,,,,,,26008,0,,622,622,,,,622,622,,,622,,,,,,,,TUMOR FREE,Alive,-16817,,,,15,,622,622,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A1KO,,,,,,,622,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,87111,,-1.112546835,0,0,0,0,-0.1325,1,,,Infiltrating Lobular Carcinoma,0.145064528,,0.209294708,0,0,0,,Negative,-0.625,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0213,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-D7-A6EV,White,STAD,,0,0,,,0,0,,0,2.54,0.59,7,20,20,,,342,,342,342,,0,0,342,342,,Malignant,47,,185,,,,19812,,,342,342,,,,342,342,,,342,,,,,,,,TUMOR FREE,Alive,-26226,,,,212,,342,342,,,[Not Available],[Not Applicable],,,,,0.31,Stomach,Unknown,,,19,,1,0.43073,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A6EV,,,,,,,342,,,,,,,,,35,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,87114,,-0.496700349,,,,,,,,,,0.04336216,Grade 3,-0.021670348,,,,Stage IIB,,-0.993,,,,,,,,,,,,,,,,-0.0904,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A6EV,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-D7-A747,White,STAD,,1,1,,,,1,,1,2.37,0.16,3,6,8,,,255,,,255,,1,1,255,255,,Malignant,17,,38,,,,20771,,,255,255,,,,,255,,,255,,,,,,,,WITH TUMOR,Dead,-20923,255,,,118,,255,255,,,Stomach Cancer,[Not Applicable],,,,,0.14,Stomach,Unknown,,,9,,0,0.18144,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A747,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,57,,,,,,,,,,,,,,,,,,,,87119,,0.842555035,,,,,,,,,,0.069098242,Grade 3,0.101716673,,,,Stage IIB,,0.032,,,,,,,,,,,,,,,,0.2704,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A747,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Female,TCGA-44-5645,Black or African American,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,2.38,0.54,2,4,4,,,852,,852,852,,0,0,852,852,,Malignant,10,,57,,,,18203,,,852,852,,,,852,852,,,852,,,,,,,,TUMOR FREE,Alive,-22471,,,,48,,852,852,,,[Not Available],[Not Applicable],,,,,0.0,,,,,10,,0,0.15157,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-5645,,,,,,,852,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87121,,1.496060685,,,,,,,,,,0.231966039,,0.132967914,,,,Stage IA,,0.952,,,,,,,,,,,,,,,,-0.0088,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,A767_V769dup (driver),,,1,A767_V769dup (driver),,,,,,-0.172906498,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.5033,,-0.0741,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HC-8213,,PRAD,308,0,0,,HC,0,0,MALE,0,1.99,0.87,0,1,0,HRP,NO,589,1-ERG,589,589,,0,0,589,589,prad_tcga,Malignant,1,,32,3.6,TCGA-HC-8213-01,0,5435,0,TCGA-HC-8213,589,589,Prostate Cancer,,,589,589,TCGA,,589,Primary,0,,A,,,,TUMOR FREE,Alive,-17673,,48,6,22,PRAD,589,589,,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,0.0,Prostate,Resection,3,dbe76fc8-1006-4d47-b1c0-2b02e9d55d22,0,,0,0.011974,[Not Available],53c43d14-2310-41e9-ac43-3cc298404338,3,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,1,,Acinar Adenocarcinoma,[Not Available],0.3,HC,0.766666666667,TCGA-HC-8213,0:DiseaseFree,1,1,Prostate Adenocarcinoma,19.35,7/8/12,589,,,,,,C61,E6CE4E34-DE42-455C-AD93-CCE42FCFE049,,0,TUMOR FREE,0.0083,0:LIVING,,,19.35,Bilateral,3,,,YES,,2011,,,TCGA-HC-8213.E6CE4E34-DE42-455C-AD93-CCE42FCFE049.pdf,,[Not Applicable],,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.5,48,,,,YES,NO,NO,NO,T2c,,6,No,,0,,,,,C61.9,8550/3,87126,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-93-A4JP,Asian,LUAD,,1,1,,Washington University - St. Louis,,0,MALE,1,2.27,0.27,4,11,17,,,578,,,578,,1,1,497,497,,Malignant,32,,54,,,,19469,,,497,497,,,,,578,,,497,,,,,,,,WITH TUMOR,Alive,-23620,,,,83,,497,497,,,[Not Available],[Not Applicable],,,,,0.5,,,,,9,,0,0.18258,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - St. Louis,,TCGA-93-A4JP,,,,,,,578,,Distant Metastasis,,,,,,,19,,,,,,,,,,,,,2012,497,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,87127,,0.272330373,,,,,,,,,,0.235154018,,0.2949622,,,,Stage IV,,0.374,,,,,,,,,,,,,,,,-0.0241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L861Q (driver),,,1,L861Q (driver),,,16.16149507,17.71060894,15.38335631,-0.235051783,LUAD,Adenocarcinoma,17.5813242,15.03695553,Adenocarcinoma,-0.824,13.03939905,-0.6394,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Female,TCGA-38-7271,White,LUAD,,1,,,,1,1,FEMALE,1,2.08,0.26,0,1,1,,,800,,304,800,,1,,304,304,,Malignant,2,,19,,,,20173,,,304,,,,,304,800,,,304,,,,,,,,WITH TUMOR,Dead,-26440,800,,,92,,304,,,,[Not Available],[Not Applicable],,,,,0.18,,,,,2,,0,1.9e-05,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,,,TCGA-38-7271,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2006,304,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,87129,,2.0758118,,,,,,,,,,0.261744136,,0.2682089,,,,Stage IA,,1.871,,,,,,,,,,,,,,,,0.2962,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.263849637,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-J4-A67K,,PRAD,,0,0,,J4,0,0,MALE,0,1.99,0.55,0,0,0,HRD,NO,1004,,1004,1004,,0,0,1004,1004,prad_tcga,Malignant,0,,15,,TCGA-J4-A67K-01,0,5472,0,TCGA-J4-A67K,1004,1004,Prostate Cancer,,557,1004,1004,TCGA,,1004,Primary,0,,A,,BRCA1,True,TUMOR FREE,Alive,-24908,,68,7,35,PRAD,1004,1004,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.01,Prostate,Resection,4,B305B74B-8977-4074-8B80-FFC75D7B8531,0,,0,0.0080311,[Not Available],C4C1B5BE-A0E7-4968-92DE-7F34C71207FB,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,1.16666666667,TCGA-J4-A67K,0:DiseaseFree,3,7,Prostate Adenocarcinoma,32.98,8/16/13,1004,,,,,,C61,F8FF8077-8922-4CC8-95DD-4AF68CCC7EEC,190,0,TUMOR FREE,0.0084,0:LIVING,0.1,,32.98,Bilateral,8,,,YES,580,2011,,,TCGA-J4-A67K.F8FF8077-8922-4CC8-95DD-4AF68CCC7EEC.pdf,Peripheral Zone,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,68,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,T2b,,M0,C61.9,8140/3,87130,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-BR-6457,White,STAD,,0.0,0,,,0,0,,0.0,2.0,0.23,4,4,6,,,416,,416,416,,0.0,0,416,416,,Malignant,14,,15,,,,21433.0,0,,416,416,,,,416,416,,,416,,,,,,,,TUMOR FREE,Alive,-25396,,,,135.0,,416,416,,,[Not Available],[Not Applicable],,,,,0.45,Stomach,Resection,,,8,,0,0.20162,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6457,,,,,,,416,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,87135,,0.379436907,,,,,,,,,,0.137756765,Grade 3,0.226725519,,,,Stage IIA,,0.226,,,,,,,,,,,,,,,,0.762,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6457,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.89,0.65,20,32,24,,,383,BRCA_Basal,383,383,,0,0,383,383,,Invasive Carcinoma,76,,65,,,,29570,0,,383,383,,,,383,383,,,383,,,,,,,,TUMOR FREE,Alive,-19010,,,,137,,383,383,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,7,,0,0.42089,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A134,,,,,,,383,,,,,,,,,20,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,87138,,1.070518249,0,0,0,0,-0.3563,1,,,Infiltrating Ductal Carcinoma,0.147926641,,0.119890881,0,0,0,,Negative,0.374,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.185,0,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7784,White,PRAD,184,0,0,,EJ,0,0,MALE,0,4.26,0.69,2,8,8,ambiguous,NO,781,1-ERG,781,781,,0,0,781,781,prad_tcga,Malignant,18,PALB2;RAD51B;RAD54L,12,4.1,TCGA-EJ-7784-01,0,5316,0,TCGA-EJ-7784,781,781,Prostate Cancer,,167,781,781,TCGA,,781,Primary,0,,A,,,,TUMOR FREE,Alive,-23183,,63,7,45,PRAD,781,781,WHITE,0.0,[Not Available],[Not Applicable],67,R0,1,Matched,0.47,Prostate,Resection,4,0d3ec78c-3da8-443f-baa6-93caed5b065c,6,Normal (no evidence of prostate cancer) [cM0],1,0.039903,[Not Available],4bc71292-60bb-4b63-86c1-0fe021083804,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,4.03333333333,TCGA-EJ-7784,0:DiseaseFree,3,24,Prostate Adenocarcinoma,25.66,4/6/12,781,,,,,NO,C61,d140c74d-8e74-43da-a181-63a7bbe718af,,10,TUMOR FREE,0.2403,0:LIVING,0.1,4,25.66,Bilateral,26,No Evidence of Extraprostatic Extension,0,YES,,2011,,,TCGA-EJ-7784.d140c74d-8e74-43da-a181-63a7bbe718af.pdf,,[Not Applicable],YES,0,81-90%,13,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,63,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,87139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-XF-AAMG,White,BLCA,,0.0,0,,,0,0,MALE,0.0,4.16,0.75,7,35,29,,,3364,,3364,3364,,0.0,0,3364.0,3364.0,,Malignant,71,,136,,,,16570.0,,,3364.0,3364,,,,3364,3364,,,3364.0,,,,,,,,TUMOR FREE,Alive,-18021,,,,1313.0,,3364.0,3364,,,[Not Available],[Not Applicable],,,,,0.23,,,,,14,,2,0.21451,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMG,,,,,,,3364,,,,,,,,,78,,,,,,,,,,,,,2004,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,49.0,,,,,,,,,,,,,,,,,,,,87142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-VQ-AA6F,White,STAD,,1,1,,,,0,,1,1.6,0.34,19,20,17,,,1646,,,1646,,1,1,546,546,,Malignant,56,,159,,,,31745,,,546,546,,,,,1646,,,546,,,,,,,,TUMOR FREE,Alive,-21170,,,,59,,546,546,,,[Not Available],[Not Applicable],,,,,0.29,Stomach,Unknown,,,12,,0,0.61261,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-AA6F,,,,,,,1646,"Other, specify",Locoregional Recurrence|New Primary Tumor,,,,,,,21,,,,,,,,,,,,,2010,546,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,57,,,,,,,,,,,,,,,,,,,,87143,,0.816878981,,,,,,,,,,0.053649607,Grade 2,0.108714974,,,,Stage IIB,,0.344,,,,,,,,,,,,,,,,0.0832,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA6F,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.66,0.72,12,4,15,,,767,BRCA_LumB,767,767,,0,0,767,767,,Invasive Carcinoma,31,,49,,,,22560,0,,767,767,,,,767,767,,,767,,,,,,,,TUMOR FREE,Alive,-13805,,,,55,,767,767,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,17,,1,0.2283,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0D4,,,,,,,767,,,,,,,,,20,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,37,,,,,,,,,,,,,,,,,,,,87148,,-1.637845971,0,0,0,0,0.311,1,,,Infiltrating Ductal Carcinoma,0.084368579,,0.182034992,0,0,0,,Negative,-1.4565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.116,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-8678,White,STAD,,0,0,,,0,0,,0,3.87,0.7,10,7,14,,,754,,754,754,,0,0,754,754,,Malignant,31,,111,,,,19138,,,754,754,,,,754,754,,,754,,,,,,,,TUMOR FREE,Alive,-28037,,,,146,,754,754,,,[Not Available],[Not Applicable],,,,,0.24,Stomach,Unknown,,,17,,2,0.33556,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8678,,,,,,,754,,,,,,,,,66,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,87155,,-0.270295218,,,,,,,,,,0.034552714,Grade 2,0.012653872,,,,Stage IB,,1.1475,,,,,,,,,,,,,,,,0.0935,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8678,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,5.61,0.54,8,25,21,,,538,BRCA_LumB,538,538,,0,0,538,538,,Benign Breast Disease,54,,130,,,,28002,N/A (Non-Malignant),,538,538,,,,538,538,,,538,,,,,,,,TUMOR FREE,Alive,-32873,,,,136,,538,538,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,23,,2,0.19007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A9RU,,,,,,,538,,,,,,,,,53,,,,,,,,,,,,,2013,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,87156,,-0.61104051,0,0,0,0,0.0312,0,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.163039226,N/A (Non-Malignant),0.057731193,0,0,1,N/A (Non-Malignant),Negative,-0.3335,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3189,1,0,H & E,0,0,,0,Jeffrey Eisenstein,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,Papilloma,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-7727,White,LUAD,,0,0,,,0,0,MALE,0,1.91,0.56,7,9,8,,,119,,119,119,,0,0,119,119,,Malignant,24,,30,,,,18998,,,119,119,,,,119,119,,,119,,,,,,,,TUMOR FREE,Alive,-25929,,,,318,,119,119,,,[Not Available],[Not Applicable],,,,,0.46,,,,,10,,0,0.24345,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,,,TCGA-55-7727,,,,,,,119,,,,,,,,,13,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,87163,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,-0.3723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.10345451,16.84387012,16.30247734,-0.117734353,LUAD,Adenocarcinoma,17.92663476,16.03810527,Adenocarcinoma,,13.68157867,0.2464,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-D7-6527,White,STAD,,1,1,,,,1,,1,5.06,0.46,10,22,19,,,312,,,312,,1,1,75,75,,Malignant,51,,57,,,,18462,,,75,75,,,,,312,,,75,,,,,,,,WITH TUMOR,Dead,-22793,312,,,276,,75,75,,,[Not Available],[Not Applicable],,,,,0.2,Stomach,Unknown,,,22,,2,0.14049,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Papillary Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6527,,,,,,,,Liver,Distant Metastasis,,,,,,,51,,,,,,,,,,,,,2010,75,,,,Stage II,,,,,,,,Progressive Disease,,,,,,62,,,,,,,,,,,,,,,,,,,,87164,,,,,,,,,,,,,Grade 2,,,,,Stage II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6527,Gastric Carcinoma,TCGA,"Adenocarcinoma, Papillary Type"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.55,6,4,4,,,1208,BRCA_LumA,1208,1208,,0,0,1208,1208,,Invasive Carcinoma,14,,14,,,,23715,0,,1208,1208,,,,1208,1208,,,1208,,,,,,,,TUMOR FREE,Alive,-17597,,,,53,,1208,1208,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.063746,Peri (6-12 months since last menstrual period),,,"Other, specify",,,,,,[Not Available],,University of Miami,,TCGA-EW-A1IX,,,,,,,1208,,,,,,,,,4,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,87171,,0.004257881,0,1,0,0,0.8659,0,,,Other,0.149747261,,0.177240476,0,0,0,,Negative,-0.409,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6822,1,0,H & E,0,0,,0,Jeffrey Eisenstein,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,ALH,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-7950,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.12,0.52,11,9,17,,,576,,576,576,,0,0,576,576,,Malignant,37,,65,,,,22784,,,576,576,,,,576,576,,,576,,,,,,,,TUMOR FREE,Alive,-16975,,,,346,,576,576,,,[Not Available],[Not Applicable],,,,,0.14,,,,,23,,1,0.4561,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-7950,,,,,,,576,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,46,,,,,,,,,,,,,,,,,,,,87174,,1.627859279,,,,,,,,,,0.197918829,,0.11072892,,,,Stage IB,,1.8315,,,,,,,,,,,,,,,,0.6042,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0703140611518736,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.5628,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-YL-A8SH,,PRAD,389,0,0,,YL,2,2,MALE,2,1.93,0.68,5,9,0,HRD,NO,875,5-SPOP,875,875,,2,2,875,875,prad_tcga,Malignant,14,,97,,TCGA-YL-A8SH-01,0,5665,0,TCGA-YL-A8SH,875,875,Prostate Cancer,,617,875,875,TCGA,,875,Primary,0,Apex|Middle|Base,B,ATM:1937:N/X:frameshift_variant,,True,TUMOR FREE,Dead,-25395,875,69,7,42,PRAD,875,875,,0.0,"Other, non-malignant disease",[Not Applicable],35,R0,1,Matched,0.02,Prostate,Resection,4,56A06467-7CB6-4DFF-9F57-88228210619E,0,,0,0.091978,[Not Available],BFB973EB-D42D-4900-A606-A381D2317555,3,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8SH,,3,14,Prostate Adenocarcinoma,,4/25/14,,,,"Other, non-malignant disease",Death Certificate,NO,C61,62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7,510,3,TUMOR FREE,0.0699,1:DECEASED,0.06,,28.75,Bilateral,15,,,YES,1481,2009,,,TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,87175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,Black or African American,BRCA,,0,0,,,2,2,FEMALE,2,3.61,0.65,13,10,23,,,2483,BRCA_LumB,2483,2483,,2,2,2483,2483,,Invasive Carcinoma,46,,86,,,,24759,0,,2483,2483,,,,2483,2483,,,2483,,,,,,,,TUMOR FREE,Dead,-25362,2483,,,114,,2483,2483,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,22,,1,0.24571,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A03O,,,,,,,,,,,,,,,,37,,,,,,,,,,,,,2002,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,87177,,0.957955911,0,0,0,0,-1.646,1,,,Infiltrating Ductal Carcinoma,0.15916937,,0.084833599,0,0,0,,Negative,0.754,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.186,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-78-8655,Unknown,LUAD,,0,0,,Prince Charles Hospital,0,0,FEMALE,0,4.26,0.46,3,5,12,,,2360,,2360,2360,,0,0,2360,2360,,Malignant,20,,55,,,,16768,,,2360,2360,,,,2360,2360,,,2360,,,,,,,,,Alive,-28379,,,,147,,2360,2360,,,[Not Available],[Not Applicable],,,,,0.31,,,,,10,,1,0.11177,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-8655,,,,,,,2360,,,,,,,,,12,,,,,,,,,,,,,2003,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,87184,,0.761976415,,,,,,,,,,0.234264311,,0.172148965,,,,Stage IA,,0.8205,,,,,,,,,,,,,,,,0.2513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12S (driver),,1,,G12S (driver),,,,,-0.137391988,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0527,,0.4849,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-CH-5763,White,PRAD,91,0,0,,CH,0,0,MALE,0,,,,,,,NO,365,3-ETV4,365,365,,0,0,365,365,prad_tcga,Malignant,,,,14.8,TCGA-CH-5763-01,0,5253,0,TCGA-CH-5763,365,365,Prostate Cancer,,360,365,365,TCGA,,365,Primary,0,,A,,,,TUMOR FREE,Alive,-24380,,66,7,15,PRAD,365,365,WHITE,0.0,[Not Available],[Not Applicable],23,R0,1,Matched,,Prostate,Resection,3,f4192448-e5b3-4a9f-8354-9fe28503017a,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],18e79a01-07a2-4cd5-b700-71d41724e041,4,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,0.766666666667,TCGA-CH-5763,0:DiseaseFree,2,,Prostate Adenocarcinoma,11.99,3/16/12,365,,,,,NO,C61,8722bfbe-6db5-41ca-9ac4-004b999a772d,,,TUMOR FREE,0.0,0:LIVING,0.1,,11.99,Bilateral,,No Evidence of Extraprostatic Extension,0,YES,,2008,,,TCGA-CH-5763.8722bfbe-6db5-41ca-9ac4-004b999a772d.pdf,Peripheral Zone,[Not Applicable],YES,0,66-75%,5,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,Yes,R0,0.5,66,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,M0,C61.9,8550/3,87185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-L5-A4OO,White,ESCA,,0,0,,,,0,,0,1.81,0.43,19,12,16,,,101,,,101,,0,0,101,101,,Malignant,47,,154,,,,21875,,,101,101,,,,,101,,,101,,,,,,,,,Alive,-27757,,,,164,,101,101,,,[Not Available],[Not Available],,,,,0.33,Esophagus,Unknown,,,9,,0,0.30318,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,University of Michigan,,TCGA-L5-A4OO,,,,,,,101,,,,,,,,,12,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Unknown],,,,,,75,,,,,,,,,,,,,,,,,,,,87196,,,,,,,,,,,,,Grade 2,,,,,Stage IIIC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,,0,0,1,Male,TCGA-NC-A5HL,White,LUSC,,0,0,,Washington University - CHUV,,2,MALE,2,2.69,0.5,20,20,27,,,88,,,88,,2,2,88,88,,Malignant,67,,206,,,,32060,,,88,88,,,,,88,,,88,,,,,,,,TUMOR FREE,Dead,-26977,88,,,289,,88,88,,,[Not Available],[Not Applicable],,,,,0.34,,,,,13,,1,0.54782,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HL,,,,,,,,,,,,,,,,42,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Applicable],,,,,,73,,,,,,,,,,,,,,,,,,,,87197,,1.189584308,,,,,,,,,,0.204535928,,-0.005237127,,,,Stage IIA,,2.599,,,,,,,,,,,,,,,,-0.0339,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.89938093,16.36043853,18.12891731,-0.0136479384815985,LUSC,Squamous Cell Carcinoma,17.79152046,16.79409241,Squamous Cell Carcinoma,-0.7644,12.41030995,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.64,2,0,4,,,84,BRCA_LumA,84,84,,0,0,84,84,,Invasive Carcinoma,6,,5,,,,31399,0,,84,84,,,,84,84,,,84,,,,,,,,,Alive,-17490,,,,34,,84,84,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,7,,0,0.097911,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24P,,,,,,,84,,,,,,,,,6,,,,,,,,,,,,,2005,,,,,Stage I,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,87199,,0.120988102,0,0,0,0,0.1841,1,,,Infiltrating Ductal Carcinoma,0.160079678,,0.169803855,0,0,0,,Negative,-0.5735,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5653,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FC-A66V,,PRAD,,0,0,,FC,0,0,MALE,0,2.0,0.44,0,0,0,HRP,NO,524,,524,524,,0,0,524,524,prad_tcga,Malignant,0,,4,,TCGA-FC-A66V-01,0,5345,0,TCGA-FC-A66V,524,524,Prostate Cancer,,-164,524,524,TCGA,,524,Primary,0,Middle|Base,A,,,True,TUMOR FREE,Alive,-27282,,74,7,0,PRAD,524,524,,0.0,[Not Available],[Not Applicable],8,,1,Matched,0.0,Prostate,Resection,4,ACCA09F5-D5AB-4699-B8FE-615A88F57B38,0,Normal (no evidence of prostate cancer) [cM0],0,0.000269,[Not Available],7466D120-6A6E-40A0-96D3-4979816D6278,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,FC,0.266666666667,TCGA-FC-A66V,0:DiseaseFree,3,0,Prostate Adenocarcinoma,17.21,7/12/13,524,,,,,NO,C61,3C1BD6CD-0915-4DEA-A013-F2DE554C267F,180,0,TUMOR FREE,0.0,0:LIVING,10.8,,17.21,Bilateral,2,No Evidence of Extraprostatic Extension,27,YES,287,2012,,,TCGA-FC-A66V.3C1BD6CD-0915-4DEA-A013-F2DE554C267F.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,28,,2,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,74,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,,T3b,NO,7,No,NO,0,N0,T3b,0,M0,C61.9,8140/3,87200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-69-7973,White,LUAD,,0,0,,Washington University - Cleveland Clinic,0,0,FEMALE,0,3.35,0.55,2,11,9,,,230,,230,230,,0,0,230,230,,Malignant,22,,15,,,,31345,,,230,230,,,,230,230,,,230,,,,,,,,TUMOR FREE,Alive,-15355,,,,345,,230,230,,,[Not Available],[Not Applicable],,,,,0.13,,,,,22,,1,0.066122,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7973,,,,,,,230,,,,,,,,,23,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,42,,,,,,,,,,,,,,,,,,,,87209,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.510596468,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2293,,-0.2686,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-HU-A4GY,Asian,STAD,,0,0,,,,0,,0,2.31,0.21,6,6,7,,,8,,,8,,0,0,8,8,,Malignant,19,,58,,,,28271,,,8,8,,,,,8,,,8,,,,,,,,TUMOR FREE,Alive,-28113,,,,77,,8,8,,,[Not Available],[Not Applicable],,,,,0.44,Stomach,Unknown,,,10,,0,0.23233,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4GY,,,,,,,8,,,,,,,,,23,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,76,,,,,,,,,,,,,,,,,,,,87210,,1.724412471,,,,,,,,,,0.192735695,Grade 3,0.197460049,,,,Stage IIIA,,1.4505,,,,,,,,,,,,,,,,0.2184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GY,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,1,1,Male,TCGA-77-8130,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,1,3.31,0.39,11,6,17,,,4765,,4765,4765,,0,0,4471,4471,,Malignant,34,,25,,,,22137,,,4765,4765,,,,4765,4765,,,4471,,,,,,,,TUMOR FREE,Alive,-25260,,,,231,,4765,4765,,,[Not Available],[Not Applicable],,,,,0.14,,,,,22,,1,0.26911,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8130,,,,,,,4765,,New Primary Tumor,,,,,,,26,,,,,,,,,,,,,2000,4471,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,87212,,-0.272694541,,,,,,,,,,0.168997539,,0.079950272,,,,Stage IIB,,-0.178,,,,,,,,,,,,,,,,1.2581,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.32208973,14.92705166,14.17855894,-0.698413359590432,LUSC,Squamous Cell Carcinoma,18.45192343,14.60578655,Squamous Cell Carcinoma,2.1863,14.85784825,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,,,,,,,,3462,,,3462,,1,1,3462,3462,,Invasive Carcinoma,,,,,,,17905,0,,3462,3462,,,,,3462,,,3462,,,,,,,,WITH TUMOR,Dead,-13138,3462,,,22,,3462,3462,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1ES,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1999,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,35,,,,,,,,,,,,,,,,,,,,87216,,-0.637100607,0,0,0,0,-0.0155,1,,,Infiltrating Ductal Carcinoma,0.101761213,,0.078348372,0,0,0,,[Not Available],-2.329,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.382,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-ZF-AA5P,White,BLCA,,0.0,0,,,,0,MALE,0.0,,,,,,,,372,,,372,,0.0,0,372.0,372.0,,Malignant,,,,,,,17237.0,,,372.0,372,,,,,372,,,372.0,,,,,,,,TUMOR FREE,Alive,-23971,,,,57.0,,372.0,372,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA5P,,,,,,,372,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,65.0,,,,,,,,,,,,,,,,,,,,87220,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-8302,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,1.78,0.46,6,5,8,,,478,,478,478,,0,0,478,478,,Malignant,19,,82,,,,33807,,,478,478,,,,478,478,,,478,,,,,,,,TUMOR FREE,Alive,-20011,,,,905,,478,478,,,[Not Available],[Not Applicable],,,,,0.63,,,,,9,,0,0.42656,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8302,,,,,,,478,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,87224,,0.901301671,,,,,,,,,,0.20459726,,0.073817867,,,,Stage IB,,2.0335,,,,,,,,,,,,,,,,0.2561,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),G417V (driver),1,,G12C (driver),G417V (driver),,,,-0.220506557,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.309,,0.1643,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.66,0.83,6,6,6,,,518,BRCA_LumA,518,518,,0,0,518,518,,Invasive Carcinoma,18,,24,,,,22485,0,,518,518,,,,518,518,,,518,,,,,,,,TUMOR FREE,Alive,-19814,,,,61,,518,518,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,14,,1,0.10207,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A0AB,,,,,,,518,,,,,,,,,14,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,87228,,-1.854385679,0,0,0,0,-0.3424,1,,,Infiltrating Lobular Carcinoma,0.122776387,,0.085422517,0,0,0,,Negative,-2.4635,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2359,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,87229,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2744,,LUSC,,0,0,,Indivumed,,0,MALE,0,2.48,0.37,12,17,16,,,30,,,30,,0,0,30,30,,Malignant,45,,78,,,,17846,,,30,30,,,,,30,,,30,,,,,,,,TUMOR FREE,Alive,-26084,,,,276,,30,30,,,[Not Available],[Not Applicable],,,,,0.18,,,,,8,,1,0.50539,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2744,,,,,,,30,,,,,,,,,40,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,87232,,1.505500958,,,,,,,,,,0.262202436,,0.150181682,,,,Stage IIB,,2.175,,,,,,,,,,,,,,,,0.6356,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.64395505,18.09643962,17.94820412,0.24554779479989,LUSC,Squamous Cell Carcinoma,18.03011377,16.88304648,Squamous Cell Carcinoma,0.4547,14.13211102,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8HK,,PRAD,370,1,1,,YL,1,0,MALE,1,1.86,0.39,10,11,8,ambiguous,NO,1491,1-ERG,1376,1491,,1,1,1376,1376,prad_tcga,Malignant,29,,71,,TCGA-YL-A8HK-01,0,5655,0,TCGA-YL-A8HK,1376,1376,Prostate Cancer,,1491,1376,1491,TCGA,,1376,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-21850,,59,9,25,PRAD,1376,1376,,0.0,[Not Available],[Not Applicable],18,R1,1,Matched,0.04,Prostate,Resection,4,38336DB5-6CA9-48D5-BF4F-1F92C8070CA2,3,Normal (no evidence of prostate cancer) [cM0],0,0.14372,[Not Available],351239DB-52D3-4AB5-BD4F-8FEAA6701BA1,5,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,YL,0.6,TCGA-YL-A8HK,1:Recurred/Progressed,5,27,Prostate Adenocarcinoma,45.2,3/13/14,1491,,Biochemical evidence of disease,,,NO,C61,AB7217AC-ABF7-4704-9413-9298DDE688EE,140,4,WITH TUMOR,0.1384,0:LIVING,1.0,,48.98,Bilateral,31,No Evidence of Extraprostatic Extension,195,YES,1477,2009,1376,,TCGA-YL-A8HK.AB7217AC-ABF7-4704-9413-9298DDE688EE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,27,26-35%,1,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,YES,No,R1,,59,Core needle biopsy,1376,Complete Remission/Response,NO,YES,YES,YES,T3b,YES,9,No,YES,0,N0,,0,M0,C61.9,8140/3,87236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-D7-6818,White,STAD,,1,1,,,,1,,1,2.37,0.43,6,9,13,,,376,,,376,,1,1,247,247,,Malignant,28,,50,,,,24969,,,247,247,,,,,376,,,247,,,,,,,,WITH TUMOR,Dead,-19391,376,,,211,,247,247,,,[Not Available],[Not Applicable],,,,,0.25,Stomach,Unknown,,,13,,1,0.36674,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6818,,,,,,,,,Locoregional Recurrence,,,,,,,36,,,,,,,,,,,,,2011,247,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,87237,,-0.414447362,,,,,,,,,,0.142431481,Grade 3,0.157647115,,,,Stage IIIA,,-0.1995,,,,,,,,,,,,,,,,0.6893,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6818,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,,0,0,0,Female,TCGA-69-7979,White,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,FEMALE,0,4.57,0.53,11,18,27,,,408,,,408,,0,0,408,408,,Malignant,56,,207,,,,23103,,,408,408,,,,,408,,,408,,,,,,,,,Alive,-26180,,,,1906,,408,408,,,[Not Available],[Not Applicable],,,,,0.3,,,,,19,,2,0.27451,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7979,,,,,,,408,,,,,,,,,61,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,71,,,,,,,,,,,,,,,,,,,,87238,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.82965608,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.5272,,-1.1932,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-EJ-5499,Asian,PRAD,91,0,0,,EJ,0,0,MALE,0,1.95,0.47,2,4,2,HRP,NO,1415,1-ERG,1415,1415,,0,0,1415,1415,prad_tcga,Malignant,8,,34,5.2,TCGA-EJ-5499-01,0,5265,0,TCGA-EJ-5499,1415,1415,Prostate Cancer,,533,1415,1415,TCGA,,1415,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-22286,,61,7,45,PRAD,1415,1415,ASIAN,0.0,[Not Available],[Not Applicable],42,R0,1,Matched,0.0,Prostate,Resection,4,22c4f5c2-1b1e-4212-8110-09dbd5ce10a9,1,,0,0.045521,[Not Available],fd1aa612-df86-4d48-892d-2acebd76ea96,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,8,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.36666666667,TCGA-EJ-5499,0:DiseaseFree,3,7,Prostate Adenocarcinoma,46.48,3/30/12,1415,,,,,,C61,f69e29da-24d1-45f2-9b4f-a32f9e5479a4,,1,TUMOR FREE,0.0438,0:LIVING,0.1,3,46.48,Bilateral,10,,,YES,,2010,,,TCGA-EJ-5499.f69e29da-24d1-45f2-9b4f-a32f9e5479a4.pdf,Overlapping / Multiple Zones,[Not Applicable],,,26-35%,19,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.9,61,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,87242,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.78,0.45,3,2,4,,,10,BRCA_LumA,10,10,,0,0,10,10,,Invasive Carcinoma,9,,5,,,,27396,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-23358,,,,50,,10,10,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,16,,1,0.055824,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0XS,,,,,,,10,,,,,,,,,16,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,87244,,0.916500046,0,0,0,0,-0.0007,1,,,Infiltrating Ductal Carcinoma,0.161031748,,0.194070383,0,0,0,,Negative,0.4565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5131,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A519,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.98,0.64,1,2,0,,,508,,508,508,,0.0,0,508.0,508.0,,Malignant,3,,4,,,,17106.0,,,508.0,508,,,,508,508,,,508.0,,,,,,,,TUMOR FREE,Alive,-26427,,,,103.0,,508.0,508,,,[Not Available],[Not Applicable],,,,,0.08,,,,,0,,0,0.017284,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A519,,,,,,,508,,,,,,,,,1,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,72.0,,,,,,,,,,,,,,,,,,,,87249,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7315,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.63,5,8,3,ambiguous,NO,1008,1-ERG,1008,1008,,0,0,1008,1008,prad_tcga,Malignant,16,,50,5.8,TCGA-EJ-7315-01,0,5299,0,TCGA-EJ-7315,1008,1008,Prostate Cancer,,289,1008,1008,TCGA,,1008,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-25154,,68,7,29,PRAD,1008,1008,WHITE,0.0,[Not Available],[Not Applicable],36,R0,1,Matched,0.01,Prostate,Resection,4,f4871dc1-a456-4d69-a5bc-30a5eb8033e9,1,,0,0.083829,[Not Available],2c7ec330-261e-49c7-9424-6d83641dba6d,3,Prostate Adenocarcinoma Acinar Type,2.5,Prostate,17,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,2.2,TCGA-EJ-7315,0:DiseaseFree,3,18,Prostate Adenocarcinoma,33.11,4/5/12,1008,,,,,NO,C61,6afa83ac-9060-4b49-90a3-dc19824822e3,,3,TUMOR FREE,0.091,0:LIVING,0.1,5,33.11,Bilateral,21,,,YES,,2011,,,TCGA-EJ-7315.6afa83ac-9060-4b49-90a3-dc19824822e3.pdf,,[Not Applicable],NO,,71-80%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.5,68,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,87258,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.33,0.71,4,1,8,,,942,BRCA_LumB,942,942,,0,0,942,942,,Invasive Carcinoma,13,,16,,,,32478,0,,942,942,,,,942,942,,,942,,,,,,,,TUMOR FREE,Alive,-17807,,,,112,,942,942,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,20,,1,0.30423,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A092,,,,,,,942,,,,,,,,,33,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,87262,,-0.006537996,0,0,0,0,-0.5527,1,,,Infiltrating Ductal Carcinoma,0.164340274,,0.066517296,0,0,0,,Negative,-0.5505,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1099,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Clinging, High Grade), Comedonecrosis",,"DCIS (Clinging, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-66-2786,,LUSC,,0,0,,Indivumed,,0,FEMALE,0,1.74,0.57,11,4,11,,,790,,,790,,0,0,790,790,,Malignant,26,,29,,,,27209,,,790,790,,,,,790,,,790,,,,,,,,TUMOR FREE,Alive,-25051,,,,292,,790,790,,,[Not Available],[Not Applicable],,,,,0.15,,,,,13,,0,0.3465,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2786,,,,,,,790,,,,,,,,,13,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Applicable],,,,,,68,,,,,,,,,,,,,,,,,,,,87266,,0.547487036,,,,,,,,,,0.240532533,,0.082497853,,,,Stage IA,,0.738,,,,,,,,,,,,,,,,0.4785,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.270538628050758,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1792,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A6B6,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.59,0.52,12,6,10,,,1115,,1115,1115,,0.0,0,1115.0,1115.0,,Malignant,28,,74,,,,32323.0,,,1115.0,1115,,,,1115,1115,,,1115.0,,,,,,,,TUMOR FREE,Alive,-21007,,,,1418.0,,1115.0,1115,,,[Not Available],[Not Applicable],,,,,0.1,,,,,15,,1,0.20486,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A6B6,,,,,,,1115,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,57.0,,,,,,,,,,,,,,,,,,,,87267,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.85,0.55,8,11,20,,,679,BRCA_LumB,679,679,,0,0,679,679,,Invasive Carcinoma,39,,67,,,,30559,0,,679,679,,,,679,679,,,679,,,,,,,,TUMOR FREE,Alive,-19563,,,,76,,679,679,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,14,,1,0.13649,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A2KD,,,,,,,679,,,,,,,,,33,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,87270,,0.952746308,0,0,0,0,-0.0363,1,,,Infiltrating Ductal Carcinoma,0.159178571,,0.128677395,0,0,0,,Negative,0.4895,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3749,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,1.98,0.82,6,4,8,,,1229,BRCA_LumA,75,1229,,1,1,75,75,,Invasive Carcinoma,18,,47,,,,22184,0,,75,75,,,,75,1229,,,75,,,,,,,,WITH TUMOR,Alive,-15085,,,,36,,75,75,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,3,,0,0.11756,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A10A,,,,,,,1229,Bone,Distant Metastasis,,,,,,,6,,,,,,,,,,,,,2007,75,,,,Stage IIB,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,87273,,-0.620995132,0,0,0,0,-0.914,1,,,Infiltrating Ductal Carcinoma,0.13059156,,0.09325421,0,0,0,,Negative,-0.8845,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2262,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A927,White,STAD,,1,1,,,,1,,1,,,,,,,,200,,,200,,1,1,200,200,,Malignant,,,,,,,22612,,,200,200,,,,,200,,,200,,,,,,,,WITH TUMOR,Dead,-29676,200,,,62,,200,200,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G1,,Barretos Cancer Hospital,,TCGA-VQ-A927,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IIIB,,,,,,,,Stable Disease,,,,,,81,,,,,,,,,,,,,,,,,,,,87282,,-0.235191473,,,,,,,,,,0.079305576,Grade 1,0.168993484,,,,Stage IIIB,,-0.0365,,,,,,,,,,,,,,,,0.2658,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A927,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,1,1,1,1,Female,TCGA-55-8299,White,LUAD,,1,1,,International Genomics Consortium,1,1,FEMALE,1,,,,,,,,469,,274,469,,1,1,274,274,,Malignant,,,,,,,21008,,,274,274,,,,274,469,,,274,,,,,,,,WITH TUMOR,Dead,-22626,469,,,258,,274,274,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8299,,,,,,,,,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2012,274,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87284,,1.647742034,,,,,,,,,,0.250055021,,0.285103066,,,,Stage IA,,1.8315,,,,,,,,,,,,,,,,0.6675,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,0.268388073,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.1953,,1.6868,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.09,0.31,7,6,10,,,3128,BRCA_Her2,3128,3128,,0,0,3128,3128,,Invasive Carcinoma,23,,28,,,,16707,1,,3128,3128,,,,3128,3128,,,3128,,,,,,,,TUMOR FREE,Alive,-17523,,,,49,,3128,3128,,,[Not Available],[Not Applicable],,,,,0.49,Lymph Node,Resection/Excision,,,8,,0,0.15492,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24U,,,,,,,3128,,,,,,,,,9,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,87285,,1.585166009,0,0,0,0,0.043,1,,,Infiltrating Ductal Carcinoma,0.232148549,,0.165242362,0,0,0,,Negative,0.796,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3541,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,1,0,Resection/Excision,Optimal,0,Lymph Node,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Lymph Node",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.44,2,2,3,,,1505,BRCA_LumA,1505,1505,,0,0,1505,1505,,Invasive Carcinoma,7,,5,,,,16487,0,,1505,1505,,,,1505,1505,,,1505,,,,,,,,TUMOR FREE,Alive,-22961,,,,21,,1505,1505,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,3,,0,0.096486,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YI,,,,,,,1505,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,87289,,0.956745574,0,0,0,0,1.5591,1,,,Infiltrating Ductal Carcinoma,0.192663898,,0.204258548,0,0,0,,Negative,0.2155,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3198,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Low Grade), No Detail Present",,"DCIS (Cribriform, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-6738,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.88,0.53,10,3,14,,,1927,,1927,1927,,0,0,1927,1927,,Malignant,27,,24,,,,16747,,,1927,1927,,,,1927,1927,,,1927,,,,,,,,TUMOR FREE,Alive,-29368,,,,451,,1927,1927,,,[Not Available],[Not Applicable],,,,,0.4,,,,,17,,0,0.32942,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-6738,,,,,,,1927,,,,,,,,,18,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,87290,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.1559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R362Q,1,,,R362Q,14.01092638,14.28981816,14.00501863,-0.628474808874668,LUSC,,17.94689144,14.92918619,Squamous Cell Carcinoma,,11.92790784,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-D7-6822,White,STAD,,0,0,,,0,0,,0,2.32,0.73,18,14,23,,,375,,375,375,,0,0,375,375,,Malignant,55,,202,,,,17447,,,375,375,,,,375,375,,,375,,,,,,,,TUMOR FREE,Alive,-28214,,,,318,,375,375,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,13,,0,0.39472,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6822,,,,,,,375,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,87293,,0.144123454,,,,,,,,,,0.026037811,Grade 2,0.015146004,,,,Stage IB,,0.797,,,,,,,,,,,,,,,,0.2265,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6822,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,3603,BRCA_LumA,3603,3603,,0,0,3603,3603,,Invasive Carcinoma,,,,,,,34306,0,,3603,3603,,,,3603,3603,,,3603,,,,,,,,TUMOR FREE,Alive,-20585,,,,28,,3603,3603,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EP,,,,,,,3603,,,,,,,,,,,,,,,,,,,,,,2004,,,,,Stage I,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,87294,,1.819581007,0,0,0,1,-0.0795,0,,,Infiltrating Lobular Carcinoma,0.282298082,,0.316190471,0,0,0,,Negative,1.655,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6342,1,0,H & E,0,0,,0,Jeffrey Eisenstein,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,UDH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.02,0.7,11,8,7,,,255,BRCA_Basal,,255,,1,1,255,255,,Invasive Carcinoma,26,,54,,,,16166,0,,255,255,,,,,255,,,255,,,,,,,,WITH TUMOR,Dead,-24235,255,,,56,,255,255,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,30,,1,0.59168,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0T2,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,87296,TRUE,0.429132222,0,0,0,0,2.0127,1,,,Infiltrating Ductal Carcinoma,0.148967257,,0.14888678,0,0,0,,Close,-0.7395,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3107,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,987,,987,987,,0,0,987,987,,Invasive Carcinoma,,,,,,,22424,0,,987,987,,,,987,987,,,987,,,,,,,,TUMOR FREE,Alive,-16983,,,,0,,987,987,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3BB,,,,,,,987,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,87300,,1.120376917,0,0,0,0,0.4199,1,,,Infiltrating Lobular Carcinoma,0.185748269,,0.238494396,0,0,0,,Negative,0.5615,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6038,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.82,0.26,5,4,4,,,492,BRCA_LumA,492,492,,0,0,492,492,,Invasive Carcinoma,13,,65,,,,19721,0,,492,492,,,,492,492,,,492,,,,,,,,WITH TUMOR,Alive,-32208,,,,217,,492,492,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,11,,0,0.34927,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A73U,,,,,,,492,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,88,,,,,,,,,,,,,,,,,,,,87305,,1.542098076,0,0,0,0,-0.551,1,,,Infiltrating Lobular Carcinoma,0.253606221,,0.194126041,0,0,0,,Negative,1.8855,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5372,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Female,TCGA-2F-A9KR,Unknown,BLCA,,1.0,1,,,1,1,FEMALE,1.0,1.74,0.89,4,2,4,,,3183,,3086,3183,,1.0,1,3086.0,3086.0,,Malignant,10,,80,,,,26184.0,,,3086.0,3086,,,,3086,3183,,,3086.0,,,,,,,,WITH TUMOR,Dead,-21848,3183,,,325.0,,3086.0,3086,,,[Not Available],[Not Applicable],,,,,0.18,,,,,10,,0,0.26607,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KR,,,,,,,,Lung,Distant Metastasis,,,,,,,8,,,,,,,,,,,,,2000,3086,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,87306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-2F-A9KP,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.96,0.64,6,10,12,,,364,,,364,,1.0,1,343.0,343.0,,Malignant,28,,70,,,,28569.0,,,343.0,343,,,,,364,,,343.0,,,,,,,,WITH TUMOR,Dead,-24428,364,,,185.0,,343.0,343,,,[Not Available],[Not Applicable],,,,,0.12,,,,,9,,1,0.087759,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KP,,,,,,,,Liver,Distant Metastasis,,,,,,,18,,,,,,,,,,,,,2011,343,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,87309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46E,,PRAD,,0,0,,EJ,0,0,MALE,0,,,,,,,NO,524,,524,524,,0,0,524,524,prad_tcga,Malignant,,,,,TCGA-EJ-A46E-01,0,5336,0,TCGA-EJ-A46E,524,524,Prostate Cancer,,503,524,524,TCGA,,524,Primary,0,,A,,,True,TUMOR FREE,Alive,-21054,,57,8,5,PRAD,524,524,,0.0,[Not Available],[Not Applicable],10,,1,Matched,,Prostate,Resection,4,ECD3D671-E830-44AF-8518-9D06ED15D04B,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],A608BF0E-A932-4541-8439-2FFB9F6294B0,4,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,EJ,0.333333333333,TCGA-EJ-A46E,0:DiseaseFree,4,,Prostate Adenocarcinoma,17.21,1/23/13,524,,,,,,C61,F2A59B31-7CFE-4DA8-A7B7-229021357746,760,,TUMOR FREE,0.0,0:LIVING,0.1,,17.21,Bilateral,,No Evidence of Extraprostatic Extension,,YES,489,2011,,,TCGA-EJ-A46E.F2A59B31-7CFE-4DA8-A7B7-229021357746.pdf,,[Not Applicable],YES,,,9,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,57,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,87316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,0,1,1,Female,TCGA-86-8075,White,LUAD,,1,1,,Asterand,1,2,FEMALE,1,4.21,0.3,7,6,16,,,694,,199,694,,1,1,199,199,,Malignant,29,,31,,,,23196,,,199,199,,,,199,694,,,199,,,,,,,,TUMOR FREE,Dead,-24402,694,,,57,,199,199,,,[Not Available],[Not Applicable],,,,,0.19,,,,,24,,2,0.32555,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8075,,,,,,,,,Locoregional Recurrence,,,,,,,60,,,,,,,,,,,,,2011,199,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,87318,,0.680497167,,,,,,,,,,0.257649408,,0.152907426,,,,Stage IB,,0.846,,,,,,,,,,,,,,,,0.8809,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.304951769,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.3146,,-1.5486,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,1.95,0.75,5,4,1,,,463,BRCA_LumA,,463,,0,0,463,463,,Invasive Carcinoma,10,,86,,,,26175,0,,463,463,,,,,463,,,463,,,,,,,,TUMOR FREE,Alive,-12755,,,,43,,463,463,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,2,,0,0.12292,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A6S9,,,,,,,463,,,,,,,,,4,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,87321,,-0.187175157,0,0,0,0,0.0382,1,,,Infiltrating Ductal Carcinoma,0.150337069,,0.118100641,0,0,0,,[Not Available],-0.228,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6251,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-DK-A3X2,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.34,0.92,8,8,13,,,547,,,547,,1.0,1,533.0,533.0,,Malignant,29,,93,,,,31778.0,,,533.0,533,,,,,547,,,533.0,,,,,,,,WITH TUMOR,Dead,-31160,547,,,168.0,,533.0,533,,,[Not Available],[Not Applicable],,,,,0.16,,,,,20,,1,0.23237,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3X2,,,,,,,,Liver,Distant Metastasis,,,,,,,27,,,,,,,,,,,,,2010,533,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,85.0,,,,,,,,,,,,,,,,,,,,87325,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.11,0.33,2,0,3,,,1288,BRCA_LumA,1288,1288,,0,0,1288,1288,,Invasive Carcinoma,5,,3,,,,25628,0,,1288,1288,,,,1288,1288,,,1288,,,,,,,,TUMOR FREE,Alive,-28304,,,,34,,1288,1288,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,5,,0,0.040674,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0W5,,,,,,,1288,,,,,,,,,7,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,87326,,1.845898593,0,0,0,0,-0.6168,1,,,Infiltrating Ductal Carcinoma,0.184980034,,0.16461322,0,0,0,,Negative,1.2625,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4202,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.56,1,0,2,,,975,BRCA_LumA,975,975,,0,0,975,975,,Invasive Carcinoma,3,,3,,,,33589,0,,975,975,,,,975,975,,,975,,,,,,,,TUMOR FREE,Alive,-15602,,,,25,,975,975,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,2,,0,0.017746,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A227,,,,,,,975,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,87335,,0.693944396,0,0,0,0,-0.4035,1,,,Infiltrating Ductal Carcinoma,0.145089052,,0.234093153,0,0,0,,Negative,0.095,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3349,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,No Detail Present,"DCIS (Cribriform, Low Grade), No Detail Present",,"DCIS (Cribriform, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-7573,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,3.2,0.33,7,9,13,,,487,,487,487,,0,0,487,487,,Malignant,29,,22,,,,16233,,,487,487,,,,487,487,,,487,,,,,,,,TUMOR FREE,Alive,-26302,,,,69,,487,487,,,[Not Available],[Not Applicable],,,,,0.26,,,,,15,,1,0.32601,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7573,,,,,,,487,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,87336,,0.853847957,,,,,,,,,,0.219576754,,0.151270951,,,,Stage IA,,0.434,,,,,,,,,,,,,,,,0.1342,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L747_E749del (driver), K754E (driver)",,,1,"L747_E749del (driver), K754E (driver)",,,,,,-0.183765997,LUAD,,,,Adenocarcinoma,-0.4122,,0.0134,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Female,TCGA-E7-A5KE,Asian,BLCA,,0.0,0,,,,0,FEMALE,0.0,3.06,0.92,8,11,12,,,17,,,17,,0.0,0,17.0,17.0,,Malignant,31,,94,,,,26704.0,,,17.0,17,,,,,17,,,17.0,,,,,,,,TUMOR FREE,Alive,-28714,,,,306.0,,17.0,17,,,[Not Available],[Not Applicable],,,,,0.26,,,,,14,,1,0.22159,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A5KE,,,,,,,17,,,,,,,,,36,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,[Not Available],,,,,,78.0,,,,,,,,,,,,,,,,,,,,87337,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-43-A56U,White,LUSC,,0,0,,Christiana Healthcare,0,0,FEMALE,0,1.89,0.17,11,15,10,,,432,,432,432,,0,0,432,432,,Malignant,36,,38,,,,22363,,,432,432,,,,432,432,,,432,,,,,,,,TUMOR FREE,Alive,-27847,,,,366,,432,432,,,[Not Available],[Not Applicable],,,,,0.5,,,,,5,,0,0.22345,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-A56U,,,,,,,432,,,,,,,,,9,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,87338,,1.924695322,,,,,,,,,,0.184784426,,0.134963594,,,,Stage IA,,1.681,,,,,,,,,,,,,,,,0.4829,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,P192R,,,1,P192R,,,,,,-0.0311779693291734,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.3195,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,1,1,1.0,1.0,Female,TCGA-ZF-A9R3,White,BLCA,,1.0,1,,,1,1,FEMALE,1.0,2.27,0.72,3,4,6,,,949,,917,949,,1.0,1,917.0,917.0,,Malignant,13,,51,,,,21350.0,,,917.0,917,,,,917,949,,,917.0,,,,,,,,WITH TUMOR,Dead,-19384,949,,,118.0,,917.0,917,,,[Not Available],[Not Applicable],,,,,0.25,,,,,12,,0,0.11599,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9R3,,,,,,,,Bone,Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2012,917,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,53.0,,,,,,,,,,,,,,,,,,,,87348,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,1.0,1.0,Male,TCGA-FD-A3NA,White,BLCA,,0.0,0,,,0,0,MALE,1.0,3.41,0.43,6,7,14,,,1845,,1845,1845,,0.0,0,1338.0,1338.0,,Malignant,27,,58,,,,16043.0,,,1845.0,1845,,,,1845,1845,,,1338.0,,,,,,,,TUMOR FREE,Alive,-21936,,,,236.0,,1845.0,1845,,,[Not Available],[Not Applicable],,,,,0.14,,,,,16,,1,0.18174,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3NA,,,,,,,1845,Lung,New Primary Tumor,,,,,,,31,,,,,,,,,,,,,2009,1338,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,87354,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Unknown,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.34,3,3,5,,,64,BRCA_LumA,64,64,,0,0,64,64,,Invasive Carcinoma,11,,21,,,,22053,0,,64,64,,,,64,64,,,64,,,,,,,,,Alive,-21555,,,,52,,64,64,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,3,,0,0.053039,[Unknown],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mount Sinai School of Medicine,,TCGA-OK-A5Q2,,,,,,,64,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,87355,,,0,0,0,0,0.0047,1,,,Infiltrating Lobular Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"LCIS, Comedonecrosis",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HF-7134,,STAD,,0,0,,,0,0,,0,,,,,,,,1588,,1588,1588,,0,0,1588,1588,,Malignant,,,,,,,27206,,,1588,1588,,,,1588,1588,,,1588,,,,,,,,TUMOR FREE,Alive,,,,,363,,1588,1588,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Ontario Institute for Cancer Research (OICR),,TCGA-HF-7134,,,,,,,1588,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,87364,,,,,,,,,,,,,Grade 2,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HF-7134,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,0,0,0,1,Male,TCGA-VQ-A923,White,STAD,,0,0,,,2,2,,2,4.1,0.41,1,4,4,,,61,,61,61,,2,2,61,61,,Malignant,9,,35,,,,31929,,,61,61,,,,61,61,,,61,,,,,,,,TUMOR FREE,Dead,-32873,61,,,137,,61,61,,,"Other, non-malignant disease",[Not Applicable],,,,,0.06,Stomach,Unknown,,,13,,1,0.013915,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A923,,,,,,,,,,,,,,,,22,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,90,,,,,,,,,,,,,,,,,,,,87365,,1.264851358,,,,,,,,,,0.108045323,Grade 3,0.145449574,,,,Stage IIIA,,1.303,,,,,,,,,,,,,,,,0.1236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A923,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Male,TCGA-KK-A6E6,,PRAD,315,0,0,,KK,,0,MALE,0,3.63,0.44,1,9,10,ambiguous,NO,3447,1-ERG,,3447,,0,0,3447,3447,prad_tcga,Malignant,20,CDK12;FANCL;RAD51D;RAD54L,21,10.3,TCGA-KK-A6E6-01,0,5505,0,TCGA-KK-A6E6,3447,3447,Prostate Cancer,,3447,,3447,TCGA,,3447,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25320,,69,9,58,PRAD,3447,3447,,0.0,[Not Available],[Not Applicable],40,R0,1,Matched,0.24,Prostate,Resection,4,F3AE5486-0F79-48AA-B10E-352D36BD2AFD,9,,1,0.030562,[Not Available],E377F873-C0D1-4810-9F3D-E551723858E1,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,KK,1.36666666667,TCGA-KK-A6E6,0:DiseaseFree,5,23,Prostate Adenocarcinoma,113.24,3/27/14,3447,,,,,NO,C61,C67B882A-02B1-4511-B55C-87A33FC3E73E,50,11,TUMOR FREE,0.0436,0:LIVING,0.1,,113.24,Bilateral,29,,,YES,3813,2002,,,TCGA-KK-A6E6.C67B882A-02B1-4511-B55C-87A33FC3E73E.pdf,Peripheral Zone,[Not Applicable],NO,,61-70%,5,Prostate Adenocarcinoma Acinar Type,1,2002,[Not Available],,NO,No,R0,,69,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,87369,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,2.95,0.6,3,2,5,,,302,BRCA_LumB,,302,,1,1,302,302,,Invasive Carcinoma,10,,12,,,,20388,0,,302,302,,,,,302,,,302,,,,,,,,WITH TUMOR,Dead,-29474,302,,,326,,302,302,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,17,,1,0.33849,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1Y1,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,87371,,-0.253349745,0,0,0,0,-0.4472,1,,,Infiltrating Ductal Carcinoma,0.192273644,,0.108948847,0,0,0,,[Not Available],-0.959,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5437,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.69,10,8,13,,,532,BRCA_LumB,532,532,,0,0,532,532,,Invasive Carcinoma,31,,64,,,,24431,0,,532,532,,,,532,532,,,532,,,,,,,,TUMOR FREE,Alive,-17879,,,,270,,532,532,,,[Not Available],[Not Applicable],,,,,0.25,Breast,Resection/Excision,,,9,,0,0.239,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1J9,,,,,,,532,,,,,,,,,14,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,87374,,0.124758559,0,0,0,0,0.5144,1,,,Infiltrating Ductal Carcinoma,0.201922317,,0.138090566,0,0,0,,Negative,-0.8245,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5229,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-22-5485,White,LUSC,,1,,,Mayo Clinic - Rochester,1,1,FEMALE,1,1.91,0.72,6,6,12,,,916,,840,916,,1,,840,840,,Malignant,24,,35,,,,16895,,,840,,,,,840,916,,,840,,,,,,,,WITH TUMOR,Dead,-21488,916,,,280,,840,,,,[Not Available],[Not Applicable],,,,,0.01,,,,,12,,0,0.33795,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5485,,,,,,,916,,,,,,,,,16,,,,,,,,,,,,,2001,840,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,87379,,-0.169914156,,,,,,,,,,0.177744695,,0.080196279,,,,Stage IA,,0.5435,,,,,,,,,,,,,,,,0.2652,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.69279349197325,LUSC,,,,Squamous Cell Carcinoma,-0.8019,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,0,0,0.0,1.0,Female,TCGA-5N-A9KI,White,BLCA,,0.0,0,,,2,2,FEMALE,2.0,3.55,0.58,6,11,14,,,76,,76,76,,2.0,2,76.0,76.0,,Malignant,31,,34,,,,19118.0,,,76.0,76,,,,76,76,,,76.0,,,,,,,,TUMOR FREE,Dead,-27777,76,,,233.0,,76.0,76,,,[Not Available],[Not Applicable],,,,,0.25,,,,,17,,1,0.12994,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University Hospital Erlangen,,TCGA-5N-A9KI,,,,,,,,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,87380,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-8078,White,STAD,,0,0,,,0,0,,0,2.14,0.66,0,0,2,,,900,,900,900,,0,0,900,900,,Malignant,2,,22,,,,29838,,,900,900,,,,900,900,,,900,,,,,,,,TUMOR FREE,Alive,-25861,,,,2378,,900,900,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,4,,0,0.0075258,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8078,,,,,,,900,,,,,,,,,3,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,87381,,1.080763227,,,,,,,,,,0.12921491,Grade 3,0.050155064,,,,Stage IIB,,1.444,,,,,,,,,,,,,,,,0.1835,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8078,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.11,0.75,2,0,3,,,694,BRCA_LumA,694,694,,0,0,694,694,,Invasive Carcinoma,5,,3,,,,20088,0,,694,694,,,,694,694,,,694,,,,,,,,TUMOR FREE,Alive,-22583,,,,52,,694,694,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,8,,0,0.04004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15C,,,,,,,694,,,,,,,,,7,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,87382,,0.175060555,0,0,0,0,0.1653,1,,,Infiltrating Ductal Carcinoma,0.129801218,,0.142999735,0,0,0,,Negative,-0.0505,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4575,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,1,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skeletal Muscle",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,313,,313,313,,0,0,313,313,,Invasive Carcinoma,,,,,,,32644,0,,313,313,,,,313,313,,,313,,,,,,,,TUMOR FREE,Alive,-22672,,,,0,,313,313,,,[Not Available],[Not Applicable],,,,,,Breast,Core Biopsy,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A3J0,,,,,,,313,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,87387,,0.772403818,0,0,0,0,-0.5412,1,,,Mucinous Carcinoma,0.114391683,,0.089760341,0,0,0,,Negative,0.549,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1771,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FJ-A871,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.99,0.81,3,3,2,,,272,,,272,,1.0,1,106.0,106.0,,Malignant,8,,33,,,,24621.0,,,106.0,106,,,,,272,,,106.0,,,,,,,,WITH TUMOR,Dead,-18051,272,,,71.0,,106.0,106,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.029834,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A871,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,0,,,,,,,,,,,,,2013,106,Pelvic,,,Stage III,,,,,,,,Progressive Disease,,,,,,49.0,,,,,,,,,,,,,,,,,,,,87390,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.55,0.6,8,5,13,,,365,BRCA_Her2,,365,,1,1,365,365,,Invasive Carcinoma,26,,71,,,,18582,0,,365,365,,,,,365,,,365,,,,,,,,WITH TUMOR,Dead,-16504,365,,,149,,365,365,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,16,,1,0.16532,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1EV,,,,,,,,,,,,,,,,20,,,,,,,,,,,,,1999,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,87398,,-1.387761703,0,0,0,0,0.7383,1,,,Infiltrating Ductal Carcinoma,0.152461654,,0.11107247,0,0,0,,[Not Available],-1.247,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3686,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.23,0.72,5,11,21,,,394,BRCA_LumB,394,394,,0,0,394,394,,Invasive Carcinoma,37,,69,,,,32324,0,,394,394,,,,394,394,,,394,,,,,,,,TUMOR FREE,Alive,-20712,,,,79,,394,394,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,16,,1,0.12585,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HN,,,,,,,394,,,,,,,,,33,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,87402,,-0.137168097,0,0,0,0,0.2695,1,,,Infiltrating Ductal Carcinoma,0.134895585,,0.096185797,0,0,0,,Negative,-1.1745,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0211,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Unknown,BRCA,,0,0,,,0,0,FEMALE,0,1.62,0.88,21,20,27,,,79,BRCA_Basal,79,79,,0,0,79,79,,Invasive Carcinoma,68,,61,,,,27986,0,,79,79,,,,79,79,,,79,,,,,,,,TUMOR FREE,Alive,-20483,,,,114,,79,79,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,8,,0,0.63868,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-HN-A2NL,,,,,,,79,,,,,,,,,18,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,87403,TRUE,1.06511159,0,0,0,0,-3.0614,1,,,Infiltrating Lobular Carcinoma,0.099496119,,0.051619324,0,0,0,,Negative,-0.0695,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2696,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-63-A5MV,Unknown,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,2.33,0.35,12,10,19,,,1100,,1100,1100,,0,0,1100,1100,,Malignant,41,,91,,,,26466,,,1100,1100,,,,1100,1100,,,1100,,,,,,,,TUMOR FREE,Alive,-25505,,,,164,,1100,1100,,,[Not Available],[Not Applicable],,,,,0.53,,,,,11,,0,0.26077,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5MV,,,,,,,1100,,,,,,,,,22,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,87405,,1.126514039,,,,,,,,,,0.230364115,,0.082546986,,,,Stage IIA,,1.861,,,,,,,,,,,,,,,,0.6575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.66847847,17.12924508,14.45003028,-0.263664806145054,LUSC,Squamous Cell Carcinoma,18.2051944,16.4941394,Squamous Cell Carcinoma,0.7275,13.31183633,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-J2-A4AG,White,LUAD,,0,0,,ABS - Lahey Clinic,0,0,FEMALE,0,2.01,0.31,2,2,4,,,988,,988,988,,0,0,988,988,,Malignant,8,,34,,,,28870,,,988,988,,,,988,988,,,988,,,,,,,,TUMOR FREE,Alive,-24224,,,,115,,988,988,,,[Not Available],[Not Applicable],,,,,0.38,,,,,2,,0,0.078101,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ABS - Lahey Clinic,,TCGA-J2-A4AG,,,,,,,988,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,87406,,1.323560415,,,,,,,,,,0.239410303,,0.1733519,,,,Stage IA,,0.7585,,,,,,,,,,,,,,,,0.4007,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,,,,-0.082705101,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.4947,,0.2762,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Female,TCGA-GV-A3QK,White,BLCA,,0.0,0,,,,0,FEMALE,0.0,2.17,0.71,6,4,7,,,832,,,832,,0.0,0,832.0,832.0,,Malignant,17,,43,,,,33260.0,,,832.0,832,,,,,832,,,832.0,,,,,,,,WITH TUMOR,Alive,-20802,,,,258.0,,832.0,832,,,[Not Available],[Not Applicable],,,,,0.15,,,,,10,,0,0.12029,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3QK,,,,,,,832,,,,,,,,,10,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,56.0,,,,,,,,,,,,,,,,,,,,87408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-A494,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,3.69,0.81,3,11,8,,,481,,481,481,,0,0,481,481,,Malignant,22,,22,,,,29173,,,481,481,,,,481,481,,,481,,,,,,,,TUMOR FREE,Alive,-22540,,,,314,,481,481,,,[Not Available],[Not Applicable],,,,,0.1,,,,,23,,1,0.067338,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A494,,,,,,,481,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87409,,-1.104584831,,,,,,,,,,0.058547713,,0.112566737,,,,Stage IB,,0.8085,,,,,,,,,,,,,,,,0.0218,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,,,,-0.978133633,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.0745,,-2.1166,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-NC-A5HN,White,LUSC,,0,0,,Washington University - CHUV,0,0,MALE,0,3.11,0.82,10,17,24,,,1499,,1499,1499,,0,0,1499,1499,,Malignant,51,,148,,,,29164,,,1499,1499,,,,1499,1499,,,1499,,,,,,,,TUMOR FREE,Alive,-28151,,,,807,,1499,1499,,,[Not Available],[Not Applicable],,,,,0.28,,,,,13,,1,0.27902,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HN,,,,,,,1499,,,,,,,,,36,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,87411,,0.06708304,,,,,,,,,,0.073806728,,-0.010729346,,,,Stage IIA,,0.943,,,,,,,,,,,,,,,,-0.189,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.45233649,13.41936233,15.76159814,-0.547840570939179,LUSC,Squamous Cell Carcinoma,17.62702617,14.94882991,Squamous Cell Carcinoma,-1.5586,11.63356285,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-34-5232,Black or African American,LUSC,,0,0,,University of Pittsburgh,0,0,FEMALE,0,1.99,0.29,5,3,2,,,2471,,2471,2471,,0,0,2471,2471,,Malignant,10,,8,,,,32442,,,2471,2471,,,,2471,2471,,,2471,,,,,,,,TUMOR FREE,Alive,-27633,,,,273,,2471,2471,,,[Not Available],[Not Applicable],,,,,0.12,,,,,7,,0,0.15492,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-5232,,,,,,,2471,,,,,,,,,5,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,87413,,1.840495709,,,,,,,,,,0.173984478,,0.072837555,,,,Stage IIA,,1.1695,,,,,,,,,,,,,,,,0.2631,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.51168299,15.47219448,16.13897881,-0.0593888819811548,LUSC,Squamous Cell Carcinoma,18.27543399,17.00609782,Squamous Cell Carcinoma,-0.5705,13.98049006,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,2.11,0.67,2,1,3,,,3945,BRCA_LumA,3945,3945,,2,2,3945,3945,,Invasive Carcinoma,6,,4,,,,28282,0,,3945,3945,,,,3945,3945,,,3945,,,,,,,,,Dead,-19802,3945,,,30,,3945,3945,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.02365,Indeterminate (neither Pre or Postmenopausal),,,"Other, specify",,,,,,[Not Available],,Duke,,TCGA-B6-A0X0,,,,,,,,,,,,,,,,4,,,,,,,,,,,,,1996,,,,,Stage I,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,87414,,-0.323205112,0,0,0,0,0.347,1,,,Other,0.06447936,,0.074407114,0,0,0,,Negative,-1.311,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0092,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Low Grade), DCIS (Solid, Low Grade), Comedonecrosis",,"DCIS (Cribriform, Low Grade), DCIS (Solid, Low Grade)",0,DCIS with Microinvasive Carcinoma,DCIS with Microinvasive Carcinoma,0,None,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.13,0.96,1,0,3,,,3456,BRCA_LumA,3456,3456,,0,0,3456,3456,,Invasive Carcinoma,4,,2,,,,28874,0,,3456,3456,,,,3456,3456,,,3456,,,,,,,,TUMOR FREE,Alive,-26466,,,,0,,3456,3456,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,5,,0,0.015827,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,MSKCC,,TCGA-AO-A125,,,,,,,3456,,,,,,,,,4,,,,,,,,,,,,,2002,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,87415,,-2.20528384,0,0,0,0,0.5746,1,,,Other,0.023185836,,0.110955358,0,0,0,,Negative,-1.188,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3862,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Suboptimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-A4YT,White,STAD,,0,0,,,0,0,,0,2.08,0.76,19,29,23,,,434,,434,434,,0,0,434,434,,Malignant,71,,89,,,,30869,,,434,434,,,,434,434,,,434,,,,,,,,TUMOR FREE,Alive,-20742,,,,417,,434,434,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,3,,0,0.24498,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-A4YT,,,,,,,434,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,87418,,-0.349571886,,,,,,,,,,-0.013147673,Grade 2,0.040733792,,,,Stage IIIA,,-0.2105,,,,,,,,,,,,,,,,-0.0129,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A4YT,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.58,0.71,7,16,19,,,858,BRCA_Basal,858,858,,0,0,858,858,,Invasive Carcinoma,42,,258,,,,24836,0,,858,858,,,,858,858,,,858,,,,,,,,TUMOR FREE,Alive,-15780,,,,50,,858,858,,,[Not Available],[Not Applicable],,,,,0.44,Breast,Core Biopsy,,,21,,1,0.60766,[Unknown],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A6VO,,,,,,,858,,,,,,,,,32,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,87419,TRUE,,0,0,0,0,-0.2798,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-BL-A5ZZ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.31,0.38,4,5,4,,,377,,242,377,,1.0,1,242.0,242.0,,Malignant,13,,19,,,,25445.0,,,242.0,242,,,,242,377,,,242.0,,,,,,,,WITH TUMOR,Alive,-29247,,,,231.0,,242.0,242,,,[Not Available],[Not Applicable],,,,,0.11,,,,,9,,0,0.028636,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Christiana Healthcare,,TCGA-BL-A5ZZ,,,,,,,377,Lung,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2012,242,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,80.0,,,,,,,,,,,,,,,,,,,,87421,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-NK-A5CX,White,LUSC,,0,0,,Washington University - Rush University,,0,MALE,0,4.72,0.51,0,6,6,,,111,,,111,,0,0,111,111,,Malignant,12,,2,,,,19325,,,111,111,,,,,111,,,111,,,,,,,,TUMOR FREE,Alive,-26879,,,,223,,111,111,,,[Not Available],[Not Applicable],,,,,0.4,,,,,17,,2,1.55e-05,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Rush University,,TCGA-NK-A5CX,,,,,,,111,,,,,,,,,59,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,87422,,0.767650638,,,,,,,,,,0.206348869,,0.044062768,,,,Stage IIA,,1.203,,,,,,,,,,,,,,,,0.7904,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.49733259,16.21648821,16.97065226,-0.109749810395891,LUSC,Squamous Cell Carcinoma,17.91083124,16.12521258,Squamous Cell Carcinoma,0.4928,13.46737225,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-49-4512,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,4.56,0.32,4,9,12,,,905,,,905,,1,1,905,905,,Malignant,25,,37,,,,24504,,,905,905,,,,,905,,,905,,,,,,,,WITH TUMOR,Dead,-25502,905,,,58,,905,905,,,[Not Available],[Not Applicable],,,,,0.24,,,,,27,,2,0.36924,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4512,,,,,,,157,,,,,,,,,48,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,87424,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98542375,16.9089662,11.37952049,-0.399506954,LUAD,,18.11303383,14.40690717,Adenocarcinoma,,13.80128998,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-BR-8059,White,STAD,,0,0,,,2,2,,2,2.18,0.37,8,23,16,,,439,,439,439,,2,2,439,439,,Malignant,47,,48,,,,19309,,,439,439,,,,439,439,,,439,,,,,,,,TUMOR FREE,Dead,-26474,439,,,1011,,439,439,,,[Not Available],[Not Applicable],,,,,0.35,Stomach,Unknown,,,3,,0,0.21642,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8059,,,,,,,,,,,,,,,,13,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,87428,,-0.369050871,,,,,,,,,,0.080105085,Grade 3,0.130249838,,,,Stage III,,-0.876,,,,,,,,,,,,,,,,0.7066,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8059,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-EJ-5503,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.0,0.9,0,0,0,HRP,NO,1391,1-ERG,1391,1391,,0,0,1391,1391,prad_tcga,Malignant,0,,0,18.4,TCGA-EJ-5503-01,0,5268,0,TCGA-EJ-5503,1391,1391,Prostate Cancer,,530,1391,1391,TCGA,,1391,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-18395,,50,8,5,PRAD,1391,1391,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,5,627b9ff8-2557-4470-824a-b76a8bcd1e9f,0,Normal (no evidence of prostate cancer) [cM0],0,0.0,[Not Available],aa252f78-ebf3-42f9-86af-bb6e57345706,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,0.8,TCGA-EJ-5503,0:DiseaseFree,4,0,Prostate Adenocarcinoma,45.7,3/30/12,1391,,,,,NO,C61,81ca6538-6023-4e21-bd59-0b248e5642ac,,0,TUMOR FREE,0.0002,0:LIVING,0.1,4,45.7,Bilateral,1,No Evidence of Extraprostatic Extension,31,YES,,2010,,,TCGA-EJ-5503.81ca6538-6023-4e21-bd59-0b248e5642ac.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,31,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.0,50,Core needle biopsy,,,YES,NO,YES,,T3a,,8,No,,0,N0,T2b,0,M0,C61.9,8550/3,87435,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-7726,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,4.09,0.26,7,3,14,,,652,,652,652,,0,0,652,652,,Malignant,24,,34,,,,19196,,,652,652,,,,652,652,,,652,,,,,,,,TUMOR FREE,Alive,-26451,,,,145,,652,652,,,[Not Available],[Not Applicable],,,,,0.4,,,,,21,,2,0.30021,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7726,,,,,,,652,,,,,,,,,62,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,87438,,0.588833301,,,,,,,,,,0.218938442,,0.153316928,,,,Stage IA,,-0.2825,,,,,,,,,,,,,,,,0.9292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.416113537,LUAD,,,,Adenocarcinoma,1.9443,,-0.8322,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.86,0.63,6,3,10,,,584,BRCA_Basal,584,584,,0,0,584,584,,Invasive Carcinoma,19,,41,,,,25918,0,,584,584,,,,584,584,,,584,,,,,,,,TUMOR FREE,Alive,-14954,,,,76,,584,584,,,[Not Available],[Not Applicable],,,,,0.47,Breast,Resection/Excision,,,10,,0,0.3001,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SP,,,,,,,584,,,,,,,,,14,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,87439,TRUE,0.636858499,0,0,0,0,-0.4701,1,,,Infiltrating Ductal Carcinoma,0.213098048,,0.096517773,0,0,0,,Negative,-0.1245,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2128,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, High Grade), Stromal Alterations",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Female,TCGA-56-7731,White,LUSC,,0,0,,International Genomics Consortium,,2,FEMALE,2,1.84,0.17,1,0,3,,,3,,,3,,2,2,3,3,,Malignant,4,,6,,,,28189,,,3,3,,,,,3,,,3,,,,,,,,TUMOR FREE,Dead,-24441,3,,,431,,3,3,,,[Not Available],[Not Applicable],,,,,0.5,,,,,9,,0,0.19614,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7731,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,66,,,,,,,,,,,,,,,,,,,,87443,,0.804617157,,,,,,,,,,0.264816934,,0.193514031,,,,Stage IB,,0.9275,,,,,,,,,,,,,,,,0.8751,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.335806271986701,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.5931,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-99-8025,Black or African American,LUAD,,0,0,,Washington University - Alabama,0,0,FEMALE,0,4.47,0.43,9,12,23,,,1060,,1060,1060,,0,0,1060,1060,,Malignant,44,,44,,,,22323,,,1060,1060,,,,1060,1060,,,1060,,,,,,,,TUMOR FREE,Alive,-26634,,,,619,,1060,1060,,,[Not Available],[Not Applicable],,,,,0.33,,,,,18,,2,0.33639,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Alabama,,TCGA-99-8025,,,,,,,1060,,,,,,,,,56,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,87457,,0.236378484,,,,,,,,,,0.166009044,,0.187123655,,,,Stage IIIA,,0.183,,,,,,,,,,,,,,,,0.4813,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13C (driver),,1,,G13C (driver),,15.00342392,14.78768697,15.15962775,-0.51824761,LUAD,Adenocarcinoma,18.18976063,14.92094839,Adenocarcinoma,0.4928,13.08903805,-1.1126,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.8,0.22,9,6,6,,,30,BRCA_Her2,30,30,,0,0,30,30,,Invasive Carcinoma,21,,23,,,,16189,1,,30,30,,,,30,30,,,30,,,,,,,,TUMOR FREE,Alive,-20940,,,,312,,30,30,,,[Not Available],[Not Applicable],,,,,0.39,Not Specific/Unknown,Resection/Excision,,,14,,0,0.35396,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A0A7,,,,,,,30,,,,,,,,,15,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,87470,,1.919349824,0,0,0,0,-0.3826,1,,,Infiltrating Lobular Carcinoma,0.252199939,,0.157214987,0,0,0,,Negative,1.68,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.3644,0,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Female,TCGA-22-4596,White,LUSC,,0,0,,Mayo Clinic - Rochester,,2,FEMALE,2,2.19,0.69,0,5,7,,,17,,,17,,2,2,17,17,,Malignant,12,,4,,,,19473,,,17,17,,,,,17,,,17,,,,,,,,TUMOR FREE,Dead,-25448,17,,,181,,17,17,,,[Not Available],[Not Applicable],,,,,0.76,,,,,6,,0,0.000233,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4596,,,,,,,17,,,,,,,,,7,,,,,,,,,,,,,2002,,,,,Stage IB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,87471,,1.460037881,,,,,,,,,,0.285016435,,0.216972588,,,,Stage IB,,2.2755,,,,,,,,,,,,,,,,0.5297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.167724202915987,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.1717,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-33-6738,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.88,0.53,10,3,14,,,1927,,1927,1927,,0,0,1927,1927,,Malignant,27,,24,,,,16747,,,1927,1927,,,,1927,1927,,,1927,,,,,,,,TUMOR FREE,Alive,-29368,,,,451,,1927,1927,,,[Not Available],[Not Applicable],,,,,0.4,,,,,17,,0,0.32942,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-6738,,,,,,,1927,,,,,,,,,18,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,87473,,0.424244383,,,,,,,,,,0.145310983,,0.036680618,,,,Stage IIIA,,-0.053,,,,,,,,,,,,,,,,0.1559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R362Q,1,,,R362Q,14.01092638,14.28981816,14.00501863,-0.628474808874668,LUSC,,17.94689144,14.92918619,Squamous Cell Carcinoma,-0.9431,11.92790784,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GU-AATQ,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.4,0.75,10,13,14,,,213,,,213,,1.0,1,213.0,213.0,,Malignant,37,,91,,,,33833.0,,,213.0,213,,,,,213,,,213.0,,,,,,,,WITH TUMOR,Dead,-25185,213,,,232.0,,213.0,213,,,[Not Available],[Not Applicable],,,,,0.23,,,,,15,,1,0.22333,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-AATQ,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2013,,,,,Stage III,,,,,,,,Stable Disease,,,,,,68.0,,,,,,,,,,,,,,,,,,,,87479,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.72,0.81,14,9,12,,,10,BRCA_LumA,10,10,,0,0,10,10,,Invasive Carcinoma,35,,60,,,,25715,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-19794,,,,23,,10,10,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,8,,0,0.33375,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0XT,,,,,,,10,,,,,,,,,9,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,87481,,-0.523481443,0,0,0,0,0.2523,1,,,Infiltrating Ductal Carcinoma,0.084783704,,0.283846657,0,0,0,,Negative,-0.8165,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0198,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-MP-A4TI,White,LUAD,,1,1,,Washington University - Mayo Clinic,,1,MALE,1,2.11,0.22,12,19,13,,,429,,,429,,1,1,84,84,,Malignant,44,,84,,,,26687,,,84,84,,,,,429,,,84,,,,,,,,WITH TUMOR,Dead,-26565,429,,,342,,84,84,,,[Not Available],[Not Applicable],,,,,0.55,,,,,7,,0,0.2496,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TI,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2010,84,,,,Stage IIA,,,,,,,,[Unknown],,,,,,72,,,,,,,,,,,,,,,,,,,,87488,,1.535086053,,,,,,,,,,0.281421079,,0.169910081,,,,Stage IIA,,2.493,,,,,,,,,,,,,,,,0.6742,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,17.61124687,19.13821583,18.50648568,0.300273942,LUAD,Adenocarcinoma,18.29287078,17.53465724,Adenocarcinoma,1.5092,13.92119006,1.1761,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-S2-AA1A,Black or African American,LUAD,,0,0,,Albert Einstein Medical Center,0,0,FEMALE,0,2.41,0.32,5,4,3,,,513,,513,513,,0,0,513,513,,Malignant,12,,42,,,,16776,,,513,513,,,,513,513,,,513,,,,,,,,TUMOR FREE,Alive,-24903,,,,157,,513,513,,,[Not Available],[Not Applicable],,,,,0.2,,,,,15,,0,0.098629,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Albert Einstein Medical Center,,TCGA-S2-AA1A,,,,,,,513,,,,,,,,,17,,,,,,,,,,,,,2013,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,87491,,1.484514081,,,,,,,,,,0.234611579,,0.229397272,,,,Stage IA,,1.2285,,,,,,,,,,,,,,,,0.5467,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.012406967,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.6131,,0.5593,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.29,1,2,2,,,2197,BRCA_LumA,2197,2197,,0,0,2197,2197,,Invasive Carcinoma,5,,4,,,,17965,1,,2197,2197,,,,2197,2197,,,2197,,,,,,,,TUMOR FREE,Alive,-19767,,,,36,,2197,2197,,,[Not Available],[Not Applicable],,,,,0.02,Not Specific/Unknown,Resection/Excision,,,3,,0,0.051196,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BO,,,,,,,2197,,,,,,,,,2,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,87492,,-0.394858522,0,0,0,0,1.3562,1,,,Infiltrating Ductal Carcinoma,0.186437295,,0.293902293,0,0,0,,Negative,1.1715,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6476,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,87494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-ZA-A8F6,White,STAD,,0,0,,,0,0,,0,2.18,0.4,2,1,2,,,525,,525,525,,0,0,525,525,,Malignant,5,,32,,,,32002,,,525,525,,,,525,525,,,525,,,,,,,,TUMOR FREE,Alive,-26122,,,,64,,525,525,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,7,,0,0.029456,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Candler,,TCGA-ZA-A8F6,,,,,,,525,,,,,,,,,5,,,,,,,,,,,,,2013,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,87496,,0.268726652,,,,,,,,,,0.180667163,Grade 2,0.132045178,,,,Stage IB,,-0.1175,,,,,,,,,,,,,,,,0.2674,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-ZA-A8F6,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.09,0.7,4,9,6,,,0,BRCA_Her2,0,0,,0,0,0,0,,Invasive Carcinoma,19,,34,,,,26225,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,,,,,214,,0,0,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,2,,0,0.076038,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12T,,,,,,,0,,,,,,,,,3,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,87497,,-0.036603895,0,0,0,0,-0.309,1,,,Infiltrating Ductal Carcinoma,0.169102663,,0.124234215,0,0,0,,Negative,-0.1645,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6589,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67R,,PRAD,,0,0,,J4,0,0,MALE,0,2.0,0.2,0,0,0,HRP,NO,910,,910,910,,0,0,910,910,prad_tcga,Malignant,0,,5,,TCGA-J4-A67R-01,0,5478,0,TCGA-J4-A67R,910,910,Prostate Cancer,,454,910,910,TCGA,,910,Primary,0,Middle|Base,A,,,True,TUMOR FREE,Alive,-23807,,65,7,21,PRAD,910,910,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.0,Prostate,Resection,4,42268A74-CFD1-4724-A8C6-4E9B977F1FBE,0,,0,0.000241,[Not Available],DB2779F6-8FE2-48C3-988B-81DB1815A678,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,J4,1.0,TCGA-J4-A67R,0:DiseaseFree,3,0,Prostate Adenocarcinoma,29.89,8/16/13,910,,,,,,C61,EAFE4CB1-BB7F-4D26-851D-49ECE5A73750,80,0,TUMOR FREE,0.0,0:LIVING,0.1,,29.89,Bilateral,1,,,YES,440,2012,,,TCGA-J4-A67R.EAFE4CB1-BB7F-4D26-851D-49ECE5A73750.pdf,Peripheral Zone,[Not Applicable],,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,87504,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-64-1678,White,LUAD,,0,0,,Fox Chase,0,0,FEMALE,0,,,,,,,,1189,,1189,1189,,0,0,1189,1189,,Malignant,,,,,,,29743,,,1189,1189,,,,1189,1189,,,1189,,,,,,,,TUMOR FREE,Alive,-25931,,,,0,,1189,1189,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-1678,,,,,,,1189,,,,,,,,,,,,,,,,,,,,,,2006,,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,87505,,-0.509622158,,,,,,,,,,0.109800998,,0.029797311,,,,Unknown,,-0.896,,,,,,,,,,,,,,,,-0.6174,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.672592364,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.1795,,-0.4026,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-EJ-7115,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.93,0.59,4,5,1,HRP,NO,2687,5-SPOP,2687,2687,,0,0,2687,2687,prad_tcga,Malignant,10,BRCA2,53,3.6,TCGA-EJ-7115-01,11,5294,0,TCGA-EJ-7115,2687,2687,Prostate Cancer,,204,2687,2687,TCGA,,2687,Primary,1,,A,,,,TUMOR FREE,Alive,-23986,,65,7,56,PRAD,2687,2687,WHITE,0.148840543,[Not Available],[Not Applicable],44,R0,1,Matched,0.01,Prostate,Resection,4,2202513c-380f-453c-824c-881296ab638c,1,Normal (no evidence of prostate cancer) [cM0],0,0.066724,[Not Available],c606918f-e8c0-4019-ad6f-47d5cd7615c4,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,10,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,2.13333333333,TCGA-EJ-7115,0:DiseaseFree,3,10,Prostate Adenocarcinoma,88.27,4/5/12,2687,,,,,NO,C61,1638ac15-f8d6-4c88-b91e-e21033ae09db,,1,TUMOR FREE,0.0616,0:LIVING,0.1,2,88.27,Bilateral,12,No Evidence of Extraprostatic Extension,10,YES,,2006,,,TCGA-EJ-7115.1638ac15-f8d6-4c88-b91e-e21033ae09db.pdf,,[Not Applicable],YES,10,11-20%,21,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.9,65,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,87507,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A632,,PRAD,308,0,0,,HC,,0,MALE,0,1.9,0.71,7,11,7,ambiguous,NO,61,1-ERG,,61,,0,0,61,61,prad_tcga,Malignant,25,BRCA2;RAD51B;RAD54L,78,2.2,TCGA-HC-A632-01,0,5450,0,TCGA-HC-A632,61,61,Prostate Cancer,,,,61,TCGA,,61,Primary,0,,A,,,False,TUMOR FREE,Alive,-24916,,68,9,43,PRAD,61,61,,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.11,Prostate,Resection,4,95E3E4D5-393D-418C-A3A9-2EC8D0AD14B3,3,,0,0.13185,[Not Available],E457EB5D-120E-41F4-8455-2ED8D534FF02,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,HC,1.26666666667,TCGA-HC-A632,0:DiseaseFree,5,31,Prostate Adenocarcinoma,2.0,10/15/13,61,,,,,,C61,9EF1E09B-C468-4A42-917E-365F88055077,30,2,TUMOR FREE,0.1546,0:LIVING,,,2.0,Bilateral,38,,,YES,85,2013,,,TCGA-HC-A632.9EF1E09B-C468-4A42-917E-365F88055077.pdf,,[Not Applicable],,,81-90%,5,Prostate Adenocarcinoma Acinar Type,1,2013,[Unknown],,NO,No,R0,,68,Core needle biopsy,,,YES,NO,YES,NO,T3a,,9,No,,0,N0,T1c,0,M0,C61.9,8140/3,87508,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,Black or African American,BRCA,,0,0,,,2,2,FEMALE,2,,,,,,,,320,,320,320,,2,2,320,320,,Invasive Carcinoma,,,,,,,17913,1,,320,320,,,,320,320,,,320,,,,,,,,TUMOR FREE,Dead,-27731,320,,,0,,320,320,,,[Not Available],[Not Applicable],,,,,,Not Specific/Unknown,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A42T,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,87511,,0.310674489,0,0,0,0,-0.8325,1,,,Infiltrating Lobular Carcinoma,0.117141193,,0.115806583,0,0,0,,Negative,0.34,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2253,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,1191,,1191,1191,,0,0,1191,1191,,None,,,,,,,18467,N/A (Non-Malignant),,1191,1191,,,,1191,1191,,,1191,,,,,,,,TUMOR FREE,Alive,-23980,,,,115,,1191,1191,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0B4,,,,,,,1191,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,87515,,0.56876916,0,0,0,0,-0.1653,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.144449426,N/A (Non-Malignant),0.261040871,0,0,0,N/A (Non-Malignant),Negative,0.177,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.5018,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-BR-A44T,White,STAD,,1,1,,,1,0,,1,2.01,0.64,0,0,0,,,1038,,682,1038,,1,1,682,682,,Malignant,0,,10,,,,16608,,,682,682,,,,682,1038,,,682,,,,,,,,WITH TUMOR,Alive,-19407,,,,28,,682,682,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,0,,0,0.0020084,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A44T,,,,,,,1038,,Locoregional Recurrence,,,,,,,0,,,,,,,,,,,,,2012,682,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,87520,,1.498886759,,,,,,,,,,0.091633682,Grade 3,0.12516067,,,,Stage IIA,,1.438,,,,,,,,,,,,,,,,-0.0307,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A44T,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.44,0.82,14,17,28,,,2654,BRCA_Basal,2654,2654,,0,0,2654,2654,,Invasive Carcinoma,59,,559,,,,26945,0,,2654,2654,,,,2654,2654,,,2654,,,,,,,,TUMOR FREE,Alive,-17474,,,,76,,2654,2654,,,[Not Available],[Not Applicable],,,,,0.25,Breast,Resection/Excision,,,17,,1,0.51747,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04U,,,,,,,2654,,,,,,,,,45,,,,,,,,,,,,,2004,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,87523,TRUE,-0.776353432,0,0,0,0,0.9201,1,,,Infiltrating Ductal Carcinoma,0.11897769,,0.102195859,0,0,0,,Negative,-1.6655,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0542,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.58,6,5,11,,,519,BRCA_LumB,519,519,,0,0,519,519,,Invasive Carcinoma,22,,45,,,,16432,0,,519,519,,,,519,519,,,519,,,,,,,,TUMOR FREE,Alive,-13243,,,,64,,519,519,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,7,,0,0.17018,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27N,,,,,,,519,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,36,,,,,,,,,,,,,,,,,,,,87532,,0.114583649,0,0,0,0,-0.1176,1,,,Infiltrating Ductal Carcinoma,0.207054268,,0.158397026,0,0,0,,Negative,-0.573,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5478,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,706,,706,706,,0,0,706,706,,Invasive Carcinoma,,,,,,,27737,0,,706,706,,,,706,706,,,706,,,,,,,,TUMOR FREE,Alive,-28416,,,,0,,706,706,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A4S0,,,,,,,706,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,87538,,-1.445968946,0,0,0,0,-0.9906,1,,,Mucinous Carcinoma,0.099905477,,0.152448004,0,0,0,,Negative,-1.3925,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.118,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2800,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.07,0.52,16,10,20,,,1492,,,1492,,0,0,1492,1492,,Malignant,46,,167,,,,23017,,,1492,1492,,,,,1492,,,1492,,,,,,,,TUMOR FREE,Alive,-25810,,,,266,,1492,1492,,,[Not Available],[Not Applicable],,,,,0.55,,,,,22,,1,0.49035,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2800,,,,,,,1492,,,,,,,,,26,,,,,,,,,,,,,2004,,,,,Stage IIIB,,,,,,,,[Not Applicable],,,,,,70,,,,,,,,,,,,,,,,,,,,87541,,0.481234321,,,,,,,,,,0.258696469,,0.076783307,,,,Stage IIIB,,0.59,,,,,,,,,,,,,,,,0.3851,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.41596628,17.46574283,14.9500466,-0.331911872382614,LUSC,Squamous Cell Carcinoma,17.68285411,15.66102832,Squamous Cell Carcinoma,0.0968,15.90091297,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7314,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.6,2,0,3,HRD,NO,1150,1-ERG,1150,1150,,0,0,1150,1150,prad_tcga,Malignant,5,,19,6.1,TCGA-EJ-7314-01,0,5297,0,TCGA-EJ-7314,1150,1150,Prostate Cancer,,295,1150,1150,TCGA,,1150,Primary,0,Apex|Middle|Base,A,CHEK2:319:I/NX:frameshift_variant,,,TUMOR FREE,Alive,-22766,,62,7,45,PRAD,1150,1150,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.07,Prostate,Resection,4,89fb9220-8f32-4030-91ee-b02264995f6d,1,,0,0.028267,[Not Available],88c87cce-4361-499c-9e3a-e9d9040af2db,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.1,TCGA-EJ-7314,0:DiseaseFree,3,5,Prostate Adenocarcinoma,37.78,4/5/12,1150,,,,,NO,C61,bbd6fa31-f4d4-4c06-aa64-1e263ccd8844,,2,TUMOR FREE,0.0268,0:LIVING,0.1,5,37.78,Bilateral,5,No Evidence of Extraprostatic Extension,14,YES,,2011,,,TCGA-EJ-7314.bbd6fa31-f4d4-4c06-aa64-1e263ccd8844.pdf,,[Not Applicable],YES,,41-50%,14,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,62,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,87542,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.91,2,2,2,,,371,BRCA_LumA,371,371,,0,0,371,371,,In Situ Carcinoma,6,,3,,,,33132,0,,371,371,,,,371,371,,,371,,,,,,,,TUMOR FREE,Alive,-28178,,,,31,,371,371,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,2,,0,0.029197,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JS,,,,,,,371,,,,,,,,,2,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,87543,,-1.543975451,0,0,0,0,0.5268,1,,,Other,0.075826969,,0.09396694,0,0,0,,Negative,-1.617,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.552,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Solid, Low Grade)",0,None,None,0,None,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.78,0.58,22,22,21,,,666,BRCA_LumB,666,666,,0,0,666,666,,None,65,,146,,,,27217,N/A (Non-Malignant),,666,666,,,,666,666,,,666,,,,,,,,TUMOR FREE,Alive,-21762,,,,124,,666,666,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,9,,0,0.45118,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A4S3,,,,,,,666,,,,,,,,,20,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,87544,,1.07110023,0,0,0,0,-1.7147,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.13533802,N/A (Non-Malignant),0.077657843,0,0,0,N/A (Non-Malignant),Negative,0.6795,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0917,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-E7-A97P,Asian,BLCA,,0.0,0,,,2,2,MALE,2.0,2.01,0.45,4,3,5,,,437,,437,437,,2.0,2,437.0,437.0,,Malignant,12,,61,,,,26578.0,,,437.0,437,,,,437,437,,,437.0,,,,,,,,TUMOR FREE,Dead,-26956,437,,,286.0,,437.0,437,,,[Not Available],[Not Applicable],,,,,0.18,,,,,2,,0,0.12026,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A97P,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,87545,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-66-2757,,LUSC,,1,,,Indivumed,,1,FEMALE,1,1.86,0.86,11,5,13,,,1338,,,1338,,1,,912,912,,Malignant,29,,35,,,,18470,,,912,,,,,,1338,,,912,,,,,,,,WITH TUMOR,Dead,-24014,1338,,,338,,912,,,,[Not Available],[Not Applicable],,,,,0.19,,,,,13,,0,0.36144,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2757,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2007,912,,,,Stage IA,,,,,,,,[Not Applicable],,,,,,65,,,,,,,,,,,,,,,,,,,,87549,,0.69480736,,,,,,,,,,0.156375861,,0.07315161,,,,Stage IA,,0.95,,,,,,,,,,,,,,,,0.0602,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.219831355163915,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.0827,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,,1,1,Male,TCGA-33-4586,White,LUSC,,1,1,,Johns Hopkins,1,,MALE,1,3.27,0.42,11,5,17,,,428,,169,428,,1,1,169,169,,Malignant,33,,46,,,,21207,,,169,169,,,,169,428,,,169,,,,,,,,,Dead,-21148,428,,,489,,169,169,,,[Not Available],[Not Applicable],,,,,0.2,,,,,21,,1,0.4552,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4586,,,,,,,,,Locoregional Recurrence,,,,,,,21,,,,,,,,,,,,,2007,169,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,87550,,-0.491504213,,,,,,,,,,0.14867182,,0.024610456,,,,Stage IIIA,,0.91,,,,,,,,,,,,,,,,0.4063,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.37155358,14.68105913,14.41155811,-0.627503212363471,LUSC,Squamous Cell Carcinoma,17.45258513,14.61924389,Squamous Cell Carcinoma,-0.2244,12.60923639,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-60-2725,White,LUSC,,0,0,,Roswell Park,0,0,MALE,0,1.73,0.35,14,2,10,,,816,,816,816,,0,0,816,816,,Malignant,26,,111,,,,19016,,,816,816,,,,816,816,,,816,,,,,,,,TUMOR FREE,Alive,-27073,,,,197,,816,816,,,[Not Available],[Not Applicable],,,,,0.27,,,,,10,,0,0.35926,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2725,,,,,,,816,,,,,,,,,15,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,87551,,1.237197021,,,,,,,,,,0.288778515,,0.16110355,,,,Stage IB,,1.9775,,,,,,,,,,,,,,,,0.4976,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0825246237340953,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4727,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-49-AAR4,Black or African American,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,1.84,0.22,10,4,7,,,879,,,879,,1,1,879,879,,Malignant,21,,87,,,,20281,,,879,879,,,,,879,,,879,,,,,,,,WITH TUMOR,Dead,-18939,879,,,743,,879,879,,,[Not Available],[Not Applicable],,,,,0.48,,,,,7,,0,0.2316,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AAR4,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,51,,,,,,,,,,,,,,,,,,,,87554,,1.98699211,,,,,,,,,,0.226217119,,0.082364106,,,,Stage IIIA,,2.1265,,,,,,,,,,,,,,,,0.5072,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.01848505,17.03111869,17.66915475,0.093445581,LUAD,,18.35314242,17.81600794,Adenocarcinoma,0.6777,13.76650629,2.5338,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-C4-A0F1,,BLCA,,0.0,0,,,,0,MALE,0.0,,,,,,,,89,,,89,,0.0,0,89.0,89.0,,Malignant,,,,,,,19192.0,,,89.0,89,,,,,89,,,89.0,,,,,,,,TUMOR FREE,Alive,-26178,,,,243.0,,89.0,89,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Indivumed,,TCGA-C4-A0F1,,,,,,,89,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage III,,,,,,,,[Not Available],,,,,,71.0,,,,,,,,,,,,,,,,,,,,87559,,,,,,,,,Redacted,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-NC-A5HQ,White,LUSC,,0,0,,Washington University - CHUV,2,,MALE,2,2.87,0.5,8,14,15,,,448,,448,448,,2,2,448,448,,Malignant,37,,108,,,,24322,,,448,448,,,,448,448,,,448,,,,,,,,,Dead,-25781,448,,,453,,448,448,,,[Not Available],[Not Applicable],,,,,0.09,,,,,17,,1,0.26551,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HQ,,,,,,,,,,,,,,,,41,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,87562,,0.992851479,,,,,,,,,,0.135334121,,0.023323178,,,,Stage IIIA,,1.9615,,,,,,,,,,,,,,,,0.0505,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.89072834,15.28853262,16.26491258,-0.251064307006343,LUSC,Squamous Cell Carcinoma,17.97685044,16.09419302,Squamous Cell Carcinoma,-0.646,13.93243427,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-ZF-AA4R,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.15,0.66,9,11,13,,,1036,,,1036,,1.0,1,750.0,750.0,,Malignant,33,,78,,,,25738.0,,,750.0,750,,,,,1036,,,750.0,,,,,,,,WITH TUMOR,Dead,-24537,1036,,,84.0,,750.0,750,,,[Not Available],[Not Applicable],,,,,0.32,,,,,8,,0,0.22669,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA4R,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,14,,,,,,,,,,,,,2008,750,,,,Stage IV,,,,,,,,[Unknown],,,,,,67.0,,,,,,,,,,,,,,,,,,,,87566,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-56-7822,Black or African American,LUSC,,1,,,International Genomics Consortium,,1,MALE,1,3.75,0.31,9,8,17,,,532,,,532,,1,,301,301,,Malignant,34,,20,,,,16181,,,301,,,,,,532,,,301,,,,,,,,WITH TUMOR,Dead,-27755,532,,,490,,301,,,,[Not Available],[Not Applicable],,,,,0.11,,,,,22,,1,0.30344,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7822,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,2011,301,,,,Stage IIB,,,,,,,,[Unknown],,,,,,75,,,,,,,,,,,,,,,,,,,,87569,,-0.124839537,,,,,,,,,,0.184668454,,0.100939149,,,,Stage IIB,,-0.412,,,,,,,,,,,,,,,,0.5223,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.12337851,15.96571491,13.47000581,-0.684112764974716,LUSC,,18.00422721,15.20117046,Squamous Cell Carcinoma,1.285,14.80567872,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-G2-A2EC,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,,,,,,,,696,,,696,,1.0,1,679.0,679.0,,Malignant,,,,,,,19026.0,,,679.0,679,,,,,696,,,679.0,,,,,,,,WITH TUMOR,Dead,-21215,696,,,244.0,,679.0,679,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,679,small bowel,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,87570,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.78,0.52,7,4,7,,,3203,BRCA_LumA,3203,3203,,0,0,3203,3203,,Invasive Carcinoma,18,,19,,,,23880,0,,3203,3203,,,,3203,3203,,,3203,,,,,,,,TUMOR FREE,Alive,-19027,,,,31,,3203,3203,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,19,,1,0.096842,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24V,,,,,,,3203,,,,,,,,,22,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,87573,,0.199579402,0,0,0,0,-1.237,1,,,Infiltrating Ductal Carcinoma,0.211449654,,0.143560592,0,0,0,,Negative,0.3045,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7175,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,TCGA-E2-A572,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1208,,1208,1208,,0,0,1208,1208,,Invasive Carcinoma,,,,,,,21982,0,,1208,1208,,,,1208,1208,,,1208,,,,,,,,TUMOR FREE,Alive,-26399,,,,40,,1208,1208,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A572,,,,,,,1208,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,87578,,-0.76844955,0,0,0,0,,0,,,,0.097017181,,0.097486317,0,0,1,,Negative,-1.215,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3809,1,0,H & E,0,0,,0,Jeffrey Eisenstein,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Solid, Intermediate Grade), Microcalcifications",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Papilloma,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-77-A5G8,Unknown,LUSC,,0,0,,Prince Charles Hospital,,0,MALE,0,3.26,0.44,10,11,20,,,1884,,,1884,,0,0,1884,1884,,Malignant,41,,62,,,,27458,,,1884,1884,,,,,1884,,,1884,,,,,,,,,Alive,-25921,,,,290,,1884,1884,,,[Not Available],[Not Applicable],,,,,0.31,,,,,21,,1,0.38914,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5G8,,,,,,,1884,,,,,,,,,36,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Unknown],,,,,,70,,,,,,,,,,,,,,,,,,,,87581,,0.507258557,,,,,,,,,,0.183565046,,0.024632928,,,,Stage IIB,,1.0595,,,,,,,,,,,,,,,,0.4635,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.44955841,16.22827967,15.98687425,-0.399786435960367,LUSC,Squamous Cell Carcinoma,17.99217257,15.22456352,Squamous Cell Carcinoma,-0.0638,13.81185098,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Female,TCGA-49-AARE,Black or African American,LUAD,,1,1,,Johns Hopkins,1,1,FEMALE,1,2.78,0.42,9,11,15,,,1229,,388,1229,,1,1,388,388,,Malignant,35,,93,,,,28055,,,388,388,,,,388,1229,,,388,,,,,,,,WITH TUMOR,Dead,-18893,1229,,,1937,,388,388,,,[Not Available],[Not Applicable],,,,,0.08,,,,,17,,1,0.27372,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AARE,,,,,,,,,Locoregional Recurrence,,,,,,,35,,,,,,,,,,,,,1999,388,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,87582,,0.711755505,,,,,,,,,,0.160827078,,0.072999482,,,,Stage IA,,0.365,,,,,,,,,,,,,,,,0.2642,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,"V155F (driver), KEAP1-EYA2",1,,,V155F (driver),,,,-0.408684806,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.4562,,-0.0162,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,1.6,0.51,6,12,14,,,8605,BRCA_Basal,3076,8605,,1,1,3076,3076,,Invasive Carcinoma,32,,37,,,,16805,0,,3076,3076,,,,3076,8605,,,3076,,,,,,,,TUMOR FREE,Alive,-14920,,,,70,,3076,3076,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,12,,0,0.54707,Indeterminate (neither Pre or Postmenopausal),,,"Other, specify",,,,,,[Not Available],,Duke,,TCGA-B6-A0RU,,,,,,,8605,"Other, specify",New Primary Tumor,,,,,,,14,,,,,,,,,,,,,1990,3076,Right Breast,,,Stage IA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,87583,,0.033876787,0,0,0,0,0.2537,1,,,Other,0.122238755,,0.210676572,0,0,0,,Negative,-1.403,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3113,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-R5-A7O7,White,STAD,,0,0,,,,0,,0,3.87,0.2,14,12,20,,,1389,,,1389,,0,0,1389,1389,,Malignant,46,,174,,,,24391,,,1389,1389,,,,,1389,,,1389,,,,,,,,TUMOR FREE,Alive,-18984,,,,158,,1389,1389,,,[Not Available],[Not Applicable],,,,,0.21,Stomach,Unknown,,,22,,2,0.38246,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,MD Anderson Cancer Center,,TCGA-R5-A7O7,,,,,,,1389,,,,,,,,,68,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,87585,,,,,,,,,,,,,Grade 2,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-R5-A7O7,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-85-A512,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.73,0.77,15,14,19,,,465,,465,465,,0,0,465,465,,Malignant,48,,138,,,,21932,,,465,465,,,,465,465,,,465,,,,,,,,TUMOR FREE,Alive,-16811,,,,211,,465,465,,,[Not Available],[Not Applicable],,,,,0.09,,,,,10,,0,0.45122,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A512,,,,,,,465,,,,,,,,,18,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,46,,,,,,,,,,,,,,,,,,,,87588,,-0.20472457,,,,,,,,,,0.1501529,,0.044293104,,,,Stage IIA,,-0.2255,,,,,,,,,,,,,,,,0.2088,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,14.85718428,14.67453605,15.01244706,-0.643000113273102,LUSC,Squamous Cell Carcinoma,18.07190001,15.32149202,Squamous Cell Carcinoma,0.0817,14.32348735,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.87,0.55,7,4,7,,,2372,BRCA_LumA,2372,2372,,0,0,2372,2372,,Invasive Carcinoma,18,,15,,,,21651,0,,2372,2372,,,,2372,2372,,,2372,,,,,,,,TUMOR FREE,Alive,-22656,,,,44,,2372,2372,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,6,,0,0.16472,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DE,,,,,,,2372,,,,,,,,,6,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,87592,,0.339022114,0,0,0,0,0.3322,1,,,Infiltrating Ductal Carcinoma,0.192043788,,0.289036077,0,0,0,,Negative,-0.0465,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.515,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,87603,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.77,2,1,4,,,2263,BRCA_LumA,2263,2263,,0,0,2263,2263,,Invasive Carcinoma,7,,12,,,,23981,0,,2263,2263,,,,2263,2263,,,2263,,,,,,,,TUMOR FREE,Alive,-23021,,,,57,,2263,2263,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,4,,0,0.045977,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0ER,,,,,,,2263,,,,,,,,,3,,,,,,,,,,,,,2005,,,,,Stage IB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,87605,,-0.15685324,0,0,0,0,-0.4634,1,,,Infiltrating Ductal Carcinoma,0.106588408,,0.120521298,0,0,0,,Negative,-1.127,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1537,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.99,0.67,15,20,19,,,1063,BRCA_LumA,,1063,,0,0,1063,1063,,Invasive Carcinoma,54,,31,,,,30125,0,,1063,1063,,,,,1063,,,1063,,,,,,,,TUMOR FREE,Alive,-18936,,,,76,,1063,1063,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,7,,0,0.26134,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1R2,,,,,,,1063,,,,,,,,,15,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,87607,,0.774037404,0,0,0,0,0.1623,1,,,Infiltrating Ductal Carcinoma,0.104769322,,0.179239908,0,0,0,,Positive,0.531,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.308,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Micropapillary, Intermediate Grade), Comedonecrosis",,"DCIS (Micropapillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-8091,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.06,0.6,5,4,5,,,600,,600,600,,0,0,600,600,,Malignant,14,,14,,,,16715,,,600,600,,,,600,600,,,600,,,,,,,,TUMOR FREE,Alive,-27385,,,,30,,600,600,,,[Not Available],[Not Applicable],,,,,0.36,,,,,9,,0,0.27599,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8091,,,,,,,600,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,87611,,0.895407161,,,,,,,,,,0.261484034,,0.175751111,,,,Stage IB,,1.4725,,,,,,,,,,,,,,,,0.7018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.015883166,LUAD,,,,Adenocarcinoma,1.7377,,-0.5878,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-67-3770,White,LUAD,,0,0,,St Joseph's Medical Center (MD),,0,FEMALE,0,,,,,,,,610,,,610,,0,0,610,610,,Malignant,,,,,,,32241,,,610,610,,,,,610,,,610,,,,,,,,TUMOR FREE,Alive,-25658,,,,286,,610,610,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-3770,,,,,,,610,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,87612,,-0.009027777,,,,,,,,,,0.283457164,,0.109985383,,,,Stage IA,,0.539,,,,,,,,,,,,,,,,-0.2334,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.083752049,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3917,,-0.2394,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A2I4,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.82,0.29,6,10,9,,,4343,,4343,4343,,0.0,0,4343.0,4343.0,,Malignant,25,,19,,,,23336.0,,,4343.0,4343,,,,4343,4343,,,4343.0,,,,,,,,TUMOR FREE,Alive,-29037,,,,1231.0,,4343.0,4343,,,[Not Available],[Not Applicable],,,,,0.39,,,,,17,,1,0.22878,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A2I4,,,,,,,4343,,,,,,,,,36,,,,,,,,,,,,,2001,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,79.0,,,,,,,,,,,,,,,,,,,,87618,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A7DU,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.67,0.84,1,2,4,,,28,,28,28,,0.0,0,28.0,28.0,,Malignant,7,,13,,,,27269.0,,,28.0,28,,,,28,28,,,28.0,,,,,,,,TUMOR FREE,Alive,-27000,,,,372.0,,28.0,28,,,[Not Available],[Not Applicable],,,,,0.14,,,,,15,,1,0.058976,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,Asterand,,TCGA-E7-A7DU,,,,,,,28,,,,,,,,,15,,,,,,,,,,,,,2013,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,87619,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.5,2,4,6,,,414,BRCA_LumA,414,414,,0,0,414,414,,Invasive Carcinoma,12,,15,,,,20759,0,,414,414,,,,414,414,,,414,,,,,,,,TUMOR FREE,Alive,-23883,,,,368,,414,414,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,5,,0,0.10402,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HP,,,,,,,414,,,,,,,,,7,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,87620,,0.255660705,0,0,0,0,0.3527,1,,,Infiltrating Lobular Carcinoma,0.151880613,,0.251219613,0,0,0,,Negative,-0.25,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4307,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A677,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,2.04,0.86,4,3,4,,,820,,820,820,,0.0,0,820.0,820.0,,Malignant,11,,25,,,,30020.0,,,820.0,820,,,,820,820,,,820.0,,,,,,,,TUMOR FREE,Alive,-29613,,,,327.0,,820.0,820,,,[Not Available],[Not Applicable],,,,,0.07,,,,,3,,0,0.0417,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,Asterand,,TCGA-E7-A677,,,,,,,820,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,81.0,,,,,,,,,,,,,,,,,,,,87626,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,424,,424,424,,0,0,424,424,,Invasive Carcinoma,,,,,,,29302,0,,424,424,,,,424,424,,,424,,,,,,,,TUMOR FREE,Alive,-22536,,,,112,,424,424,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1PD,,,,,,,424,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,87630,,-0.849752328,0,0,0,0,1.0107,1,,,Infiltrating Ductal Carcinoma,0.160084892,,0.268161544,0,0,0,,Negative,-1.1165,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.5634,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Skin",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.85,0.26,12,11,12,,,408,BRCA_Normal,408,408,,0,0,408,408,,Invasive Carcinoma,35,,71,,,,28525,0,,408,408,,,,408,408,,,408,,,,,,,,TUMOR FREE,Alive,-17921,,,,71,,408,408,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,8,,0,0.30732,Peri (6-12 months since last menstrual period),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A8HR,,,,,,,408,,,,,,,,,11,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,87633,,0.863165896,0,0,0,0,0.2378,1,,,Infiltrating Lobular Carcinoma,0.184831249,,0.308737922,0,0,0,,Negative,0.2865,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6262,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-55-7816,White,LUAD,,1,1,,,,1,FEMALE,1,,,,,,,,468,,,468,,1,1,468,468,,Malignant,,,,,,,18305,,,468,468,,,,,468,,,468,,,,,,,,WITH TUMOR,Dead,-18170,468,,,4,,468,468,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,,,TCGA-55-7816,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,49,,,,,,,,,,,,,,,,,,,,87634,,0.945275333,,,,,,,,,,0.27490209,,0.27262837,,,,Stage IV,,1.353,,,,,,,,,,,,,,,,0.4759,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.65157845,18.57198395,17.22750882,0.068561689,LUAD,Adenocarcinoma,18.03277831,15.90195657,Adenocarcinoma,,13.64900839,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Female,TCGA-49-4505,White,LUAD,,1,1,,Johns Hopkins,1,1,FEMALE,1,3.02,0.45,5,12,13,,,428,,417,428,,1,1,417,417,,Malignant,30,,24,,,,18359,,,417,417,,,,417,428,,,417,,,,,,,,WITH TUMOR,Dead,-22628,428,,,285,,417,417,,,[Not Available],[Not Applicable],,,,,0.51,,,,,20,,1,0.21126,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4505,,,,,,,,,Distant Metastasis|New Primary Tumor,,,,,,,29,,,,,,,,,,,,,1996,417,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87638,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,0.4168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.88383404,16.93429577,16.71465036,0.043107766,LUAD,,18.35721897,15.87671745,Adenocarcinoma,,14.43486803,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-BR-A4PE,White,STAD,,0,0,,,0,0,,0,3.42,0.55,4,6,12,,,621,,621,621,,0,0,621,621,,Malignant,22,,98,,,,17980,,,621,621,,,,621,621,,,621,,,,,,,,TUMOR FREE,Alive,-24986,,,,278,,621,621,,,[Not Available],[Not Applicable],,,,,0.15,Stomach,Unknown,,,16,,1,0.21767,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-A4PE,,,,,,,621,,,,,,,,,33,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,87639,,,,,,,,,,,,,Grade 2,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4PE,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,996,,996,996,,0,0,996,996,,Invasive Carcinoma,,,,,,,28691,1,,996,996,,,,996,996,,,996,,,,,,,,TUMOR FREE,Alive,-22772,,,,0,,996,996,,,[Not Available],[Not Applicable],,,,,,Lymph Node,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A441,,,,,,,996,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,87641,TRUE,1.693730856,0,0,0,0,0.4157,1,,,Infiltrating Ductal Carcinoma,0.137844927,,0.168474914,0,0,0,,Negative,1.271,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2692,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,1,0,Resection/Excision,Optimal,0,Lymph Node,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Lymph Node,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.5,0.69,6,7,11,,,607,BRCA_LumB,607,607,,0,0,607,607,,Invasive Carcinoma,24,,56,,,,21512,0,,607,607,,,,607,607,,,607,,,,,,,,TUMOR FREE,Alive,-14976,,,,67,,607,607,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,21,,1,0.093112,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08G,,,,,,,607,,,,,,,,,29,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,87644,,0.546381513,0,0,0,0,0.5496,1,,,Infiltrating Ductal Carcinoma,0.143520147,,0.093122201,0,0,0,,Negative,-0.0925,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2496,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-AA3C,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.97,0.56,3,3,4,,,211,,,211,,1.0,1,211.0,211.0,,Malignant,10,,69,,,,20804.0,,,211.0,211,,,,,211,,,211.0,,,,,,,,WITH TUMOR,Dead,-24267,211,,,336.0,,211.0,211,,,[Not Available],[Not Applicable],,,,,0.0,,,,,2,,0,0.14536,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3C,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,[Unknown],,,,,,66.0,,,,,,,,,,,,,,,,,,,,87647,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5515,White,PRAD,91,0,0,,EJ,0,0,MALE,0,,,,,,,NO,1832,8-other,1832,1832,,0,0,1832,1832,prad_tcga,Malignant,,,,4.8,TCGA-EJ-5515-01,0,5279,0,TCGA-EJ-5515,1832,1832,Prostate Cancer,,1061,1832,1832,TCGA,,1832,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-22097,,60,7,13,PRAD,1832,1832,WHITE,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,,Prostate,Resection,3,5fba6e4a-3d7d-478e-afa6-e66c816e7852,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],19cf56b2-a85b-43e7-971f-5680b9b1a67a,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.0,TCGA-EJ-5515,0:DiseaseFree,2,,Prostate Adenocarcinoma,60.18,4/3/12,1832,,,,,NO,C61,1029ba11-efb4-42b7-871c-c97192a40e12,,,TUMOR FREE,0.0,0:LIVING,0.1,4,60.18,Right,,No Evidence of Extraprostatic Extension,30,YES,,2009,,,TCGA-EJ-5515.1029ba11-efb4-42b7-871c-c97192a40e12.pdf,,[Not Applicable],YES,30,71-80%,20,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.4,60,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,87649,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Female,TCGA-ZF-AA5H,White,BLCA,,1.0,1,,,,0,FEMALE,1.0,2.87,0.58,13,12,18,,,897,,,897,,1.0,1,177.0,177.0,,Malignant,43,,98,,,,33448.0,,,177.0,177,,,,,897,,,177.0,,,,,,,,WITH TUMOR,Alive,-22122,,,,90.0,,177.0,177,,,[Not Available],[Not Applicable],,,,,0.32,,,,,16,,1,0.25363,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA5H,,,,,,,897,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,38,,,,,,,,,,,,,2012,177,peritoneum,,,Stage IV,,,,,,,,Stable Disease,,,,,,60.0,,,,,,,,,,,,,,,,,,,,87651,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-44-2656,White,LUAD,,0,0,,Christiana Healthcare,0,0,MALE,1,3.13,0.32,15,18,18,,,1429,,1429,1429,,0,0,568,568,,Malignant,51,,167,,,,16953,,,1429,1429,,,,1429,1429,,,568,,,,,,,,TUMOR FREE,Alive,-21766,,,,980,,1429,1429,,,[Not Available],[Not Applicable],,,,,0.27,,,,,16,,1,0.34781,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-2656,,,,,,,1429,,New Primary Tumor,,,,,,,31,,,,,,,,,,,,,2009,568,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,87654,,1.317027669,,,,,,,,,,0.27990904,,0.175077313,,,,Stage IB,,2.3645,,,,,,,,,,,,,,,,0.1308,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.235635142,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.211,,1.7409,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GV-A3QG,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.13,0.46,4,11,9,,,,,,,,1.0,1,84.0,84.0,,Malignant,24,,7,,,,33967.0,,,84.0,84,,,,,,,,84.0,,,,,,,,WITH TUMOR,Dead,-23847,,,,121.0,,84.0,84,,,[Not Available],[Not Applicable],,,,,0.21,,,,,2,,0,0.082983,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3QG,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,6,,,,,,,,,,,,,2011,84,Brain,,,Stage IV,,,,,,,,[Not Applicable],,,,,,65.0,,,,,,,,,,,,,,,,,,,,87656,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,0,1,1,Male,TCGA-22-5472,White,LUSC,,1,,,Mayo Clinic - Rochester,1,2,MALE,1,1.81,0.65,3,1,3,,,1975,,746,1975,,1,,746,746,,Malignant,7,,7,,,,28044,,,746,,,,,746,1975,,,746,,,,,,,,TUMOR FREE,Dead,-24482,1975,,,530,,746,,,,[Not Available],[Not Applicable],,,,,0.36,,,,,8,,0,0.22819,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5472,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2005,746,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,87661,,-0.526548585,,,,,,,,,,0.21275346,,0.158296848,,,,Stage IB,,-0.0275,,,,,,,,,,,,,,,,0.371,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.542987228441612,LUSC,,,,Squamous Cell Carcinoma,-0.601,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-BR-7959,White,STAD,,0,0,,,0,0,,0,2.84,0.41,9,10,16,,,1010,,1010,1010,,0,0,1010,1010,,Malignant,35,,192,,,,21034,,,1010,1010,,,,1010,1010,,,1010,,,,,,,,TUMOR FREE,Alive,-21730,,,,128,,1010,1010,,,[Not Available],[Not Applicable],,,,,0.19,Stomach,Unknown,,,16,,1,0.48609,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,Asterand,,TCGA-BR-7959,,,,,,,1010,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,87662,,0.039447642,,,,,,,,,,0.113962406,Grade 3,0.156979911,,,,Stage IIIA,,0.0505,,,,,,,,,,,,,,,,0.7475,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7959,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0,0,0,0,0,Male,TCGA-EJ-7793,White,PRAD,221,0,0,,EJ,0,0,MALE,0,2.0,0.3,0,0,0,HRP,NO,114,1-ERG,114,114,,0,0,114,114,prad_tcga,Malignant,0,,5,3.0,TCGA-EJ-7793-01,0,5330,0,TCGA-EJ-7793,114,114,Prostate Cancer,,114,114,114,TCGA,,114,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-17982,,49,7,10,PRAD,114,114,WHITE,0.0,[Not Available],[Not Applicable],24,R0,1,Matched,0.0,Prostate,Resection,3,11ce16b7-6cf6-416d-ac47-089c813cc34c,0,,0,0.0031313,[Not Available],da07da37-bde6-480a-a302-98683ae3931a,4,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.8,TCGA-EJ-7793,0:DiseaseFree,2,0,Prostate Adenocarcinoma,3.75,4/9/12,114,,,,,NO,C61,c9d3d69c-f362-454f-a8ff-cbda4d713c41,,0,TUMOR FREE,0.0031,0:LIVING,0.1,4,3.75,Bilateral,2,,,YES,,2011,,,TCGA-EJ-7793.c9d3d69c-f362-454f-a8ff-cbda4d713c41.pdf,,[Not Applicable],NO,,31-40%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.3,49,Core needle biopsy,,,YES,NO,NO,,T2c,,7,No,,0,,T2c,,M0,C61.9,8550/3,87666,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.5,0.78,2,1,2,,,2989,BRCA_LumA,2989,2989,,0,0,2989,2989,,Invasive Carcinoma,5,,3,,,,25551,0,,2989,2989,,,,2989,2989,,,2989,,,,,,,,TUMOR FREE,Alive,-23150,,,,0,,2989,2989,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,17,,1,0.025363,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A12B,,,,,,,2989,,,,,,,,,13,,,,,,,,,,,,,2004,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,87669,,-0.842487428,0,0,0,0,-0.4398,1,,,Infiltrating Ductal Carcinoma,0.096699625,,0.131821064,0,0,0,,Negative,-0.7935,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.4307,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-86-8359,White,LUAD,,0,0,,Asterand,,2,MALE,2,3.19,0.44,10,17,17,,,444,,,444,,2,2,444,444,,Malignant,44,,70,,,,25677,,,444,444,,,,,444,,,444,,,,,,,,TUMOR FREE,Dead,-19088,444,,,218,,444,444,,,[Not Available],[Not Applicable],,,,,0.25,,,,,12,,1,0.22671,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8359,,,,,,,,,,,,,,,,37,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,52,,,,,,,,,,,,,,,,,,,,87676,,1.599541902,,,,,,,,,,0.125745827,,0.087796023,,,,Stage IIIA,,1.2695,,,,,,,,,,,,,,,,0.4472,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,14.8089663,15.16989807,16.39645534,-0.101072159,LUAD,Adenocarcinoma,18.27401156,17.10305787,Adenocarcinoma,-0.0814,12.83818135,1.7907,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Female,TCGA-CD-8524,Asian,STAD,,1,1,,,1,0,,1,2.85,0.38,6,13,13,,,388,,69,388,,1,1,69,69,,Malignant,32,,219,,,,24049,,,69,69,,,,69,388,,,69,,,,,,,,WITH TUMOR,Alive,-22445,,,,196,,69,69,,,[Not Available],[Not Applicable],,,,,0.15,Stomach,Unknown,,,12,,1,0.4023,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8524,,,,,,,388,,Locoregional Recurrence,,,,,,,31,,,,,,,,,,,,,2010,69,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87680,,0.473800685,,,,,,,,,,0.081574129,Grade 3,0.148511849,,,,Stage II,,-0.0105,,,,,,,,,,,,,,,,0.4283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8524,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,0,0,1,Male,TCGA-22-4607,White,LUSC,,0,0,,Mayo Clinic - Rochester,,2,MALE,2,1.82,0.63,4,3,7,,,587,,,587,,2,2,587,587,,Malignant,14,,90,,,,16860,,,587,587,,,,,587,,,587,,,,,,,,TUMOR FREE,Dead,-27601,587,,,74,,587,587,,,[Not Available],[Not Applicable],,,,,0.02,,,,,11,,0,0.31134,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4607,,,,,,,587,,,,,,,,,10,,,,,,,,,,,,,2003,,,,,Stage IB,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,87686,,-0.107551094,,,,,,,,,,0.172117337,,0.097224274,,,,Stage IB,,0.1865,,,,,,,,,,,,,,,,0.3419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,AMP,1,,,,,,,-0.328108303275796,LUSC,,,,Squamous Cell Carcinoma,0.8152,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Female,TCGA-49-4505,White,LUAD,,1,1,,Johns Hopkins,1,1,FEMALE,1,3.02,0.45,5,12,13,,,428,,417,428,,1,1,417,417,,Malignant,30,,24,,,,18359,,,417,417,,,,417,428,,,417,,,,,,,,WITH TUMOR,Dead,-22628,428,,,285,,417,417,,,[Not Available],[Not Applicable],,,,,0.51,,,,,20,,1,0.21126,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4505,,,,,,,,,Distant Metastasis|New Primary Tumor,,,,,,,29,,,,,,,,,,,,,1996,417,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87691,,1.263360709,,,,,,,,,,0.2425526,,0.19873492,,,,Stage IIB,,1.482,,,,,,,,,,,,,,,,0.4168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.88383404,16.93429577,16.71465036,0.043107766,LUAD,,18.35721897,15.87671745,Adenocarcinoma,0.374,14.43486803,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-EJ-5512,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.36,2,5,0,HRD,NO,1733,1-ERG,1733,1733,,0,0,1733,1733,prad_tcga,Malignant,7,,22,6.1,TCGA-EJ-5512-01,0,5277,0,TCGA-EJ-5512,1733,1733,Prostate Cancer,,782,1733,1733,TCGA,,1733,Primary,0,Apex|Middle|Base,A,,BARD1,,TUMOR FREE,Alive,-17127,,46,7,23,PRAD,1733,1733,WHITE,0.0,[Not Available],[Not Applicable],28,R0,1,Matched,0.0,Prostate,Resection,3,d0b41403-8458-45e1-946e-21054fba65b8,0,,0,0.032474,[Not Available],c28f931f-5ab2-4899-9fe9-54024f082d92,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,0.966666666667,TCGA-EJ-5512,0:DiseaseFree,2,11,Prostate Adenocarcinoma,56.93,4/3/12,1733,,,,,,C61,8b273389-2655-4ac1-bcf0-b64505fe7b3d,,0,TUMOR FREE,0.0309,0:LIVING,0.0,3,56.93,Bilateral,13,,,YES,,2009,,,TCGA-EJ-5512.8b273389-2655-4ac1-bcf0-b64505fe7b3d.pdf,,[Not Applicable],,,51-60%,13,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,46,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,87692,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-BR-8296,White,STAD,,1,1,,,,1,,1,,,,,,,,474,,,474,,1,1,390,390,,Malignant,,,,,,,19988,,,390,390,,,,,474,,,390,,,,,,,,WITH TUMOR,Dead,-21527,474,,,98,,390,390,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8296,,,,,,,,Liver,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2011,390,,,,Stage IIIC,,,,,,,,Stable Disease,,,,,,58,,,,,,,,,,,,,,,,,,,,87693,,,,,,,,,,,,,Grade 3,,,,,Stage IIIC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8296,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,,,Black or African American,BRCA,,1,1,,,1,0,FEMALE,1,2.14,0.79,7,7,7,,,1545,BRCA_LumA,1210,1545,,1,1,1210,1210,,Invasive Carcinoma,21,,18,,,,25598,0,,1210,1210,,,,1210,1545,,,1210,,,,,,,,TUMOR FREE,Alive,-32583,,,,50,,1210,1210,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,8,,0,0.13114,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15O,,,,,,,1545,,Locoregional Recurrence,,,,,,,14,,,,,,,,,,,,,2010,1210,,,,Stage I,,,,,,,,[Not Available],,,,,,89,,,,,,,,,,,,,,,,,,,,87698,,0.134625668,0,0,0,0,-1.0519,1,,,Infiltrating Ductal Carcinoma,0.111390052,,0.07925049,0,0,0,,Negative,-0.1945,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0988,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.25,8,9,10,,,2559,BRCA_Her2,2559,2559,,0,0,2559,2559,,Invasive Carcinoma,27,,50,,,,18808,0,,2559,2559,,,,2559,2559,,,2559,,,,,,,,TUMOR FREE,Alive,-15593,,,,49,,2559,2559,,,[Not Available],[Not Applicable],,,,,0.43,Breast,Resection/Excision,,,8,,0,0.24953,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0B7,,,,,,,2559,,,,,,,,,14,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,87706,,1.230137914,0,0,0,0,0.4815,1,,,Infiltrating Ductal Carcinoma,0.210926681,,0.25852128,0,0,0,,Negative,0.5495,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6041,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-77-7338,White,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,1.97,0.52,9,9,9,,,5,,,5,,2,2,5,5,,Malignant,27,,22,,,,18139,,,5,5,,,,,5,,,5,,,,,,,,,Dead,-23480,5,,,177,,5,5,,,[Not Available],[Not Applicable],,,,,0.48,,,,,7,,0,0.2387,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7338,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1995,,,,,Stage IB,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,87708,,0.434419491,,,,,,,,,,0.224057556,,0.099538569,,,,Stage IB,,0.7555,,,,,,,,,,,,,,,,0.7441,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,S103Y,1,,,S103Y,,,,-0.437531850984762,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.7843,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-R6-A6L6,White,ESCA,,1,1,,,,1,,1,3.47,0.26,4,10,12,,,214,,,214,,1,1,214,214,,Malignant,26,,54,,,,24685,,,214,214,,,,,214,,,214,,,,,,,,WITH TUMOR,Dead,-25092,214,,,194,,214,214,,,[Not Available],Stage IV,,,,,0.19,Esophagus,Unknown,,,13,,1,0.17706,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,MD Anderson Cancer Center,,TCGA-R6-A6L6,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,2010,,,,,[Not Available],,,,,,,,,,,,,,68,,,,,,,,,,,,,,,,,,,,87710,,,,,,,,,,,,,Grade 3,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-85-A4PA,White,LUSC,,0,0,,Asterand,0,0,MALE,0,2.0,0.43,0,0,0,,,741,,741,741,,0,0,741,741,,Malignant,0,,16,,,,24758,,,741,741,,,,741,741,,,741,,,,,,,,TUMOR FREE,Alive,-22614,,,,9,,741,741,,,[Not Available],[Not Applicable],,,,,0.06,,,,,0,,0,0.0011379,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A4PA,,,,,,,741,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87711,,2.496041429,,,,,,,,,,0.173657984,,0.200727971,,,,Stage IB,,2.4,,,,,,,,,,,,,,,,-0.5146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0689056053666926,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-2.7237,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Female,TCGA-44-2665,White,LUAD,,0,0,,Christiana Healthcare,,0,FEMALE,0,2.09,0.43,6,7,9,,,1301,,,1301,,0,0,1301,1301,,Malignant,22,,67,,,,21065,,,1301,1301,,,,,1301,,,1301,,,,,,,,TUMOR FREE,Alive,-20349,,,,49,,1301,1301,,,[Not Available],[Not Applicable],,,,,0.02,,,,,7,,0,0.12274,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-2665,,,,,,,1301,,,,,,,,,11,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,55,,,,,,,,,,,,,,,,,,,,87715,,0.555603809,,,,,,,,,,0.293030861,,0.150910024,,,,Stage IIB,,1.09,,,,,,,,,,,,,,,,0.7397,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.12517195,17.55889405,14.52573433,-0.082052492,LUAD,Adenocarcinoma,18.21895899,15.66169016,Adenocarcinoma,2.888,14.00084316,-0.8254,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-EJ-5511,Black or African American,PRAD,91,0,0,,EJ,0,0,MALE,0,1.98,0.8,4,3,4,ambiguous,NO,1476,3-ETV4,1476,1476,,0,0,1476,1476,prad_tcga,Malignant,11,BRCA2;CHEK2,9,9.7,TCGA-EJ-5511-01,0,5276,0,TCGA-EJ-5511,1476,1476,Prostate Cancer,,788,1476,1476,TCGA,,1476,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-20409,,55,7,54,PRAD,1476,1476,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.06,Prostate,Resection,3,1da89009-5dbe-4d62-9406-36330f47b738,3,Normal (no evidence of prostate cancer) [cM0],0,0.077833,[Not Available],f8a42feb-fbc9-4a13-bad5-1dcefca2a9bf,4,Prostate Adenocarcinoma Acinar Type,2.0,Prostate,11,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.3,TCGA-EJ-5511,0:DiseaseFree,2,16,Prostate Adenocarcinoma,48.49,4/3/12,1476,,,,,NO,C61,4e4d79fc-ecc3-4533-ac69-9bdec44a080c,,3,TUMOR FREE,0.1235,0:LIVING,0.04,4,48.49,Bilateral,22,,,YES,,2009,,,TCGA-EJ-5511.4e4d79fc-ecc3-4533-ac69-9bdec44a080c.pdf,,[Not Applicable],NO,18,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.2,55,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,87716,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5501,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.93,0.37,4,6,2,ambiguous,NO,1365,2-ETV1,1365,1365,,0,0,1365,1365,prad_tcga,Malignant,12,,34,2.7,TCGA-EJ-5501-01,0,5266,0,TCGA-EJ-5501,1365,1365,Prostate Cancer,,729,1365,1365,TCGA,,1365,Primary,0,Middle|Base,A,,,,TUMOR FREE,Alive,-20409,,55,7,38,PRAD,1365,1365,WHITE,0.0,[Not Available],[Not Applicable],22,R0,1,Matched,0.0,Prostate,Resection,4,a1e37a0a-67f5-4a19-a540-a45cb89c4203,2,Normal (no evidence of prostate cancer) [cM0],0,0.073675,[Not Available],8df0c1e8-966c-4f46-ad15-fae9e745a32e,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,0.733333333333,TCGA-EJ-5501,0:DiseaseFree,3,14,Prostate Adenocarcinoma,44.84,3/30/12,1365,,,,,NO,C61,630dee46-15db-4a16-84ee-a9d25fcccb80,,3,TUMOR FREE,0.0709,0:LIVING,0.1,5,44.84,Bilateral,17,No Evidence of Extraprostatic Extension,9,YES,,2010,,,TCGA-EJ-5501.630dee46-15db-4a16-84ee-a9d25fcccb80.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,9,71-80%,11,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,1.0,55,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,87717,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,1.75,0.51,14,9,12,,,538,BRCA_LumA,,538,,1,1,396,396,,Invasive Carcinoma,35,,67,,,,17119,0,,396,396,,,,,538,,,396,,,,,,,,WITH TUMOR,Dead,-28940,538,,,61,,396,396,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,8,,0,0.33247,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1EY,,,,,,,,Lung,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2000,396,Liver,,,Stage IIA,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,87724,,1.307394935,0,0,0,0,-0.6958,1,,,Infiltrating Ductal Carcinoma,0.208061525,,0.131316675,0,0,0,,[Not Available],0.5665,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5411,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,Adipose Tissue,Comedonecrosis,"DCIS (Clinging, Intermediate Grade), Comedonecrosis",,"DCIS (Clinging, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-A4BX,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,,,,,,,,405,,405,405,,0,0,405,405,,Malignant,,,,,,,31485,,,405,405,,,,405,405,,,405,,,,,,,,TUMOR FREE,Alive,-25745,,,,161,,405,405,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-A4BX,,,,,,,405,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,87731,,-1.593723571,,,,,,,,,,0.043316966,,0.000838808,,,,Stage IIA,,-1.0735,,,,,,,,,,,,,,,,-0.3041,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.18898182,12.43637928,10.02202255,-1.38390369953412,LUSC,Squamous Cell Carcinoma,18.10167109,13.5367718,Squamous Cell Carcinoma,-3.1867,12.84699845,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-66-2768,,LUSC,,0,0,,Indivumed,,0,MALE,0,1.94,0.57,12,8,12,,,61,,,61,,0,0,61,61,,Malignant,32,,39,,,,18237,,,61,61,,,,,61,,,61,,,,,,,,TUMOR FREE,Alive,-20970,,,,372,,61,61,,,[Not Available],[Not Applicable],,,,,0.03,,,,,6,,0,0.21538,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2768,,,,,,,61,,,,,,,,,12,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,87742,,0.391973514,,,,,,,,,,0.178549438,,0.016923936,,,,Stage IIB,,1.0165,,,,,,,,,,,,,,,,0.4353,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.69550761,16.62922748,15.9610075,-0.134230475452082,LUSC,Squamous Cell Carcinoma,17.96784391,15.83979455,Squamous Cell Carcinoma,0.2429,14.78862147,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-UY-A8OB,White,BLCA,,0.0,0,,,,0,MALE,0.0,2.54,0.72,12,15,15,,,2109,,,2109,,0.0,0,2109.0,2109.0,,Malignant,42,,157,,,,20961.0,,,2109.0,2109,,,,,2109,,,2109.0,,,,,,,,TUMOR FREE,Alive,-23360,,,,431.0,,2109.0,2109,,,[Not Available],[Not Applicable],,,,,0.11,,,,,18,,1,0.3758,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A8OB,,,,,,,2109,,,,,,,,,39,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,63.0,,,,,,,,,,,,,,,,,,,,87745,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-G2-A2EJ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.09,0.61,9,4,7,,,1460,,910,1460,,1.0,1,910.0,910.0,,Malignant,20,,60,,,,25884.0,,,910.0,910,,,,910,1460,,,910.0,,,,,,,,TUMOR FREE,Alive,-20649,,,,428.0,,910.0,910,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.13654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EJ,,,,,,,1460,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2009,910,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,87747,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4512,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,4.56,0.32,4,9,12,,,905,,,905,,1,1,905,905,,Malignant,25,,37,,,,24504,,,905,905,,,,,905,,,905,,,,,,,,WITH TUMOR,Dead,-25502,905,,,58,,905,905,,,[Not Available],[Not Applicable],,,,,0.24,,,,,27,,2,0.36924,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4512,,,,,,,157,,,,,,,,,48,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,87748,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98542375,16.9089662,11.37952049,-0.399506954,LUAD,,18.11303383,14.40690717,Adenocarcinoma,,13.80128998,-1.6651,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Female,TCGA-G2-A2EC,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,,,,,,,,696,,,696,,1.0,1,679.0,679.0,,Malignant,,,,,,,19026.0,,,679.0,679,,,,,696,,,679.0,,,,,,,,WITH TUMOR,Dead,-21215,696,,,244.0,,679.0,679,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,679,small bowel,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,87754,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-43-2581,White,LUSC,,0,0,,Christiana Healthcare,0,0,FEMALE,0,3.77,0.29,4,2,11,,,1176,,1176,1176,,0,0,1176,1176,,Malignant,17,,25,,,,22545,,,1176,1176,,,,1176,1176,,,1176,,,,,,,,TUMOR FREE,Alive,-17447,,,,1294,,1176,1176,,,[Not Available],[Not Applicable],,,,,0.04,,,,,16,,1,0.17923,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-2581,,,,,,,1176,,,,,,,,,20,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,47,,,,,,,,,,,,,,,,,,,,87755,,0.871360798,,,,,,,,,,0.263560926,,0.128548343,,,,Stage IIIA,,1.497,,,,,,,,,,,,,,,,0.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,17.36906468,17.55566888,16.35022218,-0.0105836836871221,LUSC,Squamous Cell Carcinoma,17.5752896,16.12782599,Squamous Cell Carcinoma,0.4571,14.57046172,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-NJ-A4YG,White,LUAD,,0,0,,Washington University - Rush University,,0,MALE,0,2.34,0.32,3,2,7,,,2261,,,2261,,0,0,2261,2261,,Malignant,12,,43,,,,26475,,,2261,2261,,,,,2261,,,2261,,,,,,,,TUMOR FREE,Alive,-23812,,,,223,,2261,2261,,,[Not Available],[Not Applicable],,,,,0.35,,,,,7,,0,0.15435,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A4YG,,,,,,,2261,,,,,,,,,15,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,87761,,0.920500111,,,,,,,,,,0.252553388,,0.118198863,,,,Stage IB,,0.4525,,,,,,,,,,,,,,,,0.2931,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,,,,-0.27782289,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.3977,,-0.5612,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-66-2770,,LUSC,,0,0,,Indivumed,,0,MALE,0,1.66,0.64,6,4,6,,,700,,,700,,0,0,700,700,,Malignant,16,,26,,,,21269,,,700,700,,,,,700,,,700,,,,,,,,,Alive,-28945,,,,333,,700,700,,,[Not Available],[Not Applicable],,,,,0.8,,,,,8,,0,0.34482,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2770,,,,,,,700,,,,,,,,,10,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,87763,,1.082269713,,,,,,,,,,0.220643167,,0.07110306,,,,Stage IB,,2.186,,,,,,,,,,,,,,,,0.5056,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.153360191815309,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,,,,,,,,1272,,1272,1272,,2,2,1272,1272,,Invasive Carcinoma,,,,,,,28735,0,,1272,1272,,,,1272,1272,,,1272,,,,,,,,,Dead,-22942,1272,,,40,,1272,1272,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,87767,,1.134538044,0,0,0,0,0.0715,1,,,Infiltrating Lobular Carcinoma,0.185882324,,0.202290538,0,0,0,,Negative,1.033,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2862,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-18-3419,,LUSC,,0,0,,Princess Margaret Hospital (Canada),0,0,MALE,0,,,,,,,,2811,,2811,2811,,0,0,2811,2811,,Malignant,,,,,,,16144,,,2811,2811,,,,2811,2811,,,2811,,,,,,,,TUMOR FREE,Alive,-26813,,,,378,,2811,2811,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3419,,,,,,,2811,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,87777,,1.03087094,,,,,,,,,,0.157109242,,-0.011493154,,,,Stage IIB,,1.1115,,,,,,,,,,,,,,,,-0.1502,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.86103376,16.53789358,16.86346817,-0.0575654986736468,LUSC,,17.61082465,16.46962016,Squamous Cell Carcinoma,-1.3521,12.70887904,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-HC-7233,White,PRAD,184,0,0,,HC,0,0,MALE,0,2.0,0.54,0,0,0,HRP,NO,1355,8-other,1355,1355,,0,0,1355,1355,prad_tcga,Malignant,0,,3,7.7,TCGA-HC-7233-01,8,5415,0,TCGA-HC-7233,1355,1355,Prostate Cancer,,,1355,1355,TCGA,,1355,Primary,0,Apex,A,,,,TUMOR FREE,Alive,,,73,7,42,PRAD,1355,1355,WHITE,0.19989634,[Not Available],[Not Applicable],43,R1,1,Matched,0.04,Prostate,Resection,4,848c2c7b-918e-4a09-bad9-3b3d59bbc101,0,,0,0.000493,[Not Available],e2b33861-2247-413f-b2e5-9be3b604666c,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.6,HC,1.43333333333,TCGA-HC-7233,0:DiseaseFree,3,0,Prostate Adenocarcinoma,44.51,4/11/12,1355,,,,,,C61,3531e095-4042-4fc8-aa69-522b16e4e1fc,,0,WITH TUMOR,0.0009,0:LIVING,,,44.51,Left,1,,,YES,,2010,,,TCGA-HC-7233.3531e095-4042-4fc8-aa69-522b16e4e1fc.pdf,,[Not Applicable],,,66-75%,2,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,Yes,R1,0.9,73,Core needle biopsy,,,NO,YES,YES,,T2a,,7,No,,0,N0,,0,,C61.9,8550/3,87778,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-E7-A4IJ,Asian,BLCA,,1.0,1,,,1,1,MALE,1.0,5.43,0.48,13,18,24,,,674,,620,674,,1.0,1,620.0,620.0,,Malignant,55,,163,,,,18188.0,,,620.0,620,,,,620,674,,,620.0,,,,,,,,WITH TUMOR,Dead,-20723,674,,,486.0,,620.0,620,,,[Not Available],[Not Applicable],,,,,0.36,,,,,19,,2,0.35675,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A4IJ,,,,,,,,Bone,Distant Metastasis,,,,,,,58,,,,,,,,,,,,,2012,620,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,87780,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.11,0.62,10,18,16,,,385,BRCA_LumB,385,385,,0,0,385,385,,Invasive Carcinoma,44,,105,,,,30186,0,,385,385,,,,385,385,,,385,,,,,,,,TUMOR FREE,Alive,-17045,,,,70,,385,385,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,16,,1,0.28742,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12U,,,,,,,385,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,87782,,1.024446705,0,0,0,0,-0.1033,1,,,Infiltrating Ductal Carcinoma,0.092226168,,0.072278997,0,0,0,,Negative,0.337,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.5553,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Female,TCGA-44-2655,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,1,2.08,0.33,0,2,3,,,1324,,1324,1324,,0,0,1009,1009,,Malignant,5,,3,,,,21185,,,1324,1324,,,,1324,1324,,,1009,,,,,,,,TUMOR FREE,Alive,-23854,,,,201,,1324,1324,,,[Not Available],[Not Applicable],,,,,0.06,,,,,3,,0,0.07223,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-2655,,,,,,,1324,,New Primary Tumor,,,,,,,6,,,,,,,,,,,,,2009,1009,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,87785,,0.608948494,,,,,,,,,,0.219387849,,0.190117795,,,,Stage IA,,0.26,,,,,,,,,,,,,,,,-0.0925,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,S144F,1,,,S144F,,,,-0.420393772,LUAD,,,,Adenocarcinoma,-0.999,,-0.5959,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-69-7760,White,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,3.25,0.65,9,12,15,,,202,,,202,,0,0,202,202,,Malignant,36,,55,,,,22887,,,202,202,,,,,202,,,202,,,,,,,,TUMOR FREE,Alive,-26777,,,,95,,202,202,,,[Not Available],[Not Applicable],,,,,0.1,,,,,16,,1,0.2604,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7760,,,,,,,202,,,,,,,,,37,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,87786,,-0.50937115,,,,,,,,,,0.188271936,,0.031217927,,,,Stage IIB,,-0.857,,,,,,,,,,,,,,,,0.0787,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"E709_T710delinsD (driver), AMP (driver)",,,1,E709_T710delinsD (driver),,,14.63696846,15.26424474,12.712976,-0.721417344,LUAD,Adenocarcinoma,17.73290332,13.6103574,Adenocarcinoma,-0.1177,12.92274403,-1.8179,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,1,1,,,White,BRCA,,0,0,,,0,0,FEMALE,1,1.71,0.85,5,12,10,,,3807,BRCA_Basal,3807,3807,,0,0,1136,1136,,Invasive Carcinoma,27,,53,,,,18455,0,,3807,3807,,,,3807,3807,,,1136,,,,,,,,TUMOR FREE,Alive,-18991,,,,140,,3807,3807,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,8,,0,0.45751,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AH,,,,,,,3807,"Other, specify",New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2004,1136,Renal,,,Stage IIB,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,87790,,-0.519571022,0,0,0,0,0.6678,1,,,Infiltrating Ductal Carcinoma,0.075548977,,0.109609368,0,0,0,,Negative,-1.827,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0596,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,1,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skeletal Muscle",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,0,1,1,Male,TCGA-MP-A4SY,White,LUAD,,1,1,,Washington University - Mayo Clinic,1,2,MALE,1,2.07,0.35,4,9,3,,,1501,,489,1501,,1,1,489,489,,Malignant,16,,26,,,,18727,,,489,489,,,,489,1501,,,489,,,,,,,,TUMOR FREE,Dead,-22448,1501,,,207,,489,489,,,[Not Available],[Not Applicable],,,,,0.59,,,,,8,,0,0.12408,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4SY,,,,,,,,,Locoregional Recurrence,,,,,,,8,,,,,,,,,,,,,2002,489,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87791,,0.093739249,,,,,,,,,,0.248107378,,0.072485516,,,,Stage IIB,,0.8115,,,,,,,,,,,,,,,,0.6293,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,16.15425444,17.11286006,14.38913312,-0.455285773,LUAD,Adenocarcinoma,17.8379144,15.00671676,Adenocarcinoma,0.9004,13.49837048,-1.5496,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,,0,1,Female,TCGA-77-7335,White,LUSC,,0,0,,Prince Charles Hospital,,,FEMALE,2,2.07,0.41,8,6,11,,,2133,,,2133,,2,2,2133,2133,,Malignant,25,,15,,,,16389,,,2133,2133,,,,,2133,,,2133,,,,,,,,,Dead,-22863,2133,,,304,,2133,2133,,,[Not Available],[Not Applicable],,,,,0.02,,,,,10,,0,0.22642,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7335,,,,,,,,,,,,,,,,11,,,,,,,,,,,,,1996,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,87793,,1.930635082,,,,,,,,,,0.297117591,,0.213915638,,,,Stage IIIB,,1.3265,,,,,,,,,,,,,,,,0.7736,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.34490504,17.21943427,18.80856624,0.398549873114587,LUSC,Squamous Cell Carcinoma,18.27952648,17.03296426,Squamous Cell Carcinoma,1.483,12.95007056,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Female,TCGA-49-4505,White,LUAD,,1,1,,Johns Hopkins,1,1,FEMALE,1,3.02,0.45,5,12,13,,,428,,417,428,,1,1,417,417,,Malignant,30,,24,,,,18359,,,417,417,,,,417,428,,,417,,,,,,,,WITH TUMOR,Dead,-22628,428,,,285,,417,417,,,[Not Available],[Not Applicable],,,,,0.51,,,,,20,,1,0.21126,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4505,,,,,,,,,Distant Metastasis|New Primary Tumor,,,,,,,29,,,,,,,,,,,,,1996,417,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,87796,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,0.4168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.88383404,16.93429577,16.71465036,0.043107766,LUAD,,18.35721897,15.87671745,Adenocarcinoma,,14.43486803,0.8479,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.67,5,10,8,,,375,BRCA_LumA,375,375,,0,0,375,375,,Invasive Carcinoma,23,,19,,,,20349,0,,375,375,,,,375,375,,,375,,,,,,,,TUMOR FREE,Alive,-21640,,,,50,,375,375,,,[Not Available],[Not Applicable],,,,,0.53,Breast,Resection/Excision,,,3,,0,0.089312,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0XO,,,,,,,375,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,87799,,-1.495907045,0,0,0,0,0.6742,1,,,Infiltrating Ductal Carcinoma,0.125374866,,0.110561252,0,0,0,,Negative,-1.548,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6176,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,TCGA-E2-A106,Asian,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,2541,,2541,2541,,0,0,2541,2541,,In Situ Carcinoma,,,,,,,23167,0,,2541,2541,,,,2541,2541,,,2541,,,,,,,,TUMOR FREE,Alive,-12528,,,,0,,2541,2541,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A106,,,,,,,2541,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,87801,,,0,0,0,0,,1,,,,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,1,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade), Microcalcifications",,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade)",0,None,None,0,None,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.21,0.49,18,16,26,,,644,BRCA_Basal,644,644,,0,0,644,644,,Invasive Carcinoma,60,,254,,,,17210,1,,644,644,,,,644,644,,,644,,,,,,,,TUMOR FREE,Alive,-20080,,,,188,,644,644,,,[Not Available],[Not Applicable],,,,,0.12,Not Specific/Unknown,Resection/Excision,,,13,,1,0.55668,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A4SE,,,,,,,644,,,,,,,,,23,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,87808,TRUE,-0.002622394,0,0,0,0,0.0312,1,,,Infiltrating Ductal Carcinoma,0.170092024,,0.177690356,0,0,0,,Negative,-0.2445,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.6781,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.86,0.48,21,35,29,,,30,BRCA_Basal,30,30,,0,0,30,30,,Invasive Carcinoma,85,,87,,,,25294,1,,30,30,,,,30,30,,,30,,,,,,,,TUMOR FREE,Alive,-19298,,,,338,,30,30,,,[Not Available],[Not Applicable],,,,,0.53,Not Specific/Unknown,Resection/Excision,,,15,,1,0.52071,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08R,,,,,,,30,,,,,,,,,43,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,87809,TRUE,1.133225956,0,0,0,0,-1.9751,1,,,Infiltrating Ductal Carcinoma,0.217689227,,0.135520547,0,0,0,,Negative,1.082,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.2489,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Female,TCGA-XF-A9SY,White,BLCA,,1.0,1,,,,0,FEMALE,1.0,2.76,0.18,13,13,18,,,640,,,640,,1.0,1,168.0,168.0,,Malignant,44,,109,,,,32467.0,,,168.0,168,,,,,640,,,168.0,,,,,,,,WITH TUMOR,Alive,-22212,,,,551.0,,168.0,168,,,[Not Available],[Not Applicable],,,,,0.18,,,,,18,,1,0.4536,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SY,,,,,,,640,"Other, specify",Distant Metastasis,,,,,,,42,,,,,,,,,,,,,2006,168,Groin,,,Stage IV,,,,,,,,Progressive Disease,,,,,,60.0,,,,,,,,,,,,,,,,,,,,87810,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.05,0.61,11,6,16,,,362,BRCA_Her2,,362,,1,1,362,362,,Invasive Carcinoma,33,,110,,,,28314,0,,362,362,,,,,362,,,362,,,,,,,,WITH TUMOR,Dead,-22798,362,,,119,,362,362,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,11,,1,0.255,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0I9,,,,,,,,,,,,,,,,31,,,,,,,,,,,,,1992,,,,,Stage IV,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,87815,,-0.08890034,0,0,0,0,-0.1472,1,,,Infiltrating Ductal Carcinoma,0.145877042,,0.08969757,0,0,0,,[Not Available],-0.225,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.073,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,1.81,0.76,11,13,11,,,1699,BRCA_LumB,544,1699,,1,1,544,544,,Invasive Carcinoma,35,,98,,,,19247,0,,544,544,,,,544,1699,,,544,,,,,,,,WITH TUMOR,Dead,-19836,1699,,,280,,544,544,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,7,,0,0.30377,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TY,,,,,,,,Bone,Distant Metastasis,,,,,,,9,,,,,,,,,,,,,2004,544,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,87816,,-0.502234008,0,0,0,0,1.0125,1,,,Infiltrating Ductal Carcinoma,0.084088433,,0.163957305,0,0,0,,Negative,-1.0085,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1379,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,3.47,0.14,10,15,13,,,3015,BRCA_Normal,,3015,,0,0,3015,3015,,Invasive Carcinoma,38,,70,,,,30278,0,,3015,3015,,,,,3015,,,3015,,,,,,,,TUMOR FREE,Alive,-13556,,,,178,,3015,3015,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,21,,1,0.39663,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CL,,,,,,,3015,,,,,,,,,31,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,37,,,,,,,,,,,,,,,,,,,,87817,,2.157966378,0,0,0,0,-0.8441,1,,,Infiltrating Ductal Carcinoma,0.204373614,,0.236249308,0,0,0,,Positive,1.7775,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4319,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-97-A4M2,White,LUAD,,0,0,,Washington University - NYU,0,0,MALE,0,2.05,0.37,0,2,1,,,624,,624,624,,0,0,624,624,,Malignant,3,,6,,,,20482,,,624,624,,,,624,624,,,624,,,,,,,,TUMOR FREE,Alive,-24313,,,,29,,624,624,,,[Not Available],[Not Applicable],,,,,0.17,,,,,1,,0,0.000549,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4M2,,,,,,,624,,,,,,,,,2,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,87829,,0.914850439,,,,,,,,,,0.297825683,,0.233190972,,,,Stage IA,,1.2725,,,,,,,,,,,,,,,,-0.1022,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.024375217,LUAD,Adenocarcinoma,,,Adenocarcinoma,-2.0101,,0.8438,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-CH-5751,White,PRAD,91,1,1,,CH,1,0,MALE,1,2.02,0.54,10,9,7,HRD,NO,1065,8-other,365,1065,,1,1,365,365,prad_tcga,Malignant,26,BRCA1;BRIP1;CHEK2;RAD51C,97,22.6,TCGA-CH-5751-01,0,5247,0,TCGA-CH-5751,365,365,Prostate Cancer,92,1004,365,1065,TCGA,Equivocal,365,Primary,0,,A,,CDK12;RAD54L,,WITH TUMOR,Alive,-24957,,68,10,37,PRAD,365,365,WHITE,0.0,[Not Available],[Not Applicable],35,R1,1,Matched,0.6,Prostate,Resection,5,6d8ce214-3a06-4f7c-858b-709a40ebbe25,3,Equivocal,0,0.17976,[Not Available],721e76d0-4b1d-4e78-adb8-1344b8030062,5,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,26,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,CH,1.16666666667,TCGA-CH-5751,1:Recurred/Progressed,5,46,Prostate Adenocarcinoma,11.99,3/16/12,1065,Bone,Distant Metastasis,,,YES,C61,c4240096-b982-4b8a-b871-677a94cfd6cc,,6,TUMOR FREE,0.2044,0:LIVING,0.01,,34.99,Bilateral,52,Equivocal,92,YES,,2006,365,,TCGA-CH-5751.c4240096-b982-4b8a-b871-677a94cfd6cc.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,92,71-80%,3,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R1,1.0,68,Core needle biopsy,,,YES,NO,YES,,T4,,10,No,,0,N1,,1,M0,C61.9,8550/3,87836,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,,,White,BRCA,,0,0,,,,,FEMALE,2,3.38,0.7,5,12,16,,,1388,BRCA_LumB,,1388,,2,2,1388,1388,,Invasive Carcinoma,33,,62,,,,16838,0,,1388,1388,,,,,1388,,,1388,,,,,,,,,Dead,-16289,1388,,,73,,1388,1388,,,[Not Available],[Not Applicable],,,,,0.38,Breast,Resection/Excision,,,19,,1,0.1974,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FM,,,,,,,,,,,,,,,,22,,,,,,,,,,,,,1998,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,87837,,-1.101034657,0,0,0,0,0.2708,1,,,Infiltrating Ductal Carcinoma,0.171753402,,0.138469017,0,0,0,,[Not Available],-1.8575,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.144,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.67,4,2,5,,,1926,BRCA_LumA,1926,1926,,0,0,1926,1926,,Invasive Carcinoma,11,,12,,,,22620,0,,1926,1926,,,,1926,1926,,,1926,,,,,,,,TUMOR FREE,Alive,-18741,,,,28,,1926,1926,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,6,,0,0.078175,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0EI,,,,,,,1926,,,,,,,,,6,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,87845,,-0.842256374,0,0,0,0,0.1291,1,,,Infiltrating Ductal Carcinoma,0.129066818,,0.156302877,0,0,0,,Negative,-1.5435,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.7014,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Tubular),Invasive Ductal Carcinoma (Tubular),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-56-1622,White,LUSC,,1,1,,International Genomics Consortium,,1,MALE,1,1.73,0.9,18,11,17,,,881,,,881,,1,1,881,881,,Malignant,46,,65,,,,18463,,,881,881,,,,,881,,,881,,,,,,,,WITH TUMOR,Dead,-21371,881,,,314,,881,881,,,[Not Available],[Not Applicable],,,,,0.31,,,,,15,,0,0.50444,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-1622,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,87846,,-0.082055788,,,,,,,,,,0.11187114,,0.016459043,,,,Stage IB,,1.185,,,,,,,,,,,,,,,,0.4216,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.587204424190474,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.4031,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,,0.0,1.0,Male,TCGA-XF-A9T8,White,BLCA,,0.0,0,,,,,MALE,2.0,2.09,0.44,7,4,9,,,418,,,418,,2.0,2,418.0,418.0,,Malignant,20,,84,,,,30788.0,,,418.0,418,,,,,418,,,418.0,,,,,,,,,Dead,-23403,418,,,959.0,,418.0,418,,,[Not Available],[Not Applicable],,,,,0.03,,,,,3,,0,0.11633,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9T8,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,2008,,,,,Stage III,,,,,,,,[Unknown],,,,,,64.0,,,,,,,,,,,,,,,,,,,,87847,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-VQ-A8PE,White,STAD,,1.0,1,,,,1,,1.0,2.49,0.5,12,18,17,,,675,,,675,,1.0,1,265,265,,Malignant,47,,274,,,,29314.0,0,,265,265,,,,,675,,,265,,,,,,,,WITH TUMOR,Dead,-28755,675,,,162.0,,265,265,,,[Not Available],[Not Applicable],,,,,0.33,Stomach,Resection,,,10,,1,0.41776,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8PE,,,,,,,,,Locoregional Recurrence,,,,,,,39,,,,,,,,,,,,,2012,265,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,78,,,,,,,,,,,,,,,,,,,,87853,,0.726091031,,,,,,,,,,0.057998402,Grade 3,0.015554114,,,,Stage IIIB,,0.753,,,,,,,,,,,,,,,,0.1366,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PE,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Male,TCGA-BR-6454,White,STAD,,0,0,,,,0,,0,2.67,0.37,8,9,17,,,0,,,0,,0,0,0,0,,Malignant,34,,34,,,,20004,,,0,0,,,,,0,,,0,,,,,,,,,Alive,-21501,,,,188,,0,0,,,[Not Available],[Not Applicable],,,,,0.18,Stomach,Unknown,,,20,,1,0.37842,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6454,,,,,,,0,,,,,,,,,38,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,87855,,1.45332824,,,,,,,,,,0.077450552,Grade 3,0.065750178,,,,Stage IIA,,1.4895,,,,,,,,,,,,,,,,0.0163,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6454,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-49-4494,White,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,2.05,0.46,6,6,3,,,1081,,,1081,,1,1,1081,1081,,Malignant,15,,19,,,,20702,,,1081,1081,,,,,1081,,,1081,,,,,,,,WITH TUMOR,Dead,-28387,1081,,,257,,1081,1081,,,[Not Available],[Not Applicable],,,,,0.32,,,,,3,,0,0.2271,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4494,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1995,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,87858,,0.304246907,,,,,,,,,,0.209493877,,0.082018611,,,,Stage IIIA,,0.864,,,,,,,,,,,,,,,,0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), T790M (driver)",,,1,"L858R (driver), T790M (driver)",,,15.83983572,16.56385538,16.03537556,-0.171017566,LUAD,,17.59504698,15.01237642,Adenocarcinoma,,12.61159328,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-ZF-A9R9,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.76,0.82,2,7,11,,,864,,,864,,1.0,1,629.0,629.0,,Malignant,20,,19,,,,27840.0,,,629.0,629,,,,,864,,,629.0,,,,,,,,WITH TUMOR,Dead,-21491,864,,,268.0,,629.0,629,,,[Not Available],[Not Applicable],,,,,0.08,,,,,14,,1,0.086784,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9R9,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,23,,,,,,,,,,,,,2010,629,penis,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,87864,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-85-A50M,Asian,LUSC,,0,0,,Asterand,2,2,MALE,2,4.42,0.19,9,19,24,,,826,,826,826,,2,2,826,826,,Malignant,52,,108,,,,19291,,,826,826,,,,826,826,,,826,,,,,,,,TUMOR FREE,Dead,-17429,826,,,120,,826,826,,,[Not Available],[Not Applicable],,,,,0.36,,,,,19,,2,0.32805,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A50M,,,,,,,,,,,,,,,,59,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,47,,,,,,,,,,,,,,,,,,,,87866,,-0.072884105,,,,,,,,,,0.169434609,,0.090622342,,,,Stage IIA,,0.966,,,,,,,,,,,,,,,,0.8928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,14.77512552,15.93049782,13.84998667,-0.624252936071451,LUSC,Squamous Cell Carcinoma,17.85094678,15.39027521,Squamous Cell Carcinoma,0.9641,14.05474954,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,,0.0,1.0,Male,TCGA-XF-A9ST,White,BLCA,,0.0,0,,,,,MALE,2.0,4.0,0.87,8,26,27,,,128,,,128,,2.0,2,128.0,128.0,,Malignant,61,,126,,,,16391.0,,,128.0,128,,,,,128,,,128.0,,,,,,,,,Dead,-25080,128,,,765.0,,128.0,128,,,[Not Available],[Not Applicable],,,,,0.31,,,,,9,,2,0.26452,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9ST,,,,,,,,,,,,,,,,72,,,,,,,,,,,,,2005,,,,,Stage III,,,,,,,,[Unknown],,,,,,68.0,,,,,,,,,,,,,,,,,,,,87868,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,Black or African American,BRCA,,1,1,,,1,0,FEMALE,1,2.11,0.66,13,24,16,,,3204,BRCA_LumB,2989,3204,,1,1,2989,2989,,Invasive Carcinoma,53,,30,,,,28573,0,,2989,2989,,,,2989,3204,,,2989,,,,,,,,TUMOR FREE,Alive,-12601,,,,88,,2989,2989,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,5,,0,0.20625,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A25E,,,,,,,3204,"Other, specify",Locoregional Recurrence,,,,,,,19,,,,,,,,,,,,,2004,2989,Left Chest Wall,,,Stage IIIA,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,87872,,0.221251047,0,0,0,0,-0.1429,1,,,Infiltrating Ductal Carcinoma,0.130612252,,0.148965795,0,0,0,,Negative,-0.746,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0759,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Stromal Alterations,"DCIS (Cribriform, High Grade), Stromal Alterations",,"DCIS (Cribriform, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,87875,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,0.7605,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-49-6744,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,1.9,0.37,9,8,9,,,1683,,1683,1683,,0,0,1683,1683,,Malignant,26,,24,,,,19681,,,1683,1683,,,,1683,1683,,,1683,,,,,,,,TUMOR FREE,Alive,-23484,,,,273,,1683,1683,,,[Not Available],[Not Applicable],,,,,0.57,,,,,4,,0,0.16693,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6744,,,,,,,1683,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,87876,,1.498600374,,,,,,,,,,0.303678694,,0.223241471,,,,Stage IIA,,1.3335,,,,,,,,,,,,,,,,0.5446,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.81227495,17.88169462,15.96454625,0.112267588,LUAD,,18.26810023,16.55309108,Adenocarcinoma,0.727,14.17567917,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-BR-8373,White,STAD,,0.0,0,,,0,0,,0.0,2.97,0.58,7,10,8,,,450,,450,450,,0.0,0,450,450,,Malignant,25,,172,,,,32080.0,0,,450,450,,,,450,450,,,450,,,,,,,,TUMOR FREE,Alive,-23744,,,,129.0,,450,450,,,[Not Available],[Not Applicable],,,,,0.11,Stomach,Resection,,,15,,1,0.2829,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8373,,,,,,,450,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,87878,,0.101259959,,,,,,,,,,0.073104908,Grade 2,0.100901793,,,,Stage IIIA,,-0.111,,,,,,,,,,,,,,,,0.4883,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8373,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.74,0.53,15,24,19,,,0,BRCA_Basal,0,0,,0,0,0,0,,Invasive Carcinoma,58,,69,,,,19845,0,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-29463,,,,191,,0,0,,,[Not Available],[Not Applicable],,,,,0.32,Breast,Resection/Excision,,,4,,0,0.44889,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12K,,,,,,,0,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,87881,,1.558980556,0,0,0,0,-1.278,1,,,Infiltrating Ductal Carcinoma,0.240332828,,0.087210432,0,0,0,,Negative,1.434,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0942,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-85-A4CL,White,LUSC,,0,0,,Asterand,2,2,MALE,2,1.91,0.65,8,12,16,,,921,,921,921,,2,2,921,921,,Malignant,36,,144,,,,19149,,,921,921,,,,921,921,,,921,,,,,,,,TUMOR FREE,Dead,-24005,921,,,1067,,921,921,,,[Not Available],[Not Applicable],,,,,0.11,,,,,8,,0,0.30681,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A4CL,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,87888,,1.469941913,,,,,,,,,,0.156803663,,0.026719793,,,,Stage IA,,1.249,,,,,,,,,,,,,,,,0.1693,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0938123485965496,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.336,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-R5-A805,White,STAD,,1,1,,,,1,,1,1.88,0.44,14,13,15,,,281,,,281,,1,1,281,281,,Malignant,42,,163,,,,25056,,,281,281,,,,,281,,,281,,,,,,,,WITH TUMOR,Dead,-26122,281,,,160,,281,281,,,Stomach Cancer,[Not Applicable],,,,,0.01,Stomach,Unknown,,,9,,0,0.28104,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,MD Anderson Cancer Center,,TCGA-R5-A805,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2005,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,87892,,,,,,,,,,,,,Grade 3,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-R5-A805,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.81,0.61,6,5,6,,,595,BRCA_LumA,595,595,,0,0,595,595,,Invasive Carcinoma,17,,48,,,,19576,0,,595,595,,,,595,595,,,595,,,,,,,,TUMOR FREE,Alive,-22524,,,,56,,595,595,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.20194,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15P,,,,,,,595,,,,,,,,,8,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,87894,,-0.132938684,0,0,0,0,1.3775,1,,,Infiltrating Ductal Carcinoma,0.129514591,,0.195655415,0,0,0,,Negative,-0.5165,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2348,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"LCIS, Stromal Alterations",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-A8P3,White,STAD,,0,0,,,0,0,,0,2.0,0.57,0,1,1,,,1132,,1132,1132,,0,0,1132,1132,,Malignant,2,,277,,,,28894,,,1132,1132,,,,1132,1132,,,1132,,,,,,,,TUMOR FREE,Alive,-26582,,,,379,,1132,1132,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,0,,0,0.01701,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8P3,,,,,,,1132,,,,,,,,,0,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,87895,,0.683403339,,,,,,,,,,0.023384084,Grade 2,0.133175623,,,,Stage IIIA,,0.9475,,,,,,,,,,,,,,,,0.2387,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8P3,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Female,TCGA-NC-A5HR,White,LUSC,,0,0,,Washington University - CHUV,0,0,FEMALE,0,1.8,0.66,18,5,17,,,1244,,1244,1244,,0,0,1244,1244,,Malignant,40,,139,,,,18720,,,1244,1244,,,,1244,1244,,,1244,,,,,,,,TUMOR FREE,Alive,-27629,,,,437,,1244,1244,,,[Not Available],[Not Applicable],,,,,0.18,,,,,17,,0,0.48972,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HR,,,,,,,1244,,,,,,,,,18,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,87901,,0.409042133,,,,,,,,,,0.094442623,,0.042669222,,,,Stage IIA,,0.8555,,,,,,,,,,,,,,,,-0.172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.28341172,14.60022136,16.33044751,-0.453482760687343,LUSC,Squamous Cell Carcinoma,17.45509948,15.57035696,Squamous Cell Carcinoma,-1.4803,12.21965071,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-XF-A9SM,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.89,0.2,13,15,15,,,1048,,1048,1048,,0.0,0,1048.0,1048.0,,Malignant,43,,86,,,,19727.0,,,1048.0,1048,,,,1048,1048,,,1048.0,,,,,,,,TUMOR FREE,Alive,-27826,,,,317.0,,1048.0,1048,,,[Not Available],[Not Applicable],,,,,0.16,,,,,11,,1,0.28255,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SM,,,,,,,1048,,,,,,,,,34,,,,,,,,,,,,,2004,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,87906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-NJ-A4YP,White,LUAD,,0,0,,Washington University - Rush University,,0,MALE,0,4.21,0.23,3,1,4,,,50,,,50,,0,0,50,50,,Malignant,8,,24,,,,29983,,,50,50,,,,,50,,,50,,,,,,,,TUMOR FREE,Alive,-19106,,,,737,,50,50,,,[Not Available],[Not Applicable],,,,,0.07,,,,,7,,1,0.087416,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A4YP,,,,,,,50,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,52,,,,,,,,,,,,,,,,,,,,87923,,0.823315837,,,,,,,,,,0.177317171,,0.175580297,,,,Stage IB,,0.2445,,,,,,,,,,,,,,,,0.4808,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,L19F (driver),,1,,L19F (driver),,,,,-0.144003339,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.3542,,0.0394,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,532,,532,532,,0,0,532,532,,Invasive Carcinoma,,,,,,,23846,0,,532,532,,,,532,532,,,532,,,,,,,,TUMOR FREE,Alive,-22520,,,,0,,532,532,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A3U0,,,,,,,532,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,87928,TRUE,1.785307609,0,0,0,0,-1.2315,1,,,Infiltrating Ductal Carcinoma,0.213393656,,0.185923014,0,0,0,,Negative,1.7795,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5338,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (Tubular),Invasive Ductal Carcinoma (Tubular),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-73-4668,American Indian or Alaska Native,LUAD,,1,,,Roswell Park,1,0,FEMALE,1,3.19,0.53,13,5,17,,,467,,236,467,,1,,236,236,,Malignant,35,,45,,,,23145,,,236,,,,,236,467,,,236,,,,,,,,WITH TUMOR,Alive,-24255,,,,751,,236,,,,[Not Available],[Not Applicable],,,,,0.35,,,,,20,,1,0.29696,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4668,,,,,,,467,,,,,,,,,22,,,,,,,,,,,,,2009,236,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,87933,,0.011847003,,,,,,,,,,0.220190934,,0.142172557,,,,Stage IIB,,0.5595,,,,,,,,,,,,,,,,0.6224,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,15.25336514,16.3122448,14.23408416,-0.524221167,LUAD,Adenocarcinoma,17.80678433,15.23293153,Adenocarcinoma,0.7166,13.72490312,-0.3867,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-VQ-A91Z,White,STAD,,1.0,1,,,1,0,,1.0,2.87,0.77,8,17,12,,,1690,,1310,1690,,1.0,1,1310,1310,,Malignant,37,,152,,,,27591.0,0,,1310,1310,,,,1310,1690,,,1310,,,,,,,,WITH TUMOR,Alive,-24652,,,,187.0,,1310,1310,,,[Not Available],[Not Applicable],,,,,0.04,Stomach,Resection,,,22,,1,0.26164,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A91Z,,,,,,,1690,,Locoregional Recurrence,,,,,,,35,,,,,,,,,,,,,2010,1310,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,87936,,-0.66795658,,,,,,,,,,-0.033781532,Grade 2,-0.073544997,,,,Stage IIIA,,-1.26,,,,,,,,,,,,,,,,-0.2234,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91Z,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.16,0.69,2,6,3,,,3660,BRCA_LumA,3660,3660,,0,0,3660,3660,,Invasive Carcinoma,11,,9,,,,24805,0,,3660,3660,,,,3660,3660,,,3660,,,,,,,,TUMOR FREE,Alive,-14119,,,,34,,3660,3660,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.029648,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mixed Histology (please specify),,,,,,[Not Available],,Mayo,,TCGA-AR-A24M,,,,,,,3660,,,,,,,,,6,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,87941,,-1.418447399,0,0,0,0,0.5901,1,,,Mixed Histology (NOS),0.163939889,,0.170384323,0,0,0,,Negative,-1.346,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4353,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"DCIS (Solid, Low Grade), N/A No in Situ",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-64-1676,White,LUAD,,0,0,,Fox Chase,0,0,MALE,0,1.72,0.51,13,8,13,,,1728,,1728,1728,,0,0,1728,1728,,Malignant,34,,48,,,,29725,,,1728,1728,,,,1728,1728,,,1728,,,,,,,,TUMOR FREE,Alive,-21428,,,,770,,1728,1728,,,[Not Available],[Not Applicable],,,,,0.35,,,,,13,,0,0.4259,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-1676,,,,,,,1728,,,,,,,,,18,,,,,,,,,,,,,2005,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,87942,,0.567567594,,,,,,,,,,0.299849952,,0.093396321,,,,Stage IA,,1.277,,,,,,,,,,,,,,,,0.0257,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.123101399,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.8222,,0.5675,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,,1,1,Male,TCGA-77-8009,,LUSC,,1,,,Prince Charles Hospital,1,,MALE,1,5.7,0.67,16,22,26,,,1695,,607,1695,,1,,607,607,,Malignant,64,,150,,,,22631,,,607,,,,,607,1695,,,607,,,,,,,,,Dead,-25037,1695,,,216,,607,,,,[Not Available],[Not Applicable],,,,,0.28,,,,,21,,2,0.39107,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8009,,,,,,,,,,,,,,,,43,,,,,,,,,,,,,2007,607,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,87944,,0.238102243,,,,,,,,,,0.139885923,,0.024469307,,,,Stage IIB,,1.1615,,,,,,,,,,,,,,,,0.3703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,"V271L, AMP",1,,,V271L,15.44541477,15.79804166,16.20038251,-0.47844250084879,LUSC,Squamous Cell Carcinoma,17.66315825,15.04334579,Squamous Cell Carcinoma,-0.0797,13.04918317,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,87946,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.47,6,1,8,,,1321,BRCA_LumA,1321,1321,,0,0,1321,1321,,Invasive Carcinoma,15,,12,,,,19175,0,,1321,1321,,,,1321,1321,,,1321,,,,,,,,TUMOR FREE,Alive,-20717,,,,38,,1321,1321,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,9,,0,0.16682,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mixed Histology (please specify),,,,,,[Not Available],,UCSF,,TCGA-A1-A0SE,,,,,,,1321,,,,,,,,,11,,,,,,,,,,,,,2005,,,,,Stage I,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,87956,,-0.122139325,0,0,0,0,0.3437,1,,,Mixed Histology (NOS),0.107448454,,0.188016861,0,0,0,,Negative,-0.708,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5087,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-V1-A8MJ,,PRAD,370,0,0,,V1,,0,MALE,0,1.97,0.22,5,6,4,ambiguous,NO,1791,2-ETV1,,1791,,0,0,1791,1791,prad_tcga,Malignant,15,CHEK2,44,,TCGA-V1-A8MJ-01,0,5559,0,TCGA-V1-A8MJ,1791,1791,Prostate Cancer,,1230,,1791,TCGA,,1791,Primary,0,Apex,A,,,True,,Alive,-21535,,58,7,17,PRAD,1791,1791,,0.0,[Not Available],[Not Applicable],21,,1,Matched,0.01,Prostate,Resection,3,0874A870-9784-4F90-8B32-F28F575E9210,2,,0,0.082358,[Not Available],F4F81316-C99A-4A88-AA6C-E66FC5D60C53,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,V1,0.7,TCGA-V1-A8MJ,0:DiseaseFree,2,17,Prostate Adenocarcinoma,58.84,7/15/14,1791,,,,,NO,C61,5BF9CF4D-B724-4FFD-A336-ECE60FC80E0D,70,4,,0.0001,0:LIVING,0.015,,58.84,Bilateral,22,,,YES,,,,,TCGA-V1-A8MJ.5BF9CF4D-B724-4FFD-A336-ECE60FC80E0D.pdf,Peripheral Zone,[Not Applicable],NO,,41-50%,16,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,NO,No,R0,,58,Core needle biopsy,,,NO,YES,YES,YES,T3a,NO,7,No,NO,,N1,T2a,1,M0,C61.9,8140/3,87957,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-D7-6526,White,STAD,,0,0,,,0,0,,0,4.7,0.6,6,24,28,,,523,,523,523,,0,0,523,523,,Malignant,58,,55,,,,29400,,,523,523,,,,523,523,,,523,,,,,,,,TUMOR FREE,Alive,-24477,,,,273,,523,523,,,[Not Available],[Not Applicable],,,,,0.4,Stomach,Unknown,,,18,,2,0.11188,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6526,,,,,,,523,,,,,,,,,69,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,87959,,,,,,,,,,,,,Grade 2,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6526,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,1,1,Male,TCGA-44-7660,White,LUAD,,1,1,,Christiana Healthcare,,0,MALE,1,3.25,0.58,15,11,15,,,592,,,592,,1,1,253,253,,Malignant,41,,67,,,,21810,,,253,253,,,,,592,,,253,,,,,,,,WITH TUMOR,Alive,-26594,,,,485,,253,253,,,[Not Available],[Not Applicable],,,,,0.25,,,,,22,,1,0.41033,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-7660,,,,,,,592,,Locoregional Recurrence,,,,,,,18,,,,,,,,,,,,,2011,253,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,72,,,,,,,,,,,,,,,,,,,,87963,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V271M,1,,,V271M,,,,-0.458132906,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0136,,-0.8367,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-75-7030,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),0,0,MALE,0,,,,,,,,,,,,,0,0,,,,Malignant,,,,,,,25008,,,,,,,,,,,,,,,,,,,,TUMOR FREE,Alive,,,,,13,,,,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-7030,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,87967,,0.871572517,,,,,,,,,,0.241547969,,0.219442691,,,,Stage IIB,,0.8185,,,,,,,,,,,,,,,,0.992,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,15.27719171,16.42776344,14.73702775,-0.100482417,LUAD,Adenocarcinoma,18.54563679,16.59598699,Adenocarcinoma,1.4822,13.30339677,0.6482,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.77,0.69,3,6,7,,,224,BRCA_LumB,224,224,,0,0,224,224,,Invasive Carcinoma,16,,6,,,,28665,0,,224,224,,,,224,224,,,224,,,,,,,,TUMOR FREE,Alive,-27977,,,,2029,,224,224,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,9,,1,0.0472,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0AK,,,,,,,224,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,87969,,0.269362942,0,0,0,0,-1.1858,1,,,Infiltrating Ductal Carcinoma,0.100599347,,0.044904979,0,0,0,,Negative,-0.1425,,10/21/22,0,0,0,0,0,0,0,0,0,0,Minor (less than 10%) mucinous component and some micropapillary,0,0,-0.2714,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-98-A539,White,LUSC,,1,1,,Washington University - Alabama,,0,MALE,1,3.65,0.3,8,5,11,,,173,,,173,,1,1,173,173,,Malignant,24,,47,,,,17641,,,173,173,,,,,173,,,173,,,,,,,,WITH TUMOR,Alive,-23098,,,,247,,173,173,,,[Not Available],[Not Applicable],,,,,0.09,,,,,16,,1,0.22525,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A539,,,,,,,173,,Locoregional Recurrence,,,,,,,25,,,,,,,,,,,,,2011,173,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,87971,,0.30501679,,,,,,,,,,0.192190681,,0.095903064,,,,Stage IIB,,0.2405,,,,,,,,,,,,,,,,0.5871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R320Q (driver),1,,,R320Q (driver),15.3604635,17.2651663,13.77302316,-0.746047237249973,LUSC,Squamous Cell Carcinoma,18.10975782,14.79045287,Squamous Cell Carcinoma,-0.3416,14.70249379,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,87977,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-RD-A8N5,White,STAD,,0,0,,,2,2,,2,2.62,0.15,4,11,9,,,1747,,1747,1747,,2,2,1747,1747,,Malignant,24,,69,,,,19743,,,1747,1747,,,,1747,1747,,,1747,,,,,,,,TUMOR FREE,Dead,-28589,1747,,,43,,1747,1747,,,"Other, non-malignant disease",[Not Applicable],,,,,0.33,Stomach,Unknown,,,27,,1,0.30708,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G2,,Peter MacCallum Cancer Center,,TCGA-RD-A8N5,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,87979,,-0.668005719,,,,,,,,,,0.160401443,Grade 2,0.17824137,,,,Stage IIIA,,-0.5275,,,,,,,,,,,,,,,,0.7907,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A8N5,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.58,0.54,2,1,2,,,1519,BRCA_LumA,1519,1519,,0,0,1519,1519,,Invasive Carcinoma,5,,14,,,,16240,0,,1519,1519,,,,1519,1519,,,1519,,,,,,,,TUMOR FREE,Alive,-28699,,,,48,,1519,1519,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,12,,1,0.061509,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BV,,,,,,,1519,,,,,,,,,14,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,87983,,0.424102939,0,0,0,0,-0.1194,1,,,Infiltrating Ductal Carcinoma,0.157590978,,0.180423908,0,0,0,,Negative,-0.2615,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4677,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-E7-A5KF,Asian,BLCA,,0.0,0,,,,0,MALE,0.0,2.04,0.98,3,3,4,,,20,,,20,,0.0,0,20.0,20.0,,Malignant,10,,23,,,,19701.0,,,20.0,20,,,,,20,,,20.0,,,,,,,,TUMOR FREE,Alive,-24528,,,,290.0,,20.0,20,,,[Not Available],[Not Applicable],,,,,0.03,,,,,3,,0,0.050441,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,Asterand,,TCGA-E7-A5KF,,,,,,,20,,,,,,,,,2,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,[Not Available],,,,,,67.0,,,,,,,,,,,,,,,,,,,,87986,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-VQ-A91N,Unknown,STAD,,1,1,,,,1,,1,4.95,0.46,19,20,31,,,570,,,570,,1,1,438,438,,Malignant,70,,427,,,,17726,,,438,438,,,,,570,,,438,,,,,,,,WITH TUMOR,Dead,-21753,570,,,161,,438,438,,,Stomach Cancer,[Not Applicable],,,,,0.25,Stomach,Unknown,,,14,,2,0.54022,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A91N,,,,,,,,,Locoregional Recurrence,,,,,,,57,,,,,,,,,,,,,2009,438,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,87989,,0.297669816,,,,,,,,,,0.031610728,Grade 2,0.020249981,,,,Stage IV,,-0.4535,,,,,,,,,,,,,,,,-0.1362,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91N,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,0,0,0,1,,,,BRCA,,0,0,,,2,2,FEMALE,2,1.84,0.75,23,28,28,,,304,BRCA_Her2,304,304,,2,2,304,304,,Invasive Carcinoma,79,,90,,,,25669,0,,304,304,,,,304,304,,,304,,,,,,,,TUMOR FREE,Dead,-32842,304,,,314,,304,304,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,8,,0,0.49527,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08L,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,89,,,,,,,,,,,,,,,,,,,,87996,,0.920653498,0,0,0,0,-1.3315,1,,,Infiltrating Ductal Carcinoma,0.136047549,,0.140669704,0,0,0,,Negative,0.5275,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.1684,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-BR-A4CS,White,STAD,,0,0,,,2,2,,2,3.09,0.42,6,8,11,,,45,,45,45,,2,2,45,45,,Malignant,25,,124,,,,24897,,,45,45,,,,45,45,,,45,,,,,,,,TUMOR FREE,Dead,-28211,45,,,207,,45,45,,,[Not Available],[Not Applicable],,,,,0.34,Stomach,Unknown,,,21,,1,0.16674,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4CS,,,,,,,,,,,,,,,,39,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,87999,,-0.715070029,,,,,,,,,,0.047313976,Grade 3,0.144020916,,,,Stage IIIC,,-0.4775,,,,,,,,,,,,,,,,0.1508,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4CS,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,,0,1,Female,TCGA-22-5492,,LUSC,,0,0,,Mayo Clinic - Rochester,,,FEMALE,2,1.96,0.56,13,8,12,,,506,,,506,,2,2,506,506,,Malignant,33,,31,,,,17819,,,506,506,,,,,506,,,506,,,,,,,,,Dead,-26838,506,,,306,,506,506,,,[Not Available],[Not Applicable],,,,,0.01,,,,,7,,0,0.32955,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5492,,,,,,,506,,,,,,,,,16,,,,,,,,,,,,,2003,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,88009,,1.304519971,,,,,,,,,,0.225821206,,0.120560448,,,,Stage IIIA,,1.6075,,,,,,,,,,,,,,,,0.4942,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.41008373,17.51122037,16.63468549,-0.0337766192443554,LUSC,Squamous Cell Carcinoma,17.73634228,16.33558011,Squamous Cell Carcinoma,-0.0705,12.98906483,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.6,0.63,3,4,5,,,78,BRCA_LumA,78,78,,0,0,78,78,,Invasive Carcinoma,12,,3,,,,18858,0,,78,78,,,,78,78,,,78,,,,,,,,TUMOR FREE,Alive,-25944,,,,84,,78,78,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,23,,0,0.045998,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DS,,,,,,,78,,,,,,,,,16,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,88021,,0.194213015,0,0,0,0,-0.2162,1,,,Infiltrating Ductal Carcinoma,0.205725899,,0.196750971,0,0,0,,Negative,-0.6515,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4479,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-CD-8526,Asian,STAD,,0,0,,,0,0,,0,2.92,0.32,13,7,13,,,381,,381,381,,0,0,381,381,,Malignant,33,,168,,,,16159,,,381,381,,,,381,381,,,381,,,,,,,,TUMOR FREE,Alive,-26840,,,,70,,381,381,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,17,,1,0.50131,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8526,,,,,,,381,,,,,,,,,32,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,88031,,0.883465272,,,,,,,,,,0.049448978,Grade 3,0.128935734,,,,Stage IIIA,,0.7135,,,,,,,,,,,,,,,,0.2483,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8526,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,Male,TCGA-HU-8608,Asian,STAD,,1,1,,,1,0,,1,2.01,0.4,3,1,4,,,641,,277,641,,1,1,277,277,,Malignant,8,,35,,,,16687,,,277,277,,,,277,641,,,277,,,,,,,,WITH TUMOR,Alive,-25789,,,,115,,277,277,,,[Not Available],[Not Applicable],,,,,0.01,Stomach,Unknown,,,3,,0,0.093511,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-8608,,,,,,,641,Lung,Distant Metastasis,,,,,,,4,,,,,,,,,,,,,2012,277,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,88032,,1.699513029,,,,,,,,,,0.147722877,Grade 3,0.137104463,,,,Stage IIIB,,3.638,,,,,,,,,,,,,,,,0.0532,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-8608,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Female,TCGA-BR-6852,White,STAD,,0,0,,,0,0,,0,2.06,0.35,0,1,1,,,1367,,1367,1367,,0,0,1367,1367,,Malignant,2,,6,,,,16598,,,1367,1367,,,,1367,1367,,,1367,,,,,,,,TUMOR FREE,Alive,-23469,,,,1436,,1367,1367,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,2,,0,0.030573,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6852,,,,,,,1367,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,88035,,1.607864814,,,,,,,,,,0.109526179,Grade 3,0.086517978,,,,Stage IIA,,2.7115,,,,,,,,,,,,,,,,0.4021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6852,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.89,0.38,10,11,10,,,722,BRCA_Basal,722,722,,0,0,722,722,,Invasive Carcinoma,31,,32,,,,31498,0,,722,722,,,,722,722,,,722,,,,,,,,TUMOR FREE,Alive,-18362,,,,80,,722,722,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Core Biopsy,,,9,,0,0.34604,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A26G,,,,,,,722,,,,,,,,,12,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,88039,TRUE,1.19073824,0,0,0,0,0.262,0,,,Other,0.221263207,,0.22368589,0,0,1,,Negative,0.2575,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.6847,1,0,H & E,0,0,,0,Ioana Tolocica,"Columnar Lesion, Papilloma",0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,"Columnar Lesion, Papilloma",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-33-4587,White,LUSC,,1,1,,,,1,FEMALE,1,3.91,0.88,7,18,19,,,1656,,,1656,,1,1,1656,1656,,Malignant,44,,37,,,,23505,,,1656,1656,,,,,1656,,,1656,,,,,,,,WITH TUMOR,Dead,-23062,1656,,,309,,1656,1656,,,[Not Available],[Not Applicable],,,,,0.31,,,,,14,,1,0.1843,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,,,TCGA-33-4587,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,2003,,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,63,,,,,,,,,,,,,,,,,,,,88042,,0.004982488,,,,,,,,,,0.11763027,,0.039828795,,,,Stage IB,,-0.39,,,,,,,,,,,,,,,,-0.1023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.693478255829315,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.5847,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-V5-AASX,White,ESCA,,1.0,1,,,,0,,1.0,1.87,0.66,7,4,4,,,273,,,273,,1.0,1,273,273,,Malignant,15,,50,,,,18074.0,0,,273,273,,,,,273,,,273,,,,,,,,WITH TUMOR,Alive,-27081,,,,465.0,,273,273,,,[Not Available],Stage IV,,,,,0.71,Esophagus,Biopsy,,,4,,0,0.17928,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Duke University,,TCGA-V5-AASX,,,,,,,273,"Other, specify",Distant Metastasis,,,,,,,7,,,,,,,,,,,,,,273,bone,,,[Not Available],,,,,,,,[Unknown],,,,,,74,,,,,,,,,,,,,,,,,,,,88048,,,,,,,,,,,,,Grade 2,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,1,1,1,1,Male,TCGA-62-A46S,White,LUAD,,1,1,,Thoraxklinik at University Hospital Heidelberg,1,1,MALE,1,3.85,0.45,7,7,12,,,1653,,527,1653,,1,1,527,527,,Malignant,26,,36,,,,25901,,,527,527,,,,527,1653,,,527,,,,,,,,WITH TUMOR,Dead,-26825,1653,,,165,,527,527,,,[Not Available],[Not Applicable],,,,,0.37,,,,,13,,1,0.1319,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A46S,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,22,,,,,,,,,,,,,2007,527,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,88049,,0.208820242,,,,,,,,,,0.177045637,,0.170540857,,,,Stage IB,,0.2365,,,,,,,,,,,,,,,,-0.1239,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13D (driver),,1,,G13D (driver),,,,,-0.268658505,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.8909,,-0.3471,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-ZF-AA53,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.51,0.22,6,18,15,,,1761,,1761,1761,,0.0,0,1761.0,1761.0,,Malignant,39,,39,,,,28553.0,,,1761.0,1761,,,,1761,1761,,,1761.0,,,,,,,,TUMOR FREE,Alive,-22035,,,,236.0,,1761.0,1761,,,[Not Available],[Not Applicable],,,,,0.41,,,,,17,,1,0.072609,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA53,,,,,,,1761,,,,,,,,,32,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,88050,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-HF-7133,,STAD,,0,0,,,,0,,0,1.79,0.57,22,20,22,,,1918,,,1918,,0,0,1918,1918,,Malignant,64,,94,,,,29177,,,1918,1918,,,,,1918,,,1918,,,,,,,,TUMOR FREE,Alive,,,,,124,,1918,1918,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,10,,0,0.38733,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G2,,Ontario Institute for Cancer Research (OICR),,TCGA-HF-7133,,,,,,,1918,,,,,,,,,16,,,,,,,,,,,,,2007,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,88052,,0.744275088,,,,,,,,,,0.135083681,Grade 2,0.106513678,,,,Stage IV,,1.182,,,,,,,,,,,,,,,,0.2157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HF-7133,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,0.0,1,0,1.0,1.0,Female,TCGA-G2-A2EJ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.09,0.61,9,4,7,,,1460,,910,1460,,1.0,1,910.0,910.0,,Malignant,20,,60,,,,25884.0,,,910.0,910,,,,910,1460,,,910.0,,,,,,,,TUMOR FREE,Alive,-20649,,,,428.0,,910.0,910,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.13654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EJ,,,,,,,1460,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2009,910,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,88053,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A8I7,,PRAD,,1,1,,KK,,0,MALE,1,,,,,,ambiguous,NO,2002,,,2002,,1,1,1088,1088,prad_tcga,Malignant,,,,,TCGA-KK-A8I7-01,0,5523,0,TCGA-KK-A8I7,1088,1088,Prostate Cancer,,1877,,2002,TCGA,,1088,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20256,,55,9,23,PRAD,1088,1088,,0.0,[Not Available],[Not Applicable],19,,1,Matched,,Prostate,Resection,4,2EF0DB46-EC9C-4886-90D2-B16389362529,,,,,[Not Available],108DEE1E-B27D-4056-A167-261725F548C1,5,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,KK,0.633333333333,TCGA-KK-A8I7,1:Recurred/Progressed,5,20,Prostate Adenocarcinoma,57.69,8/18/14,2002,,Biochemical evidence of disease,,,NO,C61,70BA9BA3-05E5-4B40-9D6A-BBECCAAADD81,150,,TUMOR FREE,0.0233,0:LIVING,0.1,,65.77,Bilateral,21,No Evidence of Extraprostatic Extension,24,YES,1634,2009,1088,,TCGA-KK-A8I7.70BA9BA3-05E5-4B40-9D6A-BBECCAAADD81.pdf,Peripheral Zone,[Not Applicable],YES,,,9,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,NO,No,R1,,55,Core needle biopsy,1088,Progressive Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,88054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-VQ-AA6D,Unknown,STAD,,0,0,,,0,0,,0,1.93,0.82,11,12,16,,,521,,521,521,,0,0,521,521,,Malignant,39,,256,,,,17516,,,521,521,,,,521,521,,,521,,,,,,,,TUMOR FREE,Alive,-19090,,,,1034,,521,521,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,8,,0,0.19571,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-AA6D,,,,,,,521,,,,,,,,,9,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,88057,,-0.388227793,,,,,,,,,,0.011183444,Grade 2,-0.046557857,,,,Stage IIIA,,0.1005,,,,,,,,,,,,,,,,-0.1671,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA6D,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Female,TCGA-97-8177,White,LUAD,,0,0,,Washington University - NYU,,0,FEMALE,0,3.13,0.25,10,11,11,,,499,,,499,,0,0,499,499,,Malignant,32,,53,,,,34190,,,499,499,,,,,499,,,499,,,,,,,,TUMOR FREE,Alive,-21648,,,,51,,499,499,,,[Not Available],[Not Applicable],,,,,0.54,,,,,17,,1,0.41223,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-8177,,,,,,,499,,,,,,,,,27,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,[Not Evaluated],,,,,,59,,,,,,,,,,,,,,,,,,,,88062,,0.993901789,,,,,,,,,,0.2957911,,0.178357376,,,,Stage IB,,0.7825,,,,,,,,,,,,,,,,0.4619,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,,,,-0.111700901,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.933,,0.2356,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-K4-A6MB,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.25,0.75,9,12,14,,,469,,,469,,0.0,0,469.0,469.0,,Malignant,35,,134,,,,20899.0,,,469.0,469,,,,,469,,,469.0,,,,,,,,TUMOR FREE,Alive,-23664,,,,481.0,,469.0,469,,,[Not Available],[Not Applicable],,,,,0.06,,,,,10,,1,0.27035,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A6MB,,,,,,,469,,,,,,,,,32,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,64.0,,,,,,,,,,,,,,,,,,,,88063,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XK-AAJT,,PRAD,,0,0,,XK,,0,MALE,0,1.95,0.66,10,14,4,HRD,NO,1434,,,1434,,0,0,1434,1434,prad_tcga,Malignant,28,BARD1,257,,TCGA-XK-AAJT-01,0,5637,0,TCGA-XK-AAJT,1434,1434,Prostate Cancer,,566,,1434,TCGA,,1434,Primary,0,Base,A,,ATM;CHEK1;FANCL,True,TUMOR FREE,Alive,-27428,,75,7,35,PRAD,1434,1434,,0.0,[Not Available],[Not Applicable],42,,1,Matched,0.23,Prostate,Resection,4,4791634B-BCD4-4FDA-ABDB-DEC79BA05086,4,Normal (no evidence of prostate cancer) [cM0],0,0.15927,[Not Available],5D66AC77-1543-488B-A68F-665811BEC67A,3,Prostate Adenocarcinoma Acinar Type,,Prostate,31,,Acinar Adenocarcinoma,[Not Available],,XK,1.43333333333,TCGA-XK-AAJT,0:DiseaseFree,3,34,Prostate Adenocarcinoma,47.11,5/13/14,1434,,,,,NO,C61,7596C336-6BF6-4188-9C8B-90C0EC840911,10,5,WITH TUMOR,0.2114,0:LIVING,0.09,5,47.11,Bilateral,35,No Evidence of Extraprostatic Extension,14,YES,1135,2010,,,TCGA-XK-AAJT.7596C336-6BF6-4188-9C8B-90C0EC840911.pdf,Peripheral Zone,[Not Applicable],YES,19,,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,NO,No,R1,,75,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,88065,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-UY-A78O,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.66,0.76,2,8,18,,,2312,,2312,2312,,0.0,0,2312.0,2312.0,,Malignant,28,,71,,,,26810.0,,,2312.0,2312,,,,2312,2312,,,2312.0,,,,,,,,TUMOR FREE,Alive,-27234,,,,250.0,,2312.0,2312,,,[Not Available],[Not Applicable],,,,,0.56,,,,,12,,1,0.087763,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A78O,,,,,,,2312,,,,,,,,,26,,,,,,,,,,,,,,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,88067,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-KK-A8I9,,PRAD,370,1,1,,KK,1,0,MALE,1,1.92,0.53,4,9,0,ambiguous,NO,1001,5-SPOP,940,1001,,1,1,940,940,prad_tcga,Malignant,13,BRCA2,44,,TCGA-KK-A8I9-01,15,5525,0,TCGA-KK-A8I9,940,940,Prostate Cancer,0,721,940,1001,TCGA,No Evidence of Extraprostatic Extension,940,Primary,1,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-22295,,61,8,44,PRAD,940,940,,0.298928626,[Not Available],[Not Applicable],43,,1,Matched,0.11,Prostate,Resection,4,52FCF737-CDCC-43EA-B33C-4018039B42DD,0,Normal (no evidence of prostate cancer) [cM0],0,0.069919,[Not Available],261C3D74-706E-4751-BD15-8F3C1A402FF0,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,KK,1.46666666667,TCGA-KK-A8I9,1:Recurred/Progressed,4,25,Prostate Adenocarcinoma,30.88,8/18/14,1001,,Biochemical evidence of disease,,,YES,C61,D086A0A1-E06A-4B7E-B158-A5D04BCE06E1,50,1,TUMOR FREE,0.0643,0:LIVING,0.1,,32.88,Bilateral,27,No Evidence of Extraprostatic Extension,-3,YES,528,2012,940,,TCGA-KK-A8I9.D086A0A1-E06A-4B7E-B158-A5D04BCE06E1.pdf,Peripheral Zone,[Not Applicable],YES,0,66-75%,14,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,RX,,61,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,YES,8,No,YES,0,N0,T2b,,M0,C61.9,8140/3,88070,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,1,1,1,Male,TCGA-NC-A5HJ,White,LUSC,,0,0,,Washington University - CHUV,2,1,MALE,1,2.68,0.17,14,24,24,,,418,,418,418,,2,2,328,328,,Malignant,62,,75,,,,22876,,,418,418,,,,418,418,,,328,,,,,,,,WITH TUMOR,Dead,-21730,418,,,511,,418,418,,,[Not Available],[Not Applicable],,,,,0.26,,,,,14,,1,0.36544,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HJ,,,,,,,,,New Primary Tumor,,,,,,,35,,,,,,,,,,,,,2009,328,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,88071,,1.316743441,,,,,,,,,,0.277926198,,0.245395587,,,,Stage IIB,,2.9565,,,,,,,,,,,,,,,,-0.117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.69103001,17.88437235,18.36249929,0.150568945761244,LUSC,Squamous Cell Carcinoma,17.90141874,17.23249016,Squamous Cell Carcinoma,-1.144,12.54348738,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-55-A57B,Black or African American,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.36,0.21,8,8,5,,,546,,546,546,,0,0,546,546,,Malignant,21,,129,,,,34532,,,546,546,,,,546,546,,,546,,,,,,,,TUMOR FREE,Alive,-29452,,,,50,,546,546,,,[Not Available],[Not Applicable],,,,,0.18,,,,,18,,0,0.60304,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A57B,,,,,,,546,,,,,,,,,23,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,88073,,0.607522869,,,,,,,,,,0.211366644,,0.210983607,,,,Stage IA,,0.6795,,,,,,,,,,,,,,,,0.5008,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L747_T751del (driver),,,1,L747_T751del (driver),,,,,,-0.426016748,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1122,,-1.0095,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.3,0.31,8,10,12,,,652,BRCA_LumA,652,652,,0,0,652,652,,Invasive Carcinoma,30,,23,,,,29514,0,,652,652,,,,652,652,,,652,,,,,,,,TUMOR FREE,Alive,-23065,,,,62,,652,652,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,17,,1,0.16785,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18H,,,,,,,652,,,,,,,,,26,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,88075,,1.74809557,0,0,0,0,1.1499,1,,,Infiltrating Ductal Carcinoma,0.161546538,,0.201587188,0,0,0,,Negative,1.56,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1869,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Cribriform, Intermediate Grade), Microcalcifications",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.62,0.31,12,11,13,,,789,BRCA_Her2,789,789,,0,0,789,789,,Invasive Carcinoma,36,,24,,,,24107,0,,789,789,,,,789,789,,,789,,,,,,,,TUMOR FREE,Alive,-20764,,,,156,,789,789,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,15,,1,0.25295,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1OV,,,,,,,789,,,,,,,,,23,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,88081,TRUE,1.95950563,0,0,0,0,-2.1181,1,,,Infiltrating Ductal Carcinoma,0.177825232,,0.207149506,0,0,0,,Negative,1.728,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.2004,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-78-7158,White,LUAD,,1,,,Prince Charles Hospital,,1,FEMALE,1,2.09,0.9,2,1,2,,,179,,,179,,1,,132,132,,Malignant,5,,6,,,,28710,,,132,,,,,,179,,,132,,,,,,,,WITH TUMOR,Dead,-21742,179,,,312,,132,,,,[Not Available],[Not Applicable],,,,,0.02,,,,,4,,0,0.049384,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7158,,,,,,,,,,,,,,,,4,,,,,,,,,,,,,2007,132,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,88085,,0.024877431,,,,,,,,,,0.182652662,,0.088006793,,,,Stage IIIB,,-0.189,,,,,,,,,,,,,,,,-0.2259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L907M,,I461V,1,L907M,,I461V,15.68157761,16.12136541,13.75821473,-0.6028698,LUAD,Adenocarcinoma,17.89014231,14.85875081,Adenocarcinoma,-0.7504,12.73770124,-1.5505,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,,0,1,Male,TCGA-78-7542,White,LUAD,,0,0,,Prince Charles Hospital,,,MALE,2,4.69,0.35,9,6,16,,,321,,,321,,2,2,321,321,,Malignant,31,,30,,,,17783,,,321,321,,,,,321,,,321,,,,,,,,,Dead,-20763,321,,,498,,321,321,,,[Not Available],[Not Applicable],,,,,0.25,,,,,23,,2,0.40122,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7542,,,,,,,,,,,,,,,,52,,,,,,,,,,,,,1993,,,,,Stage IB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,88086,,0.856088518,,,,,,,,,,0.158503312,,0.032652984,,,,Stage IB,,1.7275,,,,,,,,,,,,,,,,-0.0051,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.136931375,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.2326,,-0.1641,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-JY-A93E,White,ESCA,,0.0,0,,,,0,,0.0,2.72,0.46,7,2,11,,,767,,,767,,0.0,0,767,767,,Malignant,20,,103,,,,24200.0,0,,767,767,,,,,767,,,767,,,,,,,,WITH TUMOR,Alive,-22427,,,,314.0,,767,767,,,[Not Available],[Not Available],,,,,0.08,Esophagus,Resection,,,18,,1,0.25938,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,University Health Network,,TCGA-JY-A93E,,,,,,,767,,,,,,,,,37,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,88089,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1.0,,1,1.0,1.0,Female,TCGA-BL-A13I,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.07,0.33,2,1,2,,,223,,,223,,1.0,1,216.0,216.0,,Malignant,5,,11,,,,19097.0,,,216.0,216,,,,,223,,,216.0,,,,,,,,WITH TUMOR,Dead,-20885,223,,,166.0,,216.0,216,,,[Not Available],[Not Applicable],,,,,0.13,,,,,2,,0,0.13507,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Christiana Healthcare,,TCGA-BL-A13I,,,,,,,,,Metastatic,,,,,,,3,,,,,,,,,,,,,2010,216,,,,Stage III,,,,,,,,Progressive Disease,,,,,,57.0,,,,,,,,,,,,,,,,,,,,88090,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.35,0.41,2,1,4,,,3112,BRCA_LumA,,3112,,0,0,3112,3112,,Invasive Carcinoma,7,,3,,,,22634,0,,3112,3112,,,,,3112,,,3112,,,,,,,,TUMOR FREE,Alive,-17420,,,,22,,3112,3112,,,[Not Available],[Not Applicable],,,,,0.33,Breast,Resection/Excision,,,22,,1,0.059217,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A12A,,,,,,,3112,,,,,,,,,22,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,88091,,0.508031669,0,0,0,0,-0.0007,1,,,Infiltrating Ductal Carcinoma,0.133918937,,0.205588797,0,0,0,,Close,0.281,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.425,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-GV-A3JZ,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.33,0.82,11,26,20,,,603,,,603,,0.0,0,603.0,603.0,,Malignant,57,,122,,,,28316.0,,,603.0,603,,,,,603,,,603.0,,,,,,,,WITH TUMOR,Alive,-20420,,,,625.0,,603.0,603,,,[Not Available],[Not Applicable],,,,,0.26,,,,,13,,1,0.19388,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3JZ,,,,,,,603,,,,,,,,,37,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,55.0,,,,,,,,,,,,,,,,,,,,88093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7123,White,PRAD,161,0,0,,EJ,0,0,MALE,0,1.96,0.34,4,9,3,ambiguous,NO,2572,5-SPOP,2572,2572,,0,0,2572,2572,prad_tcga,Malignant,16,BRCA2;PALB2,17,5.6,TCGA-EJ-7123-01,0,5296,0,TCGA-EJ-7123,2572,2572,Prostate Cancer,,1491,2572,2572,TCGA,,2572,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21741,,59,7,52,PRAD,2572,2572,WHITE,0.0,[Not Available],[Not Applicable],50,R0,1,Matched,0.1,Prostate,Resection,3,a7383a8a-32c0-453b-b26d-d98d6c098a90,4,,0,0.099617,[Not Available],9519be01-d78d-462c-8a95-34149538afeb,4,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,EJ,3.0,TCGA-EJ-7123,0:DiseaseFree,2,19,Prostate Adenocarcinoma,84.49,4/5/12,2572,,,,,NO,C61,1ba8d08d-0be5-46a6-9540-8f6d028e0dea,,3,TUMOR FREE,0.076,0:LIVING,0.1,3,84.49,Bilateral,24,,,YES,,2007,,,TCGA-EJ-7123.1ba8d08d-0be5-46a6-9540-8f6d028e0dea.pdf,,[Not Applicable],NO,,81-90%,22,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,NO,Yes,R0,0.4,59,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,88097,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-CG-4441,,STAD,,0,0,,,,,,2,2.05,0.63,0,1,2,,,426,,,426,,2,2,426,426,,Malignant,3,,380,,,,17793,,,426,426,,,,,426,,,426,,,,,,,,,Dead,-30528,426,,,143,,426,426,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,4,,0,0.027779,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Indivumed,,TCGA-CG-4441,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,83,,,,,,,,,,,,,,,,,,,,88099,,0.282116532,,,,,,,,,,0.111523922,Grade 2,0.085349793,,,,Stage IIIA,,0.6795,,,,,,,,,,,,,,,,0.6079,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CG-4441,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,,0,1.0,1.0,Male,TCGA-GU-AATP,White,BLCA,,0.0,0,,,,0,MALE,1.0,2.83,0.65,4,3,11,,,1003,,,1003,,0.0,0,596.0,596.0,,Malignant,18,,71,,,,22864.0,,,1003.0,1003,,,,,1003,,,596.0,,,,,,,,WITH TUMOR,Alive,-27049,,,,444.0,,1003.0,1003,,,[Not Available],[Not Applicable],,,,,0.34,,,,,16,,1,0.15999,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-AATP,,,,,,,1003,Urethra,New Primary Tumor,,,,,,,27,,,,,,,,,,,,,2012,596,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,74.0,,,,,,,,,,,,,,,,,,,,88100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.0,1.0,0,0,0,,,2759,BRCA_LumA,2759,2759,,0,0,2759,2759,,Invasive Carcinoma,0,,0,,,,17660,0,,2759,2759,,,,2759,2759,,,2759,,,,,,,,TUMOR FREE,Alive,,,,,19,,2759,2759,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,0,,0,0.0,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2FF,,,,,,,2759,,,,,,,,,0,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,88107,,1.114594713,0,0,0,0,-0.4665,1,,,Infiltrating Lobular Carcinoma,0.187415967,,0.325639024,0,0,0,,Negative,0.426,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5238,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-BR-A4J1,Asian,STAD,,0,0,,,,,,2,2.59,0.8,7,5,10,,,22,,,22,,2,2,22,22,,Malignant,22,,223,,,,26539,,,22,22,,,,,22,,,22,,,,,,,,,Dead,-23266,22,,,96,,22,22,,,[Unknown],[Not Applicable],,,,,0.21,Stomach,Unknown,,,21,,1,0.46412,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4J1,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,63,,,,,,,,,,,,,,,,,,,,88111,,-0.616213913,,,,,,,,,,-0.002544413,Grade 3,0.042031508,,,,Stage IIIA,,-1.2355,,,,,,,,,,,,,,,,-0.0875,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4J1,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-44-2666,White,LUAD,,1,1,,Christiana Healthcare,,1,MALE,1,1.93,0.56,3,4,1,,,97,,,97,,1,1,97,97,,Malignant,8,,36,,,,16246,,,97,97,,,,,97,,,97,,,,,,,,WITH TUMOR,Dead,-15970,97,,,44,,97,97,,,[Not Available],[Not Applicable],,,,,0.04,,,,,2,,0,0.10195,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-2666,,,,,,,97,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,88115,,-0.050710546,,,,,,,,,,0.176703598,,0.150561602,,,,Stage IB,,0.7845,,,,,,,,,,,,,,,,0.0094,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.398799142,LUAD,,,,Adenocarcinoma,-1.0436,,-0.0162,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-M7-A725,,PRAD,331,0,0,,M7,0,0,MALE,0,1.98,0.84,6,5,4,ambiguous,NO,573,3-ETV4,573,573,,0,0,573,573,prad_tcga,Malignant,15,BRCA1;BRIP1;CDK12;CHEK2;PALB2;RAD51C;RAD51D;RAD54L,61,,TCGA-M7-A725-01,0,5545,0,TCGA-M7-A725,573,573,Prostate Cancer,,96,573,573,TCGA,,573,Primary,0,Apex|Base,A,,,False,TUMOR FREE,Alive,-20474,,56,7,37,PRAD,573,573,,0.0,[Not Available],[Not Applicable],35,R1,1,Matched,0.11,Prostate,Resection,4,4C99BBF0-3C72-4704-BE63-560E6A697B41,4,Normal (no evidence of prostate cancer) [cM0],0,0.11035,[Not Available],FCA0331B-8096-40E8-B292-D438370C37C9,3,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,M7,1.16666666667,TCGA-M7-A725,0:DiseaseFree,3,13,Prostate Adenocarcinoma,18.82,12/10/13,573,,,,,NO,C61,5885079D-F3C7-44DB-9BA1-60DCA1C9919C,110,6,TUMOR FREE,0.1838,0:LIVING,,5,18.82,Bilateral,16,No Evidence of Extraprostatic Extension,16,YES,240,2012,,,TCGA-M7-A725.5885079D-F3C7-44DB-9BA1-60DCA1C9919C.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,16,71-80%,11,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,56,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3b,NO,7,No,NO,0,N0,T3a,0,M0,C61.9,8140/3,88117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-YL-A8SH,,PRAD,389,0,0,,YL,2,2,MALE,2,1.93,0.68,5,9,0,HRD,NO,875,5-SPOP,875,875,,2,2,875,875,prad_tcga,Malignant,14,,97,,TCGA-YL-A8SH-01,0,5665,0,TCGA-YL-A8SH,875,875,Prostate Cancer,,617,875,875,TCGA,,875,Primary,0,Apex|Middle|Base,B,ATM:1937:N/X:frameshift_variant,,True,TUMOR FREE,Dead,-25395,875,69,7,42,PRAD,875,875,,0.0,"Other, non-malignant disease",[Not Applicable],35,R0,1,Matched,0.02,Prostate,Resection,4,56A06467-7CB6-4DFF-9F57-88228210619E,0,,0,0.091978,[Not Available],BFB973EB-D42D-4900-A606-A381D2317555,3,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.16666666667,TCGA-YL-A8SH,,3,14,Prostate Adenocarcinoma,,4/25/14,,,,"Other, non-malignant disease",Death Certificate,NO,C61,62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7,510,3,TUMOR FREE,0.0699,1:DECEASED,0.06,,28.75,Bilateral,15,,,YES,1481,2009,,,TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,71-80%,21,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,88120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A27C,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.92,0.98,4,4,5,,,425,,425,425,,0.0,0,425.0,425.0,,Malignant,13,,21,,,,20232.0,,,425.0,425,,,,425,425,,,425.0,,,,,,,,TUMOR FREE,Alive,-19270,,,,215.0,,425.0,425,,,[Not Available],[Not Applicable],,,,,0.08,,,,,3,,0,0.09251,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ILSBio,,TCGA-CF-A27C,,,,,,,425,,,,,,,,,3,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,52.0,,,,,,,,,,,,,,,,,,,,88123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,1.0,0,0,0,,,1620,BRCA_LumA,1620,1620,,0,0,1620,1620,,Invasive Carcinoma,0,,19,,,,23306,0,,1620,1620,,,,1620,1620,,,1620,,,,,,,,TUMOR FREE,Alive,-16719,,,,163,,1620,1620,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,0,,0,8.1e-06,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0H5,,,,,,,1620,,,,,,,,,0,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,88129,,2.16573883,0,0,0,0,-0.6773,1,,,Infiltrating Ductal Carcinoma,0.195313221,,0.169606845,0,0,0,,Negative,2.081,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.1181,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.13,0.54,1,0,3,,,1461,BRCA_LumA,1461,1461,,0,0,1461,1461,,Invasive Carcinoma,4,,19,,,,24122,0,,1461,1461,,,,1461,1461,,,1461,,,,,,,,TUMOR FREE,Alive,-17426,,,,28,,1461,1461,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.015826,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27K,,,,,,,1461,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,88133,,0.482969811,0,0,0,0,0.0028,1,,,Infiltrating Ductal Carcinoma,0.143659508,,0.146359258,0,0,0,,Negative,0.079,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3821,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-CD-8532,Asian,STAD,,1,1,,,1,1,,1,1.8,0.5,3,5,3,,,354,,282,354,,1,1,282,282,,Malignant,11,,106,,,,18329,,,282,282,,,,282,354,,,282,,,,,,,,WITH TUMOR,Dead,-19284,354,,,55,,282,282,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,10,,0,0.24091,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,ILSBio,,TCGA-CD-8532,,,,,,,,,Locoregional Recurrence,,,,,,,6,,,,,,,,,,,,,2011,282,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,88135,,0.967017923,,,,,,,,,,0.102529247,Grade 2,0.082023673,,,,Stage II,,0.8335,,,,,,,,,,,,,,,,0.093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8532,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,Male,TCGA-49-4486,White,LUAD,,1,1,,,1,1,MALE,1,2.08,0.73,2,2,5,,,2318,,2045,2318,,1,1,2045,2045,,Malignant,9,,14,,,,25359,,,2045,2045,,,,2045,2318,,,2045,,,,,,,,WITH TUMOR,Dead,-26415,2318,,,195,,2045,2045,,,[Not Available],[Not Applicable],,,,,0.1,,,,,1,,0,0.031618,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,,,TCGA-49-4486,,,,,,,,,Distant Metastasis,,,,,,,2,,,,,,,,,,,,,1992,2045,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,88144,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.9281,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G333S (driver),1,,,G333S (driver),,,,-0.648309279,LUAD,Adenocarcinoma,,,Adenocarcinoma,-3.3853,,-0.6719,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.22,0.4,21,23,29,,,7106,BRCA_Basal,7106,7106,,0,0,7106,7106,,Invasive Carcinoma,73,,101,,,,17550,0,,7106,7106,,,,7106,7106,,,7106,,,,,,,,TUMOR FREE,Alive,-15625,,,,182,,7106,7106,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Core Biopsy,,,13,,1,0.44844,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0IJ,,,,,,,7106,,,,,,,,,36,,,,,,,,,,,,,1995,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,88151,,1.503611858,0,0,0,0,0.9368,1,,,Infiltrating Ductal Carcinoma,0.195681261,,0.077371408,0,0,0,,Negative,1.21,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.2395,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Core Biopsy,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.58,0.23,5,2,12,,,1673,BRCA_Her2,1673,1673,,0,0,1673,1673,,Invasive Carcinoma,19,,21,,,,29207,0,,1673,1673,,,,1673,1673,,,1673,,,,,,,,TUMOR FREE,Alive,-21628,,,,70,,1673,1673,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,18,,1,0.15244,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A2FR,,,,,,,1673,,,,,,,,,29,,,,,,,,,,,,,2008,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,88153,,0.55240284,0,0,0,0,-1.2906,1,,,Infiltrating Ductal Carcinoma,0.184365415,,0.217514107,0,0,0,,Negative,0.027,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.9436,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.58,0.44,12,19,20,,,358,BRCA_Her2,358,358,,0,0,358,358,,Invasive Carcinoma,51,,102,,,,24430,0,,358,358,,,,358,358,,,358,,,,,,,,TUMOR FREE,Alive,-20332,,,,228,,358,358,,,[Not Available],[Not Applicable],,,,,0.28,Breast,Resection/Excision,,,16,,1,0.28423,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12P,,,,,,,358,,,,,,,,,39,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,88154,,0.578539048,0,0,0,0,0.2113,1,,,Infiltrating Ductal Carcinoma,0.183603351,,0.137913409,0,0,0,,Negative,0.2345,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.3503,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-33-AASB,Black or African American,LUSC,,1,1,,Johns Hopkins,,1,MALE,1,2.92,0.44,17,15,21,,,211,,,211,,1,1,30,30,,Malignant,53,,175,,,,17962,,,30,30,,,,,211,,,30,,,,,,,,WITH TUMOR,Dead,-24183,211,,,480,,30,30,,,[Not Available],[Not Applicable],,,,,0.16,,,,,16,,1,0.43721,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-AASB,,,,,,,,,Distant Metastasis,,,,,,,35,,,,,,,,,,,,,2002,30,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,66,,,,,,,,,,,,,,,,,,,,88155,,-0.331413308,,,,,,,,,,0.104613921,,-0.039596435,,,,Stage IB,,-0.6395,,,,,,,,,,,,,,,,-0.1149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),R320L (driver),1,,,R320L (driver),,,,-1.1932964913397,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.9225,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-4Z-AA7N,White,BLCA,,0.0,0,,,2,2,MALE,2.0,,,,,,,,1367,,1367,1367,,2.0,2,1367.0,1367.0,,Malignant,,,,,,,31090.0,,,1367.0,1367,,,,1367,1367,,,1367.0,,,,,,,,TUMOR FREE,Dead,-24090,1367,,,25.0,,1367.0,1367,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA7N,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,65.0,,,,,,,,,,,,,,,,,,,,88156,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-A5B5,White,LUSC,,0,0,,Asterand,0,0,MALE,0,2.92,0.8,13,16,20,,,111,,111,111,,0,0,111,111,,Malignant,49,,97,,,,19267,,,111,111,,,,111,111,,,111,,,,,,,,TUMOR FREE,Alive,-21450,,,,510,,111,111,,,[Not Available],[Not Applicable],,,,,0.28,,,,,23,,1,0.34488,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A5B5,,,,,,,111,,,,,,,,,38,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,88157,,-8.92e-05,,,,,,,,,,0.129613688,,0.013359145,,,,Stage IA,,0.594,,,,,,,,,,,,,,,,0.1044,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.664964213873265,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.0688,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.9,0.83,11,11,11,,,392,BRCA_LumB,392,392,,0,0,392,392,,Invasive Carcinoma,33,,27,,,,28763,0,,392,392,,,,392,392,,,392,,,,,,,,TUMOR FREE,Alive,-19216,,,,59,,392,392,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,5,,0,0.25056,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HU,,,,,,,392,,,,,,,,,11,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,88158,,0.051146954,0,0,0,0,1.4492,1,,,Infiltrating Ductal Carcinoma,0.085192388,,0.095650523,0,0,0,,Negative,-0.6255,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0211,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Micropapillary, High Grade), Comedonecrosis",,"DCIS (Micropapillary, High Grade)",0,"Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type), Invasive Papillary Carcinoma","Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type), Invasive Papillary Carcinoma",0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.15,0.65,1,0,2,,,34,BRCA_LumA,34,34,,0,0,34,34,,Invasive Carcinoma,3,,19,,,,24751,0,,34,34,,,,34,34,,,34,,,,,,,,TUMOR FREE,Alive,-24719,,,,30,,34,34,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,9,,1,0.015826,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1RD,,,,,,,34,,,,,,,,,22,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,88159,,-0.512324094,0,0,0,0,0.2694,1,,,Infiltrating Ductal Carcinoma,0.139304832,,0.183164361,0,0,0,,Negative,-1.166,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1436,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.51,0.53,11,23,17,,,365,BRCA_LumA,365,365,,0,0,365,365,,Invasive Carcinoma,51,,38,,,,17531,0,,365,365,,,,365,365,,,365,,,,,,,,TUMOR FREE,Alive,-23741,,,,157,,365,365,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,15,,1,0.16992,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A097,,,,,,,365,,,,,,,,,28,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,88163,,0.438731875,0,0,0,0,0.0296,1,,,Infiltrating Ductal Carcinoma,0.186112157,,0.130305698,0,0,0,,Negative,-0.3975,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4942,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.42,0.5,3,1,4,,,698,BRCA_LumA,698,698,,0,0,698,698,,Invasive Carcinoma,8,,5,,,,25645,0,,698,698,,,,698,698,,,698,,,,,,,,TUMOR FREE,Alive,-18500,,,,31,,698,698,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,16,,1,0.03392,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A23E,,,,,,,698,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,88169,,-1.276053665,0,0,0,0,-0.071,1,,,Infiltrating Ductal Carcinoma,0.216886677,,0.17538143,0,0,0,,Negative,-1.0775,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.756,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,"Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A94P,White,STAD,,1,1,,,,1,,1,1.65,0.13,8,7,9,,,81,,,81,,1,1,81,81,,Malignant,24,,105,,,,22904,,,81,81,,,,,81,,,81,,,,,,,,WITH TUMOR,Dead,-21022,81,,,79,,81,81,,,Stomach Cancer,[Not Applicable],,,,,0.4,Stomach,Unknown,,,9,,0,0.48356,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,GX,,Barretos Cancer Hospital,,TCGA-VQ-A94P,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2011,,,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,57,,,,,,,,,,,,,,,,,,,,88172,,0.438284829,,,,,,,,,,0.089288479,Unknown,0.247885613,,,,Unknown,,0.3135,,,,,,,,,,,,,,,,0.4838,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A94P,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0.0,,0,1.0,1.0,Male,TCGA-K4-A83P,White,BLCA,,1.0,1,,,,0,MALE,1.0,3.31,0.09,6,23,19,,,495,,,495,,1.0,1,70.0,70.0,,Malignant,48,,54,,,,25638.0,,,70.0,70,,,,,495,,,70.0,,,,,,,,WITH TUMOR,Alive,-28463,,,,317.0,,70.0,70,,,[Not Available],[Not Applicable],,,,,0.25,,,,,25,,1,0.19558,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,[Unknown],,ABS - Lahey Clinic,,TCGA-K4-A83P,,,,,,,495,Liver,Distant Metastasis,,,,,,,35,,,,,,,,,,,,,2013,70,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,88175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.08,0.81,2,0,2,,,1363,BRCA_LumA,1363,1363,,0,0,1363,1363,,Invasive Carcinoma,4,,3,,,,26392,0,,1363,1363,,,,1363,1363,,,1363,,,,,,,,TUMOR FREE,Alive,-29115,,,,60,,1363,1363,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,4,,0,0.02932,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0E7,,,,,,,1363,,,,,,,,,4,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,88177,,-1.271352141,0,0,0,0,-0.0074,1,,,Infiltrating Ductal Carcinoma,0.114243571,,0.15105389,0,0,0,,Negative,-1.394,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.0815,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BR-6565,White,STAD,,1.0,1,,,,1,,1.0,4.81,0.32,4,10,19,,,279,,,279,,1.0,1,279,279,,Malignant,33,,33,,,,22627.0,0,,279,279,,,,,279,,,279,,,,,,,,WITH TUMOR,Dead,-24495,279,,,176.0,,279,279,,,[Not Available],[Not Applicable],,,,,0.42,Stomach,Resection,,,23,,2,0.31094,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-6565,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,88183,,1.035418713,,,,,,,,,,0.139034009,Grade 2,0.071993026,,,,Stage IIB,,1.2675,,,,,,,,,,,,,,,,0.2743,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6565,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,0,0,0.0,0.0,Male,TCGA-4Z-AA7O,Black or African American,BLCA,,0.0,0,,,0,0,MALE,0.0,1.89,0.84,3,3,6,,,512,,512,512,,0.0,0,512.0,512.0,,Malignant,12,,52,,,,29284.0,,,512.0,512,,,,512,512,,,512.0,,,,,,,,TUMOR FREE,Alive,-23645,,,,267.0,,512.0,512,,,[Not Available],[Not Applicable],,,,,0.01,,,,,4,,0,0.14141,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA7O,,,,,,,512,,,,,,,,,3,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,64.0,,,,,,,,,,,,,,,,,,,,88184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-77-8133,Unknown,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,3.21,0.4,7,2,10,,,1640,,,1640,,2,2,1640,1640,,Malignant,19,,18,,,,32979,,,1640,1640,,,,,1640,,,1640,,,,,,,,,Dead,-27139,1640,,,485,,1640,1640,,,[Not Available],[Not Applicable],,,,,0.41,,,,,19,,1,0.22213,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8133,,,,,,,,,,,,,,,,29,,,,,,,,,,,,,2001,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,88185,,1.422211242,,,,,,,,,,0.199622155,,0.073477358,,,,Stage IIA,,1.76,,,,,,,,,,,,,,,,0.1895,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,15.06467391,15.83201586,15.61617302,-0.249761149038176,LUSC,Squamous Cell Carcinoma,18.29058393,16.17118236,Squamous Cell Carcinoma,-0.7131,15.07100722,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-52-7810,White,LUSC,,0,0,,University of Miami,0,0,FEMALE,0,3.61,0.51,18,20,26,,,923,,923,923,,0,0,923,923,,Malignant,64,,82,,,,16743,,,923,923,,,,923,923,,,923,,,,,,,,TUMOR FREE,Alive,-22241,,,,576,,923,923,,,[Not Available],[Not Applicable],,,,,0.1,,,,,18,,1,0.35089,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Miami,,TCGA-52-7810,,,,,,,923,,,,,,,,,24,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,88189,,-1.002111351,,,,,,,,,,0.139035891,,-0.014886301,,,,Stage IIB,,-0.674,,,,,,,,,,,,,,,,0.5399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.96058973,13.29768013,12.30385339,-1.1432347644178,LUSC,,17.96572225,13.60547352,Squamous Cell Carcinoma,0.4368,13.85773086,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,0,1,Male,TCGA-77-8128,Unknown,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,3.1,0.64,10,10,14,,,1150,,,1150,,2,2,1150,1150,,Malignant,34,,33,,,,20646,,,1150,1150,,,,,1150,,,1150,,,,,,,,,Dead,-21986,1150,,,383,,1150,1150,,,[Not Available],[Not Applicable],,,,,0.32,,,,,16,,1,0.47823,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8128,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,1999,,,,,Stage IIIA,,,,,,,,[Not Applicable],,,,,,60,,,,,,,,,,,,,,,,,,,,88198,,-0.224629049,,,,,,,,,,0.125157345,,0.070516929,,,,Stage IIIA,,-0.432,,,,,,,,,,,,,,,,0.5653,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,13.51848395,14.62187291,13.5052551,-0.894006542541182,LUSC,Squamous Cell Carcinoma,18.30792201,14.69123622,Squamous Cell Carcinoma,0.493,14.40854501,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-4Z-AA82,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,3.88,0.58,2,12,9,,,1556,,,1556,,1.0,1,1150.0,1150.0,,Malignant,23,,87,,,,24757.0,,,1150.0,1150,,,,,1556,,,1150.0,,,,,,,,WITH TUMOR,Dead,-21893,1556,,,147.0,,1150.0,1150,,,[Not Available],[Not Applicable],,,,,0.1,,,,,15,,1,0.14435,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA82,,,,,,,,Bone,Distant Metastasis,,,,,,,30,,,,,,,,,,,,,2010,1150,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,88199,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.59,4,4,5,,,365,BRCA_LumA,365,365,,0,0,365,365,,Invasive Carcinoma,13,,9,,,,18538,0,,365,365,,,,365,365,,,365,,,,,,,,TUMOR FREE,Alive,-12965,,,,101,,365,365,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,5,,0,0.10717,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07J,,,,,,,365,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,35,,,,,,,,,,,,,,,,,,,,88201,,0.126799173,0,0,0,0,0.6353,1,,,Infiltrating Ductal Carcinoma,0.251386888,,0.248282782,0,0,0,,Negative,-0.6495,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5916,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.74,0.5,8,7,7,,,1167,BRCA_LumA,1167,1167,,0,0,1167,1167,,Invasive Carcinoma,22,,33,,,,29293,0,,1167,1167,,,,1167,1167,,,1167,,,,,,,,TUMOR FREE,Alive,-26278,,,,86,,1167,1167,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,9,,1,0.18471,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Asterand,,TCGA-E9-A22B,,,,,,,1167,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,88202,,-0.050824281,0,0,0,0,0.1519,1,,,Mixed Histology (NOS),0.178023745,,0.241331162,0,0,0,,Negative,-0.4295,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4243,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-QU-A6IM,,PRAD,,0,0,,QU,0,0,MALE,0,2.01,0.58,5,7,2,ambiguous,NO,1247,,1247,1247,,0,0,1247,1247,prad_tcga,Malignant,14,,83,,TCGA-QU-A6IM-01,0,5549,0,TCGA-QU-A6IM,1247,1247,Prostate Cancer,35,896,1247,1247,TCGA,No Evidence of Extraprostatic Extension,1247,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-21792,,59,7,83,PRAD,1247,1247,,0.0,[Not Available],[Not Applicable],70,,1,Matched,0.01,Prostate,Resection,3,9FEA5DA6-9E5C-4DB2-ADFC-62D22469C80C,1,Equivocal,0,0.061435,[Not Available],D1B31524-8034-4FCE-B14E-1CEF33C26CA5,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,QU,2.36666666667,TCGA-QU-A6IM,0:DiseaseFree,2,13,Prostate Adenocarcinoma,40.97,8/21/13,1247,,,,,YES,C61,6999B5F3-AC5C-4447-9590-548F103039C3,40,3,,0.0852,0:LIVING,0.1,,40.97,Left,16,Equivocal,50,YES,3796,2003,,,TCGA-QU-A6IM.6999B5F3-AC5C-4447-9590-548F103039C3.pdf,,[Not Applicable],YES,35,,2,Prostate Adenocarcinoma Acinar Type,1,2003,Complete Remission/Response,,NO,"Yes, History of Prior Malignancy",R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2a,NO,7,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,88211,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,1.98,0.85,3,5,2,,,0,BRCA_LumB,,0,,0,0,0,0,,Invasive Carcinoma,10,,8,,,,17943,1,,0,0,,,,,0,,,0,,,,,,,,WITH TUMOR,Alive,-30590,,,,1921,,0,0,,,[Not Available],[Not Applicable],,,,,0.0,Not Specific/Unknown,Resection/Excision,,,4,,0,0.074863,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09Z,,,,,,,0,,,,,,,,,4,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,83,,,,,,,,,,,,,,,,,,,,88218,,1.027095891,0,0,0,0,0.567,1,,,Infiltrating Lobular Carcinoma,0.104700265,,0.115304103,0,0,0,,Positive,1.4095,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1997,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A91D,White,STAD,,1,1,,,,1,,1,1.98,0.7,2,3,1,,,356,,,356,,1,1,351,351,,Malignant,6,,34,,,,29081,,,351,351,,,,,356,,,351,,,,,,,,WITH TUMOR,Dead,-25686,356,,,3398,,351,351,,,Stomach Cancer,[Not Applicable],,,,,0.04,Stomach,Unknown,,,0,,0,0.031961,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A91D,,,,,,,,,Locoregional Recurrence,,,,,,,0,,,,,,,,,,,,,2010,351,,,,Stage IIIC,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,88231,,0.206042148,,,,,,,,,,0.092588464,Grade 2,0.014404768,,,,Stage IIIC,,1.0485,,,,,,,,,,,,,,,,0.3124,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91D,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,5.2,0.31,2,1,3,,,2236,BRCA_LumA,2236,2236,,0,0,2236,2236,,Invasive Carcinoma,6,,3,,,,21455,0,,2236,2236,,,,2236,2236,,,2236,,,,,,,,TUMOR FREE,Alive,-23031,,,,33,,2236,2236,,,[Not Available],[Not Applicable],,,,,0.59,Breast,Resection/Excision,,,26,,2,0.025397,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A1KI,,,,,,,2236,,,,,,,,,46,,,,,,,,,,,,,2003,,,,,Stage I,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,88232,,-1.591383918,0,0,0,0,0.6853,1,,,Infiltrating Ductal Carcinoma,0.100098128,,0.310805067,0,0,0,,Negative,-1.6085,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3108,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-7724,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.74,0.28,5,5,6,,,705,,705,705,,0,0,705,705,,Malignant,16,,13,,,,23215,,,705,705,,,,705,705,,,705,,,,,,,,TUMOR FREE,Alive,-27891,,,,280,,705,705,,,[Not Available],[Not Applicable],,,,,0.5,,,,,10,,0,0.31959,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7724,,,,,,,705,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,88235,,0.794135032,,,,,,,,,,0.292055479,,0.236943559,,,,Stage IB,,0.1225,,,,,,,,,,,,,,,,0.176,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.03432393,LUAD,,,,Adenocarcinoma,-0.1516,,0.4639,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Male,TCGA-75-5125,,LUAD,,1,,,Ontario Institute for Cancer Research (OICR),1,1,MALE,1,3.69,0.31,8,8,12,,,2027,,1752,2027,,1,,1752,1752,,Malignant,28,,22,,,,25557,,,1752,,,,,1752,2027,,,1752,,,,,,,,WITH TUMOR,Dead,,2027,,,222,,1752,,,,[Not Available],[Not Applicable],,,,,0.44,,,,,15,,2,0.31754,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-5125,,,,,,,,,,,,,,,,69,,,,,,,,,,,,,,1752,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,88236,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.78969551,18.2021175,18.23165263,0.142313016,LUAD,Adenocarcinoma,17.94613687,16.37719422,Adenocarcinoma,0.2165,13.39578943,0.7065,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Male,TCGA-4Z-AA84,White,BLCA,,0.0,0,,,,0,MALE,0.0,4.72,0.43,15,27,26,,,460,,,460,,0.0,0,460.0,460.0,,Malignant,68,,147,,,,19746.0,,,460.0,460,,,,,460,,,460.0,,,,,,,,WITH TUMOR,Alive,-22397,,,,719.0,,460.0,460,,,[Not Available],[Not Applicable],,,,,0.27,,,,,19,,2,0.23063,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA84,,,,,,,460,,,,,,,,,67,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,61.0,,,,,,,,,,,,,,,,,,,,88238,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A59Y,,PRAD,285,0,0,,KK,0,0,MALE,0,2.0,0.77,4,6,1,HRP,NO,1968,1-ERG,1968,1968,,0,0,1968,1968,prad_tcga,Malignant,11,RAD51B;RAD51C,53,14.7,TCGA-KK-A59Y-01,0,5495,0,TCGA-KK-A59Y,1968,1968,Prostate Cancer,,1359,1968,1968,TCGA,,1968,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20768,,56,9,30,PRAD,1968,1968,,0.0,[Not Available],[Not Applicable],22,RX,1,Matched,0.01,Prostate,Resection,4,F1CA4735-9AA5-4598-8B8A-D2DF857273C8,2,Normal (no evidence of prostate cancer) [cM0],0,0.057964,[Not Available],4C197D76-DAF6-474D-B561-DED42905F52A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,KK,0.733333333333,TCGA-KK-A59Y,0:DiseaseFree,5,13,Prostate Adenocarcinoma,64.65,5/28/13,1968,,,,,NO,C61,324E4C8E-1F95-4DA6-9D1F-97E6087BA2C7,110,2,TUMOR FREE,0.1105,0:LIVING,0.1,,64.65,Bilateral,15,No Evidence of Extraprostatic Extension,13,YES,1158,2009,,,TCGA-KK-A59Y.324E4C8E-1F95-4DA6-9D1F-97E6087BA2C7.pdf,Peripheral Zone,[Not Applicable],YES,13,81-90%,4,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,RX,,56,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,T3a,2,M0,C61.9,8140/3,88241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-BR-7851,White,STAD,,0,0,,,2,2,,2,1.99,0.63,1,1,1,,,,,,,,2,2,,,,Malignant,3,,21,,,,23156,,,,,,,,,,,,,,,,,,,,TUMOR FREE,Dead,-27091,,,,1958,,,,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,0,,0,0.060658,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-7851,,,,,,,574,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,88245,,0.608635135,,,,,,,,,,0.100521554,Grade 3,0.077751177,,,,Stage IIB,,0.7695,,,,,,,,,,,,,,,,0.2779,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7851,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,,0,1,Female,TCGA-MP-A4T7,Unknown,LUAD,,0,0,,Washington University - Mayo Clinic,,,FEMALE,2,3.17,0.34,5,6,7,,,167,,,167,,2,2,167,167,,Malignant,18,,43,,,,21312,,,167,167,,,,,167,,,167,,,,,,,,,Dead,-27603,167,,,167,,167,167,,,[Not Available],[Not Applicable],,,,,0.06,,,,,14,,1,0.19604,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4T7,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2005,,,,,Stage IV,,,,,,,,[Unknown],,,,,,75,,,,,,,,,,,,,,,,,,,,88246,,0.65573778,,,,,,,,,,0.213633045,,0.132075351,,,,Stage IV,,0.324,,,,,,,,,,,,,,,,-0.0419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),G480W (driver),1,,G12V (driver),G480W (driver),15.60655692,16.90402974,15.24704348,-0.371217398,LUAD,Adenocarcinoma,18.04734491,15.72588211,Adenocarcinoma,-0.9676,13.23512007,-0.4869,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.64,0.48,21,15,29,,,1246,BRCA_Her2,1246,1246,,0,0,1246,1246,,Invasive Carcinoma,65,,256,,,,19379,0,,1246,1246,,,,1246,1246,,,1246,,,,,,,,TUMOR FREE,Alive,-28923,,,,133,,1246,1246,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,13,,1,0.49513,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14P,,,,,,,1246,,,,,,,,,38,,,,,,,,,,,,,2008,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,88253,,0.938160881,0,0,0,0,0.9928,1,,,Infiltrating Ductal Carcinoma,0.136696861,,0.095384562,0,0,0,,Negative,-0.0385,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0281,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.74,2,0,2,,,477,BRCA_LumA,477,477,,0,0,477,477,,Invasive Carcinoma,4,,2,,,,17647,0,,477,477,,,,477,477,,,477,,,,,,,,TUMOR FREE,Alive,-19192,,,,49,,477,477,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,3,,0,0.026593,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0E1,,,,,,,477,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,88254,,-1.127661039,0,0,0,0,0.3059,1,,,Infiltrating Ductal Carcinoma,0.109175867,,0.214742049,0,0,0,,Negative,-1.596,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3502,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-A3VY,Asian,BLCA,,0.0,0,,,,0,MALE,0.0,3.39,0.9,12,23,24,,,536,,,536,,0.0,0,536.0,536.0,,Malignant,59,,118,,,,32417.0,,,536.0,536,,,,,536,,,536.0,,,,,,,,WITH TUMOR,Alive,-24112,,,,1047.0,,536.0,536,,,[Not Available],[Not Applicable],,,,,0.28,,,,,17,,1,0.29614,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A3VY,,,,,,,536,,,,,,,,,25,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Stable Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,88255,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.51,9,7,9,,,437,BRCA_LumA,437,437,,0,0,437,437,,Invasive Carcinoma,25,,26,,,,30811,0,,437,437,,,,437,437,,,437,,,,,,,,,Alive,-21793,,,,45,,437,437,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,9,,0,0.22175,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SD,,,,,,,437,,,,,,,,,14,,,,,,,,,,,,,2005,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,88258,,0.327535279,0,0,0,0,0.33,1,,,Infiltrating Ductal Carcinoma,0.163398128,,0.234814703,0,0,0,,Negative,-0.194,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5223,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-D7-8579,White,STAD,,0,0,,,0,0,,0,2.12,0.25,2,4,1,,,636,,636,636,,0,0,636,636,,Malignant,7,,14,,,,25285,,,636,636,,,,636,636,,,636,,,,,,,,TUMOR FREE,Alive,-24120,,,,149,,636,636,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,2,,0,0.054325,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-8579,,,,,,,636,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,88265,,0.296149277,,,,,,,,,,0.100019318,Grade 2,0.185943985,,,,Stage IIB,,0.2415,,,,,,,,,,,,,,,,0.4043,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8579,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-2H-A9GI,Unknown,ESCA,,1,1,,,,1,,1,2.66,0.6,13,9,13,,,435,,,435,,1,1,400,400,,Malignant,35,,182,,,,25513,,,400,400,,,,,435,,,400,,,,,,,,WITH TUMOR,Dead,-25097,435,,,351,,400,400,,,[Not Available],[Not Available],,,,,0.23,Esophagus,Unknown,,,19,,1,0.32944,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Erasmus MC,,TCGA-2H-A9GI,,,,,,,,,Locoregional Recurrence,,,,,,,40,,,,,,,,,,,,,1999,400,,,,Stage III,,,,,,,,,,,,,,68,,,,,,,,,,,,,,,,,,,,88269,,,,,,,,,,,,,Grade 2,,,,,Stage III,,,Not Answered,,,,,,,,,,,,,,,,,,,,,Resection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.79,1,0,3,,,8008,BRCA_LumA,8008,8008,,0,0,8008,8008,,Invasive Carcinoma,4,,3,,,,26831,0,,8008,8008,,,,8008,8008,,,8008,,,,,,,,TUMOR FREE,Alive,-22077,,,,43,,8008,8008,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.030492,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RN,,,,,,,8008,,,,,,,,,4,,,,,,,,,,,,,1993,,,,,Stage IA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,88274,,-0.448960969,0,0,0,0,0.1122,1,,,Infiltrating Ductal Carcinoma,0.12383284,,0.1233159,0,0,0,,Negative,-0.8,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4112,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-HC-A8CY,,PRAD,370,0,0,,HC,,0,MALE,0,2.08,0.82,2,2,5,HRD,NO,290,2-ETV1,,290,,0,0,290,290,prad_tcga,Malignant,9,,37,,TCGA-HC-A8CY-01,0,5461,0,TCGA-HC-A8CY,290,290,Prostate Cancer,,290,,290,TCGA,,290,Primary,0,,A,,BRCA1,False,WITH TUMOR,Alive,-23154,,63,9,48,PRAD,290,290,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.05,Prostate,Resection,5,F3919F4C-E401-4EC4-96C5-A85BF0C398F8,4,Abnormal (not related to prostate cancer),0,0.033823,[Not Available],B6F54BDC-9B1B-4465-A6E3-F0524885E10E,4,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,HC,1.06666666667,TCGA-HC-A8CY,0:DiseaseFree,5,8,Prostate Adenocarcinoma,9.53,3/28/14,290,,,,,NO,C61,4CF73411-E5F6-43E1-8207-076C5C0FE921,70,4,WITH TUMOR,0.1393,0:LIVING,0.9,,9.53,Bilateral,16,No Evidence of Extraprostatic Extension,41,YES,153,2013,,,TCGA-HC-A8CY.4CF73411-E5F6-43E1-8207-076C5C0FE921.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,41,86-95%,3,Prostate Adenocarcinoma Acinar Type,1,2013,[Unknown],,,No,R1,,63,Core needle biopsy,,,YES,NO,YES,,T3a,,9,No,,0,N1,T1c,1,M0,C61.9,8140/3,88275,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-6803,White,STAD,,0,0,,,0,0,,0,1.83,0.3,2,2,1,,,949,,949,949,,0,0,949,949,,Malignant,5,,10,,,,18818,,,949,949,,,,949,949,,,949,,,,,,,,TUMOR FREE,Alive,-19751,,,,17,,949,949,,,[Not Available],[Not Applicable],,,,,0.23,Stomach,Unknown,,,3,,0,0.20548,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6803,,,,,,,949,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,88277,,0.647380817,,,,,,,,,,0.105155539,Grade 3,0.21839846,,,,Stage IIA,,0.4285,,,,,,,,,,,,,,,,0.4335,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6803,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,0,0,0,1,Male,TCGA-33-A5GW,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,1.73,0.82,10,13,10,,,9,,9,9,,2,2,9,9,,Malignant,33,,123,,,,21830,,,9,9,,,,9,9,,,9,,,,,,,,TUMOR FREE,Dead,-24586,9,,,266,,9,9,,,[Not Available],[Not Applicable],,,,,0.11,,,,,9,,0,0.38235,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-A5GW,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,88283,,-1.149413247,,,,,,,,,,0.086906121,,0.07282986,,,,Stage IIA,,0.1165,,,,,,,,,,,,,,,,-0.0019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,12.70910454,13.21871213,12.45301135,-1.15552207918939,LUSC,,17.30889349,14.10816003,Squamous Cell Carcinoma,,13.22355708,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-FD-A5BU,Black or African American,BLCA,,0.0,0,,,0,0,FEMALE,0.0,2.07,0.4,8,5,10,,,588,,588,588,,0.0,0,588.0,588.0,,Malignant,23,,52,,,,27867.0,,,588.0,588,,,,588,588,,,588.0,,,,,,,,TUMOR FREE,Alive,-27882,,,,91.0,,588.0,588,,,[Not Available],[Not Applicable],,,,,0.02,,,,,5,,0,0.22656,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5BU,,,,,,,588,,,,,,,,,14,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,88285,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1001,,1001,1001,,0,0,1001,1001,,Invasive Carcinoma,,,,,,,18051,0,,1001,1001,,,,1001,1001,,,1001,,,,,,,,TUMOR FREE,Alive,-28715,,,,0,,1001,1001,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A3Q9,,,,,,,1001,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,88287,,0.091972476,0,0,0,0,-0.4106,1,,,Infiltrating Lobular Carcinoma,0.16460275,,0.234967996,0,0,0,,Negative,-0.418,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1332,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-56-7730,White,LUSC,,1,1,,International Genomics Consortium,,1,MALE,1,3.09,0.8,9,10,19,,,198,,,198,,1,1,198,198,,Malignant,38,,57,,,,32572,,,198,198,,,,,198,,,198,,,,,,,,WITH TUMOR,Dead,-26699,198,,,500,,198,198,,,[Not Available],[Not Applicable],,,,,0.2,,,,,18,,1,0.39626,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7730,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,88293,,-0.899279538,,,,,,,,,,0.085304678,,0.008381839,,,,Stage IIA,,0.208,,,,,,,,,,,,,,,,-0.1331,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,"D589_T590del, C171F",1,,,"D589_T590del, C171F",12.81628002,14.83857935,14.26701348,-0.909960477389775,LUSC,,18.18953142,14.46323299,Squamous Cell Carcinoma,-2.2637,11.38947783,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,1,1,,,White,BRCA,,0,0,,,0,0,FEMALE,1,2.04,0.69,3,2,5,,,5176,BRCA_LumA,5176,5176,,0,0,4224,4224,,Invasive Carcinoma,10,,9,,,,24213,0,,5176,5176,,,,5176,5176,,,4224,,,,,,,,WITH TUMOR,Alive,-22905,,,,56,,5176,5176,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,7,,0,0.12227,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A2IU,,,,,,,5176,"Other, specify",New Primary Tumor,,,,,,,10,,,,,,,,,,,,,1998,4224,Lung,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,88295,,-0.569520469,0,0,0,0,0.9255,1,,,Infiltrating Lobular Carcinoma,0.096190912,,0.148022223,0,0,0,,Negative,-0.8315,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0124,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-18-3411,,LUSC,,0,0,,Princess Margaret Hospital (Canada),,0,FEMALE,0,4.44,0.53,11,16,23,,,3576,,,3576,,0,0,3576,3576,,Malignant,50,,54,,,,17592,,,3576,3576,,,,,3576,,,3576,,,,,,,,TUMOR FREE,Alive,-23370,,,,428,,3576,3576,,,[Not Available],[Not Applicable],,,,,0.29,,,,,17,,2,0.43286,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3411,,,,,,,3576,,,,,,,,,57,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,[Unknown],,,,,,63,,,,,,,,,,,,,,,,,,,,88296,,0.518095451,,,,,,,,,,0.20294882,,0.056320653,,,,Stage IIIA,,0.4255,,,,,,,,,,,,,,,,0.2839,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.81630023,16.36431795,15.86954689,-0.213565462183947,LUSC,,17.64258085,15.1534084,Squamous Cell Carcinoma,0.3837,13.40404852,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-HU-A4GT,Asian,STAD,,0,0,,,0,0,,0,2.22,0.78,1,2,3,,,198,,198,198,,0,0,198,198,,Malignant,6,,21,,,,16454,,,198,198,,,,198,198,,,198,,,,,,,,TUMOR FREE,Alive,-26231,,,,2139,,198,198,,,[Not Available],[Not Applicable],,,,,0.11,Stomach,Unknown,,,4,,0,0.012344,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4GT,,,,,,,198,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,88298,,-0.276297871,,,,,,,,,,0.055818821,Grade 3,0.002465965,,,,Stage IIA,,0.186,,,,,,,,,,,,,,,,-0.2685,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GT,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,522,,522,522,,0,0,522,522,,Invasive Carcinoma,,,,,,,18124,0,,522,522,,,,522,522,,,522,,,,,,,,TUMOR FREE,Alive,-13510,,,,0,,522,522,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XD,,,,,,,522,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,36,,,,,,,,,,,,,,,,,,,,88303,,-0.821594579,0,0,0,0,-0.3543,1,,,Infiltrating Ductal Carcinoma,0.117513736,,0.095407612,0,0,0,,Negative,-1.637,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4521,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-HU-8244,Asian,STAD,,0,0,,,0,0,,0,,,,,,,,742,,742,742,,0,0,742,742,,Malignant,,,,,,,28372,,,742,742,,,,742,742,,,742,,,,,,,,TUMOR FREE,Alive,-28184,,,,180,,742,742,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G1,,National Cancer Center Korea,,TCGA-HU-8244,,,,,,,742,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,88306,,,,,,,,,,,,,Grade 1,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-8244,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,1.99,0.6,7,3,7,,,1013,BRCA_LumA,,1013,,0,0,1013,1013,,Invasive Carcinoma,17,,54,,,,25725,0,,1013,1013,,,,,1013,,,1013,,,,,,,,TUMOR FREE,Alive,-25089,,,,63,,1013,1013,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,5,,0,0.13652,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A5QN,,,,,,,1013,,,,,,,,,6,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,88308,,0.237290905,1,0,0,0,0.367,0,,,Infiltrating Lobular Carcinoma,0.15144562,,0.21720395,0,0,0,,[Not Available],-0.1105,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.4553,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,"ADH, Columnar Lesion",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"None, Stromal Alterations",,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"ADH, Columnar Lesion",0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-94-8491,White,LUSC,,1,1,,Washington University - Emory,,0,MALE,1,1.84,0.52,14,27,23,,,810,,,810,,1,1,641,641,,Malignant,64,,141,,,,28605,,,641,641,,,,,810,,,641,,,,,,,,TUMOR FREE,Alive,-26698,,,,726,,641,641,,,[Not Available],[Not Applicable],,,,,0.3,,,,,5,,0,0.41551,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Emory,,TCGA-94-8491,,,,,,,810,,Distant Metastasis,,,,,,,16,,,,,,,,,,,,,2012,641,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,88311,,0.828316461,,,,,,,,,,0.169687571,,0.047005479,,,,Stage IIA,,1.1095,,,,,,,,,,,,,,,,0.1123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.93298144,16.02442962,14.25930886,-0.52362661198032,LUSC,Squamous Cell Carcinoma,18.32293321,16.09896023,Squamous Cell Carcinoma,-0.4267,13.27852146,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-G9-7509,,PRAD,,0,0,,G9,0,0,MALE,0,1.99,0.57,0,2,1,HRP,NO,1610,,1610,1610,,0,0,1610,1610,prad_tcga,Malignant,3,BRCA1,16,,TCGA-G9-7509-01,0,5382,0,TCGA-G9-7509,1610,1610,Prostate Cancer,,352,1610,1610,TCGA,,1610,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-17538,,48,6,28,PRAD,1610,1610,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.07,Prostate,Resection,3,a70549d1-2bc4-4a1e-977a-f24b1c70d4c0,0,,0,0.012005,[Not Available],7d0c6960-710f-42c7-889e-c3a7d4a30b3c,3,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,3,,Acinar Adenocarcinoma,[Not Available],0.4,G9,1.06666666667,TCGA-G9-7509,0:DiseaseFree,1,4,Prostate Adenocarcinoma,52.89,5/14/14,1610,,,,,NO,C61,CF612B37-B575-4D5B-A715-43EBEBEF7300,,0,TUMOR FREE,0.0096,0:LIVING,0.03,4,52.89,Bilateral,6,,,YES,,2009,,,TCGA-G9-7509.CF612B37-B575-4D5B-A715-43EBEBEF7300.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,1.0,48,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,6,No,NO,0,,T1c,,M0,C61.9,8550/3,88313,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-78-7159,White,LUAD,,0,0,,Prince Charles Hospital,0,0,FEMALE,0,3.82,0.29,3,8,16,,,1974,,1974,1974,,0,0,1974,1974,,Malignant,27,,10,,,,19530,,,1974,1974,,,,1974,1974,,,1974,,,,,,,,,Alive,-22261,,,,402,,1974,1974,,,[Not Available],[Not Applicable],,,,,0.61,,,,,20,,1,0.071383,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7159,,,,,,,1974,,,,,,,,,29,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,88318,,0.688074967,,,,,,,,,,0.171719946,,0.188241776,,,,Stage IA,,0.3345,,,,,,,,,,,,,,,,0.2099,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.455436573,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.3361,,-0.2623,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.93,0.5,6,3,9,,,2381,BRCA_Basal,2381,2381,,0,0,2381,2381,,None,18,,27,,,,21133,N/A (Non-Malignant),,2381,2381,,,,2381,2381,,,2381,,,,,,,,TUMOR FREE,Alive,-23628,,,,71,,2381,2381,,,[Not Available],[Not Applicable],,,,,0.59,Breast,Resection/Excision,,,8,,0,0.26552,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DL,,,,,,,2381,,,,,,,,,13,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,88320,,1.034602276,0,0,0,0,2.0083,1,,N/A (Non-Malignant),Other,0.203530155,N/A (Non-Malignant),0.064366472,0,0,0,N/A (Non-Malignant),Negative,1.559,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.146,1,0,H & E,0,0,,0,Yunjia Tang,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-69-7764,White,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,1.8,0.8,7,6,7,,,414,,,414,,0,0,414,414,,Malignant,20,,42,,,,20107,,,414,414,,,,,414,,,414,,,,,,,,TUMOR FREE,Alive,-27693,,,,119,,414,414,,,[Not Available],[Not Applicable],,,,,0.41,,,,,5,,0,0.25405,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7764,,,,,,,414,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,88332,,0.784712745,,,,,,,,,,0.140483305,,0.135882079,,,,Stage IA,,0.3775,,,,,,,,,,,,,,,,-0.0636,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.29847572,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.9866,,0.4567,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-ZF-AA4X,White,BLCA,,1.0,1,,,1,0,MALE,1.0,3.3,0.72,1,10,6,,,2044,,1665,2044,,1.0,1,1665.0,1665.0,,Malignant,17,,6,,,,22820.0,,,1665.0,1665,,,,1665,2044,,,1665.0,,,,,,,,WITH TUMOR,Alive,-20579,,,,849.0,,1665.0,1665,,,[Not Available],[Not Applicable],,,,,0.5,,,,,14,,1,0.010895,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA4X,,,,,,,2044,Bladder,Locoregional (Urothelial tumor event),,,,,,,21,,,,,,,,,,,,,2009,1665,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,88334,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FJ-A3ZE,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.91,0.96,9,10,13,,,324,,,324,,1.0,1,152.0,152.0,,Malignant,32,,91,,,,27513.0,,,152.0,152,,,,,324,,,152.0,,,,,,,,WITH TUMOR,Dead,-23866,324,,,582.0,,152.0,152,,,[Not Available],[Not Applicable],,,,,0.39,,,,,10,,0,0.25158,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3ZE,,,,,,,,Bone,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2012,152,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,65.0,,,,,,,,,,,,,,,,,,,,88341,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-R6-A8W8,White,ESCA,,1,1,,,,1,,1,2.73,0.72,10,24,23,,,88,,,88,,1,1,88,88,,Malignant,57,,215,,,,0,,,88,88,,,,,88,,,88,,,,,,,,WITH TUMOR,Dead,-26535,88,,,259,,88,88,,,[Not Available],Stage IIIA,,,,,0.04,Esophagus,Unknown,,,10,,1,0.39352,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,MD Anderson Cancer Center,,TCGA-R6-A8W8,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2012,,,,,[Not Available],,,,,,,,,,,,,,72,,,,,,,,,,,,,,,,,,,,88356,,,,,,,,,,,,,Grade 2,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,1,1,Male,TCGA-EJ-5525,White,PRAD,91,1,1,,EJ,,0,MALE,1,2.09,0.87,6,10,7,ambiguous,NO,1115,1-ERG,,1115,,1,1,546,546,prad_tcga,Malignant,23,BRCA2,24,4.0,TCGA-EJ-5525-01,30,5287,0,TCGA-EJ-5525,546,546,Prostate Cancer,,521,,1115,TCGA,,546,Primary,1,Apex|Base,A,,,,WITH TUMOR,Alive,-24535,,67,9,83,PRAD,546,546,WHITE,0.375931861,[Not Available],[Not Applicable],69,R0,1,Matched,0.0,Prostate,Resection,4,351af15c-b213-4621-8bcb-3f4ddcf72553,4,Normal (no evidence of prostate cancer) [cM0],0,0.1323,[Not Available],554a7381-46fd-4301-b91b-5af7f173c350,5,Prostate Adenocarcinoma Acinar Type,1.6,Prostate,24,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,2.23333333333,TCGA-EJ-5525,1:Recurred/Progressed,5,23,Prostate Adenocarcinoma,17.94,4/4/12,1115,Bone,Distant Metastasis,,,NO,C61,ab82e8b9-a3ba-48ef-ac3e-fd35c67a13e4,,7,WITH TUMOR,0.2169,0:LIVING,3.0,3,36.63,Bilateral,27,No Evidence of Extraprostatic Extension,-6,YES,,2009,546,,TCGA-EJ-5525.ab82e8b9-a3ba-48ef-ac3e-fd35c67a13e4.pdf,,[Not Applicable],YES,-6,71-80%,8,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,YES,No,R0,1.0,67,Core needle biopsy,338,,YES,NO,YES,,T2c,,9,No,,0,N0,T3a,0,M0,C61.9,8550/3,88358,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.72,1,0,3,,,3004,BRCA_LumA,3004,3004,,0,0,3004,3004,,Invasive Carcinoma,4,,4,,,,27748,0,,3004,3004,,,,3004,3004,,,3004,,,,,,,,TUMOR FREE,Alive,-19030,,,,57,,3004,3004,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.027818,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mixed Histology (please specify),,,,,,[Not Available],,Mayo,,TCGA-AR-A24X,,,,,,,3004,,,,,,,,,4,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,88368,,0.375939517,0,0,0,0,-0.526,1,,,Mixed Histology (NOS),0.127740507,,0.139553783,0,0,0,,Negative,-0.278,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3145,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-4547,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.91,0.49,12,11,19,,,2419,,2419,2419,,0,0,2419,2419,,Malignant,42,,169,,,,17065,,,2419,2419,,,,2419,2419,,,2419,,,,,,,,TUMOR FREE,Alive,-25056,,,,256,,2419,2419,,,[Not Available],[Not Applicable],,,,,0.02,,,,,12,,0,0.33781,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4547,,,,,,,2419,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,88371,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.7549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.460033798952849,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-44-6777,White,LUAD,,0,0,,Christiana Healthcare,2,2,FEMALE,2,1.82,0.34,4,1,7,,,987,,987,987,,2,2,987,987,,Malignant,12,,13,,,,18249,,,987,987,,,,987,987,,,987,,,,,,,,TUMOR FREE,Dead,-31234,987,,,494,,987,987,,,[Not Available],[Not Applicable],,,,,0.55,,,,,17,,0,0.37111,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6777,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,85,,,,,,,,,,,,,,,,,,,,88375,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.7154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.047761821,LUAD,,,,Adenocarcinoma,1.3298,,-0.172,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-FP-A8CX,White,STAD,,0,0,,,,0,,0,3.1,0.27,4,6,13,,,7,,,7,,0,0,7,7,,Malignant,23,,67,,,,23539,,,7,7,,,,,7,,,7,,,,,,,,TUMOR FREE,Alive,-22000,,,,118,,7,7,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,17,,1,0.075774,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,International Genomics Consortium,,TCGA-FP-A8CX,,,,,,,7,,,,,,,,,27,,,,,,,,,,,,,2013,,,,,Stage IIIC,,,,,,,,[Unknown],,,,,,60,,,,,,,,,,,,,,,,,,,,88377,,-0.010100512,,,,,,,,,,0.082772752,Grade 3,0.036534135,,,,Stage IIIC,,0.5815,,,,,,,,,,,,,,,,-0.0023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-A8CX,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.1,0.57,7,14,12,,,552,BRCA_LumA,,552,,0,0,552,552,,Invasive Carcinoma,33,,31,,,,18613,0,,552,552,,,,,552,,,552,,,,,,,,TUMOR FREE,Alive,-32872,,,,74,,552,552,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,6,,0,0.12831,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A25D,,,,,,,552,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,88380,,1.611751509,0,0,0,0,0.1352,1,,,Infiltrating Lobular Carcinoma,0.163727514,,0.250967635,0,0,0,,Positive,1.0465,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0375,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-A46H,,PRAD,,0,0,,EJ,0,0,MALE,0,2.0,0.29,0,0,0,HRP,NO,724,,724,724,,0,0,724,724,prad_tcga,Malignant,0,,5,,TCGA-EJ-A46H-01,0,5339,0,TCGA-EJ-A46H,724,724,Prostate Cancer,,131,724,724,TCGA,,724,Primary,0,,A,,,True,TUMOR FREE,Alive,-22059,,60,7,3,PRAD,724,724,,0.0,[Not Available],[Not Applicable],2,,1,Matched,0.0,Prostate,Resection,3,13A361C3-CE9D-447C-BDDD-A7AA9A1ABCFE,0,Normal (no evidence of prostate cancer) [cM0],0,0.000198,[Not Available],CEC1D2FF-36E6-497E-892C-B329724B4722,4,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,EJ,0.0666666666667,TCGA-EJ-A46H,0:DiseaseFree,2,0,Prostate Adenocarcinoma,23.78,1/24/13,724,,,,,,C61,CF251041-E282-4840-9652-67665E7B10BB,1800,0,TUMOR FREE,0.0,0:LIVING,0.1,,23.78,Bilateral,2,,,YES,188,2012,,,TCGA-EJ-A46H.CF251041-E282-4840-9652-67665E7B10BB.pdf,,[Not Applicable],,-6,,6,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,60,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,,M0,C61.9,8140/3,88382,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,648,,648,648,,0,0,648,648,,Invasive Carcinoma,,,,,,,18482,0,,648,648,,,,648,648,,,648,,,,,,,,TUMOR FREE,Alive,-17157,,,,0,,648,648,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A4RY,,,,,,,648,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,88385,,0.302402111,0,0,0,0,0.177,1,,,Infiltrating Lobular Carcinoma,0.132231128,,0.232503946,0,0,0,,Negative,0.0265,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5311,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.89,0.73,9,21,20,,,1074,BRCA_Basal,1074,1074,,0,0,1074,1074,,Invasive Carcinoma,50,,65,,,,16331,0,,1074,1074,,,,1074,1074,,,1074,,,,,,,,TUMOR FREE,Alive,-20863,,,,200,,1074,1074,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,9,,1,0.29661,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0CE,,,,,,,1074,,,,,,,,,35,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,88389,,0.063486938,0,0,0,0,0.8913,1,,,Infiltrating Ductal Carcinoma,0.120387601,,0.139598174,0,0,0,,Negative,-0.2705,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2275,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-77-A5G3,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,3.62,0.65,7,22,23,,,4570,,4570,4570,,0,0,4570,4570,,Malignant,52,,60,,,,19181,,,4570,4570,,,,4570,4570,,,4570,,,,,,,,TUMOR FREE,Alive,-23171,,,,847,,4570,4570,,,[Not Available],[Not Applicable],,,,,0.5,,,,,15,,1,0.21425,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5G3,,,,,,,4570,,,,,,,,,33,,,,,,,,,,,,,2002,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,88399,,0.618581212,,,,,,,,,,0.148154757,,-0.02126001,,,,Stage IIB,,1.952,,,,,,,,,,,,,,,,0.2784,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.52449932,14.87121739,16.81645838,-0.430934939647063,LUSC,Squamous Cell Carcinoma,17.76196412,15.99740228,Squamous Cell Carcinoma,-0.2455,13.55149356,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-43-7656,White,LUSC,,0,0,,Christiana Healthcare,0,0,MALE,0,1.75,0.59,9,9,13,,,596,,596,596,,0,0,596,596,,Malignant,31,,47,,,,16968,,,596,596,,,,596,596,,,596,,,,,,,,TUMOR FREE,Alive,-25991,,,,444,,596,596,,,[Not Available],[Not Applicable],,,,,0.07,,,,,10,,0,0.40099,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-7656,,,,,,,596,,,,,,,,,17,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,88404,,1.465542384,,,,,,,,,,0.172379457,,0.112081,,,,Stage IA,,1.8605,,,,,,,,,,,,,,,,0.243,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.100380320322198,LUSC,,,,Squamous Cell Carcinoma,0.4495,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-66-2778,,LUSC,,0,0,,Indivumed,0,0,FEMALE,0,1.93,0.38,7,3,9,,,578,,578,578,,0,0,578,578,,Malignant,19,,22,,,,22027,,,578,578,,,,578,578,,,578,,,,,,,,TUMOR FREE,Alive,-25080,,,,196,,578,578,,,[Not Available],[Not Applicable],,,,,0.09,,,,,9,,0,0.37476,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2778,,,,,,,578,,,,,,,,,16,,,,,,,,,,,,,2007,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,88406,,0.147755284,,,,,,,,,,0.20849176,,0.035894626,,,,Stage IIIB,,-0.2055,,,,,,,,,,,,,,,,-0.1629,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.01393724,16.07557487,14.04760526,-0.407940665297519,LUSC,Squamous Cell Carcinoma,17.74297843,15.07507168,Squamous Cell Carcinoma,-0.0476,15.84979658,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-DK-A3IU,White,BLCA,,1.0,1,,,1,1,MALE,1.0,2.48,0.27,2,4,5,,,706,,462,706,,1.0,1,462.0,462.0,,Malignant,11,,8,,,,22805.0,,,462.0,462,,,,462,706,,,462.0,,,,,,,,WITH TUMOR,Dead,-21369,706,,,541.0,,462.0,462,,,[Not Available],[Not Applicable],,,,,0.39,,,,,7,,0,0.17005,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IU,,,,,,,,Lung,Distant Metastasis,,,,,,,18,,,,,,,,,,,,,2011,462,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,88409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-LA-A7SW,Black or African American,LUSC,,1,1,,Candler,,1,MALE,1,2.33,0.48,20,22,22,,,408,,,408,,1,1,235,235,,Malignant,64,,301,,,,25348,,,235,235,,,,,408,,,235,,,,,,,,WITH TUMOR,Dead,-26116,408,,,128,,235,235,,,[Not Available],[Not Applicable],,,,,0.29,,,,,9,,1,0.47549,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Candler,,TCGA-LA-A7SW,,,,,,,,,Locoregional Recurrence,,,,,,,46,,,,,,,,,,,,,2013,235,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,88411,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.2653,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),E3K,,1,,E3K,,14.8897548,16.14675793,10.78972855,-0.919012785893684,LUSC,Squamous Cell Carcinoma,17.87098975,14.0823609,Squamous Cell Carcinoma,1.1715,13.74136683,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-MP-A4TF,White,LUAD,,1,1,,Washington University - Mayo Clinic,,1,FEMALE,1,4.86,0.29,11,19,22,,,336,,,336,,1,1,195,195,,Malignant,52,,94,,,,27755,,,195,195,,,,,336,,,195,,,,,,,,WITH TUMOR,Dead,-21387,336,,,573,,195,195,,,[Not Available],[Not Applicable],,,,,0.39,,,,,23,,2,0.37586,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TF,,,,,,,,,Distant Metastasis,,,,,,,55,,,,,,,,,,,,,2010,195,,,,Stage IIA,,,,,,,,Partial Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,88414,,0.51548843,,,,,,,,,,0.140968829,,0.015021598,,,,Stage IIA,,1.1685,,,,,,,,,,,,,,,,0.1757,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),"G12C (driver), AMP (driver)",,1,,G12C (driver),,14.7153089,15.01066023,16.69147513,-0.377416911,LUAD,Adenocarcinoma,17.86358251,15.5904138,Adenocarcinoma,-0.5037,14.22117452,-0.3508,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-KK-A59Z,,PRAD,285,0,0,,KK,,0,MALE,0,4.17,0.8,4,10,5,ambiguous,NO,2628,5-SPOP,,2628,,0,0,2628,2628,prad_tcga,Malignant,19,PALB2;RAD54L,54,3.5,TCGA-KK-A59Z-01,0,5496,0,TCGA-KK-A59Z,2628,2628,Prostate Cancer,,849,,2628,TCGA,,2628,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-24306,,66,7,65,PRAD,2628,2628,,0.0,[Not Available],[Not Applicable],52,R0,1,Matched,0.34,Prostate,Resection,4,CE99D7F7-F2BC-4246-8849-4752353475B3,12,Normal (no evidence of prostate cancer) [cM0],1,0.071254,[Not Available],DF7BBD9C-0B35-4855-ACDE-46F4956F4DF1,3,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,KK,1.76666666667,TCGA-KK-A59Z,0:DiseaseFree,3,26,Prostate Adenocarcinoma,86.33,5/28/13,2628,,,,,NO,C61,DDF6F24F-4406-49EE-9EE0-7129D8544677,260,17,TUMOR FREE,0.3999,0:LIVING,0.1,,86.33,Bilateral,35,No Evidence of Extraprostatic Extension,20,YES,1985,2007,,,TCGA-KK-A59Z.DDF6F24F-4406-49EE-9EE0-7129D8544677.pdf,Peripheral Zone,[Not Applicable],YES,24,41-50%,2,Prostate Adenocarcinoma Acinar Type,1,2007,[Not Applicable],,NO,No,R0,,66,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,88419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2ES,White,BLCA,,0.0,0,,,,1,MALE,1.0,2.01,0.55,4,2,10,,,1004,,,1004,,2.0,2,897.0,897.0,,Malignant,16,,44,,,,23501.0,,,1004.0,1004,,,,,1004,,,897.0,,,,,,,,WITH TUMOR,Dead,-31293,1004,,,659.0,,1004.0,1004,,,[Not Available],[Not Applicable],,,,,0.03,,,,,4,,0,0.28582,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2ES,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2009,897,,,,Stage II,,,,,,,,Progressive Disease,,,,,,85.0,,,,,,,,,,,,,,,,,,,,88430,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-EJ-5524,White,PRAD,91,1,1,,EJ,,0,MALE,1,1.91,0.61,5,6,7,HRD,NO,1882,1-ERG,,1882,,1,1,265,265,prad_tcga,Malignant,18,BRCA1;CDK12;RAD51D,45,3.8,TCGA-EJ-5524-01,0,5286,0,TCGA-EJ-5524,265,265,Prostate Cancer,,811,,1882,TCGA,,265,Primary,0,Base,A,,CHEK2;PALB2,,WITH TUMOR,Alive,-20854,,57,9,48,PRAD,265,265,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.08,Prostate,Resection,4,c197a81d-2aa5-4285-88e3-761798e2c190,0,,0,0.093838,[Not Available],4048c139-1329-4e6a-8d2f-c0aa104a68ee,5,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,19,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,1.3,TCGA-EJ-5524,1:Recurred/Progressed,5,19,Prostate Adenocarcinoma,8.71,4/4/12,1882,,Locoregional Recurrence,,,NO,C61,1f767c93-41f5-45d1-917f-3f1fc5330fb9,,3,WITH TUMOR,0.0951,0:LIVING,0.1,3,61.83,Bilateral,22,,,YES,,2009,265,,TCGA-EJ-5524.1f767c93-41f5-45d1-917f-3f1fc5330fb9.pdf,,[Not Applicable],NO,,66-75%,17,Prostate Adenocarcinoma Acinar Type,1,2009,Progressive Disease,,NO,No,R0,1.0,57,Core needle biopsy,,,YES,NO,YES,,T3a,,9,No,,0,N0,T2b,0,M0,C61.9,8550/3,88436,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.34,6,3,6,,,1247,BRCA_LumA,1247,1247,,0,0,1247,1247,,Invasive Carcinoma,15,,43,,,,18254,0,,1247,1247,,,,1247,1247,,,1247,,,,,,,,TUMOR FREE,Alive,-25289,,,,68,,1247,1247,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,10,,0,0.2344,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0H9,,,,,,,1247,,,,,,,,,10,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,88437,,-0.734087312,0,0,0,0,0.0491,1,,,Infiltrating Ductal Carcinoma,0.121121262,,0.11313861,0,0,0,,Negative,-1.623,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1449,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-G2-A2EJ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.09,0.61,9,4,7,,,1460,,910,1460,,1.0,1,910.0,910.0,,Malignant,20,,60,,,,25884.0,,,910.0,910,,,,910,1460,,,910.0,,,,,,,,TUMOR FREE,Alive,-20649,,,,428.0,,910.0,910,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.13654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EJ,,,,,,,1460,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2009,910,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,88438,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-D7-6524,White,STAD,,1,1,,,,0,,1,2.13,0.18,0,1,1,,,543,,,543,,1,1,543,543,,Malignant,2,,3,,,,16734,,,543,543,,,,,543,,,543,,,,,,,,WITH TUMOR,Alive,-19532,,,,132,,543,543,,,[Not Available],[Not Applicable],,,,,0.1,Stomach,Unknown,,,2,,0,0.099936,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6524,,,,,,,543,Non-regional / Distant Lymph Nodes,Locoregional Recurrence,,,,,,,7,,,,,,,,,,,,,2010,543,,,,Stage II,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,88447,,-0.014980596,,,,,,,,,,0.139194424,Grade 3,0.2246571,,,,Stage II,,0.4195,,,,,,,,,,,,,,,,0.8605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6524,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,,1,1,Male,TCGA-77-8007,,LUSC,,1,,,Prince Charles Hospital,,,MALE,1,3.23,0.21,9,9,15,,,198,,,198,,1,,139,139,,Malignant,33,,31,,,,25302,,,139,,,,,,198,,,139,,,,,,,,,Dead,-25102,198,,,115,,139,,,,[Not Available],[Not Applicable],,,,,0.38,,,,,17,,1,0.40304,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8007,,,,,,,,,,,,,,,,33,,,,,,,,,,,,,2001,139,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,88452,,1.216225241,,,,,,,,,,0.284568958,,0.108689954,,,,Stage IIB,,2.3195,,,,,,,,,,,,,,,,0.6162,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.26991205,18.18698617,17.42325774,-0.0180708056943715,LUSC,Squamous Cell Carcinoma,17.86458576,16.65114802,Squamous Cell Carcinoma,0.8701,14.86660821,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A6ME,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.98,0.79,9,4,9,,,731,,731,731,,0.0,0,731.0,731.0,,Malignant,22,,76,,,,18969.0,,,731.0,731,,,,731,731,,,731.0,,,,,,,,TUMOR FREE,Alive,-27670,,,,179.0,,731.0,731,,,[Not Available],[Not Applicable],,,,,0.34,,,,,7,,0,0.19379,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A6ME,,,,,,,731,,,,,,,,,11,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,88462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.74,0.46,14,33,30,,,21,BRCA_Basal,21,21,,0,0,21,21,,Invasive Carcinoma,77,,74,,,,29700,0,,21,21,,,,21,21,,,21,,,,,,,,TUMOR FREE,Alive,-19778,,,,149,,21,21,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,13,,2,0.23374,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A244,,,,,,,21,,,,,,,,,78,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,88471,,0.057532319,0,0,0,0,1.8065,1,,,Infiltrating Ductal Carcinoma,0.157524003,,0.07519425,0,0,0,,Negative,-1.268,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2434,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-MP-A4SV,Unknown,LUAD,,0,0,,Washington University - Mayo Clinic,2,,MALE,2,3.29,0.36,5,16,21,,,2620,,2620,2620,,2,2,2620,2620,,Malignant,42,,61,,,,33188,,,2620,2620,,,,2620,2620,,,2620,,,,,,,,,Dead,-24516,2620,,,454,,2620,2620,,,[Not Available],[Not Applicable],,,,,0.58,,,,,17,,1,0.1702,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4SV,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,88474,,1.394870337,,,,,,,,,,0.219169211,,0.115245321,,,,Stage IB,,1.888,,,,,,,,,,,,,,,,0.2055,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.070883656,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.196,,0.9285,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.74,0.73,5,2,2,,,385,BRCA_LumA,385,385,,0,0,385,385,,Invasive Carcinoma,9,,11,,,,26072,0,,385,385,,,,385,385,,,385,,,,,,,,TUMOR FREE,Alive,-22889,,,,70,,385,385,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,8,,1,0.10255,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12X,,,,,,,385,,,,,,,,,9,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,88475,,-0.913728435,0,0,0,0,0.4588,1,,,Mucinous Carcinoma,0.106707714,,0.166717941,0,0,0,,Negative,-0.768,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0779,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-G2-A2EO,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.23,0.37,1,3,7,,,1804,,1804,1804,,2.0,2,1804.0,1804.0,,Malignant,11,,27,,,,25306.0,,,1804.0,1804,,,,1804,1804,,,1804.0,,,,,,,,TUMOR FREE,Dead,-25440,1804,,,1247.0,,1804.0,1804,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.10692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EO,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,88476,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-22-5489,White,LUSC,,1,,,Mayo Clinic - Rochester,1,1,MALE,1,2.14,0.43,7,10,14,,,1912,,428,1912,,1,,428,428,,Malignant,31,,47,,,,18637,,,428,,,,,428,1912,,,428,,,,,,,,WITH TUMOR,Dead,-23618,1912,,,314,,428,,,,[Not Available],[Not Applicable],,,,,0.14,,,,,11,,0,0.40287,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5489,,,,,,,1912,,,,,,,,,18,,,,,,,,,,,,,2003,428,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,88477,,1.543239451,,,,,,,,,,0.257669342,,0.16366344,,,,Stage IA,,1.968,,,,,,,,,,,,,,,,0.6459,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.108283833041961,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6275,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,1,1,Male,TCGA-56-8623,White,LUSC,,0,0,,International Genomics Consortium,2,2,MALE,1,,,,,,,,692,,692,692,,2,2,645,645,,Malignant,,,,,,,27810,,,692,692,,,,692,692,,,645,,,,,,,,TUMOR FREE,Dead,-26231,692,,,0,,692,692,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8623,,,,,,,,,New Primary Tumor,,,,,,,,,,,,,,,,,,,,2012,645,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,88481,,0.51625732,,,,,,,,,,0.335597689,,0.295859454,,,,Stage IB,,1.482,,,,,,,,,,,,,,,,0.2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,not profiled,not profiled,not profiled,,,,-0.0431445257587238,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.7635,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,418,,418,418,,0,0,418,418,,Invasive Carcinoma,,,,,,,20968,0,,418,418,,,,418,418,,,418,,,,,,,,TUMOR FREE,Alive,-20539,,,,0,,418,418,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A4SB,,,,,,,418,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,88482,,-0.713791583,0,0,0,0,0.2885,1,,,Infiltrating Lobular Carcinoma,0.070339834,,0.222310113,0,0,0,,Negative,-0.5245,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1953,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.72,0.7,12,15,20,,,647,BRCA_LumB,647,647,,0,0,647,647,,Invasive Carcinoma,47,,85,,,,31450,0,,647,647,,,,647,647,,,647,,,,,,,,TUMOR FREE,Alive,-22788,,,,52,,647,647,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,17,,1,0.307,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1RG,,,,,,,647,,,,,,,,,40,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,88483,,0.246438082,0,0,0,0,0.2282,1,,,Infiltrating Ductal Carcinoma,0.138903021,,0.088305227,0,0,0,,Negative,-0.368,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2676,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7212,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.91,0.78,5,6,4,HRD,NO,870,1-ERG,870,870,,0,0,870,870,prad_tcga,Malignant,15,,15,8.0,TCGA-HC-7212-01,0,5410,0,TCGA-HC-7212,870,870,Prostate Cancer,,424,870,870,TCGA,,870,Primary,0,,A,,ATM;BRCA2;CHEK1;CHEK2,,TUMOR FREE,Alive,-20576,,56,7,24,PRAD,870,870,WHITE,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,3,92888479-b534-432d-8f70-cae857e0074b,0,,0,0.089141,[Not Available],907b64d6-a26a-4092-a247-ac9af444d1c7,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.43333333333,TCGA-HC-7212,0:DiseaseFree,2,15,Prostate Adenocarcinoma,28.58,4/11/12,870,,,,,,C61,b401d78b-78c2-4e6e-86db-c93997da85a4,,4,,0.0854,0:LIVING,0.28,,28.58,Right,18,,,YES,,2011,,,TCGA-HC-7212.b401d78b-78c2-4e6e-86db-c93997da85a4.pdf,,[Not Applicable],,,51-60%,4,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,,0.8,56,Core needle biopsy,,,YES,NO,YES,,T2a,,7,No,,0,N0,,0,M0,C61.9,8550/3,88490,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-FD-A43Y,White,BLCA,,0.0,0,,,2,2,MALE,2.0,2.02,0.44,18,8,12,,,474,,474,474,,2.0,2,474.0,474.0,,Malignant,38,,102,,,,18471.0,,,474.0,474,,,,474,474,,,474.0,,,,,,,,TUMOR FREE,Dead,-23889,474,,,89.0,,474.0,474,,,[Not Available],[Not Applicable],,,,,0.18,,,,,6,,0,0.33049,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A43Y,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,65.0,,,,,,,,,,,,,,,,,,,,88492,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-78-8660,Unknown,LUAD,,1,1,,Prince Charles Hospital,,1,MALE,1,1.96,0.33,7,8,9,,,321,,,321,,1,1,242,242,,Malignant,24,,59,,,,33970,,,242,242,,,,,321,,,242,,,,,,,,WITH TUMOR,Dead,-25422,321,,,338,,242,242,,,[Not Available],[Not Applicable],,,,,0.41,,,,,7,,0,0.22964,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-8660,,,,,,,,,Distant Metastasis,,,,,,,12,,,,,,,,,,,,,2005,242,,,,Stage IIB,,,,,,,,[Unknown],,,,,,69,,,,,,,,,,,,,,,,,,,,88493,,1.271787471,,,,,,,,,,0.229187218,,0.152074902,,,,Stage IIB,,1.9665,,,,,,,,,,,,,,,,0.0835,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.06268881,17.26462409,17.88768797,-0.00570701,LUAD,Adenocarcinoma,18.09365326,16.75253243,Adenocarcinoma,-0.4443,13.44026467,0.8816,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-55-1594,White,LUAD,,0,0,,International Genomics Consortium,,0,MALE,0,3.26,0.55,10,7,16,,,1178,,,1178,,0,0,1178,1178,,Malignant,33,,43,,,,21763,,,1178,1178,,,,,1178,,,1178,,,,,,,,TUMOR FREE,Alive,-25008,,,,268,,1178,1178,,,[Not Available],[Not Applicable],,,,,0.12,,,,,21,,1,0.3136,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-1594,,,,,,,1178,,,,,,,,,30,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,88501,,0.363053437,,,,,,,,,,0.195449882,,0.08402141,,,,Stage IIIA,,0.911,,,,,,,,,,,,,,,,-0.0452,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,15.42836705,16.78838889,16.23471829,-0.424992385,LUAD,,17.69612547,16.35675971,Adenocarcinoma,-0.2696,13.61935894,-0.2513,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-05-4405,,LUAD,,0,0,,Indivumed,,0,FEMALE,0,3.21,0.38,7,3,11,,,610,,,610,,0,0,610,610,,Malignant,21,,24,,,,27136,,,610,610,,,,,610,,,610,,,,,,,,TUMOR FREE,Alive,-27241,,,,486,,610,610,,,[Not Available],[Not Applicable],,,,,0.49,,,,,22,,1,0.2938,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4405,,,,,,,610,,,,,,,,,31,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,74,,,,,,,,,,,,,,,,,,,,88507,,-0.070443115,,,,,,,,,,0.240308183,,0.172768958,,,,Stage IB,,0.7115,,,,,,,,,,,,,,,,0.4508,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.430653834,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.5031,,0.0253,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-50-8459,White,LUAD,,1,1,,University of Pittsburgh,,0,MALE,1,1.9,0.29,3,3,1,,,1119,,,1119,,1,1,432,432,,Malignant,7,,28,,,,20102,,,432,432,,,,,1119,,,432,,,,,,,,WITH TUMOR,Alive,-24859,,,,123,,432,432,,,[Not Available],[Not Applicable],,,,,0.1,,,,,4,,0,0.11909,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-8459,,,,,,,1119,,Locoregional Recurrence,,,,,,,3,,,,,,,,,,,,,2012,432,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,68,,,,,,,,,,,,,,,,,,,,88508,,1.05911999,,,,,,,,,,0.304882577,,0.201912525,,,,Stage IIB,,1.0745,,,,,,,,,,,,,,,,1.1779,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12C (driver), AMP (driver)",,1,,G12C (driver),,17.22361292,18.87502032,14.72273952,-0.175164331,LUAD,Adenocarcinoma,18.42076537,16.27566901,Adenocarcinoma,2.1232,14.50817813,0.017,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-38-A44F,White,LUAD,,0,0,,UNC,0,0,MALE,0,2.02,0.26,0,0,0,,,133,,133,133,,0,0,133,133,,Malignant,0,,6,,,,24058,,,133,133,,,,133,133,,,133,,,,,,,,TUMOR FREE,Alive,-29534,,,,20,,133,133,,,[Not Available],[Not Applicable],,,,,0.13,,,,,1,,0,0.0013234,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-A44F,,,,,,,133,,,,,,,,,1,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,88513,,1.099900944,,,,,,,,,,0.254693607,,0.20340922,,,,Stage IB,,0.686,,,,,,,,,,,,,,,,0.345,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.020479112,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1015,,0.2609,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,5.32,0.68,10,17,27,,,1563,BRCA_LumB,1563,1563,,2,2,1563,1563,,Invasive Carcinoma,54,,62,,,,18489,0,,1563,1563,,,,1563,1563,,,1563,,,,,,,,TUMOR FREE,Dead,-26426,1563,,,178,,1563,1563,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,20,,2,0.19483,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18U,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,2003,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,88514,,0.542270161,0,0,0,0,-1.2412,1,,,Infiltrating Ductal Carcinoma,0.19028439,,0.099966954,0,0,0,,Negative,0.15,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2921,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-39-5036,White,LUSC,,0,0,,MSKCC,0,0,MALE,0,1.77,0.64,9,6,9,,,2165,,2165,2165,,0,0,2165,2165,,Malignant,24,,26,,,,27895,,,2165,2165,,,,2165,2165,,,2165,,,,,,,,TUMOR FREE,Alive,-26963,,,,333,,2165,2165,,,[Not Available],[Not Applicable],,,,,0.57,,,,,16,,0,0.39336,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5036,,,,,,,2165,,,,,,,,,16,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,88515,,0.668140249,,,,,,,,,,0.153197668,,-0.051186884,,,,Stage IB,,0.8615,,,,,,,,,,,,,,,,-0.2353,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G423V (driver),1,,,G423V (driver),,,,-0.501944269375573,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-2.1367,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.77,0.62,19,8,16,,,1780,BRCA_Basal,1780,1780,,0,0,1780,1780,,Invasive Carcinoma,43,,204,,,,18794,0,,1780,1780,,,,1780,1780,,,1780,,,,,,,,TUMOR FREE,Alive,-25643,,,,94,,1780,1780,,,[Not Available],[Not Applicable],,,,,0.55,Breast,Resection/Excision,,,10,,0,0.42607,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A5D7,,,,,,,1780,,,,,,,,,15,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,88517,,1.563189528,0,0,0,0,-1.3234,1,,,Infiltrating Ductal Carcinoma,0.143084856,,0.033879847,0,0,0,,Negative,1.409,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2315,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OF,,PRAD,,0,0,,V1,0,0,MALE,0,1.98,0.81,1,2,0,HRD,NO,1184,,1184,1184,,0,0,1184,1184,prad_tcga,Malignant,3,,28,,TCGA-V1-A9OF-01,0,5574,0,TCGA-V1-A9OF,1184,1184,Prostate Cancer,,1184,1184,1184,TCGA,,1184,Primary,0,Apex,A,CDK12:349-355:SRKSMKS/SX:frameshift_variant,,True,,Alive,-18250,,49,6,15,PRAD,1184,1184,,0.0,[Not Available],[Not Applicable],21,,1,Matched,0.0,Prostate,Resection,3,2C17D9BE-A1E8-4C37-879C-C8BAB565B3FB,0,,0,0.024024,[Not Available],D4DC7C5C-45B3-4741-B0C1-FEE477DA2EF4,3,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,V1,0.7,TCGA-V1-A9OF,0:DiseaseFree,1,3,Prostate Adenocarcinoma,38.9,7/23/14,1184,,,,,NO,C61,1C729709-EE1B-421E-A55A-7A048806FA6A,20,0,,0.0223,0:LIVING,0.01,,38.9,Bilateral,4,,,YES,,,,,TCGA-V1-A9OF.1C729709-EE1B-421E-A55A-7A048806FA6A.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,49,Core needle biopsy,,,NO,YES,NO,NO,T2c,NO,6,No,NO,,,T1c,,M0,C61.9,8140/3,88518,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-8619,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.1,0.24,0,3,0,,,416,,416,416,,0,0,416,416,,Malignant,3,,6,,,,17296,,,416,416,,,,416,416,,,416,,,,,,,,TUMOR FREE,Alive,-26616,,,,30,,416,416,,,[Not Available],[Not Applicable],,,,,0.81,,,,,1,,0,0.000298,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8619,,,,,,,416,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,88522,,1.132822976,,,,,,,,,,0.282271357,,0.257806316,,,,Stage IIB,,1.4665,,,,,,,,,,,,,,,,0.3499,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.48314403,18.68382619,15.8569492,-0.016123548,LUAD,Adenocarcinoma,18.45454354,16.60637355,Adenocarcinoma,-0.3282,14.57669815,0.7456,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-91-A4BD,White,LUAD,,0,0,,ABS - IUPUI,0,0,MALE,0,1.99,0.55,2,0,2,,,603,,603,603,,0,0,603,603,,Malignant,4,,22,,,,29429,,,603,603,,,,603,603,,,603,,,,,,,,TUMOR FREE,Alive,-28544,,,,52,,603,603,,,[Not Available],[Not Applicable],,,,,0.0,,,,,6,,0,0.079265,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ABS - IUPUI,,TCGA-91-A4BD,,,,,,,603,,,,,,,,,4,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,88523,,0.268498905,,,,,,,,,,0.236236539,,0.104914164,,,,Stage IIA,,-0.165,,,,,,,,,,,,,,,,-0.5398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.53946868,17.94933299,15.0680566,-0.300030823,LUAD,Adenocarcinoma,18.335009,15.06043997,Adenocarcinoma,1.2259,12.9898252,-0.8278,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-D7-6525,White,STAD,,1,1,,,,1,,1,1.85,0.63,7,7,9,,,406,,,406,,1,1,171,171,,Malignant,23,,52,,,,19628,,,171,171,,,,,406,,,171,,,,,,,,WITH TUMOR,Dead,-21223,406,,,210,,171,171,,,[Not Available],[Not Applicable],,,,,0.19,Stomach,Unknown,,,6,,0,0.22457,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6525,,,,,,,,,Distant Metastasis,,,,,,,13,,,,,,,,,,,,,2010,171,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,58,,,,,,,,,,,,,,,,,,,,88525,,-0.06894588,,,,,,,,,,0.093414739,Grade 3,0.00763631,,,,Stage IIIA,,1.2085,,,,,,,,,,,,,,,,0.4007,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6525,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.93,0.91,20,30,25,,,10,BRCA_Basal,10,10,,0,0,10,10,,Invasive Carcinoma,75,,161,,,,26422,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-20152,,,,186,,10,10,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,9,,0,0.46552,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0AR,,,,,,,10,,,,,,,,,21,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,88526,TRUE,-0.195660468,0,0,0,0,-0.8359,1,,,Infiltrating Ductal Carcinoma,0.097545132,,0.050176336,0,0,0,,Negative,-1.3215,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1127,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-L9-A50W,Black or African American,LUAD,,1,1,,Candler,1,1,MALE,1,1.92,0.76,10,5,6,,,442,,389,442,,1,1,389,389,,Malignant,21,,71,,,,19049,,,389,389,,,,389,442,,,389,,,,,,,,WITH TUMOR,Dead,-27414,442,,,44,,389,389,,,[Not Available],[Not Applicable],,,,,0.01,,,,,10,,0,0.1786,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Candler,,TCGA-L9-A50W,,,,,,,,,Distant Metastasis,,,,,,,8,,,,,,,,,,,,,2012,389,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,88527,,0.221983676,,,,,,,,,,0.156445814,,0.122622304,,,,Stage IIA,,0.352,,,,,,,,,,,,,,,,0.1742,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), T790M (driver)",,,1,"L858R (driver), T790M (driver)",,,15.06340684,14.88522997,15.05589664,-0.31715514,LUAD,Adenocarcinoma,18.27153681,14.90794257,Adenocarcinoma,-0.7273,11.16609238,-1.2888,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-KK-A6E5,,PRAD,315,0,0,,KK,0,0,MALE,0,1.9,0.61,7,11,4,ambiguous,NO,2073,8-other,2073,2073,,0,0,2073,2073,prad_tcga,Malignant,22,,97,9.4,TCGA-KK-A6E5-01,8,5504,0,TCGA-KK-A6E5,2073,2073,Prostate Cancer,,1496,2073,2073,TCGA,,2073,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23144,,63,7,23,PRAD,2073,2073,,0.363771701,[Not Available],[Not Applicable],21,R0,1,Matched,0.09,Prostate,Resection,4,A0A82F7B-1761-4002-B494-3B0887292651,1,Normal (no evidence of prostate cancer) [cM0],0,0.096906,[Not Available],0FB599CE-5E10-4571-8160-4F5160791A3F,3,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,KK,0.7,TCGA-KK-A6E5,0:DiseaseFree,3,30,Prostate Adenocarcinoma,68.1,3/27/14,2073,,,,,NO,C61,CB009865-4D04-4135-B3F1-5FB473029B12,60,3,TUMOR FREE,0.0884,0:LIVING,0.1,,68.1,Bilateral,34,No Evidence of Extraprostatic Extension,-19,YES,1456,2009,,,TCGA-KK-A6E5.CB009865-4D04-4135-B3F1-5FB473029B12.pdf,Peripheral Zone,[Not Applicable],YES,-19,41-50%,27,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,88556,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.4,0.3,9,5,12,,,2515,BRCA_Her2,2515,2515,,0,0,2515,2515,,Invasive Carcinoma,26,,25,,,,21332,0,,2515,2515,,,,2515,2515,,,2515,,,,,,,,TUMOR FREE,Alive,-15774,,,,81,,2515,2515,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,14,,1,0.12233,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A12D,,,,,,,2515,,,,,,,,,28,,,,,,,,,,,,,2005,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,88558,,1.741713183,0,0,0,0,0.3901,1,,,Infiltrating Ductal Carcinoma,0.210468664,,0.163744342,0,0,0,,Negative,1.1965,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5479,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-8588,White,STAD,,0,0,,,0,0,,0,2.23,0.27,7,7,6,,,389,,389,389,,0,0,389,389,,Malignant,20,,23,,,,20246,,,389,389,,,,389,389,,,389,,,,,,,,TUMOR FREE,Alive,-20177,,,,161,,389,389,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,4,,0,0.14506,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8588,,,,,,,389,,,,,,,,,13,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,88559,,0.605308557,,,,,,,,,,0.114827137,Grade 3,0.135333153,,,,Stage IIB,,0.4455,,,,,,,,,,,,,,,,0.3842,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8588,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.48,7,11,7,,,588,BRCA_LumA,588,588,,0,0,588,588,,Invasive Carcinoma,25,,36,,,,25163,0,,588,588,,,,588,588,,,588,,,,,,,,TUMOR FREE,Alive,-27160,,,,794,,588,588,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,8,,0,0.17138,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A5XS,,,,,,,588,,,,,,,,,9,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,88574,,0.811270016,0,0,0,0,2.0039,1,,,Infiltrating Lobular Carcinoma,0.160772998,,0.205841044,0,0,0,,Negative,-0.389,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1692,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-63-A5MM,Unknown,LUSC,,1,,,Ontario Institute for Cancer Research,1,1,FEMALE,1,1.95,0.35,3,3,3,,,456,,218,456,,1,,218,218,,Malignant,9,,68,,,,19245,,,218,,,,,218,456,,,218,,,,,,,,WITH TUMOR,Dead,-25348,456,,,1627,,218,,,,[Not Available],[Not Applicable],,,,,0.0,,,,,5,,0,0.13985,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5MM,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,,218,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,88578,,1.049625147,,,,,,,,,,0.18403376,,0.170124265,,,,Stage IIB,,2.4375,,,,,,,,,,,,,,,,0.6682,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.25494256,18.04231276,18.12959648,0.0876904239985236,LUSC,Squamous Cell Carcinoma,17.81817759,16.46168797,Squamous Cell Carcinoma,1.1996,13.44686374,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,,0,1,Male,TCGA-66-2769,,LUSC,,0,0,,Indivumed,,,MALE,2,3.39,0.32,5,9,18,,,215,,,215,,2,2,215,215,,Malignant,32,,40,,,,26470,,,215,215,,,,,215,,,215,,,,,,,,,Dead,-27515,215,,,459,,215,215,,,[Not Available],[Not Applicable],,,,,0.28,,,,,18,,1,0.20369,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2769,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2007,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,88579,,0.741357369,,,,,,,,,,0.287546958,,0.132715295,,,,Stage IIIB,,1.494,,,,,,,,,,,,,,,,0.6738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,R123*,,1,,R123*,,16.84575507,16.90633471,15.94202187,-0.0398759566432048,LUSC,Squamous Cell Carcinoma,17.98948499,16.34112313,Squamous Cell Carcinoma,1.6713,15.26304964,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Male,TCGA-85-A4JC,White,LUSC,,1,1,,Asterand,1,1,MALE,1,3.64,0.48,0,7,10,,,604,,548,604,,1,1,548,548,,Malignant,17,,8,,,,27917,,,548,548,,,,548,604,,,548,,,,,,,,WITH TUMOR,Dead,-30942,604,,,333,,548,548,,,[Not Available],[Not Applicable],,,,,0.15,,,,,20,,1,0.0011526,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A4JC,,,,,,,,,Locoregional Recurrence,,,,,,,16,,,,,,,,,,,,,2012,548,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,84,,,,,,,,,,,,,,,,,,,,88580,,0.720223506,,,,,,,,,,0.174771965,,0.07417585,,,,Stage IIA,,-0.2345,,,,,,,,,,,,,,,,0.6886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.14598253,15.55192083,13.72842308,-0.523129630852637,LUSC,Squamous Cell Carcinoma,18.26083944,15.62519743,Squamous Cell Carcinoma,0.95,12.44529687,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1547,BRCA_LumA,1547,1547,,0,0,1547,1547,,Invasive Carcinoma,,,,,,,19497,0,,1547,1547,,,,1547,1547,,,1547,,,,,,,,TUMOR FREE,Alive,-23404,,,,197,,1547,1547,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JC,,,,,,,1547,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,88590,,2.894193157,0,0,0,0,-0.8206,1,,,Infiltrating Ductal Carcinoma,0.163772659,,0.226362785,0,0,0,,Negative,2.222,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,-0.2378,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-56-6546,White,LUSC,,0,0,,International Genomics Consortium,,0,MALE,0,1.86,0.41,4,4,6,,,,,,,,0,0,,,,Malignant,14,,21,,,,25220,,,,,,,,,,,,,,,,,,,,TUMOR FREE,Alive,-24594,,,,460,,,,,,[Not Available],[Not Applicable],,,,,0.4,,,,,8,,0,0.30382,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-6546,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,88591,,1.506854543,,,,,,,,,,0.235748853,,0.081255565,,,,Stage IIA,,1.221,,,,,,,,,,,,,,,,0.3168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.62938948,17.06427539,17.43077183,0.0338582070357305,LUSC,Squamous Cell Carcinoma,18.1412389,16.53421385,Squamous Cell Carcinoma,0.4096,13.68410799,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-O2-A52S,White,LUSC,,1,1,,Washington University - CALGB,,1,FEMALE,1,1.76,0.75,18,10,11,,,387,,,387,,1,1,246,246,,Malignant,39,,173,,,,33992,,,246,246,,,,,387,,,246,,,,,,,,WITH TUMOR,Dead,-21182,387,,,517,,246,246,,,[Not Available],[Not Applicable],,,,,0.07,,,,,12,,0,0.43947,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CALGB,,TCGA-O2-A52S,,,,,,,,,Distant Metastasis,,,,,,,17,,,,,,,,,,,,,2006,246,,,,Stage III,,,,,,,,[Unknown],,,,,,57,,,,,,,,,,,,,,,,,,,,88595,,0.888716687,,,,,,,,,,0.167809753,,-0.006160385,,,,Stage III,,1.1165,,,,,,,,,,,,,,,,0.1086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.79222002,15.59203626,16.87099157,-0.288991580266001,LUSC,Squamous Cell Carcinoma,17.86640215,15.65972592,Squamous Cell Carcinoma,-0.8328,12.5605688,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Female,TCGA-95-A4VN,White,LUAD,,0,0,,Washington University - Emory,,0,FEMALE,0,3.49,0.18,6,11,12,,,553,,,553,,0,0,553,553,,Malignant,29,,31,,,,24273,,,553,553,,,,,553,,,553,,,,,,,,TUMOR FREE,Alive,-22927,,,,635,,553,553,,,[Not Available],[Not Applicable],,,,,0.33,,,,,24,,1,0.16123,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-A4VN,,,,,,,553,,,,,,,,,39,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,62,,,,,,,,,,,,,,,,,,,,88598,,1.435754973,,,,,,,,,,0.204113632,,0.163930232,,,,Stage IIA,,2.898,,,,,,,,,,,,,,,,0.3151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,16.6620276,17.26356987,18.40914363,0.139995338,LUAD,Adenocarcinoma,18.06335627,16.57517551,Adenocarcinoma,-0.0683,13.01432916,1.1604,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-KK-A8IK,,PRAD,370,0,0,,KK,0,0,MALE,0,4.06,0.96,8,12,11,ambiguous,NO,2052,5-SPOP,2052,2052,,0,0,2052,2052,prad_tcga,Malignant,31,ATM;BARD1;CHEK1;RAD54L,47,,TCGA-KK-A8IK-01,0,5535,0,TCGA-KK-A8IK,2052,2052,Prostate Cancer,,,2052,2052,TCGA,,2052,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20594,,56,9,47,PRAD,2052,2052,,0.0,[Not Available],[Not Applicable],31,,1,Matched,0.17,Prostate,Resection,4,A3A4C83F-C775-4C69-9179-A726379E0FB2,14,Abnormal (not related to prostate cancer),1,0.11161,[Not Available],D4F4DDC1-CFD7-4C57-ADE6-4F32CB7FFD85,5,Prostate Adenocarcinoma Acinar Type,,Prostate,35,,Acinar Adenocarcinoma,[Not Available],,KK,1.03333333333,TCGA-KK-A8IK,0:DiseaseFree,5,39,Prostate Adenocarcinoma,67.41,8/28/14,2052,,,,,NO,C61,CBFE7CBE-890E-4749-9566-0CE41A93D69D,80,17,TUMOR FREE,0.4633,0:LIVING,0.0,,67.41,Bilateral,46,No Evidence of Extraprostatic Extension,-69,YES,1759,2008,,,TCGA-KK-A8IK.CBFE7CBE-890E-4749-9566-0CE41A93D69D.pdf,Peripheral Zone,[Not Applicable],YES,-69,86-95%,6,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,,56,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,88600,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.42,3,3,4,,,2971,BRCA_LumA,2971,2971,,0,0,2971,2971,,Invasive Carcinoma,10,,5,,,,23047,0,,2971,2971,,,,2971,2971,,,2971,,,,,,,,TUMOR FREE,Alive,-22023,,,,37,,2971,2971,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.038326,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AL,,,,,,,2971,,,,,,,,,4,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,88605,,0.395059635,0,0,0,0,-0.3026,1,,,Infiltrating Lobular Carcinoma,0.144513262,,0.284689467,0,0,0,,Negative,0.023,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4344,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-95-8494,White,LUAD,,0,0,,Washington University - Emory,0,0,MALE,0,3.62,0.53,10,12,17,,,84,,84,84,,0,0,84,84,,Malignant,39,,66,,,,22467,,,84,84,,,,84,84,,,84,,,,,,,,,Alive,-24773,,,,131,,84,84,,,[Not Available],[Not Applicable],,,,,0.35,,,,,18,,1,0.17052,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-8494,,,,,,,84,,,,,,,,,27,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,88608,,0.077202857,,,,,,,,,,0.19172795,,0.064048844,,,,Stage IIA,,1.0085,,,,,,,,,,,,,,,,-0.011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,16.26237387,17.05960733,14.31941602,-0.555748374,LUAD,Adenocarcinoma,17.80366346,14.92048365,Adenocarcinoma,-0.6771,12.89140128,-1.5275,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-BR-7716,White,STAD,,0,0,,,0,0,,0,2.88,0.31,12,20,24,,,1210,,1210,1210,,0,0,1210,1210,,Malignant,56,,150,,,,20297,,,1210,1210,,,,1210,1210,,,1210,,,,,,,,TUMOR FREE,Alive,-22829,,,,198,,1210,1210,,,[Not Available],[Not Applicable],,,,,0.16,Stomach,Unknown,,,11,,1,0.44813,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-7716,,,,,,,1210,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,88613,,1.399106587,,,,,,,,,,0.122623246,Grade 2,0.040745162,,,,Stage IIB,,1.3685,,,,,,,,,,,,,,,,0.3174,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7716,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-33-6738,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.88,0.53,10,3,14,,,1927,,1927,1927,,0,0,1927,1927,,Malignant,27,,24,,,,16747,,,1927,1927,,,,1927,1927,,,1927,,,,,,,,TUMOR FREE,Alive,-29368,,,,451,,1927,1927,,,[Not Available],[Not Applicable],,,,,0.4,,,,,17,,0,0.32942,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-6738,,,,,,,1927,,,,,,,,,18,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,88617,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.1559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R362Q,1,,,R362Q,14.01092638,14.28981816,14.00501863,-0.628474808874668,LUSC,,17.94689144,14.92918619,Squamous Cell Carcinoma,,11.92790784,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-G9-7523,,PRAD,221,0,0,,G9,0,0,MALE,0,1.84,0.21,0,0,0,HRP,NO,857,7-IDH1,857,857,,0,0,857,857,prad_tcga,Malignant,0,PALB2;RAD51B,10,11.3,TCGA-G9-7523-01,5,5391,0,TCGA-G9-7523,857,857,Prostate Cancer,,324,857,857,TCGA,,857,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-16269,,44,10,17,PRAD,857,857,,0.259445228,[Not Available],[Not Applicable],50,R1,1,Matched,0.16,Prostate,Resection,5,01dee5bc-b28d-4251-8875-b0acb02a1000,6,Abnormal (not related to prostate cancer),0,0.16225,[Not Available],93e78f4c-e74b-4675-8d2c-d641fa25d8f2,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.63333333333,TCGA-G9-7523,0:DiseaseFree,5,0,Prostate Adenocarcinoma,28.15,5/31/12,857,,,,,NO,C61,8a16d779-bcf3-4371-87ec-3cd68330b1d6,,4,TUMOR FREE,0.0001,0:LIVING,0.03,,28.15,Bilateral,3,No Evidence of Extraprostatic Extension,20,YES,,2011,,,TCGA-G9-7523.8a16d779-bcf3-4371-87ec-3cd68330b1d6.pdf,,[Not Applicable],YES,20,21-30%,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.8,44,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,10,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,88621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.27,0.83,5,8,8,,,1251,BRCA_LumB,1094,1251,,1,1,1094,1094,,Invasive Carcinoma,21,,33,,,,19585,0,,1094,1094,,,,1094,1251,,,1094,,,,,,,,TUMOR FREE,Alive,-20107,,,,30,,1094,1094,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,5,,0,0.10641,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,University of Miami,,TCGA-EW-A1P0,,,,,,,1251,"Other, specify",Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2008,1094,mediastinal lymph node,,,Stage IIB,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,88623,,0.657415402,0,0,0,1,-3.5988,0,,,Other,0.144963362,,0.081974579,0,0,0,,Negative,-0.3545,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,-0.2146,1,0,H & E,0,0,,0,Ioana Tolocica,"Columnar Lesion, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,"Columnar Lesion, UDH",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-66-2763,,LUSC,,0,0,,Indivumed,,0,FEMALE,0,1.71,0.67,15,10,18,,,30,,,30,,0,0,30,30,,Malignant,43,,49,,,,21478,,,30,30,,,,,30,,,30,,,,,,,,TUMOR FREE,Alive,-23315,,,,512,,30,30,,,[Not Available],[Not Applicable],,,,,0.34,,,,,8,,0,0.43896,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2763,,,,,,,30,,,,,,,,,14,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,88629,,0.330118587,,,,,,,,,,0.181596762,,0.044398306,,,,Stage IB,,1.3535,,,,,,,,,,,,,,,,0.1082,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.261715949208353,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.4602,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.79,0.9,20,33,26,,,1239,BRCA_Basal,1239,1239,,0,0,1239,1239,,Invasive Carcinoma,79,,112,,,,30593,0,,1239,1239,,,,1239,1239,,,1239,,,,,,,,TUMOR FREE,Alive,-17300,,,,139,,1239,1239,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,9,,0,0.52003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A22G,,,,,,,1239,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,88631,,0.40653513,0,0,0,0,-0.7853,1,,,Infiltrating Ductal Carcinoma,0.133147023,,0.06470967,0,0,0,,Negative,-0.3575,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.3523,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,"Encapsulated Papillary Carcinoma, Invasive Ductal Carcinoma (No Special Type)","Encapsulated Papillary Carcinoma, Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-XF-AAMR,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.99,0.4,4,4,4,,,2790,,2790,2790,,0.0,0,2790.0,2790.0,,Malignant,12,,94,,,,29266.0,,,2790.0,2790,,,,2790,2790,,,2790.0,,,,,,,,TUMOR FREE,Alive,-17670,,,,130.0,,2790.0,2790,,,[Not Available],[Not Applicable],,,,,0.0,,,,,12,,0,0.19036,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMR,,,,,,,2790,,,,,,,,,13,,,,,,,,,,,,,2006,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,48.0,,,,,,,,,,,,,,,,,,,,88632,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-V1-A9OT,,PRAD,,1,1,,V1,,0,MALE,1,1.95,0.79,3,6,0,HRP,NO,476,,,476,,1,1,292,292,prad_tcga,Malignant,9,,40,,TCGA-V1-A9OT-01,0,5578,0,TCGA-V1-A9OT,292,292,Prostate Cancer,,349,,476,TCGA,,292,Primary,0,Middle,A,,,True,,Alive,-22630,,61,6,44,PRAD,292,292,,0.0,[Not Available],[Not Applicable],27,,1,Matched,0.0,Prostate,Resection,3,3E3BAEF3-4686-41D5-BA55-4456DF023975,0,,0,0.051566,[Not Available],18B8AD7F-0F39-4853-AE13-5B13AA5E6F7D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,V1,0.9,TCGA-V1-A9OT,1:Recurred/Progressed,1,9,Prostate Adenocarcinoma,9.59,7/23/14,476,,Biochemical evidence of disease,,,NO,C61,40B928AE-1977-4077-9F44-282E85273EF2,220,1,,0.05,0:LIVING,0.01,,15.64,Bilateral,14,,,YES,,,292,,TCGA-V1-A9OT.40B928AE-1977-4077-9F44-282E85273EF2.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,,Progressive Disease,,YES,No,R1,,61,Core needle biopsy,,,NO,YES,NO,YES,T2c,NO,6,No,NO,,,T1c,,M0,C61.9,8140/3,88648,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.64,0.78,3,0,3,,,728,BRCA_LumB,,728,,0,0,728,728,,Invasive Carcinoma,6,,12,,,,24532,0,,728,728,,,,,728,,,728,,,,,,,,TUMOR FREE,Alive,-21369,,,,26,,728,728,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,14,,1,0.091939,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0W3,,,,,,,728,,,,,,,,,13,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,88651,,-0.684294231,1,0,0,1,0.2703,0,,,Infiltrating Ductal Carcinoma,0.12200822,,0.054056262,0,0,1,,[Not Available],-1.081,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.1519,1,0,H & E,0,0,,0,Ioana Tolocica,"ADH, Papilloma, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"ADH, Papilloma, UDH",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-8573,White,STAD,,0,0,,,0,0,,0,3.06,0.62,4,6,7,,,593,,593,593,,0,0,593,593,,Malignant,17,,61,,,,23349,,,593,593,,,,593,593,,,593,,,,,,,,WITH TUMOR,Alive,-20963,,,,110,,593,593,,,[Not Available],[Not Applicable],,,,,0.23,Stomach,Unknown,,,8,,1,0.082629,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8573,,,,,,,593,,,,,,,,,25,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,88654,,,,,,,,,,,,,Grade 3,,,,,Stage IIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8573,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Male,TCGA-69-7765,Black or African American,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,2.02,0.41,5,3,6,,,165,,,165,,0,0,165,165,,Malignant,14,,14,,,,31162,,,165,165,,,,,165,,,165,,,,,,,,,Alive,-20625,,,,775,,165,165,,,[Not Available],[Not Applicable],,,,,0.38,,,,,8,,0,0.14046,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7765,,,,,,,165,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,[Discrepancy],,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,88658,,1.037536841,,,,,,,,,,0.248534117,,0.226771757,,,,Unknown,,0.7455,,,,,,,,,,,,,,,,0.6011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,Q486*,,,1,Q486*,,,,,,-0.110466958,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.2097,,0.0848,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.81,20,27,24,,,975,BRCA_LumB,975,975,,0,0,975,975,,Invasive Carcinoma,71,,111,,,,23592,0,,975,975,,,,975,975,,,975,,,,,,,,TUMOR FREE,Alive,-21428,,,,141,,975,975,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,4,,0,0.35413,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07L,,,,,,,975,,,,,,,,,20,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,88664,,-0.551284362,0,0,0,0,-0.3573,1,,,Infiltrating Ductal Carcinoma,0.130041481,,0.143962306,0,0,0,,Negative,-1.2475,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1996,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-63-5128,,LUSC,,1,1,,Ontario Institute for Cancer Research,,1,MALE,1,3.04,0.72,10,7,15,,,,,,,,1,1,,,,Malignant,32,,39,,,,17883,,,,,,,,,,,,,,,,,,,,WITH TUMOR,Dead,,,,,406,,,,,,[Not Available],[Not Applicable],,,,,0.33,,,,,21,,1,0.44725,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-5128,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,88665,,-0.517821145,,,,,,,,,,0.15767399,,0.036898861,,,,Stage IB,,-0.187,,,,,,,,,,,,,,,,0.5752,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.871391319186013,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.3514,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-HQ-A5NE,Unknown,BLCA,,1.0,1,,,1,1,MALE,1.0,4.55,0.26,8,12,22,,,370,,211,370,,1.0,1,211.0,211.0,,Malignant,42,,45,,,,23741.0,,,211.0,211,,,,211,370,,,211.0,,,,,,,,WITH TUMOR,Dead,-20647,370,,,495.0,,211.0,211,,,[Not Available],[Not Applicable],,,,,0.37,,,,,26,,2,0.23677,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Ontario Institute for Cancer Research (OICR),,TCGA-HQ-A5NE,,,,,,,,Renal Pelvis,Distant Metastasis,,,,,,,68,,,,,,,,,,,,,,211,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,57.0,,,,,,,,,,,,,,,,,,,,88670,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-ZF-A9R5,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.0,0.91,1,1,1,,,1090,,1090,1090,,0.0,0,1090.0,1090.0,,Malignant,3,,8,,,,22643.0,,,1090.0,1090,,,,1090,1090,,,1090.0,,,,,,,,TUMOR FREE,Alive,-21811,,,,133.0,,1090.0,1090,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.0068921,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9R5,,,,,,,1090,,,,,,,,,0,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,88671,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.02,0.4,3,1,4,,,2255,BRCA_LumA,1709,2255,,1,1,1709,1709,,Invasive Carcinoma,8,,5,,,,16954,0,,1709,1709,,,,1709,2255,,,1709,,,,,,,,TUMOR FREE,Alive,-14494,,,,31,,1709,1709,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.060494,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BQ,,,,,,,2255,"Other, specify",Locoregional Recurrence,,,,,,,5,,,,,,,,,,,,,2007,1709,Dermis and epidermis,,,Stage I,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,88673,,0.424504744,0,0,0,0,0.4176,0,,,Infiltrating Ductal Carcinoma,0.167067185,,0.200641078,0,0,0,,Negative,0.0615,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.7444,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-VQ-A91E,White,STAD,,0,0,,,0,0,,0,,,,,,,,664,,664,664,,0,0,664,664,,Malignant,,,,,,,29826,,,664,664,,,,664,664,,,664,,,,,,,,TUMOR FREE,Alive,-24549,,,,1082,,664,664,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A91E,,,,,,,664,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,88675,,,,,,,,,,,,,Grade 3,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91E,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,2.05,0.61,3,1,3,,,1448,BRCA_LumA,,1448,,0,0,1448,1448,,Invasive Carcinoma,7,,18,,,,29535,0,,1448,1448,,,,,1448,,,1448,,,,,,,,TUMOR FREE,Alive,-19074,,,,85,,1448,1448,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,4,,0,0.030414,[Unknown],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Columbia University,,TCGA-3C-AALK,,,,,,,1448,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,88676,,0.68892384,0,0,0,0,0.4574,1,,,Infiltrating Ductal Carcinoma,0.135389286,,0.166554124,0,0,0,,Close,-0.32,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7206,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-HI-7171,White,PRAD,184,1,1,,HI,,1,MALE,1,1.89,0.88,8,9,2,ambiguous,NO,1329,1-ERG,,1329,,1,1,1329,1329,prad_tcga,Malignant,19,BRCA1;BRCA2;CHEK2;RAD51B,55,5.6,TCGA-HI-7171-01,0,5469,0,TCGA-HI-7171,1329,1329,Prostate Cancer,,631,,1329,TCGA,No Evidence of Extraprostatic Extension,1329,Primary,0,Apex|Middle|Base,A,,,,WITH TUMOR,Dead,-20776,1329,56,9,44,PRAD,1329,1329,WHITE,0.0,[Unknown],[Not Applicable],37,R1,1,Matched,0.17,Prostate,Resection,5,b9d6c505-4d71-4189-925f-36914241b831,2,Normal (no evidence of prostate cancer) [cM0],0,0.11482,[Not Available],931feb14-3f69-41c1-8435-5fd4fb775bdf,4,Prostate Adenocarcinoma Acinar Type,1.6,Prostate,18,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HI,1.2,TCGA-HI-7171,,5,24,Prostate Adenocarcinoma,,2/22/12,,,,,,YES,C61,0bdd67bb-5cf4-4972-9ab6-9878c351857f,,3,WITH TUMOR,0.1673,1:DECEASED,0.7,,43.66,Bilateral,30,,,YES,,2008,,,TCGA-HI-7171.0bdd67bb-5cf4-4972-9ab6-9878c351857f.pdf,,[Not Applicable],NO,,41-50%,7,Prostate Adenocarcinoma Acinar Type,1,2008,Stable Disease,,YES,No,R1,1.0,56,Core needle biopsy,218,,NO,YES,YES,,T3b,,9,No,,0,N0,T3a,0,M0,C61.9,8550/3,88681,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-67-6215,White,LUAD,,0,0,,St Joseph's Medical Center (MD),0,0,FEMALE,0,2.25,0.69,2,2,6,,,174,,174,174,,0,0,174,174,,Malignant,10,,17,,,,23618,,,174,174,,,,174,174,,,174,,,,,,,,TUMOR FREE,Alive,-19310,,,,134,,174,174,,,[Not Available],[Not Applicable],,,,,0.07,,,,,7,,0,0.061443,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-6215,,,,,,,174,,,,,,,,,9,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,88689,,-0.164449342,,,,,,,,,,0.239881208,,0.100512729,,,,Stage IB,,-0.292,,,,,,,,,,,,,,,,-0.1715,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.584549755,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.5618,,-1.4121,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-XQ-A8TA,,PRAD,370,1,1,,XQ,,1,MALE,1,1.94,0.97,12,28,18,HRD,NO,146,3-ETV4,,146,,1,1,146,146,prad_tcga,Malignant,58,CDK12;CHEK2;RAD51C;RAD51D,194,,TCGA-XQ-A8TA-01,85,5640,0,TCGA-XQ-A8TA,146,146,Prostate Cancer,-10,62,,146,TCGA,Distant Metastasis [e.g. cM1],146,Primary,1,,A,,BRCA2,True,WITH TUMOR,Dead,-21889,146,59,10,151,PRAD,146,146,,0.607801737,Prostate Cancer,[Not Applicable],112,,1,Matched,0.11,Prostate,Resection,5,24EA6487-8770-452C-AB55-5BACA00E1243,4,Prostate Cancer Metastases Present [cM1b],0,0.25648,[Not Available],B47791BA-85FD-41D0-AC1F-B6FA06F18E96,5,Prostate Adenocarcinoma Acinar Type,,Prostate,59,,Acinar Adenocarcinoma,[Not Available],,XQ,3.73333333333,TCGA-XQ-A8TA,,5,60,Prostate Adenocarcinoma,,1/26/15,,,,Prostate Cancer,Medical Record,YES,C61,8AF39C5E-73E3-40EA-B328-98892AE85971,80,10,WITH TUMOR,0.3508,1:DECEASED,323.0,,4.8,Bilateral,67,Distant Metastasis [e.g. cM1],,YES,601,2012,,,TCGA-XQ-A8TA.8AF39C5E-73E3-40EA-B328-98892AE85971.pdf,Peripheral Zone,[Not Applicable],YES,,86-95%,,Prostate Adenocarcinoma Acinar Type,1,2012,Progressive Disease,,YES,No,,,59,Transurethral resection (TURBT),,Progressive Disease,,,,NO,,NO,10,"Yes, Pharmaceutical Treatment Prior to Resection",YES,0,,T3a,,M1b,C61.9,8140/3,88699,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-7697,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.83,0.36,9,7,11,,,1063,,1063,1063,,0,0,1063,1063,,Malignant,27,,25,,,,16905,,,1063,1063,,,,1063,1063,,,1063,,,,,,,,TUMOR FREE,Alive,-17921,,,,358,,1063,1063,,,[Not Available],[Not Applicable],,,,,0.39,,,,,11,,0,0.38444,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-7697,,,,,,,1063,,,,,,,,,15,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,49,,,,,,,,,,,,,,,,,,,,88704,,1.003550811,,,,,,,,,,0.138494737,,0.091048692,,,,Stage IIB,,0.4915,,,,,,,,,,,,,,,,0.5447,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.36934939,14.51301889,15.11799217,-0.504041879554234,LUSC,Squamous Cell Carcinoma,18.12403593,15.97592281,Squamous Cell Carcinoma,0.4199,13.53996682,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-2H-A9GH,Unknown,ESCA,,1,1,,,,1,,1,,,,,,,,951,,,951,,1,1,800,800,,Malignant,,,,,,,20049,,,800,800,,,,,951,,,800,,,,,,,,WITH TUMOR,Dead,-16197,951,,,207,,800,800,,,[Not Available],[Not Available],,,,,,Esophagus,Unknown,,,,,,,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Erasmus MC,,TCGA-2H-A9GH,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,1998,800,,,,Stage IIB,,,,,,,,,,,,,,44,,,,,,,,,,,,,,,,,,,,88708,,,,,,,,,,,,,Grade 2,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,0,0,0,1,Male,TCGA-BR-7722,White,STAD,,0,0,,,2,2,,2,2.04,0.69,2,2,2,,,466,,466,466,,2,2,466,466,,Malignant,6,,26,,,,34080,,,466,466,,,,466,466,,,466,,,,,,,,TUMOR FREE,Dead,-22701,466,,,51,,466,466,,,[Not Available],[Not Applicable],,,,,0.04,Stomach,Unknown,,,6,,0,0.20342,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-7722,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,88713,,-0.35485831,,,,,,,,,,0.084899691,Grade 3,0.09764933,,,,Stage IIB,,-0.5845,,,,,,,,,,,,,,,,0.167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7722,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.08,0.32,2,15,15,,,2282,BRCA_Normal,2282,2282,,0,0,2282,2282,,Invasive Carcinoma,32,,19,,,,33002,0,,2282,2282,,,,2282,2282,,,2282,,,,,,,,TUMOR FREE,Alive,-19415,,,,81,,2282,2282,,,[Not Available],[Not Applicable],,,,,0.56,Breast,Resection/Excision,,,19,,1,0.114,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DD,,,,,,,2282,,,,,,,,,33,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,88714,,1.498655016,0,0,0,0,0.4098,0,,,Infiltrating Ductal Carcinoma,0.213145199,,0.212840828,0,0,0,,Negative,1.0275,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3812,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Apocrine Metaplasia,0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Apocrine Metaplasia,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-56-8626,White,LUSC,,0,0,,International Genomics Consortium,2,2,MALE,2,2.05,0.4,11,7,11,,,302,,302,302,,2,2,302,302,,Malignant,29,,85,,,,32886,,,302,302,,,,302,302,,,302,,,,,,,,TUMOR FREE,Dead,-21908,302,,,354,,302,302,,,[Not Available],[Not Applicable],,,,,0.32,,,,,12,,0,0.24249,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8626,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,88715,,-0.091558819,,,,,,,,,,0.221745673,,0.134113306,,,,Stage IA,,-0.1125,,,,,,,,,,,,,,,,0.8797,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.730544807966858,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.7275,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3SS,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.8,0.76,13,11,10,,,391,,,391,,1.0,1,220.0,220.0,,Malignant,34,,54,,,,19036.0,,,220.0,220,,,,,391,,,220.0,,,,,,,,WITH TUMOR,Dead,-24408,391,,,676.0,,220.0,220,,,[Not Available],[Not Applicable],,,,,0.25,,,,,8,,0,0.23903,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SS,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,9,,,,,,,,,,,,,2012,220,local & retroperitonium,,,Stage IV,,,,,,,,[Unknown],,,,,,66.0,,,,,,,,,,,,,,,,,,,,88720,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.84,0.45,17,23,19,,,819,BRCA_Basal,819,819,,0,0,819,819,,Invasive Carcinoma,59,,51,,,,31361,0,,819,819,,,,819,819,,,819,,,,,,,,TUMOR FREE,Alive,-16615,,,,138,,819,819,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,5,,0,0.37168,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UNC ,,TCGA-AQ-A04J,,,,,,,819,,,,,,,,,17,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,88726,TRUE,2.016992173,0,0,0,0,0.9437,1,,,Infiltrating Ductal Carcinoma,0.180913972,,0.260124883,0,0,0,,Negative,0.277,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4478,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-CD-A486,Asian,STAD,,1,1,,,1,1,,1,3.98,0.57,12,12,17,,,192,,79,192,,1,1,79,79,,Malignant,41,,140,,,,28270,,,79,79,,,,79,192,,,79,,,,,,,,WITH TUMOR,Dead,-24879,192,,,126,,79,79,,,[Not Available],[Not Applicable],,,,,0.14,Stomach,Unknown,,,18,,1,0.1808,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,ILSBio,,TCGA-CD-A486,,,,,,,,Liver,Distant Metastasis,,,,,,,30,,,,,,,,,,,,,2011,79,liver and lung,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,88730,,0.109454022,,,,,,,,,,0.106729792,Grade 2,0.043963162,,,,Stage IIA,,-0.3285,,,,,,,,,,,,,,,,0.2505,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A486,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,,,,,,,,446,,237,446,,1,1,237,237,,Invasive Carcinoma,,,,,,,17115,1,,237,237,,,,237,446,,,237,,,,,,,,WITH TUMOR,Dead,-17569,446,,,0,,237,237,,,[Not Available],[Not Applicable],,,,,,Not Specific/Unknown,Resection/Excision,,,,,,,Peri (6-12 months since last menstrual period),,,Metaplastic Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2QJ,,,,,,,,Bone,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2011,237,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,88732,TRUE,-0.382700046,0,0,0,0,-1.3625,1,,,Metaplastic Carcinoma,0.239627431,,0.212872363,0,0,0,,Negative,-1.321,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.9256,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,None,0,0,0,0,0,1,Score 3 (High mitotic index),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OQ,,PRAD,,0,0,,V1,0,0,MALE,0,1.95,0.77,4,5,0,HRD,NO,371,,371,371,,0,0,371,371,prad_tcga,Malignant,9,,58,,TCGA-V1-A9OQ-01,11,5577,0,TCGA-V1-A9OQ,371,371,Prostate Cancer,,371,371,371,TCGA,,371,Primary,1,Apex,A,,BRCA2,True,,Alive,-24820,,67,6,60,PRAD,371,371,,0.199604945,[Not Available],[Not Applicable],48,,1,Matched,0.02,Prostate,Resection,3,819C66A0-7074-495E-9993-80A858F46B82,0,,0,0.051128,[Not Available],10271D9C-9B9C-4B5F-A845-A0F1BD03AF51,3,Prostate Adenocarcinoma Acinar Type,,Prostate,9,,Acinar Adenocarcinoma,[Not Available],,V1,1.6,TCGA-V1-A9OQ,0:DiseaseFree,1,9,Prostate Adenocarcinoma,12.19,7/11/14,371,,,,,NO,C61,8EA3FE2C-7C76-41F8-AEC4-A89C5DD2FF7B,60,1,,0.0474,0:LIVING,0.01,,12.19,Bilateral,13,,,YES,,,,,TCGA-V1-A9OQ.8EA3FE2C-7C76-41F8-AEC4-A89C5DD2FF7B.pdf,Peripheral Zone,[Not Applicable],NO,,,0,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,67,Core needle biopsy,,,NO,YES,NO,NO,T3a,NO,6,No,NO,,,T1c,,M0,C61.9,8140/3,88734,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.06,0.51,1,2,7,,,1196,BRCA_LumB,1196,1196,,0,0,1196,1196,,Invasive Carcinoma,10,,30,,,,19996,0,,1196,1196,,,,1196,1196,,,1196,,,,,,,,TUMOR FREE,Alive,-18401,,,,97,,1196,1196,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,15,,1,0.18256,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SN,,,,,,,1196,,,,,,,,,30,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,88736,,1.091432552,0,0,0,0,0.332,1,,,Infiltrating Ductal Carcinoma,0.167704381,,0.15882793,0,0,0,,Negative,0.2385,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5048,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-L5-A4OP,White,ESCA,,0,0,,,,0,,0,1.81,0.72,9,9,10,,,218,,,218,,0,0,218,218,,Malignant,28,,95,,,,28206,,,218,218,,,,,218,,,218,,,,,,,,TUMOR FREE,Alive,-24829,,,,181,,218,218,,,[Not Available],[Not Available],,,,,0.01,Esophagus,Unknown,,,10,,0,0.34407,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,University of Michigan,,TCGA-L5-A4OP,,,,,,,218,,,,,,,,,16,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Unknown],,,,,,67,,,,,,,,,,,,,,,,,,,,88739,,,,,,,,,,,,,Grade 2,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-Y6-A8TL,,PRAD,389,0,0,,Y6,,0,MALE,0,1.96,0.59,2,6,0,HRP,NO,992,5-SPOP,,992,,0,0,992,992,prad_tcga,Malignant,8,,79,,TCGA-Y6-A8TL-01,10,5643,0,TCGA-Y6-A8TL,992,992,Prostate Cancer,,775,,992,TCGA,,992,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-23776,,65,6,33,PRAD,992,992,,0.323169738,[Not Available],[Not Applicable],32,R0,1,Matched,0.0,Prostate,Resection,3,E8FA37B1-2E31-44B6-BA77-3E46DA7E4FEE,0,,0,0.047748,[Not Available],A7045324-CB44-4B37-BBAF-641642C1D903,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,Y6,1.06666666667,TCGA-Y6-A8TL,0:DiseaseFree,1,11,Prostate Adenocarcinoma,32.59,4/17/14,992,,,,,NO,C61,8DE4AB1E-913E-4763-81EE-272430E5CC4A,370,0,TUMOR FREE,0.0468,0:LIVING,0.0,,32.59,Right,12,No Evidence of Extraprostatic Extension,328,YES,677,2012,,,TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf,Peripheral Zone,[Not Applicable],YES,,56-65%,5,Prostate Adenocarcinoma Acinar Type,1,2012,[Not Available],,NO,No,R0,,65,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T2a,0,,C61.9,8140/3,88749,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.17,0.91,5,8,7,,,8391,BRCA_LumA,8391,8391,,0,0,8391,8391,,Invasive Carcinoma,20,,15,,,,16308,0,,8391,8391,,,,8391,8391,,,8391,,,,,,,,TUMOR FREE,Alive,-18748,,,,114,,8391,8391,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,6,,0,0.088425,Indeterminate (neither Pre or Postmenopausal),,,"Other, specify",,,,,,[Not Available],,Duke,,TCGA-B6-A0IA,,,,,,,8391,,,,,,,,,8,,,,,,,,,,,,,1992,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,88752,,-1.897894473,0,0,0,0,1.0752,1,,,Other,0.113944467,,-0.033944175,0,0,0,,Negative,-0.986,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3924,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Cribriform Carcinoma), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,88756,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.55,0.46,7,12,9,,,2976,BRCA_LumB,2976,2976,,0,0,2976,2976,,Invasive Carcinoma,28,,34,,,,17934,0,,2976,2976,,,,2976,2976,,,2976,,,,,,,,,Alive,-22587,,,,71,,2976,2976,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,13,,1,0.13836,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24S,,,,,,,2976,,,,,,,,,26,,,,,,,,,,,,,2006,,,,,Stage I,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,88762,,0.990057698,0,0,0,0,0.1587,1,,,Infiltrating Ductal Carcinoma,0.24967898,,0.193608883,0,0,0,,Negative,0.19,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5526,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,2.19,0.41,2,4,4,,,2207,BRCA_LumA,2207,2207,,2,2,2207,2207,,Invasive Carcinoma,10,,5,,,,21498,0,,2207,2207,,,,2207,2207,,,2207,,,,,,,,,Dead,-14532,2207,,,35,,2207,2207,,,[Not Available],[Not Applicable],,,,,0.2,Breast,Resection/Excision,,,4,,0,0.082493,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18M,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2001,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,88763,,-0.326273446,0,0,0,0,-0.1118,1,,,Infiltrating Ductal Carcinoma,0.149765777,,0.20254292,0,0,0,,Negative,-0.4005,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5306,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Low Grade), Stromal Alterations",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8WV,,PRAD,389,0,0,,V1,0,0,MALE,0,3.13,0.48,8,16,13,ambiguous,NO,686,3-ETV4,686,686,,0,0,686,686,prad_tcga,Malignant,37,BRCA2;RAD51B;RAD54L,70,,TCGA-V1-A8WV-01,8,5567,0,TCGA-V1-A8WV,686,686,Prostate Cancer,,686,686,686,TCGA,,686,Primary,0,Middle,A,,,True,,Alive,-19345,,52,9,53,PRAD,686,686,,0.163698777,[Not Available],[Not Applicable],41,,1,Matched,0.23,Prostate,Resection,4,0D44C6BB-2FF0-4ED6-8C38-F58B5CFA2530,19,,1,0.17,[Not Available],8E5B1D47-7D92-4D28-8186-4176ADA96672,5,Prostate Adenocarcinoma Acinar Type,,Prostate,40,,Acinar Adenocarcinoma,[Not Available],,V1,1.36666666667,TCGA-V1-A8WV,0:DiseaseFree,5,41,Prostate Adenocarcinoma,22.54,7/15/14,686,,,,,NO,C61,AD602A56-B2CB-49A0-A994-7927600C952B,70,23,,0.5379,0:LIVING,0.01,,22.54,Bilateral,51,No Evidence of Extraprostatic Extension,95,YES,,,,,TCGA-V1-A8WV.AD602A56-B2CB-49A0-A994-7927600C952B.pdf,Peripheral Zone,[Not Applicable],YES,,86-95%,10,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,52,Core needle biopsy,,,NO,YES,YES,NO,T3b,NO,9,No,YES,,N1,T2a,1,M0,C61.9,8140/3,88769,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-JY-A6F8,White,ESCA,,0,0,,,0,0,,0,3.56,0.71,4,17,13,,,3714,,3714,3714,,0,0,3714,3714,,Malignant,34,,73,,,,18664,,,3714,3714,,,,3714,3714,,,3714,,,,,,,,TUMOR FREE,Alive,-20550,,,,201,,3714,3714,,,[Not Available],[Not Available],,,,,0.23,Esophagus,Unknown,,,19,,1,0.10459,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G1,,University Health Network,,TCGA-JY-A6F8,,,,,,,3714,,,,,,,,,32,,,,,,,,,,,,,2003,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,88771,,,,,,,,,,,,,Grade 1,,,,,Stage I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.94,0.94,2,2,2,,,620,BRCA_LumA,620,620,,0,0,620,620,,Invasive Carcinoma,6,,9,,,,29113,0,,620,620,,,,620,620,,,620,,,,,,,,TUMOR FREE,Alive,-29331,,,,224,,620,620,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,6,,0,0.118,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JN,,,,,,,620,,,,,,,,,7,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,88775,,0.330779291,0,0,0,0,-0.0929,1,,,Infiltrating Lobular Carcinoma,0.073829622,,0.128701086,0,0,0,,Negative,-0.532,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.4938,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.85,0.2,4,4,6,,,837,BRCA_Normal,837,837,,0,0,837,837,,Invasive Carcinoma,14,,9,,,,19885,0,,837,837,,,,837,837,,,837,,,,,,,,WITH TUMOR,Alive,-23530,,,,0,,837,837,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,8,,0,0.26054,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A108,,,,,,,837,,,,,,,,,8,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,88783,,1.966644892,0,0,0,0,-0.0914,1,,,Infiltrating Ductal Carcinoma,0.247120408,,0.303565151,0,0,0,,Negative,1.722,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6354,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,DCIS with Microinvasive Carcinoma,DCIS with Microinvasive Carcinoma,0,None,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-UY-A9PH,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.4,0.44,6,4,9,,,1561,,1561,1561,,0.0,0,1561.0,1561.0,,Malignant,19,,89,,,,16807.0,,,1561.0,1561,,,,1561,1561,,,1561.0,,,,,,,,TUMOR FREE,Alive,-26654,,,,520.0,,1561.0,1561,,,[Not Available],[Not Applicable],,,,,0.18,,,,,20,,1,0.25519,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A9PH,,,,,,,1561,,,,,,,,,20,,,,,,,,,,,,,,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,88785,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.62,0.76,14,15,13,,,747,BRCA_LumB,747,747,,0,0,747,747,,Invasive Carcinoma,42,,64,,,,27449,0,,747,747,,,,747,747,,,747,,,,,,,,TUMOR FREE,Alive,-17779,,,,44,,747,747,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,14,,1,0.21344,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A27A,,,,,,,747,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,88787,,-0.34283546,0,0,0,0,-0.9192,1,,,Infiltrating Ductal Carcinoma,0.069948029,,0.092941243,0,0,0,,Negative,-0.971,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2093,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-BR-6455,White,STAD,,1,1,,,,1,,1,2.12,0.66,0,0,0,,,422,,,422,,1,1,385,385,,Malignant,0,,11,,,,22868,,,385,385,,,,,422,,,385,,,,,,,,WITH TUMOR,Dead,-21865,422,,,119,,385,385,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,6,,0,0.07782,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6455,,,,,,,,Liver,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2011,385,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,88788,,0.79873097,,,,,,,,,,0.097602889,Grade 3,0.077459556,,,,Stage IIB,,0.6305,,,,,,,,,,,,,,,,0.0972,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6455,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,0,0,1,Male,TCGA-22-4593,White,LUSC,,0,0,,Mayo Clinic - Rochester,,2,MALE,2,2.71,0.77,7,10,14,,,1067,,,1067,,2,2,1067,1067,,Malignant,31,,57,,,,25383,,,1067,1067,,,,,1067,,,1067,,,,,,,,TUMOR FREE,Dead,-28385,1067,,,252,,1067,1067,,,[Not Available],[Not Applicable],,,,,0.25,,,,,16,,1,0.29252,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4593,,,,,,,1067,,,,,,,,,31,,,,,,,,,,,,,2002,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,88792,,0.060136174,,,,,,,,,,0.193593764,,0.121678066,,,,Stage IIA,,-0.4765,,,,,,,,,,,,,,,,0.9698,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,14.11708719,15.31108517,13.80229023,-0.807679950281279,LUSC,Squamous Cell Carcinoma,18.5652016,15.53236943,Squamous Cell Carcinoma,1.0237,13.18259115,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-68-7757,White,LUSC,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,1.63,0.34,13,4,13,,,211,,,211,,0,0,211,211,,Malignant,30,,25,,,,16904,,,211,211,,,,,211,,,211,,,,,,,,,Alive,-27272,,,,393,,211,211,,,[Not Available],[Not Applicable],,,,,0.13,,,,,11,,0,0.45683,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-68-7757,,,,,,,211,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,88798,,0.368100619,,,,,,,,,,0.17863405,,0.072040099,,,,Stage IA,,0.119,,,,,,,,,,,,,,,,0.9095,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.617478049390942,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.1115,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-L9-A443,White,LUAD,,0,0,,Candler,2,2,FEMALE,2,3.54,0.48,8,9,13,,,193,,193,193,,2,2,193,193,,Malignant,30,,39,,,,19842,,,193,193,,,,193,193,,,193,,,,,,,,TUMOR FREE,Dead,-23062,193,,,332,,193,193,,,[Not Available],[Not Applicable],,,,,0.21,,,,,19,,1,0.13353,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Candler,,TCGA-L9-A443,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,88800,,0.365136149,,,,,,,,,,0.181886211,,0.176498589,,,,Stage IA,,0.204,,,,,,,,,,,,,,,,0.3835,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,-0.209451842,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.7434,,0.4756,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.3,0.39,9,16,15,,,186,BRCA_LumB,186,186,,0,0,186,186,,Invasive Carcinoma,40,,30,,,,18046,0,,186,186,,,,186,186,,,186,,,,,,,,TUMOR FREE,Alive,-24181,,,,176,,186,186,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,16,,1,0.22619,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1R4,,,,,,,186,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,88801,,1.189112534,0,0,0,0,0.3355,1,,,Infiltrating Ductal Carcinoma,0.183443695,,0.108653693,0,0,0,,Negative,1.208,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2019,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VQ-A8PK,White,STAD,,1,1,,,,1,,1,1.6,0.65,21,12,18,,,543,,,543,,1,1,263,263,,Malignant,51,,324,,,,33953,,,263,263,,,,,543,,,263,,,,,,,,WITH TUMOR,Dead,-21419,543,,,120,,263,263,,,Stomach Cancer,[Not Applicable],,,,,0.08,Stomach,Unknown,,,16,,0,0.59951,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8PK,,,,,,,,Liver,Locoregional Recurrence|Distant Metastasis,,,,,,,22,,,,,,,,,,,,,2011,263,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,58,,,,,,,,,,,,,,,,,,,,88802,,0.136138474,,,,,,,,,,0.083358017,Grade 2,0.033527903,,,,Stage IIIB,,0.4345,,,,,,,,,,,,,,,,0.5327,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PK,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,88806,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-78-7537,,LUAD,,0,0,,Prince Charles Hospital,,,MALE,2,2.08,0.74,2,1,2,,,1622,,,1622,,2,2,1622,1622,,Malignant,5,,8,,,,16179,,,1622,1622,,,,,1622,,,1622,,,,,,,,,Dead,-26610,1622,,,185,,1622,1622,,,[Not Available],[Not Applicable],,,,,0.04,,,,,2,,0,0.019126,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7537,,,,,,,,,,,,,,,,3,,,,,,,,,,,,,2002,,,,,Stage IB,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,88810,,0.277458951,,,,,,,,,,0.190596965,,0.192898253,,,,Stage IB,,-0.0205,,,,,,,,,,,,,,,,0.1141,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.430845278,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0343,,-0.0427,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.51,0.4,13,9,15,,,307,BRCA_LumB,307,307,,0,0,307,307,,Invasive Carcinoma,37,,37,,,,21958,0,,307,307,,,,307,307,,,307,,,,,,,,TUMOR FREE,Alive,-15122,,,,45,,307,307,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,19,,1,0.22307,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27R,,,,,,,307,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,88813,,0.561855866,0,0,0,0,0.3605,0,,,Infiltrating Ductal Carcinoma,0.13727392,,0.153390313,0,0,0,,Negative,0.186,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.203,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Clinging, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Clinging, High Grade), DCIS (Solid, High Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,Columnar Lesion,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-05-4398,,LUAD,,0,0,,Indivumed,0,0,FEMALE,0,4.83,0.33,13,16,18,,,1431,,1431,1431,,0,0,1431,1431,,Malignant,47,,57,,,,16067,,,1431,1431,,,,1431,1431,,,1431,,,,,,,,TUMOR FREE,Alive,-17471,,,,963,,1431,1431,,,[Not Available],[Not Applicable],,,,,0.25,,,,,19,,2,0.3221,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4398,,,,,,,1431,,,,,,,,,54,,,,,,,,,,,,,2006,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,47,,,,,,,,,,,,,,,,,,,,88815,,0.980850252,,,,,,,,,,0.248201426,,0.09314559,,,,Stage IIIB,,2.4155,,,,,,,,,,,,,,,,0.3573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.04617266,17.42633537,17.12661315,-0.065857594,LUAD,,17.92973695,16.00641583,Adenocarcinoma,0.5638,13.41931189,0.2566,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-2A-AAYU,,PRAD,,0,0,,2A,,0,MALE,0,1.96,0.82,2,3,2,HRP,NO,615,,,615,,0,0,615,615,prad_tcga,Malignant,7,,65,,TCGA-2A-AAYU-01,0,5234,0,TCGA-2A-AAYU,615,615,Prostate Cancer,52,269,,615,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),615,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20582,,56,6,32,PRAD,615,615,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.01,Prostate,Resection,3,64DDF375-8C9D-42D3-96CE-42BA38FE5B24,1,,0,0.041096,[Not Available],AA1A3A43-2F9C-456C-BA74-81C29B9801CB,3,Prostate Adenocarcinoma Acinar Type,,Prostate,7,,Acinar Adenocarcinoma,[Not Available],,2A,0.933333333333,TCGA-2A-AAYU,0:DiseaseFree,1,12,Prostate Adenocarcinoma,20.2,7/7/14,615,,,,,YES,C61,6CD9378F-F5A6-4214-8685-3D56ED6ADB0B,140,1,TUMOR FREE,0.04,0:LIVING,0.05,4,20.2,Left,14,,,YES,693,2012,,,TCGA-2A-AAYU.6CD9378F-F5A6-4214-8685-3D56ED6ADB0B.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,28,Prostate Adenocarcinoma Acinar Type,1,2012,[Discrepancy],,NO,No,R1,,56,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,6,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,88817,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.54,0.48,2,11,9,,,923,BRCA_LumA,923,923,,0,0,923,923,,Invasive Carcinoma,22,,17,,,,29244,0,,923,923,,,,923,923,,,923,,,,,,,,TUMOR FREE,Alive,-24493,,,,86,,923,923,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,26,,1,0.12099,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0GY,,,,,,,923,,,,,,,,,27,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,88821,,0.470706925,0,0,0,0,1.5974,1,,,Infiltrating Ductal Carcinoma,0.176764661,,0.113138836,0,0,0,,Negative,0.102,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4471,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Micropapillary), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-8361,White,STAD,,0,0,,,0,0,,0,2.01,0.64,4,12,11,,,946,,946,946,,0,0,946,946,,Malignant,27,,131,,,,23450,,,946,946,,,,946,946,,,946,,,,,,,,TUMOR FREE,Alive,-25999,,,,2345,,946,946,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,4,,0,0.16372,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8361,,,,,,,946,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,88824,,1.342364163,,,,,,,,,,0.023809683,Grade 3,0.046877451,,,,Stage IIIC,,1.764,,,,,,,,,,,,,,,,-0.2394,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8361,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-M7-A724,,PRAD,,0,0,,M7,,0,MALE,0,2.01,0.97,3,9,3,HRP,NO,889,,,889,,0,0,889,889,prad_tcga,Malignant,15,,269,,TCGA-M7-A724-01,0,5544,0,TCGA-M7-A724,889,889,Prostate Cancer,,483,,889,TCGA,,889,Primary,0,Apex|Base,A,,,False,WITH TUMOR,Alive,-23595,,64,8,37,PRAD,889,889,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.0,Prostate,Resection,4,8910606C-191E-4973-8C8B-F34E90198DCA,2,Abnormal (not related to prostate cancer),0,0.0911,[Not Available],F8B98552-AE2A-4609-9929-7864485B3C51,4,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,M7,1.16666666667,TCGA-M7-A724,0:DiseaseFree,4,11,Prostate Adenocarcinoma,29.2,12/10/13,889,,,,,NO,C61,AF3AE21A-2D5F-4769-B438-C42415A47330,160,3,WITH TUMOR,0.1325,0:LIVING,,,29.2,Right,14,No Evidence of Extraprostatic Extension,35,YES,351,2012,,,TCGA-M7-A724.AF3AE21A-2D5F-4769-B438-C42415A47330.pdf,Peripheral Zone,[Not Applicable],YES,11,,7,Prostate Adenocarcinoma Acinar Type,1,2012,Progressive Disease,,NO,No,R1,,64,Core needle biopsy,,Progressive Disease,YES,NO,YES,NO,T3a,NO,8,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,88831,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-JY-A93D,White,ESCA,,1.0,1,,,1,1,,1.0,2.24,0.33,9,10,11,,,960,,732,960,,1.0,1,732,732,,Malignant,30,,127,,,,21168.0,0,,732,732,,,,732,960,,,732,,,,,,,,WITH TUMOR,Dead,-18813,960,,,163.0,,732,732,,,[Not Available],[Not Available],,,,,0.63,Esophagus,Resection,,,9,,1,0.41554,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,University Health Network,,TCGA-JY-A93D,,,,,,,,"Other, specify",Locoregional Recurrence,,,,,,,43,,,,,,,,,,,,,2012,732,Mediastinal lymph node,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,88832,,,,,,,,,,,,,Grade 3,,,,,Stage IIIC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0.0,,0,0.0,0.0,Female,TCGA-GD-A3OP,White,BLCA,,0.0,0,,,,0,FEMALE,0.0,2.43,0.24,2,3,6,,,64,,,64,,0.0,0,64.0,64.0,,Malignant,11,,7,,,,16881.0,,,64.0,64,,,,,64,,,64.0,,,,,,,,,Alive,-30956,,,,452.0,,64.0,64,,,[Not Available],[Not Applicable],,,,,0.64,,,,,15,,0,0.073911,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - IUPUI,,TCGA-GD-A3OP,,,,,,,64,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,[Unknown],,,,,,84.0,,,,,,,,,,,,,,,,,,,,88837,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-D7-5578,White,STAD,,0.0,0,,,,0,,0.0,2.03,0.6,6,8,5,,,385,,,385,,0.0,0,385,385,,Malignant,19,,33,,,,22833.0,0,,385,385,,,,,385,,,385,,,,,,,,TUMOR FREE,Alive,-29390,,,,293.0,,385,385,,,[Not Available],[Not Applicable],,,,,0.54,Stomach,Resection,,,2,,0,0.16637,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-5578,,,,,,,385,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,88838,,0.36599637,,,,,,,,,,0.091160717,Grade 3,0.134895749,,,,Stage IIIA,,0.625,,,,,,,,,,,,,,,,0.2981,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-5578,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2ES,White,BLCA,,0.0,0,,,,1,MALE,1.0,2.01,0.55,4,2,10,,,1004,,,1004,,2.0,2,897.0,897.0,,Malignant,16,,44,,,,23501.0,,,1004.0,1004,,,,,1004,,,897.0,,,,,,,,WITH TUMOR,Dead,-31293,1004,,,659.0,,1004.0,1004,,,[Not Available],[Not Applicable],,,,,0.03,,,,,4,,0,0.28582,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2ES,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2009,897,,,,Stage II,,,,,,,,Progressive Disease,,,,,,85.0,,,,,,,,,,,,,,,,,,,,88841,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-56-7222,White,LUSC,,1,,,International Genomics Consortium,1,1,MALE,1,3.71,0.53,7,6,17,,,562,,427,562,,1,,427,427,,Malignant,30,,24,,,,18161,,,427,,,,,427,562,,,427,,,,,,,,WITH TUMOR,Dead,-22097,562,,,524,,427,,,,[Not Available],[Not Applicable],,,,,0.11,,,,,23,,1,0.37847,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7222,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2011,427,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,88843,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.4529,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.960659017658431,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.8342,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-55-1596,Asian,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,3.42,0.63,6,6,12,,,2065,,2065,2065,,0,0,2065,2065,,Malignant,24,,23,,,,16217,,,2065,2065,,,,2065,2065,,,2065,,,,,,,,TUMOR FREE,Alive,-20381,,,,258,,2065,2065,,,[Not Available],[Not Applicable],,,,,0.12,,,,,26,,1,0.34367,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-1596,,,,,,,2065,,,,,,,,,22,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,88849,,0.797991273,,,,,,,,,,0.139945025,,0.098697551,,,,Stage IIB,,0.0315,,,,,,,,,,,,,,,,-0.1303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.1195393,15.97027177,14.94864058,-0.308809777,LUAD,,17.59689808,15.40410869,Adenocarcinoma,-0.7923,13.4048356,-0.2655,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-A8HI,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,1.99,0.91,0,0,3,,,544,,,544,,1.0,1,468.0,468.0,,Malignant,3,,15,,,,20631.0,,,468.0,468,,,,,544,,,468.0,,,,,,,,WITH TUMOR,Dead,-21059,544,,,103.0,,468.0,468,,,[Not Available],[Not Applicable],,,,,0.07,,,,,3,,0,0.050569,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A8HI,,,,,,,,Lung,Distant Metastasis,,,,,,,2,,,,,,,,,,,,,2005,468,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,57.0,,,,,,,,,,,,,,,,,,,,88852,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-BL-A0C8,White,BLCA,,1.0,1,,,1,0,MALE,1.0,,,,,,,,1219,,630,1219,,1.0,1,630.0,630.0,,,,,,,,,18022.0,,,630.0,630,,,,630,1219,,,630.0,,,,,,,,,Alive,-26819,,,,211.0,,630.0,630,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,[Not Available],,,,,Unknown,High Grade,,Christiana Healthcare,,TCGA-BL-A0C8,,,,,,,1219,Bladder,Locoregional (Urothelial tumor event),,,,,,,,,,,,,,,,,,,,2009,630,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,88853,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,3.07,0.31,7,6,13,,,1759,BRCA_Normal,,1759,,2,2,1759,1759,,Invasive Carcinoma,26,,30,,,,33558,0,,1759,1759,,,,,1759,,,1759,,,,,,,,TUMOR FREE,Dead,-17715,1759,,,98,,1759,1759,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,17,,1,0.25252,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A208,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,1995,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,88868,,0.493281138,0,0,0,0,0.6802,1,,,Infiltrating Ductal Carcinoma,0.192889061,,0.309023016,0,0,0,,[Not Available],-0.842,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.9998,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-R6-A6XQ,White,ESCA,,1,1,,,,1,,1,4.08,0.79,16,6,8,,,193,,,193,,1,1,193,193,,Malignant,30,,471,,,,27255,,,193,193,,,,,193,,,193,,,,,,,,WITH TUMOR,Dead,-21410,193,,,130,,193,193,,,[Not Available],Stage IVB,,,,,0.43,Esophagus,Unknown,,,22,,2,0.30294,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,MD Anderson Cancer Center,,TCGA-R6-A6XQ,,,,,,,,,,,,,,,,47,,,,,,,,,,,,,2008,,,,,[Not Available],,,,,,,,,,,,,,58,,,,,,,,,,,,,,,,,,,,88874,,,,,,,,,,,,,Grade 3,,,,,Stage IVB,,,Not Answered,,,,,,,,,,,,,,,,,,,,,Biopsy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-VQ-A8E2,Asian,STAD,,0,0,,,0,0,,0,4.29,0.39,14,18,24,,,1319,,1319,1319,,0,0,1319,1319,,Malignant,56,,135,,,,16429,,,1319,1319,,,,1319,1319,,,1319,,,,,,,,TUMOR FREE,Alive,-21112,,,,144,,1319,1319,,,[Not Available],[Not Applicable],,,,,0.29,Stomach,Unknown,,,18,,2,0.2613,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8E2,,,,,,,1319,,,,,,,,,63,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,88876,,0.541539124,,,,,,,,,,0.039194372,Grade 2,0.10846216,,,,Stage IIIB,,0.61,,,,,,,,,,,,,,,,0.6443,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8E2,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.15,0.77,2,3,1,,,149,BRCA_Basal,149,149,,0,0,149,149,,Invasive Carcinoma,6,,5,,,,26347,1,,149,149,,,,149,149,,,149,,,,,,,,TUMOR FREE,Alive,-29820,,,,2033,,149,149,,,[Not Available],[Not Applicable],,,,,0.1,Not Specific/Unknown,Resection/Excision,,,1,,0,0.018507,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18G,,,,,,,149,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,81,,,,,,,,,,,,,,,,,,,,88879,TRUE,0.231061099,0,0,0,0,2.4018,1,,,Infiltrating Ductal Carcinoma,0.149225096,,0.058140514,0,0,0,,Negative,-1.1025,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.2667,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MG-AAMC,,PRAD,,0,0,,MG,0,0,MALE,0,1.94,0.79,5,1,4,HRP,NO,173,,173,173,,0,0,173,173,prad_tcga,Malignant,10,BRCA1;CDK12,62,,TCGA-MG-AAMC-01,0,5546,0,TCGA-MG-AAMC,173,173,Prostate Cancer,,54,173,173,TCGA,,173,Primary,0,,A,,,True,TUMOR FREE,Alive,-21846,,59,9,28,PRAD,173,173,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.03,Prostate,Resection,4,ACA72F05-77B0-4BF3-AA43-ED10C3898C9F,3,,0,0.066859,[Not Available],9C8447AC-5B26-4558-8BFD-F0E7046C1FB9,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,MG,0.933333333333,TCGA-MG-AAMC,0:DiseaseFree,5,11,Prostate Adenocarcinoma,5.68,7/28/14,173,,,,,,C61,CBC765C1-9191-4A40-979F-CF2434B10CAB,40,3,TUMOR FREE,0.0697,0:LIVING,0.01,3,5.68,,15,,,YES,278,2013,,,TCGA-MG-AAMC.CBC765C1-9191-4A40-979F-CF2434B10CAB.pdf,,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,,NO,T3a,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,88886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-F1-A448,White,STAD,,0,0,,,0,0,,0,2.16,0.3,1,2,0,,,647,,647,647,,0,0,647,647,,Malignant,3,,26,,,,19520,,,647,647,,,,647,647,,,647,,,,,,,,TUMOR FREE,Alive,-25846,,,,814,,647,647,,,[Not Available],[Not Applicable],,,,,0.78,Stomach,Unknown,,,4,,0,0.010248,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,UNC,,TCGA-F1-A448,,,,,,,647,,,,,,,,,2,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,88888,,0.348616807,,,,,,,,,,0.146841661,Grade 3,0.168827919,,,,Stage IIIB,,0.4155,,,,,,,,,,,,,,,,0.609,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-F1-A448,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,1.0,1,1.0,1.0,1.0,Female,TCGA-D7-8576,White,STAD,,1.0,1,,,1,1.0,,1.0,1.65,0.69,10,10,9,,,446.0,,204,446.0,,1.0,1,204.0,204.0,,Malignant,29,,75,,,,17756.0,0,,204.0,204,,,,204,446.0,,,204.0,,,,,,,,WITH TUMOR,Dead,-20014.0,446,,,77.0,,204.0,204,,,[Not Available],[Not Applicable],,,,,0.33,Stomach,Resection,,,12,,0,0.45779,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8576,,,,,,,,Lung,Locoregional Recurrence|Distant Metastasis,,,,,,,18,,,,,,,,,,,,,2012.0,204,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,54.0,,,,,,,,,,,,,,,,,,,,88892,,,,,,,,,,,,,Grade 3,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8576,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,,0,0,1,Male,TCGA-22-1011,White,LUSC,,0,0,,Mayo Clinic - Rochester,,2,MALE,2,1.53,0.36,4,2,4,,,53,,,53,,2,2,53,53,,Malignant,10,,14,,,,21392,,,53,53,,,,,53,,,53,,,,,,,,TUMOR FREE,Dead,-26732,53,,,133,,53,53,,,[Not Available],[Not Applicable],,,,,0.28,,,,,17,,0,0.49919,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-1011,,,,,,,53,,,,,,,,,12,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,88893,,1.686816908,,,,,,,,,,0.189264452,,0.151387216,,,,Stage IB,,1.434,,,,,,,,,,,,,,,,0.4572,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0850733434063799,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.0863,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.07,0.94,14,25,18,,,231,BRCA_Basal,231,231,,0,0,231,231,,Invasive Carcinoma,57,,75,,,,26454,0,,231,231,,,,231,231,,,231,,,,,,,,TUMOR FREE,Alive,-22805,,,,234,,231,231,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,7,,0,0.29415,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FL,,,,,,,231,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,88898,,-0.851559248,0,0,0,0,1.2419,1,,,Infiltrating Ductal Carcinoma,0.089773817,,0.160180761,0,0,0,,Negative,-1.8335,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1192,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Encapsulated Papillary Carcinoma,Encapsulated Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.38,0.45,7,6,8,,,2605,BRCA_Her2,2605,2605,,0,0,2605,2605,,Invasive Carcinoma,21,,40,,,,26172,0,,2605,2605,,,,2605,2605,,,2605,,,,,,,,TUMOR FREE,Alive,-18270,,,,51,,2605,2605,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,10,,1,0.13022,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A254,,,,,,,2605,,,,,,,,,26,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,88904,,0.899338643,0,0,0,0,-1.3932,1,,,Infiltrating Ductal Carcinoma,0.247868119,,0.119243216,0,0,0,,Negative,0.6415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4689,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2EL,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.79,0.98,7,6,6,,,819,,,819,,1.0,1,105.0,105.0,,Malignant,19,,45,,,,28836.0,,,105.0,105,,,,,819,,,105.0,,,,,,,,WITH TUMOR,Dead,-28370,819,,,331.0,,105.0,105,,,[Not Available],[Not Applicable],,,,,0.06,,,,,5,,0,0.26109,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EL,,,,,,,,Bone,Distant Metastasis,,,,,,,8,,,,,,,,,,,,,2009,105,,,,Stage II,,,,,,,,Stable Disease,,,,,,77.0,,,,,,,,,,,,,,,,,,,,88907,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-73-4677,White,LUAD,,1,1,,Roswell Park,,1,MALE,1,3.23,0.47,5,2,2,,,38,,,38,,1,1,38,38,,Malignant,9,,9,,,,18465,,,38,38,,,,,38,,,38,,,,,,,,WITH TUMOR,Dead,-27381,38,,,324,,38,38,,,[Not Available],[Not Applicable],,,,,0.04,,,,,11,,1,0.13269,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4677,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,[Discrepancy],,,,,,,,Stable Disease,,,,,,74,,,,,,,,,,,,,,,,,,,,88910,,0.756168434,,,,,,,,,,0.224091726,,0.184189847,,,,Unknown,,0.43,,,,,,,,,,,,,,,,-0.2105,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),K287* (driver),1,,G12A (driver),K287* (driver),,,,-0.411833327,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.2485,,0.1394,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.52,4,4,4,,,878,BRCA_LumA,878,878,,0,0,878,878,,Invasive Carcinoma,12,,9,,,,26362,0,,878,878,,,,878,878,,,878,,,,,,,,TUMOR FREE,Alive,-17257,,,,0,,878,878,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,5,,0,0.090744,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A10F,,,,,,,878,,,,,,,,,6,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,88919,,0.612525837,0,0,0,0,-0.6136,1,,,Infiltrating Lobular Carcinoma,0.209324081,,0.15625551,0,0,0,,Negative,0.565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6145,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Low Grade), Stromal Alterations",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-69-8254,White,LUAD,,0,0,,Washington University - Cleveland Clinic,0,0,MALE,0,1.95,0.41,3,3,2,,,409,,409,409,,0,0,409,409,,Malignant,8,,7,,,,29829,,,409,409,,,,409,409,,,409,,,,,,,,TUMOR FREE,Alive,-31134,,,,109,,409,409,,,[Not Available],[Not Applicable],,,,,0.17,,,,,1,,0,0.051937,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-8254,,,,,,,409,,,,,,,,,2,,,,,,,,,,,,,2012,,,,,[Not Available],,,,,,,,Complete Remission/Response,,,,,,85,,,,,,,,,,,,,,,,,,,,88920,,0.675290261,,,,,,,,,,0.197063593,,0.123135339,,,,Unknown,,1.185,,,,,,,,,,,,,,,,0.079,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,,,,-0.068015567,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.1102,,-0.0347,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,,,Black or African American,BRCA,,1,1,,,1,0,FEMALE,1,2.91,0.46,11,25,16,,,1309,BRCA_Basal,1303,1309,,1,1,1303,1303,,Invasive Carcinoma,52,,125,,,,19975,0,,1303,1303,,,,1303,1309,,,1303,,,,,,,,WITH TUMOR,Alive,-27028,,,,108,,1303,1303,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,11,,1,0.33297,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LL,,,,,,,1309,Liver,Distant Metastasis,,,,,,,34,,,,,,,,,,,,,2008,1303,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,88921,TRUE,-0.439180897,0,0,0,0,-0.1901,1,,,Infiltrating Ductal Carcinoma,0.115516777,,0.141382789,0,0,0,,Negative,-0.3635,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5633,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-FD-A6TC,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.15,0.57,11,14,20,,,187,,187,187,,0.0,0,187.0,187.0,,Malignant,45,,139,,,,28167.0,,,187.0,187,,,,187,187,,,187.0,,,,,,,,TUMOR FREE,Alive,-28963,,,,1333.0,,187.0,187,,,[Not Available],[Not Applicable],,,,,0.18,,,,,12,,1,0.25865,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TC,,,,,,,187,,,,,,,,,29,,,,,,,,,,,,,2013,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,79.0,,,,,,,,,,,,,,,,,,,,88926,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-92-7340,White,LUSC,,0,0,,Washington University - St. Louis,,0,FEMALE,0,2.11,0.39,4,6,2,,,82,,,82,,0,0,82,82,,Malignant,12,,9,,,,18029,,,82,82,,,,,82,,,82,,,,,,,,WITH TUMOR,Alive,-16447,,,,588,,82,82,,,[Not Available],[Not Applicable],,,,,0.58,,,,,3,,0,0.2553,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - St. Louis,,TCGA-92-7340,,,,,,,82,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,45,,,,,,,,,,,,,,,,,,,,88932,,1.221284253,,,,,,,,,,0.215872547,,0.174261807,,,,Stage IIA,,0.5535,,,,,,,,,,,,,,,,0.7953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,E307K,1,,,E307K,15.86108821,16.68738639,15.91541726,-0.202156567114684,LUSC,Squamous Cell Carcinoma,18.06226703,16.1104592,Squamous Cell Carcinoma,1.5576,11.03263651,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-D7-6518,White,STAD,,0,0,,,0,0,,0,2.1,0.35,3,3,6,,,582,,582,582,,0,0,582,582,,Malignant,12,,26,,,,24578,,,582,582,,,,582,582,,,582,,,,,,,,TUMOR FREE,Alive,-27594,,,,98,,582,582,,,[Not Available],[Not Applicable],,,,,0.48,Stomach,Unknown,,,11,,0,0.29252,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6518,,,,,,,582,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,88950,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6518,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,1,1,1,Male,TCGA-37-A5EL,White,LUSC,,1,1,,Cureline,,1,MALE,1,3.68,0.77,16,27,20,,,1143,,,1143,,1,1,946,946,,Malignant,63,,105,,,,34248,,,946,946,,,,,1143,,,946,,,,,,,,WITH TUMOR,Dead,-19371,1143,,,575,,946,946,,,[Not Available],[Not Applicable],,,,,0.31,,,,,19,,1,0.42361,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-A5EL,,,,,,,,,Distant Metastasis,,,,,,,30,,,,,,,,,,,,,2011,946,,,,Stage IIB,,,,,,,,[Discrepancy],,,,,,53,,,,,,,,,,,,,,,,,,,,88951,,0.211847869,,,,,,,,,,0.046808411,,-0.040656774,,,,Stage IIB,,-0.3935,,,,,,,,,,,,,,,,0.1405,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.46835961,12.90349373,13.36535842,-0.612412864261812,LUSC,Squamous Cell Carcinoma,17.84005819,14.89080041,Squamous Cell Carcinoma,-1.1417,11.44674438,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-UY-A78L,White,BLCA,,1.0,,,,,0,MALE,1.0,3.28,0.49,7,18,17,,,1127,,,1127,,1.0,,355.0,355.0,,Malignant,42,,87,,,,18135.0,,,355.0,,,,,,1127,,,355.0,,,,,,,,WITH TUMOR,Alive,-22717,,,,285.0,,355.0,,,,[Not Available],[Not Applicable],,,,,0.38,,,,,7,,2,0.32285,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A78L,,,,,,,1127,,,,,,,,,71,,,,,,,,,,,,,,355,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,62.0,,,,,,,,,,,,,,,,,,,,88953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-VQ-A8PF,,STAD,,0,0,,,2,2,,2,2.08,0.45,1,1,1,,,76,,76,76,,2,2,76,76,,Malignant,3,,20,,,,29363,,,76,76,,,,76,76,,,76,,,,,,,,TUMOR FREE,Dead,-28116,76,,,134,,76,76,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,4,,0,0.031942,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A8PF,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,88966,,1.203780193,,,,,,,,,,0.143863981,Grade 3,0.180373021,,,,Stage IIIB,,1.3735,,,,,,,,,,,,,,,,0.3121,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PF,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-HU-A4H0,Asian,STAD,,0,0,,,0,0,,0,1.98,0.33,12,10,9,,,64,,64,64,,0,0,64,64,,Malignant,31,,125,,,,20618,,,64,64,,,,64,64,,,64,,,,,,,,TUMOR FREE,Alive,-26317,,,,220,,64,64,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,18,,0,0.47881,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4H0,,,,,,,64,,,,,,,,,26,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,88967,,0.567820202,,,,,,,,,,0.083665133,Grade 3,0.043160753,,,,Stage IIIC,,1.7535,,,,,,,,,,,,,,,,-0.2866,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4H0,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,1,0,1,1,Male,TCGA-V1-A9OL,,PRAD,,1,1,,V1,1,0,MALE,1,1.95,0.9,11,17,7,ambiguous,NO,1913,,105,1913,,1,1,105,105,prad_tcga,Malignant,35,BRCA1;BRCA2;BRIP1;CDK12;CHEK2;FANCL;RAD51C;RAD51D,104,,TCGA-V1-A9OL-01,0,5576,0,TCGA-V1-A9OL,105,105,Prostate Cancer,,559,105,1913,TCGA,,105,Primary,0,Apex,A,,,True,,Alive,-24090,,65,9,45,PRAD,105,105,,0.0,[Not Available],[Not Applicable],37,,1,Matched,0.2,Prostate,Resection,5,4E9D56B5-6B3E-4CAE-BDC5-2B29890F9D26,2,,0,0.14235,[Not Available],FCBD7B29-12DA-44C8-B241-1388D1B15684,4,Prostate Adenocarcinoma Acinar Type,,Prostate,34,,Acinar Adenocarcinoma,[Not Available],,V1,1.23333333333,TCGA-V1-A9OL,1:Recurred/Progressed,5,38,Prostate Adenocarcinoma,3.45,7/11/14,1913,,Biochemical evidence of disease,,,NO,C61,E63E681C-8E25-4C1E-8C37-9EAA2697088B,190,6,,0.2705,0:LIVING,0.01,,62.84,Bilateral,44,No Evidence of Extraprostatic Extension,19,YES,,,105,,TCGA-V1-A9OL.E63E681C-8E25-4C1E-8C37-9EAA2697088B.pdf,Peripheral Zone,[Not Applicable],YES,,,9,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,131,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,,N0,T2,0,M0,C61.9,8140/3,88968,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-8510,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.95,0.28,12,11,19,,,539,,539,539,,0,0,539,539,,Malignant,42,,94,,,,19374,,,539,539,,,,539,539,,,539,,,,,,,,TUMOR FREE,Alive,-20410,,,,421,,539,539,,,[Not Available],[Not Applicable],,,,,0.35,,,,,22,,1,0.42011,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8510,,,,,,,539,,,,,,,,,31,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,88969,,1.133225956,,,,,,,,,,0.288932619,,0.192254254,,,,Stage IB,,1.815,,,,,,,,,,,,,,,,0.4038,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,D235H,1,,,D235H,,,,-0.114323441,LUAD,,,,Adenocarcinoma,0.4552,,0.8651,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-33-6738,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.88,0.53,10,3,14,,,1927,,1927,1927,,0,0,1927,1927,,Malignant,27,,24,,,,16747,,,1927,1927,,,,1927,1927,,,1927,,,,,,,,TUMOR FREE,Alive,-29368,,,,451,,1927,1927,,,[Not Available],[Not Applicable],,,,,0.4,,,,,17,,0,0.32942,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-6738,,,,,,,1927,,,,,,,,,18,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,88971,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.1559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R362Q,1,,,R362Q,14.01092638,14.28981816,14.00501863,-0.628474808874668,LUSC,,17.94689144,14.92918619,Squamous Cell Carcinoma,,11.92790784,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A3WW,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.0,0.5,2,1,2,,,633,,633,633,,0.0,0,633.0,633.0,,Malignant,5,,32,,,,30955.0,,,633.0,633,,,,633,633,,,633.0,,,,,,,,TUMOR FREE,Alive,-20909,,,,2013.0,,633.0,633,,,[Not Available],[Not Applicable],,,,,0.02,,,,,0,,0,0.040452,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3WW,,,,,,,633,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,57.0,,,,,,,,,,,,,,,,,,,,88978,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4512,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,4.56,0.32,4,9,12,,,905,,,905,,1,1,905,905,,Malignant,25,,37,,,,24504,,,905,905,,,,,905,,,905,,,,,,,,WITH TUMOR,Dead,-25502,905,,,58,,905,905,,,[Not Available],[Not Applicable],,,,,0.24,,,,,27,,2,0.36924,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4512,,,,,,,157,,,,,,,,,48,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,88979,,0.154448342,,,,,,,,,,0.246361414,,0.129455489,,,,Stage IIIA,,-0.312,,,,,,,,,,,,,,,,0.4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98542375,16.9089662,11.37952049,-0.399506954,LUAD,,18.11303383,14.40690717,Adenocarcinoma,,13.80128998,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Female,TCGA-55-7574,White,LUAD,,1,1,,International Genomics Consortium,1,1,FEMALE,1,2.25,0.19,8,2,5,,,995,,478,995,,1,1,478,478,,Malignant,15,,31,,,,19521,,,478,478,,,,478,995,,,478,,,,,,,,WITH TUMOR,Dead,-23703,995,,,309,,478,478,,,[Not Available],[Not Applicable],,,,,0.47,,,,,11,,1,0.36122,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7574,,,,,,,,,Distant Metastasis,,,,,,,36,,,,,,,,,,,,,2011,478,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,88980,,1.523403375,,,,,,,,,,0.24315417,,0.268146337,,,,Stage IB,,1.3555,,,,,,,,,,,,,,,,0.5363,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.020025139,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.8841,,1.1524,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,1.91,0.59,17,16,17,,,2866,BRCA_LumA,1414,2866,,1,1,1414,1414,,Invasive Carcinoma,50,,31,,,,25240,0,,1414,1414,,,,1414,2866,,,1414,,,,,,,,WITH TUMOR,Dead,-9706,2866,,,63,,1414,1414,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,7,,0,0.23847,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A24L,,,,,,,,,Locoregional Disease,,,,,,,12,,,,,,,,,,,,,2005,1414,,,,Stage IIB,,,,,,,,[Not Available],,,,,,26,,,,,,,,,,,,,,,,,,,,88983,,-0.694871499,0,0,0,0,-0.576,1,,,Infiltrating Ductal Carcinoma,0.158798176,,0.219501905,0,0,0,,Negative,-0.935,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.548,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A67O,,PRAD,,0,0,,J4,0,0,MALE,0,1.98,0.22,2,3,2,HRP,NO,839,,839,839,,0,0,839,839,prad_tcga,Malignant,7,RAD51B,19,,TCGA-J4-A67O-01,0,5476,0,TCGA-J4-A67O,839,839,Prostate Cancer,,490,839,839,TCGA,,839,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-21714,,59,7,29,PRAD,839,839,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.01,Prostate,Resection,3,D83270F9-98B6-4265-B080-716742DE38F8,1,,0,0.025855,[Not Available],3FC9E3B4-8BC5-4BF8-BFF6-DD90346B83A1,4,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,J4,0.8,TCGA-J4-A67O,0:DiseaseFree,2,0,Prostate Adenocarcinoma,27.56,8/16/13,839,,,,,,C61,BF98B941-3DEB-46EB-803D-4A4AF49F529E,250,2,TUMOR FREE,0.0001,0:LIVING,0.1,,27.56,Bilateral,1,,,YES,392,2012,,,TCGA-J4-A67O.BF98B941-3DEB-46EB-803D-4A4AF49F529E.pdf,Peripheral Zone,[Not Applicable],,,,2,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,88990,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-D7-6526,White,STAD,,0,0,,,0,0,,0,4.7,0.6,6,24,28,,,523,,523,523,,0,0,523,523,,Malignant,58,,55,,,,29400,,,523,523,,,,523,523,,,523,,,,,,,,TUMOR FREE,Alive,-24477,,,,273,,523,523,,,[Not Available],[Not Applicable],,,,,0.4,Stomach,Unknown,,,18,,2,0.11188,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-6526,,,,,,,523,,,,,,,,,69,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,88991,,-0.281256339,,,,,,,,,,0.063818221,Grade 2,0.00769198,,,,Stage IIIA,,-1.0915,,,,,,,,,,,,,,,,0.0782,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6526,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,,1,1,1,Male,TCGA-VQ-A91Q,Unknown,STAD,,1,1,,,,1,,1,1.85,0.71,13,13,11,,,633,,,633,,1,1,551,551,,Malignant,37,,145,,,,17141,,,551,551,,,,,633,,,551,,,,,,,,WITH TUMOR,Dead,-22303,633,,,140,,551,551,,,Stomach Cancer,[Not Applicable],,,,,0.41,Stomach,Unknown,,,5,,0,0.26314,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A91Q,,,,,,,,,Locoregional Recurrence,,,,,,,10,,,,,,,,,,,,,2009,551,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,88993,,-0.309540383,,,,,,,,,,0.048744777,Grade 3,0.147755997,,,,Stage IV,,-0.3115,,,,,,,,,,,,,,,,0.6158,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91Q,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1120,,1120,1120,,0,0,1120,1120,,Invasive Carcinoma,,,,,,,27439,0,,1120,1120,,,,1120,1120,,,1120,,,,,,,,TUMOR FREE,Alive,-18501,,,,0,,1120,1120,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A28O,,,,,,,1120,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,88998,,-0.125594507,0,0,0,0,0.2164,1,,,Infiltrating Lobular Carcinoma,0.146477954,,0.272490782,0,0,0,,Negative,0.269,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5727,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"LCIS, Stromal Alterations",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-99-8028,Black or African American,LUAD,,0,0,,Washington University - Alabama,0,0,FEMALE,0,2.1,0.18,1,7,5,,,1118,,1118,1118,,0,0,1118,1118,,Malignant,13,,8,,,,18396,,,1118,1118,,,,1118,1118,,,1118,,,,,,,,TUMOR FREE,Alive,-18542,,,,562,,1118,1118,,,[Not Available],[Not Applicable],,,,,0.54,,,,,2,,0,0.066194,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Alabama,,TCGA-99-8028,,,,,,,1118,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,50,,,,,,,,,,,,,,,,,,,,89000,,1.986264521,,,,,,,,,,0.29875426,,0.236339347,,,,Stage IA,,2.436,,,,,,,,,,,,,,,,0.6754,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12C (driver), AMP (driver)",,1,,G12C (driver),,,,,0.455928191,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.7415,,1.8728,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-K4-A6FZ,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.18,0.33,10,12,13,,,55,,55,55,,0.0,0,55.0,55.0,,Malignant,35,,80,,,,20345.0,,,55.0,55,,,,55,55,,,55.0,,,,,,,,TUMOR FREE,Alive,-27686,,,,541.0,,55.0,55,,,[Not Available],[Not Applicable],,,,,0.28,,,,,20,,1,0.32498,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A6FZ,,,,,,,55,,,,,,,,,24,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,89003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-NC-A5HD,White,LUSC,,0,0,,Washington University - CHUV,,2,MALE,2,2.92,0.61,13,14,19,,,2,,,2,,2,2,2,2,,Malignant,46,,163,,,,22802,,,2,2,,,,,2,,,2,,,,,,,,TUMOR FREE,Dead,-28916,2,,,605,,2,2,,,[Not Available],[Not Applicable],,,,,0.18,,,,,19,,1,0.51797,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HD,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Applicable],,,,,,79,,,,,,,,,,,,,,,,,,,,89005,,0.230838466,,,,,,,,,,0.074932798,,-0.015079582,,,,Stage IIB,,-0.6735,,,,,,,,,,,,,,,,0.2104,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.06964561,13.25061454,13.45626575,-0.841161826106068,LUSC,Squamous Cell Carcinoma,17.44449166,14.47014258,Squamous Cell Carcinoma,-0.8644,12.69981083,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Female,TCGA-85-A510,White,LUSC,,1,1,,Asterand,1,0,FEMALE,1,2.7,0.55,6,13,12,,,482,,363,482,,1,1,363,363,,Malignant,31,,58,,,,21565,,,363,363,,,,363,482,,,363,,,,,,,,TUMOR FREE,Alive,-27067,,,,206,,363,363,,,[Not Available],[Not Applicable],,,,,0.09,,,,,20,,1,0.30235,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A510,,,,,,,482,,Distant Metastasis,,,,,,,32,,,,,,,,,,,,,2012,363,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,89007,,0.81380597,,,,,,,,,,0.161311418,,0.103036303,,,,Stage IIB,,0.7175,,,,,,,,,,,,,,,,-0.3721,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.68378896,16.22693463,16.54824409,-0.247007101184269,LUSC,Squamous Cell Carcinoma,17.85266604,16.33930119,Squamous Cell Carcinoma,-0.5737,13.31155537,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A1AC,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.39,0.69,9,19,16,,,3981,,3981,3981,,0.0,0,3981.0,3981.0,,Malignant,44,,32,,,,21515.0,,,3981.0,3981,,,,3981,3981,,,3981.0,,,,,,,,TUMOR FREE,Alive,-26307,,,,2169.0,,3981.0,3981,,,[Not Available],[Not Applicable],,,,,0.15,,,,,12,,1,0.159,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1AC,,,,,,,3981,,,,,,,,,33,,,,,,,,,,,,,2000,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,72.0,,,,,,,,,,,,,,,,,,,,89009,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-71-6725,Asian,LUAD,,1,1,,ILSBio,,0,FEMALE,1,2.69,0.63,7,14,21,,,256,,,256,,1,1,164,164,,Malignant,42,,55,,,,31102,,,164,164,,,,,256,,,164,,,,,,,,WITH TUMOR,Alive,-17793,,,,79,,164,164,,,[Not Available],[Not Applicable],,,,,0.2,,,,,19,,1,0.33007,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ILSBio,,TCGA-71-6725,,,,,,,256,,Locoregional Recurrence,,,,,,,37,,,,,,,,,,,,,2011,164,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,48,,,,,,,,,,,,,,,,,,,,89013,,-1.502147064,,,,,,,,,,0.126613548,,0.143301777,,,,Stage IB,,-1.3365,,,,,,,,,,,,,,,,-0.2364,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.878941114,LUAD,Adenocarcinoma,,,Adenocarcinoma,-2.4443,,-3.5038,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,,,,,,,,4267,BRCA_Normal,4267,4267,,2,2,4267,4267,,Invasive Carcinoma,,,,,,,18868,0,,4267,4267,,,,4267,4267,,,4267,,,,,,,,TUMOR FREE,Dead,-25010,4267,,,58,,4267,4267,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1994,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,89016,,-2.093881063,0,0,0,0,0.9953,0,,,Infiltrating Lobular Carcinoma,0.112898615,,0.172311419,0,0,1,,Negative,-0.9565,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0528,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,Papilloma,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Papilloma,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.89,0.76,4,1,3,,,1157,BRCA_LumA,1157,1157,,0,0,1157,1157,,Invasive Carcinoma,8,,103,,,,20689,0,,1157,1157,,,,1157,1157,,,1157,,,,,,,,TUMOR FREE,Alive,-30407,,,,49,,1157,1157,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,7,,0,0.16039,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Indivumed,,TCGA-A8-A0AD,,,,,,,1157,,,,,,,,,5,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,83,,,,,,,,,,,,,,,,,,,,89018,,-0.213324857,0,0,0,0,0.0328,1,,,Mixed Histology (NOS),0.198392533,,0.114893109,0,0,0,,Negative,-0.8885,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3169,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-85-7710,White,LUSC,,0,0,,Asterand,0,0,FEMALE,0,1.9,0.73,7,9,12,,,42,,42,42,,0,0,42,42,,Malignant,28,,18,,,,23523,,,42,42,,,,42,42,,,42,,,,,,,,TUMOR FREE,Alive,-21790,,,,262,,42,42,,,[Not Available],[Not Applicable],,,,,0.0,,,,,8,,0,0.30438,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-7710,,,,,,,42,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,89019,,0.976190059,,,,,,,,,,0.148606674,,0.046479226,,,,Stage IA,,0.7195,,,,,,,,,,,,,,,,0.3883,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.235893235572952,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.3789,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-60-2708,White,LUSC,,0,0,,Roswell Park,0,0,FEMALE,0,2.8,0.58,5,3,11,,,2447,,2447,2447,,0,0,2447,2447,,Malignant,19,,39,,,,30605,,,2447,2447,,,,2447,2447,,,2447,,,,,,,,TUMOR FREE,Alive,-23691,,,,285,,2447,2447,,,[Not Available],[Not Applicable],,,,,0.28,,,,,30,,1,0.45192,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2708,,,,,,,2447,,,,,,,,,29,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,89020,,0.073778327,,,,,,,,,,0.204373481,,0.137962573,,,,Stage IIB,,0.6555,,,,,,,,,,,,,,,,1.1675,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,S720C,,,1,S720C,,,15.42516724,16.59906115,11.31341167,-0.584800207258362,LUSC,Squamous Cell Carcinoma,18.05470502,14.77126499,Squamous Cell Carcinoma,1.5173,14.44222348,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,1,1,,,White,BRCA,,0,0,,,0,0,FEMALE,1,2.0,0.74,3,0,4,,,5062,BRCA_LumA,5062,5062,,0,0,4203,4203,,Invasive Carcinoma,7,,7,,,,17229,0,,5062,5062,,,,5062,5062,,,4203,,,,,,,,TUMOR FREE,Alive,-25499,,,,422,,5062,5062,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.041254,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A2LE,,,,,,,5062,"Other, specify",New Primary Tumor,,,,,,,4,,,,,,,,,,,,,2001,4203,Endometrium,,,Stage I,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,89030,,-0.086991882,0,0,0,0,0.8152,1,,,Infiltrating Lobular Carcinoma,0.109869836,,0.215101342,0,0,0,,Negative,-0.38,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0947,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.14,0.77,2,2,2,,,51,BRCA_LumA,51,51,,0,0,51,51,,Invasive Carcinoma,6,,9,,,,24312,0,,51,51,,,,51,51,,,51,,,,,,,,TUMOR FREE,Alive,-15996,,,,55,,51,51,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Core Biopsy,,,7,,0,0.033189,[Unknown],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A6NO,,,,,,,51,,,,,,,,,6,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,89032,,-0.34171053,0,0,0,0,-0.5873,1,,,Infiltrating Ductal Carcinoma,0.068587731,,0.125177277,0,0,0,,Negative,-0.872,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1556,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-05-4244,,LUAD,,0,0,,Indivumed,,0,MALE,0,4.24,0.44,6,8,14,,,0,,,0,,0,0,0,0,,Malignant,28,,21,,,,21383,,,0,0,,,,,0,,,0,,,,,,,,TUMOR FREE,Alive,-25752,,,,280,,0,0,,,[Not Available],[Not Applicable],,,,,0.25,,,,,13,,1,0.10646,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4244,,,,,,,0,,,,,,,,,29,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,89033,,0.425325588,,,,,,,,,,0.24549693,,0.127511896,,,,Stage IV,,1.0245,,,,,,,,,,,,,,,,0.0097,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.01918021,17.5213389,14.87121708,-0.380196354,LUAD,Adenocarcinoma,17.98448651,15.5193755,Adenocarcinoma,0.1863,13.99492312,-0.5561,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.33,3,2,3,,,1474,BRCA_LumA,1474,1474,,0,0,1474,1474,,Invasive Carcinoma,8,,8,,,,17672,0,,1474,1474,,,,1474,1474,,,1474,,,,,,,,TUMOR FREE,Alive,-17702,,,,52,,1474,1474,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,3,,0,0.11517,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YL,,,,,,,1474,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,89035,,0.397452157,0,0,0,0,-0.1806,1,,,Infiltrating Lobular Carcinoma,0.161913012,,0.238325254,0,0,0,,Negative,0.357,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5253,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-YL-A9WI,,PRAD,389,0,0,,YL,,0,MALE,0,2.27,0.88,6,12,3,ambiguous,NO,1623,6-FOXA1,,1623,,0,0,1623,1623,prad_tcga,Malignant,21,,166,,TCGA-YL-A9WI-01,19,5689,0,TCGA-YL-A9WI,1623,1623,Prostate Cancer,,1259,,1623,TCGA,,1623,Primary,1,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23184,,63,9,51,PRAD,1623,1623,,0.373381833,[Not Available],[Not Applicable],41,R0,1,Matched,0.17,Prostate,Resection,4,563E009C-C93D-46CC-867D-F5C89D9336D9,10,Normal (no evidence of prostate cancer) [cM0],0,0.13134,[Not Available],2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.36666666667,TCGA-YL-A9WI,0:DiseaseFree,5,22,Prostate Adenocarcinoma,53.32,4/10/14,1623,,,,,NO,C61,746DB832-C507-4FD6-8B8A-09E6268BACC9,680,11,,0.376,0:LIVING,0.03,,53.32,Bilateral,31,No Evidence of Extraprostatic Extension,99,YES,1325,2010,,,TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,93,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R0,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,,1,M0,C61.9,8140/3,89037,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-69-8255,White,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,3.27,0.37,11,16,23,,,129,,,129,,0,0,129,129,,Malignant,50,,86,,,,19166,,,129,129,,,,,129,,,129,,,,,,,,,Alive,-26289,,,,399,,129,129,,,[Not Available],[Not Applicable],,,,,0.19,,,,,17,,1,0.34172,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-8255,,,,,,,129,,,,,,,,,38,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Unknown],,,,,,71,,,,,,,,,,,,,,,,,,,,89038,,1.506948444,,,,,,,,,,0.170152612,,0.059193746,,,,Stage IA,,1.917,,,,,,,,,,,,,,,,-0.426,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,0.047489842,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.9707,,1.7854,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,,1,1,Male,TCGA-78-7155,White,LUAD,,1,,,Prince Charles Hospital,,,MALE,1,2.5,0.82,22,27,29,,,1171,,,1171,,1,,209,209,,Malignant,78,,126,,,,21736,,,209,,,,,,1171,,,209,,,,,,,,,Dead,-24863,1171,,,1963,,209,,,,[Not Available],[Not Applicable],,,,,0.18,,,,,17,,1,0.49397,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7155,,,,,,,,,,,,,,,,41,,,,,,,,,,,,,2005,209,,,,Stage IB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,89043,,0.140934305,,,,,,,,,,0.129788618,,0.030720843,,,,Stage IB,,-0.049,,,,,,,,,,,,,,,,-0.5026,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"K754I (driver), Q432H, G901V, AMP (driver)",,,1,"K754I (driver), Q432H, G901V",,,,,,-0.640232251,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.8104,,-0.1885,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.55,1,0,0,,,258,BRCA_LumB,258,258,,0,0,258,258,,Invasive Carcinoma,1,,6,,,,28509,0,,258,258,,,,258,258,,,258,,,,,,,,TUMOR FREE,Alive,-14122,,,,51,,258,258,,,[Not Available],[Not Applicable],,,,,0.84,Breast,Resection/Excision,,,2,,0,0.052183,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1IY,,,,,,,258,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,89064,,1.257646041,0,0,0,0,-0.238,1,,,Infiltrating Ductal Carcinoma,0.16155836,,0.180392716,0,0,0,,Negative,0.4775,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3482,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.29,0.57,2,1,3,,,526,BRCA_LumA,526,526,,0,0,526,526,,Invasive Carcinoma,6,,15,,,,28611,0,,526,526,,,,526,526,,,526,,,,,,,,TUMOR FREE,Alive,-17224,,,,40,,526,526,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,9,,0,0.017535,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15D,,,,,,,526,,,,,,,,,9,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,89067,,-0.096982907,0,0,0,0,-0.6613,1,,,Infiltrating Ductal Carcinoma,0.111144459,,0.214809127,0,0,0,,Negative,-0.6315,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3188,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Female,TCGA-DK-A1A7,White,BLCA,,1.0,1,,,,0,FEMALE,1.0,3.33,0.74,10,16,23,,,560,,,560,,1.0,1,112.0,112.0,,Malignant,49,,79,,,,25053.0,,,112.0,112,,,,,560,,,112.0,,,,,,,,WITH TUMOR,Alive,-24499,,,,317.0,,112.0,112,,,[Not Available],[Not Applicable],,,,,0.22,,,,,12,,1,0.21664,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A1A7,,,,,,,560,Lung,Metastatic,,,,,,,35,,,,,,,,,,,,,2010,112,,,,Stage IV,,,,,,,,[Not Available],,,,,,67.0,,,,,,,,,,,,,,,,,,,,89073,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-77-7337,White,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,1.89,0.52,16,17,21,,,3253,,,3253,,2,2,3253,3253,,Malignant,54,,35,,,,24022,,,3253,3253,,,,,3253,,,3253,,,,,,,,,Dead,-24065,3253,,,461,,3253,3253,,,[Not Available],[Not Applicable],,,,,0.22,,,,,13,,0,0.41645,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-7337,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2000,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,89076,,0.517496362,,,,,,,,,,0.224289732,,0.124612695,,,,Stage IIB,,0.1455,,,,,,,,,,,,,,,,0.8806,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.91273782,16.82998001,15.04450333,-0.35086870856044,LUSC,Squamous Cell Carcinoma,17.79266313,15.59188861,Squamous Cell Carcinoma,1.5446,14.12957064,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-D7-5578,White,STAD,,0.0,0,,,,0,,0.0,2.03,0.6,6,8,5,,,385,,,385,,0.0,0,385,385,,Malignant,19,,33,,,,22833.0,0,,385,385,,,,,385,,,385,,,,,,,,TUMOR FREE,Alive,-29390,,,,293.0,,385,385,,,[Not Available],[Not Applicable],,,,,0.54,Stomach,Resection,,,2,,0,0.16637,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-5578,,,,,,,385,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,89083,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-5578,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.09,0.73,7,12,22,,,1351,BRCA_LumA,1351,1351,,0,0,1351,1351,,Invasive Carcinoma,41,,107,,,,18507,0,,1351,1351,,,,1351,1351,,,1351,,,,,,,,TUMOR FREE,Alive,-15284,,,,78,,1351,1351,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,7,,0,0.17162,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A03V,,,,,,,1351,,,,,,,,,11,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,89090,,-0.149946782,0,0,0,0,1.2153,1,,,Infiltrating Ductal Carcinoma,0.109502102,,0.181987509,0,0,0,,Negative,-0.974,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1791,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-YF-AA3L,Unknown,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.65,0.91,3,9,11,,,364,,364,364,,0.0,0,364.0,364.0,,Malignant,23,,47,,,,31431.0,,,364.0,364,,,,364,364,,,364.0,,,,,,,,TUMOR FREE,Alive,-17268,,,,428.0,,364.0,364,,,[Not Available],[Not Applicable],,,,,0.02,,,,,17,,1,0.12253,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Puerto Rico,,TCGA-YF-AA3L,,,,,,,364,,,,,,,,,23,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,47.0,,,,,,,,,,,,,,,,,,,,89107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HI-7169,White,PRAD,,0,0,,HI,0,0,MALE,0,2.0,0.45,0,0,0,HRP,NO,2684,,2684,2684,,0,0,2684,2684,prad_tcga,Malignant,0,,4,,TCGA-HI-7169-01,0,5467,0,TCGA-HI-7169,2684,2684,Prostate Cancer,,1941,2684,2684,TCGA,,2684,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-20133,,55,7,40,PRAD,2684,2684,WHITE,0.0,[Not Available],[Not Applicable],45,,1,Matched,,Prostate,Resection,3,aeef0836-305c-465c-a9ca-6c1825353ae7,0,Normal (no evidence of prostate cancer) [cM0],0,0.000913,[Not Available],11fb5853-8eeb-4ad8-825d-3eaaf3fa08d6,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HI,1.5,TCGA-HI-7169,0:DiseaseFree,2,0,Prostate Adenocarcinoma,88.17,2/21/12,2684,,,,,NO,C61,ed386bc1-82a8-489e-81e0-53a93325a48e,,0,TUMOR FREE,0.0009,0:LIVING,0.1,,88.17,Bilateral,3,,,YES,,2006,,,TCGA-HI-7169.ed386bc1-82a8-489e-81e0-53a93325a48e.pdf,,[Not Applicable],NO,33,,4,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R1,0.5,55,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,89109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-55-1592,White,LUAD,,1,,,International Genomics Consortium,1,1,MALE,1,3.2,0.49,8,19,16,,,701,,452,701,,1,,452,452,,Malignant,43,,31,,,,17740,,,452,,,,,452,701,,,452,,,,,,,,WITH TUMOR,Dead,,701,,,722,,452,,,,[Not Available],[Not Applicable],,,,,0.42,,,,,19,,1,0.22796,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-1592,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,2005,452,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,89111,,0.152115292,,,,,,,,,,0.287249,,0.128548486,,,,Stage IA,,0.2225,,,,,,,,,,,,,,,,0.0852,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,-0.403135779,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.3051,,-0.7134,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-58-A46L,White,LUSC,,0,0,,Thoraxklinik at University Hospital Heidelberg,0,0,MALE,0,1.96,0.58,22,15,20,,,1723,,1723,1723,,0,0,1723,1723,,Malignant,57,,179,,,,19401,,,1723,1723,,,,1723,1723,,,1723,,,,,,,,TUMOR FREE,Alive,-26685,,,,286,,1723,1723,,,[Not Available],[Not Applicable],,,,,0.13,,,,,10,,0,0.44501,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-58-A46L,,,,,,,1723,,,,,,,,,16,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,89114,,1.200877207,,,,,,,,,,0.174533551,,0.045690492,,,,Stage IIIA,,1.245,,,,,,,,,,,,,,,,0.301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,AMP,1,,,,15.39645402,15.83119031,16.99969179,-0.122067370915171,LUSC,Squamous Cell Carcinoma,17.88766049,16.41504669,Squamous Cell Carcinoma,0.2407,13.03813127,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.81,6,2,7,,,375,BRCA_LumA,375,375,,0,0,375,375,,Invasive Carcinoma,15,,22,,,,29414,0,,375,375,,,,375,375,,,375,,,,,,,,TUMOR FREE,Alive,-12715,,,,55,,375,375,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,5,,0,0.14329,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HO,,,,,,,375,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,89115,,-0.360982861,0,0,0,0,-0.9738,1,,,Infiltrating Ductal Carcinoma,0.086644989,,0.121508856,0,0,0,,Negative,-0.1725,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2255,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.57,3,2,5,,,1853,BRCA_LumA,1853,1853,,0,0,1853,1853,,Invasive Carcinoma,10,,6,,,,22882,0,,1853,1853,,,,1853,1853,,,1853,,,,,,,,TUMOR FREE,Alive,-29211,,,,50,,1853,1853,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,3,,0,0.035053,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A2FG,,,,,,,1853,,,,,,,,,3,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,89118,,-0.433504152,0,0,0,0,0.7064,1,,,Infiltrating Lobular Carcinoma,0.153829367,,0.21852136,0,0,0,,Negative,-0.767,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1852,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-7672,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,2.8,0.21,7,8,13,,,719,,719,719,,0,0,719,719,,Malignant,28,,22,,,,16064,,,719,719,,,,719,719,,,719,,,,,,,,TUMOR FREE,Alive,-19200,,,,219,,719,719,,,[Not Available],[Not Applicable],,,,,0.42,,,,,19,,1,0.1842,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-7672,,,,,,,719,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,89120,,1.694950138,,,,,,,,,,0.288434701,,0.176445637,,,,Stage IA,,1.9005,,,,,,,,,,,,,,,,0.6613,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12A (driver), AMP (driver)",,1,,G12A (driver),,,,,0.113606929,LUAD,,,,Adenocarcinoma,1.4173,,0.6232,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Male,TCGA-44-7669,Black or African American,LUAD,,1,,,Christiana Healthcare,1,1,MALE,1,3.37,0.5,10,11,16,,,574,,390,574,,1,,390,390,,Malignant,37,,60,,,,18332,,,390,,,,,390,574,,,390,,,,,,,,WITH TUMOR,Dead,-21893,574,,,595,,390,,,,[Not Available],[Not Applicable],,,,,0.11,,,,,20,,1,0.26828,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-7669,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2010,390,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,89121,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V271L,1,,,V271L,16.32372672,17.56375911,15.95985005,-0.347127969,LUAD,,17.71493027,16.07130615,Adenocarcinoma,-0.5289,13.27772659,0.2463,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Female,TCGA-FD-A5BV,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,1.79,0.89,13,10,10,,,163,,,163,,1.0,1,134.0,134.0,,Malignant,33,,84,,,,19518.0,,,134.0,134,,,,,163,,,134.0,,,,,,,,WITH TUMOR,Dead,-17501,163,,,166.0,,134.0,134,,,[Not Available],[Not Applicable],,,,,0.44,,,,,5,,0,0.3016,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5BV,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,12,,,,,,,,,,,,,2012,134,Peritoneal carcinomatosis,,,Stage III,,,,,,,,Progressive Disease,,,,,,47.0,,,,,,,,,,,,,,,,,,,,89124,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-GU-A763,White,BLCA,,1.0,1,,,,0,MALE,1.0,1.99,0.96,1,1,2,,,997,,,997,,1.0,1,303.0,303.0,,Malignant,4,,24,,,,20891.0,,,303.0,303,,,,,997,,,303.0,,,,,,,,WITH TUMOR,Alive,-26527,,,,91.0,,303.0,303,,,[Not Available],[Not Applicable],,,,,0.0,,,,,1,,0,0.031274,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A763,,,,,,,997,Lung,Distant Metastasis,,,,,,,1,,,,,,,,,,,,,2012,303,,,,Stage III,,,,,,,,Stable Disease,,,,,,72.0,,,,,,,,,,,,,,,,,,,,89127,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EQ-A4SO,White,STAD,,0,0,,,0,0,,0,1.94,0.79,15,24,18,,,494,,494,494,,0,0,494,494,,Unknown,57,,95,,,,24217,,,494,494,,,,494,494,,,494,,,,,,,,TUMOR FREE,Alive,-25897,,,,254,,494,494,,,[Not Available],[Not Applicable],,,,,0.01,Unknown,Unknown,,,6,,0,0.25522,[Not Available],,,[Discrepancy],,,,,Unknown,G2,,Christiana Healthcare,,TCGA-EQ-A4SO,,,,,,,494,,,,,,,,,11,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,89128,,-0.287536715,,,,,,,,,,0.003761063,Grade 2,0.013138728,,,,Stage IIIB,,-0.538,,,,,,,,,,,,,,,,-0.2108,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-EQ-A4SO,Gastric Carcinoma,TCGA,Unknown
0,0,,0,1,1,Male,TCGA-44-2662,White,LUAD,,1,,,Christiana Healthcare,,0,MALE,1,3.19,0.26,13,5,16,,,1280,,,1280,,1,,245,245,,Malignant,34,,109,,,,16586,,,245,,,,,,1280,,,245,,,,,,,,TUMOR FREE,Alive,-24014,,,,235,,245,,,,[Not Available],[Not Applicable],,,,,0.07,,,,,21,,1,0.26197,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-2662,,,,,,,1280,,,,,,,,,25,,,,,,,,,,,,,2009,245,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,89131,,0.681002311,,,,,,,,,,0.290005257,,0.108167836,,,,Stage IB,,1.5195,,,,,,,,,,,,,,,,0.5935,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.359896714,LUAD,,,,Adenocarcinoma,0.8831,,-1.1794,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-UY-A78P,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,1.98,0.26,7,5,9,,,2380,,2380,2380,,0.0,0,2380.0,2380.0,,Malignant,21,,88,,,,26434.0,,,2380.0,2380,,,,2380,2380,,,2380.0,,,,,,,,TUMOR FREE,Alive,-28719,,,,378.0,,2380.0,2380,,,[Not Available],[Not Applicable],,,,,0.24,,,,,4,,0,0.17728,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A78P,,,,,,,2380,,,,,,,,,11,,,,,,,,,,,,,,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,78.0,,,,,,,,,,,,,,,,,,,,89136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-G2-A2EC,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,,,,,,,,696,,,696,,1.0,1,679.0,679.0,,Malignant,,,,,,,19026.0,,,679.0,679,,,,,696,,,679.0,,,,,,,,WITH TUMOR,Dead,-21215,696,,,244.0,,679.0,679,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,679,small bowel,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,89137,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-49-6745,White,LUAD,,0,0,,Johns Hopkins,,0,MALE,0,3.83,0.24,4,3,4,,,522,,,522,,0,0,522,522,,Malignant,11,,15,,,,24410,,,522,522,,,,,522,,,522,,,,,,,,TUMOR FREE,Alive,-30133,,,,158,,522,522,,,[Not Available],[Not Applicable],,,,,0.33,,,,,9,,1,0.12048,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6745,,,,,,,522,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,89141,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,16.54620904,17.9432589,17.24792879,0.037185585,LUAD,Adenocarcinoma,18.32630782,16.40113647,Adenocarcinoma,,13.66230496,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,2019,,2019,2019,,0,0,2019,2019,,Invasive Carcinoma,,,,,,,29589,0,,2019,2019,,,,2019,2019,,,2019,,,,,,,,TUMOR FREE,Alive,-16109,,,,0,,2019,2019,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A3XN,,,,,,,2019,,,,,,,,,,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,89157,,0.481959606,0,0,0,0,0.1902,1,,,Infiltrating Lobular Carcinoma,0.164753131,,0.284065931,0,0,0,,Negative,-0.027,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6223,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-CH-5752,White,PRAD,91,0,0,,CH,0,0,MALE,0,1.97,0.79,1,2,0,HRP,NO,943,1-ERG,943,943,,0,0,943,943,prad_tcga,Malignant,3,,47,9.8,TCGA-CH-5752-01,0,5248,0,TCGA-CH-5752,943,943,Prostate Cancer,,868,943,943,TCGA,,943,Primary,0,,A,,,,TUMOR FREE,Alive,-24290,,66,8,61,PRAD,943,943,WHITE,0.0,[Not Available],[Not Applicable],56,R0,1,Matched,0.0,Prostate,Resection,4,94a01526-7771-4a05-a9ce-9694b73df3a7,0,Normal (no evidence of prostate cancer) [cM0],0,0.031827,[Not Available],d8f56d75-51ab-4a86-a502-c86e1dcd1eff,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,CH,1.86666666667,TCGA-CH-5752,0:DiseaseFree,4,3,Prostate Adenocarcinoma,30.98,3/16/12,943,,,,,NO,C61,d3549715-b952-479c-8edf-86e424811095,,0,TUMOR FREE,0.0319,0:LIVING,0.02,,30.98,Bilateral,6,No Evidence of Extraprostatic Extension,30,YES,,2006,,,TCGA-CH-5752.d3549715-b952-479c-8edf-86e424811095.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,30,61-70%,9,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,0.6,66,Core needle biopsy,,,YES,NO,YES,,T3a,,8,No,,0,N0,,0,M0,C61.9,8550/3,89159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.47,0.72,7,10,17,,,431,BRCA_Basal,431,431,,0,0,431,431,,Invasive Carcinoma,34,,50,,,,26993,0,,431,431,,,,431,431,,,431,,,,,,,,TUMOR FREE,Alive,-18984,,,,71,,431,431,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,19,,1,0.55682,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A143,,,,,,,431,,,,,,,,,40,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,89161,TRUE,0.630829272,0,0,0,0,0.2583,1,,,Infiltrating Ductal Carcinoma,0.132269468,,0.115786307,0,0,0,,Negative,0.242,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2213,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.51,6,7,9,,,2868,BRCA_LumA,2868,2868,,0,0,2868,2868,,Invasive Carcinoma,22,,91,,,,29446,0,,2868,2868,,,,2868,2868,,,2868,,,,,,,,TUMOR FREE,Alive,-14564,,,,31,,2868,2868,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.2059,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AU,,,,,,,2868,,,,,,,,,11,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,89162,,-0.091961077,0,0,0,0,-0.1937,1,,,Infiltrating Ductal Carcinoma,0.152537928,,0.188957453,0,0,0,,Negative,-0.416,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5865,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.9,0.55,9,5,9,,,1604,BRCA_LumA,1604,1604,,0,0,1604,1604,,Invasive Carcinoma,23,,27,,,,26216,0,,1604,1604,,,,1604,1604,,,1604,,,,,,,,TUMOR FREE,Alive,-15302,,,,56,,1604,1604,,,[Not Available],[Not Applicable],,,,,0.4,Breast,Resection/Excision,,,4,,0,0.18103,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A2FS,,,,,,,1604,,,,,,,,,9,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,89174,,0.724817806,0,0,0,0,0.5782,1,,,Infiltrating Ductal Carcinoma,0.094995525,,0.195268823,0,0,0,,Negative,-0.01,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1234,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type), Invasive Papillary Carcinoma","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type), Invasive Papillary Carcinoma",0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-LC-A66R,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.58,0.37,8,10,17,,,466,,,466,,0.0,0,466.0,466.0,,Malignant,35,,77,,,,31336.0,,,466.0,466,,,,,466,,,466.0,,,,,,,,TUMOR FREE,Alive,-28793,,,,187.0,,466.0,466,,,[Not Available],[Not Applicable],,,,,0.2,,,,,15,,1,0.14554,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Hartford Hospital,,TCGA-LC-A66R,,,,,,,466,,,,,,,,,23,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,78.0,,,,,,,,,,,,,,,,,,,,89175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-50-5066,Black or African American,LUAD,,1,1,,University of Pittsburgh,1,0,MALE,1,2.06,0.27,3,5,6,,,1442,,477,1442,,1,1,477,477,,Malignant,14,,27,,,,16028,,,477,477,,,,477,1442,,,477,,,,,,,,TUMOR FREE,Alive,-26385,,,,337,,477,477,,,[Not Available],[Not Applicable],,,,,0.53,,,,,9,,1,0.52495,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5066,,,,,,,1442,,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,2009,477,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,89178,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L210=,,,1,L210=,,,,,,0.17835506,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.3182,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-A9SH,Asian,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.09,0.69,2,5,6,,,1971,,,1971,,1.0,1,547.0,547.0,,Malignant,13,,45,,,,17932.0,,,547.0,547,,,,,1971,,,547.0,,,,,,,,WITH TUMOR,Dead,-24060,1971,,,62.0,,547.0,547,,,[Not Available],[Not Applicable],,,,,0.04,,,,,4,,0,0.05048,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SH,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,4,,,,,,,,,,,,,2005,547,,,,Stage II,,,,,,,,Stable Disease,,,,,,65.0,,,,,,,,,,,,,,,,,,,,89184,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A8SC,,PRAD,389,1,1,,YL,,0,MALE,1,1.95,0.66,5,2,3,ambiguous,NO,1261,2-ETV1,,1261,,1,1,152,152,prad_tcga,Malignant,10,BRCA2;FANCL,60,,TCGA-YL-A8SC-01,0,5663,0,TCGA-YL-A8SC,152,152,Prostate Cancer,,1261,,1261,TCGA,,152,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-24206,,66,9,54,PRAD,152,152,,0.0,[Not Available],[Not Applicable],44,R1,1,Matched,0.06,Prostate,Resection,4,4BEE9900-172C-43B4-9AE8-83A1B199EE1A,5,Normal (no evidence of prostate cancer) [cM0],0,0.10057,[Not Available],42FA9774-9471-4707-8F6F-8041B34C49E4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,YL,1.46666666667,TCGA-YL-A8SC,1:Recurred/Progressed,5,11,Prostate Adenocarcinoma,4.99,4/27/14,1261,,Biochemical evidence of disease,,,NO,C61,557F4A89-87FC-44FA-9460-F8D1BCA759AE,100,5,WITH TUMOR,0.1463,0:LIVING,0.65,,41.43,Bilateral,16,No Evidence of Extraprostatic Extension,47,YES,1387,2010,152,,TCGA-YL-A8SC.557F4A89-87FC-44FA-9460-F8D1BCA759AE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,40,71-80%,6,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,NO,No,R1,,66,Core needle biopsy,,Partial Remission/Response,NO,YES,YES,NO,T3a,NO,9,No,YES,0,N0,,0,M0,C61.9,8140/3,89189,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.34,0.56,7,23,17,,,606,BRCA_LumB,606,606,,0,0,606,606,,Invasive Carcinoma,47,,43,,,,20723,0,,606,606,,,,606,606,,,606,,,,,,,,TUMOR FREE,Alive,-12668,,,,136,,606,606,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,14,,1,0.23406,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XL,,,,,,,606,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,34,,,,,,,,,,,,,,,,,,,,89192,,,0,0,0,0,-0.3018,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-GD-A6C6,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.78,0.92,11,17,19,,,67,,67,67,,0.0,0,67.0,67.0,,Malignant,47,,196,,,,27512.0,,,67.0,67,,,,67,67,,,67.0,,,,,,,,TUMOR FREE,Alive,-23631,,,,391.0,,67.0,67,,,[Not Available],[Not Applicable],,,,,0.11,,,,,14,,1,0.4224,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - IUPUI,,TCGA-GD-A6C6,,,,,,,67,,,,,,,,,35,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,64.0,,,,,,,,,,,,,,,,,,,,89193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,4.57,0.57,10,23,30,,,547,BRCA_LumB,547,547,,0,0,547,547,,Invasive Carcinoma,63,,117,,,,29330,0,,547,547,,,,547,547,,,547,,,,,,,,TUMOR FREE,Alive,-25477,,,,94,,547,547,,,[Not Available],[Not Applicable],,,,,0.4,Breast,Resection/Excision,,,17,,2,0.22721,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06R,,,,,,,547,,,,,,,,,67,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,89194,,0.728567431,0,0,0,0,-0.9651,1,,,Infiltrating Ductal Carcinoma,0.199682173,,0.184001475,0,0,0,,Negative,-0.112,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4156,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.31,0.38,16,26,22,,,586,BRCA_Basal,586,586,,0,0,586,586,,None,64,,205,,,,23236,N/A (Non-Malignant),,586,586,,,,586,586,,,586,,,,,,,,TUMOR FREE,Alive,-24075,,,,234,,586,586,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,18,,1,0.56184,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-AA10,,,,,,,586,,,,,,,,,28,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,89197,TRUE,1.888787056,0,0,0,0,0.62,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.18025511,N/A (Non-Malignant),0.104610787,0,0,0,N/A (Non-Malignant),Negative,2.093,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.19,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8MK,,PRAD,,0,0,,V1,0,0,MALE,0,,,,,,,NO,508,,508,508,,0,0,508,508,prad_tcga,Malignant,,,,,TCGA-V1-A8MK-01,0,5560,0,TCGA-V1-A8MK,508,508,Prostate Cancer,,-1,508,508,TCGA,,508,Primary,0,Apex,A,,,True,,Alive,-15330,,41,6,7,PRAD,508,508,,0.0,[Not Available],[Not Applicable],15,,1,Matched,,Prostate,Resection,3,7CC7E1EB-2F2A-4721-9F05-A0BD9F3055A7,,,,,[Not Available],9938C4AD-748C-4086-9081-FAC0AEFAD440,3,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,V1,0.466666666667,TCGA-V1-A8MK,0:DiseaseFree,1,,Prostate Adenocarcinoma,16.69,7/15/14,508,,,,,NO,C61,B8FB60DC-69C5-421A-90B0-875AE69E27D5,30,,,0.0,0:LIVING,0.83,,16.69,Bilateral,,,,YES,,,,,TCGA-V1-A8MK.B8FB60DC-69C5-421A-90B0-875AE69E27D5.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R0,,41,Core needle biopsy,,,NO,YES,NO,NO,T2c,NO,6,No,NO,,N0,T2a,,M0,C61.9,8140/3,89202,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.9,0.53,6,11,14,,,1474,BRCA_LumB,1474,1474,,0,0,1474,1474,,Invasive Carcinoma,31,,133,,,,30970,1,,1474,1474,,,,1474,1474,,,1474,,,,,,,,TUMOR FREE,Alive,-22848,,,,91,,1474,1474,,,[Not Available],[Not Applicable],,,,,0.13,Skin,Resection/Excision,,,9,,1,0.13598,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Columbia University,,TCGA-3C-AALJ,,,,,,,1474,,,,,,,,,23,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,89203,,0.88381203,0,0,0,0,-0.3258,1,,,Infiltrating Ductal Carcinoma,0.133522541,,0.172420415,0,0,0,,Negative,-0.024,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.3408,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Skin,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-95-7039,White,LUAD,,1,1,,Washington University - Emory,1,0,FEMALE,1,5.66,0.41,3,23,21,,,1272,,1258,1272,,1,1,1258,1258,,Malignant,47,,39,,,,23295,,,1258,1258,,,,1258,1272,,,1258,,,,,,,,WITH TUMOR,Alive,-19981,,,,1632,,1258,1258,,,[Not Available],[Not Applicable],,,,,0.28,,,,,16,,2,0.098154,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-7039,,,,,,,1272,,Locoregional Recurrence,,,,,,,47,,,,,,,,,,,,,2011,1258,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,89210,,0.493618325,,,,,,,,,,0.188946996,,0.206991145,,,,Stage IIB,,1.018,,,,,,,,,,,,,,,,0.3419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,S921R,D33E (driver),,1,S921R,D33E (driver),,14.92459836,16.05443084,15.95827913,-0.335425445,LUAD,Adenocarcinoma,18.16047435,15.66889868,Adenocarcinoma,-0.1415,12.5538182,0.0786,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-NJ-A4YF,Black or African American,LUAD,,0,0,,Washington University - Rush University,,0,FEMALE,0,3.21,0.55,13,22,28,,,2161,,,2161,,0,0,2161,2161,,Malignant,63,,287,,,,21298,,,2161,2161,,,,,2161,,,2161,,,,,,,,TUMOR FREE,Alive,-18584,,,,822,,2161,2161,,,[Not Available],[Not Applicable],,,,,0.36,,,,,17,,1,0.43929,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A4YF,,,,,,,2161,,,,,,,,,36,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Stable Disease,,,,,,50,,,,,,,,,,,,,,,,,,,,89218,,-0.084388316,,,,,,,,,,0.128186664,,0.093642435,,,,Stage IA,,-0.274,,,,,,,,,,,,,,,,-0.0757,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.686289871,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1541,,-1.0735,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-HC-A6AQ,,PRAD,,0,0,,HC,,0,MALE,0,1.99,0.36,1,1,0,HRP,NO,106,,,106,,0,0,106,106,prad_tcga,Malignant,2,,12,,TCGA-HC-A6AQ-01,0,5455,0,TCGA-HC-A6AQ,106,106,Prostate Cancer,,,,106,TCGA,,106,Primary,0,,A,,,False,TUMOR FREE,Alive,-22208,,60,7,32,PRAD,106,106,,0.0,[Not Available],[Not Applicable],23,,1,Matched,0.02,Prostate,Resection,3,2E3E6D4D-D87C-4993-8F41-076CD028C485,0,Normal (no evidence of prostate cancer) [cM0],0,0.011128,[Not Available],3FA83688-1724-42CB-A600-472E4C500E89,4,Prostate Adenocarcinoma Acinar Type,,Prostate,2,,Acinar Adenocarcinoma,[Not Available],,HC,0.766666666667,TCGA-HC-A6AQ,0:DiseaseFree,2,5,Prostate Adenocarcinoma,3.48,9/19/13,106,,,,,NO,C61,1B1D93C4-54AB-43CA-B800-6807A81AA89A,70,1,TUMOR FREE,0.0048,0:LIVING,,,3.48,Bilateral,7,,,YES,204,2012,,,TCGA-HC-A6AQ.1B1D93C4-54AB-43CA-B800-6807A81AA89A.pdf,,[Not Applicable],NO,15,,,Prostate Adenocarcinoma Acinar Type,1,2012,[Unknown],,,"Yes, History of Prior Malignancy",R0,,60,Core needle biopsy,,,YES,NO,NO,NO,T2c,,7,No,,0,,T1c,,M0,C61.9,8140/3,89223,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-8504,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,3.73,0.35,9,6,20,,,510,,510,510,,0,0,510,510,,Malignant,35,,115,,,,27801,,,510,510,,,,510,510,,,510,,,,,,,,TUMOR FREE,Alive,-27210,,,,553,,510,510,,,[Not Available],[Not Applicable],,,,,0.23,,,,,23,,2,0.46268,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8504,,,,,,,510,,,,,,,,,64,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,89228,,0.890303816,,,,,,,,,,0.208509153,,0.063733871,,,,Stage IB,,0.5875,,,,,,,,,,,,,,,,0.3475,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R234W,1,,,R234W,,,,-0.402888715630232,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.3669,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Female,TCGA-44-A4SU,White,LUAD,,1,1,,Christiana Healthcare,1,1,FEMALE,1,2.07,0.59,13,8,8,,,409,,260,409,,1,1,260,260,,Malignant,29,,106,,,,27234,,,260,260,,,,260,409,,,260,,,,,,,,WITH TUMOR,Dead,-24820,409,,,196,,260,260,,,[Not Available],[Not Applicable],,,,,0.55,,,,,10,,1,0.46876,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-A4SU,,,,,,,,,Locoregional Recurrence,,,,,,,38,,,,,,,,,,,,,2012,260,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,89230,,1.019036936,,,,,,,,,,0.173022826,,0.088876797,,,,Stage IA,,0.9775,,,,,,,,,,,,,,,,0.3837,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"S768I (driver), G719C (driver), AMP (driver)",,,1,"S768I (driver), G719C (driver)",,,,,,-0.331657967,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.1543,,-0.6111,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-68-8251,White,LUSC,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,3.01,0.33,9,6,7,,,406,,,406,,0,0,406,406,,Malignant,22,,47,,,,20368,,,406,406,,,,,406,,,406,,,,,,,,TUMOR FREE,Alive,-28739,,,,391,,406,406,,,[Not Available],[Not Applicable],,,,,0.23,,,,,22,,1,0.34625,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-68-8251,,,,,,,406,,,,,,,,,21,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,78,,,,,,,,,,,,,,,,,,,,89232,,0.933939583,,,,,,,,,,0.235888647,,0.078950396,,,,Stage IB,,0.7695,,,,,,,,,,,,,,,,0.6704,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.206370105917839,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.8665,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Female,TCGA-55-8506,White,LUAD,,0,0,,International Genomics Consortium,,0,FEMALE,0,3.94,0.45,9,9,19,,,11,,,11,,0,0,11,11,,Malignant,37,,106,,,,24852,,,11,11,,,,,11,,,11,,,,,,,,,Alive,-22850,,,,2339,,11,11,,,[Not Available],[Not Applicable],,,,,0.24,,,,,13,,1,0.17373,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8506,,,,,,,11,,,,,,,,,23,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Applicable],,,,,,62,,,,,,,,,,,,,,,,,,,,89234,,0.617619369,,,,,,,,,,0.226088656,,0.079609767,,,,Stage IIB,,1.036,,,,,,,,,,,,,,,,0.2035,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,Q616H,1,L858R (driver),,Q616H,16.32139963,16.5388454,16.41960162,-0.279448498,LUAD,Adenocarcinoma,18.00652846,15.35472323,Adenocarcinoma,0.1517,13.67160383,-0.3119,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,0,1,1,,,Black or African American,BRCA,,1,1,,,1,2,FEMALE,1,2.02,0.66,7,6,11,,,6456,BRCA_Her2,2165,6456,,1,1,2165,2165,,Invasive Carcinoma,24,,47,,,,21083,0,,2165,2165,,,,2165,6456,,,2165,,,,,,,,TUMOR FREE,Dead,-18759,6456,,,52,,2165,2165,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,10,,0,0.1782,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RH,,,,,,,,"Other, specify",Locoregional Disease,,,,,,,8,,,,,,,,,,,,,1991,2165,Chest Wall,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,89236,,-0.170298394,0,0,0,0,0.1296,1,,,Infiltrating Ductal Carcinoma,0.139672958,,0.134515272,0,0,0,,Negative,-0.64,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5748,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-4Z-AA87,Black or African American,BLCA,,1.0,1,,,,0,MALE,1.0,3.58,0.61,8,24,22,,,1454,,,1454,,1.0,1,221.0,221.0,,Malignant,54,,195,,,,19888.0,,,221.0,221,,,,,1454,,,221.0,,,,,,,,WITH TUMOR,Alive,-26430,,,,338.0,,221.0,221,,,[Not Available],[Not Applicable],,,,,0.17,,,,,18,,1,0.12717,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA87,,,,,,,1454,Bone,Distant Metastasis,,,,,,,30,,,,,,,,,,,,,2010,221,,,,Stage III,,,,,,,,[Unknown],,,,,,72.0,,,,,,,,,,,,,,,,,,,,89237,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7317,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.98,0.67,1,1,0,HRP,NO,771,8-other,771,771,,0,0,771,771,prad_tcga,Malignant,2,BRCA2,4,14.0,TCGA-EJ-7317-01,8,5301,0,TCGA-EJ-7317,771,771,Prostate Cancer,,285,771,771,TCGA,,771,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-26064,,71,7,43,PRAD,771,771,WHITE,0.092967375,[Not Available],[Not Applicable],44,R0,1,Matched,0.04,Prostate,Resection,3,aeea2f28-0766-42d7-9e6a-c14beb03e692,0,,0,0.018949,[Not Available],68fc3693-0910-4ee8-8997-99c6333b65f4,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.63333333333,TCGA-EJ-7317,0:DiseaseFree,2,4,Prostate Adenocarcinoma,25.33,4/5/12,771,,,,,,C61,f1531404-e42a-47a0-bbd7-6b0bd5ebf56b,,0,TUMOR FREE,0.0281,0:LIVING,0.1,3,25.33,Bilateral,6,,,YES,,2011,,,TCGA-EJ-7317.f1531404-e42a-47a0-bbd7-6b0bd5ebf56b.pdf,,[Not Applicable],,,51-60%,40,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,0.8,71,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,89239,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-33-AASD,Black or African American,LUSC,,1,1,,Johns Hopkins,,1,MALE,1,3.33,0.69,15,8,23,,,3376,,,3376,,1,1,1912,1912,,Malignant,46,,156,,,,30527,,,1912,1912,,,,,3376,,,1912,,,,,,,,WITH TUMOR,Dead,-30623,3376,,,506,,1912,1912,,,[Not Available],[Not Applicable],,,,,0.11,,,,,23,,1,0.41768,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-AASD,,,,,,,,,Locoregional Recurrence,,,,,,,27,,,,,,,,,,,,,2001,1912,,,,Stage IA,,,,,,,,Progressive Disease,,,,,,83,,,,,,,,,,,,,,,,,,,,89242,,-0.091518606,,,,,,,,,,0.123465617,,-0.032257063,,,,Stage IA,,0.148,,,,,,,,,,,,,,,,0.3164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R272L (driver),1,,,R272L (driver),,,,-0.819448946982354,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.4248,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-43-6647,White,LUSC,,0,0,,Christiana Healthcare,0,0,FEMALE,0,1.81,0.25,5,7,7,,,757,,757,757,,0,0,757,757,,Malignant,19,,27,,,,17183,,,757,757,,,,757,757,,,757,,,,,,,,TUMOR FREE,Alive,-25378,,,,216,,757,757,,,[Not Available],[Not Applicable],,,,,0.39,,,,,7,,0,0.34846,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-6647,,,,,,,757,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,89246,,1.274591254,,,,,,,,,,0.241253113,,0.132439501,,,,Stage IIB,,1.6855,,,,,,,,,,,,,,,,1.3212,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.57382375,17.25920428,15.62188305,0.0172738379139917,LUSC,Squamous Cell Carcinoma,17.97205894,16.26773653,Squamous Cell Carcinoma,2.0938,15.4662484,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Male,TCGA-18-3416,,LUSC,,1,1,,Princess Margaret Hospital (Canada),1,1,MALE,1,2.99,0.51,18,19,22,,,973,,940,973,,1,1,940,940,,Malignant,59,,74,,,,17887,,,940,940,,,,940,973,,,940,,,,,,,,WITH TUMOR,Dead,-30435,973,,,433,,940,940,,,[Not Available],[Not Applicable],,,,,0.08,,,,,17,,1,0.45683,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3416,,,,,,,,,Distant Metastasis,,,,,,,32,,,,,,,,,,,,,2006,940,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,83,,,,,,,,,,,,,,,,,,,,89250,,1.94409184,,,,,,,,,,0.191678489,,0.02185535,,,,Stage IIB,,3.071,,,,,,,,,,,,,,,,-0.1464,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.62847895,16.29223475,19.32140867,0.222925189547262,LUSC,Squamous Cell Carcinoma,17.74790919,17.48210336,Squamous Cell Carcinoma,-1.3182,13.30734085,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,1,1,Female,TCGA-44-A479,Black or African American,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,1,2.14,0.36,9,11,11,,,486,,486,486,,0,0,437,437,,Malignant,31,,50,,,,31688,,,486,486,,,,486,486,,,437,,,,,,,,TUMOR FREE,Alive,-27024,,,,403,,486,486,,,[Not Available],[Not Applicable],,,,,0.65,,,,,8,,0,0.18472,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-A479,,,,,,,486,,New Primary Tumor,,,,,,,15,,,,,,,,,,,,,2012,437,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,89261,,1.661934316,,,,,,,,,,0.232538677,,0.136203344,,,,Stage IB,,1.949,,,,,,,,,,,,,,,,0.1992,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,0.170686793,LUAD,,,,Adenocarcinoma,1.2302,,1.3784,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-86-A4D0,White,LUAD,,0,0,,Asterand,2,2,MALE,2,,,,,,,,116,,116,116,,2,2,116,116,,Malignant,,,,,,,28120,,,116,116,,,,116,116,,,116,,,,,,,,TUMOR FREE,Dead,-17607,116,,,0,,116,116,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-A4D0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,48,,,,,,,,,,,,,,,,,,,,89262,,0.636963329,,,,,,,,,,0.138292018,,0.006179391,,,,Stage IIA,,0.145,,,,,,,,,,,,,,,,-0.5037,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.86655427,15.02289673,15.32239595,-0.59724657,LUAD,Adenocarcinoma,17.91653843,15.35828731,Adenocarcinoma,-0.5429,12.45566,-0.4874,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.0,0.48,9,14,19,,,394,BRCA_Her2,394,394,,0,0,394,394,,Invasive Carcinoma,42,,74,,,,17182,0,,394,394,,,,394,394,,,394,,,,,,,,TUMOR FREE,Alive,-32872,,,,958,,394,394,,,[Not Available],[Not Applicable],,,,,0.2,Breast,Resection/Excision,,,18,,1,0.35742,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A26Y,,,,,,,394,,,,,,,,,38,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,89264,TRUE,1.249694755,0,0,0,0,1.6292,1,,,Infiltrating Ductal Carcinoma,0.143782573,,0.086171087,0,0,0,,Negative,0.128,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1492,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-58-A46K,White,LUSC,,1,1,,Thoraxklinik at University Hospital Heidelberg,1,1,MALE,1,1.54,0.61,16,9,16,,,1045,,735,1045,,1,1,735,735,,Malignant,41,,143,,,,16402,,,735,735,,,,735,1045,,,735,,,,,,,,WITH TUMOR,Dead,-21867,1045,,,183,,735,735,,,[Not Available],[Not Applicable],,,,,0.55,,,,,16,,0,0.57906,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-58-A46K,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,19,,,,,,,,,,,,,2008,735,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,89265,,0.726687909,,,,,,,,,,0.098265615,,-0.011193011,,,,Stage IIIA,,2.015,,,,,,,,,,,,,,,,0.0621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,HOMDEL (driver),1,,,,14.0530336,14.14900002,17.13096201,-0.360713193098878,LUSC,Squamous Cell Carcinoma,17.44128358,16.13642483,Squamous Cell Carcinoma,-0.8815,12.12916884,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,,1,1,Female,TCGA-49-4506,White,LUAD,,1,1,,Johns Hopkins,1,,FEMALE,1,2.67,0.25,4,1,4,,,999,,692,999,,1,1,692,692,,Malignant,9,,15,,,,20949,,,692,692,,,,692,999,,,692,,,,,,,,[Discrepancy],Dead,-25132,999,,,149,,692,692,,,[Not Available],[Not Applicable],,,,,0.02,,,,,16,,1,0.32656,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4506,,,,,,,,,Locoregional Recurrence,,,,,,,27,,,,,,,,,,,,,1997,692,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,89267,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,-0.2181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13D (driver),M503K,1,,G13D (driver),M503K,15.95123481,16.55036123,16.82054215,0.016190116,LUAD,Adenocarcinoma,17.88942384,16.49569218,Adenocarcinoma,,13.24541738,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,1.92,0.77,6,14,8,,,502,BRCA_Her2,431,502,,1,1,431,431,,Invasive Carcinoma,28,,53,,,,16826,1,,431,431,,,,431,502,,,431,,,,,,,,WITH TUMOR,Alive,-21918,,,,1244,,431,431,,,[Not Available],[Not Applicable],,,,,0.03,Skin,Resection/Excision,,,5,,0,0.20418,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JA,,,,,,,502,,Locoregional Disease,,,,,,,10,,,,,,,,,,,,,2010,431,,,,[Not Available],,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,89268,,-0.182473302,0,0,0,0,-0.5805,1,,,Infiltrating Ductal Carcinoma,0.18150192,,0.086579977,0,0,0,,Negative,-0.612,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.2961,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-49-6744,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,1.9,0.37,9,8,9,,,1683,,1683,1683,,0,0,1683,1683,,Malignant,26,,24,,,,19681,,,1683,1683,,,,1683,1683,,,1683,,,,,,,,TUMOR FREE,Alive,-23484,,,,273,,1683,1683,,,[Not Available],[Not Applicable],,,,,0.57,,,,,4,,0,0.16693,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6744,,,,,,,1683,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,89272,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.5446,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.81227495,17.88169462,15.96454625,0.112267588,LUAD,,18.26810023,16.55309108,Adenocarcinoma,,14.17567917,1.0012,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,867,BRCA_Basal,867,867,,0,0,867,867,,Invasive Carcinoma,,,,,,,30041,0,,867,867,,,,867,867,,,867,,,,,,,,TUMOR FREE,Alive,-16370,,,,55,,867,867,,,[Not Available],[Not Applicable],,,,,,Breast,Core Biopsy,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1B6,,,,,,,867,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,89273,,2.280594547,0,0,0,0,-0.3035,1,,,Infiltrating Ductal Carcinoma,0.14300434,,0.110349589,0,0,0,,Negative,1.116,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2121,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-8505,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,1.87,0.32,5,6,2,,,440,,440,440,,0,0,440,440,,Malignant,13,,65,,,,18136,,,440,440,,,,440,440,,,440,,,,,,,,TUMOR FREE,Alive,-22676,,,,221,,440,440,,,[Not Available],[Not Applicable],,,,,0.54,,,,,5,,0,0.24572,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8505,,,,,,,440,,,,,,,,,8,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,89274,,-0.263814212,,,,,,,,,,0.179653854,,0.125714111,,,,Stage IIIA,,-0.6085,,,,,,,,,,,,,,,,0.6613,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q193* (driver),1,,,Q193* (driver),14.6365502,16.06061526,10.64646835,-0.783627163,LUAD,,17.91336425,14.59352412,Adenocarcinoma,0.7915,13.58668433,-1.7569,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Male,TCGA-66-2773,,LUSC,,0,0,,Indivumed,,2,MALE,2,2.83,0.41,4,12,14,,,92,,,92,,2,2,92,92,,Malignant,30,,100,,,,25024,,,92,92,,,,,92,,,92,,,,,,,,TUMOR FREE,Dead,-25355,92,,,771,,92,92,,,[Not Available],[Not Applicable],,,,,0.17,,,,,17,,1,0.24436,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2773,,,,,,,,,,,,,,,,32,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,89277,,0.573404488,,,,,,,,,,0.198425364,,0.079538244,,,,Stage IB,,1.9185,,,,,,,,,,,,,,,,0.4156,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,"R470C (driver), R320Q (driver)",1,,,"R470C (driver), R320Q (driver)",,,,-0.132589439467812,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.1381,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.8,0.45,15,16,17,,,410,BRCA_Basal,410,410,,0,0,410,410,,Invasive Carcinoma,48,,45,,,,22565,0,,410,410,,,,410,410,,,410,,,,,,,,TUMOR FREE,Alive,-21910,,,,96,,410,410,,,[Not Available],[Not Applicable],,,,,0.42,Breast,Resection/Excision,,,6,,0,0.31272,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27M,,,,,,,410,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,89286,TRUE,1.481081883,0,0,0,0,1.3929,1,,,Infiltrating Ductal Carcinoma,0.228499164,,0.122212396,0,0,0,,Negative,1.475,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6324,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-75-6207,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),2,,MALE,2,1.9,0.64,14,9,12,,,,,,,,2,2,,,,Malignant,35,,61,,,,25903,,,,,,,,,,,,,,,,,,,,,Dead,,,,,77,,,,,,[Not Available],[Not Applicable],,,,,0.31,,,,,10,,0,0.28073,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-6207,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,89290,,0.245284739,,,,,,,,,,0.211780811,,0.066542834,,,,Stage IIIA,,1.2065,,,,,,,,,,,,,,,,-0.1266,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,E746_A750del (driver),,,1,E746_A750del (driver),,,15.67999711,17.11463517,14.39255241,-0.623450273,LUAD,Adenocarcinoma,17.76421974,15.00866331,Adenocarcinoma,0.2954,13.44605229,-0.6521,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.76,4,2,6,,,2140,BRCA_LumA,2140,2140,,0,0,2140,2140,,Invasive Carcinoma,12,,22,,,,19957,0,,2140,2140,,,,2140,2140,,,2140,,,,,,,,TUMOR FREE,Alive,-16757,,,,71,,2140,2140,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.060977,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IG,,,,,,,2140,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,89292,,-0.89788221,0,0,0,0,0.3138,1,,,Infiltrating Ductal Carcinoma,0.142823377,,0.179209131,0,0,0,,Negative,-0.7695,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.6544,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-68-7755,White,LUSC,,0,0,,Washington University - Cleveland Clinic,,0,FEMALE,0,3.51,0.62,8,9,18,,,83,,,83,,0,0,83,83,,Malignant,35,,49,,,,19797,,,83,83,,,,,83,,,83,,,,,,,,TUMOR FREE,Alive,-21936,,,,371,,83,83,,,[Not Available],[Not Applicable],,,,,0.14,,,,,12,,1,0.34401,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-68-7755,,,,,,,83,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,89298,,0.333823989,,,,,,,,,,0.128280369,,0.099387998,,,,Stage IIA,,1.359,,,,,,,,,,,,,,,,0.4743,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.40688386,14.52680668,15.95416591,-0.586142836945028,LUSC,Squamous Cell Carcinoma,17.78579198,14.93735074,Squamous Cell Carcinoma,-0.1949,13.16243455,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,,,,BRCA,,1,1,,,,1,FEMALE,1,3.22,0.63,6,16,17,,,1127,BRCA_Her2,,1127,,1,1,1127,1127,,Invasive Carcinoma,39,,64,,,,25997,0,,1127,1127,,,,,1127,,,1127,,,,,,,,WITH TUMOR,Dead,-19266,1127,,,54,,1127,1127,,,[Not Available],[Not Applicable],,,,,0.48,Breast,Resection/Excision,,,13,,1,0.20228,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08J,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2005,,,,,Stage IV,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,89300,,0.123674467,0,0,0,0,0.0309,1,,,Infiltrating Ductal Carcinoma,0.172209427,,0.118696593,0,0,0,,Positive,-0.3275,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3686,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,89301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-D7-8578,White,STAD,,1.0,1,,,1,0,,1.0,1.94,0.35,5,2,4,,,643,,451,643,,1.0,1,451,451,,Malignant,11,,45,,,,16372.0,0,,451,451,,,,451,643,,,451,,,,,,,,WITH TUMOR,Alive,-26620,,,,70.0,,451,451,,,[Not Available],[Not Applicable],,,,,0.35,Stomach,Resection,,,11,,0,0.26454,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-8578,,,,,,,643,Lung,Locoregional Recurrence|Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2012,451,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,89305,,0.159074628,,,,,,,,,,0.105569846,Grade 2,0.083071767,,,,Stage IB,,0.2915,,,,,,,,,,,,,,,,0.8282,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8578,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.59,4,4,6,,,404,BRCA_LumA,404,404,,0,0,404,404,,Invasive Carcinoma,14,,25,,,,24666,0,,404,404,,,,404,404,,,404,,,,,,,,TUMOR FREE,Alive,-20077,,,,62,,404,404,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,4,,0,0.087822,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Hartford Hospital,,TCGA-LD-A7W6,,,,,,,404,,,,,,,,,5,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,89311,,0.316548651,0,0,0,0,0.6228,1,,,Other,0.111134264,,0.190403198,0,0,0,,Negative,0.1345,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2912,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"LCIS, Stromal Alterations",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-E7-A7DV,White,BLCA,,0.0,0,,,,0,MALE,0.0,2.87,0.35,13,13,21,,,37,,,37,,0.0,0,37.0,37.0,,Malignant,47,,121,,,,28512.0,,,37.0,37,,,,,37,,,37.0,,,,,,,,WITH TUMOR,Alive,-16145,,,,401.0,,37.0,37,,,[Not Available],[Not Applicable],,,,,0.28,,,,,12,,1,0.29531,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A7DV,,,,,,,37,,,,,,,,,35,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Stable Disease,,,,,,44.0,,,,,,,,,,,,,,,,,,,,89321,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A678,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,2.0,0.92,0,0,0,,,798,,798,798,,0.0,0,798.0,798.0,,Malignant,0,,11,,,,27464.0,,,798.0,798,,,,798,798,,,798.0,,,,,,,,TUMOR FREE,Alive,-20169,,,,68.0,,798.0,798,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.000376,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,Asterand,,TCGA-E7-A678,,,,,,,798,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,55.0,,,,,,,,,,,,,,,,,,,,89327,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-33-4532,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,5.54,0.56,11,14,20,,,3924,,3924,3924,,2,2,3924,3924,,Malignant,45,,150,,,,19419,,,3924,3924,,,,3924,3924,,,3924,,,,,,,,TUMOR FREE,Dead,-25169,3924,,,509,,3924,3924,,,[Not Available],[Not Applicable],,,,,0.28,,,,,22,,2,0.25208,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4532,,,,,,,,,,,,,,,,52,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,89328,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,-0.0077,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,N469Kfs*11 (driver),1,,,N469Kfs*11 (driver),,,,-0.885497586366189,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.5187,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-XF-AAML,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.59,0.74,5,10,15,,,232,,232,232,,2.0,2,232.0,232.0,,Malignant,30,,40,,,,34402.0,,,232.0,232,,,,232,232,,,232.0,,,,,,,,TUMOR FREE,Dead,-27422,232,,,695.0,,232.0,232,,,[Not Available],[Not Applicable],,,,,0.31,,,,,18,,1,0.095499,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAML,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,89331,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.77,0.61,11,12,13,,,2288,BRCA_LumB,2288,2288,,0,0,2288,2288,,Invasive Carcinoma,36,,73,,,,19802,0,,2288,2288,,,,2288,2288,,,2288,,,,,,,,TUMOR FREE,Alive,-24279,,,,89,,2288,2288,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,12,,1,0.26627,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TV,,,,,,,2288,,,,,,,,,23,,,,,,,,,,,,,2005,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,89332,,1.129100451,0,0,0,0,-4.6372,1,,,Infiltrating Ductal Carcinoma,0.193450957,,0.10180199,0,0,0,,Negative,1.0925,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.5074,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-56-6545,White,LUSC,,0,0,,International Genomics Consortium,0,0,FEMALE,0,3.31,0.32,13,13,20,,,666,,666,666,,0,0,666,666,,Malignant,46,,39,,,,17956,,,666,666,,,,666,666,,,666,,,,,,,,TUMOR FREE,Alive,-28400,,,,374,,666,666,,,[Not Available],[Not Applicable],,,,,0.25,,,,,18,,1,0.44131,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-6545,,,,,,,666,,,,,,,,,32,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,89336,,1.179590026,,,,,,,,,,0.261490127,,0.165646638,,,,Stage IB,,1.3265,,,,,,,,,,,,,,,,1.0299,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,,,,-0.0233591542283166,LUSC,,,,Squamous Cell Carcinoma,1.5149,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Male,TCGA-78-7633,White,LUAD,,1,1,,Prince Charles Hospital,1,1,MALE,1,2.19,0.75,1,1,6,,,1528,,1450,1528,,1,1,1450,1450,,Malignant,8,,5,,,,19804,,,1450,1450,,,,1450,1528,,,1450,,,,,,,,WITH TUMOR,Dead,-24713,1528,,,145,,1450,1450,,,[Not Available],[Not Applicable],,,,,0.0,,,,,9,,0,0.09514,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7633,,,,,,,,,Locoregional Recurrence,,,,,,,9,,,,,,,,,,,,,2009,1450,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,89339,,-0.439149622,,,,,,,,,,0.153856916,,0.264749192,,,,Stage IB,,-0.744,,,,,,,,,,,,,,,,-0.1064,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G333C (driver),1,,,G333C (driver),,,,-0.851921698,LUAD,Adenocarcinoma,,,Adenocarcinoma,-2.3511,,-2.0562,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.6,0.49,4,8,11,,,366,BRCA_Her2,366,366,,0,0,366,366,,Invasive Carcinoma,23,,12,,,,33398,0,,366,366,,,,366,366,,,366,,,,,,,,TUMOR FREE,Alive,-29199,,,,61,,366,366,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,20,,2,0.15775,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JF,,,,,,,366,,,,,,,,,71,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,89340,TRUE,0.379906099,1,0,1,0,-0.2421,0,,,Infiltrating Ductal Carcinoma,0.191844363,,0.115451536,0,0,0,,Negative,-0.7335,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,0.074,1,0,H & E,0,0,,0,David Jou,"ADH, Apocrine Metaplasia, FEA",0,1,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"ADH, Apocrine Metaplasia, FEA",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-GV-A3JW,White,BLCA,,1.0,1,,,,0,MALE,1.0,2.9,0.84,18,28,21,,,649,,,649,,1.0,1,271.0,271.0,,Malignant,67,,114,,,,22149.0,,,271.0,271,,,,,649,,,271.0,,,,,,,,WITH TUMOR,Alive,-27091,,,,111.0,,271.0,271,,,[Not Available],[Not Applicable],,,,,0.3,,,,,12,,1,0.3713,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3JW,,,,,,,649,Bone,Distant Metastasis,,,,,,,36,,,,,,,,,,,,,2011,271,,,,Stage II,,,,,,,,Stable Disease,,,,,,74.0,,,,,,,,,,,,,,,,,,,,89342,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-49-AAR2,Black or African American,LUAD,,0,0,,Johns Hopkins,0,0,MALE,0,1.9,0.69,10,3,6,,,2224,,2224,2224,,0,0,2224,2224,,Malignant,19,,68,,,,16296,,,2224,2224,,,,2224,2224,,,2224,,,,,,,,TUMOR FREE,Alive,-23479,,,,520,,2224,2224,,,[Not Available],[Not Applicable],,,,,0.0,,,,,7,,0,0.18736,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AAR2,,,,,,,2224,,,,,,,,,10,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,89349,,0.820358812,,,,,,,,,,0.121781246,,0.069866292,,,,Stage IB,,0.4825,,,,,,,,,,,,,,,,-0.2844,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V271L,1,,,V271L,,,,-0.454947313,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.795,,0.0919,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-KK-A8ID,,PRAD,370,0,0,,KK,0,0,MALE,0,2.27,0.66,1,6,7,HRD,NO,2107,8-other,2107,2107,,0,0,2107,2107,prad_tcga,Malignant,14,,33,,TCGA-KK-A8ID-01,0,5529,0,TCGA-KK-A8ID,2107,2107,Prostate Cancer,,1924,2107,2107,TCGA,,2107,Primary,0,Apex|Middle|Base,A,CDK12:1003:L/X:frameshift_variant,,True,TUMOR FREE,Alive,-25851,,70,9,78,PRAD,2107,2107,,0.0,[Not Available],[Not Applicable],56,,1,Matched,0.08,Prostate,Resection,5,ECB5E501-1682-4DAB-988D-70B8F01C470F,2,Normal (no evidence of prostate cancer) [cM0],0,0.01336,[Not Available],717C0FD3-527B-4D5E-A9AB-0F141FCC84E8,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,KK,1.83333333333,TCGA-KK-A8ID,0:DiseaseFree,5,15,Prostate Adenocarcinoma,69.22,8/18/14,2107,,,,,NO,C61,51303D5A-8963-4A4E-8A30-8EB0CA6D9437,160,1,TUMOR FREE,0.2165,0:LIVING,0.1,,69.22,Bilateral,19,No Evidence of Extraprostatic Extension,-5,YES,1717,2009,,,TCGA-KK-A8ID.51303D5A-8963-4A4E-8A30-8EB0CA6D9437.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,43,86-95%,19,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,,70,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,9,No,YES,0,N1,T2b,2,M0,C61.9,8140/3,89352,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Female,TCGA-22-4613,White,LUSC,,0,0,,Mayo Clinic - Rochester,,,FEMALE,2,1.99,0.62,14,11,17,,,358,,,358,,2,2,358,358,,Malignant,42,,37,,,,18790,,,358,358,,,,,358,,,358,,,,,,,,,Dead,-26722,358,,,834,,358,358,,,[Not Available],[Not Applicable],,,,,0.23,,,,,10,,0,0.31452,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4613,,,,,,,358,,,,,,,,,14,,,,,,,,,,,,,2004,,,,,Stage IA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,89362,,1.184923066,,,,,,,,,,0.22135374,,0.022049961,,,,Stage IA,,1.066,,,,,,,,,,,,,,,,-0.0371,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.117363842933555,LUSC,,,,Squamous Cell Carcinoma,-0.5654,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Male,TCGA-KK-A8IC,,PRAD,370,1,1,,KK,,0,MALE,1,1.88,0.35,11,8,7,ambiguous,NO,2051,1-ERG,,2051,,1,1,1060,1060,prad_tcga,Malignant,26,CDK12;RAD51B;RAD51D,81,,TCGA-KK-A8IC-01,0,5528,0,TCGA-KK-A8IC,1060,1060,Prostate Cancer,,2047,,2051,TCGA,,1060,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-19902,,54,9,24,PRAD,1060,1060,,0.0,[Not Available],[Not Applicable],19,,1,Matched,0.08,Prostate,Resection,4,E9774C52-8772-4F54-82A9-137E2CCD4650,5,Normal (no evidence of prostate cancer) [cM0],0,0.15986,[Not Available],70C6C3A0-B422-4541-A60F-355356A9A340,5,Prostate Adenocarcinoma Acinar Type,,Prostate,24,,Acinar Adenocarcinoma,[Not Available],,KK,0.7,TCGA-KK-A8IC,1:Recurred/Progressed,5,26,Prostate Adenocarcinoma,34.82,8/28/14,2051,,Biochemical evidence of disease,,,NO,C61,D11CB264-3D9E-49ED-85AA-57E4A26A5ED1,140,5,WITH TUMOR,0.1252,0:LIVING,0.9,,67.38,Bilateral,29,No Evidence of Extraprostatic Extension,6,YES,1784,2008,1060,,TCGA-KK-A8IC.D11CB264-3D9E-49ED-85AA-57E4A26A5ED1.pdf,Peripheral Zone,[Not Applicable],YES,7,86-95%,38,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,YES,No,R0,,54,Core needle biopsy,1060,Progressive Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,89365,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-98-7454,White,LUSC,,0,0,,Washington University - Alabama,0,0,MALE,0,1.62,0.25,1,1,0,,,652,,652,652,,0,0,652,652,,Malignant,2,,13,,,,16259,,,652,652,,,,652,652,,,652,,,,,,,,TUMOR FREE,Alive,-26827,,,,251,,652,652,,,[Not Available],[Not Applicable],,,,,0.65,,,,,13,,0,0.53627,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-7454,,,,,,,652,,,,,,,,,15,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,89370,,1.552413208,,,,,,,,,,0.270157587,,0.260634612,,,,Stage IB,,1.801,,,,,,,,,,,,,,,,0.637,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.14338012762859,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.3215,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.29,0.63,6,5,7,,,724,BRCA_LumA,291,724,,1,1,291,291,,Invasive Carcinoma,18,,13,,,,34364,0,,291,291,,,,291,724,,,291,,,,,,,,WITH TUMOR,Alive,-26423,,,,160,,291,291,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,8,,0,0.099202,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A26H,,,,,,,724,Liver,Distant Metastasis,,,,,,,12,,,,,,,,,,,,,2011,291,,,,Stage IIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,89379,,0.623392356,0,0,0,0,-0.5006,1,,,Infiltrating Ductal Carcinoma,0.215592069,,0.123715948,0,0,0,,Negative,0.38,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5209,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-95-7948,White,LUAD,,0,0,,Washington University - Emory,0,0,FEMALE,0,3.51,0.71,7,10,8,,,476,,476,476,,0,0,476,476,,Malignant,25,,30,,,,17785,,,476,476,,,,476,476,,,476,,,,,,,,TUMOR FREE,Alive,-15363,,,,183,,476,476,,,[Not Available],[Not Applicable],,,,,,,,,,15,,1,0.26216,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-7948,,,,,,,476,,,,,,,,,25,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,42,,,,,,,,,,,,,,,,,,,,89385,,-0.164341588,,,,,,,,,,0.138524783,,0.056012126,,,,Stage IB,,-0.5905,,,,,,,,,,,,,,,,0.107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.518645859,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.5779,,-0.7839,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-G9-6353,White,PRAD,161,0,0,,G9,0,0,MALE,0,2.0,1.0,0,0,0,HRP,NO,1542,1-ERG,1542,1542,,0,0,1542,1542,prad_tcga,Malignant,0,,0,4.6,TCGA-G9-6353-01,0,5359,0,TCGA-G9-6353,1542,1542,Prostate Cancer,,590,1542,1542,TCGA,,1542,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-21221,,58,7,5,PRAD,1542,1542,WHITE,0.0,[Not Available],[Not Applicable],20,R1,1,Matched,0.0,Prostate,Resection,3,4cba0ba5-58c3-455c-9cd5-7d9428d27f8c,0,,0,0.0,[Not Available],bcc94953-ce79-428e-99c1-632e42c1b9bc,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,G9,1.0,TCGA-G9-6353,0:DiseaseFree,2,1,Prostate Adenocarcinoma,50.66,3/14/12,1542,,,,,NO,C61,72b2694f-8b37-402a-a75a-2a50372a789e,,0,TUMOR FREE,0.0,0:LIVING,0.1,,50.66,Bilateral,2,,,YES,,2009,,,TCGA-G9-6353.72b2694f-8b37-402a-a75a-2a50372a789e.pdf,Peripheral Zone,[Not Applicable],NO,,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.6,58,Core needle biopsy,,,NO,YES,NO,,T3a,,7,No,,0,,T1c,,M0,C61.9,8550/3,89396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Female,TCGA-GC-A6I3,Black or African American,BLCA,,0.0,0,,,,0,FEMALE,0.0,3.28,0.32,3,19,18,,,423,,,423,,0.0,0,423.0,423.0,,Malignant,40,,89,,,,19598.0,,,423.0,423,,,,,423,,,423.0,,,,,,,,TUMOR FREE,Alive,-32873,,,,323.0,,423.0,423,,,[Not Available],[Not Applicable],,,,,0.27,,,,,16,,1,0.14184,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A6I3,,,,,,,423,,,,,,,,,29,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,90.0,,,,,,,,,,,,,,,,,,,,89406,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,89407,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,2.07,0.54,1,0,3,,,991,BRCA_LumA,991,991,,2,2,991,991,,Invasive Carcinoma,4,,2,,,,27538,0,,991,991,,,,991,991,,,991,,,,,,,,TUMOR FREE,Dead,-26548,991,,,29,,991,991,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,3,,0,0.015904,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0EA,,,,,,,,,,,,,,,,3,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,89418,,-0.286890954,0,0,0,0,-0.0535,1,,,Infiltrating Ductal Carcinoma,0.198402352,,0.269198556,0,0,0,,Negative,-0.426,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.526,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Clinging, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Clinging, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,"Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-DK-A6B1,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.3,0.83,3,5,6,,,2049,,2049,2049,,0.0,0,2049.0,2049.0,,Malignant,14,,36,,,,16410.0,,,2049.0,2049,,,,2049,2049,,,2049.0,,,,,,,,TUMOR FREE,Alive,-24607,,,,203.0,,2049.0,2049,,,[Not Available],[Not Applicable],,,,,0.14,,,,,15,,1,0.10904,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A6B1,,,,,,,2049,,,,,,,,,17,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,67.0,,,,,,,,,,,,,,,,,,,,89419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-A92D,White,STAD,,0,0,,,0,0,,0,2.44,0.7,3,6,10,,,2032,,2032,2032,,0,0,2032,2032,,Malignant,19,,125,,,,31018,,,2032,2032,,,,2032,2032,,,2032,,,,,,,,TUMOR FREE,Alive,-24595,,,,185,,2032,2032,,,[Not Available],[Not Applicable],,,,,0.09,Stomach,Unknown,,,6,,0,0.060376,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A92D,,,,,,,2032,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,89421,,-0.368155057,,,,,,,,,,0.031914005,Grade 2,0.048371856,,,,Stage IB,,-0.507,,,,,,,,,,,,,,,,0.294,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A92D,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,89424,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-FD-A5BZ,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,3.59,0.42,4,8,12,,,835,,,835,,1.0,1,533.0,533.0,,Malignant,24,,67,,,,19078.0,,,533.0,533,,,,,835,,,533.0,,,,,,,,WITH TUMOR,Dead,-28451,835,,,175.0,,533.0,533,,,[Not Available],[Not Applicable],,,,,0.17,,,,,20,,1,0.14874,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5BZ,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,21,,,,,,,,,,,,,2009,533,,,,Stage IV,,,,,,,,[Not Applicable],,,,,,77.0,,,,,,,,,,,,,,,,,,,,89425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-6776,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,1.95,0.65,4,5,5,,,2616,,2616,2616,,0,0,2616,2616,,Malignant,14,,7,,,,16937,,,2616,2616,,,,2616,2616,,,2616,,,,,,,,TUMOR FREE,Alive,-22150,,,,262,,2616,2616,,,[Not Available],[Not Applicable],,,,,0.0,,,,,4,,0,0.12331,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6776,,,,,,,2616,,,,,,,,,5,,,,,,,,,,,,,2005,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,89428,,0.042109609,,,,,,,,,,0.143638517,,0.168267784,,,,Stage IA,,-0.3355,,,,,,,,,,,,,,,,-0.2694,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),V155A (driver),1,,G12D (driver),V155A (driver),,,,-0.638052313,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.9294,,-0.9384,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Male,TCGA-60-2697,White,LUSC,,1,,,Roswell Park,1,1,MALE,1,2.03,0.18,0,0,0,,,372,,200,372,,1,,200,200,,Malignant,0,,19,,,,19653,,,200,,,,,200,372,,,200,,,,,,,,WITH TUMOR,Dead,-14984,372,,,13,,200,,,,[Not Available],[Not Applicable],,,,,0.01,,,,,1,,0,1.1e-06,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2697,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,1992,200,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,41,,,,,,,,,,,,,,,,,,,,89430,,1.837747803,,,,,,,,,,0.252189139,,0.276150354,,,,Stage IIA,,1.8815,,,,,,,,,,,,,,,,0.5311,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.34748733,16.03211945,16.33238993,-0.0442750505480456,LUSC,Squamous Cell Carcinoma,18.49545203,17.15389726,Squamous Cell Carcinoma,0.4106,13.71085592,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.15,0.48,1,1,2,,,683,BRCA_LumA,683,683,,0,0,683,683,,Invasive Carcinoma,4,,4,,,,28289,0,,683,683,,,,683,683,,,683,,,,,,,,TUMOR FREE,Alive,-23055,,,,38,,683,683,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.021505,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A1FZ,,,,,,,683,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,89434,,-0.39772835,0,0,0,0,0.1088,1,,,Infiltrating Ductal Carcinoma,0.209056433,,0.20668212,0,0,0,,Negative,-0.4775,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5159,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-GU-A42Q,White,BLCA,,0.0,0,,,2,2,MALE,2.0,2.95,0.45,11,10,13,,,344,,344,344,,2.0,2,344.0,344.0,,Malignant,34,,89,,,,22380.0,,,344.0,344,,,,344,344,,,344.0,,,,,,,,TUMOR FREE,Dead,-24534,344,,,253.0,,344.0,344,,,[Not Available],[Not Applicable],,,,,0.09,,,,,7,,1,0.22756,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A42Q,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,67.0,,,,,,,,,,,,,,,,,,,,89437,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.25,0.52,23,32,30,,,596,BRCA_Basal,596,596,,0,0,596,596,,Invasive Carcinoma,85,,305,,,,28018,0,,596,596,,,,596,596,,,596,,,,,,,,TUMOR FREE,Alive,-22544,,,,265,,596,596,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,14,,1,0.51725,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A8F5,,,,,,,596,,,,,,,,,34,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,89438,,0.838827366,0,0,0,0,0.4154,1,,,Infiltrating Ductal Carcinoma,0.160472396,,0.113413396,0,0,0,,Negative,0.5555,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2491,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,2.15,0.59,8,5,8,,,1993,BRCA_LumA,834,1993,,1,1,834,834,,Invasive Carcinoma,21,,47,,,,25580,0,,834,834,,,,834,1993,,,834,,,,,,,,WITH TUMOR,Dead,-13982,1993,,,65,,834,834,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,11,,0,0.17652,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Mixed Histology (please specify),,,,,,[Not Available],,Duke,,TCGA-B6-A0IE,,,,,,,,Bone,Distant Metastasis,,,,,,,15,,,,,,,,,,,,,1995,834,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,89439,,-0.629111607,0,0,0,0,0.2825,1,,,Mixed Histology (NOS),0.090558661,,0.171570647,0,0,0,,Negative,-1.4435,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1075,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-FJ-A3Z7,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.43,0.54,8,17,23,,,945,,,945,,0.0,0,945.0,945.0,,Malignant,48,,91,,,,28910.0,,,945.0,945,,,,,945,,,945.0,,,,,,,,TUMOR FREE,Alive,-28052,,,,448.0,,945.0,945,,,[Not Available],[Not Applicable],,,,,0.21,,,,,10,,1,0.258,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3Z7,,,,,,,945,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,89445,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A7B0,,PRAD,,1,1,,KK,,0,MALE,1,1.96,0.31,6,8,0,ambiguous,NO,1329,,,1329,,1,1,606,606,prad_tcga,Malignant,14,,58,,TCGA-KK-A7B0-01,0,5515,0,TCGA-KK-A7B0,606,606,Prostate Cancer,,999,,1329,TCGA,,606,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-24756,,67,9,46,PRAD,606,606,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,4,E93CC6CC-CE3B-45EB-8928-D5B13D7194AF,2,,0,0.093535,[Not Available],73D4E806-2C15-4C9E-A978-106FB9494E82,5,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,KK,1.06666666667,TCGA-KK-A7B0,1:Recurred/Progressed,5,15,Prostate Adenocarcinoma,19.91,8/28/14,1329,,Biochemical evidence of disease,,,NO,C61,A6F717F0-66D2-4AEB-88F6-1A95D26489BC,150,3,,0.1451,0:LIVING,0.1,,43.66,Bilateral,17,,,YES,783,2011,606,,TCGA-KK-A7B0.A6F717F0-66D2-4AEB-88F6-1A95D26489BC.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,17,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,R0,,67,Core needle biopsy,606,Stable Disease,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,89447,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.94,0.8,5,6,5,,,375,BRCA_LumA,375,375,,0,0,375,375,,Invasive Carcinoma,16,,19,,,,23376,0,,375,375,,,,375,375,,,375,,,,,,,,TUMOR FREE,Alive,,,,,70,,375,375,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,4,,0,0.095369,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HE,,,,,,,375,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,89448,,-0.258750427,0,0,0,0,0.9374,1,,,Infiltrating Ductal Carcinoma,0.144852803,,0.150290034,0,0,0,,Negative,-0.8,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1544,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"LCIS, Stromal Alterations",,LCIS,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-G2-A2EO,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.23,0.37,1,3,7,,,1804,,1804,1804,,2.0,2,1804.0,1804.0,,Malignant,11,,27,,,,25306.0,,,1804.0,1804,,,,1804,1804,,,1804.0,,,,,,,,TUMOR FREE,Dead,-25440,1804,,,1247.0,,1804.0,1804,,,[Not Available],[Not Applicable],,,,,0.14,,,,,18,,1,0.10692,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EO,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,89452,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,2.0,0.8,1,0,2,,,1004,BRCA_LumA,1004,1004,,2,2,1004,1004,,Invasive Carcinoma,3,,19,,,,32066,0,,1004,1004,,,,1004,1004,,,1004,,,,,,,,TUMOR FREE,Dead,-27241,1004,,,46,,1004,1004,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.015657,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1B4,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,89464,,-0.116130289,0,0,0,0,1.3479,1,,,Infiltrating Ductal Carcinoma,0.090425988,,0.093534293,0,0,0,,Negative,-0.9495,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0965,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6363,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.02,0.47,3,8,3,ambiguous,NO,1378,1-ERG,1378,1378,,0,0,1378,1378,prad_tcga,Malignant,14,,31,4.6,TCGA-G9-6363-01,0,5364,0,TCGA-G9-6363,1378,1378,Prostate Cancer,,993,1378,1378,TCGA,,1378,Primary,0,Base,A,,,,TUMOR FREE,Alive,-23480,,64,7,46,PRAD,1378,1378,WHITE,0.0,[Not Available],[Not Applicable],53,R0,1,Matched,0.03,Prostate,Resection,4,65d588ff-58e3-4932-a7f4-25ef23c433d5,1,Normal (no evidence of prostate cancer) [cM0],0,0.053631,[Not Available],b5b3871c-078c-46a7-ac50-ef916d4a6781,3,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,15,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,2.13333333333,TCGA-G9-6363,0:DiseaseFree,3,17,Prostate Adenocarcinoma,45.27,3/9/12,1378,,,,,NO,C61,bd52ccc2-462d-41df-a5a4-dc45bd78aea4,,3,TUMOR FREE,0.0845,0:LIVING,0.03,,45.27,Bilateral,17,No Evidence of Extraprostatic Extension,23,YES,,2009,,,TCGA-G9-6363.bd52ccc2-462d-41df-a5a4-dc45bd78aea4.pdf,,[Not Applicable],YES,58,31-40%,6,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.9,64,Core needle biopsy,,,NO,YES,YES,,T4,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,89470,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-A2EF,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.04,0.61,7,15,18,,,1884,,,1884,,0.0,0,1884.0,1884.0,,Malignant,40,,62,,,,26289.0,,,1884.0,1884,,,,,1884,,,1884.0,,,,,,,,TUMOR FREE,Alive,-18467,,,,357.0,,1884.0,1884,,,[Not Available],[Not Applicable],,,,,0.23,,,,,12,,1,0.21003,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EF,,,,,,,1884,,,,,,,,,39,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,50.0,,,,,,,,,,,,,,,,,,,,89471,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-L4-A4E5,White,LUAD,,0,0,,Gundersen Lutheran Health System,0,0,FEMALE,0,1.77,0.66,20,11,16,,,578,,578,578,,0,0,578,578,,Malignant,47,,156,,,,31268,,,578,578,,,,578,578,,,578,,,,,,,,TUMOR FREE,Alive,-17680,,,,443,,578,578,,,[Not Available],[Not Applicable],,,,,0.17,,,,,14,,0,0.49041,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Gundersen Lutheran Health System,,TCGA-L4-A4E5,,,,,,,578,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,48,,,,,,,,,,,,,,,,,,,,89472,,0.728257184,,,,,,,,,,0.139227244,,0.091816773,,,,Stage I,,1.1155,,,,,,,,,,,,,,,,0.1543,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.352558319,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2487,,-0.3049,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,222,,222,222,,0,0,222,222,,Invasive Carcinoma,,,,,,,20641,0,,222,222,,,,222,222,,,222,,,,,,,,TUMOR FREE,Alive,-18060,,,,0,,222,222,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A4RW,,,,,,,222,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,89473,,0.622657984,0,0,0,0,2.3031,1,,,Infiltrating Lobular Carcinoma,0.121250379,,0.197361592,0,0,0,,Negative,-0.0605,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5438,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,1,1,Male,TCGA-77-A5GB,Unknown,LUSC,,0,0,,Prince Charles Hospital,2,,MALE,1,1.72,0.28,9,6,8,,,937,,937,937,,2,2,229,229,,Malignant,23,,54,,,,27866,,,937,937,,,,937,937,,,229,,,,,,,,,Dead,-32872,937,,,170,,937,937,,,[Not Available],[Not Applicable],,,,,0.26,,,,,9,,0,0.37634,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5GB,,,,,,,,,New Primary Tumor,,,,,,,11,,,,,,,,,,,,,2010,229,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,90,,,,,,,,,,,,,,,,,,,,89477,,0.982875815,,,,,,,,,,0.215749821,,0.021192152,,,,Stage IB,,1.0135,,,,,,,,,,,,,,,,0.5294,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.190262404441757,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6847,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.65,3,2,3,,,396,BRCA_LumA,396,396,,0,0,396,396,,Invasive Carcinoma,8,,5,,,,27723,0,,396,396,,,,396,396,,,396,,,,,,,,TUMOR FREE,Alive,-23011,,,,102,,396,396,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,4,,0,0.048529,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06P,,,,,,,396,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,89479,,-0.17877923,0,0,0,0,0.5266,1,,,Infiltrating Ductal Carcinoma,0.164407493,,0.186074476,0,0,0,,Negative,-0.762,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6814,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OH,,PRAD,,0,0,,V1,0,0,MALE,0,2.02,0.49,4,6,4,HRD,NO,2403,,2403,2403,,0,0,2403,2403,prad_tcga,Malignant,14,BRCA2,24,,TCGA-V1-A9OH-01,21,5575,0,TCGA-V1-A9OH,2403,2403,Prostate Cancer,,1253,2403,2403,TCGA,,2403,Primary,1,Apex,A,BRCA2:212:R/X:frameshift_variant,,True,,Alive,-23360,,63,8,66,PRAD,2403,2403,,0.350149623,[Not Available],[Not Applicable],58,,1,Matched,0.05,Prostate,Resection,4,E67E581C-FBB7-431A-B796-C3089843D96E,0,,0,0.055392,[Not Available],6EF0FC2D-F274-4253-BEC5-6DBD55953D76,4,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,V1,1.93333333333,TCGA-V1-A9OH,0:DiseaseFree,4,21,Prostate Adenocarcinoma,78.94,7/23/14,2403,,,,,NO,C61,8B30DB97-6EB7-42EF-8A12-C9B1F1B5251B,70,2,,0.0905,0:LIVING,0.01,,78.94,Right,22,,,YES,,,,,TCGA-V1-A9OH.8B30DB97-6EB7-42EF-8A12-C9B1F1B5251B.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,,NO,YES,NO,NO,T2b,NO,8,No,NO,,,T1c,,M0,C61.9,8140/3,89485,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-77-8156,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,2.96,0.23,8,13,17,,,1106,,1106,1106,,0,0,1106,1106,,Malignant,38,,36,,,,32682,,,1106,1106,,,,1106,1106,,,1106,,,,,,,,,Alive,-22198,,,,293,,1106,1106,,,[Not Available],[Not Applicable],,,,,0.27,,,,,20,,1,0.52374,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8156,,,,,,,1106,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,89486,,1.572706426,,,,,,,,,,0.226872972,,0.125687638,,,,Stage IB,,1.566,,,,,,,,,,,,,,,,0.5543,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,Y1138C,,,1,Y1138C,,,,,,0.00603471870897,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.5926,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BT-A20O,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.02,0.16,1,2,1,,,370,,,370,,1.0,1,315.0,315.0,,Malignant,4,,3,,,,21135.0,,,315.0,315,,,,,370,,,315.0,,,,,,,,WITH TUMOR,Dead,-27534,370,,,241.0,,315.0,315,,,[Not Available],[Not Applicable],,,,,0.25,,,,,0,,0,0.061396,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20O,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,6,,,,,,,,,,,,,2003,315,,,,Stage III,,,,,,,,Progressive Disease,,,,,,75.0,,,,,,,,,,,,,,,,,,,,89488,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3SQ,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.97,0.5,5,7,6,,,1423,,,1423,,1.0,1,991.0,991.0,,Malignant,18,,36,,,,30870.0,,,991.0,991,,,,,1423,,,991.0,,,,,,,,WITH TUMOR,Dead,-22687,1423,,,104.0,,991.0,991,,,[Not Available],[Not Applicable],,,,,0.36,,,,,9,,0,0.16985,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SQ,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,8,,,,,,,,,,,,,2008,991,sigmoid colon,,,Stage IV,,,,,,,,Stable Disease,,,,,,62.0,,,,,,,,,,,,,,,,,,,,89489,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-78-7149,White,LUAD,,0,0,,Prince Charles Hospital,0,0,MALE,0,3.38,0.6,3,4,7,,,3940,,3940,3940,,0,0,3940,3940,,Malignant,14,,36,,,,16870,,,3940,3940,,,,3940,3940,,,3940,,,,,,,,,Alive,-26285,,,,194,,3940,3940,,,[Not Available],[Not Applicable],,,,,0.32,,,,,18,,1,0.18108,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7149,,,,,,,3940,,,,,,,,,19,,,,,,,,,,,,,2002,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,89493,,-0.192949167,,,,,,,,,,0.135383393,,0.295857782,,,,Stage IIIB,,-0.978,,,,,,,,,,,,,,,,0.0401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,W497L,1,,,W497L,13.80914339,14.43183434,13.89853628,-0.689542039,LUAD,Adenocarcinoma,18.10403036,14.8084125,Adenocarcinoma,-0.8296,12.3797493,-0.8636,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-D7-6518,White,STAD,,0,0,,,0,0,,0,2.1,0.35,3,3,6,,,582,,582,582,,0,0,582,582,,Malignant,12,,26,,,,24578,,,582,582,,,,582,582,,,582,,,,,,,,TUMOR FREE,Alive,-27594,,,,98,,582,582,,,[Not Available],[Not Applicable],,,,,0.48,Stomach,Unknown,,,11,,0,0.29252,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6518,,,,,,,582,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,89495,,0.326038542,,,,,,,,,,0.143383273,Grade 3,0.248059969,,,,Stage IIIA,,0.688,,,,,,,,,,,,,,,,0.7089,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6518,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,,0,1,Female,TCGA-05-4434,,LUAD,,0,0,,Indivumed,,,FEMALE,2,1.97,0.45,5,9,5,,,457,,,457,,2,2,457,457,,Malignant,19,,34,,,,26405,,,457,457,,,,,457,,,457,,,,,,,,,Dead,-24472,457,,,62,,457,457,,,[Not Available],[Not Applicable],,,,,0.23,,,,,2,,0,0.12047,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4434,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,89499,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.97179305,17.94112528,17.08823286,0.11015698,LUAD,,18.10373656,16.39155264,Adenocarcinoma,0.7148,14.06727348,0.3532,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-EJ-5497,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.01,0.45,0,7,2,HRP,NO,405,1-ERG,405,405,,0,0,405,405,prad_tcga,Malignant,9,,8,7.2,TCGA-EJ-5497-01,5,5263,0,TCGA-EJ-5497,405,405,Prostate Cancer,,204,405,405,TCGA,,405,Primary,0,Middle,A,,,,TUMOR FREE,Alive,-17523,,47,7,26,PRAD,405,405,WHITE,0.200493891,[Not Available],[Not Applicable],30,R0,1,Matched,0.01,Prostate,Resection,3,317be3b2-b7c1-4772-9e33-d55eb4b9faa9,0,,0,0.013986,[Not Available],dee02265-d8dd-4379-ae08-72d72b03a570,4,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.5,EJ,1.03333333333,TCGA-EJ-5497,0:DiseaseFree,2,10,Prostate Adenocarcinoma,13.3,3/30/12,405,,,,,NO,C61,4c6ab617-53f7-4556-a1a0-b44df4f67b6b,,0,TUMOR FREE,0.0283,0:LIVING,0.1,3,13.3,Bilateral,12,,,YES,,2009,,,TCGA-EJ-5497.4c6ab617-53f7-4556-a1a0-b44df4f67b6b.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,36-45%,10,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,0.6,47,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,89501,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5507,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.83,0.68,9,3,4,ambiguous,NO,1457,1-ERG,1457,1457,,0,0,1457,1457,prad_tcga,Malignant,16,BRCA2;RAD51C,37,8.9,TCGA-EJ-5507-01,0,5272,0,TCGA-EJ-5507,1457,1457,Prostate Cancer,,182,1457,1457,TCGA,,1457,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-19759,,54,9,44,PRAD,1457,1457,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.15,Prostate,Resection,4,f93327f7-0290-4915-97bb-e31bae2697dd,3,,0,0.17546,[Not Available],607200f5-df80-4f5d-90fb-fdc455a7415b,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,16,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,1.3,TCGA-EJ-5507,0:DiseaseFree,5,23,Prostate Adenocarcinoma,47.86,4/2/12,1457,,,,,NO,C61,153de441-fbe9-4c8b-9a84-9cdf9c5edcf2,,8,TUMOR FREE,0.1945,0:LIVING,0.1,4,47.86,Bilateral,27,,,YES,,2010,,,TCGA-EJ-5507.153de441-fbe9-4c8b-9a84-9cdf9c5edcf2.pdf,,[Not Applicable],NO,,81-90%,21,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.6,54,Core needle biopsy,,,YES,NO,YES,,T3b,,9,No,,0,N1,T2c,2,M0,C61.9,8550/3,89504,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-50-5045,Black or African American,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,2.22,0.22,2,4,5,,,2174,,,2174,,1,1,1433,1433,,Malignant,11,,14,,,,18678,,,1433,1433,,,,,2174,,,1433,,,,,,,,WITH TUMOR,Dead,-20961,2174,,,364,,1433,1433,,,[Not Available],[Not Applicable],,,,,0.44,,,,,3,,0,0.24146,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5045,,,,,,,,,Locoregional Recurrence,,,,,,,25,,,,,,,,,,,,,2004,1433,,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,57,,,,,,,,,,,,,,,,,,,,89505,,,,,,,,,,,,,,,,,,Unknown,,,,,,,,,,,,,,,,,,0.5228,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.180141759,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,1.0441,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-55-7283,White,LUAD,,0,0,,International Genomics Consortium,,0,FEMALE,0,3.9,0.47,3,10,10,,,609,,,609,,0,0,609,609,,Malignant,23,,12,,,,17773,,,609,609,,,,,609,,,609,,,,,,,,WITH TUMOR,Alive,-27946,,,,302,,609,609,,,[Not Available],[Not Applicable],,,,,0.06,,,,,15,,2,0.093377,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7283,,,,,,,609,,,,,,,,,68,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Partial Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,89508,,0.35332373,,,,,,,,,,0.216569682,,0.168175695,,,,Stage IIIA,,0.568,,,,,,,,,,,,,,,,-0.2312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12S (driver), AMP (driver)",,1,,G12S (driver),,15.60985993,17.22650305,15.53342109,-0.166465758,LUAD,,18.12112409,15.56072702,Adenocarcinoma,-1.5983,10.93484204,0.3138,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-VQ-A94R,White,STAD,,1.0,1,,,,1,,1.0,2.39,0.69,6,18,11,,,1294,,,1294,,1.0,1,1018,1018,,Malignant,35,,178,,,,33079.0,0,,1018,1018,,,,,1294,,,1018,,,,,,,,WITH TUMOR,Dead,-23246,1294,,,406.0,,1018,1018,,,Stomach Cancer,[Not Applicable],,,,,0.58,Stomach,Resection,,,8,,1,0.409,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A94R,,,,,,,,,Locoregional Recurrence,,,,,,,35,,,,,,,,,,,,,2010,1018,,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,63,,,,,,,,,,,,,,,,,,,,89512,,0.553136453,,,,,,,,,,0.092971453,Grade 2,0.10979881,,,,Unknown,,0.4135,,,,,,,,,,,,,,,,0.2484,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A94R,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-49-4514,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,1.79,0.35,7,13,11,,,1700,,1700,1700,,0,0,1700,1700,,Malignant,31,,47,,,,16363,,,1700,1700,,,,1700,1700,,,1700,,,,,,,,TUMOR FREE,Alive,-28908,,,,422,,1700,1700,,,[Not Available],[Not Applicable],,,,,0.01,,,,,6,,0,0.29223,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4514,,,,,,,1700,,,,,,,,,7,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,89513,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.1738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R470S (driver),1,,,R470S (driver),,,,-0.189491862,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.24,0,0,0,,,288,BRCA_LumA,288,288,,0,0,288,288,,Invasive Carcinoma,0,,0,,,,31140,0,,288,288,,,,288,288,,,288,,,,,,,,TUMOR FREE,Alive,-23318,,,,24,,288,288,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,0,,0,0.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A2JT,,,,,,,288,,,,,,,,,0,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,89534,,2.319781744,0,0,0,0,-1.7038,1,,,Infiltrating Lobular Carcinoma,0.160981931,,0.257921422,0,0,0,,Negative,2.13,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0336,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"LCIS, Stromal Alterations",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-64-5775,White,LUAD,,1,1,,Fox Chase,,1,MALE,1,3.39,0.71,4,3,9,,,62,,,62,,1,1,62,62,,Malignant,16,,18,,,,27046,,,62,62,,,,,62,,,62,,,,,,,,WITH TUMOR,Dead,-26058,62,,,651,,62,62,,,[Not Available],[Not Applicable],,,,,0.18,,,,,12,,1,0.18173,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Fox Chase,,TCGA-64-5775,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,71,,,,,,,,,,,,,,,,,,,,89540,,-0.579025329,,,,,,,,,,0.226343599,,0.135258364,,,,Stage IIIA,,0.9845,,,,,,,,,,,,,,,,0.3988,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,Q61L (driver),,1,,Q61L (driver),,16.30239622,18.00079809,14.14830486,-0.634304898,LUAD,Adenocarcinoma,18.01600592,13.92303682,Adenocarcinoma,2.087,13.64943205,-1.4105,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-XJ-A83F,,PRAD,,0,0,,XJ,0,0,MALE,0,1.91,0.81,6,5,4,ambiguous,NO,1127,,1127,1127,,0,0,1127,1127,prad_tcga,Malignant,15,CHEK2;FANCL,71,,TCGA-XJ-A83F-01,0,5623,0,TCGA-XJ-A83F,1127,1127,Prostate Cancer,,762,1127,1127,TCGA,,1127,Primary,0,Middle|Base,A,,,False,TUMOR FREE,Alive,,,67,7,38,PRAD,1127,1127,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.0,Prostate,Resection,3,4DA83354-4512-4DCA-AF59-DC8217363511,3,,0,0.088997,[Not Available],BDD4FEFA-512A-4720-9F9E-11EB3892FE3C,4,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,XJ,1.1,TCGA-XJ-A83F,0:DiseaseFree,2,25,Prostate Adenocarcinoma,37.02,3/6/14,1127,,,,,NO,C61,FAFE6F58-BE44-442F-B0E6-F3D7BD60EFBD,20,4,TUMOR FREE,0.0835,0:LIVING,0.01,,37.02,Right,30,,,YES,872,2011,,,TCGA-XJ-A83F.FAFE6F58-BE44-442F-B0E6-F3D7BD60EFBD.pdf,Peripheral Zone,[Not Applicable],NO,,,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,RX,,67,Transurethral resection (TURBT),,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,7,No,NO,0,N0,,0,,C61.9,8140/3,89541,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-VQ-A8E7,White,STAD,,1,1,,,,0,,1,2.06,0.66,9,9,9,,,1138,,,1138,,1,1,1048,1048,,Malignant,27,,144,,,,25929,,,1048,1048,,,,,1138,,,1048,,,,,,,,WITH TUMOR,Alive,-21664,,,,140,,1048,1048,,,[Not Available],[Not Applicable],,,,,0.17,Stomach,Unknown,,,7,,0,0.29017,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8E7,,,,,,,1138,"Other, specify",Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2012,1048,Adrenal,,,Stage IV,,,,,,,,Stable Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,89542,,-0.694583729,,,,,,,,,,0.022243774,Grade 2,0.079050803,,,,Stage IV,,-0.69,,,,,,,,,,,,,,,,0.3045,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8E7,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1.0,,1,1.0,1.0,Male,TCGA-FJ-A871,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.99,0.81,3,3,2,,,272,,,272,,1.0,1,106.0,106.0,,Malignant,8,,33,,,,24621.0,,,106.0,106,,,,,272,,,106.0,,,,,,,,WITH TUMOR,Dead,-18051,272,,,71.0,,106.0,106,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.029834,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A871,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,0,,,,,,,,,,,,,2013,106,Pelvic,,,Stage III,,,,,,,,Progressive Disease,,,,,,49.0,,,,,,,,,,,,,,,,,,,,89544,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-AAN1,Unknown,BLCA,,1.0,1,,,,1,FEMALE,1.0,1.95,0.91,6,4,5,,,941,,,941,,1.0,1,650.0,650.0,,Malignant,15,,83,,,,29641.0,,,650.0,650,,,,,941,,,650.0,,,,,,,,WITH TUMOR,Dead,-27687,941,,,117.0,,650.0,650,,,[Not Available],[Not Applicable],,,,,0.01,,,,,4,,0,0.1786,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAN1,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,9,,,,,,,,,,,,,2006,650,Pelvis and vagina,,,Stage III,,,,,,,,Partial Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,89552,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-DK-A3IK,White,BLCA,,0.0,0,,,,2,MALE,2.0,2.97,0.5,9,16,22,,,146,,,146,,2.0,2,146.0,146.0,,Malignant,47,,89,,,,33359.0,,,146.0,146,,,,,146,,,146.0,,,,,,,,TUMOR FREE,Dead,-32076,146,,,269.0,,146.0,146,,,[Not Available],[Not Applicable],,,,,0.14,,,,,13,,1,0.3457,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IK,,,,,,,,,,,,,,,,39,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,87.0,,,,,,,,,,,,,,,,,,,,89555,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-66-2794,,LUSC,,0,0,,Indivumed,0,0,MALE,0,2.11,0.64,10,13,16,,,1645,,1645,1645,,0,0,1645,1645,,Malignant,39,,181,,,,17056,,,1645,1645,,,,1645,1645,,,1645,,,,,,,,TUMOR FREE,Alive,-23710,,,,210,,1645,1645,,,[Not Available],[Not Applicable],,,,,0.12,,,,,10,,0,0.36067,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2794,,,,,,,1645,,,,,,,,,20,,,,,,,,,,,,,2006,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,89562,,1.655182518,,,,,,,,,,0.211257897,,0.011115065,,,,Stage IIIB,,2.5715,,,,,,,,,,,,,,,,-0.0986,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.97647367,16.4784749,18.58537934,0.248953016573838,LUSC,Squamous Cell Carcinoma,18.03449142,17.3111716,Squamous Cell Carcinoma,-0.7673,12.47347269,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BL-A3JM,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.47,0.76,1,2,4,,,205,,,205,,1.0,1,111.0,111.0,,Malignant,7,,47,,,,20417.0,,,111.0,111,,,,,205,,,111.0,,,,,,,,WITH TUMOR,Dead,-23000,205,,,277.0,,111.0,111,,,[Not Available],[Not Applicable],,,,,0.12,,,,,17,,1,0.43321,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Christiana Healthcare,,TCGA-BL-A3JM,,,,,,,,Bone,Metastatic,,,,,,,29,,,,,,,,,,,,,2010,111,,,,Stage III,,,,,,,,Progressive Disease,,,,,,62.0,,,,,,,,,,,,,,,,,,,,89563,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.2,0.8,4,4,8,,,1139,BRCA_LumA,1139,1139,,0,0,1139,1139,,Invasive Carcinoma,16,,20,,,,20464,0,,1139,1139,,,,1139,1139,,,1139,,,,,,,,TUMOR FREE,Alive,-13836,,,,34,,1139,1139,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,7,,0,0.077224,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A0D9,,,,,,,1139,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,37,,,,,,,,,,,,,,,,,,,,89564,,,0,0,0,0,-0.0642,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.14,0.5,2,2,4,,,769,BRCA_LumA,769,769,,0,0,769,769,,Invasive Carcinoma,8,,8,,,,22037,0,,769,769,,,,769,769,,,769,,,,,,,,TUMOR FREE,Alive,-23021,,,,113,,769,769,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,5,,0,0.067844,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YD,,,,,,,769,,,,,,,,,9,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,89566,,0.478870326,0,0,0,0,0.1734,1,,,Infiltrating Lobular Carcinoma,0.17827095,,0.258783318,0,0,0,,Negative,0.6685,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7424,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"LCIS, Stromal Alterations",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-EJ-A46F,,PRAD,,1,1,,EJ,,0,MALE,1,2.07,0.84,3,6,4,ambiguous,NO,783,,,783,,1,1,215,215,prad_tcga,Malignant,13,BRCA1,48,,TCGA-EJ-A46F-01,0,5337,0,TCGA-EJ-A46F,215,215,Prostate Cancer,,215,,783,TCGA,,215,Primary,0,,A,,,True,TUMOR FREE,Alive,-21160,,57,8,51,PRAD,215,215,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.04,Prostate,Resection,4,324FAFE4-0109-4273-87EA-F0E212B2BE84,4,Normal (no evidence of prostate cancer) [cM0],0,0.041826,[Not Available],08F11BDD-D665-45AB-B1A2-5485D91922C2,4,Prostate Adenocarcinoma Acinar Type,,Prostate,15,,Acinar Adenocarcinoma,[Not Available],,EJ,1.16666666667,TCGA-EJ-A46F,1:Recurred/Progressed,4,18,Prostate Adenocarcinoma,7.06,1/24/13,783,,Biochemical evidence of disease,,,,C61,E424A7C8-4DDD-4ECC-A0B4-DF22A9996D01,580,5,TUMOR FREE,0.1446,0:LIVING,19.8,3,25.72,Bilateral,26,,166,YES,286,2011,215,,TCGA-EJ-A46F.E424A7C8-4DDD-4ECC-A0B4-DF22A9996D01.pdf,,[Not Applicable],YES,166,,23,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,YES,No,R0,,57,Core needle biopsy,215,Partial Remission/Response,YES,NO,YES,YES,T3b,NO,8,No,NO,0,N1,T2c,1,M0,C61.9,8140/3,89569,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-4Z-AA7R,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,3.14,0.93,10,22,19,,,522,,,522,,1.0,1,353.0,353.0,,Malignant,51,,128,,,,25059.0,,,353.0,353,,,,,522,,,353.0,,,,,,,,WITH TUMOR,Dead,-26781,522,,,490.0,,353.0,353,,,[Not Available],[Not Applicable],,,,,0.3,,,,,13,,1,0.19839,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA7R,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,31,,,,,,,,,,,,,2010,353,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,89570,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-BT-A20Q,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.02,0.68,4,2,5,,,593,,,593,,1.0,1,593.0,593.0,,Malignant,11,,35,,,,17666.0,,,593.0,593,,,,,593,,,593.0,,,,,,,,WITH TUMOR,Dead,-26778,593,,,131.0,,593.0,593,,,[Not Available],[Not Applicable],,,,,0.0,,,,,5,,0,0.073427,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20Q,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,73.0,,,,,,,,,,,,,,,,,,,,89573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-56-8304,White,LUSC,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.67,0.54,15,9,13,,,106,,106,106,,0,0,106,106,,Malignant,37,,78,,,,22863,,,106,106,,,,106,106,,,106,,,,,,,,TUMOR FREE,Alive,-26803,,,,318,,106,106,,,[Not Available],[Not Applicable],,,,,0.33,,,,,11,,0,0.4492,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8304,,,,,,,106,,,,,,,,,15,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,89574,,0.595176701,,,,,,,,,,0.134144617,,-0.014766946,,,,Stage IA,,0.863,,,,,,,,,,,,,,,,-0.0488,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,G87C,,,1,G87C,,,,,,-0.3454109809038,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.3477,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,0,0,1,,,Black or African American,BRCA,,0,0,,,,2,FEMALE,2,2.16,0.83,2,0,2,,,2373,BRCA_LumA,,2373,,2,2,2373,2373,,Invasive Carcinoma,4,,4,,,,17921,0,,2373,2373,,,,,2373,,,2373,,,,,,,,TUMOR FREE,Dead,-21047,2373,,,47,,2373,2373,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,4,,0,0.03054,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RM,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,1993,,,,,Stage X,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,89579,,-0.314704408,0,0,0,0,-0.4185,1,,,Infiltrating Ductal Carcinoma,0.068031575,,0.065600813,0,0,0,,[Not Available],-0.9135,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.23,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.68,0.45,12,6,17,,,1631,BRCA_Her2,1631,1631,,0,0,1631,1631,,Invasive Carcinoma,35,,46,,,,22929,0,,1631,1631,,,,1631,1631,,,1631,,,,,,,,TUMOR FREE,Alive,-18346,,,,65,,1631,1631,,,[Not Available],[Not Applicable],,,,,0.4,Breast,Resection/Excision,,,24,,1,0.30836,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1B0,,,,,,,1631,,,,,,,,,34,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,89584,,0.936781615,0,0,0,0,-0.0627,1,,,Infiltrating Ductal Carcinoma,0.191296125,,0.177442366,0,0,0,,Negative,-0.01,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4851,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.05,0.38,1,2,4,,,660,BRCA_LumA,660,660,,0,0,660,660,,Invasive Carcinoma,7,,7,,,,21915,0,,660,660,,,,660,660,,,660,,,,,,,,TUMOR FREE,Alive,-15027,,,,52,,660,660,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,13,,1,0.11602,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BJ,,,,,,,660,,,,,,,,,26,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,89589,,0.26626709,0,0,0,0,1.4959,0,,,Infiltrating Ductal Carcinoma,0.151268752,,0.24017941,0,0,0,,Negative,-0.4965,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.494,1,0,H & E,0,0,,0,Ola El-Zammar,"Columnar Lesion, Sclerosing Adenosis",0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Columnar Lesion, Sclerosing Adenosis",0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-55-7907,White,LUAD,,1,1,,International Genomics Consortium,1,1,MALE,1,3.56,0.39,7,10,15,,,343,,294,343,,1,1,294,294,,Malignant,32,,48,,,,22497,,,294,294,,,,294,343,,,294,,,,,,,,WITH TUMOR,Dead,-28201,343,,,1499,,294,294,,,[Not Available],[Not Applicable],,,,,0.1,,,,,22,,1,0.22625,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-7907,,,,,,,,,Distant Metastasis,,,,,,,26,,,,,,,,,,,,,2011,294,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,89596,,1.29188771,,,,,,,,,,0.231031645,,0.117857623,,,,Stage IIA,,1.013,,,,,,,,,,,,,,,,0.2632,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),HOMDEL (driver),1,,G12C (driver),,15.8250824,16.64789181,16.87828553,-0.070908713,LUAD,Adenocarcinoma,18.19298209,16.52569215,Adenocarcinoma,0.6622,13.70117286,0.4918,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,2.43,0.64,0,1,1,,,1508,BRCA_LumA,,1508,,1,1,1508,1508,,Invasive Carcinoma,2,,3,,,,16277,0,,1508,1508,,,,,1508,,,1508,,,,,,,,WITH TUMOR,Dead,-24544,1508,,,43,,1508,1508,,,[Not Available],[Not Applicable],,,,,0.2,Breast,Resection/Excision,,,9,,0,0.040646,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1EX,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2000,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,89598,,0.730088448,0,0,0,0,0.1469,1,,,Infiltrating Ductal Carcinoma,0.198804056,,0.137783866,0,0,0,,[Not Available],-0.0555,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5605,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-66-2771,,LUSC,,0,0,,Indivumed,0,0,MALE,0,1.77,0.44,9,7,11,,,578,,578,578,,0,0,578,578,,Malignant,27,,51,,,,19504,,,578,578,,,,578,578,,,578,,,,,,,,TUMOR FREE,Alive,-22219,,,,391,,578,578,,,[Not Available],[Not Applicable],,,,,0.26,,,,,8,,0,0.40991,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2771,,,,,,,578,,,,,,,,,14,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,89602,,0.9697963,,,,,,,,,,0.241391094,,0.06558366,,,,Stage IIB,,1.3395,,,,,,,,,,,,,,,,-0.0517,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.3838542,18.10551656,16.72851722,0.0729257470297088,LUSC,Squamous Cell Carcinoma,17.96484157,16.6812644,Squamous Cell Carcinoma,0.3221,15.18569359,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-DK-A3IV,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.93,0.56,8,8,13,,,294,,,294,,1.0,1,212.0,212.0,,Malignant,29,,52,,,,27600.0,,,212.0,212,,,,,294,,,212.0,,,,,,,,WITH TUMOR,Dead,-22237,294,,,102.0,,212.0,212,,,[Not Available],[Not Applicable],,,,,0.09,,,,,7,,0,0.28064,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IV,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,15,,,,,,,,,,,,,2011,212,,,,Stage II,,,,,,,,Stable Disease,,,,,,60.0,,,,,,,,,,,,,,,,,,,,89607,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-46-3768,White,LUSC,,0,0,,St. Joseph's Medical Center (MD),2,2,MALE,2,3.41,0.75,11,6,13,,,299,,299,299,,2,2,299,299,,Malignant,30,,42,,,,27968,,,299,299,,,,299,299,,,299,,,,,,,,TUMOR FREE,Dead,-21307,299,,,388,,299,299,,,[Not Available],[Not Applicable],,,,,0.39,,,,,22,,1,0.44402,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,St. Joseph's Medical Center (MD),,TCGA-46-3768,,,,,,,4,,,,,,,,,25,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,89617,,-0.120662388,,,,,,,,,,0.184987075,,0.038549744,,,,Stage IIIA,,0.613,,,,,,,,,,,,,,,,-0.0761,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.15282106,16.55833224,14.33901056,-0.586153294653755,LUSC,Squamous Cell Carcinoma,17.63487187,15.33477223,Squamous Cell Carcinoma,-0.2412,13.5756481,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-M7-A723,,PRAD,,0,0,,M7,0,0,MALE,0,,,,,,,NO,763,,763,763,,0,0,763,763,prad_tcga,Malignant,,,,,TCGA-M7-A723-01,0,5543,0,TCGA-M7-A723,763,763,Prostate Cancer,,62,763,763,TCGA,,763,Primary,0,Apex|Middle|Base,A,,,False,TUMOR FREE,Alive,-20064,,54,7,7,PRAD,763,763,,0.0,[Not Available],[Not Applicable],5,,1,Matched,,Prostate,Resection,4,680C945D-7BFF-47A6-A520-9AAA677FA7ED,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],E27BC39B-54F1-47B5-AC8F-3245DCE690F4,3,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,M7,0.166666666667,TCGA-M7-A723,0:DiseaseFree,3,,Prostate Adenocarcinoma,25.07,12/10/13,763,,,,,NO,C61,8F42420C-A513-4A6A-A89F-B5C9303FBF59,150,,TUMOR FREE,0.0001,0:LIVING,0.1,5,25.07,Bilateral,,No Evidence of Extraprostatic Extension,11,YES,442,2012,,,TCGA-M7-A723.8F42420C-A513-4A6A-A89F-B5C9303FBF59.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,8,,17,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,54,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3b,YES,7,No,YES,0,N1,T1c,1,M0,C61.9,8140/3,89619,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-62-A46O,White,LUAD,,1,1,,Thoraxklinik at University Hospital Heidelberg,1,1,FEMALE,1,2.93,0.82,9,27,26,,,1454,,943,1454,,1,1,943,943,,Malignant,62,,114,,,,22644,,,943,943,,,,943,1454,,,943,,,,,,,,WITH TUMOR,Dead,-24050,1454,,,1273,,943,943,,,[Not Available],[Not Applicable],,,,,0.48,,,,,13,,1,0.2513,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A46O,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,35,,,,,,,,,,,,,2006,943,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,89620,,-0.396014575,,,,,,,,,,0.056789235,,-0.001932145,,,,Stage IB,,-1.1465,,,,,,,,,,,,,,,,-0.5136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G509V,1,,,G509V,,,,-1.021498409,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.4197,,-1.6113,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-D7-8579,White,STAD,,0,0,,,0,0,,0,2.12,0.25,2,4,1,,,636,,636,636,,0,0,636,636,,Malignant,7,,14,,,,25285,,,636,636,,,,636,636,,,636,,,,,,,,TUMOR FREE,Alive,-24120,,,,149,,636,636,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,2,,0,0.054325,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-8579,,,,,,,636,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,89623,,,,,,,,,,,,,Grade 2,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8579,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-BR-A4J5,Asian,STAD,,0,0,,,0,0,,0,2.11,0.23,1,3,3,,,862,,862,862,,0,0,862,862,,Malignant,7,,13,,,,18600,,,862,862,,,,862,862,,,862,,,,,,,,TUMOR FREE,Alive,-20714,,,,109,,862,862,,,[Not Available],[Not Applicable],,,,,0.12,Stomach,Unknown,,,2,,0,0.020226,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G3,,Asterand,,TCGA-BR-A4J5,,,,,,,862,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,89632,,0.364810057,,,,,,,,,,0.143181811,Grade 3,0.199863201,,,,Stage IIIA,,-0.401,,,,,,,,,,,,,,,,0.6667,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4J5,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,3.28,0.57,9,7,14,,,976,BRCA_LumB,976,976,,2,2,976,976,,Invasive Carcinoma,30,,50,,,,17526,0,,976,976,,,,976,976,,,976,,,,,,,,TUMOR FREE,Dead,-14755,976,,,46,,976,976,,,[Not Available],[Not Applicable],,,,,0.33,Breast,Resection/Excision,,,24,,1,0.41201,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1RB,,,,,,,,,,,,,,,,26,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,89639,,-0.239092124,0,0,0,0,-1.324,1,,,Infiltrating Ductal Carcinoma,0.154054087,,0.061678301,0,0,0,,Negative,-1.219,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2334,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8WW,,PRAD,389,0,0,,V1,0,0,MALE,0,1.98,0.84,2,6,4,HRP,NO,1078,1-ERG,1078,1078,,0,0,1078,1078,prad_tcga,Malignant,12,BRCA1;BRCA2;CHEK2;RAD54L,50,,TCGA-V1-A8WW-01,0,5568,0,TCGA-V1-A8WW,1078,1078,Prostate Cancer,709,695,1078,1078,TCGA,No Evidence of Extraprostatic Extension,1078,Primary,0,Apex,A,,,True,,Alive,-21900,,59,9,49,PRAD,1078,1078,,0.0,[Not Available],[Not Applicable],36,,1,Matched,0.45,Prostate,Resection,4,75733489-D3CD-4CBA-8B79-DB316298BB15,2,,0,0.065214,[Not Available],D843996C-0F17-4482-8466-9F6144981B8A,5,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,V1,1.16666666667,TCGA-V1-A8WW,0:DiseaseFree,5,11,Prostate Adenocarcinoma,35.41,7/15/14,1078,,,,,YES,C61,36FBC30B-6566-4C5F-BE51-D267B4F856B3,50,2,,0.2146,0:LIVING,0.015,,35.41,Bilateral,14,,,YES,,,,,TCGA-V1-A8WW.36FBC30B-6566-4C5F-BE51-D267B4F856B3.pdf,Peripheral Zone,[Not Applicable],NO,,91-100%,20,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,105,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,YES,,N1,T2b,1,M0,C61.9,8140/3,89641,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,1,1,Male,TCGA-39-5022,White,LUSC,,1,,,MSKCC,,2,MALE,1,1.97,0.26,3,6,6,,,1679,,,1679,,1,,1448,1448,,Malignant,15,,11,,,,21335,,,1448,,,,,,1679,,,1448,,,,,,,,TUMOR FREE,Dead,-27856,1679,,,238,,1448,,,,[Not Available],[Not Applicable],,,,,0.59,,,,,6,,0,0.30919,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5022,,,,,,,,,,,,,,,,13,,,,,,,,,,,,,2005,1448,,,,Stage IB,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,89646,,1.782361009,,,,,,,,,,0.241186246,,0.152755812,,,,Stage IB,,2.314,,,,,,,,,,,,,,,,0.6198,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.352170833013152,LUSC,,,,Squamous Cell Carcinoma,0.5811,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.22,0.17,5,6,7,,,984,BRCA_LumA,984,984,,0,0,984,984,,Invasive Carcinoma,18,,11,,,,18275,0,,984,984,,,,984,984,,,984,,,,,,,,TUMOR FREE,Alive,-17039,,,,52,,984,984,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,4,,0,0.072312,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1B5,,,,,,,984,,,,,,,,,6,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,89648,,2.002436949,0,0,0,0,-0.144,1,,,Infiltrating Lobular Carcinoma,0.169709644,,0.280050811,0,0,0,,Negative,0.8945,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.048,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MG-AAMC,,PRAD,,0,0,,MG,0,0,MALE,0,1.94,0.79,5,1,4,HRP,NO,173,,173,173,,0,0,173,173,prad_tcga,Malignant,10,BRCA1;CDK12,62,,TCGA-MG-AAMC-01,0,5546,0,TCGA-MG-AAMC,173,173,Prostate Cancer,,54,173,173,TCGA,,173,Primary,0,,A,,,True,TUMOR FREE,Alive,-21846,,59,9,28,PRAD,173,173,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.03,Prostate,Resection,4,ACA72F05-77B0-4BF3-AA43-ED10C3898C9F,3,,0,0.066859,[Not Available],9C8447AC-5B26-4558-8BFD-F0E7046C1FB9,5,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,MG,0.933333333333,TCGA-MG-AAMC,0:DiseaseFree,5,11,Prostate Adenocarcinoma,5.68,7/28/14,173,,,,,,C61,CBC765C1-9191-4A40-979F-CF2434B10CAB,40,3,TUMOR FREE,0.0697,0:LIVING,0.01,3,5.68,,15,,,YES,278,2013,,,TCGA-MG-AAMC.CBC765C1-9191-4A40-979F-CF2434B10CAB.pdf,,[Not Applicable],,,,,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,59,Core needle biopsy,,Complete Remission/Response,NO,YES,,NO,T3a,NO,9,No,NO,0,N0,T1c,,M0,C61.9,8140/3,89659,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6379,,PRAD,,0,0,,G9,0,0,MALE,0,3.81,0.21,5,11,6,ambiguous,NO,1778,,1778,1778,,0,0,1778,1778,prad_tcga,Malignant,22,,48,,TCGA-G9-6379-01,0,5375,0,TCGA-G9-6379,1778,1778,Prostate Cancer,,1393,1778,1778,TCGA,,1778,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-25126,,68,7,41,PRAD,1778,1778,,0.0,[Not Available],[Not Applicable],23,,1,Matched,0.02,Prostate,Resection,4,a9360ccf-07bc-4c71-80f3-e638b3b88cf0,2,,1,0.075351,[Not Available],d33074f0-5f88-4995-9439-76068a9f4836,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,19,,Acinar Adenocarcinoma,[Not Available],0.4,G9,0.766666666667,TCGA-G9-6379,0:DiseaseFree,3,24,Prostate Adenocarcinoma,58.41,10/29/13,1778,,,,,NO,C61,A097CB29-5440-45F9-B261-025603C37CEF,,3,TUMOR FREE,0.0722,0:LIVING,0.03,5,58.41,Bilateral,23,,,YES,,2009,,,TCGA-G9-6379.A097CB29-5440-45F9-B261-025603C37CEF.pdf,,[Not Applicable],NO,,,6,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,1.0,68,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3b,NO,7,No,NO,0,N0,T1b,0,M0,C61.9,8550/3,89664,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-G2-A2EK,White,BLCA,,1.0,1,,,,0,MALE,1.0,2.06,0.54,7,8,6,,,485,,,485,,1.0,1,485.0,485.0,,Malignant,21,,37,,,,28027.0,,,485.0,485,,,,,485,,,485.0,,,,,,,,WITH TUMOR,Alive,-20995,,,,88.0,,485.0,485,,,[Not Available],[Not Applicable],,,,,0.04,,,,,4,,0,0.1064,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EK,,,,,,,485,Renal Pelvis,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2010,485,,,,Stage II,,,,,,,,Stable Disease,,,,,,57.0,,,,,,,,,,,,,,,,,,,,89665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.98,0.39,9,9,9,,,2156,BRCA_LumA,2156,2156,,0,0,2156,2156,,Invasive Carcinoma,27,,20,,,,19322,0,,2156,2156,,,,2156,2156,,,2156,,,,,,,,TUMOR FREE,Alive,-22833,,,,80,,2156,2156,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,4,,0,0.15568,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DX,,,,,,,2156,,,,,,,,,9,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,89666,,0.007473703,0,0,0,0,1.0427,1,,,Infiltrating Ductal Carcinoma,0.259179252,,0.238583883,0,0,0,,Negative,-0.222,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6705,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-BR-8590,White,STAD,,1.0,1,,,1,1,,1.0,3.8,0.31,0,14,9,,,284,,223,284,,1.0,1,223,223,,Malignant,23,,4,,,,16066.0,0,,223,223,,,,223,284,,,223,,,,,,,,WITH TUMOR,Dead,-22937,284,,,161.0,,223,223,,,[Not Available],[Not Applicable],,,,,0.54,Stomach,Resection,,,5,,1,0.000265,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8590,,,,,,,,Lung,Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2011,223,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,89667,,0.735617734,,,,,,,,,,0.152995154,Grade 3,0.119660386,,,,Stage IIIC,,0.492,,,,,,,,,,,,,,,,0.5496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8590,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.88,0.64,14,10,10,,,448,BRCA_LumA,448,448,,0,0,448,448,,Invasive Carcinoma,34,,148,,,,18695,0,,448,448,,,,448,448,,,448,,,,,,,,TUMOR FREE,Alive,-30783,,,,243,,448,448,,,[Not Available],[Not Applicable],,,,,0.43,Breast,Core Biopsy,,,12,,0,0.33871,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A56D,,,,,,,448,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,89671,,-0.298306588,0,0,0,0,0.3485,1,,,Infiltrating Ductal Carcinoma,0.169944581,,0.107641197,0,0,0,,Negative,-0.7215,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.4025,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,3.4,0.48,7,13,16,,,504,BRCA_Her2,,504,,0,0,504,504,,Invasive Carcinoma,36,,51,,,,17086,0,,504,504,,,,,504,,,504,,,,,,,,TUMOR FREE,Alive,-24029,,,,254,,504,504,,,[Not Available],[Not Applicable],,,,,0.46,Breast,Resection/Excision,,,22,,1,0.23453,[Not Evaluated],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3W5,,,,,,,504,,,,,,,,,24,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,89673,,1.157510397,0,0,0,0,-0.3005,1,,,Infiltrating Lobular Carcinoma,0.205749918,,0.216419844,0,0,0,,Close,0.7045,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.806,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-55-6642,White,LUAD,,0,0,,International Genomics Consortium,0,0,MALE,0,2.61,0.37,7,14,13,,,2449,,2449,2449,,0,0,2449,2449,,Malignant,34,,11,,,,18291,,,2449,2449,,,,2449,2449,,,2449,,,,,,,,TUMOR FREE,Alive,-23107,,,,171,,2449,2449,,,[Not Available],[Not Applicable],,,,,0.39,,,,,12,,1,0.17583,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6642,,,,,,,2449,,,,,,,,,35,,,,,,,,,,,,,2006,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,89681,,1.010618526,,,,,,,,,,0.211233919,,0.212205232,,,,Stage IB,,0.697,,,,,,,,,,,,,,,,0.6706,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,-0.021368682,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.5186,,0.6446,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.19,0.7,4,3,6,,,92,BRCA_LumA,92,92,,0,0,92,92,,Invasive Carcinoma,13,,33,,,,32902,0,,92,92,,,,92,92,,,92,,,,,,,,TUMOR FREE,Alive,-23116,,,,59,,92,92,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,10,,0,0.1001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1R5,,,,,,,92,,,,,,,,,9,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,89686,,-0.268533348,0,0,0,0,-1.3753,1,,,Infiltrating Ductal Carcinoma,0.144617584,,0.117227443,0,0,0,,Negative,-1.7575,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3455,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.57,0.91,1,20,20,,,2278,BRCA_Basal,2278,2278,,0,0,2278,2278,,Invasive Carcinoma,41,,10,,,,17754,0,,2278,2278,,,,2278,2278,,,2278,,,,,,,,TUMOR FREE,Alive,-12841,,,,80,,2278,2278,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,15,,1,0.023067,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BL,,,,,,,2278,,,,,,,,,19,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,35,,,,,,,,,,,,,,,,,,,,89688,TRUE,1.238917752,0,0,0,0,-0.0934,1,,,Infiltrating Ductal Carcinoma,0.220933566,,0.202857665,0,0,0,,Negative,1.1505,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7723,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.9,0.53,22,8,29,,,313,BRCA_Basal,313,313,,0,0,313,313,,Invasive Carcinoma,59,,296,,,,22322,0,,313,313,,,,313,313,,,313,,,,,,,,TUMOR FREE,Alive,-18695,,,,87,,313,313,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,21,,1,0.48589,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A6VV,,,,,,,313,,,,,,,,,35,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,89691,TRUE,0.75616635,0,0,0,1,0.3206,0,,,Infiltrating Ductal Carcinoma,0.204073869,,0.145221943,0,0,0,,Negative,0.171,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.817,1,0,H & E,0,0,,0,Ola El-Zammar,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Solid, High Grade), Microcalcifications",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-CF-A9FL,Asian,BLCA,,1.0,1,,,1,1,MALE,1.0,2.0,0.85,1,6,5,,,565,,322,565,,1.0,1,322.0,322.0,,Malignant,12,,34,,,,18127.0,,,322.0,322,,,,322,565,,,322.0,,,,,,,,WITH TUMOR,Dead,-31099,565,,,81.0,,322.0,322,,,[Not Available],[Not Applicable],,,,,0.02,,,,,3,,0,0.071186,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ILSBio,,TCGA-CF-A9FL,,,,,,,,,Locoregional (Urothelial tumor event),,,,,,,3,,,,,,,,,,,,,2013,322,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,85.0,,,,,,,,,,,,,,,,,,,,89692,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7817,,PRAD,,0,0,,HC,0,0,MALE,0,,,,,,HRP,NO,928,,928,928,,0,0,928,928,prad_tcga,Malignant,,,,,TCGA-HC-7817-01,0,5429,0,TCGA-HC-7817,928,928,Prostate Cancer,,171,928,928,TCGA,No Evidence of Extraprostatic Extension,928,Primary,0,Apex|Middle|Base,B,,,,TUMOR FREE,Alive,-19207,,52,7,25,PRAD,928,928,,0.0,[Not Available],[Not Applicable],27,,1,Matched,,Prostate,Resection,4,ba22b09b-2328-4725-8810-2ee294b319c4,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],f3aa40b9-7b4d-465a-b7c9-591aebdb56c2,3,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.5,HC,0.9,TCGA-HC-7817,0:DiseaseFree,3,8,Prostate Adenocarcinoma,30.49,6/20/12,928,,,,,YES,C61,A1E3EC71-D7D2-4286-A12F-78ADFD27E53C,,,TUMOR FREE,0.0016,0:LIVING,0.1,,30.49,Bilateral,8,No Evidence of Extraprostatic Extension,,YES,,2011,,,TCGA-HC-7817.A1E3EC71-D7D2-4286-A12F-78ADFD27E53C.pdf,,[Not Applicable],YES,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.8,52,Core needle biopsy,,,YES,NO,NO,NO,T3b,,7,No,,0,,,,M0,C61.9,8140/3,89693,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-KK-A7AP,,PRAD,348,0,0,,KK,,0,MALE,0,1.99,0.89,7,12,8,HRD,NO,196,2-ETV1,,196,,0,0,196,196,prad_tcga,Malignant,27,ATM;BARD1;BRCA1;BRCA2;CDK12;CHEK1;RAD51D,48,,TCGA-KK-A7AP-01,0,5508,0,TCGA-KK-A7AP,196,196,Prostate Cancer,,,,196,TCGA,,196,Primary,0,Apex|Middle|Base,A,ATM:.:.:splice_region_variant,,True,,Alive,-20403,,55,9,48,PRAD,196,196,,0.0,[Not Available],[Not Applicable],42,,1,Matched,0.1,Prostate,Resection,4,9FB7AC6A-C6C6-48EC-93B8-E7B84AA58476,4,Normal (no evidence of prostate cancer) [cM0],0,0.1003,[Not Available],F4E9A9F9-263C-4CED-A8FB-6CB0FB088983,5,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,KK,1.4,TCGA-KK-A7AP,0:DiseaseFree,5,26,Prostate Adenocarcinoma,6.44,6/6/14,196,,,,,NO,C61,5B2E970F-CF58-4A8E-90FD-A1AA16C95142,160,4,,0.1799,0:LIVING,,,6.44,Right,28,,,YES,1130,2010,,,TCGA-KK-A7AP.5B2E970F-CF58-4A8E-90FD-A1AA16C95142.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,175,51-60%,15,Prostate Adenocarcinoma Acinar Type,1,2010,[Unknown],,,"Yes, History of Prior Malignancy",R1,,55,Core needle biopsy,,,NO,YES,YES,,T3b,,9,No,,0,N1,T2b,2,M0,C61.9,8140/3,89695,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,Black or African American,BRCA,,1,1,,,1,0,FEMALE,1,1.79,0.66,16,11,10,,,655,BRCA_LumA,143,655,,1,1,143,143,,Invasive Carcinoma,37,,39,,,,21648,0,,143,143,,,,143,655,,,143,,,,,,,,WITH TUMOR,Alive,-13307,,,,52,,143,143,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,9,,0,0.26645,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JA,,,,,,,655,Bone,Distant Metastasis,,,,,,,10,,,,,,,,,,,,,2009,143,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,36,,,,,,,,,,,,,,,,,,,,89701,,0.380199239,0,0,0,0,-0.0764,1,,,Infiltrating Ductal Carcinoma,0.175481101,,0.195360964,0,0,0,,Negative,-0.0425,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5318,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-FT-A61P,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.83,0.31,4,10,8,,,337,,,337,,0.0,0,337.0,337.0,,Malignant,22,,33,,,,24202.0,,,337.0,337,,,,,337,,,337.0,,,,,,,,TUMOR FREE,Alive,-28082,,,,221.0,,337.0,337,,,[Not Available],[Not Applicable],,,,,0.13,,,,,18,,2,0.11734,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University of Miami,,TCGA-FT-A61P,,,,,,,337,,,,,,,,,77,,,,,,,,,,,,,2013,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,76.0,,,,,,,,,,,,,,,,,,,,89703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,2.98,0.83,10,8,13,,,31,BRCA_LumB,,31,,0,0,31,31,,Invasive Carcinoma,31,,100,,,,18163,0,,31,31,,,,,31,,,31,,,,,,,,,Alive,-30984,,,,113,,31,31,,,[Not Available],[Not Applicable],,,,,0.21,Breast,Resection/Excision,,,20,,1,0.35764,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06Z,,,,,,,31,,,,,,,,,30,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,89704,,-1.2726158,0,0,0,0,0.53,1,,,Infiltrating Ductal Carcinoma,0.116164731,,0.110895171,0,0,0,,[Not Available],-1.467,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.3358,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.91,0.71,9,7,12,,,435,BRCA_LumA,435,435,,0,0,435,435,,Invasive Carcinoma,28,,50,,,,17477,0,,435,435,,,,435,435,,,435,,,,,,,,TUMOR FREE,Alive,-18152,,,,82,,435,435,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,5,,0,0.19653,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0E2,,,,,,,435,,,,,,,,,8,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,89710,,0.572331485,0,0,0,0,0.1159,1,,,Infiltrating Ductal Carcinoma,0.141744222,,0.13419903,0,0,0,,Negative,-0.1435,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5029,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.94,0.38,2,3,1,,,410,BRCA_LumA,410,410,,0,0,410,410,,Invasive Carcinoma,6,,7,,,,23462,0,,410,410,,,,410,410,,,410,,,,,,,,TUMOR FREE,Alive,-29280,,,,55,,410,410,,,[Not Available],[Not Applicable],,,,,0.47,Breast,Resection/Excision,,,3,,0,0.055199,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A145,,,,,,,410,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,89711,,0.091834569,0,0,0,0,0.0197,1,,,Infiltrating Ductal Carcinoma,0.14134868,,0.2414021,0,0,0,,Negative,0.0455,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3768,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.48,0.45,8,13,20,,,622,BRCA_Her2,622,622,,0,0,622,622,,Invasive Carcinoma,41,,46,,,,30320,0,,622,622,,,,622,622,,,622,,,,,,,,TUMOR FREE,Alive,-20468,,,,219,,622,622,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,16,,1,0.13273,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0AW,,,,,,,622,,,,,,,,,28,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,89713,,1.844836367,0,0,0,0,0.1973,1,,,Infiltrating Ductal Carcinoma,0.228848195,,0.23879262,0,0,0,,Negative,1.1305,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4287,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.58,0.65,3,1,5,,,765,BRCA_LumB,765,765,,0,0,765,765,,Invasive Carcinoma,9,,12,,,,17961,0,,765,765,,,,765,765,,,765,,,,,,,,TUMOR FREE,Alive,-16363,,,,50,,765,765,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,22,,1,0.12452,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A13F,,,,,,,765,,,,,,,,,17,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,89714,,-1.119304788,0,0,0,0,-0.8102,1,,,Infiltrating Ductal Carcinoma,0.129927263,,0.193440043,0,0,0,,Negative,-1.661,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2931,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A6TH,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.96,0.77,9,12,16,,,131,,,131,,1.0,1,126.0,126.0,,Malignant,37,,88,,,,22266.0,,,126.0,126,,,,,131,,,126.0,,,,,,,,WITH TUMOR,Dead,-23236,131,,,218.0,,126.0,126,,,[Not Available],[Not Applicable],,,,,0.63,,,,,14,,1,0.24207,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TH,,,,,,,,Lung,Distant Metastasis,,,,,,,37,,,,,,,,,,,,,2013,126,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,63.0,,,,,,,,,,,,,,,,,,,,89718,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.87,0.49,7,1,7,,,624,BRCA_LumA,624,624,,0,0,624,624,,Invasive Carcinoma,15,,19,,,,24546,0,,624,624,,,,624,624,,,624,,,,,,,,TUMOR FREE,Alive,-22849,,,,47,,624,624,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,7,,0,0.18823,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0T4,,,,,,,624,,,,,,,,,7,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,89722,,0.915893624,0,0,0,0,-0.2525,1,,,Infiltrating Lobular Carcinoma,0.207382646,,0.260939659,0,0,0,,Negative,0.0375,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5427,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"LCIS, Microcalcifications",,LCIS,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,3364,BRCA_Normal,3364,3364,,0,0,3364,3364,,Invasive Carcinoma,,,,,,,19037,0,,3364,3364,,,,3364,3364,,,3364,,,,,,,,TUMOR FREE,Alive,-29330,,,,43,,3364,3364,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A42U,,,,,,,3364,,,,,,,,,,,,,,,,,,,,,,2004,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,89723,TRUE,0.607053327,0,0,0,0,1.3636,1,,,Infiltrating Lobular Carcinoma,0.125848662,,0.261137198,0,0,0,,Negative,0.4555,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4038,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.3,0.35,22,22,21,,,24,BRCA_Basal,24,24,,0,0,24,24,,Invasive Carcinoma,65,,99,,,,22606,1,,24,24,,,,24,24,,,24,,,,,,,,TUMOR FREE,Alive,-24053,,,,155,,24,24,,,[Not Available],[Not Applicable],,,,,0.28,Not Specific/Unknown,Resection/Excision,,,19,,1,0.38576,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Metaplastic Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A5FL,,,,,,,24,,,,,,,,,33,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,89724,TRUE,0.364659185,0,0,0,0,1.7519,1,,,Metaplastic Carcinoma,0.174222067,,0.113652277,0,0,0,,Negative,-0.8545,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.407,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.45,0,0,0,,,1800,BRCA_LumA,1800,1800,,0,0,1800,1800,,Invasive Carcinoma,0,,0,,,,22819,0,,1800,1800,,,,1800,1800,,,1800,,,,,,,,TUMOR FREE,Alive,-26052,,,,20,,1800,1800,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,0,,0,0.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1IK,,,,,,,1800,,,,,,,,,0,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,89730,,0.667933497,0,0,0,1,-0.3453,0,,,Infiltrating Ductal Carcinoma,0.150920189,,0.159396396,0,0,0,,Negative,-0.3745,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2908,1,0,H & E,0,0,,0,Jeffrey Eisenstein,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Mucinous), Invasive Ductal Carcinoma (No Special Type)",0,UDH,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-4Z-AA86,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,2.98,0.28,13,13,18,,,311,,,311,,1.0,1,136.0,136.0,,Malignant,44,,58,,,,21222.0,,,136.0,136,,,,,311,,,136.0,,,,,,,,WITH TUMOR,Dead,-24465,311,,,289.0,,136.0,136,,,[Not Available],[Not Applicable],,,,,0.22,,,,,17,,1,0.2172,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA86,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,40,,,,,,,,,,,,,2009,136,Pelvis,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,66.0,,,,,,,,,,,,,,,,,,,,89733,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-NJ-A55A,White,LUAD,,0,0,,Washington University - Rush University,,0,FEMALE,0,2.03,0.21,0,1,1,,,15,,,15,,0,0,15,15,,Malignant,2,,11,,,,30139,,,15,15,,,,,15,,,15,,,,,,,,TUMOR FREE,Alive,-28022,,,,142,,15,15,,,[Not Available],[Not Applicable],,,,,0.14,,,,,1,,0,0.0038154,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A55A,,,,,,,15,,,,,,,,,1,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Stable Disease,,,,,,76,,,,,,,,,,,,,,,,,,,,89737,,1.230582537,,,,,,,,,,0.201670095,,0.159332694,,,,Stage IB,,1.1465,,,,,,,,,,,,,,,,0.1036,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.118852388,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.5325,,0.4377,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-2H-A9GK,Unknown,ESCA,,1.0,1,,,,1,,1.0,2.07,0.47,12,13,14,,,232,,,232,,1.0,1,113,113,,Malignant,39,,104,,,,19490.0,0,,113,113,,,,,232,,,113,,,,,,,,WITH TUMOR,Dead,-16067,232,,,324.0,,113,113,,,[Not Available],[Not Available],,,,,0.52,Esophagus,Resection,,,4,,0,0.29926,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Erasmus MC,,TCGA-2H-A9GK,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2000,113,Lymph node,,,Stage III,,,,,,,,,,,,,,43,,,,,,,,,,,,,,,,,,,,89739,,,,,,,,,,,,,Grade 3,,,,,Stage III,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-R6-A6KZ,White,ESCA,,1,1,,,,1,,1,2.55,0.47,11,7,15,,,154,,,154,,1,1,154,154,,Malignant,33,,167,,,,18123,,,154,154,,,,,154,,,154,,,,,,,,WITH TUMOR,Dead,-15512,154,,,242,,154,154,,,[Not Available],Stage IV,,,,,0.22,Esophagus,Unknown,,,17,,1,0.37301,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,MD Anderson Cancer Center,,TCGA-R6-A6KZ,,,,,,,,,,,,,,,,33,,,,,,,,,,,,,2010,,,,,[Not Available],,,,,,,,,,,,,,42,,,,,,,,,,,,,,,,,,,,89740,,,,,,,,,,,,,Grade 3,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-EJ-7321,Black or African American,PRAD,221,0,0,,EJ,0,0,MALE,0,3.95,0.41,0,5,2,ambiguous,NO,824,1-ERG,824,824,,0,0,824,824,prad_tcga,Malignant,7,FANCL,2,2.2,TCGA-EJ-7321-01,4,5303,0,TCGA-EJ-7321,824,824,Prostate Cancer,,128,824,824,TCGA,,824,Primary,0,,A,,,,TUMOR FREE,Alive,-21108,,57,6,38,PRAD,824,824,BLACK OR AFRICAN AMERICAN,0.104720176,[Not Available],[Not Applicable],48,R0,1,Matched,0.02,Prostate,Resection,3,3569f2bd-ab7a-4b9d-9fac-09e9e75050f3,0,Normal (no evidence of prostate cancer) [cM0],1,0.0013968,[Not Available],804ee985-18dd-4f2d-a562-61b454601cdd,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.63333333333,TCGA-EJ-7321,0:DiseaseFree,1,17,Prostate Adenocarcinoma,27.07,4/5/12,824,,,,,NO,C61,9d0d3184-b73a-4f24-919d-0ba7d5d32ff2,,2,TUMOR FREE,0.0318,0:LIVING,0.1,4,27.07,Bilateral,17,,,YES,,2011,,,TCGA-EJ-7321.9d0d3184-b73a-4f24-919d-0ba7d5d32ff2.pdf,,[Not Applicable],NO,10,81-90%,25,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,1.0,57,Core needle biopsy,,,YES,NO,YES,,T3a,,6,No,,0,N0,T1c,0,M0,C61.9,8550/3,89741,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-J4-A67N,,PRAD,,1,1,,J4,,0,MALE,1,1.9,0.74,4,8,4,ambiguous,NO,937,,,937,,1,1,442,442,prad_tcga,Malignant,16,BRCA2,98,,TCGA-J4-A67N-01,0,5475,0,TCGA-J4-A67N,442,442,Prostate Cancer,,503,,937,TCGA,,442,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-22420,,61,7,33,PRAD,442,442,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.01,Prostate,Resection,3,A48CC32C-2CA7-47D8-A051-D8206DB59381,2,,0,0.10486,[Not Available],00F7F9D3-7A34-4A5B-9D19-38810DCABBBA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,J4,1.06666666667,TCGA-J4-A67N,1:Recurred/Progressed,2,19,Prostate Adenocarcinoma,14.52,8/16/13,937,,Biochemical evidence of disease,,,,C61,70E5E77E-6B59-40A7-8E87-456EF28AED98,420,2,WITH TUMOR,0.0976,0:LIVING,0.7,,30.78,Bilateral,25,,,YES,504,2011,442,,TCGA-J4-A67N.70E5E77E-6B59-40A7-8E87-456EF28AED98.pdf,Peripheral Zone,[Not Applicable],,,,8,Prostate Adenocarcinoma Acinar Type,1,2011,Partial Remission/Response,,YES,No,R0,,61,Core needle biopsy,442,Partial Remission/Response,YES,NO,YES,YES,T3a,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,89744,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.27,0.51,12,17,18,,,715,BRCA_LumA,715,715,,0,0,715,715,,Invasive Carcinoma,47,,126,,,,23245,0,,715,715,,,,715,715,,,715,,,,,,,,TUMOR FREE,Alive,-23072,,,,115,,715,715,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,17,,1,0.18592,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A5J0,,,,,,,715,,,,,,,,,27,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,89752,,0.841590006,0,0,0,0,0.3478,1,,,Infiltrating Ductal Carcinoma,0.213956424,,0.185134962,0,0,0,,Negative,0.2385,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5333,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.29,0.78,9,15,14,,,31,BRCA_LumB,31,31,,0,0,31,31,,None,38,,84,,,,16630,N/A (Non-Malignant),,31,31,,,,31,31,,,31,,,,,,,,TUMOR FREE,Alive,-23164,,,,343,,31,31,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,17,,1,0.20168,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A06Q,,,,,,,31,,,,,,,,,28,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,89753,,-0.563940465,0,0,0,0,-0.2676,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.072930953,N/A (Non-Malignant),-0.001761124,0,0,0,N/A (Non-Malignant),Negative,-1.2615,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.6927,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-44-7659,White,LUAD,,0,0,,Christiana Healthcare,0,0,MALE,0,2.09,0.56,3,3,6,,,691,,691,691,,0,0,691,691,,Malignant,12,,3,,,,16810,,,691,691,,,,691,691,,,691,,,,,,,,TUMOR FREE,Alive,-25730,,,,189,,691,691,,,[Not Available],[Not Applicable],,,,,0.07,,,,,4,,0,0.076386,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-7659,,,,,,,691,,,,,,,,,4,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,89764,,0.323856949,,,,,,,,,,0.236541824,,0.095156411,,,,Stage IA,,0.4075,,,,,,,,,,,,,,,,-0.2343,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.371759481,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.664,,-0.539,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Male,TCGA-98-A53D,White,LUSC,,1,1,,Washington University - Alabama,1,1,MALE,1,,,,,,,,645,,413,645,,1,1,413,413,,Malignant,,,,,,,28956,,,413,413,,,,413,645,,,413,,,,,,,,WITH TUMOR,Dead,-24891,645,,,0,,413,413,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A53D,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2012,413,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,89769,,1.100834573,,,,,,,,,,0.278578997,,0.28752595,,,,Stage IIB,,2.3715,,,,,,,,,,,,,,,,0.7617,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,not profiled,not profiled,not profiled,16.26499818,17.31391298,15.89208,-0.151541537142518,LUSC,Squamous Cell Carcinoma,18.46954379,16.21321443,Squamous Cell Carcinoma,1.1704,15.23666129,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-M7-A71Z,,PRAD,,0,0,,M7,0,0,MALE,0,1.95,0.9,2,1,3,HRP,NO,643,,643,643,,0,0,643,643,prad_tcga,Malignant,6,CHEK2,62,,TCGA-M7-A71Z-01,0,5539,0,TCGA-M7-A71Z,643,643,Prostate Cancer,,209,643,643,TCGA,,643,Primary,0,Apex|Base,A,,,False,TUMOR FREE,Alive,-22785,,62,7,33,PRAD,643,643,,0.0,[Not Available],[Not Applicable],32,,1,Matched,0.02,Prostate,Resection,4,37E9C5A5-4C5D-41F9-B14D-12337432CACA,1,,0,0.051821,[Not Available],4D5D61C4-2E64-422E-ABA6-EC098F40EEEC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,4,,Acinar Adenocarcinoma,[Not Available],,M7,1.1,TCGA-M7-A71Z,0:DiseaseFree,3,5,Prostate Adenocarcinoma,21.12,12/10/13,643,,,,,NO,C61,5F9BC119-B8E9-4C05-8A34-AA8E79C490B6,160,2,TUMOR FREE,0.0483,0:LIVING,,,21.12,Right,8,,,YES,136,2013,,,TCGA-M7-A71Z.5F9BC119-B8E9-4C05-8A34-AA8E79C490B6.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,,9,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,62,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T2a,0,,C61.9,8140/3,89773,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-MX-A663,White,STAD,,1,1,,,1,1,,1,2.64,0.31,9,15,15,,,300,,218,300,,1,1,218,218,,Malignant,39,,119,,,,22196,,,218,218,,,,218,300,,,218,,,,,,,,WITH TUMOR,Dead,-24421,300,,,102,,218,218,,,[Not Available],[Not Applicable],,,,,0.49,Stomach,Unknown,,,13,,1,0.25229,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,MSKCC,,TCGA-MX-A663,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,34,,,,,,,,,,,,,2012,218,Liver and left supraclavicular lymph node,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,89781,,-0.151452755,,,,,,,,,,0.070790456,Grade 3,0.208707834,,,,Stage IIA,,-0.1715,,,,,,,,,,,,,,,,0.7169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-MX-A663,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,,,,,,,,1430,BRCA_LumA,,1430,,2,2,1430,1430,,Invasive Carcinoma,,,,,,,32921,0,,1430,1430,,,,,1430,,,1430,,,,,,,,TUMOR FREE,Dead,-26514,1430,,,189,,1430,1430,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Fox Chase,,TCGA-PE-A5DC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,89791,,-0.358522076,0,0,0,0,0.3764,1,,,Infiltrating Lobular Carcinoma,0.091712347,,0.235142711,0,0,0,,[Not Available],-0.587,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.162,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-86-8674,White,LUAD,,1,1,,Asterand,1,0,MALE,1,2.11,0.58,2,0,3,,,806,,334,806,,1,1,334,334,,Malignant,5,,21,,,,18241,,,334,334,,,,334,806,,,334,,,,,,,,TUMOR FREE,Alive,-18479,,,,413,,334,334,,,[Not Available],[Not Applicable],,,,,0.0,,,,,5,,0,0.045323,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8674,,,,,,,806,,Locoregional Recurrence,,,,,,,5,,,,,,,,,,,,,2012,334,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,50,,,,,,,,,,,,,,,,,,,,89792,,-0.180181354,,,,,,,,,,0.115175134,,0.082008361,,,,Stage IIA,,-0.086,,,,,,,,,,,,,,,,-0.2125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G13C (driver),G476V,1,,G13C (driver),G476V,13.22674497,13.5387788,14.25639905,-0.790715527,LUAD,Adenocarcinoma,17.71597232,14.15167489,Adenocarcinoma,-0.9404,11.97307979,-1.5591,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-KK-A7AZ,,PRAD,,0,0,,KK,,0,MALE,0,2.02,0.87,2,5,3,ambiguous,NO,1519,,,1519,,0,0,1519,1519,prad_tcga,Malignant,10,,60,,TCGA-KK-A7AZ-01,6,5514,0,TCGA-KK-A7AZ,1519,1519,Prostate Cancer,141,,,1519,TCGA,Equivocal,1519,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-20507,,56,7,41,PRAD,1519,1519,,0.161044334,[Not Available],[Not Applicable],39,,1,Matched,0.01,Prostate,Resection,4,CB9B0A6A-D09B-4EE9-B30E-E4DA3B6AC0AF,4,,0,0.051353,[Not Available],7D931C19-1FCE-4409-8A9C-9C65631CCBAC,3,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,KK,1.3,TCGA-KK-A7AZ,0:DiseaseFree,3,9,Prostate Adenocarcinoma,49.9,8/19/14,1519,,,,,YES,C61,5DEA3530-6618-4A73-94C7-F23DA06DA52C,200,2,,0.1127,0:LIVING,,,49.9,Right,16,,,YES,1045,2010,,,TCGA-KK-A7AZ.5DEA3530-6618-4A73-94C7-F23DA06DA52C.pdf,Peripheral Zone,[Not Applicable],NO,,,14,Prostate Adenocarcinoma Acinar Type,1,2010,[Unknown],,,No,R0,,56,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T2b,0,,C61.9,8140/3,89796,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.76,0.74,5,10,14,,,1308,BRCA_LumA,1308,1308,,0,0,1308,1308,,Invasive Carcinoma,29,,41,,,,22503,0,,1308,1308,,,,1308,1308,,,1308,,,,,,,,TUMOR FREE,Alive,-25475,,,,108,,1308,1308,,,[Not Available],[Not Applicable],,,,,0.27,Breast,Resection/Excision,,,14,,1,0.15766,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07B,,,,,,,1308,,,,,,,,,19,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,89801,,0.123015563,0,0,0,0,-0.7066,1,,,Infiltrating Ductal Carcinoma,0.164489426,,0.134017829,0,0,0,,Negative,-0.523,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1914,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-05-4395,,LUAD,,0,0,,Indivumed,,2,MALE,2,3.22,0.61,12,7,17,,,0,,,0,,2,2,0,0,,Malignant,36,,45,,,,30271,,,0,0,,,,,0,,,0,,,,,,,,TUMOR FREE,Dead,-27971,0,,,361,,0,0,,,[Not Available],[Not Applicable],,,,,0.15,,,,,22,,1,0.41815,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4395,,,,,,,,,,,,,,,,32,,,,,,,,,,,,,2006,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,89802,,0.351539331,,,,,,,,,,0.15734593,,0.077412446,,,,Stage IIIB,,0.747,,,,,,,,,,,,,,,,0.1311,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),D479G,1,,G12V (driver),D479G,15.99604844,16.78953559,15.51865086,-0.261446368,LUAD,Adenocarcinoma,18.0514822,15.97589487,Adenocarcinoma,-0.878,11.68638882,-0.2135,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-86-7953,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,3.26,0.35,15,9,15,,,997,,997,997,,0,0,997,997,,Malignant,39,,63,,,,24415,,,997,997,,,,997,997,,,997,,,,,,,,TUMOR FREE,Alive,-25315,,,,68,,997,997,,,[Not Available],[Not Applicable],,,,,0.15,,,,,21,,1,0.32132,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-7953,,,,,,,997,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,89811,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,,,,-0.334206244,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.338,,-0.0725,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-85-7696,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.96,0.76,12,7,13,,,1111,,1111,1111,,0,0,1111,1111,,Malignant,32,,23,,,,28419,,,1111,1111,,,,1111,1111,,,1111,,,,,,,,TUMOR FREE,Alive,-23413,,,,265,,1111,1111,,,[Not Available],[Not Applicable],,,,,0.49,,,,,8,,0,0.27545,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-7696,,,,,,,1111,,,,,,,,,14,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,89813,,0.847648741,,,,,,,,,,0.179413409,,0.042775731,,,,Stage IA,,0.0755,,,,,,,,,,,,,,,,0.3196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.508675272310157,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.1344,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.65,3,2,5,,,1347,BRCA_LumA,1347,1347,,0,0,1347,1347,,Invasive Carcinoma,10,,13,,,,20703,0,,1347,1347,,,,1347,1347,,,1347,,,,,,,,TUMOR FREE,Alive,-22928,,,,175,,1347,1347,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.043482,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0SY,,,,,,,1347,,,,,,,,,4,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,89814,,0.827514775,0,0,0,0,0.0578,1,,,Infiltrating Lobular Carcinoma,0.200967406,,0.212516592,0,0,0,,Negative,0.0745,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4941,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,89815,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Female,TCGA-FD-A3B4,Black or African American,BLCA,,1.0,1,,,1,1,FEMALE,1.0,2.04,0.62,6,11,14,,,510,,359,510,,1.0,1,359.0,359.0,,Malignant,31,,25,,,,29678.0,,,359.0,359,,,,359,510,,,359.0,,,,,,,,WITH TUMOR,Dead,-20379,510,,,106.0,,359.0,359,,,[Not Available],[Not Applicable],,,,,0.04,,,,,6,,0,0.1658,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3B4,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,16,,,,,,,,,,,,,2011,359,Left posterior pelvic wall,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,55.0,,,,,,,,,,,,,,,,,,,,89817,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6356,White,PRAD,108,0,0,,G9,0,0,MALE,0,2.01,0.21,1,1,1,ambiguous,NO,1434,1-ERG,1434,1434,,0,0,1434,1434,prad_tcga,Malignant,3,CHEK2,3,8.7,TCGA-G9-6356-01,0,5361,0,TCGA-G9-6356,1434,1434,Prostate Cancer,,986,1434,1434,TCGA,,1434,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22010,,60,9,30,PRAD,1434,1434,WHITE,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.1,Prostate,Resection,4,c6e0f83f-aba3-4705-abac-c81c885b53ba,1,Normal (no evidence of prostate cancer) [cM0],0,0.012384,[Not Available],1d7ffbe7-6139-412b-8739-8082a63a2b33,5,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.6,G9,2.1,TCGA-G9-6356,0:DiseaseFree,5,18,Prostate Adenocarcinoma,47.11,3/14/12,1434,,,,,NO,C61,818a2716-ca81-4534-ba13-a0fe3a18b2e9,,2,TUMOR FREE,0.0021,0:LIVING,0.13,3,47.11,Bilateral,20,No Evidence of Extraprostatic Extension,21,YES,,2009,,,TCGA-G9-6356.818a2716-ca81-4534-ba13-a0fe3a18b2e9.pdf,,[Not Applicable],YES,24,36-45%,5,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.6,60,Core needle biopsy,,,NO,YES,YES,,T3b,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,89829,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Female,TCGA-CF-A47T,Asian,BLCA,,1.0,1,,,1,1,FEMALE,1.0,2.01,0.94,2,1,4,,,385,,139,385,,1.0,1,139.0,139.0,,Malignant,7,,20,,,,22310.0,,,139.0,139,,,,139,385,,,139.0,,,,,,,,WITH TUMOR,Dead,-21347,385,,,48.0,,139.0,139,,,[Not Available],[Not Applicable],,,,,0.01,,,,,3,,0,0.067897,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A47T,,,,,,,,Bone,Distant Metastasis,,,,,,,4,,,,,,,,,,,,,2011,139,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,89836,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,,BRCA,,0,0,,,,0,FEMALE,0,1.93,0.86,5,3,4,,,304,BRCA_LumA,,304,,0,0,304,304,,Invasive Carcinoma,12,,24,,,,19144,0,,304,304,,,,,304,,,304,,,,,,,,,Alive,-28063,,,,46,,304,304,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.20669,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A099,,,,,,,304,,,,,,,,,7,,,,,,,,,,,,,2009,,,,,Stage X,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,89844,,0.171652185,0,0,0,0,-0.3224,1,,,Infiltrating Ductal Carcinoma,0.146551863,,0.149161241,0,0,0,,[Not Available],-0.822,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.032,0,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.06,0.74,6,10,6,,,3941,BRCA_LumB,,3941,,1,1,2717,2717,,Invasive Carcinoma,22,,7,,,,22114,0,,2717,2717,,,,,3941,,,2717,,,,,,,,WITH TUMOR,Dead,-23646,3941,,,101,,2717,2717,,,[Not Available],[Not Applicable],,,,,0.26,Breast,Resection/Excision,,,18,,1,0.12544,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0IB,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,25,,,,,,,,,,,,,1992,2717,"lung, bone, liver",,,Stage IV,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,89849,,-0.979064948,0,0,0,0,0.2383,1,,,Infiltrating Ductal Carcinoma,0.067818266,,0.095571507,0,0,0,,Negative,-1.442,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0289,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-77-8008,,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,2.0,0.27,7,3,7,,,2639,,,2639,,2,2,2639,2639,,Malignant,17,,16,,,,17111,,,2639,2639,,,,,2639,,,2639,,,,,,,,,Dead,-24948,2639,,,217,,2639,2639,,,[Not Available],[Not Applicable],,,,,0.25,,,,,12,,0,0.24376,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8008,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,89851,,0.72369375,,,,,,,,,,0.235825047,,0.110367796,,,,Stage IB,,0.7585,,,,,,,,,,,,,,,,1.2363,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.216844714565257,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,2.2797,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-34-8455,White,LUSC,,1,1,,University of Pittsburgh,,1,MALE,1,3.46,0.46,5,4,7,,,123,,,123,,1,1,123,123,,Malignant,16,,41,,,,18266,,,123,123,,,,,123,,,123,,,,,,,,WITH TUMOR,Dead,-24624,123,,,655,,123,123,,,[Not Available],[Not Applicable],,,,,0.01,,,,,20,,1,0.23506,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-8455,,,,,,,,,,,,,,,,17,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,89854,,0.200713758,,,,,,,,,,0.167798715,,0.13166227,,,,Stage IV,,0.058,,,,,,,,,,,,,,,,0.7489,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.54680652,16.12564791,14.96255979,-0.513382733611456,LUSC,Squamous Cell Carcinoma,18.05752027,15.315117,Squamous Cell Carcinoma,0.4914,12.90631707,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-K4-A3WS,White,BLCA,,0.0,0,,,0,0,MALE,0.0,5.35,0.4,0,29,23,,,761,,761,761,,0.0,0,761.0,761.0,,Malignant,52,,4,,,,28392.0,,,761.0,761,,,,761,761,,,761.0,,,,,,,,TUMOR FREE,Alive,-24124,,,,404.0,,761.0,761,,,[Not Available],[Not Applicable],,,,,0.29,,,,,14,,2,0.000373,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - Lahey Clinic,,TCGA-K4-A3WS,,,,,,,761,,,,,,,,,59,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,66.0,,,,,,,,,,,,,,,,,,,,89856,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FP-7829,White,STAD,,0,0,,,0,0,,0,3.19,0.73,9,17,18,,,594,,594,594,,0,0,594,594,,Malignant,44,,84,,,,18062,,,594,594,,,,594,594,,,594,,,,,,,,TUMOR FREE,Alive,-25534,,,,326,,594,594,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,14,,1,0.26966,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G2,,International Genomics Consortium,,TCGA-FP-7829,,,,,,,594,,,,,,,,,36,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,89860,,-0.960837,,,,,,,,,,0.136049295,Grade 2,0.089084427,,,,Stage IIB,,-1.038,,,,,,,,,,,,,,,,0.3442,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-7829,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,1,,1,1,1,Male,TCGA-RD-A7BT,Pacific Islander or Native Hawaiian,STAD,,1,1,,,,1,,1,,,,,,,,262,,,262,,1,1,123,123,,Malignant,,,,,,,32777,,,123,123,,,,,262,,,123,,,,,,,,WITH TUMOR,Dead,-24107,262,,,292,,123,123,,,Stomach Cancer,[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A7BT,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2002,123,Adrenal gland,,,Stage IV,,,,,,,,Progressive Disease,,,,,,66,,,,,,,,,,,,,,,,,,,,89866,,-0.596250708,,,,,,,,,,0.016195357,Grade 3,-0.014249663,,,,Stage IV,,-0.787,,,,,,,,,,,,,,,,-0.4021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A7BT,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-97-A4M0,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,0,3.78,0.55,8,8,10,,,652,,652,652,,0,0,652,652,,Malignant,26,,82,,,,33422,,,652,652,,,,652,652,,,652,,,,,,,,TUMOR FREE,Alive,-22206,,,,536,,652,652,,,[Not Available],[Not Applicable],,,,,0.2,,,,,12,,1,0.15108,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-A4M0,,,,,,,652,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,89868,,1.231925173,,,,,,,,,,0.221377588,,0.057629566,,,,Stage IB,,1.2625,,,,,,,,,,,,,,,,-0.1789,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.090273317,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.0509,,0.852,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-L4-A4E6,White,LUAD,,0,0,,Gundersen Lutheran Health System,0,0,MALE,0,,,,,,,,435,,435,435,,0,0,435,435,,Malignant,,,,,,,19216,,,435,435,,,,435,435,,,435,,,,,,,,TUMOR FREE,Alive,-24631,,,,17,,435,435,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Gundersen Lutheran Health System,,TCGA-L4-A4E6,,,,,,,435,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,89872,,0.63271781,,,,,,,,,,0.330475195,,0.299435272,,,,Stage IA,,0.9265,,,,,,,,,,,,,,,,0.1083,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.113004829,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.8873,,-0.1423,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-95-7567,White,LUAD,,0,0,,Washington University - Emory,,0,MALE,0,2.65,0.53,11,10,21,,,568,,,568,,0,0,568,568,,Malignant,42,,71,,,,17443,,,568,568,,,,,568,,,568,,,,,,,,TUMOR FREE,Alive,-22437,,,,1243,,568,568,,,[Not Available],[Not Applicable],,,,,0.16,,,,,13,,1,0.24406,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Emory,,TCGA-95-7567,,,,,,,568,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,89875,,1.018880119,,,,,,,,,,0.21318187,,0.127953537,,,,Stage IIB,,1.215,,,,,,,,,,,,,,,,0.1164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,16.2088933,16.84483119,16.68156483,-0.100362557,LUAD,Adenocarcinoma,18.07606256,15.55265214,Adenocarcinoma,0.1288,12.82612529,0.3326,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,2.01,0.73,5,6,8,,,1812,BRCA_LumA,536,1812,,1,1,536,536,,Invasive Carcinoma,19,,19,,,,17915,1,,536,536,,,,536,1812,,,536,,,,,,,,WITH TUMOR,Dead,-25490,1812,,,657,,536,536,,,[Not Available],[Not Applicable],,,,,0.03,Not Specific/Unknown,Resection/Excision,,,5,,0,0.0985,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2D9,,,,,,,,Bone,Distant Metastasis,,,,,,,6,,,,,,,,,,,,,2006,536,,,,Stage I,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,89876,,-0.184193878,0,0,0,0,0.7627,1,,,Infiltrating Ductal Carcinoma,0.134386724,,0.200390386,0,0,0,,Negative,-0.3125,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3387,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,,,White,BRCA,,1,1,,,,0,FEMALE,1,2.03,0.66,1,1,4,,,990,BRCA_LumA,,990,,1,1,756,756,,Invasive Carcinoma,6,,15,,,,29844,0,,756,756,,,,,990,,,756,,,,,,,,WITH TUMOR,Alive,-21685,,,,35,,756,756,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,4,,0,0.069151,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YC,,,,,,,990,,Locoregional Disease,,,,,,,5,,,,,,,,,,,,,2008,756,,,,Stage IIB,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,89879,,0.195359321,0,0,0,0,-0.3358,1,,,Infiltrating Ductal Carcinoma,0.16557147,,0.177603461,0,0,0,,Close,-0.2595,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.287,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A3IB,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,1.82,0.91,7,2,7,,,220,,,220,,1.0,1,220.0,220.0,,Malignant,16,,24,,,,28198.0,,,220.0,220,,,,,220,,,220.0,,,,,,,,WITH TUMOR,Dead,-24149,220,,,126.0,,220.0,220,,,[Not Available],[Not Applicable],,,,,0.05,,,,,6,,0,0.20794,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A3IB,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2008,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,66.0,,,,,,,,,,,,,,,,,,,,89881,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.84,0.58,2,0,3,,,9,BRCA_LumA,9,9,,0,0,9,9,,Invasive Carcinoma,5,,5,,,,19597,0,,9,9,,,,9,9,,,9,,,,,,,,TUMOR FREE,Alive,-25305,,,,41,,9,9,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,14,,1,0.05158,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0XP,,,,,,,9,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,89886,,-0.79083021,0,0,0,0,1.0735,1,,,Infiltrating Ductal Carcinoma,0.139505691,,0.165732812,0,0,0,,Negative,-0.3275,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3072,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.21,0.9,11,12,11,,,714,BRCA_LumA,714,714,,0,0,714,714,,Invasive Carcinoma,34,,42,,,,26644,0,,714,714,,,,714,714,,,714,,,,,,,,TUMOR FREE,Alive,-27287,,,,54,,714,714,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,9,,0,0.1792,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A1FV,,,,,,,714,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,89887,,-1.410460436,0,0,0,0,-0.8072,1,,,Infiltrating Lobular Carcinoma,0.090105577,,0.245147726,0,0,0,,Negative,-1.23,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0833,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.09,0.89,2,0,4,,,1640,BRCA_LumA,1640,1640,,0,0,1640,1640,,Invasive Carcinoma,6,,3,,,,28108,0,,1640,1640,,,,1640,1640,,,1640,,,,,,,,TUMOR FREE,Alive,-18771,,,,30,,1640,1640,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,5,,0,0.031549,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15J,,,,,,,1640,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,89896,,-1.5657981,0,0,0,0,-0.3834,1,,,Infiltrating Ductal Carcinoma,0.077588334,,0.071698554,0,0,0,,Negative,-1.359,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1539,1,0,H & E,0,0,,0,Jeffrey Eisenstein,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.87,0.53,16,26,23,,,3286,BRCA_Basal,3286,3286,,0,0,3286,3286,,Invasive Carcinoma,65,,70,,,,21279,0,,3286,3286,,,,3286,3286,,,3286,,,,,,,,TUMOR FREE,Alive,-10898,,,,0,,3286,3286,,,[Not Available],[Not Applicable],,,,,0.4,Breast,Resection/Excision,,,8,,0,0.39018,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A129,,,,,,,3286,,,,,,,,,13,,,,,,,,,,,,,2002,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,29,,,,,,,,,,,,,,,,,,,,89900,TRUE,,0,0,0,0,1.0575,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Papillary Carcinoma,Invasive Papillary Carcinoma,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-CD-8531,Asian,STAD,,0,0,,,0,0,,0,2.03,0.85,2,5,3,,,383,,383,383,,0,0,383,383,,Malignant,10,,29,,,,17194,,,383,383,,,,383,383,,,383,,,,,,,,TUMOR FREE,Alive,-24453,,,,337,,383,383,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,1,,0,0.032386,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8531,,,,,,,383,,,,,,,,,1,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,89905,,-0.268938587,,,,,,,,,,0.085260257,Grade 3,0.096307419,,,,Stage IIIA,,0.968,,,,,,,,,,,,,,,,-0.2899,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8531,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A8O7,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.96,0.84,3,3,3,,,466,,466,466,,0.0,0,466.0,466.0,,Malignant,9,,23,,,,24788.0,,,466.0,466,,,,466,466,,,466.0,,,,,,,,TUMOR FREE,Alive,-19063,,,,47.0,,466.0,466,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.048452,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,Asterand,,TCGA-E7-A8O7,,,,,,,466,,,,,,,,,2,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,52.0,,,,,,,,,,,,,,,,,,,,89909,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,4.06,0.67,8,7,9,,,266,BRCA_Basal,155,266,,1,1,155,155,,Invasive Carcinoma,24,,28,,,,22389,0,,155,155,,,,155,266,,,155,,,,,,,,WITH TUMOR,Dead,-30757,266,,,68,,155,155,,,[Not Available],[Not Applicable],,,,,0.53,Breast,Resection/Excision,,,14,,1,0.1695,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LK,,,,,,,,"Other, specify",Locoregional Disease,,,,,,,23,,,,,,,,,,,,,2008,155,Left axilla,,,Stage IIIC,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,89912,,-0.635541103,0,0,0,0,1.247,1,,,Infiltrating Ductal Carcinoma,0.135270156,,0.010354831,0,0,0,,Negative,-1.8475,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0738,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-NJ-A4YQ,White,LUAD,,0,0,,Washington University - Rush University,,0,FEMALE,0,1.74,0.29,14,14,12,,,1432,,,1432,,0,0,1432,1432,,Malignant,40,,133,,,,25160,,,1432,1432,,,,,1432,,,1432,,,,,,,,TUMOR FREE,Alive,-25427,,,,1469,,1432,1432,,,[Not Available],[Not Applicable],,,,,0.24,,,,,12,,0,0.40494,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A4YQ,,,,,,,1432,,,,,,,,,15,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Stable Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,89915,,1.68184693,,,,,,,,,,0.212647942,,0.090539364,,,,Stage IA,,1.7655,,,,,,,,,,,,,,,,-0.0548,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V79L,1,,,V79L,,,,0.065131492,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.0913,,1.5194,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.17,0.7,1,0,3,,,1873,BRCA_LumA,1873,1873,,0,0,1873,1873,,Invasive Carcinoma,4,,19,,,,21041,0,,1873,1873,,,,1873,1873,,,1873,,,,,,,,TUMOR FREE,Alive,-15524,,,,41,,1873,1873,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.015826,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0D3,,,,,,,1873,,,,,,,,,6,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,89916,,0.314331287,0,0,0,0,-0.6494,1,,,Infiltrating Ductal Carcinoma,0.078272616,,0.08588574,0,0,0,,Negative,0.26,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0378,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,1.9,0.51,9,6,10,,,612,BRCA_LumA,,612,,1,1,612,612,,Invasive Carcinoma,25,,79,,,,19067,0,,612,612,,,,,612,,,612,,,,,,,,WITH TUMOR,Dead,-20678,612,,,118,,612,612,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,4,,0,0.20419,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18J,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2000,,,,,Stage IV,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,89930,,-0.409515443,0,0,0,0,0.0373,1,,,Infiltrating Ductal Carcinoma,0.173296787,,0.151220992,0,0,0,,Negative,-0.709,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5248,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Male,TCGA-22-5491,White,LUSC,,0,0,,Mayo Clinic - Rochester,,,MALE,2,3.59,0.67,8,11,17,,,1713,,,1713,,2,2,1713,1713,,Malignant,36,,26,,,,16998,,,1713,1713,,,,,1713,,,1713,,,,,,,,,Dead,-27145,1713,,,444,,1713,1713,,,[Not Available],[Not Applicable],,,,,0.41,,,,,13,,1,0.21847,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5491,,,,,,,1713,,,,,,,,,22,,,,,,,,,,,,,2003,,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,89932,,0.350745895,,,,,,,,,,0.135601334,,0.004490352,,,,Stage IA,,0.533,,,,,,,,,,,,,,,,-0.2798,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.43746123193836,LUSC,,,,Squamous Cell Carcinoma,-2.0827,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-97-8172,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,0,3.92,0.32,2,0,5,,,545,,545,545,,0,0,545,545,,Malignant,7,,6,,,,17996,,,545,545,,,,545,545,,,545,,,,,,,,TUMOR FREE,Alive,-27416,,,,353,,545,545,,,[Not Available],[Not Applicable],,,,,0.07,,,,,12,,1,0.046177,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-8172,,,,,,,545,,,,,,,,,11,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,89938,,1.302377966,,,,,,,,,,0.255539142,,0.185544512,,,,Stage IB,,1.1575,,,,,,,,,,,,,,,,0.251,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,G627*,,,1,G627*,,,,,,-0.210391743,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.107,,0.4896,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-67-3771,Black or African American,LUAD,,0,0,,St Joseph's Medical Center (MD),,0,FEMALE,0,2.88,0.46,9,20,22,,,610,,,610,,0,0,610,610,,Malignant,51,,37,,,,32610,,,610,610,,,,,610,,,610,,,,,,,,TUMOR FREE,Alive,-28406,,,,1431,,610,610,,,[Not Available],[Not Applicable],,,,,0.26,,,,,20,,1,0.33273,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,St Joseph's Medical Center (MD),,TCGA-67-3771,,,,,,,610,,,,,,,,,37,,,,,,,,,,,,,2009,,,,,Stage IA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,89939,,0.967685968,,,,,,,,,,0.251217681,,0.102331857,,,,Stage IA,,0.986,,,,,,,,,,,,,,,,0.0033,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G417E (driver),1,,,G417E (driver),,,,-0.101206564,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.3219,,0.3932,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-G9-6361,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.95,0.73,3,4,0,ambiguous,NO,1415,1-ERG,1415,1415,,0,0,1415,1415,prad_tcga,Malignant,7,RAD51B;RAD54L,56,5.5,TCGA-G9-6361-01,0,5362,0,TCGA-G9-6361,1415,1415,Prostate Cancer,,1002,1415,1415,TCGA,,1415,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22565,,61,7,42,PRAD,1415,1415,WHITE,0.0,[Not Available],[Not Applicable],36,R1,1,Matched,0.11,Prostate,Resection,3,a369c190-964e-471c-878a-d8fade7cf992,1,Normal (no evidence of prostate cancer) [cM0],0,0.048237,[Not Available],71d14304-ccb0-4a4c-b935-8c014ca75fd0,4,Prostate Adenocarcinoma Acinar Type,1.3,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.2,TCGA-G9-6361,0:DiseaseFree,2,27,Prostate Adenocarcinoma,46.48,3/13/12,1415,,,,,NO,C61,49fe865a-79e8-4ff3-a52e-9888c4514cf2,,1,TUMOR FREE,0.0515,0:LIVING,0.1,,46.48,Bilateral,34,No Evidence of Extraprostatic Extension,31,YES,,2009,,,TCGA-G9-6361.49fe865a-79e8-4ff3-a52e-9888c4514cf2.pdf,,[Not Applicable],YES,38,31-40%,12,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.7,61,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T2c,0,M0,C61.9,8550/3,89942,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.09,0.31,1,1,3,,,2064,BRCA_LumA,2064,2064,,0,0,2064,2064,,Invasive Carcinoma,5,,2,,,,17029,0,,2064,2064,,,,2064,2064,,,2064,,,,,,,,TUMOR FREE,Alive,-19781,,,,20,,2064,2064,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,4,,0,0.015695,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DV,,,,,,,2064,,,,,,,,,2,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,89946,,-0.373828751,0,0,0,0,0.4149,1,,,Infiltrating Ductal Carcinoma,0.203173266,,0.36910122,0,0,0,,Negative,-0.298,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.8662,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-97-7554,White,LUAD,,0,0,,Washington University - NYU,0,0,FEMALE,0,5.21,0.29,6,15,16,,,775,,775,775,,0,0,775,775,,Malignant,37,,32,,,,20876,,,775,775,,,,775,775,,,775,,,,,,,,TUMOR FREE,Alive,-30327,,,,576,,775,775,,,[Not Available],[Not Applicable],,,,,0.42,,,,,24,,2,0.19399,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-7554,,,,,,,775,,,,,,,,,56,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,83,,,,,,,,,,,,,,,,,,,,89947,,0.686450166,,,,,,,,,,0.24576723,,0.202420714,,,,Stage IIIA,,1.8235,,,,,,,,,,,,,,,,0.5713,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,16.35650871,17.88119616,16.00942013,-0.117932606,LUAD,Adenocarcinoma,18.06927187,15.45613153,Adenocarcinoma,0.886,14.17547569,-0.0036,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Female,TCGA-G2-A2EC,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,,,,,,,,696,,,696,,1.0,1,679.0,679.0,,Malignant,,,,,,,19026.0,,,679.0,679,,,,,696,,,679.0,,,,,,,,WITH TUMOR,Dead,-21215,696,,,244.0,,679.0,679,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,679,small bowel,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,89959,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FC-7961,White,PRAD,308,0,0,,FC,0,0,MALE,0,3.59,0.34,11,16,8,ambiguous,NO,469,5-SPOP,469,469,,0,0,469,469,prad_tcga,Malignant,35,BRCA2;FANCL;RAD54L,66,24.7,TCGA-FC-7961-01,28,5342,0,TCGA-FC-7961,469,469,Prostate Cancer,,,469,469,TCGA,,469,Primary,1,Apex,A,,,,TUMOR FREE,Alive,-22888,,62,9,66,PRAD,469,469,WHITE,0.458905916,[Not Available],[Not Applicable],55,,1,Matched,0.12,Prostate,Resection,4,cd0a9875-737e-49d2-a66f-a4b127f22a37,10,,1,0.13765,[Not Available],a8d81122-3f2a-43f4-bdc1-479cab37a19d,5,Prostate Adenocarcinoma Acinar Type,1.9,Prostate,32,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,FC,1.86666666667,TCGA-FC-7961,0:DiseaseFree,5,46,Prostate Adenocarcinoma,15.41,3/16/12,469,,,,,,C61,38213CCD-4ED4-43B8-BFA0-38300DD35095,,14,TUMOR FREE,0.2165,0:LIVING,,,15.41,Bilateral,49,No Evidence of Extraprostatic Extension,65,YES,,2011,,,TCGA-FC-7961.38213CCD-4ED4-43B8-BFA0-38300DD35095.pdf,Peripheral Zone,[Not Applicable],YES,,81-90%,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,,0.8,62,Core needle biopsy,,,YES,NO,YES,,T3a,,9,No,,0,N0,T1c,0,M0,C61.9,8550/3,89964,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-92-8065,White,LUSC,,0,0,,Washington University - St. Louis,0,0,FEMALE,0,1.9,0.5,12,14,17,,,70,,70,70,,0,0,70,70,,Malignant,43,,60,,,,33562,,,70,70,,,,70,70,,,70,,,,,,,,TUMOR FREE,Alive,-27049,,,,347,,70,70,,,[Not Available],[Not Applicable],,,,,0.04,,,,,8,,0,0.32135,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - St. Louis,,TCGA-92-8065,,,,,,,70,,,,,,,,,13,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,89965,,1.301544574,,,,,,,,,,0.221861465,,0.048966627,,,,Stage IIB,,0.958,,,,,,,,,,,,,,,,0.2842,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.18608207,17.60157486,16.15583588,-0.214091179829752,LUSC,Squamous Cell Carcinoma,18.16485439,15.91941788,Squamous Cell Carcinoma,-0.1628,14.85699829,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.05,0.36,5,4,7,,,2645,BRCA_LumA,,2645,,0,0,2645,2645,,Invasive Carcinoma,16,,44,,,,30759,0,,2645,2645,,,,,2645,,,2645,,,,,,,,TUMOR FREE,Alive,-15216,,,,733,,2645,2645,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,23,,1,0.17613,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Fox Chase,,TCGA-PE-A5DE,,,,,,,2645,,,,,,,,,26,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,89966,,1.704733642,0,0,0,0,0.5262,1,,,Infiltrating Lobular Carcinoma,0.156019141,,0.20463488,0,0,0,,[Not Available],1.8405,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2791,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3N5,Black or African American,BLCA,,1.0,1,,,,1,MALE,1.0,3.2,0.66,6,14,13,,,685,,,685,,1.0,1,346.0,346.0,,Malignant,33,,27,,,,29502.0,,,346.0,346,,,,,685,,,346.0,,,,,,,,WITH TUMOR,Dead,-25342,685,,,460.0,,346.0,346,,,[Not Available],[Not Applicable],,,,,0.1,,,,,7,,1,0.13057,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3N5,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,23,,,,,,,,,,,,,2011,346,Pelvis,,,Stage II,,,,,,,,[Not Available],,,,,,69.0,,,,,,,,,,,,,,,,,,,,89975,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FD-A3SO,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.85,0.57,9,2,7,,,168,,,168,,1.0,1,143.0,143.0,,Malignant,18,,69,,,,16931.0,,,143.0,143,,,,,168,,,143.0,,,,,,,,WITH TUMOR,Dead,-25147,168,,,510.0,,143.0,143,,,[Not Available],[Not Applicable],,,,,0.01,,,,,10,,0,0.23352,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A3SO,,,,,,,,Renal Pelvis,Locoregional (Urothelial tumor event),,,,,,,13,,,,,,,,,,,,,2012,143,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,68.0,,,,,,,,,,,,,,,,,,,,89978,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-44-2657,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,1.71,0.34,11,7,10,,,1351,,1351,1351,,0,0,1351,1351,,Malignant,28,,24,,,,23780,,,1351,1351,,,,1351,1351,,,1351,,,,,,,,TUMOR FREE,Alive,-27298,,,,526,,1351,1351,,,[Not Available],[Not Applicable],,,,,0.34,,,,,9,,0,0.40274,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-2657,,,,,,,1351,,,,,,,,,12,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,89982,,1.635012375,,,,,,,,,,0.271479652,,0.163307656,,,,Stage IB,,1.836,,,,,,,,,,,,,,,,0.1375,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.229232654,LUAD,,,,Adenocarcinoma,-0.1806,,1.7193,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-BR-8372,White,STAD,,0,0,,,0,0,,0,2.05,0.7,0,0,0,,,951,,951,951,,0,0,951,951,,Malignant,0,,36,,,,27200,,,951,951,,,,951,951,,,951,,,,,,,,TUMOR FREE,Alive,-23346,,,,1923,,951,951,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,2,,0,0.072726,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8372,,,,,,,951,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,89985,,0.890124298,,,,,,,,,,0.093881579,Grade 3,0.006316107,,,,Stage IIIC,,1.58,,,,,,,,,,,,,,,,-0.2425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8372,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-43-7657,White,LUSC,,0,0,,Christiana Healthcare,0,0,FEMALE,0,3.2,0.44,15,9,16,,,236,,236,236,,0,0,236,236,,Malignant,40,,60,,,,25401,,,236,236,,,,236,236,,,236,,,,,,,,TUMOR FREE,Alive,-25042,,,,171,,236,236,,,[Not Available],[Not Applicable],,,,,0.22,,,,,19,,1,0.44245,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-7657,,,,,,,236,,,,,,,,,37,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,89989,,-0.838918218,,,,,,,,,,0.165743526,,0.043701022,,,,Stage IA,,-0.392,,,,,,,,,,,,,,,,0.7486,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.751024892270476,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.0218,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-XF-AAMT,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,1.69,0.56,13,6,8,,,90,,,90,,1.0,1,90.0,90.0,,Malignant,27,,94,,,,25417.0,,,90.0,90,,,,,90,,,90.0,,,,,,,,WITH TUMOR,Dead,-27397,90,,,151.0,,90.0,90,,,[Not Available],[Not Applicable],,,,,0.49,,,,,9,,0,0.3461,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMT,,,,,,,,,,,,,,,,12,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,89992,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-80-5608,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR)/Ottawa,0,0,FEMALE,0,3.13,0.48,8,6,12,,,2832,,2832,2832,,0,0,2832,2832,,Malignant,26,,20,,,,0,,,2832,2832,,,,2832,2832,,,2832,,,,,,,,TUMOR FREE,Alive,,,,,222,,2832,2832,,,[Not Available],[Not Applicable],,,,,0.27,,,,,12,,1,0.24154,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR)/Ottawa,,TCGA-80-5608,,,,,,,2832,,,,,,,,,32,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,89993,,0.577210387,,,,,,,,,,0.185214737,,0.120852472,,,,Stage IA,,0.723,,,,,,,,,,,,,,,,-0.0029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),Q92K,1,,G12A (driver),Q92K,,,,-0.346765593,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.1136,,-0.0104,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-49-4514,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,1.79,0.35,7,13,11,,,1700,,1700,1700,,0,0,1700,1700,,Malignant,31,,47,,,,16363,,,1700,1700,,,,1700,1700,,,1700,,,,,,,,TUMOR FREE,Alive,-28908,,,,422,,1700,1700,,,[Not Available],[Not Applicable],,,,,0.01,,,,,6,,0,0.29223,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4514,,,,,,,1700,,,,,,,,,7,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,89995,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.1738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R470S (driver),1,,,R470S (driver),,,,-0.189491862,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.3174,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.55,2,1,1,,,575,BRCA_LumA,575,575,,0,0,575,575,,Invasive Carcinoma,4,,5,,,,16325,0,,575,575,,,,575,575,,,575,,,,,,,,TUMOR FREE,Alive,-18334,,,,34,,575,575,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,5,,0,0.064312,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0T6,,,,,,,575,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,89996,,0.976998395,0,0,0,0,-0.4967,1,,,Infiltrating Lobular Carcinoma,0.207259005,,0.21101432,0,0,0,,Negative,0.41,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7566,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-BR-7196,White,STAD,,1,1,,,,0,,1,2.08,0.28,0,2,2,,,666,,,666,,1,1,348,348,,Malignant,4,,0,,,,18716,,,348,348,,,,,666,,,348,,,,,,,,WITH TUMOR,Alive,-23611,,,,81,,348,348,,,[Not Available],[Not Applicable],,,,,0.46,Stomach,Unknown,,,3,,0,0.0,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-7196,,,,,,,666,Lung,Distant Metastasis,,,,,,,2,,,,,,,,,,,,,2011,348,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,90016,,0.863073306,,,,,,,,,,0.132856527,Grade 3,0.22466552,,,,Stage IV,,0.727,,,,,,,,,,,,,,,,0.6233,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7196,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.06,0.46,1,0,2,,,3011,BRCA_LumA,3011,3011,,0,0,3011,3011,,Invasive Carcinoma,3,,6,,,,19543,0,,3011,3011,,,,3011,3011,,,3011,,,,,,,,TUMOR FREE,Alive,-15289,,,,26,,3011,3011,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,21,,1,0.20413,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CV,,,,,,,3011,,,,,,,,,20,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,90025,,0.279363068,0,0,0,0,0.7174,1,,,Infiltrating Ductal Carcinoma,0.136423637,,0.216710841,0,0,0,,Negative,0.0895,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4679,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-33-4583,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,3.48,0.52,7,3,9,,,4601,,4601,4601,,2,2,4601,4601,,Malignant,19,,31,,,,19840,,,4601,4601,,,,4601,4601,,,4601,,,,,,,,TUMOR FREE,Dead,-26799,4601,,,795,,4601,4601,,,[Not Available],[Not Applicable],,,,,0.21,,,,,23,,1,0.35817,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4583,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,1999,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,90026,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.2166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.36115343149994,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-ZF-A9RN,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.71,0.81,14,12,17,,,615,,,615,,1.0,1,516.0,516.0,,Malignant,43,,285,,,,24307.0,,,516.0,516,,,,,615,,,516.0,,,,,,,,WITH TUMOR,Dead,-24795,615,,,272.0,,516.0,516,,,[Not Available],[Not Applicable],,,,,0.18,,,,,17,,1,0.40865,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9RN,,,,,,,,Lung,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,2010,516,,,,Stage III,,,,,,,,Partial Remission/Response,,,,,,67.0,,,,,,,,,,,,,,,,,,,,90032,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-7519,,PRAD,221,0,0,,G9,0,0,MALE,0,1.97,0.18,0,0,0,HRD,NO,849,8-other,849,849,,0,0,849,849,prad_tcga,Malignant,0,BRCA2,3,5.1,TCGA-G9-7519-01,0,5385,0,TCGA-G9-7519,849,849,Prostate Cancer,,457,849,849,TCGA,,849,Primary,0,Apex|Base,A,CDK12:92-102:DRRENDERRGS/DX:frameshift_variant,,,TUMOR FREE,Alive,-21276,,58,7,33,PRAD,849,849,,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.01,Prostate,Resection,3,a0fd8790-8db2-4a4f-8fd6-657b263e1579,0,Abnormal (not related to prostate cancer),0,0.034792,[Not Available],0f01ec33-00a8-4188-a8f0-e90d46ad9bc7,4,Prostate Adenocarcinoma Acinar Type,1.1,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.7,G9,1.3,TCGA-G9-7519,0:DiseaseFree,2,3,Prostate Adenocarcinoma,27.89,5/31/12,849,,,,,NO,C61,07227b7d-9285-4d1b-9484-ccdb20841905,,1,TUMOR FREE,0.0001,0:LIVING,0.03,,27.89,Bilateral,9,No Evidence of Extraprostatic Extension,7,YES,,2010,,,TCGA-G9-7519.07227b7d-9285-4d1b-9484-ccdb20841905.pdf,,[Not Applicable],YES,7,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.8,58,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8550/3,90034,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-HC-A9TH,,PRAD,,1,1,,HC,,0,MALE,1,1.92,0.7,5,5,1,HRP,NO,844,,,844,,1,1,351,351,prad_tcga,Malignant,11,ATM;CHEK2;PALB2,61,,TCGA-HC-A9TH-01,0,5465,0,TCGA-HC-A9TH,351,351,Prostate Cancer,,295,,844,TCGA,,351,Primary,0,Apex|Middle|Base,A,,,False,WITH TUMOR,Alive,-21460,,58,9,65,PRAD,351,351,,0.0,[Not Available],[Not Applicable],49,,1,Matched,0.08,Prostate,Resection,5,4F86D3F7-167E-45EC-8EF5-7E26025F2BD4,0,Normal (no evidence of prostate cancer) [cM0],0,0.086114,[Not Available],433D1441-6D5B-4455-A731-65F172BB016D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,HC,1.63333333333,TCGA-HC-A9TH,1:Recurred/Progressed,5,11,Prostate Adenocarcinoma,11.53,6/10/15,844,"Other, specify",Biochemical evidence of disease,,,,C61,C2755FC2-E4BD-4997-B2F9-1F1C3A9C28AE,60,4,WITH TUMOR,0.0868,0:LIVING,0.38,5,27.73,Bilateral,12,,,YES,320,2013,351,Biochemical,TCGA-HC-A9TH.C2755FC2-E4BD-4997-B2F9-1F1C3A9C28AE.pdf,,[Not Applicable],,155,,2,Prostate Adenocarcinoma Acinar Type,1,2013,Partial Remission/Response,,NO,No,R1,,58,Transurethral resection (TURBT),,Partial Remission/Response,YES,NO,YES,NO,T3b,,9,No,NO,0,N0,T1b,0,M0,C61.9,8140/3,90036,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.67,1,0,2,,,76,BRCA_LumA,76,76,,0,0,76,76,,Invasive Carcinoma,3,,2,,,,16471,0,,76,76,,,,76,76,,,76,,,,,,,,TUMOR FREE,Alive,-17710,,,,34,,76,76,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.015828,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HO,,,,,,,76,,,,,,,,,2,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,90048,,,0,0,0,0,-0.1761,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5745,White,PRAD,,0,0,,CH,,0,MALE,0,,,,,,,NO,91,,,91,,0,0,91,91,prad_tcga,Malignant,,,,,TCGA-CH-5745-01,0,5243,0,TCGA-CH-5745,91,91,Prostate Cancer,,84,,91,TCGA,,91,Primary,0,,A,,,,TUMOR FREE,Alive,-24837,,68,7,36,PRAD,91,91,WHITE,0.0,[Not Available],[Not Applicable],48,,1,Matched,,Prostate,Resection,3,bda91e83-643b-4fae-bfe9-b4660f3bdf02,,Normal (no evidence of prostate cancer) [cM0],,,[Not Available],ac67d0df-7dc0-4a1a-8b47-beec9b94de86,4,Prostate Adenocarcinoma Acinar Type,0.8,Prostate,,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,CH,1.6,TCGA-CH-5745,0:DiseaseFree,2,,Prostate Adenocarcinoma,2.99,3/16/12,91,,,,,NO,C61,43e941e9-cfbd-45bc-91bb-28e5f5d9b767,,,TUMOR FREE,,0:LIVING,4.3,,2.99,,,,,YES,,2008,,,TCGA-CH-5745.43e941e9-cfbd-45bc-91bb-28e5f5d9b767.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,91,,5,Prostate Adenocarcinoma Acinar Type,1,2008,[Not Available],,NO,No,R0,0.5,68,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,,0,M0,C61.9,8550/3,90049,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,2.12,0.79,6,8,6,,,973,BRCA_LumA,,973,,0,0,973,973,,Invasive Carcinoma,20,,47,,,,19487,0,,973,973,,,,,973,,,973,,,,,,,,TUMOR FREE,Alive,-14853,,,,51,,973,973,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.075075,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A5D8,,,,,,,973,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,90054,,0.625672191,0,0,0,0,-0.9739,1,,,Infiltrating Ductal Carcinoma,0.070563133,,0.107629272,0,0,0,,[Unknown],0.269,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1505,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-69-7978,White,LUAD,,0,0,,Washington University - Cleveland Clinic,,0,MALE,0,3.06,0.2,5,7,13,,,134,,,134,,0,0,134,134,,Malignant,25,,32,,,,21389,,,134,134,,,,,134,,,134,,,,,,,,[Discrepancy],Alive,-21785,,,,778,,134,134,,,[Not Available],[Not Applicable],,,,,0.17,,,,,13,,1,0.26221,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Cleveland Clinic,,TCGA-69-7978,,,,,,,134,,,,,,,,,29,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Unknown],,,,,,59,,,,,,,,,,,,,,,,,,,,90058,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,17.5622179,18.4206146,18.15382851,0.307847693,LUAD,Adenocarcinoma,17.94075474,17.08343326,Adenocarcinoma,0.7572,13.59639559,1.2445,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-44-7667,White,LUAD,,0,0,,Christiana Healthcare,0,0,FEMALE,0,5.19,0.37,6,16,14,,,1097,,1097,1097,,0,0,1097,1097,,Malignant,36,,53,,,,18431,,,1097,1097,,,,1097,1097,,,1097,,,,,,,,TUMOR FREE,Alive,-18062,,,,611,,1097,1097,,,[Not Available],[Not Applicable],,,,,0.25,,,,,19,,2,0.16688,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-7667,,,,,,,1097,,,,,,,,,55,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,49,,,,,,,,,,,,,,,,,,,,90062,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,X570_splice (driver),1,,,X570_splice (driver),15.33865731,16.0016835,15.2529895,-0.771316577,LUAD,Adenocarcinoma,18.08684603,14.69605705,Adenocarcinoma,-0.7413,13.76447758,-1.0696,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.36,0.46,8,13,11,,,1914,BRCA_LumB,1914,1914,,0,0,1914,1914,,Invasive Carcinoma,32,,43,,,,18774,0,,1914,1914,,,,1914,1914,,,1914,,,,,,,,TUMOR FREE,Alive,-16688,,,,30,,1914,1914,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,23,,1,0.33143,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0AU,,,,,,,1914,,,,,,,,,17,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,90065,,1.028676799,0,0,0,0,-1.7255,1,,,Infiltrating Ductal Carcinoma,0.138788023,,0.12648872,0,0,0,,Negative,0.115,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4455,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.97,0.5,4,9,9,,,1220,BRCA_LumB,1220,1220,,0,0,1220,1220,,Invasive Carcinoma,22,,11,,,,29112,0,,1220,1220,,,,1220,1220,,,1220,,,,,,,,TUMOR FREE,Alive,-19849,,,,550,,1220,1220,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Resection/Excision,,,16,,1,0.20561,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A10C,,,,,,,1220,,,,,,,,,31,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,90071,,0.887516764,0,0,0,0,0.671,1,,,Infiltrating Ductal Carcinoma,0.157479931,,0.109291715,0,0,0,,Negative,0.0115,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.088,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.53,0.66,5,3,8,,,2365,BRCA_LumA,2365,2365,,0,0,2365,2365,,Invasive Carcinoma,16,,24,,,,29485,0,,2365,2365,,,,2365,2365,,,2365,,,,,,,,TUMOR FREE,Alive,-20625,,,,52,,2365,2365,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,18,,1,0.22901,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BT,,,,,,,2365,,,,,,,,,19,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,90082,,0.709049234,0,0,0,0,0.7432,1,,,Infiltrating Ductal Carcinoma,0.120713289,,0.121200758,0,0,0,,Negative,0.147,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1975,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,"Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-35-4123,White,LUAD,,0,0,,Cureline,,0,MALE,0,2.01,0.4,9,6,8,,,182,,,182,,0,0,182,182,,Malignant,23,,32,,,,22453,,,182,182,,,,,182,,,182,,,,,,,,TUMOR FREE,Alive,-14064,,,,389,,182,182,,,[Not Available],[Not Applicable],,,,,0.27,,,,,10,,0,0.24588,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Cureline,,TCGA-35-4123,,,,,,,182,,,,,,,,,12,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,90083,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.383816543,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.7342,,2.5621,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HC-7075,White,PRAD,161,0,0,,HC,0,0,MALE,0,1.99,0.78,0,0,0,HRP,NO,601,8-other,601,601,,0,0,601,601,prad_tcga,Malignant,0,,19,5.1,TCGA-HC-7075-01,0,5401,0,TCGA-HC-7075,601,601,Prostate Cancer,,96,601,601,TCGA,,601,Primary,0,,A,,,,TUMOR FREE,Alive,,,63,6,33,PRAD,601,601,WHITE,0.0,[Not Available],[Not Applicable],34,R0,1,Matched,0.0,Prostate,Resection,3,1fa3e5c2-e415-42fa-aea3-f6c84959522a,0,,0,0.0060158,[Not Available],5dd69c3e-9a3d-450c-9f10-10b4d6daeeba,3,Prostate Adenocarcinoma Acinar Type,0.7,Prostate,1,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,HC,1.13333333333,TCGA-HC-7075,0:DiseaseFree,1,1,Prostate Adenocarcinoma,19.74,3/29/12,601,,,,,,C61,72e3166c-bbd4-4bc1-931c-5fda225b3cf9,,0,TUMOR FREE,0.0058,0:LIVING,0.01,,19.74,Right,5,,,YES,,2010,,,TCGA-HC-7075.72e3166c-bbd4-4bc1-931c-5fda225b3cf9.pdf,,[Not Applicable],,,81-90%,,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,,No,R0,0.4,63,Core needle biopsy,,,NO,YES,NO,,T2a,,6,No,,0,,T1c,,M0,C61.9,8550/3,90094,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4507,White,LUAD,,1,,,Johns Hopkins,,1,FEMALE,1,2.69,0.35,13,13,16,,,268,,,268,,1,,158,158,,Malignant,42,,47,,,,16920,,,158,,,,,,268,,,158,,,,,,,,WITH TUMOR,Dead,-26851,268,,,259,,158,,,,[Not Available],[Not Applicable],,,,,0.25,,,,,8,,1,0.28066,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4507,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,1997,158,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,90096,,1.371744727,,,,,,,,,,0.171649528,,0.095311709,,,,Stage IIIA,,1.279,,,,,,,,,,,,,,,,0.1309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R470C (driver),1,,,R470C (driver),16.24167246,16.40136642,17.73034256,0.153775689,LUAD,Adenocarcinoma,17.80356211,17.04079249,Adenocarcinoma,0.3668,11.81999902,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-XF-AAN5,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,2.18,0.49,3,5,7,,,2293,,2293,2293,,0.0,0,2293.0,2293.0,,Malignant,15,,51,,,,23656.0,,,2293.0,2293,,,,2293,2293,,,2293.0,,,,,,,,TUMOR FREE,Alive,-22411,,,,429.0,,2293.0,2293,,,[Not Available],[Not Applicable],,,,,0.12,,,,,6,,0,0.12986,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAN5,,,,,,,2293,,,,,,,,,10,,,,,,,,,,,,,2008,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,90099,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.16,1,3,2,,,659,BRCA_LumA,659,659,,0,0,659,659,,Invasive Carcinoma,6,,12,,,,26989,0,,659,659,,,,659,659,,,659,,,,,,,,TUMOR FREE,Alive,-25097,,,,78,,659,659,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,1,,0,0.033501,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A4Z1,,,,,,,659,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,90106,,0.107186377,0,0,0,0,0.532,1,,,Infiltrating Lobular Carcinoma,0.1113006,,0.243761733,0,0,0,,Negative,-0.1885,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3074,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,3.79,0.57,3,2,3,,,1275,BRCA_LumA,1275,1275,,2,2,1275,1275,,Invasive Carcinoma,8,,13,,,,21040,0,,1275,1275,,,,1275,1275,,,1275,,,,,,,,TUMOR FREE,Dead,-26299,1275,,,60,,1275,1275,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,16,,1,0.032037,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A66K,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,90112,,,0,0,0,0,0.6949,1,,,Infiltrating Lobular Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-50-6591,White,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,4.67,0.9,7,8,14,,,119,,,119,,1,1,119,119,,Malignant,29,,56,,,,20391,,,119,119,,,,,119,,,119,,,,,,,,WITH TUMOR,Dead,-23067,119,,,70,,119,119,,,[Not Available],[Not Applicable],,,,,0.57,,,,,24,,2,0.31447,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-6591,,,,,,,,,,,,,,,,58,,,,,,,,,,,,,2007,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,63,,,,,,,,,,,,,,,,,,,,90113,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"K754_I759del (driver), L833V (driver), AMP (driver)",,,1,"K754_I759del (driver), L833V (driver)",,,12.72778762,13.33350841,9.422168917,-1.464826099,LUAD,Adenocarcinoma,17.61401671,13.03557613,Adenocarcinoma,-1.3202,12.53954065,-4.0948,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.23,0.7,3,2,4,,,213,BRCA_LumA,213,213,,0,0,213,213,,Invasive Carcinoma,9,,12,,,,20568,1,,213,213,,,,213,213,,,213,,,,,,,,TUMOR FREE,Alive,-32462,,,,68,,213,213,,,[Not Available],[Not Applicable],,,,,0.03,Not Specific/Unknown,Resection/Excision,,,21,,1,0.072021,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FK,,,,,,,213,,,,,,,,,25,,,,,,,,,,,,,2010,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,88,,,,,,,,,,,,,,,,,,,,90116,,-0.657421926,0,0,0,0,0.5384,1,,,Infiltrating Ductal Carcinoma,0.139163728,,0.17598032,0,0,0,,Negative,-1.3085,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1117,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-4Z-AA7Q,White,BLCA,,0.0,0,,,,2,MALE,2.0,2.88,0.29,15,13,13,,,510,,,510,,2.0,2,510.0,510.0,,Malignant,41,,132,,,,31869.0,,,510.0,510,,,,,510,,,510.0,,,,,,,,TUMOR FREE,Dead,-28981,510,,,318.0,,510.0,510,,,[Not Available],[Not Applicable],,,,,0.24,,,,,13,,1,0.36576,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA7Q,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,[Not Applicable],,,,,,79.0,,,,,,,,,,,,,,,,,,,,90117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.47,0,0,0,,,530,BRCA_LumA,530,530,,0,0,530,530,,Invasive Carcinoma,0,,0,,,,30526,0,,530,530,,,,530,530,,,530,,,,,,,,TUMOR FREE,Alive,-24315,,,,22,,530,530,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,0,,0,0.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A27E,,,,,,,530,,,,,,,,,0,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,90121,,0.097394348,0,0,0,0,0.0114,1,,,Other,0.129198659,,0.138009242,0,0,0,,Negative,-0.4655,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2255,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.9,0.59,8,8,7,,,1148,BRCA_LumA,1148,1148,,0,0,1148,1148,,Invasive Carcinoma,23,,52,,,,31718,0,,1148,1148,,,,1148,1148,,,1148,,,,,,,,TUMOR FREE,Alive,-13817,,,,38,,1148,1148,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,3,,0,0.14419,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A229,,,,,,,1148,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,37,,,,,,,,,,,,,,,,,,,,90124,,0.859447781,0,0,0,0,0.5165,1,,,Infiltrating Ductal Carcinoma,0.179991688,,0.133838567,0,0,0,,Negative,0.122,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6443,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,"Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)","Invasive Ductal Carcinoma (Tubular), Invasive Ductal Carcinoma (No Special Type)",0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.95,0.62,6,7,5,,,365,BRCA_LumA,365,365,,0,0,365,365,,Invasive Carcinoma,18,,12,,,,33273,0,,365,365,,,,365,365,,,365,,,,,,,,TUMOR FREE,Alive,-30742,,,,80,,365,365,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,3,,0,0.10271,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A0A1,,,,,,,365,,,,,,,,,4,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,90126,,1.071659704,0,0,0,0,0.2111,1,,,Infiltrating Lobular Carcinoma,0.280247767,,0.158900551,0,0,0,,Negative,0.631,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3917,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-D7-A4YY,White,STAD,,0,0,,,,0,,0,1.91,0.75,4,7,1,,,419,,,419,,0,0,419,419,,Malignant,12,,307,,,,16498,,,419,419,,,,,419,,,419,,,,,,,,TUMOR FREE,Alive,-22287,,,,715,,419,419,,,[Not Available],[Not Applicable],,,,,0.01,Stomach,Unknown,,,2,,0,0.15785,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A4YY,,,,,,,419,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Stable Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,90131,,0.670935815,,,,,,,,,,0.1460024,Grade 3,-0.00226511,,,,Stage IIIB,,1.1495,,,,,,,,,,,,,,,,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A4YY,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A6MF,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,2.0,0.88,0,0,0,,,750,,750,750,,0.0,0,750.0,750.0,,Malignant,0,,6,,,,17122.0,,,750.0,750,,,,750,750,,,750.0,,,,,,,,TUMOR FREE,Alive,-13867,,,,62.0,,750.0,750,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,9.77e-05,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,Asterand,,TCGA-E7-A6MF,,,,,,,750,,,,,,,,,0,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,37.0,,,,,,,,,,,,,,,,,,,,90139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-90-A59Q,White,LUSC,,1,1,,ABS - IUPUI,1,1,FEMALE,1,3.25,0.28,11,8,9,,,322,,274,322,,1,1,274,274,,Malignant,28,,77,,,,29664,,,274,274,,,,274,322,,,274,,,,,,,,WITH TUMOR,Dead,-22420,322,,,386,,274,274,,,[Not Available],[Not Applicable],,,,,0.2,,,,,22,,1,0.25856,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,ABS - IUPUI,,TCGA-90-A59Q,,,,,,,,,Distant Metastasis,,,,,,,19,,,,,,,,,,,,,2012,274,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,90141,,1.541515517,,,,,,,,,,0.187111073,,0.047474292,,,,Stage IIA,,1.6875,,,,,,,,,,,,,,,,0.3704,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.97403715,16.24673337,18.05083358,0.204137100458783,LUSC,Squamous Cell Carcinoma,17.88373636,17.3533997,Squamous Cell Carcinoma,0.8895,12.69108978,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-44-6779,White,LUAD,,1,,,Christiana Healthcare,,1,FEMALE,1,1.58,0.6,11,10,12,,,500,,,500,,1,,232,232,,Malignant,33,,43,,,,16287,,,232,,,,,,500,,,232,,,,,,,,WITH TUMOR,Dead,-18469,500,,,129,,232,,,,[Not Available],[Not Applicable],,,,,0.37,,,,,15,,0,0.48064,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-6779,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2008,232,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,50,,,,,,,,,,,,,,,,,,,,90144,,1.556408736,,,,,,,,,,0.220952464,,0.161790703,,,,Stage IIB,,1.683,,,,,,,,,,,,,,,,0.4513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,T142M,1,,,T142M,17.05939647,18.04714442,17.64748739,0.217959908,LUAD,,18.02465928,16.86342941,Adenocarcinoma,0.3432,12.98654409,1.3533,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-YL-A9WI,,PRAD,389,0,0,,YL,,0,MALE,0,2.27,0.88,6,12,3,ambiguous,NO,1623,6-FOXA1,,1623,,0,0,1623,1623,prad_tcga,Malignant,21,,166,,TCGA-YL-A9WI-01,19,5689,0,TCGA-YL-A9WI,1623,1623,Prostate Cancer,,1259,,1623,TCGA,,1623,Primary,1,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23184,,63,9,51,PRAD,1623,1623,,0.373381833,[Not Available],[Not Applicable],41,R0,1,Matched,0.17,Prostate,Resection,4,563E009C-C93D-46CC-867D-F5C89D9336D9,10,Normal (no evidence of prostate cancer) [cM0],0,0.13134,[Not Available],2D70EACC-D0C3-4121-BD1A-A47D68ECEDE5,5,Prostate Adenocarcinoma Acinar Type,,Prostate,22,,Acinar Adenocarcinoma,[Not Available],,YL,1.36666666667,TCGA-YL-A9WI,0:DiseaseFree,5,22,Prostate Adenocarcinoma,53.32,4/10/14,1623,,,,,NO,C61,746DB832-C507-4FD6-8B8A-09E6268BACC9,680,11,,0.376,0:LIVING,0.03,,53.32,Bilateral,31,No Evidence of Extraprostatic Extension,99,YES,1325,2010,,,TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,93,76-85%,15,Prostate Adenocarcinoma Acinar Type,1,2010,Stable Disease,,NO,No,R0,,63,Core needle biopsy,,Stable Disease,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,,1,M0,C61.9,8140/3,90146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.0,0.53,3,3,3,,,1477,BRCA_LumA,,1477,,0,0,1477,1477,,Invasive Carcinoma,9,,44,,,,28841,0,,1477,1477,,,,,1477,,,1477,,,,,,,,TUMOR FREE,Alive,-15393,,,,285,,1477,1477,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Other/Unknown,,,3,,0,0.044127,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,University of Sao Paulo,,TCGA-5L-AAT0,,,,,,,1477,,,,,,,,,3,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,90150,,0.775964275,0,0,0,0,0.239,1,,,Infiltrating Lobular Carcinoma,0.153990129,,0.189594151,0,0,0,,Positive,-0.0585,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.5811,1,0,IHC,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Other/Unknown,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1712,BRCA_Normal,1712,1712,,0,0,1712,1712,,Invasive Carcinoma,,,,,,,25061,0,,1712,1712,,,,1712,1712,,,1712,,,,,,,,TUMOR FREE,Alive,-15670,,,,21,,1712,1712,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3XW,,,,,,,1712,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,90161,,0.44334301,0,0,0,0,1.1294,1,,,Infiltrating Ductal Carcinoma,0.125787998,,0.187023685,0,0,0,,Negative,0.018,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4148,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-R6-A8WC,White,ESCA,,0.0,0,,,,0,,0.0,2.57,0.92,4,8,9,,,70,,,70,,0.0,0,70,70,,Malignant,21,,93,,,,19014.0,0,,70,70,,,,,70,,,70,,,,,,,,WITH TUMOR,Alive,-20812,,,,240.0,,70,70,,,[Not Available],Stage IIA,,,,,0.02,Esophagus,Biopsy,,,17,,1,0.22848,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,MD Anderson Cancer Center,,TCGA-R6-A8WC,,,,,,,70,,,,,,,,,32,,,,,,,,,,,,,2013,,,,,[Not Available],,,,,,,,[Not Applicable],,,,,,56,,,,,,,,,,,,,,,,,,,,90163,,,,,,,,,,,,,Grade 2,,,,,Stage IIA,,,Not Answered,,,,,,,,,,,,,,,,,,,,,Biopsy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-XA-A8JR,,PRAD,370,0,0,,XA,0,0,MALE,0,1.97,0.34,2,3,0,HRD,NO,376,8-other,376,376,,0,0,376,376,prad_tcga,Malignant,5,,28,,TCGA-XA-A8JR-01,10,5622,0,TCGA-XA-A8JR,376,376,Prostate Cancer,,69,376,376,TCGA,,376,Primary,0,,A,RAD51C:153-160:GEAVFIDT/GGGVFIC*:stop_gained,,True,TUMOR FREE,Alive,-25090,,68,7,26,PRAD,376,376,,0.37205705,[Not Available],[Not Applicable],25,R2,1,Matched,0.01,Prostate,Resection,4,2DA1AFB8-CBCC-4EEB-9C16-F4EEDFFC8ADF,0,,0,0.031666,[Not Available],5E15DCC7-932E-4D9A-A765-BD5FF1CD7AEA,3,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,XA,0.8,TCGA-XA-A8JR,0:DiseaseFree,3,10,Prostate Adenocarcinoma,12.35,10/9/13,376,,,,,,C61,587379B6-9AF9-471D-834C-668555ABC32A,110,0,TUMOR FREE,0.0302,0:LIVING,0.0,5,12.35,Bilateral,12,,,YES,223,2013,,,TCGA-XA-A8JR.587379B6-9AF9-471D-834C-668555ABC32A.pdf,,[Not Applicable],,,46-55%,7,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R2,,68,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,,0,M0,C61.9,8140/3,90167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-8508,Black or African American,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.94,0.38,7,11,18,,,617,,617,617,,0,0,617,617,,Malignant,36,,80,,,,22687,,,617,617,,,,617,617,,,617,,,,,,,,TUMOR FREE,Alive,-22159,,,,244,,617,617,,,[Not Available],[Not Applicable],,,,,0.24,,,,,10,,1,0.27598,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8508,,,,,,,617,,,,,,,,,32,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,90168,,0.578517493,,,,,,,,,,0.166800924,,0.151530716,,,,Stage IIA,,0.6635,,,,,,,,,,,,,,,,0.3141,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,14.94550273,16.02634051,14.58274163,-0.34205964,LUAD,Adenocarcinoma,18.04725477,15.60812751,Adenocarcinoma,0.2204,13.67290112,-0.4482,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.83,0.71,10,8,17,,,430,BRCA_LumB,430,430,,0,0,430,430,,Invasive Carcinoma,35,,40,,,,32951,0,,430,430,,,,430,430,,,430,,,,,,,,TUMOR FREE,Alive,-22317,,,,73,,430,430,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,19,,1,0.40477,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1Y3,,,,,,,430,,,,,,,,,35,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,90178,,,0,0,0,0,-0.6925,1,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.27,0.47,5,2,11,,,3159,BRCA_LumA,3159,3159,,0,0,3159,3159,,None,18,,13,,,,28243,N/A (Non-Malignant),,3159,3159,,,,3159,3159,,,3159,,,,,,,,TUMOR FREE,Alive,-25825,,,,90,,3159,3159,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,13,,0,0.10898,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AK,,,,,,,3159,,,,,,,,,15,,,,,,,,,,,,,2006,,,,,Stage I,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,90183,,0.994679863,0,0,0,0,-0.4243,1,,N/A (Non-Malignant),Infiltrating Lobular Carcinoma,0.160992568,N/A (Non-Malignant),0.254717084,0,0,0,N/A (Non-Malignant),Negative,0.9965,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2999,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,1,Adipose Tissue,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,,,,,1,FEMALE,1,2.24,0.52,6,14,12,,,1365,BRCA_LumB,,1365,,1,,653,653,,Invasive Carcinoma,32,,37,,,,27100,0,,653,,,,,,1365,,,653,,,,,,,,WITH TUMOR,Dead,-30085,1365,,,81,,653,,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,11,,1,0.40303,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0SW,,,,,,,,,,,,,,,,39,,,,,,,,,,,,,2006,653,,,,Stage IV,,,,,,,,[Not Available],,,,,,82,,,,,,,,,,,,,,,,,,,,90185,,1.283288664,0,0,0,0,0.6477,1,,,Infiltrating Ductal Carcinoma,0.184462458,,0.152893549,0,0,0,,Negative,1.0,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2211,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.76,0.54,14,14,9,,,2330,BRCA_LumA,2330,2330,,0,0,2330,2330,,Invasive Carcinoma,37,,64,,,,30868,0,,2330,2330,,,,2330,2330,,,2330,,,,,,,,TUMOR FREE,Alive,-21622,,,,79,,2330,2330,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,10,,0,0.37755,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0BR,,,,,,,2330,,,,,,,,,11,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,90186,,0.640524718,0,0,0,0,0.9605,1,,,Infiltrating Ductal Carcinoma,0.226944272,,0.203544484,0,0,0,,Negative,0.184,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.8023,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-18-3412,White,LUSC,,1,1,,Princess Margaret Hospital (Canada),,1,MALE,1,2.75,0.78,9,17,16,,,345,,,345,,1,1,273,273,,Malignant,42,,42,,,,17113,,,273,273,,,,,345,,,273,,,,,,,,WITH TUMOR,Dead,-19025,345,,,188,,273,273,,,[Not Available],[Not Applicable],,,,,0.52,,,,,15,,1,0.18531,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-3412,,,,,,,,,Distant Metastasis,,,,,,,40,,,,,,,,,,,,,2005,273,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,52,,,,,,,,,,,,,,,,,,,,90187,,0.221606176,,,,,,,,,,0.187252489,,0.039052685,,,,Stage IB,,0.4245,,,,,,,,,,,,,,,,0.1763,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.515471626982554,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.0555,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SJ,,PRAD,389,1,1,,YL,1,0,MALE,1,1.89,0.63,6,8,5,ambiguous,NO,1395,2-ETV1,752,1395,,1,1,752,752,prad_tcga,Malignant,19,BARD1;BRCA2;FANCL;PALB2;RAD51B;RAD54L,59,,TCGA-YL-A8SJ-01,0,5672,0,TCGA-YL-A8SJ,752,752,Prostate Cancer,,1426,752,1395,TCGA,,752,Primary,0,Middle|Base,B,,,True,WITH TUMOR,Alive,-21916,,60,9,36,PRAD,752,752,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.23,Prostate,Resection,4,219FC0A7-7389-40F7-AB99-C2EE6AD501AF,0,,0,0.10711,[Not Available],F3EC5BF3-97AE-4033-91A6-084A1AA152A4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,YL,1.0,TCGA-YL-A8SJ,1:Recurred/Progressed,5,18,Prostate Adenocarcinoma,24.7,4/25/14,1395,,Biochemical evidence of disease,,,NO,C61,86F65B00-7E83-4013-85E8-A4AE42686ACF,460,4,WITH TUMOR,0.0629,0:LIVING,0.24,,45.83,Bilateral,30,,,YES,1306,2010,752,,TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,66-75%,29,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,752,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,90188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4490,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,5.15,0.26,6,8,14,,,385,,,385,,1,1,385,385,,Malignant,28,,29,,,,23533,,,385,385,,,,,385,,,385,,,,,,,,WITH TUMOR,Dead,-16634,385,,,65,,385,385,,,[Not Available],[Not Applicable],,,,,0.42,,,,,26,,2,0.245,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4490,,,,,,,,,,,,,,,,48,,,,,,,,,,,,,1993,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,90189,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,14.95813934,15.40312664,13.8353783,-0.483626278,LUAD,Adenocarcinoma,18.18408044,15.19834945,Adenocarcinoma,,12.95053452,-0.7634,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,,0,1,Male,TCGA-L5-A4OE,White,ESCA,,0,0,,,2,,,2,3.6,0.44,8,6,10,,,730,,730,730,,2,2,730,730,,Malignant,24,,51,,,,28084,,,730,730,,,,730,730,,,730,,,,,,,,,Dead,-29591,730,,,519,,730,730,,,[Not Available],[Not Available],,,,,0.08,Esophagus,Unknown,,,18,,1,0.13803,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,University of Michigan,,TCGA-L5-A4OE,,,,,,,,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,90193,,,,,,,,,,,,,Grade 2,,,,,Stage IIIB,,,Not Answered,,,,,,,,,,,,,,,,,,,,,Resection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-G9-7521,,PRAD,221,0,0,,G9,,0,MALE,0,3.9,0.42,5,9,9,ambiguous,NO,942,8-other,,942,,0,0,942,942,prad_tcga,Malignant,23,BRCA2;RAD51B,13,26.3,TCGA-G9-7521-01,10,5387,0,TCGA-G9-7521,942,942,Prostate Cancer,45,487,,942,TCGA,No Evidence of Extraprostatic Extension,942,Primary,0,Apex|Base,A,,,,[Discrepancy],Alive,-19216,,52,8,37,PRAD,942,942,,0.293770367,[Not Available],[Not Applicable],35,R0,1,Matched,0.16,Prostate,Resection,4,74a8d844-92db-4829-b687-a54a41c32f36,10,Normal (no evidence of prostate cancer) [cM0],1,0.090501,[Not Available],cf70909e-5143-47ae-b8ca-c3ae6ace7be2,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,24,,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.13333333333,TCGA-G9-7521,0:DiseaseFree,4,23,Prostate Adenocarcinoma,30.95,5/31/12,942,,,,,YES,C61,b0a188e3-c084-4e2d-93dd-31de3a3f47e6,,16,TUMOR FREE,0.189,0:LIVING,0.06,5,30.95,Bilateral,30,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-G9-7521.b0a188e3-c084-4e2d-93dd-31de3a3f47e6.pdf,,[Not Applicable],YES,13,41-50%,9,Prostate Adenocarcinoma Acinar Type,1,2010,[Discrepancy],,NO,No,R0,0.8,52,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,8,No,YES,0,N1,T3a,1,M0,C61.9,8550/3,90199,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.84,0.66,7,7,7,,,529,BRCA_LumA,529,529,,0,0,529,529,,Invasive Carcinoma,21,,86,,,,27308,0,,529,529,,,,529,529,,,529,,,,,,,,TUMOR FREE,Alive,-17352,,,,40,,529,529,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,1,,0,0.17277,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-AA14,,,,,,,529,,,,,,,,,6,,,,,,,,,,,,,2013,,,,,Stage I,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,90207,,-0.575917141,0,0,0,0,0.4053,1,,,Infiltrating Ductal Carcinoma,0.131569728,,0.176529549,0,0,0,,Negative,-0.4325,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.582,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,,,White,BRCA,,0,0,,,,0,FEMALE,1,4.94,0.41,4,1,3,,,1141,BRCA_LumA,,1141,,0,0,195,195,,Invasive Carcinoma,8,,22,,,,29017,1,,1141,1141,,,,,1141,,,195,,,,,,,,TUMOR FREE,Alive,-24577,,,,0,,1141,1141,,,[Not Available],[Not Applicable],,,,,0.25,Skin,Resection/Excision,,,30,,2,0.63654,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A10B,,,,,,,1141,Lung,New Primary Tumor,,,,,,,28,,,,,,,,,,,,,2007,195,,,,Stage IIB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,90208,,0.592988363,0,0,0,0,-0.0766,1,,,Infiltrating Ductal Carcinoma,0.168997663,,0.130310852,0,0,0,,Close,-0.114,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.3076,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Skin,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Skin,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-33-4547,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.91,0.49,12,11,19,,,2419,,2419,2419,,0,0,2419,2419,,Malignant,42,,169,,,,17065,,,2419,2419,,,,2419,2419,,,2419,,,,,,,,TUMOR FREE,Alive,-25056,,,,256,,2419,2419,,,[Not Available],[Not Applicable],,,,,0.02,,,,,12,,0,0.33781,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4547,,,,,,,2419,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,90216,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.7549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.460033798952849,LUSC,,,,Squamous Cell Carcinoma,0.8326,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-FD-A62N,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.81,0.25,14,6,13,,,82,,82,82,,0.0,0,82.0,82.0,,Malignant,33,,102,,,,22224.0,,,82.0,82,,,,82,82,,,82.0,,,,,,,,TUMOR FREE,Alive,-25297,,,,131.0,,82.0,82,,,[Not Available],[Not Applicable],,,,,0.07,,,,,11,,0,0.43252,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A62N,,,,,,,82,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,69.0,,,,,,,,,,,,,,,,,,,,90218,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-43-8115,White,LUSC,,0,0,,Christiana Healthcare,,0,FEMALE,0,2.0,0.42,10,14,11,,,407,,,407,,0,0,407,407,,Malignant,35,,34,,,,20956,,,407,407,,,,,407,,,407,,,,,,,,TUMOR FREE,Alive,-26406,,,,266,,407,407,,,[Not Available],[Not Applicable],,,,,0.21,,,,,10,,0,0.37211,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-8115,,,,,,,407,,,,,,,,,18,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,72,,,,,,,,,,,,,,,,,,,,90219,,1.39538353,,,,,,,,,,0.261696671,,0.136383507,,,,Stage IIA,,1.417,,,,,,,,,,,,,,,,0.8503,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.6345043,18.36005499,16.35785898,0.0052807320362766,LUSC,,18.03177556,16.85794263,Squamous Cell Carcinoma,1.1903,13.97699712,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.56,0.74,12,12,18,,,10,BRCA_LumB,10,10,,0,0,10,10,,Invasive Carcinoma,42,,50,,,,24369,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-20347,,,,79,,10,10,,,[Not Available],[Not Applicable],,,,,0.24,Breast,Resection/Excision,,,15,,1,0.25184,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FY,,,,,,,10,,,,,,,,,31,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,90220,,0.10928294,0,0,0,0,-0.1799,1,,,Infiltrating Ductal Carcinoma,0.128018484,,0.096522797,0,0,0,,Negative,-0.9145,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3093,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.38,5,5,4,,,467,BRCA_LumA,467,467,,0,0,467,467,,Invasive Carcinoma,14,,31,,,,21158,0,,467,467,,,,467,467,,,467,,,,,,,,TUMOR FREE,Alive,-17022,,,,63,,467,467,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,3,,0,0.097081,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Spectrum Health,,TCGA-XX-A899,,,,,,,467,,,,,,,,,5,,,,,,,,,,,,,2013,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,90222,,1.035066701,0,0,0,0,-0.2024,1,,,Infiltrating Lobular Carcinoma,0.175926312,,0.235497475,0,0,0,,Negative,0.844,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6237,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,1,1,1.0,1.0,Male,TCGA-DK-A3IQ,White,BLCA,,1.0,1,,,1,1,MALE,1.0,1.84,0.35,11,10,5,,,539,,250,539,,1.0,1,250.0,250.0,,Malignant,26,,132,,,,19977.0,,,250.0,250,,,,250,539,,,250.0,,,,,,,,WITH TUMOR,Dead,-27194,539,,,248.0,,250.0,250,,,[Not Available],[Not Applicable],,,,,0.29,,,,,7,,0,0.2649,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A3IQ,,,,,,,,Lymph Node Only,Locoregional (Urothelial tumor event),,,,,,,12,,,,,,,,,,,,,2011,250,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,74.0,,,,,,,,,,,,,,,,,,,,90227,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-CD-8527,Asian,STAD,,1,1,,,1,1,,1,,,,,,,,218,,159,218,,1,1,159,159,,Malignant,,,,,,,24260,,,159,159,,,,159,218,,,159,,,,,,,,WITH TUMOR,Dead,-26503,218,,,353,,159,159,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,ILSBio,,TCGA-CD-8527,,,,,,,,Liver,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,159,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,90236,,,,,,,,,,,,,Grade 2,,,,,Stage II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8527,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-63-7022,,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,FEMALE,0,2.06,0.22,2,2,3,,,2073,,2073,2073,,0,0,2073,2073,,Malignant,7,,8,,,,26088,,,2073,2073,,,,2073,2073,,,2073,,,,,,,,TUMOR FREE,Alive,,,,,246,,2073,2073,,,[Not Available],[Not Applicable],,,,,0.52,,,,,4,,0,0.23342,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-7022,,,,,,,2073,,,,,,,,,10,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,90240,,1.515512377,,,,,,,,,,0.291298876,,0.213078048,,,,Stage IA,,1.1075,,,,,,,,,,,,,,,,1.004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0263816664799058,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.1471,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.48,0.43,10,10,13,,,380,BRCA_Her2,380,380,,0,0,380,380,,Invasive Carcinoma,33,,47,,,,22655,0,,380,380,,,,380,380,,,380,,,,,,,,TUMOR FREE,Alive,-20053,,,,60,,380,380,,,[Not Available],[Not Applicable],,,,,0.28,Breast,Resection/Excision,,,17,,1,0.26467,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A138,,,,,,,380,,,,,,,,,28,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,90243,,1.272575126,0,0,0,0,1.0605,1,,,Infiltrating Ductal Carcinoma,0.168978255,,0.224150459,0,0,0,,Negative,0.7335,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4413,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Cribriform, High Grade), DCIS (Micropapillary, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade), DCIS (Micropapillary, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.85,0.8,26,27,36,,,3506,BRCA_Basal,3506,3506,,0,0,3506,3506,,Invasive Carcinoma,89,,187,,,,27767,0,,3506,3506,,,,3506,3506,,,3506,,,,,,,,TUMOR FREE,Alive,-14174,,,,213,,3506,3506,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,14,,1,0.6329,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,MSKCC,,TCGA-AO-A124,,,,,,,3506,,,,,,,,,36,,,,,,,,,,,,,2002,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,90249,TRUE,,0,0,0,0,0.7364,1,,,Other,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Clinging, High Grade), DCIS (Cribriform, High Grade), Comedonecrosis",,"DCIS (Clinging, High Grade), DCIS (Cribriform, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-44-7662,White,LUAD,,0,0,,Christiana Healthcare,0,0,MALE,0,2.83,0.33,13,10,16,,,218,,218,218,,0,0,218,218,,Malignant,39,,58,,,,21319,,,218,218,,,,218,218,,,218,,,,,,,,TUMOR FREE,Alive,-22543,,,,731,,218,218,,,[Not Available],[Not Applicable],,,,,0.45,,,,,21,,1,0.47582,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-7662,,,,,,,218,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,90254,,0.757990446,,,,,,,,,,0.259515725,,0.187154958,,,,Stage IB,,1.402,,,,,,,,,,,,,,,,0.8302,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.188013342,LUAD,,,,Adenocarcinoma,1.6542,,-0.0118,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,2.82,0.22,4,10,6,,,1688,BRCA_Normal,,1688,,1,1,1688,1688,,Invasive Carcinoma,20,,10,,,,17429,0,,1688,1688,,,,,1688,,,1688,,,,,,,,WITH TUMOR,Dead,-16174,1688,,,134,,1688,1688,,,[Not Available],[Not Applicable],,,,,0.51,Breast,Resection/Excision,,,22,,1,0.20868,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FU,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,1997,,,,,Stage IA,,,,,,,,[Not Available],,,,,,44,,,,,,,,,,,,,,,,,,,,90255,,0.983306235,0,0,0,0,0.346,1,,,Infiltrating Ductal Carcinoma,0.175105045,,0.252377134,0,0,0,,[Not Available],0.23,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6821,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Clinging, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Clinging, High Grade), DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-VQ-AA6A,White,STAD,,0,0,,,0,0,,0,2.07,0.8,12,15,18,,,1184,,1184,1184,,0,0,1184,1184,,Malignant,45,,198,,,,24674,,,1184,1184,,,,1184,1184,,,1184,,,,,,,,TUMOR FREE,Alive,-20764,,,,126,,1184,1184,,,[Not Available],[Not Applicable],,,,,0.42,Stomach,Unknown,,,13,,0,0.40765,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-AA6A,,,,,,,1184,,,,,,,,,20,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,56,,,,,,,,,,,,,,,,,,,,90261,,-0.088572433,,,,,,,,,,0.018098307,Grade 2,0.005441484,,,,Stage IIIC,,-0.7125,,,,,,,,,,,,,,,,-0.003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA6A,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-VQ-A8P2,White,STAD,,0,0,,,0,0,,0,2.05,0.84,0,0,0,,,1160,,1160,1160,,0,0,1160,1160,,Malignant,0,,9,,,,21807,,,1160,1160,,,,1160,1160,,,1160,,,,,,,,TUMOR FREE,Alive,-25129,,,,10094,,1160,1160,,,[Not Available],[Not Applicable],,,,,0.0,Stomach,Unknown,,,2,,0,0.0017914,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",,,,,Intestinal Gastric Carcinoma (Mucinous),G2,,Barretos Cancer Hospital,,TCGA-VQ-A8P2,,,,,,,1160,,,,,,,,,1,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,90263,,-0.42671611,,,,,,,,,,-0.006271415,Grade 2,0.011950522,,,,Stage IIIA,,-0.329,,,,,,,,,,,,,,,,-0.3474,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8P2,Gastric Carcinoma,TCGA,"Adenocarcinoma, Mucinous Type"
0,1,0,0,0,1,Male,TCGA-L5-A4OX,White,ESCA,,0,0,,,2,2,,2,1.9,0.71,9,4,4,,,226,,226,226,,2,2,226,226,,Malignant,17,,86,,,,21851,,,226,226,,,,226,226,,,226,,,,,,,,TUMOR FREE,Dead,-22015,226,,,244,,226,226,,,[Not Available],[Not Available],,,,,0.33,Esophagus,Unknown,,,7,,0,0.19124,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",GX,,University of Michigan,,TCGA-L5-A4OX,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,90267,,,,,,,,,,,,,Unknown,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,3342,,3342,3342,,0,0,3342,3342,,None,,,,,,,19503,N/A (Non-Malignant),,3342,3342,,,,3342,3342,,,3342,,,,,,,,TUMOR FREE,Alive,-21534,,,,0,,3342,3342,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ABS - IUPUI,,TCGA-GI-A2C9,,,,,,,3342,,,,,,,,,,,,,,,,,,,,,,2003,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,90271,TRUE,0.066053452,0,0,0,0,0.3805,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.214508086,N/A (Non-Malignant),0.041669485,0,0,0,N/A (Non-Malignant),Negative,-0.265,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3464,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-XF-A9T0,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.88,0.76,6,14,14,,,799,,799,799,,0.0,0,799.0,799.0,,Malignant,34,,157,,,,33257.0,,,799.0,799,,,,799,799,,,799.0,,,,,,,,TUMOR FREE,Alive,-25190,,,,1142.0,,799.0,799,,,[Not Available],[Not Applicable],,,,,0.36,,,,,10,,1,0.19609,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9T0,,,,,,,799,,,,,,,,,16,,,,,,,,,,,,,2007,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,68.0,,,,,,,,,,,,,,,,,,,,90274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-55-6981,White,LUAD,,0,0,,International Genomics Consortium,2,2,FEMALE,2,3.4,0.26,4,7,10,,,1379,,1379,1379,,2,2,1379,1379,,Malignant,21,,17,,,,16435,,,1379,1379,,,,1379,1379,,,1379,,,,,,,,TUMOR FREE,Dead,-19497,1379,,,67,,1379,1379,,,[Not Available],[Not Applicable],,,,,0.41,,,,,21,,1,0.19059,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6981,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,53,,,,,,,,,,,,,,,,,,,,90275,,0.053805581,,,,,,,,,,0.214551736,,0.17302222,,,,Stage IIIA,,0.7935,,,,,,,,,,,,,,,,0.5336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L747_T751del (driver), AMP (driver)",,,1,L747_T751del (driver),,,15.05036304,16.271184,13.94675971,-0.547465506,LUAD,,17.90403068,14.83000606,Adenocarcinoma,0.2374,11.28304651,-1.7782,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Female,TCGA-DK-A2I2,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,3.29,0.3,8,12,12,,,237,,,237,,1.0,1,163.0,163.0,,Malignant,32,,53,,,,21436.0,,,163.0,163,,,,,237,,,163.0,,,,,,,,WITH TUMOR,Dead,-23116,237,,,137.0,,163.0,163,,,[Not Available],[Not Applicable],,,,,0.3,,,,,16,,1,0.32186,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A2I2,,,,,,,,Liver,Distant Metastasis,,,,,,,32,,,,,,,,,,,,,2010,163,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,63.0,,,,,,,,,,,,,,,,,,,,90277,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-J4-A83N,,PRAD,357,0,0,,J4,0,0,MALE,1,1.97,0.53,3,4,3,HRP,NO,992,1-ERG,992,992,,0,0,433,433,prad_tcga,Malignant,10,,32,,TCGA-J4-A83N-01,0,5489,0,TCGA-J4-A83N,992,992,Prostate Cancer,,530,992,992,TCGA,,433,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20841,,57,7,26,PRAD,992,992,,0.0,[Not Available],[Not Applicable],22,R0,1,Matched,0.04,Prostate,Resection,3,F3B220B7-F3DA-4EF3-96C3-C4D4091635CD,1,,0,0.072095,[Not Available],C024C4B6-0143-4071-9175-7435F1EAAC58,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,J4,0.733333333333,TCGA-J4-A83N,1:Recurred/Progressed,2,8,Prostate Adenocarcinoma,14.22,1/20/14,992,,New Primary Tumor,,,,C61,C40A9D7F-BFEC-4C07-A1C3-A34706E39713,240,4,TUMOR FREE,0.0351,0:LIVING,0.1,,32.59,Bilateral,15,,,YES,519,2012,433,,TCGA-J4-A83N.C40A9D7F-BFEC-4C07-A1C3-A34706E39713.pdf,Overlapping / Multiple Zones,[Not Applicable],,,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R0,,57,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,YES,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8140/3,90282,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.22,0.52,5,5,10,,,163,BRCA_LumA,163,163,,0,0,163,163,,Invasive Carcinoma,20,,13,,,,17888,0,,163,163,,,,163,163,,,163,,,,,,,,TUMOR FREE,Alive,-22341,,,,0,,163,163,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,12,,0,0.16214,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0XL,,,,,,,163,,,,,,,,,16,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,90286,,-0.674128735,0,0,0,0,0.0187,1,,,Infiltrating Ductal Carcinoma,0.140137289,,0.299964867,0,0,0,,Negative,-0.514,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4301,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,"LCIS, N/A No in Situ",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.74,0.55,9,11,15,,,10,BRCA_Her2,10,10,,0,0,10,10,,Invasive Carcinoma,35,,65,,,,17059,0,,10,10,,,,10,10,,,10,,,,,,,,TUMOR FREE,Alive,-21479,,,,133,,10,10,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,17,,1,0.26675,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FV,,,,,,,10,,,,,,,,,35,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,90289,,-0.722362294,0,0,0,0,0.0468,1,,,Infiltrating Ductal Carcinoma,0.136406804,,0.117569944,0,0,0,,Negative,-1.367,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4722,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-CD-A4MG,Asian,STAD,,1,1,,,1,1,,1,2.22,0.62,2,5,5,,,200,,74,200,,1,1,74,74,,Malignant,12,,28,,,,16760,,,74,74,,,,74,200,,,74,,,,,,,,WITH TUMOR,Dead,-28019,200,,,3651,,74,74,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Unknown,,,7,,0,0.024967,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-A4MG,,,,,,,,,Locoregional Recurrence,,,,,,,5,,,,,,,,,,,,,2011,74,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,90293,,-0.035770286,,,,,,,,,,0.122760331,Grade 3,0.11480903,,,,Stage IIA,,0.2385,,,,,,,,,,,,,,,,0.2094,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A4MG,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,1,1,1,1,Male,TCGA-BR-7723,White,STAD,,1,1,,,1,1,,1,4.17,0.55,7,21,16,,,874,,559,874,,1,1,559,559,,Malignant,44,,87,,,,21417,,,559,559,,,,559,874,,,559,,,,,,,,WITH TUMOR,Dead,-21839,874,,,212,,559,559,,,[Not Available],[Not Applicable],,,,,0.15,Stomach,Unknown,,,18,,2,0.14755,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-7723,,,,,,,,Liver,Distant Metastasis,,,,,,,77,,,,,,,,,,,,,2011,559,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,90295,,0.847493195,,,,,,,,,,0.09377467,Grade 3,0.070171563,,,,Stage IIIB,,0.695,,,,,,,,,,,,,,,,0.2139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7723,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-BR-A4PF,White,STAD,,0,0,,,0,0,,0,2.7,0.5,6,10,9,,,35,,35,35,,0,0,35,35,,Malignant,25,,126,,,,21174,,,35,35,,,,35,35,,,35,,,,,,,,TUMOR FREE,Alive,-26412,,,,134,,35,35,,,[Not Available],[Not Applicable],,,,,0.09,Stomach,Unknown,,,19,,1,0.33919,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4PF,,,,,,,35,,,,,,,,,32,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,90296,,1.020055692,,,,,,,,,,0.114787047,Grade 3,0.009470167,,,,Stage IIIB,,1.5215,,,,,,,,,,,,,,,,-0.147,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4PF,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,709,,709,709,,0,0,709,709,,Invasive Carcinoma,,,,,,,17329,0,,709,709,,,,709,709,,,709,,,,,,,,TUMOR FREE,Alive,-13039,,,,684,,709,709,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TU,,,,,,,709,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,35,,,,,,,,,,,,,,,,,,,,90299,TRUE,0.987103328,0,0,0,0,-0.3139,1,,,Infiltrating Ductal Carcinoma,0.14775192,,0.030562677,0,0,0,,Negative,0.3255,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.4503,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-BT-A0YX,White,BLCA,,1.0,1,,,,1,FEMALE,1.0,2.09,0.49,4,7,5,,,400,,,400,,1.0,1,326.0,326.0,,Malignant,16,,12,,,,18295.0,,,326.0,326,,,,,400,,,326.0,,,,,,,,WITH TUMOR,Dead,-25570,400,,,934.0,,326.0,326,,,[Not Available],[Not Applicable],,,,,0.04,,,,,1,,0,0.076663,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A0YX,,,,,,,,"Other, specify",Metastatic,,,,,,,7,,,,,,,,,,,,,2009,326,lower abdominal wall and right pelvis,,,Stage III,,,,,,,,Progressive Disease,,,,,,70.0,,,,,,,,,,,,,,,,,,,,90301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.95,0.8,8,10,12,,,2289,BRCA_LumA,2289,2289,,0,0,2289,2289,,None,30,,33,,,,17437,N/A (Non-Malignant),,2289,2289,,,,2289,2289,,,2289,,,,,,,,TUMOR FREE,Alive,-25959,,,,152,,2289,2289,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,23,,2,0.28215,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0CT,,,,,,,2289,,,,,,,,,56,,,,,,,,,,,,,2005,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,90321,,-0.879836117,0,0,0,0,0.3999,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.134328917,N/A (Non-Malignant),0.149956901,0,0,0,N/A (Non-Malignant),Negative,-0.439,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0572,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,1,Adipose Tissue,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-IG-A4QS,White,ESCA,,0,0,,,2,2,,2,5.62,0.61,7,13,24,,,118,,118,118,,2,2,118,118,,Malignant,44,,106,,,,18411,,,118,118,,,,118,118,,,118,,,,,,,,TUMOR FREE,Dead,-26273,118,,,359,,118,118,,,[Not Available],[Not Available],,,,,0.08,Esophagus,Unknown,,,17,,2,0.21778,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Asterand,,TCGA-IG-A4QS,,,,,,,,,,,,,,,,45,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,90325,,,,,,,,,,,,,Grade 3,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0.0,1,0,1.0,1.0,Male,TCGA-D7-8578,White,STAD,,1.0,1,,,1,0,,1.0,1.94,0.35,5,2,4,,,643,,451,643,,1.0,1,451,451,,Malignant,11,,45,,,,16372.0,0,,451,451,,,,451,643,,,451,,,,,,,,WITH TUMOR,Alive,-26620,,,,70.0,,451,451,,,[Not Available],[Not Applicable],,,,,0.35,Stomach,Resection,,,11,,0,0.26454,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-8578,,,,,,,643,Lung,Locoregional Recurrence|Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2012,451,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,90332,,,,,,,,,,,,,Grade 2,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8578,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-BR-7704,White,STAD,,0,0,,,0,0,,0,,,,,,,,1072,,1072,1072,,0,0,1072,1072,,Malignant,,,,,,,16865,,,1072,1072,,,,1072,1072,,,1072,,,,,,,,TUMOR FREE,Alive,-25300,,,,457,,1072,1072,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-7704,,,,,,,1072,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,90333,,,,,,,,,,,,,Grade 3,,,,,Stage II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7704,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.18,0.81,1,2,4,,,1066,BRCA_LumA,1066,1066,,0,0,1066,1066,,Invasive Carcinoma,7,,7,,,,18623,0,,1066,1066,,,,1066,1066,,,1066,,,,,,,,TUMOR FREE,Alive,-21464,,,,70,,1066,1066,,,[Not Available],[Not Applicable],,,,,0.3,Breast,Resection/Excision,,,20,,1,0.13768,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0ET,,,,,,,1066,,,,,,,,,23,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,90335,,0.002379018,0,0,0,0,-1.5082,1,,,Infiltrating Ductal Carcinoma,0.091345438,,0.09986468,0,0,0,,Negative,-0.651,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.6416,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-7078,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.96,0.73,7,7,9,ambiguous,NO,1985,8-other,1985,1985,,0,0,1985,1985,prad_tcga,Malignant,23,RAD54L,34,25.0,TCGA-HC-7078-01,0,5403,0,TCGA-HC-7078,1985,1985,Prostate Cancer,,1409,1985,1985,TCGA,,1985,Primary,0,,A,,,,TUMOR FREE,Alive,-25402,,69,7,42,PRAD,1985,1985,WHITE,0.0,[Not Available],[Not Applicable],47,R0,1,Matched,0.05,Prostate,Resection,3,842cacf7-8288-42c6-b2ae-1099dddeb60f,6,Normal (no evidence of prostate cancer) [cM0],0,0.16213,[Not Available],9f802576-1e98-496c-bda4-4b1dd2e411c8,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,21,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.53333333333,TCGA-HC-7078,0:DiseaseFree,2,20,Prostate Adenocarcinoma,65.21,4/10/12,1985,,,,,NO,C61,fb3865df-5e90-4a2f-b684-063d41369bfc,,9,TUMOR FREE,0.2282,0:LIVING,0.01,,65.21,Bilateral,22,No Evidence of Extraprostatic Extension,,YES,,2007,,,TCGA-HC-7078.fb3865df-5e90-4a2f-b684-063d41369bfc.pdf,,[Not Applicable],NO,,81-90%,3,Prostate Adenocarcinoma Acinar Type,1,2007,Complete Remission/Response,,,No,R0,0.5,69,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,90336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-98-A53B,White,LUSC,,0,0,,Washington University - Alabama,2,2,MALE,2,3.31,0.36,12,14,21,,,61,,61,61,,2,2,61,61,,Malignant,47,,174,,,,28414,,,61,61,,,,61,61,,,61,,,,,,,,TUMOR FREE,Dead,-25390,61,,,213,,61,61,,,[Not Available],[Not Applicable],,,,,0.05,,,,,25,,1,0.46246,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A53B,,,,,,,,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,90340,,0.810615307,,,,,,,,,,0.206521386,,0.068983282,,,,Stage IB,,0.989,,,,,,,,,,,,,,,,0.6732,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.188399837417042,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1398,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-J4-A83J,,PRAD,,0,0,,J4,0,0,MALE,0,,,,,,ambiguous,NO,696,,696,696,,0,0,696,696,prad_tcga,Malignant,,BRCA2,,,TCGA-J4-A83J-01,0,5485,0,TCGA-J4-A83J,696,696,Prostate Cancer,,235,696,696,TCGA,,696,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-24960,,68,7,65,PRAD,696,696,,0.0,[Not Available],[Not Applicable],47,,1,Matched,,Prostate,Resection,3,2426F010-6122-410C-95FD-9EE4A185F4ED,,,,,[Not Available],98240F19-BCA7-4001-8AA2-4D790C7C4C53,4,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,J4,1.56666666667,TCGA-J4-A83J,0:DiseaseFree,2,24,Prostate Adenocarcinoma,22.86,1/20/14,696,,,,,,C61,D3FF2CCF-E6D0-4C8A-9159-F78176E7EE59,210,,,0.1083,0:LIVING,0.04,,22.86,Bilateral,26,,,YES,272,2013,,,TCGA-J4-A83J.D3FF2CCF-E6D0-4C8A-9159-F78176E7EE59.pdf,Peripheral Zone,[Not Applicable],,,,1,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R1,,68,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,90342,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.94,0.81,5,3,6,,,1535,BRCA_LumA,1535,1535,,0,0,1535,1535,,Invasive Carcinoma,14,,13,,,,24568,0,,1535,1535,,,,1535,1535,,,1535,,,,,,,,TUMOR FREE,Alive,-24660,,,,51,,1535,1535,,,[Not Available],[Not Applicable],,,,,0.92,Breast,Resection/Excision,,,3,,0,0.09363,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0YF,,,,,,,1535,,,,,,,,,5,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,90347,,-0.587474777,0,0,0,0,0.5084,1,,,Infiltrating Ductal Carcinoma,0.168899172,,0.199380979,0,0,0,,Negative,-1.0955,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0755,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,Benign Breast Epithelium,Comedonecrosis,"DCIS (Clinging, High Grade), DCIS (Cribriform, High Grade), Comedonecrosis",,"DCIS (Clinging, High Grade), DCIS (Cribriform, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-E7-A85H,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,3.12,0.74,14,35,25,,,394,,394,394,,0.0,0,394.0,394.0,,Malignant,74,,254,,,,21881.0,,,394.0,394,,,,394,394,,,394.0,,,,,,,,TUMOR FREE,Alive,-23497,,,,602.0,,394.0,394,,,[Not Available],[Not Applicable],,,,,0.22,,,,,9,,1,0.23735,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A85H,,,,,,,394,,,,,,,,,33,,,,,,,,,,,,,2013,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,64.0,,,,,,,,,,,,,,,,,,,,90349,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-53-7624,White,LUAD,,1,1,,University of Miami,,1,FEMALE,1,3.02,0.69,17,25,24,,,1043,,,1043,,1,1,400,400,,Malignant,66,,92,,,,23348,,,400,400,,,,,1043,,,400,,,,,,,,WITH TUMOR,Dead,-14794,1043,,,1093,,400,400,,,[Not Available],[Not Applicable],,,,,0.24,,,,,16,,1,0.39656,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Miami,,TCGA-53-7624,,,,,,,,,Distant Metastasis,,,,,,,29,,,,,,,,,,,,,2008,400,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,40,,,,,,,,,,,,,,,,,,,,90350,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,K97N,1,,,K97N,15.00361538,15.0906185,17.01144854,-0.191000453,LUAD,Adenocarcinoma,17.44511656,15.55477003,Adenocarcinoma,-0.8555,12.07700713,-0.3623,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-98-8022,White,LUSC,,0,0,,Washington University - Alabama,2,2,MALE,2,3.09,0.42,9,10,11,,,933,,933,933,,2,2,933,933,,Malignant,30,,39,,,,26039,,,933,933,,,,933,933,,,933,,,,,,,,TUMOR FREE,Dead,-22487,933,,,305,,933,933,,,[Not Available],[Not Applicable],,,,,0.38,,,,,17,,1,0.32699,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-8022,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,90357,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,0.4841,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.125231119208439,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.0223,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.53,0.42,8,19,24,,,611,BRCA_Basal,611,611,,0,0,611,611,,Invasive Carcinoma,51,,76,,,,21778,1,,611,611,,,,611,611,,,611,,,,,,,,TUMOR FREE,Alive,-26484,,,,158,,611,611,,,[Not Available],[Not Applicable],,,,,0.46,Not Specific/Unknown,Resection/Excision,,,20,,1,0.66735,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JL,,,,,,,611,,,,,,,,,34,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,90358,TRUE,1.536880015,0,0,0,0,-0.6551,1,,,Infiltrating Ductal Carcinoma,0.214861323,,0.139331539,0,0,0,,Negative,1.4745,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.558,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-BR-8687,White,STAD,,1,1,,,,1,,1,2.76,0.62,7,10,17,,,250,,,250,,1,1,250,250,,Malignant,34,,76,,,,16886,,,250,250,,,,,250,,,250,,,,,,,,WITH TUMOR,Dead,-24472,250,,,242,,250,250,,,[Not Available],[Not Applicable],,,,,0.36,Stomach,Unknown,,,14,,1,0.21473,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8687,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,Stable Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,90365,,-0.567409751,,,,,,,,,,0.061869759,Grade 3,0.057335241,,,,Stage IIIC,,-1.076,,,,,,,,,,,,,,,,0.2621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8687,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,,0,1,Male,TCGA-77-6845,White,LUSC,,0,0,,Prince Charles Hospital,,,MALE,2,3.39,0.78,12,31,27,,,708,,,708,,2,2,708,708,,Malignant,70,,67,,,,16992,,,708,708,,,,,708,,,708,,,,,,,,,Dead,-25321,708,,,311,,708,708,,,[Not Available],[Not Applicable],,,,,0.18,,,,,16,,1,0.39965,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-6845,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2003,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,69,,,,,,,,,,,,,,,,,,,,90370,,0.25195875,,,,,,,,,,0.128556099,,0.055643303,,,,Stage IIB,,-0.272,,,,,,,,,,,,,,,,0.1984,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,T314K,1,,,T314K,13.42287751,14.83908503,10.52217041,-1.04354034855243,LUSC,Squamous Cell Carcinoma,17.7671014,13.93288011,Squamous Cell Carcinoma,-0.7587,13.35198354,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-50-5931,White,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,1.92,0.86,7,2,9,,,434,,,434,,1,1,425,425,,Malignant,18,,40,,,,17389,,,425,425,,,,,434,,,425,,,,,,,,WITH TUMOR,Dead,-27733,434,,,400,,425,425,,,[Not Available],[Not Applicable],,,,,0.43,,,,,9,,0,0.2367,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5931,,,,,,,,,Distant Metastasis,,,,,,,13,,,,,,,,,,,,,2001,425,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,75,,,,,,,,,,,,,,,,,,,,90378,,0.009070913,,,,,,,,,,0.091917602,,0.096546299,,,,Stage IB,,-1.107,,,,,,,,,,,,,,,,0.4122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.852492703,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.0627,,-1.4681,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,Male,TCGA-39-5039,White,LUSC,,0,0,,MSKCC,2,2,MALE,2,1.86,0.28,5,1,3,,,544,,544,544,,2,2,544,544,,Malignant,9,,11,,,,20448,,,544,544,,,,544,544,,,544,,,,,,,,TUMOR FREE,Dead,-27781,544,,,227,,544,544,,,[Not Available],[Not Applicable],,,,,0.35,,,,,9,,0,0.34688,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5039,,,,,,,544,,,,,,,,,18,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,90380,,-0.093015155,,,,,,,,,,0.226922394,,0.175464357,,,,Stage IIA,,-0.106,,,,,,,,,,,,,,,,0.6604,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.47308869,16.90683361,14.13650869,-0.329528134308316,LUSC,Squamous Cell Carcinoma,18.36350973,15.75734475,Squamous Cell Carcinoma,0.9853,13.70950065,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-G2-A2EJ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.09,0.61,9,4,7,,,1460,,910,1460,,1.0,1,910.0,910.0,,Malignant,20,,60,,,,25884.0,,,910.0,910,,,,910,1460,,,910.0,,,,,,,,TUMOR FREE,Alive,-20649,,,,428.0,,910.0,910,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.13654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EJ,,,,,,,1460,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2009,910,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,90382,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-8570,White,STAD,,0,0,,,0,0,,0,2.14,0.32,9,15,14,,,752,,752,752,,0,0,752,752,,Malignant,38,,65,,,,22100,,,752,752,,,,752,752,,,752,,,,,,,,WITH TUMOR,Alive,-16150,,,,160,,752,752,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,8,,0,0.15971,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8570,,,,,,,752,,,,,,,,,13,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,44,,,,,,,,,,,,,,,,,,,,90388,,1.260446207,,,,,,,,,,0.168640976,Grade 3,0.104552324,,,,Stage IIIB,,1.8475,,,,,,,,,,,,,,,,0.2582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8570,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.35,0.41,16,28,23,,,1269,BRCA_LumB,1269,1269,,0,0,1269,1269,,Invasive Carcinoma,67,,63,,,,18856,0,,1269,1269,,,,1269,1269,,,1269,,,,,,,,TUMOR FREE,Alive,-20574,,,,165,,1269,1269,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,13,,1,0.40279,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A22E,,,,,,,1269,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,90392,,1.058325854,0,0,0,0,0.5121,1,,,Infiltrating Ductal Carcinoma,0.193209539,,0.243178089,0,0,0,,Negative,0.1675,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,0.8824,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6347,,PRAD,,0,0,,G9,0,0,MALE,0,2.0,1.0,0,0,0,HRP,NO,2089,,2089,2089,,0,0,2089,2089,prad_tcga,Malignant,0,,8,,TCGA-G9-6347-01,0,5356,0,TCGA-G9-6347,2089,2089,Prostate Cancer,,1718,2089,2089,TCGA,,2089,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-21721,,59,6,29,PRAD,2089,2089,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.0,Prostate,Resection,3,d7709ea1-0f66-430a-8270-22bd5b613a18,0,,0,0.000532,[Not Available],b5268f49-2710-4d17-a78b-4a05412e8375,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.1,G9,0.966666666667,TCGA-G9-6347,0:DiseaseFree,1,0,Prostate Adenocarcinoma,68.63,10/29/13,2089,,,,,NO,C61,2ED4FCE8-5DCF-4529-95E5-C454529D7971,,0,TUMOR FREE,0.0001,0:LIVING,0.03,,68.63,Bilateral,0,,,YES,,2008,,,TCGA-G9-6347.2ED4FCE8-5DCF-4529-95E5-C454529D7971.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.4,59,Core needle biopsy,,Complete Remission/Response,NO,YES,NO,NO,T2c,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,90399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-7958,White,STAD,,0,0,,,0,0,,0,2.15,0.44,4,10,6,,,899,,899,899,,0,0,899,899,,Malignant,20,,40,,,,19356,,,899,899,,,,899,899,,,899,,,,,,,,TUMOR FREE,Alive,-22204,,,,225,,899,899,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,5,,0,0.066947,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-7958,,,,,,,899,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,90407,,1.563776636,,,,,,,,,,0.142935063,Grade 3,0.109777563,,,,Stage IIIB,,2.0315,,,,,,,,,,,,,,,,0.3496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7958,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-KK-A6E8,,PRAD,,0,0,,KK,,0,MALE,0,2.14,0.84,5,14,4,HRD,NO,1770,,,1770,,0,0,1770,1770,prad_tcga,Malignant,23,BRCA2;CHEK1,108,,TCGA-KK-A6E8-01,11,5507,0,TCGA-KK-A6E8,1770,1770,Prostate Cancer,104,1769,,1770,TCGA,No Evidence of Extraprostatic Extension,1770,Primary,1,Apex|Middle|Base,A,RAD54L:.:.:splice_region_variant,,True,TUMOR FREE,Alive,-25026,,68,9,49,PRAD,1770,1770,,0.23863741,[Not Available],[Not Applicable],49,,1,Matched,0.12,Prostate,Resection,4,EAA8850B-9A03-40C4-AB17-FE8B405B4FED,6,Normal (no evidence of prostate cancer) [cM0],0,0.094685,[Not Available],8990CE28-C671-4487-8DDA-864F0675BBB3,5,Prostate Adenocarcinoma Acinar Type,,Prostate,23,,Acinar Adenocarcinoma,[Not Available],,KK,1.6,TCGA-KK-A6E8,0:DiseaseFree,5,24,Prostate Adenocarcinoma,58.15,3/27/14,1770,,,,,YES,C61,3716A52E-E0B7-4FE0-AC2B-07F2F3A0D6AD,120,7,TUMOR FREE,0.2482,0:LIVING,0.1,,58.15,Bilateral,30,,,YES,2128,2007,,,TCGA-KK-A6E8.3716A52E-E0B7-4FE0-AC2B-07F2F3A0D6AD.pdf,Transition Zone,[Not Applicable],NO,97,,14,Prostate Adenocarcinoma Acinar Type,1,2007,[Not Available],,NO,No,RX,,68,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,9,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,90408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-55-6984,White,LUAD,,1,,,International Genomics Consortium,1,1,FEMALE,1,4.06,0.81,3,2,7,,,760,,724,760,,1,,724,724,,Malignant,12,,13,,,,23664,,,724,,,,,724,760,,,724,,,,,,,,WITH TUMOR,Dead,,760,,,33,,724,,,,[Not Available],[Not Applicable],,,,,0.03,,,,,6,,1,0.057085,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6984,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2006,724,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,90409,,0.516850609,,,,,,,,,,0.127616194,,0.129085127,,,,Stage IIB,,0.329,,,,,,,,,,,,,,,,0.3702,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12A (driver),,1,,G12A (driver),,13.91724853,15.28732246,13.03008893,-0.630060335,LUAD,,18.3660832,15.63923196,Adenocarcinoma,-1.23,13.11023789,-1.0218,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-33-AASI,Black or African American,LUSC,,1,1,,Johns Hopkins,,1,FEMALE,1,1.71,0.52,14,9,13,,,1344,,,1344,,1,1,1344,1344,,Malignant,36,,142,,,,20867,,,1344,1344,,,,,1344,,,1344,,,,,,,,WITH TUMOR,Dead,-23965,1344,,,528,,1344,1344,,,[Not Available],[Not Applicable],,,,,0.22,,,,,10,,0,0.40647,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-AASI,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,Stable Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,90413,,1.232745555,,,,,,,,,,0.09912731,,0.080492372,,,,Stage IIB,,0.9955,,,,,,,,,,,,,,,,0.1055,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.68851318,14.24425286,16.53133301,-0.164002084447704,LUSC,,17.94614627,15.84068943,Squamous Cell Carcinoma,-1.3737,12.39736649,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-EJ-7331,White,PRAD,184,0,0,,EJ,0,0,MALE,0,1.97,0.48,2,7,0,HRP,NO,742,8-other,742,742,,0,0,742,742,prad_tcga,Malignant,9,,19,7.0,TCGA-EJ-7331-01,0,5310,0,TCGA-EJ-7331,742,742,Prostate Cancer,,189,742,742,TCGA,,742,Primary,0,Apex|Middle,A,,,,TUMOR FREE,Alive,-23458,,64,7,31,PRAD,742,742,WHITE,0.0,[Not Available],[Not Applicable],39,R0,1,Matched,0.01,Prostate,Resection,3,5aa2e382-c8df-44e3-8802-994188b11d55,0,,0,0.033828,[Not Available],b424b73a-2dfa-473f-ab56-ab382cd1cdef,4,Prostate Adenocarcinoma Acinar Type,1.9,Prostate,9,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,EJ,2.16666666667,TCGA-EJ-7331,0:DiseaseFree,2,10,Prostate Adenocarcinoma,24.38,4/5/12,742,,,,,NO,C61,84790d75-bbef-49b0-9486-94e049c13ddd,,0,TUMOR FREE,0.0322,0:LIVING,0.8,3,24.38,Bilateral,11,,,YES,,2011,,,TCGA-EJ-7331.84790d75-bbef-49b0-9486-94e049c13ddd.pdf,,[Not Applicable],NO,,16-25%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,YES,No,R0,1.4,64,Core needle biopsy,189,,YES,NO,YES,,T2c,,7,No,,0,N0,T1c,0,M0,C61.9,8550/3,90414,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-86-A456,Asian,LUAD,,0,0,,Asterand,0,0,FEMALE,0,1.76,0.36,10,8,7,,,896,,896,896,,0,0,896,896,,Malignant,25,,52,,,,29789,,,896,896,,,,896,896,,,896,,,,,,,,TUMOR FREE,Alive,-28533,,,,463,,896,896,,,[Not Available],[Not Applicable],,,,,0.43,,,,,6,,0,0.24376,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-A456,,,,,,,896,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,90415,,0.877614422,,,,,,,,,,0.290926431,,0.150225393,,,,Stage IA,,1.133,,,,,,,,,,,,,,,,0.024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,-0.137570547,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2283,,0.0339,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-55-A491,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,2.57,0.45,11,12,16,,,626,,626,626,,0,0,626,626,,Malignant,39,,73,,,,16333,,,626,626,,,,626,626,,,626,,,,,,,,TUMOR FREE,Alive,-29593,,,,494,,626,626,,,[Not Available],[Not Applicable],,,,,0.63,,,,,21,,1,0.30025,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-A491,,,,,,,626,,,,,,,,,34,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,90433,,0.677421948,,,,,,,,,,0.253219713,,0.129899229,,,,Stage IA,,1.6635,,,,,,,,,,,,,,,,0.3172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.170193752,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.0382,,-0.1461,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-86-8056,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,3.87,0.37,7,5,4,,,139,,139,139,,0,0,139,139,,Malignant,16,,30,,,,23303,,,139,139,,,,139,139,,,139,,,,,,,,TUMOR FREE,Alive,-23369,,,,343,,139,139,,,[Not Available],[Not Applicable],,,,,0.02,,,,,2,,1,0.11311,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-8056,,,,,,,139,,,,,,,,,5,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,90447,,0.622263526,,,,,,,,,,0.246476393,,0.155132922,,,,Stage IIIA,,0.603,,,,,,,,,,,,,,,,-0.107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,16.43612934,17.45927095,14.53560724,-0.371264165,LUAD,Adenocarcinoma,17.79672897,15.88570363,Adenocarcinoma,-0.4751,13.01017766,-0.5491,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Male,TCGA-TP-A8TT,,PRAD,,0,0,,TP,,0,MALE,0,1.95,0.58,3,7,4,HRP,NO,526,,,526,,0,0,526,526,prad_tcga,Malignant,14,,90,,TCGA-TP-A8TT-01,0,5555,0,TCGA-TP-A8TT,526,526,Prostate Cancer,,237,,526,TCGA,,526,Primary,0,Apex|Middle|Base,A,,,True,,Alive,-23476,,64,7,41,PRAD,526,526,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.0,Prostate,Resection,4,722ABE82-A272-4E42-BE72-41FF140C9AD8,0,Normal (no evidence of prostate cancer) [cM0],0,0.065913,[Not Available],A13A7252-DE84-4950-9307-80FC8A6A668D,3,Prostate Adenocarcinoma Acinar Type,,Prostate,13,,Acinar Adenocarcinoma,[Not Available],,TP,1.1,TCGA-TP-A8TT,0:DiseaseFree,3,17,Prostate Adenocarcinoma,17.28,3/28/14,526,,,,,NO,C61,35E5E09D-8872-4BCC-99DC-876A3CCF9761,440,2,,0.0741,0:LIVING,0.024,,17.28,Left,15,No Evidence of Extraprostatic Extension,15,YES,265,2013,,,TCGA-TP-A8TT.35E5E09D-8872-4BCC-99DC-876A3CCF9761.pdf,Peripheral Zone,[Not Applicable],YES,23,,11,Prostate Adenocarcinoma Acinar Type,1,2013,Partial Remission/Response,,NO,No,R0,,64,Core needle biopsy,,Partial Remission/Response,YES,NO,YES,NO,T3a,YES,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,90450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,90452,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-6985,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,1.86,0.39,7,9,8,,,1233,,1233,1233,,0,0,1233,1233,,Malignant,24,,31,,,,22111,,,1233,1233,,,,1233,1233,,,1233,,,,,,,,TUMOR FREE,Alive,-21381,,,,607,,1233,1233,,,[Not Available],[Not Applicable],,,,,0.59,,,,,12,,0,0.30847,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-6985,,,,,,,1233,,,,,,,,,14,,,,,,,,,,,,,2004,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,90454,,1.289214382,,,,,,,,,,0.240065283,,0.146745652,,,,Stage IB,,1.5285,,,,,,,,,,,,,,,,0.6125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.006522346,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.3693,,0.5617,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.96,0.78,12,21,18,,,1006,BRCA_LumB,1006,1006,,0,0,1006,1006,,None,51,,34,,,,16061,N/A (Non-Malignant),,1006,1006,,,,1006,1006,,,1006,,,,,,,,TUMOR FREE,Alive,-27455,,,,216,,1006,1006,,,[Not Available],[Not Applicable],,,,,0.49,Breast,Resection/Excision,,,2,,0,0.19373,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09M,,,,,,,1006,,,,,,,,,13,,,,,,,,,,,,,2009,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,90456,,1.073247556,0,0,0,0,-0.1783,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.143123577,N/A (Non-Malignant),0.0890057,0,0,0,N/A (Non-Malignant),Negative,0.8955,,10/21/22,0,0,0,0,0,0,0,1,0,0,Not Answered,0,0,-0.1122,0,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,1,None of the Above,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-XJ-A9DQ,,PRAD,,0,0,,XJ,,0,MALE,0,2.0,0.65,0,0,0,HRP,NO,91,,,91,,0,0,91,91,prad_tcga,Malignant,0,,4,,TCGA-XJ-A9DQ-01,0,5628,0,TCGA-XJ-A9DQ,91,91,Prostate Cancer,,,,91,TCGA,,91,Primary,0,Apex|Base,A,,,False,,Alive,,,48,6,8,PRAD,91,91,,0.0,[Not Available],[Not Applicable],11,,1,Matched,0.01,Prostate,Resection,3,60D16CC3-08EF-41A1-8DE0-AEA3A7994F70,0,,0,0.000196,[Not Available],5D8C9B90-8D40-4CDD-900D-03681BC2D2A6,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,XJ,0.4,TCGA-XJ-A9DQ,0:DiseaseFree,1,0,Prostate Adenocarcinoma,2.99,5/21/14,91,,,,,NO,C61,CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7,20,0,,0.0007,0:LIVING,,,2.99,Right,3,,,YES,2265,2007,,,TCGA-XJ-A9DQ.CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2007,[Unknown],,NO,No,R0,,48,Core needle biopsy,,,NO,YES,NO,NO,T2a,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,90459,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,2.03,0.81,0,1,0,,,860,BRCA_LumA,716,860,,1,1,716,716,,Invasive Carcinoma,1,,0,,,,25164,0,,716,716,,,,716,860,,,716,,,,,,,,WITH TUMOR,Dead,-22688,860,,,32,,716,716,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,0,,0,0.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0X4,,,,,,,,Bone,Distant Metastasis,,,,,,,1,,,,,,,,,,,,,1996,716,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,90461,,-1.476571544,0,0,1,0,-0.4473,0,,,Infiltrating Ductal Carcinoma,0.017026385,,0.014769752,0,0,1,,Negative,-1.6075,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.326,1,0,H & E,0,0,,0,Fabio Tavora,"Apocrine Metaplasia, FEA, Papilloma",0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Apocrine Metaplasia, FEA, Papilloma",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.88,0,1,0,,,2190,BRCA_LumA,2190,2190,,0,0,2190,2190,,Invasive Carcinoma,1,,0,,,,23628,0,,2190,2190,,,,2190,2190,,,2190,,,,,,,,TUMOR FREE,Alive,-19160,,,,18,,2190,2190,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,0,,0,0.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0ES,,,,,,,2190,,,,,,,,,0,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,90465,,0.078658205,0,0,0,0,1.0294,1,,,Infiltrating Lobular Carcinoma,0.179282888,,0.243312682,0,0,0,,Negative,-0.225,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4534,1,0,H & E,0,0,,0,Fabio Tavora,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.71,0.42,3,2,12,,,584,BRCA_Basal,584,584,,0,0,584,584,,Invasive Carcinoma,17,,29,,,,32487,0,,584,584,,,,584,584,,,584,,,,,,,,TUMOR FREE,Alive,-31223,,,,59,,584,584,,,[Not Available],[Not Applicable],,,,,0.13,Breast,Resection/Excision,,,18,,1,0.36358,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A1G1,,,,,,,584,,,,,,,,,34,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,85,,,,,,,,,,,,,,,,,,,,90466,,1.093180646,0,0,0,0,0.8853,1,,,Infiltrating Ductal Carcinoma,0.216691302,,0.146318869,0,0,0,,Negative,0.547,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4342,1,0,H & E,0,0,,0,Fabio Tavora,None,0,0,0,Suboptimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,Comedonecrosis,"None, Comedonecrosis",,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.37,0.38,8,13,21,,,2193,BRCA_Her2,2193,2193,,0,0,2193,2193,,Invasive Carcinoma,42,,31,,,,28561,0,,2193,2193,,,,2193,2193,,,2193,,,,,,,,TUMOR FREE,Alive,-21344,,,,255,,2193,2193,,,[Not Available],[Not Applicable],,,,,0.45,Breast,Resection/Excision,,,15,,1,0.12948,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DH,,,,,,,2193,,,,,,,,,30,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,90468,TRUE,1.754152001,0,0,0,1,0.3168,0,,,Infiltrating Ductal Carcinoma,0.175284458,,0.087542236,0,0,0,,Negative,1.3855,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,0.1372,1,0,H & E,0,0,,0,Fabio Tavora,"Sclerosing Adenosis, UDH",0,0,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Sclerosing Adenosis, UDH",0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-MP-A4TH,White,LUAD,,0,0,,Washington University - Mayo Clinic,0,0,FEMALE,0,2.11,0.4,4,6,6,,,741,,741,741,,0,0,741,741,,Malignant,16,,39,,,,20940,,,741,741,,,,741,741,,,741,,,,,,,,TUMOR FREE,Alive,-25759,,,,154,,741,741,,,[Not Available],[Not Applicable],,,,,0.1,,,,,6,,0,0.076508,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TH,,,,,,,741,,,,,,,,,5,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,90470,,1.559202606,,,,,,,,,,0.204259834,,0.152836682,,,,Stage IA,,1.288,,,,,,,,,,,,,,,,0.0557,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.054177837,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.8875,,0.6176,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-FP-A4BF,White,STAD,,1,1,,,,1,,1,4.15,0.28,10,16,19,,,168,,,168,,1,1,159,159,,Malignant,45,,119,,,,30424,,,159,159,,,,,168,,,159,,,,,,,,WITH TUMOR,Dead,-25030,168,,,132,,159,159,,,[Not Available],[Not Applicable],,,,,0.34,Stomach,Unknown,,,18,,2,0.3977,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,International Genomics Consortium,,TCGA-FP-A4BF,,,,,,,,Lung,Distant Metastasis,,,,,,,56,,,,,,,,,,,,,2011,159,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,68,,,,,,,,,,,,,,,,,,,,90471,,1.19854356,,,,,,,,,,0.147188432,Grade 3,0.081227718,,,,Stage IIIA,,0.998,,,,,,,,,,,,,,,,0.3772,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-A4BF,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0,1,0,1,1,Female,TCGA-97-8175,White,LUAD,,1,1,,Washington University - NYU,1,0,FEMALE,1,2.07,0.43,5,2,4,,,551,,294,551,,1,1,294,294,,Malignant,11,,37,,,,21443,,,294,294,,,,294,551,,,294,,,,,,,,TUMOR FREE,Alive,-20206,,,,40,,294,294,,,[Not Available],[Not Applicable],,,,,0.29,,,,,8,,0,0.075194,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - NYU,,TCGA-97-8175,,,,,,,551,,Locoregional Recurrence,,,,,,,8,,,,,,,,,,,,,2011,294,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,90472,,0.449748919,,,,,,,,,,0.225124219,,0.086455574,,,,Stage IB,,1.1185,,,,,,,,,,,,,,,,0.1553,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.284720782,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.9613,,-1.2153,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.26,0.41,1,0,3,,,2403,BRCA_LumA,2403,2403,,0,0,2403,2403,,Invasive Carcinoma,4,,3,,,,16065,0,,2403,2403,,,,2403,2403,,,2403,,,,,,,,TUMOR FREE,Alive,-15078,,,,20,,2403,2403,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,11,,0,0.085218,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DT,,,,,,,2403,,,,,,,,,9,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,90477,,0.467546844,0,0,0,0,0.2734,1,,,Infiltrating Ductal Carcinoma,0.13086481,,0.207449524,0,0,0,,Negative,0.1965,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.5304,0,0,H & E,0,0,,0,Fabio Tavora,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,Benign Breast Epithelium,Comedonecrosis,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-98-8023,White,LUSC,,0,0,,Washington University - Alabama,0,0,MALE,0,2.74,0.29,11,15,16,,,649,,649,649,,0,0,649,649,,Malignant,42,,35,,,,25113,,,649,649,,,,649,649,,,649,,,,,,,,TUMOR FREE,Alive,-25732,,,,266,,649,649,,,[Not Available],[Not Applicable],,,,,0.32,,,,,15,,1,0.57089,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-8023,,,,,,,649,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,90481,,1.041605118,,,,,,,,,,0.2255018,,0.104399044,,,,Stage IIIA,,0.9665,,,,,,,,,,,,,,,,0.6577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.25580659,16.62162061,16.99090806,-0.0005331738080474,LUSC,Squamous Cell Carcinoma,18.28828791,16.82043477,Squamous Cell Carcinoma,0.8146,13.66644262,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-60-2711,White,LUSC,,0,0,,Roswell Park,0,0,FEMALE,0,3.17,0.65,6,16,19,,,1260,,1260,1260,,0,0,1260,1260,,Malignant,41,,27,,,,18286,,,1260,1260,,,,1260,1260,,,1260,,,,,,,,TUMOR FREE,Alive,-23651,,,,168,,1260,1260,,,[Not Available],[Not Applicable],,,,,0.19,,,,,17,,1,0.22538,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2711,,,,,,,1260,,,,,,,,,30,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,90482,,0.984765666,,,,,,,,,,0.136398549,,0.072016651,,,,Stage IB,,0.7835,,,,,,,,,,,,,,,,0.0738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.413016179188328,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.1247,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.51,0.09,1,0,2,,,2838,BRCA_LumA,2838,2838,,0,0,2838,2838,,Invasive Carcinoma,3,,6,,,,17035,0,,2838,2838,,,,2838,2838,,,2838,,,,,,,,TUMOR FREE,Alive,-18611,,,,16,,2838,2838,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,14,,1,0.054972,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A252,,,,,,,2838,,,,,,,,,22,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,90487,,2.07787195,0,0,0,0,-0.9468,1,,,Infiltrating Ductal Carcinoma,0.21040594,,0.233197144,0,0,0,,Negative,1.399,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1522,1,0,H & E,0,0,,0,MOHAMMADREZA SHERVINRAD,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,Adipose Tissue,Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-GV-A3JX,White,BLCA,,0.0,0,,,0,0,MALE,0.0,1.88,0.9,7,2,10,,,581,,581,581,,0.0,0,581.0,581.0,,Malignant,19,,41,,,,27045.0,,,581.0,581,,,,581,581,,,581.0,,,,,,,,TUMOR FREE,Alive,-21888,,,,370.0,,581.0,581,,,[Not Available],[Not Applicable],,,,,0.25,,,,,12,,0,0.36258,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3JX,,,,,,,581,,,,,,,,,18,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,90496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6343,White,PRAD,,0,0,,G9,0,0,MALE,0,1.96,0.19,1,1,0,ambiguous,NO,2450,,2450,2450,,0,0,2450,2450,prad_tcga,Malignant,2,,2,,TCGA-G9-6343-01,0,5355,0,TCGA-G9-6343,2450,2450,Prostate Cancer,,554,2450,2450,TCGA,,2450,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-22843,,62,7,35,PRAD,2450,2450,WHITE,0.0,[Not Available],[Not Applicable],26,,1,Matched,0.0,Prostate,Resection,4,084c6d1f-047e-4b0e-9034-3b0fc18d510d,1,,0,0.029447,[Not Available],36b87d12-9f96-460f-a3b5-a4c08cbf5b07,3,Prostate Adenocarcinoma Acinar Type,1.5,Prostate,2,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,0.833333333333,TCGA-G9-6343,0:DiseaseFree,3,15,Prostate Adenocarcinoma,80.49,3/16/12,2450,,,,,NO,C61,3d7d837b-a09e-4281-93af-a789123a9356,,3,TUMOR FREE,0.0142,0:LIVING,0.03,,80.49,Bilateral,19,,,YES,,2008,,,TCGA-G9-6343.3d7d837b-a09e-4281-93af-a789123a9356.pdf,,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,0.6,62,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T2a,,M0,C61.9,8550/3,90498,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-33-4533,Black or African American,LUSC,,0,0,,Johns Hopkins,0,0,FEMALE,0,4.08,0.7,9,11,12,,,4068,,4068,4068,,0,0,4068,4068,,Malignant,32,,218,,,,20460,,,4068,4068,,,,4068,4068,,,4068,,,,,,,,TUMOR FREE,Alive,-28001,,,,402,,4068,4068,,,[Not Available],[Not Applicable],,,,,0.3,,,,,8,,2,0.50033,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4533,,,,,,,4068,,,,,,,,,47,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,90500,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.6873,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.540159886413279,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-CD-8536,Asian,STAD,,0,0,,,0,0,,0,2.13,0.48,1,1,2,,,378,,378,378,,0,0,378,378,,Malignant,4,,33,,,,30238,,,378,378,,,,378,378,,,378,,,,,,,,TUMOR FREE,Alive,-27328,,,,1263,,378,378,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Unknown,,,4,,0,0.015393,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8536,,,,,,,378,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,90501,,0.488283035,,,,,,,,,,0.105860709,Grade 3,0.003649619,,,,Stage II,,0.34,,,,,,,,,,,,,,,,0.3216,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8536,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,Female,TCGA-55-8208,White,LUAD,,1,1,,International Genomics Consortium,1,0,FEMALE,1,2.22,0.24,4,8,6,,,674,,511,674,,1,1,511,511,,Malignant,18,,7,,,,29556,,,511,511,,,,511,674,,,511,,,,,,,,WITH TUMOR,Alive,-26716,,,,430,,511,511,,,[Not Available],[Not Applicable],,,,,0.62,,,,,7,,0,0.18602,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8208,,,,,,,674,,Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2012,511,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,90503,,1.696754524,,,,,,,,,,0.316377799,,0.220963033,,,,Stage IA,,2.2075,,,,,,,,,,,,,,,,0.5592,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.207310946,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.2767,,1.062,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GU-A42R,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.96,0.78,8,9,9,,,577,,,577,,1.0,1,91.0,91.0,,Malignant,26,,102,,,,26030.0,,,91.0,91,,,,,577,,,91.0,,,,,,,,WITH TUMOR,Dead,-25134,577,,,241.0,,91.0,91,,,[Not Available],[Not Applicable],,,,,0.06,,,,,6,,0,0.24645,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - UT Southwestern Medical Center at Dallas,,TCGA-GU-A42R,,,,,,,,Lung,Distant Metastasis,,,,,,,12,,,,,,,,,,,,,2012,91,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,68.0,,,,,,,,,,,,,,,,,,,,90508,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-85-8352,White,LUSC,,1,1,,Asterand,1,1,MALE,1,2.9,0.93,17,10,20,,,161,,128,161,,1,1,128,128,,Malignant,47,,187,,,,0,,,128,128,,,,128,161,,,128,,,,,,,,WITH TUMOR,Dead,-24788,161,,,346,,128,128,,,[Not Available],[Not Applicable],,,,,0.33,,,,,14,,1,0.44172,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8352,,,,,,,,,Distant Metastasis,,,,,,,39,,,,,,,,,,,,,2011,128,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,90511,,-0.318516313,,,,,,,,,,0.042456927,,0.005846252,,,,Stage IIIA,,-0.493,,,,,,,,,,,,,,,,-0.6934,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.31896827,13.08673562,14.4723463,-0.767161034006285,LUSC,Squamous Cell Carcinoma,17.8451362,14.64880329,Squamous Cell Carcinoma,-0.411,11.77791791,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,1,1,1,Male,TCGA-RD-A7C1,White,STAD,,1,1,,,1,1,,1,3.76,0.31,10,15,17,,,507,,438,507,,1,1,438,438,,Malignant,42,,90,,,,18874,,,438,438,,,,438,507,,,438,,,,,,,,WITH TUMOR,Dead,-30171,507,,,362,,438,438,,,Stomach Cancer,[Not Applicable],,,,,0.16,Stomach,Unknown,,,20,,2,0.2402,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Peter MacCallum Cancer Center,,TCGA-RD-A7C1,,,,,,,,Non-regional / Distant Lymph Nodes,Distant Metastasis,,,,,,,62,,,,,,,,,,,,,2005,438,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,82,,,,,,,,,,,,,,,,,,,,90512,,0.923358429,,,,,,,,,,0.134423784,Grade 3,0.098044668,,,,Stage IB,,1.3745,,,,,,,,,,,,,,,,0.2995,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-RD-A7C1,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,1,0,1,1,Male,TCGA-KK-A7AY,,PRAD,,1,1,,KK,1,0,MALE,1,2.0,0.78,2,6,4,HRP,NO,1754,,1124,1754,,1,1,1124,1124,prad_tcga,Malignant,12,,51,,TCGA-KK-A7AY-01,0,5513,0,TCGA-KK-A7AY,1124,1124,Prostate Cancer,,1572,1124,1754,TCGA,,1124,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-22220,,60,7,54,PRAD,1124,1124,,0.0,[Not Available],[Not Applicable],51,,1,Matched,0.01,Prostate,Resection,4,1A8A6D7F-863C-4EE0-8DBA-02EF52DC074A,0,,0,0.035296,[Not Available],F4AEBD64-A356-4C05-B847-6DD28CF26339,3,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,KK,1.7,TCGA-KK-A7AY,1:Recurred/Progressed,3,10,Prostate Adenocarcinoma,36.93,8/28/14,1754,,Biochemical evidence of disease,,,NO,C61,BA64AA42-00AD-4DAD-ABE7-BDDC253B9B45,110,1,TUMOR FREE,0.0642,0:LIVING,0.2,,57.62,Bilateral,13,,,YES,1246,2010,1124,,TCGA-KK-A7AY.BA64AA42-00AD-4DAD-ABE7-BDDC253B9B45.pdf,Peripheral Zone,[Not Applicable],NO,,,8,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,60,Core needle biopsy,1124,Complete Remission/Response,NO,YES,YES,YES,T2c,NO,7,No,NO,0,N0,T2a,0,M0,C61.9,8140/3,90514,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.84,3,2,3,,,1,BRCA_Basal,1,1,,0,0,1,1,,Invasive Carcinoma,8,,28,,,,33764,0,,1,1,,,,1,1,,,1,,,,,,,,TUMOR FREE,Alive,-20479,,,,42,,1,1,,,[Not Available],[Not Applicable],,,,,0.6,Breast,Resection/Excision,,,1,,0,0.10056,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Metaplastic Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A7VC,,,,,,,1,,,,,,,,,6,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,90515,TRUE,-1.264269033,0,0,0,0,-4.0252,1,,,Metaplastic Carcinoma,0.131719535,,0.284121386,0,0,0,,Negative,-1.308,,10/21/22,0,0,0,0,0,0,0,1,0,0,no,0,0,0.9222,0,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,"Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)","Uncommon Tumors (Benign and Malignant - Neuroendocrine, Salivary Gland, Epithelial/Myoepithelial, Mesenchymal/Soft Tissue)",0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-86-7713,White,LUAD,,0,0,,Asterand,0,0,MALE,0,3.59,0.65,8,13,14,,,1157,,1157,1157,,0,0,1157,1157,,Malignant,35,,22,,,,26049,,,1157,1157,,,,1157,1157,,,1157,,,,,,,,TUMOR FREE,Alive,-25791,,,,199,,1157,1157,,,[Not Available],[Not Applicable],,,,,0.09,,,,,13,,1,0.20144,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-7713,,,,,,,1157,,,,,,,,,22,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,90517,,-0.034097966,,,,,,,,,,0.116931586,,0.110595102,,,,Stage IIA,,-0.164,,,,,,,,,,,,,,,,-0.2286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,14.6044593,15.91523802,14.26501431,-0.698929672,LUAD,Adenocarcinoma,17.47707164,14.69548865,Adenocarcinoma,-1.2557,13.28635668,-1.6528,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.95,0.51,2,2,6,,,1887,BRCA_LumA,1887,1887,,0,0,1887,1887,,Invasive Carcinoma,10,,8,,,,34049,0,,1887,1887,,,,1887,1887,,,1887,,,,,,,,TUMOR FREE,Alive,-19758,,,,45,,1887,1887,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,3,,0,0.12025,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JJ,,,,,,,1887,,,,,,,,,5,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,90519,,1.110868248,0,1,0,0,0.5916,0,,,Infiltrating Lobular Carcinoma,0.180864875,,0.260784412,0,0,0,,Negative,0.6065,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4762,1,0,H & E,0,0,,0,Ioana Tolocica,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"LCIS, Stromal Alterations",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,ALH,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.55,8,8,14,,,2920,BRCA_LumA,2920,2920,,0,0,2920,2920,,Invasive Carcinoma,30,,63,,,,21917,0,,2920,2920,,,,2920,2920,,,2920,,,,,,,,TUMOR FREE,Alive,-16974,,,,36,,2920,2920,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,8,,0,0.26171,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AN,,,,,,,2920,,,,,,,,,14,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,46,,,,,,,,,,,,,,,,,,,,90521,,-0.306803925,0,0,0,0,0.3098,1,,,Infiltrating Ductal Carcinoma,0.183132818,,0.209361766,0,0,0,,Negative,-1.1015,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.6304,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-94-A4VJ,White,LUSC,,0,0,,Washington University - Emory,0,0,FEMALE,0,3.39,0.53,6,14,20,,,430,,430,430,,0,0,430,430,,Malignant,40,,82,,,,25182,,,430,430,,,,430,430,,,430,,,,,,,,TUMOR FREE,Alive,-25991,,,,521,,430,430,,,[Not Available],[Not Applicable],,,,,0.1,,,,,17,,1,0.18433,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Emory,,TCGA-94-A4VJ,,,,,,,430,,,,,,,,,39,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,90523,,0.447053146,,,,,,,,,,0.148875875,,0.029094526,,,,Stage IA,,0.2975,,,,,,,,,,,,,,,,0.6822,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.446915767075142,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4967,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-XF-AAMQ,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.28,0.7,8,3,10,,,2177,,2177,2177,,0.0,0,2177.0,2177.0,,Malignant,21,,150,,,,30885.0,,,2177.0,2177,,,,2177,2177,,,2177.0,,,,,,,,TUMOR FREE,Alive,-21660,,,,289.0,,2177.0,2177,,,[Not Available],[Not Applicable],,,,,0.36,,,,,18,,1,0.39873,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-AAMQ,,,,,,,2177,,,,,,,,,25,,,,,,,,,,,,,2006,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,90526,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.4,0.38,6,8,12,,,1694,BRCA_LumA,,1694,,1,1,1694,1694,,Benign Breast Disease,26,,22,,,,16132,N/A (Non-Malignant),,1694,1694,,,,,1694,,,1694,,,,,,,,WITH TUMOR,Dead,-14090,1694,,,26,,1694,1694,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,14,,1,0.17207,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1EW,,,,,,,,,,,,,,,,32,,,,,,,,,,,,,1999,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,90542,TRUE,0.995889556,0,0,0,0,-0.5498,0,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.158135721,N/A (Non-Malignant),0.21612161,0,0,0,N/A (Non-Malignant),[Not Available],0.7445,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.2932,1,0,H & E,0,0,,0,Ioana Tolocica,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,Columnar Lesion,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-J4-A83I,,PRAD,370,0,0,,J4,0,0,MALE,0,1.91,0.79,7,10,4,ambiguous,NO,685,1-ERG,685,685,,0,0,685,685,prad_tcga,Malignant,21,PALB2;RAD51B,56,,TCGA-J4-A83I-01,7,5484,0,TCGA-J4-A83I,685,685,Prostate Cancer,,257,685,685,TCGA,,685,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-23240,,63,7,40,PRAD,685,685,,0.193780289,[Not Available],[Not Applicable],28,R0,1,Matched,0.04,Prostate,Resection,4,8A59B137-8E5E-4484-A9A9-65A596A47EF8,0,,0,0.086973,[Not Available],5DC7E186-7E01-4A54-8AE8-350DACE2297B,3,Prostate Adenocarcinoma Acinar Type,,Prostate,21,,Acinar Adenocarcinoma,[Not Available],,J4,0.933333333333,TCGA-J4-A83I,0:DiseaseFree,3,21,Prostate Adenocarcinoma,22.5,1/20/14,685,,,,,,C61,E3AFE230-AE22-4120-BC42-7FE78FCB06A2,100,2,TUMOR FREE,0.0827,0:LIVING,0.1,,22.5,Bilateral,22,,,YES,183,2013,,,TCGA-J4-A83I.E3AFE230-AE22-4120-BC42-7FE78FCB06A2.pdf,Peripheral Zone,[Not Applicable],,,86-95%,2,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,90553,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.63,0.56,12,7,14,,,4233,BRCA_LumB,4233,4233,,0,0,4233,4233,,Invasive Carcinoma,33,,48,,,,32507,0,,4233,4233,,,,4233,4233,,,4233,,,,,,,,TUMOR FREE,Alive,-21183,,,,84,,4233,4233,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Resection/Excision,,,14,,1,0.21391,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A1KN,,,,,,,4233,,,,,,,,,23,,,,,,,,,,,,,1998,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,90559,,0.04034263,0,0,0,0,0.3082,1,,,Infiltrating Ductal Carcinoma,0.124540681,,0.173898299,0,0,0,,Negative,-0.1935,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.197,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade), DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,,,Black or African American,BRCA,,1,1,,,,0,FEMALE,1,2.2,0.67,3,5,2,,,271,BRCA_Normal,,271,,1,1,275,275,,None,10,,42,,,,23316,N/A (Non-Malignant),,275,275,,,,,271,,,275,,,,,,,,TUMOR FREE,Alive,-24735,,,,112,,275,275,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,8,,0,0.08225,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,University of Chicago,,TCGA-OL-A97C,,,,,,,271,Lung,Distant Metastasis,,,,,,,8,,,,,,,,,,,,,2013,275,,,,Stage IIB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,90560,,0.732245066,0,0,0,0,0.3183,1,,N/A (Non-Malignant),Other,0.177293072,N/A (Non-Malignant),0.192446019,0,0,0,N/A (Non-Malignant),[Not Available],0.5185,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.705,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-HU-A4G8,Asian,STAD,,0,0,,,0,0,,0,2.08,0.51,1,3,1,,,690,,690,690,,0,0,690,690,,Malignant,5,,41,,,,29701,,,690,690,,,,690,690,,,690,,,,,,,,TUMOR FREE,Alive,-26254,,,,2135,,690,690,,,[Not Available],[Not Applicable],,,,,0.24,Stomach,Unknown,,,2,,0,0.021259,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4G8,,,,,,,690,,,,,,,,,3,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,90562,,0.76523322,,,,,,,,,,0.100195742,Grade 3,0.045423813,,,,Stage IIB,,1.481,,,,,,,,,,,,,,,,-0.0565,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4G8,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-ZF-A9RC,White,BLCA,,0.0,0,,,0,0,MALE,0.0,6.48,0.2,5,14,28,,,2868,,2868,2868,,0.0,0,2868.0,2868.0,,Malignant,47,,45,,,,26579.0,,,2868.0,2868,,,,2868,2868,,,2868.0,,,,,,,,TUMOR FREE,Alive,-28275,,,,1366.0,,2868.0,2868,,,[Not Available],[Not Applicable],,,,,0.31,,,,,23,,2,0.13326,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9RC,,,,,,,2868,,,,,,,,,47,,,,,,,,,,,,,2007,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,90564,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-E7-A541,White,BLCA,,0.0,0,,,2,2,MALE,2.0,5.25,0.39,1,12,20,,,778,,778,778,,2.0,2,778.0,778.0,,Malignant,33,,13,,,,32721.0,,,778.0,778,,,,778,778,,,778.0,,,,,,,,TUMOR FREE,Dead,-24206,778,,,584.0,,778.0,778,,,[Not Available],[Not Applicable],,,,,0.62,,,,,24,,2,0.021456,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Asterand,,TCGA-E7-A541,,,,,,,,,,,,,,,,64,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,66.0,,,,,,,,,,,,,,,,,,,,90565,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-YL-A9WJ,,PRAD,389,1,1,,YL,,1,MALE,1,1.97,0.39,6,5,3,HRD,NO,1855,8-other,,1855,,1,1,1476,1476,prad_tcga,Malignant,14,,45,,TCGA-YL-A9WJ-01,6,5693,0,TCGA-YL-A9WJ,1476,1476,Prostate Cancer,51,838,,1855,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),1476,Primary,0,Apex|Middle,A,,BRCA2,True,WITH TUMOR,Dead,-17322,1855,47,8,29,PRAD,1476,1476,,0.249203434,Prostate Cancer,[Not Applicable],33,R1,1,Matched,0.07,Prostate,Resection,4,B6253DE4-A1CA-4C9A-8C82-5C4702009706,2,Normal (no evidence of prostate cancer) [cM0],0,0.060038,[Not Available],0B5ED938-6AB8-4E76-8558-1D86F3A90DFA,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,YL,1.1,TCGA-YL-A9WJ,1:Recurred/Progressed,4,13,Prostate Adenocarcinoma,48.49,4/14/14,,"Other, specify",Distant Metastasis,Prostate Cancer,Medical Record,YES,C61,EC025153-CB9C-4683-82B4-985AAA9E80AC,360,2,WITH TUMOR,0.0872,1:DECEASED,3.1,3,60.94,Bilateral,14,No Evidence of Extraprostatic Extension,21,YES,2017,2008,1476,Neck,TCGA-YL-A9WJ.EC025153-CB9C-4683-82B4-985AAA9E80AC.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,19,41-50%,10,Prostate Adenocarcinoma Acinar Type,1,2008,Progressive Disease,,YES,No,R1,,47,Core needle biopsy,76,Progressive Disease,NO,YES,YES,YES,T3b,YES,8,No,,0,N1,T4,1,M0,C61.9,8140/3,90577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A3MF,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,3.2,0.78,0,1,1,,,383,,383,383,,0.0,0,383.0,383.0,,Malignant,2,,10,,,,28906.0,,,383.0,383,,,,383,383,,,383.0,,,,,,,,TUMOR FREE,Alive,-12557,,,,27.0,,383.0,383,,,[Not Available],[Not Applicable],,,,,0.02,,,,,18,,1,0.15048,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A3MF,,,,,,,383,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,34.0,,,,,,,,,,,,,,,,,,,,90579,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-56-5898,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,3.33,0.36,8,8,10,,,555,,555,555,,0,0,555,555,,Malignant,26,,42,,,,25773,,,555,555,,,,555,555,,,555,,,,,,,,TUMOR FREE,Alive,-25441,,,,180,,555,555,,,[Not Available],[Not Applicable],,,,,0.2,,,,,25,,1,0.35785,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-5898,,,,,,,555,,,,,,,,,20,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,90584,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,0.6391,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.433004192565778,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.0199,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.97,0,2,1,,,754,BRCA_LumA,754,754,,0,0,754,754,,Invasive Carcinoma,3,,12,,,,33661,0,,754,754,,,,754,754,,,754,,,,,,,,TUMOR FREE,Alive,-24439,,,,54,,754,754,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,1,,0,0.0017485,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3YJ,,,,,,,754,,,,,,,,,1,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,90590,,-0.315377496,0,0,0,0,0.0576,1,,,Other,0.135868493,,0.129494416,0,0,0,,Negative,-1.0815,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.1663,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), DCIS (Papillary, Intermediate Grade), DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade), DCIS (Papillary, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,"DCIS with Microinvasive Carcinoma, Encapsulated Papillary Carcinoma","DCIS with Microinvasive Carcinoma, Encapsulated Papillary Carcinoma",0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,1,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,,,,BRCA,,1,,,,1,0,FEMALE,1,2.64,0.35,9,10,16,,,1308,BRCA_Her2,366,1308,,1,,366,366,,Invasive Carcinoma,35,,30,,,,19191,0,,366,,,,,366,1308,,,366,,,,,,,,TUMOR FREE,Alive,-15705,,,,64,,366,,,,[Not Available],[Not Applicable],,,,,0.5,Breast,Resection/Excision,,,21,,1,0.40205,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A08X,,,,,,,1308,,,,,,,,,34,,,,,,,,,,,,,2007,366,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,90593,,0.8230699,0,0,0,0,0.5267,1,,,Infiltrating Ductal Carcinoma,0.19178025,,0.141512287,0,0,0,,Negative,0.515,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.5541,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-8350,White,LUSC,,0,0,,Asterand,0,0,MALE,0,3.59,0.32,6,8,9,,,683,,683,683,,0,0,683,683,,Malignant,23,,40,,,,28768,,,683,683,,,,683,683,,,683,,,,,,,,TUMOR FREE,Alive,-22526,,,,416,,683,683,,,[Not Available],[Not Applicable],,,,,0.24,,,,,18,,1,0.26021,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8350,,,,,,,683,,,,,,,,,25,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,90597,,0.694076645,,,,,,,,,,0.207440647,,0.128153398,,,,Stage IA,,0.4155,,,,,,,,,,,,,,,,0.9051,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.453078584381531,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6015,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-BR-A4QM,White,STAD,,1,1,,,1,0,,1,,,,,,,,156,,127,156,,1,1,127,127,,Malignant,,,,,,,26461,,,127,127,,,,127,156,,,127,,,,,,,,WITH TUMOR,Alive,-23999,,,,135,,127,127,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4QM,,,,,,,156,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2012,127,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,90601,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4QM,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1.0,,,0.0,1.0,Male,TCGA-XF-A9T2,White,BLCA,,0.0,0,,,,,MALE,2.0,2.0,0.84,1,1,1,,,575,,,575,,2.0,2,575.0,575.0,,Malignant,3,,7,,,,33531.0,,,575.0,575,,,,,575,,,575.0,,,,,,,,,Dead,-19945,575,,,125.0,,575.0,575,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.010942,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9T2,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,2007,,,,,Stage III,,,,,,,,[Unknown],,,,,,54.0,,,,,,,,,,,,,,,,,,,,90603,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-52-7811,White,LUSC,,1,1,,University of Miami,,1,MALE,1,4.37,0.22,5,7,12,,,266,,,266,,1,1,153,153,,Malignant,24,,18,,,,31562,,,153,153,,,,,266,,,153,,,,,,,,WITH TUMOR,Dead,-24782,266,,,197,,153,153,,,[Not Available],[Not Applicable],,,,,0.43,,,,,12,,2,0.22213,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Miami,,TCGA-52-7811,,,,,,,,,Distant Metastasis,,,,,,,54,,,,,,,,,,,,,2009,153,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,90605,,0.542560654,,,,,,,,,,0.238414555,,0.184898304,,,,Stage IB,,0.4705,,,,,,,,,,,,,,,,0.5971,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.500546367588062,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.1249,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.62,5,2,5,,,847,BRCA_LumA,847,847,,0,0,847,847,,Invasive Carcinoma,12,,36,,,,32015,0,,847,847,,,,847,847,,,847,,,,,,,,TUMOR FREE,Alive,-16697,,,,43,,847,847,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,6,,0,0.097997,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A6HE,,,,,,,847,,,,,,,,,8,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,90607,,-0.618700759,0,0,0,0,-0.2913,1,,,Infiltrating Lobular Carcinoma,0.166530199,,0.142238696,0,0,0,,Negative,-0.478,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4184,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-MN-A4N5,White,LUAD,,0,0,,BLN - Baylor,0,0,MALE,0,3.29,0.38,13,8,18,,,84,,84,84,,0,0,84,84,,Malignant,39,,104,,,,29093,,,84,84,,,,84,84,,,84,,,,,,,,TUMOR FREE,Alive,-23257,,,,602,,84,84,,,[Not Available],[Not Applicable],,,,,0.17,,,,,17,,1,0.28854,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,BLN - Baylor,,TCGA-MN-A4N5,,,,,,,84,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,90610,,1.273835483,,,,,,,,,,0.160151024,,0.111189818,,,,Stage IA,,2.21,,,,,,,,,,,,,,,,0.1864,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,"G12C (driver), AMP (driver)",,1,,G12C (driver),,,,,-0.026157383,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.8187,,0.9397,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,812,BRCA_LumA,812,812,,0,0,812,812,,Invasive Carcinoma,,,,,,,21903,0,,812,812,,,,812,812,,,812,,,,,,,,TUMOR FREE,Alive,-22199,,,,45,,812,812,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A5FK,,,,,,,812,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,90615,,1.588291033,0,0,0,1,0.2516,0,,,Infiltrating Lobular Carcinoma,0.144373407,,0.264346622,0,0,0,,Negative,1.0955,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.2328,1,0,H & E,0,0,,0,Ioana Tolocica,"Columnar Lesion, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"Columnar Lesion, UDH",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-37-4132,White,LUSC,,0,0,,Cureline,,0,FEMALE,0,2.0,0.62,9,2,7,,,227,,,227,,0,0,227,227,,Malignant,18,,21,,,,32770,,,227,227,,,,,227,,,227,,,,,,,,TUMOR FREE,Alive,-22520,,,,397,,227,227,,,[Not Available],[Not Applicable],,,,,0.2,,,,,6,,0,0.22974,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-4132,,,,,,,227,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,90616,,0.932551868,,,,,,,,,,0.173495583,,0.084581095,,,,Stage IV,,1.162,,,,,,,,,,,,,,,,-0.2323,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R71L,1,,,R71L,16.34488317,15.86024036,16.93688008,-0.0123252461803847,LUSC,,18.24052491,17.27809544,Squamous Cell Carcinoma,-0.0013,13.36865254,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8I5,,PRAD,370,0,0,,KK,0,0,MALE,0,1.91,0.85,2,9,2,HRD,NO,3096,1-ERG,3096,3096,,0,0,3096,3096,prad_tcga,Malignant,13,RAD54L,87,,TCGA-KK-A8I5-01,0,5521,0,TCGA-KK-A8I5,3096,3096,Prostate Cancer,,1979,3096,3096,TCGA,,3096,Primary,0,Apex|Middle|Base,A,,RAD51B,True,TUMOR FREE,Alive,-20337,,55,7,49,PRAD,3096,3096,,0.0,[Not Available],[Not Applicable],33,,1,Matched,0.05,Prostate,Resection,3,2F653293-DC10-43BA-B4F0-A4BB54ADE176,0,,0,0.08479,[Not Available],7CE45134-5B1F-4EA7-ACE9-7E463B034A43,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,KK,1.1,TCGA-KK-A8I5,0:DiseaseFree,2,24,Prostate Adenocarcinoma,101.71,8/18/14,3096,,,,,NO,C61,CF19D931-B8BE-4978-8C08-081744230305,130,2,TUMOR FREE,0.1006,0:LIVING,0.1,,101.71,Right,24,,,YES,2717,2006,,,TCGA-KK-A8I5.CF19D931-B8BE-4978-8C08-081744230305.pdf,Peripheral Zone,[Not Applicable],NO,,66-75%,6,Prostate Adenocarcinoma Acinar Type,1,2006,Complete Remission/Response,,NO,No,R0,,55,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2b,NO,7,No,NO,0,N0,T2a,,M0,C61.9,8140/3,90618,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.29,0.58,15,20,23,,,710,BRCA_LumB,710,710,,0,0,710,710,,In Situ Carcinoma,58,,81,,,,17406,0,,710,710,,,,710,710,,,710,,,,,,,,TUMOR FREE,Alive,-16750,,,,76,,710,710,,,[Not Available],[Not Applicable],,,,,0.34,Breast,Resection/Excision,,,19,,1,0.34218,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15A,,,,,,,710,,,,,,,,,27,,,,,,,,,,,,,2009,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,90624,,0.675721182,1,0,1,1,-0.8877,0,,,Infiltrating Ductal Carcinoma,0.133235314,,0.134826722,0,0,1,,Negative,0.358,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.3305,1,0,H & E,0,0,,0,Ioana Tolocica,"ADH, Apocrine Metaplasia, Columnar Lesion, FEA, Papilloma, Sclerosing Adenosis, UDH",0,1,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,1,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,None,None,0,"ADH, Apocrine Metaplasia, Columnar Lesion, FEA, Papilloma, Sclerosing Adenosis, UDH",0,0,0,0,0,0,N/A - No invasive carcinoma (or uncertain),N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,N/A - No invasive carcinoma (or uncertain),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-8071,White,LUSC,,0,0,,Asterand,0,0,MALE,0,1.81,0.86,14,4,10,,,815,,815,815,,0,0,815,815,,Malignant,28,,62,,,,26001,,,815,815,,,,815,815,,,815,,,,,,,,TUMOR FREE,Alive,-19158,,,,505,,815,815,,,[Not Available],[Not Applicable],,,,,0.06,,,,,9,,0,0.42142,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8071,,,,,,,815,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,90630,,0.623691103,,,,,,,,,,0.051378608,,-0.025352111,,,,Stage IIA,,0.7525,,,,,,,,,,,,,,,,0.323,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,12.90361997,12.71938133,15.71123664,-0.742855858000521,LUSC,Squamous Cell Carcinoma,17.64979984,15.71074531,Squamous Cell Carcinoma,-1.3527,11.73156833,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-21-5787,Black or African American,LUSC,,1,,,Fox Chase Cancer Center,,1,MALE,1,2.65,0.5,12,18,20,,,329,,,329,,1,,103,103,,Malignant,50,,68,,,,29406,,,103,,,,,,329,,,103,,,,,,,,WITH TUMOR,Dead,-24071,329,,,545,,103,,,,[Not Available],[Not Applicable],,,,,0.29,,,,,19,,1,0.46062,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Fox Chase Cancer Center,,TCGA-21-5787,,,,,,,329,,,,,,,,,36,,,,,,,,,,,,,2009,103,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,90631,,2.120591456,,,,,,,,,,0.184249632,,0.158328646,,,,Stage IIIA,,1.8475,,,,,,,,,,,,,,,,0.1355,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.60079202,17.19106708,17.89377978,0.220291557738112,LUSC,,17.99562737,16.81980889,Squamous Cell Carcinoma,0.2086,12.37395557,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.9,0.42,6,14,16,,,614,BRCA_LumA,614,614,,0,0,614,614,,Invasive Carcinoma,36,,74,,,,26447,0,,614,614,,,,614,614,,,614,,,,,,,,TUMOR FREE,Alive,-26550,,,,293,,614,614,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,18,,1,0.08295,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A8OP,,,,,,,614,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,72,,,,,,,,,,,,,,,,,,,,90642,,0.19854118,0,0,0,0,0.4089,1,,,Infiltrating Ductal Carcinoma,0.115441539,,0.206933025,0,0,0,,Negative,-0.602,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.3306,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,90652,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A2ES,White,BLCA,,0.0,0,,,,1,MALE,1.0,2.01,0.55,4,2,10,,,1004,,,1004,,2.0,2,897.0,897.0,,Malignant,16,,44,,,,23501.0,,,1004.0,1004,,,,,1004,,,897.0,,,,,,,,WITH TUMOR,Dead,-31293,1004,,,659.0,,1004.0,1004,,,[Not Available],[Not Applicable],,,,,0.03,,,,,4,,0,0.28582,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2ES,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2009,897,,,,Stage II,,,,,,,,Progressive Disease,,,,,,85.0,,,,,,,,,,,,,,,,,,,,90657,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Female,TCGA-MP-A4TJ,Unknown,LUAD,,0,0,,Washington University - Mayo Clinic,2,,FEMALE,2,,,,,,,,339,,339,339,,2,2,339,339,,Malignant,,,,,,,24521,,,339,339,,,,339,339,,,339,,,,,,,,,Dead,-22875,339,,,135,,339,339,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TJ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,90660,,1.94985942,,,,,,,,,,0.25326536,,0.17505336,,,,Stage IA,,2.3355,,,,,,,,,,,,,,,,0.3576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.279035998,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.9921,,1.492,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-VQ-A8DU,White,STAD,,1,1,,,,1,,1,2.68,0.58,11,25,21,,,166,,,166,,1,1,158,158,,Malignant,57,,281,,,,21936,,,158,158,,,,,166,,,158,,,,,,,,WITH TUMOR,Dead,-23042,166,,,178,,158,158,,,Stomach Cancer,[Not Applicable],,,,,0.11,Stomach,Unknown,,,17,,1,0.34912,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8DU,,,,,,,,Liver,Distant Metastasis,,,,,,,40,,,,,,,,,,,,,2010,158,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,63,,,,,,,,,,,,,,,,,,,,90666,,0.225014128,,,,,,,,,,0.056733825,Grade 2,0.055085631,,,,Stage IIIA,,-0.5515,,,,,,,,,,,,,,,,0.1932,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8DU,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-V1-A8ML,,PRAD,389,0,0,,V1,0,0,MALE,0,1.98,0.35,1,2,1,HRP,NO,448,8-other,448,448,,0,0,448,448,prad_tcga,Malignant,4,RAD51D,20,,TCGA-V1-A8ML-01,0,5561,0,TCGA-V1-A8ML,448,448,Prostate Cancer,,448,448,448,TCGA,,448,Primary,0,Apex,A,,,True,,Alive,-23360,,63,7,17,PRAD,448,448,,0.0,[Not Available],[Not Applicable],16,,1,Matched,0.01,Prostate,Resection,3,7E64E9CD-64A6-4AD0-B851-CEA249D4A27A,1,,0,0.016485,[Not Available],69174712-AF41-422D-952A-D8D0D16D7182,4,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,V1,0.566666666667,TCGA-V1-A8ML,0:DiseaseFree,2,3,Prostate Adenocarcinoma,14.72,7/15/14,448,,,,,NO,C61,4C4405A3-FC07-4155-8C5A-2693E34F347B,10,1,,0.0045,0:LIVING,0.01,,14.72,Bilateral,8,,,YES,,,,,TCGA-V1-A8ML.4C4405A3-FC07-4155-8C5A-2693E34F347B.pdf,Peripheral Zone,[Not Applicable],NO,,66-75%,12,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,63,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,,N0,T2b,0,M0,C61.9,8140/3,90673,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-HU-A4G2,Asian,STAD,,0.0,0,,,0,0,,0.0,2.22,0.68,1,2,2,,,739,,739,739,,0.0,0,739,739,,Malignant,5,,14,,,,17012.0,0,,739,739,,,,739,739,,,739,,,,,,,,TUMOR FREE,Alive,-16791,,,,61.0,,739,739,,,[Not Available],[Not Applicable],,,,,0.21,Stomach,Resection,,,10,,0,0.041962,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4G2,,,,,,,739,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,45,,,,,,,,,,,,,,,,,,,,90678,,-0.068460213,,,,,,,,,,0.074676992,Grade 3,0.208430943,,,,Stage IIB,,-0.709,,,,,,,,,,,,,,,,-0.1079,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4G2,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1034,,1034,1034,,0,0,1034,1034,,None,,,,,,,30049,N/A (Non-Malignant),,1034,1034,,,,1034,1034,,,1034,,,,,,,,TUMOR FREE,Alive,-20820,,,,0,,1034,1034,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07C,,,,,,,1034,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,90680,TRUE,1.039255631,0,0,0,0,-1.1222,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.158578252,N/A (Non-Malignant),0.129266873,0,0,0,N/A (Non-Malignant),Negative,0.4025,,10/21/22,0,0,0,0,0,0,0,1,0,0,no,0,0,-0.175,0,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,1,None of the Above,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,,,,,,,,1093,,802,1093,,1,1,802,802,,Invasive Carcinoma,,,,,,,16099,0,,802,802,,,,802,1093,,,802,,,,,,,,WITH TUMOR,Dead,-18059,1093,,,0,,802,802,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3XY,,,,,,,,Lung,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,802,,,,Stage IIB,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,90685,TRUE,1.298857635,0,0,0,0,0.5295,1,,,Infiltrating Ductal Carcinoma,0.184291376,,0.206065263,0,0,0,,Negative,1.0015,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.7467,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.15,0.76,1,1,2,,,509,BRCA_LumB,509,509,,0,0,509,509,,Invasive Carcinoma,4,,2,,,,26926,0,,509,509,,,,509,509,,,509,,,,,,,,TUMOR FREE,Alive,-14858,,,,33,,509,509,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.0071595,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1X7,,,,,,,509,,,,,,,,,5,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,90695,,,0,0,0,0,-1.3916,1,,,Other,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,425,BRCA_Basal,425,425,,0,0,425,425,,Invasive Carcinoma,,,,,,,29064,0,,425,425,,,,425,425,,,425,,,,,,,,TUMOR FREE,Alive,-27313,,,,179,,425,425,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A142,,,,,,,425,,,,,,,,,,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,90697,,0.463880616,0,0,0,0,-0.4024,1,,,Infiltrating Ductal Carcinoma,0.190873712,,0.184536083,0,0,0,,Negative,-0.3045,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.7451,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.88,0.26,8,4,6,,,2191,BRCA_LumA,2191,2191,,0,0,2191,2191,,None,18,,46,,,,31185,N/A (Non-Malignant),,2191,2191,,,,2191,2191,,,2191,,,,,,,,TUMOR FREE,Alive,-24788,,,,52,,2191,2191,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.19976,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A4E0,,,,,,,2191,,,,,,,,,9,,,,,,,,,,,,,2007,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,90713,,0.358727222,0,0,0,0,-0.5978,1,,N/A (Non-Malignant),Infiltrating Lobular Carcinoma,0.192274092,N/A (Non-Malignant),0.382085564,0,0,0,N/A (Non-Malignant),Negative,0.674,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4453,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.69,0.32,3,0,4,,,1001,BRCA_LumA,1001,1001,,0,0,1001,1001,,Invasive Carcinoma,7,,7,,,,20192,0,,1001,1001,,,,1001,1001,,,1001,,,,,,,,TUMOR FREE,Alive,-18594,,,,78,,1001,1001,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,18,,1,0.14145,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18F,,,,,,,1001,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,90716,,0.805329333,0,0,0,0,0.1472,1,,,Infiltrating Ductal Carcinoma,0.153706566,,0.232591241,0,0,0,,Negative,-0.0475,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4299,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.82,0.55,3,3,3,,,2477,BRCA_LumA,2477,2477,,0,0,2477,2477,,None,9,,8,,,,16566,N/A (Non-Malignant),,2477,2477,,,,2477,2477,,,2477,,,,,,,,TUMOR FREE,Alive,-20776,,,,93,,2477,2477,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,8,,0,0.2116,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0B0,,,,,,,2477,,,,,,,,,6,,,,,,,,,,,,,2006,,,,,Stage I,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,90720,,1.317160474,0,0,0,0,1.1949,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.199448237,N/A (Non-Malignant),0.257119587,0,0,0,N/A (Non-Malignant),Negative,0.608,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.5869,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9Z7,,PRAD,,0,0,,V1,0,0,MALE,0,1.99,0.59,3,5,5,ambiguous,NO,874,,874,874,,0,0,874,874,prad_tcga,Malignant,13,,122,,TCGA-V1-A9Z7-01,0,5581,0,TCGA-V1-A9Z7,874,874,Prostate Cancer,,-75,874,874,TCGA,,874,Primary,0,Apex,A,,,True,,Alive,-20075,,54,9,40,PRAD,874,874,,0.0,[Not Available],[Not Applicable],29,,1,Matched,0.19,Prostate,Resection,5,726C35C5-ABBA-46E9-ADBF-818E15308957,3,,0,0.082085,[Not Available],4DB62B98-ABD4-4A7C-9FCE-8BBDA2AEC8A3,4,Prostate Adenocarcinoma Acinar Type,,Prostate,12,,Acinar Adenocarcinoma,[Not Available],,V1,0.966666666667,TCGA-V1-A9Z7,0:DiseaseFree,5,22,Prostate Adenocarcinoma,28.71,7/23/14,874,,,,,NO,C61,E50B8F61-E948-417F-A5B6-2C087A8D2B01,310,4,,0.1225,0:LIVING,28.1,,28.71,Bilateral,24,No Evidence of Extraprostatic Extension,50,YES,,,,,TCGA-V1-A9Z7.E50B8F61-E948-417F-A5B6-2C087A8D2B01.pdf,Peripheral Zone,[Not Applicable],YES,,,10,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,YES,No,R0,,54,Core needle biopsy,,,NO,YES,YES,YES,T3b,NO,9,No,NO,,N0,T2,0,M0,C61.9,8140/3,90725,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,Black or African American,BRCA,,0,0,,,2,2,FEMALE,2,1.88,0.5,5,8,6,,,1104,BRCA_Normal,1104,1104,,2,2,1104,1104,,Invasive Carcinoma,19,,59,,,,33402,0,,1104,1104,,,,1104,1104,,,1104,,,,,,,,TUMOR FREE,Dead,-26052,1104,,,72,,1104,1104,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,4,,0,0.14521,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A5D6,,,,,,,,,,,,,,,,6,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,90726,,0.167247968,0,0,0,0,0.3834,1,,,Infiltrating Ductal Carcinoma,0.181304479,,0.226799963,0,0,0,,Negative,-0.7025,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.5404,1,0,H & E,0,0,,0,Ioana Tolocica,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, High Grade), Comedonecrosis",,"DCIS (Cribriform, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-FP-A4BE,Black or African American,STAD,,0,0,,,0,0,,0,,,,,,,,337,,337,337,,0,0,337,337,,Malignant,,,,,,,25536,,,337,337,,,,337,337,,,337,,,,,,,,TUMOR FREE,Alive,-20148,,,,2144,,337,337,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,International Genomics Consortium,,TCGA-FP-A4BE,,,,,,,337,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,90728,,0.998162961,,,,,,,,,,0.097779439,Grade 3,0.033420496,,,,Stage IIA,,1.179,,,,,,,,,,,,,,,,-0.143,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-A4BE,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,Female,TCGA-44-3919,White,LUAD,,1,1,,Christiana Healthcare,1,1,FEMALE,1,1.94,0.51,5,5,6,,,1026,,921,1026,,1,1,921,921,,Malignant,16,,20,,,,24871,,,921,921,,,,921,1026,,,921,,,,,,,,WITH TUMOR,Dead,-26081,1026,,,59,,921,921,,,[Not Available],[Not Applicable],,,,,0.25,,,,,5,,0,0.10858,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-3919,,,,,,,,,Locoregional Recurrence,,,,,,,7,,,,,,,,,,,,,2010,921,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,90730,,1.308193159,,,,,,,,,,0.265257484,,0.135756316,,,,Stage IA,,1.626,,,,,,,,,,,,,,,,0.4013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.037271426,LUAD,,,,Adenocarcinoma,0.4654,,0.7894,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-38-6178,White,LUAD,,0,0,,UNC,,0,FEMALE,0,3.89,0.32,5,10,15,,,448,,,448,,0,0,448,448,,Malignant,30,,41,,,,16243,,,448,448,,,,,448,,,448,,,,,,,,WITH TUMOR,Alive,-25593,,,,82,,448,448,,,[Not Available],[Not Applicable],,,,,0.48,,,,,18,,2,0.45622,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-6178,,,,,,,448,,,,,,,,,52,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,Stable Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,90732,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5333,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"E746_A750del (driver), AMP (driver)",,,1,E746_A750del (driver),,,15.41980198,16.49531163,11.59115394,-0.395671818,LUAD,Adenocarcinoma,18.15176143,15.11689819,Adenocarcinoma,0.6272,12.89314161,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-FD-A5BY,White,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.43,0.58,14,9,18,,,251,,251,251,,0.0,0,251.0,251.0,,Malignant,41,,79,,,,19577.0,,,251.0,251,,,,251,251,,,251.0,,,,,,,,TUMOR FREE,Alive,-23080,,,,72.0,,251.0,251,,,[Not Available],[Not Applicable],,,,,0.06,,,,,25,,1,0.35149,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5BY,,,,,,,251,,,,,,,,,22,,,,,,,,,,,,,2012,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,63.0,,,,,,,,,,,,,,,,,,,,90744,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,,,White,BRCA,,0,0,,,,,FEMALE,2,2.05,0.93,1,2,1,,,1927,BRCA_LumB,,1927,,2,2,1927,1927,,Invasive Carcinoma,4,,9,,,,28096,0,,1927,1927,,,,,1927,,,1927,,,,,,,,,Dead,-24262,1927,,,51,,1927,1927,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,2,,0,0.062886,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1FJ,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,1998,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,90753,,-1.108533807,0,0,0,0,0.5445,1,,,Infiltrating Ductal Carcinoma,0.099848341,,0.112862306,0,0,0,,[Not Available],-1.588,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.0135,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Papillary, Intermediate Grade), DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Papillary, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-49-6742,White,LUAD,,1,,,Johns Hopkins,,1,MALE,1,3.61,0.49,3,2,4,,,488,,,488,,1,,214,214,,Malignant,9,,13,,,,21488,,,214,,,,,,488,,,214,,,,,,,,WITH TUMOR,Dead,-25839,488,,,364,,214,,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,1,0.068622,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6742,,,,,,,,,,,,,,,,15,,,,,,,,,,,,,2010,214,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,70,,,,,,,,,,,,,,,,,,,,90756,,0.067220328,,,,,,,,,,0.160287252,,0.1322149,,,,Stage IIA,,-0.2085,,,,,,,,,,,,,,,,-0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L268P,1,,,L268P,14.47771424,15.94131454,13.47401445,-0.704663899,LUAD,,17.8890364,13.61750443,Adenocarcinoma,,13.10424721,-0.8103,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,,,White,BRCA,,0,0,,,,2,FEMALE,2,2.79,0.32,5,7,5,,,1286,BRCA_LumA,,1286,,2,2,1286,1286,,Invasive Carcinoma,17,,41,,,,23326,0,,1286,1286,,,,,1286,,,1286,,,,,,,,TUMOR FREE,Dead,-30339,1286,,,33,,1286,1286,,,[Not Available],[Not Applicable],,,,,0.29,Breast,Resection/Excision,,,21,,1,0.18804,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1EU,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,1999,,,,,Stage I,,,,,,,,[Not Available],,,,,,83,,,,,,,,,,,,,,,,,,,,90763,,1.38145105,0,0,0,1,-0.3283,0,,,Infiltrating Ductal Carcinoma,0.225243364,,0.263081326,0,0,0,,[Not Available],0.8645,,10/21/22,0,0,0,0,0,0,0,0,0,1,E-Cadherin IHC can help determine the exact type,0,0,0.3252,1,0,H & E,0,0,,0,Guofeng Gao,"Apocrine Metaplasia, Columnar Lesion, UDH",0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Low Grade), Stromal Alterations",,"DCIS (Solid, Low Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,"Apocrine Metaplasia, Columnar Lesion, UDH",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Female,TCGA-38-4627,White,LUAD,,0,0,,UNC,2,,FEMALE,2,1.86,0.22,1,2,1,,,1147,,1147,1147,,2,2,1147,1147,,Malignant,4,,7,,,,18143,,,1147,1147,,,,1147,1147,,,1147,,,,,,,,,Dead,-23510,1147,,,38,,1147,1147,,,[Not Available],[Not Applicable],,,,,0.35,,,,,8,,0,0.15783,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,UNC,,TCGA-38-4627,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,90765,,0.410932747,,,,,,,,,,0.288350205,,0.293320013,,,,Stage IIA,,0.434,,,,,,,,,,,,,,,,0.9754,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), L62R (driver)",,,1,"L858R (driver), L62R (driver)",,,16.92485628,18.060469,14.7532358,-0.176532789,LUAD,Adenocarcinoma,18.49247145,15.75295442,Adenocarcinoma,2.1217,14.32901014,-0.449,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-56-7223,White,LUSC,,1,1,,International Genomics Consortium,,1,MALE,1,2.81,0.94,9,13,16,,,442,,,442,,1,1,132,132,,Malignant,38,,52,,,,19495,,,132,132,,,,,442,,,132,,,,,,,,WITH TUMOR,Dead,-24288,442,,,398,,132,132,,,[Not Available],[Not Applicable],,,,,0.29,,,,,19,,1,0.37026,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7223,,,,,,,,,Locoregional Recurrence,,,,,,,31,,,,,,,,,,,,,2011,132,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,66,,,,,,,,,,,,,,,,,,,,90767,,-1.272328995,,,,,,,,,,0.084960448,,0.058991432,,,,Stage IIIA,,-0.7575,,,,,,,,,,,,,,,,-0.0264,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.18782349,13.54760092,12.43468417,-1.22952862968883,LUSC,Squamous Cell Carcinoma,17.71275492,14.40074826,Squamous Cell Carcinoma,-0.9562,12.75191939,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,0,0,1,Male,TCGA-18-4083,White,LUSC,,0,0,,Princess Margaret Hospital (Canada),,2,MALE,2,2.86,0.68,8,21,21,,,188,,,188,,2,2,188,188,,Malignant,50,,59,,,,16203,,,188,188,,,,,188,,,188,,,,,,,,TUMOR FREE,Dead,-23125,188,,,490,,188,188,,,[Not Available],[Not Applicable],,,,,0.23,,,,,12,,1,0.3247,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Princess Margaret Hospital (Canada),,TCGA-18-4083,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Unknown],,,,,,63,,,,,,,,,,,,,,,,,,,,90772,,0.927520989,,,,,,,,,,0.162130735,,0.053710173,,,,Stage IIB,,2.2805,,,,,,,,,,,,,,,,0.3958,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.41313359,15.38322991,17.20525999,-0.223666606008825,LUSC,,17.91673218,16.041907,Squamous Cell Carcinoma,0.5112,14.18179508,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Female,TCGA-49-4512,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,4.56,0.32,4,9,12,,,905,,,905,,1,1,905,905,,Malignant,25,,37,,,,24504,,,905,905,,,,,905,,,905,,,,,,,,WITH TUMOR,Dead,-25502,905,,,58,,905,905,,,[Not Available],[Not Applicable],,,,,0.24,,,,,27,,2,0.36924,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4512,,,,,,,157,,,,,,,,,48,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,90773,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.4196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.98542375,16.9089662,11.37952049,-0.399506954,LUAD,,18.11303383,14.40690717,Adenocarcinoma,,13.80128998,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.83,0.59,8,12,14,,,1371,BRCA_LumB,1371,1371,,0,0,1371,1371,,Invasive Carcinoma,34,,37,,,,29801,0,,1371,1371,,,,1371,1371,,,1371,,,,,,,,TUMOR FREE,Alive,-30711,,,,196,,1371,1371,,,[Not Available],[Not Applicable],,,,,0.17,Breast,Core Biopsy,,,14,,1,0.14309,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A09I,,,,,,,1371,,,,,,,,,18,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,90774,,0.79490406,0,0,0,0,-0.4286,1,,,Infiltrating Ductal Carcinoma,0.159759967,,0.078388967,0,0,0,,Negative,0.8285,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.2275,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Suboptimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Male,TCGA-43-6773,White,LUSC,,0,0,,Christiana Healthcare,,2,MALE,2,2.11,0.21,1,3,1,,,116,,,116,,2,2,116,116,,Malignant,5,,5,,,,25995,,,116,116,,,,,116,,,116,,,,,,,,TUMOR FREE,Dead,-28036,116,,,73,,116,116,,,[Not Available],[Not Applicable],,,,,0.64,,,,,3,,0,0.15493,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-6773,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,90775,,1.218850149,,,,,,,,,,0.237831373,,0.229622686,,,,Stage IIB,,2.0305,,,,,,,,,,,,,,,,0.7157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.53895901,17.62890123,16.54033355,-0.0327381645719523,LUSC,Squamous Cell Carcinoma,18.5241669,16.67333928,Squamous Cell Carcinoma,0.7057,13.92974924,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Female,TCGA-XF-A9T6,White,BLCA,,0.0,0,,,,0,FEMALE,0.0,2.09,0.83,8,21,16,,,64,,,64,,0.0,0,64.0,64.0,,Malignant,45,,97,,,,22436.0,,,64.0,64,,,,,64,,,64.0,,,,,,,,,Alive,-32207,,,,436.0,,64.0,64,,,[Not Available],[Not Applicable],,,,,0.04,,,,,2,,0,0.18022,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9T6,,,,,,,64,,,,,,,,,7,,,,,,,,,,,,,2008,,,,,Stage III,,,,,,,,[Unknown],,,,,,88.0,,,,,,,,,,,,,,,,,,,,90776,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.0,0.9,0,0,1,,,759,BRCA_LumA,759,759,,0,0,759,759,,Invasive Carcinoma,1,,19,,,,24204,0,,759,759,,,,759,759,,,759,,,,,,,,TUMOR FREE,Alive,-22497,,,,16,,759,759,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,0,,0,8.18e-05,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A440,,,,,,,759,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,90780,,0.435709076,0,0,0,0,-0.0619,1,,,Infiltrating Lobular Carcinoma,0.249724231,,0.28622049,0,0,0,,Negative,0.377,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.8406,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Solid, Intermediate Grade), Microcalcifications",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-BR-8369,White,STAD,,1,1,,,1,0,,1,3.34,0.29,3,17,14,,,427,,419,427,,1,1,419,419,,Malignant,34,,39,,,,22861,,,419,419,,,,419,427,,,419,,,,,,,,WITH TUMOR,Alive,-28051,,,,259,,419,419,,,[Not Available],[Not Applicable],,,,,0.35,Stomach,Unknown,,,15,,1,0.17183,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8369,,,,,,,427,"Other, specify",Distant Metastasis,,,,,,,34,,,,,,,,,,,,,2011,419,Bone,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,90786,,-0.402804241,,,,,,,,,,0.076891165,Grade 3,0.132298171,,,,Stage IIIB,,-1.1415,,,,,,,,,,,,,,,,0.3361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8369,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-Y6-A9XI,,PRAD,,0,0,,Y6,0,0,MALE,0,1.92,0.83,6,7,3,ambiguous,NO,526,,526,526,,0,0,526,526,prad_tcga,Malignant,16,,32,,TCGA-Y6-A9XI-01,0,5648,0,TCGA-Y6-A9XI,526,526,Prostate Cancer,,519,526,526,TCGA,,526,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-26471,,72,8,59,PRAD,526,526,,0.0,[Not Available],[Not Applicable],43,,1,Matched,0.04,Prostate,Resection,4,4CA78561-756F-4453-9CB1-34E119BCF140,1,,0,0.075884,[Not Available],C4EBB2EB-E1F0-4490-80F3-5CF0C40A3091,4,Prostate Adenocarcinoma Acinar Type,,Prostate,16,,Acinar Adenocarcinoma,[Not Available],,Y6,1.43333333333,TCGA-Y6-A9XI,0:DiseaseFree,4,17,Prostate Adenocarcinoma,17.28,11/13/14,526,,,,,NO,C61,FA6B58B3-B9C2-437D-9041-B0179F1386ED,210,2,TUMOR FREE,0.0769,0:LIVING,0.06,,17.28,Bilateral,18,,,YES,413,2012,,,TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf,Peripheral Zone,[Not Applicable],NO,,,4,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,72,Core needle biopsy,,,NO,YES,YES,NO,,NO,8,No,NO,0,N0,,0,,C61.9,8140/3,90793,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.09,0.67,6,7,9,,,394,BRCA_LumB,394,394,,0,0,394,394,,Invasive Carcinoma,22,,47,,,,29399,0,,394,394,,,,394,394,,,394,,,,,,,,TUMOR FREE,Alive,-24877,,,,77,,394,394,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,8,,0,0.18137,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A3M8,,,,,,,394,,,,,,,,,12,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,90795,,-0.994349424,0,0,0,0,-0.6103,1,,,Infiltrating Lobular Carcinoma,0.075088321,,0.252125797,0,0,0,,Negative,-1.4435,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3262,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Papillary, Low Grade), Stromal Alterations",,"DCIS (Papillary, Low Grade)",0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.1,0.48,8,7,11,,,585,BRCA_LumA,585,585,,0,0,585,585,,Invasive Carcinoma,26,,44,,,,25286,0,,585,585,,,,585,585,,,585,,,,,,,,TUMOR FREE,Alive,-22751,,,,152,,585,585,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,4,,0,0.14072,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A23C,,,,,,,585,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,90798,,0.735456703,0,0,0,1,0.7341,0,,,Infiltrating Ductal Carcinoma,0.188663816,,0.139251416,0,0,0,,Negative,-0.1125,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3636,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Micropapillary, Intermediate Grade), Comedonecrosis",,"DCIS (Micropapillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-A9SW,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.76,0.34,17,11,15,,,362,,,362,,1.0,1,362.0,362.0,,Malignant,43,,99,,,,30695.0,,,362.0,362,,,,,362,,,362.0,,,,,,,,WITH TUMOR,Dead,-31049,362,,,87.0,,362.0,362,,,[Not Available],[Not Applicable],,,,,0.01,,,,,10,,0,0.37606,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SW,,,,,,,,,,,,,,,,13,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,85.0,,,,,,,,,,,,,,,,,,,,90802,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-55-8090,White,LUAD,,1,1,,International Genomics Consortium,1,1,MALE,1,3.62,0.41,1,4,4,,,598,,548,598,,1,1,548,548,,Malignant,9,,10,,,,19160,,,548,548,,,,548,598,,,548,,,,,,,,WITH TUMOR,Dead,-29235,598,,,122,,548,548,,,[Not Available],[Not Applicable],,,,,0.02,,,,,12,,1,0.056976,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8090,,,,,,,,,Distant Metastasis,,,,,,,13,,,,,,,,,,,,,2011,548,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,90803,,0.378207034,,,,,,,,,,0.223464551,,0.13292523,,,,Stage IA,,1.2375,,,,,,,,,,,,,,,,0.5969,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,-0.390116904,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.2292,,-0.8402,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-56-8624,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,3.89,0.28,5,7,7,,,420,,420,420,,0,0,420,420,,Malignant,19,,33,,,,17478,,,420,420,,,,420,420,,,420,,,,,,,,TUMOR FREE,Alive,-30798,,,,159,,420,420,,,[Not Available],[Not Applicable],,,,,0.17,,,,,18,,1,0.17398,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-8624,,,,,,,420,,,,,,,,,16,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,84,,,,,,,,,,,,,,,,,,,,90809,,0.108500352,,,,,,,,,,0.170128709,,0.123866781,,,,Stage IIB,,-0.2895,,,,,,,,,,,,,,,,0.4398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.456748,15.2100248,11.13447135,-0.603646640076792,LUSC,Squamous Cell Carcinoma,18.7116723,15.34139819,Squamous Cell Carcinoma,-0.013,13.0489435,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-BR-A4IY,Asian,STAD,,0,0,,,0,0,,0,2.19,0.36,6,20,19,,,392,,392,392,,0,0,392,392,,Malignant,45,,75,,,,34180,,,392,392,,,,392,392,,,392,,,,,,,,TUMOR FREE,Alive,-21314,,,,189,,392,392,,,[Not Available],[Not Applicable],,,,,0.13,Stomach,Unknown,,,7,,0,0.13539,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4IY,,,,,,,392,,,,,,,,,11,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,90814,,1.126601906,,,,,,,,,,0.134539543,Grade 3,0.05118685,,,,Stage IIB,,1.8575,,,,,,,,,,,,,,,,0.7759,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4IY,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,2.17,0.9,3,3,4,,,912,BRCA_Basal,574,912,,1,1,574,574,,Invasive Carcinoma,10,,86,,,,29949,0,,574,574,,,,574,912,,,574,,,,,,,,WITH TUMOR,Dead,-13046,912,,,48,,574,574,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,7,,0,0.2022,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A3XU,,,,,,,,Bone,Distant Metastasis,,,,,,,12,,,,,,,,,,,,,2006,574,,,,Stage IIB,,,,,,,,[Not Available],,,,,,35,,,,,,,,,,,,,,,,,,,,90817,,-1.318252443,0,0,0,0,0.4769,1,,,Infiltrating Ductal Carcinoma,0.09670971,,0.023595776,0,0,0,,Negative,-2.194,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,-0.2967,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-55-8512,White,LUAD,,1,1,,International Genomics Consortium,,1,MALE,1,1.94,0.35,8,3,5,,,607,,,607,,1,1,607,607,,Malignant,16,,50,,,,16167,,,607,607,,,,,607,,,607,,,,,,,,WITH TUMOR,Dead,-15266,607,,,71,,607,607,,,[Not Available],[Not Applicable],,,,,0.1,,,,,8,,0,0.17295,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8512,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,41,,,,,,,,,,,,,,,,,,,,90820,,-0.510466735,,,,,,,,,,0.181215458,,0.158695006,,,,Stage IV,,-0.192,,,,,,,,,,,,,,,,-0.137,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,14.37780096,16.71624307,14.04047528,-0.607098292,LUAD,,18.10781303,15.35981446,Adenocarcinoma,-3.3807,13.35638474,-0.5408,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-75-5126,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR),,0,FEMALE,0,2.29,0.24,4,6,7,,,,,,,,0,0,,,,Malignant,17,,10,,,,18447,,,,,,,,,,,,,,,,,,,,WITH TUMOR,Alive,,,,,787,,,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,7,,0,0.20628,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-5126,,,,,,,,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IIIA,,,,,,,,Partial Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,90825,,0.864355288,,,,,,,,,,0.329657843,,0.190817861,,,,Stage IIIA,,2.227,,,,,,,,,,,,,,,,0.3769,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,17.76501555,19.07855378,17.78287809,0.17951318,LUAD,Adenocarcinoma,18.14650048,16.41109779,Adenocarcinoma,-0.3012,14.73126982,1.0943,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,1,1,Male,TCGA-CD-8534,Asian,STAD,,1,1,,,,0,,1,1.81,0.95,9,3,9,,,367,,,367,,1,1,201,201,,Malignant,21,,88,,,,21127,,,201,201,,,,,367,,,201,,,,,,,,WITH TUMOR,Alive,-15227,,,,72,,201,201,,,[Not Available],[Not Applicable],,,,,0.96,Stomach,Unknown,,,9,,0,0.27965,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-8534,,,,,,,367,"Other, specify",Distant Metastasis,,,,,,,10,,,,,,,,,,,,,2011,201,"Pancreas, Transverse Colon",,,Stage II,,,,,,,,Progressive Disease,,,,,,41,,,,,,,,,,,,,,,,,,,,90832,,0.463288706,,,,,,,,,,0.082441567,Grade 3,0.151232121,,,,Stage II,,0.286,,,,,,,,,,,,,,,,-0.0107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-8534,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.28,0.51,13,15,21,,,1925,BRCA_LumB,1925,1925,,0,0,1925,1925,,Invasive Carcinoma,49,,48,,,,24572,0,,1925,1925,,,,1925,1925,,,1925,,,,,,,,TUMOR FREE,Alive,-22872,,,,339,,1925,1925,,,[Not Available],[Not Applicable],,,,,0.09,Breast,Resection/Excision,,,20,,1,0.30889,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0EY,,,,,,,1925,,,,,,,,,28,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,90834,,0.559142029,0,0,0,0,-1.0645,1,,,Infiltrating Ductal Carcinoma,0.155442403,,0.126058994,0,0,0,,Negative,-0.014,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.2379,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,1.0,0,3,0,,,707,BRCA_Normal,707,707,,0,0,707,707,,Invasive Carcinoma,3,,9,,,,21693,0,,707,707,,,,707,707,,,707,,,,,,,,TUMOR FREE,Alive,-27143,,,,22,,707,707,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Core Biopsy,,,0,,0,0.000552,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3YI,,,,,,,707,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,90837,,-0.101086256,0,0,0,1,0.6658,0,,,Infiltrating Lobular Carcinoma,0.166950539,,0.239736528,0,0,0,,Negative,0.6555,,10/21/22,0,0,0,0,0,0,0,0,0,0,E-Cadherin IHC can confirm type,0,0,0.828,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,UDH,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-BR-A44U,White,STAD,,0,0,,,2,2,,2,2.33,0.62,6,4,8,,,422,,422,422,,2,2,422,422,,Malignant,18,,95,,,,26546,,,422,422,,,,422,422,,,422,,,,,,,,TUMOR FREE,Dead,-25577,422,,,123,,422,422,,,[Not Available],[Not Applicable],,,,,0.2,Stomach,Unknown,,,9,,0,0.1369,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A44U,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,90841,,-1.000043216,,,,,,,,,,0.053274609,Grade 3,0.081298237,,,,Stage IIIB,,-2.7985,,,,,,,,,,,,,,,,0.0982,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A44U,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,1,1,Male,TCGA-JY-A6FH,White,ESCA,,1,1,,,,0,,1,1.7,0.86,14,3,16,,,1441,,,1441,,1,1,749,749,,Malignant,33,,295,,,,27288,,,749,749,,,,,1441,,,749,,,,,,,,TUMOR FREE,Alive,-19549,,,,237,,749,749,,,[Not Available],[Not Available],,,,,0.11,Esophagus,Unknown,,,15,,0,0.44599,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,University Health Network,,TCGA-JY-A6FH,,,,,,,1441,Lung,Distant Metastasis,,,,,,,18,,,,,,,,,,,,,2010,749,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,90843,,,,,,,,,,,,,Grade 2,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.63,8,7,11,,,98,BRCA_LumA,98,98,,0,0,98,98,,Invasive Carcinoma,26,,18,,,,17275,0,,98,98,,,,98,98,,,98,,,,,,,,TUMOR FREE,Alive,-15533,,,,42,,98,98,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,5,,0,0.14111,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0DQ,,,,,,,98,,,,,,,,,11,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,42,,,,,,,,,,,,,,,,,,,,90848,,-0.112424437,0,0,0,0,0.4563,0,,,Infiltrating Ductal Carcinoma,0.166341009,,0.276809564,0,0,0,,Negative,-0.8405,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6438,1,0,H & E,0,0,,0,Murray Resnick,Apocrine Metaplasia,0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Low Grade), DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Cribriform, Low Grade), DCIS (Solid, Low Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,Apocrine Metaplasia,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,1.94,0.63,15,6,14,,,825,BRCA_LumB,,825,,1,1,825,825,,Invasive Carcinoma,35,,44,,,,19651,0,,825,825,,,,,825,,,825,,,,,,,,WITH TUMOR,Dead,-23126,825,,,52,,825,825,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,10,,0,0.45363,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A0SV,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2006,,,,,Stage IV,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,90849,,0.69816086,0,0,0,1,-0.3413,0,,,Infiltrating Ductal Carcinoma,0.193184666,,0.098928179,0,0,0,,Positive,-0.2785,,10/21/22,0,0,0,0,0,0,0,0,0,1,N/A,0,0,0.4883,1,0,H & E,0,0,,0,Guofeng Gao,"Apocrine Metaplasia, Columnar Lesion, UDH",0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,"Apocrine Metaplasia, Columnar Lesion, UDH",0,0,0,0,0,0,Score 3 (High mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-BR-7197,White,STAD,,0,0,,,0,0,,0,2.54,0.63,9,8,19,,,280,,280,280,,0,0,280,280,,Malignant,36,,193,,,,17039,,,280,280,,,,280,280,,,280,,,,,,,,TUMOR FREE,Alive,-25445,,,,231,,280,280,,,[Not Available],[Not Applicable],,,,,0.15,Stomach,Unknown,,,24,,1,0.40239,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,GX,,Asterand,,TCGA-BR-7197,,,,,,,280,,,,,,,,,39,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,90853,,-0.988756878,,,,,,,,,,-0.008778334,Unknown,0.072208903,,,,Stage II,,-1.573,,,,,,,,,,,,,,,,-0.0419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7197,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-33-4533,Black or African American,LUSC,,0,0,,Johns Hopkins,0,0,FEMALE,0,4.08,0.7,9,11,12,,,4068,,4068,4068,,0,0,4068,4068,,Malignant,32,,218,,,,20460,,,4068,4068,,,,4068,4068,,,4068,,,,,,,,TUMOR FREE,Alive,-28001,,,,402,,4068,4068,,,[Not Available],[Not Applicable],,,,,0.3,,,,,8,,2,0.50033,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4533,,,,,,,4068,,,,,,,,,47,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,76,,,,,,,,,,,,,,,,,,,,90854,,-0.161671515,,,,,,,,,,0.181719266,,0.113110581,,,,Stage IB,,-0.423,,,,,,,,,,,,,,,,0.6873,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.540159886413279,LUSC,,,,Squamous Cell Carcinoma,-0.1324,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-VQ-A91Y,White,STAD,,1,1,,,,1,,1,1.83,0.42,11,9,12,,,296,,,296,,1,1,258,258,,Malignant,32,,131,,,,28793,,,258,258,,,,,296,,,258,,,,,,,,WITH TUMOR,Dead,-24774,296,,,61,,258,258,,,Stomach Cancer,[Not Applicable],,,,,0.32,Stomach,Unknown,,,7,,0,0.29021,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A91Y,,,,,,,,Lung,Distant Metastasis,,,,,,,8,,,,,,,,,,,,,2011,258,,,,Stage IIIC,,,,,,,,Progressive Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,90857,,0.898749623,,,,,,,,,,0.095272668,Grade 3,0.131405953,,,,Stage IIIC,,0.906,,,,,,,,,,,,,,,,0.5662,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91Y,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,1,,1,1,1,Male,TCGA-VQ-A8PD,White,STAD,,1,1,,,,1,,1,2.12,0.17,2,0,2,,,496,,,496,,1,1,134,134,,Malignant,4,,22,,,,28301,,,134,134,,,,,496,,,134,,,,,,,,WITH TUMOR,Dead,-25244,496,,,94,,134,134,,,[Not Available],[Not Applicable],,,,,0.27,Stomach,Unknown,,,3,,0,0.075307,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A8PD,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2012,134,,,,Stage IIIC,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,90865,,1.064097287,,,,,,,,,,0.125671374,Grade 2,0.184689963,,,,Stage IIIC,,1.2435,,,,,,,,,,,,,,,,0.4292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A8PD,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,4.7,0.3,10,10,23,,,3121,BRCA_Basal,,3121,,0,0,3121,3121,,Invasive Carcinoma,43,,52,,,,16125,0,,3121,3121,,,,,3121,,,3121,,,,,,,,TUMOR FREE,Alive,-21064,,,,43,,3121,3121,,,[Not Available],[Not Applicable],,,,,0.28,Breast,Resection/Excision,,,22,,2,0.48567,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LI,,,,,,,3121,,,,,,,,,49,,,,,,,,,,,,,2003,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,57,,,,,,,,,,,,,,,,,,,,90875,,0.647654739,0,0,0,0,0.9054,1,,,Infiltrating Ductal Carcinoma,0.132615146,,0.106747194,0,0,0,,Close,-0.154,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1478,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Clinging, High Grade), No Detail Present",,"DCIS (Clinging, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.02,0.81,2,1,5,,,554,BRCA_LumA,554,554,,0,0,554,554,,Invasive Carcinoma,8,,21,,,,20721,0,,554,554,,,,554,554,,,554,,,,,,,,TUMOR FREE,Alive,-16458,,,,45,,554,554,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.064031,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SQ,,,,,,,554,,,,,,,,,4,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,90878,,-0.714233606,0,0,0,1,-2.3167,0,,,Infiltrating Ductal Carcinoma,0.136272275,,0.185380314,0,0,0,,Negative,-0.7955,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,-0.1092,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Low Grade), Stromal Alterations",,"DCIS (Cribriform, Low Grade)",0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,UDH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,,0.0,1.0,Male,TCGA-UY-A78K,White,BLCA,,0.0,0,,,,,MALE,2.0,4.81,0.27,8,16,27,,,536,,,536,,2.0,2,536.0,536.0,,Malignant,51,,75,,,,27846.0,,,536.0,536,,,,,536,,,536.0,,,,,,,,,Dead,-22020,536,,,1084.0,,536.0,536,,,[Not Available],[Not Applicable],,,,,0.44,,,,,22,,2,0.19085,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A78K,,,,,,,,,,,,,,,,66,,,,,,,,,,,,,,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,90884,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.16,0.23,5,15,8,,,428,BRCA_Her2,428,428,,0,0,428,428,,Invasive Carcinoma,28,,55,,,,31402,0,,428,428,,,,428,428,,,428,,,,,,,,TUMOR FREE,Alive,-27489,,,,151,,428,428,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,3,,0,0.099784,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Chicago,,TCGA-OL-A66P,,,,,,,428,,,,,,,,,10,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,90885,,,0,0,0,1,-0.4336,0,,,Infiltrating Ductal Carcinoma,,,,0,0,0,,Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,,1,0,H & E,0,0,,0,Guofeng Gao,"Apocrine Metaplasia, UDH",0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Low Grade), Stromal Alterations",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,"Apocrine Metaplasia, UDH",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.13,0.56,6,6,6,,,1363,BRCA_LumA,1363,1363,,0,0,1363,1363,,Invasive Carcinoma,18,,24,,,,20031,0,,1363,1363,,,,1363,1363,,,1363,,,,,,,,TUMOR FREE,Alive,-17996,,,,267,,1363,1363,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,10,,0,0.10344,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0W7,,,,,,,1363,,,,,,,,,9,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,90887,,1.504095224,0,0,0,1,0.6206,0,,,Infiltrating Ductal Carcinoma,0.177371825,,0.142981984,0,0,0,,Negative,0.8525,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.6212,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Low Grade), Stromal Alterations",,"DCIS (Cribriform, Low Grade)",0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,UDH,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-62-A472,White,LUAD,,1,1,,Thoraxklinik at University Hospital Heidelberg,1,0,MALE,1,3.57,0.4,4,3,8,,,910,,290,910,,1,1,290,290,,Malignant,15,,51,,,,17252,,,290,290,,,,290,910,,,290,,,,,,,,WITH TUMOR,Alive,-25893,,,,77,,290,290,,,[Not Available],[Not Applicable],,,,,0.24,,,,,18,,1,0.24761,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-62-A472,,,,,,,910,,Locoregional Recurrence,,,,,,,21,,,,,,,,,,,,,2011,290,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,90894,,0.813172853,,,,,,,,,,0.206257455,,0.084584917,,,,Stage IIB,,1.639,,,,,,,,,,,,,,,,-0.1577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.8730524,16.32006943,16.93526918,-0.107020281,LUAD,Adenocarcinoma,18.32788081,16.19640588,Adenocarcinoma,0.4961,10.70413502,0.6692,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,,,Black or African American,BRCA,,0,0,,,,0,FEMALE,0,3.27,0.91,6,15,15,,,518,BRCA_LumA,,518,,0,0,518,518,,Invasive Carcinoma,36,,98,,,,20355,0,,518,518,,,,,518,,,518,,,,,,,,TUMOR FREE,Alive,-26999,,,,190,,518,518,,,[Not Available],[Not Applicable],,,,,0.07,Breast,Resection/Excision,,,16,,1,0.093565,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],, Boston Medical Center,,TCGA-UL-AAZ6,,,,,,,518,,,,,,,,,25,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,90896,,-0.55487485,0,0,0,1,-0.1411,0,,,Infiltrating Ductal Carcinoma,0.110894291,,0.05669769,0,0,0,,[Not Available],-0.951,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,-0.0948,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Low Grade), Stromal Alterations",,"DCIS (Cribriform, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.15,0.19,2,0,4,,,2629,BRCA_LumA,2629,2629,,0,0,2629,2629,,Invasive Carcinoma,6,,5,,,,32057,0,,2629,2629,,,,2629,2629,,,2629,,,,,,,,TUMOR FREE,Alive,-23507,,,,37,,2629,2629,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,5,,0,0.063973,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AX,,,,,,,2629,,,,,,,,,7,,,,,,,,,,,,,2007,,,,,Stage I,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,90903,,1.856252197,1,0,0,1,-0.7576,0,,,Infiltrating Ductal Carcinoma,0.171072007,,0.202252122,0,0,0,,Negative,1.495,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3202,1,0,H & E,0,0,,0,Guofeng Gao,"ADH, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, Intermediate Grade), Stromal Alterations",,"DCIS (Cribriform, Intermediate Grade), DCIS (Micropapillary, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"ADH, UDH",0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-22-0940,White,LUSC,,1,1,,Mayo Clinic - Rochester,,1,MALE,1,1.82,0.4,14,11,15,,,669,,,669,,1,1,669,669,,Malignant,40,,42,,,,20313,,,669,669,,,,,669,,,669,,,,,,,,WITH TUMOR,Dead,-26272,669,,,290,,669,669,,,[Not Available],[Not Applicable],,,,,0.19,,,,,8,,0,0.37207,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-0940,,,,,,,608,,,,,,,,,16,,,,,,,,,,,,,2000,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,90906,,1.676238427,,,,,,,,,,0.212652275,,0.080800609,,,,Stage IIA,,1.781,,,,,,,,,,,,,,,,0.5271,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.67051112,16.48419796,17.83326219,0.242522352366992,LUSC,,18.0362596,16.91248651,Squamous Cell Carcinoma,0.7562,13.09442474,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-92-8064,White,LUSC,,0,0,,Washington University - St. Louis,0,0,MALE,0,3.0,0.31,12,8,17,,,160,,160,160,,0,0,160,160,,Malignant,37,,25,,,,27057,,,160,160,,,,160,160,,,160,,,,,,,,TUMOR FREE,Alive,-21417,,,,274,,160,160,,,[Not Available],[Not Applicable],,,,,0.17,,,,,20,,1,0.46778,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - St. Louis,,TCGA-92-8064,,,,,,,160,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,[Discrepancy],,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,90912,,1.7554989,,,,,,,,,,0.222037538,,0.088282042,,,,Unknown,,3.02,,,,,,,,,,,,,,,,0.5272,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,,,,0.25970981521786,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4603,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-3M-AB46,White,STAD,,0,0,,,0,0,,0,1.97,0.74,18,18,15,,,1765,,1765,1765,,0,0,1765,1765,,Malignant,51,,107,,,,16261,,,1765,1765,,,,1765,1765,,,1765,,,,,,,,TUMOR FREE,Alive,,,,,244,,1765,1765,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,9,,0,0.3642,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,University of Kansas Medical Center,,TCGA-3M-AB46,,,,,,,1765,,,,,,,,,22,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,90916,,-0.937908774,,,,,,,,,,0.046977407,Grade 2,0.034549665,,,,Stage IB,,-1.645,,,,,,,,,,,,,,,,-0.0763,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-3M-AB46,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,0,,0,1,Male,TCGA-77-A5FZ,Unknown,LUSC,,0,0,,Prince Charles Hospital,2,,MALE,2,2.0,0.46,0,0,0,,,3838,,3838,3838,,2,2,3838,3838,,Malignant,0,,8,,,,29552,,,3838,3838,,,,3838,3838,,,3838,,,,,,,,,Dead,-23436,3838,,,0,,3838,3838,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.00036985,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5FZ,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,2001,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,90920,,,,,,,,,,,,,,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,0.4756,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.31465535,17.63131571,16.59786259,0.132007863980053,LUSC,Squamous Cell Carcinoma,18.66480077,17.53772199,Squamous Cell Carcinoma,1.1013,13.84916076,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,2.13,0.56,9,17,18,,,472,BRCA_LumA,,472,,0,0,472,472,,Invasive Carcinoma,44,,51,,,,18572,0,,472,472,,,,,472,,,472,,,,,,,,TUMOR FREE,Alive,-24083,,,,93,,472,472,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,8,,0,0.23898,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1Y0,,,,,,,472,,,,,,,,,18,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,90922,,1.214712113,0,0,0,0,-0.0413,1,,,Infiltrating Ductal Carcinoma,0.167225259,,0.229159235,0,0,0,,[Not Available],0.6275,,10/21/22,0,0,0,1,0,0,0,0,0,0,N/A,0,0,0.343,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-4Z-AA81,White,BLCA,,0.0,0,,,2,2,MALE,2.0,3.47,0.55,2,5,11,,,1270,,1270,1270,,2.0,2,1270.0,1270.0,,Malignant,18,,40,,,,28237.0,,,1270.0,1270,,,,1270,1270,,,1270.0,,,,,,,,TUMOR FREE,Dead,-29457,1270,,,292.0,,1270.0,1270,,,[Not Available],[Not Applicable],,,,,0.21,,,,,17,,1,0.11828,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA81,,,,,,,,,,,,,,,,30,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,80.0,,,,,,,,,,,,,,,,,,,,90924,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-75-7027,,LUAD,,1,1,,Ontario Institute for Cancer Research (OICR),1,0,MALE,1,3.09,0.62,2,1,7,,,3059,,2949,3059,,1,1,2949,2949,,Malignant,10,,23,,,,20090,,,2949,2949,,,,2949,3059,,,2949,,,,,,,,TUMOR FREE,Alive,,,,,321,,2949,2949,,,[Not Available],[Not Applicable],,,,,0.1,,,,,19,,1,0.30516,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-7027,,,,,,,3059,,Locoregional Recurrence,,,,,,,28,,,,,,,,,,,,,,2949,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,90926,,0.612417238,,,,,,,,,,0.169351155,,0.146964791,,,,Stage IB,,0.153,,,,,,,,,,,,,,,,0.6371,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),R320W (driver),1,,G12V (driver),R320W (driver),,,,-0.575057402,LUAD,Adenocarcinoma,,,Adenocarcinoma,1.2623,,-0.6539,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-A9SZ,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.0,0.46,12,14,15,,,859,,,859,,1.0,1,854.0,854.0,,Malignant,41,,111,,,,20707.0,,,854.0,854,,,,,859,,,854.0,,,,,,,,WITH TUMOR,Dead,-29100,859,,,273.0,,854.0,854,,,[Not Available],[Not Applicable],,,,,0.11,,,,,2,,0,0.23374,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SZ,,,,,,,,Lung,Distant Metastasis,,,,,,,14,,,,,,,,,,,,,2007,854,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,79.0,,,,,,,,,,,,,,,,,,,,90928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-YF-AA3M,Unknown,BLCA,,1.0,1,,,1,0,MALE,1.0,4.75,0.68,6,9,21,,,415,,381,415,,1.0,1,381.0,381.0,,Malignant,36,,69,,,,29741.0,,,381.0,381,,,,381,415,,,381.0,,,,,,,,WITH TUMOR,Alive,-21097,,,,240.0,,381.0,381,,,[Not Available],[Not Applicable],,,,,0.22,,,,,20,,2,0.13387,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Puerto Rico,,TCGA-YF-AA3M,,,,,,,415,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,67,,,,,,,,,,,,,2013,381,Pelvis,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,57.0,,,,,,,,,,,,,,,,,,,,90929,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-UY-A9PB,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.84,0.33,12,15,17,,,899,,899,899,,0.0,0,899.0,899.0,,Malignant,44,,107,,,,24594.0,,,899.0,899,,,,899,899,,,899.0,,,,,,,,TUMOR FREE,Alive,-17885,,,,791.0,,899.0,899,,,[Not Available],[Not Applicable],,,,,0.53,,,,,12,,1,0.29545,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of California San Francisco,,TCGA-UY-A9PB,,,,,,,899,,,,,,,,,41,,,,,,,,,,,,,,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,49.0,,,,,,,,,,,,,,,,,,,,90940,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-KK-A8IM,,PRAD,,0,0,,KK,0,0,MALE,0,,,,,,HRP,NO,1915,,1915,1915,,0,0,1915,1915,prad_tcga,Malignant,,,,,TCGA-KK-A8IM-01,0,5537,0,TCGA-KK-A8IM,1915,1915,Prostate Cancer,,1438,1915,1915,TCGA,,1915,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20425,,55,7,33,PRAD,1915,1915,,0.0,[Not Available],[Not Applicable],30,,1,Matched,,Prostate,Resection,4,CBC53357-B90E-459C-AD5D-B9457084E2E7,,,,,[Not Available],4434864A-8A0D-488E-B9A7-6749719663E5,3,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,KK,1.03333333333,TCGA-KK-A8IM,0:DiseaseFree,3,12,Prostate Adenocarcinoma,62.91,8/18/14,1915,,,,,NO,C61,C0D3148F-A371-4983-9E62-DA5446385173,60,,TUMOR FREE,0.0571,0:LIVING,0.1,,62.91,Bilateral,14,,,YES,1466,2009,,,TCGA-KK-A8IM.C0D3148F-A371-4983-9E62-DA5446385173.pdf,Peripheral Zone,[Not Applicable],NO,,,5,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R0,,55,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T2a,,M0,C61.9,8140/3,90944,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-A9SP,White,BLCA,,1.0,1,,,,1,MALE,1.0,5.27,0.26,5,17,21,,,454,,,454,,1.0,1,310.0,310.0,,Malignant,43,,30,,,,20536.0,,,310.0,310,,,,,454,,,310.0,,,,,,,,WITH TUMOR,Dead,-21776,454,,,409.0,,310.0,310,,,[Not Available],[Not Applicable],,,,,0.41,,,,,23,,2,0.10735,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SP,,,,,,,,Renal Pelvis,Locoregional (Urothelial tumor event),,,,,,,61,,,,,,,,,,,,,2004,310,,,,Stage III,,,,,,,,Stable Disease,,,,,,59.0,,,,,,,,,,,,,,,,,,,,90952,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-L3-A524,White,LUSC,,0,0,,Gundersen Lutheran Health System,2,2,FEMALE,2,3.49,0.59,9,14,20,,,490,,490,490,,2,2,490,490,,Malignant,43,,195,,,,19558,,,490,490,,,,490,490,,,490,,,,,,,,TUMOR FREE,Dead,-16765,490,,,445,,490,490,,,[Not Available],[Not Applicable],,,,,0.32,,,,,19,,1,0.27647,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Gundersen Lutheran Health System,,TCGA-L3-A524,,,,,,,,,,,,,,,,36,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,45,,,,,,,,,,,,,,,,,,,,90955,,0.47153558,,,,,,,,,,0.13508618,,0.035795443,,,,Stage IIB,,0.0825,,,,,,,,,,,,,,,,0.2122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.12441551,14.87827224,15.44636511,-0.652046312328231,LUSC,Squamous Cell Carcinoma,17.879304,15.3596877,Squamous Cell Carcinoma,-0.2258,13.11902513,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,1,,1,1,Male,TCGA-60-2703,White,LUSC,,1,,,Roswell Park,1,,MALE,1,3.17,0.26,9,4,15,,,2945,,1757,2945,,1,,1757,1757,,Malignant,28,,25,,,,16901,,,1757,,,,,1757,2945,,,1757,,,,,,,,,Dead,-27003,2945,,,401,,1757,,,,[Not Available],[Not Applicable],,,,,0.26,,,,,19,,1,0.39545,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2703,,,,,,,,,,,,,,,,23,,,,,,,,,,,,,2002,1757,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,90957,,0.210412162,,,,,,,,,,0.19410254,,0.114634222,,,,Stage IIB,,-0.283,,,,,,,,,,,,,,,,0.8031,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),AMP (driver),,1,,,,14.84009407,15.1211461,13.74656569,-0.700412224440788,LUSC,Squamous Cell Carcinoma,17.94021933,15.24651953,Squamous Cell Carcinoma,1.6005,14.82117503,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-66-2795,,LUSC,,0,0,,Indivumed,,0,MALE,0,2.04,0.66,9,11,19,,,122,,,122,,0,0,122,122,,Malignant,39,,52,,,,18145,,,122,122,,,,,122,,,122,,,,,,,,TUMOR FREE,Alive,-24897,,,,385,,122,122,,,[Not Available],[Not Applicable],,,,,0.19,,,,,8,,0,0.28661,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2795,,,,,,,122,,,,,,,,,13,,,,,,,,,,,,,2008,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,90963,,0.702887752,,,,,,,,,,0.206826463,,0.092370666,,,,Stage IIIB,,0.441,,,,,,,,,,,,,,,,0.4091,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.73536136,16.71086252,15.94205812,-0.126515366802649,LUSC,Squamous Cell Carcinoma,18.17007426,15.68143168,Squamous Cell Carcinoma,1.1768,13.71451118,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-66-2755,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.9,0.3,7,7,13,,,28,,,28,,0,0,28,28,,Malignant,27,,26,,,,17074,,,28,28,,,,,28,,,28,,,,,,,,TUMOR FREE,Alive,-23348,,,,302,,28,28,,,[Not Available],[Not Applicable],,,,,0.15,,,,,13,,1,0.25388,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2755,,,,,,,28,,,,,,,,,26,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,90964,,1.056028054,,,,,,,,,,0.255358741,,0.12046199,,,,Stage IB,,2.2155,,,,,,,,,,,,,,,,0.2997,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.127911131462719,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.3243,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-49-4494,White,LUAD,,1,1,,Johns Hopkins,,1,MALE,1,2.05,0.46,6,6,3,,,1081,,,1081,,1,1,1081,1081,,Malignant,15,,19,,,,20702,,,1081,1081,,,,,1081,,,1081,,,,,,,,WITH TUMOR,Dead,-28387,1081,,,257,,1081,1081,,,[Not Available],[Not Applicable],,,,,0.32,,,,,3,,0,0.2271,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4494,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,1995,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,90965,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0655,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"L858R (driver), T790M (driver)",,,1,"L858R (driver), T790M (driver)",,,15.83983572,16.56385538,16.03537556,-0.171017566,LUAD,,17.59504698,15.01237642,Adenocarcinoma,,12.61159328,0.5365,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,,1,1,Male,TCGA-MP-A4TD,White,LUAD,,1,1,,Washington University - Mayo Clinic,1,,MALE,1,,,,,,,,307,,226,307,,1,1,226,226,,Malignant,,,,,,,21547,,,226,226,,,,226,307,,,226,,,,,,,,,Dead,-25983,307,,,103,,226,226,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Mayo Clinic,,TCGA-MP-A4TD,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2008,226,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,90967,,0.786184523,,,,,,,,,,0.21012677,,0.189499328,,,,Stage IIIA,,0.3175,,,,,,,,,,,,,,,,0.4576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,15.49597516,16.27717939,14.49327867,-0.482216459,LUAD,Adenocarcinoma,18.445519,15.92963141,Adenocarcinoma,0.6097,13.4814667,-0.5635,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SI,,PRAD,,1,1,,YL,1,0,MALE,1,1.95,0.19,1,4,0,HRP,NO,1614,,1423,1614,,1,1,1423,1423,prad_tcga,Malignant,5,,21,,TCGA-YL-A8SI-01,0,5669,0,TCGA-YL-A8SI,1423,1423,Prostate Cancer,,1441,1423,1614,TCGA,,1423,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25292,,69,9,23,PRAD,1423,1423,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.03,Prostate,Resection,4,489EA5D8-AE40-405B-BBF5-E0E091193270,0,Normal (no evidence of prostate cancer) [cM0],0,0.030508,[Not Available],C5F8C89C-EF69-42F4-9B37-5B552FCCDF4B,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,YL,0.833333333333,TCGA-YL-A8SI,1:Recurred/Progressed,5,6,Prostate Adenocarcinoma,46.75,4/25/14,1614,,Biochemical evidence of disease,,,NO,C61,30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE,390,0,WITH TUMOR,0.0146,0:LIVING,0.48,,53.02,Bilateral,8,No Evidence of Extraprostatic Extension,62,YES,1345,2010,1423,,TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,47,,15,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,1423,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,90968,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,3.43,0.55,8,14,14,,,2184,BRCA_LumB,2184,2184,,0,0,2184,2184,,Invasive Carcinoma,36,,54,,,,19209,0,,2184,2184,,,,2184,2184,,,2184,,,,,,,,TUMOR FREE,Alive,-14653,,,,70,,2184,2184,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,11,,1,0.17807,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JM,,,,,,,2184,,,,,,,,,21,,,,,,,,,,,,,2005,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,90970,,0.529848168,0,0,0,0,0.2141,1,,,Infiltrating Ductal Carcinoma,0.150592999,,0.156135576,0,0,0,,Negative,-0.447,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.5635,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,1,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skeletal Muscle",Stromal Alterations,"DCIS (Cribriform, Low Grade), Stromal Alterations",,"DCIS (Cribriform, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Female,TCGA-XF-A9T5,White,BLCA,,1.0,1,,,,0,FEMALE,1.0,3.19,0.45,11,5,11,,,2027,,,2027,,1.0,1,664.0,664.0,,Malignant,27,,138,,,,27440.0,,,664.0,664,,,,,2027,,,664.0,,,,,,,,TUMOR FREE,Alive,-28578,,,,930.0,,664.0,664,,,[Not Available],[Not Applicable],,,,,0.04,,,,,21,,1,0.22878,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9T5,,,,,,,2027,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,35,,,,,,,,,,,,,2008,664,Vagina,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,78.0,,,,,,,,,,,,,,,,,,,,90971,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.24,0.6,13,15,16,,,829,BRCA_LumA,829,829,,0,0,829,829,,Invasive Carcinoma,44,,45,,,,22135,0,,829,829,,,,829,829,,,829,,,,,,,,TUMOR FREE,Alive,-19900,,,,108,,829,829,,,[Not Available],[Not Applicable],,,,,0.44,Breast,Resection/Excision,,,16,,1,0.31627,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HX,,,,,,,829,,,,,,,,,25,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,90974,,-0.00750518,0,0,0,0,0.206,1,,,Infiltrating Ductal Carcinoma,0.17202651,,0.204938253,0,0,0,,Negative,-0.4265,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.4108,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Female,TCGA-BR-8060,White,STAD,,0,0,,,2,2,,2,,,,,,,,348,,348,348,,2,2,348,348,,Malignant,,,,,,,18493,,,348,348,,,,348,348,,,348,,,,,,,,TUMOR FREE,Dead,-27561,348,,,303,,348,348,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8060,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,90975,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8060,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-VQ-A924,Unknown,STAD,,1,1,,,,1,,1,1.99,0.6,0,0,0,,,1686,,,1686,,1,1,1686,1686,,Malignant,0,,14,,,,16972,,,1686,1686,,,,,1686,,,1686,,,,,,,,WITH TUMOR,Dead,-25351,1686,,,1876,,1686,1686,,,Stomach Cancer,[Not Applicable],,,,,0.0,Stomach,Unknown,,,0,,0,0.01296,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-A924,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,2008,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,69,,,,,,,,,,,,,,,,,,,,90976,,0.701507595,,,,,,,,,,0.08679873,Grade 2,0.014772082,,,,Stage II,,0.9705,,,,,,,,,,,,,,,,0.1658,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A924,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Female,TCGA-BR-A4IU,Asian,STAD,,0,0,,,0,0,,0,2.23,0.19,1,8,6,,,838,,838,838,,0,0,838,838,,Malignant,15,,25,,,,34101,,,838,838,,,,838,838,,,838,,,,,,,,TUMOR FREE,Alive,-12601,,,,28,,838,838,,,[Not Available],[Not Applicable],,,,,0.35,Stomach,Unknown,,,3,,0,0.11071,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4IU,,,,,,,838,,,,,,,,,10,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,34,,,,,,,,,,,,,,,,,,,,90979,,0.496768356,,,,,,,,,,0.121286371,Grade 3,0.167203778,,,,Stage IIIA,,0.243,,,,,,,,,,,,,,,,0.3549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4IU,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0.0,0,0,0.0,0.0,Male,TCGA-2F-A9KT,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.62,0.41,5,9,12,,,3314,,3314,3314,,0.0,0,3314.0,3314.0,,Malignant,26,,70,,,,27942.0,,,3314.0,3314,,,,3314,3314,,,3314.0,,,,,,,,TUMOR FREE,Alive,-30520,,,,470.0,,3314.0,3314,,,[Not Available],[Not Applicable],,,,,0.08,,,,,10,,1,0.1822,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Erasmus MC,,TCGA-2F-A9KT,,,,,,,3314,,,,,,,,,15,,,,,,,,,,,,,2006,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,83.0,,,,,,,,,,,,,,,,,,,,90989,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,1.83,0.52,10,2,8,,,571,BRCA_Her2,489,571,,1,1,489,489,,Invasive Carcinoma,20,,33,,,,19750,0,,489,489,,,,489,571,,,489,,,,,,,,WITH TUMOR,Dead,-23150,571,,,277,,489,489,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,13,,0,0.39026,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0IK,,,,,,,,Brain,Distant Metastasis,,,,,,,12,,,,,,,,,,,,,1994,489,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,90990,,0.480840366,1,0,0,0,0.0329,0,,,Infiltrating Ductal Carcinoma,0.124539308,,0.15224379,0,0,0,,Negative,-0.4295,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,0.2226,1,0,H & E,0,0,,0,Murray Resnick,ADH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skin",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,ADH,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.3,3,3,6,,,568,BRCA_LumA,568,568,,0,0,568,568,,Invasive Carcinoma,12,,21,,,,28307,0,,568,568,,,,568,568,,,568,,,,,,,,TUMOR FREE,Alive,-17521,,,,37,,568,568,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,5,,0,0.068375,[Not Available],,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A6IV,,,,,,,568,,,,,,,,,6,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,47,,,,,,,,,,,,,,,,,,,,90994,,0.889925986,0,0,0,1,-0.5536,0,,,Infiltrating Lobular Carcinoma,0.226118318,,0.29482031,0,0,0,,Negative,0.558,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6121,0,0,H & E,0,0,,0,Murray Resnick,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,UDH,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-43-A56V,Black or African American,LUSC,,1,1,,Christiana Healthcare,1,0,MALE,1,1.75,0.57,13,5,14,,,366,,355,366,,1,1,355,355,,Malignant,32,,114,,,,32283,,,355,355,,,,355,366,,,355,,,,,,,,WITH TUMOR,Alive,-22475,,,,291,,355,355,,,[Not Available],[Not Applicable],,,,,0.34,,,,,15,,0,0.44448,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-A56V,,,,,,,366,,Locoregional Recurrence|Distant Metastasis,,,,,,,15,,,,,,,,,,,,,2012,355,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,90998,,0.211657122,,,,,,,,,,0.173416724,,0.044509668,,,,Stage IIIA,,-0.037,,,,,,,,,,,,,,,,0.4257,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.79192623,15.17751236,14.71050203,-0.734582780656212,LUSC,Squamous Cell Carcinoma,17.81502425,15.21784581,Squamous Cell Carcinoma,-0.2243,13.60756794,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-2A-A8VO,,PRAD,389,0,0,,2A,,0,MALE,0,1.98,0.55,2,3,0,HRP,NO,1701,8-other,,1701,,0,0,1701,1701,prad_tcga,Malignant,5,,27,,TCGA-2A-A8VO-01,0,5226,0,TCGA-2A-A8VO,1701,1701,Prostate Cancer,84,1332,,1701,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),1701,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-20958,,57,6,41,PRAD,1701,1701,,0.0,[Not Available],[Not Applicable],33,R1,1,Matched,0.0,Prostate,Resection,3,0BD35529-3416-42DD-A96A-4511A329760A,0,Normal (no evidence of prostate cancer) [cM0],0,0.023462,[Not Available],91C0D161-2B59-4B7A-8C19-6D26DEA31849,3,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,2A,1.1,TCGA-2A-A8VO,0:DiseaseFree,1,9,Prostate Adenocarcinoma,55.88,3/30/14,1701,,,,,YES,C61,B699D2D8-1EB6-4BFE-A468-D1FFA5F32D98,110,0,TUMOR FREE,0.0211,0:LIVING,0.05,4,55.88,Bilateral,11,No Evidence of Extraprostatic Extension,11,YES,1290,2010,,,TCGA-2A-A8VO.B699D2D8-1EB6-4BFE-A468-D1FFA5F32D98.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,22,66-75%,,Prostate Adenocarcinoma Acinar Type,1,2010,[Not Available],,NO,No,R1,,57,Core needle biopsy,,,NO,YES,NO,NO,T3a,NO,6,No,NO,0,,T1c,,M0,C61.9,8140/3,91000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-KK-A6E7,,PRAD,,1,1,,KK,,0,MALE,1,3.8,0.57,3,3,3,ambiguous,NO,2760,,,2760,,1,1,925,925,prad_tcga,Malignant,9,BRCA2;PALB2,30,,TCGA-KK-A6E7-01,0,5506,0,TCGA-KK-A6E7,925,925,Prostate Cancer,8,1847,,2760,TCGA,No Evidence of Extraprostatic Extension|Equivocal,925,Primary,0,Apex|Middle,A,,,True,WITH TUMOR,Alive,-17074,,46,9,37,PRAD,925,925,,0.0,[Not Available],[Not Applicable],35,,1,Matched,0.13,Prostate,Resection,5,B8852BA4-D41A-434D-9EC8-DC44961B6E77,5,Normal (no evidence of prostate cancer) [cM0],1,0.060156,[Not Available],25C669B3-4D4A-4142-A403-677BE8522875,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,KK,1.1,TCGA-KK-A6E7,1:Recurred/Progressed,5,10,Prostate Adenocarcinoma,30.39,3/27/14,2760,,Biochemical evidence of disease,,,YES,C61,8173D1A9-5564-4824-AFD6-2097B90F4008,40,6,WITH TUMOR,0.0965,0:LIVING,0.1,,90.67,Bilateral,16,No Evidence of Extraprostatic Extension,-45,YES,2151,2007,925,,TCGA-KK-A6E7.8173D1A9-5564-4824-AFD6-2097B90F4008.pdf,Transition Zone,[Not Applicable],YES,-46,,11,Prostate Adenocarcinoma Acinar Type,1,2007,Partial Remission/Response,,NO,No,R1,,46,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,9,No,NO,0,N1,T1c,1,M0,C61.9,8140/3,91001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-L5-A4OI,White,ESCA,,1,1,,,,0,,1,2.17,0.83,1,3,4,,,608,,,608,,1,1,267,267,,Malignant,8,,34,,,,20333,,,267,267,,,,,608,,,267,,,,,,,,WITH TUMOR,Alive,-29190,,,,3979,,267,267,,,[Not Available],[Not Available],,,,,0.01,Esophagus,Unknown,,,5,,0,0.014935,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,University of Michigan,,TCGA-L5-A4OI,,,,,,,608,"Other, specify",Locoregional Recurrence,,,,,,,7,,,,,,,,,,,,,2012,267,Lymph Node,,,Stage IIIC,,,,,,,,Stable Disease,,,,,,79,,,,,,,,,,,,,,,,,,,,91003,,,,,,,,,,,,,Grade 2,,,,,Stage IIIC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,1,,0,0,1,Male,TCGA-66-2789,,LUSC,,0,0,,Indivumed,,2,MALE,2,1.97,0.55,14,10,20,,,123,,,123,,2,2,123,123,,Malignant,44,,59,,,,30172,,,123,123,,,,,123,,,123,,,,,,,,TUMOR FREE,Dead,-26753,123,,,462,,123,123,,,[Not Available],[Not Applicable],,,,,0.12,,,,,13,,0,0.33408,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2789,,,,,,,,,,,,,,,,16,,,,,,,,,,,,,2008,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,91007,,0.147882485,,,,,,,,,,0.258107885,,0.151819307,,,,Stage IIIB,,-0.025,,,,,,,,,,,,,,,,0.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.7924351,16.42816824,14.46415627,-0.342142825712037,LUSC,Squamous Cell Carcinoma,17.80583264,15.58878066,Squamous Cell Carcinoma,0.9537,14.37263243,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-86-7954,White,LUAD,,0,0,,Asterand,0,0,FEMALE,0,4.41,0.27,1,17,14,,,605,,605,605,,0,0,605,605,,Malignant,32,,27,,,,20600,,,605,605,,,,605,605,,,605,,,,,,,,TUMOR FREE,Alive,-25062,,,,274,,605,605,,,[Not Available],[Not Applicable],,,,,0.13,,,,,24,,2,0.17861,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Asterand,,TCGA-86-7954,,,,,,,605,,,,,,,,,61,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,91010,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,0.045745411,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.4587,,0.3965,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,3.39,0.7,8,8,11,,,2127,BRCA_Her2,2127,2127,,2,2,2127,2127,,Invasive Carcinoma,27,,41,,,,25245,0,,2127,2127,,,,2127,2127,,,2127,,,,,,,,TUMOR FREE,Dead,-28724,2127,,,94,,2127,2127,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,21,,1,0.15977,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A1EN,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,1999,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,91027,,-0.649100897,0,0,0,0,-0.3037,1,,,Infiltrating Ductal Carcinoma,0.128004528,,0.180727233,0,0,0,,Negative,-0.1105,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1619,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.04,0.66,2,1,3,,,541,BRCA_LumB,541,541,,0,0,541,541,,Invasive Carcinoma,6,,2,,,,28617,0,,541,541,,,,541,541,,,541,,,,,,,,TUMOR FREE,Alive,-29256,,,,49,,541,541,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,11,,1,0.024103,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1X6,,,,,,,541,,,,,,,,,15,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,80,,,,,,,,,,,,,,,,,,,,91028,,-0.026681562,0,0,0,0,-3.9885,1,,,Infiltrating Ductal Carcinoma,0.142105645,,0.064838604,0,0,0,,Negative,-0.8915,,10/21/22,0,0,0,1,0,0,0,0,0,0,Not Answered,0,0,-0.1688,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,"Adipose Tissue, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,,1,1,Male,TCGA-22-5477,White,LUSC,,1,,,Mayo Clinic - Rochester,1,,MALE,1,3.51,0.73,14,12,19,,,1346,,511,1346,,1,,511,511,,Malignant,45,,53,,,,16024,,,511,,,,,511,1346,,,511,,,,,,,,,Dead,-24055,1346,,,226,,511,,,,[Not Available],[Not Applicable],,,,,0.4,,,,,12,,1,0.3468,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5477,,,,,,,1346,,,,,,,,,30,,,,,,,,,,,,,2004,511,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,91030,,0.558331532,,,,,,,,,,0.153680416,,0.061801154,,,,Stage IA,,1.625,,,,,,,,,,,,,,,,0.0185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,AMP (driver),,1,,,,,,,-0.383286125973424,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.3337,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,1.0,1.0,Female,TCGA-GD-A3OS,White,BLCA,,1.0,1,,,,0,FEMALE,1.0,2.56,0.72,11,14,16,,,638,,,638,,1.0,1,223.0,223.0,,Malignant,41,,75,,,,25168.0,,,223.0,223,,,,,638,,,223.0,,,,,,,,WITH TUMOR,Alive,-19776,,,,123.0,,223.0,223,,,[Not Available],[Not Applicable],,,,,0.12,,,,,20,,1,0.39426,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - IUPUI,,TCGA-GD-A3OS,,,,,,,638,Bladder,Locoregional (Urothelial tumor event),,,,,,,42,,,,,,,,,,,,,2011,223,,,,Stage II,,,,,,,,Progressive Disease,,,,,,54.0,,,,,,,,,,,,,,,,,,,,91037,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-85-A513,Asian,LUSC,,0,0,,Asterand,0,0,FEMALE,0,2.07,0.24,8,9,7,,,910,,910,910,,0,0,910,910,,Malignant,24,,48,,,,21700,,,910,910,,,,910,910,,,910,,,,,,,,TUMOR FREE,Alive,-21967,,,,30,,910,910,,,[Not Available],[Not Applicable],,,,,0.25,,,,,4,,0,0.12852,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A513,,,,,,,910,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,91041,,1.299554899,,,,,,,,,,0.255175483,,0.177850533,,,,Stage IA,,1.5805,,,,,,,,,,,,,,,,0.3023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0594580853803032,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.8703,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,91053,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5542,White,PRAD,91,0,0,,EJ,0,0,MALE,0,2.03,0.58,1,1,2,HRP,NO,1513,1-ERG,1513,1513,,0,0,1513,1513,prad_tcga,Malignant,4,,33,19.3,TCGA-EJ-5542-01,0,5293,0,TCGA-EJ-5542,1513,1513,Prostate Cancer,-21,519,1513,1513,TCGA,No Evidence of Extraprostatic Extension,1513,Primary,0,Apex|Middle|Base,A,,,,TUMOR FREE,Alive,-21942,,60,7,37,PRAD,1513,1513,WHITE,0.0,[Not Available],[Not Applicable],41,R0,1,Matched,0.07,Prostate,Resection,3,dffc7994-e957-4451-a9db-56d4560d6547,2,Normal (no evidence of prostate cancer) [cM0],0,0.027786,[Not Available],5a92ec4c-36ee-4588-aca2-e3303f29c7ad,4,Prostate Adenocarcinoma Acinar Type,1.7,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.4,EJ,1.36666666667,TCGA-EJ-5542,0:DiseaseFree,2,9,Prostate Adenocarcinoma,49.7,4/4/12,1513,,,,,YES,C61,d6fe7cc6-45e5-4b6c-b1f4-1dd7fd3c27be,,1,TUMOR FREE,0.0794,0:LIVING,0.1,3,49.7,Bilateral,13,No Evidence of Extraprostatic Extension,9,YES,,2010,,,TCGA-EJ-5542.d6fe7cc6-45e5-4b6c-b1f4-1dd7fd3c27be.pdf,,[Not Applicable],YES,8,61-70%,17,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,Yes,R0,0.9,60,Core needle biopsy,,,YES,NO,YES,,T3a,,7,No,,0,N0,T2b,0,M0,C61.9,8550/3,91056,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-HC-7079,White,PRAD,161,1,1,,HC,,0,MALE,1,2.0,0.91,0,0,0,HRP,NO,1184,4-FLI1,,1184,,1,1,380,380,prad_tcga,Malignant,0,,19,5.5,TCGA-HC-7079-01,0,5404,0,TCGA-HC-7079,380,380,Prostate Cancer,,126,,1184,TCGA,,380,Primary,0,Apex|Middle|Base,A,,,,WITH TUMOR,Alive,-18734,,51,7,0,PRAD,380,380,WHITE,0.0,[Not Available],[Not Applicable],6,R0,1,Matched,0.0,Prostate,Resection,3,190ef71a-5b5d-4009-b707-68f10147cb65,0,,0,1.42e-05,[Not Available],10fbe481-f111-4f88-ae45-4d67cb265567,4,Prostate Adenocarcinoma Acinar Type,0.9,Prostate,0,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,0.2,TCGA-HC-7079,1:Recurred/Progressed,2,1,Prostate Adenocarcinoma,12.48,4/10/12,1184,,Biochemical evidence of disease,,,NO,C61,8e42fce1-33e7-45e1-b8e9-2faf5a02766d,,0,WITH TUMOR,0.0,0:LIVING,0.1,,38.9,Bilateral,2,,,YES,,2010,380,,TCGA-HC-7079.8e42fce1-33e7-45e1-b8e9-2faf5a02766d.pdf,,[Not Applicable],NO,,36-45%,4,Prostate Adenocarcinoma Acinar Type,1,2010,Partial Remission/Response,,,No,R0,0.6,51,Core needle biopsy,,,NO,YES,YES,,T3a,,7,No,,0,N0,T3a,0,M0,C61.9,8550/3,91061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.81,0.62,17,16,18,,,2190,BRCA_LumB,2190,2190,,0,0,2190,2190,,Invasive Carcinoma,51,,106,,,,24811,0,,2190,2190,,,,2190,2190,,,2190,,,,,,,,TUMOR FREE,Alive,-21831,,,,166,,2190,2190,,,[Not Available],[Not Applicable],,,,,0.32,Breast,Resection/Excision,,,6,,0,0.367,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JD,,,,,,,2190,,,,,,,,,11,,,,,,,,,,,,,2005,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,59,,,,,,,,,,,,,,,,,,,,91062,,0.690318998,1,0,0,0,0.3051,0,,,Infiltrating Ductal Carcinoma,0.142620923,,0.068112236,0,0,0,,Negative,0.0075,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2067,1,0,H & E,0,0,,0,Murray Resnick,ADH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,ADH,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,,1,1,,,White,BRCA,,1,1,,,1,,FEMALE,1,2.02,0.23,0,0,0,,,616,BRCA_Normal,434,616,,1,1,434,434,,Invasive Carcinoma,0,,19,,,,20138,0,,434,434,,,,434,616,,,434,,,,,,,,,Dead,-20288,616,,,66,,434,434,,,[Not Available],[Not Applicable],,,,,0.4,Breast,Resection/Excision,,,2,,0,0.031066,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A2LH,,,,,,,,Bone,Distant Metastasis,,,,,,,2,,,,,,,,,,,,,2007,434,,,,Stage III,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,91063,,1.260973329,0,0,0,0,1.4338,1,,,Infiltrating Lobular Carcinoma,0.182984833,,0.242007333,0,0,0,,Negative,0.8255,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.2354,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Low Grade), DCIS (Solid, Low Grade), No Detail Present",,"DCIS (Cribriform, Low Grade), DCIS (Solid, Low Grade)",0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,1,1,Female,TCGA-49-4488,White,LUAD,,1,,,Johns Hopkins,,,FEMALE,1,4.96,0.45,16,13,30,,,869,,,869,,1,,634,634,,Malignant,59,,90,,,,18518,,,634,,,,,,869,,,634,,,,,,,,,Dead,-27332,869,,,400,,634,,,,[Not Available],[Not Applicable],,,,,0.51,,,,,22,,2,0.36133,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4488,,,,,,,,,,,,,,,,55,,,,,,,,,,,,,1992,634,,,,Stage IA,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,91067,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.0332,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,Q284L,1,,,Q284L,,,,-0.149715064,LUAD,,,,Adenocarcinoma,,,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,1,1,1,Male,TCGA-BR-8367,White,STAD,,1,1,,,1,1,,1,2.1,0.38,2,6,3,,,801,,580,801,,1,1,580,580,,Malignant,11,,16,,,,23938,,,580,580,,,,580,801,,,580,,,,,,,,WITH TUMOR,Dead,-20441,801,,,80,,580,580,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,1,,0,0.038297,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8367,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,3,,,,,,,,,,,,,2011,580,"Adrenal gland, bone",,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,91069,,-0.046904636,,,,,,,,,,0.122565715,Grade 3,0.155069684,,,,Stage IIIB,,-0.1465,,,,,,,,,,,,,,,,0.4136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8367,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-EJ-A46I,,PRAD,285,0,0,,EJ,0,0,MALE,0,,,,,,,NO,668,8-other,668,668,,0,0,668,668,prad_tcga,Malignant,,,,8.5,TCGA-EJ-A46I-01,0,5340,0,TCGA-EJ-A46I,668,668,Prostate Cancer,,484,668,668,TCGA,,668,Primary,0,,A,,,True,TUMOR FREE,Alive,-21046,,57,7,10,PRAD,668,668,,0.0,[Not Available],[Not Applicable],10,R0,1,Matched,,Prostate,Resection,3,2EB58022-5F91-4F18-A35C-17DFC457599B,,,,,[Not Available],9B59ED95-E97F-4356-B976-E3FA0E9EEE02,4,Prostate Adenocarcinoma Acinar Type,,Prostate,,,Acinar Adenocarcinoma,[Not Available],,EJ,0.4,TCGA-EJ-A46I,0:DiseaseFree,2,,Prostate Adenocarcinoma,21.94,1/24/13,668,,,,,,C61,741CC282-0593-45E4-BEEB-343339F891AA,150,,TUMOR FREE,0.0,0:LIVING,0.1,,21.94,Bilateral,,,,YES,520,2011,,,TCGA-EJ-A46I.741CC282-0593-45E4-BEEB-343339F891AA.pdf,,[Not Applicable],,,41-50%,,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,57,,,Complete Remission/Response,YES,NO,,NO,T3a,NO,7,No,NO,0,N0,T1c,,M0,C61.9,8140/3,91074,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-77-8148,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,3.29,0.68,13,15,17,,,2023,,2023,2023,,0,0,2023,2023,,Malignant,45,,41,,,,16988,,,2023,2023,,,,2023,2023,,,2023,,,,,,,,,Alive,-24918,,,,334,,2023,2023,,,[Not Available],[Not Applicable],,,,,0.6,,,,,18,,1,0.27535,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8148,,,,,,,2023,,,,,,,,,26,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,91079,,0.956381539,,,,,,,,,,0.176561307,,0.038091983,,,,Stage IIIA,,0.2965,,,,,,,,,,,,,,,,0.4674,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,15.16797707,15.77044123,15.59686678,-0.41138726454432,LUSC,Squamous Cell Carcinoma,18.11759347,15.87499894,Squamous Cell Carcinoma,0.299,13.8831767,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,2248,,2248,2248,,0,0,2248,2248,,Invasive Carcinoma,,,,,,,17315,0,,2248,2248,,,,2248,2248,,,2248,,,,,,,,TUMOR FREE,Alive,-27934,,,,0,,2248,2248,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A23G,,,,,,,2248,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,91084,,0.304848743,0,0,0,0,0.4968,1,,,Infiltrating Lobular Carcinoma,0.242746086,,0.295619178,0,0,0,,Negative,0.11,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.9977,0,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-BR-A453,Asian,STAD,,0.0,0,,,,2,,2.0,2.0,0.46,0,1,0,,,185,,,185,,2.0,2,185,185,,Malignant,1,,8,,,,19929.0,0,,185,185,,,,,185,,,185,,,,,,,,TUMOR FREE,Dead,-18988,185,,,65.0,,185,185,,,[Not Available],[Not Applicable],,,,,0.11,Stomach,Resection,,,0,,0,0.0057666,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A453,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,51,,,,,,,,,,,,,,,,,,,,91090,,0.168582058,,,,,,,,,,0.104776901,Grade 3,0.233419149,,,,Stage IV,,-0.3325,,,,,,,,,,,,,,,,0.5505,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A453,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,1,1,1,1,1,Male,TCGA-43-5668,White,LUSC,,1,,,Christiana Healthcare,1,1,MALE,1,3.09,0.34,13,8,23,,,559,,470,559,,1,,470,470,,Malignant,44,,66,,,,19208,,,470,,,,,470,559,,,470,,,,,,,,WITH TUMOR,Dead,-28635,559,,,865,,470,,,,[Not Available],[Not Applicable],,,,,0.19,,,,,15,,1,0.33367,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-5668,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2010,470,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,91099,,1.743318061,,,,,,,,,,0.231254757,,0.085247492,,,,Stage IIA,,1.8075,,,,,,,,,,,,,,,,0.0301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.54318628,17.69434801,17.50602561,0.140964640100702,LUSC,,17.90435562,16.62567902,Squamous Cell Carcinoma,0.4419,13.15728566,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-96-8170,White,LUSC,,0,0,,Washington University - NYU,0,0,FEMALE,0,1.96,0.35,5,1,7,,,531,,531,531,,0,0,531,531,,Malignant,13,,17,,,,20326,,,531,531,,,,531,531,,,531,,,,,,,,TUMOR FREE,Alive,-27558,,,,325,,531,531,,,[Not Available],[Not Applicable],,,,,0.01,,,,,11,,0,0.1832,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - NYU,,TCGA-96-8170,,,,,,,531,,,,,,,,,11,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,91100,,0.367199203,,,,,,,,,,0.215353573,,0.102769923,,,,Stage IIA,,0.059,,,,,,,,,,,,,,,,0.3315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.1571637,17.88102513,13.27425494,-0.665323458241547,LUSC,Squamous Cell Carcinoma,17.85001752,15.40541896,Squamous Cell Carcinoma,-0.6806,13.96941804,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-FJ-A871,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.99,0.81,3,3,2,,,272,,,272,,1.0,1,106.0,106.0,,Malignant,8,,33,,,,24621.0,,,106.0,106,,,,,272,,,106.0,,,,,,,,WITH TUMOR,Dead,-18051,272,,,71.0,,106.0,106,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.029834,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A871,,,,,,,,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,0,,,,,,,,,,,,,2013,106,Pelvic,,,Stage III,,,,,,,,Progressive Disease,,,,,,49.0,,,,,,,,,,,,,,,,,,,,91102,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.13,0.54,3,1,3,,,441,BRCA_LumA,441,441,,0,0,441,441,,Invasive Carcinoma,7,,49,,,,32115,0,,441,441,,,,441,441,,,441,,,,,,,,TUMOR FREE,Alive,-22416,,,,93,,441,441,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,6,,0,0.056335,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A740,,,,,,,441,,,,,,,,,5,,,,,,,,,,,,,2013,,,,,Stage IA,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,91104,,0.508569452,0,0,0,1,0.8022,0,,,Infiltrating Ductal Carcinoma,0.184930706,,0.212414143,0,0,0,,Negative,-0.446,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.5438,1,0,H & E,0,0,,0,Murray Resnick,"Columnar Lesion, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Columnar Lesion, UDH",0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Female,TCGA-55-8513,White,LUAD,,1,1,,International Genomics Consortium,1,0,FEMALE,1,2.0,0.5,0,0,0,,,791,,317,791,,1,1,317,317,,Malignant,0,,5,,,,21104,,,317,317,,,,317,791,,,317,,,,,,,,WITH TUMOR,Alive,-28284,,,,8,,317,317,,,[Not Available],[Not Applicable],,,,,0.0,,,,,0,,0,0.0010095,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8513,,,,,,,791,,Distant Metastasis,,,,,,,0,,,,,,,,,,,,,2012,317,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,91105,,0.607865562,,,,,,,,,,0.304184971,,0.214488612,,,,Stage IIB,,0.924,,,,,,,,,,,,,,,,0.1079,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.80192359,18.60276769,15.36525917,-0.212929811,LUAD,Adenocarcinoma,18.05916231,15.57107114,Adenocarcinoma,-0.9259,13.94526136,-0.7504,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,,,,,,,,197,,197,197,,2,2,197,197,,Invasive Carcinoma,,,,,,,24576,0,,197,197,,,,197,197,,,197,,,,,,,,TUMOR FREE,Dead,-29014,197,,,0,,197,197,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3EH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,91110,,-0.647646231,0,0,0,0,0.9649,1,,,Infiltrating Lobular Carcinoma,0.125078285,,0.124656028,0,0,0,,Negative,-0.312,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.5117,0,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-YL-A9WY,,PRAD,,1,1,,YL,,0,MALE,1,3.69,0.3,7,13,12,ambiguous,NO,1098,,,1098,,1,1,765,765,prad_tcga,Malignant,32,,56,,TCGA-YL-A9WY-01,0,5697,0,TCGA-YL-A9WY,765,765,Prostate Cancer,62,765,,1098,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1],765,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-21164,,57,9,50,PRAD,765,765,,0.0,[Not Available],[Not Applicable],38,,1,Matched,0.19,Prostate,Resection,5,3FB026CB-327C-495C-ADBE-A80F7C5C80B4,10,Normal (no evidence of prostate cancer) [cM0],1,0.11708,[Not Available],D7E22AF5-88AA-4A83-985C-1D346DFF652D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,32,,Acinar Adenocarcinoma,[Not Available],,YL,1.26666666667,TCGA-YL-A9WY,1:Recurred/Progressed,5,33,Prostate Adenocarcinoma,32.03,4/13/14,1098,,Biochemical evidence of disease,,,YES,C61,50396173-9B31-42A1-81BC-9D2B5905E54A,970,12,WITH TUMOR,0.1806,0:LIVING,1.8,,36.07,Bilateral,39,,,YES,785,2011,765,,TCGA-YL-A9WY.50396173-9B31-42A1-81BC-9D2B5905E54A.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,50,,19,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,YES,No,R1,,57,Core needle biopsy,765,,NO,YES,YES,YES,T3b,NO,9,No,YES,0,N1,T3a,11,M0,C61.9,8140/3,91112,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-ZF-A9R2,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.14,0.75,4,9,7,,,642,,642,642,,0.0,0,642.0,642.0,,Malignant,20,,79,,,,27280.0,,,642.0,642,,,,642,642,,,642.0,,,,,,,,TUMOR FREE,Alive,-27537,,,,193.0,,642.0,642,,,[Not Available],[Not Applicable],,,,,0.52,,,,,21,,1,0.30006,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9R2,,,,,,,642,,,,,,,,,22,,,,,,,,,,,,,2013,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,91117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-CD-A48C,Asian,STAD,,1,1,,,1,1,,1,4.3,0.58,12,11,19,,,353,,230,353,,1,1,230,230,,Malignant,42,,189,,,,23234,,,230,230,,,,230,353,,,230,,,,,,,,WITH TUMOR,Dead,-29203,353,,,286,,230,230,,,[Not Available],[Not Applicable],,,,,0.32,Stomach,Unknown,,,20,,2,0.36702,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,ILSBio,,TCGA-CD-A48C,,,,,,,,,Locoregional Recurrence,,,,,,,68,,,,,,,,,,,,,2011,230,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,91123,,-0.048295819,,,,,,,,,,0.1166359,Grade 3,0.050584734,,,,Stage IIB,,-0.1455,,,,,,,,,,,,,,,,0.3712,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-CD-A48C,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-X8-AAAR,White,ESCA,,0,0,,,0,0,,0,1.73,0.76,11,5,8,,,554,,554,554,,0,0,554,554,,Malignant,24,,94,,,,27196,,,554,554,,,,554,554,,,554,,,,,,,,TUMOR FREE,Alive,-25370,,,,200,,554,554,,,[Not Available],[Not Available],,,,,0.4,Esophagus,Unknown,,,8,,0,0.34808,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G1,,St. Joseph's Hospital Arizona,,TCGA-X8-AAAR,,,,,,,554,,,,,,,,,7,,,,,,,,,,,,,2013,,,,,[Unknown],,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,91124,,,,,,,,,,,,,Grade 1,,,,,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1318,,1318,1318,,0,0,1318,1318,,Invasive Carcinoma,,,,,,,20929,0,,1318,1318,,,,1318,1318,,,1318,,,,,,,,TUMOR FREE,Alive,-27389,,,,0,,1318,1318,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14U,,,,,,,1318,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,74,,,,,,,,,,,,,,,,,,,,91126,,-0.552503683,0,0,0,0,1.074,1,,,Infiltrating Lobular Carcinoma,0.109462412,,0.107738453,0,0,0,,Negative,-0.7285,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0921,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.01,0.93,19,29,22,,,4275,BRCA_Basal,4275,4275,,0,0,4275,4275,,None,70,,67,,,,17319,N/A (Non-Malignant),,4275,4275,,,,4275,4275,,,4275,,,,,,,,TUMOR FREE,Alive,-15812,,,,97,,4275,4275,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,5,,0,0.40279,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A0TP,,,,,,,4275,,,,,,,,,21,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,43,,,,,,,,,,,,,,,,,,,,91130,,-2.050448132,0,0,0,0,0.92,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.134107576,N/A (Non-Malignant),0.084407946,0,0,0,N/A (Non-Malignant),Negative,-2.2875,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3218,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.71,0.46,8,11,12,,,3021,BRCA_Basal,3021,3021,,0,0,3021,3021,,Invasive Carcinoma,31,,55,,,,29179,0,,3021,3021,,,,3021,3021,,,3021,,,,,,,,TUMOR FREE,Alive,-18109,,,,55,,3021,3021,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,15,,0,0.74094,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AQ,,,,,,,3021,,,,,,,,,28,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,49,,,,,,,,,,,,,,,,,,,,91133,,1.632240702,0,0,0,0,-1.1081,1,,,Infiltrating Ductal Carcinoma,0.199342327,,0.10868736,0,0,0,,Negative,1.4415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1667,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-FP-8631,White,STAD,,0,0,,,,0,,0,3.01,0.58,4,11,15,,,17,,,17,,0,0,17,17,,Malignant,30,,82,,,,16739,,,17,17,,,,,17,,,17,,,,,,,,TUMOR FREE,Alive,-24898,,,,130,,17,17,,,[Not Available],[Not Applicable],,,,,0.08,Stomach,Unknown,,,18,,1,0.066414,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,International Genomics Consortium,,TCGA-FP-8631,,,,,,,17,,,,,,,,,34,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Not Applicable],,,,,,68,,,,,,,,,,,,,,,,,,,,91135,,-0.377592005,,,,,,,,,,-0.002097749,Grade 2,0.078717717,,,,Stage IIIA,,-1.538,,,,,,,,,,,,,,,,0.3712,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-8631,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,3.54,0.51,15,33,29,,,3063,BRCA_Her2,2041,3063,,1,1,2041,2041,,Invasive Carcinoma,77,,82,,,,20670,0,,2041,2041,,,,2041,3063,,,2041,,,,,,,,WITH TUMOR,Dead,-14134,3063,,,207,,2041,2041,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,11,,1,0.33601,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0RS,,,,,,,,"Other, specify",New Primary Tumor,,,,,,,24,,,,,,,,,,,,,1988,2041,Breast,,,Stage IIA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,91136,,0.777043679,0,0,0,0,-2.0374,1,,,Infiltrating Ductal Carcinoma,0.194497916,,0.119931748,0,0,0,,Negative,0.371,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3308,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.06,0.42,2,2,4,,,1161,BRCA_LumA,1161,1161,,0,0,1161,1161,,Invasive Carcinoma,8,,16,,,,31592,0,,1161,1161,,,,1161,1161,,,1161,,,,,,,,TUMOR FREE,Alive,-23992,,,,57,,1161,1161,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.042238,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A2LN,,,,,,,1161,,,,,,,,,2,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,91138,,0.448664069,0,0,0,0,0.3625,1,,,Infiltrating Lobular Carcinoma,0.171865674,,0.291504763,0,0,0,,Negative,0.2365,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6669,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Suboptimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-ZF-A9RF,White,BLCA,,1.0,1,,,1,0,MALE,1.0,3.11,0.5,18,29,23,,,1949,,1565,1949,,1.0,1,1565.0,1565.0,,Malignant,70,,201,,,,32000.0,,,1565.0,1565,,,,1565,1949,,,1565.0,,,,,,,,TUMOR FREE,Alive,-27281,,,,330.0,,1565.0,1565,,,[Not Available],[Not Applicable],,,,,0.31,,,,,9,,1,0.31581,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9RF,,,,,,,1949,Bladder,Locoregional (Urothelial tumor event),,,,,,,33,,,,,,,,,,,,,2009,1565,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,74.0,,,,,,,,,,,,,,,,,,,,91140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Male,TCGA-FJ-A3Z9,White,BLCA,,0.0,0,,,2,2,MALE,2.0,2.02,0.85,1,2,1,,,385,,385,385,,2.0,2,385.0,385.0,,Malignant,4,,15,,,,20986.0,,,385.0,385,,,,385,385,,,385.0,,,,,,,,TUMOR FREE,Dead,-26515,385,,,100.0,,385.0,385,,,[Not Available],[Not Applicable],,,,,0.04,,,,,1,,0,0.010652,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Baylor,,TCGA-FJ-A3Z9,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,2012,,,,,[Not Available],,,,,,,,Complete Remission/Response,,,,,,72.0,,,,,,,,,,,,,,,,,,,,91142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.9,0.89,9,10,8,,,475,BRCA_LumA,475,475,,0,0,475,475,,None,27,,35,,,,23573,N/A (Non-Malignant),,475,475,,,,475,475,,,475,,,,,,,,TUMOR FREE,Alive,-30958,,,,43,,475,475,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,9,,0,0.21894,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,,,TCGA-AQ-A1H2,,,,,,,475,,,,,,,,,8,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,84,,,,,,,,,,,,,,,,,,,,91144,,,0,0,0,0,-0.8024,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,,N/A (Non-Malignant),,0,0,0,N/A (Non-Malignant),Negative,,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,,1,0,H & E,0,0,,0,Murray Resnick,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HU-A4GH,Asian,STAD,,0,0,,,0,0,,0,2.84,0.75,10,15,18,,,358,,358,358,,0,0,358,358,,Malignant,43,,113,,,,21616,,,358,358,,,,358,358,,,358,,,,,,,,TUMOR FREE,Alive,-27473,,,,958,,358,358,,,[Not Available],[Not Applicable],,,,,0.39,Stomach,Unknown,,,18,,1,0.2772,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4GH,,,,,,,358,,,,,,,,,32,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,91149,,-0.290705531,,,,,,,,,,0.000458512,Grade 2,-0.00928383,,,,Stage IA,,-0.5635,,,,,,,,,,,,,,,,-0.2701,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GH,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-MN-A4N1,Black or African American,LUAD,,0,0,,BLN - Baylor,0,0,MALE,0,4.7,0.48,15,21,28,,,827,,827,827,,0,0,827,827,,Malignant,64,,140,,,,29966,,,827,827,,,,827,827,,,827,,,,,,,,TUMOR FREE,Alive,-21939,,,,622,,827,827,,,[Not Available],[Not Applicable],,,,,0.55,,,,,21,,2,0.31952,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,BLN - Baylor,,TCGA-MN-A4N1,,,,,,,827,,,,,,,,,62,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,91150,,-0.529041506,,,,,,,,,,0.1618951,,0.037336126,,,,Stage IIA,,-0.347,,,,,,,,,,,,,,,,0.2204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.28281702,14.78119774,12.87663752,-0.842102347,LUAD,Adenocarcinoma,18.15320027,14.92504101,Adenocarcinoma,,13.00695147,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Female,TCGA-D7-5577,White,STAD,,1,1,,,,1,,1,2.08,0.64,2,4,4,,,782,,,782,,1,1,376,376,,Malignant,10,,17,,,,25881,,,376,376,,,,,782,,,376,,,,,,,,WITH TUMOR,Dead,-19668,782,,,152,,376,376,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,3,,0,0.11388,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,Greater Poland Cancer Center,,TCGA-D7-5577,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,9,,,,,,,,,,,,,2010,376,"liver,  peritoneal surfaces, non-regional/distant lymph nodes",,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,91153,,0.81752804,,,,,,,,,,0.096963642,Grade 2,0.020288614,,,,Stage IIIA,,1.6905,,,,,,,,,,,,,,,,-0.0205,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-5577,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.82,0.55,3,2,7,,,575,BRCA_LumB,575,575,,0,0,575,575,,Invasive Carcinoma,12,,8,,,,22931,1,,575,575,,,,575,575,,,575,,,,,,,,TUMOR FREE,Alive,-22683,,,,43,,575,575,,,[Not Available],[Not Applicable],,,,,0.21,Not Specific/Unknown,Resection/Excision,,,21,,1,0.18541,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1JE,,,,,,,575,,,,,,,,,27,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,91154,,0.023895152,0,0,0,0,0.1142,1,,,Infiltrating Ductal Carcinoma,0.210711503,,0.138864242,0,0,0,,Negative,-0.642,,10/21/22,0,0,0,0,0,0,0,0,0,0,E-Cadherin IHC to rule out lobular type area,0,0,0.5064,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,3.35,0.64,8,4,6,,,2417,BRCA_LumB,2417,2417,,2,2,2417,2417,,Invasive Carcinoma,18,,23,,,,20240,0,,2417,2417,,,,2417,2417,,,2417,,,,,,,,TUMOR FREE,Dead,-24803,2417,,,49,,2417,2417,,,[Not Available],[Not Applicable],,,,,0.58,Breast,Resection/Excision,,,21,,1,0.20327,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0WV,,,,,,,,,,,,,,,,20,,,,,,,,,,,,,1995,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,91156,,-1.522258727,0,0,0,0,-0.1265,0,,,Infiltrating Ductal Carcinoma,0.065165026,,0.048565558,0,0,0,,Negative,-1.6265,,10/21/22,0,0,0,0,0,0,0,0,0,1,N/A,0,0,0.02,1,0,H & E,0,0,,0,Guofeng Gao,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Intermediate Grade), Stromal Alterations",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-ZF-AA4N,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.83,0.77,1,2,3,,,88,,,88,,1.0,1,88.0,88.0,,,6,,82,,,,32993.0,,,88.0,88,,,,,88,,,88.0,,,,,,,,WITH TUMOR,Dead,-27056,88,,,222.0,,88.0,88,,,[Not Available],[Not Applicable],,,,,0.56,,,,,8,,0,0.25367,[Not Available],,,[Not Available],,,,,Unknown,High Grade,,University of Sheffield,,TCGA-ZF-AA4N,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,74.0,,,,,,,,,,,,,,,,,,,,91157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.62,0.61,9,13,18,,,664,BRCA_Her2,664,664,,0,0,664,664,,Invasive Carcinoma,40,,62,,,,29885,1,,664,664,,,,664,664,,,664,,,,,,,,TUMOR FREE,Alive,-27967,,,,121,,664,664,,,[Not Available],[Not Applicable],,,,,0.18,Not Specific/Unknown,Resection/Excision,,,14,,1,0.18473,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A1XJ,,,,,,,664,,,,,,,,,20,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,91162,,-0.408007669,0,0,0,0,0.2846,1,,,Other,0.170367773,,0.10888734,0,0,0,,Negative,-0.7015,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.2615,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Stromal Alterations,"DCIS (Cribriform, High Grade), Stromal Alterations",,"DCIS (Cribriform, High Grade)",0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-V1-A9OA,,PRAD,,0,0,,V1,0,0,MALE,0,1.98,0.61,7,11,8,ambiguous,NO,636,,636,636,,0,0,636,636,prad_tcga,Malignant,26,,50,,TCGA-V1-A9OA-01,0,5573,0,TCGA-V1-A9OA,636,636,Prostate Cancer,27,510,636,636,TCGA,,636,Primary,0,Apex,A,,,True,,Alive,-22630,,61,9,25,PRAD,636,636,,0.0,[Not Available],[Not Applicable],20,,1,Matched,0.05,Prostate,Resection,4,A4704150-38CD-4F08-B05E-548A526E0C79,2,,0,0.10118,[Not Available],A8396F6D-53E2-4664-A3E2-DF061D022108,5,Prostate Adenocarcinoma Acinar Type,,Prostate,25,,Acinar Adenocarcinoma,[Not Available],,V1,0.733333333333,TCGA-V1-A9OA,0:DiseaseFree,5,25,Prostate Adenocarcinoma,20.89,7/23/14,636,,,,,YES,C61,F8BC91E0-7D98-40B2-B99E-570564C3ECD2,10,4,,0.1664,0:LIVING,0.01,,20.89,Bilateral,27,,,YES,,,,,TCGA-V1-A9OA.F8BC91E0-7D98-40B2-B99E-570564C3ECD2.pdf,Peripheral Zone,[Not Applicable],NO,,,8,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,61,Core needle biopsy,,,NO,YES,YES,NO,T3b,YES,9,No,NO,,N1,T2c,1,M0,C61.9,8140/3,91168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8216,,PRAD,308,0,0,,HC,0,0,MALE,0,1.84,0.47,8,8,7,ambiguous,NO,682,8-other,682,682,,0,0,682,682,prad_tcga,Malignant,23,BRCA1;CHEK2;RAD51B,69,5.2,TCGA-HC-8216-01,23,5436,0,TCGA-HC-8216,682,682,Prostate Cancer,,137,682,682,TCGA,,682,Primary,1,Middle|Base,A,,,,TUMOR FREE,Alive,-21428,,58,7,121,PRAD,682,682,,0.168809158,[Not Available],[Not Applicable],115,R0,1,Matched,0.68,Prostate,Resection,4,bd2f1591-0615-4df9-a34f-428369b25709,4,Normal (no evidence of prostate cancer) [cM0],0,0.1954,[Not Available],89afdebe-456e-4128-8902-1001876a2106,3,Prostate Adenocarcinoma Acinar Type,0.4,Prostate,22,,Acinar Adenocarcinoma,[Not Available],0.3,HC,3.83333333333,TCGA-HC-8216,0:DiseaseFree,3,22,Prostate Adenocarcinoma,22.4,6/17/12,682,,,,,NO,C61,CD881D57-9CCB-4984-8C37-B3DDE9189814,,10,TUMOR FREE,0.0667,0:LIVING,0.19,5,22.4,Right,23,No Evidence of Extraprostatic Extension,10,YES,,2011,,,TCGA-HC-8216.CD881D57-9CCB-4984-8C37-B3DDE9189814.pdf,,[Not Applicable],YES,10,61-70%,3,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,,No,R0,0.3,58,Core needle biopsy,,,YES,NO,YES,NO,T3a,,7,No,,0,N0,T2a,0,M0,C61.9,8550/3,91174,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A47X,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,3.71,0.88,2,3,6,,,384,,384,384,,0.0,0,384.0,384.0,,Malignant,11,,20,,,,17792.0,,,384.0,384,,,,384,384,,,384.0,,,,,,,,TUMOR FREE,Alive,-22200,,,,465.0,,384.0,384,,,[Not Available],[Not Applicable],,,,,0.17,,,,,13,,1,0.030699,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A47X,,,,,,,384,,,,,,,,,18,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,91176,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-VR-AA4D,White,ESCA,,1,1,,,,1,,1,3.47,0.74,4,14,10,,,1405,,,1405,,1,1,832,832,,Malignant,28,,39,,,,31542,,,832,832,,,,,1405,,,832,,,,,,,,WITH TUMOR,Dead,-19714,1405,,,180,,832,832,,,[Not Available],Stage IA,,,,,0.05,Esophagus,Unknown,,,17,,1,0.093699,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G2,,Barretos Cancer Hospital,,TCGA-VR-AA4D,,,,,,,,Lung,Distant Metastasis,,,,,,,27,,,,,,,,,,,,,2010,832,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,91177,,,,,,,,,,,,,Grade 2,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.72,0.47,10,9,10,,,1025,BRCA_Basal,1025,1025,,0,0,1025,1025,,Invasive Carcinoma,29,,48,,,,22186,0,,1025,1025,,,,1025,1025,,,1025,,,,,,,,TUMOR FREE,Alive,-18788,,,,39,,1025,1025,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,14,,0,0.43789,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1II,,,,,,,1025,,,,,,,,,15,,,,,,,,,,,,,2008,,,,,Stage I,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,91180,,1.985451534,0,0,0,1,-1.0712,0,,,Infiltrating Ductal Carcinoma,0.182863043,,0.097427025,0,0,0,,Negative,1.88,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,-0.4482,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,UDH,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.85,0.23,2,0,3,,,926,BRCA_LumA,926,926,,0,0,926,926,,Invasive Carcinoma,5,,28,,,,23460,0,,926,926,,,,926,926,,,926,,,,,,,,TUMOR FREE,Alive,-17588,,,,52,,926,926,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,19,,1,0.082274,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A3X8,,,,,,,926,,,,,,,,,24,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,91183,,1.019307719,1,0,1,1,0.6789,0,,,Infiltrating Lobular Carcinoma,0.140876651,,0.200519137,0,0,0,,Negative,-0.08,,10/21/22,0,0,0,0,0,0,0,0,0,0,E-Cadherin IHC to confirm type,0,0,0.3108,1,0,H & E,0,0,,0,Guofeng Gao,"ADH, FEA, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,"ADH, FEA, UDH",0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SI,,PRAD,,1,1,,YL,1,0,MALE,1,1.95,0.19,1,4,0,HRP,NO,1614,,1423,1614,,1,1,1423,1423,prad_tcga,Malignant,5,,21,,TCGA-YL-A8SI-01,0,5669,0,TCGA-YL-A8SI,1423,1423,Prostate Cancer,,1441,1423,1614,TCGA,,1423,Primary,0,Apex|Middle|Base,A,,,True,TUMOR FREE,Alive,-25292,,69,9,23,PRAD,1423,1423,,0.0,[Not Available],[Not Applicable],25,,1,Matched,0.03,Prostate,Resection,4,489EA5D8-AE40-405B-BBF5-E0E091193270,0,Normal (no evidence of prostate cancer) [cM0],0,0.030508,[Not Available],C5F8C89C-EF69-42F4-9B37-5B552FCCDF4B,5,Prostate Adenocarcinoma Acinar Type,,Prostate,5,,Acinar Adenocarcinoma,[Not Available],,YL,0.833333333333,TCGA-YL-A8SI,1:Recurred/Progressed,5,6,Prostate Adenocarcinoma,46.75,4/25/14,1614,,Biochemical evidence of disease,,,NO,C61,30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE,390,0,WITH TUMOR,0.0146,0:LIVING,0.48,,53.02,Bilateral,8,No Evidence of Extraprostatic Extension,62,YES,1345,2010,1423,,TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf,Overlapping / Multiple Zones,[Not Applicable],YES,47,,15,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,,69,Core needle biopsy,1423,Complete Remission/Response,NO,YES,YES,YES,T3a,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,91188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.28,0.56,4,4,3,,,643,BRCA_LumA,643,643,,0,0,643,643,,Invasive Carcinoma,11,,36,,,,33815,0,,643,643,,,,643,643,,,643,,,,,,,,TUMOR FREE,Alive,-22936,,,,51,,643,643,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,12,,0,0.11824,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A4S2,,,,,,,643,,,,,,,,,15,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,91189,,0.694623615,1,0,0,1,-1.298,0,,,Infiltrating Lobular Carcinoma,0.173547519,,0.167082528,0,0,0,,Negative,1.0145,,10/21/22,0,0,0,0,0,0,0,0,0,0,E-Cadherin IHC to confirm type,0,0,0.4397,1,0,H & E,0,0,,0,Guofeng Gao,"ADH, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,"ADH, UDH",0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-BT-A2LA,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.29,0.95,13,11,13,,,522,,522,522,,0.0,0,522.0,522.0,,Malignant,37,,58,,,,20525.0,,,522.0,522,,,,522,522,,,522.0,,,,,,,,TUMOR FREE,Alive,-20032,,,,314.0,,522.0,522,,,[Not Available],[Not Applicable],,,,,0.33,,,,,13,,1,0.23739,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A2LA,,,,,,,522,,,,,,,,,20,,,,,,,,,,,,,2010,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,54.0,,,,,,,,,,,,,,,,,,,,91190,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Female,TCGA-RE-A7BO,White,ESCA,,0,0,,,,2,,2,3.0,0.49,7,6,12,,,213,,,213,,2,2,213,213,,Malignant,25,,141,,,,31559,,,213,213,,,,,213,,,213,,,,,,,,TUMOR FREE,Dead,-26348,213,,,356,,213,213,,,[Not Available],[Not Available],,,,,0.18,Esophagus,Unknown,,,13,,1,0.35168,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Peter MacCallum Cancer Center,,TCGA-RE-A7BO,,,,,,,,,,,,,,,,34,,,,,,,,,,,,,2006,,,,,Stage IIB,,,,,,,,,,,,,,72,,,,,,,,,,,,,,,,,,,,91192,,,,,,,,,,,,,Grade 3,,,,,Stage IIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,,0,1,1,Male,TCGA-KK-A8IF,,PRAD,370,1,1,,KK,,0,MALE,1,2.14,0.97,7,14,3,ambiguous,NO,804,5-SPOP,,804,,1,1,648,648,prad_tcga,Malignant,24,ATM;BRCA2,198,,TCGA-KK-A8IF-01,0,5530,0,TCGA-KK-A8IF,648,648,Prostate Cancer,522,788,,804,TCGA,No Evidence of Extraprostatic Extension,648,Primary,0,Apex|Middle|Base,A,,,True,WITH TUMOR,Alive,-20888,,57,7,43,PRAD,648,648,,0.0,[Not Available],[Not Applicable],30,R0,1,Matched,0.14,Prostate,Resection,4,41E46BCF-B8FD-46CA-960E-F80E8F75EA42,9,,0,0.10226,[Not Available],3F5270A2-3284-4523-BD81-54FC98C2B933,3,Prostate Adenocarcinoma Acinar Type,,Prostate,26,,Acinar Adenocarcinoma,[Not Available],,KK,1.0,TCGA-KK-A8IF,1:Recurred/Progressed,3,32,Prostate Adenocarcinoma,21.29,8/18/14,804,,Biochemical evidence of disease,,,YES,C61,BF56F683-5D52-4154-B9D4-1B6D2608C5AA,160,7,WITH TUMOR,0.2874,0:LIVING,0.7,,26.41,Bilateral,36,,,YES,2351,2007,648,,TCGA-KK-A8IF.BF56F683-5D52-4154-B9D4-1B6D2608C5AA.pdf,Transition Zone,[Not Applicable],NO,,91-100%,33,Prostate Adenocarcinoma Acinar Type,1,2007,[Unknown],,YES,No,R0,,57,Core needle biopsy,648,,NO,YES,YES,YES,T3a,,7,No,,0,N0,T2a,,M0,C61.9,8140/3,91195,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-22-4601,White,LUSC,,1,,,Mayo Clinic - Rochester,,1,FEMALE,1,1.89,0.78,12,17,16,,,1057,,,1057,,1,,525,525,,Malignant,45,,36,,,,17933,,,525,,,,,,1057,,,525,,,,,,,,WITH TUMOR,Dead,-26937,1057,,,243,,525,,,,[Not Available],[Not Applicable],,,,,0.49,,,,,7,,0,0.35321,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4601,,,,,,,1057,,,,,,,,,12,,,,,,,,,,,,,2003,525,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,91197,,0.715584498,,,,,,,,,,0.14266862,,0.056450592,,,,Stage IIIA,,0.5985,,,,,,,,,,,,,,,,0.0622,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,P1019L,,,1,P1019L,,,15.10875394,16.2951161,15.92054654,-0.393145943564243,LUSC,Squamous Cell Carcinoma,17.63211977,15.40918357,Squamous Cell Carcinoma,-0.5587,12.71296599,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-66-2785,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.06,0.4,5,15,14,,,60,,,60,,0,0,60,60,,Malignant,34,,35,,,,21537,,,60,60,,,,,60,,,60,,,,,,,,TUMOR FREE,Alive,-23772,,,,1474,,60,60,,,[Not Available],[Not Applicable],,,,,0.03,,,,,16,,1,0.32322,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2785,,,,,,,60,,,,,,,,,31,,,,,,,,,,,,,2008,,,,,Stage IB,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,91198,,1.553910672,,,,,,,,,,0.199545179,,0.034643263,,,,Stage IB,,2.059,,,,,,,,,,,,,,,,0.0176,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,AMP,1,,,,,,,0.265780707552624,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.301,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-56-5897,White,LUSC,,0,0,,International Genomics Consortium,0,0,MALE,0,1.86,0.32,6,7,5,,,378,,378,378,,0,0,378,378,,Malignant,18,,19,,,,25273,,,378,378,,,,378,378,,,378,,,,,,,,TUMOR FREE,Alive,-27118,,,,124,,378,378,,,[Not Available],[Not Applicable],,,,,0.28,,,,,10,,0,0.30654,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-5897,,,,,,,378,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,91202,,0.871319623,,,,,,,,,,0.265428968,,0.15075527,,,,Stage IA,,0.987,,,,,,,,,,,,,,,,0.9368,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.205601339477441,LUSC,,,,Squamous Cell Carcinoma,1.3585,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,456,,456,456,,0,0,456,456,,Invasive Carcinoma,,,,,,,28290,0,,456,456,,,,456,456,,,456,,,,,,,,TUMOR FREE,Alive,-27421,,,,0,,456,456,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A3TN,,,,,,,456,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,75,,,,,,,,,,,,,,,,,,,,91206,,-0.834238475,0,0,0,1,1.5528,0,,,Infiltrating Lobular Carcinoma,0.118227914,,0.135151709,0,0,0,,Negative,-1.27,,10/21/22,0,0,0,0,0,0,0,0,0,1,E-Cadherin IHC to rule out ductal,0,0,0.1293,1,0,H & E,0,0,,0,Guofeng Gao,"Columnar Lesion, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"Columnar Lesion, UDH",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Female,TCGA-G2-A2EC,Black or African American,BLCA,,1.0,1,,,,1,FEMALE,1.0,,,,,,,,696,,,696,,1.0,1,679.0,679.0,,Malignant,,,,,,,19026.0,,,679.0,679,,,,,696,,,679.0,,,,,,,,WITH TUMOR,Dead,-21215,696,,,244.0,,679.0,679,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EC,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,,,,,,,,,,,,,,2010,679,small bowel,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,91208,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-QU-A6IN,,PRAD,,0,0,,QU,0,0,MALE,0,1.96,0.81,3,6,2,HRD,NO,4264,,4264,4264,,0,0,4264,4264,prad_tcga,Malignant,11,,34,,TCGA-QU-A6IN-01,0,5550,0,TCGA-QU-A6IN,4264,4264,Prostate Cancer,43,3428,4264,4264,TCGA,,4264,Primary,0,Apex|Middle|Base,A,,BRCA2;RAD54L,True,TUMOR FREE,Alive,-22286,,61,7,37,PRAD,4264,4264,,0.0,[Not Available],[Not Applicable],24,,1,Matched,0.0,Prostate,Resection,3,BC8954D4-1D39-4F99-BD91-A3F4E3B6B1E2,0,Normal (no evidence of prostate cancer) [cM0],0,0.037656,[Not Available],D07D20F4-DD65-4FFC-ADD4-01F350CA7B65,4,Prostate Adenocarcinoma Acinar Type,,Prostate,11,,Acinar Adenocarcinoma,[Not Available],,QU,0.8,TCGA-QU-A6IN,0:DiseaseFree,2,10,Prostate Adenocarcinoma,140.08,8/21/13,4264,,,,,YES,C61,11063611-DCFF-427E-89A9-25961C79DF07,110,0,TUMOR FREE,0.0354,0:LIVING,0.1,5,140.08,Bilateral,11,,,YES,3789,2003,,,TCGA-QU-A6IN.11063611-DCFF-427E-89A9-25961C79DF07.pdf,,[Not Applicable],NO,21,,15,Prostate Adenocarcinoma Acinar Type,1,2003,Complete Remission/Response,,NO,No,R0,,61,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,91212,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A47S,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.95,0.62,6,5,6,,,333,,333,333,,0.0,0,333.0,333.0,,Malignant,17,,18,,,,18502.0,,,333.0,333,,,,333,333,,,333.0,,,,,,,,TUMOR FREE,Alive,-15225,,,,62.0,,333.0,333,,,[Not Available],[Not Applicable],,,,,0.16,,,,,5,,0,0.091087,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A47S,,,,,,,333,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,41.0,,,,,,,,,,,,,,,,,,,,91213,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-IN-7806,White,STAD,,0,0,,,0,0,,0,1.77,0.65,4,6,5,,,1106,,1106,1106,,0,0,1106,1106,,Malignant,15,,36,,,,24453,,,1106,1106,,,,1106,1106,,,1106,,,,,,,,TUMOR FREE,Alive,-18404,,,,97,,1106,1106,,,[Not Available],[Not Applicable],,,,,0.04,Stomach,Unknown,,,9,,0,0.28456,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,University of Pittsburgh,,TCGA-IN-7806,,,,,,,1106,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,50,,,,,,,,,,,,,,,,,,,,91214,,-0.451563099,,,,,,,,,,0.03854805,Grade 3,0.043001964,,,,Stage IIB,,-0.921,,,,,,,,,,,,,,,,-0.1314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-IN-7806,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Male,TCGA-98-A53J,White,LUSC,,0,0,,Washington University - Alabama,0,0,MALE,0,3.42,0.4,10,5,10,,,630,,630,630,,0,0,630,630,,Malignant,25,,76,,,,18210,,,630,630,,,,630,630,,,630,,,,,,,,TUMOR FREE,Alive,-28485,,,,151,,630,630,,,[Not Available],[Not Applicable],,,,,0.1,,,,,24,,1,0.30951,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - Alabama,,TCGA-98-A53J,,,,,,,630,,,,,,,,,19,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,91218,,-0.197513438,,,,,,,,,,0.147301423,,-0.012658527,,,,Stage IB,,0.2365,,,,,,,,,,,,,,,,0.0988,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.698988149934695,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.07,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-4Z-AA7Y,White,BLCA,,0.0,0,,,0,0,MALE,0.0,2.02,0.94,1,3,3,,,1522,,1522,1522,,0.0,0,1522.0,1522.0,,Malignant,7,,35,,,,23190.0,,,1522.0,1522,,,,1522,1522,,,1522.0,,,,,,,,TUMOR FREE,Alive,-22056,,,,409.0,,1522.0,1522,,,[Not Available],[Not Applicable],,,,,0.02,,,,,2,,0,0.058125,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA7Y,,,,,,,1522,,,,,,,,,1,,,,,,,,,,,,,2010,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,91219,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.99,0.46,3,1,3,,,70,BRCA_LumA,70,70,,0,0,70,70,,Invasive Carcinoma,7,,27,,,,16873,0,,70,70,,,,70,70,,,70,,,,,,,,TUMOR FREE,Alive,-26248,,,,93,,70,70,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,8,,0,0.14594,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A8OS,,,,,,,70,,,,,,,,,7,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,91225,,0.549463358,0,0,0,1,0.1945,0,,,Infiltrating Lobular Carcinoma,0.156538936,,0.280448323,0,0,0,,Negative,0.4085,,10/21/22,0,0,0,0,0,0,0,0,0,0,E-Cadherin IHC can help clarify ductal vs lobular vs mixed,0,0,0.5089,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,UDH,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,0,0,1,Female,TCGA-05-4402,,LUAD,,0,0,,Indivumed,,2,FEMALE,2,3.24,0.44,7,4,10,,,244,,,244,,2,2,244,244,,Malignant,21,,16,,,,22533,,,244,244,,,,,244,,,244,,,,,,,,TUMOR FREE,Dead,-20819,244,,,151,,244,244,,,[Not Available],[Not Applicable],,,,,0.55,,,,,27,,1,0.19828,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Indivumed,,TCGA-05-4402,,,,,,,,,,,,,,,,21,,,,,,,,,,,,,2007,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,91233,,0.381386082,,,,,,,,,,0.26141181,,0.087568199,,,,Stage IV,,0.293,,,,,,,,,,,,,,,,0.4149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,"T751_I759delinsN (driver), I759N, AMP (driver)",,,1,"T751_I759delinsN (driver), I759N",,,16.32188195,17.06623486,14.54437999,-0.394694802,LUAD,Adenocarcinoma,17.77973649,15.22855751,Adenocarcinoma,0.4373,13.70920582,-0.696,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,Male,TCGA-VQ-AA6G,White,STAD,,1,1,,,,1,,1,1.97,0.62,3,4,9,,,792,,,792,,1,1,469,469,,Malignant,16,,94,,,,21997,,,469,469,,,,,792,,,469,,,,,,,,WITH TUMOR,Dead,-25091,792,,,180,,469,469,,,Stomach Cancer,[Not Applicable],,,,,0.04,Stomach,Unknown,,,2,,0,0.090901,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Barretos Cancer Hospital,,TCGA-VQ-AA6G,,,,,,,,Lung,Distant Metastasis,,,,,,,5,,,,,,,,,,,,,2011,469,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,68,,,,,,,,,,,,,,,,,,,,91241,,-0.674885095,,,,,,,,,,0.050058309,Grade 2,0.074289451,,,,Stage IIA,,0.111,,,,,,,,,,,,,,,,0.0692,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-AA6G,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.03,0.87,6,6,7,,,1563,BRCA_LumB,1563,1563,,0,0,1563,1563,,Invasive Carcinoma,19,,50,,,,25363,0,,1563,1563,,,,1563,1563,,,1563,,,,,,,,TUMOR FREE,Alive,-24054,,,,51,,1563,1563,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,5,,0,0.089057,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15T,,,,,,,1563,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,91244,,-0.454418706,0,0,0,1,-0.3085,0,,,Infiltrating Ductal Carcinoma,0.123064649,,0.114731348,0,0,0,,Negative,-0.5655,,10/21/22,0,0,0,0,0,0,0,0,0,1,N/A,0,0,-0.1338,1,0,H & E,0,0,,0,Guofeng Gao,"Columnar Lesion, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Low Grade), DCIS (Papillary, Low Grade), No Detail Present",,"DCIS (Cribriform, Low Grade), DCIS (Papillary, Low Grade)",0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,"Columnar Lesion, UDH",0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-39-5027,White,LUSC,,0,0,,MSKCC,0,0,MALE,1,,,,,,,,3108,,3108,3108,,0,0,3081,3081,,Malignant,,,,,,,17652,,,3108,3108,,,,3108,3108,,,3081,,,,,,,,WITH TUMOR,Alive,-26714,,,,413,,3108,3108,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,MSKCC,,TCGA-39-5027,,,,,,,3108,,New Primary Tumor,,,,,,,,,,,,,,,,,,,,2006,3081,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,91245,,-0.370252384,,,,,,,,,,0.08205141,,-0.027449705,,,,Stage IB,,0.134,,,,,,,,,,,,,,,,0.0033,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,,,,-0.728321448809844,LUSC,,,,Squamous Cell Carcinoma,-1.9507,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,0,0,1,Female,TCGA-BR-7957,White,STAD,,0,0,,,,2,,2,1.92,0.2,0,0,0,,,276,,,276,,2,2,276,276,,Malignant,0,,5,,,,16396,,,276,276,,,,,276,,,276,,,,,,,,TUMOR FREE,Dead,-18517,276,,,57,,276,276,,,[Not Available],[Not Applicable],,,,,0.14,Stomach,Unknown,,,4,,0,0.13079,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,GX,,Asterand,,TCGA-BR-7957,,,,,,,,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,50,,,,,,,,,,,,,,,,,,,,91250,,-0.122392696,,,,,,,,,,0.118337506,Unknown,0.225656368,,,,Stage IV,,-0.249,,,,,,,,,,,,,,,,0.7673,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-7957,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.37,0.54,20,26,30,,,363,BRCA_Her2,363,363,,0,0,363,363,,Invasive Carcinoma,76,,126,,,,25642,0,,363,363,,,,363,363,,,363,,,,,,,,TUMOR FREE,Alive,-24710,,,,110,,363,363,,,[Not Available],[Not Applicable],,,,,0.23,Breast,Resection/Excision,,,16,,1,0.53394,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12L,,,,,,,363,,,,,,,,,27,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,91251,,0.409691253,0,0,0,0,-0.6494,1,,,Infiltrating Ductal Carcinoma,0.147670269,,0.075680201,0,0,0,,Negative,1.0155,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3049,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-22-5483,White,LUSC,,1,,,Mayo Clinic - Rochester,1,1,MALE,1,3.1,0.7,11,6,16,,,573,,568,573,,1,,568,568,,Malignant,33,,30,,,,30435,,,568,,,,,568,573,,,568,,,,,,,,WITH TUMOR,Dead,-27109,573,,,386,,568,,,,[Not Available],[Not Applicable],,,,,0.32,,,,,23,,1,0.33482,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5483,,,,,,,573,,,,,,,,,23,,,,,,,,,,,,,2005,568,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,91254,,0.360977967,,,,,,,,,,0.204897735,,0.131707147,,,,Stage IIA,,0.3725,,,,,,,,,,,,,,,,0.4593,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.23331057,16.66868797,15.9707813,-0.366731429157365,LUSC,Squamous Cell Carcinoma,17.90093551,16.82703322,Squamous Cell Carcinoma,1.0997,13.66936279,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-FD-A6TE,White,BLCA,,1.0,1,,,,0,MALE,1.0,3.46,0.82,12,7,13,,,376,,,376,,1.0,1,321.0,321.0,,Malignant,32,,78,,,,20599.0,,,321.0,321,,,,,376,,,321.0,,,,,,,,TUMOR FREE,Alive,-19874,,,,332.0,,321.0,321,,,[Not Available],[Not Applicable],,,,,0.25,,,,,24,,1,0.23706,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A6TE,,,,,,,376,"Other, specify",Distant Metastasis,,,,,,,23,,,,,,,,,,,,,2013,321,sacrum,,,Stage IV,,,,,,,,[Unknown],,,,,,54.0,,,,,,,,,,,,,,,,,,,,91256,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,91257,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,1,1,Male,TCGA-D7-6520,White,STAD,,1,1,,,,0,,1,3.86,0.52,8,12,12,,,573,,,573,,1,1,46,46,,Malignant,32,,51,,,,28159,,,46,46,,,,,573,,,46,,,,,,,,WITH TUMOR,Alive,-19467,,,,79,,46,46,,,[Not Available],[Not Applicable],,,,,0.06,Stomach,Unknown,,,10,,1,0.19233,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6520,,,,,,,573,Liver,Distant Metastasis,,,,,,,17,,,,,,,,,,,,,2010,46,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,53,,,,,,,,,,,,,,,,,,,,91260,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6520,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,91269,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-66-2767,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.3,0.27,16,12,17,,,61,,,61,,0,0,61,61,,Malignant,45,,35,,,,17508,,,61,61,,,,,61,,,61,,,,,,,,TUMOR FREE,Alive,-22888,,,,445,,61,61,,,[Not Available],[Not Applicable],,,,,0.28,,,,,18,,1,0.35249,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2767,,,,,,,61,,,,,,,,,32,,,,,,,,,,,,,2007,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,62,,,,,,,,,,,,,,,,,,,,91271,,1.652184331,,,,,,,,,,0.27353818,,0.124572761,,,,Stage IIIB,,2.4095,,,,,,,,,,,,,,,,0.3571,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.1756769,17.6350395,17.9318613,0.232068709691139,LUSC,Squamous Cell Carcinoma,18.2150275,17.31824084,Squamous Cell Carcinoma,0.1361,15.5470011,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Female,TCGA-99-AA5R,Black or African American,LUAD,,0,0,,Washington University - Alabama,0,0,FEMALE,0,2.0,0.96,0,0,0,,,658,,658,658,,0,0,658,658,,Malignant,0,,5,,,,29018,,,658,658,,,,658,658,,,658,,,,,,,,TUMOR FREE,Alive,-25778,,,,60,,658,658,,,[Not Available],[Not Applicable],,,,,0.01,,,,,0,,0,0.000106,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Alabama,,TCGA-99-AA5R,,,,,,,658,,,,,,,,,0,,,,,,,,,,,,,2013,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,91272,,1.370610787,,,,,,,,,,0.270625893,,0.349181692,,,,Stage IA,,1.8375,,,,,,,,,,,,,,,,0.1762,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.063414396,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.7518,,1.1459,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,1569,,1569,1569,,0,0,1569,1569,,Invasive Carcinoma,,,,,,,19896,0,,1569,1569,,,,1569,1569,,,1569,,,,,,,,TUMOR FREE,Alive,-23380,,,,110,,1569,1569,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0B8,,,,,,,1569,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage I,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,91273,,-0.393433549,0,0,0,0,0.3429,1,,,Infiltrating Ductal Carcinoma,0.137492541,,0.154680432,0,0,0,,Negative,-0.725,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.1255,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Microcalcifications,"DCIS (Solid, Intermediate Grade), Microcalcifications",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,727,,727,727,,0,0,727,727,,Invasive Carcinoma,,,,,,,16216,0,,727,727,,,,727,727,,,727,,,,,,,,TUMOR FREE,Alive,-28233,,,,1694,,727,727,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0HF,,,,,,,727,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IA,,,,,,,,[Not Available],,,,,,77,,,,,,,,,,,,,,,,,,,,91274,,0.237601149,0,0,0,0,1.218,1,,,Infiltrating Ductal Carcinoma,0.239310835,,0.248517782,0,0,0,,Negative,-0.329,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.6483,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-43-2576,White,LUSC,,0,0,,Christiana Healthcare,0,0,FEMALE,0,,,,,,,,1223,,1223,1223,,0,0,1223,1223,,Malignant,,,,,,,16115,,,1223,1223,,,,1223,1223,,,1223,,,,,,,,TUMOR FREE,Alive,-22805,,,,681,,1223,1223,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Christiana Healthcare,,TCGA-43-2576,,,,,,,1223,,,,,,,,,,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,62,,,,,,,,,,,,,,,,,,,,91275,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5377,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.43813186,16.92915819,16.19551944,-0.0604548579045848,LUSC,Squamous Cell Carcinoma,17.9860523,15.98056005,Squamous Cell Carcinoma,1.2226,14.52554277,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.12,0.6,5,6,9,,,1099,BRCA_LumB,1099,1099,,0,0,1099,1099,,Invasive Carcinoma,20,,25,,,,16639,0,,1099,1099,,,,1099,1099,,,1099,,,,,,,,TUMOR FREE,Alive,-19533,,,,72,,1099,1099,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,3,,0,0.05697,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04Y,,,,,,,1099,,,,,,,,,6,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,91278,,1.000897546,0,0,0,0,0.9851,1,,,Infiltrating Ductal Carcinoma,0.14484308,,0.177419684,0,0,0,,Negative,-0.166,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.0581,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-78-7152,White,LUAD,,1,,,Prince Charles Hospital,1,1,MALE,1,1.99,0.55,7,6,5,,,1215,,1202,1215,,1,,1202,1202,,Malignant,18,,23,,,,26428,,,1202,,,,,1202,1215,,,1202,,,,,,,,WITH TUMOR,Dead,-23782,1215,,,254,,1202,,,,[Not Available],[Not Applicable],,,,,0.03,,,,,6,,0,0.093553,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Prince Charles Hospital,,TCGA-78-7152,,,,,,,,,,,,,,,,4,,,,,,,,,,,,,2003,1202,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,91279,,1.066953977,,,,,,,,,,0.208608992,,0.16808498,,,,Stage IB,,0.4975,,,,,,,,,,,,,,,,-0.1131,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.193531658,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.4115,,0.5149,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.36,0.77,12,8,15,,,629,BRCA_Basal,629,629,,0,0,629,629,,Invasive Carcinoma,35,,150,,,,16898,0,,629,629,,,,629,629,,,629,,,,,,,,TUMOR FREE,Alive,-23314,,,,104,,629,629,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,11,,1,0.38588,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Albert Einstein Medical Center,,TCGA-S3-AA0Z,,,,,,,629,,,,,,,,,46,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,91283,,0.950404869,0,0,0,0,0.0596,0,,,Infiltrating Ductal Carcinoma,0.153409522,,0.102493417,0,0,0,,Negative,0.759,,10/21/22,0,0,0,0,0,0,0,0,0,1,Not Answered,0,0,0.1135,1,0,H & E,0,0,,0,Di (Andy) Ai,Columnar Lesion,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), DCIS (Papillary, Intermediate Grade), DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade), DCIS (Papillary, Intermediate Grade), DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,Columnar Lesion,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-EJ-5517,White,PRAD,91,0,0,,EJ,0,0,MALE,0,1.97,0.71,2,3,2,HRP,NO,1889,8-other,1889,1889,,0,0,1889,1889,prad_tcga,Malignant,7,,8,9.6,TCGA-EJ-5517-01,0,5281,0,TCGA-EJ-5517,1889,1889,Prostate Cancer,,187,1889,1889,TCGA,,1889,Primary,0,,A,,,,TUMOR FREE,Alive,-20422,,55,6,33,PRAD,1889,1889,WHITE,0.0,[Not Available],[Not Applicable],31,R0,1,Matched,0.04,Prostate,Resection,3,b5fe6254-d1c6-4ba2-bd75-5caf4fb2e2b7,0,,0,0.033171,[Not Available],4b9aa301-d2e3-47f3-b724-a34f420b2b6b,3,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,7,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,EJ,1.03333333333,TCGA-EJ-5517,0:DiseaseFree,1,7,Prostate Adenocarcinoma,62.06,4/3/12,1889,,,,,NO,C61,67b66178-bd1b-44a8-9a30-762b0fc7c1ba,,1,TUMOR FREE,0.0327,0:LIVING,0.1,2,62.06,Bilateral,8,,,YES,,2008,,,TCGA-EJ-5517.67b66178-bd1b-44a8-9a30-762b0fc7c1ba.pdf,,[Not Applicable],NO,,81-90%,4,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R0,1.0,55,Core needle biopsy,,,YES,NO,YES,,T2c,,6,No,,0,N0,T1c,0,M0,C61.9,8550/3,91286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Male,TCGA-33-AASJ,Black or African American,LUSC,,1,1,,Johns Hopkins,1,1,MALE,1,3.12,0.6,14,12,19,,,3600,,1135,3600,,1,1,1135,1135,,Malignant,45,,155,,,,18898,,,1135,1135,,,,1135,3600,,,1135,,,,,,,,WITH TUMOR,Dead,-22179,3600,,,241,,1135,1135,,,[Not Available],[Not Applicable],,,,,0.26,,,,,18,,1,0.36547,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-AASJ,,,,,,,,,Locoregional Recurrence,,,,,,,31,,,,,,,,,,,,,1999,1135,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,91287,,0.164725862,,,,,,,,,,0.10991338,,-0.094125605,,,,Stage IB,,1.376,,,,,,,,,,,,,,,,-0.3109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G186S (driver),1,,,G186S (driver),,,,-0.735667699731803,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-2.0625,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.8,8,1,5,,,1528,BRCA_LumA,1528,1528,,0,0,1528,1528,,Invasive Carcinoma,14,,18,,,,25252,0,,1528,1528,,,,1528,1528,,,1528,,,,,,,,TUMOR FREE,Alive,-20694,,,,42,,1528,1528,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,6,,0,0.18711,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0JI,,,,,,,1528,,,,,,,,,8,,,,,,,,,,,,,2007,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,56,,,,,,,,,,,,,,,,,,,,91293,,-0.153419847,0,0,0,0,-1.3533,1,,,Infiltrating Ductal Carcinoma,0.07721303,,0.111014378,0,0,0,,Negative,-0.1245,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.2964,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-J2-A4AE,White,LUAD,,0,0,,ABS - Lahey Clinic,0,0,FEMALE,0,2.18,0.52,4,7,5,,,1079,,1079,1079,,0,0,1079,1079,,Malignant,16,,39,,,,34506,,,1079,1079,,,,1079,1079,,,1079,,,,,,,,TUMOR FREE,Alive,-28163,,,,72,,1079,1079,,,[Not Available],[Not Applicable],,,,,0.08,,,,,7,,0,0.075765,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ABS - Lahey Clinic,,TCGA-J2-A4AE,,,,,,,1079,,,,,,,,,9,,,,,,,,,,,,,2012,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,91294,,0.9912656,,,,,,,,,,0.22851956,,0.118543543,,,,Stage IA,,0.8125,,,,,,,,,,,,,,,,-0.2204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.124038072,LUAD,Adenocarcinoma,,,Adenocarcinoma,-1.2065,,0.2616,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,1,0,1,1,Male,TCGA-YL-A8SJ,,PRAD,389,1,1,,YL,1,0,MALE,1,1.89,0.63,6,8,5,ambiguous,NO,1395,2-ETV1,752,1395,,1,1,752,752,prad_tcga,Malignant,19,BARD1;BRCA2;FANCL;PALB2;RAD51B;RAD54L,59,,TCGA-YL-A8SJ-01,0,5672,0,TCGA-YL-A8SJ,752,752,Prostate Cancer,,1426,752,1395,TCGA,,752,Primary,0,Middle|Base,B,,,True,WITH TUMOR,Alive,-21916,,60,9,36,PRAD,752,752,,0.0,[Not Available],[Not Applicable],29,R0,1,Matched,0.23,Prostate,Resection,4,219FC0A7-7389-40F7-AB99-C2EE6AD501AF,0,,0,0.10711,[Not Available],F3EC5BF3-97AE-4033-91A6-084A1AA152A4,5,Prostate Adenocarcinoma Acinar Type,,Prostate,20,,Acinar Adenocarcinoma,[Not Available],,YL,1.0,TCGA-YL-A8SJ,1:Recurred/Progressed,5,18,Prostate Adenocarcinoma,24.7,4/25/14,1395,,Biochemical evidence of disease,,,NO,C61,86F65B00-7E83-4013-85E8-A4AE42686ACF,460,4,WITH TUMOR,0.0629,0:LIVING,0.24,,45.83,Bilateral,30,,,YES,1306,2010,752,,TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,,66-75%,29,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,YES,No,R0,,60,Core needle biopsy,752,Complete Remission/Response,NO,YES,YES,YES,T3b,NO,9,No,NO,0,N0,,0,M0,C61.9,8140/3,91296,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A3MH,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.99,0.87,4,1,5,,,398,,398,398,,0.0,0,398.0,398.0,,Malignant,10,,24,,,,24834.0,,,398.0,398,,,,398,398,,,398.0,,,,,,,,TUMOR FREE,Alive,-27458,,,,58.0,,398.0,398,,,[Not Available],[Not Applicable],,,,,0.08,,,,,9,,0,0.20756,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A3MH,,,,,,,398,,,,,,,,,10,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,75.0,,,,,,,,,,,,,,,,,,,,91308,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-50-5068,White,LUAD,,1,1,,University of Pittsburgh,,1,FEMALE,1,2.91,0.24,5,3,6,,,1499,,,1499,,1,1,686,686,,Malignant,14,,29,,,,20186,,,686,686,,,,,1499,,,686,,,,,,,,WITH TUMOR,Dead,-21728,1499,,,115,,686,686,,,[Not Available],[Not Applicable],,,,,0.36,,,,,27,,1,0.42605,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5068,,,,,,,1499,,Distant Metastasis,,,,,,,21,,,,,,,,,,,,,2003,686,,,,Stage IIB,,,,,,,,Progressive Disease,,,,,,59,,,,,,,,,,,,,,,,,,,,91311,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,-0.3086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G423V (driver),1,,,G423V (driver),16.76015299,16.38258776,16.80648123,0.23588023,LUAD,Adenocarcinoma,18.34186037,16.92624511,Adenocarcinoma,0.7188,11.03305371,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,,,Black or African American,BRCA,,0,0,,,,2,FEMALE,2,1.97,0.53,6,6,8,,,2965,BRCA_LumA,,2965,,2,2,2965,2965,,Invasive Carcinoma,20,,16,,,,17839,0,,2965,2965,,,,,2965,,,2965,,,,,,,,TUMOR FREE,Dead,-21230,2965,,,24,,2965,2965,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,7,,0,0.22653,Indeterminate (neither Pre or Postmenopausal),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0WS,,,,,,,,,,,,,,,,10,,,,,,,,,,,,,1996,,,,,Stage X,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,91322,,1.326537274,1,0,0,0,-0.6334,0,,,Infiltrating Ductal Carcinoma,0.157639028,,0.161578799,0,0,0,,Positive,1.0945,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3684,1,0,H & E,0,0,,0,Guofeng Gao,ADH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, Low Grade), Stromal Alterations",,"DCIS (Solid, Low Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,ADH,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,0,1,1,Female,TCGA-49-AAQV,Black or African American,LUAD,,1,1,,Johns Hopkins,1,2,FEMALE,1,1.94,0.25,12,10,15,,,677,,509,677,,1,1,509,509,,Malignant,37,,92,,,,24531,,,509,509,,,,509,677,,,509,,,,,,,,TUMOR FREE,Dead,-23370,677,,,79,,509,509,,,[Not Available],[Not Applicable],,,,,0.43,,,,,10,,0,0.23305,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-AAQV,,,,,,,,,Distant Metastasis,,,,,,,11,,,,,,,,,,,,,2012,509,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,91326,,0.992229418,,,,,,,,,,0.187779465,,0.070481974,,,,Stage II,,1.306,,,,,,,,,,,,,,,,-0.0068,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.52921571,15.97780346,15.30858163,-0.330943153,LUAD,Adenocarcinoma,18.30750016,15.90868845,Adenocarcinoma,-0.4187,13.34167188,-0.0482,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-D7-8574,White,STAD,,0,0,,,0,0,,0,2.04,0.13,0,2,1,,,523,,523,523,,0,0,523,523,,Malignant,3,,15,,,,33969,,,523,523,,,,523,523,,,523,,,,,,,,TUMOR FREE,Alive,-26586,,,,43,,523,523,,,[Not Available],[Not Applicable],,,,,0.11,Stomach,Unknown,,,0,,0,0.056574,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8574,,,,,,,523,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,91328,,,,,,,,,,,,,Grade 3,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8574,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Male,TCGA-2H-A9GN,Unknown,ESCA,,1,1,,,,1,,1,2.96,0.75,8,15,11,,,272,,,272,,1,1,242,242,,Malignant,34,,276,,,,19064,,,242,242,,,,,272,,,242,,,,,,,,WITH TUMOR,Dead,-25664,272,,,224,,242,242,,,[Not Available],[Not Available],,,,,0.24,Esophagus,Unknown,,,20,,1,0.49499,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Erasmus MC,,TCGA-2H-A9GN,,,,,,,,Brain,Distant Metastasis,,,,,,,26,,,,,,,,,,,,,2000,242,,,,Stage III,,,,,,,,,,,,,,70,,,,,,,,,,,,,,,,,,,,91333,,,,,,,,,,,,,Grade 3,,,,,Stage III,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-HC-7821,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.93,0.85,5,3,3,ambiguous,NO,956,1-ERG,956,956,,0,0,956,956,prad_tcga,Malignant,11,RAD51B;RAD54L,50,31.0,TCGA-HC-7821-01,0,5433,0,TCGA-HC-7821,956,956,Prostate Cancer,,236,956,956,TCGA,,956,Primary,0,Apex|Middle|Base,A,,,,WITH TUMOR,Alive,-19894,,54,8,32,PRAD,956,956,WHITE,0.0,[Not Available],[Not Applicable],34,,1,Matched,0.13,Prostate,Resection,4,bdf77be2-f833-45f2-bd32-dbf53eb11eb4,4,,0,0.10468,[Not Available],929837f9-297a-47c0-ac9a-a142eef620d3,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,12,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.1,HC,1.03333333333,TCGA-HC-7821,0:DiseaseFree,4,33,Prostate Adenocarcinoma,31.41,4/20/12,956,,,,,,C61,89c7a876-d606-48a6-9672-7cb976058ebf,,4,WITH TUMOR,0.1347,0:LIVING,0.01,,31.41,Bilateral,38,,,YES,,2011,,,TCGA-HC-7821.89c7a876-d606-48a6-9672-7cb976058ebf.pdf,,[Not Applicable],,,61-70%,7,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,Yes,,0.9,54,Core needle biopsy,,,YES,NO,YES,,T3b,,8,No,,0,N1,,2,M0,C61.9,8550/3,91336,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-60-2706,White,LUSC,,0,0,,Roswell Park,0,0,MALE,0,3.45,0.48,10,15,20,,,2820,,2820,2820,,0,0,2820,2820,,Malignant,45,,101,,,,21288,,,2820,2820,,,,2820,2820,,,2820,,,,,,,,TUMOR FREE,Alive,-21477,,,,135,,2820,2820,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,1,0.45159,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2706,,,,,,,2820,,,,,,,,,24,,,,,,,,,,,,,2003,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,91341,,1.244181403,,,,,,,,,,0.246177166,,0.099692416,,,,Stage IA,,1.2735,,,,,,,,,,,,,,,,-0.0473,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.102225575688722,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1383,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-F1-6875,Black or African American,STAD,,0,0,,,2,2,,2,2.55,0.89,8,5,12,,,2197,,2197,2197,,2,2,2197,2197,,Malignant,25,,114,,,,16635,,,2197,2197,,,,2197,2197,,,2197,,,,,,,,TUMOR FREE,Dead,-29209,2197,,,128,,2197,2197,,,[Not Available],[Not Applicable],,,,,0.09,Stomach,Unknown,,,23,,1,0.2692,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,UNC,,TCGA-F1-6875,,,,,,,,,,,,,,,,38,,,,,,,,,,,,,1996,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,91345,,-2.300769255,,,,,,,,,,-0.011920105,Grade 2,0.023856282,,,,Stage IA,,1.1315,,,,,,,,,,,,,,,,-0.1048,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-F1-6875,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.44,0.46,1,2,2,,,554,BRCA_LumA,554,554,,0,0,554,554,,Invasive Carcinoma,5,,5,,,,29616,0,,554,554,,,,554,554,,,554,,,,,,,,TUMOR FREE,Alive,-28013,,,,81,,554,554,,,[Not Available],[Not Applicable],,,,,0.45,Breast,Resection/Excision,,,15,,0,0.06178,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mixed Histology (please specify),,,,,,[Not Available],,Roswell Park,,TCGA-E2-A15G,,,,,,,554,,,,,,,,,15,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,76,,,,,,,,,,,,,,,,,,,,91353,,-0.59570508,0,0,0,0,0.1314,1,,,Mixed Histology (NOS),0.094466862,,0.138293098,0,0,0,,Negative,-1.029,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,-0.0504,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,4.21,0.26,1,8,7,,,3418,BRCA_LumA,3418,3418,,2,2,3418,3418,,Invasive Carcinoma,16,,11,,,,29740,0,,3418,3418,,,,3418,3418,,,3418,,,,,,,,,Dead,-29907,3418,,,48,,3418,3418,,,[Not Available],[Not Applicable],,,,,0.18,Breast,Resection/Excision,,,24,,2,0.10407,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0IH,,,,,,,,,,,,,,,,58,,,,,,,,,,,,,1995,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,81,,,,,,,,,,,,,,,,,,,,91356,,0.761538798,0,1,0,1,0.6607,0,,,Infiltrating Lobular Carcinoma,0.144805167,,0.313561393,0,0,0,,Negative,0.0945,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.5103,1,0,H & E,0,0,,0,Guofeng Gao,"ALH, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,"ALH, UDH",0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-49-4490,White,LUAD,,1,1,,Johns Hopkins,,1,FEMALE,1,5.15,0.26,6,8,14,,,385,,,385,,1,1,385,385,,Malignant,28,,29,,,,23533,,,385,385,,,,,385,,,385,,,,,,,,WITH TUMOR,Dead,-16634,385,,,65,,385,385,,,[Not Available],[Not Applicable],,,,,0.42,,,,,26,,2,0.245,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-4490,,,,,,,,,,,,,,,,48,,,,,,,,,,,,,1993,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,91357,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.5283,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,L858R (driver),,,1,L858R (driver),,,14.95813934,15.40312664,13.8353783,-0.483626278,LUAD,Adenocarcinoma,18.18408044,15.19834945,Adenocarcinoma,,12.95053452,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.95,0.77,4,1,3,,,921,BRCA_Her2,,921,,1,1,921,921,,Invasive Carcinoma,8,,7,,,,18978,0,,921,921,,,,,921,,,921,,,,,,,,WITH TUMOR,Dead,-22222,921,,,447,,921,921,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,6,,1,0.056583,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18P,,,,,,,,,,,,,,,,7,,,,,,,,,,,,,2003,,,,,Stage I,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,91359,,0.507057426,0,0,0,0,-0.3724,1,,,Infiltrating Ductal Carcinoma,0.130998411,,0.134815261,0,0,0,,Negative,-0.0545,Not Answered,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3236,1,0,H & E,0,0,Resection,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",Primary Tumor,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Male,TCGA-77-A5G1,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,1,1.85,0.25,6,5,6,,,4026,,4026,4026,,0,0,2197,2197,,Malignant,17,,55,,,,18936,,,4026,4026,,,,4026,4026,,,2197,,,,,,,,,Alive,-27555,,,,193,,4026,4026,,,[Not Available],[Not Applicable],,,,,0.35,,,,,12,,0,0.26873,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5G1,,,,,,,4026,,New Primary Tumor,,,,,,,12,,,,,,,,,,,,,2002,2197,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,91363,,0.850952207,,,,,,,,,,0.218832736,,0.079374,,,,Stage IIIA,,1.015,,,,,,,,,,,,,,,,0.7267,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.67002164,16.11331052,15.57390106,-0.228933464050196,LUSC,Squamous Cell Carcinoma,18.17005287,15.85361121,Squamous Cell Carcinoma,0.5619,13.2288056,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,MALE,0,,,,,,,,974,,974,974,,0,0,974,974,,Invasive Carcinoma,,,,,,,27356,0,,974,974,,,,974,974,,,974,,,,,,,,TUMOR FREE,Alive,-28664,,,,136,,974,974,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A14W,,,,,,,974,,,,,,,,,,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,91364,,-2.427332325,0,0,0,0,0.5553,1,,,Infiltrating Ductal Carcinoma,0.085275268,,-0.013370838,0,0,0,,Negative,-2.2865,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.1261,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.66,0.57,4,4,6,,,2240,BRCA_LumA,2240,2240,,0,0,2240,2240,,Invasive Carcinoma,14,,23,,,,25068,0,,2240,2240,,,,2240,2240,,,2240,,,,,,,,TUMOR FREE,Alive,-19187,,,,44,,2240,2240,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,16,,1,0.2274,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1L8,,,,,,,2240,,,,,,,,,34,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,91369,,0.21765944,0,0,0,0,0.3484,1,,,Infiltrating Lobular Carcinoma,0.154519752,,0.198092023,0,0,0,,Negative,-0.373,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3242,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-M7-A721,,PRAD,331,0,0,,M7,0,0,MALE,0,1.87,0.24,4,10,0,ambiguous,NO,400,8-other,400,400,,0,0,400,400,prad_tcga,Malignant,14,,42,,TCGA-M7-A721-01,15,5541,0,TCGA-M7-A721,400,400,Prostate Cancer,-8,162,400,400,TCGA,No Evidence of Extraprostatic Extension,400,Primary,1,Apex|Middle|Base,A,,,False,TUMOR FREE,Alive,-25585,,70,7,37,PRAD,400,400,,0.350601438,[Not Available],[Not Applicable],36,R1,1,Matched,0.12,Prostate,Resection,3,16410934-A686-4DBD-9086-BC060135F0B4,0,Normal (no evidence of prostate cancer) [cM0],0,0.097102,[Not Available],6433F001-DB5C-476B-83C7-23F4C5397AE9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,14,,Acinar Adenocarcinoma,[Not Available],,M7,1.2,TCGA-M7-A721,0:DiseaseFree,2,20,Prostate Adenocarcinoma,13.14,12/10/13,400,,,,,YES,C61,357FE07A-B561-44BF-B59B-811F77C1F634,120,2,TUMOR FREE,0.0558,0:LIVING,,,13.14,Bilateral,21,,,YES,276,2012,,,TCGA-M7-A721.357FE07A-B561-44BF-B59B-811F77C1F634.pdf,Overlapping / Multiple Zones,[Not Applicable],NO,-8,51-60%,,Prostate Adenocarcinoma Acinar Type,1,2012,Complete Remission/Response,,NO,No,R1,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,NO,NO,T2c,NO,7,No,NO,0,,T1c,,M0,C61.9,8140/3,91370,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,,0.0,1.0,Female,TCGA-BT-A20P,White,BLCA,,0.0,0,,,,,FEMALE,2.0,2.07,0.93,4,4,3,,,544,,,544,,2.0,2,544.0,544.0,,Malignant,11,,41,,,,26029.0,,,544.0,544,,,,,544,,,544.0,,,,,,,,,Dead,-29634,544,,,135.0,,544.0,544,,,[Not Available],[Not Applicable],,,,,0.0,,,,,7,,0,0.073001,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A20P,,,,,,,,,,,,,,,,5,,,,,,,,,,,,,2005,,,,,Stage III,,,,,,,,[Not Available],,,,,,81.0,,,,,,,,,,,,,,,,,,,,91373,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,Black or African American,BRCA,,1,1,,,1,1,FEMALE,1,1.99,0.89,3,1,1,,,2097,BRCA_LumB,1343,2097,,1,1,1343,1343,,Invasive Carcinoma,5,,6,,,,21928,0,,1343,1343,,,,1343,2097,,,1343,,,,,,,,WITH TUMOR,Dead,-22380,2097,,,57,,1343,1343,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,2,,0,0.052132,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Duke,,TCGA-B6-A0X5,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,2,,,,,,,,,,,,,1995,1343,Liver and Pleura and Bone,,,Stage IIB,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,91375,,-1.350819356,0,0,0,0,0.1584,1,,,Infiltrating Ductal Carcinoma,0.131675756,,0.019236632,0,0,0,,Negative,0.6455,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,-0.4069,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,Adipose Tissue,No Detail Present,"DCIS (Papillary, Low Grade), No Detail Present",,"DCIS (Papillary, Low Grade)",0,Invasive Ductal Carcinoma (Other Type),Invasive Ductal Carcinoma (Other Type),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Male,TCGA-D7-6521,White,STAD,,1,1,,,,0,,1,2.87,0.23,3,7,7,,,564,,,564,,1,1,192,192,,Malignant,17,,40,,,,22570,,,192,192,,,,,564,,,192,,,,,,,,WITH TUMOR,Alive,-23776,,,,88,,192,192,,,[Not Available],[Not Applicable],,,,,0.45,Stomach,Unknown,,,27,,1,0.30006,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-6521,,,,,,,564,"Other, specify",Locoregional Recurrence,,,,,,,37,,,,,,,,,,,,,2010,192,,,,[Discrepancy],,,,,,,,Progressive Disease,,,,,,65,,,,,,,,,,,,,,,,,,,,91378,,0.639501,,,,,,,,,,0.155670615,Grade 3,0.146493786,,,,Unknown,,0.7765,,,,,,,,,,,,,,,,0.5431,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-6521,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,1.91,0.67,6,9,7,,,2306,BRCA_Her2,2306,2306,,0,0,2306,2306,,Invasive Carcinoma,22,,26,,,,16247,0,,2306,2306,,,,2306,2306,,,2306,,,,,,,,TUMOR FREE,Alive,-15283,,,,65,,2306,2306,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,1,,0,0.10484,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1LB,,,,,,,2306,,,,,,,,,2,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,41,,,,,,,,,,,,,,,,,,,,91380,,-0.72064551,0,0,0,0,0.1359,1,,,Infiltrating Ductal Carcinoma,0.135327304,,0.14666009,0,0,0,,Negative,-1.415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.0874,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KS,,PRAD,,0,0,,X4,,0,MALE,0,2.04,0.24,2,4,0,ambiguous,NO,979,,,979,,0,0,979,979,prad_tcga,Malignant,6,,13,,TCGA-X4-A8KS-01,0,5618,0,TCGA-X4-A8KS,979,979,Prostate Cancer,,797,,979,TCGA,,979,Primary,0,,A,,,True,TUMOR FREE,Alive,-22571,,61,7,31,PRAD,979,979,,0.0,[Not Available],[Not Applicable],30,,1,Matched,0.0,Prostate,Resection,3,874964AB-D09A-422C-9B51-7239338E78D4,2,,0,0.024833,[Not Available],56829C8D-7BB7-4AAC-999F-B1353DB4915D,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,X4,1.0,TCGA-X4-A8KS,0:DiseaseFree,2,13,Prostate Adenocarcinoma,32.16,3/7/14,979,,,,,NO,C61,30844429-3F9C-4AD0-8A23-64012532347C,160,1,TUMOR FREE,0.0004,0:LIVING,0.01,,32.16,Bilateral,18,,,YES,735,2011,,,TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf,Peripheral Zone,[Not Applicable],NO,,,,Prostate Adenocarcinoma Acinar Type,1,2011,Stable Disease,,NO,No,RX,,61,Core needle biopsy,,Stable Disease,NO,YES,NO,NO,T2c,NO,7,No,NO,0,,T2c,,M0,C61.9,8140/3,91383,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-37-3783,White,LUSC,,0,0,,Cureline,,0,MALE,0,2.27,0.36,10,15,17,,,122,,,122,,0,0,122,122,,Malignant,42,,168,,,,31573,,,122,122,,,,,122,,,122,,,,,,,,TUMOR FREE,Alive,-18728,,,,516,,122,122,,,[Not Available],[Not Applicable],,,,,0.16,,,,,10,,0,0.24524,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-3783,,,,,,,122,,,,,,,,,20,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,91385,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0416,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.7494343,15.97864166,16.78547451,0.177131659288843,LUSC,Squamous Cell Carcinoma,17.40842715,16.82294352,Squamous Cell Carcinoma,0.4744,15.52319057,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.85,0.75,7,1,5,,,890,BRCA_LumA,890,890,,0,0,890,890,,Invasive Carcinoma,13,,46,,,,26673,1,,890,890,,,,890,890,,,890,,,,,,,,TUMOR FREE,Alive,-23284,,,,95,,890,890,,,[Not Available],[Not Applicable],,,,,0.02,Not Specific/Unknown,Resection/Excision,,,5,,1,0.1087,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A4ZE,,,,,,,890,,,,,,,,,9,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,91391,,-0.023481949,0,0,0,0,0.1694,1,,,Infiltrating Lobular Carcinoma,0.093182879,,0.218429417,0,0,0,,Negative,0.0495,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.0572,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6378,Black or African American,PRAD,108,0,0,,G9,0,0,MALE,0,1.95,0.26,2,1,2,HRP,NO,1155,8-other,1155,1155,,0,0,1155,1155,prad_tcga,Malignant,5,,9,4.2,TCGA-G9-6378-01,0,5374,0,TCGA-G9-6378,1155,1155,Prostate Cancer,,223,1155,1155,TCGA,,1155,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-19879,,54,7,37,PRAD,1155,1155,BLACK OR AFRICAN AMERICAN,0.0,[Not Available],[Not Applicable],31,R1,1,Matched,0.0,Prostate,Resection,3,940bbb5c-7280-41ed-9332-47c2072ae072,1,Normal (no evidence of prostate cancer) [cM0],0,0.047512,[Not Available],12f225d0-cbff-44eb-9183-bacc7f33b090,4,Prostate Adenocarcinoma Acinar Type,1.2,Prostate,5,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.2,G9,1.0,TCGA-G9-6378,0:DiseaseFree,2,10,Prostate Adenocarcinoma,37.94,3/5/12,1155,,,,,NO,C61,425008c5-919c-45b3-beb7-2392d6866ffb,,2,TUMOR FREE,0.0009,0:LIVING,0.03,,37.94,Bilateral,11,No Evidence of Extraprostatic Extension,100,YES,,2009,,,TCGA-G9-6378.425008c5-919c-45b3-beb7-2392d6866ffb.pdf,,[Not Applicable],YES,-176,71-80%,,Prostate Adenocarcinoma Acinar Type,1,2009,Complete Remission/Response,,NO,No,R1,0.9,54,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,91400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-SY-A9G5,White,BLCA,,0.0,0,,,0,0,MALE,0.0,3.52,0.36,11,11,12,,,1186,,1186,1186,,0.0,0,1186.0,1186.0,,Malignant,34,,89,,,,20040.0,,,1186.0,1186,,,,1186,1186,,,1186.0,,,,,,,,TUMOR FREE,Alive,-24260,,,,1380.0,,1186.0,1186,,,[Not Available],[Not Applicable],,,,,0.08,,,,,16,,1,0.20709,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Mayo Clinic Arizona,,TCGA-SY-A9G5,,,,,,,1186,,,,,,,,,22,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,66.0,,,,,,,,,,,,,,,,,,,,91405,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.56,0.5,9,8,9,,,762,BRCA_Basal,762,762,,0,0,762,762,,None,26,,47,,,,31560,N/A (Non-Malignant),,762,762,,,,762,762,,,762,,,,,,,,TUMOR FREE,Alive,-18621,,,,210,,762,762,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,14,,0,0.49912,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A159,,,,,,,762,,,,,,,,,15,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,91411,,1.478317942,0,0,0,0,0.4186,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.210209633,N/A (Non-Malignant),0.101302226,0,0,0,N/A (Non-Malignant),Negative,1.4705,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.3093,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,1,Adipose Tissue,N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,440,BRCA_Her2,440,440,,0,0,440,440,,Invasive Carcinoma,,,,,,,23436,0,,440,440,,,,440,440,,,440,,,,,,,,TUMOR FREE,Alive,-18354,,,,74,,440,440,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A5YO,,,,,,,440,,,,,,,,,,,,,,,,,,,,,,2013,,,,,Stage IA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,91417,TRUE,2.015899615,0,0,0,0,0.4909,1,,,Infiltrating Ductal Carcinoma,0.215523325,,0.116761258,0,0,0,,Negative,1.5345,,10/21/22,0,0,0,0,0,0,0,0,0,0,"This is Nottingham grade 3 tumor, although mitotic figure is low (1).",0,0,0.0189,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-L5-A4OJ,White,ESCA,,0,0,,,0,0,,0,1.84,0.78,14,7,6,,,639,,639,639,,0,0,639,639,,Malignant,27,,85,,,,33015,,,639,639,,,,639,639,,,639,,,,,,,,TUMOR FREE,Alive,-25657,,,,377,,639,639,,,[Not Available],[Not Available],,,,,0.08,Esophagus,Unknown,,,2,,0,0.21029,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,University of Michigan,,TCGA-L5-A4OJ,,,,,,,639,,,,,,,,,7,,,,,,,,,,,,,2012,,,,,Stage I,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,91418,,,,,,,,,,,,,Grade 3,,,,,Stage I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.56,0.25,12,6,11,,,393,BRCA_Her2,393,393,,0,0,393,393,,Invasive Carcinoma,29,,46,,,,33417,0,,393,393,,,,393,393,,,393,,,,,,,,TUMOR FREE,Alive,-23667,,,,98,,393,393,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,17,,1,0.34854,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A135,,,,,,,393,,,,,,,,,27,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,91419,,0.787646538,0,0,0,0,-0.0808,1,,,Infiltrating Ductal Carcinoma,0.152878873,,0.224139718,0,0,0,,Negative,-0.3675,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3887,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.58,0.53,15,32,26,,,1027,BRCA_Basal,1027,1027,,0,0,1027,1027,,Invasive Carcinoma,73,,182,,,,18910,0,,1027,1027,,,,1027,1027,,,1027,,,,,,,,TUMOR FREE,Alive,-16623,,,,135,,1027,1027,,,[Not Available],[Not Applicable],,,,,0.08,Breast,Resection/Excision,,,13,,0,0.69378,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,,,TCGA-A2-A0D2,,,,,,,1027,,,,,,,,,22,,,,,,,,,,,,,2008,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,45,,,,,,,,,,,,,,,,,,,,91423,TRUE,0.912415749,0,0,0,1,0.3587,0,,,Infiltrating Ductal Carcinoma,0.150605729,,0.145150484,0,0,0,,Negative,0.217,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3733,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Stromal Alterations,"DCIS (Solid, High Grade), Stromal Alterations",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A5U8,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,1.95,0.97,0,0,0,,,399,,399,399,,0.0,0,399.0,399.0,,Malignant,0,,12,,,,18117.0,,,399.0,399,,,,399,399,,,399.0,,,,,,,,TUMOR FREE,Alive,-21734,,,,79.0,,399.0,399,,,[Not Available],[Not Applicable],,,,,0.12,,,,,2,,0,0.050758,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A5U8,,,,,,,399,,,,,,,,,1,,,,,,,,,,,,,2012,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,59.0,,,,,,,,,,,,,,,,,,,,91424,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-63-A5MR,Unknown,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,FEMALE,0,2.99,0.32,9,2,10,,,2716,,2716,2716,,0,0,2716,2716,,Malignant,21,,77,,,,22618,,,2716,2716,,,,2716,2716,,,2716,,,,,,,,TUMOR FREE,Alive,-25879,,,,228,,2716,2716,,,[Not Available],[Not Applicable],,,,,0.18,,,,,19,,1,0.42702,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-A5MR,,,,,,,2716,,,,,,,,,29,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,70,,,,,,,,,,,,,,,,,,,,91431,,0.200874993,,,,,,,,,,0.136450794,,-0.046048214,,,,Stage IB,,1.0765,,,,,,,,,,,,,,,,0.4787,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.404213423881159,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.2893,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,0,0.0,1.0,Male,TCGA-FD-A5BT,White,BLCA,,0.0,0,,,,2,MALE,2.0,2.56,0.18,4,7,8,,,328,,,328,,2.0,2,328.0,328.0,,Malignant,19,,42,,,,33342.0,,,328.0,328,,,,,328,,,328.0,,,,,,,,TUMOR FREE,Dead,-30686,328,,,181.0,,328.0,328,,,[Not Available],[Not Applicable],,,,,0.41,,,,,23,,0,0.19046,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - University Of Chicago,,TCGA-FD-A5BT,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2011,,,,,Stage III,,,,,,,,[Not Applicable],,,,,,84.0,,,,,,,,,,,,,,,,,,,,91432,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-34-A5IX,White,LUSC,,0,0,,University of Pittsburgh,0,0,MALE,0,3.08,0.36,16,12,13,,,1031,,1031,1031,,0,0,1031,1031,,Malignant,41,,194,,,,33413,,,1031,1031,,,,1031,1031,,,1031,,,,,,,,TUMOR FREE,Alive,-29391,,,,370,,1031,1031,,,[Not Available],[Not Applicable],,,,,0.11,,Resection/Excision,,,25,,1,0.44192,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Pittsburgh,,TCGA-34-A5IX,,,,,,,1031,,,,,,,,,22,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,80,,,,,,,,,,,,,,,,,,,,91433,,0.462957831,,,,,,,,,,0.119536971,,0.016473178,,,,Stage IIB,,0.206,Not Answered,,,,,,,,,,,,,,,0.2241,,,,,,Resection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Primary Tumor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.84927293,15.29531063,15.22906741,-0.514001997337721,LUSC,,17.74234978,15.43219204,Squamous Cell Carcinoma,-0.249,13.11260825,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-BR-A4J4,Asian,STAD,,0,0,,,,0,,0,2.19,0.45,5,7,5,,,16,,,16,,0,0,16,16,,Malignant,17,,43,,,,22516,,,16,16,,,,,16,,,16,,,,,,,,TUMOR FREE,Alive,-14459,,,,97,,16,16,,,[Not Available],[Not Applicable],,,,,0.03,Stomach,Unknown,,,9,,0,0.14716,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-A4J4,,,,,,,16,,,,,,,,,12,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,91437,,0.518694819,,,,,,,,,,0.055427359,Grade 3,0.034497597,,,,Stage IIIB,,0.4765,,,,,,,,,,,,,,,,0.3133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-A4J4,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,1.86,0.64,13,6,13,,,381,BRCA_LumB,381,381,,0,0,381,381,,Invasive Carcinoma,32,,41,,,,20295,0,,381,381,,,,381,381,,,381,,,,,,,,TUMOR FREE,Alive,-21391,,,,77,,381,381,,,[Not Available],[Not Applicable],,,,,0.1,Breast,Resection/Excision,,,6,,0,0.24143,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A26W,,,,,,,381,,,,,,,,,8,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,91438,,0.924814836,0,0,0,1,0.2023,0,,,Infiltrating Ductal Carcinoma,0.148780152,,0.163874057,0,0,0,,Negative,0.2425,,10/21/22,0,0,0,0,0,0,0,0,0,0,AR and Adipophilin IHC can help,0,0,0.2424,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"Other/Uncommon DCIS Subtype (Apocrine, Neuroendocrine, Signet Ring Cell, Clear Cell), No Detail Present",,"Other/Uncommon DCIS Subtype (Apocrine, Neuroendocrine, Signet Ring Cell, Clear Cell)",0,Invasive Ductal Carcinoma (Apocrine),Invasive Ductal Carcinoma (Apocrine),0,UDH,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,3.17,0.53,15,14,21,,,489,BRCA_Basal,489,489,,0,0,489,489,,Invasive Carcinoma,50,,150,,,,21779,0,,489,489,,,,489,489,,,489,,,,,,,,TUMOR FREE,Alive,-18520,,,,78,,489,489,,,[Not Available],[Not Applicable],,,,,0.26,Breast,Resection/Excision,,,15,,1,0.40382,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Candler,,TCGA-LL-A6FR,,,,,,,489,,,,,,,,,33,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,91439,,-0.810935,0,0,0,1,0.6134,0,,,Infiltrating Ductal Carcinoma,0.175075614,,0.055659473,0,0,0,,Negative,-1.4885,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.4007,1,0,H & E,0,0,,0,Guofeng Gao,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, High Grade), Comedonecrosis",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3D,White,BLCA,,0.0,0,,,,0,MALE,0.0,1.88,0.69,11,7,11,,,2139,,,2139,,0.0,0,2139.0,2139.0,,Malignant,29,,135,,,,19749.0,,,2139.0,2139,,,,,2139,,,2139.0,,,,,,,,TUMOR FREE,Alive,-22205,,,,281.0,,2139.0,2139,,,[Not Available],[Not Applicable],,,,,0.53,,,,,5,,0,0.16294,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3D,,,,,,,2139,,,,,,,,,7,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,60.0,,,,,,,,,,,,,,,,,,,,91447,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-XF-A9SK,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.14,0.47,8,8,19,,,486,,,486,,1.0,1,382.0,382.0,,Malignant,35,,126,,,,32392.0,,,382.0,382,,,,,486,,,382.0,,,,,,,,WITH TUMOR,Dead,-24019,486,,,196.0,,382.0,382,,,[Not Available],[Not Applicable],,,,,0.19,,,,,19,,1,0.26865,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Southern California,,TCGA-XF-A9SK,,,,,,,,Bone,Distant Metastasis,,,,,,,28,,,,,,,,,,,,,2004,382,,,,Stage IV,,,,,,,,Stable Disease,,,,,,65.0,,,,,,,,,,,,,,,,,,,,91450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.13,0.68,1,2,4,,,1133,BRCA_LumA,1133,1133,,0,0,1133,1133,,Invasive Carcinoma,7,,8,,,,24104,0,,1133,1133,,,,1133,1133,,,1133,,,,,,,,TUMOR FREE,Alive,-19627,,,,51,,1133,1133,,,[Not Available],[Not Applicable],,,,,0.36,Breast,Resection/Excision,,,17,,2,0.029979,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1BD,,,,,,,1133,,,,,,,,,59,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,53,,,,,,,,,,,,,,,,,,,,91452,,-1.102266992,0,0,0,0,0.6186,1,,,Infiltrating Ductal Carcinoma,0.094553881,,0.203053298,0,0,0,,Negative,-1.12,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.2963,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-VQ-A91X,White,STAD,,0,0,,,2,2,,2,4.13,0.53,9,8,19,,,289,,289,289,,2,2,289,289,,Malignant,36,,164,,,,32672,,,289,289,,,,289,289,,,289,,,,,,,,TUMOR FREE,Dead,-27314,289,,,278,,289,289,,,"Other, non-malignant disease",[Not Applicable],,,,,0.1,Stomach,Unknown,,,19,,2,0.30049,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Barretos Cancer Hospital,,TCGA-VQ-A91X,,,,,,,,,,,,,,,,57,,,,,,,,,,,,,2010,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,91468,,-0.796767229,,,,,,,,,,-0.026264742,Grade 3,-0.097668012,,,,Stage IIIB,,-1.3035,,,,,,,,,,,,,,,,-0.6927,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-VQ-A91X,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.92,0.82,12,3,11,,,640,BRCA_LumB,640,640,,0,0,640,640,,Invasive Carcinoma,26,,48,,,,30204,1,,640,640,,,,640,640,,,640,,,,,,,,TUMOR FREE,Alive,-21348,,,,95,,640,640,,,[Not Available],[Not Applicable],,,,,0.01,Not Specific/Unknown,Resection/Excision,,,6,,0,0.21478,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A155,,,,,,,640,,,,,,,,,10,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,58,,,,,,,,,,,,,,,,,,,,91479,,-0.162604083,0,1,0,0,-0.0913,0,,,Infiltrating Ductal Carcinoma,0.061441594,,0.099931687,0,0,0,,Negative,-1.122,,10/21/22,0,0,0,0,0,0,0,0,0,0,E-Cadherin IHC can help to confirm ductal vs lobular vs mixed,0,0,-0.2484,1,0,H & E,0,0,,0,Guofeng Gao,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,Adipose Tissue,No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,ALH,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-BR-8690,White,STAD,,0,0,,,0,0,,0,,,,,,,,325,,325,325,,0,0,325,325,,Malignant,,,,,,,19510,,,325,325,,,,325,325,,,325,,,,,,,,TUMOR FREE,Alive,-19855,,,,204,,325,325,,,[Not Available],[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8690,,,,,,,325,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,91481,,,,,,,,,,,,,Grade 2,,,,,Stage IIIB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8690,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,1,,1,1,1,Female,TCGA-D7-A6EY,White,STAD,,1,1,,,,1,,1,2.07,0.39,2,3,3,,,348,,,348,,1,1,348,348,,Malignant,8,,50,,,,24471,,,348,348,,,,,348,,,348,,,,,,,,WITH TUMOR,Dead,-26526,348,,,1954,,348,348,,,Stomach Cancer,[Not Applicable],,,,,0.04,Stomach,Unknown,,,2,,0,0.057282,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A6EY,,,,,,,,,,,,,,,,3,,,,,,,,,,,,,2013,,,,,Stage IIIB,,,,,,,,Progressive Disease,,,,,,72,,,,,,,,,,,,,,,,,,,,91485,,1.179219748,,,,,,,,,,0.092362337,Grade 3,0.062375196,,,,Stage IIIB,,1.9135,,,,,,,,,,,,,,,,0.144,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A6EY,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,,0,0,0,Female,TCGA-80-5607,,LUAD,,0,0,,Ontario Institute for Cancer Research (OICR)/Ottawa,,0,FEMALE,0,2.02,0.49,1,0,2,,,,,,,,0,0,,,,Malignant,3,,7,,,,0,,,,,,,,,,,,,,,,,,,,WITH TUMOR,Alive,,,,,165,,,,,,[Not Available],[Not Applicable],,,,,0.0,,,,,3,,0,0.043412,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR)/Ottawa,,TCGA-80-5607,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,,,,,,,,,,,,,,,,,,,,,91487,,,,,,,,,,,,,,,,,,Stage IIB,,,,,,,,,,,,,,,,,,0.1678,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.87459799,17.09837289,15.82729613,0.008666565,LUAD,Adenocarcinoma,18.36483325,16.47978667,Adenocarcinoma,-0.5648,13.04145062,0.9967,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-HU-A4G6,Asian,STAD,,0,0,,,0,0,,0,3.42,0.81,1,5,3,,,738,,738,738,,0,0,738,738,,Malignant,9,,24,,,,28963,,,738,738,,,,738,738,,,738,,,,,,,,TUMOR FREE,Alive,-27208,,,,108,,738,738,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,14,,1,0.036068,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Papillary Type",,,,,Intestinal Gastric Carcinoma,G3,,National Cancer Center Korea,,TCGA-HU-A4G6,,,,,,,738,,,,,,,,,22,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,91489,,-0.362658984,,,,,,,,,,-0.020401478,Grade 3,-0.000643422,,,,Stage IA,,-0.9795,,,,,,,,,,,,,,,,-0.7018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4G6,Gastric Carcinoma,TCGA,"Adenocarcinoma, Papillary Type"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.64,5,3,4,,,210,BRCA_LumA,210,210,,0,0,210,210,,Invasive Carcinoma,12,,21,,,,25147,0,,210,210,,,,210,210,,,210,,,,,,,,TUMOR FREE,Alive,-20352,,,,122,,210,210,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,3,,0,0.07099,Peri (6-12 months since last menstrual period),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FS,,,,,,,210,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,55,,,,,,,,,,,,,,,,,,,,91500,,-1.272785332,0,0,0,0,-0.1242,1,,,Infiltrating Lobular Carcinoma,0.144876973,,0.259199769,0,0,0,,Negative,-1.1485,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4477,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,0,No,0,Adipose Tissue,No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-R6-A6DN,White,ESCA,,1,1,,,,1,,1,3.37,0.73,15,13,22,,,243,,,243,,1,1,199,199,,Malignant,50,,206,,,,16640,,,199,199,,,,,243,,,199,,,,,,,,WITH TUMOR,Dead,-21259,243,,,174,,199,199,,,[Not Available],Stage IV,,,,,0.26,Esophagus,Unknown,,,13,,2,0.3223,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,MD Anderson Cancer Center,,TCGA-R6-A6DN,,,,,,,,"Other, specify",Distant Metastasis,,,,,,,76,,,,,,,,,,,,,2011,199,Brain,,,[Not Available],,,,,,,,Partial Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,91509,,,,,,,,,,,,,Grade 3,,,,,Stage IV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.05,0.44,8,13,11,,,1437,BRCA_LumA,1437,1437,,0,0,1437,1437,,Invasive Carcinoma,32,,11,,,,17843,0,,1437,1437,,,,1437,1437,,,1437,,,,,,,,TUMOR FREE,Alive,-14595,,,,145,,1437,1437,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,2,,0,0.084178,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,UCSF,,TCGA-A1-A0SH,,,,,,,1437,,,,,,,,,6,,,,,,,,,,,,,2006,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,91510,,-0.374975109,0,0,0,0,0.6974,1,,,Infiltrating Ductal Carcinoma,0.187091413,,0.172510697,0,0,0,,Negative,-0.843,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.871,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,,,White,BRCA,,1,1,,,1,1,FEMALE,1,1.98,0.7,5,4,6,,,385,BRCA_LumA,21,385,,1,1,21,21,,Invasive Carcinoma,15,,37,,,,32349,0,,21,21,,,,21,385,,,21,,,,,,,,WITH TUMOR,Dead,-29125,385,,,62,,21,21,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.099502,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Mucinous Carcinoma,,,,,,[Not Available],,Greater Poland Cancer Center,,TCGA-D8-A73W,,,,,,,,Lung,Distant Metastasis,,,,,,,5,,,,,,,,,,,,,2013,21,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,91513,,-0.058467165,0,0,0,0,0.0132,1,,,Mucinous Carcinoma,0.199399563,,0.225915886,0,0,0,,Negative,0.457,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.4248,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Mucinous),Invasive Ductal Carcinoma (Mucinous),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-HC-8258,,PRAD,221,0,0,,HC,0,0,MALE,0,,,,,,HRD,NO,847,5-SPOP,847,847,,0,0,847,847,prad_tcga,Malignant,,,,4.3,TCGA-HC-8258-01,0,5439,0,TCGA-HC-8258,847,847,Prostate Cancer,,162,847,847,TCGA,,847,Primary,0,,A,PALB2:89-110:DEETGEKTSITLDVGPESFNPG/X:frameshift_variant,,,TUMOR FREE,Alive,-20703,,56,6,14,PRAD,847,847,,0.0,[Not Available],[Not Applicable],25,,1,Matched,,Prostate,Resection,3,b8881603-9353-4f63-93d7-e14efed64aa6,,,,,[Not Available],da5b0169-e4f4-4674-b348-220af03ff4b5,3,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,,,Acinar Adenocarcinoma,[Not Available],0.2,HC,0.833333333333,TCGA-HC-8258,0:DiseaseFree,1,,Prostate Adenocarcinoma,27.83,6/20/12,847,,,,,,C61,fffd3795-6c0c-43a0-afe4-30e759e5f20a,,,TUMOR FREE,0.0,0:LIVING,0.01,,27.83,Bilateral,,,,YES,,2011,,,TCGA-HC-8258.fffd3795-6c0c-43a0-afe4-30e759e5f20a.pdf,,[Not Applicable],,,61-70%,2,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,,0.5,56,Core needle biopsy,,,YES,NO,YES,NO,T2c,,6,No,,0,N0,,0,,C61.9,8550/3,91525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-NC-A5HE,White,LUSC,,0,0,,Washington University - CHUV,0,0,MALE,0,1.78,0.32,17,9,11,,,2336,,2336,2336,,0,0,2336,2336,,Malignant,37,,119,,,,32382,,,2336,2336,,,,2336,2336,,,2336,,,,,,,,TUMOR FREE,Alive,-22179,,,,270,,2336,2336,,,[Not Available],[Not Applicable],,,,,0.41,,,,,9,,0,0.43702,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HE,,,,,,,2336,,,,,,,,,16,,,,,,,,,,,,,2008,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,60,,,,,,,,,,,,,,,,,,,,91526,,1.824573777,,,,,,,,,,0.26054817,,0.072112535,,,,Stage IIB,,2.147,,,,,,,,,,,,,,,,0.2235,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.30343929,17.77920113,18.81393785,0.300082486235913,LUSC,Squamous Cell Carcinoma,18.21566719,17.73309769,Squamous Cell Carcinoma,0.4099,12.56916279,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,1.0,1.0,Female,TCGA-GD-A2C5,White,BLCA,,1.0,1,,,,0,FEMALE,1.0,5.25,1.0,8,21,18,,,812,,,812,,1.0,1,214.0,214.0,,Malignant,47,,32,,,,21906.0,,,214.0,214,,,,,812,,,214.0,,,,,,,,WITH TUMOR,Alive,-19498,,,,363.0,,214.0,214,,,[Not Available],[Not Applicable],,,,,0.35,,,,,16,,2,0.18714,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,ABS - IUPUI,,TCGA-GD-A2C5,,,,,,,812,Lung,Metastatic,,,,,,,59,,,,,,,,,,,,,2011,214,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,53.0,,,,,,,,,,,,,,,,,,,,91532,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-93-8067,Asian,LUAD,,0,0,,Washington University - St. Louis,0,0,MALE,0,4.4,0.32,7,14,19,,,186,,186,186,,0,0,186,186,,Malignant,40,,168,,,,27176,,,186,186,,,,186,186,,,186,,,,,,,,TUMOR FREE,Alive,-28453,,,,688,,186,186,,,[Not Available],[Not Applicable],,,,,0.2,,,,,16,,2,0.32509,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - St. Louis,,TCGA-93-8067,,,,,,,186,,,,,,,,,55,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,77,,,,,,,,,,,,,,,,,,,,91534,,0.55786532,,,,,,,,,,0.154647231,,0.112279835,,,,Stage IB,,0.2705,,,,,,,,,,,,,,,,0.2253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12V (driver),,1,,G12V (driver),,,,,-0.620184313,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.2915,,-1.1508,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,91535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,91536,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-77-A5GH,Unknown,LUSC,,0,0,,Prince Charles Hospital,0,0,MALE,0,1.89,0.46,11,10,18,,,1182,,1182,1182,,0,0,1182,1182,,Malignant,39,,120,,,,29489,,,1182,1182,,,,1182,1182,,,1182,,,,,,,,,Alive,-29843,,,,343,,1182,1182,,,[Not Available],[Not Applicable],,,,,0.35,,,,,12,,0,0.41805,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-A5GH,,,,,,,1182,,,,,,,,,18,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,81,,,,,,,,,,,,,,,,,,,,91539,,1.511792824,,,,,,,,,,0.190214923,,0.069975941,,,,Stage IB,,1.852,,,,,,,,,,,,,,,,0.3734,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.0930404939479143,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.0961,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-A2EF,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.04,0.61,7,15,18,,,1884,,,1884,,0.0,0,1884.0,1884.0,,Malignant,40,,62,,,,26289.0,,,1884.0,1884,,,,,1884,,,1884.0,,,,,,,,TUMOR FREE,Alive,-18467,,,,357.0,,1884.0,1884,,,[Not Available],[Not Applicable],,,,,0.23,,,,,12,,1,0.21003,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EF,,,,,,,1884,,,,,,,,,39,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Partial Remission/Response,,,,,,50.0,,,,,,,,,,,,,,,,,,,,91549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.16,0.49,6,3,12,,,943,BRCA_Her2,943,943,,0,0,943,943,,Invasive Carcinoma,21,,34,,,,17134,0,,943,943,,,,943,943,,,943,,,,,,,,TUMOR FREE,Alive,-24850,,,,209,,943,943,,,[Not Available],[Not Applicable],,,,,0.22,Breast,Resection/Excision,,,19,,2,0.12282,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0EE,,,,,,,943,,,,,,,,,59,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,91550,,0.62455212,0,0,0,0,1.5681,1,,,Infiltrating Ductal Carcinoma,0.098136228,,0.052377057,0,0,0,,Negative,0.207,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.5518,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.93,0.54,6,6,6,,,3519,BRCA_LumA,3519,3519,,0,0,3519,3519,,Invasive Carcinoma,18,,54,,,,16990,0,,3519,3519,,,,3519,3519,,,3519,,,,,,,,TUMOR FREE,Alive,-18475,,,,60,,3519,3519,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,5,,0,0.13805,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A2DL,,,,,,,3519,,,,,,,,,8,,,,,,,,,,,,,2003,,,,,Stage I,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,91555,,-0.058372459,0,0,0,0,0.4243,1,,,Infiltrating Ductal Carcinoma,0.194624189,,0.183511841,0,0,0,,Negative,-0.72,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,0.7503,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,Adipose Tissue,Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,1.61,0.78,13,8,16,,,875,BRCA_LumB,875,875,,0,0,875,875,,None,37,,81,,,,31666,N/A (Non-Malignant),,875,875,,,,875,875,,,875,,,,,,,,TUMOR FREE,Alive,-25830,,,,55,,875,875,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,13,,0,0.46488,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Miami,,TCGA-EW-A1J6,,,,,,,875,,,,,,,,,16,,,,,,,,,,,,,2009,,,,,Stage I,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,91556,,1.103581669,0,0,0,0,-1.4139,1,,N/A (Non-Malignant),Infiltrating Ductal Carcinoma,0.120505037,N/A (Non-Malignant),0.164317693,0,0,0,N/A (Non-Malignant),Negative,0.0275,,10/21/22,0,0,0,0,0,0,0,0,0,0,Not Answered,0,0,-0.378,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,1,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,None,None,0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-4Z-AA7W,White,BLCA,,1.0,1,,,1,0,MALE,1.0,2.63,0.32,15,22,18,,,840,,760,840,,1.0,1,760.0,760.0,,Malignant,55,,113,,,,27491.0,,,760.0,760,,,,760,840,,,760.0,,,,,,,,WITH TUMOR,Alive,-20424,,,,727.0,,760.0,760,,,[Not Available],[Not Applicable],,,,,0.15,,,,,16,,1,0.40849,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Barretos Cancer Hospital,,TCGA-4Z-AA7W,,,,,,,840,"Other, specify",Locoregional (Urothelial tumor event),,,,,,,37,,,,,,,,,,,,,2012,760,Rectum,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,55.0,,,,,,,,,,,,,,,,,,,,91559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,1.99,0.94,2,0,3,,,1542,BRCA_LumA,1542,1542,,2,2,1542,1542,,Invasive Carcinoma,5,,7,,,,22978,0,,1542,1542,,,,1542,1542,,,1542,,,,,,,,TUMOR FREE,Dead,-32872,1542,,,62,,1542,1542,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.044533,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Duke,,TCGA-B6-A0IC,,,,,,,,,,,,,,,,2,,,,,,,,,,,,,1992,,,,,Stage X,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,91561,,-1.961436378,0,0,0,0,-0.167,1,,,Other,0.064351695,,-0.006594323,0,0,0,,Negative,-2.11,,10/21/22,0,0,0,1,0,0,0,0,0,0,NA,0,0,-0.5672,1,0,H & E,0,0,,0,Naziheh Assarzadegan,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Cribriform Carcinoma),Invasive Ductal Carcinoma (Cribriform Carcinoma),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 1 (Low grade): Less than 1.5x benign epithelial nucleus, minimal pleomorphism, even chromatin, no or very inconspicuous nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 1 (>75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.04,0.74,9,5,15,,,541,BRCA_LumB,541,541,,0,0,541,541,,Invasive Carcinoma,29,,20,,,,27344,0,,541,541,,,,541,541,,,541,,,,,,,,TUMOR FREE,Alive,-28660,,,,59,,541,541,,,[Not Available],[Not Applicable],,,,,0.37,Breast,Resection/Excision,,,9,,0,0.21659,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A1KT,,,,,,,541,,,,,,,,,13,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,78,,,,,,,,,,,,,,,,,,,,91565,,-0.098402934,0,0,0,0,-0.0618,1,,,Infiltrating Ductal Carcinoma,0.162349679,,0.136566393,0,0,0,,Negative,-0.8415,,10/21/22,0,0,0,0,0,0,0,0,0,0,Na,0,0,0.3787,1,0,H & E,0,0,,0,Naziheh Assarzadegan,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-75-6214,,LUAD,,1,1,,Ontario Institute for Cancer Research (OICR),1,1,FEMALE,1,2.76,0.64,10,12,19,,,1115,,419,1115,,1,1,419,419,,Malignant,41,,64,,,,0,,,419,419,,,,419,1115,,,419,,,,,,,,WITH TUMOR,Dead,,1115,,,912,,419,419,,,[Not Available],[Not Applicable],,,,,0.53,,,,,16,,1,0.33247,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Ontario Institute for Cancer Research (OICR),,TCGA-75-6214,,,,,,,,,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,,419,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,91566,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.3599,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,AMP (driver),,,1,,,,14.4340725,15.11642982,14.48553208,-0.473511038,LUAD,Adenocarcinoma,17.53320291,14.88034641,Adenocarcinoma,-0.6057,14.11475779,-0.8945,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,2991,,2991,2991,,0,0,2991,2991,,Invasive Carcinoma,,,,,,,27243,0,,2991,2991,,,,2991,2991,,,2991,,,,,,,,TUMOR FREE,Alive,-19123,,,,0,,2991,2991,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AM,,,,,,,2991,,,,,,,,,,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,91569,,0.641737296,0,0,0,0,0.7728,1,,,Infiltrating Lobular Carcinoma,0.154687462,,0.167932778,0,0,0,,Negative,-0.04,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3857,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Female,TCGA-G2-A2EJ,White,BLCA,,1.0,1,,,1,0,FEMALE,1.0,2.09,0.61,9,4,7,,,1460,,910,1460,,1.0,1,910.0,910.0,,Malignant,20,,60,,,,25884.0,,,910.0,910,,,,910,1460,,,910.0,,,,,,,,TUMOR FREE,Alive,-20649,,,,428.0,,910.0,910,,,[Not Available],[Not Applicable],,,,,0.05,,,,,7,,0,0.13654,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A2EJ,,,,,,,1460,Lung,Distant Metastasis,,,,,,,7,,,,,,,,,,,,,2009,910,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,56.0,,,,,,,,,,,,,,,,,,,,91575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Male,TCGA-CF-A3MI,Asian,BLCA,,0.0,0,,,0,0,MALE,0.0,3.84,0.79,3,6,9,,,370,,370,370,,0.0,0,370.0,370.0,,Malignant,18,,25,,,,33163.0,,,370.0,370,,,,370,370,,,370.0,,,,,,,,TUMOR FREE,Alive,-22716,,,,93.0,,370.0,370,,,[Not Available],[Not Applicable],,,,,0.3,,,,,15,,1,0.051556,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,Low Grade,,ILSBio,,TCGA-CF-A3MI,,,,,,,370,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,62.0,,,,,,,,,,,,,,,,,,,,91579,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.8,0.68,18,29,32,,,3030,BRCA_Basal,3030,3030,,0,0,3030,3030,,Invasive Carcinoma,79,,153,,,,29247,1,,3030,3030,,,,3030,3030,,,3030,,,,,,,,TUMOR FREE,Alive,-18771,,,,230,,3030,3030,,,[Not Available],[Not Applicable],,,,,0.05,Not Specific/Unknown,Resection/Excision,,,10,,1,0.53226,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A251,,,,,,,3030,,,,,,,,,33,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,51,,,,,,,,,,,,,,,,,,,,91583,,0.427182346,0,0,0,0,-1.351,1,,,Infiltrating Ductal Carcinoma,0.173054333,,0.107997014,0,0,0,,Negative,-0.342,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.2124,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,1,0,FFPE,,0,1,0,Yes,0,"Adipose Tissue, Skeletal Muscle",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-BR-8291,White,STAD,,0,0,,,2,2,,2,1.8,0.35,7,4,6,,,607,,607,607,,2,2,607,607,,Malignant,17,,23,,,,21334,,,607,607,,,,607,607,,,607,,,,,,,,TUMOR FREE,Dead,-22552,607,,,36,,607,607,,,[Not Available],[Not Applicable],,,,,0.19,Stomach,Unknown,,,8,,0,0.2553,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,GX,,Asterand,,TCGA-BR-8291,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,2011,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,91585,,0.588612108,,,,,,,,,,0.162631206,Unknown,0.228261875,,,,Stage IIB,,0.2255,,,,,,,,,,,,,,,,0.7296,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8291,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,0,0,0,1,,,White,BRCA,,0,0,,,2,2,FEMALE,2,2.21,0.52,7,11,9,,,1142,BRCA_Her2,1142,1142,,2,2,1142,1142,,Invasive Carcinoma,27,,61,,,,18539,0,,1142,1142,,,,1142,1142,,,1142,,,,,,,,TUMOR FREE,Dead,-18524,1142,,,43,,1142,1142,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,4,,0,0.11497,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18R,,,,,,,,,,,,,,,,9,,,,,,,,,,,,,2001,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,50,,,,,,,,,,,,,,,,,,,,91588,,0.52044268,0,0,0,0,-1.3211,1,,,Infiltrating Ductal Carcinoma,0.108290913,,0.105045786,0,0,0,,Negative,-0.5675,,10/21/22,0,0,0,0,0,0,0,0,0,0,Coverslip artifact involves a large portion of the silde,0,0,0.0392,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Poor (so bad that tissue is not evaluable),0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-CH-5740,White,PRAD,91,0,0,,CH,,0,MALE,0,1.95,0.67,3,7,4,HRD,NO,31,1-ERG,,31,,0,0,31,31,prad_tcga,Malignant,14,,58,,TCGA-CH-5740-01,4,5239,0,TCGA-CH-5740,31,31,Prostate Cancer,31,,,31,TCGA,No Evidence of Extraprostatic Extension,31,Primary,0,,A,,BRCA1;CHEK2;RAD51D,,TUMOR FREE,Alive,-20880,,57,7,24,PRAD,31,31,WHITE,0.147766175,[Not Available],[Not Applicable],36,R0,1,Matched,0.01,Prostate,Resection,3,3865d892-c7e5-4c56-a9de-887450fce5bb,0,Normal (no evidence of prostate cancer) [cM0],0,0.063574,[Not Available],cd113dc4-915a-47d2-bce0-9dba915a9d29,4,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,14,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,CH,1.2,TCGA-CH-5740,0:DiseaseFree,2,14,Prostate Adenocarcinoma,1.02,3/21/12,31,,,,,YES,C61,25992d81-7441-4d60-a773-457618dcedbc,,0,TUMOR FREE,0.076,0:LIVING,1.6,,1.02,Bilateral,18,,,YES,,2009,,,TCGA-CH-5740.25992d81-7441-4d60-a773-457618dcedbc.pdf,,[Not Applicable],NO,31,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2009,[Not Available],,NO,No,R0,0.8,57,Core needle biopsy,,,YES,NO,YES,,T2c,,7,No,,0,N0,,0,M0,C61.9,8550/3,91590,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Black or African American,BRCA,,0,0,,,0,0,FEMALE,0,2.67,0.48,13,15,18,,,441,BRCA_Basal,441,441,,0,0,441,441,,Invasive Carcinoma,46,,220,,,,16097,1,,441,441,,,,441,441,,,441,,,,,,,,TUMOR FREE,Alive,-19131,,,,82,,441,441,,,[Not Available],[Not Applicable],,,,,0.2,Not Specific/Unknown,Core Biopsy,,,16,,1,0.45215,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Christiana Healthcare,,TCGA-A7-A4SD,,,,,,,441,,,,,,,,,33,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,91592,,1.097860325,0,0,0,0,0.3673,1,,,Infiltrating Ductal Carcinoma,0.207362983,,0.046171331,0,0,0,,Negative,1.5005,,10/21/22,0,0,0,0,0,0,0,1,0,0,no,0,0,0.6019,0,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Medullary),Invasive Ductal Carcinoma (Medullary),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-85-8287,White,LUSC,,0,0,,Asterand,2,2,MALE,2,3.01,0.34,3,13,13,,,23,,23,23,,2,2,23,23,,Malignant,29,,45,,,,22026,,,23,23,,,,23,23,,,23,,,,,,,,TUMOR FREE,Dead,-26401,23,,,323,,23,23,,,[Not Available],[Not Applicable],,,,,0.16,,,,,17,,1,0.37387,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8287,,,,,,,,,,,,,,,,28,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,91593,,1.610626892,,,,,,,,,,0.241474468,,0.165134415,,,,Stage IA,,1.1235,,,,,,,,,,,,,,,,0.8919,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.117591391551492,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.3033,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Female,TCGA-44-A47A,White,LUAD,,1,1,,Christiana Healthcare,1,0,FEMALE,1,3.67,0.34,2,7,7,,,466,,397,466,,1,1,397,397,,Malignant,16,,12,,,,30115,,,397,397,,,,397,466,,,397,,,,,,,,WITH TUMOR,Alive,-28782,,,,278,,397,397,,,[Not Available],[Not Applicable],,,,,0.32,,,,,20,,1,0.025891,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Christiana Healthcare,,TCGA-44-A47A,,,,,,,466,,Distant Metastasis,,,,,,,22,,,,,,,,,,,,,2012,397,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,91595,,1.034467535,,,,,,,,,,0.249108655,,0.08989626,,,,Stage IB,,1.1845,,,,,,,,,,,,,,,,-0.095,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12D (driver),,1,,G12D (driver),,,,,-0.211236115,LUAD,,,,Adenocarcinoma,0.0231,,-0.4725,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-58-A46M,White,LUSC,,0,0,,Thoraxklinik at University Hospital Heidelberg,0,0,MALE,0,3.41,0.55,23,19,30,,,1072,,1072,1072,,0,0,1072,1072,,Malignant,72,,210,,,,25509,,,1072,1072,,,,1072,1072,,,1072,,,,,,,,TUMOR FREE,Alive,-22592,,,,559,,1072,1072,,,[Not Available],[Not Applicable],,,,,0.18,,,,,18,,2,0.50322,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Thoraxklinik at University Hospital Heidelberg,,TCGA-58-A46M,,,,,,,1072,,,,,,,,,70,,,,,,,,,,,,,2010,,,,,Stage IIB,,,,,,,,Complete Remission/Response,,,,,,61,,,,,,,,,,,,,,,,,,,,91596,,0.859070677,,,,,,,,,,0.168296049,,-0.020662879,,,,Stage IIB,,2.146,,,,,,,,,,,,,,,,-0.1205,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,HOMDEL,,N482_R483delinsS,1,,,N482_R483delinsS,15.59523704,16.27454776,18.30791873,-0.0579482855106673,LUSC,Squamous Cell Carcinoma,17.67893183,16.08631612,Squamous Cell Carcinoma,-1.0667,12.10450646,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,,,White,BRCA,,1,1,,,,1,FEMALE,1,3.44,0.67,4,6,11,,,174,BRCA_Her2,,174,,1,1,174,174,,Invasive Carcinoma,21,,40,,,,19447,0,,174,174,,,,,174,,,174,,,,,,,,WITH TUMOR,Dead,-32873,174,,,6711,,174,174,,,[Not Available],[Not Applicable],,,,,0.12,Breast,Core Biopsy,,,15,,1,0.11528,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A23H,,,,,,,,,,,,,,,,29,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,90,,,,,,,,,,,,,,,,,,,,91598,,-0.527365238,0,0,0,0,-0.2206,1,,,Infiltrating Ductal Carcinoma,0.147101416,,0.098672431,0,0,0,,Negative,-0.784,,10/21/22,0,0,0,0,0,0,0,1,0,0,no,0,0,0.327,0,0,H & E,0,0,,0,Hua Guo,None,0,0,0,Optimal,0,0,Core Biopsy,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,None of the Above,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-85-8049,White,LUSC,,0,0,,Asterand,0,0,MALE,0,2.78,0.2,5,5,6,,,579,,579,579,,0,0,579,579,,Malignant,16,,10,,,,18208,,,579,579,,,,579,579,,,579,,,,,,,,TUMOR FREE,Alive,-20995,,,,295,,579,579,,,[Not Available],[Not Applicable],,,,,0.42,,,,,23,,1,0.23547,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-8049,,,,,,,579,,,,,,,,,31,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,57,,,,,,,,,,,,,,,,,,,,91608,,1.470741304,,,,,,,,,,0.235148578,,0.172450183,,,,Stage IB,,1.803,,,,,,,,,,,,,,,,0.8799,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.0442359094410874,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.9001,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Female,TCGA-BR-8363,White,STAD,,0,0,,,2,2,,2,2.09,0.35,1,3,2,,,8,,8,8,,2,2,8,8,,Malignant,6,,15,,,,24399,,,8,8,,,,8,8,,,8,,,,,,,,TUMOR FREE,Dead,-26976,8,,,1737,,8,8,,,"Other, non-malignant disease",[Not Applicable],,,,,0.02,Stomach,Unknown,,,3,,0,0.010577,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8363,,,,,,,,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,91612,,1.362947604,,,,,,,,,,0.127425951,Grade 3,0.096539224,,,,Stage IB,,1.847,,,,,,,,,,,,,,,,0.2249,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8363,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,Male,TCGA-WW-A8ZI,,PRAD,389,0,0,,WW,0,0,MALE,0,1.91,0.94,3,4,3,HRP,NO,449,8-other,449,449,,0,0,449,449,prad_tcga,Malignant,10,,69,,TCGA-WW-A8ZI-01,0,5601,0,TCGA-WW-A8ZI,449,449,Prostate Cancer,,176,449,449,TCGA,,449,Primary,0,Apex,A,,,True,TUMOR FREE,Alive,-25593,,70,8,42,PRAD,449,449,,0.0,[Not Available],[Not Applicable],37,R0,1,Matched,0.02,Prostate,Resection,4,E377F5C9-452C-4AEC-BA78-739E4AA6B844,2,Normal (no evidence of prostate cancer) [cM0],0,0.091174,[Not Available],ABEB0894-862F-4035-A6D9-FE0BA61630A9,4,Prostate Adenocarcinoma Acinar Type,,Prostate,10,,Acinar Adenocarcinoma,[Not Available],,WW,1.23333333333,TCGA-WW-A8ZI,0:DiseaseFree,4,10,Prostate Adenocarcinoma,14.75,3/26/14,449,,,,,NO,C61,91350D32-096F-4839-ABE4-6AC4354E7B68,170,1,TUMOR FREE,0.0819,0:LIVING,0.0,,14.75,Bilateral,12,No Evidence of Extraprostatic Extension,20,YES,135,2013,,,TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf,,[Not Applicable],YES,13,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,2013,Complete Remission/Response,,NO,No,R0,,70,Core needle biopsy,,Complete Remission/Response,YES,NO,YES,NO,T2c,NO,8,No,NO,0,N0,T2c,0,M0,C61.9,8140/3,91614,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,91615,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-NC-A5HG,White,LUSC,,0,0,,Washington University - CHUV,0,0,MALE,0,3.53,0.75,13,8,17,,,1963,,1963,1963,,0,0,1963,1963,,Malignant,38,,127,,,,17129,,,1963,1963,,,,1963,1963,,,1963,,,,,,,,TUMOR FREE,Alive,-21608,,,,820,,1963,1963,,,[Not Available],[Not Applicable],,,,,0.21,,,,,18,,1,0.40485,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HG,,,,,,,1963,,,,,,,,,27,,,,,,,,,,,,,2009,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,59,,,,,,,,,,,,,,,,,,,,91622,,-0.63115182,,,,,,,,,,0.058030867,,-0.010690637,,,,Stage IIIA,,-1.4265,,,,,,,,,,,,,,,,-0.3202,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.30095597,13.64267418,13.50997199,-1.02787785634628,LUSC,Squamous Cell Carcinoma,17.25519369,14.0267703,Squamous Cell Carcinoma,-1.9926,12.94334625,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-FP-8210,Asian,STAD,,1,1,,,,1,,1,2.0,0.5,0,0,0,,,153,,,153,,1,1,153,153,,Malignant,0,,3,,,,23546,,,153,153,,,,,153,,,153,,,,,,,,WITH TUMOR,Dead,-17562,153,,,4,,153,153,,,Stomach Cancer,[Not Applicable],,,,,0.0,Stomach,Unknown,,,0,,0,0.000247,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,International Genomics Consortium,,TCGA-FP-8210,,,,,,,,,,,,,,,,0,,,,,,,,,,,,,2006,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,48,,,,,,,,,,,,,,,,,,,,91623,,1.310721213,,,,,,,,,,0.137334786,Grade 3,0.241250109,,,,Stage IIIA,,0.87,,,,,,,,,,,,,,,,0.5263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-FP-8210,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Female,TCGA-BR-8679,White,STAD,,0,0,,,0,0,,0,3.65,0.53,4,10,8,,,0,,0,0,,0,0,0,0,,Malignant,22,,115,,,,18290,,,0,0,,,,0,0,,,0,,,,,,,,TUMOR FREE,Alive,-23084,,,,199,,0,0,,,[Not Available],[Not Applicable],,,,,0.23,Stomach,Unknown,,,26,,2,0.35271,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Asterand,,TCGA-BR-8679,,,,,,,0,,,,,,,,,55,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,63,,,,,,,,,,,,,,,,,,,,91628,,-0.780892014,,,,,,,,,,0.063251242,Grade 2,0.10405365,,,,Stage IB,,-0.3795,,,,,,,,,,,,,,,,0.2093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8679,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.03,0.53,12,17,20,,,1935,BRCA_Basal,1935,1935,,0,0,1935,1935,,Invasive Carcinoma,49,,66,,,,31346,0,,1935,1935,,,,1935,1935,,,1935,,,,,,,,TUMOR FREE,Alive,-17580,,,,90,,1935,1935,,,[Not Available],[Not Applicable],,,,,0.31,Breast,Resection/Excision,,,14,,1,0.37778,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A150,,,,,,,1935,,,,,,,,,29,,,,,,,,,,,,,2009,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,48,,,,,,,,,,,,,,,,,,,,91637,TRUE,1.091364078,0,0,0,0,1.2575,1,,,Infiltrating Ductal Carcinoma,0.163794017,,0.156317008,0,0,0,,Negative,0.2865,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3143,1,0,H & E,0,0,,0,Di (Andy) Ai,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-V1-A9O5,,PRAD,,1,1,,V1,1,0,MALE,1,2.15,0.58,8,10,9,ambiguous,NO,1932,,124,1932,,1,1,124,124,prad_tcga,Malignant,27,ATM;BRCA2;CHEK1,66,,TCGA-V1-A9O5-01,0,5570,0,TCGA-V1-A9O5,124,124,Prostate Cancer,,1776,124,1932,TCGA,,124,Primary,0,Apex,A,,,True,,Alive,-23725,,64,9,44,PRAD,124,124,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.28,Prostate,Resection,5,9F03470E-516E-4D9C-8424-0D7A05780504,4,,0,0.14626,[Not Available],E0DFC37A-4A2E-4353-9673-241B100B3467,4,Prostate Adenocarcinoma Acinar Type,,Prostate,28,,Acinar Adenocarcinoma,[Not Available],,V1,1.3,TCGA-V1-A9O5,1:Recurred/Progressed,5,28,Prostate Adenocarcinoma,4.07,7/23/14,1932,,Biochemical evidence of disease,,,NO,C61,4C94E826-144A-4879-99A3-E3B1655D4066,230,11,,0.259,0:LIVING,3.26,,63.47,Bilateral,133,No Evidence of Extraprostatic Extension,25,YES,,,124,,TCGA-V1-A9O5.4C94E826-144A-4879-99A3-E3B1655D4066.pdf,Peripheral Zone,[Not Applicable],YES,,,20,Prostate Adenocarcinoma Acinar Type,2,,Complete Remission/Response,,YES,No,R1,,64,Core needle biopsy,124,Complete Remission/Response,NO,YES,YES,YES,T4,YES,9,No,YES,,N1,T2b,6,M0,C61.9,8140/3,91638,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,1,1,Female,TCGA-NC-A5HI,White,LUSC,,0,0,,Washington University - CHUV,0,0,FEMALE,1,1.8,0.6,16,9,15,,,1743,,1743,1743,,0,0,70,70,,Malignant,40,,109,,,,33839,,,1743,1743,,,,1743,1743,,,70,,,,,,,,TUMOR FREE,Alive,-24981,,,,574,,1743,1743,,,[Not Available],[Not Applicable],,,,,0.32,,,,,10,,0,0.39161,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Washington University - CHUV,,TCGA-NC-A5HI,,,,,,,1743,,New Primary Tumor,,,,,,,15,,,,,,,,,,,,,2009,70,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,91641,,1.119383001,,,,,,,,,,0.097397233,,-0.024427257,,,,Stage IB,,-0.171,,,,,,,,,,,,,,,,-0.1483,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.745754334485888,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-1.8241,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-KK-A7B1,,PRAD,331,0,0,,KK,0,0,MALE,0,1.97,0.54,0,3,0,HRD,NO,1063,1-ERG,1063,1063,,0,0,1063,1063,prad_tcga,Malignant,3,,47,,TCGA-KK-A7B1-01,0,5516,0,TCGA-KK-A7B1,1063,1063,Prostate Cancer,52,179,1063,1063,TCGA,No Evidence of Extraprostatic Extension,1063,Primary,0,Apex|Middle|Base,A,CHEK1:.:.:splice_region_variant,,True,,Alive,-23803,,65,7,22,PRAD,1063,1063,,0.0,[Not Available],[Not Applicable],27,R0,1,Matched,0.01,Prostate,Resection,4,F769B0D1-5736-4A74-A418-9D66A6BE5B75,0,,0,0.027501,[Not Available],7315BB0A-96A1-45AB-A704-B084D237CF5C,3,Prostate Adenocarcinoma Acinar Type,,Prostate,3,,Acinar Adenocarcinoma,[Not Available],,KK,0.9,TCGA-KK-A7B1,0:DiseaseFree,3,3,Prostate Adenocarcinoma,34.92,6/6/14,1063,,,,,YES,C61,F7802347-53BA-44B9-ACFE-7A10A014822B,110,0,,0.0261,0:LIVING,0.1,,34.92,Bilateral,6,,,YES,839,2011,,,TCGA-KK-A7B1.F7802347-53BA-44B9-ACFE-7A10A014822B.pdf,Peripheral Zone,[Not Applicable],NO,,51-60%,21,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R0,,65,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,,T3a,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8140/3,91644,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-55-8205,White,LUAD,,1,1,,International Genomics Consortium,,0,FEMALE,1,3.33,0.22,6,1,9,,,599,,,599,,1,1,495,495,,Malignant,16,,20,,,,32828,,,495,495,,,,,599,,,495,,,,,,,,WITH TUMOR,Alive,-28063,,,,757,,495,495,,,[Not Available],[Not Applicable],,,,,0.16,,,,,18,,2,0.2602,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8205,,,,,,,599,,Distant Metastasis,,,,,,,73,,,,,,,,,,,,,2012,495,,,,Stage IIA,,,,,,,,Progressive Disease,,,,,,76,,,,,,,,,,,,,,,,,,,,91650,,1.422296139,,,,,,,,,,0.265055375,,0.162104258,,,,Stage IIA,,2.5665,,,,,,,,,,,,,,,,0.2103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,17.65729478,19.11023105,18.54685832,0.208488568,LUAD,Adenocarcinoma,17.89322868,16.91744168,Adenocarcinoma,-0.094,12.88319938,1.4858,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,,,,,,,,803,,803,803,,0,0,803,803,,Invasive Carcinoma,,,,,,,29668,1,,803,803,,,,803,803,,,803,,,,,,,,TUMOR FREE,Alive,-23371,,,,0,,803,803,,,[Not Available],[Not Applicable],,,,,,Not Specific/Unknown,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,Asterand,,TCGA-E9-A5UP,,,,,,,803,,,,,,,,,,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,91653,,-0.720657254,0,0,0,0,-0.4031,1,,,Other,0.136315781,,-0.017377087,0,0,0,,Negative,-0.893,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.4401,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Not Specific/Unknown,Suboptimal,0,0,0,0,0,FFPE,,0,1,0,Yes,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-HF-7136,,STAD,,0.0,0,,,,0,,0.0,3.05,0.75,11,15,21,,,,,,,,0.0,0,,,,Malignant,47,,133,,,,30027.0,0,,,,,,,,,,,,,,,,,,,WITH TUMOR,Alive,,,,,118.0,,,,,,[Not Available],[Not Applicable],,,,,0.22,Stomach,Resection,,,15,,1,0.57742,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,Ontario Institute for Cancer Research (OICR),,TCGA-HF-7136,,,,,,,,,,,,,,,,33,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,,,,,,,,,,,,,,,,,,,,,91654,,0.039597873,,,,,,,,,,0.072991042,Grade 2,0.060470056,,,,Stage IIIA,,0.5745,,,,,,,,,,,,,,,,0.5762,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HF-7136,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,4.14,0.53,3,6,5,,,3361,BRCA_LumA,3361,3361,,0,0,3361,3361,,Invasive Carcinoma,14,,15,,,,33153,0,,3361,3361,,,,3361,3361,,,3361,,,,,,,,TUMOR FREE,Alive,-23041,,,,118,,3361,3361,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,6,,1,0.058961,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MD Anderson,,TCGA-GM-A3NW,,,,,,,3361,,,,,,,,,8,,,,,,,,,,,,,2003,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,91657,,-0.020527577,0,0,0,0,-0.3259,0,,,Infiltrating Lobular Carcinoma,0.139253742,,0.166622494,0,0,0,,Negative,-0.3175,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.0041,1,0,H & E,0,0,,0,Hua Guo,Apocrine Metaplasia,0,1,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,Apocrine Metaplasia,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.66,0.4,3,4,9,,,788,BRCA_LumA,788,788,,0,0,788,788,,Invasive Carcinoma,16,,20,,,,32403,0,,788,788,,,,788,788,,,788,,,,,,,,TUMOR FREE,Alive,-14316,,,,342,,788,788,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,19,,1,0.067079,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,University of Miami,,TCGA-EW-A2FV,,,,,,,788,,,,,,,,,19,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,39,,,,,,,,,,,,,,,,,,,,91664,,0.949354675,0,0,0,0,1.0774,1,,,Other,0.159052855,,0.246214353,0,0,0,,Negative,0.2595,,10/21/22,0,0,0,1,0,0,0,0,0,0,no,0,0,0.2929,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,1,0,1.0,1.0,Male,TCGA-E5-A4U1,Unknown,BLCA,,1.0,1,,,1,0,MALE,1.0,3.4,0.78,5,10,15,,,1181,,705,1181,,1.0,1,705.0,705.0,,Malignant,30,,85,,,,22059.0,,,705.0,705,,,,705,1181,,,705.0,,,,,,,,WITH TUMOR,Alive,-26305,,,,819.0,,705.0,705,,,[Not Available],[Not Applicable],,,,,0.23,,,,,15,,1,0.1602,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Roswell Park,,TCGA-E5-A4U1,,,,,,,1181,Bone,Distant Metastasis,,,,,,,24,,,,,,,,,,,,,2011,705,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,72.0,,,,,,,,,,,,,,,,,,,,91677,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-55-8301,White,LUAD,,1,1,,International Genomics Consortium,1,0,MALE,1,2.2,0.26,7,6,9,,,534,,238,534,,1,1,238,238,,Malignant,22,,27,,,,27460,,,238,238,,,,238,534,,,238,,,,,,,,WITH TUMOR,Alive,-21535,,,,380,,238,238,,,[Not Available],[Not Applicable],,,,,0.5,,,,,5,,0,0.3978,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8301,,,,,,,534,,Locoregional Recurrence,,,,,,,27,,,,,,,,,,,,,2012,238,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,58,,,,,,,,,,,,,,,,,,,,91681,,1.608211984,,,,,,,,,,0.262842507,,0.135770612,,,,Stage IB,,2.3075,,,,,,,,,,,,,,,,0.2738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.265963356,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.173,,1.0464,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Male,TCGA-33-4547,White,LUSC,,0,0,,Johns Hopkins,0,0,MALE,0,1.91,0.49,12,11,19,,,2419,,2419,2419,,0,0,2419,2419,,Malignant,42,,169,,,,17065,,,2419,2419,,,,2419,2419,,,2419,,,,,,,,TUMOR FREE,Alive,-25056,,,,256,,2419,2419,,,[Not Available],[Not Applicable],,,,,0.02,,,,,12,,0,0.33781,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4547,,,,,,,2419,,,,,,,,,18,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,91686,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,0.7549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.460033798952849,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,,0,1,Male,TCGA-33-4538,White,LUSC,,0,0,,Johns Hopkins,2,,MALE,2,3.06,0.59,12,12,12,,,2979,,2979,2979,,2,2,2979,2979,,Malignant,36,,108,,,,22964,,,2979,2979,,,,2979,2979,,,2979,,,,,,,,,Dead,-24174,2979,,,253,,2979,2979,,,[Not Available],[Not Applicable],,,,,0.19,,,,,18,,1,0.37264,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4538,,,,,,,,,,,,,,,,24,,,,,,,,,,,,,2002,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,66,,,,,,,,,,,,,,,,,,,,91687,,,,,,,,,,,,,,,,,,Stage IIIA,,,,,,,,,,,,,,,,,,0.0937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,L310P,1,,,L310P,14.68356532,14.6882359,15.88063545,-0.478316025939243,LUSC,Squamous Cell Carcinoma,17.99054955,15.50903637,Squamous Cell Carcinoma,,12.04674545,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,,0.0,1.0,Male,TCGA-ZF-AA54,White,BLCA,,0.0,0,,,,,MALE,2.0,3.18,0.43,12,5,17,,,590,,,590,,2.0,2,590.0,590.0,,Malignant,34,,83,,,,24755.0,,,590.0,590,,,,,590,,,590.0,,,,,,,,,Dead,-26128,590,,,254.0,,590.0,590,,,[Not Available],[Not Applicable],,,,,0.08,,,,,20,,1,0.33495,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-AA54,,,,,,,,,,,,,,,,32,,,,,,,,,,,,,2009,,,,,Stage III,,,,,,,,[Unknown],,,,,,71.0,,,,,,,,,,,,,,,,,,,,91693,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-85-A4QQ,White,LUSC,,0,0,,Asterand,2,2,MALE,2,1.95,0.56,12,8,16,,,927,,927,927,,2,2,927,927,,Malignant,36,,69,,,,16158,,,927,927,,,,927,927,,,927,,,,,,,,TUMOR FREE,Dead,-25065,927,,,415,,927,927,,,[Not Available],[Not Applicable],,,,,0.42,,,,,11,,0,0.3337,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Asterand,,TCGA-85-A4QQ,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2012,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,68,,,,,,,,,,,,,,,,,,,,91699,,-0.144001136,,,,,,,,,,0.089041124,,-0.044227948,,,,Stage IB,,-0.2615,,,,,,,,,,,,,,,,0.1678,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.662933884800865,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.1652,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.85,0.89,10,16,13,,,651,BRCA_LumB,651,651,,0,0,651,651,,Invasive Carcinoma,39,,49,,,,16442,0,,651,651,,,,651,651,,,651,,,,,,,,TUMOR FREE,Alive,-24519,,,,112,,651,651,,,[Not Available],[Not Applicable],,,,,0.11,Breast,Resection/Excision,,,11,,1,0.17548,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,"Other, specify",,,,,,[Not Available],,MSKCC,,TCGA-AO-A0J3,,,,,,,651,,,,,,,,,34,,,,,,,,,,,,,2009,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,67,,,,,,,,,,,,,,,,,,,,91702,,-0.683692763,0,0,0,0,-1.6616,1,,,Other,0.081992389,,0.087864781,0,0,0,,Negative,-1.2585,,10/21/22,0,0,0,0,0,0,0,0,0,0,"may add inv carcinoma, unsure of type.",0,0,-0.5693,1,0,H & E,0,0,,0,Alma Reyes-Trocchia,None,0,0,0,Suboptimal,0,0,Resection/Excision,Suboptimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-77-8150,Unknown,LUSC,,1,1,,Prince Charles Hospital,,1,MALE,1,3.72,0.56,7,9,17,,,1655,,,1655,,1,1,1278,1278,,Malignant,33,,23,,,,23387,,,1278,1278,,,,,1655,,,1278,,,,,,,,WITH TUMOR,Dead,-23474,1655,,,169,,1278,1278,,,[Not Available],[Not Applicable],,,,,0.15,,,,,18,,1,0.3011,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8150,,,,,,,,,Locoregional Recurrence,,,,,,,20,,,,,,,,,,,,,2007,1278,,,,Stage IIIA,,,,,,,,[Not Applicable],,,,,,64,,,,,,,,,,,,,,,,,,,,91703,,1.200807789,,,,,,,,,,0.137439536,,0.08795486,,,,Stage IIIA,,2.01,,,,,,,,,,,,,,,,0.2924,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.50597522,15.61648125,17.19967356,-0.275235940718977,LUSC,Squamous Cell Carcinoma,18.20311097,16.46653744,Squamous Cell Carcinoma,-0.8548,10.99311129,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.46,0.39,4,4,8,,,343,BRCA_LumA,343,343,,0,0,343,343,,Invasive Carcinoma,16,,19,,,,34239,0,,343,343,,,,343,343,,,343,,,,,,,,TUMOR FREE,Alive,,,,,76,,343,343,,,[Not Available],[Not Applicable],,,,,0.16,Breast,Resection/Excision,,,22,,1,0.14103,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HI,,,,,,,343,,,,,,,,,23,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,40,,,,,,,,,,,,,,,,,,,,91704,,-0.497420084,0,0,0,0,0.7148,1,,,Infiltrating Ductal Carcinoma,0.146589454,,0.128382346,0,0,0,,Negative,-0.9875,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.1561,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Cribriform, Intermediate Grade), Other/Uncommon DCIS Subtype (Apocrine, Neuroendocrine, Signet Ring Cell, Clear Cell), Comedonecrosis",,"DCIS (Cribriform, Intermediate Grade), Other/Uncommon DCIS Subtype (Apocrine, Neuroendocrine, Signet Ring Cell, Clear Cell)",0,Invasive Ductal Carcinoma (Apocrine),Invasive Ductal Carcinoma (Apocrine),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-63-7020,,LUSC,,0,0,,Ontario Institute for Cancer Research,0,0,MALE,0,3.13,0.48,7,7,11,,,2133,,2133,2133,,0,0,2133,2133,,Malignant,25,,28,,,,17245,,,2133,2133,,,,2133,2133,,,2133,,,,,,,,TUMOR FREE,Alive,,,,,246,,2133,2133,,,[Not Available],[Not Applicable],,,,,0.33,,,,,27,,1,0.49819,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Ontario Institute for Cancer Research,,TCGA-63-7020,,,,,,,2133,,,,,,,,,24,,,,,,,,,,,,,2007,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,,,,,,,,,,,,,,,,,,,,,91715,,0.842467556,,,,,,,,,,0.207554359,,0.071407023,,,,Stage IA,,1.141,,,,,,,,,,,,,,,,0.6991,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.129040251514518,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,-0.1747,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-F1-6874,White,STAD,,0,0,,,0,0,,0,2.07,0.6,3,1,1,,,440,,440,440,,0,0,440,440,,Malignant,5,,9,,,,28672,,,440,440,,,,440,440,,,440,,,,,,,,TUMOR FREE,Alive,-29083,,,,1314,,440,440,,,[Not Available],[Not Applicable],,,,,0.07,Stomach,Unknown,,,4,,0,0.05011,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,UNC,,TCGA-F1-6874,,,,,,,440,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,79,,,,,,,,,,,,,,,,,,,,91719,,0.740345181,,,,,,,,,,0.136162227,Grade 3,0.146024944,,,,Stage IB,,1.078,,,,,,,,,,,,,,,,0.5878,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-F1-6874,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,,0,0,0,Male,TCGA-66-2777,,LUSC,,0,0,,Indivumed,,0,MALE,0,3.27,0.3,10,15,16,,,61,,,61,,0,0,61,61,,Malignant,41,,128,,,,21209,,,61,61,,,,,61,,,61,,,,,,,,TUMOR FREE,Alive,-26085,,,,224,,61,61,,,[Not Available],[Not Applicable],,,,,0.33,,,,,23,,1,0.38046,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2777,,,,,,,61,,,,,,,,,26,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,71,,,,,,,,,,,,,,,,,,,,91721,,0.549553269,,,,,,,,,,0.277535829,,0.096231589,,,,Stage IB,,0.8115,,,,,,,,,,,,,,,,0.4914,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,S224Y,1,,,S224Y,,,,-0.422515941735127,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.2082,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-V1-A8X3,,PRAD,389,0,0,,V1,0,0,MALE,0,1.94,0.65,4,3,3,HRP,NO,202,3-ETV4,202,202,,0,0,202,202,prad_tcga,Malignant,10,CHEK2;PALB2,22,,TCGA-V1-A8X3-01,0,5569,0,TCGA-V1-A8X3,202,202,Prostate Cancer,,202,202,202,TCGA,,202,Primary,0,Apex,A,,,True,,Alive,-18980,,51,7,36,PRAD,202,202,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.07,Prostate,Resection,3,7A6297FE-B95F-44ED-A658-F2CA33D17435,1,,0,0.056423,[Not Available],86B82965-B19B-4285-B1A5-51A5D5267103,4,Prostate Adenocarcinoma Acinar Type,,Prostate,8,,Acinar Adenocarcinoma,[Not Available],,V1,0.933333333333,TCGA-V1-A8X3,0:DiseaseFree,2,10,Prostate Adenocarcinoma,6.64,7/23/14,202,,,,,NO,C61,267C0EAB-ECC4-44BC-89C9-8C54F3B22A6E,170,2,,0.0612,0:LIVING,0.03,,6.64,Bilateral,14,,,YES,,,,,TCGA-V1-A8X3.267C0EAB-ECC4-44BC-89C9-8C54F3B22A6E.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,18,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R1,,51,Core needle biopsy,,,NO,YES,YES,NO,T2c,NO,7,No,NO,,N0,T1c,0,M0,C61.9,8140/3,91723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-G2-AA3F,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.72,0.68,4,8,12,,,893,,,893,,0.0,0,893.0,893.0,,Malignant,24,,47,,,,30554.0,,,893.0,893,,,,,893,,,893.0,,,,,,,,TUMOR FREE,Alive,-28457,,,,198.0,,893.0,893,,,[Not Available],[Not Applicable],,,,,0.35,,,,,11,,1,0.067433,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-AA3F,,,,,,,893,,,,,,,,,29,,,,,,,,,,,,,2012,,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,77.0,,,,,,,,,,,,,,,,,,,,91734,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GV-A3JV,White,BLCA,,1.0,1,,,,1,MALE,1.0,3.36,0.66,2,3,6,,,434,,,434,,1.0,1,134.0,134.0,,Malignant,11,,26,,,,20764.0,,,134.0,134,,,,,434,,,134.0,,,,,,,,WITH TUMOR,Dead,-24243,434,,,162.0,,134.0,134,,,[Not Available],[Not Applicable],,,,,0.34,,,,,16,,1,0.1412,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,BLN - Cleveland Clinic,,TCGA-GV-A3JV,,,,,,,,Bladder,Locoregional (Urothelial tumor event),,,,,,,22,,,,,,,,,,,,,2011,134,,,,Stage IV,,,,,,,,Partial Remission/Response,,,,,,66.0,,,,,,,,,,,,,,,,,,,,91735,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-50-5066,Black or African American,LUAD,,1,1,,University of Pittsburgh,1,0,MALE,1,2.06,0.27,3,5,6,,,1442,,477,1442,,1,1,477,477,,Malignant,14,,27,,,,16028,,,477,477,,,,477,1442,,,477,,,,,,,,TUMOR FREE,Alive,-26385,,,,337,,477,477,,,[Not Available],[Not Applicable],,,,,0.53,,,,,9,,1,0.52495,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5066,,,,,,,1442,,Distant Metastasis,,,,,,,38,,,,,,,,,,,,,2009,477,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,91742,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,0.17835506,LUAD,Adenocarcinoma,,,Adenocarcinoma,,,1.6158,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,,0,0,0,Female,TCGA-60-2720,White,LUSC,,0,0,,Roswell Park,,0,FEMALE,0,1.75,0.33,5,7,7,,,97,,,97,,0,0,97,97,,Malignant,19,,18,,,,18836,,,97,97,,,,,97,,,97,,,,,,,,TUMOR FREE,Alive,-22238,,,,539,,97,97,,,[Not Available],[Not Applicable],,,,,0.31,,,,,11,,0,0.4016,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2720,,,,,,,97,,,,,,,,,14,,,,,,,,,,,,,2007,,,,,Stage IB,,,,,,,,[Not Available],,,,,,60,,,,,,,,,,,,,,,,,,,,91745,,0.528624311,,,,,,,,,,0.214242439,,0.108052567,,,,Stage IB,,0.528,,,,,,,,,,,,,,,,0.8076,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.18699821833699,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.1205,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-2A-A8VV,,PRAD,389,0,0,,2A,,0,MALE,0,1.99,0.84,0,0,0,HRP,NO,671,1-ERG,,671,,0,0,671,671,prad_tcga,Malignant,0,,22,,TCGA-2A-A8VV-01,6,5228,0,TCGA-2A-A8VV,671,671,Prostate Cancer,204,560,,671,TCGA,No Evidence of Extraprostatic Extension,671,Primary,0,Apex|Middle,A,,,True,TUMOR FREE,Alive,-19065,,52,6,32,PRAD,671,671,,0.186713199,[Not Available],[Not Applicable],26,R0,1,Matched,0.04,Prostate,Resection,3,CCADED36-56B9-471B-8348-094B33634EEB,0,Equivocal,0,0.011447,[Not Available],75A7AFB5-66D5-47E3-8A8A-3E3A1E749A96,3,Prostate Adenocarcinoma Acinar Type,,Prostate,0,,Acinar Adenocarcinoma,[Not Available],,2A,0.866666666667,TCGA-2A-A8VV,0:DiseaseFree,1,3,Prostate Adenocarcinoma,22.04,3/29/14,671,,,,,YES,C61,E42BC148-77A7-4FEB-9ACE-8BC2FFD33BF7,140,0,TUMOR FREE,0.0092,0:LIVING,0.05,4,22.04,Right,12,No Evidence of Extraprostatic Extension,29,YES,1155,2010,,,TCGA-2A-A8VV.E42BC148-77A7-4FEB-9ACE-8BC2FFD33BF7.pdf,Peripheral Zone,[Not Applicable],YES,167,31-40%,16,Prostate Adenocarcinoma Acinar Type,1,2010,[Not Available],,NO,No,R0,,52,Core needle biopsy,,,NO,YES,YES,NO,T2b,NO,6,No,NO,0,N0,T2b,0,M0,C61.9,8140/3,91747,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Female,TCGA-77-8140,Unknown,LUSC,,0,0,,Prince Charles Hospital,,,FEMALE,2,1.81,0.53,10,6,15,,,351,,,351,,2,2,351,351,,Malignant,31,,43,,,,25425,,,351,351,,,,,351,,,351,,,,,,,,,Dead,-24415,351,,,481,,351,351,,,[Not Available],[Not Applicable],,,,,0.05,,,,,13,,0,0.37258,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8140,,,,,,,,,,,,,,,,14,,,,,,,,,,,,,2003,,,,,Stage IIB,,,,,,,,[Not Applicable],,,,,,66,,,,,,,,,,,,,,,,,,,,91750,,0.222019761,,,,,,,,,,0.112450636,,0.060363475,,,,Stage IIB,,-0.326,,,,,,,,,,,,,,,,0.1328,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,13.44742585,13.71941631,12.78050436,-0.810112288354363,LUSC,Squamous Cell Carcinoma,17.8722748,15.34820052,Squamous Cell Carcinoma,-1.3117,12.34736176,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-KB-A93J,White,STAD,,0,0,,,0,0,,0,1.69,0.73,17,20,9,,,1124,,1124,1124,,0,0,1124,1124,,Malignant,46,,150,,,,26073,,,1124,1124,,,,1124,1124,,,1124,,,,,,,,,Alive,-28599,,,,219,,1124,1124,,,[Not Available],[Not Applicable],,,,,0.16,Stomach,Unknown,,,5,,0,0.32214,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,"University Health Network, Toronto",,TCGA-KB-A93J,,,,,,,1124,,,,,,,,,12,,,,,,,,,,,,,2008,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,91751,,0.821894757,,,,,,,,,,0.126179656,Grade 3,0.045712687,,,,Stage II,,1.2275,,,,,,,,,,,,,,,,-0.136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-KB-A93J,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,0,0,0,0,0,Female,TCGA-55-1595,Asian,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,3.63,0.52,3,16,15,,,1479,,1479,1479,,0,0,1479,1479,,Malignant,34,,20,,,,18816,,,1479,1479,,,,1479,1479,,,1479,,,,,,,,TUMOR FREE,Alive,,,,,443,,1479,1479,,,[Not Available],[Not Applicable],,,,,0.52,,,,,21,,1,0.12327,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-1595,,,,,,,1479,,,,,,,,,35,,,,,,,,,,,,,2004,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,91754,,1.035024916,,,,,,,,,,0.215385011,,0.187864601,,,,Stage IA,,0.9995,,,,,,,,,,,,,,,,0.3226,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.229655652,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.793,,0.3149,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0.0,,0,0.0,0.0,Female,TCGA-E5-A2PC,White,BLCA,,0.0,0,,,,0,FEMALE,0.0,3.44,0.79,7,6,9,,,1326,,,1326,,0.0,0,1326.0,1326.0,,Malignant,22,,45,,,,31879.0,,,1326.0,1326,,,,,1326,,,1326.0,,,,,,,,TUMOR FREE,Alive,-22308,,,,332.0,,1326.0,1326,,,[Not Available],[Not Applicable],,,,,0.12,,,,,22,,1,0.22211,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Roswell Park,,TCGA-E5-A2PC,,,,,,,1326,,,,,,,,,18,,,,,,,,,,,,,2008,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,61.0,,,,,,,,,,,,,,,,,,,,91760,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-D7-8574,White,STAD,,0,0,,,0,0,,0,2.04,0.13,0,2,1,,,523,,523,523,,0,0,523,523,,Malignant,3,,15,,,,33969,,,523,523,,,,523,523,,,523,,,,,,,,TUMOR FREE,Alive,-26586,,,,43,,523,523,,,[Not Available],[Not Applicable],,,,,0.11,Stomach,Unknown,,,0,,0,0.056574,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-8574,,,,,,,523,,,,,,,,,3,,,,,,,,,,,,,2012,,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,72,,,,,,,,,,,,,,,,,,,,91767,,1.645341585,,,,,,,,,,0.121291143,Grade 3,0.168694704,,,,Stage IIIA,,0.944,,,,,,,,,,,,,,,,0.3207,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-8574,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,2.95,0.21,12,13,17,,,612,BRCA_Basal,305,612,,1,1,305,305,,Invasive Carcinoma,42,,29,,,,25011,0,,305,305,,,,305,612,,,305,,,,,,,,WITH TUMOR,Alive,-19035,,,,99,,305,305,,,[Not Available],[Not Applicable],,,,,0.51,Breast,Resection/Excision,,,18,,1,0.38495,Peri (6-12 months since last menstrual period),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A243,,,,,,,612,Bone,Distant Metastasis,,,,,,,26,,,,,,,,,,,,,2011,305,,,,Stage IIA,,,,,,,,[Not Available],,,,,,52,,,,,,,,,,,,,,,,,,,,91771,,1.947148768,0,0,0,1,-0.5361,0,,,Infiltrating Ductal Carcinoma,0.276724209,,0.137955636,0,0,0,,Negative,1.436,,10/21/22,0,0,0,0,0,0,0,0,0,1,no,0,0,0.0516,1,0,H & E,0,0,,0,Hua Guo,"Columnar Lesion, UDH",0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Solid, High Grade), No Detail Present",,"DCIS (Solid, High Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Columnar Lesion, UDH",0,0,0,0,0,0,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,1,1,1,1,Female,TCGA-HJ-7597,White,STAD,,1,1,,,1,1,,1,,,,,,,,805,,231,805,,1,1,231,231,,Malignant,,,,,,,31302,,,231,231,,,,231,805,,,231,,,,,,,,WITH TUMOR,Dead,-26264,805,,,1072,,231,231,,,Stomach Cancer,[Not Applicable],,,,,,Stomach,Unknown,,,,,,,[Not Available],,,"Stomach Adenocarcinoma, Signet Ring Type",,,,,Diffuse Gastric Carcinoma,G3,,Fox Chase,,TCGA-HJ-7597,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2005,231,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,91774,,,,,,,,,,,,,Grade 3,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HJ-7597,Gastric Carcinoma,TCGA,Signet Ring Cell Carcinoma
0,0,0,0,0,0,Male,TCGA-V1-A8WL,,PRAD,389,0,0,,V1,0,0,MALE,0,1.96,0.69,2,2,3,HRP,NO,1948,8-other,1948,1948,,0,0,1948,1948,prad_tcga,Malignant,7,,34,,TCGA-V1-A8WL-01,0,5564,0,TCGA-V1-A8WL,1948,1948,Prostate Cancer,,1175,1948,1948,TCGA,,1948,Primary,0,Apex,A,,,True,,Alive,-23725,,64,7,39,PRAD,1948,1948,,0.0,[Not Available],[Not Applicable],28,,1,Matched,0.04,Prostate,Resection,3,2913B17A-D36B-43D4-9ADA-9AAA6B3249EC,1,,0,0.039,[Not Available],F7FC3F2E-C70E-460D-B34D-BB2EA423A0AE,4,Prostate Adenocarcinoma Acinar Type,,Prostate,6,,Acinar Adenocarcinoma,[Not Available],,V1,0.933333333333,TCGA-V1-A8WL,0:DiseaseFree,2,6,Prostate Adenocarcinoma,63.99,7/23/14,1948,,,,,NO,C61,6E301400-1200-40F7-8249-AD310C44A212,90,1,,0.0359,0:LIVING,0.015,,63.99,Bilateral,7,,,YES,,,,,TCGA-V1-A8WL.6E301400-1200-40F7-8249-AD310C44A212.pdf,Peripheral Zone,[Not Applicable],NO,,86-95%,4,Prostate Adenocarcinoma Acinar Type,1,,Complete Remission/Response,,NO,No,R0,,64,Core needle biopsy,,,NO,YES,YES,NO,T3a,NO,7,No,NO,,N0,T1c,0,M0,C61.9,8140/3,91775,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,1,0,1,1,Male,TCGA-BR-8380,White,STAD,,1,1,,,1,0,,1,2.0,0.26,1,1,1,,,21,,467,21,,1,1,467,467,,Malignant,3,,5,,,,20405,,,467,467,,,,467,21,,,467,,,,,,,,WITH TUMOR,Alive,-20157,,,,88,,467,467,,,[Not Available],[Not Applicable],,,,,0.12,Stomach,Unknown,,,0,,0,0.060642,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-8380,,,,,,,21,,Locoregional Recurrence,,,,,,,2,,,,,,,,,,,,,2012,467,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,55,,,,,,,,,,,,,,,,,,,,91781,,-0.224296833,,,,,,,,,,0.086329703,Grade 3,0.157432563,,,,Stage IIIC,,-0.187,,,,,,,,,,,,,,,,0.5422,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-8380,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,1,0,1,1,,,White,BRCA,,1,1,,,1,0,FEMALE,1,3.27,0.38,2,2,5,,,1613,BRCA_LumA,1066,1613,,1,1,1066,1066,,Invasive Carcinoma,9,,10,,,,16611,0,,1066,1066,,,,1066,1613,,,1066,,,,,,,,WITH TUMOR,Alive,-22642,,,,213,,1066,1066,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,15,,1,0.17943,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,MSKCC,,TCGA-AO-A0J9,,,,,,,1613,Bone,Distant Metastasis,,,,,,,26,,,,,,,,,,,,,2007,1066,,,,Stage IIIC,,,,,,,,[Not Available],,,,,,61,,,,,,,,,,,,,,,,,,,,91782,,0.827984626,0,0,0,0,0.2108,1,,,Infiltrating Lobular Carcinoma,0.221456156,,0.296206988,0,0,0,,Negative,-0.2605,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4104,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Male,TCGA-G9-6351,White,PRAD,161,0,0,,G9,0,0,MALE,0,1.96,0.33,2,2,0,ambiguous,NO,2048,1-ERG,2048,2048,,0,0,2048,2048,prad_tcga,Malignant,4,,7,6.8,TCGA-G9-6351-01,0,5358,0,TCGA-G9-6351,2048,2048,Prostate Cancer,,1215,2048,2048,TCGA,,2048,Primary,0,Apex,A,,,,TUMOR FREE,Alive,-18723,,51,7,24,PRAD,2048,2048,WHITE,0.0,[Not Available],[Not Applicable],25,R1,1,Matched,0.02,Prostate,Resection,3,92436584-12d6-4cf2-9ab1-cdf98e4e8260,0,Normal (no evidence of prostate cancer) [cM0],0,0.035305,[Not Available],f59b9c65-46e8-4cc3-aa71-8844f6c2273c,4,Prostate Adenocarcinoma Acinar Type,0.6,Prostate,4,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.53333333333,TCGA-G9-6351,0:DiseaseFree,2,19,Prostate Adenocarcinoma,67.28,3/14/12,2048,,,,,NO,C61,7942304b-0a3d-492c-bbb2-65695f1958e4,,1,TUMOR FREE,0.0335,0:LIVING,0.03,,67.28,Bilateral,22,No Evidence of Extraprostatic Extension,11,YES,,2008,,,TCGA-G9-6351.7942304b-0a3d-492c-bbb2-65695f1958e4.pdf,,[Not Applicable],YES,8,36-45%,,Prostate Adenocarcinoma Acinar Type,1,2008,Complete Remission/Response,,NO,No,R1,0.3,51,Core needle biopsy,,,NO,YES,NO,,T2c,,7,No,,0,,T1c,,M0,C61.9,8550/3,91783,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-77-8138,Unknown,LUSC,,1,1,,Prince Charles Hospital,,1,MALE,1,,,,,,,,539,,,539,,1,1,289,289,,Malignant,,,,,,,27697,,,289,289,,,,,539,,,289,,,,,,,,WITH TUMOR,Dead,-27225,539,,,129,,289,289,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-8138,,,,,,,,,Locoregional Recurrence,,,,,,,,,,,,,,,,,,,,2003,289,,,,Stage IB,,,,,,,,[Not Applicable],,,,,,74,,,,,,,,,,,,,,,,,,,,91785,,,,,,,,,,,,,,,,,,Stage IB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.418045900212849,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,1.1416,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,,,,BRCA,,0,0,,,0,0,FEMALE,0,1.97,0.52,6,6,8,,,608,BRCA_LumA,608,608,,0,0,608,608,,Invasive Carcinoma,20,,47,,,,21520,0,,608,608,,,,608,608,,,608,,,,,,,,TUMOR FREE,Alive,-29800,,,,0,,608,608,,,[Not Available],[Not Applicable],,,,,0.01,Breast,Resection/Excision,,,5,,0,0.1579,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Indivumed,,TCGA-A8-A07E,,,,,,,608,,,,,,,,,7,,,,,,,,,,,,,2008,,,,,Stage X,,,,,,,,[Not Available],,,,,,81,,,,,,,,,,,,,,,,,,,,91791,,0.526767519,0,0,0,0,0.2071,1,,,Infiltrating Ductal Carcinoma,0.157386039,,0.295748693,0,0,0,,Negative,-0.1285,,10/21/22,0,0,0,1,0,0,0,0,0,0,no,0,0,0.7209,0,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Suboptimal,0,Breast,Suboptimal,0,0,0,0,0,FFPE,,0,1,1,Yes,0,"Benign Breast Epithelium, Skin",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-33-4583,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,3.48,0.52,7,3,9,,,4601,,4601,4601,,2,2,4601,4601,,Malignant,19,,31,,,,19840,,,4601,4601,,,,4601,4601,,,4601,,,,,,,,TUMOR FREE,Dead,-26799,4601,,,795,,4601,4601,,,[Not Available],[Not Applicable],,,,,0.21,,,,,23,,1,0.35817,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4583,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,1999,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,91792,,,,,,,,,,,,,,,,,,Stage IA,,,,,,,,,,,,,,,,,,-0.2166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.36115343149994,LUSC,,,,Squamous Cell Carcinoma,-1.9662,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-G9-7525,,PRAD,,0,0,,G9,0,0,MALE,0,3.98,0.62,1,2,2,HRP,NO,994,,994,994,,0,0,994,994,prad_tcga,Malignant,5,,74,,TCGA-G9-7525-01,0,5393,0,TCGA-G9-7525,994,994,Prostate Cancer,,512,994,994,TCGA,,994,Primary,0,Base,A,,,,TUMOR FREE,Alive,-23481,,64,7,43,PRAD,994,994,,0.0,[Not Available],[Not Applicable],48,,1,Matched,0.0,Prostate,Resection,4,bd13998c-d615-4af6-9eab-b59fad85f31f,0,Normal (no evidence of prostate cancer) [cM0],1,0.031145,[Not Available],f4e17ba1-f14f-480e-8fe3-415909fc320a,3,Prostate Adenocarcinoma Acinar Type,1.8,Prostate,5,,Acinar Adenocarcinoma,[Not Available],0.4,G9,1.6,TCGA-G9-7525,0:DiseaseFree,3,8,Prostate Adenocarcinoma,32.65,5/31/12,994,,,,,NO,C61,837a5284-61ec-4a13-9743-010fc6a8df6a,,2,TUMOR FREE,0.0583,0:LIVING,0.03,,32.65,Bilateral,11,No Evidence of Extraprostatic Extension,12,YES,,2010,,,TCGA-G9-7525.837a5284-61ec-4a13-9743-010fc6a8df6a.pdf,,[Not Applicable],YES,12,,6,Prostate Adenocarcinoma Acinar Type,1,2010,Complete Remission/Response,,NO,No,R0,0.9,64,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T2c,NO,7,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,91795,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,1.0,1.0,Female,TCGA-H4-A2HQ,Black or African American,BLCA,,1.0,1,,,,0,FEMALE,1.0,4.57,0.8,7,9,20,,,590,,,590,,1.0,1,318.0,318.0,,Malignant,36,,38,,,,31780.0,,,318.0,318,,,,,590,,,318.0,,,,,,,,WITH TUMOR,Alive,-23538,,,,618.0,,318.0,318,,,[Not Available],[Not Applicable],,,,,0.34,,,,,22,,2,0.20329,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Medical College of Georgia,,TCGA-H4-A2HQ,,,,,,,590,Lung,Distant Metastasis,,,,,,,61,,,,,,,,,,,,,2010,318,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,64.0,,,,,,,,,,,,,,,,,,,,91797,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,,,White,BRCA,,0,0,,,,0,FEMALE,0,3.19,0.55,2,8,5,,,530,BRCA_LumA,,530,,0,0,530,530,,Invasive Carcinoma,15,,12,,,,27823,0,,530,530,,,,,530,,,530,,,,,,,,TUMOR FREE,Alive,-28876,,,,115,,530,530,,,[Not Available],[Not Applicable],,,,,0.06,Breast,Resection/Excision,,,18,,1,0.057031,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,International Genomics Consortium,,TCGA-AC-A62Y,,,,,,,530,,,,,,,,,23,,,,,,,,,,,,,2012,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,79,,,,,,,,,,,,,,,,,,,,91798,,-0.314596644,0,1,0,0,1.2458,0,,,Infiltrating Lobular Carcinoma,0.20620952,,0.171925773,0,0,0,,Positive,-0.9555,,10/21/22,0,0,0,0,0,0,0,0,0,0,No,0,0,0.1418,1,0,H & E,0,0,,0,Hua Guo,ALH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,0,No,0,Adipose Tissue,No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,ALH,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-R5-A7ZI,White,STAD,,0,0,,,,0,,0,2.27,0.37,1,3,1,,,2267,,,2267,,0,0,2267,2267,,Malignant,5,,52,,,,26890,,,2267,2267,,,,,2267,,,2267,,,,,,,,TUMOR FREE,Alive,-16396,,,,1177,,2267,2267,,,[Not Available],[Not Applicable],,,,,0.02,Stomach,Unknown,,,14,,0,0.13055,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,MD Anderson Cancer Center,,TCGA-R5-A7ZI,,,,,,,2267,,,,,,,,,13,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,44,,,,,,,,,,,,,,,,,,,,91800,,1.304554923,,,,,,,,,,0.107253172,Grade 3,0.049788326,,,,Stage IV,,1.95,,,,,,,,,,,,,,,,-0.3826,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-R5-A7ZI,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,0,,0,1,,,White,BRCA,,0,0,,,2,,FEMALE,2,3.62,0.76,1,1,2,,,1148,BRCA_LumA,1148,1148,,2,2,1148,1148,,Invasive Carcinoma,4,,14,,,,16567,0,,1148,1148,,,,1148,1148,,,1148,,,,,,,,,Dead,-32404,1148,,,49,,1148,1148,,,[Not Available],[Not Applicable],,,,,0.02,Breast,Resection/Excision,,,20,,1,0.027625,[Not Available],,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A18N,,,,,,,,,,,,,,,,19,,,,,,,,,,,,,2001,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,88,,,,,,,,,,,,,,,,,,,,91802,,-1.000472788,0,0,0,0,-1.0785,1,,,Infiltrating Ductal Carcinoma,0.124637761,,0.179659313,0,0,0,,Negative,-1.8635,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.0332,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,0,0,1,Male,TCGA-33-4583,White,LUSC,,0,0,,Johns Hopkins,2,2,MALE,2,3.48,0.52,7,3,9,,,4601,,4601,4601,,2,2,4601,4601,,Malignant,19,,31,,,,19840,,,4601,4601,,,,4601,4601,,,4601,,,,,,,,TUMOR FREE,Dead,-26799,4601,,,795,,4601,4601,,,[Not Available],[Not Applicable],,,,,0.21,,,,,23,,1,0.35817,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Johns Hopkins,,TCGA-33-4583,,,,,,,,,,,,,,,,25,,,,,,,,,,,,,1999,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,73,,,,,,,,,,,,,,,,,,,,91810,,0.662495597,,,,,,,,,,0.122846392,,-0.005045769,,,,Stage IA,,1.331,,,,,,,,,,,,,,,,-0.2166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.36115343149994,LUSC,,,,Squamous Cell Carcinoma,,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-HC-7744,White,PRAD,184,0,0,,HC,0,0,MALE,0,1.98,0.81,1,2,0,HRD,NO,531,1-ERG,531,531,,0,0,531,531,prad_tcga,Malignant,3,BARD1;BRCA1;CDK12;RAD51D,43,4.4,TCGA-HC-7744-01,8,5422,0,TCGA-HC-7744,531,531,Prostate Cancer,42,282,531,531,TCGA,Extraprostatic Extension Localized (e.g. seminal vesicles),531,Primary,0,Apex|Middle|Base,A,,RAD51C,,TUMOR FREE,Alive,-17065,,46,7,31,PRAD,531,531,WHITE,0.23562957,[Not Available],[Not Applicable],43,R1,1,Matched,0.06,Prostate,Resection,4,41e0d8f7-e104-43c4-b3bb-fd0b5cb3c7b2,0,Normal (no evidence of prostate cancer) [cM0],0,0.018255,[Not Available],f6381367-142c-45d0-92b3-c1727d1813ce,3,Prostate Adenocarcinoma Acinar Type,1.0,Prostate,3,NOT HISPANIC OR LATINO,Acinar Adenocarcinoma,[Not Available],0.3,HC,1.43333333333,TCGA-HC-7744,0:DiseaseFree,3,3,Prostate Adenocarcinoma,17.44,4/11/12,531,,,,,YES,C61,01b8c2af-bdf8-4627-bf6e-c7a41d929b94,,0,WITH TUMOR,0.0174,0:LIVING,0.04,,17.44,Bilateral,5,,40,YES,,2011,,,TCGA-HC-7744.01b8c2af-bdf8-4627-bf6e-c7a41d929b94.pdf,,[Not Applicable],YES,10,81-90%,8,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.6,46,Core needle biopsy,,,YES,NO,YES,,T3b,,7,No,,0,N0,,0,M0,C61.9,8550/3,91812,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.47,0.49,11,20,18,,,200,BRCA_LumA,200,200,,0,0,200,200,,Invasive Carcinoma,49,,81,,,,18438,0,,200,200,,,,200,200,,,200,,,,,,,,TUMOR FREE,Alive,-25119,,,,190,,200,200,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,14,,1,0.3013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Asterand,,TCGA-E9-A1RF,,,,,,,200,,,,,,,,,30,,,,,,,,,,,,,2011,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,91814,,0.879936321,0,0,0,1,-0.4633,0,,,Infiltrating Ductal Carcinoma,0.188183961,,0.147739203,0,0,0,,Negative,0.636,,10/21/22,0,0,0,0,0,0,0,0,0,0,Please indicate which (if any) of the following types of benign breast disease are present * I think there should be a category with unremarkable breast parenchyma,0,0,0.4595,0,0,H & E,0,0,,0,Hua Guo,UDH,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,Benign Breast Epithelium,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,UDH,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Female,TCGA-D7-A748,White,STAD,,1,1,,,,1,,1,2.08,0.15,2,4,5,,,132,,,132,,1,1,99,99,,Malignant,11,,11,,,,33926,,,99,99,,,,,132,,,99,,,,,,,,WITH TUMOR,Dead,-15190,132,,,53,,99,99,,,Stomach Cancer,[Not Applicable],,,,,0.09,Stomach,Unknown,,,2,,0,0.035919,[Not Available],,,"Stomach, Adenocarcinoma, Diffuse Type",,,,,Diffuse Gastric Carcinoma,G3,,Greater Poland Cancer Center,,TCGA-D7-A748,,,,,,,,,Locoregional Recurrence|Distant Metastasis,,,,,,,4,,,,,,,,,,,,,2013,99,,,,Stage IV,,,,,,,,Progressive Disease,,,,,,41,,,,,,,,,,,,,,,,,,,,91815,,0.21345077,,,,,,,,,,0.196762962,Grade 3,0.177762141,,,,Stage IV,,0.3205,,,,,,,,,,,,,,,,0.6146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-D7-A748,Gastric Carcinoma,TCGA,"Adenocarcinoma, Diffuse Type"
0,1,,1,1,1,Male,TCGA-ZR-A9CJ,White,ESCA,,1,1,,,,1,,1,3.48,0.33,12,16,22,,,600,,,600,,1,1,163,163,,Malignant,50,,92,,,,31171,,,163,163,,,,,600,,,163,,,,,,,,WITH TUMOR,Dead,-23752,600,,,209,,163,163,,,[Not Available],[Not Available],,,,,0.29,Esophagus,Unknown,,,13,,1,0.28573,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Tayside Tissue Bank,,TCGA-ZR-A9CJ,,,,,,,,Liver,Distant Metastasis,,,,,,,32,,,,,,,,,,,,,2012,163,,,,Stage IIIC,,,,,,,,[Unknown],,,,,,65,,,,,,,,,,,,,,,,,,,,91820,,,,,,,,,,,,,Grade 3,,,,,Stage IIIC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,Female,TCGA-KB-A6F7,Unknown,STAD,,0,0,,,0,0,,0,1.85,0.62,6,3,7,,,1935,,1935,1935,,0,0,1935,1935,,Malignant,16,,122,,,,27410,,,1935,1935,,,,1935,1935,,,1935,,,,,,,,TUMOR FREE,Alive,-19765,,,,142,,1935,1935,,,[Not Available],[Not Applicable],,,,,0.61,Stomach,Unknown,,,8,,0,0.31007,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,"University Health Network, Toronto",,TCGA-KB-A6F7,,,,,,,1935,,,,,,,,,14,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,54,,,,,,,,,,,,,,,,,,,,91822,,0.941155121,,,,,,,,,,0.094196135,Grade 3,0.023929571,,,,Stage IB,,0.718,,,,,,,,,,,,,,,,-0.1556,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-KB-A6F7,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.7,0.63,9,10,20,,,702,BRCA_LumA,702,702,,0,0,702,702,,Invasive Carcinoma,39,,147,,,,16200,0,,702,702,,,,702,702,,,702,,,,,,,,TUMOR FREE,Alive,-23972,,,,100,,702,702,,,[Not Available],[Not Applicable],,,,,0.19,Breast,Resection/Excision,,,17,,1,0.2765,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,University of Pittsburgh,,TCGA-BH-A0H7,,,,,,,702,,,,,,,,,34,,,,,,,,,,,,,2008,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,65,,,,,,,,,,,,,,,,,,,,91826,,0.457640102,0,0,0,0,0.9166,1,,,Infiltrating Ductal Carcinoma,0.150779643,,0.140527083,0,0,0,,Negative,-0.9015,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.6474,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,0,0,0.0,0.0,Female,TCGA-DK-A6AV,Asian,BLCA,,0.0,0,,,0,0,FEMALE,0.0,3.09,0.5,11,8,16,,,1952,,1952,1952,,0.0,0,1952.0,1952.0,,Malignant,35,,115,,,,24703.0,,,1952.0,1952,,,,1952,1952,,,1952.0,,,,,,,,TUMOR FREE,Alive,-30089,,,,172.0,,1952.0,1952,,,[Not Available],[Not Applicable],,,,,0.07,,,,,25,,1,0.32362,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,Memorial Sloan Kettering,,TCGA-DK-A6AV,,,,,,,1952,,,,,,,,,25,,,,,,,,,,,,,2008,,,,,Stage II,,,,,,,,Complete Remission/Response,,,,,,82.0,,,,,,,,,,,,,,,,,,,,91829,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1.0,0,0,0.0,1.0,Female,TCGA-BT-A2LB,White,BLCA,,0.0,0,,,2,2,FEMALE,2.0,3.02,0.5,6,7,10,,,492,,492,492,,2.0,2,492.0,492.0,,Malignant,23,,32,,,,22499.0,,,492.0,492,,,,492,492,,,492.0,,,,,,,,TUMOR FREE,Dead,-26846,492,,,859.0,,492.0,492,,,[Not Available],[Not Applicable],,,,,0.13,,,,,22,,1,0.23333,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Pittsburgh,,TCGA-BT-A2LB,,,,,,,,,,,,,,,,27,,,,,,,,,,,,,2010,,,,,Stage III,,,,,,,,Complete Remission/Response,,,,,,73.0,,,,,,,,,,,,,,,,,,,,91831,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-55-8203,White,LUAD,,0,0,,International Genomics Consortium,0,0,FEMALE,0,3.67,0.38,4,4,7,,,547,,547,547,,0,0,547,547,,Malignant,15,,17,,,,34061,,,547,547,,,,547,547,,,547,,,,,,,,TUMOR FREE,Alive,-25477,,,,555,,547,547,,,[Not Available],[Not Applicable],,,,,0.22,,,,,15,,1,0.12126,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,International Genomics Consortium,,TCGA-55-8203,,,,,,,547,,,,,,,,,20,,,,,,,,,,,,,2011,,,,,Stage IA,,,,,,,,Complete Remission/Response,,,,,,69,,,,,,,,,,,,,,,,,,,,91838,,1.231460441,,,,,,,,,,0.214762205,,0.140113022,,,,Stage IA,,1.1055,,,,,,,,,,,,,,,,0.1186,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,,,,-0.142434736,LUAD,Adenocarcinoma,,,Adenocarcinoma,0.3566,,0.5751,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,1,,1,1,Male,TCGA-77-6844,White,LUSC,,1,,,Prince Charles Hospital,1,,MALE,1,1.96,0.66,10,6,14,,,2284,,1788,2284,,1,,1788,1788,,Malignant,30,,22,,,,27287,,,1788,,,,,1788,2284,,,1788,,,,,,,,,Dead,-27220,2284,,,263,,1788,,,,[Not Available],[Not Applicable],,,,,0.03,,,,,11,,0,0.26053,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Prince Charles Hospital,,TCGA-77-6844,,,,,,,,,,,,,,,,13,,,,,,,,,,,,,2002,1788,,,,Stage IIIA,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,91839,,0.563501653,,,,,,,,,,0.127158417,,0.088335349,,,,Stage IIIA,,0.7875,,,,,,,,,,,,,,,,0.0999,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.28012313,15.60582976,14.92711185,-0.560248113152975,LUSC,Squamous Cell Carcinoma,17.6275718,15.7034455,Squamous Cell Carcinoma,-1.4927,12.68176044,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,,1,1,1,Male,TCGA-56-7579,White,LUSC,,1,1,,International Genomics Consortium,,1,MALE,1,1.99,0.66,16,15,18,,,951,,,951,,1,1,149,149,,Malignant,49,,49,,,,16489,,,149,149,,,,,951,,,149,,,,,,,,WITH TUMOR,Dead,-22632,951,,,333,,149,149,,,[Not Available],[Not Applicable],,,,,0.19,,,,,10,,0,0.30058,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,International Genomics Consortium,,TCGA-56-7579,,,,,,,,,Locoregional Recurrence,,,,,,,16,,,,,,,,,,,,,2011,149,,,,Stage IIIA,,,,,,,,Progressive Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,91843,,-0.592467554,,,,,,,,,,0.185997181,,0.093093178,,,,Stage IIIA,,-1.024,,,,,,,,,,,,,,,,0.2621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.97692735,16.10871969,13.15606242,-0.935980057577478,LUSC,Squamous Cell Carcinoma,17.67477312,12.91327444,Squamous Cell Carcinoma,-0.1891,14.72826517,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-37-5819,White,LUSC,,0,0,,Cureline,,0,MALE,0,2.94,0.71,13,23,27,,,103,,,103,,0,0,103,103,,Malignant,63,,128,,,,18414,,,103,103,,,,,103,,,103,,,,,,,,TUMOR FREE,Alive,-23726,,,,981,,103,103,,,[Not Available],[Not Applicable],,,,,0.25,,,,,17,,1,0.543,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Cureline,,TCGA-37-5819,,,,,,,103,,,,,,,,,31,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,64,,,,,,,,,,,,,,,,,,,,91845,,0.748848875,,,,,,,,,,0.150094651,,0.114694717,,,,Stage IIIA,,0.314,,,,,,,,,,,,,,,,-0.2029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,14.63101421,14.76093314,15.75763081,-0.413044419510076,LUSC,Squamous Cell Carcinoma,18.17125985,15.59508316,Squamous Cell Carcinoma,-0.0565,12.38540918,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,,0,0,0,Male,TCGA-91-A4BC,White,LUAD,,0,0,,ABS - IUPUI,,0,MALE,0,2.55,0.22,12,22,18,,,44,,,44,,0,0,44,44,,Malignant,52,,116,,,,29358,,,44,44,,,,,44,,,44,,,,,,,,,Alive,-21565,,,,588,,44,44,,,[Not Available],[Not Applicable],,,,,0.39,,,,,21,,1,0.49372,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,ABS - IUPUI,,TCGA-91-A4BC,,,,,,,44,,,,,,,,,41,,,,,,,,,,,,,2012,,,,,Stage IIA,,,,,,,,[Unknown],,,,,,59,,,,,,,,,,,,,,,,,,,,91847,,1.739024492,,,,,,,,,,0.213535526,,0.178282583,,,,Stage IIA,,1.6915,,,,,,,,,,,,,,,,0.4409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.55730299,17.14734177,18.29335297,0.202955806,LUAD,Adenocarcinoma,18.30878222,17.87739616,Adenocarcinoma,1.226,10.99412148,2.5347,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.14,0.72,2,1,4,,,4354,BRCA_LumA,4354,4354,,0,0,4354,4354,,Invasive Carcinoma,7,,3,,,,31829,0,,4354,4354,,,,4354,4354,,,4354,,,,,,,,TUMOR FREE,Alive,-24155,,,,63,,4354,4354,,,[Not Available],[Not Applicable],,,,,0.04,Breast,Resection/Excision,,,3,,0,0.026798,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Walter Reed,,TCGA-A2-A04N,,,,,,,4354,,,,,,,,,5,,,,,,,,,,,,,2002,,,,,Stage IA,,,,,,,,[Not Available],,,,,,66,,,,,,,,,,,,,,,,,,,,91852,,-0.195542245,0,0,0,0,0.4635,1,,,Infiltrating Ductal Carcinoma,0.140729548,,0.160224647,0,0,0,,Negative,-0.8935,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,0.4959,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,1,No,0,"Adipose Tissue, Benign Breast Epithelium",N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (Micropapillary),Invasive Ductal Carcinoma (Micropapillary),0,None,0,0,0,0,0,1,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-NJ-A55O,White,LUAD,,0,0,,Washington University - Rush University,,0,FEMALE,0,,,,,,,,13,,,13,,0,0,13,13,,Malignant,,,,,,,20055,,,13,13,,,,,13,,,13,,,,,,,,TUMOR FREE,Alive,-20628,,,,180,,13,13,,,[Not Available],[Not Applicable],,,,,,,,,,,,,,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Washington University - Rush University,,TCGA-NJ-A55O,,,,,,,13,,,,,,,,,,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,56,,,,,,,,,,,,,,,,,,,,91855,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,-0.0532,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,G12C (driver),,1,,G12C (driver),,16.08142001,17.53116178,15.17730178,-0.299303858,LUAD,Adenocarcinoma,18.13721051,15.32601287,Adenocarcinoma,-1.4567,13.87729219,-0.7672,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1,,0,0,1,Female,TCGA-6A-AB49,Black or African American,LUSC,,0,0,,University of Kansas,,2,FEMALE,2,2.91,0.69,10,14,21,,,,,,,,2,2,,,,Malignant,45,,238,,,,24209,,,,,,,,,,,,,,,,,,,,TUMOR FREE,Dead,,,,,516,,,,,,[Not Available],[Not Applicable],,,,,0.1,,,,,16,,1,0.50641,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,University of Kansas,,TCGA-6A-AB49,,,,,,,,,,,,,,,,35,,,,,,,,,,,,,2009,,,,,Stage IB,,,,,,,,Progressive Disease,,,,,,73,,,,,,,,,,,,,,,,,,,,91860,,0.057980316,,,,,,,,,,0.069342383,,-0.090876638,,,,Stage IB,,0.5645,,,,,,,,,,,,,,,,-0.0484,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.833614507041612,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.6826,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0.0,,0,1.0,1.0,Male,TCGA-ZF-A9R1,White,BLCA,,1.0,1,,,,0,MALE,1.0,1.88,0.64,8,12,8,,,773,,,773,,1.0,1,758.0,758.0,,Malignant,28,,82,,,,25577.0,,,758.0,758,,,,,773,,,758.0,,,,,,,,WITH TUMOR,Alive,-29610,,,,136.0,,758.0,758,,,[Not Available],[Not Applicable],,,,,0.05,,,,,11,,0,0.24011,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,University of Sheffield,,TCGA-ZF-A9R1,,,,,,,773,Bone,Distant Metastasis,,,,,,,9,,,,,,,,,,,,,2013,758,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,81.0,,,,,,,,,,,,,,,,,,,,91862,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,,0,1,Female,TCGA-22-4599,White,LUSC,,0,0,,Mayo Clinic - Rochester,,,FEMALE,2,3.27,0.47,12,4,17,,,1161,,,1161,,2,2,1161,1161,,Malignant,33,,23,,,,19311,,,1161,1161,,,,,1161,,,1161,,,,,,,,,Dead,-26925,1161,,,479,,1161,1161,,,[Not Available],[Not Applicable],,,,,0.2,,,,,26,,1,0.48648,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-4599,,,,,,,1161,,,,,,,,,31,,,,,,,,,,,,,2002,,,,,Stage IB,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,91864,,1.236562352,,,,,,,,,,0.265441012,,0.06339922,,,,Stage IB,,1.4515,,,,,,,,,,,,,,,,0.1469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,V155F (driver),1,,,V155F (driver),,,,0.157462250096319,LUSC,,,,Squamous Cell Carcinoma,0.2861,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,0,0,0,0,Male,TCGA-66-2783,,LUSC,,0,0,,Indivumed,0,0,MALE,0,2.05,0.57,11,8,13,,,759,,759,759,,0,0,759,759,,Malignant,32,,88,,,,16470,,,759,759,,,,759,759,,,759,,,,,,,,TUMOR FREE,Alive,-24686,,,,327,,759,759,,,[Not Available],[Not Applicable],,,,,0.06,,,,,9,,0,0.29707,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Indivumed,,TCGA-66-2783,,,,,,,759,,,,,,,,,19,,,,,,,,,,,,,2008,,,,,Stage IIIB,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,91868,,0.411578954,,,,,,,,,,0.186433951,,0.074134267,,,,Stage IIIB,,1.2595,,,,,,,,,,,,,,,,0.2593,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,15.14197395,15.9596835,14.72720344,-0.373085894065026,LUSC,Squamous Cell Carcinoma,17.93341142,15.78152806,Squamous Cell Carcinoma,-0.16,13.20313942,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-22-5474,White,LUSC,,0,0,,Mayo Clinic - Rochester,2,2,MALE,2,1.92,0.55,6,4,8,,,445,,445,445,,2,2,445,445,,Malignant,18,,36,,,,28338,,,445,445,,,,445,445,,,445,,,,,,,,TUMOR FREE,Dead,-27271,445,,,117,,445,445,,,[Not Available],[Not Applicable],,,,,0.41,,,,,8,,0,0.45988,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-5474,,,,,,,445,,,,,,,,,21,,,,,,,,,,,,,2005,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,74,,,,,,,,,,,,,,,,,,,,91869,,1.500780343,,,,,,,,,,0.225969612,,0.090694963,,,,Stage IB,,2.4935,,,,,,,,,,,,,,,,0.2274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,0.166282055545821,LUSC,,,,Squamous Cell Carcinoma,-0.3469,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,0,1,0,1,1,Male,TCGA-BR-6707,White,STAD,,1,1,,,1,0,,1,2.13,0.53,1,1,1,,,491,,426,491,,1,1,426,426,,Malignant,3,,3,,,,17496,,,426,426,,,,426,491,,,426,,,,,,,,WITH TUMOR,Alive,-27529,,,,87,,426,426,,,[Not Available],[Not Applicable],,,,,0.05,Stomach,Unknown,,,8,,0,0.087327,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6707,,,,,,,491,,Locoregional Recurrence,,,,,,,5,,,,,,,,,,,,,2011,426,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,75,,,,,,,,,,,,,,,,,,,,91870,,0.666853521,,,,,,,,,,0.115349963,Grade 3,0.074125331,,,,Stage IIA,,1.251,,,,,,,,,,,,,,,,-0.1421,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6707,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,3.46,0.34,7,0,5,,,488,BRCA_LumA,488,488,,0,0,488,488,,Invasive Carcinoma,12,,63,,,,24771,0,,488,488,,,,488,488,,,488,,,,,,,,TUMOR FREE,Alive,-25000,,,,278,,488,488,,,[Not Available],[Not Applicable],,,,,0.0,Breast,Resection/Excision,,,28,,1,0.17952,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Spectrum Health,,TCGA-XX-A89A,,,,,,,488,,,,,,,,,13,,,,,,,,,,,,,2013,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,68,,,,,,,,,,,,,,,,,,,,91871,,0.937786933,0,0,0,0,-0.0349,1,,,Infiltrating Lobular Carcinoma,0.219230811,,0.250784159,0,0,0,,Negative,0.486,,10/21/22,0,0,0,0,0,0,0,0,0,0,E-Cadherin can confirm,0,0,0.7057,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,No,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"DCIS (Cribriform, Intermediate Grade), No Detail Present",,"DCIS (Cribriform, Intermediate Grade)",0,Invasive Lobular Carcinoma (Classical/Pleomorphic),Invasive Lobular Carcinoma (Classical/Pleomorphic),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,0,1,0,1,Male,TCGA-HU-A4GQ,Asian,STAD,,0,0,,,2,1,,2,2.18,0.55,0,2,2,,,3,,3,3,,2,2,3,3,,Malignant,4,,15,,,,19993,,,3,3,,,,3,3,,,3,,,,,,,,[Discrepancy],Dead,-26200,3,,,2603,,3,3,,,Stomach Cancer,[Not Applicable],,,,,0.0,Stomach,Unknown,,,6,,0,0.000757,[Not Available],,,"Stomach, Intestinal Adenocarcinoma, Tubular Type",,,,,Intestinal Gastric Carcinoma,G2,,National Cancer Center Korea,,TCGA-HU-A4GQ,,,,,,,,,,,,,,,,4,,,,,,,,,,,,,2011,,,,,Stage IIIC,,,,,,,,Complete Remission/Response,,,,,,71,,,,,,,,,,,,,,,,,,,,91872,,0.111600944,,,,,,,,,,0.100764286,Grade 2,0.051304269,,,,Stage IIIC,,0.5765,,,,,,,,,,,,,,,,0.2257,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-HU-A4GQ,Gastric Carcinoma,TCGA,"Adenocarcinoma, Tubular Type"
0,0,0,0,0,0,Male,TCGA-G9-7523,,PRAD,221,0,0,,G9,0,0,MALE,0,1.84,0.21,0,0,0,HRP,NO,857,7-IDH1,857,857,,0,0,857,857,prad_tcga,Malignant,0,PALB2;RAD51B,10,11.3,TCGA-G9-7523-01,5,5391,0,TCGA-G9-7523,857,857,Prostate Cancer,,324,857,857,TCGA,,857,Primary,0,Apex|Base,A,,,,TUMOR FREE,Alive,-16269,,44,10,17,PRAD,857,857,,0.259445228,[Not Available],[Not Applicable],50,R1,1,Matched,0.16,Prostate,Resection,5,01dee5bc-b28d-4251-8875-b0acb02a1000,6,Abnormal (not related to prostate cancer),0,0.16225,[Not Available],93e78f4c-e74b-4675-8d2c-d641fa25d8f2,5,Prostate Adenocarcinoma Acinar Type,1.4,Prostate,0,,Acinar Adenocarcinoma,[Not Available],0.3,G9,1.63333333333,TCGA-G9-7523,0:DiseaseFree,5,0,Prostate Adenocarcinoma,28.15,5/31/12,857,,,,,NO,C61,8a16d779-bcf3-4371-87ec-3cd68330b1d6,,4,TUMOR FREE,0.0001,0:LIVING,0.03,,28.15,Bilateral,3,No Evidence of Extraprostatic Extension,20,YES,,2011,,,TCGA-G9-7523.8a16d779-bcf3-4371-87ec-3cd68330b1d6.pdf,,[Not Applicable],YES,20,21-30%,10,Prostate Adenocarcinoma Acinar Type,1,2011,Complete Remission/Response,,NO,No,R1,0.8,44,Core needle biopsy,,Complete Remission/Response,NO,YES,YES,NO,T3a,NO,10,No,NO,0,N0,T1c,0,M0,C61.9,8550/3,91874,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,4.12,0.69,5,8,12,,,358,BRCA_LumB,358,358,,0,0,358,358,,Invasive Carcinoma,25,,62,,,,27120,1,,358,358,,,,358,358,,,358,,,,,,,,TUMOR FREE,Alive,-25811,,,,97,,358,358,,,[Not Available],[Not Applicable],,,,,0.27,Not Specific/Unknown,Resection/Excision,,,15,,1,0.11173,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,ILSBio,,TCGA-C8-A12M,,,,,,,358,,,,,,,,,25,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,[Not Available],,,,,,70,,,,,,,,,,,,,,,,,,,,91875,,0.612593383,0,0,0,0,-2.8552,1,,,Infiltrating Ductal Carcinoma,0.068911695,,0.225351724,0,0,0,,Negative,-0.242,,10/21/22,0,0,0,0,0,0,0,1,0,0,"uncertain of lobular versus ductal, or invasive carcinoma. E-Cadherin and p63 IHC can help",0,0,-0.3133,0,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Not Specific/Unknown,Optimal,0,0,0,0,0,FFPE,,0,0,0,No,0,None of the Above,No Detail Present,"Other/Uncommon DCIS Subtype (Apocrine, Neuroendocrine, Signet Ring Cell, Clear Cell), No Detail Present",,"Other/Uncommon DCIS Subtype (Apocrine, Neuroendocrine, Signet Ring Cell, Clear Cell)",0,Uncertain if Invasive Disease Present,Uncertain if Invasive Disease Present,0,None,0,0,0,0,0,0,Score 1 (Infrequent mitoses),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-60-2710,White,LUSC,,0,0,,Roswell Park,0,0,FEMALE,0,1.96,0.65,11,6,12,,,2024,,2024,2024,,0,0,2024,2024,,Malignant,29,,25,,,,16967,,,2024,2024,,,,2024,2024,,,2024,,,,,,,,TUMOR FREE,Alive,-24669,,,,275,,2024,2024,,,[Not Available],[Not Applicable],,,,,0.05,,,,,10,,0,0.27527,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Roswell Park,,TCGA-60-2710,,,,,,,2024,,,,,,,,,14,,,,,,,,,,,,,2005,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,67,,,,,,,,,,,,,,,,,,,,91877,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.5657,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,R470C (driver),1,,,R470C (driver),16.10515713,16.69797514,15.87293301,-0.265872076546217,LUSC,Squamous Cell Carcinoma,17.89740119,16.01994068,Squamous Cell Carcinoma,-0.1002,13.47653773,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1,0,0,0,1,Male,TCGA-22-1016,White,LUSC,,0,0,,Mayo Clinic - Rochester,2,2,MALE,2,2.58,0.33,10,8,16,,,822,,822,822,,2,2,822,822,,Malignant,34,,32,,,,22416,,,822,822,,,,822,822,,,822,,,,,,,,TUMOR FREE,Dead,-24078,822,,,473,,822,822,,,[Not Available],[Not Applicable],,,,,0.36,,,,,18,,1,0.48556,[Not Available],,,Lung Squamous Cell Carcinoma,,,,,Squamous Cell Carcinoma,[Not Available],,Mayo Clinic - Rochester,,TCGA-22-1016,,,,,,,802,,,,,,,,,34,,,,,,,,,,,,,2001,,,,,Stage IB,,,,,,,,Complete Remission/Response,,,,,,65,,,,,,,,,,,,,,,,,,,,91881,,0.445341573,,,,,,,,,,0.27266615,,0.230371874,,,,Stage IB,,0.765,,,,,,,,,,,,,,,,0.6383,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.47066729086547,LUSC,Squamous Cell Carcinoma,,,Squamous Cell Carcinoma,0.4907,,,N/A (Not Adenocarcinoma),Unknown SCC Subtype,,,,
0,1.0,,1,1.0,1.0,Male,TCGA-G2-A3IE,White,BLCA,,1.0,1,,,,1,MALE,1.0,1.94,0.69,11,16,14,,,612,,,612,,1.0,1,612.0,612.0,,Malignant,41,,36,,,,24722.0,,,612.0,612,,,,,612,,,612.0,,,,,,,,WITH TUMOR,Dead,-18983,612,,,506.0,,612.0,612,,,[Not Available],[Not Applicable],,,,,0.38,,,,,4,,0,0.19016,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,MD Anderson,,TCGA-G2-A3IE,,,,,,,,,,,,,,,,8,,,,,,,,,,,,,2007,,,,,Stage II,,,,,,,,Progressive Disease,,,,,,51.0,,,,,,,,,,,,,,,,,,,,91886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Female,TCGA-73-4666,White,LUAD,,0,0,,Roswell Park,,0,FEMALE,0,3.2,0.45,6,3,8,,,800,,,800,,0,0,800,800,,Malignant,17,,20,,,,19231,,,800,800,,,,,800,,,800,,,,,,,,TUMOR FREE,Alive,-19074,,,,508,,800,800,,,[Not Available],[Not Applicable],,,,,0.28,,,,,20,,1,0.30609,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Roswell Park,,TCGA-73-4666,,,,,,,800,,,,,,,,,31,,,,,,,,,,,,,2009,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,52,,,,,,,,,,,,,,,,,,,,91887,,1.485413067,,,,,,,,,,0.254898595,,0.075388281,,,,Stage IV,,2.7085,,,,,,,,,,,,,,,,-0.0069,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,G603W,1,,,G603W,17.35359075,18.59600592,18.77964536,0.138440185,LUAD,Adenocarcinoma,17.83877289,16.8029827,Adenocarcinoma,-0.4888,12.5396659,1.5004,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,Female,TCGA-BR-6452,White,STAD,,0,0,,,0,0,,0,2.11,0.47,0,0,0,,,1055,,1055,1055,,0,0,1055,1055,,Malignant,0,,19,,,,20067,,,1055,1055,,,,1055,1055,,,1055,,,,,,,,TUMOR FREE,Alive,-28827,,,,8188,,1055,1055,,,[Not Available],[Not Applicable],,,,,0.12,Stomach,Unknown,,,2,,0,7.73e-05,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G3,,Asterand,,TCGA-BR-6452,,,,,,,1055,,,,,,,,,2,,,,,,,,,,,,,2011,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,78,,,,,,,,,,,,,,,,,,,,91890,,0.779317942,,,,,,,,,,0.112218421,Grade 3,0.036575495,,,,Stage IIA,,1.1125,,,,,,,,,,,,,,,,0.286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-BR-6452,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,2.16,0.77,4,0,5,,,1150,BRCA_LumA,1150,1150,,0,0,1150,1150,,Invasive Carcinoma,9,,9,,,,18270,0,,1150,1150,,,,1150,1150,,,1150,,,,,,,,TUMOR FREE,Alive,-20028,,,,48,,1150,1150,,,[Not Available],[Not Applicable],,,,,0.15,Breast,Resection/Excision,,,6,,0,0.06908,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Mayo,,TCGA-AR-A1AS,,,,,,,1150,,,,,,,,,10,,,,,,,,,,,,,2007,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,54,,,,,,,,,,,,,,,,,,,,91896,,-1.306568268,0,0,0,0,0.2021,1,,,Infiltrating Ductal Carcinoma,0.148088176,,0.042869856,0,0,0,,Negative,-2.194,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.3775,1,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,0,Yes,0,Adipose Tissue,No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,,,Asian,BRCA,,0,0,,,0,0,FEMALE,0,3.79,0.69,4,5,8,,,317,BRCA_LumB,317,317,,0,0,317,317,,Invasive Carcinoma,17,,23,,,,21176,0,,317,317,,,,317,317,,,317,,,,,,,,TUMOR FREE,Alive,,,,,42,,317,317,,,[Not Available],[Not Applicable],,,,,0.03,Breast,Resection/Excision,,,11,,1,0.1031,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,"Other, specify",,,,,,[Not Available],,ILSBio,,TCGA-C8-A1HL,,,,,,,317,,,,,,,,,11,,,,,,,,,,,,,2010,,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,38,,,,,,,,,,,,,,,,,,,,91897,,-0.510193759,0,0,0,0,0.832,1,,,Other,0.138972159,,0.280902371,0,0,0,,Negative,-2.0975,,10/21/22,0,0,0,0,0,0,0,0,0,0,na,0,0,0.2817,1,0,H & E,0,0,,0,Naziheh Assarzadegan,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,1,0,No,0,Adipose Tissue,N/A No in Situ,None,,None,0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,None,0,0,0,0,0,1,Score 3 (High mitotic index),"Score 3 (High grade): >2x size of benign epithelial nucleus, vesicular chromatin, markedly pleomorphic, often prominent nucleoli",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,Score 2 (10-75% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-CU-A3QU,White,BLCA,,0.0,0,,,,0,MALE,0.0,3.6,0.9,14,10,14,,,158,,,158,,0.0,0,158.0,158.0,,Malignant,38,,95,,,,16885.0,,,158.0,158,,,,,158,,,158.0,,,,,,,,TUMOR FREE,Alive,-21233,,,,159.0,,158.0,158,,,[Not Available],[Not Applicable],,,,,0.18,,,,,12,,1,0.2914,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,,,TCGA-CU-A3QU,,,,,,,158,,,,,,,,,21,,,,,,,,,,,,,2011,,,,,Stage IV,,,,,,,,Complete Remission/Response,,,,,,58.0,,,,,,,,,,,,,,,,,,,,91900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,,,White,BRCA,,1,1,,,,0,FEMALE,1,,,,,,,,849,,,849,,1,1,681,681,,Invasive Carcinoma,,,,,,,28416,0,,681,681,,,,,849,,,681,,,,,,,,WITH TUMOR,Alive,-26883,,,,0,,681,681,,,[Not Available],[Not Applicable],,,,,,Breast,Resection/Excision,,,,,,,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Lobular Carcinoma,,,,,,[Not Available],,Gundersen Lutheran Health System,,TCGA-LQ-A4E4,,,,,,,849,Bone,Distant Metastasis,,,,,,,,,,,,,,,,,,,,2011,681,,,,Stage IIIA,,,,,,,,[Not Available],,,,,,73,,,,,,,,,,,,,,,,,,,,91901,,-1.315167237,0,0,0,0,0.4546,1,,,Infiltrating Lobular Carcinoma,0.108266463,,0.118440956,0,0,0,,Positive,-1.6575,,10/21/22,0,0,0,0,0,0,0,0,0,0,no,0,0,-0.0618,1,0,H & E,0,0,,0,Whitney Wedel,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,1,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",No Detail Present,"LCIS, No Detail Present",,LCIS,0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,1,1,Female,TCGA-50-5942,White,LUAD,,1,1,,University of Pittsburgh,,0,FEMALE,1,1.95,0.69,2,0,2,,,1847,,,1847,,1,1,1378,1378,,Malignant,4,,3,,,,33093,,,1378,1378,,,,,1847,,,1378,,,,,,,,WITH TUMOR,Alive,-24781,,,,78,,1378,1378,,,[Not Available],[Not Applicable],,,,,0.0,,,,,2,,0,0.050984,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,University of Pittsburgh,,TCGA-50-5942,,,,,,,1847,,Locoregional Recurrence,,,,,,,2,,,,,,,,,,,,,2009,1378,,,,Stage IA,,,,,,,,Stable Disease,,,,,,67,,,,,,,,,,,,,,,,,,,,91902,,0.499925421,,,,,,,,,,0.183393238,,0.186853745,,,,Stage IA,,0.1815,,,,,,,,,,,,,,,,0.187,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,,,,-0.338014612,LUAD,Adenocarcinoma,,,Adenocarcinoma,-0.5628,,0.0783,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,1.0,,1,1.0,1.0,Male,TCGA-GC-A3I6,White,BLCA,,1.0,1,,,,1,MALE,1.0,2.46,0.73,4,0,4,,,630,,,630,,1.0,1,546.0,546.0,,Malignant,8,,12,,,,26629.0,,,546.0,546,,,,,630,,,546.0,,,,,,,,WITH TUMOR,Dead,-16504,630,,,258.0,,546.0,546,,,[Not Available],[Not Applicable],,,,,0.29,,,,,15,,1,0.10594,[Not Available],,,Muscle invasive urothelial carcinoma (pT2 or above),,,,,Urothelial Carcinoma,High Grade,,International Genomics Consortium,,TCGA-GC-A3I6,,,,,,,,Bladder,Locoregional (Urothelial tumor event),,,,,,,34,,,,,,,,,,,,,2011,546,,,,Stage III,,,,,,,,Progressive Disease,,,,,,45.0,,,,,,,,,,,,,,,,,,,,91906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,,,,,,,,,,,,,,,,,,,,,,
0,1,,1,1,1,Male,TCGA-2H-A9GO,Unknown,ESCA,,1,1,,,,1,,1,1.55,0.56,16,8,12,,,494,,,494,,1,1,362,362,,Malignant,36,,229,,,,20902,,,362,362,,,,,494,,,362,,,,,,,,WITH TUMOR,Dead,-21486,494,,,249,,362,362,,,[Not Available],[Not Available],,,,,0.67,Esophagus,Unknown,,,9,,0,0.64555,[Not Available],,,"Esophagus Adenocarcinoma, NOS",,,,,"Adenocarcinoma, NOS",G3,,Erasmus MC,,TCGA-2H-A9GO,,,,,,,,,Locoregional Recurrence,,,,,,,24,,,,,,,,,,,,,2000,362,,,,Stage IVA,,,,,,,,,,,,,,58,,,,,,,,,,,,,,,,,,,,91907,,,,,,,,,,,,,Grade 3,,,,,Stage IVA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ESCA,,,,,,,,,,,,,"Esophagus Adenocarcinoma, NOS"
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.08,0.74,2,5,4,,,172,BRCA_LumB,172,172,,0,0,172,172,,Invasive Carcinoma,11,,12,,,,25875,0,,172,172,,,,172,172,,,172,,,,,,,,TUMOR FREE,Alive,-11929,,,,34,,172,172,,,[Not Available],[Not Applicable],,,,,0.05,Breast,Resection/Excision,,,3,,0,0.06326,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Cureline,,TCGA-AN-A0FF,,,,,,,172,,,,,,,,,6,,,,,,,,,,,,,2010,,,,,Stage IA,,,,,,,,[Not Available],,,,,,32,,,,,,,,,,,,,,,,,,,,91908,,0.484549745,0,0,0,0,0.2502,1,,,Infiltrating Ductal Carcinoma,0.154244162,,0.175213375,0,0,0,,Negative,-0.235,,10/21/22,0,0,0,0,0,0,0,0,0,0,N/A,0,0,0.4341,0,0,H & E,0,0,,0,Guofeng Gao,None,0,0,0,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,Benign Breast Epithelium,No Detail Present,"DCIS (Solid, Intermediate Grade), No Detail Present",,"DCIS (Solid, Intermediate Grade)",0,Invasive Carcinoma (Mixed Ductal-Lobular Features),Invasive Carcinoma (Mixed Ductal-Lobular Features),0,None,0,0,0,0,0,0,Score 2 (Intermediate mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,,0,0,0,Male,TCGA-X4-A8KQ,,PRAD,,0,0,,X4,,0,MALE,0,1.98,0.57,5,6,6,ambiguous,NO,1383,,,1383,,0,0,1383,1383,prad_tcga,Malignant,17,BRCA1;BRIP1;CDK12;RAD51C;RAD51D;RAD54L,47,,TCGA-X4-A8KQ-01,0,5609,0,TCGA-X4-A8KQ,1383,1383,Prostate Cancer,,963,,1383,TCGA,,1383,Primary,0,,A,,,True,WITH TUMOR,Alive,-23999,,65,9,57,PRAD,1383,1383,,0.0,[Not Available],[Not Applicable],40,,1,Matched,0.03,Prostate,Resection,4,13705117-87CB-40D8-BF8A-ED91AEA397A0,5,,0,0.096434,[Not Available],56353D9C-9578-4D62-9DCD-92D800EFDEA0,5,Prostate Adenocarcinoma Acinar Type,,Prostate,18,,Acinar Adenocarcinoma,[Not Available],,X4,1.33333333333,TCGA-X4-A8KQ,0:DiseaseFree,5,17,Prostate Adenocarcinoma,45.43,3/7/14,1383,,,,,NO,C61,978B4E1F-FDA4-41FA-8341-ED6E851168A6,250,7,TUMOR FREE,0.1748,0:LIVING,0.25,,45.43,Right,19,,,YES,1078,2010,,,TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf,Peripheral Zone,[Not Applicable],NO,,,3,Prostate Adenocarcinoma Acinar Type,1,2010,Progressive Disease,,NO,No,RX,,65,Core needle biopsy,,Progressive Disease,NO,YES,YES,NO,T3b,YES,9,No,YES,0,N0,T1c,0,M0,C61.9,8140/3,91910,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0,0,0,0,0,Female,TCGA-49-6744,White,LUAD,,0,0,,Johns Hopkins,0,0,FEMALE,0,1.9,0.37,9,8,9,,,1683,,1683,1683,,0,0,1683,1683,,Malignant,26,,24,,,,19681,,,1683,1683,,,,1683,1683,,,1683,,,,,,,,TUMOR FREE,Alive,-23484,,,,273,,1683,1683,,,[Not Available],[Not Applicable],,,,,0.57,,,,,4,,0,0.16693,[Not Available],,,Lung Adenocarcinoma,,,,,Adenocarcinoma,[Not Available],,Johns Hopkins,,TCGA-49-6744,,,,,,,1683,,,,,,,,,10,,,,,,,,,,,,,2010,,,,,Stage IIA,,,,,,,,Complete Remission/Response,,,,,,64,,,,,,,,,,,,,,,,,,,,91912,,,,,,,,,,,,,,,,,,Stage IIA,,,,,,,,,,,,,,,,,,0.5446,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nan,,,,0,,,,16.81227495,17.88169462,15.96454625,0.112267588,LUAD,,18.26810023,16.55309108,Adenocarcinoma,,14.17567917,,Unknown Adenocarcinoma Subtype,N/A (Not Squamous Cell Carcinoma),,,,
0,0,0,0,0,0,,,White,BRCA,,0,0,,,0,0,FEMALE,0,2.62,0.48,12,15,15,,,2329,BRCA_Basal,2329,2329,,0,0,2329,2329,,Invasive Carcinoma,42,,86,,,,18815,0,,2329,2329,,,,2329,2329,,,2329,,,,,,,,TUMOR FREE,Alive,-23230,,,,83,,2329,2329,,,[Not Available],[Not Applicable],,,,,0.14,Breast,Resection/Excision,,,18,,1,0.3898,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Infiltrating Ductal Carcinoma,,,,,,[Not Available],,Roswell Park,,TCGA-E2-A1AZ,,,,,,,2329,,,,,,,,,34,,,,,,,,,,,,,2004,,,,,Stage IIB,,,,,,,,[Not Available],,,,,,63,,,,,,,,,,,,,,,,,,,,91916,,1.563429702,0,0,1,0,-0.6281,0,,,Infiltrating Ductal Carcinoma,0.185224087,,0.191911201,0,0,0,,Negative,0.9725,,10/21/22,0,0,0,0,0,0,0,0,0,1,N/A,0,0,0.3672,1,0,H & E,0,0,,0,Guofeng Gao,"Apocrine Metaplasia, Columnar Lesion, FEA, Sclerosing Adenosis",0,1,1,Optimal,0,0,Resection/Excision,Optimal,0,Breast,Optimal,0,0,0,0,0,FFPE,,0,0,1,Yes,0,"Adipose Tissue, Benign Breast Epithelium",Comedonecrosis,"DCIS (Solid, Intermediate Grade), Comedonecrosis",,"DCIS (Solid, Intermediate Grade)",0,Invasive Ductal Carcinoma (No Special Type),Invasive Ductal Carcinoma (No Special Type),0,"Apocrine Metaplasia, Columnar Lesion, FEA, Sclerosing Adenosis",0,0,0,0,0,0,Score 3 (High mitotic index),"Score 2 (Intermediate grade): Nuclei 1.5-2x benign epithelial cell, mild/mod pleomorphism, visible small nucleoli)",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,Score 3 (<10% of cancer forms tubules with polarized epithelium),0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,
0,0.0,,0,0.0,0.0,Male,TCGA-MX-A666,White,STAD,,0.0,0,,,,0,,0.0,2.97,0.38,11,17,20,,,427,,,427,,0.0,0,427,427,,Malignant,48,,166,,,,22079.0,0,,427,427,,,,,427,,,427,,,,,,,,TUMOR FREE,Alive,-22288,,,,146.0,,427,427,,,[Not Available],[Not Applicable],,,,,0.41,Stomach,Biopsy,,,14,,1,0.44822,[Not Available],,,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",,,,,Intestinal Gastric Carcinoma,G2,,MSKCC,,TCGA-MX-A666,,,,,,,427,,,,,,,,,37,,,,,,,,,,,,,2013,,,,,Stage IIA,,,,,,,,Stable Disease,,,,,,61,,,,,,,,,,,,,,,,,,,,91920,,0.369755935,,,,,,,,,,0.051502481,Grade 2,0.099296782,,,,Stage IIA,,0.3175,,,,,,,,,,,,,,,,-0.0132,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,STAD,,,,,,,,,,TCGA-MX-A666,Gastric Carcinoma,TCGA,"Adenocarcinoma, NOS"
